TY  - JOUR
TI  - Gambling disorder
T2  - Nature Reviews Disease Primers
J2  - Nat. Rev. Disease Prim.
VL  - 5
IS  - 1
PY  - 2019
DO  - 10.1038/s41572-019-0099-7
SN  - 2056676X (ISSN) 
AU  - Potenza, M.N.
AU  - Balodis, I.M.
AU  - Derevensky, J.
AU  - Grant, J.E.
AU  - Petry, N.M.
AU  - Verdejo-Garcia, A.
AU  - Yip, S.W.
AD  - Department of Psychiatry, Yale School of Medicine, New Haven, CT, United States
AD  - Department of Neuroscience, Yale University, New Haven, CT, United States
AD  - Child Study Center, Yale School of Medicine, New Haven, CT, United States
AD  - Connecticut Mental Health Center, New Haven, CT, United States
AD  - Connecticut Council on Problem Gambling, Wethersfield, CT, United States
AD  - Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neuroscience, McMaster University, Hamilton, ON, Canada
AD  - Department of Educational and Counselling Psychology, McGill University, Montreal, QC, Canada
AD  - Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, IL, United States
AD  - Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, United States
AD  - Turner Institute for Brain and Mental Health, Monash University, Melbourne, VIC, Australia
AB  - Gambling disorder is characterized by a persistent, recurrent pattern of gambling that is associated with substantial distress or impairment. The prevalence of gambling disorder has been estimated at 0.5% of the adult population in the United States, with comparable or slightly higher estimates in other countries. The aetiology of gambling disorder is complex, with implicated genetic and environmental factors. Neurobiological studies have implicated cortico-striato-limbic structures and circuits in the pathophysiology of this disorder. Individuals with gambling disorder often go unrecognized and untreated, including within clinical settings. Gambling disorder frequently co-occurs with other conditions, particularly other psychiatric disorders. Behavioural interventions, particularly cognitive-behavioural therapy but also motivational interviewing and Gamblers Anonymous, are supported in the treatment of gambling disorder. No pharmacological therapy has a formal indication for the treatment of gambling disorder, although placebo-controlled trials suggest that some medications, such as opioid-receptor antagonists, may be helpful. Given the associations with poor quality of life and suicide, improved identification, prevention, policy and treatment efforts are needed to help people with gambling disorder. © 2019, Springer Nature Limited.
KW  - glutamatergic drug
KW  - glutamic acid derivative
KW  - monoamine derivative
KW  - monoaminergic drug
KW  - opiate antagonist
KW  - unclassified drug
KW  - amygdala
KW  - Article
KW  - cognitive behavioral therapy
KW  - cognitive therapy
KW  - comorbidity
KW  - corpus striatum
KW  - demography
KW  - dopaminergic system
KW  - heritability
KW  - hippocampus
KW  - human
KW  - insula
KW  - molecular genetics
KW  - neurobiology
KW  - pathological gambling
KW  - pathophysiology
KW  - prevalence
KW  - priority journal
KW  - quality of life
KW  - risk factor
KW  - screening test
PB  - Nature Publishing Group
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C7  - 51
C2  - 31346179
LA  - English
N1  - Correspondence Address: Potenza, M.N.; Department of Psychiatry, Yale School of MedicineUnited States; email: marc.potenza@yale.edu
N1  - Funding details: Connecticut Mental Health Center Foundation, CMHCF
N1  - Funding details: National Center for Responsible Gaming, NCRG
N1  - Funding details: State of Connecticut Department of Mental Health and Addiction Services, DMHAS
N1  - Funding details: National Institutes of Health, NIH
N1  - Funding details: Ohio Department of Mental Health and Addiction Services, OhioMHAS
N1  - Funding details: Gambling Research Exchange Ontario, GREO
N1  - Funding details: MRF1141214
N1  - Funding details: Gambling Research Exchange Ontario, GREO
N1  - Funding details: National Center for Responsible Gaming, NCRG
N1  - Funding details: National Institutes of Health, NIH
N1  - Funding details: State of Connecticut Department of Mental Health and Addiction Services, DMHAS
N1  - Funding details: Jazz Pharmaceuticals
N1  - Funding details: Shire
N1  - Funding text 1: The research for and preparation of this report was supported in part by grants R01 DA039136, K01DA039299 and R21 DA042900 from the National Institutes of Health; the Connecticut State Department of Mental Health and Addiction Services; the Connecticut Mental Health Center; the Connecticut Council on Problem Gambling; and a Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming. This work was also partially supported by the Peter Boris Centre for Addictions Research and Gambling Research Exchange of Ontario. This work was also partially supported by a Career Development Fellowship of the Australian Medical Research Future Fund (MRF1141214). A.V.-G. is supported by a Career Development Fellowship of the Australian Medical Research Future Fund (MRF1141214). The funding agencies did not provide input or comment on the content of the manuscript, and the content of the manuscript reflects the contributions and thoughts of the authors and does not necessarily reflect the views of the funding agencies.
N1  - Funding text 2: The authors report no conflicts of interest with respect to the content of this manuscript. M.N.P. has consulted for and advised Shire, INSYS, RiverMend Health, Addiction Policy Forum, Game Day Data, the National Council on Problem Gambling, Opiant/Lightlake Therapeutics and Jazz Pharmaceuticals; has received unrestricted research support from Mohegan Sun Casino and grant support from the National Center for Responsible Gaming; has participated in surveys, mailings or telephone consultations related to drug addiction, impulse control disorders or other health topics; has consulted for and advised legal and gambling entities on issues related to addictions and impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has edited journals and journal sections; has given academic lectures in grand rounds, Continuing Medical Education events and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. S.W.Y. is on the Board of Directors for the Connecticut Council on Problem Gambling and has received funding support from the National Center for Responsible Gaming. N.M.P. served on the American Psychiatric Association Workgroup for the DSM-5, for which travel costs were covered but she received no compensation. N.M.P. also wrote a report for the National Gambling Trust, has reviewed grants for NIH and other agencies, and has served as an expert for legal cases related to gambling and impulse control disorders. I.M.B. has received funding from the National Center for Responsible Gaming and from the Gambling Research Exchange of Ontario. The other authors report no disclosures.
N1  - References: Potenza, M.N., Kosten, T.R., Rounsaville, B.J., Pathological gambling (2001) JAMA, 286, pp. 141-144. , COI: 1:STN:280:DC%2BD3MvgslCguw%3D%3D; 
Blum, A.W., Grant, J.E., Behavioral addictions and criminal responsibility (2017) J. Am. Acad. Psychiatry Law, 45, pp. 464-471. , PID: 29282238; 
Easton, T., Newell, S., Are daily fantasy sports gambling? J (2019) Sports Analytics, 5, pp. 35-43; 
Marchica, L., Derevensky, J., Fantasy sports: a growing concern among college student-athletes (2016) Int. J. Ment. Health Addict., 14, pp. 635-645; 
Bailey, J.M., (2018) A Video Game ‘loot box’ Offers Coveted Rewards, but is It Gambling, , https://www.nytimes.com/2018/04/24/business/loot-boxes-video-games.html, New York Times; 
King, D.L., Delfabbro, P.H., Predatory monetization schemes in video games (for example, ‘loot boxes’) and internet gaming disorder (2018) Addiction, 113, pp. 1967-1969; 
Gainsbury, S., (2012) Internet Gambling: Current Research Findings and Implications, , Springer Science & Business Media; 
Rodenberg, R., United States of sports betting: An updated map of where every state stands (2019) ESPN, , http://www.espn.com/chalk/story/_/id/19740480/gambling-sports-betting-bill-tracker-all-50-states; 
(2013) Diagnostic and Statistical Manual of Mental Disorders 5Th Edn, , American Psychiatric Association; 
(1994) Diagnostic and Statistical Manual of Mental Disorders 4Th Edn, , American Psychiatric Association; 
Weinstock, J., April, L.M., Kallmi, S., Is subclinical gambling really subclinical? (2017) Addict. Behav., 73, pp. 185-191; 
Potenza, M.N., Should addictive disorders include non-substance-related conditions? (2006) Addiction, 101, pp. 142-151; 
Potenza, M., Koran, L., Pallanti, S., The relationship between obsessive-compulsive and impulse control disorders: a current understanding and future research directions (2009) Psychiatry Res., 170, pp. 22-31. , PID: 2792582, Together with Ref 12, this article provides a systematic review of domains that provided support for classifying GD as a behavioural addiction; 
(2019), https://icd.who.int/dev11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f1041487064, 6C50 gambling disorder. ICD-11; Custer, R.L., Profile of the pathological gambler (1984) J. Clin. Psychiatry, 45, pp. 35-38. , COI: 1:STN:280:DyaL2M%2FlsVKrug%3D%3D, PID: 6501244; 
Slutske, W.S., Natural recovery and treatment-seeking in pathological gambling: results of two U.S. national surveys (2006) Am. J. Psychiatry, 163, pp. 297-302; 
Gerstein, D.R., (1999) Gambling Impact and Behavior Study: Report to the National Gambling Impact Study Commission, , National Opinion Research Center; 
Dowling, N., Smith, D., Thomas, T., Electronic gaming machines: are they the ‘crack cocaine’ of gambling? (2005) Addiction, 100, pp. 33-45; 
Chambers, R.A., Potenza, M.N., Schizophrenia and pathological gambling (2001) Am. J. Psychiatry, 158, pp. 497-498; 
Yakovenko, I., Fortgang, R., Prentice, J., Hoff, R.A., Potenza, M.N., Correlates of frequent gambling and gambling-related chasing behaviors in individuals with schizophrenia-spectrum disorders (2018) J. Behav. Addict., 7, pp. 375-383. , PID: 6174591; 
Gainsbury, S.M., Russell, A., Wood, R., Hing, N., Blaszczynski, A., How risky is Internet gambling? A comparison of subgroups of Internet gamblers based on problem gambling status (2015) New Media Soc., 17, pp. 861-879; 
Slutske, W.S., Blaszczynski, A., Martin, N.G., Sex differences in the rates of recovery, treatment-seeking, and natural recovery in pathological gambling: results from an Australian community-based twin survey (2009) Twin Res. Hum. Genet., 12, pp. 425-432; 
Shaffer, H., Hall, M.N., Vander Bilt, J., Estimating the prevalence of disordered gambling in the United States and Canada: a research synthesis (1999) Am. J. Publ. Health, 89, pp. 1369-1376. , COI: 1:STN:280:DyaK1MvgtlyjsQ%3D%3D; 
Kessler, R.C., DSM-IV pathological gambling in the National Comorbidity Survey Replication (2008) Psychol. Med., 38, pp. 1351-1360. , COI: 1:STN:280:DC%2BD1cvpsFylsw%3D%3D, PID: 2293303; 
Lorains, F.K., Cowlishaw, S., Thomas, S.A., Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys (2011) Addiction, 106, pp. 490-498; 
Wardle, H., (2011) British Gambling Prevalence Survey 2010, , Her Majesty’s Stationery Office; 
Erbas, B., Buchner, U.G., Pathological gambling: prevalence, diagnosis, comorbidity, and intervention in Germany (2012) Dtsch. Arztebl. Int., 109, pp. 173-179. , PID: 3317374; 
Delfabbro, P., King, D., Gambling in Australia: experiences, problems, research and policy (2012) Addiction, 107, pp. 1556-1561; 
Wong, I.L., So, E.M., Prevalence estimates of problem and pathological gambling in Hong Kong (2003) Am. J. Psychiatry, 160, pp. 1353-1354; 
Calado, F., Griffiths, M.D., Problem gambling worldwide: an update and systematic review of empirical research (2000–2015) (2016) J. Behav. Addict., 5, pp. 592-613. , PID: 5370365; 
Petry, N.M., Blanco, C., Stinchfield, R., Volberg, R., An empirical evaluation of proposed changes for gambling diagnosis in the DSM-5 (2013) Addiction, 108, pp. 575-581; 
Denis, C., Fatseas, M., Auriacombe, M., Analyses related to the development of DSM-5 criteria for substance use related disorders: 3. An assessment of pathological gambling criteria (2012) Drug Alcohol Depend., 122, pp. 22-27; 
Petry, N.M., Blanco, C., Jin, C., Grant, B.F., Concordance between gambling disorder diagnoses in the DSM-IV and DSM-5: results from the National Epidemiological Survey of Alcohol and Related Disorders (2014) Psychol. Addict. Behav., 28, pp. 586-591. , PID: 4669212; 
Shaffer, H., Hall, M.N., Updating and refining prevalence estimates of disordered gambling behavior in the United States and Canada (2001) Can. J. Public Health, 92, pp. 168-172. , COI: 1:STN:280:DC%2BD3MvltFOmsw%3D%3D, PID: 11496623; 
Petry, N.M., Stinson, F.S., Grant, B.F., Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions (2005) J. Clin. Psychiatry, 66, pp. 564-574. , This article provides prevalence estimates for DSM-IV pathological gambling and its co-occurrence with other psychiatric disorders a large, nationally representative population the United States; 
Kessler, R.C., The prevalence and correlates of DSM-IV pathological gambling in the National Comorbidity Survey Replication (2008) Psychol. Med., 38, pp. 1351-1360. , COI: 1:STN:280:DC%2BD1cvpsFylsw%3D%3D, PID: 2293303; 
(2015) Report of Survey on Participation in Gambling Activities among Singapore Residents, 2014, , http://www.ncpg.org.sg/en/pdf/2014%20NCPG%20Gambling%20Participation%20Survey_FINAL.pdf, NCPG; 
Grant, J.E., Levine, L., Kim, D., Potenza, M.N., Impulse control disorders in adult psychiatric populations (2005) Am. J. Psychiatry, 162, pp. 2184-2188; 
Cowlishaw, S., Hakes, J.K., Pathological and problem gambling in substance use treatment: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) (2015) Am. J. Addict., 24, pp. 467-474; 
Bruneau, M., Gambling transitions among adult gamblers: a multi-state model using a Markovian approach applied to the JEU cohort (2016) Addict. Behav., 57, pp. 13-20; 
Grant, J.E., Kim, S.W., Comorbidity of impulse control disorders in pathological gamblers (2003) Acta Psychiatr. Scand., 108, pp. 203-207. , COI: 1:STN:280:DC%2BD3szlslClsQ%3D%3D; 
Weintraub, D., Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients (2010) Arch. Neurol., 67, pp. 589-595. , This article provides prevalence estimates for DSM-IV pathological gambling and other impulse-control disorders/behaviours a large sample of individuals with Parkinson disease; 
Santangelo, G., Barone, P., Trojano, L., Vitale, C., Pathological gambling in Parkinson’s disease. A comprehensive review (2013) Parkinsonism Relat. Disord., 19, pp. 645-653; 
Desai, R., Desai, M., Potenza, M., Gambling, health and age: data from the National Epidemiologic Survey on Alcohol and Related Conditions (2007) Psychol. Addict. Behav., 21, pp. 431-440; 
Black, D.W., Shaw, M., McCormick, B., Allen, J., Pathological gambling: relationship to obesity, self-reported chronic medical conditions, poor lifestyle choices, and impaired quality of life (2013) Compr. Psychiatry, 54, pp. 97-104; 
Yip, S.W., White, M.A., Grilo, C.M., Potenza, M.N., An exploratory study of clinical measures associated with subsyndromal pathological gambling in patients with binge eating disorder (2011) J. Gambl. Stud, 27, pp. 257-270. , PID: 3655332; 
Blanco, C., Hasin, D.S., Petry, N., Stinson, F.S., Grant, B.F., Sex differences in subclinical and DSM-IV pathological gambling: results from the National Epidemiologic Survey on Alcohol and Related Conditions (2006) Psychol. Med., 36, pp. 943-953; 
Worhunsky, P.D., Malison, R.T., Rogers, R.D., Potenza, M.N., Altered neural correlates of reward and loss processing during simulated slot-machine fMRI in pathological gambling and cocaine dependence (2014) Drug Alcohol. Depend., 145, pp. 77-86. , PID: 4266109; 
Yip, S.W., Shared microstructural features of behavioral and substance addictions revealed in areas of crossing fibers (2017) Biol. Psychiatry Cogn. Neurosci. Neuroimaging, 2, pp. 188-195. , PID: 5373810; 
Xian, H., Giddens, J.L., Scherrer, J.F., Eisen, S.A., Potenza, M.N., Environmental factors selectively impact co-occurrence of problem/pathological gambling with specific drug-use disorders in male twins (2014) Addiction, 109, pp. 635-644. , PID: 3951667; 
Welte, J.W., Barnes, G.M., Tidwell, M.O., Wieczorek, W.F., Predictors of problem gambling in the U.S (2017) J. Gambl. Stud., 33, pp. 327-342; 
Calado, F., Alexandre, J., Griffiths, M.D., Prevalence of adolescent problem gambling: a systematic review of recent research (2017) J. Gambl. Stud., 33, pp. 397-424; 
Dowling, N.A., Early risk and protective factors for problem gambling: a systematic review and meta-analysis of longitudinal studies (2017) Clin. Psychol. Rev., 51, pp. 109-124. , COI: 1:STN:280:DC%2BC2snnt1aitA%3D%3D; 
Petry, N.M., Steinberg, K.L., Childhood maltreatment in male and female treatment-seeking pathological gamblers (2005) Psychol. Addict. Behav., 19, pp. 226-229; 
Chambers, R.A., Potenza, M.N., Neurodevelopment, impulsivity, and adolescent gambling (2003) J. Gambl. Stud., 19, pp. 53-84; 
Chambers, R.A., Taylor, J.R., Potenza, M.N., Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability (2003) Am. J. Psychiatry, 160, pp. 1041-1052. , PID: 2919168; 
Potenza, M.N., Gender-related differences in the characteristics of problem gamblers using a gambling helpline (2001) Am. J. Psychiatry, 158, pp. 1500-1505. , COI: 1:STN:280:DC%2BD3MvovFKqtw%3D%3D; 
Valleur, M., Towards a validation of the three pathways model of pathological gambling (2016) J. Gambl. Stud., 32, pp. 757-771; 
Blanco, C., Towards a comprehensive developmental model of pathological gambling (2015) Addiction, 110, pp. 1340-1351. , PID: 4503473; 
Potenza, M.N., The neural bases of cognitive processes in gambling disorder (2014) Trends Cogn. Sci., 18, pp. 429-438. , PID: 4112163; 
Sacco, P., Torres, L.R., Cunningham-Williams, R.M., Woods, C., Unick, G.J., Differential item functioning of pathological gambling criteria: an examination of gender, race/ethnicity, and age (2011) J. Gambl. Stud., 27, pp. 317-330. , PID: 4459593; 
Zakiniaeiz, Y., Cosgrove, K.P., Mazure, C.M., Potenza, M.N., Does telescoping exist in male and female gamblers? Does it matter? (2017) Front. Psychol., 8, p. 1510. , PID: 5591942; 
Sharpe, L., Tarrier, N., Towards a cognitive-behavioral theory of problem gambling (1993) Br. J. Psychiatry, 162, pp. 407-412. , COI: 1:STN:280:DyaK3s3gtFajtg%3D%3D; 
Sharpe, L., A reformulated cognitive-behavioral model of problem gambling: a biopsychosocial perspective (2002) Clin. Psychol. Rev., 22, pp. 1-25; 
Blaszczynski, A., Nower, L., A pathways model of problem and pathological gambling (2002) Addiction, 97, pp. 487-499; 
Mader, J., (2017) An Evaluation of the Pathways Model of Problem Gambling Using the Quinte Longitudinal Dataset Thesis, , Univ. Lethbridge; 
Ladouceur, R., Cognitive treatment of pathological gambling (2001) J. Nerv. Ment. Dis., 189, pp. 774-780. , COI: 1:STN:280:DC%2BD38%2FjsVCktA%3D%3D; 
Clark, L., Studer, B., Bruss, J., Tranel, D., Bechara, A., Damage to insula abolishes cognitive distortions during simulated gambling (2014) Proc. Natl Acad. Sci. USA, 111, pp. 6098-6103. , COI: 1:CAS:528:DC%2BC2cXmtlWru7Y%3D; 
Limbrick-Oldfield, E.H., Neural substrates of cue reactivity and craving in gambling disorder (2017) Transl Psychiatry, 7. , COI: 1:STN:280:DC%2BC1c7hsFGjtw%3D%3D, PID: 5545724; 
Eisen, S., Neuman, R., Goldberg, J., Rice, J., True, W., Determining zygosity in the Vietnam Era Twin Registry: an approach using questionnaires (1989) Clin. Genet., 35, pp. 423-432. , COI: 1:STN:280:DyaL1M3ovVKqsA%3D%3D; 
Eisen, S.A., Familial influences on gambling behavior: an analysis of 3359 twin pairs (1998) Addiction, 93, pp. 1375-1384. , COI: 1:STN:280:DyaK1M7isFCmuw%3D%3D, This article was the first to provide estimates of genetic and environmental contributions to pathological gambling; 
Potenza, M.N., Xian, H., Shah, K., Scherrer, J.F., Eisen, S.A., Shared genetic contributions to pathological gambling and major depression in men (2005) Arch. Gen. Psychiatry, 62, pp. 1015-1021; 
Giddens, J.L., Xian, H., Scherrer, J.F., Eisen, S.A., Potenza, M.N., Shared genetic contributions to anxiety disorders and pathological gambling in a male population (2011) J. Affect. Disord., 132, pp. 406-412. , PID: 3671371; 
Scherrer, J.F., Xian, H., Slutske, W.S., Eisen, S.A., Potenza, M.N., Associations between obsessive-compulsive classes and pathological gambling in a national cohort of male twins (2015) JAMA Psychiatry, 72, pp. 342-349; 
Slutske, W.S., Common genetic vulnerability for pathological gambling and alcohol dependence in men (2000) Arch. Gen. Psychiatry, 57, pp. 666-674. , COI: 1:STN:280:DC%2BD3czlt1yksQ%3D%3D; 
Slutske, W.S., Zhu, G., Meier, M.H., Martin, N.G., Genetic and environmental influences on disordered gambling in men and women (2010) Arch. Gen. Psychiatry, 67, pp. 624-630. , PID: 3600804; 
Richmond-Rakerd, L.S., Slutske, W.S., Heath, A.C., Martin, N.G., Genetic and environmental influences on the ages of drinking and gambling initiation: evidence for distinct aetiologies and sex differences (2014) Addiction, 109, pp. 323-331; 
Slutske, W.S., Cho, S.B., Piasecki, T.M., Martin, N.G., Genetic overlap between personality and risk for disordered gambling: evidence from a national community-based Australian twin study (2013) J. Abnorm. Psychol., 122, pp. 250-255; 
Slutske, W.S., Deutsch, A.R., Statham, D.J., Martin, N.G., Local area disadvantage and gambling involvement and disorder: evidence for gene–environment correlation and interaction (2015) J. Abnorm. Psychol., 124, pp. 606-622. , PID: 4573820; 
Hillemacher, T., Alterations in DNA-methylation of the dopamine-receptor 2 gene are associated with abstinence and health care utilization in individuals with a lifetime history of pathologic gambling (2015) Prog. Neuropsychopharmacol. Biol. Psychiatry, 63, pp. 30-34. , COI: 1:CAS:528:DC%2BC2MXhtVSgt7nF; 
Hillemacher, T., Dopamine-receptor 2 gene-methylation and gambling behavior in relation to impulsivity (2016) Psychiatry Res., 239, pp. 154-155. , COI: 1:CAS:528:DC%2BC28XktVeiu7g%3D; 
Yao, Y.H., Yip, S.W., Potenza, M.N., (2014) Principles of Addiction Medicine 5Th Edn, , (eds Ries, R. K., Fiellin, D. A., Miller, S. C. & Saitz, R.), Lippincott Williams & Wilkins; 
Leeman, R.F., Potenza, M.N., A targeted review of the neurobiology and genetics of behavioural addictions: an emerging area of research (2013) Can. J. Psychiatry, 58, pp. 260-273. , PID: 3762982; 
Lobo, D.S.S., Kennedy, J.L., Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities (2009) Addiction, 104, pp. 1454-1465; 
Lind, P.A., Genome-wide association study of a quantitative disordered gambling trait (2013) Addict. Biol., 18, pp. 511-522. , COI: 1:CAS:528:DC%2BC3sXlvVCjsLk%3D; 
Lang, M., Genome-wide association study of pathological gambling (2016) Eur. Psychiatry, 36, pp. 38-46. , COI: 1:STN:280:DC%2BC2s7htVKltQ%3D%3D; 
Grant, J.E., A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation (2013) Eur. Neuropsychopharmacol., 23, pp. 1587-1596. , COI: 1:CAS:528:DC%2BC3sXht1KlurnF; 
Yang, B.Z., Balodis, I.M., Lacadie, C.M., Xu, J.S., Potenza, M.N.A., Preliminary study of DBH (encoding dopamine beta-hydroxylase) genetic variation and neural correlates of emotional and motivational processing in individuals with and without pathological gambling (2016) J. Behav. Addict., 5, pp. 282-292. , PID: 5387779; 
Bevilacqua, L., Goldman, D., Genetics of impulsive behaviour (2013) Phil. Trans. R. Soc. B, 368, p. 20120380. , COI: 1:CAS:528:DC%2BC3sXltVaqs7Y%3D; 
Clark, L., Boileau, I., Zack, M., Neuroimaging of reward mechanisms in gambling disorder: an integrative review (2018) Mol. Psychiatry, 24, pp. 674-693; 
Jessup, R.K., O’Doherty, J.P., Human dorsal striatal activity during choice discriminates reinforcement learning behavior from the gambler’s fallacy (2011) J. Neurosci., 31, pp. 6296-6304. , COI: 1:CAS:528:DC%2BC3MXls1OlsLw%3D, PID: 6622656; 
Luijten, M., Schellekens, A.F., Kühn, S., Machielse, M.W.J., Sescousse, G., Disruption of reward processing in addiction: an image-based meta-analysis of functional magnetic resonance imaging studies (2017) JAMA Psychiatry, 74, pp. 387-398. , This work is a meta-analysis showing similarities and differences the neural correlates of reward processing individuals with gambling and SUDs; 
Koehler, S., Hasselmann, E., Wustenberg, T., Heinz, A., Romanczuk-Seiferth, N., Higher volume of ventral striatum and right prefrontal cortex in pathological gambling (2015) Brain Struct. Funct., 220, pp. 469-477; 
Contreras-Rodriguez, O., Cocaine-specific neuroplasticity in the ventral striatum network are linked to delay discounting and drug relapse (2015) Addiction, 110, pp. 1953-1962; 
Clark, L., Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity (2012) Neuroimage, 63, pp. 40-46. , COI: 1:CAS:528:DC%2BC38Xht1GksLvK, PID: 3438449; 
Lawrence, A.D., Brooks, D.J., Whone, A.L., Ventral striatal dopamine synthesis capacity predicts financial extravagance in Parkinson’s disease (2013) Front. Psychol., 4, p. 90. , PID: 3583186; 
Boileau, I., In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO (2014) Mol. Psychiatry, 19, pp. 1305-1313. , COI: 1:CAS:528:DC%2BC3sXhvFensbjO; 
Chase, H.W., Clark, L., Gambling severity predicts midbrain response to near-miss outcomes (2010) J. Neurosci., 30, pp. 6180-6187. , COI: 1:CAS:528:DC%2BC3cXovVWmsL4%3D, PID: 2929454; 
Boileau, I., The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride (2013) Addiction, 108, pp. 953-963; 
Potenza, M.N., Searching for replicable dopamine-related findings in gambling disorder (2018) Biol. Psychiatry, 83, pp. 984-986; 
Potenza, M.N., How central is dopamine to pathological gambling or gambling disorder? (2013) Front. Behav. Neurosci., 7, p. 206. , PID: 3870289; 
Nutt, D.J., Lingford-Hughes, A., Erritzoe, D., Stokes, P.R., The dopamine theory of addiction: 40 years of highs and lows (2015) Nat. Rev. Neurosci., 16, pp. 305-312. , COI: 1:CAS:528:DC%2BC2MXmsFSntb4%3D; 
Molina, J.A., Pathologic gambling in Parkinson’s disease: a behavioral manifestation of pharmacologic treatment? (2000) Mov Disord., 15, pp. 869-872. , COI: 1:STN:280:DC%2BD3cvlt1yisw%3D%3D; 
Steeves, T.D., Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C]raclopride PET study (2009) Brain, 132, pp. 1376-1385. , COI: 1:STN:280:DC%2BD1MzisFWgsg%3D%3D, PID: 3479148; 
Weintraub, D., Dopamine agonist use is associated with impulse control disorders in Parkinson’s disease (2006) Arch. Neurol., 63, pp. 969-973. , PID: 1761054; 
Joutsa, J., Mesolimbic dopamine release is linked to symptom severity in pathological gambling (2012) Neuroimage, 60, pp. 1992-1999. , COI: 1:CAS:528:DC%2BC38XltVyqs7Y%3D; 
Worhunsky, P.D., Regional and source-based patterns of [11C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D2 and D3 receptor availability in cocaine-use disorder (2017) Neuroimage, 148, pp. 343-351. , COI: 1:CAS:528:DC%2BC2sXitVSlsbY%3D, PID: 5344702; 
Heinz, A., Correlation between dopamine D2 receptors in the ventral striatum and central processing of alcohol cues and craving (2004) Am. J. Psychiatry, 161, pp. 1783-1789; 
Volkow, N.D., Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects (1997) Nature, 386, pp. 830-833. , COI: 1:CAS:528:DyaK2sXivVGjtbc%3D; 
Mick, I., Blunted endogenous opioid release following an oral amphetamine challenge in pathological gamblers (2016) Neuropsychopharmacology, 41, pp. 1742-1750. , COI: 1:CAS:528:DC%2BC2MXitVWrtbrJ; 
Allain, F., Minogianis, E.A., Roberts, D.C., Samaha, A.N., How fast and how often: the pharmacokinetics of drug use are decisive in addiction (2015) Neurosci. Biobehav. Rev., 56, pp. 166-179; 
Potenza, M.N., Gambling urges in pathological gambling: a functional magnetic resonance imaging study (2003) Arch. Gen. Psychiatry, 60, pp. 828-836; 
Reuter, J., Pathological gambling is linked to reduced activation of the mesolimbic reward system (2005) Nat. Neurosci., 8, pp. 147-148. , COI: 1:CAS:528:DC%2BD2MXnslKmtw%3D%3D; 
Potenza, M.N., An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers (2003) Am. J. Psychiatry, 160, pp. 1990-1994; 
de Ruiter, M.B., Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers (2009) Neuropsychpharmacology, 34, pp. 1027-1038; 
Balodis, I.M., Diminished frontostriatal activity during processing of monetary rewards and losses in pathological gambling (2012) Biol. Psychiatry, 71, pp. 749-757. , PID: 3460522; 
Kennerley, S.W., Behrens, T.E., Wallis, J.D., Double dissociation of value computations in orbitofrontal and anterior cingulate neurons (2011) Nat. Neurosci., 14, pp. 1581-1589. , COI: 1:CAS:528:DC%2BC3MXhtlyis7bI, PID: 3225689; 
Wallis, J.D., Kennerley, S.W., Contrasting reward signals in the orbitofrontal cortex and anterior cingulate cortex (2011) Ann. NY Acad. Sci., 1239, pp. 33-42; 
van Holst, R.J., van den Brink, W., Veltman, D.J., Goudriaan, A.E., Why gamblers fail to win: a review of cognitive and neuroimaging findings in pathological gambling (2010) Neurosci. Biobehav. Rev., 34, pp. 87-107; 
Cohen, M.X., Krohn-Grimberghe, A., Elger, C.E., Weber, B., Dopamine gene predicts the brain’s response to dopaminergic drug (2007) Eur. J. Neurosci., 26, pp. 3652-3660; 
Verdejo-Garcia, A., Neural substrates of cognitive flexibility in cocaine and gambling addictions (2015) Br. J. Psychiatry, 207, pp. 158-164; 
Worhunsky, P.D., Potenza, M.N., Rogers, R.D., Alterations in functional brain networks associated with loss-chasing in gambling disorder and cocaine-use disorder (2017) Drug Alcohol. Depend., 178, pp. 363-371. , PID: 5551408; 
van Holst, R.J., Chase, H.W., Clark, L., Striatal connectivity changes following gambling wins and near-misses: associations with gambling severity (2014) Neuroimage Clin., 5, pp. 232-239. , PID: 4110887; 
Miedl, S.F., Peters, J., Buchel, C., Altered neural reward representations in pathological gamblers revealed by delay and probability discounting (2012) Arch. Gen. Psychiatry, 69, pp. 177-186; 
Beck, A., Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics (2009) Biol. Psychiatry, 66, pp. 734-742. , COI: 1:CAS:528:DC%2BD1MXht1aisr%2FP; 
Andrews, M.M., Individuals family history positive for alcoholism show functional magnetic resonance imaging differences in reward sensitivity that are related to impulsivity factors (2011) Biol. Psychiatry, 69, pp. 675-683; 
Craig, A.D., How do you feel — now? The anterior insula and human awareness (2009) Nat. Rev. Neurosci., 10, pp. 59-70. , COI: 1:CAS:528:DC%2BD1MXpt1Ok; 
Droutman, V., Read, S.J., Bechara, A., Revisiting the role of the insula in addiction (2015) Trends Cogn. Sci., 19, pp. 414-420. , PID: 4486609; 
Panitz, C., Wacker, J., Stemmler, G., Mueller, E.M., Brain–heart coupling at the P300 latency is linked to anterior cingulate cortex and insula — a cardio-electroencephalographic covariance tracing study (2013) Biol. Psychol., 94, pp. 185-191; 
Mohr, P.N., Biele, G., Heekeren, H.R., Neural processing of risk (2010) J. Neurosci., 30, pp. 6613-6619. , COI: 1:CAS:528:DC%2BC3cXhtVaiurbJ; 
Kober, H., Brain activity during cocaine craving and gambling urges: an fMRI study (2016) Neuropsychopharmacology, 41, pp. 628-637. , COI: 1:CAS:528:DC%2BC2MXht1Chu7nN; 
Contreras-Rodriguez, O., Increased corticolimbic connectivity in cocaine dependence versus pathological gambling is associated with drug severity and emotion-related impulsivity (2016) Addict. Biol., 21, pp. 709-718. , COI: 1:CAS:528:DC%2BC28XmtFSqsr4%3D; 
Clark, L., Lawrence, A.J., Astley-Jones, F., Gray, N., Gambling near-misses enhance motivation to gamble and recruit win-related brain circuitry (2009) Neuron, 61, pp. 481-490. , COI: 1:CAS:528:DC%2BD1MXltFSntb0%3D, PID: 2658737; 
Brevers, D., Comfort for uncertainty in pathological gamblers: a fMRI study (2015) Behav. Brain Res., 278, pp. 262-270; 
Verdejo-Garcia, A., Clark, L., Dunn, B.D., The role of interoception in addiction: a critical review (2012) Neurosci. Biobehav. Rev., 36, pp. 1857-1869; 
Dedovic, K., Duchesne, A., Andrews, J., Engert, V., Pruessner, J.C., The brain and the stress axis: the neural correlates of cortisol regulation in response to stress (2009) Neuroimage, 47, pp. 864-871. , COI: 1:CAS:528:DC%2BC2MXnt1emtLY%3D; 
Guitart-Masip, M., Talmi, D., Dolan, R., Conditioned associations and economic decision biases (2010) Neuroimage, 53, pp. 206-214. , PID: 2923756; 
Shohamy, D., Myers, C.E., Hopkins, R.O., Sage, J., Gluck, M.A., Distinct hippocampal and basal ganglia contributions to probabilistic learning and reversal (2009) J. Cogn. Neurosci., 21, pp. 1821-1833; 
Rahman, A.S., Xu, J., Potenza, M.N., Hippocampal and amygdalar volumetric differences in pathological gambling: a preliminary study of the associations with the behavioral inhibition system (2014) Neuropsychopharmacology, 39, pp. 738-745; 
Elman, I., Yohimbine-induced amygdala activation in pathological gamblers: a pilot study (2012) PLOS ONE, 7. , COI: 1:CAS:528:DC%2BC38XisFCjsb4%3D, PID: 3271103; 
van Holst, R.J., Veltman, D.J., Buchel, C., van den Brink, W., Goudriaan, A.E., Distorted expectancy coding in problem gambling: is the addictive in the anticipation? (2012) Biol. Psychiatry, 71, pp. 741-748; 
Sescousse, G., Barbalat, G., Domenech, P., Dreher, J.C., Imbalance in the sensitivity to different types of rewards in pathological gambling (2013) Brain, 136, pp. 2527-2538; 
Tschernegg, M., Abnormalities of functional brain networks in pathological gambling: a graph-theoretical approach (2013) Front. Hum. Neurosci., 7, p. 625. , PID: 3784685; 
Naqvi, N.H., Gaznick, N., Tranel, D., Bechara, A., The insula: a critical neural substrate for craving and drug seeking under conflict and risk (2014) Ann. NY Acad. Sci., 1316, pp. 53-70; 
Yip, S.W., Gray-matter relationships to diagnostic and transdiagnostic features of drug and behavioral addictions (2018) Addict. Biol., 23, pp. 394-402. , COI: 1:CAS:528:DC%2BC1cXhsFKgt7g%3D; 
Joutsa, J., Saunavaara, J., Parkkola, R., Niemela, S., Kaasinen, V., Extensive abnormality of brain white matter integrity in pathological gambling (2011) Psychiatry Res., 194, pp. 340-346; 
van Holst, R.J., de Ruiter, M.B., van den Brink, W., Veltman, D.J., Goudriaan, A.E., A voxel-based morphometry study comparing problem gamblers, alcohol abusers, and healthy controls (2012) Drug Alcohol. Depend., 124, pp. 142-148; 
Zois, E., Frontal cortex gray matter volume alterations in pathological gambling occur independently from substance use disorder (2017) Addict. Biol., 22, pp. 864-872; 
Yao, Y.-W., Functional and structural neural alterations in Internet gaming disorder: a systematic review and meta-analysis (2017) Neurosci. Biobehav. Rev., 83, pp. 313-324; 
Petry, N.M., An overview of and rationale for changes proposed for pathological gambling in DSM-5 (2014) J. Gambl. Stud., 30, pp. 493-502. , PID: 3722301; 
(1980) Diagnostic and Statistical Manual of Mental Disorders, , 3rd edn, American Psychiatric Association; 
Lesieur, H., Blume, S., The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers (1987) Am. J. Psychiatry, 144, pp. 1184-1188. , COI: 1:STN:280:DyaL2szitlKltw%3D%3D; 
(1987) Diagnostic and Statistical Manual of Mental Disorders 3Rd Edn, Revised, , American Psychiatric Association; 
Shaffer, H., LaBrie, R., Scanlan, K., Cummings, T., Pathological gambling among adolescents: Massachusetts Gambling Screen (MAGS) (1994) J. Gambl. Stud., 10, pp. 339-362. , COI: 1:STN:280:DC%2BC2c7ntVGqsQ%3D%3D; 
Winters, K., Specker, S., Stinchfield, R., (2002) The Downside: Problem and Pathological Gambling, pp. 143-148. , Marotta, J. J., Cornelius, J. A., Eadington, W. R., Univ. of Nevada, Reno; 
Ferris, J., Wynne, H., (2001) The Canadian Problem Gambling Index: Final Report, , Canadian Centre on Substance Abuse; 
Ben-Tovim, D., Esterman, A., Tolchard, B., Battersby, M., (2001) The Victorian Gambling Screen: Project Report, , Victoria Research Panel; 
Grant, B.F., The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample (2003) Drug Alcohol. Depend., 71, pp. 7-16; 
Kessler, R.C., Üstün, T.B., The World Mental Health (WMH) survey initiative version of the World Health Organization (WHO) composite international diagnostic interview (CIDI) (2004) Int. J. Methods Psychiatr. Res., 13, pp. 93-121; 
Johnson, E., The Lie/Bet Questionnaire for screening pathological gamblers (1997) Psychol. Rep., 80, pp. 83-88. , COI: 1:STN:280:DyaK2s3ivFOgtw%3D%3D; 
Toce-Gerstein, M., Gerstein, D., Volberg, R., The NODS–CLiP: a rapid screen for adult pathological and problem gambling (2009) J. Gambl. Stud., 25, pp. 514-555; 
Volberg, R., Munck, I., Petry, N., A quick and simple screening method for pathological and problem gamblers in addiction programs and practices (2011) Am. J. Addict., 20, pp. 220-227. , PID: 3076109; 
Gebauer, L., LaBrie, R., Shaffer, H., Optimizing DSM-IV-TR classification accuracy: a brief biosocial screen for detecting current gambling disorders among gamblers in the general household population (2010) Can. J. Psychiatry, 55, pp. 82-90. , PID: 20181303; 
Room, R., Turner, N., Ialomiteanu, A., Community effects of the opening of the Niagara casino (1999) Addiction, 94, pp. 1449-1466. , COI: 1:STN:280:DC%2BD3c3ltFCqtg%3D%3D; 
Stinchfield, R., (2014) The Wiley-Blackwell Handbook of Disordered Gambling, pp. 165-204. , (eds Richard, D. C. S., Blaszczynski, A. & Nower, L.), John Wiley & Sons; 
Winters, K.C., Stinchfield, R.D., Fulkerson, J., Toward the development of an adolescent gambling problem severity scale (1993) J. Gambl. Stud., 9, pp. 63-84; 
Fisher, S., Measuring pathological gambling in children: the case of fruit machines in the UK (1992) J. Gambl. Stud., 8, pp. 263-285. , COI: 1:STN:280:DC%2BC2c7ntlyntg%3D%3D; 
Fisher, S., Developing the DSM-IV-MR-J criteria to identify adolescent problem gambling in non-clinical populations (2000) J. Gambl. Stud., 16, pp. 253-273. , COI: 1:STN:280:DC%2BD3srlsVGitQ%3D%3D; 
Wiebe, J., Wynne, H., Stinchfield, R., Tremblay, J., (2007) The Canadian Adolescent Gambling Inventory (CAGI): Phase II Final Report, , Canadian Centre on Substance Abuse; 
Derevensky, J., Gupta, R., Prevalence estimates of adolescent gambling: a comparison of the SOGS-RA, DSM-IV-J, and the GA 20 questions (2000) J. Gambl. Stud., 16, pp. 227-251. , COI: 1:STN:280:DC%2BD3srlsVGitA%3D%3D; 
Sullivan, S., Don’t let an opportunity go by: validation of the EIGHT gambling screen (2007) Int. J. Ment. Health Addict., 5, pp. 381-389; 
Weintraub, D., Validation of the questionnaire for impulsive-compulsive disorders in Parkinson’s disease (2009) Mov. Disord., 24, pp. 1461-1467. , PID: 2848971; 
Blaszczynski, A., (2002) Harm Minimization Strategies in Gambling: An Overview of International Initiatives and Interventions, , The Australian Gaming Council; 
Gainsbury, S.M., Review of self-exclusion from gambling venues as an intervention for problem gambling (2014) J. Gambl. Stud., 30, pp. 229-251; 
Nordmyr, J., Österman, K., Raising the legal gambling age in Finland: problem gambling prevalence rates in different age groups among past-year gamblers pre- and post-implementation (2016) Int. Gambl. Stud., 16, pp. 347-356; 
Slutske, W.S., Piasecki, T.M., Blaszczynski, A., Martin, N.G., Pathological gambling recovery in the absence of abstinence (2010) Addiction, 105, pp. 2169-2175. , PID: 2975751; 
Courtney, K.E., Ghahremani, D.G., Ray, L.A., The effect of alcohol priming on neural markers of alcohol cue-reactivity (2015) Am. J. Drug Alcohol Abuse, 41, pp. 300-308. , PID: 4651007; 
Hodgson, R., Rankin, H., Stockwell, T., Alcohol dependence and the priming effect (1979) Behav. Res. Ther., 17, pp. 379-387. , COI: 1:STN:280:DyaL3c%2FitVSlsA%3D%3D; 
Blaszczynski, A., Ladouceur, R., Shaffer, H., A science-based framework for responsible gambling: the Reno model (2004) J. Gambl. Stud., 20, pp. 301-317. , This study presents an initial framework for responsible gambling guidelines; 
(2019) Yourplay — Victoria’s Pre-Commitment Scheme, , https://www.justice.vic.gov.au/safer-communities/gambling/yourplay-victorias-pre-commitment-scheme, Victoria State Government; 
McCormick, A.V., Cohen, I.M., Davies, G., Differential effects of formal and informal gambling on symptoms of problem gambling during voluntary self-exclusion (2018) J. Gambl. Stud., 34, pp. 1013-1031; 
Nelson, S.E., Kleschinsky, J.H., LaBrie, R.A., Kaplan, S., Shaffer, H.J., One decade of self exclusion: Missouri casino self-excluders four to ten years after enrollment (2010) J. Gambl. Stud., 26, pp. 129-144; 
(2014) Gamesense. BC Responsible & Problem Gambling Program, , https://www.bcresponsiblegambling.ca/responsible-gambling/gamesense; 
Ladouceur, R., Shaffer, P., Blaszczynski, A., Shaffer, H.J., Responsible gambling: a synthesis of the empirical evidence (2017) Addict. Res. Theory, 25, pp. 225-235; 
Hing, N., Sproston, K., Brook, K., Brading, R., The structural features of sports and race betting inducements: issues for harm minimisation and consumer protection (2017) J. Gambl. Stud., 33, pp. 685-704; 
Blaszczynski, A., A critical examination of the link between gaming machines and gambling-related harm (2013) J. Gambl. Business Econ., 7, pp. 55-76; 
St-Pierre, R., Walker, D., Derevensky, J., Gupta, R., How availability and accessibility of gambling venues influence problem gambling: a review of the literature. Gaming Law (2014) Rev. Econ., 8, pp. 150-172; 
Binde, P., (2014) Gambling Advertising: A Critical Research Review, , The Responsible Gambling Trust; 
Binde, P., (2018) A Bibliography of Empirical Studies on Gambling Advertising 2Nd Edn, , University of Gothenburg, Sweden; 
King, D.L., Russell, A., Gainsbury, S., Delfabbro, P.H., Hing, N., The cost of virtual wins: an examination of gambling-related risks in youth who spend money on social casino games (2016) J. Behav. Addict., 5, pp. 401-409. , PID: 5264407; 
Kim, H.S., Wohl, M.J.A., Salmon, M.M., Gupta, R., Derevensky, J., Do social casino gamers migrate to online gambling? An assessment of migration rate and potential predictors (2015) J. Gambl. Stud., 31, pp. 1819-1831; 
Zendle, D., Cairns, P., Video game loot boxes are linked to problem gambling: results of a large-scale survey (2018) PLOS ONE, 13. , COI: 1:CAS:528:DC%2BC1MXjtlyktr4%3D, PID: 6248934; 
Potenza, M.N., Correlates of at-risk/problem Internet gambling in adolescents (2011) J. Am. Acad. Child Adolesc. Psychiatry, 50, pp. 150-159; 
Bristow, L.A., Bilevicius, E., Stewart, S.H., Goldstein, A.L., Keough, M.T., Solitary gambling mediates the risk pathway from anxiety sensitivity to excessive gambling: evidence from a longitudinal ecological momentary assessment study (2018) Psychol. Addict. Behav., 32, pp. 689-696; 
(2010) Gambling Productivity Commission Inquiry Report, , Australian Government; 
Williams, R.J., West, B.L., Simpson, R.I., (2012) Prevention of Problem Gambling: A Comprehensive Review of the Evidence and Identified Practices, , Ontario Problem Gambling Research Centre and the Ontario Ministry of Health and Long Term Care; 
Todirita, I., Lupu, V., Gambling prevention program among children (2013) J. Gambl. Stud., 29, pp. 161-169; 
Campbell, C., Derevensky, J., Meerkamper, E., Cutajar, J., The influence of cultural background on parental perceptions of adolescent gambling behaviour: a Canadian study (2012) Int. J. Ment. Health Addict., 10, pp. 537-550; 
Derevensky, J., St-Pierre, R., Temcheff, C., Gupta, R., Teacher awareness and attitudes regarding adolescent risky behaviours: is adolescent gambling perceived to be a problem? (2014) J. Gambl. Stud., 30, pp. 435-451; 
Temcheff, C., Derevensky, J., St-Pierre, R., Gupta, R., Martin, I., Beliefs and attitudes of mental health professionals with respect to gambling and other high risk behaviors in schools (2014) Int. J. Ment. Health Addict., 12, pp. 716-729; 
LaPlante, D.A., Shaffer, H.J., Understanding the influence of gambling opportunities: expanding exposure models to include adaptation (2007) Am. J. Orthopsychiatry, 77, pp. 616-623; 
Walker, M., Framework for reporting outcomes in problem gambling treatment research: the Banff, Alberta Consensus (2006) Addiction, 101, pp. 504-511. , This work presents consensus guidelines for how best to assess for outcomes trials testing treatments for GD; 
Pickering, D., Keen, B., Entwistle, G., Blaszczynski, A., Measuring treatment outcomes in gambling disorders: a systematic review (2018) Addiction, 113, pp. 411-426; 
Stewart, R.M., Brown, R.I., An outcome study of Gamblers Anonymous (1988) Br. J. Psychiatry, 152, pp. 284-288. , COI: 1:STN:280:DyaL1M%2FgtFKrtQ%3D%3D; 
Hodgins, D.C., Peden, N., Cassidy, E., The association between comorbidity and outcome in pathological gambling: a prospective follow-up of recent quitters (2005) J. Gambl. Stud., 21, pp. 255-271; 
Petry, N.M., Patterns and correlates of Gamblers Anonymous attendance in pathological gamblers seeking professional treatment (2003) Addict. Behav., 28, pp. 1049-1062; 
Petry, N.M., (2005) Pathological Gambling: Etiology, Comorbidity and Treatment, , American Psychological Association; 
Ladouceur, R., Group therapy for pathological gamblers: a cognitive approach (2003) Behav. Res. Ther., 41, pp. 587-596. , COI: 1:STN:280:DC%2BD3s7pt1Srsg%3D%3D; 
Sylvain, C., Ladouceur, R., Boisvert, J.M., Cognitive and behavioral treatment of pathological gambling: a controlled study (1997) J. Consult. Clin. Psychol., 65, pp. 727-732. , COI: 1:STN:280:DyaK2svnvVKnug%3D%3D; 
Pallesen, S., Mitsem, M., Kvale, G., Johnsen, B.H., Molde, H., Outcome of psychological treatments of pathological gambling: a review and meta-analysis (2005) Addiction, 100, pp. 1412-1422; 
Petry, N.M., Ginley, M.K., Rash, C.J., A systematic review of treatments for problem gambling (2017) Psychol. Addict. Behav., 31, p. 951. , PID: 5714688; 
Menchon, J., Mestre-Bach, G., Steward, T., Fernández-Aranda, F., Jiménez-Murcia, S., An overview of gambling disorder: from treatment approaches to risk factors [version 1; peer review: 2 approved] (2018) F1000Res., 7, p. 434. , PID: 5893944; 
Cowlishaw, S., Psychological therapies for pathological and problem gambling (2012) Cochrane Database Syst. Rev., 11, p. CD008937. , PID: 23152266; 
Carlbring, P., Smit, F., Randomized trial of Internet-delivered self-help with telephone support for pathological gamblers (2008) J. Consult. Clin. Psychol., 76, pp. 1090-1094; 
Petry, N.M., Cognitive-behavioral therapy for pathological gamblers (2006) J. Consult. Clin. Psychol., 74, pp. 555-567. , This work is a large-scale randomized clinical trial demonstrating the efficacy of CBT the treatment of DSM-IV pathological gambling; 
Miller, W.R., Rollnick, S., (1991) Motivational Interviewing: Preparing People to Change Addictive Behavior, , Guilford Press; 
Grant, J.E., Imaginal desensitisation plus motivational interviewing for pathological gambling: randomised controlled trial (2009) Br. J. Psychiatry, 195, pp. 266-267. , PID: 2801822; 
Hodgins, D.C., Currie, S.R., el-Guebaly, N., Motivational enhancement and self-help treatments for problem gambling (2001) J. Consult. Clin. Psychol., 69, pp. 50-57. , COI: 1:STN:280:DC%2BD3M3lvF2nsg%3D%3D; 
Hodgins, D.C., Currie, S., el-Guebaly, N., Peden, N., Brief motivational treatment for problem gambling: a 24-month follow-up (2004) Psychol. Addict. Behav., 18, pp. 293-296; 
Hodgins, D.C., Currie, S.R., Currie, G., Fick, G.H., Randomized trial of brief motivational treatments for pathological gamblers: more is not necessarily better (2009) J. Consult. Clin. Psychol., 77, pp. 950-960; 
Hodgins, D.C., Currie, S.R., el-Guebaly, N., Diskin, K.M., Does providing extended relapse prevention bibliotherapy to problem gamblers improve outcome? (2007) J. Gambl. Stud., 23, pp. 41-54; 
Cunningham, J.A., Hodgins, D.C., Toneatto, T., Murphy, M., A randomized controlled trial of a personalized feedback intervention for problem gamblers (2012) PLOS ONE, 7. , COI: 1:CAS:528:DC%2BC38XivFaksrc%3D, PID: 3279405; 
Cunningham, J.A., Hodgins, D.C., Toneatto, T., Rai, A., Cordingley, J., Pilot study of a personalized feedback intervention for problem gamblers (2009) Behav. Ther., 40, pp. 219-224; 
Larimer, M.E., Brief motivational feedback and cognitive behavioral interventions for prevention of disordered gambling: a randomized clinical trial (2012) Addiction, 107, pp. 1148-1158. , PID: 3528181; 
Petry, N.M., Weinstock, J., Morasco, B.J., Ledgerwood, D.M., Brief motivational interventions for college student problem gamblers (2009) Addiction, 104, pp. 1569-1578. , PID: 2758481; 
Petry, N.M., Weinstock, J., Ledgerwood, D.M., Morasco, B., A randomized trial of brief interventions for problem and pathological gamblers (2008) J. Consult. Clin. Psychol., 76, pp. 318-328. , PID: 2738749; 
Petry, N.M., Rash, C.J., Alessi, S.M., A randomized controlled trial of brief interventions for problem gambling in substance abuse treatment patients (2016) J. Consult. Clin. Psychol., 84, pp. 874-886. , PID: 5036993; 
Carlbring, P., Jonsson, J., Josephson, H., Forsberg, L., Motivational interviewing versus cognitive behavioral group therapy in the treatment of problem and pathological gambling: a randomized controlled trial (2010) Cogn. Behav. Ther., 39, pp. 92-103; 
Toneatto, T., Gunaratne, M., Does the treatment of cognitive distortions improve clinical outcomes for problem gambling? (2009) J. Contemp. Psychother., 39, pp. 221-229; 
Chen, P., Jindani, F., Perry, J., Turner, N.L., Mindfulness and problem gambling treatment (2014) Asian J. Gambl. Issues Public Health, 4, p. 2; 
Maynard, B.R., Wilson, A.N., Labuzienski, E., Whiting, S.W., Mindfulness-based approaches in the treatment of disordered gambling: a systematic review and meta-analysis (2018) Res. Soc. Work Pract., 28, pp. 348-362; 
Challet-Bouju, G., Bruneau, M., Group, I., Victorri-Vigneau, C., Grall-Bronnec, M., Cognitive remediation interventions for gambling disorder: a systematic review (2017) Front. Psychol., 8, p. 1961. , PID: 5723090; 
Chebli, J.-L., Blaszczynski, A., Gainsbury, S.M., Internet-based interventions for addictive behaviours: a systematic review (2016) J. Gambl. Stud., 32, pp. 1279-1304; 
Naish, K.R., Vedelago, L., MacKillop, J., Amlung, M., Effects of neuromodulation on cognitive performance in individuals exhibiting addictive behaviour: a systematic review protocol (2018) Syst. Rev., 7. , PID: 6020343; 
Pallesen, S., Outcome of pharmacological treatments of pathological gambling: a review and meta-analysis (2007) J. Clin. Psychopharmacol., 27, pp. 357-364; 
Bartley, C.A., Bloch, M.H., Meta-analysis: pharmacological treatment of pathological gambling (2013) Expert Rev. Neurother., 13, pp. 887-894. , COI: 1:CAS:528:DC%2BC3sXhtlSit7rL; 
Bullock, S.A., Potenza, M.N., Pathological gambling: neuropsychopharmacology and treatment (2012) Curr. Psychopharmacol., 1, pp. 67-85. , COI: 1:CAS:528:DC%2BC3sXhsFaku7w%3D; 
Grant, J.E., Schreiber, L.R., Odlaug, B.L., Phenomenology and treatment of behavioural addictions (2013) Can. J. Psychiatry, 58, pp. 252-259; 
Theile, J.W., Morikawa, H., Gonzales, R.A., Morrisett, R.A., GABAergic transmission modulates ethanol excitation of ventral tegmental area dopamine neurons (2011) Neuroscience, 172, pp. 94-103. , COI: 1:CAS:528:DC%2BC3cXhs1ajs7zO; 
Kim, S.W., Grant, J.E., Adson, D.E., Shin, Y.C., Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling (2001) Biol. Psychiatry, 49, pp. 914-921. , COI: 1:CAS:528:DC%2BD3MXjslSltr4%3D; 
Grant, J.E., Kim, S.W., Hartman, B.K., A double-blind, placebo-controlled study of the opiate antagonist naltrexone in the treatment of pathological gambling urges (2008) J. Clin. Psychiatry, 69, pp. 783-789. , COI: 1:CAS:528:DC%2BD1cXnvVGjsrg%3D; 
Grant, J.E., Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling (2006) Am. J. Psychiatry, 163, pp. 303-312; 
Grant, J.E., Odlaug, B.L., Potenza, M.N., Hollander, E., Kim, S.W.A., Multi-center, double-blind, placebo-controlled study of the opioid antagonist nalmefene in the treatment of pathological gambling (2010) Br. J. Psychiatry, 197, pp. 330-331; 
Grant, J., Kim, S., Hollander, E., Potenza, M., Predicting response to opiate antagonists and placebo in the treatment of pathological gambling (2008) Psychopharmacology, 200, pp. 521-527. , COI: 1:CAS:528:DC%2BD1cXhtFOjsbvE, PID: 3683409; 
Kovanen, L., A randomised, double-blind, placebo-controlled trial of as-needed naltrexone in the treatment of pathological gambling (2016) Eur. Addict. Res., 22, pp. 70-79; 
Potenza, M.N., Hollander, E., (2002) Neuropsychopharmacology: The 5Th Generation of Progress, pp. 1725-1741. , Davis, K. L., Charney, D., Coyle, J. T., Nemeroff, C. B., Lippincott Williams & Wilkins; 
Potenza, M.N., Neurobiology of gambling behaviors (2013) Curr. Opin. Neurobiol., 23, pp. 660-667. , COI: 1:CAS:528:DC%2BC3sXltVentrg%3D, PID: 3803105; 
Goudriaan, A.E., Oosterlaan, J., de Beurs, E., Van den Brink, W., Pathological gambling: a comprehensive review of biobehavioral findings (2004) Neurosci. Biobehav. Rev., 28, pp. 123-141; 
Fong, T., Kalechstein, A., Bernhard, B., Rosenthal, R., Rugle, L., A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers (2008) Pharmacol. Biochem. Behav., 89, pp. 298-303. , COI: 1:CAS:528:DC%2BD1cXjs1Wns7o%3D; 
McElroy, S.L., Nelson, E.B., Welge, J.A., Kaehler, L., Keck, P.E.J., Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial (2008) J. Clin. Psychiatry, 69, pp. 433-440. , COI: 1:CAS:528:DC%2BD1cXltVKhurg%3D; 
Zack, M., Poulos, C.X.A., D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers (2007) Neuropsychopharmacology, 32, pp. 1678-1686. , COI: 1:CAS:528:DC%2BD2sXnslGks78%3D; 
Zack, M., Poulos, C.X., Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers (2004) Neuropsychopharmacology, 29, pp. 195-207. , COI: 1:CAS:528:DC%2BD3sXhtVSqsL7L; 
Black, D.W., Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study (2007) J. Clin. Psychopharmacol., 27, pp. 143-150. , COI: 1:CAS:528:DC%2BD2sXjvVOgsL0%3D; 
Hodgins, D.C., Stea, J.N., Grant, J.E., Gambling disorders (2011) Lancet, 378, pp. 1874-1876; 
Tunbridge, E.M., Bannerman, D.M., Sharp, T., Harrison, P.J., Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex (2004) J. Neurosci., 24, pp. 5331-5335. , COI: 1:CAS:528:DC%2BD2cXltFCgtbc%3D; 
Cocker, P.J., Winstanley, C.A., Irrational beliefs, biases and gambling: exploring the role of animal models in elucidating vulnerabilities for the development of pathological gambling (2015) Behav. Brain Res., 279, pp. 259-273. , COI: 1:STN:280:DC%2BC2Mzitlyquw%3D%3D; 
Winstanley, C.A., Clark, L., Translational models of gambling-related decision-making (2016) Curr. Top. Behav. Neurosci., 28, pp. 93-120. , COI: 1:CAS:528:DC%2BC2sXht1Cit7nN; 
Cocker, P.J., Hosking, J.G., Murch, W.S., Clark, L., Winstanley, C.A., Activation of dopamine D4 receptors within the anterior cingulate cortex enhances the erroneous expectation of reward on a rat slot machine task (2016) Neuropsychopharmacology, 105, pp. 186-195. , COI: 1:CAS:528:DC%2BC28XhtlOnu7g%3D; 
Cocker, P.J., Lin, M.Y., Barrus, M.M., Le Foll, B., Winstanley, C.A., The agranular and granular insula differentially contribute to gambling-like behavior on a rat slot machine task: effects of inactivation and local infusion of a dopamine D4 agonist on reward expectancy (2016) Psychopharmacology, 233, pp. 3135-3147. , COI: 1:CAS:528:DC%2BC28XhtFOit73E; 
Cocker, P.J., Winstanley, C.A., (2019) Gambling Disorder, pp. 101-125. , Heinz, A., Romanczuk-Seiferth, N., Potenza, M. N., Springer; 
Kalivas, P.W., Volkow, N., Seamans, J., Unmanageable motivation in addiction: a pathology in prefrontal–accumbens glutamate transmission (2005) Neuron, 45, pp. 647-650. , COI: 1:CAS:528:DC%2BD2MXis1yrs78%3D; 
Kalivas, P.W., Volkow, N.D., The neural basis of addiction: a pathology of motivation and choice (2005) Am. J. Psychiatry, 162, pp. 1403-1413; 
Kalivas, P.W., The glutamate homeostasis hypothesis of addiction (2009) Nat. Rev. Neurosci., 10, pp. 561-572. , COI: 1:CAS:528:DC%2BD1MXnvFans74%3D; 
Kalivas, P.W., Volkow, N.D., New medications for drug addiction hiding in glutamatergic neuroplasticity (2011) Mol. Psychiatry, 16, pp. 974-986. , COI: 1:CAS:528:DC%2BC3MXht1CltrbI, PID: 3192324; 
Nordin, C., Gupta, R.C., Sjodin, I., Cerebrospinal fluid amino acids in pathological gamblers and healthy controls (2007) Neuropsychobiology, 56, pp. 152-158. , COI: 1:CAS:528:DC%2BD1cXisVensr8%3D; 
Grant, J.E., Kim, S.W., Odlaug, B.L., N-Acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study (2007) Biol. Psychiatry, 62, pp. 652-657. , COI: 1:CAS:528:DC%2BD2sXhtVSjs73E; 
Blaszczynski, A., Nower, L., Imaginal desensitisation (2003) J. Creat. Ment. Health, 2, pp. 1-14; 
Grant, J.E., A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers (2014) J. Clin. Psychiatry, 75, pp. 39-45. , COI: 1:CAS:528:DC%2BC2cXlt1Sgs78%3D; 
Dowling, N.A., Merkouris, S.S., Lorains, F.K., Interventions for comorbid problem gambling and psychiatric disorders: advancing a developing field of research (2016) Addict. Behav., 58, pp. 21-30. , COI: 1:STN:280:DC%2BC28jjtFWksQ%3D%3D; 
Yip, S., Potenza, M., Treatment of gambling disorders (2014) Curr. Treat Options Psychiatry, 1, pp. 189-203. , PID: 4041397; 
Hollander, E., Pallanti, S., Allen, A., Sood, E., Rossi, N.B., Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? (2005) Am. J. Psychiatry, 162, pp. 137-145; 
de Brito, A.M., Topiramate combined with cognitive restructuring for the treatment of gambling disorder: a two-center, randomized, double-blind clinical trial (2017) J. Gambl. Stud., 33, pp. 249-263; 
Grant, J.E., Potenza, M.N., Escitalopram treatment of pathological gambling with co-occurring anxiety: an open-label pilot study with double-blind discontinuation (2006) Int. Clin. Psychopharmacol., 21, pp. 203-209; 
Grant, J.E., Kim, S.W., Quality of life in kleptomania and pathological gambling (2005) Compr. Psychiatry, 46, pp. 34-37; 
Scherrer, J.F., Effect of genes, environment, and lifetime co-occurring disorders on health-related quality of life in problem and pathological gamblers (2005) Arch. Gen. Psychiatry, 62, pp. 677-683; 
Kim, H.S., Hodgins, D.C., Bellringer, M., Abbott, M., Gender differences among helpline callers: prospective study of gambling and psychosocial outcomes (2016) J. Gambl. Stud., 32, pp. 605-623; 
Shek, D.T., Chan, E.M., Wong, R.H., Associations between pathological gambling and psychiatric comorbidity among help-seeking populations in Hong Kong (2012) ScientificWorldJournal, 2012, p. 571434. , PID: 3385621; 
Leppink, E.W., Grant, J.E., Traumatic event exposure and gambling: associations with clinical, neurocognitive, and personality variables (2015) Ann. Clin. Psychiatry, 27, pp. 16-24. , PID: 25696777; 
Loo, J.M., Shi, Y., Pu, X., Gambling, drinking and quality of life: evidence from Macao and Australia (2016) J. Gambl. Stud., 32, pp. 391-407; 
Sander, W., Peters, A., Pathological gambling: influence of quality of life and psychological distress on abstinence after cognitive-behavioral inpatient treatment (2009) J. Gambl. Stud., 25, pp. 253-262; 
Morasco, B.J., Petry, N.M., Gambling problems and health functioning in individuals receiving disability (2006) Disabil. Rehabil., 28, pp. 619-623; 
Pilver, C.E., Potenza, M.N., Increased incidence of cardiovascular conditions among older adults with pathological gambling features in a prospective study (2013) J. Addict. Med., 7, pp. 387-393; 
Grant, J.E., Kim, S.W., Demographic and clinical features of 131 adult pathological gamblers (2001) J. Clin. Psychiatry, 62, pp. 957-962. , COI: 1:STN:280:DC%2BD38%2FlsFequg%3D%3D, PID: 11780876; 
Ledgerwood, D.M., Who goes to treatment? Predictors of treatment initiation among gambling help-line callers (2013) Am. J. Addict., 22, pp. 33-38. , PID: 23398224; 
Ledgerwood, D., Petry, N.M., Gambling and suicidality in treatment seeking pathological gamblers (2004) J. Nerv. Ment. Dis., 192, pp. 711-714; 
Karlsson, A., Håkansson, A., Gambling disorder, increased mortality, suicidality, and associated comorbidity: a longitudinal nationwide register study (2018) J. Behav. Addict., 7, pp. 1091-1099. , PID: 6376387; 
Ronzitti, S., Current suicidal ideation in treatment-seeking individuals in the United Kingdom with gambling problems (2017) Addict. Behav., 74, pp. 33-40; 
Ronzitti, S., Kraus, S.W., Hoff, R.A., Clerici, M., Potenza, M.N., Problem-gambling severity, suicidality and DSM-IV Axis II personality disorders (2018) Addict. Behav., 82, pp. 142-150; 
Yi, S., Shame-prone gamblers and their coping with gambling loss. J. Gambl (2012) Issues, 27, pp. 1-21; 
Potenza, M.N., Illegal behaviors in problem gambling: analysis of data from a gambling helpline (2000) J. Am. Acad. Psychiatry Law, 28, pp. 389-403. , COI: 1:STN:280:DC%2BD3M7ptFClsQ%3D%3D, PID: 11196248; 
LaPlante, D.A., Nelson, S.E., LaBrie, R.A., Shaffer, H.J., Stability and progression of disordered gambling: lessons from longitudinal studies (2008) Can. J. Psychiatry, 53, pp. 52-60; 
Grant, J.E., Levine, L., Kim, D., Potenza, M.N., Prevalence of impulse control disorders in adult psychiatric inpatients (2005) Am. J. Psychiatry, 162, pp. 2184-2188; 
Grant, J.E., Williams, K.A., Potenza, M.N., Impulse-control disorders in adolescent psychiatric inpatients: co-occurring disorders and sex differences (2007) J. Clin. Psychiatry, 68, pp. 1584-1592; 
Kahn, R.S., Schizophrenia (2015) Nat. Rev. Dis. Primers, 1, p. 15067; 
Rennert, L., DSM-5 gambling disorder: prevalence and characteristics in a substance use disorder sample (2014) Exp. Clin. Psychopharmacol., 22, pp. 50-56. , PID: 4019046; 
Kundu, P.V., Gambling-related attitudes and behaviors in adolescents having received instant (scratch) lottery tickets as gifts (2013) J. Adolesc. Health, 52, pp. 456-464; 
Xu, J.S., Large-scale functional network overlap is a general property of brain functional organization: reconciling inconsistent fMRI findings from general-linear-model-based analyses (2016) Neurosci. Biobehav. Rev., 71, pp. 83-100. , PID: 5140707; 
Leong, J.K., Pestilli, F., Wu, C.C., Samanez-Larkin, G.R., Knutson, B., White-matter tract connecting anterior insula to nucleus accumbens correlates with reduced preference for positively skewed gambles (2016) Neuron, 89, pp. 63-69. , COI: 1:CAS:528:DC%2BC28XktVejsA%3D%3D, PID: 4720154; 
Reid, R.C., Di Tirro, C., Fong, T.W., Mindfulness in patients with gambling disorders (2014) J. Soc. Work Pract. Addict., 14, pp. 327-337; 
Gavriel-Fried, B., The crucial role of recovery capital in individuals with a gambling disorder (2018) J. Behav. Addict., 7, pp. 792-799. , PID: 6426400; 
Gavriel-Fried, B., Moretta, T., Potenza, M.N., Modeling intrinsic spirituality in gambling disorder Addict. Res. Treat., , (in the press); 
Slutske, W.S., Jackson, K.M., Sher, K.J., The natural history of problem gambling from age 18 to 29 (2003) J. Abnorm. Psychol., 112, pp. 263-274; 
Marotta, J., (2016) Survey of Problem Gambling Services in the United States, , Association of Problem Gambling Service Administrators, 2017; 
Science has a gambling problem (2018) Nature, 553, p. 379. , No authors listed; 
Potenza, M.N., Higuchi, S., Brand, M., Call for research into a wider range of behavioural addictions (2018) Nature, 555, p. 30. , COI: 1:CAS:528:DC%2BC1cXjs1agt7Y%3D; 
Dadayan, L., (2016) The Blinken Report: State Revenues from Gambling: Short-Term Relief, Long-Term Disappointment, , The Nelson A. Rockefeller Institute of Government; 
Gainsbury, S.M., Online gambling addiction: the relationship between internet gambling and disordered gambling (2015) Curr. Addict. Rep., 2, pp. 185-193. , PID: 4610999; 
(2019) Size of the Online Gambling Market in 2017 and 2024 (In Billion U.S. Dollars). Statista, , https://www.statista.com/statistics/270728/market-volume-of-online-gaming-worldwide; 
Gainsbury, S.M., Abarbanel, B., Blaszczynski, A., Intensity and gambling harms: exploring breadth of gambling involvement among esports bettors (2017) Gaming Law Rev., 21, pp. 610-615; 
Marchica, L., Zhao, Y., Derevensky, J., Ivoska, W., Understanding the relationship between sports-relevant gambling and being at-risk for a gambling problem among American adolescents (2017) J. Gambl. Stud., 33, pp. 437-448; 
Shead, N.W., Derevensky, J.L., Paskus, T.S., Trends in gambling behavior among college student-athletes: a comparison of 2004 and 2008 NCAA Survey data. J. Gambl (2014) Issues, 29, pp. 1-21; 
Deans, E.G., Thomas, S.L., Derevensky, J., Daube, M., The influence of marketing on the sports betting attitudes and consumption behaviours of young men: implications for harm reduction and prevention strategies (2017) Harm Reduct. J., 14. , PID: 5247806; 
Trendacosta, K., The next generation of slot machines will be way more immersive (2014) GIZMODO, , https://io9.gizmodo.com/the-next-generation-of-slot-machines-will-be-way-more-i-1663053193; 
Martinelli, D., Skin gambling: have we found the millennial goldmine or imminent trouble? Gaming (2017) Law Rev., 21, pp. 557-565; 
King, D.L., Delfabbro, P.H., Video game monetization (for example, ‘loot boxes’): a blueprint for practical social responsibility measures (2019) Int. J. Ment. Health Addict., 17, pp. 166-179; 
Hern, A., (2017) Video Games are Unlocking Child Gambling. This has to Be Reined In. the Guardian, , https://www.theguardian.com/commentisfree/2017/dec/28/video-games-unlock-child-gambling-loot-box-addiction; 
(2019) QE21 Hazardous Gambling Or Betting, , https://icd.who.int/dev11/l-m/en#/http%3a%2f%2fid.who.int%2ficd%2fentity%2f233747706, ICD-11; 
Shaffer, H.J., Korn, D.A., Gambling and related mental disorders: a public health analysis (2002) Annu. Rev. Public Health, 23, pp. 171-212; 
Leeman, R.F., Grant, J.E., Potenza, M.N., Behavioral and neurological foundations for the moral and legal implications of intoxication, addictive behaviors and disinhibition (2009) Behav. Sci. Law, 27, pp. 237-259. , PID: 2748412; 
Stinchfield, R., Reliability, validity. and classification accuracy of a measure of DSM-IV diagnostic criteria for pathological gambling (2003) Am. J. Psychiatry, 160, pp. 180-182
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070628688&doi=10.1038%2fs41572-019-0099-7&partnerID=40&md5=b1a95624cc7ef5428064ef558ef72c53
ER  - 

TY  - JOUR
TI  - Development of a Novel Neuro-immune and Opioid-Associated Fingerprint with a Cross-Validated Ability to Identify and Authenticate Unknown Patients with Major Depression: Far Beyond Differentiation, Discrimination, and Classification
T2  - Molecular Neurobiology
J2  - Mol. Neurobiol.
VL  - 56
IS  - 11
SP  - 7822
EP  - 7835
PY  - 2019
DO  - 10.1007/s12035-019-01647-0
SN  - 08937648 (ISSN) 
AU  - Al-Hakeim, H.K.
AU  - Al-Fadhel, S.Z.
AU  - Al-Dujaili, A.H.
AU  - Carvalho, A.
AU  - Sriswasdi, S.
AU  - Maes, M.
AD  - Department of Chemistry, College of Science, University of Kufa, Kufa, Iraq
AD  - Department of Clinical Laboratory Sciences, College of Pharmacy, University of Kufa, Kufa, Iraq
AD  - Faculty of Medicine, University of Kufa, Kufa, Iraq
AD  - Department of Psychiatry, University of Toronto, Toronto, ON, Canada
AD  - Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada
AD  - Research Affairs, Chulalongkorn University, Bangkok, Thailand
AD  - Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
AD  - Department of Psychiatry, Medical University Plovdiv, Plovdiv, Bulgaria
AD  - IMPACT Strategic Research Center, Barwon Health, Deakin University, Geelong, VIC, Australia
AB  - Major depressive disorder (MDD) is characterized by signaling aberrations in interleukin (IL)-6, IL-10, beta-endorphins as well as μ (MOR) and κ (KOR) opioid receptors. Here we examined whether these biomarkers may aid in the classification of unknown subjects into the target class MDD. The aforementioned biomarkers were assayed in 60 first-episode, drug-naïve depressed patients and 30 controls. We used joint principal component analysis (PCA) performed on all subjects to check whether subjects cluster by classes; support vector machine (SVM) with 10-fold validation; and linear discriminant analysis (LDA) and SIMCA performed on calibration and validation sets and we computed the figures of merit and learnt from the data. PCA shows that both groups were well separated using the first three PCs, while correlation loadings show that all five biomarkers have discriminatory value. SVM and LDA yielded an accuracy of 100% in validation samples. Using SIMCA, there was a highly significant discrimination of both groups (model-to-model distance = 110.2); all biomarkers showed a significant discrimination and modeling power, while 100% of the patients were authenticated as MDD cases with a specificity of 93.3%. We have delineated that MDD is a distinct class with respect to neuro-immune and opioid biomarkers and that future unknown subjects can be authenticated as having MDD using this SIMCA fingerprint. Precision psychiatry should employ SIMCA to (a) authenticate patients as belonging to the claimed target class and identify other subjects as outsiders, members of another class, or aliens; and (b) acquire knowledge through learning from the data by constructing a biomarker fingerprint of the target class. © 2019, Springer Science+Business Media, LLC, part of Springer Nature.
KW  - Cytokines
KW  - Inflammation
KW  - Major depression
KW  - Neuro-immune
KW  - Opioids
KW  - Supervised learning
KW  - beta endorphin
KW  - interleukin 10
KW  - interleukin 6
KW  - kappa opiate receptor
KW  - mu opiate receptor
KW  - opiate
KW  - adolescent
KW  - adult
KW  - aged
KW  - Article
KW  - biochemical analysis
KW  - controlled study
KW  - cross-sectional study
KW  - diagnostic accuracy
KW  - diagnostic test accuracy study
KW  - discrimination learning
KW  - disease severity
KW  - human
KW  - major clinical study
KW  - major depression
KW  - male
KW  - mental disease
KW  - molecular fingerprinting
KW  - neuroimmunology
KW  - patient coding
KW  - patient identification
KW  - principal component analysis
KW  - protein blood level
KW  - sensitivity and specificity
KW  - supervised machine learning
KW  - support vector machine
KW  - validation process
PB  - Humana Press Inc.
N1  - Cited By :1
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: MONBE
C2  - 31124079
LA  - English
N1  - Correspondence Address: Maes, M.; IMPACT Strategic Research Center, Barwon Health, Deakin UniversityAustralia; email: dr.michaelmaes@hotmail.com
N1  - Chemicals/CAS: beta endorphin, 59887-17-1; opiate, 53663-61-9, 8002-76-4, 8008-60-4
N1  - References: (2017) Depression and Other Common Mental Disorders, , WHO reference number: WHO/MSD/MER/2017.2; 
Maes, M., Evidence for an immune response in major depression: a review and hypothesis (1995) Prog Neuro-Psychopharmacol Biol Psychiatry, 19, pp. 11-38. , COI: 1:STN:280:DyaK2M3isVansg%3D%3D; 
de Melo, L.G.P., Nunes, S.O.V., Anderson, G., Vargas, H.O., Barbosa, D.S., Galecki, P., Carvalho, A.F., Maes, M., Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders (2017) Prog Neuro-Psychopharmacol Biol Psychiatry, 78, pp. 34-50; 
Maes, M., Major depression and activation of the inflammatory response system (1999) Adv Exp Med Biol, 461, pp. 25-46. , COI: 1:CAS:528:DC%2BD3cXis1equ7c%3D, PID: 10442165; 
Köhler, C.A., Freitas, T.H., Maes, M., de Andrade, N.Q., Liu, C.S., Fernandes, B.S., Stubbs, B., Solmi, M., Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies (2017) Acta Psychiatr Scand, 135 (5), pp. 373-387. , PID: 28122130; 
Maes, M., Carvalho, A.F., The compensatory immune-regulatory reflex system (CIRS) in depression and bipolar disorder (2018) Mol Neurobiol, 55 (12), pp. 8885-8903. , COI: 1:CAS:528:DC%2BC1cXmvVekurk%3D, PID: 29611101; 
Köhler, C.A., Freitas, T.H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N.Q., Morris, G., Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis (2018) Mol Neurobiol, 55 (5), pp. 4195-4206; 
Maes, M., Rief, W., Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway (2012) Psychiatry Res, 196 (2-3), pp. 243-249. , COI: 1:CAS:528:DC%2BC38XnslOht70%3D, PID: 22364930; 
Gururajan, A., Clarke, G., Dinan, T.G., Cryan, J.F., Molecular biomarkers of depression (2016) Neurosci Biobehav Rev, 64, pp. 101-133. , COI: 1:CAS:528:DC%2BC28XjtFChtLk%3D, PID: 26906761; 
Hacimusalar, Y., Eşel, E., Suggested biomarkers for major depressive disorder (2018) Noro Psikiyatr Ars, 55 (3), pp. 280-290. , PID: 30224877; 
Crowley, N.A., Kash, T.L., Kappa opioid receptor signaling in the brain: circuitry and implications for treatment (2015) Prog Neuro-Psychopharmacol Biol Psychiatry, 62, pp. 51-60. , COI: 1:CAS:528:DC%2BC2MXitlShurg%3D; 
Carlezon, W.A., Jr., Krystal, A.D., Kappa-opioid antagonists for psychiatric disorders: from bench to clinical trials (2016) Depress Anxiety, 33 (10), pp. 895-906. , COI: 1:CAS:528:DC%2BC28Xhs1SjtLjK, PID: 27699938; 
Al-Fadhel, S.Z., Al-Hakeim, H.K., Al-Dujaili, A.H., Maes, M., IL-10 is associated with increased mu-opioid receptor levels in major depressive disorder (2019) Eur Psychiatry, 21 (57), pp. 46-51; 
Berk, M., Kapczinski, F., Andreazza, A.C., Dean, O.M., Giorlando, F., Maes, M., Yücel, M., Gama, C.S., Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors (2011) Neurosci Biobehav Rev, 35 (3), pp. 804-817. , COI: 1:CAS:528:DC%2BC3cXhsFCrurvO, PID: 20934453; 
Carroll, B.J., Clinical applications of the dexamethasone suppression test for endogenous depression (1982) Pharmacopsychiatria, 15 (1), pp. 19-25. , COI: 1:STN:280:DyaL387ltFeltg%3D%3D, PID: 7038718; 
Angst, J., Adolfsson, R., Benazzi, F., Gamma, A., Hantouche, E., Meyer, T.D., Skeppar, P., Vieta, E., The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients (2005) J Affect Disord, 88 (2), pp. 217-233. , PID: 16125784; 
Alciati, A., Sarzi-Puttini, P., Batticciotto, A., Torta, R., Gesuele, F., Atzeni, F., Angst, J., Overactive lifestyle in patients with fibromyalgia as a core feature of bipolar spectrum disorder (2012) Clin Exp Rheumatol, 30, pp. 122-128. , PID: 23261011; 
Maes, M., Schotte, C., Maes, L., Cosyns, P., Clinical subtypes of unipolar depression: part II. Quantitative and qualitative clinical differences between the vital and nonvital depression groups (1990) Psychiatry Res, 34 (1), pp. 43-57. , COI: 1:STN:280:DyaK3M%2FpsFGjsw%3D%3D, PID: 2267263; 
Kanchanatawan, B., Sriswasdi, S., Thika, S., Sirivichayakul, S., Carvalho, A.F., Geffard, M., Kubera, M., Maes, M., Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning (2018) Metab Brain Dis, 33 (4), pp. 1053-1067. , PID: 29527624; 
Wold, S., Sjostrom, M., SIMCA: A method for analysing chemical data in terms of similarity and analogy (1977) Chemometrics: Theory and Application, Cahter 12, ACS Symposium Series, 52, pp. 243-282. , Washington; 
Harman, H.H., (1976) Modern Factor Analysis, 3Rd Edn Revised, , University of Chicago Press, Chicago; 
Derde, M.-P., Coomans, D., Massart, D.L., SIMCA (soft independent modeling of class analogy) demonstrated with characterization and classification of Italian olive oil (1984) J Assoc Off Anal Chem, 67, pp. 721-726. , COI: 1:CAS:528:DyaL2cXltV2hsL4%3D; 
Maes, M., Maes, L., Schotte, C., Cosyns, P., A clinical and biological validation of the DSM-III melancholia diagnosis in men: results of pattern recognition methods (1992) J Psychiatr Res, 26 (3), pp. 183-196. , COI: 1:STN:280:DyaK3s%2FlvVyhsg%3D%3D, PID: 1432845; 
Maes, M., Twisk, F.N., Johnson, C., Myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS), and chronic fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data (2012) Psychiatry Res, 200 (2-3), pp. 754-760. , PID: 22521895; 
(2019) The Unscrambler Appendices: Method References, , www.camo.com/helpdocs/The_Unscrambler_Method_References.pdf, 2019, Accessed 19-3-2019; 
Ripley, B.D., (2008) Pattern recognition and neural networks, , Cambridge University Press, Cambridge: Paperback. ISBN-13: 978-0521717700; 
Brownlee, J., (2016) Supervised and unsupervised machine learning algorithms; understand machine learning algorithms, , https://machinelearningmastery.com/supervised-and-unsupervised-machine-learning-algorithms/, As assessed, Accessed online 19 Mar 2019; 
Green, S.B., Salkind, N.J., Akey, T.M., (2008) Using SPSS for Windows and Macintosh: analyzing and understanding data, , Prentice Hall, New Jersey; 
Çokluk-Bökeoğlu, Ö., Büyüköztürk, Ş., Discriminant function analysis: Concept and application (2008) Eurasian J Educ Res, (33), pp. 73-92; 
Qiao, Z., Zhou, L., Huang, J.Z., Effective linear discriminant analysis for high dimensional (2008) Low Sample Size Data in Proceeding of the World Congress on Engineering (2), Citeseer, pp. 2-4; 
Cawley, G.C., Talbot, N.C.L., On over-fitting in model selection and subsequent selection bias in performance evaluation (2010) J Mach Learn Res, 11, pp. 2079-2107; 
Alamprese, C., Casiraghi, E., Application of FT-NIR and FT-IR spectroscopy to fish fillet authentication (2015) Lebensm Wiss Technol, 63 (1), pp. 720-725. , COI: 1:CAS:528:DC%2BC2MXls1ant7s%3D; 
Derde, M.-P., Massart, D.L., Extraction of information from large data sets by pattern recognition (1982) Fresmius’Z Anal Chem, 313, pp. 484-495. , COI: 1:CAS:528:DyaL3sXosFOiug%3D%3D; 
(2000) Diagnostic and statistical manual of mental disorders, 4. , Author, Washington, DC: text revision; 
Al-Hakeim, H.K., Al-Fadhel, S.Z., Al-Dujaili, A.H., Maes, M., (2019) Major depression, increased serum dynorphin and kappa opioid receptor levels are positively associated with mu opioid receptor levels and immune activation and are attenuated by nicotine dependence, p. 2019040176. , https://doi.org/10.20944/preprints201904.0176.v1, Preprints 2019; 
Chu, Y., Zhao, X., Zou, Y., Xu, W., Han, J., Zhao, Y., A decoding scheme for incomplete motor imagery EEG with deep belief network (2018) Front Neurosci, 12, p. 680. , PID: 30323737; 
Yang, J., Zhang, M., Ahn, H., Zhang, Q., Jin, T.B., Li, I., Nemesure, M., Joshi, N., Development and evaluation of a multimodal marker of major depressive disorder (2018) Hum Brain Mapp, 39 (11), pp. 4420-4439. , PID: 30113112; 
Mumtaz, W., Ali, S.S.A., Yasin, M.A.M., Malik, A.S., A machine learning framework involving EEG-based functional connectivity to diagnose major depressive disorder (MDD) (2018) Med Biol Eng Comput, 56 (2), pp. 233-246. , PID: 28702811; 
Zheng, H., Zheng, P., Zhao, L., Jia, J., Tang, S., Xu, P., Xie, P., Gao, H., Predictive diagnosis of major depression using NMR-based metabolomics and least-squares support vector machine (2017) Clin Chim Acta, 464, pp. 223-227. , COI: 1:CAS:528:DC%2BC28XitVOjs7jI, PID: 27931880; 
De Maesschalk, A., Candolfi, A., massart, D.L., Heuerding, S., Decision criteria for soft independent modelling of class analogy applied to near infrared data (1999) Chemom Intell Lab Syst, 47 (1), pp. 65-77; 
Rácz, A., Gere, A., Bajusz, D., Héberger, K., Is soft independent modeling of class analogies a reasonable choice for supervised pattern recognition? (2018) RSC Advances, 8 (1), pp. 10-21; 
Naes, T., Mevik, B.-H., Understanding the collinearity problem in regression and discriminant analysis (2001) J Chemometrics, 15 (4), pp. 413-426. , COI: 1:CAS:528:DC%2BD3MXktFyhtro%3D; 
Maes, M., Moraes, J.B., Congio, A., Bonifacio, K.L., Barbosa, D.S., Vargas, H.O., Michelin, A.P., Nunes, S.O.V., Development of a Novel Staging Model for Affective Disorders Using Partial Least Squares Bootstrapping: Effects of Lipid-Associated Antioxidant Defenses and Neuro-Oxidative Stress (2019) Molecular Neurobiology, 56 (9), pp. 6626-6644; 
Maes, M., Song, C., Lin, A.H., Bonaccorso, S., Kenis, G., De Jongh, R., Bosmans, E., Scharpé, S., Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion (1999) Neuropsychopharmacology, 20 (4), pp. 370-379. , COI: 1:CAS:528:DyaK1MXitVSnur4%3D, PID: 10088138; 
Stojanov, D., Korf, J., Jonge, P., Popov, G., The possibility of evidence-based psychiatry: depression as a case (2011) Clin Epigenetics, 2 (1), pp. 7-15. , PID: 22704266; 
Stojanov, D., Machamer, P.K., Schaffner, K.F., Rivera-Hernández, R., The challenge of psychiatric nosology and diagnosis (2012) J Eval Clin Pract, 18 (3), pp. 704-709; 
Zachar, P., Stoyanov, D.S., Aragona, M., Jablensky, A., (2014) Alternative perspectives on psychiatric validation: DSM, ICD, RDoC, and beyond, , (eds), OUP, Oxford; 
Kendler, K.S., Parnas, J., (2015) Philosophical issues in psychiatry: explanation, phenomenology, and nosology, , (eds), JHU Press, Baltimore; 
Fernandes, B.S., Williams, L.M., Steiner, J., Leboyer, M., Carvalho, A.F., Berk, M., The new field of ‘precision psychiatry’ (2017) BMC Med, 15 (1), p. 80. , PID: 28403846
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066235456&doi=10.1007%2fs12035-019-01647-0&partnerID=40&md5=062423d4645bcc40287e27cfa24a7f43
ER  - 

TY  - JOUR
TI  - Relationships Between Alexithymia and Psychopathy in Heroin Dependent Individuals
T2  - Frontiers in Psychology
J2  - Front. Psychol.
VL  - 10
PY  - 2019
DO  - 10.3389/fpsyg.2019.02269
SN  - 16641078 (ISSN) 
AU  - Psederska, E.
AU  - Savov, S.
AU  - Atanassov, N.
AU  - Vassileva, J.
AD  - Department of Cognitive Science and Psychology, New Bulgarian University, Sofia, Bulgaria
AD  - Bulgarian Addictions Institute, Sofia, Bulgaria
AD  - Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, United States
AD  - Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, United States
AB  - Background: Psychopathy and substance use disorders are highly co-morbid and their co-occurrence is associated with higher severity of addictive behavior and increased risk of violent offending. Both substance use disorders and psychopathy are related to prominent impairments in emotion processing, which are also central features of alexithymia. The nature of the relationship between psychopathy and alexithymia is not well-understood and has been particularly understudied among substance dependent individuals. Aim: Our goal was to evaluate the levels of psychopathy and alexithymia in a relatively homogeneous sample of heroin dependent individuals (HDIs) and healthy controls and to examine group differences in the pattern of associations between these constructs. Methods: We examined 62 participants (31 heroin dependent individuals and 31 healthy controls) with the Psychopathy Checklist: Screening version (PCL:SV, Hart et al., 1995) and the Toronto Alexithymia Scale-20 (TAS-20, Bagby et al., 1994). Results: Heroin dependent individuals were characterized by higher levels of both psychopathy and alexithymia as compared to the control group. In addition, HDIs with higher levels of psychopathy reported more difficulties in identifying and verbalizing emotional states. In the heroin group, alexithymia was more strongly associated with the impulsive/antisocial characteristics (impulsivity, irresponsibility, antisocial behavior) than with the interpersonal/affective features of psychopathy (grandiosity, manipulativeness, lack of empathy, and remorse). Conclusion: Our findings suggest that alexithymia may be one potential mechanism linking psychopathy with opioid use disorders. The development of interventions targeting alexithymia could have significant applications in relapse prevention programs and psychotherapy of substance use disorders with concurrent psychopathy. © Copyright © 2019 Psederska, Savov, Atanassov and Vassileva.
KW  - alexithymia
KW  - emotion processing
KW  - opioid use disorder
KW  - psychopathy
KW  - substance use disorders
PB  - Frontiers Media S.A.
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C7  - 2269
LA  - English
N1  - Correspondence Address: Savov, S.; Department of Cognitive Science and Psychology, New Bulgarian UniversityBulgaria; email: ssavov@nbu.bg
N1  - Funding details: Fogarty International Center, FIC
N1  - Funding details: National Institute on Drug Abuse, NIDA
N1  - Funding text 1: We would like to thank all volunteers for their participation in this study. We express our gratitude to Georgi Vasilev, Kiril Bozgunov, Dimitar Nedelchev, Rada Naslednikova, Ivaylo Raynov, Emiliya Peneva, and Victoria Dobrojalieva for assistance with recruitment and testing of study participants. Funding. This research was supported by grant R01 DA021421 (JV) from the National Institute on Drug Abuse (NIDA), and the Fogarty International Center (FIC).
N1  - References: Ahn, W.Y., Vasilev, G., Lee, S.H., Busemeyer, J.R., Kruschke, J.K., Bechara, A., Decision-making in stimulant and opiate addicts in protracted abstinence: evidence from computational modeling with pure users (2014) Front. Psychol, 5 (849). , 25161631; 
Ahn, W.Y., Vassileva, J., Machine learning identifies substance-specific behavioral markers of heroin and amphetamine dependence (2016) Drug Alcohol Depend, 161, pp. 247-257. , 26905209; 
Alterman, A.I., Rutherford, M.J., Cacciola, J.S., McKay, J.R., Boardman, C.R., Prediction of 7 months methadone maintenance treatment response by four measures of antisociality (1998) Drug Alcohol Depend, 49, pp. 217-223. , 9571386; 
Andersson, H.W., Wenaas, M., Nordfjærn, T., Relapse after inpatient substance use treatment: a prospective cohort study among users of illicit substances (2019) Addict. Behav, 90, pp. 222-228. , 30447514; 
Badiani, A., Belin, D., Epstein, D., Calu, D., Shaham, Y., Opiate versus psychostimulant addiction: the differences do matter (2011) Nat. Rev. Neuroscience, 12, pp. 685-700. , 21971065; 
Bagby, R.M., Parker, J.D., Taylor, G.J., The twenty-item toronto alexithymia scale—I. Item selection and cross-validation of the factor structure (1994) J. Psychosom. Res, 38, pp. 23-32. , 8126686; 
Bagby, R.M., Taylor, G.J., Parker, J.D., Dickens, S.E., The development of the toronto structured interview for alexithymia: item selection, factor structure, reliability and concurrent validity (2006) Psychother. Psychosom, 75, pp. 25-39. , 16361872; 
Baker, T.B., Piper, M.E., McCarthy, D.E., Majeskie, M.R., Fiore, M.C., Addiction motivation reformulated: an affective processing model of negative reinforcement (2004) Psychol. Rev, 111, pp. 33-51. , 14756584; 
Bennett, T., Holloway, K., The causal connection between drug misuse and crime (2009) Br. J. Criminol, 49, pp. 513-531; 
Bennett, T., Holloway, K., Farrington, D., The statistical association between drug misuse and crime: a meta-analysis (2008) Aggress. Violent Behav, 13, pp. 107-118; 
Blackburn, R., Coid, J.W., Psychopathy and the dimensions of personality disorder in violent offenders (1998) Pers. Individ. Diff, 25, pp. 129-145; 
Blair, R.J.R., A cognitive developmental approach to morality: investigating the psychopath (1995) Cognition, 57, pp. 1-29. , 7587017; 
Bozgunov, K., Vasilev, G., Vassileva, J., Investigating the association between psychopathy and intelligence in the Bulgarian population (2014) Clin. Consult. Psychol, 7, pp. 3-16; 
Brorson, H.H., Arnevik, E.A., Rand-Hendriksen, K., Duckert, F., Drop-out from addiction treatment: a systematic review of risk factors (2013) Clin. Psychol. Rev, 33, pp. 1010-1024. , 24029221; 
Buckley, P.F., Prevalence and consequences of the dual diagnosis of substance abuse and severe mental illness (2006) J. Clin. Psychiatry, 67, pp. 5-9. , 16961418; 
Castellanos-Ryan, N., Conrod, P., Personality and substance misuse: evidence for a four-factor model of vulnerability (2012) Drug Abuse and Addiction in Medical Illness, pp. 47-62. , Verster J.C., Brady K., Galanter M., Conrod P., (eds), New York, NY, Springer; 
Clark, L.A., Watson, D., Constructing validity: basic issues in objective scale development (1995) Psychol. Assess, 7, pp. 309-319; 
Cleckley, H., (1976) The Mask of Sanity, , 5th Edn, St. Louis, MO, C. V. Mosby; 
Cleland, C., Magura, S., Foote, J., Rosenblum, A., Kosanke, N., Psychometric properties of the Toronto Alexithymia Scale (TAS-20) for substance users (2005) J. Psychosom. Res, 58, pp. 299-306. , 15865955; 
Conrod, P.J., Pihl, R.O., Stewart, S.H., Dongier, M., Validation of a system of classifying female substance abusers on the basis of personality and motivational risk factors for substance abuse (2000) Psycholol. Addict. Behav, 14, pp. 243-256. , 10998950; 
Contreras-Rodríguez, O., Pujol, J., Batalla, I., Harrison, B.J., Bosque, J., Ibern-Regas, I., Disrupted neural processing of emotional faces in psychopathy (2013) Soc. Cogn. Affect. Neurosci, 9, pp. 505-512. , 23386739; 
Cooper, M.L., Agocha, V.B., Sheldon, M.S., A motivational perspective on risky behaviors: the role of personality and affect regulatory processes (2000) J. Pers, 68, pp. 1059-1088. , 11130732; 
Cooper, M.L., Frone, M.R., Russell, M., Mudar, P., Drinking to regulate positive and negative emotions: a motivational model of alcohol use (1995) J. Pers. Soc. Psychol, 69, pp. 990-1005. , 7473043; 
Crocker, A.G., Mueser, K.T., Drake, R.E., Clark, R.E., McHugo, G.J., Ackerson, T.H., Antisocial personality, psychopathy, and violence in persons with dual disorders: a longitudinal analysis (2005) Crim. Justice Behav, 32, pp. 452-476. , 9571387; 
Cruise, K.E., Becerra, R., Alexithymia and problematic alcohol use: a critical update (2017) Addict. Behav, 77, pp. 232-246. , 29107201; 
Dawel, A., O’kearney, R., McKone, E., Palermo, R., Not just fear and sadness: meta-analytic evidence of pervasive emotion recognition deficits for facial and vocal expressions in psychopathy (2012) Neurosci. Biobehav. Rev, 36, pp. 2288-2304. , 22944264; 
Del Gaizo, A.L., Falkenbach, D.M., Primary and secondary psychopathic-traits and their relationship to perception and experience of emotion (2008) Pers. Individ. Diff, 45, pp. 206-212; 
Dingle, G.A., Neves, D.D.C., Alhadad, S.S., Hides, L., Individual and interpersonal emotion regulation among adults with substance use disorders and matched controls (2018) Br. J. Clin. Psychol, 57, pp. 186-202. , 29277906; 
Drayton, L.A., Santos, L.R., Baskin-Sommers, A., Psychopaths fail to automatically take the perspective of others (2018) Proc. Natl. Acad. Sci. U.S.A, 115, pp. 3302-3307. , 29531085; 
Farges, F., Corcos, M., Speranza, M., Loas, G., Perez-Diaz, F., Venisse, J.L., Alexithymia, depression and drug addiction (2004) L’Encephale, 30, pp. 201-211; 
First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., (1996) Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV), , Washington, DC, American Psychiatric Press; 
Garofalo, C., Neumann, C.S., Velotti, P., Difficulties in emotion regulation and psychopathic traits in violent offenders (2018) J. Crim. Justice, 57, pp. 116-125; 
Garofalo, C., Velotti, P., Zavattini, G.C., Emotion regulation and aggression: the incremental contribution of alexithymia, impulsivity, and emotion dysregulation facets (2017) Psychol. Violence, 8, pp. 470-483; 
Ghalehban, M., Besharat, M.A., Examination and comparison of alexithymia and self-regulation in patients with substance abuse disorder and normal individuals (2011) Proc. Soc. Behav. Sci, 30, pp. 38-42; 
Gillespie, S.M., Garofalo, C., Velotti, P., Emotion regulation, mindfulness, and alexithymia: specific or general impairments in sexual, violent, and homicide offenders? (2018) J. Crim. Justice, 58, pp. 56-66. , 29660642; 
Glenn, A.L., Raine, A., Schug, R.A., Young, L., Hauser, M., Increased DLPFC activity during moral decision-making in psychopathy (2009) Mol. Psychiatry, 14, pp. 909-911; 
Gori, A., Craparo, G., Sareri, G.I., Caretti, V., Giannini, M., Meringolo, P., Antisocial and psychopathic personalities in a sample of addicted subjects: differences in psychological resources, symptoms, alexithymia and impulsivity (2014) Compr. Psychiatry, 55, pp. 1580-1586. , 25081732; 
Grieve, R., Mahar, D., The emotional manipulation–psychopathy nexus: relationships with emotional intelligence, alexithymia and ethical position (2010) Pers. Individ. Diff, 48, pp. 945-950; 
Groat, L.L., Shane, M.S., A motivational account of psychopathy: etiological considerations and implications for violence reduction (2019) PsyArXiv; 
Gudonis, L.C., Derefinko, K., Giancola, P.R., The treatment of substance misuse in psychopathic individuals: why heterogeneity matters (2009) Subst. Use Misuse, 44, pp. 1415-1433. , 19938925; 
Hanel, P.H., Vione, K.C., Do student samples provide an accurate estimate of the general public? (2016) PLoS One, 11 (e0168354). , 28002494; 
Hare, R.D., (1991) Manual for the Hare Psychopathy Checklist –Revised, , Toronto, ON, Multi-Health Systems; 
Hare, R.D., (2003) Manual for the Hare Psychopathy Checklist –Revised, , 2nd Edn, Toronto, ON, Multi-Health Systems; 
Hare, R.D., Harpur, T.J., Hakstian, A.R., Forth, A.E., Hart, S.D., Newman, J.P., The revised psychopathy checklist: reliability and factor structure (1990) Psychol. Assess, 2, pp. 338-341; 
Hare, R.D., Neumann, C.S., The PCL-R assessment of psychopathy (2006) Handbook of Psychopathy, pp. 58-88. , Patrick C.J., (ed), New York, NY, The Guilford Press; 
Harpur, T.J., Hare, R.D., Hakstian, A.R., Two-factor conceptualization of psychopathy: construct validity and assessment implications (1989) Psychol. Assess, 1, pp. 6-17; 
Hart, S., Cox, D.N., Hare, R.D., (1995) The Hare Psychopathy Checklist: Screening Version (PCL-SV), , North Tonowanda, NY, Multi-Health Systems; 
Hart, S.D., Hare, R.D., Discriminant validity of the Psychopathy Checklist in a forensic psychiatric population (1989) Psychol. Assess. J. Consult. Clin. Psychol, 1, pp. 211-218; 
Haviland, M.G., Hendryx, M.S., Shaw, D.G., Henry, J.P., Alexithymia in women and men hospitalized for psychoactive substance dependence (1994) Compr. Psychiatry, 35, pp. 124-128. , 8187475; 
Hemphill, J.F., Hart, S.D., Hare, R.D., Psychopathy and substance use (1994) J. Pers. Disord, 8, pp. 169-180; 
Hicks, B.M., Markon, K.E., Patrick, C.J., Krueger, R.F., Newman, J.P., Identifying psychopathy subtypes on the basis of personality structure (2004) Psychol. Assess, 16, pp. 276-288. , 15456383; 
Hoshi, R., Bisla, J., Curran, H.V., The acute and sub-acute effects of ‘ecstasy’ (MDMA) on processing of facial expressions: preliminary findings (2004) Drug Alcohol Depend, 76, pp. 297-304. , 15561480; 
Kadam, M., Sinha, A., Nimkar, S., Matcheswalla, Y., De Sousa, A., A comparative study of factors associated with relapse in alcohol dependence and opioid dependence (2017) Indian J. Psychol. Med, 39, pp. 627-633. , 29200559; 
Karpman, B., The myth of the psychopathic personality (1948) Am. J. Psychiatry, 104, pp. 523-534. , 18911629; 
Khantzian, E.J., Understanding addictive vulnerability: an evolving psychodynamic perspective (2003) Neuropsychoanalysis, 5, pp. 5-21; 
Kiehl, K.A., Smith, A.M., Hare, R.D., Mendrek, A., Forster, B.B., Brink, J., Limbic abnormalities in affective processing by criminal psychopaths as revealed by functional magnetic resonance imaging (2001) Biol. Psychiatry, 50, pp. 677-684. , 11704074; 
Kimonis, E.R., Frick, P.J., Cauffman, E., Goldweber, A., Skeem, J., Primary and secondary variants of juvenile psychopathy differ in emotional processing (2012) Dev. Psychopathol, 24, pp. 1091-1103. , 22781873; 
Kirsch, L.G., Becker, J.V., Emotional deficits in psychopathy and sexual sadism: implications for violent and sadistic behavior (2007) Clin. Psychol. Rev, 27, pp. 904-922. , 17343965; 
Kober, H., Bolling, D., Emotion regulation in substance use disorders (2014) Handbook of Emotion Regulation, pp. 428-446. , Gross J.J., (ed), 2nd Edn, New York, NY, Guilford; 
Koob, G.F., A role for brain stress systems in addiction (2008) Neuron, 59, pp. 11-34. , 18614026; 
Koob, G.F., LeMoal, M., Addiction and the brain antireward system (2008) Ann. Rev. Psychol, 59, pp. 29-53. , 18154498; 
Koob, G.F., Volkow, N., Neurocircuitry of addiction (2010) Neuropsychopharmacology, 39, pp. 217-238. , 19710631; 
Kornreich, C., Foisy, M.L., Philippot, P., Dan, B., Tecco, J., Noel, X., Impaired emotional facial expression recognition in alcoholics, opiate dependence subjects, methadone maintained subjects and mixed alcohol-opiate antecedents subjects compared with normal controls (2003) Psychiatry Res, 119, pp. 251-260. , 12914896; 
Kroner, D.G., Forth, A.E., The Toronto alexithymia scale with incarcerated offenders (1995) Pers. Individ. Diff, 19, pp. 625-634; 
Krueger, R.F., Hicks, B.M., Patrick, C.J., Carlson, S.R., Iacono, W.G., McGue, M., Etiologic connections among substance dependence, antisocial behavior, and personality: modeling the externalizing spectrum (2002) J. Abnorm. Psychol, 111, pp. 411-424. , 12150417; 
Kwako, L.E., Momenan, R., Litten, R.Z., Koob, G.F., Goldman, D., Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders (2016) Biol. Psychiatry, 80, pp. 179-189. , 26772405; 
Lander, G.C., Lutz-Zois, C.J., Rye, M.S., Goodnight, J.A., The differential association between alexithymia and primary versus secondary psychopathy (2012) Pers. Individ. Diff, 52, pp. 45-50; 
Lane, R.D., Weihs, K.L., Herring, A., Hishaw, A., Smith, R., Affective agnosia: expansion of the alexithymia construct and a new opportunity to integrate and extend Freud’s legacy (2015) Neurosci. Biobehav. Rev, 55, pp. 594-611. , 26054794; 
Lilienfeld, S.O., Widows, M.R., (2005) Psychopathic Personality Inventory-Revised: Professional Manual, , Lutz, FL, Psychological Assessment Resources Inc; 
Loas, G., Braun, S., Delhaye, M., Linkowski, P., The measurement of alexithymia in children and adolescents: psychometric properties of the alexithymia questionnaire for children and the twenty-item toronto alexithymia scale in different non-clinical and clinical samples of children and adolescents (2017) PLoS One, 12 (e0177982). , 28542508; 
Loas, G., Corcos, M., Stephan, P., Pellet, J., Bizouard, P., Venisse, J.L., Factorial structure of the 20-item toronto alexithymia scale: confirmatory factorial analyses in nonclinical and clinical samples (2001) J. Psychosom. Res, 50, pp. 255-261. , 11399282; 
Louth, S.M., Hare, R.D., Linden, W., Psychopathy and alexithymia in female offenders (1998) Can. J. Behav. Sci, 30, pp. 91-98; 
Lykken, D.T., A study of anxiety in the sociopathic personality (1957) J. Abnorm. Soc. Psychol, 55, pp. 6-10. , 13462652; 
Mayer, S.V., Jusyte, A., Klimecki-Lenz, O.M., Schönenberg, M., Empathy and altruistic behavior in antisocial violent offenders with psychopathic traits (2018) Psychiatry Res, 269, pp. 625-632. , 30208352; 
Möller, C., Falkenström, F., Holmqvist Larsson, M., Holmqvist, R., Mentalizing in young offenders (2014) Psychoanal. Psychol, 31, pp. 84-99; 
Morie, K.P., Nich, C., Hunkele, K., Potenza, M.N., Carroll, K.M., Alexithymia level and response to computer-based training in cognitive behavioral therapy among cocaine-dependent methadone maintained individuals (2015) Drug Alcohol Depend, 152, pp. 157-163. , 25982006; 
Morie, K.P., Yip, S.W., Nich, C., Hunkele, K., Carroll, K.M., Potenza, M.N., Alexithymia and addiction: a review and preliminary data suggesting neurobiological links to reward/loss processing (2016) Curr. Addict. Rep, 3, pp. 239-248. , 27695665; 
Newman, J.P., Curtin, J.J., Bertsch, J.D., Baskin-Sommers, A.R., Attention moderates the fearlessness of psychopathic offenders (2010) Biol. Psychiatry, 67, pp. 66-70. , 19793581; 
O’Neill, M.L., Lidz, V., Heilbrun, K., Adolescents with psychopathic characteristics in a substance abusing cohort: treatment process and outcomes (2003) Law Hum. Behav, 27, pp. 299-313. , 12794966; 
Patkar, A.A., Murray, H.W., Mannelli, P., Gottheil, E., Weinstein, S.P., Vergare, M.J., Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for african—american cocaine—dependent patients (2004) J. Addict. Dis, 23, pp. 109-122. , 15132346; 
Patrick, C.J., Emotion and psychopathy: startling new insights (1994) Psychophysiology, 31, pp. 319-330. , 10690912; 
Patrick, C.J., Hicks, B.M., Krueger, R.F., Lang, A.R., Relations between psychopathy facets and externalizing in a criminal offender sample (2005) J. Pers. Disord, 19, pp. 339-356. , 16178678; 
Pham, T.H., Ducro, C., Luminet, O., Psychopathy, alexithymia and emotional intelligence in a forensic hospital (2010) Int. J. Forensic Mental Health, 9, pp. 24-32; 
Pinard, L., Negrete, J.C., Annable, L., Audet, N., Alexithymia in substance abusers: persistence and correlates of variance (1996) Am. J. Addict, 5, pp. 32-39; 
Popov, V., Psederska, E., Peneva, E., Bozgunov, K., Vasilev, G., Nedelchev, D., Psychometric characteristics of the bulgarian version of the toronto alexithymia scale (TAS-20) (2016) Psychol. Res, 2, pp. 25-41; 
Porter, S., Without conscience or without active conscience? The etiology of psychopathy revisited (1996) Aggress. Violent Behav, 1, pp. 179-189; 
Poythress, N.G., Skeem, J.L., Disaggregating psychopathy (2006) Handbook of Psychopathy, pp. 172-192. , Patrick C.J., (ed), New York, NY, The Guilford Press; 
Preacher, K.J., (2002) Calculation for the test of the difference between two independent correlation coefficients [Computer software], , http://quantpsy.org/corrtest/corrtest.htm, (accessed May 20, 2019; 
Ramey, T., NIDA Phenotyping Battery (2017) the Proceedings of the NIDA Genetics Consortium Meeting, , Bethesda, MD, in; 
Rasmussen, K., Storsæter, O., Levander, S., Personality disorders, psychopathy, and crime in a Norwegian prison population (1999) Int. J. Law Psychiatry, 22, pp. 91-97; 
Richards, H.J., Casey, J.O., Lucente, S.W., Psychopathy and treatment response in incarcerated female substance abusers (2003) Crim. Justice Behav, 30, pp. 251-276. , 29529409; 
Rutherford, M.J., Alterman, A.I., Cacciola, J.S., Psychopathy and substance abuse: a bad mix (2000) The Clinical and Forensic Assessment of Psychopathy: A Practitioner’s Guide, pp. 351-368. , Gacono C.B., (ed), Abingdon, Routledge; 
Samur, D., Tops, M., Schlinkert, C., Quirin, M., Cuijpers, P., Koole, S.L., Four decades of research on alexithymia: moving toward clinical applications (2013) Front. Psychol, 4 (861). , 24312069; 
Shurman, J., Koob, G.F., Gutstein, H.B., Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain (2010) Pain Med, 11, pp. 1092-1098. , 20545871; 
Sifneos, P.E., The prevalence of ‘alexithymic’characteristics in psychosomatic patients (1973) Psychother. Psychosom, 22, pp. 255-262. , 4770536; 
Smith, S.S., Newman, J.P., Alcohol and drug abuse-dependence disorders in psychopathic and nonpsychopathic criminal offenders (1990) J. Abnorm. Psychol, 99, pp. 430-439. , 2266219; 
Smyth, B.P., Barry, J., Keenan, E., Ducray, K., Lapse and relapse following inpatient treatment of opiate dependence (2010) Ir. Med. J, 103, pp. 176-179. , 20669601; 
Snowden, R.J., Gray, N.S., Impulsivity and psychopathy: associations between the barrett impulsivity scale and the psychopathy checklist revised (2011) Psychiatry Res, 187, pp. 414-417. , 21377739; 
Staiger, P.K., Kambouropoulos, N., Dawe, S., Should personality traits be considered when refining substance misuse treatment programs? (2007) Drug Alcohol Rev, 26, pp. 17-23. , 17364832; 
Thomson, N.D., Bozgunov, K., Psederska, E., Vassileva, J., Sex differences on the four facets of psychopathy predict physical, verbal, and indirect aggression (2019) Aggress. Behav, 45, pp. 265-274. , 30699249; 
(2017) World Drug Report 2017, 1. , New York, NY, United Nations Publications; 
Vanheule, S., Verhaeghe, P., Desmet, M., In search of a framework for the treatment of alexithymia (2011) Psychol. Psychother, 84, pp. 84-97; 
Vassileva, J., Georgiev, S., Martin, E.M., Gonzalez, R., Segalà, L., Psychopathic heroin addicts are not uniformly impaired across neurocognitive domains of impulsivity (2011) Drug Alcohol Depend, 114, pp. 194-200; 
Vassileva, J., Kosson, D.S., Abramowitz, C., Conrod, P.J., Psychopathy vs. psychopathies in classifying criminal offenders (2005) Legal Criminol. Psychol, 10, pp. 27-43; 
Vassileva, J., Petkova, P., Georgiev, S., Martin, E.M., Tersiyski, R., Raycheva, M., Impaired decision-making in psychopathic heroin addicts (2007) Drug Alcohol Depend, 86, pp. 287-289. , 16930861; 
Vassileva, J., Shahidi, R., Wang, Q., Taylor, B.A., Moeller, F.G., Vasilev, G., Machine learning identifies common and specific markers of dependence on five different classes of drugs (2019) Biol. Psychiatry, 85 (S209); 
Verdejo-García, A., Rivas-Pérez, C., Vilar-López, R., Pérez-García, M., Strategic self-regulation, decision-making and emotion processing in poly-substance abusers in their first year of abstinence (2007) Drug Alcohol Depend, 86, pp. 139-146. , 16806737; 
Vidal, S., Skeem, J., Camp, J., Emotional intelligence: painting different paths for low-anxious and high-anxious psychopathic variants (2010) Law Hum. Behav, 34, pp. 150-163. , 19390956; 
Weiss, N.H., Tull, M.T., Viana, A.G., Anestis, M.D., Gratz, K.L., Impulsive behaviors as an emotion regulation strategy: examining associations between PTSD, emotion dysregulation, and impulsive behaviors among substance dependent inpatients (2012) J. Anxiety Disord, 26, pp. 453-458. , 22366447; 
Wilson, M.J., Abramowitz, C., Vasilev, G., Bozgunov, K., Vassileva, J., Psychopathy in Bulgaria: the cross-cultural generalizability of the hare psychopathy checklist (2014) J. Psychopathol. Behav. Assess, 36, pp. 389-400. , 25313268; 
Wilson, M.J., Vassileva, J., Neurocognitive and psychiatric dimensions of hot, but not cool, impulsivity predict HIV sexual risk behaviors among drug users in protracted abstinence (2016) Am. J. Drug Alcohol Abuse, 42, pp. 231-241. , 26837332; 
Wise, R.A., Koob, G.F., The development and maintenance of drug addiction (2014) Neuropsychopharmacology, 39, pp. 254-262. , 24121188; 
Witkiewitz, K., Villarroel, N.A., Dynamic association between negative affect and alcohol lapses following alcohol treatment (2009) J. Consult. Clin. Psychol, 77, pp. 633-644. , 19634957; 
Woicik, P.A., Stewart, S.H., Pihl, R.O., Conrod, P.J., The substance use risk profile scale: a scale measuring traits linked to reinforcement-specific substance use profiles (2009) Addict. Behav, 34, pp. 1042-1055. , 19683400
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074135201&doi=10.3389%2ffpsyg.2019.02269&partnerID=40&md5=8dc4bb9d12153778fc641f59b8505abd
ER  - 

TY  - JOUR
TI  - Binomial Logistic Regression and Artificial Neural Network Methods to Classify Opioid-Dependent Subjects and Control Group Using Quantitative EEG Power Measures
T2  - Clinical EEG and Neuroscience
J2  - Clin. EEG Neurosci.
VL  - 50
IS  - 5
SP  - 303
EP  - 310
PY  - 2019
DO  - 10.1177/1550059418824450
SN  - 15500594 (ISSN) 
AU  - Erguzel, T.T.
AU  - Noyan, C.O.
AU  - Eryilmaz, G.
AU  - Ünsalver, B.Ö.
AU  - Cebi, M.
AU  - Tas, C.
AU  - Dilbaz, N.
AU  - Tarhan, N.
AD  - Department of Software Engineering, Faculty of Engineering and Natural Sciences, Uskudar University, Istanbul, Turkey
AD  - Department of Psychology, Faculty of Humanities and Social Sciences, Uskudar University, Istanbul, Turkey
AB  - Logistic regression (LR) and artificial neural networks (ANNs) are widely referred approaches in medical data classification studies. LR, a statistical fitting model, is suggested in medical problems because of its well-established methodology and coefficients contributing to the evaluation of clinical interpretations. ANNs are graphical models structured with node networks interconnected with arcs each of which is expressed in terms of weights discovered throughout the modeling process. Since ANNs have a complex structure with its layers and nodes in the layers, which provides ANNs the ability to model any data with complex relationships. Among the various models having origins in statistics and computer science, LR and ANNs have prevailed in the area of mass medical data classification. In this study, we introduce the 2 aforementioned approaches in order to generate a model dichotomizing 75 opioid-dependent patients and 59 control subjects from each other. Quantitative electroencephalography (QEEG) absolute power value of each electrode were calculated for 4 consecutive frequency bands namely delta, theta, alpha, and beta with the frequencies, 0.5 to 4, 4 to 8, 8 to 12, and 12 to 20 Hz, respectively. Significant independent variables contributing to the classification were underlined in LR while a feature selection (FS) method, genetic algorithm, is being applied to the ANN model to reveal more informative features. The performances of the classifiers were finally compared considering overall classification accuracies, area under receiver operating characteristic curve scores, and Gini coefficient. Although ANN-based classifier outperformed compared with LR, both models performed satisfactorily for absolute power measure in beta frequency band. Our results underline the potential benefit of the introduced methodology is promising and is to be treated as a clinical interface in dichotomizing substance use disorders subjects and for other medical data analysis studies. © EEG and Clinical Neuroscience Society (ECNS) 2019.
KW  - artificial neural network
KW  - logistic regression
KW  - opioid use disorder
KW  - quantitative EEG
PB  - SAGE Publications Inc.
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: CENLB
C2  - 30642219
LA  - English
N1  - Correspondence Address: Erguzel, T.T.; Department of Software Engineering, Faculty of Engineering and Natural Sciences, Uskudar UniversityTurkey; email: turker.erguzel@uskudar.edu.tr
N1  - References: Dreiseitl, S., Ohno-Machado, L., Logistic regression and artificial neural network classification models: a methodology review (2002) J Biomed Inform, 35, pp. 352-359; 
Menezes, F., Liska, G., Cirillo, M., Data classification with binary response through the Boosting algorithm and logistic regression (2017) Expert Syst Appl, 69, pp. 62-73; 
Hedegaard, H., Chen, L.H., Warner, M., Drug-poisoning deaths involving heroin: United States, 2000-2013 (2015) NCHS Data Brief, (190), pp. 1-8; 
Vorma, H., Sokero, P., Altonen, M., Turtiainen, S., Hughes, L.A., Savolainen, J., Participation in opioid substitution treatment reduces the rate of criminal convictions: evidence from a community study (2013) Addict Behav, 38, pp. 2313-2316; 
White, A.G., Birnbaum, H.G., Mareva, M.N., Direct costs of opioid abuse in an insured population in the United States (2005) J Manag Care Pharm, 11, pp. 469-479; 
Sokhadze, T.M., Cannon, R.L., Trudeau, D.L., EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research (2008) Appl Psychophysiol Biofeedback, 33, pp. 1-28; 
Rausch, M., Zehetleitner, M., Should metacognition be measured by logistic regression? (2017) Conscious Cogn, 49, pp. 291-312; 
Rodrguez, G., Lecture notes on generalized linear models, , https://data.princeton.edu/wws509/notes/a2.pdf, Accessed March 16, 2017; 
Agarwal, S., Kachroo, P., Regentova, E., A hybrid model using logistic regression and wavelet transformation to detect traffic incidents (2016) IATSS Res, 40, pp. 56-63; 
Tino, P., Benuskova, L., Sperduti, A., Artificial neural network models (2015) Springer Handbook of Computational Intelligence, pp. 455-471. , Kacprzyk J., Pedrycz W., (eds), Berlin, Germany, Springer-Verlag, In:, eds; 
Platt, J.C., Using analytic QP and sparseness to speed training of support vector machines (1999) Advances in Neural Information Processing Systems 11, pp. 557-563. , Kearns M.S., Solla S.A., Cohn D.A., (eds), Cambridge, MA, MIT Press, In:, eds; 
Platt, J.C., Cristianini, N.N., Shawe-Taylor, J., Large margin DAG’s for multiclass classification (2000) Advances in Neural Information Processing Systems 12, pp. 547-553. , Solla S.A., Leen T.K., Klaus-Robert M., (eds), Cambridge, MA, MIT Press, In:, eds; 
Whitley, D., Beveridge, R., Guerra, C., Graves, C., Messy genetic algorithms for subset feature selection, pp. 568-575. , Proceedings of the 7th International Conference on Genetic Algorithms, July 19-23, 1997, Boston, MA, In:; 
Garrett, D., Peterson, D.A., Anderson, C.W., Thaut, M.H., Comparison of linear, nonlinear, and feature selection methods for EEG signal classification (2003) IEEE Trans Neural Syst Rehabil Eng, 11, pp. 141-144; 
Ocak, H., Optimal classification of epileptic seizures in EEG using wavelet analysis and genetic algorithm (2008) Signal Process, 88, pp. 1858-1867; 
Montgomery, D.C., (2001) Design and Analysis of Experiments, , 8th ed., Hoboken, NJ, Wiley; 
Lin, C.C., Ou, Y.O., Chen, S.H., Liu, Y.C., Lin, J., Comparison of artificial neural network and logistic regression models for predicting mortality in elderly patients with hip fracture (2010) Injury, 41, pp. 869-873; 
Liew, P.L., Lee, Y.C., Lin, Y.C., Comparison of artificial neural networks with logistic regression in prediction of gallbladder disease among obese patients (2007) Dig Liver Dis, 39, pp. 356-362; 
Subasi, A., Ercelebi, E., Classification of EEG signals using neural network and logistic regression (2005) Comput Methods Programs Biomed, 78, pp. 87-99; 
Green, M., Björk, J., Forberk, J., Ekelund, U., Edenbrandt, L., Ohlsson, M., Comparison between neural networks and multiple logistic regression to predict acute coronary syndrome in the emergency room (2006) Artif Intell Med, 38, pp. 305-318; 
Capecci, E., Kasabov, N., Wang, G.Y., Analysis of connectivity in NeuCube spiking neural network models trained on EEG data for the understanding of functional changes in the brain: a case study on opiate dependence treatment (2015) Neural Netw, 68, pp. 62-77; 
Doborjeh, M.G., Wang, G.Y., Kasabov, N.K., Kydd, R., Russell, B., A spiking neural network methodology and system for learning and comparative analysis of EEG data from healthy versus addiction treated versus addiction not treated subjects (2016) IEEE Trans Biomed Eng, 63, pp. 1830-1841
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85060652888&doi=10.1177%2f1550059418824450&partnerID=40&md5=5efc64edace67b9c297a03b808fd4a9d
ER  - 

TY  - SER
TI  - Towards automating location-specific opioid toxicosurveillance from twitter via data science methods
C3  - Studies in Health Technology and Informatics
J2  - Stud. Health Technol. Informatics
VL  - 264
SP  - 333
EP  - 337
PY  - 2019
DO  - 10.3233/SHTI190238
SN  - 09269630 (ISSN); 9781643680026 (ISBN)
AU  - Sarker, A.
AU  - Gonzalez-Hernandez, G.
AU  - Perrone, J.
AD  - Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
AD  - Division of Informatics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Level 4, 423 Guardian Drive, Philadelphia, PA  19104, United States
AB  - Social media may serve as an important platform for the monitoring of population-level opioid abuse in near real-time. Our objectives for this study were to (i) manually characterize a sample of opioid-mentioning Twitter posts, (ii) compare the rates of abuse/misuse related posts between prescription and illicit opiods, and (iii) to implement and evaluate the performances ofsupervised machine learning algorithms for the characterization of opioid-related chatter, which can potentially automate social media based monitoring in the future.. We annotated a total of 9006 tweets into four categories, trained several machine learning algorithms and compared their performances. Deep convolutional neural networks marginally outperformed support vector machines and random forests, with an accuracy of 70.4%. Lack of context in tweets and data imbalance resulted in misclassification of many tweets to the majority class. The automatic classification experiments produced promising results, although there is room for improvement. © 2019 International Medical Informatics Association (IMIA) and IOS Press. This article is published online with Open Access by IOS Press and distributed under the terms of the Creative Commons Attribution Non-Commercial License 4.0 (CC BY-NC 4.0).
KW  - Opioids
KW  - Social media
KW  - Surveillance
KW  - Decision trees
KW  - Deep neural networks
KW  - Health
KW  - Machine learning
KW  - Medical informatics
KW  - Neural networks
KW  - Social networking (online)
KW  - Space surveillance
KW  - Support vector machines
KW  - Automatic classification
KW  - Convolutional neural network
KW  - Data imbalance
KW  - Misclassifications
KW  - Opioids
KW  - Population levels
KW  - Science methods
KW  - Social media
KW  - Learning algorithms
KW  - narcotic analgesic agent
KW  - human
KW  - machine learning
KW  - opiate addiction
KW  - social media
KW  - Analgesics, Opioid
KW  - Data Science
KW  - Humans
KW  - Machine Learning
KW  - Opioid-Related Disorders
KW  - Social Media
A2  - Seroussi B.
A2  - Ohno-Machado L.
A2  - Ohno-Machado L.
A2  - Seroussi B.
PB  - IOS Press
T2  - 17th World Congress on Medical and Health Informatics, MEDINFO 2019
Y2  - 25 August 2019 through 30 August 2019
N1  - Conference code: 150814
N1  - Export Date: 13 November 2019
M3  - Conference Paper
DB  - Scopus
C2  - 31437940
LA  - English
N1  - Correspondence Address: Sarker, A.; Division of Informatics, Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Level 4, 423 Guardian Drive, United States; email: abeed@pennmedicine.upenn.edu
N1  - Chemicals/CAS: Analgesics, Opioid
N1  - Funding details: Foundation for the National Institutes of Health, FNIH, R01DA046619
N1  - Funding details: Pennsylvania Department of Health, PDH
N1  - Funding text 1: Research reported in this publication was supported in part by the National Institute on Drug Abuse of the National Institutes of Health under Award Number R01DA046619. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The data collection and annotation efforts were partly funded by a grant from the Pennsylvania Department of Health. The Titan Xp used for this research was donated by the NVIDIA Corporation. The authors would like to thank Karen O’Connor, Alexis Upshur and Annika DeRoos for performing the annotations. This study was approved by the institutional review board at the University of Pennsylvania.
N1  - References: Kolodny, A., Frieden, T.R., Ten steps the federal government should take now to reverse the opioid addiction epidemic (2017) JAMA, 318, pp. 1537-1538; 
Han, B., Compton, W.M., Blanco, C., Crane, E., Lee, J., Jones, C.M., Prescription opioid use, misuse, and use disorders in U.S. Adults: 2015 National survey on drug use and health (2017) Ann Intern Med, 167, pp. 293-301; 
Jalal, H., Buchanich, J.M., Roberts, M.S., Balmert, L.C., Zhang, K., Burke, D.S., Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016 (2018) Science, 361, p. 1184; 
Rudd, R.A.R., Seth, P., David, F., Scholl, L., Increases in drug and opioid-involved overdose deaths - United States, 2010-2015 (2016) Morb Mortal Wkly Rep, 65, pp. 1445-1452; 
Schuchat, A., Houry, D., Guy, G.P., New data on opioid use and prescribing in the United States (2017) JAMA, 318, pp. 425-426; 
Shutler, L., Nelson, L.S., Portelli, I., Blachford, C., Perrone, J., Drug use in the Twittersphere: A qualitative contextual analysis of tweets about prescription drugs (2015) J Addict Dis, 34, pp. 303-310; 
Chary, M., Genes, N., Giraud-Carrier, C., Hanson, C., Nelson, L.S., Manini, A.F., Epidemiology from tweets: Estimating misuse of prescription opioids in the USA from social media (2017) J Med Toxicol, 13, pp. 278-286; 
Cameron, D., Predose: A semantic web platform for drug abuse epidemiology using social media (2013) J Biomed Inform, 46, pp. 985-997; 
Sarker, A., Social media mining for toxicovigilance: Automatic monitoring of prescription medication abuse from Twitter (2016) Drug Saf, 39, pp. 231-240; 
Graves, R.L., Tufts, C., Meisel, Z.F., Polsky, D., Ungar, L., Merchant, R.M., Opioid discussion in the Twittersphere (2018) Subst Use Misuse, 53, pp. 2132-2139; 
(2018) Slang Terms and Code Words: A Reference for Law Enforcement Personnel, , DEA Houston Division, US Drug Enforcement Administration, Washington, DC; 
Sarker, A., Gonzalez-Hernandez, G., An unsupervised and customizable misspelling generator for mining noisy health-related text sources (2018) J Biomed Inform, 88, pp. 98-107; 
Sarker, A., Social media mining for toxicovigilance: Automatic monitoring of prescription medication abuse from Twitter (2016) Drug Saf, 39, pp. 231-240; 
Sarker, A., Gonzalez, G., A corpus for mining drug-related knowledge from Twitter chatter: Language models and their utilities (2017) Data in Brief, 10, pp. 122-131; 
Pedregosa, F., Scikit-learn: Machine learning in Python (2011) J Mach Learn Res, 12, pp. 2825-2830; 
Abadi, M., (2016) TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems, , Google Research, Mountain View, CA; 
Cohen, J., A coefficient of agreement for nominal scales (1960) Educ Psychol Meas, 20, pp. 37-46
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071478983&doi=10.3233%2fSHTI190238&partnerID=40&md5=524598d2f53e0f7f9ded1aec2e396c2a
ER  - 

TY  - CONF
TI  - Predicting opioid use disorder (OUD) using a random forest
C3  - Proceedings - International Computer Software and Applications Conference
J2  - Proc Int Comput Software Appl Conf
VL  - 1
SP  - 960
EP  - 961
PY  - 2019
DO  - 10.1109/COMPSAC.2019.00161
SN  - 07303157 (ISSN); 9781728126074 (ISBN)
AU  - Wadekar, A.S.
AD  - Saint John's High, Shrewsbury, MA  01545, United States
AB  - Opioid Use Disorder (OUD), defined as physical or psychological reliance on opioids, is quickly becoming a public health epidemic. This research demonstrates how supervised machine learning can be used to predict adults at risk for OUD by considering interactions between various demographic, socioeconomic, physical, and psychological features in an integrated manner. A labeled data set was built from the responses to the 2016 edition of the National Survey on Drug Use and Health (NSDUH). This labeled data set was used to train and test a random forest classifier while accounting for class imbalance. The classifier can predict adults at risk for OUD accurately (sensitivity = 0.81, specificity = 0.76, AUC = 0.86), although the prevalence of OUD is only about 1%. Early initiation of marijuana (prior to 18 years of age) emerges as the dominant predictor for developing OUD in adult life. This is surprising because it ranks higher than both mental illness and disability; two conditions that are often comorbid with substance use disorders. Thus, curbing early initiation of marijuana may be the best prevention strategy. This highlights the crucial role that educators, counselors, and parents can play in alleviating the United States' opioid overdose crisis. © 2019 IEEE.
KW  - Early Initiation of Marijuana
KW  - Machine Learning
KW  - Opioid Use Disorder
KW  - Random Forest
KW  - Application programs
KW  - Classification (of information)
KW  - Decision trees
KW  - Diseases
KW  - Learning systems
KW  - Machine learning
KW  - Statistical tests
KW  - Supervised learning
KW  - Early Initiation of Marijuana
KW  - National surveys
KW  - Opioid Use Disorder
KW  - Prevention strategies
KW  - Psychological features
KW  - Random forest classifier
KW  - Random forests
KW  - Supervised machine learning
KW  - Forecasting
A2  - Getov V.
A2  - Gaudiot J.-L.
A2  - Yamai N.
A2  - Cimato S.
A2  - Chang M.
A2  - Teranishi Y.
A2  - Yang J.-J.
A2  - Leong H.V.
A2  - Shahriar H.
A2  - Takemoto M.
A2  - Towey D.
A2  - Takakura H.
A2  - Elci A.
A2  - Takeuchi S.
A2  - Puri S.
PB  - IEEE Computer Society
T2  - 43rd IEEE Annual Computer Software and Applications Conference, COMPSAC 2019
Y2  - 15 July 2019 through 19 July 2019
N1  - Conference code: 151742
N1  - Export Date: 13 November 2019
M3  - Conference Paper
DB  - Scopus
C7  - 8753945
N1  - CODEN: PSICD
LA  - English
N1  - Correspondence Address: Wadekar, A.S.; Saint John's HighUnited States; email: adwayw4@gmail.com
N1  - References: (2019), https://www.cdc.gov/drugoverdose/training/oud/accessible/index.html, Center for Disease Control, Module 5: Assessing and Addressing Opioid Use Disorder (OUD). (n.d.). Retrieved Feb; (2019), https://www.cdc.gov/drugoverdose/epidemic/index.html, Center for Disease Control, CDC Injury Center, Understanding the Epidemic. Retrieved Feb; (2019), https://www.cdc.gov/drugoverdose/data/statedeaths.html,RetrievedFeb, Center for Disease Control, CDC Injury Center, Drug Overdose Deaths; (2016) 2016 National Survey for Drug Use and Health [Data File and Code Book, , https://www.datafiles.samhsa.gov/, [NSDUH] Substance Abuse and Mental Health Services Administration Available from Substance Abuse and Mental Health Data Archive Retrieved Feb 2019; 
(2019), https://www.drugabuse.gov/related-topics/criminaljustice/science-drug-use-discussion-points, National Institute on Drug Abuse. The Science of Drug Use: Discussion Points. February 2017, Retrieved Feb; (2011), https://naric.com/q=en/publications/volume-6-number-1-january-2011-substance-abuse-individuals-disabilities, National Rehabilitation Information Center, Substance Abuse and Individuals with Disabilities 6 11, JanuaryRetrieved Feb 2019; https://www.nber.org/digest/apr02/w8699.html, National Bureau of Economic Research, Mental Illness and Substance Abuse, Retrieved Feb2019; Acion, L., Kelmansky, D., Van Der Laan, M., Sahker, E., Use of A Machine Learning Framework to Predict Substance Use Disorder Treatment Success, , https://doi.org/10.1371/journal.pone.0175383, April 2017; 
Ahn, W.Y., Vassileva, J., Machine-learning identifies substancespecific behavioral markers for opiate and stimulant dependence (2016) Drug and Alcohol Dependence, 161; 
Bresnick, J., For opioids and substance abuse, big data analytics is just the beginning Health IT Analytics, , https://healthitanalytics.com/features/for-opioids-and-substance-abuse-bigdata-analytics-is-just-the-beginning, Retrieved Nov 2018; 
Kubat, M., (2017) An Introduction to Machine Learning, , (2nd ed.). Cham, Switzerland: Springer; 
Kuhn, M., Classification and Regression Training. November 2018, Retrieved from the Comprehensive R Archive Network Database; 
Liaw, A., Breiman and Cutler's Random Forests for Classification and Regression, , March 2015, Retrieved from The Comprehensive R Archive Network database; 
Rice, M., Harris, G., Comparing effect sizes in follow-up studies: Roc area, cohen's d, and r (2005) Law and Human Behavior, 29 (5), pp. 615-620. , http://www.jstor.org/stable/4499443; 
Robin, X., Turck, N., Hainard, A., Siegert, S., September 2018, Package 'pROC'. Retrieved from The Comprehensive R Archive Network databaseUR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072710770&doi=10.1109%2fCOMPSAC.2019.00161&partnerID=40&md5=f72b0d07ac5a872d3303c5c43a77a868
ER  - 

TY  - JOUR
TI  - National Institute on Drug Abuse genomics consortium white paper: Coordinating efforts between human and animal addiction studies
T2  - Genes, Brain and Behavior
J2  - Genes Brain Behav.
VL  - 18
IS  - 6
PY  - 2019
DO  - 10.1111/gbb.12577
SN  - 16011848 (ISSN) 
AU  - Cates, H.M.
AU  - Benca-Bachman, C.E.
AU  - de Guglielmo, G.
AU  - Schoenrock, S.A.
AU  - Shu, C.
AU  - Kallupi, M.
AD  - Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
AD  - Department of Psychology, Emory University, Atlanta, GA, United States
AD  - Department of Neuroscience, The Scripps Research Institute, La Jolla, CA, United States
AD  - Department of Genetics, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
AD  - Department of Psychiatry, Yale School of Medicine, New Haven, CT, United States
AB  - The National Institute on Drug Abuse Genetics and Epigenetics Cross-Cutting Research Team convened a diverse group of researchers, clinicians, and healthcare providers on the campus of the University of California, San Diego, in June 2018. The goal was to develop strategies to integrate genetics and phenotypes across species to achieve a better understanding of substance use disorders through associations between genotypes and addictive behaviors. This conference (a) discussed progress in harmonizing large opioid genetics cohorts, (b) discussed phenotypes that are used for genetics studies in humans, (c) examined phenotypes that are used for genetics studies in animal models, (d) identified synergies and gaps in phenotypic analyses of human and animal models and (e) identified strategies to integrate genetics and genomics data with phenotypes across species. The meeting consisted of panels that focused on phenotype harmonization (Dr. Laura Bierut, Dr. Olivier George, Dr. Dan Larach and Dr. Sesh Mudumbai), translating genetic findings between species (Dr. Elissa Chesler, Dr. Gary Peltz and Dr. Abraham Palmer), interpreting and understanding allelic variations (Dr. Vanessa Troiani and Dr. Tamara Richards) and pathway conservation in animal models and human studies (Dr. Robert Hitzemann, Dr. Huda Akil and Dr. Laura Saba). There were also updates that were provided by large consortia (Dr. Susan Tapert, Dr. Danielle Dick, Dr. Howard Edenberg and Dr. Eric Johnson). Collectively, the conference was convened to discuss progress and changes in genome-wide association studies. © 2019 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society
KW  - addiction models
KW  - big data
KW  - drug
KW  - genetic variants
KW  - GWAS
KW  - opioids
KW  - substance use disorders
KW  - opiate
KW  - allele
KW  - brain development
KW  - clinical study
KW  - drug dependence
KW  - epigenetics
KW  - genetic variation
KW  - genome-wide association study
KW  - genomics
KW  - genotype
KW  - genotype environment interaction
KW  - human
KW  - medical education
KW  - mental development
KW  - national health organization
KW  - nonhuman
KW  - opiate addiction
KW  - phenotype
KW  - priority journal
KW  - Review
PB  - Blackwell Publishing Ltd
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
C7  - e12577
N1  - CODEN: GBBEA
C2  - 31012252
LA  - English
N1  - Correspondence Address: Cates, H.M.; Friedman Brain Institute, Icahn School of Medicine at Mount SinaiUnited States; email: hannah.cates@icahn.mssm.edu
N1  - Chemicals/CAS: opiate, 53663-61-9, 8002-76-4, 8008-60-4
N1  - Funding details: National Human Genome Research Institute, NHGRI
N1  - Funding details: Tobacco-Related Disease Research Program, TRDRP, 27IR-0047
N1  - Funding details: National Institute on Alcohol Abuse and Alcoholism, NIAAA, R01 AA042691, R01 AA006420, R01 AA026081
N1  - Funding details: National Institutes of Health, NIH, DP1 DA042103, U01 DA043799, R01 DA043980, P50 DA039841, U01 DA044451, R01 DA042742
N1  - Funding text 1: To this end, including animal researchers in the large consortium efforts that are discussed herein would be beneficial. Currently, most genetic/genomic consortia consist of only human or animal research groups. Expanding these efforts to include both types of groups would move the field forward in terms of both phenotypic harmonization and the translation of genetic findings, thus providing a better understanding of addiction as a whole. One good example of cross-species collaboration is the Encyclopedia of DNA Elements (ENCODE) Consortium (encode.org), funded by the National Human Genome Research Institute. ENCODE began as a purely human-focused endeavor and expanded to include animal models. Studies of SUDs generally and OUD specifically would benefit from NIDA offering specific funding within the NGC to bring together the Human Genetics Consortium and Animal Models of Addictive Behaviors Consortium in a more tangible way.
N1  - Funding text 2: The authors confirm that we have no conflicts of interest to declare. This work was supported by NIH grants U01 DA043799, U01 DA044451, R01 DA042742, R01 DA043980, DP1 DA042103, P50 DA039841, NIAAA grants R01 AA026081, R01 AA006420, R01 AA042691 and Tobacco-Related Disease Research Program grant 27IR-0047.
N1  - References: Volkow, N.D., Koob, G., Baler, R., Biomarkers in substance use disorders (2015) ACS Chem Nerosci, 6 (4), pp. 522-525. , https://doi.org/10.1021/acschemneuro.5b00067; 
Davenport, S., Matthews, K., (2018) Opioid Use Disorder in the United States: Diagnosed Prevalence by Payer, Age, Sex, and State, , Dallas, TX, Milliman White Paper; 
Seth, P., Scholl, L., Rudd, R.A., Bacon, S., Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016 (2018) Morb Mortal Wkly Rep, 67 (12), pp. 349-358. , https://doi.org/10.15585/mmwr.mm6712a1; 
Przewlocki, R., Opioid abuse and brain gene expression (2004) Eur J Pharmacol, 500 (1), pp. 331-349. , https://doi.org/10.1016/j.ejphar.2004.07.036; 
Zhou, Z., Enoch, M.-A., Goldman, D., Gene expression in the addicted brain (2014) Int Rev Neurobiol, 116, pp. 251-273. , https://doi.org/10.1016/B978-0-12-801105-8.00010-2; 
Solovieff, N., Cotsapas, C., Lee, P.H., Purcell, S.M., Smoller, J.W., Pleiotropy in complex traits: challenges and strategies (2013) Nat Rev Genet, 14 (7), pp. 483-495. , https://doi.org/10.1038/nrg3461; 
Kendler, K.S., Chen, X., Dick, D., Recent advances in the genetic epidemiology and molecular genetics of substance use disorders (2012) Nat Neurosci, 15 (2), pp. 181-189. , https://doi.org/10.1038/nn.3018; 
Schuckit, M.A., A brief history of research on the genetics of alcohol and other drug use disorders (2014) J Stud Alcohol Drugs Suppl, 75, pp. 59-67; 
Jensen, K.P., A review of genome-wide association studies of stimulant and opioid use disorders (2016) Mol Neuropsychiatry, 2 (1), pp. 37-45. , https://doi.org/10.1159/000444755; 
Bennett, S.N., Caporaso, N., Fitzpatrick, A.L., Phenotype harmonization and cross-study collaboration in GWAS consortia: the GENEVA experience (2011) Genet Epidemiol, 35 (3), pp. 159-173. , https://doi.org/10.1002/gepi.20564; 
(2013) Diagnostic and Statistical Manual of Mental Disorders, , 5th, ed., Arlington, VA, American Psychiatric Publishing; 
Brown, T.A., Holland, L.A., Keel, P.K., Comparing operational definitions of DSM-5 anorexia nervosa for research contexts (2014) Int J Eat Disord, 47 (1), pp. 76-84. , https://doi.org/10.1002/eat.22184; 
Teeters, J.B., Lancaster, C.L., Brown, D.G., Back, S.E., Substance use disorders in military veterans: prevalence and treatment challenges (2017) Subst Abuse Rehabil, 8, pp. 69-77. , https://doi.org/10.2147/SAR.S116720; 
Bohnert, A.S.B., Ilgen, M.A., Galea, S., McCarthy, J.F., Blow, F.C., Accidental poisoning mortality among patients in the Department of Veterans Affairs Health System (2011) Med Care, 49 (4), pp. 393-396; 
Seal, K.H., Shi, Y., Cohen, G., Association of mental health disorders with prescription opioids and high-risk opioid use in us veterans of Iraq and Afghanistan (2012) JAMA, 307 (9), pp. 940-947. , https://doi.org/10.1001/jama.2012.234; 
George, O., Koob, G.F., Individual differences in the neuropsychopathology of addiction (2017) Dialogues Clin Neurosci, 19 (3), pp. 217-229; 
Kwako, L.E., Momenan, R., Litten, R.Z., Koob, G.F., Goldman, D., Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders (2016) Biol Psychiatry, 80 (3), pp. 179-189. , https://doi.org/10.1016/j.biopsych.2015.10.024; 
Hancock, D.B., Guo, Y., Reginsson, G.W., Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence (2017) Mol Psychiatry, 23 (9), pp. 1-9. , https://doi.org/10.1038/mp.2017.1193; 
Baker, E.J., Jay, J.J., Bubier, J.A., Langston, M.A., Chesler, E.J., GeneWeaver: a web-based system for integrative functional genomics (2012) Nucleic Acids Res, 40 (D1), pp. D1067-D1076. , https://doi.org/10.1093/nar/gkr968; 
Chu, L.F., Liang, D.-Y., Li, X., From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics (2009) Pharmacogenet Genomics, 19 (3), pp. 193-205. , https://doi.org/10.1097/FPC.0b013e328322e73d; 
Cheng, Z., Zhou, H., Sherva, R., Farrer, L.A., Kranzler, H.R., Gelernter, J., Genome-wide association study identifies a regulatory variant of RGMA associated with opioid dependence in European Americans (2017) Biol Psychiatry, 84, pp. 762-770. , https://doi.org/10.1016/j.biopsych.2017.12.016; 
Shabani, S., McKinnon, C.S., Reed, C., Cunningham, C.L., Phillips, T.J., Sensitivity to rewarding or aversive effects of methamphetamine determines methamphetamine intake (2011) Genes Brain Behav, 10 (6), pp. 625-636. , https://doi.org/10.1111/j.1601-183X.2011.00700.x; 
Harkness, J.H., Shi, X., Janowsky, A., Phillips, T.J., Trace amine-associated receptor 1 regulation of methamphetamine intake and related traits (2015) Neuropsychopharmacology, 40 (9), pp. 2175-2184. , https://doi.org/10.1038/npp.2015.61; 
Reed, C., Baba, H., Zhu, Z., A spontaneous mutation in Taar1 impacts methamphetamine-related traits exclusively in DBA/2 mice from a single vendor (2018) Front Pharmacol, 8 (993), pp. 1-8. , https://doi.org/10.3389/fphar.2017.00993; 
Walters, R.K., Polimanti, R., Johnson, E.C., Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders (2018) Nat Neurosci, 21 (12), pp. 1656-1669. , https://doi.org/10.1038/s41593-018-0275-1; 
Ahn, W.-Y., Vassileva, J., Machine-learning identifies substance-specific behavioral markers for opiate and stimulant dependence (2016) Drug Alcohol Depend, 161, pp. 247-257. , https://doi.org/10.1016/j.drugalcdep.2016.02.008; 
Badiani, A., Belin, D., Epstein, D., Calu, D., Shaham, Y., Opiate versus psychostimulant addiction: the differences do matter (2011) Nat Rev Neurosci, 12, p. 685. , https://doi.org/10.1038/nrn3104, https://www.nature.com/articles/nrn3104#supplementary-information; 
Kallupi, M., Scuppa, G., de Guglielmo, G., Genetic deletion of the nociceptin/orphanin FQ receptor in the rat confers resilience to the development of drug addiction (2017) Neuropsychopharmacology, 42 (3), pp. 695-706. , https://doi.org/10.1038/npp.2016.171; 
Wade, C.L., Kallupi, M., Hernandez, D.O., High-frequency stimulation of the subthalamic nucleus blocks compulsive-like re-escalation of heroin taking in rats (2017) Neuropsychopharmacology, 42 (9), pp. 1850-1859. , https://doi.org/10.1038/npp.2016.270; 
Dedova, I., Harding, A., Sheedy, D., The importance of brain banks for molecular neuropathological research: the New South Wales tissue resource centre experience (2009) Int J Mol Sci, 10 (1), pp. 366-384; 
Deep-Soboslay, A., Benes, F.M., Haroutunian, V., Ellis, J.K., Kleinman, J.E., Hyde, T.M., Psychiatric brain banking: three perspectives on current trends and future directions (2011) Biol Psychiatry, 69 (2), pp. 104-112. , https://doi.org/10.1016/j.biopsych.2010.05.025; 
Nichols, L., Freund, M., Ng, C., The National Institutes of Health Neurobiobank: a federated National Network of human brain and tissue repositories (2014) Biol Psychiatry, 75 (12), pp. e21-e22. , https://doi.org/10.1016/j.biopsych.2013.07.039; 
Palmer-Aronsten, B., Sheedy, D., McCrossin, T., Kril, J., An international survey of brain banking operation and characterization practices (2016) Biopreserv Biobank, 14 (6), pp. 464-469. , https://doi.org/10.1089/bio.2016.0003; 
(2017), https://www.womenshealth.gov, . Final report opioid use, misuseoverdose in women., https://www.womenshealth.gov/files/documents/final-report-opioid-508.pdf; Aziz, N.M., Guedj, F., Pennings, J.L.A., Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome (2018) Dis Model Mech, 11 (6), p. dmm031013. , https://doi.org/10.1242/dmm.031013; 
Block, A., Ahmed, M.M., Dhanasekaran, A.R., Tong, S., Gardiner, K.J., Sex differences in protein expression in the mouse brain and their perturbations in a model of Down syndrome (2015) Biol Sex Differ, 6, p. 24. , https://doi.org/10.1186/s13293-015-0043-9; 
Gershoni, M., Pietrokovski, S., The landscape of sex-differential transcriptome and its consequent selection in human adults (2017) BMC Biol, 15 (1), p. 7. , http://europepmc.org/abstract/MED/28173793, http://europepmc.org/articles/PMC5297171?pdf=render http://europepmc.org/articles/PMC5297171 https://doi.org/10.1186/s12915-017-0352-z; 
Kumar, V.J., Grissom, N.M., McKee, S.E., Linking spatial gene expression patterns to sex-specific brain structural changes on a mouse model of 16p11.2 hemideletion (2018) Transl Psychiatry, 8 (1), p. 109. , https://doi.org/10.1038/s41398-018-0157-z; 
Trabzuni, D., Ramasamy, A., Imran, S., Widespread sex differences in gene expression and splicing in the adult human brain (2013) Nat Commun, 4, p. 2771. , https://doi.org/10.1038/ncomms3771; 
Blum, K., Febo, M., Badgaiyan, R.D., Common neurogenetic diagnosis and meso-limbic manipulation of hypodopaminergic function in reward deficiency syndrome (RDS): changing the recovery landscape (2017) Curr Neuropharmacol, 15 (1), pp. 184-194. , https://doi.org/10.2174/1570159X13666160512150918; 
Lewohl, J.M., Nunez, Y.O., Dodd, P.R., Tiwari, G.R., Harris, R.A., Mayfield, R.D., Up-regulation of MicroRNAs in brain of human alcoholics (2011) Alcohol Clin Exp Res, 35 (11), pp. 1928-1937. , https://doi.org/10.1111/j.1530-0277.2011.01544.x; 
Yadav, S., Pandey, A., Shukla, A., miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and Cyclin D2 (2011) J Biol Chem, 286 (43), pp. 37347-37357. , https://doi.org/10.1074/jbc.M111.235531; 
LaMarca, E.A., Powell, S.K., Akbarian, S., Brennand, K.J., Modeling neuropsychiatric and neurodegenerative diseases with induced pluripotent stem cells (2018) Front Pediatr, 6 (82), pp. 1-15. , https://doi.org/10.3389/fped.2018.00082; 
Rajarajan, P., Borrman, T., Liao, W., Neuron-specific signatures in the chromosomal connectome associated with schizophrenia risk (2018) Science, 362 (6420). , https://doi.org/10.1126/science.aat4311; 
Readhead, B., Hartley, B.J., Eastwood, B.J., Author correction: expression-based drug screening of neural progenitor cells from individuals with schizophrenia (2018) Nat Commun, 9 (1), p. 4926. , https://doi.org/10.1038/s41467-018-07326-3; 
Jernigan, T.L., Brown, S.A., Introduction (2018) Dev Cogn Neurosci, 32, pp. 1-3. , https://doi.org/10.1016/j.dcn.2018.02.002; 
Dick, D.M., Aliev, F., Wang, J.C., Using dimensional models of externalizing psychopathology to aid in gene identification (2008) Arch Gen Psychiatry, 65 (3), pp. 310-318. , https://doi.org/10.1001/archpsyc.65.3.310; 
Agrawal, A., Edenberg, H.J., Gelernter, J., Meta-analyses of genome-wide association data hold new promise for addiction genetics (2016) J Stud Alcohol Drugs, 77 (5), pp. 676-680. , https://doi.org/10.15288/jsad.2016.77.676; 
Breen, G., Li, Q., Roth, B.L., Translating genome-wide association findings into new therapeutics for psychiatry (2016) Nat Neurosci, 19, pp. 1392-1396. , https://doi.org/10.1038/nn.4411, https://www.nature.com/articles/nn.4411#supplementary-information; 
Smoller, J.W., Andreassen, O.A., Edenberg, H.J., Faraone, S.V., Glatt, S.J., Kendler, K.S., Psychiatric genetics and the structure of psychopathology (2018) Mol Psychiatry, 24, pp. 409-420. , https://doi.org/10.1038/s41380-017-0010-4; 
Sullivan, P.F., Agrawal, A., Bulik, C.M., Psychiatric genomics: an update and an agenda (2018) Am J Psychiatry, 175 (1), pp. 15-27. , https://doi.org/10.1176/appi.ajp.2017.17030283; 
A framework for interpreting genome-wide association studies of psychiatric disorders (2008) Mol Psychiatry, 14, pp. 10-17. , https://doi.org/10.1038/mp.2008.126; 
Gelernter, J., Sherva, R., Koesterer, R., Genomewide association study of cocaine dependence and related traits: FAM53B identified as a risk gene (2014) Mol Psychiatry, 19 (6), pp. 717-723. , https://doi.org/10.1038/mp.2013.99; 
Ripke, S., Neale, B.M., Corvin, A., Biological insights from 108 schizophrenia-associated genetic loci (2014) Nature, 511, p. 421. , https://doi.org/10.1038/nature13595, https://www.nature.com/articles/nature13595#supplementary-information; 
Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis (2013) Lancet, 381 (9875), pp. 1371-1379. , https://doi.org/10.1016/S0140-6736(12)62129-1; 
Gelernter, J., Kranzler, H.R., Sherva, R., Genome-wide association study of nicotine dependence in American populations: identification of novel risk loci in both African-Americans and European-Americans (2015) Biol Psychiatry, 77 (5), pp. 493-503. , https://doi.org/10.1016/j.biopsych.2014.08.025; 
Lind, P.A., Macgregor, S., Vink, J.M., A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations (2010) Twin Res Hum Genet, 13 (1), pp. 10-29. , https://doi.org/10.1375/twin.13.1.10; 
Bierut, L.J., Agrawal, A., Bucholz, K.K., A genome-wide association study of alcohol dependence (2010) Proc Natl Acad Sci U S A, 107 (11), pp. 5082-5087. , https://doi.org/10.1073/pnas.0911109107; 
Edenberg, H.J., Koller, D.L., Xuei, X., Genome-wide association study of alcohol dependence implicates a region on chromosome 11 (2010) Alcohol Clin Exp Res, 34 (5), pp. 840-852. , https://doi.org/10.1111/j.1530-0277.2010.01156.x; 
Gelernter, J., Kranzler, H.R., Sherva, R., Genomewide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways (2014) Biol Psychiatry, 76 (1), pp. 66-74. , https://doi.org/10.1016/j.biopsych.2013.08.034; 
Nishizawa, D., Fukuda, K., Kasai, S., Genome-wide association study identifies a potent locus associated with human opioid sensitivity (2014) Mol Psychiatry, 19 (1), pp. 55-62. , https://doi.org/10.1038/mp.2012.164; 
Smith, A.H., Jensen, K.P., Li, J., Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1 (2017) Mol Psychiatry, 22 (3), pp. 346-352. , https://doi.org/10.1038/mp.2016.257; 
Uhl, G.R., Drgon, T., Johnson, C., Molecular genetics of addiction and related heritable phenotypes (2008) Ann N Y Acad Sci, 1141, pp. 318-381. , https://doi.org/10.1196/annals.1441.018; 
Wang, S.-C., Chung, R.-H., Kuo, H.-W., GRK5 is associated with the regulation of methadone dosage in heroin dependence (2018) Int J Neuropsychopharmacol, 21 (10), pp. 910-917. , https://doi.org/10.1093/ijnp/pyy066; 
Sanchez-Roige, S., Fontanillas, P., Elson, S.L., Publisher correction: genome-wide association study of delay discounting in 23,217 adult research participants of European ancestry (2018) Nat Neurosci, 21 (7), p. 1018. , https://doi.org/10.1038/s41593-018-0117-1; 
Sanchez-Roige, S., Fontanillas, P., Elson, S.L., Genome-wide association studies of impulsive personality traits (BIS-11 and UPPSP) and drug experimentation in up to 22,861 adult research participants identify loci in the CACNA1I and CADM2 genes (2019) J Neurosci, 39 (13), pp. 2562-2572. , https://doi.org/10.1523/JNEUROSCI.2662-18.2019; 
Mulligan, M.K., Mozhui, K., Prins, P., Williams, R.W., GeneNetwork: a toolbox for systems genetics (2017) Methods Mol Biol, 1488, pp. 75-120; 
Saba, L., Hoffman, P., Tabakoff, B., Using baseline transcriptional connectomes in rat to identify genetic pathways associated with predisposition to complex traits (2017) Systems Genetics: Methods and Protocols, pp. 299-317. , Schughart K, Williams RW, eds., New York, NY, Springer New York; 
Walker, D.M., Cates, H.M., Heller, E.A., Nestler, E.J., Regulation of chromatin states by drugs of abuse (2015) Curr Opin Neurobiol, 30, pp. 112-121. , https://doi.org/10.1016/j.conb.2014.11.002
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066028425&doi=10.1111%2fgbb.12577&partnerID=40&md5=06f8e43279a5e65eecd319f8f98e19ee
ER  - 

TY  - JOUR
TI  - Machine learning for prediction of sustained opioid prescription after anterior cervical discectomy and fusion
T2  - Spine Journal
J2  - Spine J.
VL  - 19
IS  - 6
SP  - 976
EP  - 983
PY  - 2019
DO  - 10.1016/j.spinee.2019.01.009
SN  - 15299430 (ISSN) 
AU  - Karhade, A.V.
AU  - Ogink, P.T.
AU  - Thio, Q.C.B.S.
AU  - Broekman, M.L.D.
AU  - Cha, T.D.
AU  - Hershman, S.H.
AU  - Mao, J.
AU  - Peul, W.C.
AU  - Schoenfeld, A.J.
AU  - Bono, C.M.
AU  - Schwab, J.H.
AD  - Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
AD  - Neurosurgical Center Holland, Leiden University MC & Haaglanden MC & HAGA Teaching Hospital, Leiden, Netherlands
AD  - Divison of Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States
AD  - Department of Orthopedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
AB  - BACKGROUND CONTEXT: The severity of the opioid epidemic has increased scrutiny of opioid prescribing practices. Spine surgery is a high-risk episode for sustained postoperative opioid prescription. PURPOSE: To develop machine learning algorithms for preoperative prediction of sustained opioid prescription after anterior cervical discectomy and fusion (ACDF). STUDY DESIGN/SETTING: Retrospective, case-control study at two academic medical centers and three community hospitals. PATIENT SAMPLE: Electronic health records were queried for adult patients undergoing ACDF for degenerative disorders between January 1, 2000 and March 1, 2018. OUTCOME MEASURES: Sustained postoperative opioid prescription was defined as uninterrupted filing of prescription opioid extending to at least 90–180 days after surgery. METHODS: Five machine learning models were developed to predict postoperative opioid prescription and assessed for overall performance. RESULTS: Of 2,737 patients undergoing ACDF, 270 (9.9%) demonstrated sustained opioid prescription. Variables identified for prediction of sustained opioid prescription were male sex, multilevel surgery, myelopathy, tobacco use, insurance status (Medicaid, Medicare), duration of preoperative opioid use, and medications (antidepressants, benzodiazepines, beta-2-agonist, angiotensin-converting enzyme-inhibitors, gabapentin). The stochastic gradient boosting algorithm achieved the best performance with c-statistic=0.81 and good calibration. Global explanations of the model demonstrated that preoperative opioid duration, antidepressant use, tobacco use, and Medicaid insurance were the most important predictors of sustained postoperative opioid prescription. CONCLUSIONS: One-tenth of patients undergoing ACDF demonstrated sustained opioid prescription following surgery. Machine learning algorithms could be used to preoperatively stratify risk these patients, possibly enabling early intervention to reduce the potential for long-term opioid use in this population. © 2019 Elsevier Inc.
KW  - Anterior cervical discectomy and fusion
KW  - Cervical spine
KW  - Machine learning
KW  - Opioid use
KW  - Prediction
KW  - Predictive analytics
KW  - Spine surgery
KW  - antidepressant agent
KW  - benzodiazepine derivative
KW  - beta 2 adrenergic receptor stimulating agent
KW  - dipeptidyl carboxypeptidase inhibitor
KW  - gabapentin
KW  - narcotic analgesic agent
KW  - adult
KW  - algorithm
KW  - Article
KW  - case control study
KW  - computer prediction
KW  - discectomy
KW  - female
KW  - human
KW  - machine learning
KW  - major clinical study
KW  - male
KW  - medicaid
KW  - middle aged
KW  - postoperative period
KW  - prescription
KW  - priority journal
KW  - retrospective study
KW  - spine fusion
KW  - tobacco use
PB  - Elsevier Inc.
N1  - Cited By :6
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: SJPOA
C2  - 30710731
LA  - English
N1  - Correspondence Address: Schwab, J.H.; Department of Orthopedic Surgery, Massachusetts General Hospital, Associate Professor of Orthopedic Surgery, Harvard Medical School, 55 Fruit St, United States; email: jhschwab@mgh.harvard.edu
N1  - Chemicals/CAS: gabapentin, 60142-96-3
N1  - References: Florence, C.S., Zhou, C., Luo, F.J., Xu, L.K., The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013 (2016) Med Care, 54, pp. 901-906; 
Barnett, M.L., Gray, J., Zink, A., Jena, A.B., Coupling policymaking with evaluation—the case of the opioid crisis (2017) N Engl J Med, 377, pp. 2306-2309; 
Wood, E., Strategies for reducing opioid-overdose deaths—lessons from Canada (2018) N Engl J Med, 378, pp. 1565-1567; 
Blendon, R.J., Benson, J.M., The public and the opioid-abuse epidemic (2018) N Engl J Med, 378, pp. 407-411; 
Jalal, H., Buchanich, J.M., Roberts, M.S., Balmert, L.C., Zhang, K., Burke, D.S., Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016 (2018) Science, 361; 
Jiang, X., Orton, M., Feng, R., Hossain, E., Malhotra, N.R., Zager, E.L., Chronic opioid usage in surgical patients in a large academic center (2017) Ann Surg, 265, pp. 722-727; 
Brummett, C.M., Waljee, J.F., Goesling, J., Moser, S., Lin, P., Englesbe, M.J., New persistent opioid use after minor and major surgical procedures in US adults (2017) JAMA Surg, 152; 
Reid, D.B., Shah, K.N., Ruddell, J.H., Shapiro, B.H., Akelman, E., Robertson, A.P., Effect of Narcotic prescription limiting legislation on opioid utilization following lumbar spine surgery (2018) Spine J; 
Schoenfeld, A.J., Belmont Jr, P.J., Blucher, J.A., Jiang, W., Chaudhary, M.A., Koehlmoos, T., Sustained preoperative opioid use is a predictor of continued use following spine surgery (2018) J Bone Joint Surg Am Vol, 100, pp. 914-921; 
Schoenfeld, A.J., Nwosu, K., Jiang, W., Yau, A.L., Chaudhary, M.A., Scully, R.E., Risk factors for prolonged opioid use following spine surgery, and the association with surgical intensity, among opioid-naive patients (2017) J Bone Joint Surg Am Vol, 99, pp. 1247-1252; 
Jain, N., Brock, J.L., Phillips, F.M., Weaver, T., Khan, S.N., Chronic preoperative opioid use is a risk factor for increased complications, resource use, and costs after cervical fusion (2018) Spine J, 18 (11), pp. 1989-1998; 
Jain, N., Phillips, F.M., Weaver, T., Khan, S.N., Preoperative chronic opioid therapy: a risk factor for complications, readmission, continued opioid use and increased costs after one- and two-level posterior lumbar fusion (2018) Spine, 43, pp. 1331-1338; 
Collins, G.S., Reitsma, J.B., Altman, D.G., Moons, K.G., Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement (2015) BMC Med, 13, p. 1; 
Luo, W., Phung, D., Tran, T., Gupta, S., Rana, S., Karmakar, C., Guidelines for developing and reporting machine learning predictive models in biomedical research: a multidisciplinary view (2016) J Med Internet Res, 18 (12), p. e323; 
Clarke, H., Soneji, N., Ko, D.T., Yun, L., Wijeysundera, D.N., Rates and risk factors for prolonged opioid use after major surgery: population based cohort study (2014) BMJ, 348, p. g1251; 
Schoenfeld, A.J., Sieg, R.N., Li, G., Bader, J.O., Belmont, P.J., Jr., Bono, C.M., Outcomes after spine surgery among racial/ethnic minorities: a meta-analysis of the literature (2011) Spine J, 11, pp. 381-388; 
Alam, A., Gomes, T., Zheng, H., Mamdani, M.M., Juurlink, D.N., Bell, C.M., Long-term analgesic use after low-risk surgery: a retrospective cohort study (2012) Arch Intern Med, 172, pp. 425-430; 
Sun, E.C., Darnall, B.D., Baker, L.C., Mackey, S., Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period (2016) JAMA Intern Med, 176, pp. 1286-1293; 
Guy, G.P., Jr, Zhang, K., Bohm, M.K., Losby, J., Lewis, B., Young, R., Vital signs: changes in opioid prescribing in the United States, 2006-2015 (2017) MMWR Morb Mortal Wkly Rep, 66, pp. 697-704; 
Oleisky, E.R., Pennings, J.S., Hills, J., Sivaganesan, A., Khan, I., Call, R., Comparing different chronic preoperative opioid use definitions on outcomes after spine surgery (2019) Spine J; 
Quan, H., Li, B., Couris, C.M., Fushimi, K., Graham, P., Hider, P., Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries (2011) Am J Epidemiol, 173, pp. 676-682; 
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.C., Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data (2005) Medical Care, pp. 1130-1139; 
Lurie, J.D., Tosteson, A.N., Deyo, R.A., Tosteson, T., Weinstein, J., Mirza, S.K., Indications for spine surgery: validation of an administrative coding algorithm to classify degenerative diagnoses (2014) Spine, 39, p. 769; 
American Community Survey 5-Year Data (2009-2016). United States Census Bureau; 2018 [cited 2018 September 2]; Lu, C.Y., Barratt, J., Vitry, A., Roughead, E., Charlson and Rx-risk comorbidity indices were predictive of mortality in the Australian health care setting (2011) J Clin Epidemiol, 64, pp. 223-228; 
Stekhoven, D.J., Bühlmann, P., MissForest—non-parametric missing value imputation for mixed-type data (2011) Bioinformatics, 28, pp. 112-118; 
Kuhn, M., Johnson, K., Applied predictive modeling (2013), Springer; Wainer, J., (2016), Comparison of 14 different families of classification algorithms on 115 binary datasets. arXiv preprint arXiv:160600930; Friedman, J., Hastie, T., Tibshirani, R., The elements of statistical learning (2001), Springer Series in Statistics New York, NY, USA; Steyerberg, E.W., Vergouwe, Y., Towards better clinical prediction models: seven steps for development and an ABCD for validation (2014) Eur Heart J, 35, pp. 1925-1931; 
Greenwell, B.M., Boehmke, B.C., McCarthy, A.J., (2018), A simple and effective model-based variable importance measure. arXiv preprint arXiv:180504755; Ribeiro, M.T., Singh, S., Guestrin, C., (2016), Model-agnostic interpretability of machine learning. arXiv preprint arXiv:160605386; Kalakoti, P., Hendrickson, N.R., Bedard, N.A., Pugely, A.J., Opioid utilization following lumbar arthrodesis: trends and factors associated with long-term use (2018) Spine, 43, pp. 1208-1216; 
Pugely, A.J., Bedard, N.A., Kalakoti, P., Hendrickson, N.R., Shillingford, J.N., Laratta, J.L., Opioid use following cervical spine surgery: trends and factors associated with long-term use (2018) Spine J, 18 (11), pp. 1974-1981; 
Anderson, J.T., Haas, A.R., Percy, R., Woods, S.T., Ahn, U.M., Ahn, N.U., Chronic opioid therapy after lumbar fusion surgery for degenerative disc disease in a workers' Compensation Setting (2015) Spine, 40, pp. 1775-1784; 
O'Connell, C., Azad, T.D., Mittal, V., Vail, D., Johnson, E., Desai, A., Preoperative depression, lumbar fusion, and opioid use: an assessment of postoperative prescription, quality, and economic outcomes (2018) Neurosurg Focus, 44, p. E5; 
Jones, C.M., Trends and key correlates of prescription opioid injection misuse in the United States (2018) Addict Behav, 78, pp. 145-152; 
Zheng, F., Cammisa, F.P., Jr., Sandhu, H.S., Girardi, F.P., Khan, S.N., Factors predicting hospital stay, operative time, blood loss, and transfusion in patients undergoing revision posterior lumbar spine decompression, fusion, and segmental instrumentation (2002) Spine, 27, pp. 818-824; 
Senders, J.T., Staples, P.C., Karhade, A.V., Zaki, M.M., Gormley, W.B., Broekman, M.L., Machine learning and neurosurgical outcome prediction: a systematic review (2018) World Neurosurg, 109, pp. 476-486. , e1; 
Senders, J.T., Arnaout, O., Karhade, A.V., Dasenbrock, H.H., Gormley, W.B., Broekman, M.L., Natural and artificial intelligence in neurosurgery: a systematic review (2018) Neurosurgery, 83, pp. 181-192
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061455729&doi=10.1016%2fj.spinee.2019.01.009&partnerID=40&md5=1305de8648aa9d1509353ca1f15a551d
ER  - 

TY  - CONF
TI  - Discovering alternative treatments for opioid use recovery using social media
C3  - Conference on Human Factors in Computing Systems - Proceedings
J2  - Conf Hum Fact Comput Syst Proc
PY  - 2019
DO  - 10.1145/3290605.3300354
SN  - 9781450359702 (ISBN)
AU  - Chancellor, S.
AU  - Nitzburg, G.
AU  - Hu, A.
AU  - Zampieri, F.
AU  - De Choudhury, M.
AD  - Georgia Tech., Atlanta, GA, United States
AD  - Teachers College Columbia University, New York, NY, United States
AB  - Opioid use disorder (OUD) poses substantial risks to personal well-being and public health. In online communities, users support those seeking recovery, in part by promoting clinically grounded treatments. However, some communities also promote clinically unverified OUD treatments, such as unregulated and untested drugs. Little research exists on which alternative treatments people use, whether these treatments are effective for recovery, or if they cause negative side effects. We provide the first large-scale social media study of clinically unverified, alternative treatments in OUD recovery on Reddit, partnering with an addiction research scientist. We adopt transfer learning across 63 subreddits to precisely identify posts related to opioid recovery. Then, we quantitatively discover potential alternative treatments and contextualize their effectiveness. Our work benefits health research and practice by identifying undiscovered recovery strategies. We also discuss the impacts to online communities dealing with stigmatized behavior and research ethics. © 2019 Association for Computing Machinery.
KW  - Addiction
KW  - Alternative treatment
KW  - Online communities
KW  - Opioid use disorder
KW  - Recovery
KW  - Reddit
KW  - Behavioral research
KW  - Drug interactions
KW  - Health risks
KW  - Human computer interaction
KW  - Human engineering
KW  - Online systems
KW  - Public risks
KW  - Recovery
KW  - Addiction
KW  - Alternative treatment
KW  - On-line communities
KW  - Opioid use disorder
KW  - Reddit
KW  - Social networking (online)
PB  - Association for Computing Machinery
T2  - 2019 CHI Conference on Human Factors in Computing Systems, CHI 2019
Y2  - 4 May 2019 through 9 May 2019
N1  - Conference code: 147770
N1  - Cited By :1
N1  - Export Date: 13 November 2019
M3  - Conference Paper
DB  - Scopus
LA  - English
N1  - References: Amato, L., Davoli, M., Perucci, C.A., Ferri, M., Faggiano, F., Mattick, R.P., An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research (2005) Journal of Substance Abuse Treatment, 28 (4), pp. 321-329; 
Andalibi, N., Haimson, O.L., De Choudhury, M., Forte, A., Understanding social media disclosures of sexual abuse through the lenses of support seeking and anonymity (2016) Proceedings of the 2016 CHI Conference on Human Factors in Computing Systems, pp. 3906-3918. , ACM; 
Andalibi, N., Ozturk, P., Forte, A., Sensitive self-disclosures, responses, and social support on instagram: The case of #depression (2017) Proceedings of the 2017 ACM Conference on Computer Supported Cooperative Work and Social Computing, , ACM; 
Anderson, L., Using social listening data to monitor misuse and nonmedical use of bupropion: A content analysis (2017) JMIR Public Health and Surveillance, 3, p. 1; 
Anstice, S., Strike, C.J., Brands, B., Supervised methadone consumption: Client issues and stigma (2009) Substance Use & Misuse, 44 (6), pp. 794-808; 
(2013) Diagnostic and Statistical Manual of Mental Disorders (DSM-5®), , American Psychiatric Pub; 
Ayers, J.W., Caputi, T.L., Nebeker, C., Dredze, M., Don’t quote me: Reverse identification of research participants in social media studies (2018) Npj Digital Medicine, 1, p. 30; 
Babu, K.M., McCurdy, C.R., Boyer, E.W., Opioid receptors and legal highs: Salvia divinorum and kratom (2008) Clinical Toxicology, 46 (2), pp. 146-152. , issn: 1556-3650; 
Boyer, E.W., Babu, K.M., Macalino, G.E., Compton, W., Self-treatment of opioid withdrawal with a dietary supplement, Kratom (2007) American Journal on Addictions, 16 (5), pp. 352-356; 
Campbell, S.W., Kelley, M.J., Mobile phone use among alcoholics anonymous members: New sites for recovery (2008) New Media & Society, 10 (6), pp. 915-933; 
Cartwright, W.S., Economic costs of drug abuse: Financial, cost of illness, and services (2008) Journal of Substance Abuse Treatment, 34 (2), pp. 224-233; 
Cavazos-Rehg, P., Krauss, M., Grucza, R., Bierut, L., Characterizing the followers and tweets of a marijuana-focused twitter handle (2014) Journal of Medical Internet Research, 16, p. 6; 
Chancellor, S., Hu, A., De Choudhury, M., Norms matter: Contrasting social support around behavior change in online weight loss communities (2018) Proceedings of the 2018 CHI Conference on Human Factors in Computing Systems, p. 666. , ACM; 
Chancellor, S., Lin, Z.J., De Choudhury, M., This post will just get taken down: Characterizing removed pro-eating disorder social media content (2016) Proceedings of the 2016 CHI Conference on Human Factors in Computing Systems, pp. 1157-1162. , ACM; 
Chancellor, S., Mitra, T., De Choudhury, M., Recovery amid pro-anorexia: Analysis of recovery in social media (2016) Proceedings of CHI, 2016, pp. 2111-2123; 
Chancellor, S., Pater, J.A., Clear, T., Gilbert, E., De Choudhury, M., #thyghGapp: Instagram content moderation and lexical variation in pro-eating disorder communities (2016) Proceedings of the 19th ACM Conference on Computer-Supported Cooperative Work & Social Computing, pp. 1201-1213; 
Chandrasekharan, E., Pavalanathan, U., Srinivasan, A., Glynn, A., Eisenstein, J., Gilbert, E., You can’t stay here: The efficacy of reddit’s 2015 ban examined through hate speech (2017) Proceedings of the ACM on Human-Computer Interaction, 1, p. 31. , CSCW; 
Chen, K.W., Berger, C.C., Forde, D.P., D’Adamo, C., Weintraub, E., Gandhi, D., Benzodi-azepine use and misuse among patients in a methadone program (2011) BMC Psychiatry, 11 (1), p. 90; 
Cherian, R., Westbrook, M., Ramo, D., Sarkar, U., Representations of codeine misuse on instagram: Content analysis (2018) JMIR Public Health and Surveillance, 4, p. 1; 
(2018) Google Big Query, , https://cloud.google.com/bigquery/, 2018; 
Conner, K.O., Rosen, D., You’re nothing but a junkie": Multiple experiences of stigma in an aging methadone maintenance population (2008) Journal of Social Work Practice in the Addictions, 8 (2), pp. 244-264; 
Culotta, A., Estimating county health statistics with twitter (2014) Proceedings of the SIGCHI Conference on Human Factors in Computing Systems, , ACM; 
D’Agostino, A.R., Optican, A.R., Sowles, S.J., Krauss, M.J., Lee, K.E., Cavazos-Rehg, P.A., Social networking online to recover from opioid use disorder: A study of community interactions (2017) Drug and Alcohol Dependence, 181, pp. 5-10; 
De Choudhury, M., Gamon, M., Counts, S., Horvitz, E., Predicting depression via social media (2013) ICWSM, 13, pp. 1-10; 
(2017) Drug Overdose Death Data, , https://www.cdc.gov/drugoverdose/data/statedeaths.html, Dec. 2017; 
Egan, K.G., Moreno, M.A., Alcohol references on undergraduate males’ facebook profiles (2011) American Journal of Men’S Health, 5 (5), pp. 413-420; 
Emmens, T., Phippen, A., (2010) Evaluating Online Safety Programs, , Harvard Berkman Center for Internet and Society.[23 July 2011; 
Epstein, E.E., (2013) Addictions: A Comprehensive Guidebook, , Oxford University Press; 
(2018) Erowid, , https://www.erowid.org/, Sept. 2018; 
Eskisabel-Azpiazu, A., Cerezo-Menéndez, R., Gayo-Avello, D., An ethical inquiry into youth suicide prevention using social media mining (2017) Internet Research Ethics for the Social Age, p. 227; 
Fan, Y., Zhang, Y., Ye, Y., Zheng, W., Social media for opioid addiction epidemiology: Automatic detection of opioid addicts from Twitter and case studies (2017) Proceedings of the 26th ACM International Conference on Information and Knowledge Management, pp. 1259-1267; 
Frost, J., Okun, S., Vaughan, T., Heywood, J., Wicks, P., Patient-reported outcomes as a source of evidence in off-label prescribing: Analysis of data from PatientsLikeMe (2011) Journal of Medical Internet Research, 13, p. 1; 
Ghenai, A., Mejova, Y., Fake cures: User-centric modeling of health misinformation in social media (2018) CSCW; 
Gianutsos, G., (2017) The Dea Changes Its Mind on Kratom, , https://www.uspharmacist.com/article/the-dea-changes-its-mind-on-kratom, 2017; 
Glick, S.D., Kuehne, M.E., Raucci, J., Wilson, T.E., Larson, D., Keller, R.W., Jr., Carlson, J.N., Effects of iboga alkaloids on morphine and cocaine self-administration in rats: Relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum (1994) Brain Res, 657 (1-2), pp. 14-22; 
Goffman, E., (2009) Stigma: Notes on the Management of Spoiled Identity, , Simon and Schuster; 
Gossop, M., Johns, A., Green, L., Opiate withdrawal: Inpatient versus outpatient programmes and preferred versus random assignment to treatment (1986) British Medical Journal, 293 (6539). , Clinical research ed, 103; 
Graves, R.L., Tufts, C., Meisel, Z.F., Polsky, D., Ungar, L., Merchant, R.M., Opioid discussion in the Twittersphere (2018) Substance Use & Misuse, 6084, pp. 1-8; 
Hassan, Z., From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction (2013) Neuroscience and Biobehavioral Reviews, 37 (2), pp. 138-151; 
Hecht, B., (2018) It’S Time to Do Something: Mitigating the Negative Impacts of Computing through A Change to the Peer Review Process, , https://acm-fca.org/2018/03/29/negativeimpacts/, Mar. 2018; 
Jaffe, J.H., Kanzler, M., Green, J., Abuse potential of loperamide (1980) Clinical Pharmacology & Therapeutics, 28 (6), pp. 812-819; 
Jann, M., Kennedy, W.K., Lopez, G., Benzodiazepines: A major component in unintentional prescription drug overdoses with opioid analgesics (2014) Journal of Pharmacy Practice, 27 (1), pp. 5-16; 
Jansen, K.L.R., Prast, C.J., Ethnopharmacology of kratom and the mitragyna alkaloids (1988) Journal of Ethnopharmacology, 23 (1), pp. 115-119; 
Jones, J.D., Mogali, S., Comer, S.D., Poly-drug abuse: A review of opioid and benzodiazepine combination use (2012) Drug and Alcohol Dependence, 125 (1-2), pp. 8-18; 
Katsuki, T., Mackey, T.K., Cuomo, R., Establishing a link between prescription drug abuse and illicit online pharmacies: Analysis of twitter data (2015) Journal of Medical Internet Research, 17 (12), pp. 1-12; 
Keegan, B.C., Cavazos-Rehg, P., Nguyen, A.N., Savage, S., Kaye, J., De Choudhury, M., Paul, M.J., Chi-nnabis: Implications of marijuana legalization for and from human-computer interaction (2017) Proceedings of the 2017 CHI Conference Extended Abstracts on Human Factors in Computing Systems, pp. 1312-1317. , ACM; 
Kim, S.J., Marsch, L.A., Hancock, J.T., Das, A.-D.K., Scaling up research on drug abuse and addiction through social media big data (2017) Journal of Medical Internet Research, 19, p. 10; 
Kıcıman, E., Counts, S., Gasser, M., Using longitudinal social media analysis to understand the effects of early college alcohol use (2018) ICWSM; 
Koratana, A., Dredze, M., Chisolm, M.S., Johnson, M.W., Paul, M.J., Studying anonymous health issues and substance use on college campuses with yik yak (2016) AAAI Workshop: WWW and Population Health Intelligence; 
Kornfield, R., Sarma, P.K., Shah, D.V., Mc-Tavish, F., Landucci, G., Pe-Romashko, K., Gustafson, D.H., Detecting recovery problems just in time: Application of automated linguistic analysis and supervised machine learning to an online substance abuse forum (2018) Journal of Medical Internet Research, 20, p. 6; 
Kornfield, R., Toma, C.L., Shah, D.V., Moon, T.J., Gustafson, D.H., What do you say before you relapse? How Language Use in a Peer-to-peer Online Discussion Forum Predicts Risky Drinking among Those in Recovery (2018) Health Communication, 33 (9), pp. 1184-1193; 
Kuntsche, E., Kuntsche, S., Thrul, J., Gmel, G.-H., Binge drinking: Health impact, prevalence, correlates and interventions (2017) Psychology & Health, 32 (8), pp. 976-1017; 
Livingston, J.D., Milne, T., Fang, M.L., Amari, E., The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review (2012) Addiction, 107 (1), pp. 39-50; 
Lloyd, C., The stigmatization of problem drug users: A narrative literature review (2013) Drugs: Education, Prevention and Policy, 20 (2), pp. 85-95; 
Lurie, P., Reingold, A.L., Bowser, B., Chen, D., Foley, J., Guydish, J., Kahn, J.G., Sorensen, J., (1993) The Public Health Impact of Needle Exchange Programs in the United States and Abroad: Summary, Conclusions and Recommendations, , Atlanta: Centers for Disease Control and Prevention; 
MacLean, D., Gupta, S., Lembke, A., Manning, C., Heer, J., (2015) Forum77: An Analysis of An Online Health Forum Dedicated to Addiction Recovery, pp. 1511-1526; 
Manikonda, L., De Choudhury, M., Modeling and understanding visual attributes of mental health disclosures in social media (2017) Proceedings of the 2017 CHI Conference on Human Factors in Computing Systems, pp. 170-181. , ACM; 
Alan Marlatt, G., Larimer, M.E., Witkiewitz, K., (2011) Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors, , Guilford Press; 
McCreanor, T., Lyons, A., Griffin, C., Goodwin, I., Barnes, H.M., Hutton, F., Youth drinking cultures, social networking and alcohol marketing: Implications for public health (2013) Critical Public Health, 23 (1), pp. 110-120; 
Meacham, M.C., Paul, M.J., Ramo, D., Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings (2018) Drug and Alcohol Dependence; 
Mikolov, T., Chen, K., Corrado, G., Dean, J., (2013) Efficient Estimation of Word Representations in Vector Space, , arXiv preprint; 
Moreno, M.A., Christakis, D.A., Egan, K.G., Brockman, L.N., Becker, T., Associations between displayed alcohol references on facebook and problem drinking among college students (2012) Archives of Pediatrics & Adolescent Medicine, 166 (2), pp. 157-163; 
Moreno, M.A., Grant, A., Kacvinsky, L., Egan, K.G., Fleming, M.F., College students’ alcohol displays on facebook: Intervention considerations (2012) Journal of American College Health, 60 (5), pp. 388-394; 
Nelsen, J.L., Lapoint, J., Hodgman, M.J., Aldous, K.M., Seizure and Coma following Kratom (Mitragynina speciosa Korth) Exposure (2010) Journal of Medical Toxicology, 6 (4), pp. 424-426; 
Nelson, L.S., Perrone, J., Curbing the opioid epidemic in the United States: The risk evaluation and mitigation strategy (rems) (2012) JAMA, 308 (5), pp. 457-458. , issn: 0098-7484; 
O’Connor, K., Pimpalkhute, P., Nikfarjam, A., Ginn, R., Smith, K.L., Gonzalez, G., Pharmacovigilance on twitter? Mining tweets for adverse drug reactions (2014) AMIA Annual Symposium Proceedings, 2014, p. 924. , American Medical Informatics Association; 
Olsen, Y., Sharfstein, J.M., Confronting the stigma of opioid use disorder – and its treatment (2014) JAMA, 311, p. 1393; 
Orme, J., Samaritans pulls "suicide watch" radar app over privacy concerns (2014) The Guardian, , 9th November; 
Park, A., Conway, M., Opioid surveillance using social media: How urls are shared among reddit members (2018) Online Journal of Public Health Informatics, 10, p. 1; 
Park, A., Conway, M., Towards tracking opium related discussions in social media (2017) Online Journal of Public Health Informatics, 9 (1), pp. 1947-2579. , issn; 
Paul, M.J., Chisolm, M.S., Johnson, M.W., Vandrey, R.G., Dredze, M., Assessing the validity of online drug forums as a source for estimating demographic and temporal trends in drug use (2016) Journal of Addiction Medicine, 10 (5), pp. 324-330; 
Paul, M.J., Dredze, M., You are what you tweet: Analyzing Twitter for public health (2011) ICWSM. Aaai.Org, pp. 265-272; 
Prochaska, J.O., DiClemente, C.C., Toward a comprehensive model of change (1986) Treating Addictive Behaviors, pp. 3-27. , Springer; 
Prochaska, J.O., DiClemente, C.C., Norcross, J.C., In search of how people change: Applications to addictive behaviors (1992) American Psychologist, 47 (9), p. 1102; 
Prozialeck, W.C., Jivan, J.K., Andurkar, S.V., Pharmacology of kratom: An emerging botanical agent with stimulant, analgesic and opioid-like effects (2012) The Journal of the American Osteopathic Association, 112 (12), pp. 792-799; 
(2018) Psychonaut Wiki, , https://psychonautwiki.org/wiki/Main_Page, Sept. 2018; 
Scott, K.R., Nelson, L., Meisel, Z., Perrone, J., Opportunities for exploring and reducing prescription drug abuse through social media (2015) Journal of Addictive Diseases, 34 (2-3), pp. 178-184; 
(2018) R/Opiatesrecovery, , https://www.reddit.com/r/OpiatesRecovery/, 2018; 
Rondzisty, A., Dziekan, K., Kowalska, A., Psychoactive plants used in designer drugs as a threat to public health (2015) Herba Polonica, 61 (2), pp. 73-86; 
Rosenbaum, C.D., Carreiro, S.P., Babu, K.M., Here today, gone tomorrow...and back again? A review of herbal marijuana alternatives (k2, spice), synthetic cathinones (bath salts), kratom, salvia divinorum, methoxetamine, and piperazines (2012) Journal of Medical Toxicology, 8 (1), pp. 15-32; 
Rubya, S., Facilitating peer support for recovery from substance use disorders (2017) Proceedings of the 2017 CHI Conference Extended Abstracts on Human Factors in Computing Systems, pp. 172-177. , ACM; 
Rubya, S., Yarosh, S., Interpretations of online anonymity in alcoholics anonymous and narcotics anonymous (2017) PACMHCI (CSCW), 1, p. 22. , November; 
Rubya, S., Yarosh, S., Video-mediated peer support in an online community for recovery from substance use disorders (2017) 2017 ACM Conference on Computer Supported Cooperative Work and Social Computing, CSCW 2017, , ACM; 
Saha, K., De Choudhury, M., Modeling stress with social media around incidents of gun violence on college campuses (2017) Proc. ACM Hum.-Comput. Interact.(CSCW), 92, pp. 1-92; 
Sarker, A., Ginn, R., Nikfarjam, A., O’Connor, K., Smith, K., Jayaraman, S., Upadhaya, T., Gonzalez, G., Utilizing social media data for pharmacovigilance: A review (2015) Journal of Biomedical Informatics, 54, pp. 202-212; 
Sarker, A., O’Connor, K., Ginn, R., Scotch, M., Smith, K., Malone, D., Gonzalez, G., Social media mining for toxicovigilance: Automatic monitoring of prescription medication abuse from twitter (2016) Drug Safety, 39 (3), pp. 231-240. , issn: 1179-1942; 
Schmitt, Z., Yarosh, S., Participatory design of technologies to support recovery from substance use disorders (2018) Proceedings of the ACM on Human-Computer Interaction, 2, pp. 1-27. , CSCW; 
Sharma, E., De Choudhury, M., Mental health support and its relationship to linguistic accommodation in online communities (2018) Conference on Human Factors in Computing Systems (CHI); 
Shutler, L., Nelson, L.S., Portelli, I., Blachford, C., Perrone, J., Drug use in the twittersphere: A qualitative contextual analysis of tweets about prescription drugs (2015) Journal of Addictive Diseases, 34 (4), pp. 303-310; 
Simpson, S.S., Adams, N., Brugman, C.M., Conners, T.J., Detecting novel and emerging drug terms using natural language processing: A social media corpus study (2018) JMIR Public Health and Surveillance, 4 (1), pp. 2369-2960. , issn; 
Singh, D., Müller, C.P., Vicknasingam, B.K., Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users (2014) Drug and Alcohol Dependence, 139, pp. 132-137; 
Tamersoy, A., De Choudhury, M., Chau, D.H., Characterizing smoking and drinking abstinence from social media (2015) Proceedings of the 26th ACM Conference on Hypertext & Social Media, pp. 139-148. , ACM; 
Veilleux, J.C., Colvin, P.J., Anderson, J., York, C., Heinz, A.J., A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction (2010) Clinical Psychology Review, 30 (2), pp. 155-166; 
Vicknasingam, B., Narayanan, S., Beng, G.T., Mansor, S.M., The informal use of ketum (mitragyna speciosa) for opioid withdrawal in the northern states of peninsular Malaysia and implications for drug substitution therapy (2010) International Journal of Drug Policy, 21 (4), pp. 283-288. , issn: 0955-3959; 
Warner, M.L., Kaufman, N.C., Grundmann, O., The pharmacology and toxicology of kratom: From traditional herb to drug of abuse (2016) International Journal of Legal Medicine, 130 (1), pp. 127-138; 
Westgate, E.C., Neighbors, C., Heppner, H., Jahn, S., Lindgren, K.P., I will take a shot for every’like’ I get on this status": Posting alcohol-related facebook content is linked to drinking outcomes (2014) Journal of Studies on Alcohol and Drugs, 75 (3), pp. 390-398; 
White, R.W., Tatonetti, N.P., Shah, N.H., Altman, R.B., Horvitz, E., Web-scale pharmacovigilance: Listening to signals from the crowd (2013) Journal of the American Medical Informatics Association, 20 (3), pp. 404-408; 
White, R.W., Wang, S., Pant, A., Harpaz, R., Shukla, P., Sun, W., DuMouchel, W., Horvitz, E., Early identification of adverse drug reactions from search log data (2016) Journal of Biomedical Informatics, 59, pp. 42-48; 
Wightman, R.S., Perrone, J., Erowid, F., Erowid, E., Meisel, Z.F., Nelson, L.S., Comparative analysis of opioid queries on erowid. Org: An opportunity to advance harm reduction (2017) Substance Use & Misuse, 52 (10), pp. 1315-1319; 
Williams, A.R., Bisaga, A., From AIDS to opioids-how to combat an epidemic (2016) New England Journal of Medicine, 375 (9), pp. 813-815; 
(2017) Commitment of Newcomers and Old-Timers to Online Health Support Communities, , ACM; 
Yom-Tov, E., Gabrilovich, E., Postmarket drug surveillance without trial costs: Discovery of adverse drug reactions through large-scale analysis of web search queries (2013) Journal of Medical Internet Research, 15, p. 6; 
Young, S.D., Zheng, K., Chu, L.F., Humphreys, K., Internet searches for opioids predict future emergency department heroin admissions (2018) Drug and Alcohol Dependence
A4  - ACM SIGCHI
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85067622469&doi=10.1145%2f3290605.3300354&partnerID=40&md5=dfb5500ee5b65be510e2312c19ef9d2f
ER  - 

TY  - JOUR
TI  - Misuse of prescribed opioids in the United States
T2  - Pharmacoepidemiology and Drug Safety
J2  - Pharmacoepidemiol. Drug Saf.
VL  - 28
IS  - 3
SP  - 345
EP  - 353
PY  - 2019
DO  - 10.1002/pds.4743
SN  - 10538569 (ISSN) 
AU  - Mojtabai, R.
AU  - Amin-Esmaeili, M.
AU  - Nejat, E.
AU  - Olfson, M.
AD  - Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States
AD  - Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
AD  - College of Dentistry, University of Tennessee Health Sciences Center, Memphis, TN, United States
AD  - Department of Psychiatry, Columbia University and New York State Psychiatric Institute, New York, NY, United States
AB  - Purpose: To assess the prevalence and correlates of self-reported misuse of prescribed-opioid medications in the US general population. Method: In 31 068 adult participants of the National Survey on Drug Use and Health (NSDUH) 2015 and 2016 who reported using opioids in the past year, we assessed the prevalence and correlates of self-reported misuse of prescribed opioids, defined as using a larger dose, more frequently, or longer than prescribed. Multivariable logistic-regression models and the machine-learning method of boosted regression were used to identify the correlates of misuse. Results: On the basis of weighted NSDUH estimates, of more than 89 million US adults who used prescription opioids every year, close to 3.9 million (4.4%) reported misused the prescribed medications. Prescribed-opioid misuse was most strongly associated with co-occurring misuse of opioids without a prescription, misuse of benzodiazepines, other drug-use disorders, history of illegal activity, and psychological distress. Misuse of prescribed opioids was also strongly associated with prescription opioid–use disorder, especially among those who misused more potent opioids or started misusing opioids before the current year. Conclusions: Misuse of prescribed opioids is associated with other high-risk behaviors and adverse health outcomes. The findings call for better monitoring of opioid prescription in clinical practice. © 2019 John Wiley & Sons, Ltd.
KW  - drug use disorder
KW  - medication misuse
KW  - painkillers
KW  - pharmacoepidemiology
KW  - prescription opioid
KW  - acetylsalicylic acid plus oxycodone plus oxycodone terephthalate
KW  - benzodiazepine derivative
KW  - buprenorphine
KW  - buprenorphine plus naloxone
KW  - codeine
KW  - fentanyl
KW  - hydrocodone
KW  - hydrocodone bitartrate plus paracetamol
KW  - hydromorphone
KW  - methadone
KW  - morphine
KW  - morphine sulfate
KW  - opiate
KW  - oxycodone
KW  - oxycodone plus paracetamol
KW  - oxymorphone
KW  - paracetamol
KW  - pethidine
KW  - tramadol
KW  - adolescent
KW  - adult
KW  - aged
KW  - Article
KW  - clinical practice
KW  - distress syndrome
KW  - drug monitoring
KW  - DSM-IV
KW  - female
KW  - health care personnel
KW  - human
KW  - machine learning
KW  - major clinical study
KW  - male
KW  - middle aged
KW  - prescription drug misuse
KW  - prevalence
KW  - priority journal
KW  - self report
KW  - United States
PB  - John Wiley and Sons Ltd
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: PDSAE
C2  - 30723973
LA  - English
N1  - Correspondence Address: Mojtabai, R.; Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins UniversityUnited States; email: rmojtab1@jhu.edu
N1  - Chemicals/CAS: acetylsalicylic acid plus oxycodone plus oxycodone terephthalate, 64336-56-7; buprenorphine, 52485-79-7, 53152-21-9; codeine, 76-57-3; fentanyl, 437-38-7; hydrocodone, 125-29-1, 25968-91-6, 34366-67-1; hydromorphone, 466-99-9, 71-68-1; methadone, 1095-90-5, 125-56-4, 23142-53-2, 297-88-1, 76-99-3; morphine, 52-26-6, 57-27-2; morphine sulfate, 23095-84-3, 35764-55-7, 64-31-3; opiate, 53663-61-9, 8002-76-4, 8008-60-4; oxycodone, 124-90-3, 76-42-6; oxymorphone, 357-07-3, 76-41-5; paracetamol, 103-90-2; pethidine, 28097-96-3, 50-13-5, 57-42-1; tramadol, 27203-92-5, 36282-47-0
N1  - References: Blanco, C., Wall, M.M., Okuda, M., Wang, S., Iza, M., Olfson, M., Pain as a predictor of opioid use disorder in a nationally representative sample (2016) Am J Psychiatry, 173 (12), pp. 1189-1195; 
Boscarino, J.A., Rukstalis, M., Hoffman, S.N., Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system (2010) Addiction, 105 (10), pp. 1776-1782; 
Compton, W.M., Volkow, N.D., Major increases in opioid analgesic abuse in the United States: concerns and strategies (2006) Drug Alcohol Depend, 81 (2), pp. 103-107; 
Edlund, M.J., Martin, B.C., Fan, M.Y., Devries, A., Braden, J.B., Sullivan, M.D., Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study (2010) Drug Alcohol Depend, 112 (1-2), pp. 90-98; 
Edlund, M.J., Martin, B.C., Russo, J.E., DeVries, A., Braden, J.B., Sullivan, M.D., The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription (2014) Clin J Pain, 30 (7), pp. 557-564; 
Atluri, S., Sudarshan, G., Manchikanti, L., Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011 (2014) Pain Physician, 17 (2), pp. E119-E128; 
Hoffman, L.A., Lewis, B., Nixon, S.J., Opioid misuse trends in treatment seeking populations: revised prescription opioid policy and temporally corresponding changes (2017) Subst Use Misuse, 52 (14), pp. 1850-1858; 
Jones, C.M., Trends and key correlates of prescription opioid injection misuse in the United States (2017) Addict Behav, 78, pp. 145-152; 
Brady, K.T., McCauley, J.L., Back, S.E., Prescription opioid misuse, abuse, and treatment in the United States: an update (2016) Am J Psychiatry, 173 (1), pp. 18-26; 
Jones, C.M., Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers—United States, 2002-2004 and 2008-2010 (2013) Drug Alcohol Depend, 132 (1-2), pp. 95-100; 
Muhuri, P.K., Gfroerer, J.C., Davies, M.C., (2013) Associations of nonmedical pain reliever use and initiation of heroin use in the United States, pp. 1-17. , https://www.samhsa.gov/data/sites/default/files/DR006/DR006/nonmedical-pain-reliever-use-2013.htm, CBHSQ Data Review;, Accessed 29 Jan 2018; 
Han, B., Compton, W.M., Blanco, C., Crane, E., Lee, J., Jones, C.M., Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health (2017) Ann Intern Med, 167 (5), pp. 293-301; 
Minozzi, S., Amato, L., Davoli, M., Development of dependence following treatment with opioid analgesics for pain relief: a systematic review (2013) Addiction, 108 (4), pp. 688-698; 
Fishbain, D.A., Cole, B., Lewis, J., Rosomoff, H.L., Rosomoff, R.S., What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review (2008) Pain Med, 9 (4), pp. 444-459; 
Timmerman, L., Stronks, D.L., Groeneweg, J.G., Huygen, F.J., Prevalence and determinants of medication non-adherence in chronic pain patients: a systematic review (2016) Acta Anaesthesiol Scand, 60 (4), pp. 416-431; 
Boudreau, D., Von Korff, M., Rutter, C.M., Trends in long-term opioid therapy for chronic non-cancer pain (2009) Pharmacoepidemiol Drug Saf, 18 (12), pp. 1166-1175; 
Chou, R., Deyo, R., Devine, B., (2014) The effectiveness and risks of long-term opioid treatment of chronic pain, , https://www.ncbi.nlm.nih.gov/books/NBK258809/pdf/Bookshelf_NBK258809.pdf, Evidence report/technology assessment No, 218, Accessed 20 June 2017; 
Brat, G.A., Agniel, D., Beam, A., Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study (2018) BMJ, 360, p. j5790; 
Mundkur, M.L., Rough, K., Huybrechts, K.F., Patterns of opioid initiation at first visits for pain in United States primary care settings (2018) Pharmacoepidemiol Drug Saf, 27 (5), pp. 495-503; 
Volkow, N.D., McLellan, T.A., Cotto, J.H., Karithanom, M., Weiss, S.R., Characteristics of opioid prescriptions in 2009 (2011) JAMA, 305 (13), pp. 1299-1301; 
(2016) National Survey on Drug Use and Health public use file codebook 2018, , https://samhda.s3-us-gov-west-1.amazonaws.com/s3fs-public/field-uploads-protected/studies/NSDUH-2016/NSDUH-2016-datasets/NSDUH-2016-DS0001/NSDUH-2016-DS0001-info/NSDUH-2016-DS0001-info-codebook.pdf; 
Perlis, T.E., Des Jarlais, D.C., Friedman, S.R., Arasteh, K., Turner, C.F., Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs (2004) Addiction, 99 (7), pp. 885-896; 
Turner, C.F., Ku, L., Rogers, S.M., Lindberg, L.D., Pleck, J.H., Sonenstein, F.L., Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology (1998) Science, 280 (5365), pp. 867-873; 
(2015) Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys, , 8th, ed., Lenexa, KS, American Association for Public Opinion Research; 
(2010) Reliability of key measures in the National Survey on Drug Use and Health, , https://www.samhsa.gov/data/sites/default/files/2k6ReliabilityP/2k6ReliabilityP.pdf, Accessed 29 Jan 2018; 
(1994) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, , 4th, ed., Washington, DC, American Psychiatric Association; 
Jordan, B.K., Karg, R.S., Batts, K.R., Epstein, J.F., Wiesen, C., A clinical validation of the National Survey on Drug Use and Health assessment of substance use disorders (2008) Addict Behav, 33 (6), pp. 782-798; 
Shiffman, S., Waters, A., Hickcox, M., The nicotine dependence syndrome scale: a multidimensional measure of nicotine dependence (2004) Nicotine Tob Res, 6 (2), pp. 327-348; 
Kessler, R.C., Barker, P.R., Colpe, L.J., Screening for serious mental illness in the general population (2003) Arch Gen Psychiatry, 60 (2), pp. 184-189; 
Kessler, R.C., Andrews, G., Colpe, L.J., Short screening scales to monitor population prevalences and trends in non-specific psychological distress (2002) Psychol Med, 32 (6), pp. 959-976; 
Prochaska, J.J., Sung, H.Y., Max, W., Shi, Y., Ong, M., Validity study of the K6 scale as a measure of moderate mental distress based on mental health treatment need and utilization (2012) Int J Methods Psychiatr Res, 21 (2), pp. 88-97; 
Kessler, R.C., Berglund, P., Demler, O., The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) (2003) JAMA, 289 (23), pp. 3095-3105; 
Haro, J.M., Arbabzadeh-Bouchez, S., Brugha, T.S., Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys (2006) Int J Methods Psychiatr Res, 15 (4), pp. 167-180; 
Merikangas, K.R., He, J.P., Burstein, M., Lifetime prevalence of mental disorders in U.S. adolescents: results from the national Comorbidity Survey Replication–Adolescent Supplement (NCS-A) (2010) J Am Acad Child Adolesc Psychiatry, 49 (10), pp. 980-989; 
Elith, J., Leathwick, J.R., Hastie, T., A working guide to boosted regression trees (2008) J Anim Ecol, 77 (4), pp. 802-813; 
Breiman, L., (1984) Classification and Regression Trees, , Belmont, CA, Wadsworth International Group; 
Schonlau, M., Boosted regression (boosting): an introductory tutorial and a Stata plugin (2005) Stata Journal, 5 (3), pp. 330-354; 
Friedman, J., Greedy function approximation: a gradient boosting machine (2001) Ann Stat, 29 (5), pp. 1189-1232; 
McCracken, L.M., Hoskins, J., Eccleston, C., Concerns about medication and medication use in chronic pain (2006) J Pain, 7 (10), pp. 726-734; 
Broekmans, S., Dobbels, F., Milisen, K., Morlion, B., Vanderschueren, S., Pharmacologic pain treatment in a multidisciplinary pain center: do patients adhere to the prescription of the physician? (2010) Clin J Pain, 26 (2), pp. 81-86; 
Ives, T.J., Chelminski, P.R., Hammett-Stabler, C.A., Predictors of opioid misuse in patients with chronic pain: a prospective cohort study (2006) BMC Health Serv Res, 6 (1), p. 46; 
Grattan, A., Sullivan, M.D., Saunders, K.W., Campbell, C.I., Von Korff, M.R., Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse (2012) Ann Fam Med, 10 (4), pp. 304-311; 
Barth, K.S., Balliet, W., Pelic, C.M., Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain (2014) Pain Med, 15 (8), pp. 1359-1364; 
Cochran, G., Rosen, D., McCarthy, R.M., Engel, R.J., Risk factors for symptoms of prescription opioid misuse: do older adults differ from younger adult patients? (2017) J Gerontol Soc Work, 60 (6-7), pp. 443-457; 
Morasco, B.J., Turk, D.C., Donovan, D.M., Dobscha, S.K., Risk for prescription opioid misuse among patients with a history of substance use disorder (2013) Drug Alcohol Depend, 127 (1-3), pp. 193-199; 
Rice, J.B., White, A.G., Birnbaum, H.G., Schiller, M., Brown, D.A., Roland, C.L., A model to identify patients at risk for prescription opioid abuse, dependence, and misuse (2012) Pain Med, 13 (9), pp. 1162-1173; 
Manchikanti, L., Abdi, S., Atluri, S., American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2—guidance (2012) Pain Physician, 15 (3), pp. S67-S116; 
Manchikanti, L., Kaye, A.M., Knezevic, N.N., Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines (2017) Pain Physician, 20 (2S), pp. S3-S92; 
Sun, E.C., Dixit, A., Humphreys, K., Darnall, B.D., Baker, L.C., Mackey, S., Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis (2017) BMJ, 356, p. j760
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061047359&doi=10.1002%2fpds.4743&partnerID=40&md5=f2a454c0a5d4f74dd62d9426360cd7b6
ER  - 

TY  - JOUR
TI  - Subtypes in patients with opioid misuse: A prognostic enrichment strategy using electronic health record data in hospitalized patients
T2  - PLoS ONE
J2  - PLoS ONE
VL  - 14
IS  - 7
PY  - 2019
DO  - 10.1371/journal.pone.0219717
SN  - 19326203 (ISSN) 
AU  - Afshar, M.
AU  - Joyce, C.
AU  - Dligach, D.
AU  - Sharma, B.
AU  - Kania, R.
AU  - Xie, M.
AU  - Swope, K.
AU  - Salisbury-Afshar, E.
AU  - Karnik, N.S.
AD  - Department of Public Health Sciences, Loyola University, Maywood, IL, United States
AD  - Center for Health Outcomes and Informatics Research, Loyola University, Maywood, IL, United States
AD  - Stritch School of Medicine, Loyola University, Maywood, IL, United States
AD  - Department of Computer Science, Loyola University Medical Center, Maywood, IL, United States
AD  - Department of Mathematics and Statistics, Loyola University, Chicago, IL, United States
AD  - Center for Multi-System Solutions to the Opioid Epidemic, American Institute for Research, Chicago, IL, United States
AD  - Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, United States
AB  - Background Approaches are needed to better delineate the continuum of opioid misuse that occurs in hospitalized patients. A prognostic enrichment strategy with latent class analysis (LCA) may facilitate treatment strategies in subtypes of opioid misuse. We aim to identify subtypes of patients with opioid misuse and examine the distinctions between the subtypes by examining patient characteristics, topic models from clinical notes, and clinical outcomes. Methods This was an observational study of inpatient hospitalizations at a tertiary care center between 2007 and 2017. Patients with opioid misuse were identified using an operational definition applied to all inpatient encounters. LCA with eight class-defining variables from the electronic health record (EHR) was applied to identify subtypes in the cohort of patients with opioid misuse. Comparisons between subtypes were made using the following approaches: (1) descriptive statistics on patient characteristics and healthcare utilization using EHR data and census-level data; (2) topic models with natural language processing (NLP) from clinical notes; (3) association with hospital outcomes. Findings The analysis cohort was 6,224 (2.7% of all hospitalizations) patient encounters with opioid misuse with a data corpus of 422,147 clinical notes. LCA identified four subtypes with differing patient characteristics, topics from the clinical notes, and hospital outcomes. Class 1 was categorized by high hospital utilization with known opioid-related conditions (36.5%); Class 2 included patients with illicit use, low socioeconomic status, and psychoses (12.8%); Class 3 contained patients with alcohol use disorders with complications (39.2%); and class 4 consisted of those with low hospital utilization and incidental opioid misuse (11.5%). The following hospital outcomes were the highest for each subtype when compared against the other subtypes: readmission for class 1 (13.9% vs. 10.5%, p<0.01); discharge against medical advice for class 2 (12.3% vs. 5.3%, p<0.01); and in-hospital death for classes 3 and 4 (3.2% vs. 1.9%, p<0.01). Conclusions A 4-class latent model was the most parsimonious model that defined clinically interpretable and relevant subtypes for opioid misuse. Distinct subtypes were delineated after examining multiple domains of EHR data and applying methods in artificial intelligence. The approach with LCA and readily available class-defining substance use variables from the EHR may be applied as a prognostic enrichment strategy for targeted interventions. © 2019 Afshar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
KW  - opiate
KW  - adult
KW  - alcoholism
KW  - Article
KW  - cohort analysis
KW  - disease classification
KW  - drug misuse
KW  - electronic health record
KW  - female
KW  - health care utilization
KW  - hospital discharge
KW  - hospital patient
KW  - hospital readmission
KW  - hospital utilization
KW  - human
KW  - intermethod comparison
KW  - major clinical study
KW  - male
KW  - methodology
KW  - middle aged
KW  - observational study
KW  - prognosis
KW  - social status
KW  - tertiary care center
KW  - young adult
PB  - Public Library of Science
N1  - Cited By :1
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C7  - e0219717
N1  - CODEN: POLNC
C2  - 31310611
LA  - English
N1  - Correspondence Address: Afshar, M.; Department of Public Health Sciences, Loyola UniversityUnited States; email: mafshar@luc.edu
N1  - Chemicals/CAS: opiate, 53663-61-9, 8002-76-4, 8008-60-4
N1  - References: (2019) Enrichment Strategies for Clinical Trials to Support Determination of Effectiveness of Human Drugs and Biological Products, , https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidelines/default.htm, U.S. Department of Health and Human Services Food and Drug Administration. March Accessed February 2, 2019; 
Barry, D.T., Irwin, K.S., Jones, E.S., Becker, W.C., Tetrault, J.M., Sullivan, L.E., Opioids, chronic pain, and addiction in primary care J Pain, 11 (12), pp. 1442-1450. , https://doi.org/10.1016/j.jpain.2010.04.002, PMID: 20627817; 
Banerjee, G., Edelman, E.J., Barry, D.T., Becker, W.C., Cerda, M., Gaither, J.R., Non-medical use of prescription opioids is associated with heroin initiation among US veterans: A prospective cohort study Addiction, 111 (11), pp. 2021-2031. , https://doi.org/10.1111/add.13491, PMID: 27552496; 
Burke, D.S., Forecasting the opioid epidemic Science, 354 (6312), p. 529. , https://doi.org/10.1126/science.aal2943, PMID: 27811241; 
Meltzer, E.C., Rybin, D., Saitz, R., Samet, J.H., Schwartz, S.L., Butler, S.F., Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the Current Opioid Misuse Measure (COMM) Pain, 152 (2), pp. 397-402. , https://doi.org/10.1016/j.pain.2010.11.006, PMID: 21177035; 
Dowell, D., Haegerich, T.M., Chou, R., CDC guideline for prescribing opioids for chronic pain—United States, 2016 (2016) JAMA, 315 (15), pp. 1624-1645. , https://doi.org/10.1001/jama.2016.1464, PMID: 26977696; 
Bennett, A.S., Golub, A., Elliott, L., A behavioral typology of opioid overdose risk behaviors among recent veterans in New York City (2017) PLoS One, 12. , https://doi.org/10.1371/journal.pone.0179054, PMID: 28594892; 
Cochran, G., Hruschak, V., Bacci, J.L., Hohmeier, K.C., Tarter, R., Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis (2017) Res Social Adm Pharm, 13 (6), pp. 1055-1061. , https://doi.org/10.1016/j.sapharm.2016.11.005, 27876595; 
Fong, C., Matusow, H., Cleland, C.M., Rosenblum, A., Characteristics of non-opioid substance misusers among patients enrolling in opioid treatment programs: A latent class analysis (2015) J Addict Dis, 34 (2-3), pp. 141-1450. , https://doi.org/10.1080/10550887.2015.1059226, PMID: 26075932; 
Green, T.C., Black, R., Grimes Serrano, J.M., Budman, S.H., Butler, S.F., Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment (2011) PLoS One, 6 (11). , https://doi.org/10.1371/journal.pone.0027244, PMID: 22087270; 
Chen, Y., Ghosh, J., Bejan, C.A., Gunter, C.A., Gypta, A., Kho, A., Building bridges across electronic health record systems through inferred phenotypic topics (2015) J Biomed Inform, 55, pp. 82-93. , https://doi.org/10.1016/j.jbi.2015.03.011, PMID: 25841328; 
Arnold, C.W., Oh, A., Chen, S., Speier, W., Evaluating topic model interpretability from a primary care physician perspective (2016) Comput Methods Programs Biomed, 124, pp. 67-75. , https://doi.org/10.1016/j.cmpb.2015.10.014, PMID: 26614020; 
Huang, Z., Dong, W., Duan, H., A probabilistic topic model for clinical risk stratification from electronic health records (2015) J Biomed Inform, 58, pp. 28-36. , https://doi.org/10.1016/j.jbi.2015.09.005, PMID: 26370451; 
Compton, W.M., Jones, C.M., Baldwin, G.T., Relationship between nonmedical prescription-opioid use and heroin use (2016) N Engl J Med, 374 (2), pp. 154-163. , https://doi.org/10.1056/NEJMra1508490, PMID: 26760086; 
Bergman, L.R., Magnusson, D., A person-oriented approach in research on developmental psychopathology (1997) Dev Psychopathol, 9 (2), pp. 291-319. , PMID: 9201446; 
Collins, L.M., (2010) Latent Class and Latent Transition Analysis: With Applications in the Social, Behavioral, and Health Sciences, , New York: Wiley; 
Hylan, T.R., Von Korff, M., Saunders, K., Masters, E., Palmer, R.E., Carrell, D., Automated prediction of risk for problem opioid use in a primary care setting (2015) J Pain, 16 (4), pp. 380-387. , https://doi.org/10.1016/j.jpain.2015.01.011, PMID: 25640294; 
Edlund, M.J., Steffick, D., Hudson, T., Harris, K.M., Sullivan, M., Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain (2007) Pain, 129 (3), pp. 355-362. , https://doi.org/10.1016/j.pain.2007.02.014, PMID: 17449178; 
Sullivan, M.D., Edlund, M.J., Zhang, L., Unutzer, J., Wells, K.B., Association between mental health disorders, problem drug use, and regular prescription opioid use (2006) Arch Intern Med, 166 (19), pp. 2087-2093. , https://doi.org/10.1001/archinte.166.19.2087, PMID: 17060538; 
Lee, C., Sharma, M., Kantorovich, S., Brenton, A., A predictive algorithm to detect opioid use disorder: What is the utility in a primary care setting? (2018) Health Serv Res Manag Epidemiol, 5. , https://doi.org/10.1177/2333392817747467, 2333392817747467. PMID: 29383324; 
Han, B.H., Sherman, S.E., Palamar, J.J., Prescription opioid misuse among middle-aged and older adults in the United States, 2015–2016 (2019) Prev Med, 121, pp. 94-98. , https://doi.org/10.1016/j.ypmed.2019.02.018, PMID: 30763631; 
Zhang, Z., Abarda, A., Contractor, A.A., Wang, J., Dayton, C.M., Exploring heterogeneity in clinical trials with latent class analysis (2018) Ann Transl Med, 6 (7), p. 119. , https://doi.org/10.21037/atm.2018.01.24, 29955579; 
Tonelli, M., Wiebe, N., Fortin, M., Gurthrie, B., Hemmelgarn, B.R., James, M.T., Methods for identifying 30 chronic conditions: Application to administrative data (2015) BMC Med Inform Decis Mak, 15, p. 31. , https://doi.org/10.1186/s12911-015-0155-5, PMID: 25886580; 
Weiss, A.J., Bailey, M.K., O’Malley, L., Barrett, M.L., Elixhauser, A., Steiner, C.A., (2006) Patient Characteristics of Opioid-Related Inpatient Stays and Emergency Department Visits Nationally and by State, 2014: Statistical Brief #224 Healthcare Cost and Utilization Project (HCUP) Statistical Briefs Rockville (MD); 
Davern, M., Quinn, B.C., Kenney, G.M., Blewett, L.A., The American Community Survey and health insurance coverage estimates: Possibilities and challenges for health policy researchers (2009) Health Serv Res, 44 (2), pp. 593-605. , https://doi.org/10.1111/j.1475-6773.2008.00921.x, PMID: 19040425; 
Krieger, N., Waterman, P.D., Spasojevic, J., Li, W., Maduro, G., Van Wye, G., Public health monitoring of privilege and deprivation with the index of concentration at the extremes (2016) Am J Public Health, 106 (2), pp. 256-263. , https://doi.org/10.2105/AJPH.2015.302955, PMID: 26691119; 
Krieger, N., Chen, J.T., Waterman, P.D., Soobader, M.J., Subramanian, S.V., Carson, R., Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: Does the choice of area-based measure and geographic level matter?: The public health disparities geocoding project (2002) Am J Epidemiol, 156 (5), pp. 471-482. , https://doi.org/10.1093/aje/kwf068, PMID: 12196317; 
Hausauer, A.K., Keegan, T.H., Chang, E.T., Glaser, S.L., Howe, H., Clarke, C.A., Recent trends in breast cancer incidence in US white women by county-level urban/rural and poverty status (2009) BMC Med, 7, p. 31. , https://doi.org/10.1186/1741-7015-7-31, PMID: 19558637; 
Savova, G.K., Masanz, J.J., Ogren, P.V., Zheng, J., Sohn, S., Kipper-Schuler, K.C., Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): Architecture, component evaluation and applications (2010) J Am Med Inform Assoc, 17 (5), pp. 507-513. , https://doi.org/10.1136/jamia.2009.001560, PMID: 20819853; 
McCoy, T.H., Jr., Castro, V.M., Roberson, A.M., Snapper, L.A., Perlis, R.H., Improving prediction of suicide and accidental death after discharge from general hospitals with natural language processing (2016) JAMA Psychiatry, 73 (10), pp. 1064-1071. , https://doi.org/10.1001/jamapsychiatry.2016.2172, PMID: 27626235; 
Rumshisky, A., Ghassemi, M., Naumann, T., Szolovits, P., Castro, V.M., McCoy, T.H., Predicting early psychiatric readmission with natural language processing of narrative discharge summaries (2016) Transl Psychiatry, 6 (10), p. e921. , https://doi.org/10.1038/tp.2015.182, PMID: 27754482; 
Shatte, A.B.R., Hutchinson, D.M., Teague, S.J., Machine learning in mental health: A scoping review of methods and applications (2019) Psychol Med, 49 (9), pp. 1-23; 
Ford, E., Carroll, J.A., Smith, H.E., Scott, D., Cassell, J.A., Extracting information from the text of electronic medical records to improve case detection: A systematic review (2016) J Am Med Inform Assoc, 23 (5), pp. 1007-1015. , https://doi.org/10.1093/jamia/ocv180, PMID: 26911811; 
Meystre, S.M., Savova, G.K., Kipper-Schuler, K.C., Hurdle, J.F., Extracting information from textual documents in the electronic health record: A review of recent research (2008) Yearb Med Inform, pp. 128-144. , PMID: 18660887; 
Roder, M.B.A., Hinneburg, A., Exploring the space of topic coherence measures (2015) Proceedings of the Eighth ACM International Conference on Web Search and Data Mining; 
Desai, N.R., Ross, J.S., Kwon, J.Y., Herrin, J., Dharmarajan, K., Bernheim, S.M., Association between hospital penalty status under the Hospital readmission reduction program and readmission rates for target and nontarget conditions (2016) JAMA, 316 (24), pp. 2647-2656. , https://doi.org/10.1001/jama.2016.18533, PMID: 28027367; 
Cowen, M.E., Dusseau, D.J., Toth, B.G., Guisinger, C., Zodet, M.W., Shyr, Y., Casemix adjustment of managed care claims data using the clinical classification for health policy research method (1998) Med Care, 36 (7), pp. 1108-11013. , PMID: 9674627; 
Rehurek, R.S.P., Software framework for topic modelling with large corpora (2010) Proc LR 2010 Work New Challenges NLP Fram, pp. 45-50; 
Smothers, B.A., Yahr, H.T., Alcohol use disorder and illicit drug use in admissions to general hospitals in the United States (2005) Am J Addict, 14 (3), pp. 256-267. , https://doi.org/10.1080/10550490590949433, 16019976; 
Friedmann, P.D., Wilson, D., Nunes, E.V., Hoskinson, R., Jr., Lee, J.D., Gordon, M., Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder? (2018) J Subst Abuse Treat, 85, pp. 61-65. , https://doi.org/10.1016/j.jsat.2017.01.018, PMID: 28236511; 
Scherer, M., Romano, E., Voas, R., Taylor, E., Latent classes of polydrug users as a predictor of crash involvement and alcohol consumption (2018) J Stud Alcohol Drugs, 79 (3), pp. 481-489. , https://doi.org/10.15288/jsad.2018.79.481, PMID: 29885157; 
Thompson, H.H.K., Jadhav, R., Webb, T.A., Pollack, M., Karnik, N., The subtance use intervention team: A preliminary analysis of a population-level strategy to address the opioid crisis at an academic health center (2019) J Addict Med, , Epub ahead of print; 
Jeffery, R.M., Dickinson, L., Ng, N.D., DeGeorge, L.M., Nable, J.V., Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency (2017) J Am Coll Health, 65 (3), pp. 212-216. , https://doi.org/10.1080/07448481.2016.1277730, PMID: 28059635; 
Moreno, J.L., Wakeman, S.E., Duprey, M.S., Roberts, R.J., Jacobson, J.S., Devlin, J.W., Predictors for 30-day and 90-day hospital readmission among patients with opioid use disorder (2019) J Addict Med, , Epub ahead of print; 
Pytell, J.D., Rastegar, D.A., Who leaves early? Factors associated with against medical advice discharge during alcohol withdrawal treatment (2018) J Addict Med, 12 (6), pp. 447-452. , https://doi.org/10.1097/ADM.0000000000000430, PMID: 29939873; 
Watson, D.P., Shuman, V., Kowalsky, J., Golembiewski, E., Brown, M., Housing First and harm reduction: A rapid review and document analysis of the US and Canadian open-access literature (2017) Harm Reduct J, 14 (1), p. 30. , https://doi.org/10.1186/s12954-017-0158-x, PMID: 28535804; 
Fitzpatrick-Lewis, D., Ganann, R., Krishnaratne, S., Ciliska, D., Kouyoumdjian, F., Hwang, S.W., Effectiveness of interventions to improve the health and housing status of homeless people: A rapid systematic review (2011) BMC Public Health, 11, p. 638. , https://doi.org/10.1186/1471-2458-11-638, PMID: 21831318; 
Murphy, S.A., Lynch, K.G., Oslin, D., McKay, J.R., TenHave, T., Developing adaptive treatment strategies in substance abuse research (2007) Drug Alcohol Depend, 88, pp. S24-S30; 
Thompson, S.K., Collins, L.M., Adaptive sampling in research on risk-related behaviors (2002) Drug Alcohol Depend, 68, pp. S57-S67. , PMID: 12324175; 
Piper, M.E., Schlam, T.R., Cook, J.W., Smith, S.S., Bolt, D.M., Loh, W.Y., Toward precision smoking cessation treatment I: Moderator results from a factorial experiment (2017) Drug Alcohol Depend, 171, pp. 59-65. , https://doi.org/10.1016/j.drugalcdep.2016.11.025, PMID: 28013098; 
Lei, H., Nahum-Shani, I., Lynch, K., Oslin, D., Murphy, S.A., A "SMART" design for building individualized treatment sequences (2012) Annu Rev Clin Psychol, 8, pp. 21-48. , https://doi.org/10.1146/annurev-clinpsy-032511-143152, PMID: 22224838; 
Nahum-Shani, I., Qian, M., Almirall, D., Pelham, W.E., Gnagy, B., Fabiano, G.A., Experimental design and primary data analysis methods for comparing adaptive interventions (2012) Psychol Methods, 17, pp. 457-477. , https://doi.org/10.1037/a0029372, PMID: 23025433; 
Hay, K.R., Huhn, A.S., Tompkins, D.A., Dunn, K.E., Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use (2019) J Addict Med, , Epub ahead of print; 
Chen, J.H., Goldstein, M.K., Asch, S.M., Mackey, L., Altman, R.B., Predicting inpatient clinical order patterns with probabilistic topic models vs conventional order sets (2017) J Am Med Inform Assoc, 24 (3), pp. 472-480. , https://doi.org/10.1093/jamia/ocw136, PMID: 27655861; 
Huang, Z., Ge, Z., Dong, W., He, K., Duan, H., Probabilistic modeling personalized treatment pathways using electronic health records (2018) J Biomed Inform, 86, pp. 33-48. , https://doi.org/10.1016/j.jbi.2018.08.004, PMID: 30138699
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069736756&doi=10.1371%2fjournal.pone.0219717&partnerID=40&md5=c3f09bd802984b2b1acc85a5f7448fd7
ER  - 

TY  - JOUR
TI  - Forging neuroimaging targets for recovery in opioid use disorder
T2  - Frontiers in Psychiatry
J2  - Front. Psychiatry
VL  - 10
IS  - MAR
PY  - 2019
DO  - 10.3389/fpsyt.2019.00117
SN  - 16640640 (ISSN) 
AU  - Stewart, J.L.
AU  - May, A.C.
AU  - Aupperle, R.L.
AU  - Bodurka, J.
AD  - Laureate Institute for Brain Research, Tulsa, OK, United States
AD  - Department of Community Medicine, University of Tulsa, Tulsa, OK, United States
AD  - Joint Doctoral Program in Clinical Psychology, San Diego State University, University of California, San Diego, San Diego, CA, United States
AB  - The United States is in the midst of an opioid epidemic and lacks a range of successful interventions to reduce this public health burden. Many individuals with opioid use disorder (OUD) consume drugs to relieve physical and/or emotional pain, a pattern that may increasingly result in death. The field of addiction research lacks a comprehensive understanding of physiological and neural mechanisms instantiating this cycle of Negative Reinforcement in OUD, resulting in limited interventions that successfully promote abstinence and recovery. Given the urgency of the opioid crisis, the present review highlights faulty brain circuitry and processes associated with OUD within the context of the Three-Stage Model of Addiction (1). This model underscores Negative Reinforcement processes as crucial to the maintenance and exacerbation of chronic substance use together with Binge/Intoxication and Preoccupation/Anticipation processes. This review focuses on cross-sectional as well as longitudinal studies of relapse and treatment outcome that employ magnetic resonance imaging (MRI), functional near-infrared spectroscopy (fNIRs), brain stimulation methods, and/or electroencephalography (EEG) explored in frequency and time domains (the latter measured by event-related potentials, or ERPs). We discuss strengths and limitations of this neuroimaging work with respect to study design and individual differences that may influence interpretation of findings (e.g., opioid use chronicity/recency, comorbid symptoms, and biological sex). Lastly, we translate gaps in the OUD literature, particularly with respect to Negative Reinforcement processes, into future research directions involving operant and classical conditioning involving aversion/stress. Overall, opioid-related stimuli may lessen their hold on frontocingulate mechanisms implicated in Preoccupation/Anticipation as a function of prolonged abstinence and that degree of frontocingulate impairment may predict treatment outcome. In addition, longitudinal studies suggest that brain stimulation/drug treatments and prolonged abstinence can change brain responses during Negative Reinforcement and Preoccupation/Anticipation to reduce salience of drug cues, which may attenuate further craving and relapse. Incorporating this neuroscience-derived knowledge with the Three-Stage Model of Addiction may offer a useful plan for delineating specific neurobiological targets for OUD treatment. Copyright © 2019 Stewart, May, Aupperle and Bodurka.
KW  - Abstinence
KW  - Electroencephalography
KW  - Event related potentials
KW  - Magnetic resonance imaging
KW  - Neuroimaging
KW  - Opioid use disorder
KW  - Recovery
KW  - abstinence
KW  - aversive behavior
KW  - brain depth stimulation
KW  - brain function
KW  - cognition
KW  - conceptual framework
KW  - conditioned reflex
KW  - connectome
KW  - early positive negativity
KW  - electroencephalography
KW  - error related negativity
KW  - event related potential
KW  - executive function
KW  - functional magnetic resonance imaging
KW  - functional near-infrared spectroscopy
KW  - human
KW  - instrumental conditioning
KW  - interoception
KW  - nervous system electrophysiology
KW  - neurobiology
KW  - neuroimaging
KW  - nonhuman
KW  - opiate addiction
KW  - recurrence risk
KW  - reinforcement
KW  - relapse
KW  - repetitive transcranial magnetic stimulation
KW  - resting state network
KW  - Review
KW  - reward
KW  - slow positive wave
KW  - task performance
KW  - time series analysis
KW  - treatment outcome
PB  - Frontiers Media S.A.
N1  - Cited By :1
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
C7  - 117
LA  - English
N1  - Correspondence Address: Stewart, J.L.; Laureate Institute for Brain ResearchUnited States; email: jstewart@laureateinstitute.org
N1  - References: Koob, G.F., Volkow, N.D., Neurobiology of addiction: A neurocircuitry analysis (2016) Lancet Psychiatry, 3, pp. 760-773; 
Florence, C., Luo, F., Xu, L., Zhou, C., The economic burden of prescription opioid overdose, abuse and dependence in the United States, 2013 (2016) Med Care, 54, pp. 901-906; 
Gomes, T., Tadrous, M., Mamdani, M.M., Paterson, J.M., Juurlink, D.N., The Burden of opioid-related mortality in the United States (2018) JAMA Network Open, 1; 
Hagemeier, N.E., Introduction to the opioid epidemic: The economic burden on the healthcare system and impact on quality of life (2018) Am J Manag Care, 24, pp. S200-S206; 
Oquendo, M.A., Volkow, N.D., Suicide: A silent contributor to opioid-overdose deaths (2018) N Engl J Med, 378, pp. 1567-1569; 
Garfield, J.B., Cotton, S.M., Allen, N.B., Cheetham, A., Kras, M., Yücel, M., Evidence that anhedonia is a symptom of opioid dependence associated with recent use (2017) Drug Alcohol Depend, 177, pp. 29-38; 
Huhn, A.S., Harris, J., Cleveland, H.H., Lydon, D.M., Stankoski, D., Cleveland, M.J., Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence (2016) Brain Res Bull, 123, pp. 94-101; 
Neale, J., Pickering, L., Nettleton, S., (2012) The Everyday Lives of Recovering Heroin Users, , London: Royal Society of Arts; 
Nettleton, S., Neale, J., Pickering, L., I don't think there's much of a rational mind in a drug addict when they are in the thick of it': Towards an embodied analysis of recovering heroin users (2011) Sociol Health Illn, 33, pp. 341-355; 
Preston, K.L., Epstein, D.H., Stress in the daily lives of cocaine and heroin users: Relationship to mood, craving, relapse triggers, and cocaine use (2011) Psychopharmacology, 218, pp. 29-37; 
Koob, G.F., Le Moal, M., Drug addiction, dysregulation of reward, and allostasis (2001) Neuropsychopharmacology, 24, pp. 97-129; 
Mars, S.G., Bourgois, P., Karandinos, G., Montero, F., Ciccarone, D., Every ‘never' I ever said came true”: Transitions from opioid pills to heroin injecting (2014) Int J Drug Policy, 25, pp. 257-266; 
Schuckit, M.A., Treatment of opioid-use disorders (2016) N Engl J Med, 375, pp. 357-368; 
Blum, J., Gerber, H., Gerhard, U., Schmid, O., Petitjean, S., Riecher-Rössler, A., Acute effects of heroin on emotions in heroin-dependent patients (2013) Am J Addict, 22, pp. 598-604; 
Volkow, N.D., Koob, G.F., McLellan, A.T., Neurobiologic advances from the brain disease model of addiction (2016) N Engl J Med, 374, pp. 363-371; 
Koob, G.F., Negative reinforcement in drug addiction: The darkness within (2013) Curr Opin Neurobiol, 23, pp. 559-563; 
Everitt, B.J., Robbins, T.W., Neural systems of reinforcement for drug addiction: From actions to habits to compulsion (2005) Nat Neurosci, 8, pp. 1481-1489; 
Robinson, T.E., Berridge, K.C., The neural basis of drug craving: An incentive-sensitization theory of addiction (1993) Brain Res Rev, 18, pp. 247-291; 
Robinson, T.E., Berridge, K.C., The psychology and neurobiology of addiction: An incentive–sensitization view (2000) Addiction, 95, pp. 91-117; 
Berridge, K.C., Robinson, T.E., Liking, wanting, and the incentive-sensitization theory of addiction (2016) Am Psychol, 71, pp. 670-679; 
Kwako, L.E., Koob, G.F., Neuroclinical framework for the role of stress in addiction (2017) Chronic Stress, 1, pp. 1-14; 
Aston-Jones, G., Delfs, J.M., Druhan, J., Zhu, Y., The bed nucleus of the stria terminalis: A target site for noradrenergic actions in opiate withdrawal (1999) Ann N Y Acad Sci, 877, pp. 486-498; 
Koob, G.F., Buck, C.L., Cohen, A., Edwards, S., Park, P.E., Schlosburg, J.E., Addiction as a stress surfeit disorder (2014) Neuropharmacology, 76, pp. 370-382; 
Garavan, H., Insula and drug cravings (2010) Brain Struct Funct, 214, pp. 593-601; 
George, O., Koob, G.F., Individual differences in the neuropsychopathology of addiction (2017) Dialog Clin Neurosci, 19, pp. 217-229; 
Naqvi, N.H., Bechara, A., The INS and drug addiction: An interoceptive view of pleasure, urges, and decision-making (2010) Brain Struct Funct, 214, pp. 435-450; 
Jasinska, A.J., Stein, E.A., Kaiser, J., Naumer, M.J., Yalachkov, Y., Factors modulating neural reactivity to drug cues in addiction: A survey of human neuroimaging studies (2014) Neurosci Biobehav Rev, 38, pp. 1-16; 
Droutman, V., Read, S.J., Bechara, A., Revisiting the role of the insula in addiction (2015) Trends Cogn Sci, 19, pp. 414-420; 
Goldstein, R.Z., Volkow, N.D., Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications (2011) Nat Rev Neurosci, 12, pp. 652-669; 
Volkow, N.D., Wang, G.J., Fowler, J.S., Tomasi, D., Telang, F., Addiction: Beyond dopamine reward circuitry (2011) Proc Natl Acad Sci, 108, pp. 15037-15042; 
Nomi, J.S., Farrant, K., Damaraju, E., Rachakonda, S., Calhoun, V.D., Uddin, L.Q., Dynamic functional network connectivity reveals unique and overlapping profiles of INS subdivisions (2016) Hum Brain Mapp, 37, pp. 1770-1787; 
Wager, T.D., Barrett, L.F., From affect to control: Functional specialization of the insula in motivation and regulation (2017) bioRxiv; 
Kolling, N., Wittmann, M.K., Behrens, T.E., Boorman, E.D., Mars, R.B., Rushworth, M.F., Value, search, persistence and model updating in anterior cingulate cortex (2016) Nat Neurosci, 19, pp. 1280-1285; 
Seminowicz, D.A., Moayedi, M., The dorsolateral prefrontal cortex in acute and chronic pain (2017) J Pain, 18, pp. 1027-1035; 
Arnsten, A.F., Stress signalling pathways that impair prefrontal cortex structure and function (2009) Nat Rev Neurosci, 10, pp. 410-422; 
Baur, V., Hänggi, J., Langer, N., Jäncke, L., Resting-state functional and structural connectivity within an INS–amygdala route specifically index state and trait anxiety (2013) Biol Psychiatry, 73, pp. 85-92; 
Li, M., Tian, J., Zhang, R., Qiu, Y., Wen, X., Ma, X., Abnormal cortical thickness in heroin-dependent individuals (2014) Neuroimage, 88, pp. 295-307; 
Liu, H., Hao, Y., Kaneko, Y., Ouyang, X., Zhang, Y., Xu, L., Frontal and cingulate gray matter volume reduction in heroin dependence: Optimized voxel-based morphometry (2009) Psychiatry Clin Neurosci, 63, pp. 563-568; 
Schmidt, A., Walter, M., Borgwardt, S., Impaired cognition control and inferior frontal cortex modulation in heroin addiction (2016) Neuropathology of Drug Addictions and Substance Misuse, pp. 1037-1047. , Preedy VR, editor. Cambridge, MA: Academic Press; 
Seifert, C.L., Magon, S., Sprenger, T., Lang, U.E., Huber, C.G., Denier, N., Reduced volume of the nucleus accumbens in heroin addiction (2015) Eur Arch Psychiatry Clin Neurosci, 265, pp. 637-645; 
Upadhyay, J., Maleki, N., Potter, J., Elman, I., Rudrauf, D., Knudsen, J., Alterations in brain structure and functional connectivity in prescription opioid-dependent patients (2010) Brain, 133, pp. 2098-2114; 
Yuan, Y., Zhu, Z., Shi, J., Zou, Z., Yuan, F., Liu, Y., Gray matter density negatively correlates with duration of heroin use in young lifetime heroin-dependent individuals (2009) Brain Cogn, 71, pp. 223-228; 
Yuan, K., Qin, W., Dong, M., Liu, J., Sun, J., Liu, P., Gray matter deficits and resting-state abnormalities in abstinent heroin-dependent individuals (2010) Neurosci Lett, 482, pp. 101-105; 
Tolomeo, S., Matthews, K., Steele, D., Baldacchino, A., Compulsivity in opioid dependence (2018) Prog Neuro-Psychopharmacol Biol Psychiatry, 81, pp. 333-339; 
Tolomeo, S., Gray, S., Matthews, K., Steele, J.D., Baldacchino, A., Multifaceted impairments in impulsivity and brain structural abnormalities in opioid dependence and abstinence (2016) Psychol Med, 46, pp. 2841-2853; 
Raichle, M.E., A paradigm shift in functional brain imaging (2009) J Neurosci, 29, pp. 12729-12734; 
Snyder, A.Z., Raichle, M.E., A brief history of the resting state: The Washington University perspective (2012) Neuroimage, 62, pp. 902-910; 
Fareed, A., Kim, J., Ketchen, B., Kwak, W.J., Wang, D., Shongo-Hiango, H., Effect of heroin use on changes of brain functions as measured by functional magnetic resonance imaging, a systematic review (2017) J Addict Dis, 36, pp. 105-116; 
Xie, C., Shao, Y., Ma, L., Zhai, T., Ye, E., Fu, L., Imbalanced functional link between valuation networks in abstinent heroin-dependent subjects (2014) Mol Psychiatry, 19, pp. 10-12; 
Wang, P.W., Lin, H.C., Liu, G.C., Yang, Y.H.C., Ko, C.H., Yen, C.F., Abnormal interhemispheric resting state functional connectivity of the INS in heroin users under methadone maintenance treatment (2016) Psychiatry Res Neuroimaging, 255, pp. 9-14; 
Jiang, G.H., Qiu, Y.W., Zhang, X.L., Han, L.J., Lv, X.F., Li, L.M., Amplitude low-frequency oscillation abnormalities in the heroin users: A resting state fMRI study (2011) Neuroimage, 57, pp. 149-154; 
Liu, J., Qin, W., Yuan, K., Li, J., Wang, W., Li, Q., Interaction between dysfunctional connectivity at rest and heroin cues-induced brain responses in Male abstinent heroin-dependent individuals (2011) PLoS ONE, 6; 
Hassani-Abharian, P., Ganjgahi, H., Tabatabaei-Jafari, H., Oghabian, M.A., Mokri, A., Ekhtiari, H., Exploring neural correlates of different dimensions in drug craving self-reports among heroin dependents (2015) Basic Clin Neurosci, 6, pp. 271-284; 
Jiang, Y.L., Tian, W., Lu, G., Rudd, J.A., Lai, K.F., Yeung, L.Y., Patterns of cortical activation following motor tasks and psychological-inducing movie cues in heroin users: An fMRI study (2014) Int J Psychiatry Med, 47, pp. 25-40; 
Li, Q., Wang, Y., Zhang, Y., Li, W., Yang, W., Zhu, J., Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: An event-related fMRI study (2012) Brain Res, 1469, pp. 63-72; 
Li, Q., Wang, Y., Zhang, Y., Li, W., Zhu, J., Zheng, Y., Assessing cue-induced brain response as a function of abstinence duration in heroin-dependent individuals: An event-related fMRI study (2013) PLoS ONE, 8; 
Lou, M., Wang, E., Shen, Y., Wang, J., Cue-elicited craving in heroin addicts at different abstinent time: An fMRI pilot study (2012) Subst Use Misuse, 47, pp. 631-639; 
Tabatabaei-Jafari, H., Ekhtiari, H., Ganjgahi, H., Hassani-Abharian, P., Oghabian, M.A., Moradi, A., Patterns of brain activation during craving in heroin dependents successfully treated by methadone maintenance and abstinence-based treatments (2014) J Addict Med, 8, pp. 123-129; 
Walter, M., Denier, N., Gerber, H., Schmid, O., Lanz, C., Brenneisen, R., Orbitofrontal response to drug-related stimuli after heroin administration (2015) Addict Biol, 20, pp. 570-579; 
Wang, W., Li, Q., Wang, Y., Tian, J., Yang, W., Li, W., Brain fMRI and craving response to heroin-related cues in patients on methadone maintenance treatment (2011) Am J Drug Alcohol Abuse, 37, pp. 123-130; 
Xiao, Z., Lee, T., Zhang, J.X., Wu, Q., Wu, R., Weng, X., Thirsty heroin addicts show different fMRI activations when exposed to water-related and drug-related cues (2006) Drug Alcohol Depend, 83, pp. 157-162; 
Yang, Z., Xie, J., Shao, Y.C., Xie, C.M., Fu, L.P., Li, D.J., Dynamic neural responses to cue-reactivity paradigms in heroin-dependent users: An fMRI study (2009) Hum Brain Mapp, 30, pp. 766-775; 
Huhn, A.S., Meyer, R.E., Harris, J.D., Ayaz, H., Deneke, E., Stankoski, D.M., Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence (2016) Brain Res Bull, 123, pp. 102-109; 
Gradin, V.B., Baldacchino, A., Balfour, D., Matthews, K., Steele, J.D., Abnormal brain activity during a reward and loss task in opiate-dependent patients receiving methadone maintenance therapy (2014) Neuropsychopharmacology, 39, pp. 885-894; 
Zhao, Q., Li, H., Hu, B., Wu, H., Liu, Q., Abstinent heroin addicts tend to take risks: ERP and source localization (2017) Front Neurosci, 11, p. 681; 
Forman, S.D., Dougherty, G.G., Casey, B.J., Siegle, G.J., Braver, T.S., Barch, D.M., Opiate addicts lack error-dependent activation of rostral anterior cingulate (2004) Biol Psychiatry, 55, pp. 531-537; 
Fu, L.P., Bi, G.H., Zou, Z.T., Wang, Y., Ye, E.M., Ma, L., Impaired response inhibition function in abstinent heroin dependents: An fMRI study (2008) Neurosci Lett, 438, pp. 322-326; 
Lee, T.M., Zhou, W.H., Luo, X.J., Yuen, K.S., Ruan, X.Z., Weng, X.C., Neural activity associated with cognitive regulation in heroin users: A fMRI study (2005) Neurosci Lett, 382, pp. 211-216; 
Schmidt, A., Walter, M., Gerber, H., Schmid, O., Smieskova, R., Bendfeldt, K., Inferior frontal cortex modulation with an acute dose of heroin during cognitive control (2013) Neuropsychopharmacology, 38, pp. 2231-2239; 
Yücel, M., Lubman, D.I., Harrison, B.J., Fornito, A., Allen, N.B., Wellard, R.M., A combined spectroscopic and functional MRI investigation of the dorsal anterior cingulate region in opiate addiction (2007) Mol Psychiatry, 12, pp. 691-702; 
Wang, Z.X., Zhang, J.X., Wu, Q.L., Liu, N., Hu, X.P., Chan, R.C., Alterations in the processing of non-drug-related affective stimuli in abstinent heroin addicts (2010) Neuroimage, 49, pp. 971-976; 
Smoski, M.J., Salsman, N., Wang, L., Smith, V., Lynch, T.R., Dager, S.R., Functional imaging of emotion reactivity in opiate-dependent borderline personality disorder (2011) Person Disord Theory Res Treat, 2, pp. 230-241; 
Schmidt, A., Borgwardt, S., Gerber, H., Wiesbeck, G.A., Schmid, O., Riecher-Rössler, A., Acute effects of heroin on negative emotional processing: Relation of amygdala activity and stress-related responses (2014) Biol Psychiatry, 76, pp. 289-296; 
Murphy, A., Lubman, D.I., McKie, S., Bijral, P.S., Peters, L.A., Faiz, Q., Time-dependent neuronal changes associated with craving in opioid dependence: An fMRI study (2017) Addict Biol, 23, pp. 1168-1178; 
Langleben, D.D., Ruparel, K., Elman, I., Busch-Winokur, S., Pratiwadi, R., Loughead, J., Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues (2008) Am J Psychiatry, 165, pp. 390-394; 
Yu, J., Zhang, S., Epstein, D.H., Fang, Y., Shi, J., Qin, H., Gender and stimulus difference in cue-induced responses in abstinent heroin users (2007) Pharmacol Biochem Behav, 86, pp. 485-492; 
De Arcos, F.A., Verdejo-García, A., Ceverino, A., Montañez-Pareja, M., López-Juárez, E., Sánchez-Barrera, M., Dysregulation of emotional response in current and abstinent heroin users: Negative heightening and positive blunting (2008) Psychopharmacology, 198, pp. 159-166; 
Stathopoulou, G., Pollack, M.H., Otto, M.W., Anxiety sensitivity moderates drug cravings in response to induced negative affect in opioid dependent outpatients (2018) Addict Behav, 84, pp. 75-78; 
Ahn, W.Y., Vasilev, G., Lee, S.H., Busemeyer, J.R., Kruschke, J.K., Bechara, A., Decision-making in stimulant and opiate addicts in protracted abstinence: Evidence from computational modeling with pure users (2014) Front Psychol, 5, p. 849; 
Hou, Y., Zhao, L., Yao, Q., Ding, L., Altered economic decision-making in abstinent heroin addicts: Evidence from the ultimatum game (2016) Neurosci Lett, 627, pp. 148-154; 
Myers, C.E., Rego, J., Haber, P., Morley, K., Beck, K.D., Hogarth, L., Learning and generalization from reward and punishment in opioid addiction (2017) Behav Brain Res, 317, pp. 122-131; 
Ersche, K.D., Roiser, J.P., Clark, L., London, M., Robbins, T.W., Sahakian, B.J., Punishment induces risky decision-making in methadone-maintained opiate users but not in heroin users or healthy volunteers (2005) Neuropsychopharmacology, 30, pp. 2115-2124; 
Garrison, J., Erdeniz, B., Done, J., Prediction error in reinforcement learning: A meta-analysis of neuroimaging studies (2013) Neurosci Biobehav Rev, 37, pp. 1297-1310; 
Bunce, S.C., Harris, J.D., Bixler, E.O., Taylor, M., Muelly, E., Deneke, E., Possible evidence for re-regulation of HPA axis and brain reward systems over time in treatment in prescription opioid-dependent patients (2015) J Addict Med, 9, pp. 53-60; 
Fabiani, M., Gratton, G., Coles, M., Event-related brain potentials: Methods, theory, and applications (2000) Handbook of Psychophysiology, pp. 53-84. , JT Cacioppo, LG Tassinary, editors. 2nd ed. Cambridge, UK: Cambridge University Press; 
Sauseng, P., Klimesch, W., Schabus, M., Doppelmayr, M., Fronto-parietal EEG coherence in theta and upper alpha reflect central executive functions of working memory (2005) Int J Psychophysiol, 57, pp. 97-103; 
Sauseng, P., Griesmayr, B., Freunberger, R., Klimesch, W., Control mechanisms in working memory: A possible function of EEG theta oscillations (2010) Neurosci Biobehav Rev, 34, pp. 1015-1022; 
Trujillo, L.T., Allen, J.J., Theta EEG dynamics of the error-related negativity (2007) Clin Neurophysiol, 118, pp. 645-668; 
Klimesch, W., Sauseng, P., Hanslmayr, S., EEG alpha oscillations: The inhibition–timing hypothesis (2007) Brain Res Rev, 53, pp. 63-88; 
Jenkinson, N., Brown, P., New insights into the relationship between dopamine, beta oscillations and motor function (2011) Trends Neurosci, 34, pp. 611-618; 
Herrmann, C.S., Munk, M.H., Engel, A.K., Cognitive functions of gamma-band activity: Memory match and utilization (2004) Trends Cogn Sci, 8, pp. 347-355; 
Ieong, H.F.H., Yuan, Z., Abnormal resting-state functional connectivity in the orbitofrontal cortex of heroin users and its relationship with anxiety: A pilot fNIRS study (2017) Sci Rep, 7, p. 46522; 
Wang, A.L., Elman, I., Lowen, S.B., Blady, S.J., Lynch, K.G., Hyatt, J.M., Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence (2015) Transl Psychiatry, 5; 
Polunina, A.G., Davydov, D.M., EEG spectral power and mean frequencies in early heroin abstinence (2004) Prog Neuro-Psychopharmacol Biol Psychiatry, 28, pp. 73-82; 
Motlagh, F., Ibrahim, F., Rashid, R., Seghatoleslam, T., Habil, H., Investigation of brain electrophysiological properties among heroin addicts: Quantitative EEG and event-related potentials (2017) J Neurosci Res, 95, pp. 1633-1646; 
Gorricho, M.D., Usón, J.R.V., QEEG mapping and methadone (2008) Euro J Psychiatry, 22, pp. 29-37; 
Costa, L., Bauer, L., Quantitative electroencephalographic differences associated with alcohol, cocaine, heroin and dual-substance dependence (1997) Drug Alcohol Depend, 46, pp. 87-93; 
Fingelkurts, A.A., Fingelkurts, A.A., Kivisaari, R., Autti, T., Borisov, S., Puuskari, V., Increased local and decreased remote functional connectivity at EEG alpha and beta frequency bands in opioid-dependent patients (2006) Psychopharmacology, 188, pp. 42-52; 
Fingelkurts, A.A., Fingelkurts, A.A., Kivisaari, R., Autti, T., Borisov, S., Puuskari, V., Reorganization of the composition of brain oscillations and their temporal characteristics in opioid dependent patients (2006) Prog Neuro-Psychopharmacol Biol Psychiatry, 30, pp. 1453-1465; 
Fingelkurts, A.A., Fingelkurts, A.A., Kivisaari, R., Autti, T., Borisov, S., Puuskari, V., Opioid withdrawal results in an increased local and remote functional connectivity at EEG alpha and beta frequency bands (2007) Neurosci Res, 58, pp. 40-49; 
Franken, I.H., Stam, C.J., Hendriks, V.M., Van Den Brink, W., Neurophysiological evidence for abnormal cognitive processing of drug cues in heroin dependence (2003) Psychopharmacology, 170, pp. 205-212; 
Bauer, L.O., CNS recovery from cocaine, cocaine and alcohol, or opioid dependence: A P300 study (2001) Clin Neurophysiol, 112, pp. 1508-1515; 
Chen, H., Jiang, H., Guo, Q., Du, J., Wang, J., Zhao, M., Case-control study of error-related negativity among males with heroin dependence undergoing rehabilitation (2013) Shanghai Arch Psychiatry, 25, pp. 141-148; 
Papageorgiou, C., Liappas, I., Asvestas, P., Vasios, C., Matsopoulos, G.K., Nikolaou, C., Abnormal P600 in heroin addicts with prolonged abstinence elicited during a working memory test (2001) Neuroreport, 12, pp. 1773-1778; 
Papageorgiou, C., Rabavilas, A., Liappas, I., Stefanis, C., Do obsessive-compulsive patients and abstinent heroin addicts share a common psychophysiological mechanism? (2003) Neuropsychobiology, 47, pp. 1-11; 
Papageorgiou, C.C., Liappas, I.A., Ventouras, E.M., Nikolaou, C.C., Kitsonas, E.N., Uzunoglu, N.K., Long-term abstinence syndrome in heroin addicts: Indices of P300 alterations associated with a short memory task (2004) Prog Neuro-Psychopharmacol Biol Psychiatry, 28, pp. 1109-1115; 
Singh, S.M., Basu, D., Kohli, A., Prabhakar, S., Auditory P300 event-related potentials and neurocognitive functions in opioid dependent men and their brothers (2009) Am J Addict, 18, pp. 198-205; 
Su, B., Wang, S., Sumich, A., Li, S., Yang, L., Cai, Y., Reduction in N2 amplitude in response to deviant drug-related stimuli during a two-choice oddball task in long-term heroin abstainers (2017) Psychopharmacology, 234, pp. 3195-3205; 
Yang, L., Xu, Q., Li, S., Zhao, X., Ma, L., Zheng, Y., The effects of methadone maintenance treatment on heroin addicts with response inhibition function impairments: Evidence from event-related potentials (2015) J Food Drug Analy, 23, pp. 260-266; 
Yang, B., Yang, S., Zhao, L., Yin, L., Liu, X., An, S., Event-related potentials in a Go/Nogo task of abnormal response inhibition in heroin addicts (2009) Sci China Series C Life Sci, 52, pp. 780-788; 
Schupp, H.T., Junghöfer, M., Weike, A.I., Hamm, A.O., The selective processing of briefly presented affective pictures: An ERP analysis (2004) Psychophysiology, 41, pp. 441-449; 
Nieuwenhuis, S., Yeung, N., Van Den Wildenberg, W., Ridderinkhof, K.R., Electrophysiological correlates of anterior cingulate function in a go/no-go task: Effects of response conflict and trial type frequency (2003) Cognit Affect Behav Neurosci, 3, pp. 17-26; 
Van Veen, V., Carter, C.S., The anterior cingulate as a conflict monitor: FMRI and ERP studies (2002) Physiol Behav, 77, pp. 477-482; 
Morie, K.P., Garavan, H., Bell, R.P., De Sanctis, P., Krakowski, M.I., Foxe, J.J., Intact inhibitory control processes in abstinent drug abusers (II): A high-density electrical mapping study in former cocaine and heroin addicts (2014) Neuropharmacology, 82, pp. 151-160; 
Zhao, Q., Li, H., Hu, B., Li, Y., Gillebert, C.R., Mantini, D., Neural correlates of drug-related attentional bias in heroin dependence (2018) Front Hum Neurosci, 11, p. 646; 
Lubman, D.I., Allen, N.B., Peters, L.A., Deakin, J.F.W., Electrophysiological evidence that drug cues have greater salience than other affective stimuli in opiate addiction (2008) J Psychopharmacol, 22, pp. 836-842; 
Diedrich, O., Naumann, E., Maier, S., Becker, G., Bartussek, D., A frontal positive slow wave in the ERP associated with emotional slides (1997) J Psychophysiol, 1, pp. 71-84; 
Schupp, H.T., Cuthbert, B.N., Bradley, M.M., Cacioppo, J.T., Ito, T., Lang, P.J., Affective picture processing: The late positive potential is modulated by motivational relevance (2000) Psychophysiology, 37, pp. 257-261; 
Olvet, D.M., Hajcak, G., The error-related negativity (ERN) and psychopathology: Toward an endophenotype (2008) Clin Psychol Rev, 28, pp. 1343-1354; 
Shen, Y., Cao, X., Tan, T., Shan, C., Wang, Y., Pan, J., 10-Hz repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex reduces heroin cue craving in long-term addicts (2016) Biol Psychiatry, 80, pp. e13-e14; 
Zhou, H., Xu, J., Jiang, J., Deep brain stimulation of nucleus accumbens on heroin-seeking behaviors: A case report (2011) Biol Psychiatry, 69, pp. e41-e42; 
Zhang, C., Huang, Y., Zheng, F., Zeljic, K., Pan, J., Sun, B., Death from opioid overdose after deep brain stimulation: A case report (2018) Biol Psychiatry, 83, pp. e9-e10; 
Chen, L., Li, N., Ge, S., Lozano, A.M., Lee, D.J., Yang, C., Long-term results after deep brain stimulation of nucleus accumbens and the anterior limb of the internal capsule for preventing heroin relapse: An open-label pilot study (2019) Brain Stimul, 12, pp. 175-183; 
Kuhn, J., Möller, M., Treppmann, J.F., Bartsch, C., Lenartz, D., Gründler, T.O., Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction (2014) Mol Psychiatry, 19, pp. 145-146; 
Peisker, C.B., Schüller, T., Peters, J., Wagner, B.J., Schilbach, L., Müller, U.J., Nucleus accumbens deep brain stimulation in patients with substance use disorders and delay discounting (2018) Brain Sci, 8, p. 21; 
Lubman, D.I., Yücel, M., Kettle, J.W., Scaffidi, A., MacKenzie, T., Simmons, J.G., Responsiveness to drug cues and natural rewards in opiate addiction: Associations with later heroin use (2009) Arch Gen Psychiatry, 66, pp. 205-212; 
Fink, B.C., Steele, V.R., Maurer, M.J., Fede, S.J., Calhoun, V.D., Kiehl, K.A., Brain potentials predict substance abuse treatment completion in a prison sample (2016) Brain Behav, 6; 
Steele, V.R., Fink, B.C., Maurer, J.M., Arbabshirani, M.R., Wilber, C.H., Jaffe, A.J., Brain potentials measured during a Go/NoGo task predict completion of substance abuse treatment (2014) Biol Psychiatry, 76, pp. 75-83; 
Li, Q., Li, W., Wang, H., Wang, Y., Zhang, Y., Zhu, J., Predicting subsequent relapse by drug-related cue-induced brain activation in heroin addiction: An event-related functional magnetic resonance imaging study (2015) Addict Biol, 20, pp. 968-978; 
Li, Q., Liu, J., Wang, W., Wang, Y., Li, W., Chen, J., Disrupted coupling of large-scale networks is associated with relapse behaviour in heroin-dependent men (2018) J Psychiatry Neurosci, 43, pp. 48-57; 
Steele, V.R., Maurer, J.M., Arbabshirani, M.R., Claus, E.D., Fink, B.C., Rao, V., Machine learning of functional magnetic resonance imaging network connectivity predicts substance abuse treatment completion (2018) Biol Psychiatry Cognit Neurosci Neuroimag, 3, pp. 141-149; 
Langleben, D.D., Ruparel, K., Elman, I., Loughead, J.W., Busch, E.L., Cornish, J., Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients (2014) Addict Biol, 19, pp. 262-271; 
Shi, Z., Wang, A.L., Jagannathan, K., Fairchild, V.P., O'Brien, C.P., Childress, A.R., Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder (2018) J Psychiatry Neurosci, 43, pp. 254-261; 
Wang, A.L., Lowen, S.B., Elman, I., Shi, Z., Fairchild, V.P., Bouril, A., Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder (2018) J Subst Abuse Treat, 85, pp. 70-77; 
Ye, J.J., Li, W., Zhang, D.S., Li, Q., Zhu, J., Chen, J.J., Longitudinal behavioral and fMRI-based assessment of inhibitory control in heroin addicts on methadone maintenance treatment (2018) Exp Ther Med, 16, pp. 3202-3210; 
Fahmy, R., Wasfi, M., Mamdouh, R., Moussa, K., Wahba, A., Wittemann, M., Mindfulness-based interventions modulate structural network strength in patients with opioid dependence (2018) Addict Behav, 82, pp. 50-56; 
Marsh, J.C., Park, K., Lin, Y.A., Bersamira, C., Gender differences in trends for heroin use and nonmedical prescription opioid use, 2007–2014 (2018) J Subst Abuse Treat, 87, pp. 79-85; 
Zakiniaeiz, Y., Potenza, M.N., Gender-related differences in addiction: A review of human studies (2018) Curr Opin Behav Sci, 23, pp. 171-175; 
Motlagh, F., Ibrahim, F., Menke, J.M., Rashid, R., Seghatoleslam, T., Habil, H., Neuroelectrophysiological approaches in heroin addiction research: A review of literatures (2016) J Neurosci Res, 94, pp. 297-309; 
Sinha, R., Chronic stress, drug use, and vulnerability to addiction (2008) Ann N Y Acad Sci, 1141, pp. 105-130; 
Gray, M.A., Critchley, H.D., Interoceptive basis to craving (2007) Neuron, 54, pp. 183-186; 
Paulus, M.P., Stewart, J.L., Interoception and drug addiction (2014) Neuropharmacology, 76, pp. 342-350; 
Paulus, M.P., Tapert, S.F., Schulteis, G., The role of interoception and alliesthesia in addiction (2009) Pharmacol Biochem Behav, 94, pp. 1-7; 
Verdejo-Garcia, A., Clark, L., Dunn, B.D., The role of interoception in addiction: A critical review (2012) Neurosci Biobehav Rev, 36, pp. 1857-1869; 
Sönmez, M.B., Kahyaci Kiliç, E., Ateş Çöl, I., Görgülü, Y., Köse Çinar, R., Decreased interoceptive awareness in patients with substance use disorders (2017) J Subst Use, 22, pp. 60-65; 
Garland, E.L., Bryan, C.J., Kreighbaum, L., Nakamura, Y., Howard, M.O., Froeliger, B., Prescription opioid misusing chronic pain patients exhibit dysregulated context-dependent associations: Investigating associative learning in addiction with the cue-primed reactivity task (2018) Drug Alcohol Depend, 187, pp. 13-21; 
Stewart, J.L., Parnass, J.M., May, A.C., Davenport, P.W., Paulus, M.P., Altered frontocingulate activation during aversive interoceptive processing in young adults transitioning to problem stimulant use (2013) Front Syst Neurosci, 7, p. 89; 
Stewart, J.L., May, A.C., Poppa, T., Davenport, P.W., Tapert, S.F., Paulus, M.P., You are the danger: Attenuated INS response in methamphetamine users during aversive interoceptive decision-making (2014) Drug Alcohol Depend, 142, pp. 110-119; 
Stewart, J.L., Juavinett, A.L., May, A.C., Davenport, P.W., Paulus, M.P., Do you feel alright? Attenuated neural processing of aversive interoceptive stimuli in current stimulant users (2015) Psychophysiology, 52, pp. 249-262; 
Fullana, M.A., Harrison, B.J., Soriano-Mas, C., Vervliet, B., Cardoner, N., Àvila-Parcet, A., Neural signatures of human fear conditioning: An updated and extended meta-analysis of fMRI studies (2016) Mol Psychiatry, 21, pp. 500-508; 
Alvarez, R.P., Biggs, A., Chen, G., Pine, D.S., Grillon, C., Contextual fear conditioning in humans: Cortical-hippocampal and amygdala contributions (2008) J Neurosci, 28, pp. 6211-6219; 
Harnett, N.G., Shumen, J.R., Wagle, P.A., Wood, K.H., Wheelock, M.D., Baños, J.H., Neural mechanisms of human temporal fear conditioning (2016) Neurobiol Learn Mem, 136, pp. 97-104; 
LaBar, K.S., Gatenby, J.C., Gore, J.C., LeDoux, J.E., Phelps, E.A., Human amygdala activation during conditioned fear acquisition and extinction: A mixed-trial fMRI study (1998) Neuron, 20, pp. 937-945; 
Lindner, K., Neubert, J., Pfannmöller, J., Lotze, M., Hamm, A.O., Wendt, J., Fear-potentiated startle processing in humans: Parallel fMRI and orbicularis EMG assessment during cue conditioning and extinction (2015) Int J Psychophysiol, 98, pp. 535-545; 
Knight, D.C., Smith, C.N., Cheng, D.T., Stein, E.A., Helmstetter, F.J., Amygdala and hippocampal activity during acquisition and extinction of human fear conditioning (2004) Cognit Affect Behav Neurosci, 4, pp. 317-325; 
Phelps, E.A., O'Connor, K.J., Gatenby, J.C., Gore, J.C., Grillon, C., Davis, M., Activation of the left amygdala to a cognitive representation of fear (2001) Nat Neurosci, 4, pp. 437-441; 
Baczkowski, B.M., Johnstone, T., Walter, H., Erk, S., Veer, I.M., Sliding-window analysis tracks fluctuations in amygdala functional connectivity associated with physiological arousal and vigilance during fear conditioning (2017) Neuroimage, 153, pp. 168-178; 
Critchley, H.D., Mathias, C.J., Dolan, R.J., Fear conditioning in humans: The influence of awareness and autonomic arousal on functional neuroanatomy (2002) Neuron, 33, pp. 653-663; 
Fullana, M.A., Albajes-Eizagirre, A., Soriano-Mas, C., Vervliet, B., Cardoner, N., Benet, O., Fear extinction in the human brain: A meta-analysis of fMRI studies in healthy participants (2018) Neurosci Biobehav Rev, 88, pp. 16-25; 
Barad, M., Gean, P.W., Lutz, B., The role of the amygdala in the extinction of conditioned fear (2006) Biol Psychiatry, 60, pp. 322-328; 
Phelps, E.A., Delgado, M.R., Nearing, K.I., LeDoux, J.E., Extinction learning in humans: Role of the amygdala and vmPFC (2004) Neuron, 43, pp. 897-905; 
Hajcak, G., Nieuwenhuis, S., Reappraisal modulates the electrocortical response to unpleasant pictures (2006) Cognit Affect Behav Neurosci, 6, pp. 291-297
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85066441010&doi=10.3389%2ffpsyt.2019.00117&partnerID=40&md5=e820c258db772ab1ea882778e2a4dd9b
ER  - 

TY  - JOUR
TI  - Integrating Carbon Nanomaterials with Metals for Bio-sensing Applications
T2  - Molecular Neurobiology
J2  - Mol. Neurobiol.
PY  - 2019
DO  - 10.1007/s12035-019-01767-7
SN  - 08937648 (ISSN) 
AU  - Sainio, S.
AU  - Leppänen, E.
AU  - Mynttinen, E.
AU  - Palomäki, T.
AU  - Wester, N.
AU  - Etula, J.
AU  - Isoaho, N.
AU  - Peltola, E.
AU  - Koehne, J.
AU  - Meyyappan, M.
AU  - Koskinen, J.
AU  - Laurila, T.
AD  - Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, Menlo Park, CA  94025, United States
AD  - Department of Chemistry and Materials Science, School of Chemical Technology, Aalto University, Espoo, 02150, Finland
AD  - Department of Electrical Engineering and Automation, School of Electrical Engineering, Aalto University, Espoo, 02150, Finland
AD  - Center for Nanotechnology, NASA Ames Research Center, Moffett Field, Mountain View, CA  94035, United States
AB  - Age structure in most developed countries is changing fast as the average lifespan is increasing significantly, calling for solutions to provide improved treatments for age-related neurological diseases and disorders. In order to address these problems, a reliable way of recording information about neurotransmitters from in vitro and in vivo applications is needed to better understand neurological diseases and disorders as well as currently used treatments. Likewise, recent developments in medicine, especially with the opioid crisis, are demanding a swift move to personalized medicine to administer patient needs rather than population-wide averages. In order to enable the so-called personalized medicine, it is necessary to be able to do measurements in vivo and in real time. These actions require sensitive and selective detection of different analytes from very demanding environments. Current state-of-the-art materials are unable to provide sensitive and selective detection of neurotransmitters as well as the required time resolution needed for drug molecules at a reasonable cost. To meet these challenges, we have utilized different metals to grow carbon nanomaterials and applied them for sensing applications showing that there are clear differences in their electrochemical properties based on the selected catalyst metal. Additionally, we have combined atomistic simulations to support optimizing materials for experiments and to gain further understanding of the atomistic level reactions between different analytes and the sensor surface. With carbon nanostructures grown from Ni and Al + Co + Fe hybrid, we can detect dopamine, ascorbic acid, and uric acid simultaneously. On the other hand, nanostructures grown from platinum provide a feasible platform for detection of H2O2 making them suitable candidates for enzymatic biosensors for detection of glutamate, for example. Tetrahedral amorphous carbon electrodes have an ability to detect morphine, paracetamol, tramadol, and O-desmethyltramadol. With carbon nanomaterial-based sensors, it is possible to reach metal-like properties in sensing applications using only a fraction of the metal as seed for the material growth. We have also seen that by using nanodiamonds as growth catalyst for carbon nanofibers, it is not possible to detect dopamine and ascorbic acid simultaneously, although the morphology of the resulting nanofibers is similar to the ones grown using Ni. This further indicates the importance of the metal selection for specific applications. However, Ni as a continuous layer or as separate islands does not provide adequate performance. Thus, it appears that metal nanoparticles combined with fiber-like morphology are needed for optimized sensor performance for neurotransmitter detection. This opens up a new research approach of application-specific nanomaterials, where carefully selected metals are integrated with carbon nanomaterials to match the needs of the sensing application in question. © 2019, The Author(s).
KW  - Bio-sensing
KW  - Carbon
KW  - Carbon nanomaterials
KW  - Dopamine
PB  - Humana Press Inc.
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: MONBE
C2  - 31520316
LA  - English
N1  - Correspondence Address: Laurila, T.; Department of Electrical Engineering and Automation, School of Electrical Engineering, Aalto UniversityFinland; email: tomi.laurila@aalto.fi
N1  - Funding details: Instrumentariumin Tiedesäätiö
N1  - Funding text 1: Author S.S. acknowledges Instrumentarium Science Foundation funding. Carbodeon is acknowledged for providing the ND used in this study. Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
N1  - References: Gustavsson, A., Svensson, M., Jacobi, F., Allgulander, C., Alonso, J., Beghi, E., Dodel, R., Olesen, J., Cost of disorders of the brain in Europe 2010 (2011) Eur Neuropsychopharmacol, 21, pp. 718-779; 
Murray, C.J.L., Atkinson, C., Bhalla, K., Birbeck, G., Burstein, R., Chou, D., Dellavalle, R., Murray, The state of US health, 1990-2010: burden of diseases, injuries, and risk factors (2013) JAMA, 310, pp. 591-608; 
Meyyappan, M., Nano biosensors for neurochemical monitoring (2015) Nano Convergence, 2, p. 18; 
Laurila, T., Sainio, S., Caro, M.A., Hybrid carbon based nanomaterials for electrochemical detection of biomolecules (2017) Prog Mater Sci, 88, pp. 499-594; 
Palomäki, T., Peltola, E., Sainio, S., Wester, N., Pitkänen, O., Kordas, K., Koskinen, J., Laurila, T., Corrigendum to “Unmodified and multi-walled carbon nanotube modified tetrahedral amorphous carbon (ta-C) films as in vivo sensor materials for sensitive and selective detection of dopamine” [Bios. Bioelectron. 118 (2018) 23-30] (2019) Biosens Bioelectron, 123, pp. 281-284; 
Isoaho, N., Peltola, E., Sainio, S., Koskinen, J., Laurila, T., Pt-grown carbon nanofibers for enzymatic glutamate biosensors and assessment of their biocompatibility (2018) RSC Adv, 8, pp. 35802-35812; 
Wester, N., Etula, J., Lilius, T., Sainio, S., Laurila, T., Koskinen, J., Selective detection of morphine in the presence of paracetamol with anodically pretreated dual layer Ti/tetrahedral amorphous carbon electrodes (2018) Electrochem Commun, 86, pp. 166-170; 
Mynttinen, E., Wester, N., Lilius, T., Kalso, E., Koskinen, J., Laurila, T., Simultaneous electrochemical detection of tramadol and O-desmethyltramadol with Nafion-coated tetrahedral amorphous carbon electrode (2019) Electrochim Acta, 295, pp. 347-353; 
Sainio, S., Nordlund, D., Caro, M.A., Gandhiraman, R., Koehne, J., Wester, N., Koskinen, J., Laurila, T., Correlation between sp3-to-sp2 ratio and surface oxygen functionalities in tetrahedral amorphous carbon (ta-C) thin film electrodes and implications of their electrochemical properties (2016) J Phys Chem C, 120, pp. 8298-8304; 
Aarva, A., Deringer, V.L., Sainio, S., Laurila, T., Caro, M.A., Understanding X-Ray Spectroscopy of Carbonaceous Materials by Combining Experiments, Density Functional Theory and Machine Learning, , fingerprint spectra; 
Aarva, A., Deringer, V.L., Sainio, S., Laurila, T., Caro, M.A., Understanding X-ray spectroscopy of carbonaceous materials by combining experiments, density functional theory and machine learning Part II: Quantitative Fitting of Spectra; 
Sainio, S., Palomäki, T., Rhode, S., Kauppila, M., Pitkänen, O., Selkälä, T., Toth, G., Laurila, T., Carbon nanotube (CNT) forest grown on diamond-like carbon (DLC) thin films significantly improves electrochemical sensitivity and selectivity towards dopamine (2015) Sens Actuators B Chem, 211, pp. 177-186; 
Sainio, S., Palomäki, T., Tujunen, N., Protopopova, V., Koehne, J., Kordas, K., Koskinen, J., Laurila, T., Integrated carbon nanostructures for detection of neurotransmitters (2015) Mol Neurobiol, 52, pp. 859-866; 
Sainio, S., Jiang, H., Caro, M.A., Koehne, J., Lopez-Acevedo, O., Koskinen, J., Meyyappan, M., Laurila, T., Structural morphology of carbon nanofibers grown on different substrates (2016) Carbon, 98, pp. 343-351; 
Venton, B.J., Wightman, R.M., Psychoanalytical electrochemistry: dopamine and behavior (2003) Anal Chem, 75, pp. 414 A-421 A; 
Robinson, D.L., Venton, B.J., Heien, M.L.A.V., Wightman, R.M., Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo (2003) Clin Chem, 49, pp. 1763-1773; 
Laurila, T., Sainio, S., Jiang, H., Koskinen, J., Koehne, J., Meyyappan, M., The role of extra carbon source during the pre-annealing stage in the growth of carbon nanofibers (2016) Carbon N Y, 100, pp. 351-354; 
Sainio, S., Nordlund, D., Gandhiraman, R., Jiang, H., Koehne, J., Koskinen, J., Meyyappan, M., Laurila, T., What does nitric acid really do to carbon nanofibers? (2016) J Phys Chem C, 120, pp. 22655-22662; 
Laurila, T., Sainio, S., Jiang, H., Isoaho, N., Koehne, J.E., Etula, J., Koskinen, J., Meyyappan, M., Application-specific catalyst layers: Pt-containing carbon nanofibers for hydrogen peroxide detection (2017) ACS Omega, 2, pp. 496-507; 
Wester, N., Sainio, S., Palomäki, T., Nordlund, D., Singh, V.K., Johansson, L.S., Koskinen, J., Laurila, T., Partially reduced graphene oxide modified tetrahedral amorphous carbon thin-film electrodes as a platform for nanomolar detection of dopamine (2017) J Phys Chem C, 121, pp. 8153-8164; 
Rand, E., Periyakaruppan, A., Tanaka, Z., Zhang, D.A., Marsh, M.P., Andrews, R.J., Lee, K.H., Koehne, J.E., A carbon nanofiber based biosensor for simultaneous detection of dopamine and serotonin in the presence of ascorbic acid (2013) Biosens Bioelectron, 42, pp. 434-438; 
Peltola, E., Heikkinen, J.J., Sovanto, K., Sainio, S., Aarva, A., Franssila, S., Jokinen, V., Laurila, T., SU-8 based pyrolytic carbon for the electrochemical detection of dopamine (2017) J Mater Chem B Mater Biol Med, 5, pp. 9033-9044; 
Tujunen, N., Kaivosoja, E., Protopopova, V., Valle-Delgado, J.J., Österberg, M., Koskinen, J., Laurila, T., Electrochemical detection of hydrogen peroxide on platinum-containing tetrahedral amorphous carbon sensors and evaluation of their biofouling properties (2015) Mater Sci Eng C Mater Biol Appl, 55, pp. 70-78; 
Isoaho, N., Peltola, E., Sainio, S., Wester, N., Protopopova, V., Wilson, B.P., Koskinen, J., Laurila, T., Carbon nanostructure based platform for enzymatic glutamate biosensors (2017) J Phys Chem C, 121, pp. 4618-4626; 
Isoaho, N., Wester, N., Peltola, E., Johansson, L.S., Boronat, A., Koskinen, J., Feliu, J., Laurila, T., Amorphous carbon thin film electrodes with intrinsic Pt-gradient for hydrogen peroxide detection (2017) Electrochim Acta, 251, pp. 60-70; 
Caro, M.A., Aarva, A., Deringer, V.L., Csányi, G., Laurila, T., Reactivity of amorphous carbon surfaces: rationalizing the role of structural motifs in functionalization using machine learning (2018) Chem Mater, 30, pp. 7446-7455; 
Deringer, V.L., Caro, M.A., Jana, R., Aarva, A., Elliott, S.R., Laurila, T., Csányi, G., Pastewka, L., Computational surface chemistry of tetrahedral amorphous carbon by combining machine learning and density functional theory (2018) Chem Mater, 30, pp. 7438-7445; 
Caro, M.A., Deringer, V.L., Koskinen, J., Laurila, T., Csányi, G., Growth mechanism and origin of high sp^{3} content in tetrahedral amorphous carbon (2018) Phys Rev Lett, 120, p. 166101
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073954645&doi=10.1007%2fs12035-019-01767-7&partnerID=40&md5=dc806ab9093c198c21fd3916674fb059
ER  - 

TY  - JOUR
TI  - Pharmacogenomics in chronic pain therapy: From disease to treatment and challenges for clinical practice
T2  - Pharmacogenomics
J2  - Pharmacogenomics
VL  - 20
IS  - 13
SP  - 971
EP  - 982
PY  - 2019
DO  - 10.2217/pgs-2019-0066
SN  - 14622416 (ISSN) 
AU  - Yamamoto, P.A.
AU  - Conchon Costa, A.C.
AU  - Lauretti, G.R.
AU  - De Moraes, N.V.
AD  - São Paulo State University, UNESP - School of Pharmaceutical Sciences, Araraquara, SP, Brazil
AD  - São Paulo University, USP - School of Pharmaceutical Sciences of Ribeirão Preto, Ribeirão Preto, SP, Brazil
AD  - São Paulo University, USP - School of Medicine of Ribeirão Preto, Ribeirão Preto, SP, Brazil
AD  - Queen's University Belfast, Belfast, United Kingdom
AB  - Pharmacogenomics (PGx) has emerged as an encouraging tool in chronic pain therapy. Genetic variations associated with drug effectiveness or adverse reactions (amitriptyline/nortriptyline/codeine/oxycodone/tramadol-CYP2D6, amitriptyline-CYP2C19, carbamazepine-HLA-A, carbamazepine/oxcarbazepine-HLA-B) can be used to guide chronic pain management. Despite this evidence, many obstacles still need to be overcome for the effective clinical implementation of PGx. To translate the pharmacogenetic testing into actionable clinical decisions, the Clinical Pharmacogenetics Implementation Consortium has been developing guidelines for several drug-gene pairs. This review will show the applicability of PGx in chronic pain from disease to treatment; report the drug-gene pairs with strongest evidences in the clinic; and the challenges for the clinical implementation of PGx. © 2019 Future Medicine Ltd.
KW  - anticonvulsants
KW  - chronic pain
KW  - CPIC
KW  - cytochrome P450
KW  - opioids
KW  - pharmacogenetics
KW  - tricyclic antidepressants
KW  - amitriptyline
KW  - botulinum toxin A
KW  - capsaicin
KW  - carbamazepine
KW  - citalopram
KW  - clomipramine
KW  - cytochrome P450 2C19
KW  - cytochrome P450 2D6
KW  - desipramine
KW  - duloxetine
KW  - escitalopram
KW  - fentanyl
KW  - gabapentin
KW  - hydromorphone
KW  - imipramine
KW  - lacosamide
KW  - lamotrigine
KW  - methadone
KW  - morphine
KW  - nortriptyline
KW  - oxcarbazepine
KW  - oxycodone
KW  - paroxetine
KW  - tapentadol
KW  - topiramate
KW  - tramadol
KW  - valproic acid
KW  - venlafaxine
KW  - Article
KW  - bipolar disorder
KW  - chronic pain
KW  - clinical practice
KW  - diabetic neuropathy
KW  - epilepsy
KW  - erythromelalgia
KW  - evidence based medicine
KW  - fibromyalgia
KW  - genetic variability
KW  - human
KW  - low back pain
KW  - neuropathic pain
KW  - pharmacogenomics
KW  - trigeminus neuralgia
PB  - Future Medicine Ltd.
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: PARMF
C2  - 31486733
LA  - English
N1  - Correspondence Address: De Moraes, N.V.; São Paulo State University, UNESP - School of Pharmaceutical SciencesBrazil; email: natalia.v.moraes@unesp.br
N1  - Chemicals/CAS: amitriptyline, 50-48-6, 549-18-8; botulinum toxin A, 93384-43-1, 1309378-01-5, 1800016-51-6, 1638949-86-6; capsaicin, 404-86-4; carbamazepine, 298-46-4, 8047-84-5; citalopram, 59729-33-8; clomipramine, 17321-77-6, 303-49-1; desipramine, 50-47-5, 58-28-6; duloxetine, 116539-59-4, 136434-34-9; escitalopram, 128196-01-0, 219861-08-2; fentanyl, 437-38-7; gabapentin, 60142-96-3; hydromorphone, 466-99-9, 71-68-1; imipramine, 113-52-0, 50-49-7; lacosamide, 175481-36-4; lamotrigine, 84057-84-1; methadone, 1095-90-5, 125-56-4, 23142-53-2, 297-88-1, 76-99-3; morphine, 52-26-6, 57-27-2; nortriptyline, 72-69-5, 894-71-3; oxcarbazepine, 28721-07-5; oxycodone, 124-90-3, 76-42-6; paroxetine, 61869-08-7; tapentadol, 175591-09-0, 175591-23-8; topiramate, 97240-79-4; tramadol, 27203-92-5, 36282-47-0; valproic acid, 1069-66-5, 99-66-1; venlafaxine, 93413-69-5, 99300-78-4
N1  - References: Jambunathan, J., Chappy, S., Siebers, J.J., Deda, A., Patient-centered care for chronic pain in the emergency department: A qualitative study (2016) Int. Emerg. Nurs., 24, pp. 22-27; 
Todd, K.H., Ducharme, J., Choiniere, M., Pain in the emergency department: Results of the pain and emergency medicine initiative (PEMI) multicenter study (2007) J. Pain, 8 (6), pp. 460-466; 
Smith, B.H., Fors, E.A., Korwisi, B., The IASP classification of chronic pain for ICD-11: Applicability in primary care (2019) Pain, 160 (1), pp. 83-87; 
Treede, R.D., The International Association for the Study of Pain definition of pain: As valid in 2018 as in 1979, but in need of regularly updated footnotes (2018) Pain Rep., 3 (2), p. e643; 
Binder, A., Baron, R., The pharmacological therapy of chronic neuropathic pain (2016) Dtsch. Arztebl. Int., 113 (37), pp. 616-625; 
American Geriatrics Society 2019 Updated AGS Beers Criteria R - for Potentially Inappropriate Medication Use in Older Adults (2019) J. Am. Geriatr. Soc., 67 (4), pp. 674-694. , American Geriatrics Society Beers Criteria R - Update Expert Panel; 
Gerrits, M.M., Van Oppen, P., Leone, S.S., Van Marwijk, H.W., Van Der Horst, H.E., Penninx, B.W., Pain, not chronic disease, is associated with the recurrence of depressive and anxiety disorders (2014) BMC Psychiatry, 14, p. 187; 
Tang, N.K., Crane, C., Suicidality in chronic pain: A review of the prevalence, risk factors and psychological links (2006) Psychol. Med., 36 (5), pp. 575-586; 
Cheatle, M.D., Wasser, T., Foster, C., Olugbodi, A., Bryan, J., Prevalence of suicidal ideation in patients with chronic non-cancer pain referred to a behaviorally based pain program (2014) Pain Physician, 17 (3), pp. E359-E367; 
Campbell, G., Bruno, R., Darke, S., Prevalence and correlates of suicidal thoughts and suicide attempts in people prescribed pharmaceutical opioids for chronic pain (2016) Clin. J. Pain, 32 (4), pp. 292-301; 
Owen-Smith, A.A., Ahmedani, B.K., Peterson, E., The mediating effect of sleep disturbance on the relationship between nonmalignant chronic pain and suicide death (2019) Pain Pract., 19 (4), pp. 382-389; 
Alvestad, S., Lydersen, S., Brodtkorb, E., Rash from antiepileptic drugs: Influence by gender, age, and learning disability (2007) Epilepsia, 48 (7), pp. 1360-1365; 
Richardson, J., Holdcroft, A., Gender differences and pain medication (2009) Womens Health (Lond.), 5 (1), pp. 79-90; 
Chung, W.H., Hung, S.I., Hong, H.S., Medical genetics: A marker for Stevens-Johnson syndrome (2004) Nature, 428 (6982), p. 486; 
Kim, S.H., Lee, K.W., Song, W.J., Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans (2011) Epilepsy Res., 97 (1-2), pp. 190-197; 
McCormack, M., Alfirevic, A., Bourgeois, S., HLA-A 3101 and carbamazepine-induced hypersensitivity reactions in Europeans (2011) N. Engl. J. Med., 364 (12), pp. 1134-1143; 
Zhu, X.Y., Huang, C.S., Li, Q., P300 exerts an epigenetic role in chronic neuropathic pain through its acetyltransferase activity in rats following chronic constriction injury (CCI) (2012) Mol. Pain, 8, p. 84; 
Qi, F., Zhou, Y., Xiao, Y., Promoter demethylation of cystathionine-β-synthetase gene contributes to inflammatory pain in rats (2013) Pain, 154 (1), pp. 34-45; 
Wang, X., Shen, X., Xu, Y., The etiological changes of acetylation in peripheral nerve injury-induced neuropathic hypersensitivity (2018) Mol. Pain, 14, p. 798408; 
Meloto, C.B., Benavides, R., Lichtenwalter, R.N., Human pain genetics database: A resource dedicated to human pain genetics research (2018) Pain, 159 (4), pp. 749-763; 
Knezevic, N.N., Tverdohleb, T., Knezevic, I., Candido, K.D., The role of genetic polymorphisms in chronic pain patients (2018) Int. J. Mol. Sci., 19 (6); 
Arnold, L.M., Fan, J., Russell, I.J., The fibromyalgia family study: A genome-wide linkage scan study (2013) Arthritis Rheumatism, 65 (4), pp. 1122-1128; 
Barbosa, F.R., Matsuda, J.B., Mazucato, M., Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients (2012) Rheumatol. Int., 32 (2), pp. 427-430; 
Cohen, H., Neumann, L., Glazer, Y., Ebstein, R.P., Buskila, D., The relationship between a common catechol-O-methyltransferase (COMT) polymorphism val(158) met and fibromyalgia (2009) Clin. Exp. Rheumatol., 27 (5), pp. S51-S56; 
Gursoy, S., Erdal, E., Herken, H., Madenci, E., Alaşehirli, B., Erdal, N., Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome (2003) Rheumatol. Int., 23 (3), pp. 104-107; 
Martínez-Jauand, M., Sitges, C., Rodríguez, V., Pain sensitivity in fibromyalgia is associated with catechol-O-methyltransferase (COMT) gene (2013) Eur. J. Pain, 17 (1), pp. 16-27; 
Matsuda, J.B., Barbosa, F.R., Morel, L.J., Serotonin receptor (5-HT 2A) and catechol-O-methyltransferase (COMT) gene polymorphisms: Triggers of fibromyalgia? (2010) Rev. Bras. Rheumatol., 50 (2), pp. 141-149; 
Vargas-Alarcón, G., Fragoso, J.M., Cruz-Robles, D., Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia (2007) Arthritis Res. Ther., 9 (5), p. R110; 
Chou, W.Y., Yang, L.C., Lu, H.F., Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty (2006) Acta Anaesthesiol. Scand., 50 (7), pp. 787-792; 
Olsen, M.B., Jacobsen, L.M., Schistad, E.I., Pain intensity the first year after lumbar disc herniation is associated with the A118G polymorphism in the opioid receptor mu 1 gene: Evidence of a sex and genotype interaction (2012) J. Neurosci., 32 (29), pp. 9831-9834; 
Diatchenko, L., Fillingim, R.B., Smith, S.B., Maixner, W., The phenotypic and genetic signatures of common musculoskeletal pain conditions (2013) Nat. Rev. Rheumatol., 9 (6), pp. 340-350; 
Jacobsen, L.M., Schistad, E.I., Storesund, A., The COMT rs4680 Metallele contributes to long-lasting low back pain, sciatica and disability after lumbar disc herniation (2012) Eur. J. Pain, 16 (7), pp. 1064-1069; 
Gruber, H.E., Sha, W., Brouwer, C.R., Steuerwald, N., Hoelscher, G.L., Hanley, E.N., A novel catechol-O-methyltransferase variant associated with human disc degeneration (2014) Int. J. Med. Sci., 11 (7), pp. 748-753; 
Guo, T.M., Liu, M., Zhang, Y.G., Guo, W.T., Wu, S.X., Association between caspase-9 promoter region polymorphisms and discogenic low back pain (2011) Connect. Tissue Res., 52 (2), pp. 133-138; 
Mu, J., Ge, W., Zuo, X., Chen, Y., Huang, C., Analysis of association between IL-1β, CASP-9, and GDF5 variants and low-back pain in Chinese male soldier: Clinical article (2013) J. Neurosurg. Spine, 19 (2), pp. 243-247; 
Microvascular complications and foot care: Standards of medical care in diabetes-2018 (2018) Diabetes Care, 41, pp. S105-S118. , American Diabetes Association.10; 
Blesneac, I., Themistocleous, A.C., Fratter, C., Rare NaV1.7 variants associated with painful diabetic peripheral neuropathy (2018) Pain, 159 (3), pp. 469-480; 
Meng, W., Deshmukh, H.A., Donnelly, L.A., A genome-wide association study provides evidence of sex-specific involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) with diabetic neuropathic pain (2015) EBioMedicine, 2 (10), pp. 1386-1393; 
Meng, W., Deshmukh, H.A., Van Zuydam, N.R., A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain (2015) Eur. J. Pain, 19 (3), pp. 392-399; 
Rudofsky, G., Reismann, P., Witte, S., Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with Type 2 diabetes (2004) Diabetes Care, 27 (1), pp. 179-183; 
De Toledo, I.P., Conti Réus, J., Fernandes, M., Prevalence of trigeminal neuralgia: A systematic review (2016) J. Am. Dent. Assoc., 147 (7), pp. 570-576. , e572; 
Cui, W., Yu, X., Zhang, H., The serotonin transporter gene polymorphism is associated with the susceptibility and the pain severity in idiopathic trigeminal neuralgia patients (2014) J. Headache Pain, 15, p. 42; 
Gulve, A., Erythromelalgia (2019) Pain: A Review Guide, pp. 1265-1268. , Abd-Elsayed A (Ed.). Springer International Publishing, Cham, Switzerland; 
McDonnell, A., Schulman, B., Ali, Z., Inherited erythromelalgia due to mutations in SCN9A: Natural history, clinical phenotype and somatosensory profile (2016) Brain, 139, pp. 1052-1065; 
Dib-Hajj, S.D., Yang, Y., Black, J.A., Waxman, S.G., The Na(V)1.7 sodium channel: From molecule to man (2013) Nat. Rev. Neurosci., 14 (1), pp. 49-62; 
Cao, L., McDonnell, A., Nitzsche, A., Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia (2016) Sci. Transl. Med., 8 (335), p. 335ra356; 
Fischer, T.Z., Gilmore, E.S., Estacion, M., A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia (2009) Ann. Neurol., 65 (6), pp. 733-741; 
Geha, P., Yang, Y., Estacion, M., Pharmacotherapy for pain in a family with inherited erythromelalgia guided by genomic analysis and functional profiling (2016) JAMA Neurol., 73 (6), pp. 659-667; 
Yang, Y., Adi, T., Effraim, P.R., Chen, L., Dib-Hajj, S.D., Waxman, S.G., Reverse pharmacogenomics: Carbamazepine normalizes activation and attenuates thermal hyperexcitability of sensory neurons due to Na (2018) Br. J. Pharmacol., 175 (12), pp. 2261-2271; 
Kia, S., Choy, E., Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology (2017) Biomedicines, 5 (2), pp. 1-24; 
Moulin, D., Boulanger, A., Clark, A.J., Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society (2014) Pain Res. Management, 19 (6), pp. 328-335; 
Attal, N., Cruccu, G., Baron, R., EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision (2010) Eur. J. Neurol., 17 (9), pp. e1113-e1188; 
(2013) Neuropathic Pain: The Pharmacological Management of Neuropathic Pain in Adults in Non-specialist Settings, , Centre for Clinical Practice at NICE In: National Institute for Health and Care Excellence: Clinical Guidelines (No. 173). National Institute for Health and Care Excellence, London, UK; 
Finnerup, N.B., Attal, N., Haroutounian, S., Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis (2015) Lancet Neurol., 14 (2), pp. 162-173; 
Hicks, J.K., Sangkuhl, K., Swen, J.J., Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update (2017) Clin. Pharmacol. Ther., 102 (1), pp. 37-44; 
Hiemke, C., Bergemann, N., Clement, H.W., Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: Update 2017 (2018) Pharmacopsychiatry, 51 (1-2), pp. 9-62; 
(2010) Practice Guideline for the Treatment of Patients with Major Depressive Disorder, , https://psychiatryonline.org/pb/assets/raw/sitewide/practiceguidelines/guidelines/mdd.pdf, American Psychiatric Association(Third edition), DC, USA; 
Phillips, E.J., Sukasem, C., Whirl-Carrillo, M., Clinical Pharmacogenetics Implementation Consortium Guideline for HLA genotype and use of carbamazepine and oxcarbazepine: 2017 update (2018) Clin. Pharmacol. Ther., 103 (4), pp. 574-581; 
Crews, K.R., Gaedigk, A., Dunnenberger, H.M., Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update (2014) Clin. Pharmacol. Ther., 95 (4), pp. 376-382; 
Swen, J.J., Nijenhuis, M., De Boer, A., Pharmacogenetics: From bench to byte-an update of guidelines (2011) Clin. Pharmacol. Ther., 89 (5), pp. 662-673; 
Tegretol (Carbamazepine), Package Insert, , Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 
Bendtsen, L., Zakrzewska, J.M., Abbott, J., European Academy of Neurology guideline on trigeminal neuralgia (2019) Eur. J. Neurol., , (Epub ahead of print); 
Dean, L., Carbamazepine therapy and HLA genotype (2012) Medical Genetics Summaries [Internet], , Pratt V, McLeod H, Rubinstein W, Dean L, Kattman B, Malheiro A (Eds.), National Center for Biotechnology Information, Bethesda, MD, USA; 
Ozeki, T., Mushiroda, T., Yowang, A., Genome-wide association study identifies HLA-A 3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population (2011) Hum. Mol. Genet., 20 (5), pp. 1034-1041; 
Hsiao, Y.H., Hui, R.C., Wu, T., Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: Strength and clinical correlations (2014) J. Dermatol. Sci., 73 (2), pp. 101-109; 
Chen, C.B., Hsiao, Y.H., Wu, T., Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians (2017) Neurology, 88 (1), pp. 78-86; 
Medicines and healthcare products regulatory agency, commission on human medicines drug safety update (2008) Latest Advice for All Medicines Users., 1 (9), pp. 1-10. , www.sefap.it/farmacovigilanzanews200804/Drug-Safety-Update-April-2008%5B1%5D.pdf; 
Chen, Z., Liew, D., Kwan, P., Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions (2014) PloS ONE, 9 (5), p. e96990; 
Lee, M.T., Mahasirimongkol, S., Zhang, Y., Clinical application of pharmacogenomics: The example of HLA-based drug-induced toxicity (2014) Public Health Genomics, 17 (5-6), pp. 248-255; 
Amstutz, U., Shear, N.H., Rieder, M.J., Recommendations for HLA-B 15:02 and HLA-A 31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions (2014) Epilepsia, 55 (4), pp. 496-506; 
Chen, P., Lin, J.J., Lu, C.S., Carbamazepine-induced toxic effects and HLA-B 1502 screening in Taiwan (2011) N. Engl. J. Med., 364 (12), pp. 1126-1133; 
Mushiroda, T., Takahashi, Y., Onuma, T., Association of HLA-A 31:01 screening with the incidence of carbamazepine-induced cutaneous adverse reactions in a Japanese population (2018) JAMA Neurol., 75 (7), pp. 842-849; 
Locharernkul, C., Loplumlert, J., Limotai, C., Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B 1502 allele in Thai population (2008) Epilepsia, 49 (12), pp. 2087-2091; 
Fricke-Galindo, I., Llerena, A., López-López, M., An update on HLA alleles associated with adverse drug reactions (2017) Drug Metab. Pers. Ther., 32 (2), pp. 73-87; 
Fallon, M., Giusti, R., Aielli, F., Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines (2018) Ann. Oncol., 29, pp. iv166-iv191; 
Matic, M., De Wildt, S.N., Tibboel, D., Van Schaik, R.H.N., Analgesia and opioids: A pharmacogenetics shortlist for implementation in clinical practice (2017) Clinical Chem., 63 (7), pp. 1204-1213; 
Owusu, O.A., Hamadeh, I., Smith, M., Review of opioid pharmacogenetics and considerations for pain management (2017) Pharmacotherapy, 37 (9), pp. 1105-1121; 
Lassen, D., Damkier, P., Brøsen, K., The pharmacogenetics of tramadol (2015) Clin. Pharmacokinetics, 54 (8), pp. 825-836; 
Balyan, R., Mecoli, M., Venkatasubramanian, R., CYP2D6 pharmacogenetic and oxycodone pharmacokinetic association study in pediatric surgical patients (2017) Pharmacogenomics, 18 (4), pp. 337-348; 
Ciszkowski, C., Madadi, P., Phillips, M.S., Lauwers, A.E., Koren, G., Codeine, ultrarapid-metabolism genotype, and postoperative death (2009) N. Engl. J. Med., 61 (8), pp. 827-828; 
Kelly, L.E., Rieder, M., Van Den Anker, J., More codeine fatalities after tonsillectomy in North American children (2012) Pediatrics, 129 (5), pp. e1343-e1347; 
Orliaguet, G., Hamza, J., Couloigner, V., A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol (2015) Pediatrics, 135 (3), pp. e753-e755; 
Voronov, P., Przybylo, H.J., Jagannathan, N., Apnea in a child after oral codeine: A genetic variant-an ultra-rapid metabolizer (2007) Paediatr. Anaesth., 17 (7), pp. 684-687; 
(2015) FDA Restricts Use of Prescription Codeine Pain and Cough Medicines and Tramadol Pain Medicines in Children; Recommends Against Use in Breastfeeding Women, , www.fda.gov/Drugs/DrugSafety/ucm549679.htm, FDA Drug Safety Communication; 
Gammal, R.S., Crews, K.R., Haidar, C.E., Pharmacogenetics for safe codeine use in sickle cell disease (2016) Pediatrics, 138 (1), p. e20153479; 
Gammal, R.S., Caudle, K.E., Quinn, C.T., The case for pharmacogenetics-guided prescribing of codeine in children (2018) Clin. Pharmacol. Ther, , (Epub ahead of print); 
Smith, D.M., Weitzel, K.W., Elsey, A.R., CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: A pragmatic clinical trial (2019) Genet. Med., , (Epub ahead of print ); 
Jannetto, P.J., Bratanow, N.C., Utilization of pharmacogenomics and therapeutic drug monitoring for opioid pain management (2009) Pharmacogenomics, 10 (7), pp. 1157-1167; 
Lazaridis, K.N., Improving therapeutic Odyssey: Preemptive pharmacogenomics utility in patient care (2017) Clin. Pharmacol. Ther., 101 (1), pp. 39-41; 
Dragic, L.L., Wegrzyn, E.L., Schatman, M.E., Fudin, J., Pharmacogenetic guidance: Individualized medicine promotes enhanced pain outcomes (2018) J. Pain Res., 11, pp. 37-40; 
Olson, J.E., Rohrer, V.C.R., Bell, E.J., Participant-perceived understanding and perspectives on pharmacogenomics: The Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time) (2017) Genet. Med., 19 (7), pp. 819-825; 
Just, K.S., Steffens, M., Swen, J.J., Patrinos, G.P., Guchelaar, H.J., Stingl, J.C., Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx) (2017) European J. Clin. Pharmacol., 73 (10), pp. 1247-1252; 
Athreya, A.P., Neavin, D., Carrillo-Roa, T., Pharmacogenomics-driven prediction of antidepressant treatment outcomes: A machine learning approach with multi-trial replication (2019) Clin. Pharmacol. Ther., , (Epub ahead of print); 
Verbelen, M., Weale, M.E., Lewis, C.M., Cost-effectiveness of pharmacogenetic-guided treatment: Are we there yet? (2017) Pharmacogenomics J., 17 (5), pp. 395-402; 
Moretti, M.E., Lato, D.F., Berger, H., Koren, G., Ito, S., Ungar, W.J., A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events (2018) Pharmacogenomics J., 18 (3), pp. 391-397; 
Borobia, A.M., Dapia, I., Tong, H.Y., Clinical implementation of pharmacogenetic testing in a hospital of the Spanish National Health System: Strategy and experience over 3 years (2018) Clin. Transl. Sci., 11 (2), pp. 189-199
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071777833&doi=10.2217%2fpgs-2019-0066&partnerID=40&md5=461040d8fd162d5c6461836b1b0936f9
ER  - 

TY  - JOUR
TI  - A deep convolutional neural network approach for astrocyte detection
T2  - Scientific Reports
J2  - Sci. Rep.
VL  - 8
IS  - 1
PY  - 2018
DO  - 10.1038/s41598-018-31284-x
SN  - 20452322 (ISSN) 
AU  - Suleymanova, I.
AU  - Balassa, T.
AU  - Tripathi, S.
AU  - Molnar, C.
AU  - Saarma, M.
AU  - Sidorova, Y.
AU  - Horvath, P.
AD  - Laboratory of Molecular Neuroscience, Research Program in Developmental Biology, Institute of Biotechnology (HiLIFE), University of Helsinki, Viikinkaari 5D, Helsinki, FI-00014, Finland
AD  - Synthetic and Systems Biology Unit, Hungarian Academy of Sciences, Biological Research Centre (BRC), Temesvári körút 62, Szeged, 6726, Hungary
AD  - Research Program Unit, Helsinki Institute of Life Science (HiLIFE), Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, Helsinki, 00014, Finland
AD  - Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Tukholmankatu 8, Helsinki, 00014, Finland
AB  - Astrocytes are involved in various brain pathologies including trauma, stroke, neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, or chronic pain. Determining cell density in a complex tissue environment in microscopy images and elucidating the temporal characteristics of morphological and biochemical changes is essential to understand the role of astrocytes in physiological and pathological conditions. Nowadays, manual stereological cell counting or semi-automatic segmentation techniques are widely used for the quantitative analysis of microscopy images. Detecting astrocytes automatically is a highly challenging computational task, for which we currently lack efficient image analysis tools. We have developed a fast and fully automated software that assesses the number of astrocytes using Deep Convolutional Neural Networks (DCNN). The method highly outperforms state-of-the-art image analysis and machine learning methods and provides precision comparable to those of human experts. Additionally, the runtime of cell detection is significantly less than that of other three computational methods analysed, and it is faster than human observers by orders of magnitude. We applied our DCNN-based method to examine the number of astrocytes in different brain regions of rats with opioid-induced hyperalgesia/tolerance (OIH/OIT), as morphine tolerance is believed to activate glia. We have demonstrated a strong positive correlation between manual and DCNN-based quantification of astrocytes in rat brain. © 2018, The Author(s).
KW  - animal
KW  - area under the curve
KW  - artificial neural network
KW  - astrocyte
KW  - biological model
KW  - human
KW  - image processing
KW  - machine learning
KW  - physiology
KW  - rat
KW  - software
KW  - Animals
KW  - Area Under Curve
KW  - Astrocytes
KW  - Humans
KW  - Image Processing, Computer-Assisted
KW  - Machine Learning
KW  - Models, Biological
KW  - Neural Networks (Computer)
KW  - Rats
KW  - Software
PB  - Nature Publishing Group
N1  - Cited By :5
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C7  - 12878
C2  - 30150631
LA  - English
N1  - Correspondence Address: Horvath, P.; Synthetic and Systems Biology Unit, Hungarian Academy of Sciences, Biological Research Centre (BRC), Temesvári körút 62, Hungary; email: horvath.peter@brc.mta.hu
N1  - Funding details: 602919
N1  - Funding details: European Commission
N1  - Funding details: GINOP-2.3.2-15-2016-00006, GINOP-2.3.2-15-2016-00026
N1  - Funding details: M.S.I. Foundation
N1  - Funding details: Tekes, 40294/13
N1  - Funding text 1: P.H. acknowledges support from the Finnish TEKES FiDiPro Fellow Grant 40294/13, and the HAS-LENDULET-BIOMAG, I.S., Y.S. and M.S. acknowledge the support from the EU FP7/2007–2013 under grant agreement No. 602919. B.T., C.M., and P.H. acknowledge funding from the European Union and the European Regional Development Funds (GINOP-2.3.2-15-2016-00006, GINOP-2.3.2-15-2016-00026). The authors would like to thank Prof. Eija Kalso and Prof. Pekka Rauhala for support, Dr. Viljami Jokinen and Dr. Hanna Viisanen-Kuopila for sharing samples/images used in our study, Jenni Montonen for assistance with cells annotation and data collection, and Dora Bokor, PharmD, for proofreading the manuscript.
N1  - References: von Bartheld, C.S., Bahney, J., Herculano-Houzel, S., The search for true numbers of neurons and glial cells in the human brain: A review of 150 years of cell counting (2016) Journal of Comparative Neurology, 524, pp. 3865-3895; 
Verkhratsky, A., Butt, A.M., Neuroglia: Definition, Classification, Evolution, Numbers, Development (2013) Glial Physiology and Pathophysiology, pp. 73-104. , eds Verkhratsky, A. and Butt, A. M, John Wiley and Sons, Ltd; 
Barker, A.J., Ullian, E.M., New roles for astrocytes in developing synaptic circuits (2008) Communicative and Integrative Biology, 1, pp. 207-211. , PID: 19513261; 
Sloan, S.A., Barres, B.A., Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders (2014) Current Opinion in Neurobiology, 347, pp. 882-886; 
Schneider, C.A., Rasband, W.S., Eliceiri, K.W., NIH Image to ImageJ: 25 years of image analysis (2012) Nature Methods, 9, pp. 671-675. , PID: 22930834; 
Sommer, C., Straehle, C., Köthe, U., Hamprecht, F.A., Ilastik: Interactive Learning and Segmentation Toolkit (2011) 8Th IEEE International Symposium on Biomedical Imaging, pp. 230-233; 
Zhas, K.R., Wu, T., Confocal Microscopic Study of Glial-Vascular Relationships in the Retinas of Pigmented Rats (2001) Journal of Comparative Neurology, 429, pp. 253-269; 
Kang, K., Lee, S.W., Han, J.E., Choi, J.W., Song, M.R., The complex morphology of reactive astrocytes controlled by fibroblast growth factor signaling (2014) GLIA, 62, pp. 1328-1344. , PID: 24796693; 
LeCun, Y., Bengio, Y., Hinton, G., Deep learning (2015) Nature, 521, pp. 436-444. , PID: 26017442; 
Hinton, G.E., Salakhutdinov, R.R., Reducing the Dimensionality of Data with Neural Networks (2006) Science, 313, pp. 504-507. , PID: 16873662; 
Hinton, G., Osindero, E.S., Teh, Y.W., A fast learning algorithm for deep belief nets (2006) Neural Computation, vol., 18, pp. 1527-1554; 
Lecun, Y., Handwritten digit recognition with a back-propagation network (1989) Neural Information Processing Systems Conference, pp. 396-404; 
Unadkat, S.B., (2001) Recurrent neural networks: Design and applications, p. 414. , eds Medsker, L. R. & Jain, L. C, CRC Press LLC; 
Deng, L., Yu, D., Deep Learning: Methods and Applications (2014) Foundations and Trends® in Signal Processing, 7, pp. 197-387; 
Cireşan, D.C., Giusti, A., Gambardella, L.M., Schmidhuber, J., Mitosis detection in breast cancer histology images with deep neural networks (2013) Medical Image Computing and Computer-Assisted Intervention – MICCAI, 2013, pp. 411-418; 
Gao, Z., Wang, L., Zhou, L., Zhang, J., HEp-2 Cell Image Classification with Deep Convolutional Neural Networks (2017) IEEE Journal of Biomedical and Health Informatics, 21, pp. 416-428. , PID: 26887016; 
Chen, T., Chefd’hotel, C., Deep Learning Based Automatic Immune Cell Detection for Immunohistochemistry Images (2014) Machine Learning and Medical Imaging, vol. LNCS, 8679, pp. 17-24; 
Sirinukunwattana, K., Locality Sensitive Deep Learning for Detection and Classification of Nuclei in Routine Colon Cancer Histology Images (2016) IEEE Transactions on Medical Imaging, 35, pp. 1196-1206. , PID: 26863654; 
Xue, Y., Ray, N., Cell Detection in Microscopy Images with Deep Convolutional Neural Network and Compressed Sensing, , Submitted IEEE Transactions on Image Processing; 
Dong, B., da Costa, M., Frangi, A.F., Deep learning for automatic cell detection in wide-field microscopy zebrafish images (2015) IEEE 12Th International Symposium, pp. 772-776; 
Penttinen, A.M., Characterization of a new low-dose 6-hydroxydopamine model of Parkinson’s disease in rat (2016) Journal of Neuroscience Research, 328, pp. 318-328; 
Martin, S.A., Clark, D., Opioid-induced Hyperalgesia: A Qualitative Systematic Review (2006) Anesthesiology, 104, pp. 570-587; 
Han, Y., Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signalling (2014) European Journal of Pain, 18, pp. 1458-1470. , PID: 24756886; 
Watkins, L.R., Hutchinson, M.R., Rice, K.C., Maier, S.F., The “Toll” of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia (2009) Trends in Pharmacological Science, 30, pp. 581-591; 
Tracey, I., Mantyh, P.W., The cerebral signature for pain perception and its modulation (2007) Neuron, 55, pp. 377-391. , PID: 17678852; 
Peyron, R., Laurent, B., García-Larrea, L., Functional imaging of brain responses to pain (2000) Neurophysiologie Clinique Clinical Neurophysiology, 30, pp. 263-288. , PID: 11126640; 
Jokinen, V., Differential spinal and supraspinal activation of glia in morphine tolerance in the rat (2018) Neuroscience, 375, pp. 10-24. , PID: 29421434; 
Zimmermann, M., Ethical guidelines for investigations of experimental pain in conscious animals (1983) Pain, 16, pp. 109-110. , PID: 6877845; 
Jia, Y., Caffe: Convolutional Architecture for Fast Feature Embedding (2014) Proceedings of the 22Nd ACM International Conference on Multimedia, pp. 675-678; 
Szegedy, C., Going Deeper with Convolutions (2015) Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, pp. 1-9; 
Kingma, D.P., Ba, J.L., Adam: A Method for Stochastic Optimization (2015) International Conference on Learning Representations, pp. 1-13; 
Molnar, C., Accurate Morphology Preserving Segmentation of Overlapping Cells based on Active Contours (2016) Scientific Report, 6, pp. 1-10; 
Howard, C.V., Reed, M.G., (2005) Unbiased Stereology, pp. 1-17. , QTP Publications; 
Biggerstaff, J., Weidow, B., Amirkhosravi, A., Francis, J.L., Enumeration of leukocyte infiltration in solid tumors by confocal laser scanning microscopy (2006) BMC Immunology, 7. , PID: 16859557; 
Peng, H., Bioimage informatics: A new area of engineering biology (2008) Bioinformatics, 24, pp. 1827-1836. , PID: 18603566; 
Andriezen, W.L., The neuroglia elements in the human brain (1893) British Medical Journal, 29, pp. 227-230; 
Barker, J., Sarathy, S., July, A.T., (2016) Detectnet: Deep Neural Network for Object Detection in DIGITS, , https://devblogs.nvidia.com/parallelforall/detectnet-deep-neural-network-object-detection-digits/, NVIDIA Developer Blogs
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052320591&doi=10.1038%2fs41598-018-31284-x&partnerID=40&md5=fa9f8560dd949527361214ed7237f75a
ER  - 

TY  - JOUR
TI  - Inferring phenotypes from substance use via collaborative matrix completion
T2  - BMC Systems Biology
J2  - BMC Syst. Biol.
VL  - 12
PY  - 2018
DO  - 10.1186/s12918-018-0623-5
SN  - 17520509 (ISSN) 
AU  - Lu, J.
AU  - Sun, J.
AU  - Wang, X.
AU  - Kranzler, H.
AU  - Gelernter, J.
AU  - Bi, J.
AD  - Department of Computer Science and Engineering, University of Connecticut, 371 Fairfield Way, Unit 4155, Storrs, CT, United States
AD  - Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, 3535 Market St., Crescenz Veterans Affairs Med. Center, Philadelphia, PA, United States
AD  - Departments of Psychiatry, Genetics, and Neurobiology, Yale University School of Medicine, 333 Cedar St, New Haven, CT, United States
AB  - Background: Although substance use disorders (SUDs) are heritable, few genetic risk factors for them have been identified, in part due to the small sample sizes of study populations. To address this limitation, researchers have aggregated subjects from multiple existing genetic studies, but these subjects can have missing phenotypic information, including diagnostic criteria for certain substances that were not originally a focus of study. Recent advances in addiction neurobiology have shown that comorbid SUDs (e.g., the abuse of multiple substances) have similar genetic determinants, which makes it possible to infer missing SUD diagnostic criteria using criteria from another SUD and patient genotypes through statistical modeling. Results: We propose a new approach based on matrix completion techniques to integrate features of comorbid health conditions and individual's genotypes to infer unreported diagnostic criteria for a disorder. This approach optimizes a bi-linear model that uses the interactions between known disease correlations and candidate genes to impute missing criteria. An efficient stochastic and parallel algorithm was developed to optimize the model with a speed 20 times greater than the classic sequential algorithm. It was tested on 3441 subjects who had both cocaine and opioid use disorders and successfully inferred missing diagnostic criteria with consistently better accuracy than other recent statistical methods. Conclusions: The proposed matrix completion imputation method is a promising tool to impute unreported or unobserved symptoms or criteria for disease diagnosis. Integrating data at multiple scales or from heterogeneous sources may help improve the accuracy of phenotype imputation. © 2018 The Author(s).
KW  - Addiction
KW  - Matrix completion
KW  - Parallel computing
KW  - Phenotype imputation
KW  - Substance use disorder
PB  - BioMed Central Ltd.
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C7  - 104
C2  - 30463556
LA  - English
N1  - Correspondence Address: Bi, J.; Department of Computer Science and Engineering, University of Connecticut, 371 Fairfield Way, Unit 4155, United States; email: jinbo.bi@uconn.edu
N1  - Funding details: National Sleep Foundation, CCF-1514357, DBI-1356655
N1  - Funding details: National Institutes of Health, K02DA043063, R01DA037349
N1  - Funding details: National Institutes of Health
N1  - Funding text 1: This work was supported by NSF grants CCF-1514357 and DBI-1356655, and NIH grants R01DA037349 and K02DA043063 to J Bi. Publication costs were funded by NIH grant R01DA037349.
N1  - Funding text 2: Following the data sharing policy of the National Institutes of Health (NIH) of the US, the GWAS data were deposited to NIH’s dbGaP system. The exome microarray data were recently collected and the deposition of this dataset is undergoing with dbGaP. All computer programs for the proposed algorithm are available at https://github.com/Roadin/CoPhi.
N1  - References: Key substance use and mental health indicators in the United States: results from the 2015 National Survey on Drug Use and Health (HHS Publication No SMA 16-4984, NSDUH Series H-51 (2016), https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2015/NSDUH-FFR1-2015/NSDUH-FFR1-2015.pdf; Degenhardt, L., Hall, W., Extent of illicit drug use and dependence, and their contribution to the global burden of disease (2012) The Lancet, 379 (9810), pp. 55-70; 
Wang, H., Naghavi, M., Allen, C., Barber, R.M., Bhutta, Z.A., Carter, A., Casey, D.C., Coates, M.M., Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the global burden of disease study 2015 (2016) The lancet, 388, pp. 1459-1544. , 10053; 
Kassebaum, N.J., Arora, M., Barber, R.M., Bhutta, Z.A., Brown, J., Carter, A., Casey, D.C., Coggeshall, M., Global, regional, and national disability-adjusted life-years (dalys) for 315 diseases and injuries and healthy life expectancy (hale), 1990-2015: a systematic analysis for the global burden of disease study 2015 (2016) The Lancet, 388, pp. 1603-1658. , 10053; 
Jensen, K.P., A review of genome-wide association studies of stimulant and opioid use disorders (2016) Mol Neuropsychiatry, 2 (1), pp. 37-45; 
Wray, N.R., Lee, S.H., Mehta, D., Vinkhuyzen, A.A.E., Dudbridge, F., Middeldorp, C.M., Research Review: Polygenic methods and their application to psychiatric traits (2014) J Child Psychol Psychiatry Allied Discip, 55 (10), pp. 1068-1087; 
Loh, P.-R., Kichaev, G., Gazal, S., Schoech, A.P., Price, A.L., Mixed-model association for biobank-scale datasets (2018) Nat Genet, 50, pp. 906-908. , July; 
Gelernter, J., Kranzler, H.R., Sherva, R., Koesterer, R., Almasy, L., Zhao, H., Farrer, L., Genome-wide association study of opioid dependence: Multiple associations mapped to calcium and potassium pathways (2014) Biol Psychiatry, 76, pp. 66-74; 
Gelernter, J., Sherva, R., Koesterer, R., Almasy, L., Zhao, H., Kranzler, H.R., Farrer, L., Genome-wide association study of cocaine dependence and related traits: FAM53B identified as a risk gene (2014) Mol Psychiatry, 19 (6), p. 717; 
Goldman, D., Oroszi, G., Ducci, F., The genetics of addictions: uncovering the genes (2005) Nat Rev Genet, 6 (7), p. 521; 
Ball, J.C., Ross, A., The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome (2012), New York: Springer; Cai, J.-F., Candès, E.J., Shen, Z., A singular value thresholding algorithm for matrix completion (2010) SIAM J Optim, 20 (4), pp. 1956-1982; 
Keshavan, R.H., Montanari, A., Oh, S., Matrix completion from a few entries (2010) Inf Theory IEEE Trans, 56 (6), pp. 2980-2998; 
Menon, A.K., Chitrapura, K-P., Garg, S., Agarwal, D., Kota, N., Response prediction using collaborative filtering with hierarchies and side-information (2011) Proceedings of the 17th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, pp. 141-149. , New York City: ACM; 
Natarajan, N., Dhillon, I.S., Inductive matrix completion for predicting gene-disease associations (2014) Bioinformatics, 30 (12), pp. 60-68; 
Jain, P., Dhillon, I.S., Provable inductive matrix completion (2013); Xu, M., Jin, R., Zhou, Z-H., Speedup matrix completion with side information: Application to multi-label learning (2013) Advances in Neural Information Processing Systems, pp. 2301-2309. , San Diego: Neural Information Processing Systems Foundation, Inc; 
Chiang, K-Y., Hsieh, C-J., Dhillon, I.S., Matrix completion with noisy side information San Diego: Neural Information Processing Systems Foundation, Inc.: 2015, pp. 3429-3437. , Advances in Neural Information Processing Systems; 
Liu, G., Li, P., Low-rank matrix completion in the presence of high coherence (2016) IEEE Trans Sig Process, 64 (21), pp. 5623-5633; 
Lu, J., Liang, G., Sun, J., Bi, J., A sparse interactive model for matrix completion with side information (2016) Advances in Neural Information Processing Systems, pp. 4071-4079. , San Diego: Neural Information Processing Systems Foundation, Inc; 
Gelernter, J., Kranzler, H.R., Sherva, R., Koesterer, R., Almasy, L., Zhao, H., Farrer, L., Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways (2014) Biol Psychiatry, 76 (1), pp. 66-74; 
Pierucci-Lagha, A., Gelernter, J., Feinn, R., Cubells, J.F., Pearson, D., Pollastri, A., Farrer, L., Kranzler, H.R., Diagnostic reliability of the semi-structured assessment for drug dependence and alcoholism (SSADDA) (2005) Drug Alcohol Depend, 80 (3), pp. 303-312; 
Pierucci-Lagha, A., Gelernter, J., Chan, G., Arias, A., Cubells, J.F., Farrer, L., Kranzler, H.R., Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA) (2007) Drug Alcohol Depend, 91 (1), pp. 85-90; 
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (2000), Washington, DC: American Psychiatric Association; Howie, B.N., Donnelly, P., Marchini, J., A flexible and accurate genotype imputation method for the next generation of genome-wide association studies (2009) PLoS Genet, 5 (6); 
Speed, D., Cai, N., Johnson, M.R., Nejentsev, S., Balding, D.J., Consortium, U., Re-evaluation of SNP heritability in complex human traits (2017) Nat Genet, 49 (7), p. 986; 
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A.R., Bender, D., Maller, J., Sham, P.C., PLINK: A tool set for whole-genome association and population-based linkage analyses (2007) Am J Hum Genet, 81 (3), pp. 559-575. , abs/arXiv:1011.1669v3; 
Zhou, X., Stephens, M., Genome-wide efficient mixed-model analysis for association studies (2012) Nat Genet, 44 (7), p. 821; 
Willer, C.J., Li, Y., Abecasis, G.R., METAL: Fast and efficient meta-analysis of genomewide association scans (2010) Bioinformatics, 26 (17), pp. 2190-2191; 
Ouyang, H., He, N., Tran, L., Gray, A., Stochastic alternating direction method of multipliers (2013) International Conference on Machine Learning, pp. 80-88. , Brookline: Microtome Publishing; 
Zhong, W., Kwok, J., Fast stochastic alternating direction method of multipliers (2014) International Conference on Machine Learning, pp. 46-54. , Brookline: Microtome Publishing; 
Azadi, S., Sra, S., Towards an optimal stochastic alternating direction method of multipliers International Conference on Machine Learning, pp. 620-628. , Brookline: Microtome Publishing: 2014; 
Fang, C., Cheng, F., Lin, Z., Faster and non-ergodic O(1/k) stochastic alternating direction method of multipliers (2017) Advances in Neural Information Processing Systems, pp. 4479-4488. , San Diego: Neural Information Processing Systems Foundation, Inc; 
Yang, J., Yuan, X.-M., Linearized augmented lagrangian and alternating direction methods for nuclear norm minimization (2013) Math Comput, 82, pp. 301-329; 
Beck, A., Teboulle, M., A fast iterative shrinkage-thresholding algorithm for linear inverse problems (2009) SIAM J Imaging Sci, 2 (1), pp. 183-202; 
Moulines, E., Bach, F.R., Non-asymptotic analysis of stochastic approximation algorithms for machine learning (2011) Advances in Neural Information Processing Systems, pp. 451-459. , San Diego: Neural Information Processing Systems Foundation, Inc; 
Nemirovski, A., Juditsky, A., Lan, G., Shapiro, A., Robust stochastic approximation approach to stochastic programming (2009) SIAM J Optim, 19 (4), pp. 1574-1609; 
Mahdavi, M., Yang, T., Jin, R., Stochastic convex optimization with multiple objectives Advances in Neural Information Processing Systems, pp. 1115-1123. , San Diego: Neural Information Processing Systems Foundation, Inc.: 2013; 
Yu, H., Neely, M., Wei, X., Online convex optimization with stochastic constraints Advances in Neural Information Processing Systems, pp. 1427-1437. , San Diego: Neural Information Processing Systems Foundation, Inc.: 2017; 
Lu, J., Sun, J., Wang, X., Kranzler, H.R., Gelernter, J., Bi, J., Collaborative phenotype inference from comorbid substance use disorders and genotypes (2017), pp. 392-397. , Bioinformatics and Biomedicine (BIBM), 2017 IEEE International Conference On Piscataway: IEEEUR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056933425&doi=10.1186%2fs12918-018-0623-5&partnerID=40&md5=41f5836124a93088b721156e96674fe1
ER  - 

TY  - CHAP
TI  - The spaces where addiction acts: Focus on drug-induced molecular and cellular changes in the cerebellum
T2  - Development of the Cerebellum: Clinical and Molecular Perspectives
J2  - Dev. of the Cerebellum: Clin. and Mol. Perspect.
SP  - 69
EP  - 117
PY  - 2018
SN  - 9781536143188 (ISBN); 9781536143171 (ISBN)
AU  - Solouki, S.
AU  - Soltanloo, H.
AD  - Department of Biomedical Engineering, Human Motor Control and Computational Neuroscience Lab, University of Tehran, Tehran, Iran
AD  - Department of Artificial Intelligence, Association for Computing Machinery Community, University of Tehran, Tehran, Iran
AB  - Acute and chronic opioid consumption causes significant impairments in motor functioning, suggest an involvement of cerebellar circuits in fine tuning of movement patterns. Increasing evidence has involved the cerebellum in addictive behavior. We aimed on cellular and molecular targets in the cerebellum where opioids can induce or alter mechanisms of neuroplasticity that may contribute to the development of an addictive behavioral pattern. Also, we investigated the consequences of repetitive drug administration on cerebellar synaptic efficiency. Insight into the neural mechanisms underlying these impairments has largely stemmed from clinical animal studies. The results of these studies agree to relevant participation of the cerebellum in the functional systems underlying druginduced long-term memory and the perseverative behavioral phenotype. The molecular and neuronal actions of addictive drugs in the cerebellum involve long-term adaptive changes in receptors, neurotransmitters and intracellular signaling transduction pathways that may lead to the reorganization of cerebellar micro complexes or recreation of new domains of attraction. As a part of this functional reorganization, drug-induced cerebellar hyper-responsiveness appears to be central in reducing the influence of executive control of the prefrontal cortex on behavior and aiding the transition to an automatic mode of control. As a result, it can be expected that improved understanding of the neural mechanisms affected by drug addiction has the potential to advance the diagnoses, treatment or even prevention of behavioral disorders. © 2018 Nova Science Publishers, Inc.
KW  - Amphetamine
KW  - Cerebellar plasticity
KW  - Cocaine
KW  - Conditioning
KW  - Drug addiction
KW  - Endocannabinoids
KW  - Ethanol
KW  - Morphine
KW  - Sensitization
PB  - Nova Science Publishers, Inc.
N1  - Export Date: 13 November 2019
M3  - Book Chapter
DB  - Scopus
LA  - English
N1  - Correspondence Address: Solouki, S.; Department of Biomedical Engineering, Human Motor Control and Computational Neuroscience Lab, University of TehranIran; email: saidsolooki@gmail.com
N1  - References: Weissbach, A., Werner, E., Bally, J.F., Tunc, S., Löns, S., Timmann, D., Zeuner, K.E., Klein, C., Alcohol improves cerebellar learning deficit in myoclonus-dystonia: A clinical and electrophysiological investigation (2017) Annals of neurology, 82 (4), pp. 543-553. , Oct 1; 
Moulton, E.A., Elman, I., Becerra, L.R., Goldstein, R.Z., Borsook, D., The cerebellum and addiction: Insights gained from neuroimaging research (2014) Addiction biology, 19 (3), pp. 317-331. , May 1; 
Greer, T.L., Thompson, L.T., Eyeblink Classical Conditioning in Psychiatric Conditions: Novel Uses for a Classic Paradigm (2017) Frontiers in psychiatry, 8, p. 48. , Mar 27; 
Jörntell, H., Cerebellar physiology: Links between microcircuitry properties and sensorimotor functions (2017) The Journal of physiology, 595 (1), pp. 11-27. , Jan 1; 
Voogd, J., Marani, E., Gross Anatomy of the Cerebellum (2016) In Essentials of Cerebellum and Cerebellar Disorders, pp. 33-38. , Springer, Cham; 
Ito, M., Cerebellar microcomplexes (1997) In International review of neurobiology, 41, pp. 475-487. , Jan 1, Academic Press; 
Gao, Z., Van Beugen, B.J., De Zeeuw, C.I., Distributed synergistic plasticity and cerebellar learning (2012) Nature Reviews Neuroscience, 13 (9), p. 619. , Sep; 
Solouki, S., Pooyan, M., Arrangement and Applying of Movement Patterns in the Cerebellum Based on Semi-supervised Learning (2016) The Cerebellum, 15 (3), pp. 299-305. , Jun 1; 
Luque, N.R., Garrido, J.A., Naveros, F., Carrillo, R.R., D'Angelo, E., Ros, E., Distributed cerebellar motor learning: A spike-timing-dependent plasticity model (2016) Frontiers in computational neuroscience, 10, p. 17. , Mar 2; 
D'Angelo, E., Nieus, T., Maffei, A., Armano, S., Rossi, P., Taglietti, V., Fontana, A., Naldi, G., Theta-frequency bursting and resonance in cerebellar granule cells: Experimental evidence and modeling of a slow K+-dependent mechanism (2001) Journal of Neuroscience, 21 (3), pp. 759-770. , Feb 1; 
Chadderton, P., Margrie, T.W., Häusser, M., Integration of quanta in cerebellar granule cells during sensory processing (2004) Nature, 428 (6985), p. 856. , Apr; 
Bower, J.M., The organization of cerebellar cortical circuitry revisited (2002) Annals of the New York Academy of Sciences, 978 (1), pp. 135-155. , Dec 1; 
Hirono, M., Yoshioka, T., Konishi, S., GABA B receptor activation enhances mGluR-mediated responses at cerebellar excitatory synapses (2001) Nature neuroscience, 4 (12), p. 1207. , Dec; 
Batchelor, A.M., Garthwaite, J., Novel synaptic potentials in cerebellar Purkenje cells: Probable mediation by metabotropic glutamate receptors (1993) Neuropharmacology, 32 (1), pp. 11-20. , Jan 1; 
Ito, M., Cerebellar circuitry as a neuronal machine (2006) Progress in neurobiology, 78 (3), pp. 272-303. , Apr 30; 
Simpson, J.I., Wylie, D.R., De Zeeuw, C.I., On climbing fiber signals and their consequence (s) (1996) Behavioral and Brain Sciences, 19 (3), pp. 384-398. , Sep; 
Ito, M., Mechanisms of motor learning in the cerebellum (2000) Brain research, 886 (1-2), pp. 237-245. , Dec 15; 
Bastian, A.J., Learning to predict the future: The cerebellum adapts feedforward movement control (2006) Current opinion in neurobiology, 16 (6), pp. 645-649. , Dec 1; 
Ito, M., Sakurai, M., Tongroach, P., Climbing fibre induced depression of both mossy fibre responsiveness and glutamate sensitivity of cerebellar Purkinje cells (1982) The Journal of Physiology, 324 (1), pp. 113-134. , Mar 1; 
Sakurai, M., Synaptic modification of parallel fibre-Purkinje cell transmission in in vitro guinea-pig cerebellar slices (1987) The Journal of Physiology, 394 (1), pp. 463-480. , Dec 1; 
Safo, P.K., Regehr, W.G., Endocannabinoids control the induction of cerebellar LTD (2005) Neuron, 48 (4), pp. 647-659. , Nov 23; 
Miquel, M., Toledo, R., García, L.I., Coria-avila, G.A., Manzo, J., Why should we keep the cerebellum in mind when thinking about addiction? (2009) Current drug abuse reviews, 2 (1), pp. 26-40. , Jan 1; 
Anderson, C.M., Maas, L.C., de Frederick, B., Bendor, J.T., Spencer, T.J., Livni, E., Lukas, S.E., Kaufman, M.J., Cerebellar vermis involvement in cocaine-related behaviors (2006) Neuropsychopharmacology, 31 (6), p. 1318. , Jun; 
Wolf, M.E., Sun, X., Mangiavacchi, S., Chao, S.Z., Psychomotor stimulants and neuronal plasticity (2004) Neuropharmacology, 47, pp. 61-79. , Jan 1; 
Goodman, A., Addiction: Definition and implications (1990) Addiction, 85 (11), pp. 1403-1408. , Nov 1; 
West, R., Theories of addiction (2001) Addiction, 96 (1), pp. 3-13. , Jan; 
Hyman, S.E., Malenka, R.C., Nestler, E.J., Neural mechanisms of addiction: The role of reward-related learning and memory (2006) Annu. Rev. Neurosci, 29, pp. 565-598. , Jul 21; 
Hyman, S.E., Addiction: A disease of learning and memory (2005) American Journal of Psychiatry, 162 (8), pp. 1414-1422. , Aug 1; 
Fillmore, M.T., Acute alcohol-induced impairment of cognitive functions: Past and present findings (2007) International Journal on Disability and Human Development, 6 (2), pp. 115-126; 
Gilpin, N.W., Koob, G.F., Neurobiology of alcohol dependence: Focus on motivational mechanisms (2008) Alcohol Research & Health, 31 (3), p. 185; 
Yokota, O., Tsuchiya, K., Terada, S., Oshima, K., Ishizu, H., Matsushita, M., Kuroda, S., Akiyama, H., Frequency and clinicopathological characteristics of alcoholic cerebellar degeneration in Japan: A cross-sectional study of 1,509 postmortems (2006) Acta neuropathologica, 112 (1), pp. 43-51. , Jul 1; 
Chanraud, S., Martelli, C., Delain, F., Kostogianni, N., Douaud, G., Aubin, H.J., Reynaud, M., Martinot, J.L., Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning (2007) Neuropsychopharmacology, 32 (2), p. 429. , Feb; 
Belmeguenai, A., Botta, P., Weber, J.T., Carta, M., De Ruiter, M., De Zeeuw, C.I., Valenzuela, C.F., Hansel, C., Alcohol impairs long-term depression at the cerebellar parallel fiber-Purkinje cell synapse (2008) Journal of neurophysiology, 100 (6), pp. 3167-3174. , Dec; 
Luo, J., (2015) Effects of ethanol on the cerebellum: Advances and prospects, pp. 383-385; 
Lovinger, D.M., White, G., Weight, F.F., Ethanol inhibits NMDA- activated ion current in hippocampal neurons (1989) Science, 243 (4899), pp. 1721-1724. , Mar 31; 
Piochon, C., Irinopoulou, T., Brusciano, D., Bailly, Y., Mariani, J., Levenes, C., NMDA receptor contribution to the climbing fiber response in the adult mouse Purkinje cell (2007) Journal of Neuroscience, 27 (40), pp. 10797-10809. , Oct 3; 
Carta, M., Mameli, M., Valenzuela, C.F., Alcohol potently modulates climbing fiber→ Purkinje neuron synapses: Role of metabotropic glutamate receptors (2006) Journal of Neuroscience, 26 (7), pp. 1906-1912. , Feb 15; 
Jörntell, H., Hansel, C., Synaptic memories upside down: Bidirectional plasticity at cerebellar parallel fiber-Purkinje cell synapses (2006) Neuron, 52 (2), pp. 227-238. , Oct 19; 
Servais, L., Hourez, R., Bearzatto, B., Gall, D., Schiffmann, S.N., Cheron, G., Purkinje cell dysfunction and alteration of long-term synaptic plasticity in fetal alcohol syndrome (2007) Proceedings of the National Academy of Sciences, 104 (23), pp. 9858-9863. , Jun 5; 
Gruol, D.L., Parsons, K.L., DiJulio, N., Acute ethanol alters calcium signals elicited by glutamate receptor agonists and K+ depolarization in cultured cerebellar Purkinje neurons (1997) Brain research, 773 (1-2), pp. 82-89. , Oct 31; 
Sanna, P.P., Simpson, C., Lutjens, R., Koob, G., ERK regulation in chronic ethanol exposure and withdrawal (2002) Brain research, 948 (1-2), pp. 186-191. , Sep 6; 
Barco, A., Bailey, C.H., Kandel, E.R., Common molecular mechanisms in explicit and implicit memory (2006) Journal of neurochemistry, 97 (6), pp. 1520-1533. , Jun 1; 
Asher, O., Cunningham, T.D., Yao, L., Gordon, A.S., Diamond, I., Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription via CRE-binding protein and cAMP-dependent protein kinase (2002) Journal of pharmacology and experimental therapeutics, 301 (1), pp. 66-70. , Apr 1; 
Light, K.E., Hayar, A.M., Pierce, D.R., Electrophysiological and immunohistochemical evidence for an increase in GABAergic inputs and HCN channels in Purkinje cells that survive developmental ethanol exposure (2015) The Cerebellum, 14 (4), pp. 398-412. , Aug 1; 
Lindquist, D.H., Sokoloff, G., Milner, E., Steinmetz, J.E., Neonatal ethanol exposure results in dose-dependent impairments in the acquisition and timing of the conditioned eye blink response and altered cerebellar interpositus nucleus and hippocampal CA1 unit activity in adult rats (2013) Alcohol, 47 (6), pp. 447-457. , Sep 1; 
Servais, L., Bearzatto, B., Delvaux, V., Noël, E., Leach, R., Brasseur, M., Schiffmann, S.N., Guy, C., Effect of chronic ethanol ingestion on Purkinje and Golgi cell firing in vivo and on motor coordination in mice (2005) Brain research, 1055 (1-2), pp. 171-179. , Sep 7; 
Diwadkar, V.A., Meintjes, E.M., Goradia, D., Dodge, N.C., Warton, C., Molteno, C.D., Jacobson, S.W., Jacobson, J.L., Differences in corticostriatal-cerebellar activation during working memory in syndromal and nonsyndromal children with prenatal alcohol exposure (2013) Human brain mapping, 34 (8), pp. 1931-1945. , Aug 1; 
Parks, M.H., Morgan, V.L., Pickens, D.R., Price, R.R., Dietrich, M.S., Nickel, M.K., Martin, P.R., Brain fMRI activation associated with self-paced finger tapping in chronic alcohol-dependent patients (2003) Alcoholism: Clinical and Experimental Research, 27 (4), pp. 704-711. , Apr 1; 
du Plessis, L., Jacobson, S.W., Molteno, C.D., Robertson, F.C., Peterson, B.S., Jacobson, J.L., Meintjes, E.M., Neural correlates of cerebellar-mediated timing during finger tapping in children with fetal alcohol spectrum disorders (2015) Neuro Image: Clinical, 7, pp. 562-570. , Jan 1; 
Victor, M., Adams, R.D., Mancall, E.L., A restricted form of cerebellar cortical degeneration occurring in alcoholic patients (1959) AMA Archives of Neurology, 1 (6), pp. 579-688. , Dec 1; 
Dikranian, K., Qin, Y.Q., Labruyere, J., Nemmers, B., Olney, J.W., Ethanol-induced neuroapoptosis in the developing rodent cerebellum and related brain stem structures (2005) Developmental Brain Research, 155 (1), pp. 1-3. , Mar 22; 
Paula-barbosa, M.M., Tavares, M.A., Long term alcohol consumption induces microtubular changes in the adult rat cerebellar cortex (1985) Brain research, 339 (1), pp. 195-199. , Jul 22; 
Tavares, M.A., Paula-barbosa, M.M., Gray, E.G., A morphometric Golgi analysis of the Purkinje cell dendritic tree after long-term alcohol consumption in the adult rat (1983) Journal of neurocytology, 12 (6), pp. 939-948. , Dec 1; 
Tavares, M.A., Paula-barbosa, M.M., Cadete-leite, A., Morphological evidence of climbing fiber plasticity after long-term alcohol intake (1986) Neurobehavioral toxicology and teratology, 8 (5), pp. 481-485; 
Sullivan, E.V., Deshmukh, A., Desmond, J.E., Mathalon, D.H., Rosenbloom, M.J., Lim, K.O., Pfefferbaum, A., Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia (2000) Archives of general psychiatry, 57 (9), pp. 894-902. , Sep 1; 
Spottiswoode, B.S., Meintjes, E.M., Anderson, A.W., Molteno, C.D., Stanton, M.E., Dodge, N.C., Gore, J.C., Jacobson, S.W., Diffusion tensor imaging of the cerebellum and eye blink conditioning in fetal alcohol spectrum disorder (2011) Alcoholism: Clinical and Experimental Research, 35 (12), pp. 2174-2183. , Dec 1; 
Mattson, S.N., Riley, E.P., Jernigan, T.L., Garcia, A., Kaneko, W.M., Ehlers, C.L., Jones, K.L., A decrease in the size of the basal ganglia following prenatal alcohol exposure: A preliminary report (1994) Neurotoxicology and teratology, 16 (3), pp. 283-289. , May 1; 
Chanraud, S., Reynaud, M., Wessa, M., Penttilä, J., Kostogianni, N., Cachia, A., Artiges, E., Cointepas, Y., Diffusion tensor tractography in mesencephalic bundles: Relation to mental flexibility in detoxified alcohol-dependent subjects (2009) Neuro-psychopharmacology, 34 (5), p. 1223. , Apr; 
Autti-rämö, I., Autti, T., Korkman, M., Kettunen, S., Salonen, O., Valanne, L., MRI findings in children with school problems who had been exposed prenatally to alcohol (2002) Developmental medicine and child neurology, 44 (2), pp. 98-106. , Feb; 
Cheng, D.T., Jacobson, S.W., Jacobson, J.L., Molteno, C.D., Stanton, M.E., Desmond, J.E., Eyeblink classical conditioning in alcoholism and fetal alcohol spectrum disorders (2015) Frontiers in psychiatry, 6, p. 155. , Nov 2; 
Oomah, B.D., Busson, M., Godfrey, D.V., Drover, J.C., Characteristics of hemp (Cannabis sativa L.) seed oil (2002) Food chemistry, 76 (1), pp. 33-43. , Jan 1; 
Casu, M.A., Pisu, C., Sanna, A., Tambaro, S., Spada, G.P., Mongeau, R., Pani, L., Effect of P9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: An immunohistochemical study (2005) Brain research, 1048 (1-2), pp. 41-47. , Jun 28; 
Viganò, D., Cascio, M.G., Rubino, T., Fezza, F., Vaccani, A., Di Marzo, V., Parolaro, D., Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain (2003) Neuropsychopharmacology, 28 (6), p. 1160. , Jun; 
Vinod, K.Y., Yalamanchili, R., Xie, S., Cooper, T.B., Hungund, B.L., Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system (2006) Neurochemistry international, 49 (6), pp. 619-625. , Nov 1; 
Basavarajappa, B.S., Hungund, B.L., Role of the endocannabinoid system in the development of tolerance to alcohol (2004) Alcohol and alcoholism, 40 (1), pp. 15-24. , Nov 18; 
Cousijn, J., Wiers, R.W., Ridderinkhof, K.R., van den Brink, W., Veltman, D.J., Goudriaan, A.E., Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls (2012) Neuroimage, 59 (4), pp. 3845-3851. , Feb 15; 
Sim, M.E., Lyoo, I.K., Streeter, C.C., Covell, J., Sarid-segal, O., Ciraulo, D.A., Kim, M.J., Renshaw, P.F., Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects (2007) Neuropsychopharmacology, 32 (10), p. 2229. , Oct; 
Barrós-loscertales, A., Garavan, H., Bustamante, J.C., Ventura-campos, N., Llopis, J.J., Belloch, V., Parcet, M.A., Ávila, C., Reduced striatal volume in cocaine-dependent patients (2011) Neuroimage, 56 (3), pp. 1021-1026. , Jun 1; 
Schmahmann, J.D., Sherman, J.C., The cerebellar cognitive affective syndrome (1998) Brain: A journal of neurology, 121 (4), pp. 561-579. , Apr 1; 
Kalivas, P.W., Volkow, N.D., The neural basis of addiction: A pathology of motivation and choice (2005) American Journal of Psychiatry, 162 (8), pp. 1403-1413. , Aug 1; 
Vazquez-sanroman, D., Carbo-gas, M., Leto, K., Cerezo-garcia, M., Gil-miravet, I., Sanchis-segura, C., Carulli, D., Miquel, M., Cocaine-induced plasticity in the cerebellum of sensitised mice (2015) Psychopharmacology, 232 (24), pp. 4455-4467. , Dec 1; 
Schadrack, J., Willoch, F., Platzer, S., Bartenstein, P., Mahal, B., Dworzak, D., Wester, H.J., Tölle, T.R., Opioid receptors in the human cerebellum: Evidence from [11C] diprenorphine PET, mRNA expression and autoradiography (1999) Neuroreport, 10 (3), pp. 619-624. , Feb 25; 
Walhovd, K.B., Moe, V., Slinning, K., Due-tønnessen, P., Bjørnerud, A., Dale, A.M., Van der Kouwe, A., Fischl, B., Volumetric cerebral characteristics of children exposed to opiates and other substances in utero (2007) Neuroimage, 36 (4), pp. 1331-1344. , Jul 15; 
Bora, E., Yücel, M., Fornito, A., Pantelis, C., Harrison, B.J., Cocchi, L., Pell, G., Lubman, D.I., White matter microstructure in opiate addiction (2012) Addiction biology, 17 (1), pp. 141-148. , Jan 1; 
Saal, D., Dong, Y., Bonci, A., Malenka, R.C., Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons (2003) Neuron, 37 (4), pp. 577-582. , Feb 20; 
Brown, L.F., Kroenke, K., Theobald, D.E., Wu, J., Tu, W., The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain (2010) Psycho-Oncology, 19 (7), pp. 734-741. , Jul 1; 
Nugent, F.S., Penick, E.C., Kauer, J.A., Opioids block long-term potentiation of inhibitory synapses (2007) Nature, 446 (7139), p. 1086. , Apr; 
Nugent, F.S., Niehaus, J.L., Kauer, J.A., PKG and PKA signaling in LTP at GABAergic synapses (2009) Neuropsychopharmacology, 34 (7), p. 1829. , Jun; 
Wang, G.J., Volkow, N.D., Logan, J., Pappas, N.R., Wong, C.T., Zhu, W., Netusll, N., Fowler, J.S., Brain dopamine and obesity (2001) The Lancet, 357 (9253), pp. 354-357. , Feb 3; 
Melchitzky, D.S., Lewis, D.A., Tyrosine hydroxylase- and dopamine transporter-immunoreactive axons in the primate cerebellum (2000) Neuropsychopharmacology, 22 (5), p. 466. , May; 
Klitenick, M.A., Tham, C.S., Fibiger, H.C., Cocaine and d-amphetamine increase c-fos expression in the rat cerebellum (1995) Synapse, 19 (1), pp. 29-36. , Jan 1; 
Carlezon, W.A., Jr., Nestler, E., Elevated levels of GluR1 in the midbrain: A trigger for sensitization to drugs of abuse? (2002) Trends in neurosciences, 25 (12), pp. 610-615. , Dec 1; 
Berridge, K.C., Robinson, T.E., Liking, wanting, and the incentive-sensitization theory of addiction (2016) American Psychologist, 71 (8), p. 670. , Nov; 
Robinson, T.E., Berridge, K.C., The psychology and neurobiology of addiction: An incentive-sensitization view (2000) Addiction, 95 (8), pp. 91-117. , Aug 1; 
Everitt, B.J., Robbins, T.W., Neural systems of reinforcement for drug addiction: From actions to habits to compulsion (2005) Nature neuroscience, 8 (11), p. 1481. , Nov; 
Vezina, P., Sensitization of midbrain dopamine neuron reactivity and the self-administration of psychomotor stimulant drugs (2004) Neuroscience & Biobehavioral Reviews, 27 (8), pp. 827-839. , Jan 1; 
De Fonseca, F.R., Gorriti, M.A., Fernandez-ruiz, J.J., Palomo, T., Ramos, J.A., Downregulation of rat brain cannabinoid binding sites after chronic R9-tetrahydrocannabinol treatment (1994) Pharmacology Bio-chemistry and Behavior, 47 (1), pp. 33-40. , Jan 1; 
Miquel, M., Font, L., Sanchis-segura, C., Aragon, C.M., Neonatal administration of monosodium glutamate prevents the development of ethanol-but not psychostimulant-induced sensitization: A putative role of the arcuate nucleus (2003) European Journal of Neuroscience, 17 (10), pp. 2163-2170. , May 1; 
Bhargava, H.N., Kumar, S., Sensitization to the locomotor stimulant effect of cocaine modifies the binding of [3H] MK-801 to brain regions and spinal cord of the mouse (1999) General Pharmacology: The Vascular System, 32 (3), pp. 359-363. , Mar 1; 
Couceyro, P., Pollock, K.M., Drews, K., Douglass, J., Cocaine differentially regulates activator protein-1 mRNA levels and DNA- binding complexes in the rat striatum and cerebellum (1994) Molecular pharmacology, 46 (4), pp. 667-676. , Oct 1; 
Barik, S., de Beaurepaire, R., Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat (2005) Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29 (5), pp. 718-726. , Jun 1; 
Lou, M., Wang, E., Shen, Y., Wang, J., Cue-elicited craving in heroin addicts at different abstinent time: An fMRI pilot study (2012) Substance use & misuse, 47 (6), pp. 631-639. , Apr 17; 
Schneider, F., Habel, U., Wagner, M., Franke, P., Salloum, J.B., Shah, N.J., Toni, I., Gaebel, W., Subcortical correlates of craving in recently abstinent alcoholic patients (2001) American Journal of Psychiatry, 158 (7), pp. 1075-1083. , Jul 1; 
Sell, L.A., Morris, J.S., Bearn, J., Frackowiak, R.S., Friston, K.J., Dolan, R.J., Neural responses associated with cue evoked emotional states and heroin in opiate addicts (2000) Drug & Alcohol Dependence, 60 (2), pp. 207-216. , Aug 1; 
Kilts, C.D., Schweitzer, J.B., Quinn, C.K., Gross, R.E., Faber, T.L., Muhammad, F., Ely, T.D., Drexler, K.P., Neural activity related to drug craving in cocaine addiction (2001) Archives of general psychiatry, 58 (4), pp. 334-341. , Apr 1; 
Volkow, N.D., Wang, G.J., Ma, Y., Fowler, J.S., Zhu, W., Maynard, L., Telang, F., Swanson, J.M., Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers (2003) Journal of neuroscience, 23 (36), pp. 11461-11468. , Dec 10; 
Dum, R.P., Strick, P.L., An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex (2003) Journal of neurophysiology, 89 (1), pp. 634-639. , Jan 1; 
Berlin, H.A., Rolls, E.T., Kischka, U., Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions (2004) Brain, 127 (5), pp. 1108-1126. , May 1; 
Anand, B.K., Malhotra, C.L., Singh, B., Dua, S., Cerebellar projections to limbic system (1959) Journal of neurophysiology, 22 (4), pp. 451-457. , Jul 1; 
Snider, R.S., Maiti, A., Cerebellar contributions to the Papez circuit (1976) Journal of neuroscience research, 2 (2), pp. 133-146. , Jan 1; 
Marcinkiewicz, M., Morcos, R., Chretien, M.C., CNS connections with the median raphe nucleus: Retrograde tracing with WGA-apoHRP- gold complex in the rat (1989) Journal of Comparative Neurology, 289 (1), pp. 11-35. , Nov 1; 
Paradiso, S., Robinson, R.G., Boles Ponto, L.L., Watkins, G.L., Hichwa, R.D., Regional cerebral blood flow changes during visually induced subjective sadness in healthy elderly persons (2003) The Journal of neuropsychiatry and clinical neurosciences, 15 (1), pp. 35-44. , Feb; 
Goel, V., Dolan, R.J., The functional anatomy of humor: Segregating cognitive and affective components (2001) Nature neuroscience, 4 (3), p. 237. , Mar; 
Schmahmann, J.D., Caplan, D., Cognition, emotion and the cerebellum (2006) Brain, 129 (2), pp. 290-292. , Feb 1; 
Grant, S., London, E.D., Newlin, D.B., Villemagne, V.L., Liu, X., Contoreggi, C., Phillips, R.L., Margolin, A., Activation of memory circuits during cue-elicited cocaine craving (1996) Proceedings of the National Academy of Sciences, 93 (21), pp. 12040-12045. , Oct 15; 
Bonson, K.R., Grant, S.J., Contoreggi, C.S., Links, J.M., Metcalfe, J., Weyl, H.L., Kurian, V., London, E.D., Neural systems and cue-induced cocaine craving (2002) Neuropsychopharmacology, 26 (3), p. 376. , Mar; 
Duvauchelle, C.L., Ikegami, A., Asami, S., Robens, J., Kressin, K., Castaneda, E., Effects of cocaine context on NAcc dopamine and behavioral activity after repeated intravenous cocaine administration (2000) Brain research, 862 (1-2), pp. 49-58. , Apr 17; 
Hemby, S.E., Koves, T.R., Smith, J.E., Dworkin, S.I., Differences in extracellular dopamine concentrations in the nucleus accumbens during response-dependent and response-independent cocaine administration in the rat (1997) Psychopharmacology, 133 (1), pp. 7-16. , Sep 1; 
Hubert, V., Beaunieux, H., Chételat, G., Platel, H., Landeau, B., Danion, J.M., Viader, F., Eustache, F., The dynamic network subserving the three phases of cognitive procedural learning (2007) Human brain mapping, 28 (12), pp. 1415-1429. , Dec; 
Fliessbach, K., Trautner, P., Quesada, C.M., Elger, C.E., Weber, B., Cerebellar contributions to episodic memory encoding as revealed by fMRI (2007) Neuroimage, 35 (3), pp. 1330-1337. , Apr 15; 
Snider, R.S., Maiti, A., Snider, S.R., Cerebellar pathways to ventral midbrain and nigra (1976) Experimental neurology, 53 (3), pp. 714-728. , Dec 1; 
Schweighofer, N., Doya, K., Kuroda, S., Cerebellar aminergic neuromodulation: Towards a functional understanding (2004) Brain Research Reviews, 44 (2-3), pp. 103-116. , Mar 1; 
Buck, R., The biological affects: A typology (1999) Psychological review, 106 (2), p. 301. , Apr; 
Papez, J.W., A proposed mechanism of emotion (1937) Archives of Neurology & Psychiatry, 38 (4), pp. 725-743. , Oct 1; 
Frijda, N.H., (1986) The emotions, , Cambridge University Press; 
Jentsch, J.D., Taylor, J.R., Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli (1999) Psychopharmacology, 146 (4), pp. 373-390. , Oct 1; 
Bechara, A., Decision making, impulse control and loss of willpower to resist drugs: A neurocognitive perspective (2005) Nature neuroscience, 8 (11), p. 1458. , Nov; 
Volkow, N.D., Fowler, J.S., Wang, G.J., The addicted human brain viewed in the light of imaging studies: Brain circuits and treatment strategies (2004) Neuropharmacology, 47, pp. 3-13. , Jan 1; 
Montague, P.R., Hyman, S.E., Cohen, J.D., Computational roles for dopamine in behavioural control (2004) Nature, 431 (7010), p. 760. , Oct 13; 
Goldstein, R.Z., Volkow, N.D., Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications (2011) Nature reviews neuroscience, 12 (11), p. 652. , Nov; 
Strick, P.L., Dum, R.P., Fiez, J.A., Cerebellum and nonmotor function (2009) Annual review of neuroscience, 32, pp. 413-434. , Jul 21; 
Kelly, R.M., Strick, P.L., Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate (2003) Journal of neuroscience, 23 (23), pp. 8432-8444. , Sep 10; 
Ito, M., Control of mental activities by internal models in the cerebellum (2008) Nature Reviews Neuroscience, 9 (4), p. 304. , Apr; 
Hester, R., Garavan, H., Executive dysfunction in cocaine addiction: Evidence for discordant frontal, cingulate, and cerebellar activity (2004) Journal of Neuroscience, 24 (49), pp. 11017-11022. , Dec 8; 
Desmond, J.E., Chen, S.A., DeRosa, E., Pryor, M.R., Pfefferbaum, A., Sullivan, E.V., Increased frontocerebellar activation in alcoholics during verbal working memory: An fMRI study (2003) Neuroimage, 19 (4), pp. 1510-1520. , Aug 1; 
Bolla, K.I., Eldreth, D.A., Matochik, J.A., Cadet, J.L., Neural substrates of faulty decision-making in abstinent marijuana users (2005) Neuroimage, 26 (2), pp. 480-492. , Jun 1; 
Martin-sölch, C., Magyar, S., Künig, G., Missimer, J., Schultz, W., Leenders, K., Changes in brain activation associated with reward processing in smokers and nonsmokers (2001) Experimental Brain Research, 139 (3), pp. 278-286. , Aug 1
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85061180257&partnerID=40&md5=0700be21645e95ef9fff0489243ffdfa
ER  - 

TY  - JOUR
TI  - Opioid Discussion in the Twittersphere
T2  - Substance Use and Misuse
J2  - Subst. Use Misuse
VL  - 53
IS  - 13
SP  - 2132
EP  - 2139
PY  - 2018
DO  - 10.1080/10826084.2018.1458319
SN  - 10826084 (ISSN) 
AU  - Graves, R.L.
AU  - Tufts, C.
AU  - Meisel, Z.F.
AU  - Polsky, D.
AU  - Ungar, L.
AU  - Merchant, R.M.
AD  - Penn Medicine Center for Digital Health, University of Pennsylvania, Philadelphia, PA, United States
AD  - Department of Emergency Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
AD  - Department of Computer and Information Science, University of Pennsylvania, Philadelphia, PA, United States
AD  - Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, United States
AB  - Background: The rise in opioid use and overdose has increased the importance of improving data collection methods for the purpose of targeting resources to high-need populations and responding rapidly to emerging trends. Objective: To determine whether Twitter data could be used to identify geographic differences in opioid-related discussion and whether opioid topics were significantly correlated with opioid overdose death rate. Methods: We filtered approximately 10 billion tweets for keywords related to opioids between July 2009 and October 2015. The content of the messages was summarized into 50 topics generated using Latent Dirchlet Allocation, a machine learning analytic tool. The correlation between topic distribution and census region, census division, and opioid overdose death rate were quantified. Results: We evaluated a tweet cohort of 84,023 tweets from 72,211 unique users across the US. Unique opioid-related topics were significantly correlated with different Census Bureau divisions and with opioid overdose death rates at the state and county level. Drug-related crime, language of use, and online drug purchasing emerged as themes in various Census Bureau divisions. Drug-related crime, opioid-related news, and pop culture themes were significantly correlated with county-level opioid overdose death rates, and online drug purchasing was significantly correlated with state-level opioid overdoses. Conclusions: Regional differences in opioid-related topics reflect geographic variation in the content of Twitter discussion about opioids. Analysis of Twitter data also produced topics significantly correlated with opioid overdose death rates. Ongoing analysis of Twitter data could provide a means of identifying emerging trends related to opioids. © 2018, © 2018 Taylor & Francis Group, LLC.
KW  - Crime
KW  - opioids
KW  - overdose
KW  - social media
KW  - twitter
KW  - narcotic analgesic agent
KW  - cohort analysis
KW  - crime
KW  - cross-sectional study
KW  - drug overdose
KW  - epidemic
KW  - geography
KW  - human
KW  - interpersonal communication
KW  - mortality
KW  - opiate addiction
KW  - psychology
KW  - social media
KW  - United States
KW  - Analgesics, Opioid
KW  - Cohort Studies
KW  - Communication
KW  - Correlation of Data
KW  - Crime
KW  - Cross-Sectional Studies
KW  - Drug Overdose
KW  - Epidemics
KW  - Geography
KW  - Humans
KW  - Opioid-Related Disorders
KW  - Social Media
KW  - United States
PB  - Taylor and Francis Ltd
N1  - Cited By :2
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: SUMIF
C2  - 29659320
LA  - English
N1  - Correspondence Address: Graves, R.L.; Center for Emergency Care Research Policy, Blockley Hall 407, 423 Guardian Drive, University of PennsylvaniaUnited States; email: Gravesra@uphs.upenn.edu
N1  - Chemicals/CAS: Analgesics, Opioid
N1  - Funding details: Pennsylvania Department of Health, PDH
N1  - Funding text 1: This project is funded, in part, under a grant with the Pennsylvania Department of Health. The Department specifically disclaims responsibility for anyanalyses, interpretations or conclusions.
N1  - References: (2012) Proceeding of the system demonstrations, , http://www.anthology.aclweb.org/P/P12/P12-3.pdf#page=37, Retrieved from; 
Beletsky, L., Davis, C.S., Today's fentanyl crisis: Prohibition's Iron Law, revisited (2017) International Journal of Drug Policy, 46, pp. 156-159; 
Blanco, C., Alderson, D., Ogburn, E., Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991–1992 and 2001–2002 (2007) Drug and Alcohol Dependence, 90 (2-3), pp. 252-260. , et al; 
Blei, D.M., Franks, K., Jordan, M.I., Mian, I.S., Statistical modeling of biomedical corpora: Mining the Caenorhabditis Genetic Center Bibliography for genes related to life span (2006) BMC Bioinformatics, 7, p. 250; 
(2014) Opioid painkiller prescribing infographic, , https://www.cdc.gov/vitalsigns/opioid-prescribing/infographic.html, Retrieved from; 
(2016) Drug overdose death data, , https://www.cdc.gov/drugoverdose/data/statedeaths.html, Retrieved from; 
(2016) Prescribing data, , https://www.cdc.gov/drugoverdose/data/prescribing.html, Retrieved from; 
(2017) Wide-ranging online data for epidemiologic research (WONDER), , https://wonder.cdc.gov, Retrieved from; 
Deutsch, K., Fentanyl outpaces heroin as deadliest drug on Long Island (2016) New York Times, , https://www.nytimes.com/2016/12/28/nyregion/fentanyl-epidemic-long-island.html, Retrieved from; 
Dredze, M., Wood-Doughty, Z., Quinn, S.C., Broniatowski, D.A., Vaccine opponents' use of Twitter during the 2016 US presidential election: Implications for practice and policy (2017) Vaccine; 
Gabler, E., Harris, R., On Reddit, intimate glimpses of addicts in thrall to opioids (2017) New York Times, , https://www.nytimes.com/2017/07/20/us/opioid-reddit.html, Retrieved from; 
Gilson, A.M., Ryan, K.M., Joranson, D.E., Dahl, J.L., A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997–2002 (2004) Journal of Pain and Symptom Management, 28 (2), pp. 176-188; 
Glowacki, E.M., Glowacki, J.B., Wilcox, G.B., A text-mining analysis of the public's reactions to the opioid crisis (2017) Subt Abus, 19; 
Gruebner, O., Lowe, S.R., Sykora, M., Shankardass, K., Subramanian, S.V., Galea, S., A novel surveillance approach for disaster mental health (2017) PLoS One, 12 (7); 
Guntuju, S.C., Yaden, D.B., Kern, M.L., Ungar, L.H., Eichstaedt, J.C., Detecting depression and mental illness on social media: An integrative review (2017) Current Opinion in Behavioral Sciences, 18, pp. 43-49; 
Joranson, D.E., Ryan, K.M., Gilson, A.M., Dahl, J.L., Trends of medical use and abuse of opioid analgesics (2000) JAMA, 283 (13), pp. 1710-1714; 
Katz, J., Drug deaths in America are rising faster than ever (2017) New York Times, , https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html, Retrieved from; 
Keyes, K.M., Cerda, M., Brady, J.E., Havens, J.R., Galea, S., Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States (2014) AJPH, 104 (2), pp. e52-e59; 
Marques-Toledo, C.A., Degener, C.M., Vinhal, L., Coelho, G., Meira, W., Codeco, C.T., Teixeira, M.M., Dengue prediction by the web: Tweets are a useful tool for estimating and forecasting Dengue at county and city level (2017) PLOS Neglected Tropical Diseases, 11 (7), p. e0005729; 
Monroe, B.L., Colaresi, M.P., Quinn, K.M., Fightin' words: Lexical feature selection and evaluation for identifying the content of political conflict (2008) Political Analysis, 16 (4), pp. 372-403; 
(2016) Overview of state pain management and prescribing policies, , Charlottesville, VA: National Alliance for Model State Drug Laws; 
(2016) Compilation of prescription monitoring program maps, , Manchester, IA: National Alliance for Model State Drug Laws; 
(1987) Federal Information Processing Standards Publication 5-2, , Gaithersburg, MD: United States Department of Commerce; 
Paulozzi, L.J., Opioid analgesic involvement in drug abuse deaths in American metropolitan areas (2006) American Journal of Public Health, 96 (10), pp. 1755-1757; 
Paulozzi, J., Budnitz, D.S., Xi, Y., Increasing deaths from opioid analgesics in the United States (2006) Pharmacoepidemiology and Drug Safety, 15 (9), pp. 618-627; 
Paulozzi, L.J., Ryan, G.W., Opioid analgesics and rats of fatal drug poisoning in the United States (2006) American Journal of Preventive Medicine, 311 (6), pp. 506-511; 
Popper, N., Opioid dealers embrace the dark web to send deadly drugs by mail (2017) New York Times, , https://www.nytimes.com/2017/06/10/business/dealbook/opioid-dark-web-drug-overdose.html, Retrieved from; 
Schwartz, H.A., Eichstaedt, J.C., Kern, M.L., (2013) Characterizing geographic variation in well-being using tweets, , Boston, MA: Proceedings of the Seventh International AAAI Conference on Weblogs and Social Media (ICWSM), et al; 
Schwartz, H.A., Eichstaedt, J.C., Kern, M.L., Personality, gender, and age in the language of social media: The open-vocabulary approach (2013) PloS One, 8 (9). , et al; 
Seelye, K.Q., Heroin epidemic is yielding to deadlier cousin: Fentanyl (2016) New York Times, , https://www.nytimes.com/2016/03/26/us/heroin-fentanyl.html, Retrieved from; 
Sinnenberg, L., DiSilvestro, C.L., Mancheno, C., Twitter as a potential data source for cardiovascular disease research (2016) JAMA Cardiology, 1 (9), pp. 1032-1036. , et al; 
Slavova, S., Costich, J.F., Bunn, T.L., Heroin and fentanyl overdoses in Kentucky: Epidemiology and surveillance (2017) International Journal of Drug Policy, 46, pp. 120-129. , et al; 
Smith, R.J., Crutchley, P., Schwartz, H.A., Ungar, L., Shofer, F., Padrez, K.A., Merchant, R.M., Variations in Facebook posting patterns across validated patient health conditions: A prospective cohort study (2017) Journal of Medical Internet Research, 19 (1), p. e7; 
(2017) New user FAQs, , https://support.Twitter.com/articles/13920, Retrieved from; 
Unick, G.J., Ciccarone, D., US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations (2017) International Journal of Drug Policy, 46, pp. 112-119; 
Wong, C.A., Sap, M., Schwartz, A., Town, R., Baker, T., Ungar, L., Merchant, R.M., Twitter sentiment predicts Affordable Care Act marketplace enrollment (2015) Journal of Medical Internet Research, 17 (2), p. e51; 
Woo, H., Sung, C.H., Shim, E., Lee, J.K., Lee, K., Song, G., Cho, Y., Identification of keywords from Twitter and web blog posts to detect influence epidemics in Korea (2017) Disaster Medicine and Public Health Preparedness, 31, pp. 1-8; 
Zacny, J., Bigelow, G., Compton, P., Foley, K., Iguchi, M., Annerud, C., College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: Position statement (2003) Drug and Alcohol Dependence, 69 (3), pp. 215-232. , https://doi.org/10.1016/S0376-8716(03)00003-6
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045441436&doi=10.1080%2f10826084.2018.1458319&partnerID=40&md5=a0e2e2e989d1b998f7e0ee64ef433e66
ER  - 

TY  - JOUR
TI  - A computational strategy for finding novel targets and therapeutic compounds for opioid dependence
T2  - PLoS ONE
J2  - PLoS ONE
VL  - 13
IS  - 11
PY  - 2018
DO  - 10.1371/journal.pone.0207027
SN  - 19326203 (ISSN) 
AU  - Wu, X.
AU  - Xie, S.
AU  - Wang, L.
AU  - Fan, P.
AU  - Ge, S.
AU  - Xie, X.-Q.
AU  - Wu, W.
AD  - Computational Biology Department, School of Computer Science, Carnegie Mellon University, Pittsburgh, PA, United States
AD  - Department of Pharmaceutical Sciences and Computational Chemical Genomics Screening Center, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA, United States
AD  - Drug Discovery Institute, University of Pittsburgh, Pittsburgh, PA, United States
AD  - School of Information, Renmin University of China, Beijing, China
AD  - Department of Computational and Systems Biology, University of Pittsburgh, Pittsburgh, PA, United States
AD  - Department of Structural Biology, University of Pittsburgh, Pittsburgh, PA, United States
AB  - Opioids are widely used for treating different types of pains, but overuse and abuse of prescription opioids have led to opioid epidemic in the United States. Besides analgesic effects, chronic use of opioid can also cause tolerance, dependence, and even addiction. Effective treatment of opioid addiction remains a big challenge today. Studies on addictive effects of opioids focus on striatum, a main component in the brain responsible for drug dependence and addiction. Some transcription regulators have been associated with opioid addiction, but relationship between analgesic effects of opioids and dependence behaviors mediated by them at the molecular level has not been thoroughly investigated. In this paper, we developed a new computational strategy that identifies novel targets and potential therapeutic molecular compounds for opioid dependence and addiction. We employed several statistical and machine learning techniques and identified differentially expressed genes over time which were associated with dependence-related behaviors after exposure to either morphine or heroin, as well as potential transcription regulators that regulate these genes, using time course gene expression data from mouse striatum. Moreover, our findings revealed that some of these dependence-associated genes and transcription regulators are known to play key roles in opioid-mediated analgesia and tolerance, suggesting that an intricate relationship between opioid-induce pain-related pathways and dependence may develop at an early stage during opioid exposure. Finally, we determined small compounds that can potentially target the dependence-associated genes and transcription regulators. These compounds may facilitate development of effective therapy for opioid dependence and addiction. We also built a database (http://daportals.org) for all opioid-induced dependenceassociated genes and transcription regulators that we discovered, as well as the small compounds that target those genes and transcription regulators. © 2018 Wu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
KW  - benserazide
KW  - buspirone
KW  - calmidazolium
KW  - diamorphine
KW  - gabapentin
KW  - isocorydine
KW  - meclofenoxate
KW  - morphine
KW  - phenacetin
KW  - piperacetazine
KW  - prilocaine
KW  - procyclidine
KW  - regulator protein
KW  - securinine
KW  - spiradoline
KW  - diamorphine
KW  - morphine
KW  - narcotic analgesic agent
KW  - analgesia
KW  - Article
KW  - corpus striatum
KW  - drug effect
KW  - drug exposure
KW  - epigenetics
KW  - gene control
KW  - gene expression
KW  - gene identification
KW  - genetic transcription
KW  - heredity
KW  - human
KW  - immune response
KW  - machine learning
KW  - nonhuman
KW  - opiate addiction
KW  - statistical analysis
KW  - animal
KW  - drug therapy
KW  - gene expression regulation
KW  - gene ontology
KW  - immunology
KW  - machine learning
KW  - metabolism
KW  - molecular library
KW  - mouse
KW  - nerve cell
KW  - opiate addiction
KW  - pharmacology
KW  - Analgesics, Opioid
KW  - Animals
KW  - Corpus Striatum
KW  - Gene Expression Regulation
KW  - Gene Ontology
KW  - Heroin
KW  - Machine Learning
KW  - Mice
KW  - Morphine
KW  - Neurons
KW  - Opioid-Related Disorders
KW  - Small Molecule Libraries
PB  - Public Library of Science
N1  - Cited By :1
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C7  - e0207027
N1  - CODEN: POLNC
C2  - 30403753
LA  - English
N1  - Chemicals/CAS: benserazide, 14919-77-8, 322-35-0; buspirone, 33386-08-2, 36505-84-7; calmidazolium, 57265-65-3, 95013-41-5; diamorphine, 1502-95-0, 561-27-3; gabapentin, 60142-96-3; isocorydine, 475-67-2; meclofenoxate, 3685-84-5, 51-68-3; morphine, 52-26-6, 57-27-2; phenacetin, 62-44-2; piperacetazine, 3819-00-9; prilocaine, 1786-81-8, 721-50-6; procyclidine, 1508-76-5, 77-37-2; securinine, 5610-40-2, 7104-26-9; spiradoline, 87151-85-7; Analgesics, Opioid; Heroin; Morphine; Small Molecule Libraries
N1  - References: Pergolizzi, J., Boger, R.H., Budd, K., Dahan, A., Erdine, S., Hans, G., Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone) (2008) Pain Pract, 8 (4), pp. 287-313. , https://doi.org/10.1111/j.1533-2500.2008.00204.x, Epub 2008/05/28. PMID: 18503626; 
Brady, K.T., McCauley, J.L., Back, S.E., Prescription opioid misuse, abuse, and treatment in the United States: An Update (2016) Am J Psychiatry, 173 (1), pp. 18-26. , https://doi.org/10.1176/appi.ajp.2015.15020262, Epub 2015/09/05. PMID: 26337039; PubMed Central PMCID: PMCPMC4782928; 
Manchikanti, L., Helm, S., II, Fellows, B., Janata, J.W., Pampati, V., Grider, J.S., Opioid epidemic in the United States (2012) Pain Physician, 15 (3), pp. ES38-ES39. , Suppl):, Epub 2012/07/20. PMID: 22786464; 
Nutt, D., King, L.A., Saulsbury, W., Blakemore, C., Development of a rational scale to assess the harm of drugs of potential misuse (2007) Lancet, 369 (9566), pp. 1047-1053. , https://doi.org/10.1016/S0140-6736(07)60464-4, Epub 2007/03/27. PMID: 17382831; 
Ron, D., Jurd, R., The "ups and downs" of signaling cascades in addiction (2005) Sci STKE, 2005 (309), p. re14. , https://doi.org/10.1126/stke.3092005re14, Epub 2005/11/10. PMID: 16278489; 
Hutchinson, M.R., Shavit, Y., Grace, P.M., Rice, K.C., Maier, S.F., Watkins, L.R., Exploring the neuroimmunopharmacology of opioids: An integrative review of mechanisms of central immune signaling and their implications for opioid analgesia (2011) Pharmacol Rev, 63 (3), pp. 772-810. , https://doi.org/10.1124/pr.110.004135, Epub 2011/07/15. PMID: 21752874; PubMed Central PMCID: PMCPMC3141878; 
Robison, A.J., Nestler, E.J., Transcriptional and epigenetic mechanisms of addiction (2011) Nat Rev Neurosci, 12 (11), pp. 623-637. , https://doi.org/10.1038/nrn3111, Epub 2011/10/13. PMID: 21989194; PubMed Central PMCID: PMCPMC3272277; 
Yager, L.M., Garcia, A.F., Wunsch, A.M., Ferguson, S.M., The ins and outs of the striatum: Role in drug addiction (2015) Neuroscience, 301, pp. 529-541. , https://doi.org/10.1016/j.neuroscience.2015.06.033, Epub 2015/06/28. PMID: 26116518; PubMed Central PMCID: PMCPMC4523218; 
Everitt, B.J., Robbins, T.W., Neural systems of reinforcement for drug addiction: From actions to habits to compulsion (2005) Nat Neurosci, 8 (11), pp. 1481-1489. , https://doi.org/10.1038/nn1579, Epub 2005/10/28. PMID: 16251991; 
Badiani, A., Belin, D., Epstein, D., Calu, D., Shaham, Y., Opiate versus psychostimulant addiction: The differences do matter (2011) Nat Rev Neurosci, 12 (11), pp. 685-700. , https://doi.org/10.1038/nrn3104, Epub 2011/10/06. PMID: 21971065; PubMed Central PMCID: PMCPMC3721140; 
Steidl, S., Wasserman, D.I., Blaha, C.D., Yeomans, J.S., Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons (2017) Neurosci Biobehav Rev, 83, pp. 72-82. , https://doi.org/10.1016/j.neubiorev.2017.09.022, Epub 2017/09/28. PMID: 28951251; PubMed Central PMCID: PMCPMC5730464; 
Gysling, K., Wang, R.Y., Morphine-induced activation of A10 dopamine neurons in the rat (1983) Brain Res, 277 (1), pp. 119-127. , Epub 1983/10/24. PMID: 6315137; 
Johnson, S.W., North, R.A., Opioids excite dopamine neurons by hyperpolarization of local interneurons (1992) J Neurosci, 12 (2), pp. 483-488. , Epub 1992/02/01. PMID: 1346804; 
Klitenick, M.A., DeWitte, P., Kalivas, P.W., Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: An in vivo microdialysis study (1992) J Neurosci, 12 (7), pp. 2623-2632. , Epub 1992/07/01. PMID: 1319478; 
Margolis, E.B., Hjelmstad, G.O., Fujita, W., Fields, H.L., Direct bidirectional mu-opioid control of midbrain dopamine neurons (2014) J Neurosci, 34 (44), pp. 14707-14716. , https://doi.org/10.1523/JNEUROSCI.2144-14.2014, Epub 2014/10/31. PMID: 25355223; PubMed Central PMCID: PMCPMC4212068; 
Matthews, R.T., German, D.C., Electrophysiological evidence for excitation of rat ventral tegmental area dopamine neurons by morphine (1984) Neuroscience, 11 (3), pp. 617-625. , Epub 1984/03/01. PMID: 6717805; 
Russo, S.J., Dietz, D.M., Dumitriu, D., Morrison, J.H., Malenka, R.C., Nestler, E.J., The addicted synapse: Mechanisms of synaptic and structural plasticity in nucleus accumbens (2010) Trends Neurosci, 33 (6), pp. 267-276. , https://doi.org/10.1016/j.tins.2010.02.002, Epub 2010/03/09.PMID: 20207024; PubMed Central PMCID: PMCPMC2891948; 
Kosten, T.A., Kosten, T.R., Pharmacological blocking agents for treating substance abuse (1991) J Nerv Ment Dis, 179 (10), pp. 583-592. , Epub 1991/10/01. PMID: 1919542; 
Soyka, M., Mutschler, J., Treatment-refractory substance use disorder: Focus on alcohol, opioids, and cocaine (2016) Prog Neuropsychopharmacol Biol Psychiatry, 70, pp. 148-161. , https://doi.org/10.1016/j.pnpbp.2015.11.003, Epub 2015/11/19.PMID: 26577297; 
Bailey, C.P., Husbands, S.M., Novel approaches for the treatment of psychostimulant and opioid abuse- focus on opioid receptor-based therapies (2014) Expert Opin Drug Discov, 9 (11), pp. 1333-1344. , https://doi.org/10.1517/17460441.2014.964203, Epub 2014/09/26. PMID: 25253272; PubMed Central PMCID: PMCPMC4587358; 
Jacobsen, J.H., Hutchinson, M.R., Mustafa, S., Drug addiction: Targeting dynamic neuroimmune receptor interactions as a potential therapeutic strategy (2016) Curr Opin Pharmacol, 26, pp. 131-137. , https://doi.org/10.1016/j.coph.2015.10.010, Epub 2015/12/15. PMID: 26657076; 
Melik, P.S., Rivat, C., Rostene, W., Reaux-Le, G.A., Opioid and chemokine receptor crosstalk: A promising target for pain therapy? (2015) Nat Rev Neurosci, 16 (2), pp. 69-78. , https://doi.org/10.1038/nrn3858, Epub 2015/01/16. PMID: 25588373; 
Nutt, D.J., Lingford-Hughes, A., Erritzoe, D., Stokes, P.R., The dopamine theory of addiction: 40 years of highs and lows (2015) Nat Rev Neurosci, 16 (5), pp. 305-312. , https://doi.org/10.1038/nrn3939, Epub 2015/04/16.PMID: 25873042; 
Piechota, M., Korostynski, M., Solecki, W., Gieryk, A., Slezak, M., Bilecki, W., The dissection of transcriptional modules regulated by various drugs of abuse in the mouse striatum (2010) Genome Biol, 11 (5), p. R48. , https://doi.org/10.1186/gb-2010-11-5-r48, Epub 2010/05/13. PMID: 20459597; PubMed Central PMCID: PMCPMC2898085; 
Tanga, F.Y., Raghavendra, V., DeLeo, J.A., Quantitative real-time RT-PCR assessment of spinal microglial and astrocytic activation markers in a rat model of neuropathic pain (2004) Neurochem Int, 45 (2-3), pp. 397-407. , https://doi.org/10.1016/j.neuint.2003.06.002, Epub 2004/05/18, PMID: 15145554; 
Tanga, F.Y., Nutile-McMenemy, N., DeLeo, J.A., The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy (2005) Proc Natl Acad Sci U S A, 102 (16), pp. 5856-5861. , https://doi.org/10.1073/pnas.0501634102, Epub 2005/04/06. PMID: 15809417; PubMed Central PMCID: PMCPMC556308; 
Vabulas, R.M., Ahmad-Nejad, P., Ghose, S., Kirschning, C.J., Issels, R.D., Wagner, H., HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway (2002) J Biol Chem, 277 (17), pp. 15107-15112. , https://doi.org/10.1074/jbc.M111204200, Epub 2002/02/14. PMID: 11842086; 
Tsan, M.F., Gao, B., Cytokine function of heat shock proteins (2004) Am J Physiol Cell Physiol, 286 (4), pp. C739-C744. , https://doi.org/10.1152/ajpcell.00364.2003, Epub 2004/03/06. PMID: 15001423; 
Ndengele, M.M., Cuzzocrea, S., Masini, E., Vinci, M.C., Esposito, E., Muscoli, C., Spinal ceramide modulates the development of morphine antinociceptive tolerance via peroxynitrite-mediated nitroxidative stress and neuroimmune activation (2009) J Pharmacol Exp Ther, 329 (1), pp. 64-75. , https://doi.org/10.1124/jpet.108.146290, Epub 2008/11/27. PMID: 19033555; PubMed Central PMCID: PMCPMC2670603; 
Buchanan, M.M., Hutchinson, M., Watkins, L.R., Yin, H., Toll-like receptor 4 in CNS pathologies (2010) J Neurochem, 114 (1), pp. 13-27. , https://doi.org/10.1111/j.1471-4159.2010.06736.x, Epub 2010/04/21. PMID: 20402965; PubMed Central PMCID: PMCPMC2909662; 
Perry, V.H., Hume, D.A., Gordon, S., Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain (1985) Neuroscience, 15 (2), pp. 313-326. , Epub 1985/06/01. PMID: 3895031; 
Grace, P.M., Hutchinson, M.R., Maier, S.F., Watkins, L.R., Pathological pain and the neuroimmune interface (2014) Nat Rev Immunol, 14 (4), pp. 217-231. , https://doi.org/10.1038/nri3621, Epub 2014/03/01. PMID: 24577438; PubMed Central PMCID: PMCPMC5525062; 
Guegan, T., Cebria, J.P., Maldonado, R., Martin, M., Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity (2016) Addict Biol, 21 (6), pp. 1113-1126. , https://doi.org/10.1111/adb.12281, Epub 2016/10/26. PMID: 26179931; 
Suarez-Roca, H., Abdullah, L., Zuniga, J., Madison, S., Maixner, W., Multiphasic effect of morphine on the release of substance P from rat trigeminal nucleus slices (1992) Brain Res, 579 (2), pp. 187-194. , Epub 1992/05/08. PMID: 1378346; 
Glaum, S.R., Miller, R.J., Hammond, D.L., Inhibitory actions of delta 1-, delta 2-, and mu-opioid receptor agonists on excitatory transmission in lamina II neurons of adult rat spinal cord (1994) J Neurosci, 14 (8), pp. 4965-4971. , Epub 1994/08/01. PMID: 8046463; 
Grudt, T.J., Williams, J.T., Mu-Opioid agonists inhibit spinal trigeminal substantia gelatinosa neurons in Guinea pig and rat (1994) J Neurosci, 14 (3), pp. 1646-1654. , Epub 1994/03/01. PMID: 8126561; 
Stellwagen, D., Beattie, E.C., Seo, J.Y., Malenka, R.C., Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha (2005) J Neurosci, 25 (12), pp. 3219-3228. , https://doi.org/10.1523/JNEUROSCI.4486-04.2005, Epub 2005/03/25. PMID: 15788779; 
Raghavendra, V., Rutkowski, M.D., DeLeo, J.A., The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats (2002) J Neurosci, 22 (22), pp. 9980-9989. , Epub 2002/11/13. PMID: 12427855; 
Zhang, N., Rogers, T.J., Caterina, M., Oppenheim, J.J., Proinflammatory chemokines, such as C-C chemokine ligand 3, desensitize mu-opioid receptors on dorsal root ganglia neurons (2004) J Immunol, 173 (1), pp. 594-599. , Epub 2004/06/24. PMID: 15210821; 
Zhang, R.X., Li, A., Liu, B., Wang, L., Ren, K., Zhang, H., IL-1ra alleviates inflammatory hyperalgesia through preventing phosphorylation of NMDA receptor NR-1 subunit in rats (2008) Pain, 135 (3), pp. 232-239. , https://doi.org/10.1016/j.pain.2007.05.023, Epub 2007/08/11. PMID: 17689191; PubMed Central PMCID: PMCPMC2323207; 
Iwasaki, A., Medzhitov, R., Toll-like receptor control of the adaptive immune responses (2004) Nat Immunol, 5 (10), pp. 987-995. , https://doi.org/10.1038/ni1112, Epub 2004/09/30. PMID: 15454922; 
Hong, J., Cho, I.H., Kwak, K.I., Suh, E.C., Seo, J., Min, H.J., Microglial Toll-like receptor 2 contributes to kainic acid-induced glial activation and hippocampal neuronal cell death (2010) J Biol Chem, 285 (50), pp. 39447-39457. , https://doi.org/10.1074/jbc.M110.132522, Epub 2010/10/07.PMID: 20923777; PubMed Central PMCID: PMCPMC2998094; 
Maze, I., Covington, H.E., III, Dietz, D.M., LaPlant, Q., Renthal, W., Russo, S.J., Essential role of the histone methyltransferase G9a in cocaine-induced plasticity (2010) Science, 327 (5962), pp. 213-216. , https://doi.org/10.1126/science.1179438, Epub 2010/01/09. PMID: 20056891; PubMed Central PMCID: PMCPMC2820240; 
Auerbach, R.K., Chen, B., Butte, A.J., Relating genes to function: Identifying enriched transcription factors using the ENCODE ChIP-Seq significance tool (2013) Bioinformatics, 29 (15), pp. 1922-1924. , https://doi.org/10.1093/bioinformatics/btt316, Epub 2013/06/05. PMID: 23732275; PubMed Central PMCID: PMCPMC3712221; 
Blattler, A., Yao, L., Wang, Y., Ye, Z., Jin, V.X., Farnham, P.J., ZBTB33 binds unmethylated regions of the genome associated with actively expressed genes (2013) Epigenetics Chromatin, 6 (1), p. 13. , https://doi.org/10.1186/1756-8935-6-13, Epub 2013/05/23. PMID: 23693142; PubMed Central PMCID: PMCPMC3663758; 
Mulligan, M.K., Wang, X., Adler, A.L., Mozhui, K., Lu, L., Williams, R.W., Complex control of GABA(A) receptor subunit mRNA expression: Variation, covariation, and genetic regulation (2012) PLoS One, 7 (4), p. e34586. , https://doi.org/10.1371/journal.pone.0034586, Epub 2012/04/17. PMID: 22506031; PubMed Central PMCID: PMCPMC3323555; 
Godino, A., Jayanthi, S., Cadet, J.L., Epigenetic landscape of amphetamine and methamphetamine addiction in rodents (2015) Epigenetics, 10 (7), pp. 574-580. , https://doi.org/10.1080/15592294.2015.1055441, Epub 2015/05/30. PMID: 26023847; PubMed Central PMCID: PMCPMC4622560; 
Popovic, R., Martinez-Garcia, E., Giannopoulou, E.G., Zhang, Q., Zhang, Q., Ezponda, T., Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation (2014) PLoS Genet, 10 (9), p. e1004566. , https://doi.org/10.1371/journal.pgen.1004566, Epub 2014/09/05.PMID: 25188243; PubMed Central PMCID: PMCPMC4154646; 
Cao, R., Zhang, Y., SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex (2004) Mol Cell, 15 (1), pp. 57-67. , https://doi.org/10.1016/j.molcel.2004.06.020, Epub 2004/07/01.PMID: 15225548; 
Schoofs, T., Rohde, C., Hebestreit, K., Klein, H.U., Gollner, S., Schulze, I., DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding (2013) Blood, 121 (1), pp. 178-187. , https://doi.org/10.1182/blood-2012-08-448860, Epub 2012/11/16, PMID: 23152544; 
Higgins, G.A., Allyn-Feuer, A., Athey, B.D., Epigenomic mapping and effect sizes of noncoding variants associated with psychotropic drug response (2015) Pharmacogenomics, 16 (14), pp. 1565-1583. , https://doi.org/10.2217/pgs.15.105, Epub 2015/09/05. PMID: 26340055; 
Guelen, L., Pagie, L., Brasset, E., Meuleman, W., Faza, M.B., Talhout, W., Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions (2008) Nature, 453 (7197), pp. 948-951. , https://doi.org/10.1038/nature06947, Epub 2008/05/09. PMID: 18463634; 
Asensio-Juan, E., Gallego, C., Martinez-Balbas, M.A., The histone demethylase PHF8 is essential for cytoskeleton dynamics (2012) Nucleic Acids Res, 40 (19), pp. 9429-9440. , https://doi.org/10.1093/nar/gks716, Epub 2012/08/02. PMID: 22850744; PubMed Central PMCID: PMCPMC3479184; 
Stowe, G.N., Schlosburg, J.E., Vendruscolo, L.F., Edwards, S., Misra, K.K., Schulteis, G., Developing a vaccine against multiple psychoactive targets: A case study of heroin (2011) CNS Neurol Disord Drug Targets, 10 (8), pp. 865-875. , Epub 2012/01/11. PMID: 22229311; PubMed Central PMCID: PMCPMC3327724; 
Andersen, J.M., Ripel, A., Boix, F., Normann, P.T., Morland, J., Increased locomotor activity induced by heroin in mice: Pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo (2009) J Pharmacol Exp Ther, 331 (1), pp. 153-161. , https://doi.org/10.1124/jpet.109.152462, Epub 2009/06/23. PMID: 19541908; 
Oldendorf, W.H., Hyman, S., Braun, L., Oldendorf, S.Z., Blood-brain barrier: Penetration of morphine, codeine, heroin, and methadone after carotid injection (1972) Science, 178 (4064), pp. 984-986. , Epub 1972/12/01. PMID: 5084666; 
Loader, C., (1999) Local Regression and Likelihood, 13, p. 290. , New York: Springer, p; 
Wu, W., Dave, N.B., Yu, G., Strollo, P.J., Kovkarova-Naumovski, E., Ryter, S.W., Network analysis of temporal effects of intermittent and sustained hypoxia on rat lungs (2008) Physiol Genomics, 36 (1), pp. 24-34. , https://doi.org/10.1152/physiolgenomics.00258.2007, Epub 2008/10/02. PMID: 18826996; PubMed Central PMCID: PMCPMC2604785; 
Sun, J.Y., Loader, C.R., Simultaneous confidence bands for linear-regression and smoothing (1994) Ann Stat, 22 (3), pp. 1328-1345. , https://doi.org/10.1214/aos/1176325631, PubMed PMID: WOS: A1994QJ59900012; 
Hartigan, J., Wong, M., A K-Means clustering algorithm (1979) Journal of the Royal Statistical Society Series C (Applied Statistics), 28 (1), pp. 100-108; 
Wu, W., Bleecker, E., Moore, W., Busse, W.W., Castro, M., Chung, K.F., Unsupervised phenotyping of severe asthma research program participants using expanded lung data (2014) J Allergy Clin Immun, 133 (5), pp. 1280-1288. , https://doi.org/10.1016/j.jaci.2013.11.042, PubMed PMID: WOS:000335450700007. PMID: 24589344; 
Falcon, S., Gentleman, R., Using GOstats to test gene lists for GO term association (2007) Bioinformatics, 23 (2), pp. 257-258. , https://doi.org/10.1093/bioinformatics/btl567, PubMed PMID: WOS:000243992400060. PMID: 17098774; 
Iorio, F., Rittman, T., Ge, H., Menden, M., Saez-Rodriguez, J., Transcriptional data: A new gateway to drug repositioning? (2013) Drug Discovery Today, 18 (7), pp. 350-357; 
Lamb, J., Crawford, E.D., Peck, D., Modell, J.W., Blat, I.C., Wrobel, M.J., The Connectivity Map: Using geneexpression signatures to connect small molecules, genes, and disease (2006) Science, 313 (5795), pp. 1929-1935. , https://doi.org/10.1126/science.1132939, PMID: 17008526; 
Lamb, J., The connectivity map: A new tool for biomedical research (2007) Nature Reviews Cancer, 7 (1), pp. 54-60. , https://doi.org/10.1038/nrc2044, PMID: 17186018; 
Kupershmidt, I., Su, Q.J., Grewal, A., Sundaresh, S., Halperin, I., Flynn, J., Ontology-based meta-analysis of global collections of high-throughput public data (2010) PloS One, 5 (9), p. e13066. , https://doi.org/10.1371/journal.pone.0013066, PMID: 20927376
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056397331&doi=10.1371%2fjournal.pone.0207027&partnerID=40&md5=48ea5e0b84ea4ca6b3804d0d23da7ae0
ER  - 

TY  - JOUR
TI  - Drug-Abuse Nanotechnology: Opportunities and Challenges
T2  - ACS Chemical Neuroscience
J2  - ACS Chem. Neurosci.
VL  - 9
IS  - 10
SP  - 2288
EP  - 2298
PY  - 2018
DO  - 10.1021/acschemneuro.8b00127
SN  - 19487193 (ISSN) 
AU  - Mahmoudi, M.
AU  - Pakpour, S.
AU  - Perry, G.
AD  - Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA  02115, United States
AD  - Infectious Disease and Microbiome, Broad Institute, Cambridge, MA  02142, United States
AD  - School of Engineering, University of British Columbia, Kelowna, BC  V1V 1V7, Canada
AD  - Neurosciences Institute, Department of Biology, College of Sciences, University of Texas, San Antonio, TX  78249, United States
AB  - Opioid drug abuse and dependence/addiction are complex disorders regulated by a wide range of interacting networks of genes and pathways that control a variety of phenotypes. Although the field has been extensively progressed since the birth of the National Institute on Drug Abuse in 1974, the fundamental knowledge and involved mechanisms that lead to drug dependence/addiction are poorly understood, and thus, there has been limited success in the prevention of drug addiction and development of therapeutics for definitive treatment and cure of addiction disease. The lack of success in both identification of addiction in at-risk populations and the development of efficient drugs has resulted in a serious social and economic burden from opioid drug abuse with global increasing rate of mortality from drug overdoses. This perspective aims to draw the attention of scientists to the potential role of nanotechnologies, which might pave the way for the development of more practical platforms for either drug development or identification and screening of patients who may be vulnerable to addiction after using opioid drugs. © Copyright 2018 American Chemical Society.
KW  - dependence/addiction
KW  - early detection
KW  - nanoparticle
KW  - nanotechnology
KW  - Opioid drug abuse
KW  - therapeutics
PB  - American Chemical Society
N1  - Cited By :2
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
N1  - CODEN: ACNCD
C2  - 29851334
LA  - English
N1  - Correspondence Address: Mahmoudi, M.; Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical SchoolUnited States; email: mmahmoudi@bwh.harvard.edu
N1  - References: Andreou, C., Hoonejani, M.R., Barmi, M.R., Moskovits, M., Meinhart, C.D., Rapid detection of drugs of abuse in saliva using surface enhanced Raman spectroscopy and microfluidics (2013) ACS Nano, 7, pp. 7157-7164; 
Oslin, D.W., Berrettini, W., Kranzler, H.R., Pettinati, H., Gelernter, J., Volpicelli, J.R., O'Brien, C.P., A functional polymorphism of the μ-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients (2003) Neuropsychopharmacology, 28, p. 1546; 
Hoehe, M.R., Köpke, K., Wendel, B., Rohde, K., Flachmeier, C., Kidd, K.K., Berrettini, W.H., Church, G.M., Sequence variability and candidate gene analysis in complex disease: Association of μ opioid receptor gene variation with substance dependence (2000) Human Molecular Genetics, 9, pp. 2895-2908; 
Crowley, J.J., Oslin, D.W., Patkar, A.A., Gottheil, E., DeMaria, P.A., Jr., O'Brien, C.P., Berrettini, W.H., Grice, D.E., A genetic association study of the mu opioid receptor and severe opioid dependence (2003) Psychiatr. Genet., 13, pp. 169-173; 
Jin, J., Kittanakom, S., Wong, V., Reyes, B.A., Van Bockstaele, E.J., Stagljar, I., Berrettini, W., Levenson, R., Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: Potential implications for opioid dependence (2010) BMC Neurosci., 11, p. 33; 
Crist, R.C., Clarke, T.-K., Ang, A., Ambrose-Lanci, L.M., Lohoff, F.W., Saxon, A.J., Ling, W., Berrettini, W.H., An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans (2013) Neuropsychopharmacology, 38, p. 2003; 
Kahan, M., Srivastava, A., Wilson, L., Gourlay, D., Midmer, D., Misuse of and dependence on opioids: Study of chronic pain patients (2006) Canadian Family Physician, 52, pp. 1081-1087; 
Carmichael, A.-N., Morgan, L., Del Fabbro, E., Identifying and assessing the risk of opioid abuse in patients with cancer: An integrative review (2016) Substance Abuse and Rehabilitation, 7, p. 71; 
Gourlay, D.L., Heit, H.A., Caplan, Y.H., (2010) Urine Drug Testing in Clinical Practice: The Art and Science of Patient Care, , PharmaCom Group; 
Christo, P.J., Manchikanti, L., Ruan, X., Bottros, M., Hansen, H., Solanki, D.R., Jordan, A.E., Colson, J., Urine drug testing in chronic pain (2011) Pain Physician, 14, pp. 123-143; 
https://www.drugabuse.gov/nidamed-medical-health-professionals/tool-resources-your-practice/screening-assessment-drug-testing-resources/chart-evidence-based-screening-tools-adults, National Institute on Drug Abuse. Chart of Evidence-Based Screening Tools for Adults and Adolescents; Vaglienti, R.M., Huber, S.J., Noel, K.R., Johnstone, R.E., Misuse of prescribed controlled substances defined by urinalysis (2003) West Virginia Medical Journal, 99, pp. 67-70; 
Katz, N.P., Sherburne, S., Beach, M., Rose, R.J., Vielguth, J., Bradley, J., Fanciullo, G.J., Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy (2003) Anesth. Analg., 97, pp. 1097-1102; 
Shankaran, D.R., Gobi, K.V., Miura, N., Recent advancements in surface plasmon resonance immunosensors for detection of small molecules of biomedical, food and environmental interest (2007) Sens. Actuators, B, 121, pp. 158-177; 
Koob, G.F., Drugs of abuse: Anatomy, pharmacology and function of reward pathways (1992) Trends Pharmacol. Sci., 13, pp. 177-184; 
Robinson, T.E., Berridge, K.C., The neural basis of drug craving: An incentive-sensitization theory of addiction (1993) Brain Res. Rev., 18, pp. 247-291; 
Kiraly, D.D., Walker, D.M., Calipari, E.S., Labonte, B., Issler, O., Pena, C.J., Ribeiro, E.A., Nestler, E.J., Alterations of the host microbiome affect behavioral responses to cocaine (2016) Sci. Rep., 6, p. 35455; 
Sacerdote, P., Opioids and the immune system (2006) Palliative Medicine, 20, pp. 9-15; 
Postler, T.S., Ghosh, S., Understanding the holobiont: How microbial metabolites affect human health and shape the immune system (2017) Cell Metab., 26, pp. 110-130; 
Fiala, M., Gan, X.-H., Zhang, L., House, S., Newton, T., Graves, M., Shapshak, P., Witte, M., Cocaine enhances monocyte migration across the blood-brain barrier (1998) Drugs of Abuse, Immunomodulation, and Aids, pp. 199-205. , Springer; 
Kim, B.Y., Rutka, J.T., Chan, W.C., Nanomedicine (2010) N. Engl. J. Med., 363, pp. 2434-2443; 
Farokhzad, O.C., Langer, R., Impact of nanotechnology on drug delivery (2009) ACS Nano, 3, pp. 16-20; 
Brigger, I., Dubernet, C., Couvreur, P., Nanoparticles in cancer therapy and diagnosis (2012) Adv. Drug Delivery Rev., 64, pp. 24-36; 
Laurent, S., Dutz, S., Häfeli, U.O., Mahmoudi, M., Magnetic fluid hyperthermia: Focus on superparamagnetic iron oxide nanoparticles (2011) Adv. Colloid Interface Sci., 166, pp. 8-23; 
Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J.S., Moseley, M., Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues (2016) Nat. Nanotechnol., 11, p. 986; 
Shi, J., Votruba, A.R., Farokhzad, O.C., Langer, R., Nanotechnology in drug delivery and tissue engineering: From discovery to applications (2010) Nano Lett., 10, pp. 3223-3230; 
Shi, J., Kantoff, P.W., Wooster, R., Farokhzad, O.C., Cancer nanomedicine: Progress, challenges and opportunities (2017) Nat. Rev. Cancer, 17, p. 20; 
Mahmoudi, M., Yu, M., Serpooshan, V., Wu, J.C., Langer, R., Lee, R.T., Karp, J.M., Farokhzad, O.C., Multiscale technologies for treatment of ischemic cardiomyopathy (2017) Nat. Nanotechnol., 12, p. 845; 
Hajipour, M.J., Santoso, M.R., Rezaee, F., Aghaverdi, H., Mahmoudi, M., Perry, G., Advances in alzheimer's diagnosis and therapy: The implications of nanotechnology (2017) Trends Biotechnol., 35, pp. 937-953; 
Lavan, D.A., McGuire, T., Langer, R., Small-scale systems for in vivo drug delivery (2003) Nat. Biotechnol., 21, p. 1184; 
Mahmoudi, M., Sant, S., Wang, B., Laurent, S., Sen, T., Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy (2011) Adv. Drug Delivery Rev., 63, pp. 24-46; 
Bonoiu, A.C., Mahajan, S.D., Ding, H., Roy, I., Yong, K.-T., Kumar, R., Hu, R., Prasad, P.N., Nanotechnology approach for drug addiction therapy: Gene silencing using delivery of gold nanorod-siRNA nanoplex in dopaminergic neurons (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 5546-5550; 
Green-Sadan, T., Kuttner, Y., Lublin-Tennenbaum, T., Kinor, N., Boguslavsky, Y., Margel, S., Yadid, G., Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats (2005) Exp. Neurol., 194, pp. 97-105; 
Rao, P., Yallapu, M.M., Sari, Y., Fisher, P.B., Kumar, S., Designing novel nanoformulations targeting glutamate transporter excitatory amino acid transporter 2: Implications in treating drug addiction (2015) Journal of Personalized Nanomedicine, 1, p. 3; 
Ignatowski, T., Aalinkeel, R., Reynolds, J., Nair, B., Sykes, D., Gleason, C., Law, W., Mahajan, S.D., Nanotherapeutic Approach for Opiate Addiction Using DARPP-32 Gene Silencing in an Animal Model of Opiate Addiction (2015) Journal of Neuroimmune Pharmacology, 10, pp. 136-152; 
Chen, W., Peng, C., Jin, Z., Qiao, R., Wang, W., Zhu, S., Wang, L., Xu, C., Ultrasensitive immunoassay of 7-aminoclonazepam in human urine based on CdTe nanoparticle bioconjugations by fabricated microfluidic chip (2009) Biosens. Bioelectron., 24, pp. 2051-2056; 
Han, Z., Liu, H., Wang, B., Weng, S., Yang, L., Liu, J., Three-dimensional surface-enhanced Raman scattering hotspots in spherical colloidal superstructure for identification and detection of drugs in human urine (2015) Anal. Chem., 87, pp. 4821-4828; 
Dong, R., Weng, S., Yang, L., Liu, J., Detection and direct readout of drugs in human urine using dynamic surface-enhanced Raman spectroscopy and support vector machines (2015) Anal. Chem., 87, pp. 2937-2944; 
Inscore, F., Shende, C., Sengupta, A., Huang, H., Farquharson, S., Detection of drugs of abuse in saliva by surface-enhanced Raman spectroscopy (SERS) (2011) Appl. Spectrosc., 65, pp. 1004-1008; 
Farquharson, S., Shende, C., Sengupta, A., Huang, H., Inscore, F., Rapid detection and identification of overdose drugs in saliva by surface-enhanced Raman scattering using fused gold colloids (2011) Pharmaceutics, 3, pp. 425-439; 
Kaminsky, Y.G., Kosenko, E., Alexandrovich, Y.G., Ataullakhanov, F., Experiments on alcocytes containing enzyme nanoparticles for reducing toxic blood concentration of ethanol (2012) Bull. Exp. Biol. Med., 153, pp. 170-172; 
Ribeiro, J.A., Fernandes, P.M., Pereira, C.M., Silva, F., Electrochemical sensors and biosensors for determination of catecholamine neurotransmitters: A review (2016) Talanta, 160, pp. 653-679; 
Krol, S., Macrez, R., Docagne, F., Defer, G., Laurent, S., Rahman, M., Hajipour, M.J., Mahmoudi, M., Therapeutic benefits from nanoparticles: The potential significance of nanoscience in diseases with compromise to the blood brain barrier (2013) Chem. Rev., 113, pp. 1877-1903; 
Gould, T.D., Manji, H.K., DARPP-32: A molecular switch at the nexus of reward pathway plasticity (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 253-254; 
Calabresi, P., Gubellini, P., Centonze, D., Picconi, B., Bernardi, G., Chergui, K., Svenningsson, P., Greengard, P., Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity (2000) J. Neurosci., 20, pp. 8443-8451; 
Valjent, E., Hervé, D., Girault, J.-A., Drugs of abuse, protein phosphatases, and ERK pathway (2005) Med Sci, 21, p. 453; 
Law, W.-C., Mahajan, S.D., Kopwitthaya, A., Reynolds, J.L., Liu, M., Liu, X., Chen, G., Aalinkeel, R., Gene silencing of human neuronal cells for drug addiction therapy using anisotropic nanocrystals (2012) Theranostics, 2, p. 695; 
Umezaki, Y., Iohara, D., Anraku, M., Ishitsuka, Y., Irie, T., Uekama, K., Hirayama, F., Preparation of hydrophilic C60 (OH) 10/2-hydroxypropyl-β-cyclodextrin nanoparticles for the treatment of a liver injury induced by an overdose of acetaminophen (2015) Biomaterials, 45, pp. 115-123; 
Daglish, M.R., Weinstein, A., Malizia, A.L., Wilson, S., Melichar, J.K., Britten, S., Brewer, C., Nutt, D.J., Changes in regional cerebral blood flow elicited by craving memories in abstinent opiate-dependent subjects (2001) Am. J. Psychiatry, 158, pp. 1680-1686; 
Lapchak, P., Araujo, D., Collier, B., Regulation of endogenous acetylcholine release from mammalian brain slices by opiate receptors: Hippocampus, striatum and cerebral cortex of guinea-pig and rat (1989) Neuroscience, 31, pp. 313-325; 
Ellgren, M., Spano, S.M., Hurd, Y.L., Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats (2007) Neuropsychopharmacology, 32, p. 607; 
Le Merrer, J., Becker, J.A., Befort, K., Kieffer, B.L., Reward processing by the opioid system in the brain (2009) Physiol. Rev., 89, pp. 1379-1412; 
Koob, G.F., Neurobiology of addiction (2011) Focus, 9, pp. 55-65; 
Mahmoudi, M., Hofmann, H., Rothen-Rutishauser, B., Petri-Fink, A., Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles (2012) Chem. Rev., 112, pp. 2323-2338; 
Mahmoudi, M., Hosseinkhani, H., Hosseinkhani, M., Boutry, S., Simchi, A., Journeay, W.S., Subramani, K., Laurent, S., Magnetic resonance imaging tracking of stem cells in vivo using iron oxide nanoparticles as a tool for the advancement of clinical regenerative medicine (2011) Chem. Rev., 111, pp. 253-280; 
Sharifi, S., Seyednejad, H., Laurent, S., Atyabi, F., Saei, A.A., Mahmoudi, M., Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging (2015) Contrast Media Mol. Imaging, 10, pp. 329-355; 
Sagar, V., Atluri, V.S.R., Pilakka-Kanthikeel, S., Nair, M., Magnetic nanotherapeutics for dysregulated synaptic plasticity during neuroAIDS and drug abuse (2016) Mol. Brain, 9, p. 57; 
Sagar, V., Pilakka-Kanthikeel, S., Atluri, V.S., Ding, H., Arias, A.Y., Jayant, R.D., Kaushik, A., Nair, M., Therapeutical neurotargeting via magnetic nanocarrier: Implications to opiate-induced neuropathogenesis and neuroAIDS (2015) J. Biomed. Nanotechnol., 11, pp. 1722-1733; 
He, M., Li, Z., Ge, Y., Liu, Z., Portable upconversion nanoparticles-based paper device for field testing of drug abuse (2016) Anal. Chem., 88, pp. 1530-1534; 
Krishnan, S., Alden, N., Lee, K., Pathways and functions of gut microbiota metabolism impacting host physiology (2015) Curr. Opin. Biotechnol., 36, pp. 137-145; 
Fukuda, S., Ohno, H., Gut microbiome and metabolic diseases (2014) Semin. Immunopathol., 36, pp. 103-114; 
Kinross, J.M., Darzi, A.W., Nicholson, J.K., Gut microbiome-host interactions in health and disease (2011) Genome Med., 3, p. 14; 
Gérard, P., Metabolism of cholesterol and bile acids by the gut microbiota (2014) Pathogens, 3, pp. 14-24; 
David, L.A., Materna, A.C., Friedman, J., Campos-Baptista, M.I., Blackburn, M.C., Perrotta, A., Erdman, S.E., Alm, E.J., Host lifestyle affects human microbiota on daily timescales (2014) Genome Biology, 15, p. R89; 
Temko, J.E., Bouhlal, S., Farokhnia, M., Lee, M.R., Cryan, J.F., Leggio, L., The Microbiota, the Gut and the Brain in Eating and Alcohol Use Disorders: A 'Ménage à Trois'? (2017) Alcohol Alcohol., 52, pp. 403-413; 
Jangi, S., Gandhi, R., Cox, L.M., Li, N., Von Glehn, F., Yan, R., Patel, B., Glanz, B.L., Alterations of the human gut microbiome in multiple sclerosis (2016) Nat. Commun., 7, p. 12015; 
Scheperjans, F., Aho, V., Pereira, P.A., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Pohja, M., Gut microbiota are related to Parkinson's disease and clinical phenotype (2015) Mov. Disord., 30, pp. 350-358; 
Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Gradinaru, V., Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease (2016) Cell, 167, pp. 1469-1480. , e1412; 
Jose, P.A., Raj, D., Gut microbiota in hypertension (2015) Curr. Opin. Nephrol. Hypertens., 24, pp. 403-409; 
Forsythe, P., Bienenstock, J., Kunze, W.A., Lyte, M., Cryan, J.F., Vagal Pathways for Microbiome-Brain-Gut Axis Communication (2014) Microbial Endocrinology: The Microbiota-Gut-Brain Axis in Health and Disease, pp. 115-133. , (Eds.), Springer; 
O'Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis (2015) Behav. Brain Res., 277, pp. 32-48; 
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R.D., Shanahan, F., Dinan, T.G., Cryan, J.F., The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner (2013) Mol. Psychiatry, 18, pp. 666-673; 
Akbarali, H.I., Dewey, W.L., The gut-brain interaction in opioid tolerance (2017) Curr. Opin. Pharmacol., 37, pp. 126-130; 
Nestler, E.J., Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction (2004) Trends Pharmacol. Sci., 25, pp. 210-218; 
Valjent, E., Pascoli, V., Svenningsson, P., Paul, S., Enslen, H., Corvol, J.-C., Stipanovich, A., Nairn, A.C., Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 491-496; 
Nestler, E.J., Molecular basis of long-term plasticity underlying addiction (2001) Nat. Rev. Neurosci., 2, p. 119; 
Leclercq, S., De Saeger, C., Delzenne, N., De Timary, P., Stärkel, P., Role of inflammatory pathways, blood mononuclear cells, and gut-derived bacterial products in alcohol dependence (2014) Biol. Psychiatry, 76, pp. 725-733; 
Taylor, A., Revealing a Brain-Gut Microbiome Connection Following Chronic Opioid Treatment (2018) J. Pain, 19, p. S1; 
Eisenstein, T.K., Opioids and the immune system: What is their mechanism of action? (2011) British Journal of Pharmacology, 164, pp. 1826-1828; 
Schulzke, J.D., Ploeger, S., Amasheh, M., Fromm, A., Zeissig, S., Troeger, H., Richter, J., Fromm, M., Epithelial tight junctions in intestinal inflammation (2009) Ann. N. Y. Acad. Sci., 1165, pp. 294-300; 
Hilburger, M.E., Adler, M.W., Truant, A.L., Meissler, J.J., Jr., Satishchandran, V., Rogers, T.J., Eisenstein, T.K., Morphine induces sepsis in mice (1997) J. Infect. Dis., 176, pp. 183-188; 
Macfarlane, A.S., Peng, X., Meissler, J.J., Jr., Rogers, T.J., Geller, E.B., Adler, M.W., Eisenstein, T.K., Morphine increases susceptibility to oral Salmonella typhimurium infection (2000) J. Infect. Dis., 181, pp. 1350-1358; 
Babrowski, T., Holbrook, C., Moss, J., Gottlieb, L., Valuckaite, V., Zaborin, A., Poroyko, V., Alverdy, J.C., Pseudomonas aeruginosa virulence expression is directly activated by morphine and is capable of causing lethal gut derived sepsis in mice during chronic morphine administration (2012) Ann. Surg., 255, p. 386; 
Harari, Y., Weisbrodt, N.W., Moody, F.G., The effect of morphine on mast cell-mediated mucosal permeability (2006) Surgery, 139, pp. 54-60; 
Brosnahan, A.J., Jones, B.J., Dvorak, C.M., Brown, D.R., Morphine attenuates apically-directed cytokine secretion from intestinal epithelial cells in response to enteric pathogens (2014) Pathogens, 3, pp. 249-257; 
Wang, F., Roy, S., Gut Homeostasis, Microbial Dysbiosis, and Opioids (2017) Toxicol. Pathol., 45, pp. 150-156; 
Keshishian, H., Burgess, M.W., Specht, H., Wallace, L., Clauser, K.R., Gillette, M.A., Carr, S.A., Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry (2017) Nat. Protoc., 12, p. 1683; 
Monopoli, M.P., Åberg, C., Salvati, A., Dawson, K.A., Biomolecular coronas provide the biological identity of nanosized materials (2012) Nat. Nanotechnol., 7, p. 779; 
Nel, A.E., Mädler, L., Velegol, D., Xia, T., Hoek, E.M., Somasundaran, P., Klaessig, F., Thompson, M., Understanding biophysicochemical interactions at the nano-bio interface (2009) Nat. Mater., 8, p. 543; 
Mahmoudi, M., Lynch, I., Ejtehadi, M.R., Monopoli, M.P., Bombelli, F.B., Laurent, S., Protein- nanoparticle interactions: Opportunities and challenges (2011) Chem. Rev., 111, pp. 5610-5637; 
Vilaseca, P., Dawson, K.A., Franzese, G., Understanding and modulating the competitive surface-adsorption of proteins through coarse-grained molecular dynamics simulations (2013) Soft Matter, 9, p. 6978; 
Kharazian, B., Hadipour, N.L., Ejtehadi, M.R., Understanding the nanoparticle-protein corona complexes using computational and experimental methods (2016) Int. J. Biochem. Cell Biol., 75, pp. 162-174; 
Distler, U., Tenzer, S., Tools for Pathogen Proteomics: Fishing with Biomimetic Nanosponges (2017) ACS Nano, 11, pp. 11768-11772; 
Wang, W., Sedykh, A., Sun, H., Zhao, L., Russo, D.P., Zhou, H., Yan, B., Zhu, H., Predicting Nano-Bio Interactions by Integrating Nanoparticle Libraries and Quantitative Nanostructure Activity Relationship Modeling (2017) ACS Nano, 11, pp. 12641-12649; 
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., Dawson, K.A., Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 14265-14270; 
Mahmoudi, M., Abdelmonem, A.M., Behzadi, S., Clement, J.H., Dutz, S., Ejtehadi, M.R., Hartmann, R., Maffre, P., Temperature: The "ignored" factor at the nanobio interface (2013) ACS Nano, 7, pp. 6555-6562; 
Mueller, L.K., Simon, J., Rosenauer, C., Mailänder, V., Morsbach, S., Landfester, K., The transferability from animal models to humans: Challenges regarding aggregation and protein corona formation of nanoparticles (2018) Biomacromolecules, 19, p. 374; 
Serpooshan, V., Sheibani, S., Pushparaj, P., Wojcik, M., Jang, A.Y., Santoso, M.R., Jang, J.H., Mahmoudi, M., Effect of Cell Sex on Uptake of Nanoparticles: The Overlooked Factor at the Nanobio Interface (2018) ACS Nano, 12, pp. 2253-2266; 
Mahmoudi, M., Debugging Nano-Bio Interfaces: Systematic Strategies to Accelerate Clinical Translation of Nanotechnologies (2018) Trends Biotechnol., p. 1; 
Kennedy, L., Mehl, T.D., Elder, E., Varghese, M., Merimee, T.J., Nonenzymatic glycosylation of serum and plasma proteins (1982) Diabetes, 31, pp. 52-56; 
Engström, G., Lind, P., Hedblad, B., Stavenow, L., Janzon, L., Lindgärde, F., Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men (2002) Circulation, 105, pp. 2632-2637; 
Lin, Y.-P., Yang, C.-Y., Liao, C.-C., Yu, W.-C., Chi, C.-W., Lin, C.-H., Plasma protein characteristics of long-term hemodialysis survivors (2012) PLoS One, 7, p. e40232; 
Acharya, S., Dimichele, D., Rare inherited disorders of fibrinogen (2008) Haemophilia, 14, pp. 1151-1158; 
Kelly-Spratt, K.S., Pitteri, S.J., Gurley, K.E., Liggitt, D., Chin, A., Kennedy, J., Wong, C.-H., Wang, H., Plasma proteome profiles associated with inflammation, angiogenesis, and cancer (2011) PLoS One, 6, p. e19721; 
Bowen, D.J., Haemophilia A and haemophilia B: Molecular insights (2002) Mol. Pathol., 55, p. 1; 
Blennow, K., Hampel, H., Weiner, M., Zetterberg, H., Cerebrospinal fluid and plasma biomarkers in Alzheimer disease (2010) Nat. Rev. Neurol., 6, pp. 131-144; 
Ridker, P.M., Brown, N.J., Vaughan, D.E., Harrison, D.G., Mehta, J.L., Established and emerging plasma biomarkers in the prediction of first atherothrombotic events (2004) Circulation, 109, pp. IV6-IV19; 
El-Agnaf, O.M., Salem, S.A., Paleologou, K.E., Curran, M.D., Gibson, M.J., Schlossmacher, M.G., Allsop, D., Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease (2006) FASEB J., 20, pp. 419-425; 
Hanash, S.M., Pitteri, S.J., Faca, V.M., Mining the plasma proteome for cancer biomarkers (2008) Nature, 452, pp. 571-579; 
Wei, J., Gao, W., Zhu, C.-J., Liu, Y.-Q., Mei, Z., Cheng, T., Shu, Y.-Q., Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer (2011) Aizheng, 30, p. 407; 
Hajipour, M.J., Laurent, S., Aghaie, A., Rezaee, F., Mahmoudi, M., Personalized protein coronas: A "key" factor at the nanobiointerface (2014) Biomater. Sci., 2, pp. 1210-1221; 
Caracciolo, G., Farokhzad, O.C., Mahmoudi, M., Biological Identity of Nanoparticles in Vivo: Clinical Implications of the Protein Corona (2017) Trends Biotechnol., 35, pp. 257-264; 
Hajipour, M.J., Raheb, J., Akhavan, O., Arjmand, S., Mashinchian, O., Rahman, M., Abdolahad, M., Mahmoudi, M., Personalized disease-specific protein corona influences the therapeutic impact of graphene oxide (2015) Nanoscale, 7, pp. 8978-8994; 
Corbo, C., Molinaro, R., Tabatabaei, M., Farokhzad, O.C., Mahmoudi, M., Personalized protein corona on nanoparticles and its clinical implications (2017) Biomater. Sci., 5, pp. 378-387; 
Caputo, D., Papi, M., Coppola, R., Palchetti, S., Digiacomo, L., Caracciolo, G., Pozzi, D., A protein corona-enabled blood test for early cancer detection (2017) Nanoscale, 9, pp. 349-354; 
Strojan, K., Leonardi, A., Bregar, V.B., Križaj, I., Svete, J., Pavlin, M., Dispersion of nanoparticles in different media importantly determines the composition of their protein corona (2017) PLoS One, 12, p. e0169552; 
Vlasova, M., Smirin, B.V., Personalized Approach in Nanomedicine: Understanding Adverse Effects and Their Risk Assessment (2017) Recent Advances in Drug Delivery Technology, pp. 1-21; 
Park, S.-M., Aalipour, A., Vermesh, O., Yu, J.H., Gambhir, S.S., Towards clinically translatable in vivo nanodiagnostics (2017) Nature Reviews Materials, 2, p. 17014; 
Colapicchioni, V., Tilio, M., Digiacomo, L., Gambini, V., Palchetti, S., Marchini, C., Pozzi, D., Caracciolo, G., Personalized liposome-protein corona in the blood of breast, gastric and pancreatic cancer patients (2016) Int. J. Biochem. Cell Biol., 75, pp. 180-187; 
Choi, H., Lee, Y.-S., Hwang, D.W., Lee, D.S., Translational radionanomedicine: A clinical perspective (2016) Eur. J. Nanomed., 8, pp. 71-84; 
Tavakol, M., Montazeri, A., Naghdabadi, R., Hajipour, M., Zanganeh, S., Caracciolo, G., Mahmoudi, M., Disease-related metabolites affect protein-nanoparticle interactions (2018) Nanoscale, 10, p. 7108; 
Salomon, F., Cuneo, R.C., Hesp, R., Sönksen, P.H., The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency (1989) N. Engl. J. Med., 321, pp. 1797-1803; 
Beger, R.D., Sun, J., Schnackenberg, L.K., Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity (2010) Toxicol. Appl. Pharmacol., 243, pp. 154-166; 
Goldstein, A., The interactions of drugs and plasma proteins (1949) Pharmacol. Rev., 1, pp. 102-165; 
Martin, B., Potential effect of the plasma proteins on drug distribution (1965) Nature, 207, p. 274; 
Davis, B.D., The binding of sulfonamide drugs by plasma proteins. A factor in determining the distribution of drugs in the body (1943) J. Clin. Invest., 22, pp. 753-762; 
Leggett, R., Lee-Smith, E.E., Jickells, S.M., Russell, D.A., Intelligent" fingerprinting: Simultaneous identification of drug metabolites and individuals by using antibody-functionalized nanoparticles (2007) Angew. Chem., 119, pp. 4178-4181; 
Hazarika, P., Jickells, S.M., Wolff, K., Russell, D.A., Imaging of latent fingerprints through the detection of drugs and metabolites (2008) Angew. Chem., Int. Ed., 47, pp. 10167-10170; 
Matsumoto, M., Kibe, R., Ooga, T., Aiba, Y., Kurihara, S., Sawaki, E., Koga, Y., Benno, Y., Impact of intestinal microbiota on intestinal luminal metabolome (2012) Sci. Rep., 2, p. 233; 
Wikoff, W.R., Anfora, A.T., Liu, J., Schultz, P.G., Lesley, S.A., Peters, E.C., Siuzdak, G., Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 3698-3703; 
Clarke, G., Stilling, R.M., Kennedy, P.J., Stanton, C., Cryan, J.F., Dinan, T.G., Minireview: Gut microbiota: The neglected endocrine organ (2014) Mol. Endocrinol., 28, pp. 1221-1238; 
Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Kynurenine pathway metabolism and the microbiota-gut-brain axis (2017) Neuropharmacology, 112, pp. 399-412; 
De La Fuente-Nunez, C., Meneguetti, B.T., Franco, O.L., Lu, T.K., Neuromicrobiology: How Microbes Influence the Brain (2018) ACS Chem. Neurosci., 9, pp. 141-150; 
Saha, K., Agasti, S.S., Kim, C., Li, X., Rotello, V.M., Gold nanoparticles in chemical and biological sensing (2012) Chem. Rev., 112, pp. 2739-2779; 
Zheng, T., Pierre-Pierre, N., Yan, X., Huo, Q., Almodovar, A.J.O., Valerio, F., Rivera-Ramirez, I., Zhu, N., Gold Nanoparticle-Enabled Blood Test for Early Stage Cancer Detection and Risk Assessment (2015) ACS Appl. Mater. Interfaces, 7, pp. 6819-6827; 
Zheng, T., Finn, C., Parrett, C.J., Dhume, K., Hwang, J.H., Sidhom, D., Strutt, T.M., Huo, Q., A Rapid Blood Test to Determine the Active Status and Duration of Acute Viral Infection (2017) ACS Infect. Dis., 3, pp. 866-873; 
Du, Y., Li, B., Guo, S., Zhou, Z., Zhou, M., Wang, E., Dong, S., G-Quadruplex-based DNAzyme for colorimetric detection of cocaine: Using magnetic nanoparticles as the separation and amplification element (2011) Analyst, 136, pp. 493-497; 
Goldberg, D.E., Holland, J.H., Genetic algorithms and machine learning (1988) Machine Learning, 3, pp. 95-99; 
Deo, R.C., Machine learning in medicine (2015) Circulation, 132, pp. 1920-1930; 
Murdoch, T.B., Detsky, A.S., The inevitable application of big data to health care (2013) Jama, 309, pp. 1351-1352; 
McAfee, A., Brynjolfsson, E., Davenport, T.H., Patil, D., Barton, D., Big data: The management revolution (2012) Harvard Business Review, 90, pp. 60-68; 
Cohen, J.D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Papadopoulos, N., Detection and localization of surgically resectable cancers with a multi-analyte blood test (2018) Science, 359, pp. 926-930; 
Yan, J., Charles, J.F., Gut microbiota and IGF-1 (2018) Calcif. Tissue Int., 102, pp. 406-414; 
Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., Codelli, J.A., Petrosino, J.F., Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders (2013) Cell, 155, pp. 1451-1463; 
Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Mayer, E.A., Consumption of fermented milk product with probiotic modulates brain activity (2013) Gastroenterology, 144, pp. 1394-1401; 
Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Bienenstock, J., Cryan, J.F., Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve (2011) Proc. Natl. Acad. Sci. U. S. A., 108, pp. 16050-16055; 
Acosta-Martinez, V., Dowd, S., Sun, Y., Allen, V., Tag-encoded pyrosequencing analysis of bacterial diversity in a single soil type as affected by management and land use (2008) Soil Biol. Biochem., 40, pp. 2762-2770; 
Partty, A., Kalliomaki, M., Wacklin, P., Salminen, S., Isolauri, E., A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: A randomized trial (2015) Pediatr. Res., 77, pp. 823-828; 
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., Dinan, T.G., The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat (2008) J. Psychiatr. Res., 43, pp. 164-174; 
Fröhlich, E.E., Fröhlich, E., Cytotoxicity of nanoparticles contained in food on intestinal cells and the gut microbiota (2016) Int. J. Mol. Sci., 17, p. 509; 
Van Den Brûle, S., Ambroise, J., Lecloux, H., Levard, C., Soulas, R., De Temmerman, P.-J., Palmai-Pallag, M., Lison, D., Dietary silver nanoparticles can disturb the gut microbiota in mice (2015) Part. Fibre Toxicol., 13, p. 38; 
Javurek, A.B., Suresh, D., Spollen, W.G., Hart, M.L., Hansen, S.A., Ellersieck, M.R., Bivens, N.J., Rosenfeld, C.S., Gut dysbiosis and neurobehavioral alterations in rats exposed to silver nanoparticles (2017) Sci. Rep., 7, p. 2822; 
Williams, K., Milner, J., Boudreau, M.D., Gokulan, K., Cerniglia, C.E., Khare, S., Effects of subchronic exposure of silver nanoparticles on intestinal microbiota and gut-associated immune responses in the ileum of Sprague-Dawley rats (2015) Nanotoxicology, 9, pp. 279-289; 
Fallon, M.S., Varshney, M., Dennis, D.M., Chauhan, A., A physiologically-based pharmacokinetic model of drug detoxification by nanoparticles (2004) J. Pharmacokinet. Pharmacodyn., 31, pp. 381-400; 
Wolfbeis, O.S., Nanoparticle-Enhanced Fluorescence Imaging of Latent Fingerprints Reveals Drug Abuse (2009) Angew. Chem., Int. Ed., 48, pp. 2268-2269
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055017625&doi=10.1021%2facschemneuro.8b00127&partnerID=40&md5=ada8025545e3c277c2b8d843035b609b
ER  - 

TY  - JOUR
TI  - Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder
T2  - Psychopharmacology
J2  - Psychopharmacology
VL  - 235
IS  - 9
SP  - 2713
EP  - 2723
PY  - 2018
DO  - 10.1007/s00213-018-4966-9
SN  - 00333158 (ISSN) 
AU  - Preston, K.L.
AU  - Kowalczyk, W.J.
AU  - Phillips, K.A.
AU  - Jobes, M.L.
AU  - Vahabzadeh, M.
AU  - Lin, J.-L.
AU  - Mezghanni, M.
AU  - Epstein, D.H.
AD  - Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, United States
AB  - Rationale: Ecological momentary assessment (EMA) of specific events usually focuses more on antecedents and concomitants than on aftermaths. Objectives: To examine mental state both before and after discrete episodes of stress and drug use. Methods: For up to 16 weeks, outpatients on opioid-agonist treatment carried smartphones on which they initiated entries for stressful events (SEs) or lapses to drug use (DUs), and thrice daily when randomly prompted (RPs). Participants rated their stress, opioid craving, cocaine craving, and moods. RP entries within 5 h of an event were analyzed and compared to other RPs. Results: Stress, negative mood, and craving were generally higher before and after DUs and SEs compared to background levels in participants with at least one DU (n = 149) or SE (n = 158). Before DUs, there were increases in negative mood, opioid craving, and cocaine craving, but not background stress. Before SEs, there were increases in background stress, opioid craving, and cocaine craving, but not negative mood. These changes were more variable after events than before. Neither DUs nor SEs were significantly related to positive mood. Conclusions: Stress increased before stressful-event entries, but was less evident before drug use. Craving increased in the hours before drug use and stressful events—and remained elevated in the hours after either event. These results suggest a stronger link between drug use and craving than between drug use and stress. Lapses to drug use did not improve mood or reduce stress, at least not at our 1-h-bin time resolution, suggesting that if such benefits exist, they are brief. © 2018, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
KW  - Cocaine
KW  - Craving
KW  - Ecological momentary assessment
KW  - Opioid
KW  - Stress
KW  - opiate
KW  - adult
KW  - Article
KW  - behavioral stress
KW  - controlled study
KW  - craving
KW  - drug craving
KW  - drug use
KW  - female
KW  - human
KW  - life stress
KW  - major clinical study
KW  - male
KW  - mental health
KW  - mental instability
KW  - mood
KW  - mood change
KW  - opiate addiction
KW  - priority journal
KW  - stress
PB  - Springer Verlag
N1  - Cited By :4
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: PSCHD
LA  - English
N1  - Correspondence Address: Preston, K.L.; Intramural Research Program, National Institute on Drug AbuseUnited States; email: kpreston@intra.nida.nih.gov
N1  - Chemicals/CAS: opiate, 53663-61-9, 8002-76-4, 8008-60-4
N1  - Funding details: National Institutes of Health
N1  - Funding details: National Institute on Drug Abuse
N1  - Funding text 1: Funding This study was supported by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health.
N1  - References: Abroms, L.C., Johnson, P.R., Leavitt, L.E., Cleary, S.D., Bushar, J., Brandon, T.H., Chiang, S.C., A randomized trial of text messaging for smoking cessation in pregnant women (2017) Am J Prev Med, 53, pp. 781-790. , PID: 28982527; 
Businelle, M.S., Ma, P., Kendzor, D.E., Frank, S.G., Wetter, D.W., Vidrine, D.J., Using intensive longitudinal data collected via mobile phone to detect imminent lapse in smokers undergoing a scheduled quit attempt (2016) J Med Internet Res, 18. , PID: 27751985; 
Campbell, E.M., Jia, H., Shankar, A., Hanson, D., Luo, W., Masciotra, S., Owen, S.M., Switzer, W.M., Detailed transmission network analysis of a large opiate-driven outbreak of HIV infection in the United States (2017) J Infect Dis, 216, pp. 1053-1062. , PID: 29029156; 
Dowell, D., Arias, E., Kochanek, K., Anderson, R., Guy, G.P., Jr., Losby, J.L., Baldwin, G., Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000-2015 (2017) JAMA, 318, pp. 1065-1067. , PID: 28975295; 
Epstein, D.H., Willner-Reid, J., Vahabzadeh, M., Mezghanni, M., Lin, J.L., Preston, K.L., Real-time electronic diary reports of cue exposure and mood in the hours before cocaine and heroin craving and use (2009) Arch Gen Psychiatry, 66, pp. 88-94. , PID: 19124692; 
Epstein, D.H., Marrone, G.F., Heishman, S.J., Schmittner, J., Preston, K.L., Tobacco, cocaine, and heroin: craving and use during daily life (2010) Addict Behav, 35, pp. 318-324. , PID: 19939575; 
Furnari, M., Epstein, D.H., Phillips, K.A., Jobes, M.L., Kowalczyk, W.J., Vahabzadeh, M., Lin, J.L., Preston, K.L., Some of the people, some of the time: field evidence for associations and dissociations between stress and drug use (2015) Psychopharmacology, 232, pp. 3529-3537. , PID: 26153066; 
Gustafson, D.H., McTavish, F.M., Chih, M.Y., Atwood, A.K., Johnson, R.A., Boyle, M.G., Levy, M.S., Shah, D., A smartphone application to support recovery from alcoholism: a randomized clinical trial (2014) JAMA Psychiatry, 71, pp. 566-572. , PID: 24671165; 
Lin, M., Mahmooth, Z., Dedhia, N., Frutchey, R., Mercado, C.E., Epstein, D.H., Preston, K.L., Cheskin, L.J., Tailored, interactive text messages for enhancing weight loss among African American adults: the TRIMM randomized controlled trial (2015) Am J Med, 128, pp. 896-904. , PID: 25840035; 
Mahoney, J.J., 3rd, Kalechstein, A.D., De La Garza, R., 2nd, Newton, T.F., A qualitative and quantitative review of cocaine-induced craving: the phenomenon of priming (2007) Prog Neuro-Psychopharmacol Biol Psychiatry, 31, pp. 593-599; 
McLellan, A.T., Luborsky, L., Cacciola, J., Griffith, J., Evans, F., Barr, H.L., O'Brien, C.P., New data from the addiction severity index: reliability and validity in three centers (1985) J Nerv Ment Dis, 173, pp. 412-423. , PID: 4009158; 
Preston, K.L., Epstein, D.H., Stress in the daily lives of cocaine and heroin users: relationship to mood, craving, relapse triggers, and cocaine use (2011) Psychopharmacology, 218, pp. 29-37. , PID: 21336579; 
Preston, K.L., Vahabzadeh, M., Schmittner, J., Lin, J.L., Gorelick, D.A., Epstein, D.H., Cocaine craving and use during daily life (2009) Psychopharmacology, 207, pp. 291-301. , PID: 19777216; 
Preston, K.L., Kowalczyk, W.J., Phillips, K.A., Jobes, M.L., Vahabzadeh, M., Lin, J.L., Mezghanni, M., Epstein, D.H., Context and craving during stressful events in the daily lives of drug-dependent patients (2017) Psychopharmacology, 234, pp. 2631-2642. , PID: 28593441; 
Preston, K.L., Kowalczyk, W.J., Phillips, K.A., Jobes, M.L., Vahabzadeh, M., Lin, J.L., Mezghanni, M., Epstein, D.H., Exacerbated craving in the presence of stress and drug cues in drug-dependent patients (2018) Neuropsychopharmacology, 43, pp. 859-867. , PID: 29105663; 
Robins, L.N., Cottler, L.B., Bucholz, K.K., Compton, W.M., III, (1995) The diagnostic interview schedule, Version IV, , Washington University, St. Louis; 
Rudd, R.A., Seth, P., David, F., Scholl, L., Increases in drug and opioid-involved overdose deaths—United States, 2010-2015 (2016) MMWR Morb Mortal Wkly Rep, 65, pp. 1445-1452. , PID: 28033313; 
Scott, C.K., Dennis, M.L., Gustafson, D.H., Using smartphones to decrease substance use via self-monitoring and recovery support: study protocol for a randomized control trial (2017) Trials, 18, p. 374. , PID: 28797307; 
Scott-Sheldon, L.A., Lantini, R., Jennings, E.G., Thind, H., Rosen, R.K., Salmoirago-Blotcher, E., Bock, B.C., Text messaging-based interventions for smoking cessation: a systematic review and meta-analysis (2016) JMIR Mhealth Uhealth, 4. , PID: 27207211; 
Shiffman, S., Waters, A.J., Negative affect and smoking lapses: a prospective analysis (2004) J Consult Clin Psychol, 72, pp. 192-201. , PID: 15065954; 
Shiffman, S., Stone, A.A., Hufford, M.R., Ecological momentary assessment (2008) Annu Rev Clin Psychol, 4, pp. 1-32. , PID: 18509902; 
Sinha, R., Garcia, M., Paliwal, P., Kreek, M.J., Rounsaville, B.J., Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes (2006) Arch Gen Psychiatry, 63, pp. 324-331. , PID: 16520439; 
Treloar, H., Piasecki, T.M., McCarthy, D.M., Sher, K.J., Heath, A.C., Ecological evidence that affect and perceptions of drink effects depend on alcohol expectancies (2015) Addiction, 110, pp. 1432-1442. , PID: 25959045; 
Vahabzadeh, M., Epstein, D.H., Mezghanni, M., Lin, J.-L., Preston, K.L., An electronic diary software for ecological momentary assessment (EMA) in clinical trials (2004) Proceedings of the 17Th IEEE Symposium on Computer-Based Medical Systems (CBMS), pp. 167-172; 
Vahabzadeh, M., Mezghanni, M., Lin, J.-L., Context aware mobile device software for substance abuse interventions and behavioral modification (2012) Fed Regist, 77, pp. 48997-48998; 
Yarkoni, T., Westfall, J., Choosing prediction over explanation in psychology: lessons from machine learning (2017) Perspect Psychol Sci, 12, pp. 1100-1122. , PID: 28841086; 
Zibbell, J.E., Asher, A.K., Patel, R.C., Kupronis, B., Iqbal, K., Ward, J.W., Holtzman, D., Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014 (2018) Am J Public Health, 108, pp. 175-181. , PID: 29267061
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049598907&doi=10.1007%2fs00213-018-4966-9&partnerID=40&md5=d84ef312969e043cd58dc07bccdcc743
ER  - 

TY  - JOUR
TI  - Inter-individual differences in serotonin and glutamate co-transmission reflect differentiation in context-induced conditioned 50-kHz USVs response after morphine withdrawal
T2  - Brain Structure and Function
J2  - Brain Struct. Funct.
VL  - 223
IS  - 7
SP  - 3149
EP  - 3167
PY  - 2018
DO  - 10.1007/s00429-018-1683-4
SN  - 18632653 (ISSN) 
AU  - Hamed, A.
AU  - Kursa, M.B.
AD  - Laboratory of Spatial Memory, Department of Cellular and Molecular Biology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, Warsaw, 02-093, Poland
AD  - Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw, Pawinskiego 5A, Warsaw, 02-106, Poland
AB  - A growing body of research provides compelling evidence that in rats 50-kHz USVs are a form of expression of positive emotions. Context-induced 50-kHz USVs emission is variable among rats, indicating individual differences in contextual response bound up with pharmacological reward. The aims of this study were to: extract the most important neurotransmitters related to context-induced conditioned 50-kHz USVs response; find biological basis of existing inter-individual differences in context-induced conditioned 50-kHz USVs response; create a model of all-to-all neurotransmitters correlations. The data collected here confirms that re-exposure to the context of morphine administration after the withdrawal period increases the level of 50-kHz USVs and this contextual response is associated with elevated serotonin concentrations in amygdala, hippocampus and mPFC and with increased Glu/Gln ratio in nucleus accumbens. The concentration of serotonin increases simultaneously in amygdala, nucleus accumbens and hippocampus. Moreover, 5-HT concentration in amygdala is bound up with glutamate level in this structure as well as in hippocampus. Furthermore, Glu/Gln ratio in nucleus accumbens has strong associations with Glu/Gln ratio simultaneously in VTA, amygdala, striatum and hippocampus. All-to-all-analysis indicate that concentration of glutamate in hippocampus is proportional to glutamate in VTA and GABA concentration in the hippocampus. We have also demonstrated that Glu/GABA ratio in VTA and amygdala was elevated after post withdrawal re-exposure to the pharmacological reward paired context. Presented analysis indicates a strong correlation between serotonergic and glutamatergic systems in context-induced conditioned response. The strength of this co-transmission correlates with the number of 50-kHz USVs emitted in response to morphine-paired context. © 2018, The Author(s).
KW  - 5-HT
KW  - Amygdala
KW  - Co-transmission
KW  - Context conditioning
KW  - Context-induced
KW  - GABA
KW  - Glu/Gln ratio
KW  - Glutamate
KW  - Incubation of craving
KW  - Inter-individual differences;
KW  - Machine learning
KW  - Morphine
KW  - Neurochemistry
KW  - Nucleus accumbens
KW  - Reward
KW  - Serotonin
KW  - Ultrasonic vocalization
KW  - USVs
KW  - 3 o methyldopamine
KW  - 3,4 dihydroxyphenylacetic acid
KW  - 4 aminobutyric acid
KW  - 4 hydroxy 3 methoxyphenylethylene glycol
KW  - 5 hydroxyindoleacetic acid
KW  - alanine
KW  - dopamine
KW  - glutamic acid
KW  - glutamine
KW  - homovanillic acid
KW  - morphine
KW  - noradrenalin
KW  - serotonin
KW  - taurine
KW  - 4 aminobutyric acid
KW  - glutamic acid
KW  - serotonin
KW  - adult
KW  - amino acid transport
KW  - amygdala
KW  - animal experiment
KW  - Article
KW  - conditioned reflex
KW  - controlled study
KW  - corpus striatum
KW  - hippocampus
KW  - male
KW  - medial prefrontal cortex
KW  - nonhuman
KW  - nucleus accumbens
KW  - priority journal
KW  - rat
KW  - reward
KW  - separation-induced ultrasonic vocalization test
KW  - serotoninergic transmission
KW  - animal
KW  - animal behavior
KW  - brain
KW  - conditioning
KW  - disease model
KW  - metabolism
KW  - opiate addiction
KW  - pathophysiology
KW  - psychology
KW  - Sprague Dawley rat
KW  - synaptic transmission
KW  - time factor
KW  - ultrasound
KW  - vocalization
KW  - withdrawal syndrome
KW  - Animals
KW  - Behavior, Animal
KW  - Brain
KW  - Conditioning (Psychology)
KW  - Disease Models, Animal
KW  - gamma-Aminobutyric Acid
KW  - Glutamic Acid
KW  - Male
KW  - Morphine
KW  - Opioid-Related Disorders
KW  - Rats, Sprague-Dawley
KW  - Reward
KW  - Serotonin
KW  - Substance Withdrawal Syndrome
KW  - Synaptic Transmission
KW  - Time Factors
KW  - Ultrasonic Waves
KW  - Vocalization, Animal
PB  - Springer Verlag
N1  - Cited By :1
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C2  - 29774428
LA  - English
N1  - Correspondence Address: Hamed, A.; Laboratory of Spatial Memory, Department of Cellular and Molecular Biology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, Poland; email: a.hamed@nencki.gov.pl
N1  - Chemicals/CAS: 3 o methyldopamine, 554-52-9; 3,4 dihydroxyphenylacetic acid, 102-32-9; 4 aminobutyric acid, 28805-76-7, 56-12-2; 4 hydroxy 3 methoxyphenylethylene glycol, 534-82-7; 5 hydroxyindoleacetic acid, 1321-73-9, 54-16-0; alanine, 56-41-7, 6898-94-8; dopamine, 51-61-6, 62-31-7; glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4; glutamine, 56-85-9, 6899-04-3; homovanillic acid, 306-08-1; morphine, 52-26-6, 57-27-2; noradrenalin, 1407-84-7, 51-41-2; serotonin, 50-67-9; taurine, 107-35-7; gamma-Aminobutyric Acid; Glutamic Acid; Morphine; Serotonin
N1  - Funding details: Narodowe Centrum Nauki, 501-003-13-043
N1  - Funding text 1: Acknowledgements This research was supported by Grant DEC-2011/03/B/NZ7/04155 from the National Science Centre, Poland. The study was supported by the Institute of Psychiatry and Neurology statutory found no. 501-003-13-043. We would like to thank Danuta Turzyńska and Alicja Sobolewska from Institute of Psychiatry and Neurology (Department of Neurochemistry) for HPLC analysis. Many thanks to Tomasz Jaroszewski for co-creation of RatRec software, who provided us with recording and detailed analysis of the USVs FFT spectrograms.
N1  - References: Abdolahi, A., Acosta, G., Breslin, F.J., Hemby, S.E., Lynch, W.J., Incubation of nicotine seeking is associated with enhanced protein kinase A-regulated signaling of dopamine- and cAMP-regulated phosphoprotein of 32 kDa in the insular cortex (2010) Eur J Neurosci, 31, pp. 733-741. , PID: 20384816; 
Abrams, D.B., Monti, P.M., Carey, K.B., Pinto, R.P., Jacobus, S.I., Reactivity to smoking cues and relapse: two studies of discriminant validity (1988) Behav Res Ther, 26, pp. 225-233. , PID: 3408457; 
Ahrens, A.M., Ma, S.T., Maier, E.Y., Duvauchelle, C.L., Schallert, T., Repeated intravenous amphetamine exposure: rapid and persistent sensitization of 50-kHz ultrasonic trill calls in rats (2009) Behav Brain Res, 197 (1), pp. 205-209. , PID: 18809437; 
Akirav, I., Richter-Levin, G., Priming stimulation in the basolateral amygdala modulates synaptic plasticity in the rat dentate gyrus (1999) Neurosci Lett, 270, pp. 83-86. , PID: 10462103; 
Bechtholt-Gompf, A.J., Walther, H.V., Adams, M.A., Carlezon, W.A., Jr., Ongür, D., Cohen, B.M., Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory (2010) Neuropsychopharmacology, 35 (10), pp. 2049-2059. , PID: 20531459; 
Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing (1995) J R Stat Soc Ser B, 57 (1), pp. 289-300; 
Berridge, K.C., The debate over dopamine’s role in reward: the case for incentive salience (2007) Psychopharmacology, 191, pp. 391-431. , PID: 17072591; 
Bosker, F.J., Cremers, T.I., Jongsma, M.E., Westerink, B.H., Wikström, H.V., den Boer, J.A., Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala (2001) J Neurochem, 76 (6), pp. 1645-1653. , PID: 11259482; 
Breiman, L., Random forests (2001) Mach Learn, 45, pp. 5-32; 
Britt, J.P., Benaliouad, F., McDevitt, R.A., Stuber, G.D., Wise, R.A., Bonci, A., Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens (2012) Neuron, 76, pp. 790-803. , PID: 23177963; 
Bromberg-Martin, E.S., Matsumoto, M., Hikosaka, O., Dopamine in motivational control: rewarding, aversive, and alerting (2010) Neuron, 68 (5), pp. 815-834. , PID: 21144997; 
Brown, P., Molliver, M.E., Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity (2000) J Neurosci, 20 (5), pp. 1952-1963. , PID: 10684896; 
Brudzynski, S.M., Ethotransmission: communication of emotional states through ultrasonic vocalization in rats (2013) Curr Opin Neurobiol, 23, pp. 310-317. , PID: 23375168; 
Brudzynski, S.M., Ethotransmission: communication of emotional states through ultrasonic vocalization in rats (2013) Curr Opin Neurobiol, 23 (3), pp. 310-317. , PID: 23375168; 
Brudzynski, S.M., Pniak, A., Social contacts and production of 50-kHz short ultrasonic calls in adult rats (2002) J Comp Psychol, 116 (1), pp. 73-82. , PID: 11926686; 
Brudzynski, S.M., Silkstone, M., Komadoski, M., Scullion, K., Duffus, S., Burgdorf, J., Kroes, R.A., Panksepp, J., Effects of intraaccumbens amphetamine on production of 50kHz vocalizations in three lines of selectively bred Long–Evans rats (2011) Behav Brain Res, 217 (1), pp. 32-40. , PID: 20937325; 
Buck, C.L., Vendruscolo, L.F., Koob, G.F., George, O., Dopamine D1 and mu-opioid receptor antagonism blocks anticipatory 50kHz ultrasonic vocalizations induced by palatable food cues in Wistar rats (2014) Psychopharmacology, 231, pp. 929-937. , PID: 24221826; 
Bunzeck, N., Guitart-Masip, M., Dolan, R.J., Düzel, E., Contextual novelty modulates the neural dynamics of reward anticipation (2011) J Neurosci, 31 (36), pp. 12816-12822. , PID: 21900560; 
Burgdorf, J., Knutson, B., Panksepp, J., Anticipation of rewarding electrical brain stimulation evokes ultrasonic vocalization in rats (2000) Behav Neurosci, 114 (2), pp. 320-327. , PID: 10832793; 
Burgdorf, J., Knutson, B., Panksepp, J., Ikemoto, S., Nucleus accumbens amphetamine microinjections unconditionally elicit 50-kHz ultrasonic vocalization in rats (2001) Behav Neurosci, 115, pp. 940-944. , PID: 11508733; 
Burgdorf, J., Wood, P., Kroes, R., Moskal, J., Panksepp, J., Neurobiology of 50 kHz ultrasonic vocalization in rats: electrode mapping, lesion, and pharmacology studies (2007) Behav Brain Res, 182, pp. 274-283. , PID: 17449117; 
Burgdorf, J., Colechio, E.M., Stanton, P., Panksepp, J., Positive emotional learning induces resilience to depression: a role for NMDA receptor-mediated synaptic plasticity (2017) Curr Neuropharmacol, 15 (1), pp. 3-10. , PID: 27102428; 
Cohen, J.Y., Haesler, S., Vong, L., Lowell, B.B., Uchida, N., Neuron-type-specific signals for reward and punishment in the ventral tegmental area (2012) Nature, 482, pp. 85-88. , PID: 22258508; 
Conrad, K.L., Tseng, K.Y., Uejima, J.L., Reimers, J.M., Heng, L.J., Shaham, Y., Marinelli, M., Wolf, M.E., Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving (2008) Nature, 454, pp. 118-121. , PID: 18500330; 
Costa, G., Morelli, M., Simola, N., Involvement of glutamate NMDA receptors in the acute, long-term, and conditioned effects of amphetamine on rat 50kHz ultrasonic vocalizations (2015) Int J Neuropsychopharmacol, 18 (11), p. pyv057. , PID: 25991653; 
Cremers, T.I., de Boer, P., Liao, Y., Bosker, F.J., den Boer, J.A., Westerink, B.H., Wikström, H.V., Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram (2000) Eur J Pharmacol, 397 (1), pp. 63-74. , PID: 10844100; 
Dayan, P., Balleine, B.W., Reward, motivation, and reinforcement learning (2002) Neuron, 36, pp. 285-298. , PID: 12383782; 
Drummond, D.C., What does cue-reactivity have to offer clinical research? (2000) Addiction, 95, pp. 129-144; 
Drummond, D.C., Cooper, T., Glautier, S.P., Conditioned learning in alcohol dependence: implications for cue exposure treatment (1990) Br J Addict, 85, pp. 725-743. , PID: 2198966; 
French, S.J., Totterdell, S., Individual nucleus accumbens-projection neurons receive both basolateral amygdala and ventral subicular afferents in rats (2003) Neuroscience, 119 (1), pp. 19-31. , PID: 12763065; 
Friedman, D.P., Aggleton, J.P., Saunders, R.C., Comparison of hippocampal, amygdala, and perirhinal projections to the nucleus accumbens: combined anterograde and retrograde tracing study in the macaque brain (2002) J Comp Neurol, 450, pp. 345-365. , PID: 12209848; 
Fu, X.W., Brudzynski, S.M., High-frequency ultrasonic vocalization induced by intracerebral glutamate in rats (1994) Pharmacol Biochem Behav, 49 (4), pp. 835-841. , PID: 7886095; 
Funk, D., Coen, K., Tamadon, S., Hope, B.T., Shaham, Y., Lê, A., Role of central amygdala neuronal ensembles in incubation of nicotine (2016) Craving J Neurosci, 36 (33), pp. 8612-8623. , PID: 27535909; 
Gawin, F.H., Kleber, H.D., Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations (1986) Arch Gen Psychiatry, 43, pp. 107-113. , PID: 3947206; 
George, M.S., Anton, R.F., Bloomer, C., Teneback, C., Drobes, D.J., Lorberbaum, J.P., Nahas, Z., Vincent, D.J., Activation of prefrontal cortex and anterior thalamus in alcoholic subjects on exposure to alcohol-specific cues (2001) Arch Gen Psychiatry, 58, pp. 345-352. , PID: 11296095; 
Gill, K.M., Grace, A.A., Heterogeneous processing of amygdala and hippocampal inputs in the rostral and caudal subregions of the nucleus accumbens (2011) Int J Neuropsychopharmacol, 14 (10), pp. 1301-1314. , PID: 21211108; 
Grimm, J.W., Hope, B.T., Wise, R.A., Shaham, Y., Neuroadaptation. Incubation of cocaine craving after withdrawal (2001) Nature, 412, pp. 141-142. , PID: 11449260; 
Grimm, J.W., Shaham, Y., Hope, B.T., Effect of cocaine and sucrose withdrawal period on extinction behavior, cue-induced reinstatement, and protein levels of the dopamine transporter and tyrosine hydroxylase in limbic and cortical areas in rats (2002) Behav Pharmacol, 13, pp. 379-388. , PID: 12394414; 
Groenewegen, H.J., Vermeulen-Van der Zee, E., te Kortschot, A., Witter, M.P., Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin (1987) Neuroscience, 23 (1), pp. 103-120. , PID: 3683859; 
Hall, J., Thomas, K.L., Everitt, B.J., Cellular imaging of zif268 expression in the hippocampus and amygdala during contextual and cued fear memory retrieval: selective activation of hippocampal CA1 neurons during the recall of contextual memories (2001) J Neurosci, 21, pp. 2186-2193. , PID: 11245703; 
Hamed, A., Jaroszewski, T., Maciejak, P., Szyndler, J., Lehner, M., Kamecka, I., Plaznik, A., The effects of buspirone and diazepam on aversive context- and social isolation-induced ultrasonic vocalization (2009) Physiol Behav, 98, pp. 474-480. , PID: 19660481; 
Hamed, A., Taracha, E., Szyndler, J., Krząścik, P., Lehner, M., Maciejak, P., Skórzewska, A., Płaźnik, A., The effects of morphine and morphine conditioned context on 50kHz ultrasonic vocalisation in rats (2012) Behav Brain Res, 229 (2), pp. 447-450. , PID: 22326697; 
Hamed, A., Szyndler, J., Taracha, E., Turzyńska, D., Sobolewska, A., Lehner, M., Krząścik, P., Daszczuk, P., κ-opioid receptor as a key mediator in the regulation of appetitive 50-kHz ultrasonic vocalizations (2015) Psychopharmacology, 232 (11), pp. 1941-1955. , PID: 25466704; 
Hamed, A., Daszczuk, P., Kursa, M.B., Turzyńska, D., Sobolewska, A., Lehner, M., Boguszewski, P.M., Szyndler, J., Non-parametric analysis of neurochemical effects and Arc expression in amphetamine-induced 50-kHz ultrasonic vocalization (2016) Behav Brain Res, 312, pp. 174-185. , PID: 27288591; 
Herberg, L.J., Rose, I.C., Excitatory amino acid pathways in brain-stimulation reward (1990) Behav Brain Res, 20 (3), pp. 230-239; 
Hernández-Rabaza, V., Hontecillas-Prieto, L., Velázquez-Sánchez, C., Ferragud, A., Pérez-Villaba, A., Arcusa, A., Barcia, J.A., Canales, J.J., The hippocampal dentate gyrus is essential for generating contextual memories of fear and drug-induced reward (2008) Neurobiol Learn Mem, 90, pp. 553-559. , PID: 18644245; 
Hertz, L., Functional interactions between neurons and astrocytes I. Turnover and metabolism of putative amino acid transmitters (1979) Prog Neurobiol, 13 (3), pp. 277-323. , PID: 42117; 
Hinton, D.J., Lee, M.R., Jacobson, T.L., Mishra, P.K., Frye, M.A., Mrazek, D.A., Macura, S.I., Doo-Sup, C., Ethanol withdrawal-induced brain metabolites and the pharmacological effects of acamprosate in mice lacking ENT1 (2012) Neuropharmacology, 62 (8), pp. 2480-2488. , PID: 22616110; 
Hnasko, T.S., Sotak, B.N., Palmiter, R.D., Morphine reward in dopamine-deficient mice (2005) Nature, 438 (7069), pp. 854-857. , PID: 16341013; 
Hnasko, T.S., Sotak, B.N., Palmiter, R.D., Cocaine-conditioned place preference by dopamine-deficient mice is mediated by serotonin (2007) J Neurosci, 27 (46), pp. 12484-12488. , PID: 18003826; 
Hollup, S.A., Molden, S., Donnett, J.G., Moser, M.B., Moser, E.I., Place fields of rat hippocampal pyramidal cells and spatial learning in the watermaze (2001) Eur J Neurosci, 13 (6), pp. 1197-1208. , PID: 11285017; 
Holm, S., A simple sequentially rejective multiple test procedure (1979) Scand J Stat, 6, pp. 65-70; 
Ikegaya, Y., Saito, H., Abe, K., Attenuated hippocampal longterm potentiation in basolateral amygdala-lesioned rats (1994) Brain Res, 656, pp. 157-164. , PID: 7804830; 
Ikegaya, Y., Saito, H., Abe, K., Dentate gyrus field potentials evoked by stimulation of the basolateral amygdaloid nucleus in anesthetized rats (1996) Brain Res, 718, pp. 53-60. , PID: 8773766; 
Ikegaya, Y., Saito, H., Abe, K., The basomedial and basolateral amygdaloid nuclei contribute to the induction of long-term potentiation in the dentate gyrus in vivo (1996) Eur J Neurosci, 8, pp. 1833-1839. , PID: 8921274; 
Ikemoto, S., Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex (2007) Brain Res Rev, 56, pp. 27-78. , PID: 17574681; 
Ito, R., Robbins, T.W., McNaughton, B.L., Everitt, B.J., Selective excitotoxic lesions of the hippocampus and basolateral amygdala have dissociable effects on appetitive cue and place conditioning based on path integration in a novel Y-maze procedure (2006) Eur J Neurosci, 23 (11), pp. 3071-3080. , PID: 16819997; 
Ito, R., Robbins, T.W., Pennartz, C.M., Everitt, B.J., Functional interaction between the hippocampus and nucleus accumbens shell is necessary for the acquisition of appetitive spatial context conditioning (2008) J Neurosci, 28 (27), pp. 6950-6959. , PID: 18596169; 
John, C.S., Smith, K.L., Van’t Veer, A., Gompf, H.S., Carlezon, W.A., Jr., Cohen, B.M., Öngür, D., Bechtholt-Gompf, A.J., Blockade of astrocytic glutamate uptake in the prefrontal cortex induces anhedonia (2012) Neuropsychopharmacology, 37 (11), pp. 2467-2475. , PID: 22739467; 
Johnson, S.W., North, R.A., Opioids excite dopamine neurons by hyperpolarization of local interneurons (1992) J Neurosci, 12 (2), pp. 483-488. , PID: 1346804; 
Johnson, L.R., Aylward, R.L., Hussain, Z., Totterdell, S., Input from the amygdala to the rat nucleus accumbens: its relationship with tyrosine hydroxylase immunoreactivity and identified neurons (1994) Neuroscience, 61 (4), pp. 851-865. , PID: 7530817; 
Kaneda, N., Asano, M., Nagatsu, T., Simple method for simultaneous determination of acetylcholine, choline, noradrenaline, dopamine and serotonin in brain tissue by high-performance liquid chromatography with electrochemical detection (1986) J Chromatogr, 36, pp. 211-218; 
Knutson, B., Burgdorf, J., Panksepp, J., Anticipation of play elicits high-frequency ultrasonic vocalizations in young rats (1998) J Comp Psychol, 112, pp. 65-73. , PID: 9528115; 
Knutson, B., Burgdorf, J., Panksepp, J., High-frequency ultrasonic vocalizations index conditioned pharmacological reward in rats (1999) Physiol Behav, 66 (4), pp. 639-643. , PID: 10386908; 
Koob, G.F., Drug of abuse: anatomy, pharmacology and function of reward pathways (1992) Trands Pharmacol Sci, 13, pp. 177-184; 
Kursa, M.B., Rudnicki, W.R., Feature selection with the Boruta Package (2010) J Stat Softw, 36 (11), pp. 1-13. , http://www.jstatsoft.org/v36/i11/; 
Lammel, S., Ion, D.I., Roeper, J., Malenka, R.C., Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli (2011) Neuron, 70, pp. 855-862. , PID: 21658580; 
Lammel, S., Ion, D.I., Roeper, J., Malenka, R.C., Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli (2011) Neuron, 70 (5), pp. 855-862. , PID: 21658580; 
Lammel, S., Lim, B.K., Ran, C., Huang, K.W., Betley, M.J., Tye, K.M., Deisseroth, K., Malenka, R.C., Input-specific control of reward and aversion in the ventral tegmental area (2012) Nature, 491, pp. 212-217. , PID: 23064228; 
Langleben, D.D., Ruparel, K., Elman, I., Busch-Winokur, S., Pratiwadi, R., Loughead, J., O’Brien, C.P., Childress, A.R., Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues (2008) Am J Psychiatry, 165, pp. 390-394. , PID: 18056224; 
Langleben, D.D., Ruparel, K., Elman, I., Loughead, J.W., Busch, E.L., Cornish, J., Lynch, K.G., O’Brien, C.P., Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients (2014) Addict Biol, 19, pp. 262-271. , PID: 22747521; 
LeDoux, J.E., Emotion circuits in the brain (2000) Annu Rev Neurosci, 23, pp. 155-184. , PID: 10845062; 
Lee, Y., Gaskins, D., Anand, A., Shekhar, A., Glia mechanisms in mood regulation: a novel model of mood disorders (2007) Psychopharmacology, 191 (1), pp. 55-65. , PID: 17225169; 
Lee, B.R., Ma, Y.Y., Huang, Y.H., Wang, X., Otaka, M., Ishikawa, M., Neumann, P.A., Dong, Y., Maturation of silent synapses in amygdala-accumbens projection contributes to incubation of cocaine craving (2013) Nat Neurosci, 16, pp. 1644-1651. , PID: 24077564; 
Li, Y.Q., Li, F.Q., Wang, X.Y., Wu, P., Zhao, M., Xu, C.M., Shaham, Y., Lu, L., Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving (2008) J Neurosci, 28, pp. 13248-13257. , PID: 19052216; 
Li, Q., Wang, Y., Zhang, Y., Li, W., Yang, W., Zhu, J., Wu, N., Tian, J., Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: an event-related fMRI study (2012) Brain Res, 1469, pp. 63-72. , PID: 22759909; 
Li, X., Zeric, T., Kambhampati, S., Bossert, J.M., Shaham, Y., The central amygdala nucleus is critical for incubation of methamphetamine craving (2015) Neuropsychopharmacology, 40 (5), pp. 1297-1306. , PID: 25475163; 
Li, Y., Zhong, W., Wang, D., Feng, Q., Liu, Z., Zhou, J., Jia, C., Luo, M., Serotonin neurons in the dorsal raphe nucleus encode reward signals (2016) Nat Commun, 7, p. 10503. , PID: 26818705; 
Li, Y., Zhong, W., Wang, D., Feng, Q., Liu, Z., Zhou, J., Jia, C., Luo, M., Serotonin neurons in the dorsal raphe nucleus encode reward signals (2016) Nat Commun, 7, p. 10503. , PID: 26818705; 
Lisman, J.E., Grace, A.A., The hippocampal-VTA loop: controlling the entry of information into long-term memory (2005) Neuron, 46 (5), pp. 703-713. , PID: 15924857; 
Liu, Z., Zhou, J., Li, Y., Hu, F., Lu, Y., Ma, M., Feng, Q., Luo, M., Dorsal raphe neurons signal reward through 5-HT and glutamate (2014) Neuron, 81 (6), pp. 1360-1374. , PID: 24656254; 
Lu, L., Hope, B.T., Dempsey, J., Liu, S.Y., Bossert, J.M., Shaham, Y., Central amygdala ERK signaling pathway is critical to incubation of cocaine craving (2005) Nat Neurosci, 8 (2), pp. 212-219. , PID: 15657599; 
Lu, L., Uejima, J.L., Gray, S.M., Bossert, J.M., Shaham, Y., Systemic and central amygdala injections of the mGluR(2/3) agonist LY379268 attenuate the expression of incubation of cocaine craving (2007) Biol Psychiatry, 61 (5), pp. 591-598. , PID: 16893525; 
Luo, A.H., Tahsili-Fahadan, P., Wise, R.A., Lupica, C.R., Aston-Jones, G., Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area (2011) Science, 15 (6040), pp. 353-357; 
Luo, M., Zhou, J., Liu, Z., Reward processing by the dorsal raphe nucleus: 5-HT and beyond (2015) Learn Mem, 22 (9), pp. 452-460. , PID: 26286655; 
Luo, M., Li, Y., Zhong, W., Do dorsal raphe 5-HT neurons encode “beneficialness”? (2016) Neurobiol Learn Mem, 135, pp. 40-49. , PID: 27544850; 
Ma, Y.Y., Lee, B.R., Wang, X., Guo, C., Liu, L., Cui, R., Lan, Y., Dong, Y., Bidirectional modulation of incubation of cocaine craving by silent synapse-based remodeling of prefrontal cortex to accumbens projections (2014) Neuron, 83, pp. 1453-1467. , PID: 25199705; 
Malvaez, M., Greenfield, V.Y., Wang, A.S., Yorita, A.M., Feng, L., Linker, K.E., Monbouquette, H.G., Wassum, K.M., Basolateral amygdala rapid glutamate release encodes an outcome-specific representation vital for reward-predictive cues to selectively invigorate reward-seeking actions (2015) Sci Rep, 5, p. 12511. , PID: 26212790; 
Maren, S., Fanselow, M.S., Synaptic plasticity in the basolateral amygdala induced by hippocampal formation stimulation in vivo (1995) J Neurosci, 15 (11), pp. 7548-7564. , PID: 7472506; 
Matthews, G.A., Nieh, E.H., Vander Weele, C.M., Halbert, S.A., Pradhan, R.V., Yosafat, A.S., Glober, G.F., Tye, K.M., Dorsal raphe dopamine neurons represent the experience of social isolation (2016) Cell, 164 (4), pp. 617-631. , PID: 26871628; 
McDonald, A.J., Topographical organization of amygdaloid projections to the caudatoputamen, nucleus accumbens, and related striatal-like areas of the rat brain (1991) Neuroscience, 44 (1), pp. 15-33. , PID: 1722890; 
Mei, W., Zhang, J.X., Xiao, Z., Acute effects of sublingual buprenorphine on brain responses to heroin-related cues in early-abstinent heroin addicts: an uncontrolled trial (2010) Neuroscience, 170, pp. 808-815. , PID: 20678551; 
Mello, L.E., Tan, A.M., Finch, D.M., GABAergic synaptic transmission in projections from the basal forebrain and hippocampal formation to the amygdala: an in vivo iontophoretic study (1992) Brain Res, 31, pp. 41-48; 
Mello, L.E., Tan, A.M., Finch, D.M., Convergence of projections from the rat hippocampal formation, medial geniculate and basal forebrain onto single amygdaloid neurons: an in vivo extra- and intracellular electrophysiological study (1992) Brain Res, 31, pp. 24-40; 
Murphy, A., Lubman, D.I., McKie, S., Bijral, P.S., Peters, L.A., Faiz, Q., Holmes, S.E., Elliott, R., Time-dependent neuronal changes associated with craving in opioid dependence: an fMRI study (2017) Addict Biol; 
Nagai, T., Yamada, K., Yoshimura, M., Ishikawa, K., Miyamoto, Y., Hashimoto, K., Noda, Y., Nabeshima, T., The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release (2004) Proc Natl Acad Sci USA, 101 (10), pp. 3650-3655. , PID: 14988509; 
Nakao, K., Matsuyama, K., Matsuki, N., Ikegaya, Y., Amygdala stimulation modulates hippocampal synaptic plasticity (2004) Proc Natl Acad Sci USA, 101 (39), pp. 14270-14275. , PID: 15381775; 
Ntamati, N.R., Lüscher, C., VTA projection neurons releasing GABA and glutamate in the dentate gyrus (2016) eNeuro 3(4); 
O’Donnell, P., Grace, A.A., Synaptic interactions among excitatory afferents to nucleus accumbens neurons: hippocampal gating of prefrontal cortical input (1995) J Neurosci, 15 (5), pp. 3622-3639. , PID: 7751934; 
Opiol, H., Pavlovski, I., Michalik, M., Mistlberger, R.E., Ultrasonic vocalizations in rats anticipating circadian feeding schedules (2015) Behav Brain Res, 284, pp. 42-50. , PID: 25677650; 
Panksepp, J., Burgdorf, J., Laughing” rats and the evolutionary antecedents of human joy? (2003) Physiol Behav, 79 (3), pp. 533-547. , PID: 12954448; 
Pascoli, V., Terrier, J., Espallergues, J., Valjent, E., O’Connor, E.C., Lüscher, C., Contrasting forms of cocaine-evoked plasticity control components of relapse (2014) Nature, 509 (7501), pp. 459-464. , PID: 24848058; 
Paxinos, G., Watson, C., (1998) The rat brain in stereotaxic coordinates, , Academic Press, San Diego; 
Petrovich, G.D., Risold, P.Y., Swanson, L.W., Organization of projections from the basomedial nucleus of the amygdala: a PHAL study in the rat (1996) J Comp Neurol, 374 (3), pp. 387-420. , PID: 8906507; 
Phillipson, O.T., Griffiths, A.C., The topographic order of inputs to nucleus accumbens in the rat (1985) Neuroscience, 16 (2), pp. 275-296. , PID: 4080159; 
Purgianto, A., Scheyer, A.F., Loweth, J.A., Ford, K.A., Tseng, K.Y., Wolf, M.E., Different adaptations in AMPA receptor transmission in the nucleus accumbens after short vs long access cocaine self-administration regimens (2013) Neuropsychopharmacology, 38 (9), pp. 1789-1797. , PID: 23546386; 
Qi, J., Zhang, S., Wang, H.L., Wang, H., de Jesus Aceves Buendia, J., Hoffman, A.F., Lupica, C.R., Morales, M., A glutamatergic reward input from the dorsal raphe to ventral tegmental area dopamine neurons (2014) Nat Commun, 5, p. 5390. , PID: 25388237; 
Core Team, R., (2017) R: a language and environment for statistical computing, , http://www.R-project.org/, R Foundation for Statistical Computing, Vienna; 
Rowley, H.L., Martin, K.F., Marsden, C.A., Determination of in vivo amino acid neurotransmitters by high-performance liquid chromatography with o-phthalaldehyde-sulphite derivatisation (1995) J Neurosci Methods, 57, pp. 93-99. , PID: 7791370; 
Sadananda, M., Natusch, C., Karrenbauer, B., Schwarting, R.K., 50-kHz calls in rats: effects of MDMA and the 5-HT(1A) receptor agonist 8-OH-DPAT (2012) Pharmacol Biochem Behav, 10, pp. 258-264; 
Savicky, P., Spearman’s rank correlation test R package version, p. 3. , https://CRAN.R-project.org/package=pspearman, (2014) pspearman; 
Schultz, W., Dayan, P., Montague, P.R., A neural substrate of prediction and reward (1997) Science, 275, pp. 1593-1599. , PID: 9054347; 
Scofield, M.D., Kalivas, P.W., Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis (2014) Neuroscientist, 20 (6), pp. 610-622. , PID: 24496610; 
Scoville, W.B., Milner, B., Loss of recent memory after bilateral hippocampal lesions (1957) J Neurol Neurosurg Psychiatry, 20, pp. 11-21. , PID: 13406589; 
Sengupta, A., Bocchio, M., Bannerman, D.M., Sharp, T., Capogna, M., Control of amygdala circuits by 5-HT neurons via 5-HT and glutamate cotransmission (2017) J Neurosci, 37 (7), pp. 1785-1796. , PID: 28087766; 
Sesack, S.R., Grace, A.A., Cortico-basal ganglia reward network: microcircuitry (2010) Neuropsychopharmacology, 35 (1), pp. 27-47. , PID: 19675534; 
Shalev, U., Morales, M., Hope, B., Yap, J., Shaham, Y., Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats (2001) Psychopharmacology, 156, pp. 98-107. , PID: 11465640; 
Shepard, J.D., Bossert, J.M., Liu, S.Y., Shaham, Y., The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse (2004) Biol Psychiatry, 55, pp. 1082-1089. , PID: 15158427; 
Shinonaga, Y., Takada, M., Mizuno, N., Topographic organization of collateral projections from the basolateral amygdaloid nucleus to both the prefrontal cortex and nucleus accumbens in the rat (1994) Neuroscience, 58 (2), pp. 389-397. , PID: 8152545; 
Simola, N., Fenu, S., Costa, G., Pinna, A., Plumitallo, A., Morelli, M., Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward (2012) Neuropharmacology, 63, pp. 224-234. , PID: 22465816; 
Sladeczek, F., Pin, J.P., Recasens, M., Bockaert, J., Weiss, S., Glutamate stimulates inositol phosphate formation in striatal neurones (1985) Nature, 317, pp. 717-719. , PID: 2865680; 
Stefaniuk, M., Beroun, A., Lebitko, T., Markina, O., Leski, S., Meyza, K., Grzywacz, A., Kaczmarek, L., Matrix metalloproteinase-9 and synaptic plasticity in the central amygdala in control of alcohol-seeking behavior (2017) Biol Psychiatry, 81 (11), pp. 907-917. , PID: 28190519; 
Stuber, G.D., Sparta, D.R., Stamatakis, A.M., van Leeuwen, W.A., Hardjoprajitno, J.E., Cho, S., Tye, K.M., Bonci, A., Excitatory transmission from the amygdala to nucleus accumbens facilitates reward seeking (2011) Nature, 475, pp. 377-380. , PID: 21716290; 
Szyndler, J., Maciejak, P., Turzyńska, D., Sobolewska, A., Lehner, M., Taracha, E., Walkowiak, J., Plaznik, A., Changes in the concentration of amino acids in the hippocampus of pentylenetetrazole-kindled rats (2008) Neurosci Lett, 439, pp. 245-249. , PID: 18534751; 
Szyndler, J., Maciejak, P., Turzyńska, D., Sobolewska, A., Bidziński, A., Plaznik, A., Time course of changes in the concentrations of monoamines in the brain structures of pentylenetetrazole-kindled rats (2010) J Neural Transm, 117, pp. 707-718. , PID: 20449617; 
Tani, H., Dulla, C.G., Farzampour, Z., Taylor-Weiner, A., Huguenard, J.R., Reimer, R.J., A local glutamate-glutamine cycle sustains synaptic excitatory transmitter release (2014) Neuron, 19 (4), pp. 888-900; 
Taracha, E., Hamed, A., Krząścik, P., Lehner, M., Skórzewska, A., Płaźnik, A., Chrapusta, S.J., Inter-individual diversity and intra-individual stability of amphetamine-induced sensitization of frequency-modulated 50-kHz vocalization in Sprague–Dawley rats (2012) Psychopharmacology, 222 (4), pp. 619-632. , PID: 22354555; 
Thompson, B., Leonard, K.C., Brudzynski, S.M., Amphetamine-induced 50 kHz calls from rat nucleus accumbens: a quantitative mapping study and acoustic analysis (2006) Behav Brain Res, 168 (1), pp. 64-73. , PID: 16343652; 
Tran, L., Lasher, B.K., Young, K.A., Keele, N.B., Depletion of serotonin in the basolateral amygdala elevates glutamate receptors and facilitates fear-potentiated startle (2013) Transl Psychiatry, 3. , PID: 24002084; 
Uejima, J.L., Bossert, J.M., Poles, G.C., Lu, L., Systemic and central amygdala injections of the mGluR2/3 agonist LY379268 attenuate the expression of incubation of sucrose craving in rats (2007) Behav Brain Res, 181 (2), pp. 292-296. , PID: 17537525; 
Van Bockstaele, E.J., Pickel, V.M., Ultrastructure of serotonin-immunoreactive terminals in the core and shell of the rat nucleus accumbens: cellular substrates for interactions with catecholamine afferents (1993) J Comp Neurol, 334 (4), pp. 603-617. , PID: 8408768; 
Wang, H., Liang, S., Burgdorf, J., Wess, J., Yeomans, J., Ultrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice (2008) PLoS One, 3 (4). , PID: 18382674; 
Wintink, A.J., Brudzynski, S.M., The related roles of dopamine and glutamate in the initiation of 50-kHz ultrasonic calls in adult rats (2001) Pharmacol Biochem Behav, 70 (2-3), pp. 317-323. , PID: 11701203; 
Wöhr, M., Rippberger, H., Schwarting, R.K., van Gaalen, M.M., Critical involvement of 5-HT2C receptor function in amphetamine-induced 50-kHz ultrasonic vocalizations in rats (2015) Psychopharmacology, 232 (10), pp. 1817-1829. , PID: 25417553; 
Wolf, M.E., Synaptic mechanisms underlying persistent cocaine craving (2016) Nat Rev Neurosci, 17, pp. 351-365. , PID: 27150400; 
Wolf, M.E., Tseng, K.Y., Calcium-permeable AMPA receptors in the VTA and nucleus accumbens after cocaine exposure: when, how, and why? (2012) Front Mol Neurosci, 5, p. 72. , PID: 22754497; 
Wright, M.N., Ziegler, A., ranger: a fast implementation of random forests for high dimensional data in C++ and R (2017) J Stat Softw, 77 (1), pp. 1-17; 
Wright, J.M., Gourdon, J.C., Clarke, P.B., Identification of multiple call categories within the rich repertoire of adult rat 50-kHz ultrasonic vocalizations: effects of amphetamine and social context (2010) Psychopharmacology, 211 (1), pp. 1-13. , PID: 20443111; 
Wright, J.M., Dobosiewicz, M.R., Clarke, P.B., α- and β-adrenergic receptors differentially modulate the emission of spontaneous and amphetamine-induced 50-kHz ultrasonic vocalizations in adult rats (2012) Neuropsychopharmacology, 37 (3), pp. 808-821. , PID: 22030713; 
Wright, J.M., Deng, L., Clarke, P.B., Failure of rewarding and locomotor stimulant doses of morphine to promote adult rat 50-kHz ultrasonic vocalizations (2012) Psychopharmacology (Berl), 224 (4), pp. 477-487; 
Wright, J.M., Dobosiewicz, M.R., Clarke, P.B., The role of dopaminergic transmission through D1-like and D2-like receptors in amphetamine-induced rat ultrasonic vocalizations (2013) Psychopharmacology, 225 (4), pp. 853-868. , PID: 23052567; 
Zink, M., Vollmayr, B., Gebicke-Haerter, P.J., Henn, F.A., Reduced expression of glutamate transporters vGluT1, EAAT2 and EAAT4 in learned helpless rats, an animal model of depression (2010) Neuropharmacology, 58 (2), pp. 465-473. , PID: 19747495; 
Zink, M., Rapp, S., Donev, R., Gebicke-Haerter, P.J., Thome, J., Fluoxetine treatment induces EAAT2 expression in rat brain (2011) J Neural Transm, 118 (6), pp. 849-855. , PID: 21161710; 
Zweifel, L.S., Fadok, J.P., Argilli, E., Garelick, M.G., Jones, G.L., Dickerson, T.M., Allen, J.M., Palmiter, R.D., (2011) Activation of dopamine neurons is critical for aversive conditioning and prevention of generalized anxiety, 14 (5), pp. 620-626
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047163936&doi=10.1007%2fs00429-018-1683-4&partnerID=40&md5=6b97f3075ac3f846517f7c85162eb0cd
ER  - 

TY  - JOUR
TI  - The impact of opioid epidemic trends on hospitalised inflammatory bowel disease patients
T2  - Journal of Crohn's and Colitis
J2  - J. Crohn's Colitis
VL  - 12
IS  - 9
SP  - 1030
EP  - 1035
PY  - 2018
DO  - 10.1093/ecco-jcc/jjy062
SN  - 18739946 (ISSN) 
AU  - Cohen-Mekelburg, S.
AU  - Rosenblatt, R.
AU  - Gold, S.
AU  - Burakoff, R.
AU  - Waljee, A.K.
AU  - Saini, S.
AU  - Schackman, B.R.
AU  - Scherl, E.
AU  - Crawford, C.
AD  - Division of Gastroenterology and Hepatology, New York Presbyterian Weill Cornell Medical Center, New York, NY, United States
AD  - Department of Medicine, New York Presbyterian Weill Cornell Medical Center, New York, NY, United States
AD  - Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI, United States
AD  - VA Ann Arbor Health Services Research and Development Center of Clinical Management Research, Ann Arbor, MI, United States
AD  - Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, United States
AB  - Background and Aims Opioid use disorder [OUD] has become a public health crisis among patients with chronic disease. Inflammatory bowel disease [IBD] patients are at high risk for OUD because they suffer from chronic relapsing-remitting pain. We aimed to describe the prevalence and trends in OUD-related diagnoses among hospitalised IBD patients. Methods A retrospective study was performed using weighted Nationwide Inpatient Sample data from 2005 to 2014. Adult IBD hospital visits and OUD-related diagnoses were identified using a previously published schema. Annual diagnoses were calculated. Characteristics associated with OUD were assessed using multivariable logistic regression. Associations between OUD and length of stay were assessed overall and separately for surgical and non-surgical stays. Results In all, 2.2% of 2585174 weighted discharges with any diagnosis of IBD also had an OUD-related diagnosis, with an 8.8% average annual increase. In multivariable analysis, Crohn's disease, public payer or no insurance, and psychiatric comorbidities were associated with a higher likelihood of OUD, whereas a primary diagnosis of an IBD-related complication was associated with a lower likelihood. An OUD-related diagnosis was associated with 0.84 days (95% confidence interval [CI] 0.71, 0.97] increased length of stay overall, 2.79 days [95% CI 1.44, 4.14] for surgical stays, and 0.71 days [95% CI 0.59, 0.82] for non-surgical stays. Conclusions OUD-related diagnoses are increasing among IBD patients and are associated with increased length of stay. With a rising prevalence, it is important to screen and diagnose OUD in IBD and refer patients for evidence-based treatment to address unmet patient needs and reduce health care utilisation. © 2018 European Crohn's and Colitis Organisation (ECCO). Published by Oxford University Press.
KW  - Crohn's disease
KW  - Substance abuse
KW  - ulcerative colitis
KW  - opiate
KW  - adult
KW  - Article
KW  - chronic pain
KW  - comorbidity
KW  - complication
KW  - cross-sectional study
KW  - diagnostic test
KW  - disease association
KW  - epidemic
KW  - health insurance
KW  - hospital discharge
KW  - hospital patient
KW  - human
KW  - inflammatory bowel disease
KW  - inflammatory bowel disease related complication
KW  - length of stay
KW  - major clinical study
KW  - mental disease
KW  - opiate addiction
KW  - prevalence
KW  - priority journal
KW  - retrospective study
KW  - surgical patient
KW  - trend study
PB  - Oxford University Press
N1  - Cited By :2
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
LA  - English
N1  - Correspondence Address: Cohen-Mekelburg, S.1305 York Avenue, United States; email: Shc9085@nyp.org
N1  - Chemicals/CAS: opiate, 53663-61-9, 8002-76-4, 8008-60-4
N1  - Funding details: National Institute on Drug Abuse, P30DA040500
N1  - Funding details: Takeda Pharmaceuticals North America
N1  - Funding details: Janssen Pharmaceuticals
N1  - Funding details: AstraZeneca
N1  - Funding details: Pfizer
N1  - Funding details: Janssen Research and Development
N1  - Funding details: Abbott Laboratories, AbbVie
N1  - Funding text 1: A retrospective cross-sectional observational study was performed using Nationwide Inpatient Sample [NIS] data from 2005 to 2014. NIS is the largest all-payer inpatient database in the USA. It is funded by the US Agency for Healthcare Research and Quality as part of the Healthcare Cost and Utilisation Project [HCUP]. NIS includes discharge visit-level information including diagnoses, visit-related characteristics, and healthcare utilisation data.16 The unit of analysis for inpatient data is the hospital discharge, and a person who is readmitted will be counted for each admission as for a separate inpatient stay. The data were weighted to represent national estimates.17
N1  - Funding text 2: This work was supported by the Louis and Rachel Rudin Foundation and the National Institute on Drug Abuse [P30DA040500].
N1  - Funding text 3: ES has received grant/research support from Abbott Laboratories [AbbVie], AstraZeneca, Janssen Research & Development, and Pfizer, and serves as a consultant to AbbVie, Janssen Pharmaceutical, and Takeda Pharmaceuticals. The other authors have no relevant conflicts of interest to disclose.
N1  - References: Murthy, V.H., Ending the opioid epidemic - A call to action (2016) N Engl J Med, 375, pp. 2413-2415; 
Demsey, D., Carr, N.J., Clarke, H., Vipler, S., Managing opioid addiction risk in plastic surgery during the perioperative period (2017) Plast Reconstr Surg, 140, pp. 613e-619e; 
Schuckit, M.A., Treatment of opioid-use disorders (2016) N Engl J Med, 375, pp. 1596-1597; 
Rudd, R.A., Seth, P., David, F., Scholl, L., Increases in drug and opioid-involved overdose deaths United States, 2010-2015 (2016) MMWR Morb Mortal Wkly Rep, 65, pp. 1445-1452; 
Hedegaard, H., Warner, M., Miniño, A.M., Drug overdose deaths in the United States, 1999-2016 (2017) NCHS Data Brief, 294, pp. 1-8; 
Weiss, A.J., Elixhauser, A., Barrett, M.L., (2016) Opioid-related Inpatient Stays and Emergency Department Visits by State, 2009-2014, , Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Rockville, MD: Agency for Healthcare Research and Quality; 
Dowell, D., Haegerich, T.M., Chou, R., CDC guideline for prescribing opioids for chronic pain - United States, 2016 (2016) MMWR Recomm Rep, 65, pp. 1-49; 
Ballantyne, J.C., Opioids for the treatment of chronic pain: Mistakes made, lessons learned, and future directions (2017) Anesth Analg, 125, pp. 1769-1778; 
Targownik, L.E., Nugent, Z., Singh, H., Bugden, S., Bernstein, C.N., The prevalence and predictors of opioid use in inflammatory bowel disease: A population-based analysis (2014) Am J Gastroenterol, 109, pp. 1613-1620; 
Sweeney, L., Moss-Morris, R., Czuber-Dochan, W., Meade, L., Chumbley, G., Norton, C., Systematic review: Psychosocial factors associated with pain in inflammatory bowel disease (2018) Aliment Pharmacol Ther, 47, pp. 715-729; 
Balbale, S.N., Trivedi, I., O'Dwyer, L.C., Strategies to identify and reduce opioid misuse among patients with gastrointestinal disorders: A systematic scoping review (2017) Dig Dis Sci, 62, pp. 2668-2685; 
Hanson, K.A., Loftus, E.V., Jr., Harmsen, W.S., Diehl, N.N., Zinsmeister, A.R., Sandborn, W.J., Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: A case-control study (2009) Inflamm Bowel Dis, 15, pp. 772-777; 
Cross, R.K., Wilson, K.T., Binion, D.G., Narcotic use in patients with Crohn's disease (2005) Am J Gastroenterol, 100, pp. 2225-2229; 
Burr, N.E., Smith, C., West, R., Hull, M.A., Subramanian, V., Increasing prescription of opiates and mortality in patients with inflammatory bowel diseases in England (2018) Clin Gastroenterol Hepatol, 16, pp. 534-534e6; 
Han, B., Compton, W.M., Blanco, C., Crane, E., Lee, J., Jones, C.M., Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 national survey on drug use and health (2017) Ann Intern Med, 167, pp. 293-301; 
(2018) Healthcare Cost and Utilization Project [HCUP]. HCUP National Inpatient Sample [NIS], , Rockville, MD: Agency for Healthcare Research and Quality; 
Healthcare Cost and Resource Utilization Project. Weights for HCUP NIS Data, , Rockville, MD: Agency for Healthcare Research and Quality; 
Barnes, E.L., Kochar, B., Long, M.D., Modifiable risk factors for hospital readmission among patients with inflammatory bowel disease in a nationwide database (2017) Inflamm Bowel Dis, 23, pp. 875-881; 
Ananthakrishnan, A.N., McGinley, E.L., Binion, D.G., Saeian, K., A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalisations (2011) J Gastrointest Surg, 15, pp. 267-276; 
(2017) Agency for the Healthcare Cost and Resource Utilization Project. NIS Checklist, , Rockville, MD: Agency for Healthcare Research and Quality; 
(2017) Agency for the Healthcare Cost and Resource Utilization Project. Nationwide Data Use Agreement, , Rockville, MD: Agency for Healthcare Research and Quality; 
Ananthakrishnan, A.N., McGinley, E.L., Binion, D.G., Does it matter where you are hospitalised for inflammatory bowel disease? A nationwide analysis of hospital volume (2008) Am J Gastroenterol, 103, pp. 2789-2798; 
Damle, R.N., Cherng, N.B., Flahive, J.M., Clostridium difficile infection after colorectal surgery: A rare but costly complication (2014) J Gastrointest Surg, 18, pp. 1804-1811; 
Xu, J., Tang, M., Shen, J., Trends and factors affecting hospitalisation costs in patients with inflammatory bowel disease: A two-center study over the past decade (2013) Gastroenterol Res Pract, 2013, p. 267630; 
Ananthakrishnan, A.N., McGinley, E.L., Infection-related hospitalisations are associated with increased mortality in patients with inflammatory bowel diseases (2013) J Crohns Colitis, 7, pp. 107-112; 
Ananthakrishnan, A.N., McGinley, E.L., Saeian, K., Binion, D.G., Laparoscopic resection for inflammatory bowel disease: Outcomes from a nationwide sample (2010) J Gastrointest Surg, 14, pp. 58-65; 
Brady, M.T., Patts, G.J., Rosen, A., Postoperative venous thromboembolism in patients undergoing abdominal surgery for IBD: A common but rarely addressed problem (2017) Dis Colon Rectum, 60, pp. 61-67; 
Nguyen, G.C., Munsell, M., Harris, M.L., Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalised inflammatory bowel disease patients (2008) Inflamm Bowel Dis, 14, pp. 1105-1111; 
Ramsey, M., Krishna, S.G., Stanich, P.P., Inflammatory bowel disease adversely impacts colorectal cancer surgery short-term outcomes and health-care resource utilisation (2017) Clin Transl Gastroenterol, 8, p. e127; 
(2017) Agency for the Healthcare Cost and Resource Utilization Project. Clinical Classifications Software [CCS] for ICD-9-CM, , Rockville, MD: Agency for Healthcare Research and Quality; 
Cochran, G., Gordon, A.J., Lo-Ciganic, W.H., An examination of claimsbased predictors of overdose from a large Medicaid program (2017) Med Care, 55, pp. 291-298; 
Docherty, M.J., Jones, I.I.I.R.C., Wallace, M.S., Managing pain in inflammatory bowel disease (2011) Gastroenterol Hepatol, 7, pp. 592-601; 
Lichtenstein, G.R., Feagan, B.G., Cohen, R.D., Serious infection and mortality in patients with Crohn's disease: More than 5 years of follow-up in the TREAT registry (2012) Am J Gastroenterol, 107, pp. 1409-1422; 
Shiner, B., Leonard Westgate, C., Bernardy, N.C., Schnurr, P.P., Watts, B.V., Trends in opioid use disorder diagnoses and medication treatment among veterans with posttraumatic stress disorder (2017) J Dual Diagn, 13, pp. 201-212; 
Srinath, A., Young, E., Szigethy, E., Pain management in patients with inflammatory bowel disease: Translational approaches from bench to bedside (2014) Inflamm Bowel Dis, 20, pp. 2433-2449; 
Mazer-Amirshahi, M., Mullins, P.M., Rasooly, I., Van Den Anker, J., Pines, J.M., Rising opioid prescribing in adult U.S. emergency department visits: 2001-2010 (2014) SAcad Emerg Med, 21, pp. 236-243; 
Kirson, N.Y., Shei, A., Rice, J.B., The burden of undiagnosed opioid abuse among commercially insured individuals (2015) Pain Med, 16, pp. 1325-1332; 
Katz, C., El-Gabalawy, R., Keyes, K.M., Martins, S.S., Sareen, J., Risk factors for incident nonmedical prescription opioid use and abuse and dependence: Results from a longitudinal nationally representative sample (2013) Drug Alcohol Depend, 132, pp. 107-113; 
Larney, S., Bohnert, A.S., Ganoczy, D., Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011 (2015) Drug Alcohol Depend, 147, pp. 32-37; 
Guy, G.P., Jr., Zhang, K., Bohm, M.K., Vital signs: Changes in opioid prescribing in the United States, 2006-2015 (2017) MMWR Morb Mortal Wkly Rep, 66, pp. 697-704; 
Poojary, P., Saha, A., Chauhan, K., Predictors of hospital readmissions for ulcerative colitis in the United States: A national database study (2017) Inflamm Bowel Dis, 23, pp. 347-356; 
Edwards, J.T., Radford-Smith, G.L., Florin, T.H., Chronic narcotic use in inflammatory bowel disease patients: Prevalence and clinical characteristics (2001) J Gastroenterol Hepatol, 16, pp. 1235-1238; 
Crocker, J.A., Yu, H., Conaway, M., Tuskey, A.G., Behm, B.W., Narcotic use and misuse in Crohn's disease (2014) Inflamm Bowel Dis, 20, pp. 2234-2238; 
Menendez, M.E., Ring, D., Bateman, B.T., Preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery (2015) Clin Orthop Relat Res, 473, pp. 2402-2412; 
Ahn, W.Y., Vassileva, J., Machine-learning identifies substance-specific behavioral markers for opiate and stimulant dependence (2016) Drug Alcohol Depend, 161, pp. 247-257; 
Micic, D., Gaetano, J.N., Rubin, J.N., Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease (2017) Plos One, 12, p. e0182900
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055806285&doi=10.1093%2fecco-jcc%2fjjy062&partnerID=40&md5=db4cc47e8af3ddc69a128b0bbbc8bfe9
ER  - 

TY  - JOUR
TI  - Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
T2  - BMJ Open
J2  - BMJ Open
VL  - 8
IS  - 8
PY  - 2018
DO  - 10.1136/bmjopen-2018-025204
SN  - 20446055 (ISSN) 
AU  - Larney, S.
AU  - Hickman, M.
AU  - Fiellin, D.A.
AU  - Dobbins, T.
AU  - Nielsen, S.
AU  - Jones, N.R.
AU  - Mattick, R.P.
AU  - Ali, R.
AU  - Degenhardt, L.
AD  - National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
AD  - Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, United Kingdom
AD  - Schools of Medicine and Public Health, Yale University, New Haven, CT, United States
AD  - Monash Addiction Research Centre, Monash University, Melbourne, VIC, Australia
AD  - Medical Sciences, University of Adelaide, Adelaide, SA, Australia
AB  - Introduction North America is amid an opioid use epidemic. Opioid agonist treatment (OAT) effectively reduces extramedical opioid use and related harms. As with all pharmacological treatments, there are risks associated with OAT, including fatal overdose. There is a need to better understand risk for adverse outcomes during and after OAT, and for innovative approaches to identifying people at greatest risk of adverse outcomes. The Opioid Agonist Treatment and Safety study aims to address these questions so as to inform the expansion of OAT in the USA. Methods and analysis This is a retrospective cohort study using linked, routinely collected health data for all people seeking OAT in New South Wales, Australia, between 2001 and 2017. Linked data include hospitalisation, emergency department presentation, mental health diagnoses, incarceration and mortality. We will use standard regression techniques to model the magnitude and risk factors for adverse outcomes (eg, mortality, unplanned hospitalisation and emergency department presentation, and unplanned treatment cessation) during and after OAT, and machine learning approaches to develop a risk-prediction model. Ethics and dissemination This study has been approved by the Population and Health Services Research Ethics Committee (2018HRE0205). Results will be reported in accordance with the REporting of studies Conducted using Observational Routinely-collected health Data statement. © Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
KW  - buprenorphine
KW  - data linkage
KW  - methadone
KW  - opiate substitution treatment
KW  - opiate agonist
KW  - buprenorphine
KW  - methadone
KW  - narcotic analgesic agent
KW  - opiate receptor
KW  - adverse outcome
KW  - Article
KW  - Australia
KW  - cohort analysis
KW  - drug safety
KW  - emergency ward
KW  - hospitalization
KW  - human
KW  - machine learning
KW  - mental health
KW  - mortality
KW  - New South Wales
KW  - prediction
KW  - retrospective study
KW  - risk assessment
KW  - risk factor
KW  - treatment withdrawal
KW  - drug overdose
KW  - epidemiology
KW  - hospital emergency service
KW  - methodology
KW  - opiate addiction
KW  - patient dropout
KW  - regression analysis
KW  - Analgesics, Opioid
KW  - Buprenorphine
KW  - Drug Overdose
KW  - Emergency Service, Hospital
KW  - Hospitalization
KW  - Humans
KW  - Methadone
KW  - New South Wales
KW  - Opioid-Related Disorders
KW  - Patient Dropouts
KW  - Receptors, Opioid
KW  - Regression Analysis
KW  - Research Design
KW  - Retrospective Studies
KW  - Risk Factors
PB  - BMJ Publishing Group
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C7  - e025204
C2  - 30082370
LA  - English
N1  - Correspondence Address: Larney, S.; National Drug and Alcohol Research Centre, University of New South WalesAustralia; email: s.larney@unsw.edu.au
N1  - Chemicals/CAS: buprenorphine, 52485-79-7, 53152-21-9; methadone, 1095-90-5, 125-56-4, 23142-53-2, 297-88-1, 76-99-3; Analgesics, Opioid; Buprenorphine; Methadone; Receptors, Opioid
N1  - Funding details: National Institute on Drug Abuse, R01DA044170
N1  - Funding details: National Health and Medical Research Council
N1  - Funding details: National Health and Medical Research Council, GNT1140938
N1  - Funding details: GNT1132433
N1  - Funding details: National Health and Medical Research Council, GNT1135991
N1  - Funding details: Department of Health and Ageing, Australian Government
N1  - Funding details: National Drug and Alcohol Research Centre
N1  - Funding text 1: Funding This publication was supported by the National Institute on Drug Abuse grant number R01DA044170. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute on Drug Abuse. SL is supported by an Australian National Health and Medical Research Council (NHMRC) Career Development Fellowship (GNT1140938).
N1  - Funding text 2: LD is supported by an Australian NHMRC Senior Principal Research Fellowship (GNT1135991). SN is supported by an Australian NHMRC Translating Research Into Practice Fellowship (GNT1132433). MH acknowledges support from NIHR HPRU in Evaluation. The National Drug and Alcohol Research Centre at UNSW Sydney is supported by the Australian Government Department of Health and Ageing.
N1  - References: Seth, P., Scholl, L., Rudd, R.A., Overdose deaths involving opioids, cocaine, and psychostimulants-United States, 2015-2016 (2018) MMWR Morb Mortal Wkly Rep, 67, pp. 349-358; 
Roxburgh, A., Hall, W.D., Dobbins, T., Trends in heroin and pharmaceutical opioid overdose deaths in Australia (2017) Drug Alcohol Depend, 179, pp. 291-298; 
(2018) Illicit Drug Overdose Deaths in BC, , British Columbia Coroners Service Vancouver: British Columbia Coroners Service; 
Han, B., Compton, W.M., Jones, C.M., Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013 (2015) JAMA, 314, pp. 1468-1478; 
Smolina, K., Gladstone, E., Morgan, S.G., Determinants of trends in prescription opioid use in British Columbia, Canada, 2005-2013 (2016) Pharmacoepidemiol Drug Saf, 25, pp. 553-559; 
Karanges, E.A., Buckley, N.A., Brett, J., Trends in opioid utilisation in Australia, 2006-2015: Insights from multiple metrics (2018) Pharmacoepidemiol Drug Saf, 27, pp. 504-512; 
Jones, A.A., Jang, K., Panenka, W.J., Rapid change in fentanyl prevalence in a community-based, high-risk sample (2018) JAMA Psychiatry, 75, pp. 298-300; 
Jones, C.M., Einstein, E.B., Compton, W.M., Changes in synthetic opioid involvement in drug overdose deaths in the United States, 2010-2016 (2018) JAMA, 319, pp. 1819-1821; 
Conrad, C., Bradley, H.M., Broz, D., Community outbreak of HIV infection linked to injection drug use of oxymorphone-Indiana, 2015 (2015) MMWR Morb Mortal Wkly Rep, 64, pp. 443-444; 
Zibbell, J.E., Hart-Malloy, R., Barry, J., Risk factors for HCV infection among young adults in rural New York who inject prescription opioid analgesics (2014) Am J Public Health, 104, pp. 2226-2232; 
Stanley, M.M., Guilfoyle, S., Vergeront, J.M., Hepatitis C virus infections among young adults-rural Wisconsin, 2010 (2012) Morbidity and Mortality Weekly Report, 61, p. 358; 
Onofrey, S., Church, D., Kludt, P., Hepatitis C virus infection among adolescents and young adults-Massachusetts, 2002-2009 (2011) Morbidity and Mortality Weekly Report, 60, pp. 538-541; 
Peters, P.J., Pontones, P., Hoover, K.W., HIV infection linked to injection use of oxymorphone in Indiana, 2014-2015 (2016) N Engl J Med, 375, pp. 229-239; 
(2017) The Underestimated Cost of the Opioid Crisis, , The Council of Economic Advisers Washington DC: Executive Office of the President of the United States; 
(2009) Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence, , World Health Organization Geneva: World Health Organization; 
Nielsen, S., Larance, B., Degenhardt, L., Opioid agonist treatment for pharmaceutical opioid dependent people (2016) Cochrane Database Syst Rev, 2016, p. 172; 
Degenhardt, L., Bucello, C., Mathers, B., Mortality among regular or dependent users of heroin and other opioids: A systematic review and meta-analysis of cohort studies (2011) Addiction, 106, pp. 32-51; 
Platt, L., Minozzi, S., Reed, J., Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: Findings from a Cochrane Review and meta-analysis (2018) Addiction, 113, pp. 545-563; 
MacArthur, G.J., Minozzi, S., Martin, N., Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis (2012) BMJ, 345, p. e5945; 
Kendall, C.E., Boucher, L.M., Mark, A.E., A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada (2017) Harm Reduction Journal, 14 (1); 
Robertson, A.G., Easter, M.M., Lin, H.-J., Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness (2018) J Subst Abuse Treat, 86, pp. 17-25; 
Mohlman, M.K., Tanzman, B., Finison, K., Impact of medicationassisted treatment for opioid addiction on medicaid expenditures and health services utilization rates in Vermont (2016) J Subst Abuse Treat, 67, pp. 9-14; 
Krebs, E., Kerr, T., Montaner, J., Dynamics in the costs of criminality among opioid dependent individuals (2014) Drug Alcohol Depend, 144, pp. 193-200; 
Deck, D., Wiitala, W., McFarland, B., Medicaid coverage, methadone maintenance, and felony arrests: Outcomes of opiate treatment in two states (2009) J Addict Dis, 28, pp. 89-102; 
Russolillo, A., Moniruzzaman, A., McCandless, L.C., Associations between methadone maintenance treatment and crime: A 17-year longitudinal cohort study of Canadian provincial offenders (2018) Addiction, 113; 
Sordo, L., Barrio, G., Bravo, M.J., Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies (2017) BMJ, 357, p. j1550; 
Kimber, J., Larney, S., Hickman, M., Mortality risk of opioid substitution therapy with methadone versus buprenorphine: A retrospective cohort study (2015) Lancet Psychiatry, 2, pp. 901-908; 
Hickman, M., Steer, C., Tilling, K., The impact of buprenorphine and methadone on mortality: A primary care cohort study in the United Kingdom (2018) Addiction, 113, pp. 1461-1476; 
Bramness, J.G., Skurtveit, S., Mørland, J., An increased risk of motor vehicle accidents after prescription of methadone (2012) Addiction, 107, pp. 967-972; 
Kao, D.P., Haigney, M.C.P., Mehler, P.S., Arrhythmia associated with buprenorphine and methadone reported to the food and drug administration (2015) Addiction, 110, pp. 1468-1475; 
Dasgupta, N., Bailey, E.J., Cicero, T., Post-marketing surveillance of methadone and buprenorphine in the United States (2010) Pain Medicine, 11, pp. 1078-1091; 
Johanson, C.-E., Arfken, C.L., Di Menza, S., Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians (2012) Drug Alcohol Depend, 120, pp. 190-195; 
Larance, B., Mattick, R.P., Ali, R., Diversion and injection of buprenorphine-naloxone film two years post-introduction in Australia (2016) Drug Alcohol Rev, 35, pp. 83-91; 
Kampman, K., Jarvis, M., American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use (2015) J Addict Med, 9, pp. 358-367; 
(2005) Medication-assisted Treatment for Opioid Addiction in Opioid Treatment Programs, , Center for Substance Abuse Treatment Treatment Improvement Protocol (TIP) Series 43. Rockville MD: Substance Abuse and Mental Health Services Administration; 
(2004) Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction, , Center for Substance Abuse Treatment Treatment Improvement Protocol (TIP) series 40. Rockville MD: Substance Abuse and Mental Health Services Administration; 
Kessler, R.C., Warner, C.H., Ivany, C., Predicting suicides after psychiatric hospitalization in US army soldiers: The Army Study to Assess Risk and Resilience in Servicemembers (Army STARRS) (2015) JAMA Psychiatry, 72, pp. 49-57; 
(2017) National Opioid Pharmacotherapy Statistics (NOPSAD) 2016, , AIHW Canberra: Australian Institute of Health and Welfare; 
(2006) Opioid Treatment Program: Clinical Guidelines for Methadone and Buprenorphine Treatment, , NSW Health Department Sydney: NSW Health Department; 
Ritter, A., Chalmers, J., (2009) Polygon: The Many Sides to the Australian Opioid Pharmacotherapy Maintenance System, , Canberra: Australian National Council on Drugs; 
Lawrence, G., Dinh, I., Taylor, L., The centre for health record linkage: A new resource for health services research and evaluation (2008) Health Information Management Journal, 37, pp. 60-62; 
Breiman, L., Random forests (2001) Mach Learn, 45, pp. 5-32; 
Friedman, J., Hastie, T., Tibshirani, R., Regularization paths for generalized linear models via coordinate descent (2010) J Stat Softw, 33, pp. 1-22; 
Zou, H., Hastie, T., Regularization and variable selection via the elastic net (2005) Journal of the Royal Statistical Society: Series B, 67, pp. 301-320; 
Benchimol, E.I., Smeeth, L., Guttmann, A., The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) Statement (2015) PLoS Med, 12, p. e1001885
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053165252&doi=10.1136%2fbmjopen-2018-025204&partnerID=40&md5=0f7e3ac3125f91df07a6da50919194b4
ER  - 

TY  - JOUR
TI  - Pathways from epigenomics and glycobiology towards novel biomarkers of addiction and its radical cure
T2  - Medical Hypotheses
J2  - Med. Hypotheses
VL  - 116
SP  - 10
EP  - 21
PY  - 2018
DO  - 10.1016/j.mehy.2018.04.011
SN  - 03069877 (ISSN) 
AU  - Reece, A.S.
AU  - Wang, W.
AU  - Hulse, G.K.
AD  - Division of Psychiatry, University of Western Australia, Crawley, Western Australia  6009, Australia
AD  - School of Medical and Health Sciences, Edith Cowan University, Joondalup, Western Australia  6027, Australia
AB  - The recent demonstration that addiction-relevant neuronal ensembles defined by known master transcription factors and their connectome is networked throughout mesocorticolimbic reward circuits and resonates harmonically at known frequencies implies that single-cell pan-omics techniques can improve our understanding of Substance Use Disorders (SUD's). Application of machine learning algorithms to such data could find diagnostic utility as biomarkers both to define the presence of the disorder and to quantitate its severity and find myriad applications in a developmental pipeline towards therapeutics and cure. Recent epigenomic studies have uncovered a wealth of clinically important data relating to synapse-nucleus signalling, memory storage, lineage-fate determination and cellular control and are contributing greatly to our understanding of all SUD's. Epigenetics interacts extensively with glycobiology. Glycans decorate DNA, RNA and many circulating critical proteins particularly immunoglobulins. Glycosylation is emerging as a major information-laden post-translational protein modification with documented application for biomarker development. The integration of these two emerging cutting-edge technologies provides a powerful and fertile algorithmic-bioinformatic space for the development both of SUD biomarkers and novel cutting edge therapeutics. Hypotheses: These lines of evidence provide fertile ground for hypotheses relating to both diagnosis and treatment. They suggest that biomarkers derived from epigenomics complemented by glycobiology may potentially provide a bedside diagnostic tool which could be developed into a clinically useful biomarker to gauge both the presence and the severity of SUD's. Moreover they suggest that modern information-based therapeutics acting on the epigenome, via RNA interference or by DNA antisense oligonucleotides may provide a novel 21st century therapeutic development pipeline towards the radical cure of addictive disorders. Such techniques could be focussed and potentiated by neurotrophic vectors or the application of interfering electric or magnetic fields deep in the medial temporal lobes of the brain. © 2018
KW  - Aging
KW  - Biomarker
KW  - Epigenomics
KW  - Glycobiology
KW  - Opioid
KW  - Single cell assays
KW  - biological marker
KW  - DNA
KW  - immunoglobulin
KW  - opiate
KW  - protein
KW  - RNA
KW  - antisense oligonucleotide
KW  - biological marker
KW  - DNA
KW  - immunoglobulin
KW  - RNA
KW  - transcription factor
KW  - Article
KW  - cell fate
KW  - cell nucleus
KW  - connectome
KW  - epigenetics
KW  - glycobiology
KW  - glycosylation
KW  - human
KW  - machine learning
KW  - nerve cell
KW  - nonhuman
KW  - opiate addiction
KW  - pathogenesis
KW  - RNA interference
KW  - signal transduction
KW  - synapse
KW  - addiction
KW  - algorithm
KW  - brain
KW  - cell lineage
KW  - DNA methylation
KW  - drug dependence
KW  - genetic epigenesis
KW  - genetics
KW  - glycobiology
KW  - magnetic field
KW  - metabolism
KW  - pathology
KW  - temporal lobe
KW  - Algorithms
KW  - Behavior, Addictive
KW  - Biomarkers
KW  - Brain
KW  - Cell Lineage
KW  - DNA
KW  - DNA Methylation
KW  - Epigenesis, Genetic
KW  - Epigenomics
KW  - Glycomics
KW  - Glycosylation
KW  - Humans
KW  - Immunoglobulins
KW  - Machine Learning
KW  - Magnetic Fields
KW  - Oligonucleotides, Antisense
KW  - RNA
KW  - RNA Interference
KW  - Substance-Related Disorders
KW  - Temporal Lobe
KW  - Transcription Factors
PB  - Churchill Livingstone
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: MEHYD
C2  - 29857889
LA  - English
N1  - Correspondence Address: Reece, A.S.39 Gladstone Rd., Highgate Hill, Australia; email: sreece@bigpond.net.au
N1  - Chemicals/CAS: DNA, 9007-49-2; immunoglobulin, 9007-83-4; opiate, 53663-61-9, 8002-76-4, 8008-60-4; protein, 67254-75-5; RNA, 63231-63-0; Biomarkers; DNA; Immunoglobulins; Oligonucleotides, Antisense; RNA; Transcription Factors
N1  - References: Degenhardt, L., Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010 (2013) Lancet, 382 (9904), pp. 1564-1574; 
Murthy, V.H., Ending the opioid epidemic — a call to action (2016) N Engl J Med, 375 (25), pp. 2413-2415; 
Hutchinson, M.R., Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia (2011) Pharmacol Rev, 63 (3), pp. 772-810; 
Reece, A.S., Hulse, G.K., Hypothalamic pathophysiology in the neuroimmune, dysmetabolic and longevity complications of chronic opiate dependency (2014) J. Forensic Toxicol Pharmacol, 3, pp. 3-46; 
Reece, A.S., Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management (2012) Subst Abuse, 6, pp. 115-133; 
Degenhardt, L., Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved (2009) Drug Alcohol Depend, 105 (1-2), pp. 9-15; 
Robison, A.J., Nestler, E.J., Transcriptional and epigenetic mechanisms of addiction (2011) Nat Rev Neurosci, 12 (11), pp. 623-637; 
Borrelli, E., Decoding the epigenetic language of neuronal plasticity (2008) Neuron, 60 (6), pp. 961-974; 
Liu, C., A DNA methylation biomarker of alcohol consumption (2016) Mol Psychiatry; 
Huang, H., Fine-mapping inflammatory bowel disease loci to single-variant resolution (2017) Nature, 547 (7662), pp. 173-178; 
Yu, X., Profiling IgG N-glycans as potential biomarker of chronological and biological ages: a community-based study in a Han Chinese population (2016) Medicine (Baltimore), 95 (28), p. e4112; 
Vuckovic, F., Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome (2015) Arthritis Rheumatol, 67 (11), pp. 2978-2989; 
Russell, A.C., The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease (2017) Glycobiology, 27 (5), pp. 501-510; 
Sebastian, A., Glycan biomarkers for rheumatoid arthritis and its remission status in Han Chinese patients (2016) OMICS, 20 (6), pp. 343-351; 
Hebb, D.O., The organization of behavior: a neuropsychological theory (1949), Lawrence Erlbaum Associates; Calipari, E.S., Dopaminergic dynamics underlying sex-specific cocaine reward (2017) Nat Commun, 8, p. 13877; 
Xue, Y.X., Selective inhibition of amygdala neuronal ensembles encoding nicotine-associated memories inhibits nicotine preference and relapse (2017) Biol Psychiatry; 
Leao, R.M., Chronic nicotine activates stress/reward-related brain regions and facilitates the transition to compulsive alcohol drinking (2015) J Neurosci, 35 (15), pp. 6241-6253; 
Caprioli, D., Role of dorsomedial striatum neuronal ensembles in incubation of methamphetamine craving after voluntary abstinence (2017) J Neurosci, 37 (4), pp. 1014-1027; 
Cruz, F.C., Role of nucleus accumbens shell neuronal ensembles in context-induced reinstatement of cocaine-seeking (2014) J Neurosci, 34 (22), pp. 7437-7446; 
Whitaker, L.R., Bidirectional modulation of intrinsic excitability in rat prelimbic cortex neuronal ensembles and non-ensembles after operant learning (2017) J Neurosci, 37 (36), pp. 8845-8856; 
Bossert, J.M., Ventral medial prefrontal cortex neuronal ensembles mediate context-induced relapse to heroin (2011) Nat Neurosci, 14 (4), pp. 420-422; 
Cruz, F.C., Using c-fos to study neuronal ensembles in corticostriatal circuitry of addiction (2015) Brain Res, 1628, pp. 157-173; 
Zeisel, A., Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq (2015) Science, 347 (6226), pp. 1138-1142; 
Hsiang, H.L., Manipulating a “cocaine engram” in mice (2014) J Neurosci, 34 (42), pp. 14115-14127; 
Trouche, S., Recoding a cocaine-place memory engram to a neutral engram in the hippocampus (2016) Nat Neurosci, 19 (4), pp. 564-567; 
Koya, E., Targeted disruption of cocaine-activated nucleus accumbens neurons prevents context-specific sensitization (2009) Nat Neurosci, 12 (8), pp. 1069-1073; 
Fanous, S., Role of orbitofrontal cortex neuronal ensembles in the expression of incubation of heroin craving (2012) J Neurosci, 32 (34), pp. 11600-11609; 
Kandel, E.R., The molecular biology of memory storage: a dialogue between genes and synapses (2001) Science, 294 (5544), pp. 1030-1038; 
Nabavi, S., Engineering a memory with LTD and LTP (2014) Nature, 511 (7509), pp. 348-352; 
Nestler, E.J., Transgenerational epigenetic contributions to stress responses: fact or fiction? (2016) PLoS Biol, 14 (3), p. e1002426; 
Buzsaki, G., Draguhn, A., Neuronal oscillations in cortical networks (2004) Science, 304 (5679), pp. 1926-1929; 
Yaffe, R.B., Cued memory retrieval exhibits reinstatement of high gamma power on a faster timescale in the left temporal lobe and prefrontal cortex (2017) J Neurosci, 37 (17), pp. 4472-4480; 
Tomassini, A., Theta oscillations locked to intended actions rhythmically modulate perception (2017) Elife, 6, p. e25618; 
Tort, A.B., Theta-gamma coupling increases during the learning of item-context associations (2009) Proc Natl Acad Sci U S A, 106 (49), pp. 20942-20947; 
Buzsaki, G., Moser, E.I., Memory, navigation and theta rhythm in the hippocampal-entorhinal system (2013) Nat Neurosci, 16 (2), pp. 130-138; 
Canolty, R.T., High gamma power is phase-locked to theta oscillations in human neocortex (2006) Science, 313 (5793), pp. 1626-1628; 
Cohen, M.X., Oscillatory activity and phase-amplitude coupling in the human medial frontal cortex during decision making (2009) J Cogn Neurosci, 21 (2), pp. 390-402; 
Garcia-Cordero, I., Attention, in and out: scalp-level and intracranial EEG correlates of interoception and exteroception (2017) Front Neurosci, 11, p. 411; 
Zhou, F., Frequency-dependent changes in local intrinsic oscillations in chronic primary insomnia: a study of the amplitude of low-frequency fluctuations in the resting state (2017) Neuroimage Clin, 15, pp. 458-465; 
Sato, W., Rapid, high-frequency, and theta-coupled gamma oscillations in the inferior occipital gyrus during face processing (2014) Cortex, 60, pp. 52-68; 
Cohen, M.X., Good vibrations: cross-frequency coupling in the human nucleus accumbens during reward processing (2009) J Cogn Neurosci, 21 (5), pp. 875-889; 
Sato, W., Bidirectional electric communication between the inferior occipital gyrus and the amygdala during face processing (2017) Hum Brain Mapp, 38 (9), pp. 4511-4524; 
Axmacher, N., Cross-frequency coupling supports multi-item working memory in the human hippocampus (2010) Proc Natl Acad Sci U S A, 107 (7), pp. 3228-3233; 
Amadei, E.A., Dynamic corticostriatal activity biases social bonding in monogamous female prairie voles (2017) Nature, 546 (7657), pp. 297-301; 
Wang, H., Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles (2013) Nat Neurosci, 16 (7), pp. 919-924; 
Ferguson, D., Essential role of SIRT1 signaling in the nucleus accumbens in cocaine and morphine action (2013) J Neurosci, 33 (41), pp. 16088-16098; 
Mazei-Robison, M.S., Nestler, E.J., Opiate-induced molecular and cellular plasticity of ventral tegmental area and locus coeruleus catecholamine neurons (2012) Cold Spring Harb Perspect Med, 2 (7), p. a012070; 
Rehni, A.K., Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome (2012) Naunyn Schmiedebergs Arch Pharmacol, 385 (6), pp. 605-619; 
Cedar, H., Bergman, Y., Linking DNA methylation and histone modification: patterns and paradigms (2009) Nat Rev Genet, 10 (5), pp. 295-304; 
Heller, E.A., Locus-specific epigenetic remodeling controls addiction- and depression-related behaviors (2014) Nat Neurosci, 17 (12), pp. 1720-1727; 
Miller, C.A., DNA methylation and histone acetylation work in concert to regulate memory formation and synaptic plasticity (2008) Neurobiol Learn Mem, 89 (4), pp. 599-603; 
Sweatt, J.D., Neural plasticity and behavior - sixty years of conceptual advances (2016) J Neurochem, 139, pp. 179-199; 
Heller, E.A., Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental area (2015) J Neurochem, 132 (2), pp. 243-253; 
Nestler, E.J., Reflections on: “A general role for adaptations in G-Proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function” (2016) Brain Res, 1645, pp. 71-74; 
Sun, H., Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens (2012) J Neurosci, 32 (48), pp. 17454-17464; 
Koo, J.W., Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area (2015) Nat Neurosci, 18 (3), pp. 415-422; 
Sanchis-Segura, C., Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition (2009) Neuropsychopharmacology, 34 (13), pp. 2642-2654; 
Wang, R., The extinction of morphine-induced conditioned place preference by histone deacetylase inhibition (2010) Neurosci Lett, 483 (2), pp. 137-142; 
Miller, C.A., Cortical DNA methylation maintains remote memory (2010) Nat Neurosci, 13 (6), pp. 664-666; 
Meadows, J.P., Dynamic DNA methylation regulates neuronal intrinsic membrane excitability (2016) Sci Signal, 9 (442), p. ra83; 
Song, C.X., Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming (2013) Cell, 153 (3), pp. 678-691; 
Kumar, D., Tet1 oxidase regulates neuronal gene transcription, active DNA hydroxy-methylation, object location memory, and threat recognition memory (2015) Neuroepigenetics, 4, pp. 12-27; 
Heyward, F.D., Obesity weighs down memory through a mechanism involving the neuroepigenetic dysregulation of Sirt1 (2016) J Neurosci, 36 (4), pp. 1324-1335; 
Feng, J., Tet1 in nucleus accumbens opposes depression- and anxiety-like behaviors (2017) Neuropsychopharmacology, 42 (8), pp. 1657-1669; 
Feng, J., Role of Tet1 and 5-hydroxymethylcytosine in cocaine action (2015) Nat Neurosci, 18 (4), pp. 536-544; 
Yan, C., Structure of a yeast step II catalytically activated spliceosome (2017) Science, 355 (6321), pp. 149-155; 
Gilbert, W.V., Messenger RNA modifications: form, distribution, and function (2016) Science, 352 (6292), pp. 1408-1412; 
Roundtree, I.A., Dynamic RNA modifications in gene expression regulation (2017) Cell, 169 (7), pp. 1187-1200; 
Savell, K.E., Extra-coding RNAs regulate neuronal DNA methylation dynamics (2016) Nat Commun, 7, p. 12091; 
Yap, K.L., Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a (2010) Mol Cell, 38 (5), pp. 662-674; 
Tripathi, V., Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB (2013) PLoS Genet, 9 (3), p. e1003368; 
Chen, C.K., Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing (2016) Science, 354 (6311), pp. 468-472; 
Boks, M.P., Longitudinal changes of telomere length and epigenetic age related to traumatic stress and post-traumatic stress disorder (2015) Psychoneuroendocrinology, 51, pp. 506-512; 
Li, Y., An epigenetic signature in peripheral blood associated with the haplotype on 17q21.31, a risk factor for neurodegenerative tauopathy (2014) PLoS Genet, 10 (3), p. e1004211; 
Levine, A.J., Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease (2013) BMC Med Genomics, 6, p. 4; 
Horvath, S., Ritz, B.R., Increased epigenetic age and granulocyte counts in the blood of Parkinson's disease patients (2015) Aging (Albany NY), 7 (12), pp. 1130-1142; 
Horvath, S., Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels (2016) Aging (Albany NY), 8 (7), pp. 1485-1512; 
Levine, M.E., Epigenetic age of the pre-frontal cortex is associated with neuritic plaques, amyloid load, and Alzheimer's disease related cognitive functioning (2015) Aging (Albany NY), 7 (12), pp. 1198-1211; 
Ando, B., Personality traits and coping compensate for disadvantageous decision-making in long-term alcohol abstinence (2012) Alcohol Alcohol, 47 (1), pp. 18-24; 
Khalid, O., Gene expression signatures affected by alcohol-induced DNA methylomic deregulation in human embryonic stem cells (2014) Stem Cell Res, 12 (3), pp. 791-806; 
Carroll, J.E., Epigenetic aging and immune senescence in women with insomnia symptoms: findings from the women's health initiative study (2016) Biol Psychiatry; 
Levine, M.E., Menopause accelerates biological aging (2016) Proc Natl Acad Sci U S A, 113 (33), pp. 9327-9332; 
Ceriello, A., Opiate addict as diabetic patient? (1988) Diabetes Care, 11 (5), p. 443; 
Claude Bernard, M., Lecons Sur Le Diabete et la Glycogenese Animale (1877) Cours Med; 
Passariello, N., Glucose tolerance and hormonal responses in heroin addicts. A possible role for endogenous opiates in the pathogenesis of non-insulin-dependent diabetes (1983) Metabolism, 32 (12), pp. 1163-1165; 
Ceriello, A., Impaired glucose metabolism in heroin and methadone users (1987) Horm Metab Res, 19 (9), pp. 430-433; 
Reece, A.S., Manifold implications of forgotten hyperglycaemia in clinical opiate dependence (2013) Drug Chem Toxicol, 36 (1), pp. 55-66; 
Passariello, N., Impaired insulin response to glucose but not to arginine in heroin addicts (1986) J Endocrinol Invest, 9 (5), pp. 353-357; 
Olson, V.G., Regulation of morphine reward and feeding by CREB in the lateral hypothalamus (2007) Synapse, 61 (2), pp. 110-113; 
Neri, S., Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers (2005) Psychopharmacology (Berl), 179 (3), pp. 700-704; 
Reece, A.S., Relative and age dependent stimulation of soluble and cellular immunity in opiate dependence (2012) J Addict Med, 6 (1), pp. 10-17; 
Reece, A.S., Hulse, G.K., Impact of lifetime opioid exposure on arterial stiffness and vascular age: cross-sectional and longitudinal studies in men and women (2014) BMJ Open, 4 (6), pp. 1-19; 
Sadeghian, S., The association of opium with coronary artery disease (2007) Eur J Cardiovasc Prev Rehabil, 14 (5), pp. 715-717; 
Pasmant, E., ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS (2010) FASEB J, 25 (2), pp. 444-448; 
Solis, E., Jr., Intravenous heroin induces rapid brain hypoxia and hyperglycemia that precede brain metabolic response (2017) eNeuro, 4 (3); 
Russo, S.J., IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates (2007) Nat Neurosci, 10 (1), pp. 93-99; 
Li, Y., Morphine induces desensitization of insulin receptor signaling (2003) Mol Cell Biol, 23 (17), pp. 6255-6266; 
Wang, Y., Glycomics and its application potential to precision medicine in precision medicine in China (2016) Science, 354 (6319), pp. 36-39; 
Yang, X., Recruitment of O-GlcNAc transferase to promoters by corepressor mSin3A: coupling protein O-GlcNAcylation to transcriptional repression (2002) Cell, 110 (1), pp. 69-80; 
Czjzek, M., Biochemistry: a wine-induced breakdown (2017) Nature, 544 (7648), pp. 45-46; 
Ndeh, D., Complex pectin metabolism by gut bacteria reveals novel catalytic functions (2017) Nature, 544 (7648), pp. 65-70; 
Sun, C., O-GlcNAcylation: a bridge between glucose and cell differentiation (2016) J Cell Mol Med, 20 (5), pp. 769-781; 
Peres, G.B., Impact of high glucose and AGEs on cultured kidney-derived cells. Effects on cell viability, lysosomal enzymes and effectors of cell signaling pathways (2017) Biochimie, 135, pp. 137-148; 
Wong, T.Y., Hyaluronan keeps mesenchymal stem cells quiescent and maintains the differentiation potential over time (2017) Aging Cell, 16 (3), pp. 451-460; 
Lee, H.J., Glycerol-3-phosphate acyltransferase-1 upregulation by O-GlcNAcylation of Sp1 protects against hypoxia-induced mouse embryonic stem cell apoptosis via mTOR activation (2016) Cell Death Dis, 7, p. e2158; 
Novakovic, B., beta-Glucan reverses the epigenetic state of LPS-induced immunological tolerance (2016) Cell, 167 (5). , 1354-1368 e14; 
Gambetta, M.C., Essential role of the glycosyltransferase sxc/Ogt in polycomb repression (2009) Science, 325 (5936), pp. 93-96; 
Costa, C., Abnormal protein glycosylation and activated PI3K/Akt/mTOR pathway: role in bladder cancer prognosis and targeted therapeutics (2015) PLoS One, 10 (11), p. e0141253; 
Kelly, W.G., RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc (1993) J Biol Chem, 268 (14), pp. 10416-10424; 
Ronningen, T., Prepatterning of differentiation-driven nuclear lamin A/C-associated chromatin domains by GlcNAcylated histone H2B (2015) Genome Res, 25 (12), pp. 1825-1835; 
Ahmed, A.A., Structural characterization of anti-inflammatory immunoglobulin G Fc proteins (2014) J Mol Biol, 426 (18), pp. 3166-3179; 
Lauc, G., Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers (2013) PLoS Genet, 9 (1), p. e1003225; 
Kristic, J., Glycans are a novel biomarker of chronological and biological ages (2014) J Gerontol A Biol Sci Med Sci, 69 (7), pp. 779-789; 
Lauc, G., Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation (2010) PLoS Genet, 6 (12), p. e1001256; 
Lu, J.P., Screening novel biomarkers for metabolic syndrome by profiling human plasma N-glycans in Chinese Han and Croatian populations (2011) J Proteome Res, 10 (11), pp. 4959-4969; 
Wang, Y., The association between glycosylation of immunoglobulin G and hypertension: a multiple ethnic cross-sectional study (2016) Medicine (Baltimore), 95 (17), p. e3379; 
McLachlan, F., A case-control study in an Orcadian population investigating the relationship between human plasma N-glycans and metabolic syndrome (2016) J Glycomics Lipidomics, 6, p. 139; 
Fanous, S., Unique gene alterations are induced in FACS-purified Fos-positive neurons activated during cue-induced relapse to heroin seeking (2013) J Neurochem, 124 (1), pp. 100-108; 
Guez-Barber, D., FACS purification of immunolabeled cell types from adult rat brain (2012) J Neurosci Methods, 203 (1), pp. 10-18; 
Marchant, N.J., Role of ventral subiculum in context-induced relapse to alcohol seeking after punishment-imposed abstinence (2016) J Neurosci, 36 (11), pp. 3281-3294; 
Pickens, C.L., Neurobiology of the incubation of drug craving (2011) Trends Neurosci, 34 (8), pp. 411-420; 
Suto, N., Distinct memory engrams in the infralimbic cortex of rats control opposing environmental actions on a learned behavior (2016) Elife, 5; 
Lobo, M.K., FACS-array profiling of striatal projection neuron subtypes in juvenile and adult mouse brains (2006) Nat Neurosci, 9 (3), pp. 443-452; 
Dewey, F.E., Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease (2017) N Engl J Med, 377 (3), pp. 211-221; 
Graham, M.J., Cardiovascular and metabolic effects of ANGPTL3 antisense oligonucleotides (2017) N Engl J Med, 377 (3), pp. 222-232; 
Keaney, J.F., Jr., CHIP-ping away at atherosclerosis (2017) N Engl J Med, 377 (2), pp. 184-185; 
Pasi, K.J., Targeting of Antithrombin in Hemophilia A or B with RNAi therapy (2017) N Engl J Med, 377 (9), pp. 819-828; 
Mendell, J.R., Single-dose gene-replacement therapy for spinal muscular atrophy (2017) N Engl J Med, 377 (18), pp. 1713-1722; 
Kaiser, J., Gene therapy triumph (2017) Science, 358 (6370), p. 1526; 
Filippakopoulos, P., Selective inhibition of BET bromodomains (2010) Nature, 468 (7327), pp. 1067-1073; 
Loven, J., Selective inhibition of tumor oncogenes by disruption of super-enhancers (2013) Cell, 153 (2), pp. 320-334; 
Lozano, A.M., Waving hello to noninvasive deep-brain stimulation (2017) N Engl J Med, 377 (11), pp. 1096-1098; 
Wallace, V.J., Neurons internalize functionalized micron-sized silicon dioxide microspheres (2017) Cell Mol Neurobiol, 37 (8), pp. 1487-1499; 
Birney, E., Epigenome-wide association studies and the interpretation of disease -omics (2016) PLoS Genet, 12 (6), p. e1006105; 
http://www.sciencemag.org/new-research-offers-blueprint-tackling-addiction, American Academy for Advancement of Science. PINS Prize in Science of AAAS 2017. (2017) (accessed 15th January 2018); Reece, A.S., Evidence of accelerated ageing in clinical drug addiction from immune, hepatic and metabolic biomarkers (2007) Immun Ageing, 4 (1), pp. 6-15; 
Reece, A.S., Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addiction (2008) Addict Biol, 14 (2), p. 214; 
Fauci, A.S., (eds.). Harrison's Principles of Internal Medicine, seventeenth ed. McGraw Hill; (2008); Pattabiraman, G., Aging-associated dysregulation of homeostatic immune response termination (and not initiation) (2017) Aging Cell, 16 (3), pp. 585-593; 
Fulop, T., From inflamm-aging to immune-paralysis: a slippery slope during aging for immune-adaptation (2016) Biogerontology, 17 (1), pp. 147-157; 
Pangrazzi, L., “Inflamm-aging” influences immune cell survival factors in human bone marrow (2016) Eur J Immunol, 47 (3), pp. 481-492; 
Brunton, L.L., (2006) Goodman and Gilman's the pharmacologic basis of therapeutics, , McGraw Hill; 
Reece, A.S., Clinical implications of addiction related immunosuppression (2008) J Infect, 56 (6), pp. 437-445; 
Reece, A.S., Chronic viral hepatitis is a significant contributor to the immunosenescent phenotype of parenteral drug addiction (2009) Addict Biol, 14 (2), pp. 214-226; 
Saggu, R., Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia (2016) Acta Neuropathol Commun, 4 (1), p. 76; 
Carpentier, P.A., Palmer, T.D., Immune influence on adult neural stem cell regulation and function (2009) Neuron, 64 (1), pp. 79-92; 
Deverman, B.E., Patterson, P.H., Cytokines and CNS development (2009) Neuron, 64 (1), pp. 61-78; 
Leoni, C., Dnmt3a restrains mast cell inflammatory responses (2017) Proc Natl Acad Sci U S A, 114 (8), pp. E1490-E1499; 
Zhang, Q., Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 (2015) Nature, 525 (7569), pp. 389-393; 
Fuster, J.J., Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice (2017) Science, 355 (6327), pp. 842-847; 
Chavan, S.S., Mechanisms and therapeutic relevance of neuro-immune communication (2017) Immunity, 46 (6), pp. 927-942; 
Hayes, J.M., Fc gamma receptors: glycobiology and therapeutic prospects (2016) J Inflamm Res, 9, pp. 209-219; 
Bennun, S.V., Systems glycobiology: integrating glycogenomics, glycoproteomics, glycomics, and other ‘omics data sets to characterize cellular glycosylation processes (2016) J Mol Biol, 428 (16), pp. 3337-3352; 
Sackstein, R., Translational glycobiology: patient-oriented glycoscience research (2016) Glycobiology, 26 (6), pp. 544-545; 
Georgescu, D., Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal (2003) J Neurosci, 23 (8), pp. 3106-3111; 
Sharpe, M.J., Lateral hypothalamic GABAergic neurons encode reward predictions that are relayed to the ventral tegmental area to regulate learning (2017) Curr Biol, 27 (14). , 2089-2100.e5; 
Reece, A.S., Dramatic acceleration of reproductive aging, contraction of biochemical fecundity and healthspan-lifespan implications of opioid-induced endocrinopathy-FSH/LH ratio and other interrelationships (2016) Reprod Toxicol, 66, pp. 20-30; 
Zhang, G., Hypothalamic programming of systemic ageing involving IKK-[bgr], NF-[kgr]B and GnRH (2013) Nature, 497 (7448), pp. 211-216; 
Ben-Meir, A., Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging (2015) Aging Cell, 14 (5), pp. 887-895; 
Partridge, L., Sex and death: what is the connection? (2005) Cell, 120 (4), pp. 461-472; 
Kirkwood, T.B., Understanding the odd science of aging (2005) Cell, 120 (4), pp. 437-447; 
Kohrt, W.M., Wierman, M.E., Preventing fat gain by blocking follicle-stimulating hormone (2017) N Engl J Med, 377 (3), pp. 293-295; 
Nunez Miguel, R., Glycosylation pattern analysis of glycoprotein hormones and their receptors (2017) J Mol Endocrinol, 58 (1), pp. 25-41; 
Juric, J., (2017), p. 1. , Immunoglobulin G Glycosylation in Menstrual Cycle. In Poster Presentation at 12th Jenner Glycobiology and Medicine Genos-Genes Conference Symposium. Translational Glycobiology, Dubrovnik, CroatiaUR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045654024&doi=10.1016%2fj.mehy.2018.04.011&partnerID=40&md5=aef1e8e0e5680796975ab3d6078f258d
ER  - 

TY  - JOUR
TI  - Prediction of Future Chronic Opioid Use Among Hospitalized Patients
T2  - Journal of General Internal Medicine
J2  - J. Gen. Intern. Med.
VL  - 33
IS  - 6
SP  - 898
EP  - 905
PY  - 2018
DO  - 10.1007/s11606-018-4335-8
SN  - 08848734 (ISSN) 
AU  - Calcaterra, S.L.
AU  - Scarbro, S.
AU  - Hull, M.L.
AU  - Forber, A.D.
AU  - Binswanger, I.A.
AU  - Colborn, K.L.
AD  - Hospital Medicine, Denver Health Medical Center, Denver, CO, United States
AD  - Division of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, United States
AD  - University of Colorado Adult and Child Consortium for Health Outcomes Research and Delivery Science, Aurora, CO, United States
AD  - Rocky Mountain Prevention Research Center, Colorado School of Public Health, University of Colorado Denver, Aurora, CO, United States
AD  - Department of Biostatistics and Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, United States
AD  - Institute for Health Research, Kaiser Permanente Colorado, Denver, CO, United States
AB  - Background: Opioids are commonly prescribed in the hospital; yet, little is known about which patients will progress to chronic opioid therapy (COT) following discharge. We defined COT as receipt of ≥ 90-day supply of opioids with < 30-day gap in supply over a 180-day period or receipt of ≥ 10 opioid prescriptions over 1 year. Predictive tools to identify hospitalized patients at risk for future chronic opioid use could have clinical utility to improve pain management strategies and patient education during hospitalization and discharge. Objective: The objective of this study was to identify a parsimonious statistical model for predicting future COT among hospitalized patients not on COT before hospitalization. Design: Retrospective analysis electronic health record (EHR) data from 2008 to 2014 using logistic regression. Patients: Hospitalized patients at an urban, safety net hospital. Main Measurements: Independent variables included medical and mental health diagnoses, substance and tobacco use disorder, chronic or acute pain, surgical intervention during hospitalization, past year receipt of opioid or non-opioid analgesics or benzodiazepines, opioid receipt at hospital discharge, milligrams of morphine equivalents prescribed per hospital day, and others. Key Results: Model prediction performance was estimated using area under the receiver operator curve, accuracy, sensitivity, and specificity. A model with 13 covariates was chosen using stepwise logistic regression on a randomly down-sampled subset of the data. Sensitivity and specificity were optimized using the Youden’s index. This model predicted correctly COT in 79% of the patients and no COT correctly in 78% of the patients. Conclusions: Our model accessed EHR data to predict 79% of the future COT among hospitalized patients. Application of such a predictive model within the EHR could identify patients at high risk for future chronic opioid use to allow clinicians to provide early patient education about pain management strategies and, when able, to wean opioids prior to discharge while incorporating alternative therapies for pain into discharge planning. © 2018, Society of General Internal Medicine.
KW  - hospital medicine
KW  - prediction rules
KW  - statistical modeling
KW  - benzodiazepine
KW  - morphine
KW  - opiate
KW  - adult
KW  - aged
KW  - Article
KW  - chronic pain
KW  - clinical practice
KW  - cohort analysis
KW  - controlled study
KW  - drug dependence
KW  - female
KW  - hospital discharge
KW  - hospital patient
KW  - human
KW  - major clinical study
KW  - male
KW  - mental disease
KW  - opiate addiction
KW  - outcome assessment
KW  - pain
KW  - patient education
KW  - practice guideline
KW  - prediction
KW  - retrospective study
KW  - risk assessment
KW  - risk factor
KW  - safety net hospital
KW  - sensitivity and specificity
KW  - surgical technique
KW  - tobacco dependence
KW  - urban area
KW  - very elderly
PB  - Springer New York LLC
N1  - Cited By :4
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: JGIME
C2  - 29404943
LA  - English
N1  - Correspondence Address: Calcaterra, S.L.; Division of General Internal Medicine, Department of Medicine, University of Colorado School of MedicineUnited States; email: susan.calcaterra@ucdenver.edu
N1  - Chemicals/CAS: benzodiazepine, 12794-10-4; morphine, 52-26-6, 57-27-2; opiate, 53663-61-9, 8002-76-4, 8008-60-4
N1  - Funding details: University of Colorado
N1  - Funding details: Foundation for the National Institutes of Health, R34DA035952, R01DA042059
N1  - Funding text 1: Corresponding Author: S. L. Calcaterra, MD, MPH; Division of General Internal Medicine, Department of MedicineUniversity of Colorado School of Medicine, Aurora, USA Funding Information Funders: The authors would like to acknowledge the University of Colorado, Department of Medicine, Division of General Internal Medicine Small Grants Program for their generous grant which funded this project. Dr. Binswanger was supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Numbers R34DA035952 and R01DA042059. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Prior Presentations: This work was presented at the National Society of General Internal Medicine Conference on April 21, 2017.
N1  - References: Han, B., Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health (2017) Ann Intern Med, 167 (5), pp. 293-301. , PID: 28761945; 
Wasan, A.D., Wootton, J., Jamison, R.N., Dealing with difficult patients in your pain practice (2005) Reg Anesth Pain Med, 30 (2), pp. 184-192. , PID: 15765460; 
Edlund, M.J., Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain (2007) Pain, 129 (3), pp. 355-362. , PID: 17449178; 
Sullivan, M.D., Association between mental health disorders, problem drug use, and regular prescription opioid use (2006) Arch Intern Med, 166 (19), pp. 2087-2093. , PID: 17060538; 
Butler, S.F., Development and validation of the current opioid misuse measure (2007) Pain, 130 (1-2), pp. 144-156. , PID: 17493754; 
Akbik, H., Validation and clinical application of the Screener and Opioid Assessment for Patients with Pain (SOAPP) (2006) J Pain Symptom Manage, 32 (3), pp. 287-293. , PID: 16939853; 
Webster, L.R., Webster, R.M., Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool (2005) Pain Med, 6 (6), pp. 432-442. , PID: 16336480; 
Compton, P., Darakjian, J., Miotto, K., Screening for addiction in patients with chronic pain and “problematic” substance use: evaluation of a pilot assessment tool (1998) J Pain Symptom Manag, 16 (6), pp. 355-363; 
Herzig, S.J., Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals (2014) J Hosp Med, 9 (2), pp. 73-81. , PID: 24227700; 
Calcaterra, S.L., Opioid prescribing at hospital discharge contributes to chronic opioid use (2016) J Gen Intern Med, 31 (5), pp. 478-485. , PID: 26553336; 
Sun, E.C., Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period (2016) JAMA Intern Med, 176 (9), pp. 1286-1293. , PID: 27400458; 
Bateman, B.T., Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women (2016) Am J Obstet Gynecol, 215 (3), pp. 353.e1-353.e18; 
Thielke, S.M., A prospective study of predictors of long-term opioid use among patients with chronic noncancer pain (2017) Clin J Pain, 33 (3), pp. 198-204. , PID: 27428547; 
Iwashyna, T.J., Liu, V., What’s so different about big data?. A primer for clinicians trained to think epidemiologically (2014) Ann Am Thorac Soc, 11 (7), pp. 1130-1135. , PID: 25102315; 
Chekroud, A.M., Cross-trial prediction of treatment outcome in depression: a machine learning approach (2016) Lancet Psychiatry, 3 (3), pp. 243-250. , PID: 26803397; 
Churpek, M.M., Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards (2016) Crit Care Med, 44 (2), pp. 368-374. , PID: 26771782; 
Taylor, R.A., Prediction of in-hospital mortality in emergency department patients with sepsis: a local big data-driven, machine learning approach (2016) Acad Emerg Med, 23 (3), pp. 269-278. , PID: 26679719; 
Gabow, P., Eisert, S., Wright, R., Denver Health: a model for the integration of a public hospital and community health centers (2003) Ann Intern Med, 138 (2), pp. 143-149. , PID: 12529097; 
Gabow, P.A., Mehler, P.S., A broad and structured approach to improving patient safety and quality: lessons from Denver Health (2011) Health Aff (Millwood), 30 (4), pp. 612-618; 
Collins, G.S., Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (tripod): the tripod statement (2015) Ann Intern Med, 162 (1), pp. 55-63. , PID: 25560714; 
Paice, J.A., Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline (2016) J Clin Oncol, 34 (27), pp. 3325-3345. , PID: 27458286; 
Chow, R., Needs assessment of primary care physicians in the management of chronic pain in cancer survivors (2017) Support Care Cancer, 25 (11), pp. 3505-3514. , PID: 28589311; 
Vanderlip, E.R., National study of discontinuation of long-term opioid therapy among veterans (2014) Pain, 155 (12), pp. 2673-2679. , PID: 25277462; 
Von Korff, M., De facto long-term opioid therapy for noncancer pain (2008) Clin J Pain, 24 (6), pp. 521-527. , PID: 18574361; 
Amit, Y., Geman, D., Shape quantization and recognition with randomized trees (1997) Neural Comput, 9 (7), pp. 1545-1588; 
(2013) Classification of Diseases, Functioning, and Disability, , https://www.cdc.gov/nchs/icd/index.htm, Available from, Accessed 12/11/2017; 
Charlson, M.E., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation (1987) J Chronic Dis, 40 (5), pp. 373-383. , PID: 3558716; 
Colorado, S.O., (2000) Colorado Amendment 20. Legalization of Medicinal Marijuana, , https://www.colorado.gov/pacific/sites/default/files/CHEIS_MMJ_Colorado-Constitution-Article-XVIII.pdf, Accessed 12/11/2017; 
Cleveland, W.S., Devlin, S.J., Locally weighted regression: an approach to regression analysis by local fitting (1988) J Am Stat Assoc, 83 (403), pp. 596-610; 
Von Korff, M., Defacto long-term opioid therapy for non-cancer pain (2008) Clin J Pain, 24 (6), pp. 521-527. , PID: 18574361; 
Herzig, S.J., Opioid utilization and opioid-related adverse events in non-surgical patients in US hospitals (2014) J Hosp Med, 9 (2), pp. 73-81. , PID: 24227700; 
Lin, W.-J., Chen, J.J., Class-imbalanced classifiers for high-dimensional data (2013) Brief Bioinform, 14 (1), pp. 13-26. , PID: 22408190; 
Ruopp, M.D., Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection (2008) Biom J, 50 (3), pp. 419-430. , PID: 18435502; 
What is R?, , https://www.r-project.org/about.html, Foundation, T.R, [cited 2017 11/3/2017]; Available from, Accessed 12/11/2017; 
Butler, S.F., Validation of the revised Screener and Opioid Assessment for Patients with Pain (SOAPP-R) (2008) J Pain, 9 (4), pp. 360-372. , PID: 18203666; 
Raebel, M.A., Chronic opioid use emerging after bariatric surgery (2014) Pharmacoepidemiol Drug Saf, 23 (12), pp. 1247-1257. , PID: 24733580; 
Inacio, M.C., Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: A retrospective cohort study (2016) BMJ Open, 6 (4); 
Gudin, J.A., Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use (2013) Postgrad Med, 125 (4), pp. 115-130. , PID: 23933900; 
Guccione, A.A., The effects of specific medical conditions on the functional limitations of elders in the Framingham Study (1994) Am J Public Health, 84 (3), pp. 351-358. , PID: 8129049; 
Schmaling, K.B., Betterton, K.L., Neurocognitive complaints and functional status among patients with chronic fatigue syndrome and fibromyalgia (2016) Qual Life Res, 25 (5), pp. 1257-1263. , PID: 26471263; 
Murray, C.J., The state of US health, 1990-2010: burden of diseases, injuries, and risk factors (2013) JAMA, 310 (6), pp. 591-608. , PID: 23842577; 
Casanova, R., Prediction of incident diabetes in the Jackson Heart Study using high-dimensional machine learning (2016) Plos One, 11 (10); 
Pearce, C.B., Machine learning can improve prediction of severity in acute pancreatitis using admission values of APACHE II score and C-reactive protein (2006) Pancreatology, 6 (1-2), pp. 123-131. , PID: 16327290; 
Shameer, K., Predictive modeling of hospital readmission rates using electronic medical record-wide machine learning: a case-study using Mount Sinai Heart Failure Cohort (2016) Pac Symp Biocomput, 22, pp. 276-287; 
Alsolamy, S., Diagnostic accuracy of a screening electronic alert tool for severe sepsis and septic shock in the emergency department (2014) BMC Med Inform Decis Mak, 14, p. 105. , PID: 25476738; 
Kucher, N., Electronic alerts to prevent venous thromboembolism among hospitalized patients (2005) N Engl J Med, 352 (10), pp. 969-977. , PID: 15758007; 
Ng, C.K., Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong (2008) Qual Saf Health Care, 17 (5), pp. 387-392. , PID: 18842981; 
McNeil, V., Cruickshank, M., Duguid, M., Safer use of antimicrobials in hospitals: the value of antimicrobial usage data (2010) Med J Aust, 193, pp. S114-S117. , PID: 20955139; 
MacDougall, C., Polk, R.E., Antimicrobial stewardship programs in health care systems (2005) Clin Microbiol Rev, 18 (4), pp. 638-656. , PID: 16223951; 
Fishman, N., Antimicrobial stewardship (2006) Am J Med, 119, pp. S53-S61. , PID: 16735152, discussion S62-70
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85045130462&doi=10.1007%2fs11606-018-4335-8&partnerID=40&md5=f2dff8f65c8686c7ac8b7c229b177422
ER  - 

TY  - JOUR
TI  - Endogenous Opiates and Behavior: 2016
T2  - Peptides
J2  - Peptides
VL  - 101
SP  - 167
EP  - 212
PY  - 2018
DO  - 10.1016/j.peptides.2018.01.011
SN  - 01969781 (ISSN) 
AU  - Bodnar, R.J.
AB  - This paper is the thirty-ninth consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2016 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior, and the roles of these opioid peptides and receptors in pain and analgesia, stress and social status, tolerance and dependence, learning and memory, eating and drinking, drug abuse and alcohol, sexual activity and hormones, pregnancy, development and endocrinology, mental illness and mood, seizures and neurologic disorders, electrical-related activity and neurophysiology, general activity and locomotion, gastrointestinal, renal and hepatic functions, cardiovascular responses, respiration and thermoregulation, and immunological responses. © 2018 Elsevier Inc.
KW  - Delta opioid receptor
KW  - Dynorphin
KW  - Endomorphin
KW  - Endorphin
KW  - Enkephalin
KW  - Kappa opioid receptor
KW  - Morphine
KW  - Mu opioid receptor
KW  - Nociception
KW  - Orphan opioid receptor
KW  - alcohol
KW  - analgesic agent
KW  - delta opiate receptor
KW  - delta opiate receptor agonist
KW  - endorphin derivative
KW  - glucose
KW  - hormone
KW  - kappa opiate receptor
KW  - kappa opiate receptor agonist
KW  - morphine
KW  - mu opiate receptor
KW  - mu opiate receptor agonist
KW  - opiate
KW  - opiate agonist
KW  - peptide
KW  - opiate peptide
KW  - opiate receptor
KW  - addiction
KW  - analgesia
KW  - animal behavior
KW  - aversion
KW  - behavior
KW  - blood pressure
KW  - breathing
KW  - cancer pain
KW  - cardiovascular response
KW  - cesarean section
KW  - chronic pain
KW  - drinking
KW  - drug abuse
KW  - drug self administration
KW  - eating
KW  - emotion
KW  - endocrinology
KW  - gastrointestinal tract function
KW  - genetic difference
KW  - heart protection
KW  - heart rate
KW  - human
KW  - hysterectomy
KW  - ingestion
KW  - intestine function
KW  - ischemic preconditioning
KW  - kidney function
KW  - liver function
KW  - locomotion
KW  - mental disease
KW  - mood
KW  - morphine addiction
KW  - morphine tolerance
KW  - nausea
KW  - neuroanatomy
KW  - neurologic disease
KW  - nonhuman
KW  - pain
KW  - pancreas function
KW  - place preference
KW  - pregnancy
KW  - priority journal
KW  - Review
KW  - reward
KW  - seizure
KW  - sexual behavior
KW  - social status
KW  - stress
KW  - thermoregulation
KW  - tooth pain
KW  - vomiting
KW  - animal
KW  - mental disease
KW  - metabolism
KW  - neurologic disease
KW  - pain
KW  - pathology
KW  - Analgesia
KW  - Animals
KW  - Humans
KW  - Mental Disorders
KW  - Nervous System Diseases
KW  - Opioid Peptides
KW  - Pain
KW  - Receptors, Opioid
PB  - Elsevier Inc.
N1  - Cited By :22
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
N1  - CODEN: PPTDD
C2  - 29366859
LA  - English
N1  - Chemicals/CAS: alcohol, 64-17-5; glucose, 50-99-7, 84778-64-3; morphine, 52-26-6, 57-27-2; opiate, 53663-61-9, 8002-76-4, 8008-60-4; Opioid Peptides; Receptors, Opioid
N1  - References: Aasyang, E.K., Lunn, T.H., Hansen, T.B., Kristensen, P.W., Solgaard, S., Kehlet, H., Chronic pre-operative opioid use and acute pain after fast-track total knee arthroplasty (2016) Acta Anaesthesiol. Scand., 60, pp. 529-536; 
Abassi, M., Abolghasemi, A., Temperment and characteristic dimensions: correlates of impulsivity in morphine addicts (2015) Int. J. High Risk Behav. Addict., 4, p. e21142; 
Abbasloo, E., Najafipour, H., Esmaeli-Mahani, S., Induction of antinociceptive tolerance to the chronic intrathcal administration of apelin-13 in rat (2016) Neuropeptides, 60, pp. 7-12; 
Abdel-Ghany, R., Nabil, M., Abdel-Aal, M., Barakat, W., Nalbuphine could decrease the rewarding effect induced by tramadol in mice while enhancing its antinociceptive activity (2015) Eur. J. Pharmacol., 758, pp. 11-15; 
Abdolhossein-Davoodabadi, Reza-Fazel, M., Reza-Vafaei, H., Parvuz, S., Comparison of the effects of intrapleural bupivacaine and morphine on post-thoracotomy pain (2015) Middle East J. Anaesthesiol., 23, pp. 267-272; 
Abdollahi, H., Ghaem-Jandabi, M., Azizi, H., Semnanian, S., The role of orexin-1 receptors in the development of morphine tolerance in locus coeruleus: an electrophysiological perspective (2016) Brain Res., 1646, pp. 91-97; 
Abe, K., Kobayashi, K., Yoshino, S., Taguchi, K., Nojima, H., Withdrawal of repeated morphine enhances histamine-induced scratching responses in mice (2015) Drug Chem. Toxicol., 38, pp. 167-173; 
Abreu, M., Aguado, D., Benito, J., Garcia-Fernandez, J., Segura, I.A., Hyperalgesia and increased sevoflurane minimum alveolar concentration induced by opioids in the rat: a randomized experimental study (2015) Eur. J. Anaesthesiol., 32, pp. 232-241; 
Abu-Halaweh, S., Obeidat, F., Absalom, A.R., AlOweidi, A., Abeelah, M.A., Qudaisat, I., Robinson, F., Mason, K.P., Dexemedetomidine versus morphine infusion following laparoscopic bariatric surgery: effect on supplemental narcotic requirement during the first 24 h (2016) Surg. Endosc., 30, pp. 3368-3374; 
Aceves, M., Mathai, B.B., Hook, M.A., Evaluation of the effects of specific opioid receptor agonists in a rodent model of spinal cord injury (2016) Spinal Cord, 54, pp. 767-777; 
Adamska, A., Kluczyk, A., Cerlesi, M.C., Calo, G., Janeska, A., Borics, A., Synthesis, biological evaluation and structural analysis of novel peripheral morphiceptin analogs (2016) Bioorg. Med. Chem., 24, pp. 1582-1588; 
Afsharimani, B., Doornebal, C.W., Cabot, P.J., Hollmann, M.W., Parat, M.W., Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis (2015) Br. J. Pharmacol., 172, pp. 251-259; 
Ahlers, S.J., Valitalo, P.A., Peeters, M.Y., Gulik, L.V., van Dongen, E.P., Dahan, A., Tibboel, D., Knibbe, C.A., Morphine glucuronidation and elimination in intensive care patients: a comparison with healthy volunteers (2015) Anesth. Analg., 121, pp. 1261-1273; 
Ahmadalipour, A., Sadeghzadeh, J., Vafaei, A.A., Mohammadkhani, R., Rashidy-Pour, A., Effects of environmental enrichment on behavioral deficits and alterations in hippocampal BDNF induced by prenatal exposure to morphine in juvenile rats (2015) Neuroscience, 305, pp. 372-383; 
Ahmadalipour, A., Rashidy-Pour, A., Effects of treadmill running exercise during the adolescent period of life on behavioral deficits in juvenile rats induced by prenatal morphine exposure (2015) Physiol. Behav., 139, pp. 26-33; 
Ahmadi, S., Rafieenia, F., Rostamzadeh, J., Morphine-induced analgesic tolerance effect on gene expression of the NMDA receptor subunit 1 in rat striatum and prefrontal cortex (2016) Basic Clin. Neurosci., 7, pp. 241-248; 
Ahn, J., Bohl, D.D., Elbohdady, I., Aboushaala, K., Mayo, B.C., Hassanzadeh, H., Singh, K., Postoperative narcotic consumption in workman's compensation patients following a minimally invasive transforaminal lumbar interbody fusion (2015) Spine (Phila Pa 1976), 40, pp. 1284-1288; 
Aira, Z., Barrenetxea, T., Buesa, I., Garcia Del Cano, G., Azkue, J.J., Dopamine D1-like receptors regulate constitutive, mu-opioid receptor-mediated repression of use-dependent synaptic plasticity in dorsal horn neurons: more harm than good? (2016) J. Neurosci., 36, pp. 5661-5673; 
Akbar, S., Subhan, F., Karim, N., Shahid, M., Ahmad, N., Ali, G., Mahmood, W., Fawad, K., 6-methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic pain (2016) Biomed. Pharmacother., 84, pp. 962-971; 
Aksu, R., Bicer, C., Ulgev, A., Bayram, A., Gunes, I., Guney, A., Yildirim, M.D., Yildiz, K., Comparison of intrascalene brachial plexus block and intra-articular local anesthetic administration on postoperative pain management in arthroscopic shoulder surgery (2015) Braz. J. Anaesth., 65, pp. 222-229; 
Al Dabbagh, Z., Jansson, K.A., Stiller, C.O., Montgomery, S., Weiss, R.J., Long-term pattern of opioid prescriptions after femoral shaft fractures (2016) Acta Anaesthesiol. Scand., 60, pp. 634-641; 
Al-Hashimi, M., McDonald, J., Thompson, J.P., Lambert, J.G., Evidence for nociception/orphanin FQ (NOP) but not mu (MOP), delta (DOP) or kappa (KOP) opioid receptor mRNA in whole human blood (2016) Br. J. Anesth., 116, pp. 423-429; 
Al-Hashimi, M., Scott, S., Griffin-Teall, N., Thompson, J., Influence of ethnicity on the perception and treatment of early-postoperative pain (2015) Br. J. Pain, 9, pp. 167-172; 
Al-Hossaini, A.M., Suntornsuk, L., Lunte, S.M., Separation of dynorphin peptides by capillary electrochromatography using a polydiallldimehtylammonium chloride gold nanoparticle-modified capillary (2016) Electrophoresis, 37, pp. 2297-2304; 
Al-Zahrani, T., Doais, K.S., Aljassir, F., Alshaygy, I., Albishi, W., Terkawi, A.S., Randomized clinical trial of continuous femoral nerve block combined with sciatic block versus epidural analgesia for unilateral total knee arthroplasty (2015) J. Arthroplasty, 30, pp. 149-154; 
Alavi, M.S., Hosseinzadeh, H., Shamsizadeh, A., Roohbakhsh, A., The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence (2016) Pharmacol. Res., 68, pp. 592-597; 
Alijanpour, S., Tirgar, F., Zarrindast, M.R., Role of dorsal hippocampal orexin-1 receptors in memory restoration induced by morphine sensitization phenomenon (2016) Neuroscience, 312, pp. 215-226; 
Alizadeh, S., Mahmoudi, G.A., Solhi, H., Sadeghi-Sedeh, B., Behzadi, R., Kazemifar, A.M., Post-operative analgesia in opioid-dependent patients: comparison of intravenous morphine and sublingual buprenorphine (2015) Addict Health, 7, pp. 60-65; 
Aljabi, Y., El-Shawarby, A., Cawley, D.T., Aherne, T., Effect of epidural methylprednisolone on post-operative pain and length of hospital stay in patients undergoing lumbar microdiscectomy (2015) Surgeon, 13, pp. 245-249; 
Alongkronrusmee, D., Chiang, T., van Rijn, R.M., Involvement of delta opioid receptors in alcohol withdrawal-induced mechanical allodynia in male C57BL/6 mice (2016) Drug Alcohol Depend., 167, pp. 190-198; 
Altarifi, A.A., Negus, S.S., Differential tolerance to morphine antinociception in assays of pain-stimulated versus pain-depressed behavior in rats (2015) Eur. J. Pharmacol., 748, pp. 76-82; 
Altun, A., Ozdemir, E., Yildirim, K., Gursoy, S., Durmus, N., Bagcivan, I., The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats (2015) Gen. Physiol. Biophys., 34, pp. 433-440; 
Alvarado-Banuelos, M., Barrios De Tomasi, E., Juarez, J., Changes in the incentive value of food after naltrexone treatment depend on a differential preference for a palatable food in male rats (2016) Nutr. Neurosci., 20, pp. 418-423; 
Alvarez, M.P., Foley, K.E., Zebley, D.M., Fassler, S.A., Comprehensive enhanced recovery pathway significantly reduces postoperative length of stay and opioid usage in elective laparoscopic colectomy (2015) Surg. Endosc., 29, pp. 2506-2511; 
Aman, Y., Pitcher, T., Simeoli, R., Ballard, C., Malcangio, M., Reduced thermal sensitivity and increased opioidergic tone in the TASTPM mouse model of Alzheimer's disease (2016) Pain, 157, pp. 2285-2296; 
Ameyaw, E.O., Kukuia, K.K., Thomford, A.K., Kyei, S., Mante, P.K., Boampong, J.N., Analgesic properties of aqueous leaf extract of Haematostahis barteri: involvement of ATP-sensitive potassium channels, adrenergic, opioidergic, muscarinic, adenosinergic and serotonergic pathways (2016) J. Basic Clin. Physiol. Pharmacol., 27, pp. 557-561; 
Amini-Lhoei, H., Amiri, S., Shirzadian, A., Haj-Mirzaiian, A., Alijanpour, S., Rahimi-Balaei, M., Mohammadi-Asl, A., Dehpour, A.R., Experiencing early maternal separation increased the seizure threshold in adult male mice: involvement of the opioid system (2015) Epilepsy Behav., 52, pp. 37-41; 
Anand, P., Yiangou, Y., Anand, U., Mukerji, G., Sinisi, M., Fox, M., McQuillan, A., Hein, P., Nocicpein/orphanin FQ receptor expression in clinical pain disorders and functional effects in cultured neurons (2016) Pain, 157, pp. 1960-1969; 
Anderson, J.T., Haas, A.R., Percy, R., Woods, S.T., Ahn, U.M., Ahn, N.U., Single-level lumbar fusion for degenerative disc disease is associated with worse outcomes compared with fusion for spondylolisthesis in a workers’ compensation setting (2015) Spine (Phila Pa 1976), 40, pp. 323-331; 
Anderson, R.I., Lopez, M.F., Becker, H.C., Stress-induced enhancement of ethanol intake in C57BL/6J mice with a history of chronic ethanol exposure: involvement of kappa opioids receptors (2016) Front. Cell. Neurosci., 10, p. 45; 
Ando, A., Sasago, S., Ohzone, Y., Miyamoto, Y., Drug-drug interactions of a novel kappa opioid receptor agonist, nalfurafine hydrochloride involving the P-glycoprotein (2016) Eur. J. Drug Metab. Pharmacokinet., 41, pp. 549-558; 
Andoh, T., Shinohara, A., Kuraishi, Y., Inhibitory effect of fentanyl citrate on the release of endothelin-1 induced by bradykinin in melanoma cells (2016) Pharmacol. Rep., 69, pp. 139-142; 
Andziak, M., Beta, J., Barwijuk, M., Issat, T., Jakimiuk, A.J., Efficacy and tolerability of intravenous morphine patient-controlled analgesia (PCA) in women undergoing cesarean delivery (2015) Ginekol. Pol., 86, pp. 453-456; 
Anghelescu, D.L., Snaman, J.M., Trujillo, L., Sykes, A.D., Yuan, Y., Baker, J.N., Patient-controlled analgesia at the end of life at a pediatric oncology institution (2015) Pediatr. Blood Cancer, 62, pp. 1237-1244; 
Anoush, M., Jani, A., Sahebgharani, M., Jafari, M.R., Effects of estrogen receptor modulators on morphine induced sensitization in mice memory (2015) Iran. J. Psychiat., 10, pp. 192-199; 
Antunes, H.K., Leite, G.S., Lee, K.S., Barreto, A.T., Santos, R.V., Souza Hde, S., Tufik, S., de Mello, M.T., Exercise deprivation increases negative mood in exercise-addicted subjects and modifies their biochemical markers (2016) Physiol. Behav., 156, pp. 182-190; 
Arab, M., Mirkheshti, A., Noghabaei, G., Ashori, A., Ghasemi, T., Hosseini-Zijoud, S.M., The effect of premenstrual syndrome and menstrual phase on postoperative pain (2015) Anesth. Pain Med., 5, p. e19333; 
Araldi, D., Ferrari, L.F., Levine, J.D., Adenosine-A1 receptor agonist induced hyperalgesic priming type II (2016) Pain, 157, pp. 698-709; 
Arbit, B., Marston, N., Shah, K., Lee, E.L., Aramin, H., Clopton, P., Maisel, A.S., Prognostic usefulness of proenkephin in stable ambulatory patients with heart failure (2016) Am. J. Cardiol., 117, pp. 1310-1314; 
Arcuri, L., Viaro, R., Bido, S., Longo, F., Calcagno, M., Fernagut, P.O., Zaveri, N.T., Morari, M., Genetic and pharmacological evidence that endogenous nociception/orphanin FQ contributes to dopamine cell loss in Parkinson's disease (2016) Neurobiol. Dis., 89, pp. 55-64; 
Ardianto, C., Yonemuchi, N., Yamamoto, S., Yang, L., Takenova, F., Shioda, S., Nagase, H., Kamei, J., Opioid systems in the lateral hypothalamus regulate feeding behavior through orexin and GABA neurons (2016) Neuroscience, 320, pp. 183-193; 
Arezoomandan, R., Haghparast, A., Administration of the glial cell modulator, minocycline, in the nucleus accumbens attenuated the maintenance and reinstatement of morphine-seeking behavior (2016) Can. J. Physiol. Pharmacol., 94, pp. 257-264; 
Arezoomandan, R., Khodagholi, F., Haghparast, A., Administration of the glial condition medium in the nucleus accumbens prolong maintenance and intensify reinstatement of morphine-seeking behavior (2016) Neurochem. Res., 41, pp. 855-868; 
Arnatt, C.K., Falls, B.A., Yuan, C., Raborg, T.J., Masvekar, R.R., El-Hage, N., Selley, D.E., Zhang, Y., Exploration of bivalent ligands targeting putative mu opioid receptor and chemokine receptor CCR5 dimerization (2016) Bioorg. Med. Chem., 24, pp. 5969-5987; 
Asth, L., Ruzza, C., Malfacini, D., Medeiros, I., Guerrini, R., Zaveri, N.T., Gavioli, E.C., Calo, G., Beta-arrestin 2 rather than G-protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociception/orphanin FQ receptor ligands (2016) Neuropharmacology, 105, pp. 434-442; 
Auh, Q.S., Chun, Y.H., Melemedjian, O.K., Zhang, Y., Ro, J.Y., Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia (2016) Brain Res. Bull., 125, pp. 211-217; 
Awwad, H.O., Durand, G.D., Gonzalez, L.P., Tompkins, P., Zhang, Y., Lerner, M.R., Brackett, D.J., Standifer, K.M., Post-blast treatment with nociception/orphanin FQ peptide (NOP) receptor antagonist reduces brain-injury-induiced hypoxia and signaling proteins in vestibulomotor-related brain regions (2016) Behav. Brain Res., S0166-4328 (16), pp. 30918-30924; 
Aydogan, M.S., Bicakcioglu, M., Sayan, H., Durmus, M., Yilmaz, S., Effects of two different techniques of postoperative analgesia management in liver transplant donors: a prospective, randomized double-blind study (2015) Transplant. Proc., 47, pp. 1204-1206; 
Aziz, A.M., Brothers, S., Sartor, G., Holm, L., Heilig, M., Wahlestedt, C., Thorsell, A., The nociception/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models (2016) Psychopharmacology (Berl.), 233, pp. 3553-3563; 
Baaklini, L.G., Arruda, G.V., Sakata, R.K., Assessment of the analgesic effect of magnesium and morphine in combination in patients with cancer pain: a comparative randomized double-blind study (2015) Am. J. Hosp. Palliat. Care, 34 (4), pp. 353-357; 
Bada, H.S., Sithsarn, T., Gibson, J., Garlitz, K., Caldwell, R., Capilouto, G., Li, Y., Breheny, P., Morphine versus clonidine for neonatal abstinence syndrome (2015) Pediatrica, 135, pp. e383-391; 
Badzynska, B., Lipkowski, A.W., Sadowski, J., An antihypertensive opioid: biphalin, a synthetic non-addictive enkephalin analog decreases blood pressure in spontaneously hypertensive rats (2016) Pharmacol. Rep., 68, pp. 51-55; 
Baek, S.K., Kim do, Y., Kang, S.Y., Sym, S.J., Kim, Y.S., Lee, J.Y., A Korean nationwide survey for breakthrough cancer pain in an inpatient setting (2016) Cancer Res. Treat., 48, pp. 766-774; 
Bag, S.S., Jana, S., Pradhan, M.K., Syntheis, photophysical properites of triazolyl-donor/acceptor chromophores decorated unnatural amino acids: incorporation of a pair into Leu-enkephalin peptide and application of triazollylperylene amino acid in sensing BSA (2016) Bioorg. Med. Chem., 24, pp. 3579-3595; 
Bagdas, D., Muldoon, P.P., AlSharari, S., Carroll, F.I., Negus, S.S., Damaj, M.I., Expression and pharmacological modulation of visceral pain-induced conditioned place aversion in mice (2016) Neuropharm, 102, pp. 236-243; 
Baharlouei, N., Sarihi, A., Komaki, A., Shahidi, S., Haghparast, A., Blockage of acquisition and expression of morphine-induced conditioned place preference in rats due to activation of glutamate receptors type II/III in nucleus accumbens (2015) Pharmacol. Biochem. Behav., 135, pp. 192-198; 
Bai, S.A., Xiang, Q., Finn, A., Evaluation of the pharmacokinetics of single- and multiple-dose buprenorphine buccal film in healthy volunteers (2016) Clin. Ther., 38, pp. 358-369; 
Bahrenberg, A., Dzikiti, B.T., Fosgate, G.T., Stegmann, F.G., Tacke, S.P., Rioja, E., Antinociceptive effect of epidural magnesium alone and in combination with morphine in dogs (2015) Vet. Anesth. Analg., 42, pp. 319-328; 
Baimel, C., Borgland, S.L., Orexin signaling in the VTA gates morphine-induced synaptic plasticity (2015) J. Neurosci., 35, pp. 7295-7303; 
Balchin, R., Linde, J., Balckhurst, D., Rauch, H.L., Schonbachiar, G., Sweating away depression? The impact of intensive exercise on depression (2016) J. Affect. Disord., 200, pp. 218-221; 
Bandari, J., Bansal, U., Zhang, Z., Shen, B., Wang, J., Lamm, V., Chang, V., Tai, C., Neurotransmitter mechanisms underlying sacral neuromodulation of bladder overactivity in cats (2016) Neuromodulation, 20, pp. 81-87; 
Bameshki, A., Peivandi Yazdi, A., Sheybani, S., Rezaei Boroujerdi, H., Taghavi Gilani, M., The assessment of addition of either intravenous paracetamol or diclofenac suppositories to patient-controlled morphine analgesia for psotgastrectomy pain control (2015) Anesth. Pain Med., 5, p. e29688; 
Bandieri, C., Romero, M., Ripamonti, C.I., Artioli, F., Sichetti, D., Fanizza, C., Santini, D., Luppi, M., Randomized trial of low-dose morphine versus weak opioids in moderate cancer pain (2016) J. Clin. Oncol., 34, pp. 436-442; 
Banerjee, T.S., Hazra, A., Mondal, N.B., Das, S., The quinolone compound, S4 effectively antagonizes alcohol intake in mice: possible association with the histone H3 modifications (2015) Neurochem. Int., 87, pp. 117-127; 
Bao, Y., Hou, W., Yang, L., Kong, X., Du, M., Zheng, H., Gao, Y., Hua, B., Protease-activated receptor 2 antagonist potentiates analgesic effects of systemic morphine in a rat model of bone cancer pain (2015) Reg. Anesth. Pain Med., 40, pp. 158-165; 
Bao, Y., Gao, Y., Yang, L., Kong, X., Yu, J., Hou, W., Hua, B., The mechanism of mu-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence (2015) Channels (Austin), 9, pp. 235-243; 
Baronowska-Bosiacka, I., Listos, J., Gutowska, I., Machoy-Mokrzynska, A., Kolasa-Wolosiuk, A., Tarnowski, M., Puchalowicz, A., Chlubek, D., Effects of perinatal exposure to lead (Pb) on purine receptor expression in the brain and gliosis in rats tolerant to morphine analgesia (2016) Toxicology, 339, pp. 19-33; 
Barcelos, A., Garcia, P.C., Portela, J.L., Piva, J.P., Garcia, J.P., Santana, J.C., Comparison of two analgesic protocols for the treatment of pediatric orthopedic emergencies (2015) Rev. Assoc. Med. Bras. (1992), 61, pp. 362-367; 
Bartuzi, D., Kaczor, A.A., Matosiuk, D., Interplay between two allosteric sites and their influence on agonist binding in human mu opioid receptor (2016) J. Chem. Int. Model., 56, pp. 563-570; 
Bashandy, G.M., Abbas, D.N., Pectoral nerves I and II blocks in multimodal analgesia for breast cancer surgery: a randomized clinical trial (2015) Reg. Anesth. Pain Med., 40, pp. 68-74; 
Basso, L., Boue, J., Mahiddine, K., Bianpied, C., Robiou-du-Pont, S., Vergnolle, N., Deraison, C., Dietrich, G., Endogenous analgesia mediated by CD4(+) T lymphocytes is dependent on enkephalins in mice (2016) J. Neuroinflamm., 13, p. 132; 
Batdord, N.J., Lemaine, V., Lovely, J.K., Ballman, K.V., Goede, W.J., Martinez-Jorge, J., Booth-Kowalczyk, A.L., Saint-Cyr, M., Enhanced recovery after surgery in microvascular breast reconstruction (2015) J. Plast Reconstr. Anesth. Surg., 68, pp. 395-402; 
Beckley, J.T., Randall, P.K., Smith, R.J., Hughes, B.A., Kalivas, P.W., Woodward, J.J., Phenotype-dependent inhibition of glutamatergic transmission on nucleus accumbens medium spiny neurons by the abused inhalant toluene (2016) Addict. Biol., 21, pp. 530-546; 
Bednar, D.A., Wong, A., Farrokhyar, F., Paul, J., Dexamethasone perioperative coanalgesia in lumbar spine fusion: a controlled cohort study of efficacy and safety (2015) J. Spinal Disord. Tech., 28, pp. e422-426; 
Bence, C., Bonord, A., Rebillard, C., Vaast, P., Alexandre, C., Jardri, R., Rolland, B., Neonatal abstinence syndrome following tianeptine dependence during pregnancy (2016) Pediatrics, 137, p. 1542; 
Berecki, G., Motin, L., Adams, D.J., Voltage-gated R-type calcium channel inhibition via human mu-, delta- and kappa-opioid receptors is voltage-independently mediated by Gbeta-gamma protein subunits (2016) Mol. Pharmacol., 89, pp. 187-196; 
Berecki, G., Motin, L., Adams, D.J., Mechanisms of direct Cav2.2 channel block by the kappa opioid receptor agonist U50488H (2016) Neuropharmacol, 109, pp. 49-58; 
Berg, J.A., Schjott, J., Fossan, K.O., Riedel, B., Cross-reactivity of the CEDIA buprenorphine assay in drugs of abuse screening: influence of dose and metabolites of opioids (2015) Substain. Abuse Rehabil., 6, pp. 131-139; 
Betten, J., Roness, A.K., Endreseth, B.H., Tronnes, H., Tyvold, S.S., Klepstad, P., Nordseth, T., Assessment of the time-dependent need for stay in a high dependency unit (HDU) after major surgery from an anesthesia information management system (2016) J. Clin. Monit. Comput., 30, pp. 235-241; 
Bhatt, K., Kumar, A., Mechanism of morphine addiction by inhibiting the soluble guanylate cyclase-nitric oxide (sGC-NO) pathway (2015) Math. Biosci., 366, pp. 85-92; 
Bhavsar, R., Ryhammer, P.K., Greisen, J., Rasmussen, L.A., Jakobsen, C.J., Remifentanil compared with sufentanil does not enhance fast-track possibilities in cardiac surgery- a randomized study (2016) J. Cardiothorac. Vasc. Anesth., 30, pp. 1212-1220; 
Bian, H., Yu, L.C., Intra-nucleus accumbens administration of the calcium/calmodulin-dependent protein kinase II inhibitor AIP induced antinociception in rats with mononeuropathy (2015) Neurosci. Lett., 599, pp. 129-132; 
Bian, X., Zhou, R., Yang, Y., Li, P., Hang, Y., Hu, Y., Yang, L., Wen, D., Divergent effect of dezocine, morphine and sufentanil on intestinal motor function in rats (2015) Int. J. Med. Sci., 12, pp. 848-852; 
Biau, D.J., Porcher, R., Roren, A., Babinet, A., Rosencher, N., Chevret, S., Poiraudeau, S., Anract, P., Neither pre-operative education or a mimimally invasive procedure have any influence on recovery time after total hip replacement (2015) Int. Orthop., 39, pp. 1475-1481; 
Bidari, A., Ghavidel-Parsa, B., Rajabi, S., Sanaei, O., Toutounchi, M., The acute effect of maximal exercise on plasma beta-endorphin levels in fibromyalgia patients (2016) Korean J. Pain, 29, pp. 249-254; 
Biegler, J.M., Freet, C.S., Horvath, N., Rogers, A.M., Hajnal, A., Increased morphine self-administration following Roux-en-Y gastric bypass in dietary obese rats (2016) Brain Res. Bull., 123, pp. 47-52; 
Bimonte, S., Batrbieri, A., Rea, D., Palma, G., Luciano, A., Cuomo, A., Arra, C., Izzo, F., Morphine promotes tumor angiogenesis and increases breast cancer progression (2015) BioMed Res. Int., 2015, p. 161508; 
Bindu, M., Kumar, A.A., Kesavan, M., Suresh, V., Effect of preoperative gabalin on postoperative pain relief in thyroidectomy patients: a prospective observational study (2015) Anesth. Essays Res., 9, pp. 161-166; 
Bird, M.F., Cerlesi, M.C., Brown, M., Malfacini, D., Vezzi, V., Molinari, P., Micheli, L., Lambert, D.G., Characterization of the novel mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) (2016) PLoS One, 11, p. e156897; 
Blanco, R., Ansari, T., Girgis, E., Quadratus lumborum block for postoperative pain after caesarean section: a randomized controlled trial (2015) Eur. J. Anaesthesiol., 32, pp. 812-818; 
Blankenstein, T.N., Gibson, L.M., Claydon, M.A., Is intramuscular morphine satisfying frontline medical personnels’ requirement for battlefield analgesia in Helmand Province, Afghanistan? a questionnaire study (2015) Br. J. Pain, 9, pp. 115-121; 
Bobeck, E.N., Ingram, S.L., Hermes, S.M., Aicher, S.A., Morgan, M.M., Ligand-based activation of extracellular signal-related kinase ½ leads to differences in opioid induced antinociception and tolerance (2016) Behav. Brain Res., 298, pp. 17-24; 
Bojovic, O., Bramham, C.R., Tjolsen, A., Chronic morphine treatment enhances sciatic nerve stimulation-induced immediate early gene expression in the rat dorsal horn (2015) Acta Neurobiol. Exp. (Wars), 75, pp. 305-313; 
Bonet, A., Koo, M., Sabate, A., Otero, I., Bocos, J., Pi, A., Ultrasound-guided saphenous nerve block is an effective for periperative analgesia in ambulatory arthroscopic surgery of the internal knee compartment (2015) Rev. Exp. Anestesiol. Reanim, 62, pp. 428-435; 
Bonnard, E., Poras, H., Fournie-Zaluski, M.C., Roques, B.P., Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain (2016) Eur. J. Pharmacol., 788, pp. 176-182; 
Borriello, R., Carfora, A., Cassandro, P., Petrella, R., Clinical and forensic diagnosis of very recent heroin intake by 6-acetylmorphine immunoassay test and LC–MS/MS analysis in urine and blood (2015) Ann. Clin. Lab. Sci., 45, pp. 414-418; 
Bose, S., Khanna, A., You, J., Arora, L., Qavi, S., Turan, A., Low serum vitamin D levels are not associated with increased postoperative pain and opioid requirements: a historical cohort study (2015) Can. J. Anaesth., 62, pp. 770-776; 
Boselli, E., Bouvet, L., Augris-Mathieu, C., Begou, G., Diot-Junique, N., Rahali, N., Vertu-Ciolino, D., Allouchiche, B., Infraorbtal and infratrochlear nerve blocks combined with general anaestheisa for outpatient rhinoseptoplasty: a prospective randomized double-blind placebo-controlled stuy (2016) Anaesth. Crit. Care Pain Med., 35, pp. 31-36; 
Bostick, G.P., Toth, C., Carr, E.C., Stitt, L.W., Morley-Forster, P., Clark, A.J., Lynch, M., Moulin, D.E., Physical functioning and opioid use in patients with neuropathic pain (2015) Pain Med., 16, pp. 1361-1368; 
Brackley, A.D., Gomez, R., Akopian, A.M., Henry, M.A., Jeeke, N.A., GRK2 consitutively governs peripheral delta opioid receptor activity (2016) Cell Rep., 16, pp. 2686-2696; 
Brechova, J., Vosahlikova, M., Roubalova, L., Parenti, M., Mauri, M., Chernyavsiy, O., Svoboda, P., Plasma membrane cholesterol level and agonist-induced internalization of delta-opioid receptors: colocalization study with intracellular membrane markers of Rab family (2016) J. Bioenerg. Biomembr., 48, pp. 375-396; 
Bree, D., Moriarty, O., Broom, D.C., Kelly, J.P., Roche, M., Finn, D.P., Characterization of the affective component of acute postoperative pain associated with a novel rat model of inguinal hernia repair pain (2016) CNS Neurosci. Ther., 22, pp. 146-153; 
Bree, D., Moriarty, O., O'Mahony, C.M., Morris, B., Bannerton, K., Broom, D.C., Kelly, J.P., Finn, D.P., Development and characterization of a novel, anatomically relevant rat model of acute postoperative pain (2015) J. Pain, 16, pp. 421-435; 
Briao, F.F., Horta, M.L., Horta, B.L., de Barros, G.A., Behrensdorf, A.P., Severo, I., Nunes, M.A., Real, A., Comparison of droperidol and ondansetron prophylactic effect on subarachnoid morphine-induced pruritus (2015) Braz. J. Anesthesiol., 65, pp. 244-248; 
Broad, J., Manuel, D., Kung, V.W., Hicks, G.A., Schemann, M., Barnes, M.R., Kenaken, T.F., Sanger, G.J., Human native kappa opioid receptor functions not predicted by recombinant receptors: implications for drug design (2016) Sci. Rep., 6, p. 30797; 
Brogan, S.E., Winter, N.B., Okifuji, A., Prospective observational study of patient-controlled intrathecal analgesia: impact on cancer-associated symptoms, breakthrough pain control and patient satisfaction (2015) Reg. Anesth. Pain Med., 40, pp. 369-375; 
Brokjaer, A., Olesen, A.E., Kreilgaard, M., Graversen, C., Gram, M., Christup, L.L., Dahan, A., Drewes, A.M., Objective markers of the analgesic response to morphine in experimental pain research (2015) J. Pharmacol. Toxicol. Methods, 73, pp. 7-14; 
Brousseau, D.C., Scott, J.P., Badaki-Makun, O., Darbari, D.S., Chumpitazi, C.E., Airewele, G.E., Ellison, A.E., Panepinto, J.A., A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children (2015) Blood, 126, pp. 1651-1657; 
Brumelte, S., Chau, C.M., Cepeda, I.L., Degenhardt, A., Weinberg, J., Synnes, A.R., Grunau, R.E., Cortisol levels in former preterm children at school age are predicted by neonatal procedural pain-related stress (2015) Psychoneuroendocrinology, 51, pp. 151-163; 
Brust, A., Croker, D.E., Colless, B., Ragnarsson, L., Andersson, A., Jain, K., Garcia-Caraballo, S., Lewis, R.J., Conopeptide-derived kappa-opioid agonists (conorphins): potent, selective and metabolic stable dynorphin A mimetics with antinociceptive properties (2016) J. Med. Chem., 59, pp. 2381-2395; 
Bryden, L.A., Nicholson, J.R., Doods, H., Pekcec, A., Deficits in spontaneous burrowing behavior in the rat bilateral monosodium iodoacetate model of osteoarthritis: an objective measure of pain-related behavior and analgesic efficacy (2015) Osteoarthritis Cartilage, 23, pp. 1605-1612; 
Bryskin, R.B., Londergan, B., Wheatley, R., Heng, R., Lewis, M., Barraza, M., Mercer, E., Ye, G., Transversus abdominis plane block versus caudal epidural for lower abdominal surgery in children: a double-blinded randomized controlled trial (2015) Anesth. Analg., 121, pp. 471-478; 
Bui, K., She, F., Zhou, D., Butler, K., Al-Huniti, N., Sostek, M., The effect of quinidine, a strong P-glycoprotein inhibitor, on the pharmacokinetics and central nervous system distribution of naloxogel (2016) J. Clin. Pharmacol., 56, pp. 497-505; 
Busse, J.W., Mahmood, H., Magbool, B., Zahran, A., Alwosaibai, A., Alshaqaq, E., Persaud, N., Buckley, D.N., Characteristics of patients receiving long-term opioid therapy for chronic noncancer pain: a cross-sectional survey of patients attending the pain management centre at Hamilton General Hospital, Hamilton, Ontario (2015) CMAJ Open, 3, pp. e324-330; 
Cai, X., Huang, H., Kuzirian, M.S., Snyder, L.M., Matsushita, M., Lee, M.C., Ferguson, C., Ross, S.E., Generation of a KOR-Cre knockin mouse strain to study cells involved in kappa opioid signaling (2016) Genesis, 54, pp. 29-37; 
Cai, Y., Lu, D., Chen, Z., Ding, Y., Chung, N.N., Li, T., Schiller, P.W., [Dmt(1)]DALDA analogues modified with tyrosin analogues at position 1 (2016) Bioorg. Med. Chem. Lett., 26, pp. 3629-3631; 
Caldwell, C.D., Watterberg, K.L., Effect of premedication regimen on infant pain and stress response to endotracheal intubation (2015) J. Perinataol., 35, pp. 415-418; 
Campbell, G., Nielsen, S., Bruno, R., Lintzeris, N., Cohen, M., Hall, W., Larance, B., Degenhardt, L., The pain and opioids IN treatment study: characteristics of a cohort using opioids to manage chronic non-cancer pain (2015) Pain, 156, pp. 231-242; 
Campbell, G., Nielsen, S., Larance, B., Bruno, R., Mattick, R.P., Hall, W., Lintzeris, N., Degenhardt, L., Pharmaceutical opioid use and dependence among people living with chronic pain: associations observed within the pain and opioids in treatment cohort (2015) Pain Med., 16, pp. 1745-1758; 
Campbell, L.A., Avdoshina, V., Day, C., Lim, S.T., Mocchetti, I., Pharmacological induction of CCL5 in vivo prevents gp120-mediated neuronal injury (2015) Neuropharm, 92, pp. 98-107; 
Cao, L., Fu, M., Kumar, S., Kumar, A., Methamphetamine potentiates HIV-1 gp120-mediated autophagy via Beclin-1 and Atg5/7 as a pro-survival response in astrocytes (2016) Cell Chem. Dis., 7, p. e2425; 
Caputi, F.F., Palmisano, M., Carboni, L., Candeletti, S., Romualdi, P., Opioid gene expression changes and post-tranlational histone modifications at promoter regions in the rat nucleus accumbens after acute and repeated 3, 4-methylenedioxy-methamphetamine (MDMA) exposure (2016) Pharmacol. Res., 114, pp. 209-218; 
Carboni, L., Romoli, B., Romualdi, P., Zoli, M., Repeated nicotine exposure modulates prodynorphin and pronociceptin levels in the reward pathway (2016) Drug Alcohol Depend., 166, pp. 150-158; 
Carver, C.S., Johnson, S.L., Kim, Y., Mu opioid receptor polymorphism, early social adversity and social traits (2016) Soc. Neurosci., 11, pp. 515-524; 
Case, L.K., Ceko, M., Gracely, J.L., Richards, L.A., Olausson, H., Bushnell, M.C., Touch perception altered by chronic pain and by opioid blockade (2016) eNeuro, 3, pp. 0138-0215; 
Castany, S., Carcole, M., Leanez, S., Pol, O., The antinociceptive effect of a delta-opioid agonist in mice with painful diabetic neuropathy: involvement of heme oxygenase 1 (2016) Neurosci. Lett., 614, pp. 49-54; 
Castany, S., Carcole, M., Leanez, S., Pol, O., The induction of heme oxygenase 1 decreases painful diabetic neuropathy and enhances the antinociceptive effects of morphine in diabetic mice (2016) PLoS One, 11, p. e0146427; 
Castel, D., Sabbag, I., Brenner, O., Meilin, S., Peripheral neuritis trauma in pigs: a neuropathic pain model (2016) J. Pain, 17, pp. 36-49; 
Celik, M.O., Labuz, D., Henning, K., Busch-Dienstfertig, M., Gaveriaux-Ruff, C., Kieffer, B.L., Zimmer, A., Machelska, H., Leukocyte opioid receptors mediate analgesia via Ca(2+)-regulated release of opioid peptides (2016) Brain Behav. Immun., 57, pp. 227-242; 
Cenak, N., Castreo, M., Desomeaux, C., Colin, P., Sie, M., Ranger, M., Vergnolle, N., A novel orally administered trimebutine compound (GIC-1001) is antinociceptive and features peripheral opioid agonistic activity and hydrogen sulphide-releasing capacity in mice (2016) Eur. J. Pain, 20, pp. 723-730; 
Cernea, M., Phillips, R., Padmanabhan, V., Coolen, L.M., Lehman, M.N., Prenatal terstosterone exposure decreases colocalization of insulin receptors in kisspeptin/neurokininin B/dynorphin and agouti-related peptide neurons of the adult ewe (2016) Eur. J. Neurosci., 44, pp. 2557-2568; 
Cerritelli, S., Hirschberg, S., Hill, R., Balthasar, N., Pickering, A.E., Activation of brainstem pro-opiomelanocortin neurons produces opioidergic analgesia, bradycardia and bradypnoea (2016) PLoS One, 216 (11), p. e153187; 
Chabbi, A., Ganesh, C.B., Neuroanatomical evidence for the involvement of beta-endorphin during reproductive stress response in the fish Oreochromis mossambicus (2016) J. Chem. Neuroanat., 77, pp. 161-168; 
Chahkandi, M., Askari, N., Asadkaram, G., The effect of acute and chronic morphine on some blood biochemical parameters in an inflammatory condition in gonadectomized male rats (2016) Addict Health, 7, pp. 130-139; 
Chakrabarti, S., Chang, A., Liu, N.J., Gintzler, A.R., Chronic opioid treatment augments caveolin-1 scaffolding: relevance to stimulatory mu-opioid receptor adenylyl cyclase signaling (2016) J. Neurochem., 139, pp. 737-747; 
Chakrabarti, S., Madia, P.A., Gintzler, A.R., Selective upregulation of functional mu-opioid receptor splice variants by chronic opioids (2015) J. Neurochem., p. 13519; 
Chalmers, D.J., Bielsky, A., Wild, T.T., Siparsky, G.L., Wilcox, D.T., Continuous local anesthetic infusion for children with spina bifida undergoing major reconstruction of the lower urinary tract (2015) J. Pediatr. Urol., 72, pp. e1-5; 
Chang, G.Q., Karatayev, O., Lukatshaya, O., Leibowitz, S.F., Prenatal fat exposure and hypothalamic PPAR beta/delta: possible relationbship to increased neurogenesis of orexienic peptide neurons (2016) Peptides, 79, pp. 16-26; 
Chang, S.C., Ma, C.C., Lee, C.T., Hsieh, S.W., Pharmacoepidemiology of chronic noncancer pain patients requiring chronic opioid therapy: a nationwide population-based study (2015) Acta Anaesthesiol. Taiwan, 53, pp. 89-94; 
Charkhpour, M., Ghavimi, H., Ghanbarzadeh, S., Yousefi, B., Khorrami, A., Mesgari, M., Hassanzadeh, K., Protective effect of pioglitazone on morphine-induced neuroinflammation in the rat lumbar spinal cord (2015) J. Biomed. Sci., 22, p. 82; 
Chartoff, E.H., Ebner, S.R., Sparrow, A., Potter, D., Baker, P.M., Ragozzino, M.E., Roitman, M.F., Relative timing behavior between kappa opioid receptor activation and cocaine determines the impact on reward and dopamine release (2016) Neuropsychopharmacology, 41, pp. 989-1002; 
Chatti, J., Creveaux, J., Woillard, J.B., Langlais, S., Amara, A., Ben Falma, L., Saad, A., Libert, E., Association of the OPRM1 and COMT genes’ polymorphisms with the efficacy of morphine in Tunisian cancer patients: impact of high genetic heterogeneity in Tunisia? (2016) Therapie, 71, pp. 507-513; 
Chaudet, A., Bouhours, G., Rineau, E., Hamel, J.F., Leblanc, D., Steiger, V., Lasocki, S., Impact of preoperative continuous femoral blockades on morphine consumption and morphine side effects in hip-fracture patients: a randomized placebo-controlled study (2016) Anesth. Crit. Care Pain Med., 35, pp. 37-43; 
Chavez, J.R., Ibancovichi, J.A., Sanchez-Aparicio, P., Acevedo-Arcique, C.M., Moran-Munoz, R., Recillas-Morales, S., Effect of acetaminophen alone or in combination with morphine and tramadol on the minimum alveolar concentration of isoflurane in rats (2015) PLoS One, 10, p. e0143710; 
Chen, C., Chiu, Y.T., Wu, W., Huang, P., Mann, A., Schulz, S., Liu-Chen, L.Y., Determination of sites of U50488H-promoted phosphorylation of the mouse kappa-opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization (2016) Biochem. J., 473, pp. 497-508; 
Chen, C., Xi, C., Liang, X., Ma, J., Su, D., Abel, T., Liu, R., The role of kappa opioid receptors in brain ischemia (2016) Cell Care Med., 44, pp. e1219-e1225; 
Chen, J., Zhu, W., Zhang, Z., Zhu, L., Zhang, W., Du, Y., Efficacy of celecoxib for acute pain management following total hip arthroplasty in elderly patients: a prospective, randomized placebo-control trial (2015) Exp. Ther. Med., 10, pp. 737-742; 
Chen, M., Yu, H., Sun, S., Pan, T., Wang, Z., Fu, S., Lin, F., Clinical research of percutaneous bilateral splanchnic merve lesion for pain relief in patients with pancreatic cancer under X-ray guidance (2015) Int. J. Clin. Exp. Med., 8, pp. 20092-20096; 
Chen, M., Zhao, Y., Yang, H., Luan, W., Song, J., Cui, D., Dong, Y., Zheng, P., Morphine disinhibits glutamatergic input to VTA dopamine neurons and promotes dopamine neuron excitation (2015) Elife, 4, p. 09275; 
Chen, T., Li, J., Hui, R., Dong, Y.L., Huo, F.Q., Zhang, T., Yin, J.B., Du JQ, L.Y., Mechanisms underlying the analgesic effect exerted by endomorphin-1 in the rat ventrolateral periaqueductal gray (2016) Mol. Neurobiol., 53, pp. 2036-2053; 
Chen, T., Wang, K., Xu, J., Ma, W., Zhou, J., Electroacupuncture reduces postoperative pain and analgesic consumption in patients undergoing thoracic surgery: a randomized study (2016) Evid. Based Complement. Altern. Med., 2016, p. 2126416; 
Chen, T., Yuan, S.J., Yu, X.C., Jiao, L.B., Hu, W., Chen, W.L., Xie, B., Effect of toad skin extract on the pain behavior of cancer model mice and its peripheral mechanism of action (2016) Int. Immunopharmacol., 42, pp. 90-99; 
Chen, W.K., Ren, L., Wei, Y., Zhu, D.X., Miao, C.H., Xu, J.M., General anesthesia combined with epidural anesthesia ameliorates the effect of fast-track surgery by mitigating immunosuppression and facilitating intestinal functional recovery in colon cancer patients (2015) Int. J. Colorectal Dis., 30, pp. 475-481; 
Chen, Z.G., Liu, X., Wang, W., Geng, F., Gao, J., Chai, J.R., He, L., Liu, J.G., Dissociative role for dorsal hippocampus in mediating heroin self-administration and relapse through CDK5 and RhoB signaling revealed by proteonomic analysis (2016) Addict. Biol., p. 12435; 
Cheng, G., Sun, X., Li, W., Liu, G., Tu, Y., Tang, Y., Molecular switches of the kappa opioid receptor triggered by 6′-GNTI and 5′-GNTI (2016) Sci. Rep., 6, p. 18913; 
Cheng, I.C., Chang, C.S., Tsai, W.I., Long-term usage of narcotic analgesics by chronic injectable noncancer pain patients in Taiwanfrom 2003 to 2012 (2016) J. Formos. Med. Assoc., 115, pp. 773-778; 
Cheng, X., Zhang, Y.E., Lu, X., Lu, Y., Chen, Z., The involvement of central beta-endorphin in the cardioprotective effects of remote preconditioning mediated by the intracerebroventricular administration of morphine (2016) Ir. J. Med. Sci., 185, pp. 423-431; 
Chieng, T., Sansuk, K., van Rijn, R.M., Beta-arrestin 2 dependence of delta opioid receptor agonists is correlated with alcohol intake (2016) Br. J. Pharmacol., 173, pp. 332-343; 
Chindo, B.A., Schroder, H., Koeberle, A., Werz, O., Becker, A., Analgesic potential of standardized methonal stem bark extract of Ficus platyphilla in mice: mechanisms of action (2016) J. Ethnopharmacol., 184, pp. 101-108; 
Cho, P.S., Lee, H.K., Lee, S.H., Im, J.Z., Jung, S.J., DAMGO modulates two-pore domain K(+) channels in the substantia gelatinosa neurons of rat spinal cord (2016) Korean J. Physiol. Pharmacol., 20, pp. 525-531; 
Choi, G.J., Kang, H., Kim, W.J., Kwon, J.W., Kim, B.G., Choi, Y.S., Che, Y.J., Ko, J.S., Rubus occidentalis analgesic effect in a rat model of incisional pain (2016) J. Surg. Res., 206, pp. 223-230; 
Chopda, G.R., Parge, V., Thakur, G.A., Gatley, S.J., Makriyannis, A., Paronis, C.A., Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice (2016) J. Pharmacol. Exp. Ther., 358, pp. 334-341; 
Christofferson, D.J., Brasch-Andersen, C., Thomsen, J.L., Worm-Leonhard, M., Damkier, P., Brosen, K., Quantification of morphine, morphine 6-glucuronide, bupremorphine and the enantiomers of methadone by enantioselective mass spectrometric chromatography in whole blood (2015) Forensic Sci. Med. Pathol., 11, pp. 193-201; 
Ciechanowska, M., Lapot, M., Matusiak, K., Paruszewska, E., Malewski, T., Krawczynska, A., Przekop, F., The central effect of beta-endorphin and naloxone on the biosynthesis of GnRH and GnRH receptor in the hypothalamic-pituitary unit of follicular-phase ewes (2016) Reprod. Domest. Anim., 5, pp. 555-561; 
Clarke, H., Page, G.M., McCartney, C.J., Huang, A., Stratford, P., Andrion, J., Kennedy, D., Katz, J., Pregabalin reduces postoperative opioid consumption and pain for 1 week after hospital discharge, but does not affect function at 6 weeks or 3 months after total hip arthroplasty (2015) Br. J. Anesth., 115, pp. 903-911; 
Cleveland, E.M., Peirce, G.S., Freemyer, J.D., Schriver, J.P., Ahnfeldt, E.P., Rice, W.V., Prospective randomized double-blind controlled trial of continuous local anesthetic infusion to reduce narcotic use in laparoscopic sleeve gastrectomy (2015) Surg. Obes. Relat. Dis., 11, pp. 1152-1156; 
Cohen, A.S., Palek, R., Enkemann, S.A., Johnson, J.O., Chen, T., Toloza, E., Vagner, J., Morse, D.L., Delta-opioid receptor (DOR) targeted near-infrared fluorescent agent for imaging of lung cancer: synthesis and evaluation in vitro and in vivo (2016) Bioconjug. Chem., 27, pp. 427-438; 
Collins, L.M., Dai Bo, G., Calcagno, M., Monzon-Sandoval, J., Sullivan, A.L., Gutierrez, H., Morari, M., O'Keefe, G.W., Nociceptin/orphanin FQ inhibits the survival and axon growth of midbrain dopaminergic neurons through a p38-MAPK dependent mechanism (2016) Mol. Neurobiol., 53, pp. 7284-7297; 
Conde, K., Meza, C., Kelly, M.J., Sinchak, K., Wagner, E.J., Estradiol rapidly attenuates ORL-1 receptor-mediated inhibition of proopiomelanocortinneurons via Gq-coupled, membrane-initiated signaling (2016) Neuroendocrin, 103, pp. 787-805; 
Cong, Y., Sun, K., He, X., Li, J., Dong, Y., Zheng, B., Tan, X., Song, X.J., A traditional Chinese medicine Xiao-Ai-Tong suppresses pain through modulation of cytokines and prevents adverse reactions of morphine treatment in bone cancer pain patients (2015) Mediators Inflamm., 2015, p. 961635; 
Cooper, Z.D., Johnson, K.W., Pavlicova, M., Glass, A., Vosburg, S.K., Sullivan, M.A., Manubay, J.M., Comer, S.D., The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers (2016) Addict. Biol., 21, pp. 895-903; 
Craig, M.M., Bajic, D., Long-term behavioral effects in a rat model of prolonged postnatal morphine exposure (2015) Behav. Neurosci., 129, pp. 643-655; 
Crociolli, G.C., Cassu, R.N., Barbero, R.C., Rocha, T.L., Gomes, D.R., Nicacio, G.M., Gabapentin as an adjuvant for postoperative pain management in dogs undergoing mastectomy (2015) J. Vet. Med. Sci., 77, pp. 1011-1015; 
Cronin-Fenton, D.P., Heide-Jorgensen, U., Ahern, T.P., Lash, T.L., Christiansen, P.M., Ejlertsen, B., Sjogren, P., Sorenson, H.T., Opioids and breast cancer recurrence: a Danish population-based study (2015) Cancer, 121, pp. 3507-3514; 
Crowley, N.A., Bloodgood, D.W., Hardaway, J.A., Kendra, A.M., McCall, J.G., Al-Hasani, R., McCall, N.M., Kash, T.L., Dynorphin controls the gain of an amygdalar anxiety circuit (2016) Cell Rep., 14, pp. 2774-2783; 
Crowley, R.S., Riley, A.P., Sherwood, A.M., Groer, C.E., Shivaperumal, N., Biscaia, M., Paton, K., Psisinzano, T.E., Synthetic studies of neoclerodane diterpenes from Salvia divinorum: identification of a potent and centrally acting mu opioid analgesic with reduced abuse liability (2016) J. Med. Chem., 59, pp. 11027-11038; 
Cruz, A.M., Sukihara, M.H., Felicio, F., Late pregnancy progesterone treatment as a modulatory signal for postpartum behavior (2015) Pharmacol. Biochem. Behav., 130, pp. 40-45; 
da Fonseca Pacheco, D., Freitas, A.C., Pimenta, A.M., Duarte, I.D., de Lima, M.E., A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems (2016) J. Venom Anim. Toxins Incl. Trop. Dis., 22, p. 34; 
da Silva, M.P., Liebano, R.E., Rodrigues, V.A., Abla, L.E., Ferreira, L.M., Transcutaneous electrical nerve stimulation for pain relief after liposuction: a randomized controlled trial (2015) Aesthetic Plast. Surg., 39, pp. 262-269; 
Daiziel, J.E., Anderson, R.C., Bassett, S.A., Lloyd-West, C.M., Haggarty, N.W., Roy, N.C., Influence of bovine whry protein concentrate and hydrolysate preparation methods on motiity in the isolated rat distal colon (2016) Nutrients, 8, p. e809; 
Darlington, T.M., McCarthy, R.D., Cox, R.J., Miyamoto-Ditmon, J., Galiego, X., Ehringer, M.A., Voluntary wheel running reduces voluntary consumption of ethanol in mice: identification of candidate genes through striatal gene expression profiling (2016) Genes Brain Behav., 15, pp. 474-490; 
Dart, R.C., Surratt, H.L., Cicero, T.J., Parrino, M.W., Severtson, S.G., Bucher-Bartelson, B., Green, J.L., Trends in opioid analgesic abuse and mortality in the United States (2015) N. Engl. J. Med., 372, pp. 241-248; 
Day, A.R., Smith, R.V., Scott, M.J., Fawcett, W.J., Rockall, T.A., Randomized clinical trial investigating the stress response from two different methods of analgesia after laparoscopic colorectal surgery (2015) Br. J. Surg., 102, pp. 1473-1479; 
Deaton, T., Auten, J.D., Darracq, M.A., Nebulized fentanyl vs intravenous morphine for ED patients with acute abdominal pain: a randomized double-blinded, placebo-controlled clinical trial (2015) Am. J. Emerg. Med., 33, pp. 791-795; 
de Carvalho, L.L., Nishimura, L.T., Borges, L.P., Cerejo, S.A., Villela, I.O., Auckburally, A., de Mattos-Junior, E., Sedative and cardiopulmonary effects of xylazine alone or in combination with methadone, morphine or tramadol in sheep (2016) Vet. Anaesth. Analg., 43, pp. 179-188; 
Deekonda, S., Cole, J., Sunna, S., Rankin, D., Largent-Milnes, T.M., Davis, P., Bassiri Rad, N.M., Hruby, V.J., Enkephalin analogues with N-phenyl-N-(piperidin-2-ymethyl) propioamide derivatives: synthesis and biological evaluations (2016) Bioorg. Med. Chem. Lett., 26, pp. 222-227; 
Deekonda, S., Rankin, D., Davis, P., Vanderah, T.W., Porreca, F., Hruby, V.J., Design synthesis and structure-activity relationship of 5-substituted (tetrahydonaphthalen–2yl)methyl with N-phenyl-N-(piperidin-2-yl)propionamide derivatives as opioid ligands (2016) Bioorg. Med. Chem., 24, pp. 85-91; 
de Freitas, R.L., Medeiros, P., da Silva, J.A., de Oliveira, R., Ullah, F., Khan, A.U., Coimbra, N.C., The mu1-opioid receptor and 5HT2A- and 5HT2C-serotinergic receptors of the locus coeruleus are critical in elaborating hypoalagesia induced by tonic and clonic seizures (2016) Neuroscience, 336, pp. 133-145; 
de Freitas, R.L., Medeiros, P., Khan, A.U., Coimbra, N.C., Mu1-opioid receptors in the dorsomedial and ventrolateral columns of the periaqueductal gray matter are critical for the enhancement of post-ictal antinociception (2016) Synapse, 70, pp. 519-530; 
de la Calle Gil, A.B., Pena Vergara, I., Cormane Bornacelly, M.A., Pajuelo Gallego, A., Intrathecal ziconotide and morphine for pain relief: a case series of eight patients with refractory cancer pain, including five cases of neuropathic pain (2015) Neurol. Ther., 4, pp. 159-168; 
Della Longa, S., Arcovito, A., A dynamic picture of the early events in nociception binding to the NOP receptor by metadynamics (2016) Biophys. J., 111, pp. 1203-1213; 
de Los Monteros-Zuniga, A.E., Izquierdo, T., Quinonez-Bastidas, G.N., Rocha-Gonzalez, H.I., Godinez Chaparro, B., Anti-allodynic effect of mangiferin in neuropathic rats: involvement of nitric oxide-cyclic GMP-ATP sensitivie K+ channel pathway and serotonergic system (2016) Pharmacol. Biochem. Behav., 150-151, pp. 190-197; 
De Marco, R., Bedini, A., Spampinato, S., Cavina, L., Pirazzoli, E., Gentilucci, L., Versatile picklocks to access all opioid receptors: tuning the selectivity and functional profile of the cyclotetrapeptide c [Phe-d-Pro-Phe-Trp] (CJ-15, 208) (2016) J. Med. Chem., 59, pp. 9255-9261; 
Dennis, T.S., Beck, K.D., Cominski, T.P., Bobzean, S.A., Kuzhikandathil, E.V., Servatius, R.J., Perrotti, L.I., Exposure to morphine-associated cues increases mu opioid receptor mRNA expression in the nucleus accumbens of Wistar Kyoto rats (2016) Behav. Brain Res., 313, pp. 208-214; 
De Oliveira, G.S., Jr, Castro-Alves, I.J., McCarthy, R.J., Single-dose systemic acetaminophen to prevent postoperative pain: a meta-analysis of randomized controlled trials (2015) Clin. J. Pain, 31, pp. 86-93; 
de Oliveira Junior, J.O., de Freitas, M.F., Bullara de Andrade, C., Chacur, M., Ashmawi, H.A., Local analgesic effect of tramadol is mediated by opioid receptors in late postoperative pain after plantar incision in rats (2016) J. Pain Res., 9, pp. 797-802; 
DeRossi, R., Hermeto, L.C., Jardim, P.H., de Andrade Bicudo, N., de Assis, K.T., Postoperative pain control in cats: clinical trials with pre-emptive lidocaine co-administered with morphine or methadone (2015) J. Feline Med. Surg., 18, pp. 882-888; 
Desai, R.J., Huybrechts, K.F., Hernandez-Diaz, S., Mogun, H., Patorno, E., Kaltenbach, K., Kerzner, L.S., Bateman, B.T., Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study (2015) BMJ, 350, p. h2102; 
de Souza Grava, A.L., Ferrari, L.F., Parada, C.A., Defino, H.L., Pharmacologic treatment of hyperalgesia experimentally induced by nucleus pulposus (2015) Rev. Bras. Orthop., 45, pp. 569-576; 
Devarapalli, M., Leonard, M., Briyat, S., Stefanov, G., Puppala, B.L., Schweig, L., Gulati, A., Prenatal oxycodone exposure alters CNS endothlin receptor expression in neonatal rats (2016) Drug Res. (Stuttg.), 66, pp. 246-250; 
Deveaugh-Geiss, A., Kadakia, A., Chilcoat, H., Alexander, L., Coplan, P., A retrospective cohort study of long-term immediate-release hydrocodone/acetaminophen use and acetaminophen dosing above the Food and Drug Administration recommended maximum daily limit among commercially insured individuals in the United States (2008–2013) (2015) J. Pain, 16, pp. 569-579; 
Dever, S.M., Rodriguez, M., Lapierre, J., Costin, B.N., El-Hage, N., Differing roles of autophagy in HIV-associated neurocognitive impairment and encephalitis with implications for morphine co-exposure (2015) Front. Microbiol., 6, p. 653; 
de Waha, S., Eitel, I., Desch, S., Fuernau, G., Lurz, P., Urban, D., Schuler, G., Thiele, H., Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging (2015) Clin. Res. Cardiol., 104, pp. 727-734; 
Dholakiya, S.L., Aliberti, A., Barile, F.A., Morphine sulfate concomitantly decreases neuronal differentiation and opioid receptor expression in embryonic stem cells (2016) Toxicol. Lett., 247, pp. 45-55; 
Di Cesare Mannelli, L., Corti, F., Micheli, L., Zanardelli, M., Ghelardini, C., Delay of morphine tolerance by palmitoylethanolamide (2015) BioMed Res. Int., 2015, p. 894732; 
Dimov, L.F., Franciosi, A.C., Campos, A.C., Brunoni, A.R., Pagano, R.L., Top-down effect of direct current stimulation on the nociceptive response of rats (2016) PLoS One, 11, p. e153506; 
Ding, H., Czoty, P.W., Kiguchi, N., Cami-Kobeci, G., Sukhtankar, D.D., Nader, M.A., Husbands, S.M., Ko, M.C., A novel orvinaol analog, BU08028, as a safe opioid analgesic without abuse liability in primates (2016) Proc. Natl. Acad. Sci. U. S. A., 113, pp. E5511-5518; 
Ding, L., Zhang, J.L., Yu, S.H., Sheng, L.F., Investigation of genes in chronic and acute morphine-treated mice using microarray datasets (2015) Genet. Mol. Res., 14, pp. 10193-10205; 
Ding, W., Guo, Y., Cui, X., Zhang, B., Li, D., Li, W., Morphine-induced delayed pre-conditioning against anoxia/reoxygenation injury in pulmonary artery endothelial cells: the role of mitochondrial KATP channels (2016) Mol. Med. Rep., 13, pp. 1047-1053; 
Dirkmann, D., Groeben, H., Farhan, H., Stahl, D.L., Eikermann, M., Effects of parecoxib on analgesia benefit and blood loss following open prostectomy: a multicenter randomized trial (2015) BMC Anesthesiol., 15, p. 31; 
Dogishi, K., Kodera, M., Oyama, S., Shirakawa, H., Nagagawa, T., Kanecko, S., Long-lasting pain-related behaviors in mouse chronic cystitis model induced by a single intravesical injection of hydrogen peroxide (2015) J. Pharmacol. Sci., 129, pp. 244-246; 
Doi, S., Mori, T., Uzawa, N., Arima, T., Takahashi, T., Uchida, M., Yawata, A., Narita, M., Characterization of methadone as a beta-arrestin-biased mu-opioid receptor agonist (2016) Mol. Pain, 12. , 1744806916654146; 
Donnerer, J., Liebmann, I., ERK1/2 phosphorylation in the rat supraoptic nucleus, dorsal raphe nucleus and locus coeruleus neurons following noxious stimulation to the hindpaw (2016) Pharmacology, 97, pp. 57-62; 
Dooley, R., Dooley, J., Antone, I., Guilfoyle, J., Gerber-Finn, L., Kakekagumick, K., Cromarty, H., Kelly, L., Narcotic tapering in pregnancy using long-acting morphine: an 18-month prospective cohort study in northwestern Ontario (2015) Can. Fam. Physician, 61, pp. e88-95; 
Doornebal, C.W., Vrijland, K., Hau, C.S., Coffelt, S.B., Ciampricotti, M., Jonkers, J., de Visser, K.E., Hollmann, M.W., Morphine does not facilitate breast cancer progression in two preclinical mouse models for human invasive lobular and HER2 breast cancer (2015) Pain, 156, pp. 1424-1432; 
Dou, M.Y., Wu, H., Zhu, H.J., Jin, S.Y., Zhang, Y., He, S.F., Remifentanil preconditioning protects rat cardiomyocytes against hypoxia-reoxygenation injury via delta-opioid receptor mediated activation of PI3K/Akt and ERK pathways (2016) Eur. J. Pharmacol., 789, pp. 395-401; 
Du, C., Duan, Y., Wei, W., Cai, Y., Chai, H., Lv, J., Du, X., Xie, X., Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promortes oligodendrocyte-mediated remyelination (2016) Nat. Commoun., 7, p. 11120; 
Du, J.Y., Liang, Y., Fang, J.F., Jiang, Y.L., Shao, X.M., He, X.F., Fang, J.Q., Effect of systemic injection of heterogeneous and homogenous opioids on peripheral cellular immune response in rats with bonce cancer pain: a comparative study (2016) Exp. Ther. Med., 12, pp. 2568-2576; 
Duan, L., Wang, J., Sun, X., Yang, X., Shan, L., Liu, Y., Wang, H., The role and significance of endomorphin-1 and mu-opioid receptor in rats with endometriosis (2016) Gynecol. Endocrinol., 32, pp. 912-915; 
Dynewicz, J., Lipinski, P.F., Kosson, P., Lesniak, A., Bochynska-Czyz, M., Muchowska, A., Tourwe, D., Lipkowski, A.W., Hydrazone linker as a useful tool for preparing chimeric peptide/nonpeptide bifunctional compounds (2016) ACS Med. Chem. Lett., 8, pp. 73-77; 
Ebrahimian, F., Naghavi, F.S., Yazdi, F., Sadeghzadeh, F., Taslimi, Z., Haghparast, A., Differential roles for orexin receptors within the dentate gyrus in stress- and drug priming-induced reinstatement of conditioned place preference in rats (2016) Behav. Neurosci., 130, pp. 91-102; 
Eftekhar-Vaghefi, S., Esmaeili-Mahani, S., Elyasi, L., Abbasnejad, M., Involvement of mu opioid receptor signaling in the protective effect of opioid against 6-hydroxydopamine-induced SH-SY5Y human neuroblastoma cell apoptosis (2015) Basic Clin. Neurosci., 6, pp. 171-178; 
Eichenbaum, G., Gohler, K., Etropolski, M., Steigerwald, I., Pergolizzi, J., Kim, M., Vorsanger, G., Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency (2015) J. Opioid Manag., 11, pp. 211-227; 
Eidi, A., Oryan, S., Zaringhalam, Rad, J.M., Antinociceptive and anti-inflammatory effects of the aerial parts of Artemesia dracunculus in mice (2016) Pharm. Biol., 54, pp. 549-554; 
Einni, S., Konstantinos, K., Despikna, P., Nikolaos, S., Georgia, K., Paraskevi, M., Remifentanil vs fentanyl during day case dental surgery in people wth special needs: a comparative, pilot study of their effect on stress response and postoperative pain (2016) Middle East J. Anaesthesiol., 23, pp. 509-515; 
El Ahl, M.S., Femoral nerve block versus abductor canal block for postoperative pain control after anterior cruciate ligament reconstruction: a randomized controlled double blind study (2015) Saudi J. Anesth., 9, pp. 279-282; 
El Kenany, S., El Tahan, M.R., Effective of preoperative pregabalin on post-cesarean delivery analgesia: a dose-response study (2016) Int. J. Obstet. Anesth., 26, pp. 24-31; 
Elkomy, M.H., Drover, D.R., Glotzbach, K.L., Galinkin, J.L., Frymoyer, A., Su, F., Hammer, G.B., Pharmacokinetics of morphine and its metabolites in infants and young children after congenital heart surgery (2016) AAPS J., 18, pp. 124-133; 
Ellis, J.J., Sadowsky, A.B., Ten Eyck, L.L., Mudumby, P., Cappelleri, J.C., Ndehi, L., Suehs, B.T., Parsons, B., A retrospective matched cohort study of potential drug–drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine (2015) BMC Health Serv. Res., 15, p. 159; 
Emerich, B.L., Ferreira, R.C., Cordero, M.N., Borges, M.H., Pimenta, A.M., Figueirrdo, S.G., Duarte, I.D., de Lima ME. Delta-ctenltoxin-Pn1a, a peptide from Phoneutria nigriventer spider venom, shows antinociceptive effect involving opioid and cannabinoid systems in rats (2016) Toxins (Basel), 8, p. 106; 
Engen, D.J., Carns, P.E., Allen, M.S., Bauer, B.A., Loehrer, L.L., Cha, S.S., Chartrand, C.M., Wahner-Roedler, D.L., Evaluating efficacy and feasibility of transcutaneous nerve stimulation for postoperative pain after video-assisted thoracoscopic surgery: a randomized pilot trial (2016) Complement. Ther. Clin. Pract., 23, pp. 141-148; 
Enrico, P., Migliore, M., Spiga, S., Mulas, G., Caboni, F., Diana, M., Morphofunctional alterations in ventral tegmental area dopamine neurons in acute and prolonged opiates withdrawal: a computational perspective (2016) Neuroscience, 322, pp. 195-207; 
Erbabacan, E., Kandigeien, P., Koksal, G.M., Tutucu, C., Ekici, B.B., Seker, T.B., Kaya, G., Altindas, F., Comparison of transversus abdominis plane block and IV patient-controlled analgesia after lower abdominal surgery (2015) Turk. J. Anaesthesiol. Reanim., 43, pp. 24-28; 
Erbs, E., Faget, L., Ceredig, R.A., Matifas, A., Vonesch, J.L., Kieffer, B.L., Massotte, D., Impact of chronic morphine on delta-opioid receptor expressing neurons in the mouse hippocampus (2016) Neuroscience, 313, pp. 46-56; 
Erdogan An, D., Yildirim Ar, A., Karadodan, F., Ozcabi, Y., Kocoglu, A., Kilic, F., Akgun, F.N., Ultra-sound transversus plane block in patients undergoing open inguinal hernia repair: 0. 125% bupivacaine provides similar analgesic effect compared to 0. 25% bupivacaine (2016) J. Clin. Anesth., 28, pp. 41-46; 
Escudero, G.E., Romafluk, C.B., Toledo, M.E., Olivera, M.E., Manzo, R.H., Laino, C.H., Analgesic enhancement and prevention of tolerance to morphine: beneficial effects of combined therapy with omega-3 fatty acids (2015) J. Pharm. Pharmacol., 67, pp. 1251-1262; 
Esmaeili-Mahani, S., Ebrahimi, B., Abbasnejad, M., Rasoulian, B., Sheibani, V., Satureja khuzestanica prevents the development of morphine analgesic tolerance through suppression of spinal glial cell activation in rats (2015) J. Nat. Med., 69, pp. 165-170; 
Esmailian, M., Moshiri, R., Zamani, M., Comparison of the analgesic effect of intravenous acetaminophen and morphine sulfate in rib fracture: a randomized double-blind clinical trial (2015) Emergency (Tehran), 3, pp. 99-102; 
Estomba, H., Munoa-Hoyos, I., Gianzo, M., Urizar-Arenaza, I., Casius, L., Irazusta, J., Subiran, N., Expression and localization of opioid receptors in male germ cells and the implication for mouse spermatogenesis (2016) PLoS One, 11, p. e0152162; 
Estrada, J.A., Barlow, M.A., Yoshidhige, D., Williams, A.G., Jr, Downey, H.F., Mallet, R.T., Caffrey, J.L., Delta-opioid receptors: pivotal role in intermittent hypoxia-augmentation of cardiac parasympathetic control and plasticity (2016) Auton. Neurosci., 198, pp. 38-48; 
Estrada, J.A., Williams, A.G., Jr, Sun, J., Gonzalez, L., Downey, H.F., Caffrey, J.L., Mallet, R.T., Delta-opioid receptor signaling and reactive oxygen species mediate in intermittent hypoxia induced protection of canine myocardium (2016) Basic Res. Cardiol., 111, p. 17; 
Fadaei-Kenarsary, M., Farbood, Y., Taghi Mansouri, S.M., Fathi Moghaddam, H., Effects of venlafaxine and methadone alone and in combination with spontaneous morphine withdrawal syndrome and pain sensation in rats (2015) Basic Clin. Neurosci., 6, pp. 21-28; 
Falcato, L., Beck, T., Reimer, J., Verthein, U., Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized crossover clinical trial (2015) J. Clin. Psychopharmacol., 35, pp. 150-157; 
Falcon, E., Browne, C.A., Leon, R.M., Fleites, V.C., Sweeney, R., Kirby, L.G., Lucki, I., Antidepressant effects of buprenorphine are mediated by kappa opioid receptors (2016) Neuropsychopharmacology, 41, pp. 2344-2351; 
Fallah, F., Hamidikenari, A., Sajadi, S.N., Sajadi, S.R., Shiran, M., Influence of methadone on clopidogrel in addicts on methadone maintenance therapy: drug interaction between methadone and clopidogrel (2016) Caspian J. Intern. Med., 7, pp. 133-135; 
Fan, H., Li, T.F., Gong, N., Wang, Y.X., Shanzhiside methyl ester, the principal effective iridoid glycoside from the analgesic herb Lamiophlomis rotate, reduces neuropathic pain by stimulating spinal microglial beta-endorphin expression (2016) Neuropharm, 101, pp. 98-109; 
Fancourt, D., Williamon, A., Carvalho, L.A., Steptoe, A., Dow, R., Lewis, I., Singing modulates mood, stress, cortisol, cytokine and neuropeptide activity in cancer patients and carers (2016) Ecancemed. Sci., 10, p. 531; 
Farahmandfar, M., Kadivar, M., Naghdi, N., Possible interaction of hippocampal nitric oxide and calcium/calmodulin-dependent protein kinase II on reversal of spatial memory impairment induced by morphine (2015) Eur. J. Pharmacol., 751, pp. 99-111; 
Farahmandfar, M., Kadivar, M., Rashipisheh, S., Blockade of dorsal hippocampal orexin-1 receptors impaired morphine-induced state-dependent learning (2016) Neuropeptides, 60, pp. 13-19; 
Farasatinasab, M., Kouchek, M., Sistanizad, M., Goharini, R., Miri, M., Solouki, M., Ghaeli, P., Mokhtari, M., A randomized placebo-controlled trial of clonidine impact on sedation of mechanically ventilated ICU patients (2015) Iran. J. Pharm. Res., 14, pp. 167-175; 
Farrow, S.C., Facchini PJ. Papaverine 7-O-demethylase, a novel 2-oxoglutarate/Fe(2+)-dependent dioxygenase from opioid poppy (2015) FEBS Lett., 589, pp. 2701-2708; 
Farrow, S.C., Hagel, J.M., Beaudoin, G.A., Burns, D.C., Facchini, P.J., Stereochemical inversion of (S)-retiuline by a cytochrome P450 fusion in opium poppy (2015) Nat. Chem. Biol., 11, pp. 728-732; 
Fassini, A., Scopinho, A.A., Resstel, L.B., Correa, F.M., NOP receptors in the prelimbic cortex have an inhibitory influence on cardiovascular responses induced by restraint stress (2016) Neuropeptides, 57, pp. 35-44; 
Fauno, P., Lund, B., Christiansen, S.E., Giorderum, O., Lind, M., Analgesic effect of hamstring block after anterior cruciate ligament reconstruction compared with placebo: a prospective randomized trial (2015) Arthroscopy, 31, pp. 63-68; 
Fazalul Rahiman, S.S., Morgan, M., Gray, P., Shaw, P.N., Cabot, P.J., Dynorphin 1–17 and its N-terminal biotransformation fragments modulate lipopolysaccharidestimulated nuclear factor-kappa B nuclear translocation, interleukin-1 beta and tumor necrosis factor-alpha in differentiated THP-1 cells (2016) PLoS One, 11, p. e153005; 
Feizi, N., Nourazanian, A., Rahbanghazi, R., Nozad Charoudeh, H., Abdyazdari, N., Montazersaheb, S., Narimani, M., Morphine inhibited the rat neural stem cell proliferation rate by increasing neuro steroid genesis (2016) Neurochem. Res., 41, pp. 1410-1419; 
Feldriech, A., Ernberg, M., Rosen, A., Reduction in maximum pain after surgery in temporomandibular joint patients is associated with decreased beta-endorphin levels – a pilot study (2016) Int. J. Oral Maxillofac. Surg., 46, pp. 97-103; 
Ferrari, F., Cerlisi Malfacini, M.C.D., Asth, L., Gavioli, E.C., Journigan, B.V., Kamakolanu, U.G., Meyer, M.E., Calo, G., In vitro functional characterization of novel nociception/orphanin FQ receptor agonists in recombinant and native preparations (2016) Eur. J. Pharmacol., 793, pp. 1-113; 
Ferrari, L.L., Agolstinelli, L.J., Krashes, M.J., Lowell, B.B., Scammell, T.E., Arrigoni, E., Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms (2016) J. Physiol., 594, pp. 1069-1085; 
Ferreira, D.H., Silva, J.P., Quinn, S., Abernathy, A.P., Johnson, M.J., Oxberry, S.G., Currow, D.C., Blinded patient preference for morphine compared to placebo in the setting of chronic refractory breathlessness – an exploratory study (2016) J. Pain Symptom Manag., 51, pp. 247-254; 
Ferslew, B.C., Johnston, C.K., Tsakalozou, E., Bridges, A.S., Paine, M.F., Jia, W., Stewart, P.W., Barritt, A.S., 4th, Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis (2015) Clin. Pharmacol. Ther., 97, pp. 419-427; 
Fiedler, L., Elsner, F., Rajagopal, M.R., Pastrama, T., Associations to pain and analgesia in Indian pain patients and health workers (2015) Pain Manag., 5, pp. 349-358; 
Fields, A.C., Gonzalez, D.O., Chin, E.H., Nguyen, S.Q., Zhang, L.P., Divino, C.M., Laparoscopic-assisted transversus abdominis plane block for postoperative pain control in laparoscopic ventral hernia repair: a randomized controlled trial (2015) J. Am. Coll. Surg., 221, pp. 462-469; 
Fiorelli, A., Izzo, A.C., Frongillo, E.M., Del Prete, A., Liguori, G., Di Costanzo, E., Vicidomini, G., Santini, M., Efficacy of wound analgesia for controlling post-thoracotomy pain: a randomized double-blind study (2016) Eur. J. Cardiothorac. Surg., 49, pp. 339-347; 
Fiorelli, A., Mazzella, A., Passavanti, B., Sansone, P., Chiodini, P., Ianotti, M., Aurilio, C., Santini, M., Is pre-emptive administration of ketamine a significant adjunction to intravenous morphine analgesia for controlling postoperative pain? A randomized double-blind, placebo-controlled clinical trial (2015) Interact Cardiovasc. Thorac. Surg., 21, pp. 284-290; 
Firouzian, A., Alipour, A., Rashidian Dezfouli, H., Zamani Kiasari, A., Gholipour Baradani, A., Emami Zeydi, A., Amini Ahidashti, H., Yazdani Kouchuei, F., Does lidocaine as an adjuvant to morphine improve pain relief in patients presenting to the ED with acute renal colic? A double-blind, randomized controlled trial (2016) Am. J. Emerg. Med., 34, pp. 443-448; 
Fisker, A.K., Iversen, B.N., Christenson, S., Linde, F., Nielsen, K.K., Borglum, J., Bendtsen, T.F., Combined saphenous and sciatic catheters for analgesia after major ankle surgery: a double-blinded randomized controlled trial (2015) Can. J. Anaesth., 62, pp. 875-882; 
Fitting, S., Stevens, D.L., Khan, F.A., Scoggins, K.L., Enga, R.M., Beardsley, P.M., Knapp, P.E., Hauser, K.F., Morphine tolerance and physical dependence are altered in conditional HIV-1 Tat transgenic mice (2016) J. Pharmacol. Exp. Ther., 356, pp. 96-105; 
Fiuza, F.P., Silva, K.D., Pessoa, R.A., Pontes, A.L., Cavalcanti, R.L., Pires, R.S., Soares, J.G., Cavalcante, J.S., Age-related changes in neurochemical components and retinal projections of rat intergeniculate leaflet (2016) Age (Dordr.), 38, p. 4; 
Fleckenstein, J., Kohis, N., Evtouchenko, E., Lehmeyer, L., Kramer, S., Lang, P.M., Siebeck, M., Imich, D., No effect of the cyclooxygenase-2 inhigbitor etoricoxib on pre-emptive and postoperative analgesia in visceral surgery: results of a randomized controlled trial (2016) Eur. J. Pain, 20, pp. 186-195; 
Forentino, I.F., Silva, D.P.B., Galdino, P.M., Lino, R.C., Martins, J.L.R., Silva, D.M., de Paula, J.R., Costa, E.A., Antinociceptive and anti-inflammatory effects of Memora nodosa and allantoin in mice (2016) J. Ethnopharmacol., 186, pp. 296-304; 
Flory, J.H., Wesenthal, A.C., Thaler, H.T., Koranteng, L., Moryl, N., Methadone use and the risk of hypoglycemia for inpatients with cancer pain (2016) J. Pain Symptom Manage., 51, pp. 79-87; 
Fois, G.R., Diana, M., Opioid antagonists block acetaldehyde-induced increments in dopamine neurons activity (2016) Drug Alcohol Depend., 158, pp. 172-176; 
Forcelli, P.A., Turner, J.R., Olson, T.T., Xie, T., Xiao, Y., Blendy, J.A., Keller, K.J., Anxiolytic- and antidepressant effects of the methadone metabolite 2-ethyl-5-methyl-3, 3-dipheny-1-pyrroline (EMDP) (2016) Neuropharmacology, 101, pp. 46-56; 
Foroud, M., Veasl, N., Evaluation of the antinociceptive effects of morphine, tramadol, meloxicam and their combinations using the tail-flick test in rats (2015) Vet. Res. Forum, 6, pp. 313-318; 
Fortin, S.M., Chartoff, E.M., Roitman, M.F., The aversicve agent lthium chloride suppresses phasic dopamine release through central GLP-1 receptors (2016) Neuropsychopharmacology, 41, pp. 906-915; 
Fossati, E., Narcross, L., Ekins, A., Falqueyret, J.P., Martin, V.J., Synthesis of morphinan alkaloids in Saccharomyces cerevisiae (2015) PLoS One, 10, p. e0124459; 
Frczak, O., Lasota, A., Tymecka, D., Kosson, P., Muchowska, A., Misicka, A., Olma, A., Synthesis, binding affinities and metabolic activity of dimeric dermorphin analogs modified with beta3-homo-amino acids (2016) J. Pept. Sci., 22, pp. 222-227; 
Fraga, D., Zanoni, C., Zampronio, A.R., Parada, C.A., Rae, G.A., Souza, G.E., Endocannabinoids, through opioids and prostaglandins contribute to fever induced by key pyrogenic mediators (2016) Brain Behav. Immun., 51, pp. 204-211; 
Frassanito, L., Messina, A., Vergari, A., Colombo, D., Chierichini, A., Della Corte, F., Navalesi, P., Antonelli, M., Intravenous infusion of magnesium sulfate and postoperative analgesia in total knee arthroplasty (2015) Minerva Anesthesiol., 81, pp. 1184-1191; 
Frederickson, M.J., Danesh-Clough, T.K., Spinal anaesthesia with adjunctive intrathecal morphine versus continuous lumbar plexus blockade: a randomized comparison for analgesia after hip replacement (2015) Anaesth. Intensive Care, 43, pp. 449-453; 
Freitas, A.C., Pacheco, D.F., Machado, M.F., Carmona, A.K., Duarte, I.D., de Lima, M.E., PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase (2016) Br. J. Pharmacol., 173, pp. 1491-1501; 
Friedrichsdorf, S.J., Postier, A., Eull, D., Weidner, C., Foster, L., Gilbert, M., Campbell, F., Pain outcomes in a US children's hospital: a prospective cross-sectional survey (2015) Hosp. Pediatr., 5, pp. 18-26; 
Frost, J., Lokken, T.N., Brede, W.R., Hegstad, S., Nordrum, I.S., Slordal, L., A validated method for simultaneous determination of codeine, codeine-6-glucuronide, norcodeine, morphine, morphine-3-glucuronide and morphine-6-glucuronide in post-mortem blood, vitreous fluid, muscle, fat and brain tissue by LC–MS (2015) J. Anal. Toxicol., 39, pp. 203-212; 
Fu, D., Liu, H., Zhu, H., Li, S., Yao, J., Protective effect of delta opioid receptor agonist (D-Ala2, D-Leu5) enkephalin on permanent focal cerebral ischemia in rats (2016) Neuroreport, 27, pp. 749-754; 
Fu, K., Lin, H., Miyamoto, Y., Wu, C., Yang, J., Uno, K., Nitta, A., Pseudoginsenoside-F11 inhibits methamphetamine-induced behaviors by regulating dopaminergic and GABAergic neurons in the nucleus accumbens (2016) Psychopharmacology (Berl.), 233, pp. 831-840; 
Fu, R., Chen, X., Zuo, W., Li, J., Kang, S., Zhou, L.H., Siegel, A., Ye, J.H., Ablation of mu opioid receptor-expressing GABA neurons in rostromedial tegmental nucleus increases ethanol consumption and regulates ethanol-related behaviors (2016) Neuropharmacology, 107, pp. 58-67; 
Fulton-Kehoe, D., Sullivan, M.D., Turner, J.A., Garg, R.K., Bauer, A.M., Wickizer, T.M., Franklin, G.M., Opioid poisonings in Washington State Medicaid: trends, dosing and guidelines (2015) Med. Care, 53, pp. 679-685; 
Fustran, N., Dalmau, A., Ferreres, E., Camprudi, I., Sanzol, R., Redondo, S., Kreisler, E., Sabate, A., Postoperative analgesia with continuous wound infusion of local anesthesia vs. saline: a double-blind randomized controlled trial in colorectal surgery (2015) Colorectal Dis., 17, pp. 342-350; 
Gac, L., Butterick, T.A., Duffy, C.M., Teske, J.A., Oerez-Leighton, C.E., Role of the non-opioid dynorphin peptide des-Tyr-dynorphin (DYN-A(2–17) in food intake and physical activity, and its interaction with orexin-A (2016) Peptides, 76, pp. 14-18; 
Gage, A.R., Kang, M., Grider, J.R., Damaj, M.I., Dewey, W.L., Akbaral, H.I., Enhanced sensitivity of alpha3beta4 nicotinic receptors in enteric neurons after long-term morphine: implication for opioid-induced constipation (2016) J. Pharmacol. Exp. Ther., 357, pp. 520-528; 
Ganem, V.J., Mora, A.G., Varney, S.M., Bebarta, V.S., Emergency department opioid prescribing practices for chronic pain: a 3-year analysis (2015) J. Med. Toxicol., 11, pp. 288-294; 
Gao, F., Zhang, L.H., Su, T.F., Li, L., Zhou, R., Peng, M., Wu, C.H., Li, M., Signaling mechanisms of cannabinoid receptor-2 activation-induced beta-endorphin release (2016) Mol. Neurobiol., 53, pp. 3616-3625; 
Garcia-Carmona, A., Jimenez-Gonzalez, A., Rodriguez, R.E., Mu opioid receptor expression after morphine administration is regulated by miR-212/132 cluster (2016) PLoS One, 11, p. e0157806; 
Garcia-Carmona, J.A., Camejo, D.M., Almela, P., Jimenez, A., Milanes, M.V., Sevilla, F., Laorden, M.L., CP- modifies CREB phosphorylation and thiordoxin-1 expression in the dentate gyrus following morphine-conditioned place preference (2015) PLoS One, 10, p. e0136164; 
Garcia-Perez, D., Ferenczi, S., Kovacs, K.J., Laorden, M.L., Milanes, M.V., Nunez, C., Different concentration of glucocorticoids in the basolateral amygdala to the formation and expression of opiate withdrawal-associated memories (2016) Psychoneuroendocrinology, 74, pp. 350-362; 
Garcia-Perez, D., Laorden, M.L., Milanes, M.V., Regulation of pleiotrophin, midkine, receptor protein tyrosine phosphatase beta/gamma and their intracellular signaling cascades in the nucleus accumebns during opiate administration (2015) Int. J. Neuropsychopharmacol., 19. , (pyv077); 
Garcia-Perez, D., Lopez-Bellido, R., Hidalgo, J.M., Rodriguez, R.E., Laorden, M.L., Nunez, C., Milanes, M.V., Morphine regulates argonate 2 and TH expression and activity but not miR-133b in midbrain dopaminergic neurons (2015) Addict. Biol., 20, pp. 104-119; 
Gardner, K.D., Wiemer, D.F., Selective prenylation of protected phenols for synthesis of pawhuskin A analogues (2016) J. Org. Chem., 81, pp. 1585-1592; 
Gautam, S., Franzini, L., Mikhail, O.I., Chan, W., Turner, B.J., Novel measure of opioid dose and costs of care for diabetes mellitus: opioid dose and health care costs (2016) J. Pain, 17, pp. 319-327; 
Gautam, S., Franzini, L., Mikhail, O.I., Chan, W., Turner, B.J., Longitudinal analysis of opioid analgesic dose and diabetes quality of care measures (2015) Pain Med., 16, pp. 2134-2141; 
Gauvin, D.V., McComb, M., Code, R., Dalton, J.A., Baird, T.J., Abuse liability assessment of hydrocodone under current draft regulatory guidelines (2015) J. Pharmacol. Toxicol. Mehtods, 75, pp. 118-129; 
Ge, D.J., Qi, B., Tang, G., Li, J.Y., Intraoperative dexmedetomidine promotes postoperative analgesia in patients after abdominal coloctomy: a consort-prospective, randomized controlled clinical trial (2015) Medicine (Baltimore), 94, p. e1514; 
Geerling, J.C., Kim, M., Mahoney, C.E., Abbott, S.B., Agostinelli, L.J., Garfield, A.S., Krashes, M.J., Scammell, T.E., Genetic identity of thermosensory relay neurons in the lateral parabrachial nucleus (2016) Am. J. Physiol. Regul. Integr. Comp. Physiol., 310, pp. R41-R54; 
Gein, S.V., Sharavieva, I.L., Effect of opiate receptors blockade on microbicidal potential and production of IL-beta, TNF-alpha and IL-10 by peritoneal macrophages under stress conditions (2016) Bull. Exp. Biol. Med., 161, pp. 339-343; 
Georgiou, P., Zanos, P., Garcia-Carmona, J.A., Horani, S., Kitchen, I., Kieffer, B.L., Laorden, M.L., Bailey, A., The oxytocin analogue carbetocin prevents priming-induced reinstatement of morphine-seeking: involvement of dopaminergic, noradrenergic and MORr systems (2015) Eur. Neuropsychopharmacol., 25, pp. 2459-2464; 
Georgiou, P., Zanos, P., Garcia-Carmona, J.A., Horani, S., Kitchen, I., Laorden, M.L., Bailey, A., Methamphetamine abstinence induces changes in mu-opioid receptor, oxytocin and CRF systems: association with an anxiogenic phenotype (2016) Neuropharmacology, 106, pp. 520-532; 
Gerak, L.R., Zanettini, C., Koek, W., France, C.P., Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys (2015) Psychopharmacology (Berl.), 232, pp. 3637-3647; 
Gerra, G., Manfredini, M., Somaini, L., Maremmani, I., Leonardi, C., Donnini, C., Sexual dusfunction in men receiving methadone maintenance treatment: clinical history and psychobiological correlates (2016) Eur. Addict. Res., 22, pp. 163-175; 
Gessi, S., Bures, P.A., Bencivenni, S., Fazzi, D., Varani, K., Merighi, S., The activation of mu-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia (2016) FEBS Lett., 590, pp. 2813-2826; 
Ghadirian, S., Vesal, N., Maghsoudi, B., Akhlagh, S.H., Comparison of lidocaine, lidocaine-morphine, lidocaine-tramadol or bupivacaine for neural blockade of the brachial plexus in fat-tailed lambs (2016) Vet. Anaesth. Analg., 43, pp. 109-116; 
Ghasemzadeh, Z., Rezeyof, A., Role of hippocampal and prefrontal cortical signaling pathways in dextromethorphan effect on morphine-induced memory impairment in rats (2016) Neurobiol. Learn Mem., 128, pp. 23-32; 
Ghavipanjah, G.R., Pourshanazari, A.A., Alaei, H., Karimi, S., The influence of electrical stimulation on dorsal raphe nucleus with different current intensities on morphine-induced conditioned place preference in male rats (2015) Pharmacol. Rep., 67, pp. 832-836; 
Ghavipanjah, G.R., Pourshanazari, A.A., Alaei, H., Karimi, S., Nejad, M.A., Effects of temporary inactivation and electrical stimulation of the dorsal raphe nucleus on morphine-induced conditioned place preference (2015) Malays J. Med. Sci., 22, pp. 33-40; 
Gholami, M., Saboory, E., Mehraban, S., Niakani, A., Banihabib, N., Azad, M.R., Fereidoni, J., Time dependent antinociceptive effects of morphine and tramadol in the hot-plate test: using different methods of drug administration in female rats (2015) Iran. J. Pharm. Res., 14, pp. 303-311; 
Ghorbanzadeh, B., Mansouri, M.T., Sahraei, H., Alboghobesh, S., Involvement of opioid receptors in the systemic and peripheral antinociception actions of montelukast in the animal models of pain (2016) Eur. J. Pharmacol., 779, pp. 38-45; 
Ghowsi, M., Yousofvand, N., Impact of morphine dependency and detoxification by methadone on the male rat's reproductive system (2015) Iran. J. Reprod. Med., 13, pp. 275-282; 
Gilron, I., Tu, D., Holden, R.R., Jackson, A.C., DuMerton-Shore, D., Combination of morphine with nortriptyline for neuropathic pain (2015) Pain, 156, pp. 1440-1448; 
Gilron, I., Tu, D., DuMerton-Shore, D., Duggan, S., Rooney, R., McGrath, M., Orr, E., The effect of triple vs. double nonopioid therapy on postoperative pain and functional outcome after abdominal hysterectomy: a randomized double-blind control trial (2015) Eur. J. Anaesthesiol., 32, pp. 269-276; 
Giorno, T.B., Ballard, Y.L., Cordeiro, M.S., Silva, B.V., Pinto, A.C., Fernandes, P.D., Central and peripheral antinociceptive activity of 3-(2-oxopropyl)-3-hydroxy-2-oxindoles (2015) Pharmacol. Biochem. Behav., 135, pp. 13-19; 
Giorno, T.B., Silva, B.V., Pinto Ade, C., Fernandes, P.D., Antinociceptive effect and mechanism of action of isatin, N-methyl isatin and oxypropyl isatin in mice (2016) Life Sci., 151, pp. 189-198; 
Giraldes, A.L., Sousa, A.M., Slullitel, A., Guimaraes, G.M., Santos, M.G., Pinto, R.E., Ashmawi, H.A., Sakata, R.K., Tramadol wound infiltration is not different from intravenous tramadol in children: a randomized clinical trial (2016) J. Clin. Anesth., 28, pp. 62-66; 
Giron, R., Perez-Garcia, I., Abato, R., X-ray analysis of gastrointestinal motility in conscious mice: effects of morphine and comparison with rats (2016) Neurogastroenterol. Motil., 28, pp. 74-84; 
Gladstone, E.J., Smolina, K., Weymann, D., Rutherford, K., Morgan, S.G., Geographic variations in prescription opioid dispensations and deaths among women and men in British Columbia, Canada (2015) Med. Care, 53, pp. 954-959; 
Glanzmann, C., Frey, B., Vonbach, F., Meier, C.R., Drugs as risk factors of acute kidney injury in critically ill children (2016) Peditr. Nephrol., 31, pp. 145-151; 
Glissmeyer, C., Johnson, W., Sherman, B., Glissmeyer, M., Garreau, J., Johnson, N., Effect of paravertebral nerve blocks on narcotic use after mastectomy with reconstruction (2015) Am. J. Surg., 209, pp. 881-883; 
Golabi, M., Naem, S., Imani, M., Dalirezh, N., Evidence of morphine like substance and mu-opioid receptor expression in Toxacara canis (Nematoda: Ascaridae) (2016) Vet. Res. Forum, 7, pp. 335-338; 
Golder, F.J., Dax Baby, S.S.M., Gruber, R., Hoshi, T., Ideo, C., Kennedy, A., Peng, S., MacIntyre, D.E., Identification and characterization of GAL-021 as a novel breathing control modulator (2015) Anesthesiol, 123, pp. 1093-1104; 
Gong, G., Hu, L., Oin, F., Yin, L., Yi, X., Yuan, L., Wu, W., Spinal WNT pathway contributes to remifentanil induced hyperalgesia through regulating fractalkine and CX3CR1 in rats (2016) Neurosci. Lett., 633, pp. 21-27; 
Gong, K., Bhargava, A., Jasmin, L., GluN2 BN-methyl-D-aspartate receptor and excitatory amino acid 3 are upregulated in primary sensory neurons after 7 days of morphine administration in rats: implication for opiate-induced hyperalgesia (2016) Pain, 157, pp. 147-158; 
Gopinath, M.V., Ravishankar, M., Nag, K., Kumar, V.H., Velrasj, J., Parthasarathy, S., Estimation of effect-site concentration of propofol for laryngeal mask airway insertion using fentanyl or morphine as adjuvant (2015) Indian J. Anaesth., 59, pp. 295-299; 
Gough, A.E., Chang, S., Reddy, S., Ferrigno, L., Zerey, M., Grotts, J., Yim, S., Thoman, D.S., Periprosthetic anesthetic for postoperative pain after laparoscopic ventral hernia repair: a randomized clinical trial (2015) JAMA Surg., 150, pp. 835-840; 
Gould, S.A., Doods, H., Lamla, T., Pekcec, A., Pharmacological characterization of intraplantar Complete Freund's Adjuvant-induced burrowing deficits (2016) Behav. Brain Res., 301, pp. 142-151; 
Gram, M., Graversen, C., Olesen, A.E., Drewes, A.M., Machine learning on encephalographic activity may predict opioid analgesia (2015) Eur. J. Pain, 19, pp. 1552-1561; 
Grider, J.S., Etscheidt, M.A., Hamed, M.E., Lea, J., Smith, B., Lamar, C., Bux, A., Trialing and maintenance dosing using a low-dose intrathecal opioid method for chronic nonmalignant pain: a prospective 36-month study (2016) Neuromodulation, 19, pp. 206-219; 
Grinnell, S.G., Ansonoff, M., Marrone, G.F., Lu, Z., Narayan, A., Xu, J., Rossi, G., Pasternak, G.W., Mediation of buprenorphine analgesia by a combination of traditional and truncated mu opioid receptor splice variants (2016) Synapse, 70, pp. 395-407; 
Grissa, M.H., Boubaker, H., Zorgati, A., Beltaief, K., Zhani, W., Msoli, M.A., Bzeouich, N., Nouira, S., Efficacy and safety of nebulized morphine given at 2 different doses compared to IV titrated morphine in trauma pain (2015) Am. J. Emerg. Med., 33, pp. 1557-1561; 
Guegan, T., Cebria, J.P., Maldonado, R., Martin, M., Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system that was dependent on CB1-R activity (2016) Addict Boil, 21, pp. 1113-1126; 
Guerrieri, E., Bermudez, M., Wolber, G., Berzetei-Gurske, I.P., Schmidhammer, H., Spetea, M., Structural determinants of diphenethylamines for interaction with the kappa opioid receptor: synthesis, pharmacology and molecular modeling studies (2016) Bioorg. Med. Chem. lett., 26, pp. 4769-4774; 
Gugusheff, J.R., Bae, S.E., Rao, A., Clarke, I.J., Poston, L., Taylor, P.D., Coen, C.W., Muhlhauser, B.S., Sex and age-dependent effects of a maternal junk food diet on the mu-opioid receptor in rat offspring (2016) Behav. Brain Res., 301, pp. 124-131; 
Guillemyn, K., Starnowska, J., Lagard, C., Dyniewicz, J., Rojewska, E., Mika, J., Chung, N.N., Ballet, S., Bifunctional peptide-based opioid agonist-nociceptin antagonist ligands for dual treatment of acute and neuropathic pain (2016) J. Med. Chem., 59, pp. 3777-3792; 
Gulur, P., Koury, K., Arnstein, P., Lee, H., McCarthy, P., Coley, C., Mort, E., Morphine versus hydromorphone: does choice of opioid influence outcomes? (2015) Pain Res. Treat., 2015, p. 482081; 
Guo, S.J., Cui, Y., Huang, Z.Z., Liu, H., Zhang, X.Q., Jiang, J.X., Xin, W.J., Orexin A-mediated AKT signaling in the dentate gyrus contributes to the acquisition, expression and reinstatement of morphine-induced conditioned place preference (2016) Addict. Biol., 21, pp. 547-559; 
Gupta, A., Gomes, I., Bobeck, E.N., Fakira, A.K., Massaro, N., Sharma, I., Cave, A., Devi, L.A., Collybolide is a novel biased agonist of kappa opioid receptors with potent antipruritic activity (2016) Proc. Natl. Acad. Sci. U. S. A., 113, pp. 6041-6046; 
Gupta, B., Banerjee, S., Prasad, A., Farooqua, K., Sharma, V., Trikha, V., Analgesic efficacy of three different dosages of intra-articular morphine in arthroscopic knee surgery: randomized double-blind trial (2015) Indian J. Anaeth., 59, pp. 642-647; 
Guner Can, M., Goz, R., Berber, I., Kaspar, C., Cakir, U., Ultrasound/laparoscopic camera-guided transversus abdominis plane block for renal transplant donors: a randomized controlled trial (2015) Ann. Transplant., 20, pp. 418-423; 
Gurkan, Y., Tas, Z., Toker, K., Solak, M., Ultrasound guided bilateral cervical plexus block reduces postoperative opioid consumption following thyroid surgery (2015) J. Clin. Monit. Comput., 29, pp. 579-584; 
Hahn, Y.K., Paris, J.J., Lichtman, A.H., Hauser, K.F., Sim-Selly, L.J., Selley, D.E., Knapp, P.E., Central HIV-1 Tat exposure elevates anxiety and fear conditioned responses of male mice concurrent with altered mu-opioid receptor-mediated G-protein activation and beat-arrestin 2 activity in the forebrain (2016) Neurobiol. Dis., 92, pp. 124-136; 
Haj-Mirzaian, A., Kordjazy, N., Ostadhadi, S., Amiri, S., Haj-Mirzaian, A., Dehpour, A., Fluoxetine reverses the behavioral despair induced by neurogenic stress in mice: role of N-methyl-D-aspartate and opioid receptors (2016) Can. J. Physiol. Pharmacol., 94, pp. 599-612; 
Haliloglu, M., Ozdemir, M., Uzture, N., Ceniksoy, P.O., Baan, N., Perioperative low-dose ketamine improves postoperative analgesia following Cesarean delivery with general anesthesia (2016) J. Matern. Fetal Neonatal Med., 29, pp. 962-966; 
Hall, E.S., Wexelblatt, S.L., Crowley, M., Grow, J.L., Jasin, L.R., Kiebanoff, M.A., McClead, R.E., Walsh, M.C., Implementation of a neonatal abstinence syndrome weaning protocol: a multicenter cohort study (2015) Pediatrics, 136, pp. e803-810; 
Hall, M.J., Dixon, S.M., Bracey, M., MacIntyre, P., Powell, R.J., Toms, A.D., A randomized controlled trial of postoperative analgesia following total knee replacement: transdermal fentanyl patches versus patient controlled analgesia (PCA) (2015) Eur J Orthop Surg Traumatol, 25, pp. 1073-1079; 
Hall, S.M., LeBaron, L., Ramos-Colon, C., Qu, C., Xie, J.Y., Porreca, F., Lai, J., Hruby, V.J., Discovery of stable non-opioid dynorphin A analogues interacting at the bradykinin receptors for the treatment of neuropathic pain (2016) ACS Chem. Neurosci., 7, pp. 1746-1752; 
Halls, M.L., Yeatman, H.R., Nowell, C.J., Thompson, G.L., Gondin, A.B., Civcirisov, S., Bunnett, N.W., Canals, M., Plasma membrane localization of the mu-opioid receptor controls spatiotemporal signaling (2016) Sci. Signal., 9, p. 9; 
Hammer, L.A., Waldner, H., Zagon, I.S., McLaughlin, P.J., Opioid growth factor and low dose naltrexone impair central nervous system infiltration by CD4+T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis (2016) Exp. Biol. Med. (Maywood), 241, pp. 71-78; 
Han, H., Dong, Z., Jia, Y., Mao, R., Zhou, Q., Yang, Y., Wang, L., Cao, J., Opioid addiction and withdrawal differentially drive long-term depression of in hibitory synaptic transmission in the hippocampus (2015) Sci. Rep., 5, p. 9666; 
Han, R.T., Lee, H., Lee, J., Lee, S.B., Kim, H.J., Back, S.K., Na, H.S., Brief isolation changes nociceptive behaviors and compromises drug tests in mice (2016) Pain Pract., 16, pp. 749-757; 
Hansen, R.W., Wang, X., Golab, A., Bornert, O., Oswald, C., Wagner, R., Martinez, K.L., Functional stability of the human kappa opioid receptor reconsitutued in nanodiscs revealed by a time-resolved scintiullation proximity assay (2016) PLoS One, 11, p. e0150658; 
Hansen, T.M., Olesen, A.E., Graversen, C., Drewes, A.M., Frokjaer, J.B., The effect of oral morphine on pain-related brain activation – an experimental functional magnetic resonance imaging study (2015) Basic Clin. Pharmacol. Toxicol., 117, pp. 316-322; 
Hansen, T.M., Graversen, C., Frokjaer, J.B., Olesen, A.E., Valeriani, M., Drewes, A.M., Single-sweep spectral analysis of contact heat evoked potentials: a novel approach to identify altered cortical processing after morphine treatment (2016) Br. J. Clin. Pharmacol., 79, pp. 926-936; 
Harasawa, I., Johanson, J.P., Fields, H.L., Porreca, F., Meng, I.D., Alterations in the rostral ventromedial medulla after the selective ablation of mu-opioid receptor expressing neurons (2016) Pain, 157, pp. 166-173; 
Hardaway, J.A., Jensen, J., Kim, M., Mazzone, C.M., Sugam, J.A., Diberto, J.F., Lowery-Gionta, E.G., Kash, T.L., Nococeptin receptor antagonist SB 612111 decreases high fat diet binge eating (2016) Behav. Brain Res., 307, pp. 25-34; 
Harden, P., Ahmed, S., Ano, K., Wiedemer, N., Clinical implications of tapering chronic opioids in a veteran population (2015) Pain Med., 16, pp. 1975-1981; 
Harland, A.A., Bender, A.M., Griggs, N.W., Gao, C., Anand, J.P., Pogozheva, I.D., Traynoir, J.R., Mosberg, H.I., Effects of N-substitutions on the tetrahydroquinoline (THQ) core of mixed-efficacy mu opioid receptor (MOR)/delta opioid receptor (DOR) ligands (2016) J. Med. Chem., 59, pp. 4985-4998; 
Harshberger, E., Gilson, E.A., Gillett, K., Stone, J.H., El Amrani, L., Valdez, G.R., Nor-BNI antagonism of kappa opioid agonist-induced reinstatement of ethanol-seeking behavior (2016) J. Addict., 2016, p. 1084235; 
Hashemi, S.M., Esmaeelijah, A., Golzari, S., Keyhani, S., Maserrat, A., Mohseni, G., Ardehali, S., Intravenous paracetamol versus patient-controlled analgesia with morphine for the pain management following diagnostic knee arthroscopy in trauma patients: a randomized clinical trial (2015) Arch. Trauma Res., 21, p. e30788; 
Hassaneen, A., Naniwa, Y., Suetomi, Y., Matsuyama, S., Kimura, K., Ieda, N., Inoue, N., Ohkura, S., Immunohistochemical characterization of the arcuate kisspeptin/neurokinin B/dynorphin (KNDy) and preoptic kisspeptin neuronal populations during the estrous cycle of the ewe (2016) J. Reprod. Dis., 62, pp. 471-477; 
Hassani, E., Mahoori, A., Sane, S., Tolumehr, A., Comparison the effects of paracetamol with sufentanil infusion on postoperative pain control after craniotomy in patients with brain tumor (2015) Adv. Biomed. Res., 4, p. 64; 
Haw, A.W., Meyer, L.C., Greer, J.J., Fukller, A., Ampakine CX2942 attenuates opioid-induced respiratory depression and corrects the hypoaaemic effects of rtorphine in immobilized goats (Capra hircus) (2016) Vet. Anaesth. Analg., 43, pp. 528-538; 
Hawkins, E.J., Malte, C.A., Grossbard, J.R., Saxon, A.J., Prevalence and trends of concurrent opioid analgesic and benzodiazepine use among Veterans Affairs patients with post-traumatic stress disorder, 2003–2011 (2015) Pain Med., 16, pp. 1943-1954; 
Hayashi, M., Sakuma, H., Immunohistochemical analysis of brainstem lesions in the autopsy cases with severe motor and intellectual disabilities showing sudden unexplained death (2016) Front. Neurol., 7, p. 93; 
Hayashi, S., Ohashi, K., Minara, S., Nakata, E., Emoto, C., Ohta, A., Discovery of small-molecule neuropeptide antagonists of nociception/orphanin FQ receptor: the studies of design, synthesis and structure-activity relationships for (4-arylpiperidine substituted-methyl)-[bicyclic (hetero) cycloalkanobenzene] derivatives (2016) Eur. J. Med. Chem., 114, pp. 345-364; 
Hayashi, Y., Morinaga, S., Zhang, J., Satoh, Y., Meredith, A.L., Nakata, T., Wu, Z., Nakanishi, H., BK channels in microglia are required for morphine-induced hyperalgesia (2016) Nat. Commun., 7, p. 11697; 
Hayek, S.M., Veizi, E., Hanes, M., Intrathecal hydromorphone and bupivacaine combination therapy for post-laminectomy syndrome optimized with patient-activated bolus device (2016) Pain Med., 17, pp. 561-571; 
He, C., Gong, J., Yang, L., Zhang, H., Dong, S., Zhou, L., Pain regulation of endokinin A/B or endokinin C/D on chimeric peptide MCRT in mice (2016) Can. J. Physiol. Pharmacol., 94, pp. 955-960; 
He, H., Huh, J., Wang, H., Kang, Y., Lou, J., Xu, Z., Mitochondrial events responsible for morphine's cardioprotection against ischemia/reperfusion injury (2016) Toxicol. Appl. Pharmacol., 290, pp. 66-73; 
He, S.F., Jin, S.Y., Wu, H., Zhang, S.J., Zhu, H.J., Irwin, M.G., Wong, T.M., Zhang, Y., Morphine preconditioning confers cardiprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3beta pathway independent of PI3K/Akt (2015) Toxicol. Appl. Pharmacol., 288, pp. 349-358; 
He, S.F., Zhu, H.J., Han, Z.Y., Wu, H., Jin, S.Y., Irwin, M.G., Zhang, Y., MicroRNA-133b-5p is involved in cardiprotection of morphine preconditioning in rat cardiomyocytes by targeting Fas (2016) Can. J. Cardiol., 32, pp. 996-1007; 
Heiskanen, T., Langel, K., Gunnar, T., Lillsunde, P., Kalso, E.A., Opioid concentrations in oral fluid and plasma of cancer patients with pain (2015) J. Pain Symptom Manage., 50, pp. 524-532; 
Hendershot, C.S., Claus, E.D., Ramchandani, V.A., Associations of OPRM1 A118G and alcohol sensitivity with intravenous alcohol self-administration in young adults (2016) Addict. Biol., 21, pp. 125-135; 
Henderson-Redmond, A.N., Yuill, M.B., Lowe, T.E., Kline, A.M., Zee, M.L., Guindon, J., Morgan, D.J., Morphine-induced antinociception and reward in “humanized” mice expressing the mu opioid receptor A118G polymorphism (2016) Brain Res. Bull., pp. 1235-1322; 
Heo, B.H., Lee, H.J., Lee, H.G., Kim, M.Y., Park, K.S., Choi, J.L., Yoon, M.H., Kim, W.M., Femoral nerve block for patient undergoing total knee arthroplasty: prospective, randomized, double-blinded study evaluating analgesic effect of perineural fentanyl additive to local anesthetics (2016) Medicine (Baltimore), 95, p. e4771; 
Hernandez-Leon, A., Fernandez-Guasti, A., Gonzalez-Trujano, M., Rutin antinociception involves opioidergic mechanism and descending modulation of ventrolateral periaqueductal grey matter in rats (2016) Eur. J. Pain, 20, pp. 274-283; 
Herrera, J.J., Fedynska, S., Ghasem, P.R., Weman, T., Clark, P.J., Gray, N., Loetz, E., Greenwood, B.N., Neurochemical and behavioural indices of exercise reward are independent of exercise controllability (2016) Eur. J. Neurosci., 43, pp. 1190-12202; 
Heusler, P., Tardif, S., Cussac, D., Agonist stimulation at human mu opioid receptors in a [(35)S]GTPgammaS incorporation assay: observation of “bell-shaped” concentration-response relationships under conditions of strong G protein coupling (2016) J. Recept. Signal Transduct. Res., 36, pp. 158-166; 
Hill, R., Lyndon, A., Withey, S., Roberts, J., Kershaw, Y., MacLachlan, J., Lingford-Hughes, A., Henderson, G., Ethanol reversal of tolerance to the respiratory depressant effects of morphine (2016) Neuropsychopharmacology, 41, pp. 762-773; 
Hilly, J., Horlin, A.L., Kinderf, J., Ghez, C., Menrath, S., Delivet, H., Brasher, C., Dahmani, S., Preoperative preparation workshop reduces postoperative maladaptive behavior in children (2016) Paediatr. Anaesth., 20915 (25), pp. 990-998; 
Hina, N., Fletcher, D., Poindessous-Jazat, F., Martinez, V., Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery: an observational case-control study (2015) Eur. J. Anaesthesiol., 32, pp. 255-261; 
Hishimoto, A., Nomanu, H., Ye, K., Nishi, A., Lim, J., Aguilan, J.T., Nieves, E., Hiroi, N., Molecular histochemistry identifies peptidomic organization and reorganization along striatal projection units (2016) Biol. Psychiat., 79, pp. 415-420; 
Hobl, E.L., Reiter, B., Schoergenhofer, C., Schwameis, M., Derhaschnig, U., Kubica, J., Stimpfl, T., Jilma, B., Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteers (2016) Eur. J. Clin. Invest., 46, pp. 7-14; 
Hobl, E.L., Reiter, B., Schoergenhofer, C., Schwameis, M., Derhaschnig, U., Lang, I.M., Stimpfl, T., Jilma, B., Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers (2016) Clin. Res. Cardiol., 105, pp. 349-355; 
Hofstad, J.K., Winther, S.B., Rian, T., Foss, O.A., Husby, O.S., Wik, T.S., Perioperative local infiltration anesthesia with ropivacaine has no effect on postoperative pain after total hip arthroplasty (2015) Acta Orthop., 86, pp. 654-658; 
Holanda, V.A., Medeiros, R.J., Asth, L., Guerrini, R., Calo, G., Gavioli, E.C., Antidepressant activity of nociception/orphanin FQ receptor antagonists in the mouse learned helplessness (2016) Psychopharmacology (Berl.), 233, pp. 2525-2532; 
Hosseini-Sharifabad, A., Rabbani, M., Sharifzadeh, M., Bagheri, N., Acute and chronic tramadol administration impair spatial memory in rat (2016) Res. Pharm. Sci., 11, pp. 49-57; 
Hosseinzadeh, H., Parvadeh, S., Masoudi, A., Moghimi, M., Mahboobifard, F., Attenuation of morphine tolerance and dependence by thymoquinone in mice (2016) Avicenna J. Phytomed., 6, pp. 55-66; 
Hotta, K., Inoue, S., Taira, K., Sata, N., Tamai, K., Takeuchi, M., Comparion of the analgesic effect between continuous wound infiltration and single-injection transversus abdominis plane block after gynecologic laparotomy (2016) J. Anesth., 30, pp. 31-38; 
Hou, M., Zhou, N.B., Li, H., Wang, B.S., Wang, X.Q., Wang, X.W., Wang, K.G., Xue, F.S., Morphine and ketamine inhibit immune function of gastric cancer patients by increasing percentage of CD4(+)CD25(+)Foxp3(+) regulatory T cells in vitro (2016) J. Surg. Res., 203, pp. 306-312; 
Hou, W., Li, H., Jiang, W., Zhang, C., McNutt, M.A., Li, G., Simian immunodeficiency virus impacts microRNA-16 mediated post-transcriptional regulation of mu opioid receptor in CEM x 174 cells (2016) J. Cell. Biochem., 117, pp. 84-93; 
Hough, L.B., Nalwalk, J.W., Ding, X., Scheer, N., Opioid analgesia in P450 gene cluster knockout mice: a search for analgesia-relevant isoforms (2015) Drug Metab. Dispos., 43, pp. 1326-1330; 
Hsieh, Y.L., Hong, C.Z., Liu, S.Y., Chou, L.W., Yang, C.C., Acupuncture at distant myofascial trigger spots enhances endogenous opioids in rabbits: a possible mechanism for managing orofacial pain (2016) Acupunct. Med., 34, pp. 302-309; 
Hu, M., Giulianotti, M.A., McLaughlin, J.P., Shao, J., Debevec, G., Maida, L.E., Geer, P., Yu, Y., Synthesis and biological evaluation of novel endomorphin analogues containing alpha-hydroxy-beta-phenylalanine (AHPBA) displaying mixed mu/delta opioid receptor agonist and delta opioid receptor antagonist activities (2015) Eur. J. Med. Chem., 92, pp. 270-281; 
Hu, X., Huang, F., Szymusiak, M., Tian, X., Liu, Y., Wang, Z.J., PLGA-curcumin attenuates opioid-induced hyperalgesia and inhibits spinal CaMKIIalpha (2016) PLoS One, 11, p. e0146393; 
Hu, X.M., Cao, S.B., Zhang, H.L., Lyu, D.M., Chen, L.P., Xu, H., Pan, Z.Q., Shen, W., Downregulation of miR-219 enhances brain-derived neurotrophic factor production in mouse dorsal root ganglia to mediate morphine analgesic tolerance by upregulating CaMKIIgamma (2016) Mol. Pain, p. 12; 
Hua, Z., Liu, L., Shen, J., Cheng, K., Liu, A., Yang, J., Wang, L., Cheng, J., Mesenchymal stem cells reversed morphine tolerance and opioid-induced hyperalgesia (2016) Sci. Rep., 6, p. 32096; 
Huang, A.C., Wang, C.C., Wang, S., Examinations of the reward comparison hypothesis: the modulation of gender and footshock (2015) Physiol. Behav., 151, pp. 129-138; 
Huang, C.H., Hsieh, Y.J., Wei, K.H., Sun, W.Z., Tsao, S.L., A comparison of spinal and epidural anesthesia for cesarean section following epidural labor analgesia: a retrospective cohort study (2015) Acta Anaethesiol. Taiwan, 53, pp. 7-11; 
Huang, E.Y., Chen, Y.H., Huang, T.Y., Chen, Y.J., Chow, L.H., Chronic administration of nandrolone increases susceptibility to morphine dependence without correlation with LVV-hemorphin 7 in rats (2016) Neuropeptides, 59, pp. 63-69; 
Huang, J., Lakkaraju, S.K., Coop, A., MacKerell, A.D., Jr., Confirmational heterogeneity of intracellular loop 3 of the mu-opioid G-protein coupled receptor (2016) J. Phys. Chem. B, 120, pp. 11897-11904; 
Huang, P., Tunis, J., Parry, C., Tallarida, R., Liu-Chen, L.Y., Synergistic antidepressant effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test (2016) Eur. J. Pharmacol., 781, pp. 53-59; 
Huang, P., Yakovieva, T., Aldrich, J.V., Tunis, J., Perry, C., Liu-Chen, L.Y., Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibit different behavioral effects from the long-acting antagonist, nor-binaltorphamine in mouse anxiety tests (2016) Neurosci. Lett., 615, pp. 15-20; 
Huang, Q., Mao, X.F., Wu, H.Y., Li, T.F., Sun, M.L., Liu, H., Wang, Y.X., Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models (2016) J. Neuroinflamm., 13, p. 214; 
Huang, Y., Li, X., Zhu, T., Lin, J., Tao, G., Efficacy and safety of ropovacaine addition to intrathecal morphine for pain management in intractable cancer (2015) Mediators Inflamm., 2015, p. 439014; 
Hughes, P.A., Costello, S.P., Bryant, R.V., Andrews, J.M., Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanism and clinical implications (2016) Am. J. Physiol. Gastroenterol. Liver Physiol., 311, pp. G501-G513; 
Hung, C.H., Wang, J.C., Strichartz, G.R., Spontaneous chronic pain after experimental thoracotomy revealed by conditioned place preference: morphine differentiates tactile evoked pain from spontaneous pain (2015) J. Pain, 16, pp. 903-912; 
Huroy, S., Kanawaty, A., Magomedova, L., Cummins, C.L., George, S.R., van der Kooy, D., Henderson, J.T., EphB2 reverse signaling regulates learned opioid tolerance via hippocampal function (2016) Behav. Brain Res., 300, pp. 85-96; 
Hutsell, B.A., Cheng, K., Rice, K.C., Negus, S.S., Banks, M.L., Effects of the kappa opioid receptor antagonist nor-binaltorphamine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys (2016) Addict. Biol., 21, pp. 360-373; 
Huynh, A.S., Estrella, V., Stark, V.E., Cohen, A.S., Chen, T., Casagni, T.J., Josan, J.S., Moese, D.L., Tumor targeting and pharmacokinetics of a near-infrared fluoresecent-labeled delta-opioid receptor antagonist agent, Dmt-Tic-Cy5 (2016) Mol. Pharm., 13, pp. 534-544; 
Hwa, L.S., Shimamoto, A., Kayyali, T., Norman, K.J., Valentino, R.J., DeBold, J.F., Miczek, K.A., Dissociation of mu-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice (2016) Addict. Biol., 21, pp. 111-124; 
Ibach, B.W., Loeber, C., Shukry, M., Hagemann, T.M., Harrison, D., Johnson, P.N., Duration of intrathecal morphine effect in children with idiopathic scoliosis undergoing posterior spinal fusion (2015) J. Opioid Manag., 11, pp. 295-303; 
Ignatowski, T.A., Aalinkeel, R., Reynolds, J.A., Nair Sykes, B.B.D.E., Gleason, C.P., Law, W.C., Mammen, M.J., Mahajan, S.D., Nanotherapeutic approach for opiate addiction using DARPP-32 gene silencing in an animal model of opiate addiction (2015) J. Neuroimmune Pharmacol., 10, pp. 136-152; 
Imani, S., Atef Vahid, M.K., Gharraee, B., Habibi, M., Bowen, S., Noroozi, A., Comparing mindfulness-based group therapy with treatment as usual for opioid dependents: a pilot randomized clinical trial study protocol (2015) Iran. J. Psychiatr. Behav. Sci., 9, p. e216; 
Imbermon, M., Sanchez-Rebordelo, E., Romero-Pico, A., Kallo, I., Chee, M.J., Porteiro, B., Al-Massadi, O., Nogueiras, R., Hypothalamic kappa opioid receptor mediates both diet-induced and melanin concentrating hormone-induced liver damage through inflammation and endoplasmic reticulum stress (2016) Hepatology, 64, pp. 1086-1104; 
Inusuka, A., Yamashita, A., Chowdhury, S., Nakai, J., Ohkura, M., Taguchi, T., Yamanaka, A., The integrative role of orexin/hypocretin neurons in nociceptive perceptions and analgesic regulation (2016) Sci. Rep., 6, p. 29480; 
Ishida, T., Sakamoto, A., Tanaka, H., Ide, S., Ishida, K., Tanaka, S., Mori, T., Kawamata, M., Tranversus abdominis plane block with 0.25% lveobupivacaine: a prospective, randomized double-blinded clinical study (2015) J. Anesth., 29, pp. 557-561; 
Ishikawa, K., Mochizuki, Y., Hirayama, S., Nemoto, T., Nagai, K., Itoh, K., Fujii, H., Synthesis and evaluation of novel opioid ligand with a C-homomorphinan skeleton (2016) Bioorg. Med. Chem., 24, pp. 2199-2205; 
Islam, M.R., Yang, L., Lee, Y.S., Hruby, V.J., Karamyan, V.T., Abbruscato, T.J., Enkephalin-fentanyl multifunctional opioids as potnetial neuroprotectants for ischemic stroke treatment (2016) Curr. Pharm. Des., 22, pp. 6459-6468; 
Islam, S., Shajib, M.S., Ahmed, T., Antinociceptive effect of methanol extract of Celosia cristata Linn. in mice (2016) BMC Complement. Altern. Med., 16, p. 400; 
Jacobsohn, K., Davis, T.D., El-Arabi, A.M., Tiachac, J., Langenstroer, P., O'Connor, R.C., Guralnick, M.L., Schlosser, R., Initial experience with ketamine-based analgesia in patients undergoing robotic radical cystectomy and diversion (2015) Can. Urol. Assoc. J., 9, pp. E367-371; 
Jafari-Sabet, M., Jafari-Sabet, A.R., Dizaji-Ghadim, A., Tramadol state-dependent memory: involvement of dorsal hippocampal muscarinic acetylcholine receptors (2016) Behav. Pharmacol., 27, pp. 470-478; 
Jafarinejad-Farsingi, S., Farazmand, A., Rezayof, A., Darbandi, N., Proteome analysis of rat hippocampus following morphine-induced amnesia and state-dependent learning (2015) Iran. J. Pharm. Res., 14, pp. 591-602; 
Jain, P., Hassan, A.M., Koyani, C.N., Mayerhofer, R., Reichmann, F., Farzi, A., Schuligol, R., Holzer, P., Behavioral and molecular processing of visceral pain in the brain of mice: impact of colitis and psychological stress (2015) Front. Behav. Neurosci., 9, p. 177; 
Jain, P.N., Pai, K., Chetterjee, A.S., The prevalence of severe pain, its etiopathological characteristics and treatment profile of patients referred to a tertiary cancer care pain clinic (2015) Indian J. Palliat. Care, 21, pp. 148-151; 
Jamshedi, R.J., Sullivan, L.C., Jacobs, B.A., Chavera, T.A., Berg, K.A., Clarke, W.P., Long-term reduction of kappa opioid receptor function by the biased ligand, nor-binaltorphamine, requires c-Jun N-terminal kinase activity and new protein synthesis in peripheral sensory neurons (2016) J. Pharmacol. Exp. Ther., 359, pp. 319-328; 
Janda, A.M., As-Sanie, S., Rajala, B., Tsodikov, A., Moser, S.E., Clauw, D.J., Brummett, C.M., Fibromyalgia survey criteria are associated with increased postoperative opioid consumption in women undergoing hysterectomy (2015) Anesthesiol, 122, pp. 1103-1111; 
Janssen, D.J., de Hosson, S.M., bij de Vaate, E., Mooren, K.J., Baas, A.A., Attitudes towards opioids for refractory dyspnea in COPD among Dutch chest physicians (2015) Chron. Respir. Dis., 12, pp. 85-92; 
Ji, C., Xiong, Y., Pan, X., Guo, X., Li, Z., Qian, S., Xu, C., Liao, W.Q., Effect of non-steroidal anti-inflammatory drugs on the increasing the incidence of colonic anastomosis in rats (2015) Int. J. Clin. Exp. Pathol., 8, pp. 6126-6134; 
Jia, S.S., Shang, L., Li, M.E., Zhao, D.M., Xu, W.H., Wang, Y.Q., Modified glascow prognostic score predicting high conversion ratio in opioid switching from oral oxycodone to transdermal fentanyl in patients with cancer pain (2015) Int. J. Clin. Exp. Med., 8, pp. 7606-7612; 
Jia, W., Fei, G.H., Hu, J.G., Hu, X.W., A study on the effect of IL-6 gene polymorphism on the prognosis of non-small-cell lung cancer (2015) Oncol. Targets Ther., 8, pp. 2699-2704; 
Jiang, L., Ding, S., Yan, H., Li, Y., Zhang, L., Chen, X., Yin, X., Zhang, J., A retrospective comparison of dexmedetomidine versus midazolam for pediatric patients with congenital heart disease requiring postoperative sedation (2015) Pediatr. Cardiol., 36, pp. 993-999; 
Jiang, L., Hu, J., He, S., Zhang, L., Zhang, Y., Spinal neuronal NOS signaling contributes to morphine cardiuoprotection in ischemia reperfusion injury in rats (2016) J. Pharmacol. Exp. Ther., 358, pp. 450-456; 
Jiang, Q.Y., Wang, M.Y., Li, L., Mo, H.X., Song, J.L., Tang, Q.L., Feng, X.T., Electroacupuncture relieves labour pain and influences the spinal dynorphin/kappa-opioid receptor system in rats (2016) Acupunct. Med., 34, pp. 223-228; 
Jiang, X., Fuller, T.W., Bandari, J., Bensal, U., Zhang, Z., Shen, B., Wang, J., Tai, C., Contribution of GABAA, glycine and opioid receptors to sacral neuromodulation of bladder overactivity in cats (2016) J. Pharmacol. Exp. Ther., 359, pp. 436-441; 
Jiang, Z., Wu, S., Wu, X., Zhong, J., Lv, A., Jiao, J., Chen, Z., Blocking mammalian target of rapamycin alleviates bone cancer pain and morphine tolerance via mu-opioid receptor (2016) Int. J. Cancer, 138, pp. 2013-2020; 
Jimenez-Gonzalez, A., Garcia-Concejo, A., Lopez-Benito, S., Gonzalez-Nunez, V., Arevalo, J.C., Rodriguez, R.E., Role of morphine, miuR-212/132 and mu opioid receptor in the regulation of Bdnf in zebrafish embryos (2016) Biochim. Biophys. Acra, 1860, pp. 1308-1316; 
Jin, S.Q., Ding, X.B., Tong, Y., Ren, H., Chen, Z.X., Wang, X., Li, Q., Effect of saphenous nerve block for postoperative pain on knee surgery: a meta-analysis (2015) Int. J. Clin. Exp. Med., 8, pp. 368-376; 
Johnson, J.L., Kwok, Y.H., Sumracki, N.M., Swift, J.E., Hutchinson, M.R., Johnson, K., Williams, D.B., Rolan, P.E., Glial attenuation with ibudilast in the treatment of medication overuse headache: a double-blind, randomized, placebo-controlled pilot trial of efficacy and safety (2015) Headache, 55, pp. 1192-1208; 
Johnson, K.V., Dunbar, R.I., Pain tolerance predicts human social network size (2016) Sci. Rep., 6, p. 25267; 
Johnson, M.W., MacLean, K.A., Caspers, M.J., Prisinzano, T.E., Griffiths, R.R., Time course of pharmacokinetic and hormonal effects of inhaled high-dose salvinorin A in humans (2016) J. Psychopharmacol., 30, pp. 323-329; 
Jokinen, V., Lilius, T.O., Laitila, J., Niemi, M., Rauhala, P.V., Kalso, E.A., Pregabalin enhances the antinociceptive effect of oxycodone and morphine in thermal models of nociception in the rat without any pharmacokinetic interactions (2016) Eur. J. Pain, 20, pp. 297-306; 
Jolley, C.J., Bell, J., Rafferty, G.F., Moxham, J., Strang, J., Understanding heroin overdose: a study of the acute respiratory depressant effects of injected pharmaceutical heroin (2015) PLoS One, 10, p. e0140995; 
Jolly, C., Jathieres, F., Keita, H., Jaouen, E., Guyot, B., Torre, A., Cesarean analgesia using levobupivacaine continuous wound infiltration: a randomized trial (2015) Eur. J. Obstet. Gynecol. Reprod. Biol., 194, pp. 125-130; 
Jones, J.D., Luba, R.R., Vogelamn, J.L., Comer, S.D., Searching for evidence of genetic mediation of opioid withdrawal by opioid receptor gene polymorphisms (2016) Am. J. Addict., 25, pp. 41-48; 
Jones, J.D., Sullivan, M.A., Manubay, J.M., Mogali, S., Metz, V.E., Ciccocioppo, R., Comer, S.D., The effects of pioglitazone, a PPARgamma receptor agonist, on the abuse liability of oxycodone among nondependent opioid users (2016) Physiol. Behav., 159, pp. 33-39; 
Jones, M.E., Lebonville, C.L., Barrus, D., Lysle, D.T., The role of brain interleukin-1 in stress-enhanced fear learning (2015) Neuropsychopharmacology, 40, pp. 1289-1296; 
Jorand, R., Biswas, S., Wakefield, D.L., Tobin, S.J., Golfetto, O., Hilton, K., Ko, M., Jovanovic-Talisman, T., Molecular signatures of mu opioid receptor and somatostatin receptor 2 in pancreatic cancer (2016) Mol. Biol. Cell, 27, pp. 3659-3672; 
Joselyn, A., Bhalla, T., McKee, C., Pepper, V., Diefenbach, K., Michalsky, M., Tobias, J.D., Perioperative analgesic requirements in severely obese adolescents and young adults undergoing laparascopic versus robotic-assisted gastric sleeve resection (2015) Saudi J. Anesth., 9, pp. 442-445; 
Joyce-Zuniga, N.M., Newberry, R.C., Robbins, C.T., Ware, J.V., Jansen, H.T., Nelson, O.L., Positive reinforecement training for blood collection in grizzly bears (Ursons arctos horribilus) results in undetectable elevations in serum cortisol levels: a preliminary investigation (2016) J. Appl. Anim. Welf. Sci., 19, pp. 210-215; 
Jules-Elysee, K.M., Goon, A.K., Westrich, G.H., Padgett, D.E., Mayman, D.J., Ranawat, A.S., Ranawat, C.S., YaDeau, J.T., Patient-controlled epidural analgesia or multimodal pain regimen with periarticular injection after total hip arthroplasty: a randomized, double-blind, placebo-controlled study (2015) J. Bone Joint Surg. Am., 97, pp. 789-798; 
Jungling, K., Blaesse, P., Goedecke, L., Pape, H.C., Dynorphin-dependent reduction of excitability and attenuation of inhibitory afferents of NPS neurons in the pericoerulear region of mice (2016) Front. Cell Neurosci., 10, p. 61; 
Jurga, A.M., Piotrowska, A., Starnowska, J., Rojewska, E., Makuch, W., Mika, J., Treatment with a carbon monoxide-releasing molecule (CORM-2) inhibits neuropathic pain and enhances opioid effectiveness in rats (2016) Pharmacol. Rep., 88, pp. 206-213; 
Jurga, A.M., Rojewska, E., Piotrowska, A., Makuch, W., Pilat, D., Przewlocka, B., Mika, J., Blockade of toll-like receptors (TLR2, TLR4) attenuates pain and potentiates buprenorphine analgesia in a rat neuropathic pain model (2016) Neural Plast., 2016, p. 5238730; 
Jussila, A., Huotari-Orava, R., Ylianttila, L., Partonen, T., Snellman, E., Narrow-band ultraviolet B radiation induces the expression of beta-endorphin in human skin in vivo (2016) J. Photochem. Photociol. B, 155, pp. 104-108; 
Kabadi, R., Kouya, F., Cohen, H.W., Banik, R.K., Spontaneous pain-like behaviors are more sensitive to morphine and buprenorphine than mechanically evoked behaviors in a rat model of acute postoperative pain (2015) Anesth. Analg., 120, pp. 472-478; 
Kaka, U., Hui Chang, C., Meng, G.Y., Fakurazi, S., Kaka, A., Behan, A.A., Ebrahimi, M., Electroencephalographic changes associated with antinociceptive actions of lidocaine, ketamine, meloxicam and morphine administration in minimally anaesthetized dogs (2015) BioMed Res. Int., 2015, p. 305367; 
Kalil, B., Ramaswamy, S., Plant, T.M., The distribution of substance P and kisspeptin in the mediobasal hypothalamus of the male rhesus monkey and a comparison of intravenous administration of these peptides to release GnRH as reflected by LH secretion (2016) Neuroendocrinology, 103, pp. 711-723; 
Kamysz, E., Salaga, M., Sobocinska, M., Gieldon, A., Fichna, J., Anti-inflammatory effect of novel analogs of natural enkephinase inhibitos in a mouse model of experimental colitis (2016) Future Med. Chem., 8, pp. 2231-2243; 
Kaneta, M., Ochiai, W., Nagae, M., Suto, W., Hanagata, M., Suzuki, H., Kiaoka, S., Sugiyama, K., Mechanism for increased expression of UGT2B in the liver of mice with neuropathic pain (2016) Biol. Pharm. Bull., 39, pp. 1809-1814; 
Kang, J., Compton, D.R., Vaz, R.J., Rampe, D., Proarrhythmic mechanism of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic (2016) Naunyn. Schmiedebergs Arch. Pharmacol., 389, pp. 1133-1137; 
Kao, S., Lee, H., Cheng, C., Lin, C., Tsai, H., Pain control after total knee arthroplasty: comparing intra-articular local anesthetic injections with femoral nerve block (2015) BioMed Res. Int., 2015, p. 649140; 
Karamese, M., Akdag, O., Kara, I., Yildiran, G.U., Tosun, Z., The comparison of intrathecal morphine and IV morphine PCA on pain control, patient satisfaction, morphine consumption and adverse effects in patients undergoing reduction mammoplasty (2015) Eplasty, 15, p. e15; 
Kariman, H., Majidi, A., Taheri, S., Shahrami, A., Hatamabadi, H.R., Analgesic effects of inhalation of nitric oxide (Entonox) and parenteral morphine sulfate in patients with renal colic: a randomized clinical trial (2015) Bull. Emerg. Treat., 3, pp. 46-52; 
Karkhanis, A.N., Huggins, K.N., Rose, J.H., Jones, S.R., Switch from excitatory to inhibitory actions of ethanol on dopamine levels after chronic exposure: role of kappa opioid receptors (2016) Neuropharmacology, 110, pp. 190-197; 
Karkhanis, A.N., Rose, J.H., Weiner, J.L., Jones, S.R., Early-life social isolation stress increases kappa opioid receptor responsiveness and downregulates the dopamine system (2016) Neuropsychopharmacology, 41, pp. 2263-2274; 
Karlsson, H.K., Tuulari, J.J., Tuominen, L., Hirvonen, J., Honka, H., Parkkola, R., Helin, S., Nummenmaa, L., Weight loss after bariatric surgery normalizes brain opioid receptors in morbid obesity (2016) Mol. Psychiatr., 21, pp. 1057-1062; 
Kartalov, A., Jankulovsi, N., Kuzmanovska, B., Zdravkovska, M., Shosholcheeva, M., Spirovska, T., Petrusheva, A.P., Sivevski, A., Effect of dexamethasone as a ropivacaine adjuvant in ultrasound-guided transversus abdominis plane block for inguinal hernia repair (2015) Pril (Makedon Akad Nauk Umet Odd Med Nauki), 36, pp. 35-41; 
Kasai, S., Nishizawa, D., Hasegawa, J., Sato, N., Tanioka, F., Sugimura, H., Ikeda, K., Nociceptin/orphanin FQ receptor gene variation is associated with smoking status in Japanese (2016) Pharmacogenom, 17L, pp. 1441-1451; 
Kasap, M., Can, O.D., Opioid system mediated anti-nociceptive effect of agomelatine in mice (2016) Life Sci., 163, pp. 55-63; 
Kaserer, T., Lantero, A., Schmidhammer, H., Spetea, M., Schuster, D., Mu opioid receptor: novel antagonists and structural modeling (2016) Sci. Rep., 6, p. 21548; 
Kaufner, L., Heimann, S., Zander, D., Weizacker, K., Correns, I., Sander, M., Spies, C., Von Heymann, C., Neuraxial anesthesia for pain control after cesarean section: a prospective randomized trial comparing three different neuraxial techniques in clinical practice (2016) Minerva Anestesiol., 82, pp. 514-524; 
Kaur, S., Saroa, R., Aggarwari, S., Effect of intraoperative infusion of low-dose ketamine on management of postoperative analgesia (2015) J. Nat. Sci. Biol. Med., 6, pp. 378-382; 
Kawabata, K., Nishimura, I., Fujiwara, T., Terauchi, S., Minami, T., Ito, S., Okuda-Ashitaka, E., Intrathecal administration of low-dose nociception.orphanin FQ induces allodynia via c-Jun N-terminal kinase and monocyte chrmoattractant protein-1 (2016) Eur. J. Neurosci., 43, pp. 1499-1508; 
Kazarooni, R., Tran, M.H., Evaluation of celecoxib addition to pain protocol after total hip and knee arthroplasty stratified by opioid tolerance (2015) Clin. J. Pain, 31, pp. 903-908; 
Kelly, L.E., Knoppert, D., Roukema, H., Rieder, M.J., Koren, G., Oral morphine weaning for neonatal abstinence syndrome at home as compared with in-hospital: an observational cohort study (2015) Paediatr. Drugs, 17, pp. 151-157; 
Kelly, L.E., Sommer, D.D., Ramaknishna, J., Hoffbauer, S., Arbab-Tafti, S., Reid, D., Maclean, J., Koren, G., Morphine or ibuprofen for post-tonsillectomy analgesia: a randomized trial (2015) Pediatr, 135, pp. 307-313; 
Kemppainen, H., Numi, H., Raivio, N., Kianmaa, K., Enhanced extracellular glutamate and dopamine in the ventral palldum of alcohol-preferring AA and alcohol-avoiding ANA rats after morphine (2015) Front. Psychiatr., 6, p. 1; 
Keshvari-Shirvani, M., Darabi-Mahboub, M., Ghazi, M., Delijani, A., A comparison of the effects of morphine and sublingual desmopressin combination therapy with morphine alone in treatment of renal colic: a controlled clinical trial (2015) Urol. J., 12, pp. 2001-2004; 
Khabbazi, S., Xie, N., Pu, W., Goumon, Y., Parat, M.O., The TLR4-active morphine metabolite morphine-3-glucuronide does not elicit macrophage classical activation in vitro (2016) Front. Pharmacol., 7, p. 441; 
Khakpour-Taleghani, B., Reisi, Z., Haghparast, A., The blockade of D1/D2-like dopamine receptors within the dentate gyrus of hippocampus decreased the reinstatement of morphine-extinguished conditioned place preference in rats (2015) Basic Clin. Neurosci., 6, pp. 73-82; 
Khaliq, T., Williams, T.D., Senadheera, S.N., Aldrich, J.V., Development of a robust, sensitive and selective liquid chromatography-tandem mass spectrometry assay for the quantification of the novel macrocyclic peptide kappa opioid receptor antagonist [D-Trp]CJ-15, 208 in plasma and application in an initial pharmacokinetic study (2016) J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 1028, pp. 11-15; 
Khaloo, P., Sadecghi, B., Ostadhadi, S., Norouzi-Javidan, A., Haj-Mazarian, A., Zolfagharie, S., Dehpour, A.R., Lithium attenuated the behavioral despair induced by acute neurogenic stress through blockade odf opioid receptors in mice (2016) Biomed. Pharmacother., 83, pp. 1006-1015; 
Khan, R.A., Synthesis of met-enkephalin by solution-phase peptide synthesis metholology utilizing para-touuene sufonic acid as N-terminal masking of l-mthionine amino acid (2016) Chem. Biol. Drug Des., 88, pp. 884-888; 
Khedr, A.I., Ibrahim, S.R., Mohamed, G.A., Ahmed, H.E., Ahmad, A.S., Ramadan, M.A., El-Baky, A.E., Ross, S.A., New ursane titerpenoids from Ficus pandurate and their binding affinity for human cannabinoid and opioid receptors (2016) Arch. Pharm. Res., 39, pp. 897-911; 
Khoshdel, Z., Takshad, M.A., Owji, A.A., Effects of intrathecal amylin on formalin-induced antinociception and on cAMP accumulation in the rat embryonic spinal cells (2016) Neuropeptides, 57, pp. 95-100; 
Kialka, M., Milewicz, T., Spalkowska, M., Krzyczkowska-Sendrakowska, M., Wasyl, B., Pelka, A., Krzysiek, J., Beta-endorphins plasma level is higher in lean polycystic ovary syndrome (PCOS) wonen (2016) Exp. Clin. Endocrinol. Diabetes, 124, pp. 55-60; 
Kialka, M., Milewicz, T., Sztefko, K., Rogatko, I., Majewska, R., Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome (2016) Drug Des. Dev. Ther., 10, pp. 2483-2490; 
Kibaly, C., Kam, A.Y., Loh, H.H., Law, P.Y., Naltrexone facilitates learning and delays extinction by increasing AMPA receptor phosphorylation and membrane insertion (2016) Biol. Psychiatr., 79, pp. 906-916; 
Kiguchi, Y., Aono, Y., Watanabe, Y., Yamamoto-Nemoto, S., Shimizu, K., Shimizu, T., Kosuge, Y., Saigusa, T., In vivo neurochemical evidence that delta-1, delta–2and mu-2 opioid receptors, but not mu-1 opioid receptors, inhibit acetylcholine efflux in the nucleus accumbens of freely moving rats (2016) Eur. J. Pharmacol., 789, pp. 402-410; 
Kim, H.C., Bae, J.Y., Kim, T.K., Jeon, Y., Min, J.J., Goo, E.K., Hong, D.M., Efficacy of intrathecal morphine for postoperative pain management following open nephrectomy (2016) J. Int. Med. Res., 44, pp. 42-53; 
Kim, H.J., Kim, H., Jung, M.H., Kwon, Y.K., Kim, B.J., Berberine induces pacemaker potential inhibition via cGMP-dependent ATP-sensitive K+ channels by stimulating mu/delta opioid receptors in cultured intestinal cells of Cajal from mouse small intestine (2016) Mol. Med. Res., 14, pp. 3985-3991; 
Kim, H.T., Uchimoto, K., Duelmann, T., Yang, J., Automated assessment of pain using a voluntarily accessed static weight-bearing test (2015) Physiol. Behav., 151, pp. 139-146; 
Kim, J., Kim, Y., Hahm, S.C., Yoon, Y.W., Effect of the combination of CI-988 and morphine on neuropathic pain after spinal cord injury in rats (2015) Korean J. Physiol. Psychol., 19, pp. 125-130; 
Kim, J.S., Ahmadfinia, K., Li, X., Hamilton, J.L., Andrews, S., Haralampus, C.A., Xiao, G., Im, H.J., Development of an experimental animal model for lower back pain by percutaneous injury-induced lumbar facet joint osteoarthritis (2015) J. Cell. Physiol., 230, pp. 2837-2847; 
Kim, J.S., Brown, C.H., Anderson, G.M., Anti-opioid effects of RFRP-3 on magnocellular neuron activity in morphine-naïve and morphine-treated female rats (2016) Endocrinology, 157, pp. 4003-4011; 
Kim, J.Y., Ahn, H.J., Kim, J.K., Kim, J., Lee, S.H., Chae, H.B., Morphine suppresses lung cancer cell proliferation through the interaction with opioid growth factor receptor: an in vitro and hunman lung tissue study (2016) Anesth. Analg., 123, pp. 1429-1436; 
Kim, S.I., Ha, K.Y., Oh, I.S., Preemptive multimodal analgesia for postoperative pain management after lumbar fusion surgery: a randomized controlled trial (2016) Eur. Spine J., 25, pp. 1614-1619; 
Kim, T.W., Park, S.J., Lim, S.H., Seong, S.C., Lee, S., Lee, M.C., Which analgesic mixture is appropriate for periarticular injection after total knee arthroplasty? Prospective, randomized, double-blind study (2015) Knee Surg. Sports Traumatol. Arthrosc., 23, pp. 638-645; 
Kim, W., Kim, M.J., Go, D., Min, B.I., Na, H.S., Kim, S.K., Combined effects of bee venom cupuncture and morphine on oxaliplatin-induced neuropathic pain in mice (2016) Toxuins (Basel), 8, p. 33; 
Kim, Y.J., Dev, R., Reddy, A., Hui, D., Tanco, K., Park, M., Liu, D., Bruera, E., Association between tobacco use, symprom expression and alcohol and illicit drug use in advanced cancer patients (2016) J. Pain Symptom Manag., 51, pp. 762-768; 
Kim, Y.J., Kang, Y., Park, H.Y., Lee, J.R., Yu, D.Y., Murata, T., Gondo, Y., Kim, K.S., STEP signaling pathway mediates psychomotor stimulation and morphine withdrawal symptoms, but not for reward, analgesia and tolerance (2016) Exp. Mol. Med., 48, p. e212; 
Kim, Y.S., Kim, W.Y., Kim, Y.H., Yoo, J.W., Min, T.J., The protective effect of hydromorphone to ischemia in rat glial cells (2016) Springerplus, 5, p. 610; 
Kimura, S., Ohi, Y., Haji, A., Blockade of phosphodiesterase 4 reverses morphine-induced ventilator disturbance without loss of analgesia (2015) Life Sci., 127, pp. 32-38; 
Kirshenbaum, A.P., Suhaka, J.A., Phillips, J.L., Voltolini de Souza Pinto, M., Nicotine enhancement and reinforcer devaluation: interaction with opioid receptors (2016) Pharmacol. Biochem. Behav., 150-151, pp. 1-7; 
Kissler, J.L., Walker, B.M., Dissociating motivational from physiological withdrawal in alcohol dependence: role of central amygdala kappa-opioid receptors (2016) Neuropsychopharmacology, 41, pp. 560-567; 
Kitamura, S., Kawano, T., Kaminaga, S., Yamanaka, D., Tateiwa, H., Locatelli, F.M., Yokoyama, M., Effects of fentanyl on serotonin syndrome-like behaviors in rats (2016) J. Anesth., 30, pp. 178-182; 
Kleinloog, D., Rombouts, S., Zoethout, R., Klumpers, L., Niesters, M., Khalili-Mahani, N., Dahan, A., van Gerven, J., Subjective effects of ethanol, morphine, delta(9)-tetrahydrocannibinol and ketamine following a pharmacological challenge are related to functional brain connectivity (2015) Brain Connect, 5, pp. 641-648; 
Knight, R.B., Walker, P.W., Keegan, K.A., Overholser, S.M., Baumgartner, T.S., Ebertowski, J.S., 2nd, Aden, J.K., White, M.A., A randomized controlled trial for pain control in laparoscopic urologic surgery: 0. 25% bupivacaine versus long-acting liposomal bupivacaine (2015) J. Endourol., 28, pp. 1019-1024; 
Knothe, C., Oertel, B.G., Ultsch, A., Kettner, M., Schmidt, P.H., Wunder, C., Toennes, S.W., Lotsch, J., Pharmacoepigenetics of the role of DNA methylation in mu-opioid receptor expression in different human brain regions (2016) Epigenomics, 8, pp. 1583-1599; 
Kobrin, K.L., Moody, O., Arena, D.T., Moore, C.F., Heinrichs, S.C., Kaplan, G.B., Acquisition of morphine conditioned place preference increases the dendritic complexity of nucleus accumbens core neurons (2016) Addict. Biol., 21, pp. 1086-1096; 
Koek, W., Gerak, L.R., France, C.P., Effects of amphetamine, morphine and CP 55, 940 on go/no go task performance in rhesus monkeys (2015) Behav. Pharmacol., 26, pp. 481-484; 
Koju, R.B., Gurung, B.S., Dongol, Y., Prophylactic administration of ondansetron in prevention of intrathecal morphine-induced pruritis and post-opertive nausea and vomiting in patients undergoing cesarean section (2015) BMC Anesthesiol., 15, p. 18; 
Kolacz, M., Karlinski, M., Walerzak, K., Trzebicki, J., Preoperative local administration of morphine as an add-on therapy in patients undergoing surgical removal of an odontogenic maxillary cyst: a randomized, double-blind pilot study (2015) J. Oral Facial Pain Headache, 29, pp. 378-383; 
Kolbow, J., Modess, C., Wagner, D., Oswald, S., Maritz, M.A., Rey, H., Weitschies, W., Siegmund, W., Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects (2016) J. Clin. Pharmacol., 56, pp. 239-245; 
Komatsu, T., Katsuyama, S., Nagase, H., Mizoguchi, H., Sakurada, C., Tsuzuki, M., Sakurada, S., Sakurada, T., Intrathecal morphine-3-glucuronide-induced nociceptive behavior via delta-2 opioid receptors in the spinal cord (2016) Pharmacol. Biochem. Behav., 140, pp. 68-74; 
Kon, R., Ikarashi, N., Hayakawa, A., Haga, Y., Fueki, A., Kusunoki, Y., Tajima, M., Sugiyama, K., Morphine-induced constipation develops with increased aquaporin-3 expression in the colon via increased serotonin secretion (2015) Toxicol. Sci., 145, pp. 337-347; 
Kong, M., Yang, L., Li, J., Zhong, Z., Cheng, Y., Wu, Z., Guo, R., Low-dose butorphanol alleviates remifentanil-induced hyperalgesia in patients undergoing laparoscopic cholecystectomy (2016) J. Clin. Anesth., 34, pp. 41-45; 
Kononenko, O., Bazov, I., Watanabe, H., Gerashchenko, G., Dyachok, O., Verbeek, D.S., Alkass, K., Balkalkin, G., Opioid precursor protein precursor is targeted to the cell nuclei in the human brain (2016) Biochim. Biophys. Acta, 1861, pp. 246-255; 
Konopka-Filippow, M., Zabrocka, E., Wojtowicz, A., Skalij, P., Woitukiewicz, M.Z., Sierko, E., Strong opioid pain management was employed during radiotherapy and radiochemotherapy in oropharyngeal cancer patients: single-institution experience (2015) Int. Dent. J., 65, pp. 242-248; 
Konstantatos, A.H., Howard, W., Story, D., Mok, L.Y., Boyd, D., Chan, M.T., A randomized controlled trial of peri-operative pregabalin vs. placebo for video-assisted thoracoscopic surgery (2016) Anaesth, 71, pp. 192-197; 
Koo, J.W., Mazer-Robison, M.S., LaPlant, Q., Egervari, G., Braunscheidel, K.M., Adank, D.N., Ferguson, D., Nestler, E.J., Epigenetic basis of opiate suppression of Bdnf gene expression in the ventral tegmental area (2015) Nat. Neurosci., 18, pp. 415-422; 
Kosarmadar, N., Ghasemzadeh, Z., Rezavof, A., Inhibition of microglia in the basolateral amygdala enhanced morphine-induced antinociception: possible role of GABA-A receptors (2015) Eur. J. Pharmacol., 765, pp. 157-163; 
Kosiorek-Witek, A., Makulska-Nowak, H.E., Morphine analgesia modification in normotensive and hypertensive female rats after repeated fluoxetine administration (2016) Basic Clin. Pharmacol. Toxicol., 118, pp. 45-52; 
Kotecki, L., Hearing, M., McCall, N.M., Marron Fernandez de Velasco, E., Pravetoni, M., Arora, D., Victoria, N.C., Wickman, K., GIRK channels modulate opioid-induced motor activity in a cell type- and subunit-dependent manner (2015) J. Neurosci., 35, pp. 7131-7142; 
Kou, Z.Z., Wan, F.P., Bai, Y., Li, C.Y., Hu, J.C., Zhang, G.T., Zhang, T., Li, Y.Q., Decreased endomorphin-2 and mu-opioid receptor in the spinal cord are associated with painful diabetic neuropathy (2016) Front. Med. Neurosci., 9, p. 80; 
Kouya, F., Igbal, Z., Charen, D., Shah, M., Banik, R.K., Evaluation of anxiety-like behavior in a rat model of acute postoperative pain (2015) Eur. J. Anaethesiol., 32, pp. 242-247; 
Kovanen, L., Basnet, S., Castren, S., Pankakowski, M., Saankowski, S.T., Partonen, T., Alho, H., Lahti, T., A randomized double-blind placebo-controlled trial of as-needed naltrexone in the treatment of pathological gambling (2016) Eur. Addict. Res., 22, pp. 70-79; 
Krakauer, E.L., Nguyen, T.P., Husain, S.A., Nguyen, T.H., Joranson, D.E., Luong, N.K., Maurer, M.A., Toward safe accessibility of opioid pain medicines in Vietnam and other developing countries: a balanced policy method (2015) J. Pain Symptom Manage., 49, pp. 916-922; 
Kramlinger, V.M., Alvarado Rojas, M., Kanamori, T., Guengerich, F.P., Cytochrome P450 3A enzymes catalyze the O6-demethylation of thebaine, a key step in endogenous mammalian morphine biosynthesis (2015) J. Biol. Chem., 290, pp. 20200-20210; 
Kremer, M., Yalcin, I., Nexon, L., Wurtz, X., Ceredig, R.A., Daniel, D., Hawkes, R.A., Barrot, M., The antiallodynic action of pregabalin in neuropathic pain is independent from the opioid system (2016) Mol. Pain, 12. , 1733806916633477; 
Kren, N.P., Zagon, I.S., McLaughlin, P.J., Nuclear export of opioid growth factor receptor is CRM1 depoendent (2016) Exp. Biol. Med. (Maywood), 241, pp. 273-281; 
Kringel, D., Lotsch, J., Next-generation sequencing of human opioid receptor genes based on a custom AmpliSeq library and ion torrent personal genome machine (2016) Clin. Chim. Acta, 463, pp. 32-38; 
Kruegel, A.C., Gassawy, M.M., Kapoor, A., Varadi, A., Majumdar, S., Filizola, M., Javitch, J.A., Semes, D., Synthetiuc and receptor signaling explorations of the mitragyna alkaloids: mitragynine as an atypical molecular framework for opioid receptor modulators (2016) J. Am. Chem. Soc., 138, pp. 6754-6764; 
Krupitsky, E., Zvartau, E., Blokhina, E., Verbitskaya, E., Wahlgren, V., Tsoy-Podosenin, M., Bushara, N., Woody, G., Anhedonia, deptression, anxiety and craving in opiate dependent patients stabilized on oral naltrexone or an extended release naltrexone implant (2016) Am. J. Drug Alcohol Abuse, 42, pp. 614-620; 
Kruse, H., Christensen, K.P., Moller, A.M., Gogenur, I., Tourniquet use during ankle surgery leads to increased postoperative opioid use (2015) J. Clin. Anesth., 27, pp. 380-384; 
Kubica, J., Adamski, P., Ostrowska, M., Sikora, J., Kubica, J.M., Sroka, W.D., Stankowska, K., Kozinski, M., Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial (2016) Eur. Heart J., 37, pp. 245-252; 
Kubica, J., Adamski, P., Ostrowska, M., Kozinski, M., Obonska, K., Laskowska, E., Obonska, E., Paciorek, P., Influence of morphine on pharmacokinetics and pharmacodynamics of ticagrelor in patients with myocardial infarction (IMPRESSION): study protocol for a randomized controlled trial (2015) Trials, 16, p. 198; 
Kuczeriska, M., Lipkowski, A.W., Sadowski, J., Kompanowska-Jezierska, E., An endomorphin analog ([d-Ala(2)-endomorphin 2, TAPP) lowers blood pressure and enhances tissue nitric oxide in anesthetized rats (2016) Pharmacol. Rep., 68L, pp. 616-619; 
Kumar, K., Pandey, R.K., Bhalla, A.P., Kashyap, L., Garg, R., Darlong, V., Malhotra, R., Yadav, C.S., Comparison of conventional infrainguinal versus modified proximal suprainguinal approach of fascia iliaca compartment block for postoperative analgesia in total hip arthroplasty. A prospective randomized study (2015) Acta Anaesthesiol. Belg., 66, pp. 95-100; 
Kumar, P., Reithofer, V., Reisinger, M., Wallner, S., Pavkov-Keller, T., Macheroux, P., Gruber, K., Substrate complexes of human dipeptidyl peptidase III reveal the mechanism of enzyme inhibition (2016) Sci. Rep., 6, p. 23787; 
Kumar, V., Bonifazi, A., Ellenberger, M.P., Keck, T.M., Pommier, E., Rais, R., Slusher, B.S., Newman, A.H., Highly selective dopamine D3 receptor (D3R) antagonists and partial agonists based on eticlopride and the D3R crystal structure: new leads for opioid dependence treatment (2016) J. Med. Chem., 59, pp. 7634-7650; 
Kundu, R., Baidya, D.K., Arora, M.K., Maitra, S., Darfong, V., Goswami, D., Mohanselvi, S., Bajpai, M., Caudal bupivacaine and morphine provides effective postoperative analgesia but does not prevent hemodynamic response to pneumoperitoneum for major laparoscopic surgeries in children (2015) J. Anesth., 29, pp. 618-621; 
Kunecki, M., Plazak, W., Roleder, T., Biernat, J., Olesky, T., Podolec, P., Golba, K.S., Opioidergic postconditioning of heart muscle during ischemia/reperfusion injury (2016) Cardiol. J., 24 (4), pp. 419-426; 
Kunkel, F., Fey, E., Borg, D., Stripp, R., Getto, C., Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction (2015) J. Opioid Manag., 11, pp. 435-442; 
Kuo, C.C., Shen, H., Harvey, B.K., Yu, S.J., Kopajtic, T., Hinkle, J.J., Kyrkanides, S., Wang, Y., Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of mu opioid receptors in nucleus accumbens and ventral tegmental area (2016) Psychopharmacology (Berl.), 233, pp. 661-672; 
Kurita, G.P., Lundstrom, S., Siogren, P., Ekholm, O., Christup, L., Davies, A., Kaasa, S., Dale, O., Renal function and symptoms/adverse effects in opioid-treated patients with cancer (2015) Acta Anaestesiol. Scand., 59, pp. 1049-1059; 
Kurovilla, H., Schmidt, B., Song, S., Bhajjan, M., Merical, M., Alley, C., Griffin, C., Hurtubise, A., Netrin-1 peptide is chemorepellant in tetrahymena thermophila (2016) Int. J. Pept., 2016, p. 7142868; 
Kwiatkowski, K., Piotrowska, A., Rojewska, E., Makuch, W., Jurga, A., Slusarczyk, J., Trjan, E., Mika, J., Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats (2016) Prog. Neuropsychopharmacol. Biol. Psychiatr., 64, pp. 68-78; 
Kyhl, L.E., Li, S., Faerch, K.U., Soegaard, B., Larsonen, F., Areberg, J., Population pharmacokinetics of nalmefene in healthy subjects and its relation to mu-opioid receptor occupancy (2016) Br. J. Clin. Pharmacol., 81, pp. 290-300; 
Labuz, D., Celik, M.O., Zimmer, A., Machelska, H., Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain (2016) Sci. Rep., 6, p. 32799; 
Labuz, D., Spahn, V., Celik, M.O., Machelska, H., Opioids and TRPV1 in the peripheral control of neuropathic pain – defining a target site in the injured nerve (2016) Neuropharmacology, 101, pp. 330-340; 
Lahlou-Casulli, M., Chaize-Avril, C., Pouliquen, E., Desfourneaux, V., Mazoit, J.X., Malledant, Y., Beloeil, H., The median effective analgesic dose (ED50) of ropivacaine in ultrasound-guided transversus abdominis plane block for analgesia in reversal of ileostomy: a double-blind up-down dose-finding study (2015) Eur. J. Anaesthesiol., 32, pp. 640-644; 
Lam, D.M., Choi, S.W., Wong, S.S., Irwin, M.G., Cheung, C.W., Efficacy of pregabalin in acute postoperative pain under different surgical categories: a meta-analysis (2015) Medicine (Balktimore), 94, p. e1944; 
Lange, A., Lasser, K.E., Xuan, Z., Khalid, L., Beers, D., Heymann, O.D., Shanahan, C.W., Liebschutz, J.M., Variability in opioid prescription monitoring and evidence of aberrant medication taking behaviors in urban safety-net clinics (2015) Pain, 156, pp. 335-340; 
Larance, B., Lintzeris, N., Bruno, R., Peacock, A., Cama, E., Ali, R., Kihas, I., Degenhardt, L., The characteristics of a cohort who tamper with prescribed and diverted opioid medications (2015) J. Subst. Abuse Treat., 58, pp. 51-61; 
Larochelle, M.R., Liebschutz, J.M., Zhang, F., Ross-Degnan, D., Wharam, J.F., Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study (2016) Am. Intern. Med., 164, pp. 1-9; 
Larochelle, M.R., Zhang, F., Ross-Degnan, D., Wharam, J.F., Rates of opioid dispensing and overdose after introduction of abuse-deterrent extended-release oxycodone and withdrawal from propoxyphene (2015) JAMA Intern. Med., 175, pp. 978-987; 
Larson, A.A., Nunez, M.G., Kissel, C.L., Kovacs, K.J., Intrathecal urocortin I in the spinal cord as a murine model of stress hormone-induced musculoskeletal and tactile hyperalgesia (2015) Eur. J. Neurosci., 42, pp. 2772-2782; 
Larson, M.E., Berg, R.L., Flanagan, J., Quantification of oxycodone and morphine analytes in urine: assessment of adherence (2015) J. Opioid Manag., 11, pp. 489-500; 
Lasota, A., Fraczak, O., Muchowska, A., Nowakowski, M., Maciejczyk, M., Ejchart, A., Olma, A., Synthesis, biological activity and NMR-based structural studies of deltorphin-1 analogs modified in message domain with a new alpha, alpha-disubstituted glycines (2016) Chem. Biol. Drug Des., 87, pp. 824-832; 
Laureano, D.P., Dalie Molle, R., Alves, M.B., Luft, C., Desai, M., Ross, M.G., Silveira, P.P., Intrauterine growth restriction modifies the hedonic response to sweet taste in newborn pups – role of the accumbal mu-opioid receptors (2016) Neuroscience, 322, pp. 500-508; 
Lay, J., Carbone, S.E., DiCello, J.J., Bunnett, N.W., Canals, M., Poole, D.P., Distribution and trafficking of the mu-opioid receptor in enteric neurons of the guinea pig (2016) Am. J. Physiol. Gastrointest. Liver Physiol., 311, pp. G252-G266; 
Leah, P.M., Heath, E.M., Balleine, B.W., Christie, M.J., Chronic morphine reduces surface expression of delta-opioid receptors in subregions of rostral striatum (2016) Neurochem. Res., 41, pp. 500-509; 
Leal, P.C., Salamao, R., Brunialti, M.K., Sakata, R.K., Evaluation of the effect of ketamine on remifentanil-induced hyperalgesia: a double-blind, randomized study (2015) J. Clin. Anesth., 27, pp. 331-337; 
Lebonville, C.L., Jones, M.E., Hutson, L.W., Cooper, L.B., Fuchs, R.A., Lysle, D.T., Acquisition of heroin conditioned immunosuppression requires IL-1 signaling in the dorsal hippocampus (2016) Brain Behav. Immun., 56, pp. 325-334; 
Lechner, W.V., Knopik, V.S., McGeary, J.E., Spillane, N.S., Tidey, J.W., McKee, S.A., Metrik, J., Kahler, C.W., Influence of the A118G polymorphism of the OPRM1 gene and exon 3 VNTR polymorphism of the DRD4 gene on cigarette craving after alcohol administration (2016) Nicotine Tob. Res., 18, pp. 632-636; 
Lee, B.H., Zhao, R.J., Lee, B.G., Kim, N.J., Yang, C.H., Kim, H.Y., Gwak, Y.S., Lee, H.J., Acupuncture suppresses morphine craving in progressive ratio through the GABA system (2015) J. Acupunct. Meridian Stud., 8, pp. 175-182; 
Lee, E.Y., Lee, H.S., Dual projections odf single orexin- or CART-immunoreactive lateral hypothalamic neurons to the paraventricular thalamic nucleus and nucleus accumbens shell in the rat: light microscopic study (2016) Brain Res., 1834, pp. 104-118; 
Lee, H.J., Chang, L.Y., Ho, Y.C., Teng, S.F., Hwang, L.L., Mackie, K., Chiou, L.C., Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray (2016) Neuropharmacology, 105, pp. 577-586; 
Lee, K.S., Zhang, Y., Asgar, J., Auh, Q.S., Chung, M.K., Ro, J.Y., Androgen receptor transcriptionally regulates mu-opioid receptor expression in rat trigeminal ganglia (2016) Neuroscience, 331, pp. 52-61; 
Lee, S.Y., Chen, S.L., Chang, Y.H., Chu, C.H., Chen, S.H., Chen, P.S., Huang, S.Y., Lu, R.B., A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment (2015) Int. J. Neuropsychopharmacol., 18. , (pyv008); 
Lee, Y.C., Jung, J., Park, S.J., Remifentanil-induced preconditioning has cross-talk with A1 and A2 B adenosine receptors in ischemic-reperfused rat heart (2016) Bosn. J. Basic Med. Sci., 16, pp. 64-70; 
Lee, Y.J., Suh, S.Y., Song, J., Lee, S.S., Seo, A.R., Ahn, H.Y., Lee, M.A., Klepstad, P., Serum and urine concentrations of morphine and morphine metabolites in patients with advanced cancer receiving continuous intravenous morphine: an observational study (2015) BMC Palliat. Care, 14, p. 53; 
Lee, Y.S., Kupp, R., Remesic, M.V., Ramos-Colon, C., Hall, S.M., Chan, C., Rankin, D., Hruby, V.J., Various modifications of the amphipathic dynorphin A pharmacophore for rat brain bradykinin receptors (2016) Chem. Biol. Drug Des., 88, pp. 515-519; 
Lee, Y.S., Remesic, M.V., Ramos-Colon, C., Hall, S.M., Kuzmin, A., Rankin, D., Porreca, F., Hruby, V.J., Cyclic non-opioid dynorphin A analogues for the bradykinin receptors (2016) Bioorg. Med. Chem. Lett., 26, pp. 5513-5516; 
Lengyei, I., Toth, F., Biyashev, D., Szatmari, I., Monory, K., Tomboly, C., Toth, G., Borsodi, A., A novel non-opioid binding site for endomorphin-1 (2016) J. Physiol. Pharmacol., 67, pp. 605-616; 
Lentine, K.L., Lam, N.N., Xiao, H.C., Tuttle-Newhall, J.E., Axelrod, D., Brennan, D.C., Dhamidharka, V.R., Schnitzler, M.A., Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation (2015) Am. J. Nephrol., 41, pp. 165-176; 
Lentine, K.L., Yuan, H., Tuttle-Newhall, J.E., Xiao, H., Chawa, V., Axelrod, D., Brennan, D.C., Schnitzler, M.A., Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data (2015) Transplantation, 99, pp. 187-196; 
Leonard, M.G., Jing, S., Andukar, S.V., Gulati, A., Centhaquin attenuates hyperalgesia and non-evoked guarding in a rat model of postoperative pain primarily through alpha2B-adrenoreceptors (2016) Eur. J. Pharmacol., 789, pp. 81-87; 
Leppert, W., Kowalski, G., Long-term administration of high doses of transdermal buprenorphine in cancer patients with severe neuropathic pain (2015) Oncol. Targets Ther., 8, pp. 3621-3627; 
Lesniak, A., Bochynska-Czyz, M., Sacharczuk, M., Benhye, S., Misicka, A., Bujalska-Zadrozny, M., Biphalin preferentially recruits peripheral opioid receptors to facilitate analgesia in a mouse model of cancer pain – a comparison with morphine (2016) Eur. J. Pharm. Sci., 89, pp. 39-49; 
Lesniak, A., Pick, C.G., Misicka, A., Lipkowsi, A.W., Sacharczuk, M., Biphalin protects against cognitive deficits in a mouse model of mild traumatic brain injury (mTBI) (2016) Neuropharmacology, 101, pp. 506-518; 
Levran, O., Randesi, M., Peles, E., Correa da Rosa Ott, J.J., Rotrosen, J., Adelson, M., Kreek, M.J., African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction (2016) Pharmacogenomics, 16, pp. 995-1003; 
Levy-Cooperman, N., McIntyre, G., Bonifacio, L., McDonnell, M., Davenport, J.M., Covington, P.S., Dove, L.S., Sellers, E.M., Abuse potential and pharmacodynamics characteristics of oral and intranasal eluxadoline, a mixed mu- and kappa-opioid receptor agonist and delta-opioid receptor antagonist (2016) J. Pharmacol. Exp. Ther., 359, pp. 471-481; 
Lewin, A.E., Vicini, S., Richardson, J., Dretchen, K.L., Gillis, R.A., Sahibzada, N., Optogenetic and pharmacological evidence that somatostatin-GABA neurons are important regulators of parasympathetic outflow to the stomach (2016) J. Physiol., 594, pp. 2661-2679; 
Lewis, S.S., Hutchinson, M.R., Frick, M.M., Zhang, Y., Maier, S.F., Sammakia, T., Rice, K.C., Watkins, L.R., Select steroid hormone glucuronide metabolites can cause toll-like receptor 4 activation and enhanced pain (2015) Brain Behav. Immun., 44, pp. 128-136; 
Lewis, T., Erfe, B.L., Ezell, T., Gauda, E., Pharmacoepidemiology of opiate use in the neonatal ICU: increasing cumulative doses and iatrogenic opiate withdrawal (2015) J. Opioid Manag., 11, pp. 305-312; 
Li, C., Sugam, J.A., Lowery-Gionta, E.G., McElliott, Z.A., McCall, N.M., Lopez, A.J., McKlveen, J.M., Kash, T.L., Mu opioid receptor modulation of dopamine neurons in the periaqueductal gray/dorsal raphe: a role in regulation of pain (2016) Neuropsychopharmacology, 41, pp. 2122-2132; 
Li, G., Wang, Y., Yan, M., Xu, Y., Song, X., Li, Q., Zhang, J., Wu, Y., Inhibition of actin polymerization in the NAc shell inhibits morphine-induced CPP by disrupting its reconsolidation (2015) Sci. Rep., 5, p. 16283; 
Li, G.Z., Liu, Z.H., Wei, X., Zhao, P., Yang, C.X., Xu, M.Y., Effect of acetylcholine receptors on the pain-related electrical activities in the hippocampal CA3 region of morphine-addicted rats (2015) Iran. J. Basic Med. Sci., 18, pp. 664-671; 
Li, J., Liang, X., Zhou, Y., Zhang, S., Yang, F., Guo, H., Fan, R., Pei, J., Role of dynorphin in hypoxic pulmonary hypertension (2016) Eur. J. Pharmacol., 791, pp. 78-84; 
Li, M., Tien-A-Looi, S.C., Guo, Z.L., Longhurst, J.C., Repetitive electroacupuncture attenuates cold-induced hypertension through enkephalin in the rostral ventral lateral medulla (2016) Sci. Rep., 6, p. 35791; 
Li, M.C., Yu, J.H., Yu, S.S., Chi, Y.Y., Xiang, Y.B., MicroRNA-873 inhibits morphine-induced macrophage apoptosis by elevating A20 expression (2015) Pain Med., 16, pp. 1993-1999; 
Li, N., Han, Z.L., Wang, Z.L., Xing, Y.H., Sun, Y.L., Li, X.H., Song, J.J., Wang, R., BN-9, a chimeric peptide with opioid and neuropeptide FF receptor agonistic properties, produces non-tolerance-forming antinociception in mice (2016) Br. J. Pharmacol., 173, pp. 1864-1880; 
Li, Q., Kim, S.K., Goddard, W.A., 3rd, Chen, G., Tan, H., Predicted structures for kappa opioid G-protein coupled receptor to selective agonists (2015) J. Chem. Inf. Model., 55, pp. 614-627; 
Li, T.F., Fan, H., Wang, Y.X., Aconitum-derived bulleyaconitine A exhibits antihypersensitivity through direct stimulating dynorphin A expression in spinal microglia (2016) J. Pain, 17, pp. 530-548; 
Li, T.F., Gong, N., Wang, Y.X., Ester hydrolysis differentially reduces aconitine-induced anti-hypersensitivity and acute neurotoxicity: involvement of spinal microglial dynorphin expression and implications for aconitum processing (2016) Front. Pharmacol., 7, p. 367; 
Li, W., Li, Y., Zhu, S., Ji, Q., Shu, Y., Zhang, L., Liu, J., Rosuvastatin attenuated the existing morphine tolerance in rats with L5 spinal nerve transection through inhibiting activation of astrocytes and phosphorylation of ERK42/44 (2015) Neurosci. Lett., 584, pp. 314-319; 
Li, X., Zhou, M., Xia, Q., Li, J., Parecoxib sodium reduces the need for opioids after tonsillectomy in children: a double-blind placebo-controlled randomized clinical trial (2016) Can. J. Anaesth., 63, pp. 268-274; 
Li, Y., Cazares, M., Wu, J., Houghten, R.A., Toll, L., Dooley, C., Potent mu-opioid receptor agonists from cyclic peptides Tyr-c [D-Lys-Xxx-Tyr-Gly]: synthesis, biological and structural evaluation (2016) J. Med. Chem., 59, pp. 1239-1245; 
Li, Y., Shu, Y., Ji, Q., Liu, J., He, X., Li, W., Attenuation of morphine analgesic tolerance by rosuvastatin in naïve and morphine tolerance rats (2015) Inflammation, 38, pp. 134-141; 
Liang, L., Zhao, J.Y., Gu, X., Wu, S., Mo, K., Xiong, M., Marie Lutz, B., Tao, Y.X., G8a inhibits CREB-triggered expression of mu opioid receptor in primary sensory neurons following peripheral nerve injury (2016) Mol. Pain, 12. , (1744806910082242); 
Liao, M.F., Yeh, S.R., Lo, A.L., Chao, P.K., Lee, Y.L., Hung, Y.H., Lu, K.T., Ro, L.S., An early granulocyte colony-stimulating factor treatment attenuates neuropathic pain through activation of mu opioid receptors on the injured nerve (2016) Sci. Rep., 6, p. 25490; 
Lilius, T.O., Jokinen, V., Neuvonen, M.S., Niemi, M., Kalso, E.A., Rauhala, P.V., Ketamine coadministration attenuates morphine tolerance and leads to increased brain concentrations of both drugs in the rat (2015) Br. J. Pharmacol., 172, pp. 2799-2813; 
Lima, L.B., Metzger, M., Furigo, I.C., Donato, J.H., Leptin receptor-positive and leptin receptor-negative proopiomelanocortin neurons innervate an identical set of brain structures (2016) Brain Res., 1646, pp. 366-376; 
Lin, C.K., Hung, C.C., Peng, C.Y., Chao, E., Lee, T.S., Factors associated with methadone treatment duration: a Cox regression analysis (2015) PLoS One, 10, p. e123687; 
Lin, C.P., Kang, K.H., Lin, T.H., Wu, M.Y., Liou, H.C., Chuang, W.J., Sun, W.Z., Fu, W.M., Role of spinal CXCL1 (GROalpha) in opioid tolerance: a human-to-rodent translational study (2015) Anesthesiology, 122, pp. 666-676; 
Lin, J.C., Chu, L.F., Stringer, E.A., Baker, K.S., Sayyid, Z.N., Sun, J., Campbell, K.A., Younger, J.W., One month of oral morphine decreases gray matter volume in the right amygdala of individuals with low back pain: confirmation of previously reported magnetic resonance imaging results (2016) Pain Med., 17, pp. 1497-1504; 
Lin, K.J., Ching, A., Edmonds, K.P., Roeland, E.J., Revta, C., Ma, J.D., Atayee, R.S., Variable patterns of continuous morphine infusions at end of life (2015) J. Palliat. Med., 18, pp. 786-789; 
Lin, X.J., Zhang, J.J., Yu, L.C., GluR2-3Y inhibits the acquisition and reinstatement of morphine-induced conditioned place preference in rats (2016) Neurosci. Bull., 32, pp. 177-182; 
Lin, Y.T., Kao, S.C., Day, Y.J., Chang, C.C., Chen, J.C., Altered nociception and morphine tolerance in neuropeptide FF receptor type 2 over-expressing mice (2016) Eur. J. Pain, 20, pp. 895-906; 
Linares, O.A., Fudin, J., Schiesser, W.E., Daly Linares, A.L., Boston, R.C., CYP2D6 phenotype-specific codeine population pharmacokinetics (2015) J. Pain Palliat. Care Pharmacother., 29, pp. 4-15; 
Lindley, E.M., Milligan, K., Farmer, R., Burger, E.L., Patel, V.V., Patient-controlled transdermal fentanyl versus intravenous morphine pump after spine surgery (2015) Orthopedics, 38, pp. e819-824; 
Lindqvist, A., Jonsson, S., Hammarlund-Udenaes, M., Exploring factors causing low penetration of the opioid peptide DAMGO through experimental modthods and modeling (2016) Mol. Pharm., 13, pp. 1258-1266; 
Lindqvist, A., Rip, J., vaqn Kreglen, J., Gaillard, P.J., Hammarlund-Udenaes, M., In vivo functional evaluation of increased brain delivery of the opioid peptide DAMGO by gluthione-PEGlycated liposomes (2016) Pharm. Res., 33, pp. 177-185; 
Lingford-Hughes, A., Myers, J., Watson, B., Reid, A.G., Kalk, N., Feeney, A., Hammers, A., Nutt, D.J., Using [(11)C]Ro15 4513 PET to characterize GABA-benzodiazepine receptors in opiate addiction: similarities and differences with alcoholism (2016) Neuroimage, 132, pp. 1-7; 
Link, A., Muller, C.E., G-protein-coupled receptors: sustained signaling via intracellular megaplexes and pathway-specific drugs (2016) Angew. Chem. Int. Ed. Engl., 55, pp. 15962-15964; 
Listos, J., Baranowska-Boslacka, I., Wasik, A., Talarek, S., Tarnowski, M., Listos, P., Lupina, M., Fidecka, S., The adenosinergic system is involved in sensitization to morphine withdrawal signs in rats- neurochemical and molecular basis in dopaminergic system (2016) Psychopharmacology (Berl.), 233, pp. 2383-2397; 
Listos, J., Talarek, S., Listos, P., Orzelska, J., Lupina, M., Fidecka, S., Effects of the adenosinergic system on the expression and acquisition of sensitization to conditioned place preference in morphine-conditioned rats (2016) Naunyn. Schmiedebergs Arch. Pharmacol., 389, pp. 233-241; 
Liu, C., Fang, X., Wu, Q., Jin, G., Zhen, X., Prefrontal cortex gates acute morphine action on dopamine neurons in the ventral tegmental area (2015) Neuropharmacology, 95, pp. 299-308; 
Liu, D.S., Guan, F., Wang, B., Zhang, T., Combined usage with intraperitoneal and incisional ropivacaine reduces pain severity after laparoscopic cholecystectomy (2015) Int. J. Clin. Exp. Med., 8, pp. 22460-22468; 
Liu, F.Y., Zhang, M.M., Zeng, P., Liu, W.W., Wang, J.L., Dai, Q., Wei, J., Study on the molecular mechanism of antinociception induced by ghrelin in acute pain in mice (2016) Peptides, 83, pp. 1-7; 
Liu, H., Chen, B., Li, S., Yao, J., Dose-dependent neuroprotection of delta-opioid peptide [D-Ala(2), D-Leu(5)] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into the abdominal aorta in rabbits (2016) J. Vasc. Surg., 63, pp. 1074-1081; 
Liu, H., Tian, Y., Ji, B., Lu, H., Xin, Q., Jiang, Y., Ding, L., Bai, B., Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel beta-arrestin-2-biased pathway (2016) Biochim. Biophys. Acta, 1863, pp. 2719-2738; 
Liu, H.C., Lee, H.T., Hsu, Y.C., Huang, M.H., Liu, R.H., Chen, T.J., Lin, D.L., Direct injection LC–MS–MS analysis of opiates, methamphetamine, buprenorphine, methadone and their metabolites in oral fluid from substitution therapy patients (2015) J. Anal. Toxicol., 39, pp. 472-480; 
Liu, Y., Li, D., Liu, Z., Zhou, Y., Chu, D., Li, X., Jiang, X., Zhang, C.Y., Targeted exosome-mediated delivery of opioid receptor mu siRNA for the treatment of morphine relapse (2015) Sci. Rep., 5, p. 17543; 
Liu, Y., Wang, X.J., Wang, N., Cui, C.L., Wu, L.Z., Electroacupuncture analgesia ameliorates propofol-induced cognitive impairment via an opioid receptor-independent mechanism (2016) Am. J. Chin. Med., 44, pp. 705-719; 
Liu, Z., Wang, L., Zhou, Z., Sun, Y., Wang, M., Wang, H., Hou, Z., Song, L., The simple neuroendocrine-immune regulatory network in the oyster Crassostrea gigas mediates complex functions (2016) Sci. Rep., 6, p. 26396; 
Lojanapiwat, B., Chureemas, T., Kittrattarakarn, P., The efficacy of peritubal analgesic infiltration in postoperative pain following percutaneous nephrolithotomy – a prospective randomized controlled study (2015) Int. Braz. J. Urol., 41, pp. 945-952; 
Lopez, J.A., Bedenbaugh, M.N., McCosh, R.B., Weems, P.W., Meadows, L.J., Wisman, B., Coolen, L.M., Hileman, S.M., Does dynorphin play a role in the onset of puberty in female sheep? (2016) J. Neuroendocrinol., 28, p. 12445; 
Lopez, W.O., Kluge Schroeder, H., I Santana Neville, Jacobsen Teixeira, M., Costa Barbosa, D., Assumpcao de Monaco, B., Talamoni Fonoff, E., Intrathecal morphine therapy in the management of status dystonicus in neurodegeneration brain iron accumulation type 1 (2015) Pediatr. Neurosurg., 50, pp. 94-98; 
Lorenzutti, A.M., Martin-Flores, M., Litterio, N.J., Himelfarb, M.A., Zarazaga, M.P., Evaluation of the antiemetic efficacy of maropitant in dogs medicated with morphine and acepromazine (2016) Vet. Anaesth. Analg., 43, pp. 195-198; 
Lu, X.H., Ran, K., Xiao, Y.Y., Yang, D.L., Chang, Y.T., Duan, K.M., Ou, Y.W., Protective effects of morphine preconditioning in delayed phase on myocardial ischemia-reperfusion injury in rabbits (2015) Enet. Mol. Res., 14, pp. 647-6954; 
Lufty, K., Parikh, D., Lee, D.L., Liu, Y., Ferrini, M.G., Hamid, A., Friedman, T.C., Prohormone convertase 2 (PC2) null mice have increased mu-opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence (2016) Neuroscience, 329, pp. 318-325; 
Luna, S.P., Martino, I.D., Lorena, S.E., Capua, M.L., Lima, A.F., Santos, B.P., Brondani, J.T., Vesce, G., Acupuncture and pharmacopuncture are as effective as morphine or carprofen for postoperative analgesia in bitches undergoing oviariohysterectomy (2015) Acta Cir. Bras., 30, pp. 831-837; 
Lunger, F., Vehmas, A.P., Furnrohr, B.G., Sopper, S., Wildt, L., Seeber, B., Opiate receptor blockade on human granulosa cells inhibits VEGF release (2016) Reprod. Biomed. Online, 32, pp. 316-322; 
Lunn, T.H., Husted, H., Laursen, M.B., Hansen, L.T., Kehlet, H., Analgesic and sedative effects of perioperative gabapentin in total knee arthroplasty: a randomized, double-blind, placebo-controlled dose-finding study (2015) Pain, 156, pp. 2438-2448; 
Lunn, T.H., Frokjaer, V.G., Hansen, T.B., Kristensen, P.W., Lind, T., Kehlet, H., Analgesic effect of perioperative escitalopram in high pain catastrophizing patients after total knee arthroplasty: a randomized, double-blind, placebo-controlled trial (2015) Anesthesiology, 122, pp. 884-894; 
Ma, F., Wang, C., Yoder, W.E., Westlund, K.N., Carlson, C.R., Miller, C.S., Danaher, R.J., Efficacy of herpes simplex virus vector encoding the human proenkephalin gene for the treatment of facial pain in mice (2016) J. Oral Facial Pain Headache, 30, pp. 42-50; 
Ma, S., Li, X.Y., Gong, N., Wang, Y.X., Contributions of spinal D-amino oxidase to chronic morphine-induced hyperalgesia (2015) J. Pharm. Biomed. Anal., 116, pp. 131-138; 
Macedo, C.G., Fanton, L.E., Fischer, L., Tambeli, C.H., Coactivation of mu and kappa-opioid receptors may mediate the protective effect of testosterone on the development of temporomandibular joint nociception in male rats (2016) J. Oral Facial Pain Headache, 30, pp. 61-67; 
Macedo, C.G., Napimoga, M.H., Rocha-Neto, L.M., Abdalla, H.B., Clemente-Mapimoga, J.T., The role of endogenous opioid peptides in the antinociceptive effect of 15-deoxy(delta12, 14)-prostaglandin J2 in the temporomandibular joint (2016) Prostaglandins Leukot. Essent. Fatty Acids, 110, pp. 27-34; 
Machoki, M.S., Millar, A.J., Albetyn, H., Cox, S.Q., Thomas, J., Numanoglu, A., Local anesthetic wound infusion versus standard analgesia in pediatric post-operative pain control (2015) Pediatr. Surg. Int., 31, pp. 1087-1097; 
Maciejczyk, M., Lasota, A., Fraczak, O., Kosson, P., Misicka, A., Nowakowski, M., Ejchart, A., Olma, A., The impact of beta-azido(or 1-piperidinyl)methylamino acids in position 2 or 3 on biological activity and confirmation of dermorphin analogues (2016) J. Pept. Sci., 22, pp. 545-551; 
Mackeen, A.D., Khalifeh, A., Fleischer, J., Han, C., Leiby, B., Berghella, V., Pain associated with cesarean delivery skin closure: a randomized controlled trial (2015) Obstet. Gynecol., 126, pp. 702-707; 
Madani, S., Oudilou, E., Exbrayat, J.M., Hammouche, S., 17-beta-estradiol effect on testicular beta-endorphin expression in Psammomys obesus (2016) Folia Histochem. Cytobiol., 54, pp. 108-117; 
Maguire, D.R., France, C.P., Additive antinociceptive effects of mixtures of the kappa-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats (2016) Behav. Pharmacol., 27, pp. 69-72; 
Mahmoud, S., Farraq, M., Ruiz-Velasco, V., G-gamma-7 proteins contribute to coupling of nociception/orphanin FQ peptide (NOP) opioid receptors and voltage-gated Ca(2+) channels in rat stellate ganglion neurons (2016) Neurosci. Lett., 627, pp. 77-83; 
Mahran, E., Hassan, M.E., Comparison of pregabalin versus ketamine in postoperative pain management in breast cancer surgery (2015) Saudi. J. Anaesth., 9, pp. 253-257; 
Maioli, N.A., Zarpelon, A.C., Mizokami, S.S., Calixto-Campos, C., Guazelli, C.F., Hohmann, M.S., Pinho-Ribeiro, F.A., Verri, W.A., Jr., The superoxide anion donor, potassium superoxide, induces pain and inflammation in mice through production of reactive oxygen species and cyclooxygenase-2 (2015) Braz. J. Med. Biol. Res., 48, p. 321331; 
Maire, J.J., Close, L.N., Heinricher, M.M., Selden, N.R., Distinct pathways for norepinephrine- and opioid-triggered antinociception from the amygdala (2016) Eur. J. Pain, 20, pp. 206-214; 
Majidi, A., Dinpanah, H., Ashoori, S., Motamed, H., Tabatabaev, A., Comparison of morphine-midazolam versus morphine injection for pain relief in patients with limb fractures – a clinical trial (2015) Ulus Travma Acil Cerrahi Derg, 21, pp. 22-26; 
Mak, P., Broadbear, J.H., Kolosov, A., Goodchild, C.S., Long-term antihyperalgesic and opioid-sparing effects of a 5-day ketamine and morphine infusion (‘burst ketamine’) in diabetic neuropathic rats (2015) Pain Med., 16, pp. 1781-1793; 
Mamaliglas, A.A., Cai, Y., Ford, C.P., Nicotinic and opioid receptor regulation of striatal dopamine D2-receptor mediated transmission (2016) Sci. Rep., 6, p. 37834; 
Mambretti, E.M., Kistner, K., Mayer, S., Massotte, D., Kieffer, B.L., Hoffman, C., Reeh, P.W., Rittner, H.L., Functional and structural characterization of axonal opioid receptors as targets for analgesia (2016) Mol. Pain, 12. , 1744806916628734; 
Manduca, A., Lassalle Sepers, O.M., Campolongo, P., Cuomo, V., Marsicano, G., Kieffer, B., Vanderschuren, L.J., Manzoni, O.J., Interacting cannabinoid and opioid receptors in the nucleus accumbens core control adolescent social play (2016) Front. Behav. Neurosci., 10, p. 211; 
Manglik, A., Lin, H., Aryal, D.K., McCorvy, J.D., Dengler, D., Corder, G., Levit, A., Shoichet, B.K., Structure-based discovery of aopioid analgesics with reduced side effects (2016) Nature, 537, pp. 185-190; 
Manjoch, H., Vainer Em Matar, M., Ifergane, G., Zonar, J., Kaplan, Z., Cohen, H., Predator-scent stress, ethanol consumption and the opioid system in an animal model of PTSD (2016) Behav. Brain Res., 306, pp. 91-105; 
Maraschin, J.C., Rangel, M.P., Bonfim, A.J., Kitayama, M., Graeff, F.G., Zangrossi, H., Jr, Audi, E.A., Opiorphin causes a panicolytic-like effect in rat panic models mediated by mu-opioid receptors in the dorsal periaqueductal gray (2016) Neuropharmacology, 101, pp. 264-270; 
Marchant, N.J., Campbell, E.J., Whitaker, L.R., Harvey, B.K., Kaganovsky, K., Adhikary, S., Hope, B.T., Shaham, Y., Role of ventral subiculum in context-induced relapse to alcohol seeking after punishment-imposed abstinence (2016) J. Neurosci., 38, pp. 3281-3294; 
Marcus, D.J., Zee, M., Hughes, A., Yuill, M.B., Hohmann, A.G., Mackie, K., Guindon, J., Morgan, D.J., Tolerance to the antinociceptive effects of chronic morphine requires C-Jun N-terminal kinase (2015) Mol. Pain, 11, p. 34; 
Margolis, E.B., Fields, H.L., Mu opioid receptor actions in the lateral habenula (2016) PLoS One, 11, p. e01599097; 
Marino, K.A., Prada-Gracia, D., Provasi, D., Filizola, M., Impact of lipid composition and receptor conformation on the spatio-temporal organization of mu-opioid receptors in a multi-component plasma membrane model (2016) PLoS Comput. Biol., 12, p. e1005240; 
Marks, K.R., Lile, J.A., Stoops, W.W., Glaser, P.E., Hays, L.R., Rush, C.R., Separate and combined effects of naltrexone and extended-release alprazolam on the reinforcing, subject-rated and cardiovascular effects of methamphetamine (2016) J. Clin. Psychpharmacol., 36, pp. 213-221; 
Marrone, G.F., Grinnell, S.G., Lu, Z., Rossi, G.C., Le Rouzic, V., Xu, J., Majumdar, S., Pasternak, G.W., Truncated mu opioid GCPR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS (2016) Proc. Natl. Acad. Sci. U. S. A., 113, pp. 3663-3668; 
Marrone, G.F., Lu, Z., Rossi, G., Narayan, A., Hunkele, A., Marx, S., Xu, J., Pasternak, G.W., Tetrapeptide endomorphin A analogs require both full length and truncated splice variants of the mu opioid receptor gene Oprm1 for analgesia (2016) ACS Chem. Neurosci., 7, pp. 1717-1727; 
Marschell, U., L'hoest, H., Radbruch, L., Hauser, W., Long-term opioid therapy for chronic non-cancer pain in Germany (2016) Eur. J. Pain, 20, pp. 767-776; 
Martinez, V., Ucelever, N., Ben Ammar, S., Alvarez, J.C., Gaudot, F., Sommer, C., Bouhassira, D., Fletcher, D., Clinical, histological and biochemical predictors of postsurgical neuropathic pain (2015) Pain, 156, pp. 2390-2398; 
Martini, C., van Velzen, M., Drewes, A., Aarts, L., Dahan, A., Niesters, M., A randomized controlled trial on the effect of tapentadol and morphine on conditioned pain modulation in healthy volunteers (2015) PLoS One, 10, p. e128997; 
Martins, R.T., Currow, D.C., Abernethy, A.P., Johnson, M.J., Toson, B., Eckert, D.J., Effects of low-dose morphine on perceived sleep quality in patients with refractory breathlessness: a hypothesis generating study (2016) Respirology, 21, pp. 386-391; 
Maskell, P.D., Albeishy, M., De Paoli, G., Wilson, N.E., Seetohul, L.N., Postmortem redistribution of the heroin metabolites morphine and morphine-3-glucoronide in rabbits over 24 h (2016) Int. J. Legal Med., 130, pp. 519-531; 
Maskevar, R.R., El-Hage, N., Hauser, K.F., Knapp, P.E., GSK3beta-activation is a point of convergence for HIV-1 and opiate-mediated interactive neurotoxicity (2015) Mol. Cell. Neurosci., 65, pp. 11-20; 
Mosocha, W., Gonzalez, L.G., Agil, A., Distinguishing subgroups among mu-opioid receptor agonists using Na(+), K(+)-ATPase as an effector mechanism (2016) Eur. J. Pharmacol., 774, pp. 43-49; 
Mateo-Carrasco, H., Munoz-Aguilera, E.M., Garcia-Torrecillas, J.M., Abu Al-Robb, H., Serotonin syndrome probably triggered by a morphine-phenelzine interaction (2015) Pharmacotherapy, 35, pp. e102-e105; 
Matsue, Y., Ter Maaten, J.M., Struck, J., Metra, M., O'Connor, C.M., Ponikowski, P., Teerlink, J.R., Voors, A.A., Clinical correlates and prognostic value of proenkephalin in acute and chronic heart failure (2016) J. Card. Fail., 23, pp. 231-239; 
Matsumoto, K., Umemoto, H., Mori, T., Akatsu, R., Saito, S., Tashima, K., Shibasaki, M., Horie, S., Differences in the morphine-induced inhibition of small and large intestinal transit: involvement of central and peripheral mu-opioid receptors in mice (2016) Eur. J. Pharmacol., 771, pp. 220-228; 
Matsushima, A., Nishimura, H., Matsuyama, Y., Liu, X., Costa, T., Shimohigashi, Y., Specific affinity-labeling of the nociceptin ORL1 receptor using a thiol-activated Cys (Npys)-containing peptide ligand (2016) Biopolymers, 106, pp. 460-469; 
Matsuura, W., Kageyama, E., Harada, S., Tokuyama, S., Unique action mechanism of tramadol in global cerebral ischemia-induced mechanical allodynia (2016) Neuroreport, 27, pp. 699-704; 
Mazid, S., Hall, B.S., Odell, S.C., Stafford, K., Dyer, A.D., Van Kempen, T.A., Selegean, J., Milner, T.A., Sex differences in subcellular distribution of delta opioid receptors in the rat hippocampus in response to acute and chronic stress (2016) Neurobiol. Stress, 5, pp. 37-53; 
McAdams, R.M., McPherson, R.J., Beyer, R.P., Bammler, T.K., Fann, F.M., Juul, S.E., Dose-dependent effects of morphine exposure and microRNA (miR) in hippocampus of stressed neonatal mice (2015) PLoS One, 10, p. e0123047; 
McCormick, Z.L., Marshall, B., Walker, J., McCarthy, R., Walega, D.R., Long-term function, pain and medication use outcomes of radiofrequency ablation for lumbar facet syndrome (2015) Int. J. Anesth. Anesth., 2. , (pii 028); 
McGonigle, C.E., Nentwig, T.B., Wilson, D.E., Rhinehart, E.M., Grisel, J.E., Beta-endorphin regulates alcohol consumption induced by exercise restriction in female mice (2016) Alcohol, 53, pp. 51-60; 
McMillan, D.M., Tyndale, R.F., Nicotine increases codeine analgesia through the induction of brain CYP2D and central activation of codeine to morphine (2015) Neuropsychopharmacology, 40, pp. 1804-1812; 
Mehdipour, S., Alaei, H.A., Pilehvarivan, A.A., The effect of medial prefrontal cortex electrical stimulation on passive avoidance memory in healthy and addict rats (2015) Adv. Biomed. Res., 4, p. 254; 
Mehrzadi, S., Shojaii, A., Pur, S.A., Motevalian, M., Anticonvulsant activity of hydroalcoholic extract of Citrullus colocynthis fruit: involvement of benzodiazepine and opioid receptors (2016) J. Evid. Based Complement. Altern. Med., 21. , (NP31-35); 
Mei, F., Mayoral, S.R., Nobuta, H., Wang, F., Desponts, C., Lorrain, D.S., Xiao, L., Chan, J.R., Identification of the kappa-opioid receptor as a therapeutic target for oligodendrocyte remyelination (2016) J. Neurosci., 36, pp. 7925-7935; 
Meirsman, A.C., Le Merrer, J., Pellissier, L.P., Diaz, J., Clesse, D., Kieffer, B.L., Becker, J.A., Mice lacking GPR88 show motor deficit, improved spatial learning and low anxiety recersed by delta opioid antagonist (2016) Biol. Psychiatr., 79, pp. 917-927; 
Melkes, B., Hejnova, L., Novotny, J., Biased mu-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins (2016) Naunyn. Schmiedebergs Arch. Pharmacol., 389, pp. 1289-1300; 
Mellbye, A., Karlstad, O., Skurtveit, S., Borchgrevink, P.C., Fredheim, C.M., The duration and course of opioid therapy in patients with chronic non-malignant pain (2016) Acta Anaesthsiol. Scand., 60, pp. 128-137; 
Mendes, I.A., Maidment, N.T., Murphy, N.P., Parsing the hedonic and motivational influences of nociception on feeding using licking microstructure analysis in mice (2016) Behav. Pharmacol., 27, pp. 516-527; 
Mennini, N., Mura, P., Nalivi, C., Richichi, B., Di Cesare Mannelli, L., Ghelardini, C., Injectable liposomal formulations of dynorphin as a new therapeutic strategy in pain management (2015) Future Sci. OA, 1. , (FSO2); 
Mercadante, S., Adile, C., Cuomo, A., Aielli, F., Cortegiani, A., Casuccio, A., Porzio, G., Fentanyl buccal tablet vs oral morphine in doses proportional to the basal opioid regimen for the management of breakthrough cancer pain: a randomized, crossover, comparison study (2015) J. Pain Symptom Manage., 50, pp. 579-586; 
Mick, I., Myers, J., Ramos, A.C., Stokes, P.R., Erritzoe, D., Colasanti, A., Gunn, R.N., Lingford-Hughes, A.R., Blunted endogenous opioid release following an oral amphetamine challenge in pathological gamblers (2016) Neuropsychopharmacology, 41, pp. 1742-1750; 
Miller, J.P., Schauer, S.G., Ganem, V.J., Bebarta, V.S., Low-dose ketamine vs morphine for acute pain in the ED: a randomized controlled trial (2015) Am. J. Emerg. Med., 33, pp. 402-408; 
Miller, L.L., Altarifi, A.A., Negus, S.S., Effects of repeated morphine on intracranial self-stimulation in male rats in the presence or absence of a noxious pain stimulus (2015) Exp. Clin. Psychopharmacol., 23, pp. 405-414; 
Millington, W.R., Yilmaz, M.S., Feleder, C., The initial fall in arterial pressure evoked by endotoxin is mediated by the ventrolateral periaqueductal gray (2016) Clin. Exp. Pharmacol. Physiol., 43, pp. 612-615; 
Mills, H., Ortega, A., Law, W., Hapiak, V., Summers, P., Clark, T., Komuniecki, R., Opiates modulate noxious chemical nociception through a complex monoaminergic/peptidergic cascade (2016) J. Neurosci., 36, pp. 5498-5508; 
Milne, M., Ashton, J.C., Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord (2016) Neurosci. Lett., 614, pp. 39-42; 
Minoshima, R., Kosugi, S., Nishimura, D., Ihara, N., Seki, H., Yamada, T., Watanabe, K., Morisaki, H., Intra- and postoperative low-dose ketamine for adolescent idiopathic scoliosis surgery: a randomized controlled trial (2015) Acta Anaesthesiol. Scand., 59, pp. 1260-1268; 
Miranda-Morales, R.S., Pautassi, R.M., Pharmacological characterization of the nociception/orphanin FQ receptor on ethanol-mediated motivational effects in infant and adolescent rats (2016) Behav. Brain Res., 298, pp. 88-96; 
Mireskandari, S.M., Pestei, K., Hajipour, A., Jafarzadeh, A., Samadi, S., Nabaviari, O., Effects of preoperative magnesium sulphate on post-cesarean pain, a placebo controlled double blind study (2015) J. Family Reprod. Health, 9, pp. 29-33; 
Mitchell, A., McGhie, J., Owen, M., McGinn, G., Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period (2015) Palliat. Med., 29, pp. 554-563; 
Mithbaokar, P., Fiorito, F., Della Morte, R., Maharajan, V., Costagliola, A., Chronic maternal morphine alters calbindin D-28k expression pattern in postnatal mouse brain (2016) Synapse, 70, pp. 15-23; 
Mittelman-Smith, M.A., Krajewski-Hall, S.J., McMullen, N.T., Rance, N.E., Ablation of KNDy neurons results in hypogonadotropic hypogonadism and amplifies the steroid-induced LH surge in female rats (2016) Endocrinol, 157, pp. 2015-2027; 
Mohamed, S.J., Kristensen, B.B., Lindgaard, L., Bisgard, T., Acceptable effect of multimodal analgesic treatment after a Bascom cleft lift operation (2015) Dan. Med. J., 62, p. A4985; 
Mohammadi, R., Jahanshahi, M., Jameie, S.B., 5HT2A serotonin receptor density in male rats’ hippocampus after morphine-based conditioned place preference (2016) Basic Clin. Neurosci., 7, pp. 249-258; 
Mohta, M., Kalra, B., Sethi, A.K., Kaur, N., Efficacy of dexmedetomidine as an adjuvant in paravertebral block in breast cancer surgery (2016) J. Anesth., 30, pp. 252-260; 
Molaei, M., Fatahi, Z., Zaringhalam, J., Haghparast, A., CB1 cannabinoid agonist (WIN55, 212-2) within the basolateral amygdala induces sensitization to morphine and increased the level of mu-opioid receptors and c-fos in the nucleus (2016) J. Mol. Neurosci., 58, pp. 446-455; 
Moller, J., Laflamme, L., Soderberg Lofdal, K., CYP2D6-inhibitng drugs and the increased risk of fall-related injuries due to newly initiated opioid treatment - a Swedish, register-based case-crossover study (2015) Basic Clin. Pharmacol. Toxicol., 116, pp. 134-139; 
Molnar, C., Simon, E., Kazup, A., Gal, J., Molnar, L., Novak, L., Bereczki, D., Fulesdi, B., A single preoperative dose of diclofenac reduces the intensity of acute postcraniotomy headache and decreases analgesic requirements over five postoperative days in adults: a single center, randomized blinded trial (2015) J. Neurol. Sci., 353, pp. 70-73; 
Molnar, C.S., Sarvari, M., Vastagh, C., Maurnyi, C., Fekete, C., Liposits, Z., Hrabowsky, E., Altered gene expression profiles of the hypothalamic arcuate nucleus of male mice suggest profound developmental changes in peptidergic signaling (2016) Neuroendocrinology, 103, pp. 269-382; 
Mongi-Bragato, B., Zamponi, E., Garcia-Keller, C., Assis, M.A., Vigolini, M.B., Masco, D.H., Zimmer, A., Cancela, L.M., Enkephalin is essential for the molecular and behavioral expression of cocaine sensitization (2016) Addict. Biol., 21, pp. 326-336; 
Monibi, F.A., Dodam, J.R., Axiak-Bechtel, S.M., Amorim, J., Zhang, Y., Tsuruta, K., Mann, F.A., DeClue, A.E., Morphine and buprenorphine do not alter leukocyte cytokine production capacity, early apoptosis or neutrophil phagocytic function in healthy dogs (2015) Res. Vet. Sci., 99, pp. 70-76; 
Moninuzzaman, M., Hossain, M.S., Bhattacharjee, P.S., Evaluation of antinociceptive activity of the methanolic extract of leaves of Stephania japonica Lin (2016) J. Ethnopharmacol., 186, pp. 205-208; 
Montandon, G., Ren, J., Victoria, N.C., Liu, H., Wickman, K., Greer, J.J., Homer, R.L., G-protein inwardly rectifying potassium channels modulate respiratory depression by opioids (2016) Anesthesiol, 124, pp. 641-650; 
Monteiro, E.R., Coelho, K., Bressen, T.F., Simoes, C.R., Monteiro, B.S., Effects of acepromazine-morphine and acepromazine-methadone premedication on the minimum alveolar concentration of isoflurane in dogs (2016) Vet. Anaesth. Analg., 43, pp. 27-34; 
Moon, S.W., Park, E.H., Suh, H.R., Ko, D.H., Kim, Y.I., Han, H.C., The contribution of activated peripheral kappa opioid receptors (KORs) in the inflamed knee joint to anti-nociception (2016) Brain Res., 1648, pp. 11-18; 
Moore, K., Madularu, D., Iriah, S., Yee, J.R., Kulkarni, P., Daroq, E., Kieffer, B.L., Ferris, C.F., BOLD imaging in awake wild-type and mu-opioid receptor knock-out mice reveals on-target activation maps in response to oxycocdone (2016) Front. Neurosci., 10, p. 471; 
Moradi, M., Mahmoodi, M., Raoofi, A., HGhanbari, A., Chorionic morphine, naltrexone and pentoxifylline effect on hypophyso-gonadal hormones of male rats (2015) Bratsl Lek Listy, 116, pp. 276-279; 
Morisot, N., Contarino, A., The CRF1 and the CRF2 receptor mediate recognition memory deficits and vulnerability induced by opioid withdrawal (2016) Neuropharmacology, 105, pp. 500-507; 
Morteza-Bagi, H.R., Amjadi, M., Mirzali-Sousefidi, R., The comparison of apotel plus low dose of morphine and full dose of morphine in pain relief in patients with acute renal colic (2015) Addict Health, 7, pp. 66-73; 
Morton, R.A., Baptista-Hon, D.T., Hales, T.G., Lovinger, D.M., Agonist- and antagonist-induced up-regulation of surface 5-HT3A receptors (2015) Br. J. Pharmacol., 172, pp. 4066-4077; 
Motaghineiad, M., Motaghineiad, O., Hosseini, P., Attenuation of morphine physical dependence and blood levels of cortisol by central and systemic administration of ramelteon in rat (2015) Iran. J. Med. Sci., 40, pp. 240-247; 
Motamed, C., Bourgain, J.L., Postoperative nausea and vomiting in the post-anesthetic care unit, a 5 year survey of a quality assurance program in surgical cancer patients (2015) Bull. Cancer, 102, pp. 405-410; 
Motov, S., Rockoff, B., Cohen, V., Pushkar, J., Likourezos, A., McKay, C., Soleyman-Zomalan, E., Fromm, C., Intravenous subdissociative-dose ketamine versus morphine for analgesia in the emergency department: a randomized controlled trial (2015) Ann. Emerg. Med., 66, pp. 222-229; 
Mousa, S.A., Shaqura, M., Winkler, J., Khalefa, B.L., Al-Madol, M.A., Shakibaei, M., Schulz, S., Schafer, M., Protein kinase C-mediated mu-opioid receptor phosphorylation and desensitization in rats, and its prevention during early diabetes (2016) Pain, 157, pp. 910-921; 
Mudgal, A., Kumar, K., Mollereau, C., Pasha, S., NPYFa, a chimeric peptide of met-enkephalin and NPFF induces tolerance-free analgesia (2016) Chem. Biol. Drug Des., 87, pp. 885-894; 
Muelbi, M.J., Nawarawong, N.N., Clancy, P.T., Nettesheim, C.E., Lim, Y.W., Olsen, C.M., Responses to drugs of abuse and non-drug rewards in leptin deficient ob/ob mice (2016) Psychopharmacology (Berl.), 233, pp. 2799-2811; 
Muhly, W.T., Gurnaney, H.G., Kraemer, F.W., Ganesh, A., Maxwell, L.G., A retrospective comparison of ropivacine and 2-chloroprocaine continuous thoracic epidural analgesia for the management of postthoracotomy pain in infants (2015) Paediatr. Anaesth., 25, pp. 1162-1167; 
Mukae, T., Uchida, H., Ueda, H., Donepezil reverses intermittent stress-induced generalized chronic pain syndrome in mice (2015) J. Pharmacol. Exp. Ther., 353, pp. 471-479; 
Mukherjee, A., Haldar, C., Effect of naltrexone on photoperiodic regulation of testicular steroidogenesis in adult golden hamsters, Mesocricetus auratus (2016) Gen. Comp. Endocrinol., 239, pp. 89-96; 
Mukhomedzyanov, A.V., Maslov, L.N., Tsibulnikov, S.Y., Pei, J.M., Endomorphins and beta-endorphin do not affect heart tolerance to the pathogenic effect of reperfusion (2016) Bull. Exp. Biol. Med., 162, pp. 23-26; 
Murai, N., Sekizawa, T., Gotoh, T., Watabiki, T., Takahashi, M., Kakimoto, S., Takahashi, Y., Nagakura, Y., Spontaneous and evoked pain-associated behaviors in a rat model of neuropathic pain respond differently to drugs with different mechanisms of action (2016) Pharmacol. Biochem. Behav., 141, pp. 10-17; 
Murakawa, H., Iwata, K., Takeshita, T., Ozawa, H., Immunoelectron microscopic observation of the subcellular localization of kisspeptin, neurokinin B and dynorphin A in KNDy neurons in the arcuate nucleus of the female rat (2016) Neurosci. Lett., 612, pp. 161-166; 
Murphy, G.S., Szokol, J.W., Avram, M.J., Greenberg, S.B., Marymont, J.H., Shear, T., Parikh, K.N., Gupta, D.K., Intraoperative methadone for the prevention of postoperative pain: a randomized, double-blinded clinical trial in a cardiac surgical pateient (2015) Anesth, 122, pp. 1112-1122; 
Naganawa, M., Dickinson, G.L., Zheng, M.Q., Henry, S., Vandenhende, F., Witcher, J., Bell, R., Carson, R.E., Receptor occupancy of the kappa-opioid receptor antagonist LY2456302 measured with positron emission tomography and the novel radiotracer 11C-LY2795050 (2016) J. Pharmacol. Exp. Ther., 356, pp. 260-266; 
Nakao, K., Hirakata, M., Miyamoto, Y., Kainoh, M., Wakasa, Y., Yanagita, T., Nalfurafine hydrochloride, a selective kappa receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys (2016) J. Pharmacol. Sci., 130, pp. 8-14; 
Nakasone, T., Sugimoto, Y., Kamei, C., The interaction between histamine H1 receptor and mu-opioid receptor in scratching behavior in ICR mice (2016) Eur. J. Pharmacol., 777, pp. 124-128; 
Narayanswamy, S., Prague, J.K., Jayasena, C.N., Papadopoulou, D.A., Mizamtsidi, M., Shah, A.J., Bassett, P., Dhillo, W.S., Investigating the KNDy hypothesis in humans by coadministration of kisspeptin, neurokinin B and naltrexone in men (2016) J. Clin. Endocrinol. Metab., 101, pp. 3429-3436; 
Nasr, D.A., Abdelhamid, H.M., Mohsen, M., Aly, A.H., The analgesic efficacy of continuous presternal bupivacaine infusion through a single catheter after cardiac surgery (2015) Ann. Card. Anaesth., 18, pp. 15-20; 
Nayeri, F., Sheikh, M., Kalani, M., Niknafs, P., Shariat, M., Dalilli, H., Dehpour, A.R., Phenobarbital versus morphine in the management of neonatal abstinence syndrome: a randomized controlled trial (2015) BMC Pediatr., 15, p. 57; 
Neelakantan, H., Ward, S.J., Walker, E.A., Discriminative stimulus effects of morphine and oxycodone in the absence and presence of acetic acid in male and female C57Bl/6 mice (2015) Exp. Clin. Pharmacol., 23, pp. 217-227; 
Nelson, E.C., Agrawal, A., Heath, A.C., Bogdan, R., Sherva, R., Zhang, B., Al-Hasani, R., Montgomery, G.W., Evidence of CNIH3 involvement in opioid dependence (2016) Mol. Psychiatr., 21, pp. 608-614; 
Nenke, M.A., Havlock, C.L., Rankin, W., Inder, W.J., Gagliardi, L., Eldridge, C., Rolan, P., Torpy, D.J., Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized placebo-controlled tiral (2015) Psychoneuroendocrinology, 56, pp. 157-167; 
Nespovitaya, N., Gath, J., Barylyuk, K., Seuring, C., Meier, B.H., Riek, R., Dynamic assembly and disassembly of functional beta-endorphin amyloid fibrils (2016) J. Am. Chem. Soc., 138, pp. 846-856; 
Nestor, L.J., Murphy, A., McGonigle, J., Orban, C., Reed, L., Taylor, E., Flechais, R., Robbins, T.W., Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and non-alcoholic polysubstance-dependent populations during a monetary incentive delay task (2016) Addict. Biol., 10, p. 12484; 
Nielsen, L.M., Olesen, A.E., Sato, H., Christup, L.L., Drewes, A.M., Association between gene polymorphisms and pain sensitivity assessed in a multi-modal multi-tissue human experimental model – an explorative study (2016) Basic Clin. Pharmacol. Toxicol., 119, pp. 360-366; 
Nielsen, R.V., Siegel, H., Fomsgaard, J.S., Andersen, J.D., Martusevicius, R., Mathiesen, O., Dahl, J.B., Preoperative dexamethasone reduces acute but not sustained pain after lumbar disk surgery: a randomized, blinded, placebo-controlled tiral (2015) Pain, 156, pp. 2638-2644; 
Nielsen, S., Roxburgh, A., Bruno, R., Lintzeris, N., Jefferson, A., Deenhardt, L., Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroinfrom 2002 to 2011 (2015) Drug Alcohol Depend., 149, pp. 212-219; 
Nilsson, M., Brock, C., Poulsen, J.L., Bindslev, N., Hansen, M.B., Louring Christup, L., Drewes, A.M., Short-term oxycodone treatment does not affect electrogenic ion transport in isolated mucosa from the human rectosigmoid colon (2016) Scand. J. Gastroenterol., 51, pp. 538-547; 
Nishiyama, D., Sakai, Y., Sekiguchi, H., Chiba, H., Misu, R., Oishi, S., Fujii, N., Ohno, H., Novel 3,4,7-substituted benzofuran derivatives having binding affinity to kappa-opioid receptor (2016) Chem. Pharm. Bull. (Tokyo), 64L, pp. 996-1003; 
Niu, D.G., Peng, F., Zhang, W., Guan, Z., Zhao, H.D., Li, J.L., Wang, K.L., Liu, Q., Morphine promotes cancer stem cell properties contributing to chemoresistance in breast cancer (2015) Oncotarget, 28, pp. 3963-3976; 
Noorbakhsh, S., Zeinodini, Z., Khanjani, Z., Poorsharifi, H., Rajezi Esfahani, S., Personality disorders, narcotics and stimulants: relationship in Inranian male susbstance dependents population (2015) Iran. Red Crescent Med. J., 17, p. e23038; 
Nosotti, M., Russo, L., Tosi, D., Pallaschi, A., Mendogni, P., Righi, I., Marenghi, C., Santambrogio, L., Preventive analgesia in thoracic surgery: controlled, randomized, double-blinded study (2015) Eur. J. Cardiothorac. Surg., 48, pp. 428-433; 
Nucci-Martins, C., Nascimento, L.F., Venzke, D., Brethanha, L.C., Sako, A.V., Oliveira, A.S., Brighente, I.M., Santos, A.R., Antinociceptive effect of hydroalcoholic extract and isoflavone isolated from Polygala molluginifolia in mice: evidence for the involvement of opioid receptors and TRPV1 and TRPA1 (2016) Phytomedicine, 23, pp. 429-440; 
Nuechterlein, E.B., Ni, L., Domino, E.F., Zubieta, J.K., Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms (2016) Prog. Neuropsychopharmacol. Biol. Psychiatr., 69, pp. 69-77; 
Nummenmaa, L., Tuominen, L., Dunbar, R., Hirvonen, J., Manninen, S., Arponen, E., Machin, A., Sams, M., Social touch modulates endogenous mu-opioid system activity in humans (2016) Neuroimage, 138, pp. 242-247; 
Nygard, S.K., Hourguettes, N.J., Sobczak, G.G., Carlezon, W.A., Bruchas, M.R., Stress-induced reinstatement of nicotine preference requires dynorphin/kappa opioid activity in the basolateral amygdala (2016) J. Neurosci., 36, pp. 9937-9947; 
Nyland, J.E., Alexander, D.N., Grigson, P.S., Drug-motivated behavior in rats with lesions of the thalamic orosensory area (2016) Behav. Neurosci., 130, pp. 103-113; 
Odekon, L., Landau, R., Biouin, J.L., Brodow, D., Wang, S., Smiley, R.M., The effect of beta2-adrenoceptor genotype on phenylephrine dose administered during spinal anesthesia for cesarean delivery (2015) Anesth. Analg., 120, pp. 1309-1316; 
Odom-Forren, J., Rayens, M.K., Gokun, Y., Jalota, L., Radke, O., Hooper, V., Wiggins, A.T., Apfel, C.C., The relationship of pain and nausea in postoperative patients for 1 week after ambulatory surgery (2015) Clin. J. Pain, 31, pp. 845-851; 
Oh, C.S., Lee, S.H., Yoo, Y.B., Yang, J.H., Kim, S.H., Mu-opioid receptor polymorphisms and breast cancer in a Korean female adult population: a retrospective study (2016) J. Breast Cancer, 19, pp. 206-209; 
Ohbuchi, K., Miyagi, C., Suzuki, Y., Mizuhara, Y., Mizuno, K., Omiya, Y., Yamamoto, M., Uezono, Y., Ignavine: a novel allosteric modulator of the mu opioid receptor (2016) Sci. Rep., 6, p. 31748; 
Olive, D.J., Barrington, M.J., Simone, S.A., Kluger, R., A randsomised controlled trial comparing three analgesia regimens following total knee joint replacement: continuous femoral nerve block, intrathecal morphine or both (2015) Anaesth. Intensive Care, 43, pp. 454-460; 
Olsen, R., Foster, D.J., Upton, R.N., Olesen, A.E., Ross, J.R., Droney, J., Sato, H., Kreilgaard, M., Modelling the PKPD of oxycodone in experimental pain –impact of opioid receptor polymorphisms (2016) Eur. J. Pharm. Sci., 86, pp. 41-49; 
Ono, H., Nakamura, A., Kanomasa, T., Sakaguchi, G., Shinohara, S., Effect of estrogen on morphine- and oxycodone-induced antinociception in a female femur bone cancer pain model (2016) Eur. J. Pharmacol., 773, pp. 1-12; 
Oral, E.G., Hanci, A., Ulufer Sivrikaya, G., Dobrucali, H., Turkoglu Kilinc, L., The analgesic effects of morphine and tramadol added to intra-articular levobupivacaine-tenoxicam combination for arthroscopic knee surgery on postoperative pain: a randomized clinical trial (2015) Anesth. Pain Med., 5, p. e24047. , (4.5); 
Orduna, A.R., Beaudry, F., Characterization of endoproteolytic processing of dynorphins by proprotein convertases using mouse spinal cord S9 fractions and mass spectrometry (2016) Neuropeptides, 57, pp. 85-94; 
Oremule, B., Johnson, M., Sanderson, L., Lutz, J., Dodd, J., Hans, P., Oral morphine for pain management in paediatric patients after tonsillectomy and adenotonsillectomy (2015) Int. J. Pediatr. Otorhinolaryngol., 79, pp. 2166-2169; 
Orvain, C., Moles-Moreau, M.P., Francois, S., Mercier, M., Moal, F., Hamel, J.F., Parot-Schinkel, E., Tanguy-Schmidt, A., Miconazole mucoadhesive buccal tablet in high-dose therapy with autologous stem cell transplantation (HDT/ASCT)-induced mucositis (2015) Support. Care Cancer, 23, pp. 359-364; 
Ostadhadi, S., Haj-Mirzaian, A., Nikoui, V., Kordjazy, N., Dehpor, A.R., Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice (2016) Clin. Exp. Pharmacol. Physiol., 43, pp. 203-212; 
Pacesova, D., Volfova, B., Cervena, K., Heinova, L., Novotny, J., Bendova, Z., Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3beta kinases and Per1 expression in the rat suprachiasmatic nucleus (2015) Br. J. Pharmacol., 172, pp. 3638-3649; 
Page-Wilson, G., Nguyen, K.T., Atalayer, D., Meece, K., Bainbridge, H.A., Komer, J., Gordon, R.J., Wardlaw, S.L., Evaluation of CSF and plasma biomarkers of brain melanocortin activity in response to caloric restriction in humans (2016) Am. J. Physiol. Endorinol. Metab., 312, pp. E18-E26; 
Pal, A., Das, S., Morphine causes persistent induction of nitrated neurofilaments in cortex and subcortex even during abstinence (2015) Neuroscience, 291, pp. 177-188; 
Palma, A., Viegas, J., Manlhiot, C., McCrindle, B., Benson, L., Use of local anesthetic (0.25% bupivacaine) for pain control after pediatric cardiac catheterization: a randomized controlled trial (2016) Catheter. Cardiovasc. Interv., 87, pp. 318-323; 
Palotai, M., Telegdy, G., Bagosi, Z., Jaszberger, M., The action of neuropeptide AF on passive avoidance learning – involvement of neurotransmitters (2016) Neurobiol. Learn Mem., l127, pp. 34-41; 
Palus, K., Calka, J., Alterations of neurochemical expression of the coeliac-superior mesenteric ganglion complex (CSMG) neurons supplying the prepyloric region of the porcine stomach following partial stomach resention (2016) J. Chem. Neuroanat., 72, pp. 25-33; 
Palus, K., Calka, J., Neurochemical plasticity of the coeliac-superior mesenteric ganglion complex neurons projecting to the prepyloric region of the porcine stomach following hyperacidity (2016) Neural Plast., 2016, p. 8596214; 
Pan, F.P., Zhou, H.K., Bu, H.Q., Chen, Z.Q., Zhang, H., Xu, L.P., Tang, J., Chen, L., Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK (2016) Oncol. Rep., 35, pp. 1941-1949; 
Pan, W., Wang, Y., Lin, L., Zhou, G., Hua, X., Mo, L., Outcomes of dexmedetomidine treatment in pediatric patients undergoing congenital heart disease surgery: a meta-analysis (2016) Paediatr. Anaesth., 26, pp. 239-248; 
Pang, G., Wu, X., Tao, X., Mao, R., Liu, X., Zhang, Y.M., Li, G., Zhang, G., Blockade of serotonin 5 HT2A receptors suppresses behavioral sensitization and nalocxone-precipitated withdrawal symptoms in morphine-treated mice (2016) Front. Pharmacol., 7, p. 514; 
Pannell, M., Labuz, D., Celik, M.O., Keye, J., Batra, A., Siegmund, B., Machelska, H., Adoptive transfer of M2 macrophages reduce meuropathic pain via opioid peptides (2016) J. Neuroinflamm., 13, p. 262; 
Papathanasiou, T., Juul, R.V., Heegaard, A.M., Kreilgaard, M., Lund, T.M., Co-administration of morphine and gabapentin leads to dose dependent synergistic effects in a rat model of postoperative pain (2016) Eur. J. Pharm. Sci., 82, pp. 97-105; 
Parenti, C., Arico, G., Pennisi, M., Venditti, A., Scoto, G.M., Harpagophytum procumbens extract potentiates morphine antinociception in neuropathic rats (2016) Nat. Prod. Res., 30, pp. 1248-1255; 
Parikh, T.J., Divecha, V., Dalwadi, D., Comparative study between epidural morphine and bupivacaine with epidural clonidine and bupivacaine for postoperative pain relief in abdominal surgeries (2015) Anesth. Essays Res., 9, pp. 28-33; 
Park, S.K., Choi, Y.S., Choi, S.W., Song, S.W., A comparison of three methods for postoperative pain control in patients undergoing arthroscopic shoulder surgery (2015) Korean J. Pain, 28, pp. 45-51; 
Parker, M.O., Evans, A.M., Brock, A.J., Combe, F.J., Teh, M.T., Brennan, C.H., Moderate alcohol exposure during early brain development increases stimulus-response habits in adulthood (2016) Addict. Biol., 21, pp. 49-60; 
Parvaresh, N., Sabahi, A.R., Mazhari, S., Gilani, H., A study of sexual function, sleep and weight status of patients after 6 months of methadone maintenance treatment (2015) Addict Health, 7, pp. 24-29; 
Pasquinucci, L., Turnaturi, R., Arico, G., Parenti, C., Pallaki, P., Georgoussi, Z., Ronsisvalle, S., Evaluation of N-substituent structural variation in opioid receptor profile of LP1 (2016) Bioorg. Med. Chem., 24, pp. 2832-2842; 
Patton, M.H., Roberts, B.M., Levinger, D.M., Mathur, B.N., Ethanol disinhibits dorsolateral striatal medium spiny neurons through activation of a presynaptic delta opioid receptor (2016) Neuropsychopharmacology, 41, pp. 1831-1840; 
Paul, J.E., Nantha-Aree, M., Buckley, N., Shahzad, U., Cheng, J., Thabane, L., Tidy, A., Avram, V., Randomized controlled trial of gabapentin as an adjunct to periperative analgesia in total hip arthroplasty (2015) Can. J. Anaesth., 62, pp. 476-484; 
Paulozzi, L., Strickler, G.K., Kreiner, P.W., Koris, C.M., Controlled substance prescribing patterns – prescription behavior surveillance system, eight states (2013) MMWR Surveil. Summ., 2016 (64), pp. 1-14; 
Pedrero-Perez, E.J., MethaQol, G., Methdone dosage and its relationship to quality of life, satisfaction, psychopathology, cognitive performance and additional consumption of non-prescribed drugs (2016) Adicciones, 29, pp. 37-54; 
Pedron, V.T., Varani, A.P., Salerio, G.N., Baclofen prevents the elevated plus maze behavior and BDNF expression during naloxone precipitated morphine withdrawal in male and female mice (2016) Synapse, 70, pp. 187-197; 
Pendyala, G., Periyasamy, P., Callen, S., Fox, H.S., Lisco, S.J., Buch, S.J., Chronic SIV and morphine increases heat shock protein 5 expression at the synapse (2015) J. Neurovirol., 21, pp. 592-598; 
Perdreau, A., Joudet, T., Efficacy of multimodal analgesia injection combined with corticosteroids after arthroscopic rotator cuff repair (2015) Orthop. Traumatol. Surg. Res., 101, pp. 5337-5345; 
Peregud, D., Yakovley, A.A., Stepanichev, M.V., Panchenko, L.F., Gulyaeva, N.V., Expression of BDNF and TrkB phosphylation in the rat frontal cortex during morphine withdrawal are NO dependent (2016) Cell Mol. Neurosci., 36, pp. 839-849; 
Perez-Torres, E.M., Ramos-Ortolaza, D.L., Morales, R., Santini, E., Rios-Ruiz, E.J., Torres-Reveron, A., Morphine administration during low ovarian hormone stage results in transient overexpression of fear memories in females (2015) Front. Behav. Neurosci., 5 (9), p. 129; 
Perlikowska, R., Piekielna, J., Gentilucci, L., De Marco, R., Ceriesi, M.C., Calo, G., Artali, R., Janecka, A., Synthesis of mixed MOR/KOR efficacy opioid peptide analogs with antinociceptive activity after systemic administration (2016) Eur. J. Med. Chem., 109, pp. 276-286; 
Perret, M., Fletcher, P., Firth, L., Yates, P., Comparison of patient outcomes in periarticular and intraarticular local anaesthetic infiltration in total knee arthroplasty (2015) J. Orthop. Surg. Res., 10, p. 119; 
Petracci, E., Nanni, L., Maltoni, M., Derni, S., Campana, G., Scarpi, E., Impact of admission to hospice on pain intensity and type of pain therapies administered (2016) Support. Care Cancer, 24, pp. 225-232; 
Petz, L.N., Tyner, S., Barnard, E., Ervin, A., Mora, A., Clifford, J., Fowler, M., Berbarta, V.S., Prehospital and en route analgesic use in the combat setting: a prospectively designed, multicenter, observational study (2015) Mil. Med., 180, pp. 14-18; 
Pi, Z.B., Lin, H., He, G.D., Cai, Z., Xu, X.Z., Rndomized and controlled prospective trials of ultrasound-guided spinal nerve posterior ramus pulsed radiofrequency treatment for lower back post-herpetic neuralgia (2015) Clin. Ther., 166, pp. e301-305; 
Piekieina, J., De Marco, R., Gentilucci, L., Ceriesi, M.C., Calo, G., Tomboly, C., Artali, R., Janeska, A., Redoubling the ring size of an endomorhin-2 analog transforms a centrally acting mu-opioid receptor agonist into a pure peripheral analgesic (2016) Biopolymers, 106, pp. 309-317; 
Pilat, D., Piotrowska, A., Rojewska, E., Jurga, A.M., Slusarczyk, J., Makuch, W., Przewlocka, B., Mika, J., Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine (2016) Mol. Cell. Neurosci., 71, pp. 114-124; 
Pilat, D., Rojewska, E., Jurga, A.M., Piotrowska, A., Makuch, W., Przewlocka, B., Mika, J., IL-1 antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model (2015) Eur. J. Pharmacol., 764, pp. 240-248; 
Pina, P., Sabri, E., Lawlor, P.G., Characteristis and associations of pain intensity in patients referred to a specialist cancer pain clinic (2015) Pain Res. Manag., 20, pp. 249-254; 
Pinaeva, O.G., Sazonova, E.N., Lebed'ko, O.A., Timoshin, S.S., Correction of negative effect of antenatal hypoxia on liver tissue homeostasis in newborn albino rats with opioid peptides (2016) Bull. Exp. Biol. Med., 162, pp. 203-206; 
Pinheiro, L.Q., Neri Junior, E., Fernandes, R.M., Cardozo, R.T., Rezende, P.R., Reconstruction of the anterior cruciate ligament: comparison of analgesia using intrathecal morphine, intra-articular morphine and intra-articular levobupivacaine (2015) Rev. Bras. Ortop., 50, pp. 300-304; 
Poon, K., Abramova, D., Ho, H.T., Leibowitz, S., Prenatal fat-rich diet exposure alters responses of embryonic neurons to the chemokine, CCL2, in the hypothalamus (2016) Neuroscience, 324, pp. 407-419; 
Poon, K., Barson, J.R., Ho, H.T., Leibowitz, S., Relationship of the chemokine, CXCL12 to effects of dietary fat on feeding-related behaviors and hypothalamic neuropeptide systems (2016) Front. Behav. Neurosci., 10, p. 51; 
Pope, D., El-Othmani, M.M., Manning, B.T., Sepula, M., Markwell, S.J., Saleh, K.J., Impact of age, gender and anesthesia modality on post-operative pain in total knee arthroplasty patients (2015) Iowa Orthop. J., 35, pp. 92-98; 
Posa, L., Accane, A., Noble, F., Marie, N., Methadone reverses analgesic tolerance induced by morphine pretreatment (2016) Int. J. Neuropsychopharmacol., 19. , (pyv108); 
Post, A., Smart, T.S., Jackson, K., Mann, J., Mohs, R., Rorick-Kehn, L., Statnick, M., Wong, C.J., Proof-of-concept study to assess the nociceptin receptor antagonist LY2940094 as a new treatment for alcohol dependence (2016) Alcohol. Clin. Exp. Res., 40, pp. 1935-1944; 
Post, A., Smart, T.S., Krikke-Workel, J., Dawson, G.R., Harmer, C.J., Browning, M., Jackson, K., Witkin, J.M., A selective nociceptin receptor antagonist to treat depression: evidence from preclinical and clinical studies (2016) Neuropsychopharmacology, 41, pp. 1803-1812; 
Potter, J.J., MacFarlane, P.D., Love, E.J., Tremaine, H., Taylor, P.M., Murrell, J.C., Preliminary investigation comparing a detomidine continuous rate infusion combined with morphine or buprenorphine for standing sedation in horses (2016) Vet. Anaesth. Analg., 43, pp. 189-194; 
Pradhan, A.A., Perroy, J., Walwyn, W.M., Smith, M.L., Vicente-Sanchez, A., Segura, L., Bana, A., Evans, C.J., Agonist-specific recruitment of arrestin isoforms differentially modify delta opioid receptor function (2016) J. Neurosci., 36, pp. 3541-3551; 
Price, R.C., Christou, N.V., Backman, S.B., Stone, L., Schweinhardt, P., Opioid receptor antagonism increases pain and decreases pleasure in obese and non-obese individuals (2016) Psychopharmacologyogy (Berl.), 233, pp. 3869-3879; 
Prossin, A.R., Koch, A.E., Campbell, P.L., Barichello, T., Zaloman, S.S., Zubieta, J.K., Acute experimental changes in mood state regulate immune function in relation to central opioid neurotransmission: a model of human CNS-peripheral inflammatory interaction (2016) Mol. Psychiatr., 21, pp. 243-251; 
Pucci, M., Micioni Di Bonaventura, M.V., Giussepponi, M.E., Romano, A., Filaferro, M., Maccarrone, M., Cicocioppo, R., D-Addario, C., Epigenetic regulation of nociception/orphanin FQ and corticotropic-releasing factor system genes in frustration stress-induced binge-like palatable food consumption (2016) Addict. Biol., 21, pp. 1168-1185; 
Puymirat, E., Lamhaut, L., Bonnet, N., Aissaoui, N., Henry, P., Cavia, G., Cattari, S., Danchin, N., Correlates of pre-hospital morphine use in ST-elevation myocardial infarction aptients and its association with in-hospital outcomes and long-term mortality: the FAST-MI (French Registry of acute ST-elevation and non-ST-elevation myocardial infarction)programme (2016) Eur. Heart J., 37, pp. 1063-1071; 
Qi, C., Wang, X., Ge, F., Li, Y., Shen, F., Wang, J., Cui, C., mGluR5 in the nucleus accumebns shell regulates morphine-associated contextual memory through reactive oxygen species signaling (2015) Addict. Biol., 20, pp. 927-940; 
Qin, Z.L., Yang, L.Q., Li, N., Yue, J.N., Wu, B.S., Tang, Y.Z., Guo, Y.N., Ni, J.X., Clinical study of cerebrospinal fluid neuropeptides in patients with primary trigeminal neuralgia (2016) Clin. Neurol. Neurosurg., 143, pp. 111-115; 
Qiu, J., Nestor, C.C., Zhang, C., Padilla, S.L., Palmiter, R.D., Kelly, M.J., Rennekleiv, O.K., High-frequency stimulation-induced peptide release synchronizes arcuate kissspeptin neurons and excites GnRH neurons (2016) Elife, 5, p. e16246; 
Qiu, Y., Zheng, Y., Li, J.X., Discriminative stimulus effects of the imidazoline I2 e = receptor ligands BU224 and phenyzoline in rats (2015) Eur. J. Pharmacol., 749, pp. 133-141; 
Raddad, E., Chappell, A., Meyer, J., Wilson, A., Ruegg, C.E., Tauscher, J., Statnick, M.A., Verfaille, S.J., Occupany of nociception/orphanin FQ peptide receptors by the antagonist LY2940094 in rats and healthy human subjects (2016) Drug Metab. Dispos., 44, pp. 1536-1542; 
Radke, A.K., Gewirtz, J.C., Carroll, M.E., Effects of age, but not sex on elevated startle during withdrawal from acute morphine in adolescent and adult rats (2015) Behav. Pharmacol., 26, pp. 485-488; 
Raffan, E., Dennis, R.J., O'Donovan, C.J., Becker, J.M., Scott, R.A., Smith, S.P., Withers, D.J., O'Rahilly, S., A deletion of the canine POMC gene is associated with weight and appetite in obesity-prone Labrador retriever dogs (2016) Cell Metab., 23, pp. 893-900; 
Raith, W., Schmolzer, G.M., Resch, B., Reiterer, F., Avian, A., Koesternberger, M., Uriesberger, B., Laser acupuncture for neonatal abstinence syndrome: a randoimized controlled trial (2015) Pediatr, 136, pp. 876-884; 
Raithel, D.S., Ohler, K.H., Porto, I., Bicknese, A.R., Kraus, D.M., Morphine: an effective abortive therapy for pediatric paroxysmal sympathetic hypweractivity after hypoxic brain injury (2015) J. Pediatr. Pharmacol. Ther., 20, pp. 335-340; 
Ramos-Colon, C.N., Lee, Y.S., Remesic, M., Hall, S.M., LaVigne, J., Davis, P., Sandweiss, A.J., Hruby, V.J., Structure-activitry relationships of [des-Arg7]dynorphin A analogues at the kappa opioid receptor (2016) J. Med. Chem., 59, pp. 10291-10298; 
Ran, K., Gong, Z.X., Yang, D.L., Chang, Y.T., Duan, K.M., Ou, Y.W., Effect of morphine preconditioning in the delayed phase on the expression of p38 mitogen-activated protein kinase in a rabbit model of myocardial ischemia-reperfusion injury (2015) Genet. Mol. Res., 14, pp. 6642-6648; 
Ray, W.A., Chung, C.P., Murray, K.T., Cooper, W.O., Hall, K., Stein, C.M., Out-of-hospital mortality among patients receiving methadone for noncancer pain (2015) JAMA Intern. Med., 175, pp. 420-427; 
Razavi, S.S., Pevvandi, H., Badrkhani Jam, A.R., Safari, F., Teymourian, H., Mohajerani, S.A., Magnesium versus bupivacaine infiltration in controlling posterative pain in inguinal hernia repair (2015) Anesth. Pain Med., 5, p. e30643; 
Reddy, A., Tayiasanant, S., Haider, A., Heung, Y., Wu, J., Liu, D., Yennurajalingam, S., Bruera, E., The opioid rotation ratio of strong opioids to transdermal fentanyl in cancer patients (2016) Cancer, 122, pp. 149-156; 
Reeta, K.H., Prabhakar, P., Gupta, Y.K., Anticonvulsant activity of the antidepressant drug taineptine againat pentylenetrazole-induced seizures mitigates cognitive impairment in rats (2016) Behav. Pharmacol., 27, pp. 623-632; 
Regan, P.M., Sarivedr, J.K., Langford, T.D., Datta, P.K., Khalifi, K., Morphine-induced MOR-1X and ASF/SF2 expressions are independent of transcriptional regulation: implications for MOR-1X signaling (2016) J. Cell. Physiol., 231, pp. 1542-1553; 
Restendez, S.L., Keyes, P.C., Day, J.J., Hambro, C., Austin, C.J., Maina, F.K., Eidson, L., Aragona, B.J., Dopamine and opioid systems interact within the nucleus accumbens to maintain monogamous pair bonds (2016) Elife, 5, p. e15325; 
Ribeiro, K.A., Chaves, H.V., Fine, S.M., Pinto, A.R., Monteiro, D.A., Matos, S.A., Santi-Gadelha, T., Silva, A.A., Alpha-2 adrenergic and opioids receptors participation in mice gastroprotection of Abelmoschus esculentus Lectin (2016) Curr. Pharm. Des., 22, pp. 4736-4742; 
Richard, J.M., Fields, H.L., Mu-opioid receptor activation in the medial shell of the nucleus accumbens produces alcohol consumption, self-administration and cue-induced reinstatement (2016) Neuropharmacology, 108, pp. 14-23; 
Richards, E.M., Mathews, D.C., Luckenbaugh, D.A., Ionescu, D.F., Machado-Vieira, R., Niclu, M.J., Duncan, W.C., Zarate, C.A., Jr., A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression (2016) Psychopharmacology (Berl.), 233, pp. 1119-1130; 
Riedeger, C., Haschke, M., Bitter, C., Fabbro, T., Schaeren, S., Urwyler, A., Ruppen, W., The analgesic effect of combined treatment with intranasal S-ketamine and intranasal midazolam compared with morphine patient-controlled analgesia in spinal surgery patients: a pilot study (2015) J. Pain Res., 8, pp. 87-94; 
Rivera, P.D., Raghavan, R.K., Yun, S., Latchnev, S.E., McGovern, M.K., Garcia, E.F., Birnbaum, S.G., Eisch, A.J., Retrieval of morphine-associated context induces c-Fos in dentate gyrus neurons (2015) Hippocampus, 25, pp. 409-414; 
Rivero, G., Martin-Guerrero, I., de Prado, E., Gabilondo, A.M., Callado, L.F., Garcia-Sevilla, J.A., Garcia-Orad, A., Meana, J.J., Alpha2C-adenoceptor Del322-325 polymorphism and risk of psychiatric disorders: significant association with opiate abuse and dependence (2016) World J. Biol. Psychiatr., 17, pp. 308-315; 
Rizi, A.A., Reisi, P., Naghsh, N., Effect of forced treadmill exercise and blocking of opioid receptors with naloxone on memory in male rats (2016) Adv. Biomed. Res., 5, p. 20; 
Rizzi, A., Cerlesi, M.C., Ruzza, A., Malfacini Ferrari, D.F., Blanco, S., Costa, T., Guerrini, R., Calo, G., Pharmacological characterization of cebranopadol, a novel analgesic acting as mixed nociception/orphanin FQ and opioid receptor agonist (2016) Pharmacol. Res. Perspect., 4, p. e00247; 
Robinson, D.L., Jr, Nag, S., Mokha, S.S., Estrogen facilitates and the kappa and mu opioid receptors mediate antinociception produced by intrathecal (?)-pentazocine in female rats (2016) Behav. Brain Res., 312, pp. 163-168; 
Roczniak, W., Oswiecimska, J.M., Brodziak-Dopierala, B., Cipora, E., Nowak, P.G., Babuska-Roczmiak, M., Evaluation of the analgesic effect of morphine on models of acute nociceptive pain in rats with a central noradrenergic system lesion (2016) Neuro Endocrinol. Lett., 37, pp. 239-244; 
Rodriguez-Arias, M., Navarrete, F., Blanco-Gandia, M.C., Arenas, M.C., Bartoli-Andres, A., Aguilar, M.A., Rubo, G., Manzanares, J., Social defeat in adolescent mice increases vulnerability to alcohol consumption (2016) Addict. Biol., 21, pp. 87-97; 
Rogers, S.A., Kempen, T.A., Pickel, V.M., Miner, T.A., Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knockout mice (2016) Neurosci. Lett., 620, pp. 97-103; 
Rohrs, E.L., Kloefkorn, H.E., Lakes, E.H., Jacobs, B.Y., Neubert, J.K., Caudle, R.M., Allen, K.D., A novel operant-based behavioral assay of mechanical allodynia in the ororfacial region of rats (2015) J. Neurosci. Meth., 248, pp. 1-6; 
Rojewska, E., Piotrowska, A., Makuch, W., Przewlocka, B., Mika, J., Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model (2016) Neuropharm, 102, p. 465. , 80-91. (3.6); 
Rojewska, E., Popiolek-Barczak, K., Kolosowska, W., Piotrowska, A., Zychowska, M., Makuch, W., Przewlocka, B., Mika, J., PD98059 influences immune factors and enhances opioid analgesia in model of neuropathy (2015) PLoS One, 10, p. e0138583; 
Rojskjaer, J.O., Gade, E., Kile, L.B., Lind, M.N., Pedersen, L.M., Kristensen, B.B., Rasmussen, Y.H., Foss, N.B., Analgesic effect of ultrasound-guided transversus abdominis plane block after total abdominal hysterectomy: a randomized double-blind, placebo-controlled trial (2015) Acta Obstet. Gynecol. Scand., 94, pp. 274-278; 
Ronsisvalle, S., Arico, G., Panarello, F., Spadaro, A., Pasquinucci, P., Pappalardo, M.S., Parenti, C., Ronsisvalle, N., An LP1 analogue, selective MOR agonist with a peculiar pharmacological profile, used to scrutiny the ligand binding domain (2016) Bioorg. Med. Chem., 24, pp. 5280-5290; 
Rorick-Kehn, L.M., Ciccocioppo, R., Wong, C.J., Witkin, J.M., Martinez-Grau, M.A., Stopponi, S., Adams, B.L., Statnick, M.A., A novel orally bioavailable nociception receptor antagonist, LY2940084, reduces ethanol self-administration and ethanol seeking in animal models (2016) Alcohol. Clin. Exp. Res., 40, pp. 945-954; 
Rosander, S., Nause-Osthoff, R., Voepel-Lewis, T., Tait, A.R., A comparison of the postoperative pain experience in children with and without attention-deficit hyperactivity disorder (ADHD) (2015) Paediatr. Anesth., 25, pp. 1020-1025; 
Rosas, M., Porru, S., Fenu, S., Ruiu, S., Peana, A.T., Papale, A., Brambilla, R., Acquas, E., Role of nucleus accumbens mu opioid receptors in the effects of morphine on ERK1/2 phosphorylation (2016) Psychopharmacology (Berl.), 233, pp. 2943-2954; 
Rose, J.H., Karkhanis, A.N., Chen, R., Gioia, D., Lopez, M.F., Becker, H.C., McCool, B.A., Jones, S.R., Supersensitive kappa opioid receptors promotes ethanol withdrawal-related behaviors and reduce dopamine signaling in the nucleus accumbens (2016) Int. J. Neuropsychopharmacol., 19. , (pyv127); 
Rose, J.H., Karkhanis, A.N., Steiniger-Brach, B., Jones, S.R., Distinct effects of nalmefene on dopamine uptake rates and kappa opioid receptor activity in the nucleus accumbens following chronic intermittent ethanol exposure (2016) Int. J. Mol. Sci., 17, p. E1216; 
Rose, L., Burry, L., Mallick, R., Luk, E., Cook, D., Fergusson, D., Dodek, P., Mehta, S., Prevelance, risk factors and outcomes associated with physical restraint use in mechanically ventilated adults (2016) J. Crit. Care, 31, pp. 31-35; 
Rose, P., Sakai, J., Argue, R., Froelich, K., Tang, R., Opioid information pamphlet increases postoperative opioid disposal rates: a before versus after quality improvement study (2016) Can. J. Anaesth., 63, pp. 31-37; 
Rosen, L.G., Zunder, J., Renard, J., Fu, J., Rushlow, W., Laviolette, S.R., Opiate exposure state controls a D2-CaMKIIalpha-dependent memory switch in the amygdala-prefrontal cortex circuit (2016) Neuropsychopharmacology, 41, pp. 847-857; 
Ross, C.L., Teli, T., Harrison, B.S., Effect of electromagnetic field on cyclic adenosine monophosphate (cAMP) in a human mu-opioid receptor cell model (2016) Electromagn. Biol. Med., 35, pp. 206-213; 
Ruegsegger, G.N., Brown, J.D., Kovarik, M.C., Miller, D.K., Booth, F.W., Mu-opioid receptor inhibition decreases voluntary wheel running in a dopamine-dependent manner in rats bred for high voluntary running (2016) Neuroscience, 339, pp. 525-537; 
Ruka, K.A., Burger, L.L., Moenter, S.M., Both estrogen and androgen modify the responses of neurokinin-3 and kappa-opioid receotrs in arcuate kisspeptin neurons from male mice (2016) Endocrinology, 157, pp. 752-763; 
Russell, S.E., Puttick, D.J., Sawyer, A.M., Potter, D.N., Mague, S., Carlezon, W.A., Jr, Chartoff, E.H., Nucleus accumbens AMPA receptors are necessary for morphine-withdrawal-induced negative-affective states in rats (2016) J. Neurosci., 36, pp. 5748-5762; 
Rutkow, L., Chang, H.Y., Daubresse, M., Webster, D.W., Stuart, E.A., Alexander, G.C., Effect of Florida's drug monitoring program and pill mill laws on opioid prescribing and use (2015) JAMA Intern. Med., 175, pp. 1642-1649; 
Ruwanpathirana, R., Abdel-Latif, M.E., Burns, L., Chen, J., Craig, F., Lui, K., Oei, J.L., Prematurity reduces the severity and need for treatment of neonatal abstinence syndrome (2015) Acta Paeditr., 104, pp. e188-194; 
Saar, V., Pilakka-Kanthikeel, S., Atlun, V.S., Ding, H., Arias, A.Y., Javant, R.D., Kaushik, A., Nair, M., Therapetical neurotargeting via magnetic nanocarrier: implications to opiate-induced neuropathogenesis and neuroAIDS (2015) J. Biomed. Nanothechnol., 11, pp. 1722-1733; 
Saboory, E., Ebrahimi, L., Roshan-Milani, S., Hashemi, P., Interaction of prenatal stress and morphine alters prolactin and sezure in rat pups (2015) Physiol. Behav., 149, pp. 181-186; 
Saccone, P.A., Zelenock, K.A., Lindsey, A.M., Sulima, A., Rice, K.C., Prinssen, E.P., Wichmann, J., Woods, J.H., Characterization of the discriminative stimulus effects of a NOP receptor agonist Ro 64–6198 in rhesus monkeys (2016) J. Pharmacol. Exp. Ther., 357, pp. 17-23; 
Sadeghzadeh, F., Babapour, V., Haghparast, A., Role of dopamine D1-like receptor within the nucleus accumbens in acute food deprivation- and drug priming-induced reinstatement of morphine seeking in rats (2015) Behav. Brain Res., 287, pp. 172-181; 
Sadeghzadeh, F., Namyar, P., Naghavi, F.S., Haghparast, A., Differential effects of inta-accumbal orexin-1 and -2 receptor antagonists on the expression and extinction of morphine-induced conditioned place preference in rats (2016) Pharmacol. Biochem. Behav., 142, pp. 8-14; 
Sadhasivam, S., Zhang, X., Chidambaran, V., Mavi, J., Pilipenko, V., Mersha, T.B., Meller, J., McAuliffe, J., Novel associations between FAAH genetic variants and postoperative opioid-related adverse effects (2015) Pharmacogenomics J., 15, pp. 436-442; 
Saffer, C.S., Minkowitz, H.S., Ding, L., Danesi, H., Jones, J.B., Fentanyl iontophoretic transdermal system versus morphine intravenous patient-controlled analgesia for pain management following gynecological surgery: a meta-analysis of randomized controlled trials (2015) Pain Manag., 5, pp. 339-348; 
Sakakihara, M., Imamachi, N., Saito, Y., Effects of intrathecal kappa-opioid receptor agonist on morphine-induced itch and antinociception in mice (2016) Reg. Anesth. Pain Med., 41, pp. 69-74; 
Sahbaie, P., Liang, D.Y., Shi, X.Y., Sun, Y., Clark, J.D., Epigenetic regulation of spinal cord gene expression contributes to enhanced postoperative pain and analgesic tolerance subsequent to continuous opioid exposure (2016) Mol. Pain, 12. , 1744806916641950; 
Saify, K., Saadat, I., Expression levels of OPRM1 and PDYN in human SH-SY5Y cells treated with morphine and methadone (2016) Life Sci., 150, pp. 39-41; 
Saify, K., Saadat, I., Saadat, M., Down-regulation of antioxidant genes in human SH-SY5Y cells after treatment with morphine (2016) Life Sci., 144, pp. 26-29; 
Samikkannu, T., Ranjith, D., Rao, K.V., Atlun, V.S., Pimentel, E., El-Hage, N., Nair, M.P., HIV-1 gp120 and morphine-induced oxidative stress: rolein cell cycle regulation (2015) Front. Microbiol., 6, p. 614; 
Samini, S., Taheri, A., Davari Tanha, F., Comparison between intraperitoneal and intravenous lidocaine for post-operative analgesia after elective abdominal hysterectomy: a double-blind placebo controlled study (2015) J. Family Reprod. Health, 9, pp. 193-198; 
Sanchez, M.L., Diaz-Cabiale, Z., Navaez, J.A., Manso Salinas, B.P., Rivada, E., Smith, V., Covenas, R., Mapping of methionine-enkephalin-arg6-gly7-leu8 in the human diencephalon (2016) Neuroscience, 334, pp. 245-258; 
Sanders, R.A., Moeschler, S.M., Gazelka, H.M., Lamer, T.J., Wang, Z., Qu, W., Hoelzer, B.C., Patient outcomes and spinal cord stimulation: a retrospective xase series evaluating patient satisfaction, pain scores and opioid requirements (2016) Pain Pract., 16, pp. 899-904; 
Sanel, S., Arpaz, O., Unay, K., Turkmen, I., Simsek, S., Ugutmen, E., Comparison of intra-articular bupivacaine-morphine with bupivacaine-tenxoicam combinations on post-operative analgesia in patients with arthroscopic meniscectomy: a prospective, randomized study (2016) Int. Orthop., 40, pp. 601-605; 
Sarkar, S., Subramaniam, E., Konthoujam, J., A novel approach in the detoxification of intravenous buprenorphine dependence (2016) Indian J. Psychiatry, 56, pp. 152-156; 
Sarotti, D., Rabozzi, R., Franci, P., Comparison of epidural versus intrathecal anesthesia in dogs undergoing pelvic limb orthpaedic surgery (2015) Vet. Anesth. Analg., 42, pp. 405-413; 
Sartor, G.C., Powell, S.K., Wiednesr, H.J., Wahlestedt, C., Brothers, S.P., Nociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in mice (2016) Brain Res., 1632, pp. 34-41; 
Sartori, D., Lewis, T., Breaud, A., Clarke, W., The development of high-performance liquid chromatography-tandem mass spectrometric method for simultaneous quantification of morphine, morphine-3-beta-glucuronide, morphine-6-beta glucuronide, hydromorphone and normorphine in serum (2015) Clin. Biochem., 48, pp. 1283-1290; 
Saryazdi, H., Yazdani, A., Sajedi, P., Aghadavoudi, O., Comparative evaluation of adding different opiates (morphine, meperidine, buprenorphine or fentanyl) to lidocaine in duration and quality of axillary brachial plexus block (2015) Adv. Biomed. Res., 4, p. 232; 
Sazonova, E.N., Samarina, E.Y., Lebed'ko, O.A., Maltsava, I.M., Timoshin, S.S., Cytoprotective effect of peptide sedatin, an agonist of mu/delta-opioid receptors on primary culture of pulmonary fibroblasts of albino rats under conditions of oxidative stress (2016) Bull. Exp. Biol. Med., 161, pp. 41-44; 
Scalia Catenacci, S., Lovisari, F., Peng, S., Allegri, M., Somaini, M., Ghislanzoni, L., Greco, M., Ingelmo, P.M., Postoperative analgesia after laparoscopic ovarian cyst resention: double-blind multicenter randomized control trial comparing intraperitoneal and peritoneal instillation of ropivacaine (2015) J. Minim. Invasive Gynecol., 22, pp. 759-766; 
Schacherer, N.M., Erikson Ramirez, D., Frazier, S.B., Perkins, A.M., Expedited delivery of pain medication for long-bone fractures using an intranasal fentanyl clinical pathway (2015) Pediatr. Emerg. Care, 31, pp. 560-563; 
Scherrer, J.F., Salas, J., Lustman, P.J., Burge, S., Schneider, F.D., Change in opioid dose and change in depression in a longitudinal primary care patient cohort (2015) Pain, 156, pp. 348-355; 
Schiller, P.W., Nguyen, T.M., Saray, A., Poon, A.W., Faferriere, A., Coderre, T.J., The bifunctional mu opioid agonist-antioxidant [Dmt(1)]DALDA is a superior analgesic in an animal model of complex regional pain syndrome-type i (2015) ACS Chem. Neurosci., 6, pp. 1789-1793; 
Schmidt, A., Denier, N., Magon, S., Radue, E.W., Huber, C.G., Reichetr-Rossier, A., Wiesbeck, G.A., Walter, M., Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution (2015) Transl. Psychiat., 5, p. e533; 
Schmitz, A., Schulz, C., Friebel, U., Hohlfeld, T., Bausewein, C., Patient-controlled therapy of breathlessness in palliative care: a new therapeutic concept for opioid administration? (2016) J. Pain Symptom Manage., l51, pp. 581-588; 
Schneider, S., Provasi, D., Filizola, M., How oliceridine (TRV-130) binds and stabilizes a mu-opioid receptor conformational state that selectively triggers G protein signaling pathways (2016) Biochemistry, 55, pp. 6456-6466; 
Schou, M., Varnas, K., Lundquist, S., Nakao, R., Amini, N., Takano, A., Finnema Halldin, S.J.C., Farde, L., Large variation in brain exposure of reference CNS drugs: a PET study in nonhuman primates (2015) Int. J. Neuropsychopharmacol., 18. , (pyv036); 
Schulz, C.A., Chreistesson, A., Ericson, U., Almgren, P., Hindy, G., Nilsson, P.M., Struck, J., Orho-Melander, M., High levels of fasting plasma proenkephalin-A predicts deterioration of kidney function and incidence of CKD (2016) J. Am. Soc. Neprol., 28, pp. 281-303; 
Schwantes -An, T.H., Zhang, J., Chen, L.S., Hartz, S.M., Culverhouse, R.C., Chen, X., Coon, H., Saccone, N.L., Association of the OPRM1 variant rs1799971 (A118G) with non-specific liability to substance dependence in a collaborative de novo meta-analysis of European ancestry cohorts (2016) Behav. Genet., 46, pp. 151-169; 
Seal, K.H., Maguen, S., Bertenthal, D., Batki, S.L., Striebel, J., Stein, M.B., Madden, E., Neylan, T.C., Observational evidence of buprenorphine's impact on posttraumatic stress symptoms in veterans with chronic pain and opioid use disorder (2016) J. Clin. Psychiatr., 77, pp. 1182-1188; 
Setnik, B., Roland, C.L., Goli, V., Pixton, G.C., Levy-Cooperman, N., Smith, I., Webster, L., Self-reports of prescription opioid abuse and diversion among recreational opioid users in a Canadian and a United States city (2015) J. Opioid Manag., 11, pp. 463-473; 
Setnik, B., Roland, C.L., Sommerville, K.W., Pixton, G.C., Berke, R., Calkins, A., Goli, V., A multi-center, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse and diversion in opioid-experienced patients with chronic moderate-to-severe pain (2015) J. Pain Res., 8, pp. 361-373; 
Setnik, B., Roland, C.L., Sommerville, K.W., Pixton, G.C., Berke, R., Calkins, A., Goli, V., A multi-center, primary care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naloxone hydrochloride extended-release capsules using a standard conversion guide (2015) J. Pain Res., 8, pp. 347-360; 
Sgroi, S., Capper-Loup, C., Paganetti, P., Kaelin-Lang, A., Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and leve-dopa-induced dyskinesia in parkinsonian rats (2016) Exp. Neurol., 280, pp. 70-88; 
Sha, J., Meng, C., Li, L., Cui, N., Xiu, Q., Zhu, D., Correlation of serum beta-endorphin and the quality of life in allergic rhinitis (2016) Dis. Makers, 2016, p. 2025418; 
Shackelford, S.A., Fowler, M., Schultz, K., Summers, A., Galvagno, S.M., Gross, K.R., Mabry Bailey, R.L.J.A., Butler, F.K., Prehospital pain medication use by U. S. forces in Afghanistan (2015) Mil. Med., 180, pp. 304-309; 
Shafie, A., Mradi, F., Izadpaneh, E., Mokarizadeh, A., Maloudi, M.R., Nikzaban, M., Hassanzadeh, K., Neuroprotection of donepezil against morphine-induced apoptosis is mediated through Toll-like receptors (2015) Eur. J. Pharmacol., 764, pp. 292-297; 
Shah, A., Rowlands, M., Krishnan, N., Patel, A., Ott-Young, A., Thoracic intercostal nerve blocks reduce opioid consumption and length of stay in patients undergoing implant-based breast reconstruction (2015) Plast. Reconstr. Surg., 136, pp. 584e-591e; 
Shang, Y., Yeatman, H.R., Provasi, D., Alt, A., Christopoulos, A., Canals, M., Filizola, M., Proposed mode of binding and action of positive allosteric modulators at opioid receptors (2016) ACS Chem. Biol., 11, pp. 1220-1229; 
Sheehy, K.A., Muller, E.A., Lippold, C., Nouraie, M., Finkel, J.C., Quezado, Z.M., Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study (2015) BMC Pediatr., 15, p. 198; 
Sheikh, M., Shirzadian, A., Dehdashtian, A., Amiri, A., Ostadhadi, S., Ghasemi, M., Dehpour, A.R., Involvement of ATP-sensitive potassium channels and the opioid system in the anticonvulsive effect of zolpidem in mice (2016) Epilepsy Behav., 62, pp. 291-296; 
Shen, F., Wang, X.W., Ge, F.F., Li, Y.J., Cui, C.L., Essential role of the NO signaling pathway in the hippocampal CA1 in morphine-associated memory depends on glutaminergic neurons (2016) Neuropharmacology, 102, pp. 216-226; 
Shen, J.T., Li, Y.S., Xia, Z.Q., Wen, S.H., Yao, X., Yang, W.J., Li, C., Liu, K.X., Remifentanil preconditioning protects the small intestine against ischemia/reperfusion injury via intestinal delta- and mu-opioid receptors (2016) Surgery, 159, pp. 548-559; 
Shen, Q., Qian, Y., Huang, X., Xu, X., Li, W., Liu, J., Fu, W., Discovery of potent and selective agonists of delta opioid receptor by revisiting the “message-address” concept (2016) ACS Med. Chem. Lett., 7, pp. 391-398; 
Shen, Y.L., Chen, S.T., Hung, T.W., Tao, P.L., Liao, R.M., Chan, M.H., Chen, H.H., Delayed extinction and stronger drug-primed reinstatement of methamphetamine seeking in rats prenatally exposed to morphine (2016) Neurobiol. Learn Mem., 128, pp. 56-64; 
Shenoda, B.B., Alexander, G.M., Ajit, S.K., Has-miR-34a mediated repression of corticotropin releasing hormone receptor 1 regulates pro-opiomelanocortin expression in patients with complex regional pain syndrome (2016) J. Transl. Med., 14, p. 64; 
Shi, W., Ma, C., Qi, Q., Liu, L., Cong, B., Li, Y., The effect of different durations of morphine exposure on mesencephalic dopaminergic neurons in morphine dependent rats (2015) Neurotoxicology, 51, pp. 51-57; 
Shimoyama, N., Gomyo, I., Teramoto, O., Kojima, K., Higuchi, H., Yukitoshi, N., Ohta, E., Shimoyama, M., Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain (2015) Jpn. J. Clin. Oncol., 45, pp. 189-196; 
Shokoofeh, S., Homa, M., Leila, D., Samra, D., Expression of spinal cord GABA transporter 1 in morphine-tolerant male Wistar rats (2015) Eur. J. Pharmacol., 767, pp. 77-81; 
Siddiqui, K.M., Khan, F.A., Effect of preinduction low-dose ketamine bolus on intraoperative and immediate postoperative analgesia requirement in day care surgery: a randomized controlled trial (2015) Saudi J. Anaesth., 9, pp. 422-427; 
Siemian, J.N., Oeng, S., Zhang, Y., Zhang, Y., Li, J.X., Antinociceptive interactions between the imidazoline I2 receptor agonist and opioids in rats: role of efficacy at the mu-opioid receptor (2016) J. Pharmacol. Exp. Ther., 357, pp. 509-519; 
Silva, L.C., Castor, M.G., Navarro, L.C., Romero, T.R., Duarte, I.D., Kappa-opioid receptor participates of NSAID's peripheral antinociception (2016) Neurosci. Lett., 622, pp. 6-9; 
Silvain, J., Storey, R.F., Cayla, G., Esteve, J.B., Dillinger, J.G., Rosseau, H., Tsatsaris, A., Montalescot, G., P2Y12 receptor inhibition and effect of morphine in patients undergoing primary PCI for ST-segment elevation myocardial infarction: the PRIVATE-ATLANTIC study (2016) Thromb. Haemost., 116, pp. 369-378; 
Simola, N., Costa, G., Morelli, M., Activation of adenosine A2A receptors suppresses the emission of pro-social and drug-stimulated 50-kHz ultrasonic vocalization in rats: possible relevance to reward and motivation (2016) Psychopharmacology (Berl.), 233, pp. 507-519; 
Simon, M.J., Higuera-Matas, A., Roura-Martinez, D., Ucha, M., Santos-Toscano, R., Garcia-Lecumbem, C., Ambrosio, E., Puerto, A., Changes in D1 but not D2 or mu-opioid receptor expression in limbic and motor structures after lateral hypothalamus electrical self-stimulation: a quantitative autoradiographic study (2016) Neurobiol. Learn Mem., 127, pp. 17-26; 
Singh, S.R., Sullo, N., Matteis, M., Spaziano, G., McDonald, J., Saunders, R., Woodman, L., Lambert, D.G., Nociceptin/orphanin FQ (N-OFQ) modulates immunopathology and airway hyperresponsiveness representing a novel target for the treatment of asthma (2016) Br. J. Pharmacol., 173, pp. 1288-1301; 
Singhal, N.R., Jones, J., Semenova, J., Williamson, A., McCollum, K., Tong, D., Jerman, J., Nguyen, H., Multimodal anesthesia with the addition of methadone is superior to epidural analgesia: a retrospective comparison of intraoperative anesthetic techniques and pain management for 124 pediatric patients undergoing the Nuss procedure (2016) J. Pediatr. Surg., 51, pp. 612-616; 
Sipahi, A., Satilmis, T., Basa, S., Comparative study in patients with symptomatic internal derangements of the temporomandibular joint: analgesic outcomes of arthrocentesis with or without intra-articular morphine and tramadol (2015) Br. J. Oral Maxillofac. Surg., 53, pp. 316-320; 
Sirohi, S., Aldrich, J.V., Walker, B.M., Species differences in the effects of the kappa-opioid receptor antagonist zyklophin (2016) Alcohol, 51, pp. 43-49; 
Sitbon, P., Van Elstraete, A., Hamdi, L., Juarez-Perez, V., Mazoit, J.X., Benhamou, D., Rougeot, C., STR-324, a stable analog of opiorphin, causes analgesia in postoperative pain by activating endogenous opioid receptor-dependent pathways (2016) Anesthesiology, 125, pp. 1017-1028; 
Skitek, M., Jerin, A., Proenkephalin A and protachikinin in ischemic neurological complications after cardiac surgery (2016) Med. Glas. (Zenica), 13, pp. 6-13; 
Skobowiat, C., Slominski, A.T., Ultraviolet B stimulates proopiomelanocrtin signaling in the arcuate nucleus of the hypothalamus in mice (2016) Exp. Dermatol., 25, pp. 120-123; 
Skorpen, F., von Hofacker, S., Bjorngaard, M., Skogholt, A.H., Dale, O., Kaasa, S., Klepstad, P., The rare Arg181Cys mutation in the mu opioid receptor can abolish opioid responses (2016) Acta Anaesthesiol. Scand., 60, pp. 1084-1091; 
Small, B.A., Lu, Y., Hau, A.K., Gross, G.J., Gross, E.R., Morphine reduces myocardial infarct size via heat shock protein 90 in rodents (2015) BioMed Res. Int., 2015, p. 129612; 
Smeets, C.J., Zmorzynska, J., Melo, M.N., Stargardt, A., Dooley, C., Bakalkin, G., McLaughlin, J., Verbeek, D.S., Altered secondary structure of dynorphin A associates with loss of opioid signaling and NMDA-mediated excitotoxicity in SCA23 (2016) Hum. Mol. Genet., 25, pp. 2728-2737; 
Smith, J.E., Rockett, M.S.S.C., Squire, R., Hayward, C., Ewings, P., Barton, A., Pritchard, C., Benger, J., Pain SoluTions in the Emergency Setting (PASTIES) – patient controlled analgesia versus routine care in emergency department patients with pain from traumatic injuries: randomized trial (2015) BMJ, 350, p. h2988; 
Smith, J.E., Rockett, M., Creanor, S., Squire, R., Hayward, C., Ewings, P., Barton, A., Benger, J., Pain SoluTions in the Emergency Setting (PASTIES) – patient controlled analgesia versus routine care in emergency department patients with non-traumatic abdominal pain: randomized trial (2015) BMJ, 350, p. h3147; 
Smith, K.M., Boyle, K.A., Mustapa, M., Jobling, P., Callister, R.J., Hughes, D.I., Graham, B.A., Distinct forms of synaptic inhibition and neuromodulation regulate calretin-positive neuron excitability in the spinal cord dorsal horn (2016) Neuroscience, 326, pp. 10-21; 
Smith, S.R., Draganic, B., Pockney, P., Holz, P., Holmes, R., McManus, B., Carroll, R., Transversus abdominis plane blockade in laparocopic colorectal surgery: a double-blind randomized clinical trial (2015) Int. J. Colorectal Dis., 30, pp. 1237-1245; 
Soleimannejad, M., Tehrani-Doost, M., Khorrami, A., Joghataei, M.T., Pishyareh, E., Evaluation of attention bias in morphine and methamphetamine abusers towards emotional scenes during early abstinence: an eye-tracking study (2015) Basic Clin. Neurosci., 6, pp. 223-230; 
Song, J., Li, L., Yu, P., Gao, T., Liu, K., Preemptive scalp infiltration with 0.5% ropivacaine and 1% lidocaine reduces postoperative pain after craniotomy (2015) Acta Neurochir. (Wien), 157, pp. 993-998; 
Souza, G.F., Solon, C., Nasciementoi, L.F., De-Lima-Junior, J.C., Negueira, G., Moura, R., Rocha, G.Z., Velloso, L.A., Defective regulation of POMC precedes hypothalamic inflammation in diet-induced obesity (2016) Sci. Rep., 6, p. 29290; 
Srivastava, S., Fergason-Cantrell, E.A., Nahas, R.I., Lever, J.R., Synthesis and opioid receptor binding of indium (III) and [111In]-labeled macrocyclic conjugates of diprenorphine: novel ligands desgined for imaging studies of peripheral opioid receptors (2016) Tetrahedron, 72, pp. 6127-6135; 
Stathopoulos, A.M., Helena, C.V., Cristancho-Gordo, R., Gonzalez-Iglesias, A.E., Bertram, R., Influence of dynorphin on estradiol- and cervical stimulation-induced prolactin surges in ovariectomized rats (2016) Endocrine, 53, pp. 585-594; 
Statnick, M.A., Chen, Y., Ansonoff, M., Witkin, J.M., Rorick-Kehn, L., Suter, T.M., Song, M., Pintar, J.E., A novel nociception receptor antagonist LY2940094 inhibits excessive feeding behavior in rodents: a possible mechanism for the treatment of binge eating disorder (2016) J. Pharmacol. Exp. Ther., 356, pp. 493-502; 
Stefano, G.B., Mantione, K.J., Capellan, C., Casares, F.M., Challenger, S., Ramin, R., Samuel, J.M., Kream, R.M., Morphine stimulates nitric oxide release in human mitochondria (2015) J. Bioenerg. Biomembr., 47, pp. 409-417; 
Steidl, S., Myal, S., Wise, R.A., Supplemental morphine infusion into the posterior ventral tegmentum extends the satiating effects of self-administered intravenous heroin (2015) Pharmacol. Biochem. Behav., 134, pp. 1-5; 
Stein, T., Souza-Silva, E., Mascarin, L., Eto, C., Fin, F.E., Tonussi, C.R., Histaminergic pharmacology modulates the analgesic and antiedematogenic effects of spinally injected morphine (2011) Anesth. Analg., 6 (123), pp. 238-243; 
Steinhorn, R., McPherson, C., Anderson, P.J., Neil, J., Doyle, L.W., Inder, T., Neonatal morphine exposure in very ptreterm infants – cerebral development and outcomes (2015) J. Pediatr., 166, pp. 1200-1207; 
Stockton, S.D., Jr, Gomes, I., Liu, T., Moraje, C., Hipolito, L., Jones, M.R., Ma'avan, A., Devi, L.A., Morphine regulated synaptic networks revealed by integrated proteomics and network analysis (2015) Mol. Cell Proteonomics, 14, pp. 2564-2576; 
Strack, M., Bedini, A., Yip, K.T., Lombardi, S., Siegmund, D., Stoll, R., Spampinato, S.M., Metzler-Nolte, N., A blocking group scan using a spherical organometallic complex identifies an unprecedented binding mode with potent activity in vitro and in vivo for the opioid peptide dermorphin (2016) Chemistry, 22, pp. 14805-14810; 
Subramanian, N., Condic-Jurkic, K., Mark, A.E., O'Mara, M.L., Identification of possible binding sites for morphine and nicardipine on the multidrug transporter P-glycoprotein using umbrella sampling techniques (2015) J. Chem. Int. Model., 55, pp. 1202-1217; 
Sudakov, S.K., Bogdanova, N.O., Activation of peripheral kappa-opioid receptors normalizes caffeine effects modified in nicotine-dependent rats during nicotine withdrawal (2016) Bull. Exp. Biol. Med., 161, pp. 743-745; 
Sullivan, L.C., Chavera, T.S., Jamshidi, R.J., Berg, K.A., Clarke, W.P., Consituttive desensitization of opioid receptors in peripheral sensory neurons (2016) J. Pharmacol. Exp. Ther., 359, pp. 411-419; 
Sumie, M., Shiokawa, H., Yamaura, K., Karashima, Y., Hoka, S., Yoshimura, M., Direct effect of remifentanil and glycine contained in Ultiva on nociceptive transmission in the spinal cord: in vivo and slice patch clamp analysis (2016) PLoS One, 11, p. e0147339; 
Sun, Y., Zong, W., Zhou, M., Ma, Y., Wang, J., Pre-conditioned place preference treatment of chloral hydrate interrupts the rewarding effect of morphine (2015) Pharmacol. Biochem. Behav., 135, pp. 60-63; 
Sushchyk, S., Xi, Z.X., Wang, J.B., Combination of levo-tetrahydropalmatine and low dose naltrexone: a promising treatment for prevention of cocaine relapse (2016) J. Pharmacol. Exp. Ther., 357, pp. 248-257; 
Sustkova-Fiserova, M., Jerabek, P., Havlicklova, T., Syslova, K., Kacer, P., Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens (2016) Psychopharmacology (Berl.), 233, pp. 469-484; 
Sutton, L.P., Ostrovskaya, O., Dao, M., Xie, K., Orlandi, C., Smith, R., Wee, S., Martemyanov, K.A., Regulation of G-protein signaling 7 regulates reward behavior by controlling opioid signaling in the striatum (2016) Biol. Psychiatr., 80, pp. 235-245; 
Szklarczyk, K., Korostynski, M., Golda, S., Piechota, M., Ficek, J., Przewlocki, R., Endogenous opioids regulate glucocorticoid-dependent stress-coping strategies in mice (2016) Neuroscience, 330, pp. 121-137; 
Sverrisdottir, E., Foster, D.J., Upton, R.N., Olesen, A.E., Lund, T.M., Gabel-Jensen, C., Drewes, A.M., Kreilgaard, M., Modelling concentration-analgesia relationships for morphine to evaluate experimental pain models (2015) Eur. J. Pharm. Sci., 66, pp. 50-58; 
Szkutnik-Fiedler, D., Billert, H., Grabowski, T., Lisiecka, J., Michalak, M., Uriasz, H., Grzeskowiak, E., Effects of low-dose escheria coli lipopolysaccharide-induced endotoxemia on morphine pharmacokinetics in an animal model (2016) Pain Med., 17, pp. 1407-1415; 
Szucs, E., Buki, A., Kekesi, G., Horvath, G., Benyhe, S., Mu-opioid (MOP) receptor mediated G-protein signaling is impaired in specific brain regions in a rat model of schizophrenia (2016) Neurosci. Lett., 619, pp. 29-33; 
Tabatabaie, O., Matin, N., Heidari, A., Tabatabaie, A., Hadaegh, A., Yazdanynejad, S., Tabatabaie, K., Spinal anesthesia reduces postoperative delirium in opioid dependent patients undergoing coronary artery bypass grafting (2015) Acta Anaesthesiol. Belg., 66, pp. 49-54; 
Takasu, K., Ogawa, K., Nakamura, A., Kanbara, T., Ono, H., Tomii, T., Morioka, Y., Sakaguchi, G., Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model (2015) Br. J. Pharmacol., 172, pp. 2148-2164; 
Tan, E.C., Lim, E.C., Ocampo, C.E., Allen, J.C., Sng, B.L., Sia, A.T., Common variants of catechol-O-methytransferase influence patient-controlled analgesia and postoperative pain in patients undergoing total hysterectomy (2016) Pharmacogenomics J., 16, pp. 186-192; 
Tanco, V.M., Whitlock, B.K., Jones, M.A., Wilborn, R.R., Brandebourg, T.D., Foradori, C.D., Distribution and regulation of gaonadotropin-releasing hormone, kisspeptin, RF-amide related peptide-3 and dynorphin in the bovine hypothalamus (2016) Peer J., 4, p. e1833; 
Tang, B., Hu, Z., Li, Y., Yuan, S., Wang, Z., Yu, S., He, S., Downregulation of delta opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug-resistant human hepatocellular carcinoma cells to 5-FU (2016) Mol. Med. Rep., 13, pp. 59-66; 
Tanggaard, K., Jensen, K., Lenz, K., Vazin, M., Binzer, J., Lindberg-Larsen, V.O., Niegsch, M., Borglum, J., A randomized controlled trial of bilateral dual transversis abdominis plane blockade for laparoscopic appendicectomy (2015) Anaesth, 70, pp. 1395-1400; 
Tao, W., Zhou, W., Wang, Y., Sun, T., Wang, H., Zhang, Z., Jin, Y., Histone deacetylase inhibitor-induced emergence of synaptic delta-opioid receptors and behavioral antinociception in persistent neuropathic pain (2016) Neuroscience, 339, pp. 54-63; 
Tariq, S., Nurulain, S.M., Rashed, H., Lofty, M., Emerald, S.B., Koturan, S., Tekes, K., Adeghate, E., Diabetes-induced changes in the morphology and nocieptinergic innervation of the rat uterus (2016) J. Mol. Histol., 47, pp. 21-33; 
Taylor, A.M., Castonguay, A., Ghogha, A., Vayssiere, P., Pradhan, A.A., Xue, L., Mehrabani, S., Cahill, C.M., Neuroimmune regulation of GABAergic neurons within the ventral tegmental area during withdrawal from chronic morphine (2016) Neuropsychopharmacology, 41, pp. 949-959; 
Taylor, A.M., Castonguay, A., Taylor, A.J., Murphy, N.P., Ghogha, A., Cook, C., Xue, L., Cahill, C.M., Microglia disrupt mesolimbic reward circuitry in chronic pain (2015) J. Neurosci., 35. , 8442–7450; 
Telletxea, S., Gonzalez, J., Portugal, V., Alvarez, R., Aguirre, U., Anton, A., Arizaga, A., Analgesia with intrafasical continuous wound infiltration after laparoscopic colon surgery: a randomized clinical trial (2016) Rev. Exp. Anestesiol. Reanim, 63, pp. 197-206; 
Telnes, A., Skogvoll, E., Lonnee, H., Transversus abdominis plane block vs. wound infiltration in caesarean section: a randomized controlled trial (2015) Acta Anaesthesiol. Scand., 59, pp. 496-504; 
Teramoto, H., Yamauchi, T., Sasaki, S., Higashiyama, K., Development of kappa opioid receptor agonists by focusing on phenyl substituents of 4-dimethylamino-3-phenylpiperidine derivatives: structure-activity relationship study of matrine type alkaloids (2016) Chem. Pharm. Bull. (Tokyo), 64, pp. 420-431; 
Teramoto, H., Yamauchi, T., Terado, Y., Odagiri, S., Sasaki, S., Higashiyama, K., Design and synthesis of a piperidinone scaffold as an analgesic through kappa opioid receptor: structure-activity relationship study of matrine type alkaloids (2016) Chem. Pharm. Bull. (Tokyo), 64, pp. 410-419; 
Tesone-Coelho, C., Morel, L.J., Bhatt, J., Estevez, L., Naudon, L., Giros, B., Zwiller, J., Dauge, V., Vulnerability to opiate intake in maternally deprived rats: implication for MeCP2 and of histone acetylation (2015) Addict. Biol., 20, pp. 120-131; 
Tetsunaga, T., Sato, T., Shiota, N., Tetsunaga, T., Yoshida, M., Okazaki, Y., Yamada, K., Comparison of continuous epidural analgesia, patient-controlled analgesia with morphine, and continuous three-in-one femoral nerve block on postoperative outcomes after total hip arthroplasty (2015) Clin. Orthop. Surg., 7, pp. 164-170; 
Thakur, D.P., Tian, J.B., Jeon, J., Xiong, J., Huang, Y., Flockerzi, V., Zhu, M.X., Critical roles of Gi/o proteins and phospholipase C-delta1 in the activation of receptor-operated TRPC-4 channels (2016) Proc. Natl. Acad. Sci. U. S. A., 113, pp. 1092-1097; 
Thakur, N.A., DeBoyace, S.D., Margulies, B.S., Antagonism of the Met5-enkephalin-opioid growth factor receptor-signaling axis promotes MSC to differentiate into osteoblasts (2016) J. Orthop. Res., 34, pp. 1195-1205; 
Thomas, A., Miller, A., Riughan, J., Malik, A., Haylor, K., Sandersen, C., Flecknell, P., Leach, M., Efficacy of intrathecal morphine in a model of surgical pain in rats (2016) PLoS One, 11, p. e0163909; 
Thomazeau, J., Rouquette, A., Martinez, V., Raubel, C., Prince, N., Laplanche, J.L., Nizard, R., Lloret-Linares, C., Acute pain factors predictive of post-operative pain and opioid requirement in multimodal analgesia following knee replacement (2016) Eur. J. Pain, 20, pp. 822-832; 
Thompson, G.L., Lane, J.R., Coudrat, T., Sexton, P.M., Christopoulos, A., Canais, M., Systematic analysis of factors influencing observations of biased agonism at the mu-opioid receptor (2016) Biochem. Pharmacol., 113, pp. 70-87; 
Thorn, D.A., Zhang, Y., Li, J.X., Effects of the imidazoline I2 receptor agonist 2-BFI on the development of tolerance to and physical dependence on morphine in rats (2016) Br. J. Pharmacol., 173, pp. 1363-1372; 
Tian, Y., Liu, M., Mao-Ying, Q.L., Liu, H., Wang, Z.F., Zhang, M.T., Wang, J., Wang, Y.Q., Early single aspirin-triggered lipoxin blocked morphine anti-nociception tolerance through inhibiting NALP1 inflammasome: involvement of PI3k/Akt signaling pathway (2015) Brain Behav. Immun., 50, pp. 63-77; 
Tiwari, V., Yang, F., He, S.Q., Shechter, R., Zhang, C., Shu, B., Zhang, T., Raja, S.N., Activation of peripheral mu-opioid receptors by dermorphin [D-Arg2, Lys4] (1–4) amide leads to modality-preferred inhibition of neuropathic pain (2016) Anesthesiology, 124, pp. 706-720; 
Tjen-A-Looi, S.C., Guo, Z.L., Fu, L.W., Longhurst, J.C., Paraventricular nucleus modulates excitatory cardiovascular relexes during electroacupuncture (2016) Sci. Rep., 6, p. 25910; 
Tolia, V.N., Patrick, S.W., Bennett, M.M., Murthy, K., Sousa, J., Smith, P.B., Clark, R.H., Soitzer, A.R., Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs (2015) N. Engl. J. Med., 372, pp. 2118-2126; 
Tomim, D.H., Pontarolla, F.M., Bertolini, J.F., Arase, M., Tobaldini, G., Lima, M.M., Fischer, L., The pronociceptive effect of paradoxical sleep deprivation in rats: evidence for a role in descending pain modulation mechanisms (2016) Mol. Neurobiol., 53, pp. 1706-1717; 
Tong, G., Zhang, B., Zhou, X., Zhao, J., Sun, Z., Tao, Y., Pei, J., Zhang, W., Kappa-opioid agonist U50488H-mediated protection against heart failure following myocardial ischemia/reperfusion: dual roles of heme oxygenase 1 (2016) Cell. Physiol. Biochem., 39, pp. 2157-2172; 
Tonnsfeldt, K.J., Suchland, K.L., Beeson, K.A., Lowe, J.D., Li, M.H., Ingram, S.L., Sex differences in GABAA signaling in the periaqueductal gray induced by persistent inflammation (2016) J. Neurosci., 36, pp. 1669-1681; 
Torkaman-Boutorabi, A., Sheidadoust, H., Hashemi-Hezaveh, S.M., Zarrindast, M.R., Influcne of morphine on medial prefrontal cortex alph2 adrenergic system in passive avoidance learning in rats (2015) Pharmacol. Biochem. Behav., 133, pp. 92-98; 
Torres-Reveron, A., Palermo, K., Hernandez-Lopez, A., Hernandez, S., Cruz, M.L., Thompson, K.J., Flores, I., Appleyard, C.B., Endometriosis is associated with a shift in mu opioid and NMDA receptor expression in the brain periaqueductal gray (2016) Reprod. Sci., 23, pp. 1158-1167; 
Torup, H., Bogeskov, M., Hansen, E.G., Palle, C., Rosenberg, J., Mitchell, A.U., Petersen, P.L., Moller, A.M., Transversus abdominis plane (TAP) block after robot-assisted laparoscopic hysterectomy: a randomized clinical trial (2015) Acta Anaesthesiol. Scand., 59, pp. 928-935; 
Treskatsch, S., Feldheiser, A., Shaqura, M., Dehe, L., Habazetti, H., Roepke, T.K., Shakibaei, M., Mousa, S.A., Cellular localization and adaptive changes of the cardiac delta opioid receptor system in an experimental model of heart failure in rats (2016) Heart Vessels, 31, pp. 241-250; 
Treskatsch, S., Shaqura, M., Dehe, L., Roepke, T.K., Shakibaei, M., Schafer, M., Mousa, S.A., Evidence for MOR on cell membrane, sarcoplasmatic reticulum and mitochondria in left ventricular myocardium in rats (2016) Heart Vessels, 31, pp. 1380-1388; 
Tripi, P.A., Kuestner, M.E., Poe-Kochert, C.S., Rubin, K., Son-Hing, J.P., Thompson, G.H., Tobias, J.D., Intrathecal morphine attenuates acute opioid toleraqnce secondary to remifentanil infusions during spinal surgery in adolescents (2015) J. Pain Res., 8, pp. 637-640; 
Trivedi, M., Zhang, Y., Lopez-Toledano, M., Clarke, A., Deth, R., Differential neurogenic effects of casein-derived opioid peptides on neuronal stem cells: implications for redox epigenetic changes (2016) J. Nutr. Biochem., 37, pp. 39-46; 
Trivedi, M., Hodgson, N.W., Walker, S.J., Tropskens, G., Nair, V., Deth, R.C., Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells (2015) Nutr. Metab. (Lond.), 12, p. 54; 
Trottier, E.D., Ali, S., Le May, S., Gravel, J., Treating and reducing anxiety and pain in ther paediatrtic emergency department: the TRAPPED survey (2015) Paediatr Child Health, 20, pp. 239-244; 
Tsai, R.Y., Wang, J.C., Chou, K.Y., Wong, C.S., Cherng, C.H., Resveratrol reverses morphine-induced neuroinflammation in morphine-tolerant rats by reversal HDAC1 expression (2016) J. Formos. Med. Assoc., 115, pp. 445-454; 
Tsanova, A., Jordanova, A., Lalchev, Z., Effects of leucine-enkephalin on surface characterisitcs and morphology of model membranes composed of raft-forming lipids (2016) J. Membr. Biol., 249, pp. 229-238; 
Tu, H.J., Kang, K.H., Ho, S.Y., Kiou, H.C., Liou, H.H., Lin, C.P., Fu, W.M., Leukemia inhibitory factor (LIF) potentiates antinociception activity and inhibits tolerance induction of opioids (2016) Br. J. Anaesth., 117, pp. 512-520; 
Tudori, E., Beiroa, D., Stegbauer, J., Ferna, J., Lopez, M., Dieguez, C., Nogueiras, R., Acute stimulation of the brain mu opioid receptors inhibits glucose-stimulated insulin secretion via sympathetic innervation (2016) Neuropharmacology, 110, pp. 322-332; 
Turner, B.J., Liang, Y., Drug overdose in a retrospective cohort with non-cancer pain treated with opioids, antidepressants and/or sedative-hypnotics: interactions with mental health disorders (2015) J. Gen. Intern. Med., 30, pp. 1081-1096; 
Turner, T.B., Habib, A.S., Broadwater, G., Valea, F.A., Fleming, N.D., Ehrisman, J.A., Di Santo, N., Hayrielsky, L.J., Postoperative pain scores and narcotic use in robotic-assisted versus laparoscopic hysterectomy for endometrial cancer staging (2015) J. Minim Invasive Gyneceol., 22, pp. 1004-1010; 
Ueberall, M.A., Eberhardt, A., Mueller-Schwerfe, G.H., Physicians experience with and expectations of the safety and tolerability of WHO-step III opioids for chronic (low) back pain: post-hoc analysis of data from a German cross-sectional physician survey (2015) Pain Res. Treat., 2015, p. 745048; 
Uhari-Vaananen, J., Raasmaja, A., Backstrom, P., Oinio, V., Airavaara, M., Piepponen, P., Kiianmas, K., Accumbal mu-opioid receptors modulate ethanol intake in alcohol-preferring Alko alcohol rats (2016) Alcohol. Clin. Exp. Res., 40, pp. 2114-2123; 
Ulmer-Yaniv, A., Avitsur, R., Kanat-Maymon, Y., Schneiderman, I., Zagoory-Sharon, O., Feldman, R., Affiliation, reward and immune biomarkers coalesce to support social synchrony during periods of bond formation in humans (2016) Brain Behav. Immun., 56, pp. 130-139; 
Ulugol, A., Topuz, R.D., Gunduz, O., Kizilay, G., Karadag, H.C., Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance (2016) Fundam. Clin. Pharmacol., 30, pp. 537-548; 
Urban-Kowalczyk, M., Smigelski, J., Strzelecki, D., Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophreinia (2016) Neuropsychiatr. Dis. Treat., 12, pp. 863-868; 
Urizar-Arenaza, I., Estomba, H., Munoa-Hoyos, I., Matorras, R., Esposito, A., Candenas, L., Pinto, F.M., Subiran, N., The opioid peptide beta-endorphin stimulates acrosome reaction in human spermatozoa (2016) Andrology, 4, pp. 143-151; 
Uskur, T., Barnes, M.A., Akkan, A.G., Shahzadi, A., Uzbay, T., Dexmedetmidine induces conditioned place preference in rats: involvement of opioid receptors (2016) Behav. Brain Res., 296, pp. 163-168; 
Vahabi, S., Abaszadeh, A., Yari, F., Yousefi, N., Postoperative pain, nausea and vomiting among pre- and postmenstrual women undergoing cystocele and rectocele repair surgery (2015) Korean J. Anesthesiol., 68, pp. 581-585; 
Vaishya, R., Wani, A.M., Vijay, V., Local infiltration analgesia reduces pain and hospital stay after primary TKA: randomized controlled double blind trial (2015) Acta Orthop. Belg., 81, pp. 720-729; 
Valentine, A.R., Carvalho, B., Lazo, T.A., Riley, E.T., Scheduled acetaminophen with as-needed opioids compared to as-needed acetaminophen plus opioids for post-cesarean pain management (2015) Int. J. Obstet. Anesth., 24, pp. 210-216; 
Valenza, M., Picetti, R., Yuferov, V., Butelman, E.R., Kreek, M.J., Strain and cocaine-induced differential opioid gene expression may predispose Lewis but not Fischer rats to escalate cocaine self-administration (2016) Neuropharmacology, 105, pp. 639-650; 
Valkenburg, A.J., van den Bosch, G.E., de Graaf, J., van Lingen, R.A., Weisglas-Kuperus, N., van Rosmalen, J., Groot Jebbink, L.J., van Dijk, M., Long-term effects of neonatal morphine infusion on pain sensitivity: follow-up of a randomized controlled trial (2015) J. Pain, 16, pp. 926-933; 
van Amsterdam, J., Phillips, L., Henderswon, G., Bell, J., Bowden-Jones, O., Hemmersley, R., Ramsey, J., Nutt, D., Ranking the harm of non-medically used prescription opioids in the UK (2015) Regul. Toxicol. Pharmacol., 73, pp. 999-1004; 
Van't Veer, A., Smith, K.L., Cohen, B.M., Carlezon, W.A., Jr, Bechtholt, A.J., Kappa-opioid receptors differentially regulate low and high levels of ethanol intake in female mice (2016) Brain Behav., 6, p. e00523; 
Varadi, A., Marrone, G.F., Palmer, T.C., Narayan, A., Szabo, M.R., Le Rouzic, V., Grinnell, S.G., Majumdar, S., Mitragynine/corynantheidine pseudoindoxyls as opioids analgesics with mu agonism and delta antagonism which do not recruit beta-arrestin-2 (2016) J. Med. Chem., 59, pp. 8381-8397; 
Varghese, S.P., Montalvo-Ortiz, J.L., Csermansky, J.G., Eiger RI. Herrold AA, Koola MM, Dong H. Early life stress as a risk factor for substance abuise disorders: clinical and neurobiological studies (2015) Indian J. Psychol. Med., 37, pp. 36-41; 
Vassoler, F.M., Wright, S.J., Byrnes, E.M., Exposure to opiates in female adolescents alters mu opiate receptor expression and increases the rewarding effects of morphine in future offspring (2016) Neuropharmacology, 106, pp. 112-121; 
Vega, A., Cancino-Rodenzo, A., Valle-Leija, P., Sanchez-Tafolla, B.M., Elinos, D., Cifuentes, E., Morales, M.A., Neurotrophin-dependent plasticity of neurotransmitter segregation in the rat superior cervical ganglion in vivo (2016) Dev. Neurobiol., 76, pp. 832-846; 
Velez de Mendizabel, N., Jimenez-Mendez, R., Cooke, E., Montgomery, C.J., Dawes, J., Rieder, M.J., Aleksa, K., Carleton, B.C., A compartmental analysis of morphine and its metabolites in young children after a single oral dose (2015) Clin. Pharmacokinet., 54, pp. 1083-1090; 
Verthein, U., Beck, T., Haasen, C., Reimer, J., Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study (2015) Eur. Addict. Res., 21, pp. 97-104; 
Vey, L.T., Rosa, H.Z., Barcelos, R.C., Segat, H.J., Metz, V.G., Dias, V.T., Duarte, T., Burger, M.E., Stress during the gestational period modifies pups’ emotionality parameters and favors preference for morphine in adolescent rats (2016) Behav. Brain Res., 296, pp. 406-417; 
Vicente-Carrillo, A., Alvarez-Rodriguez, M., Rodriguez-Martinez, H., The mu and delta opioid receptors modulate boar sperm motility (2016) Mol. Reprod. Dev., 83, pp. 724-734; 
Vickery, O.N., Machtens, J.P., Tamburrino, G., Seeliger, D., Zachariae, U., Structural mechanisms of voltage sensing in G-protein coupled receptors (2016) Structure, 24, pp. 997-1007; 
Vijay, A., Wang, S., Worhunskay, P., Zheng, M.Q., Nabulski, N., Ropchan, J., Krishnan-Sarin, S., Morris, E.D., PET imaging reveals sex differences in kappa opioid receptor availability in humans in vivo (2016) Am. J. Nucl. Med. Imaging, 6, pp. 205-214; 
Vilhegas, S., Cassu, R.N., Barbero, R.C., Crociolli, G.C., Rocha, T.L., Gomes, D.R., Botulinum toxin A as an adjunct in postoperative pain management in dogs undergoing radical mastectomy (2015) Vet. Rec., 177, p. 391; 
Villar, I.C., Bubb, K.J., Moyes, A.J., Steiness, E., Gulbrandsen, T., Levy, F.O., Hobbs, A.J., Functional pharmacological characterization of SER100 in cardiovascular health and disease (2016) Br. J. Pharmacol., 173 (23), pp. 3386-3401; 
Vincent-Lambert, C., de Kock, J.M., Use of morphine sulphate by South African paramedics for prehospital pain management (2015) Pain Res. Manag., 20, pp. 141-144; 
Visconti, A.J., Santos, G.M., Lemos, N.P., Burke, C., Coffin, P.O., Opioid overdose deaths in the city and county of San Francisco: prevelance, distribution and disparities (2015) J. Urban Health, 92, pp. 758-772; 
Viscusi, E.R., Grond, S., Ding, L., Danesi, H., Jones, J.B., Sinatra, R.S., A comparison of opioid-relatred adverse events with fentanyl iontophoretic transdermal system versus morphine intravenous patient-controlled analgesia in acute postoperative pain (2016) Pain Manag., 6, pp. 19-24; 
Viscusi, E.R., Webster, L., Kuss, M., Daniels, S., Bolognese, J.A., Zuckerman, S., Soergel, D.G., Skobieranda, F., A randomized, phase 2 study investigating TRV130, a biased ligand of the mu-opioid receptor, for the intravenous treatment of acute pain (2016) Pain, 157, pp. 264-272; 
Vo, L., Hood, S., Drummond, P.D., Involvement of opioid receptors and alpha-2-adrenoceptors in inhibitory pain modulation processes: a double-blind placebo-controlled crossover study (2016) J. Pain, 17L, pp. 1164-1173; 
Von Korff, M., Dublin, S., Walker, R.L., Parchman, M., Shortreed, S.M., Hansen, R.N., Saunders, K., The impact of opioid risk reduction initiatives on high-dose opioid prescribing for patients on chronic opioid therapy (2016) J. Pain, 17, pp. 101-110; 
Wada, T., Asahi, T., Sawamura, N., Nuclear cerebion modulates transcriptional activity of Ikaros and regulates its downstream target, enkephalin in human neuroblastoma cells (2016) Biochem. Biophys. Res. Commun., 477, pp. 388-394; 
Wagner, L., Bjorkvist, M., Lundh, S.H., Wolf, R., Borgel, A., Schlenzig, D., Ludwig, H.H., von Horsten, S., Meuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30 fragment (2016) J. Neurochem., 137, pp. 820-837; 
Walwyn, W.M., Chen, W., Kim, H., Minaysyan, A., Ennes, H.S., McRoberts, J.A., Marvizon, J.C., Sustained suppression of hyperalgesia during latent sensitization by mu, delta and kappa-opioid receptors and alpha2A-adrenergic receptors: role of constitutive activity (2016) J. Neurosci., 36, pp. 204-221; 
Wan, J., Ma, J., Anand, V., Ramakrishnan, S., Roy, S., Morphine potentiates LPS-induced autophagy initiation but inhibits autophagosomal maturation through distinct TLR4-dependent and independent pathways (2015) Acta Physiol. (Oxf.), 214, pp. 189-199; 
Wang, D., Zeng, J., Li, Q., Huang, J., Couture, R., Hong, Y., Contribution of adrenomedullin to the switch of G-protein coupled mu-opioid receptors from Gi to Gs in the spinal dorsal horn following chronic morphine exposure in rats (2016) Br. J. Pharmacol., 173, pp. 1196-1207; 
Wang, D.M., Wang, Q.C., Yang, J., Plotnikoff, N.P., Griffin, N., Han, Y.M., Qi, R.Q., Shan, F.P., Inhibition of the growth of human melanoma cells by methionine enkephalin (2016) Mol. Med. Res., 14, pp. 5521-5527; 
Wang, G.Y., Kydd, R.R., Russell, B.R., Quantitative EEG and low-resolution electromagnetic tomography (LORETA) imaging of patients undergoing methadone treatment for opioid addiction (2016) Clin. EEG Neurosci., 47, pp. 180-187; 
Wang, K., Qu, X., Wang, Y., Shen, H., Liu, Q., Du, J., Effect of mu agonists on long-term survival and recurrence in nonsmall cell lung cancer patients (2015) Medicine (Baltimore), 94, p. e1333; 
Wang, N., Zhang, J.B., Zhao, J., Cai, X.T., Zhu, Y.S., Li, S.B., Association between dopamine D2 receptor gene polymorphisms and the risk of heroin dependence (2016) Genet. Mol. Res., 15, p. 4238; 
Wang, Q., Long, Y., Hang, A., Zan, G.Y., Shu, X.H., Wang, Y.J., Liu, J.G., The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel kappa agonist and partial mu agonist, in mice (2016) Psychopharmacology (Berl.), 233, pp. 2411-2418; 
Wang, R., Ding, Y., Bai, H., Duan, S., Ye, R., Yang, Y., Wang, J., He, N., Illicit heroin and methamphetamine use among methadone maintenance treatment patients in Dehong prefecture of Yunan province, China (2015) PLoS One, 10, p. e133431; 
Wang, S.Y., Cui, X.L., Xue, F.S., Duan, R., Li, R.P., Liu, G.P., Yang, G.Z., Sun, C., Combined morphine and limb remote ischemic preconditioning provides an enhanced protection against myocardial ischemia/reperfusion injury by antiapoptosis (2016) J. Surg. Res., 2002, pp. 13-25; 
Wang, S.Y., Duan, Y.L., Zhao, B., Wang, X.R., Zhao, Z., Zhang, G.M., Effect of delta opioid receptor activation on spatial cognition and neurogenesis in cerebral ischemic rats (2016) Neurosci. Lett., 620, pp. 20-26; 
Wang, X., Wang, Y., Zhang, C., Liu, C., Zhao, B., Wei, N., Zhang, J.G., Zhang, K., CB1 receptor antagonism prevents long-term hyperexcitability after head injury by regulation of dynorphin-KOR system and mGluR5 in rat hippocampus (2016) Brain Res., 1646, pp. 174-181; 
Wang, X.F., Barbier, E., Chiu, Y.T., He, Y., Zhan, J., Bi, G.H., Zhang, H.Y., Xi, Z.X., T394A mutation at the mu opioid receptor blocks opioid tolerance and increases vulnerability to heroin self-administration (2016) J. Neurosci., 36, pp. 10392-10403; 
Wang, X.F., Zhao, T.Y., Su, R.B., Wu, N., Li, J., Agmatine prevents adaptation of the hippocampal glutamate system in chronic morphine-treated rats (2016) Neurosci. Bull., 32, pp. 523-530; 
Wang, X.H., Zeng, J.F., Lin, C., Chen, S.B., Effects of morphine and sufentanil preconditioning against myocaridial ischemic-reperfusion injury in rabbits (2015) Int. J. Clin. Exp. Med., 8, pp. 15892-15899; 
Wang, Y.J., Hang, A., Lu, Y.C., Long, Y., Zan, G.Y., Li, X.P., Wang, Q., Liu, J.G., Kappa opioid receptor activation in different brain regions modulates anxiety—related behaviors in mice (2016) Neuropharmacol, 110, pp. 92-101; 
Wang, Y.L., Zeng, C., Xie, D.X., Yang, Y., Wei, J., Yang, T., Li, H., Lei, G.H., Single-dose intra-artiular bupivacaine plus morphine after knee arthroscopic surgery: a meta-analysis of randomized placebo-controlled studies (2015) BMJ Open, 5, p. e006815; 
Wang, Y.P., Wei, S.G., Zhu, Y.S., Zhao, B., Xun, X., Lai, J.H., Dopamine receptor D1 but not D3 essential for morphine-induced conditioned responses (2015) Genet. Mol. Res., 14, pp. 180-189; 
Wang, Y.Y., Liu, S., Zhang, N., Yang, J., Zhang, Y., Impaired hippocampal synaptic plasticity and NR2A/2B expression ration in remifentanil withdrawal rats (2016) Neurotoxicol, 53, pp. 115-123; 
Wang, Z., Yuan, Y., Xie, K., Tang, X., Zhang, L., Ao, J., Li, N., Wang, G., PICK1 regulates the expression and trafficking of AMPA receptors in remifentanil-induced hyperalgesia (2016) Anesth. Analg., 123, pp. 771-781; 
Wang, Z.L., Li, N., Wang, P., Tang, H.H., Han, Z.L., Song, J.J., Li, X.H., Wang, R., Pharmacological characterization of EN-9, a novel chimeric peptide of endomorphin-2 and neuropeptide FF that produces potent antinociceptive activity and limited tolerance (2016) Neuropharmacology, 108, pp. 364-372; 
Wang, Z.L., Pan, J.X., Song, J.J., Tang, H.H., Yu HP, L.X., Li, N., Zhang, T., Wang, R., Structure-based optimization of multifunctional agonists for opioid and neuropeptide FF receptors with potent nontolerance forming analgesic activities (2016) J. Med. Chem., 59, pp. 10198-10208; 
Wardle, M.C., Barshad, A.K., de Wit, H., Naltrexone alters the processing of social and emotional stimuli in healthy adults (2016) Soc. Neurosci., 11, pp. 579-591; 
Wasan, A.D., Michna, E., Edwards, R.R., Katz, J.N., Nedejkovic, S.S., Dolman, A.J., Janfaza, D., Jamison, R.N., Psychiatric comorbidity is associated postoperatively with diminished opioid analgesia and increased opioid misuse in patients with low back pain (2015) Anesthesiology, 123, pp. 861-872; 
Wasilewski, A., Lesniak, A., Bujalska-Zadrozny, M., Sadowski, B., Fichna, J., Sacharczuk, M., The effect of opioid agonists and antagonists on gastroinetestinal motility in mice selected for high and low swim stress-induced analgesia (2016) Neurogastroenterol. Motil., 28, pp. 175-185; 
Wasserman, D.I., Tan, J.M., Kim, J.C., Yeomans, J.S., Muscarinic control of rostromedial tegmental nucleus GABA neurons and morphine-induced locomotion (2016) Eur. J. Neurosci., 44, pp. 1761-1770; 
Wasserman, R.A., Hassett, A.L., Harte, S.E., Goesling, J., Mainoff, H.L., Berland, D.W., Zollars, J., Brummett, C.M., Pressure pain sensitivity in patients with suspected opioid-induced hyperalgesia (2015) Reg. Anesth. Pain Med., 40, pp. 687-693; 
Wassum, K.M., Greenfield, V.Y., Linker, K.E., Maidment, N.T., Ostlund, S.B., Inflated reward value in early opiate withdrawal (2016) Addict. Biol., 21, pp. 221-233; 
Watanabe, S., Common experience modifies the reinforcing properties of methamphetamine-injected cage mates but not morphine-injected cage mates in C57 mice (2015) Behav. Pharmacol., 26, pp. 636-641; 
Webb, B.T., Spears, J.R., Smith, L.S., Malkani, A.L., Periarticular injection of liposomal bupivacaine in total knee arthroplasty (2015) Arthroplast Today, 1, pp. 117-120; 
Webb, R.J., Shelton, C.P., The benefits of authorized agent controlled analgesia to control pain and other symptoms at the end of life (2015) J. Pain Symptom Manage., 50, pp. 371-374; 
Weber, S.C., Beck-Schimmer, B., Kajdi, M.E., Muller, D., Tobler, P.N., Quednow, B.B., Dopamine 2/3 and mu opioid receptor antagonism reduce cue-induced responding and reward impulsivity in humans (2016) Transl. Psychiatr., 6, p. e850; 
Webster, L., Hjelmstrom, P., Sumner, M., Gunderson, E.W., Efficacy and safety of a sublingual buprenorphine/naltrexone rapidly dissolving tablet for the treatment of adults with opioid dependence: a randomized trial (2016) J. Addict. Dis., 35, pp. 325-338; 
Webster, L.R., Brenner, D.M., Barrett, A.C., Paterson, C., Bortey, E., Forbes, W.P., Analysis of opioid-mediated analgesia in Phase III studies of methylnaltrexone for opioid-induced constipation in pateints with chronic noncancer pain (2015) J. Pain Res., 8, pp. 771-780; 
Weems, P.W., Witty, C.F., Amstalden, M., Coolen, L.M., Goodman, R.L., Lehman, M.N., Kappa-opioid receptor is colocalized in GnRH and KNDy cells in the female ovine and rat brain (2016) Endocrinology, 157, pp. 2367-2379; 
Wei, H., Wu, H.Y., Fan, H., Li, T.F., Ma, A.N., Li, X.Y., Wang, Y.X., Pertovaara, A., Potential role of spinal TRPA1 channels in antinociceptive tolerance to spinally administered morphine (2016) Pharmacol. Rep., 68, pp. 472-475; 
Wei, L., Zhu, Y.M., Zhang, Y.X., Laing, F., Li, T., Gao, H.Y., Huo, F.Q., Yan, C.X., The alpha-1 adrenoceptors in ventrolateral orbital cotext contribute to the expression of morphine-induced behavioral sensitization in rats (2016) Neurosci. Lett., 610, pp. 30-35; 
Wei, X.B., Xiao, X., Han, Z.X., Lin, D.Q., Yu, P., The cytochrome P450 2D6*10 genetic polymorphism alters postoperative analgesia (2015) Int. J. Clin. Exp. Med., 8, pp. 2760-2765; 
Wei, Y.C., Zhang, B., Li, X., Liu, X.M., Zhang, J., Lei, B., Li, B., Li, Y., Upregulation and activation of delta opioid receptors promotes the progression of human breast cancer (2016) Oncol. Rep., 36, pp. 2579-2586; 
Weingarten, T.N., Chong, E.Y., Schroeder, D.R., Spung, J., Predictors and outcomes following naloxone administration during Phase I anesthesia recovery (2016) J. Anesth., 30, pp. 116-122; 
Weingarten, T.N., Hawkins, N.M., Bearn, W.B., Brandt, H.A., Koepp, D.J., Kellogg, T.A., Spung, J., Factos associated with prolonged anesthesia recovery following laparoscopic bariatric surgery: a retrospective analysis (2015) Obes. Surg., 25, pp. 1024-1030; 
Weingarten, T.N., McGlinch, B.P., Liedl, L., Kendrick, M.L., Kellogg, T.A., Schroeder, D.R., Spung, J., Intranasal nicotine increases post-operative nausea and is ineffective in reducing pain following laparoscopic bariatric surgery in tobacco–0naive females: a randomized, double-blind trial (2015) Obes. Surg., 25, pp. 506-513; 
Weisberg, D.F., Gordon, K.S., Barry, D.T., Becker, W.C., Crystal, S., Edelman, E.J., Gaither, J., Fiellin, D.A., Long-term prescription of opioids and/or benzodiazepines and mortality among HIV-infected and uninfected patients (2015) J. Acquir. Immune Defic. Syndr., 69, pp. 223-233; 
Weldon, E.R., Ariano, R.E., Grierson, R.A., Comparison of fentanyl and morphine in the prehospital treatment of ischemic type chest pain (2016) Prehosp. Emerg. Care, 20, pp. 45-51; 
Weltrowska, G., Nguyen, T.M., Chung, N.N., Wood, J., Ma, X., Guo, J., Wilkes, B.C., Schiller, P.W., A cyclic tretrapeptide (“Cyclodal”) and its mirror-image isomer are both high-affinity mu opioid receptor antagonists (2016) J. Med. Chem., 59, pp. 9243-9254; 
Wen, D.C., Hu, X.Y., Wang, Y.Y., Luo, J.X., Lin, W., Jia, L.Y., Gong, X.Y., Effects of aqueous extracts from Panax ginseng and Hippophae rhamnoides on acute alcohol intoxication: an experimental study using mouse model (2016) J. Ethnopharmacol., 192, pp. 67-73; 
Wendt-Hornickle, E., Snyder, L.B., Comparison of anesthesia with morphine-lidocaine-ketamine infusion or a morphine-lidocaine epidural on time to extubation in dogs (2016) Vet. Anesth. Analg., 43, pp. 86-90; 
West, N.A., Severtson, S.G., Green, J.L., Dart, R.C., Trends in abuse and misuse of prescription opioids among older adults (2015) Drug Alchol Depend., 149, pp. 117-121; 
Westanmo, A., Marshall, P., Jones, E., Burns, K., Krebs, E.E., Opioid dose reduction in a VA health care system – implementation of a primary-care population-level initiative (2015) Pain Med., 18, pp. 1019-1026; 
Wetmore, L.A., Pascoe, P.J., Shilo-Benjamini, Y., Lindsey, J.C., Effects of fentanyl administration on locomotor response in horses with the G57C mu-opioid receptor polymorphism (2016) Am. J. Vet. Res., 77, pp. 828-832; 
White, A.G., LeCates, J., Birnbaum, H.G., Cheng, W., Roland, C.L., Mardekian, J., Positive subjective measures in abuse liability studies and real-world nonmedical use: potential impact of abuse deterrent opioids on rates of nonmedical use and associated healthcare costs (2015) J. Opioid Manag., 11, pp. 199-210; 
Wibbenmeyer, L., Oltrogge, K., Kleusner, K., Zimmerman, M.B., Kealey, P.G., An evaluation of discharge opioid prescribing practices in a burn population (2015) J. Burn Care Res., 36, pp. 329-335; 
Wiebelhaus, J.M., Walentiny, D.M., Beardsley, P.M., Effects of acute and repeated administration of oxycodone and naloxone-precipitated withdrawal on intracranial self-stimulatioon in rats (2016) J. Pharmacol. Exp. Ther., 356, pp. 43-52; 
Wilkerson, J.L., Niphakis, M.J., Grim, T.W., Mustafa, M.A., Abdullah, R.A., Poklis, J.L., Dewey, W.L., Lichtman, A.H., The selective monoacylglycerol lipase inhibitor MJN110 produces opioid-sparing effects in a mouse neuropathic pain model (2016) J. Pharmacol. Exp. Ther., 357, pp. 145-156; 
Williams, C.J., James, L.E., Bertelsen, M.E., Wang, T., Tachycardia in response to remote capsaicin injection as a model for nociception in the ball python (Python regius) (2016) Vet. Anesth. Analg., 43, pp. 429-434; 
Wills, K.L., Petrie, G.N., Millett, G., Limebeer, C.L., Rock, E.M., Niphakis, M.J., Cravatt, B.F., Parker, L.A., Double dissociation of monoacylglycerol lipase inhibition and CB1 antagonism in the central amygdala, basolateral amygdala and the interoceptive insular cortex on the affective properties of acute naloxone-precipitated morphine withdrawl in rats (2016) Neuropsychopharamacology, 41, pp. 1865-1873; 
Windpassinger, M., Plattner, O., Gemeiner, J., Bohler, K., Luntzer, R., Klimscha, W., Yang, D., Sessler, D.I., Opioid use after propofol or sevoflurane anesthesia: a randomized trial (2016) Can. J. Anaesth., 63, pp. 1258-1265; 
Winpenny, D., Clark, M., Cawkill, D., Biased ligand quantification in drug discovery” from theory to high throughput screening to identify new biased mu opioid receptor agonists (2016) Br. J. Pharmacol., 173, pp. 1393-1403; 
Witkin, J.M., Rorick-Kehn, L.M., Benvenga, M.J., Adams, B.L., Gleason, S.D., Knitowski, K.M., Li, X., Statnick, M.A., Preclinical findings predicting efficacy and side-effect profile of LY2940094, an antagonist of nociception receptors (2016) Pharmacol. Res. Perspect., 4, p. 300275; 
Woode, E., Ameyaw, E.O., Abotsi, W.K., Boakye-Gyasi, E., An isobolographic analysis of the antinociceptive effect of xylopic acid in combination with morphine or diclofenac (2015) J. Basic Clin. Pharmacol., 6, pp. 103-108; 
Wu, F.X., He, Y., Di, H.T., Sun, Y.M., Pan, R.R., Yu, W.F., Liu, R., An engineered endomorphin-2 gene for morphine withdrawal syndrome (2016) PLoS One, 11, p. e0149877; 
Wu, K., Chen, C., Moyzis, R.K., Greenberger, E., Yu, Z., Gender interacts with opioid receptor polymorphism A118G and serotonin receptor polymorphism -1438 A/G on speed-dating success (2016) Hum. Nat., 27, pp. 244-260; 
Wu, W.Y., Liu, C.Y., Tsai, M.L., Yen, C.T., Nocifensive behavior-related laser heat-enoked component in the rostral agranular insular cortex revealed using morphine analgesia (2016) Physiol. Behav., 154, pp. 129-134; 
Xia, M., Tong, J.H., Zhou, Z.Q., Duan, M.L., Xu, J.G., Zeng, H.J., Wang, S.H., Tramadol inhibits proliferation, migration and invasion via alpha2-adrenoceptor signaling in breast cancer cells (2016) Eur. Rev. Med. Pharmacol. Sci., 20, pp. 157-165; 
Xiao, Z., Li, Y.Y., Sun, M.J., Activation of P2×7 receptors in the midbrain periaqueductal gray of rats facilitates morphine tolerance (2015) Pharmacol. Biochem. Behav., 135, pp. 145-153; 
Xie, K., Colgan, L.A., Dao, M.T., Muntean, B.S., Sutton, L.P., Orlandi, C., Bove, S.L., Martemyanov, K.A., NF1 is a direct G protein effector for opioid signaling to Ras in the striatum (2016) Curr. Biol., 26, pp. 2992-3003; 
Xin, J., Zhang, Y., He, Z., Wang, Z., Highly selective non-opioid kappa opioid receptor (KOR) agonist salvinorin A protects against forebrain ischemia-induced brain injury in rats (2016) Brain Res., 1637, pp. 168-176; 
Xing, J.G., Abdallah, F.W., Brull, R., Oldfield, S., Dold, A., Murnaghan, M.L., Whelan, D.B., Postoperative femoral nerve block for hip arthroplasty: a randomized, triple-maked controlled trial (2015) Am. J. Sports Med., 43, pp. 2680-2687; 
Xing, Z.M., Zhang, Z.Q., Zhang, W.S., Liu, Y.F., Effects of analgesia methods on serum IL-6 and IL-10 levels after cesarean delivery (2015) Genet. Mol. Res., 14, pp. 4778-4783; 
Xu, C., Fitting, S., Inhibition of GABAergic neurotransmission by HIV-1 Tat and opioid treatment in the striatum involves mu-opioid receptors (2016) Front. Neurosci., 10, p. 497; 
Xu, C., Zheng, H., Loh, H.H., Law, P.Y., Morphine promotes astrocyte-preferential differentiation of mouse hippocampal progenitor cells via PKC-epsilon-dependent ERK activation and TRBP phosphorylation (2015) Stem Cells, 33, pp. 2762-2772; 
Xu, G.G., Zolotarskaya, O.Y., Williams, D.A., Yuan, Y., Selley, D.E., Dewey, W.L., Akbarali, H.I., Zhang, Y., Nanoconjugated NAP as a potent and periphery selective mu opioid receptor modulator to treat opioid-induced constipation (2016) ACS Med. Chem. Lett., 8, pp. 78-83; 
Xu, H., Xu, T., Ma, X., Jiang, W., Involvement of neuronal TGF-beta activated kinase 1 in the development of tolerance to morphine-induced antinociception in rat spinal cord (2015) Br. J. Pharmacol., 172, pp. 2892-2904; 
Xu, J.T., Sun, L., Lutz, B.M., Bekkar, A., Tao, Y.X., Intrathecal rapamycin attenuates morphine-induced analgesic tolerance and hyperalgesia in rats with neuropathic pain (2015) Transl. Perioper Pain Med., 2, pp. 27-34; 
Xu, W., Daneshmand, S., Bazargani, S.T., Cai, J., Miranda, G., Schuckman, A.K., Djaladat, H., Postoperative pain management after radical cystectomy: comparing traditional and enhanced recovery protocol pathway (2015) J. Urol., 194, pp. 1208-1213; 
Xu, X., Gao, Y., Wen, L., Zhai, Z., Zhang, S., Shan, F., Feng, J., Methionine enkephalin regulaes microglia polarization and function (2016) Int. Immunopharmacol., 40, pp. 90-97; 
Xu, Y., Zhi, F., Shao, N., Wang, R., Yang, Y., Xia, Y., Cytoprotection against hypoxic and/or MPP injury: effect of delta-opioid receptor activation on capsase 3 (2016) Int. J. Mol. Sci., 17, p. E1179; 
Xu, Y., Lin, D., Yu, X., Xie, X., Wang, L., Lain, L., Fei, N., Pan, J., The antinociceptive effect of ferulic acid on neuropathic pain: involvement of descending monoaminergic system and opoioid receptors (2016) Oncologist, 7, pp. 20455-20468; 
Yadlapalli, J.S., Ford, B.M., Ketkar, A., Wan, A., Penthala, N.R., Eoff, R.L., Prather, P.L., Crooks, P.A., Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: comparative role of mu- and delta-opioid receptors (2016) Pharmacol. Res., 113, pp. 335-347; 
Yamada, T., Kanazawa, Y., Aoki, Y., Uchida, E., Incidence of nausea and vomiting induced by oxycodone administered with prochlorperazine in Japanese cancer patients (2015) J. Nippon Med. Sch., 82, pp. 100-105; 
Yan, T., Rizak, J.D., Wang, J., Yang, S., Ma, Y., Hu, X., Severe dopaminergic neuron loss in rhesus monkey brain impairs morphine-induced conditioned place preference (2015) Front. Behav. Neurosci., 9, p. 273; 
Yan, X., Yan, Z., Lai, W., Ding, H., Qiao, S., Chen, G., Wang, X., Zhang, L., External application of traditional Chinese medicine in the treatment of bone cancer pain: a meta-analysis (2016) Support. Care Cancer, 24, pp. 11-17; 
Yang, D.J., Lee, K.S., Ko, C.M., Moh, S.H., Song, J., Hur, L.C., Cheon, Y.W., Kim, K.W., Leucine-enkephalin promotes wound repair through the regulation of hemidesmosome dynamics and matrix metalloprotease (2016) Peptides, 76, pp. 57-64; 
Yang, H.C., Chu, S.K., Huang, C.L., Kuo, H.W., Wang, S.C., Liu, S.W., Ho, I.K., Liu, Y.L., Genome-wide pharmacogenetic study on methadone maintenance treatment identifies SNP rs17180299 and multiple haplotypes on CYP2B6, SPON1 and GSGL1L associated with plasma concentrations of methadone R- and S-enantiomers in heroin-depemndent patients (2016) PLoS One, 12, p. e1005910; 
Yang, J.A., Yasrebi, A., Snyder, M., Roepke, T.A., The interaction of fasting, caloric restriction and diet-induced obesity with 17 beta-estradiol on the expression of KNDy neuropeptides and their receptors in the female mouse (2016) Med. Cell. Endocrinol., 437, pp. 35-50; 
Yang, L.H., Xu, G.M., Wang, Y., Up-regulation of CXCL1 and CXCR2 contributes to remifentanil-induced hypernociception via modulating spinal NMDA receptor expression and phosphorylation in rats (2016) Neurosci. Lett., 626, pp. 135-141; 
Yang, P.P., Yeh, G.C., Yeh, T.K., Xi, J., Loh, H.H., Law, P.Y., Tao, P.L., Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice (2016) Pharmacol. Res., 111, pp. 867-876; 
Yang, S.P., Muo, C.H., Wang, I.K., Chang, Y.J., Lai, S.W., Lee, C.W., Morisky, D.E., Risk of diabetes mellitus in female breast cancer patients treated with morphine: a retrospective population-based time-dependent cohort study (2015) DiabetsRes. Clin. Pract., 110, pp. 285-290. , (16.4); 
Yang, X., Peng, N., Li, N., Li, J., Effect of cyclooxygenase-2-specific inhibotrs on postoperative analgesia after major open abdominal surgery (2015) Pain Manag. Nurs., 16, pp. 242-248; 
Yao, P., Ding, Y., Wang, Z., Ma, J., Hong, T., Zhu, Y., Li, H., Pan, S., Impacts of anti-nerve growth factor antibody on pain-related behaviors and expressions of opioid receptor in spinal dorsal horn and dorsal root ganglion of rats with cancer-induced bone pain (2016) Mol. Pain, 12. , 1744806916644928; 
Yawata, T., Higashi, Y., Shimizu, T., Shimizu, S., Nakamura, K., Taniuchi, K., Ueba, T., Saito, M., Brain opioid and nociception receptors are involved in the regulation of bombesin-induced activation of sympatho-adrenomedullary outflow in the rat (2016) Mol. Cell. Biochem., 411, pp. 201-211; 
Ye, L., Xiao, L., Bai, X., Yang, S.Y., Li, Y., Chen, Y., Cui, Y., Chen, Y., Spinal mitochondrial-derived ROS contributes to remifentanil-induced postoperative hyperalgesia via modulating NMDA receptor in rats (2016) Neurosci. Lett., 634, pp. 79-86; 
Yen, D., Turner, K., Mark, D., Is a single low dose of intrathecal morphine a useful adjunct to patient-controlled analgesia for postoperative pain control following lumbar spine surgery? A preliminary report (2015) Pain Res. Manag., 20, pp. 129-132; 
Yi, Z., Guo, S., Hu, X., Wang, X., Zhang, X., Griffin, N., Shan, F., Functional modulation on macrophage by low dose naltrexone (LDN) (2016) Int. Immunopharmacol., 39, pp. 397-402; 
Yokota, E., Koyanagi, Y., Nakamura, H., Horinuki, E., Oi, Y., Kobayashi, M., Opposite effects of mu and delta opioid receptor agonists on excitatory propagation induced in rat somatosensory and insular cortices by dental pulp stimulation (2016) Neurosci. Lett., 626, pp. 52-58; 
Yokota, E., Koyanagi, Y., Yamamoto, K., Oi, Y., Koshikawa, N., Kobayashi, M., Opioid subtype- and cell-type-dependent regulation of inhibitory synaptic transmission in the rat insula cortex (2016) Neuroscience, 339, pp. 478-490; 
Zadina, J.E., Nilges, M.R., Morgenweck, J., Zhang, X., Hackler, L., Fasold, M.B., Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance and glial activation relative to morphine (2016) Neuropharmacology, 105, pp. 215-227; 
Zakeria, Z.A., Jaios, E.S., Omar, M.H., Abd Rahman, S., Hamid, S.S., Ching, S.M., The, L.K., Taher, M., Antinociception of petroleum ether fraction derived from crude methanol extract of Melkastoma malabathricum leaves and its possible mechanisms of action in naumimal models (2016) BMC Complement. Altern. Med., 16, p. 488; 
Zan, G.Y., Wang, Q., Wang, Y.J., Wu, X., Yang, C.H., Chai, J.R., Li, M., Liu, J.G., P38 mitogen-activated protein kinase activation in amygdala mediates kappa opioid receptor agonist U50488H-induced conditioned place aversion (2016) Neuroscience, 320, pp. 122-128; 
Zeidan, F., Adler-Neal, A.L., Wells, R.E., Stagnaro, E., May, L.M., Eisenach, J.C., McHaffie, J.G., Coghill, R.C., Mindfulness-meditation-based pain relief is not mediated by endogenous opioids (2016) J. Neurosci., 36, pp. 3391-3397; 
Zeinivand, M., Pourshanazari, A.A., Hassanshahi, G., Coronary angiogenesis during morphine and nicotine withdrawal in two-kidney one clip hypertensive (2K1C) rats (2015) Bratisl. Lek. Listy, 118, pp. 554-559; 
Zengin, S.U., Saracoglu, A., Eti, Z., Umuroglu, T., Gogus, F.Y., The effects of preoperative oral pregabalin and perioperative intravenous lidocaine infusion on postoperative morphine requirement in patients undergoing laparotomy (2015) Pain Res. Manag., 20, pp. 179-182; 
Zhan, B., Ma, H.Y., Wang, J.L., Liu, C.B., Sex differences in morphine-induced behavioral sensitization and social behaviors in ICR mice (2015) Dongwuxue Yanjiu, 36, pp. 103-108; 
Zhang, C., Franklin, T., Sarkar, D.K., Inhibition of mammary cancer progression in fetal alcohol exposed rats by beta-endorphin neurons (2016) Alcohol. Clin. Exp. Res., 40, pp. 134-140; 
Zhang, G., Wu, X., Zhang, Y.M., Liu, H., Jiang, Q., Pang, G., Tao, X., Stackman, R.W., Jr., Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice (2016) Neuropharmacology, 101, pp. 246-254; 
Zhang, J., McDonald, A.J., Light and electron microscopic analysis of enkephalin-like immunoreactivity in the basolateral amygdala, including evidence for convergence of enkephalin-containing axon terminals and norepinephrine transporter-containing axon terminals onto common targets (2016) Brain Res., 1636, pp. 62-73; 
Zhang, J.J., Liu, X.D., Yu, L.C., Influences of morphine on the spontaneous and evoked excitatory postsynaptic currents in lateral amygdala of rats (2016) Physiol. Res., 65, pp. 165-169; 
Zhang, L., Stuber, F., Lippuner, C., Schiff, M., Stamer, U.M., Phorbol-12-myristate-13-acetate induces nociception in human Mono Mac 6 cells via multiple transduction signalling pathways (2016) Br. J. Anesth., 117, pp. 250-257; 
Zhang, L.S., Wang, Y.J., Ju, Y.Y., Zan, G.Y., Xu, C., Hong, M.H., Wang, Y.H., Liu, J.G., Role for engagement of beta-arrestin 2 by the transactivated EGFR in agonist-specific regulation of delta receptor activation of ERK1/2 (2016) Br. J. Pharmacol., 172, pp. 4847-4863; 
Zhang, M., Wang, K., Ma, M., Tian, S., Wei, N., Wang, G., Low-dose cannabinoid type 2 receptor agonist attenuates tolerance to repeated morphine administration via regulating mu opioid receptor expression in Walker 256 tumor-bearing rats (2016) Anesth. Analg., 122, pp. 1031-1037; 
Zhang, Q., Liu, Q., Li, T., Wang, L., Zhang, Z., Liu, H., Hu, M., Niu, H., Expression and colocolozation of NMDA receptor and FosB/deltaFosB in sensitive brain regions in rats after chronic morphine exposure (2016) Neurosci. Lett., 614, pp. 70-76; 
Zhang, S., Paul, J., Nantha-Aree, M., Buckley, N., Shahzad, U., Cheng, J., DeBeer, J., Thabane, L., Reanalysis of morphine consumption from two randomized controlled trials of gabapentin using longitudinal statistical methods (2015) J. Pain Res., 8, pp. 79-85; 
Zhang, X., Wang, J., Yu, T., Du, D., Jian\g, W., Minocycline can delay the development of morphine tolerance, but cannot reverse exising tolerance in the maintenance period of neuropathic pain in rats (2015) Clin. Exp. Pharmacol. Physiol., 42, pp. 94-101; 
Zhang, X., Shu, L., Lin, C., Yang, P., Zhou, Y., Wang, Q., Wu, Y., Li, T., Comparison between intraoperative two-space injection thoracic paravertebral block and wound infiltration as a component of multimodal analgesia for postoperative pain management after video-assisted thorascopic lobectomy: a randomized controlled trial (2015) J. Cardiothrorac. Visc. Anesth., 29, pp. 1550-1556; 
Zhang, Y., Chen, S.R., Laumet, G., Chen, H., Pan, H.L., Nerve injury diminishes opioid analgesia through lysine methyltransferase-mediated transcriptional repression of mu-opioid receptors in primary sensory neurons (2016) J. Biol. Chem., 291, pp. 8475-8485; 
Zhang, Y., Williams, D.A., Zaidi, S.A., Yuan, Y., Braithwaite, A., Bilsky, E.J., Dewey, W.L., Selley, D.E., 17-cyclopropopylmethyl-3, 14beta-dihyfdroxy-4, 5alpha-epoxy-6beta-(4′-pyridylcarboxamido)morphinan (NAP) modulating the mu opioid receptor in a biased fashion (2016) ACS Chem. Neurosci., 7, pp. 297-304; 
Zhao, J., Wang, H., Song, T., Yang, Y., Gu, K., Ma, P., Zhang, Z., Wang, W., Thalidomide promotes morphine efficacy and prevents morphine-induced trolerance in rats with diabetic neuropathy (2016) Neurochem. Res., 41, pp. 3171-3180; 
Zhi, F., Xue, L., Shao, N., Deng, D., Kang, X., Chao, D., Xu, Y., Xia, Y., Delta-opioid receptor activation and mRNA expression in the rat heart under prolonged hypoxia (2016) Cell. Physiol. Biochem., 39, pp. 1118-1128; 
Zhou, P., Li, Y., Yong, Z., Yan, H., Su, R., Gong, Z., Effects of thienorphine on the contraction of isolated ureter and bladder of guinea pigs (2016) Eur. J. Pharmacol., 789, pp. 144-151; 
Zhou, T., Zhang, X., Dong, Y., Zhuang, F., Jiang, F., Yu, J., Zhang, B., High-dose oxycontin to treat pain associated with bone metastasis in parients with small-cell lung cancer: a case study report (2016) Drug Des. Dev. Ther., 10, pp. 383-387; 
Zhou, X., Zhang, C., Wang, M., Yu, L., Yan, M., Dezocine for preventing postoperative pain: a meta-analysis of randomized controlled pain (2015) PLoS One, 10, p. e136091; 
Zhu, Q., Mao, L.N., Liu, C.P., Sun, Y.H., Jiang, B., Zhang, W., Li, J.X., Antinociceptive effects of vitexin in a mouse model of postoperative pain (2016) Sci. Rep., 6, p. 19266; 
Zhu, X., Sun, W., Li, X., Tan, S., Zhang, X., Effects of spatial memory on morphine CPP and locomotor sensitization in mice (2015) Physiol. Behav., 149, pp. 187-191; 
Zhu, Y., Wienecke, C.F., Nachtrab, G., Chen, X., A thalamic input to the nucleus accumbens mediates opioid dependence (2016) Nature, 530, pp. 219-222; 
Zhu, Y., Zhang, H., Evidence for the contribution of genetic variations in regulator of G protein signaling 9 to the genetic susceptibility of heroin dependence (2015) Mol. Med. Rep., 11, pp. 3908-3913; 
Zielinska, M., Jamuz, A., Salaga, M., Lipkowski, A.W., Fichna, J., Mixed MOP/DOP agonist biphalin elicits anti-transit effect in mouse models mimicking diarrhea-predominant irritable bowel syndrome symptoms (2016) Pharmacol. Rep., 68, pp. 32-36; 
Zimmerman, K.O., Hornik, C.P., Ku, L., Watt, K., Laughon, M.M., Bidegain, M., Clark, R.H., Smith, P.B., Sedatives and analgesics given to infants in neonatal intensive care units at the end of life (2015) J. Pediatr., 167, pp. 299-304; 
Ziolkowska, B., Gieryk, A., Solecki, W., Przewlocki, R., Temporal and anatomic patterns of immediate-early gene expression in the forebrain of C57BL/6 and DBA/2 mice after morphine administration (2015) Neuroscience, 284, pp. 107-124
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041696692&doi=10.1016%2fj.peptides.2018.01.011&partnerID=40&md5=d51a67bfca013c12ad078fee8a88a7e5
ER  - 

TY  - JOUR
TI  - Dopaminergic and opioid pathways associated with impulse control disorders in Parkinson's disease
T2  - Frontiers in Neurology
J2  - Front. Neurol.
VL  - 9
IS  - FEB
PY  - 2018
DO  - 10.3389/fneur.2018.00109
SN  - 16642295 (ISSN) 
AU  - Erga, A.H.
AU  - Dalen, I.
AU  - Ushakova, A.
AU  - Chung, J.
AU  - Tzoulis, C.
AU  - Tysnes, O.B.
AU  - Alves, G.
AU  - Pedersen, K.F.
AU  - Maple-Grødem, J.
AD  - The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway
AD  - Department of Research, Section of Biostatistics, Stavanger University Hospital, Stavanger, Norway
AD  - Department of Neurology, Haukeland University Hospital, Bergen, Norway
AD  - Department of Clinical Medicine, University of Bergen, Bergen, Norway
AD  - Department of Neurology, Stavanger University Hospital, Stavanger, Norway
AD  - Department of Mathematics and Natural Sciences, University of Stavanger, Stavanger, Norway
AD  - The Centre for Organelle Research, University of Stavanger, Stavanger, Norway
AB  - Introduction: Impulse control disorders (ICDs) are frequent non-motor symptoms in Parkinson's disease (PD), with potential negative effects on the quality of life and social functioning. ICDs are closely associated with dopaminergic therapy, and genetic polymorphisms in several neurotransmitter pathways may increase the risk of addictive behaviors in PD. However, clinical differentiation between patients at risk and patients without risk of ICDs is still troublesome. The aim of this study was to investigate if genetic polymorphisms across several neurotransmitter pathways were associated with ICD status in patients with PD. Methods: Whole-exome sequencing data were available for 119 eligible PD patients from the Norwegian ParkWest study. All participants underwent comprehensive neurological, neuropsychiatric, and neuropsychological assessments. ICDs were assessed using the self-report short form version of the Questionnaire for Impulsive-Compulsive Disorders in PD. Single-nucleotide polymorphisms (SNPs) from 17 genes were subjected to regression with elastic net penalization to identify candidate variants associated with ICDs. The area under the curve of receiver-operating characteristic curves was used to evaluate the level of ICD prediction. Results: Among the 119 patients with PD included in the analysis, 29% met the criteria for ICD and 63% were using dopamine agonists (DAs). Eleven SNPs were associated with ICDs, and the four SNPs with the most robust performance significantly increased ICD predictability (AUC = 0.81, 95% CI 0.73-0.90) compared to clinical data alone (DA use and age; AUC = 0.65, 95% CI 0.59-0.78). The strongest predictive factors were rs5326 in DRD1, which was associated with increased odds of ICDs, and rs702764 in OPRK1, which was associated with decreased odds of ICDs. Conclusion: Using an advanced statistical approach, we identified SNPs in nine genes, including a novel polymorphism in DRD1, with potential application for the identification of PD patients at risk for ICDs. © 2018 Erga, Dalen, Ushakova, Chung, Tzoulis, Tysnes, Alves, Pedersen and Maple-Grødem.
KW  - Addiction
KW  - DRD1
KW  - Elastic net
KW  - Impulse control disorders
KW  - OPRK1
KW  - Parkinson's disease
KW  - dopamine receptor stimulating agent
KW  - opiate
KW  - age
KW  - aged
KW  - Article
KW  - controlled study
KW  - cross-sectional study
KW  - depression
KW  - disease association
KW  - dopaminergic system
KW  - DRD1 gene
KW  - female
KW  - gene
KW  - gene identification
KW  - genetic risk
KW  - human
KW  - impulse control disorder
KW  - major clinical study
KW  - male
KW  - Montgomery and Aasberg Depression Rating Scale
KW  - neurologic examination
KW  - neuropsychological test
KW  - Norway
KW  - OPRK1 gene
KW  - Parkinson disease
KW  - patient identification
KW  - performance
KW  - prediction
KW  - psychologic test
KW  - questionnaire
KW  - Questionnaire for Impulsive-Compulsive Disorders in Parkinson Disease
KW  - rating scale
KW  - receiver operating characteristic
KW  - self report
KW  - single nucleotide polymorphism
KW  - Unified Parkinson Disease Rating Scale
KW  - whole exome sequencing
PB  - Frontiers Media S.A.
N1  - Cited By :5
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C7  - 109
LA  - English
N1  - Correspondence Address: Erga, A.H.; The Norwegian Centre for Movement Disorders, Stavanger University HospitalNorway; email: aleksander.erga@gmail.com
N1  - Chemicals/CAS: opiate, 53663-61-9, 8002-76-4, 8008-60-4
N1  - References: Weintraub, D., Koester, J., Potenza, M.N., Siderowf, A.D., Stacy, M., Voon, V., Impulse control disorders in Parkinson disease: a cross-sectional study of 3, 090 patients (2010) Arch Neurol, 67 (5), pp. 589-595; 
Erga, A.H., Alves, G., Larsen, J.P., Tysnes, O.B., Pedersen, K.F., Impulsive and compulsive behaviors in Parkinson's disease: the Norwegian ParkWest study (2017) J Parkinsons Dis, 7 (1), pp. 183-191; 
Weintraub, D., Papay, K., Siderowf, A.D., Screening for impulse control symptoms in patients with de novo Parkinson disease-a case-control study (2013) Neurology, 80, pp. 176-180; 
Grosset, D.G., Cardoso, F., Lees, A., Dopamine agonists vs levodopa in impulse control disorders (2011) Arch Neurol, 68 (4), pp. 544-546; 
Voon, V., Thomsen, T., Miyasaki, J.M., de Souza, M., Shafro, A., Fox, S.H., Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease (2007) Arch Neurol, 64 (2), pp. 212-216; 
Lee, J.Y., Lee, E.K., Park, S.S., Lim, J.Y., Kim, H.J., Kim, J.S., Association of DRD3 and GRIN2B with impulse control and related behaviors in Parkinson's disease (2009) Mov Disord, 24 (12), pp. 1803-1810; 
Hoenicka, J., Garcia-Ruiz, P.J., Ponce, G., Herranz, A., Martinez-Rubio, D., Perez-Santamarina, E., The addiction-related gene ANKK1 in parkinsonian patients with impulse control disorder (2015) Neurotox Res, 27 (3), pp. 205-208; 
Zainal Abidin, S., Tan, E.L., Chan, S.C., Jaafar, A., Lee, A.X., Abd Hamid, M.H., DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson's disease patients (2015) BMC Neurol, 15, p. 59; 
Krishnamoorthy, S., Rajan, R., Banerjee, M., Kumar, H., Sarma, G., Krishnan, S., Dopamine D3 receptor Ser9Gly variant is associated with impulse control disorders in Parkinson's disease patients (2016) Parkinsonism Relat Disord, 30, pp. 13-17; 
Lee, J.Y., Jeon, B.S., Kim, H.J., Park, S.S., Genetic variant of HTR2A associates with risk of impulse control and repetitive behaviors in Parkinson's disease (2012) Parkinsonism Relat Disord, 18 (1), pp. 76-78; 
Cilia, R., Benfante, R., Asselta, R., Marabini, L., Cereda, E., Siri, C., Tryptophan hydroxylase type 2 variants modulate severity and outcome of addictive behaviors in Parkinson's disease (2016) Parkinsonism Relat Disord, 29, pp. 96-103; 
Kraemmer, J., Smith, K., Weintraub, D., Guillemot, V., Nalls, M.A., Cormier-Dequaire, F., Clinical-genetic model predicts incident impulse control disorders in Parkinson's disease (2016) J Neurol Neurosurg Psychiatry, 87 (10), pp. 1106-1111; 
Alves, G., Muller, B., Herlofson, K., HogenEsch, I., Telstad, W., Aarsland, D., Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study (2009) J Neurol Neurosurg Psychiatry, 80 (8), pp. 851-857; 
Fahn, S., Elton, R., Unified Parkinson's Disease Rating Scale (1987) Recent Development in Parkinson's Disease, pp. 153-163. , Fahn S, Marsden C, Calne D, editors. Florham Park, NJ: MacMillan Health Care Information; 
Hoehn, M.M., Yahr, M.D., Parkinsonism: onset, progression and mortality (1967) Neurology, 17 (5), pp. 427-442; 
Tomlinson, C., Stowe, R., Patel, S., Rick, C., Gray, R., Clarke, C., Systematic review of levodopa dose equivalency reporting in Parkinson's disease (2010) Mov Disord, 25 (15), pp. 2649-2653; 
Folstein, M.F., Folstein, S.E., McHugh, P.R., Mini mental state. A practical method for grading the cognitive state of patients for the clinician (1975) J Psychiatr Res, 12 (3), pp. 189-198; 
Montgomery, S.A., Asberg, M., A new depression scale designed to be sensitive to change (1979) Br J Psychiatry, 134, pp. 382-389; 
Weintraub, D., Mamikonyan, E., Papay, K., Shea, J.A., Xie, S.X., Siderowf, A., Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (2012) Mov Disord, 27 (2), pp. 242-247; 
Weintraub, D., Hoops, S., Shea, J.A., Lyons, K.E., Pahwa, R., Driver-Dunckley, E.D., Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease (2009) Mov Disord, 24 (10), pp. 1461-1467; 
Johnson, A.D., Handsaker, R.E., Pulit, S.L., Nizzari, M.M., O'Donnell, C.J., de Bakker, P.I., SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap (2008) Bioinformatics, 24 (24), pp. 2938-2939; 
Lange, J., Lunde, K.A., Sletten, C., Moller, S.G., Tysnes, O.B., Alves, G., Association of a BACE1 gene polymorphism with Parkinson's disease in a Norwegian population (2015) Parkinsons Dis, 2015; 
Lange, K., Papp, J.C., Sinsheimer, J.S., Sobel, E.M., Next generation statistical genetics: modeling, penalization, and optimization in high-dimensional data (2014) Annu Rev Stat Appl, 1 (1), pp. 279-300; 
Pavlou, M., Ambler, G., Seaman, S., De Iorio, M., Omar, R.Z., Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events (2016) Stat Med, 35 (7), pp. 1159-1177; 
Wei, Z., Wang, W., Bradfield, J., Li, J., Cardinale, C., Frackelton, E., Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease (2013) Am J Hum Genet, 92 (6), pp. 1008-1012; 
Huls, A., Ickstadt, K., Schikowski, T., Kramer, U., Detection of gene-environment interactions in the presence of linkage disequilibrium and noise by using genetic risk scores with internal weights from elastic net regression (2017) BMC Genet, 18, p. 55; 
Schelldorfer, J., Meier, L., Bühlmann, P., GLMMLasso: an algorithm for high-dimensional generalized linear mixed models using l1-penalization (2014) J Comput Graph Stat, 23 (2), pp. 460-477; 
van Dunnen, J., Antonarakis, S., Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion (2000) Hum Mutat, 15, pp. 7-12; 
Rothmond, D.A., Weickert, C.S., Webster, M.J., Developmental changes in human dopamine neurotransmission: cortical receptors and terminators (2012) BMC Neurosci, 13, p. 18; 
Fasano, A., Petrovic, I., Insights into pathophysiology of punding reveal possible treatment strategies (2010) Mol Psychiatry, 15 (6), pp. 560-573; 
Comings, D.E., Gade, R., Wu, S., Chiu, C., Dietz, G., Muhleman, D., Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors (1997) Mol Psychiatry, 2 (1), pp. 44-56; 
Huang, W., Ma, J.Z., Payne, T.J., Beuten, J., Dupont, R.T., Li, M.D., Significant association of DRD1 with nicotine dependence (2008) Hum Genet, 123 (2), pp. 133-140; 
Pan, Y., Yao, J., Wang, B., Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis (2014) Neuropsychiatr Dis Treat, 10, pp. 1133-1139; 
Levran, O., Randesi, M., da Rosa, J.C., Ott, J., Rotrosen, J., Adelson, M., Overlapping dopaminergic pathway genetic susceptibility to heroin and cocaine addictions in African Americans (2015) Ann Hum Genet, 79 (3), pp. 188-198; 
Tsang, J., Fullard, J.F., Giakoumaki, S.G., Katsel, P., Katsel, P., Karagiorga, V.E., The relationship between dopamine receptor D1 and cognitive performance (2015) NPJ Schizophr, 1, p. 14002; 
Zhao, L., Lin, Y., Lao, G., Wang, Y., Guan, L., Wei, J., Association study of dopamine receptor genes polymorphism with cognitive functions in bipolar I disorder patients (2015) J Affect Disord, 170, pp. 85-90; 
Blum, K., Sheridan, P., Wood, R., Braverman, E., Chen, T.J., Cull, J., The D2 dopamine receptor gene as a determinant of reward deficiency syndrome (1996) J R Soc Med, 89, pp. 396-400; 
Seeman, P., Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors (2015) Synapse, 69 (4), pp. 183-189; 
Ritchie, T., Noble, E.P., Association of seven polymorphisms of the D2 dopamine receptor-binding characteristics (2003) Neurochem Res, 28 (1), pp. 73-82; 
Rodriguez-Jimenez, R., Hoenicka, J., Jimenez-Arriero, M.A., Ponce, G., Bagney, A., Aragues, M., Performance in the Wisconsin Card Sorting Test and the C957T polymorphism of the DRD2 gene in healthy volunteers (2006) Neuropsychobiology, 54 (3), pp. 166-170; 
Doehring, A., Hentig, N., Graff, J., Salamat, S., Schmidt, M., Geisslinger, G., Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution (2009) Pharmacogenet Genomics, 19 (6), pp. 407-414; 
Colzato, L.S., van den Wildenberg, W.P., Van der Does, A.J., Hommel, B., Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity (2010) Neuroscience, 170 (3), pp. 782-788; 
Markett, S.A., Montag, C., Reuter, M., The association between dopamine DRD2 polymorphisms and working memory capacity is modulated by a functional polymorphism on the nicotinic receptor gene CHRNA4 (2010) J Cogn Neurosci, 22 (9), pp. 1944-1954; 
Stelzel, C., Basten, U., Montag, C., Reuter, M., Fiebach, C.J., Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density (2010) J Neurosci, 30 (42), pp. 14205-14212; 
Markett, S., Reuter, M., Montag, C., Weber, B., The dopamine D2 receptor gene DRD2 and the nicotinic acetylcholine receptor gene CHRNA4 interact on striatal gray matter volume: evidence from a genetic imaging study (2013) Neuroimage, 64, pp. 167-172; 
Cox, S.M., Frank, M.J., Larcher, K., Fellows, L.K., Clark, C.A., Leyton, M., Striatal D1 and D2 signaling differentially predict learning from positive and negative outcomes (2015) Neuroimage, 109, pp. 95-101; 
Aracil-Bolanos, I., Strafella, A.P., Molecular imaging and neural networks in impulse control disorders in Parkinson's disease (2016) Parkinsonism Relat Disord, 22, pp. S101-S105; 
Chefer, V.I., Czyzyk, T., Bolan, E.A., Moron, J., Pintar, J.E., Shippenberg, T.S., Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine (2005) J Neurosci, 25 (20), pp. 5029-5037; 
Levran, O., Yuferov, V., Kreek, M.J., The genetics of the opioid system and specific drug addictions (2012) Hum Genet, 131 (6), pp. 823-842; 
Spanagel, R., Herz, A., Shippenberg, T.S., Opposing tonical active endogenous opioid systems modulate the mesolimbic dopaminergic pathway (1992) Proc Natl Acad Sci U S A, 89, pp. 2046-2050; 
Huiping Zhang, Z.L., Analyzing interaction of μ-, δ-and γ-opioid receptor gene variants on alcohol or drug dependence using a pattern discovery-based method (2012) J Addict Res Ther, 7, p. 007; 
Crowley, N.A., Kash, T.L., Kappa opioid receptor signaling in the brain: circuitry and implications for treatment (2015) Prog Neuropsychopharmacol Biol Psychiatry, 62, pp. 51-60; 
Papay, K., Xie, S.X., Stern, M., Hurtig, H., Siderowf, A., Duda, J.E., Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study (2014) Neurology, 83 (9), pp. 826-833; 
Blum, K., Braverman, E.R., Holder, J.M., Lubar, J.F., Monastra, V.J., Miller, D., The reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive and compulsive behaviors (2000) J Psychoactive Drugs, 32, pp. 1-112; 
Blum, K., Febo, M., Badgaiyan, R.D., Demetrovics, Z., Simpatico, T., Fahlke, C., Common neurogenetic diagnosis and meso-limbic manipulation of hypodopaminergic function in reward deficiency syndrome (RDS): changing the recovery landscape (2017) Curr Neuropharmacol, 15 (1), pp. 184-194; 
Santangelo, G., Raimo, S., Barone, P., The relationship between impulse control disorders and cognitive dysfunctions in Parkinson's disease: a meta-analysis (2017) Neurosci Biobehav Rev, 77, pp. 129-147; 
Voon, V., Napier, T.C., Frank, M.J., Sgambato-Faure, V., Grace, A.A., Rodriguez-Oroz, M., Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update (2017) Lancet Neurol, 16 (3), pp. 238-250; 
Cormier, F., Muellner, J., Corvol, J.C., Genetics of impulse control disorders in Parkinson's disease (2013) J Neural Transm, 120 (4), pp. 665-671
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042685121&doi=10.3389%2ffneur.2018.00109&partnerID=40&md5=03b7faeb90e555d38f9b6a5ed782206a
ER  - 

TY  - JOUR
TI  - Focusing on the Opioid System for Addiction Biomarker Discovery
T2  - Trends in Molecular Medicine
J2  - Trends Mol. Med.
VL  - 24
IS  - 2
SP  - 206
EP  - 220
PY  - 2018
DO  - 10.1016/j.molmed.2017.12.004
SN  - 14714914 (ISSN) 
AU  - Belzeaux, R.
AU  - Lalanne, L.
AU  - Kieffer, B.L.
AU  - Lutz, P.-E.
AD  - McGill Group for Suicide Studies, Douglas Hospital Research Center, Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, QC, Canada
AD  - Pôle de Psychiatrie, Assistance Publique Hôpitaux de Marseille, Marseille, France
AD  - Department of Psychiatry and Addictology, University Hospital of Strasbourg and Medical School of Strasbourg, Strasbourg, France
AD  - Fédération de Médecine Translationnelle de Strasbourg, University Hospital of Strasbourg and Medical School of Strasbourg, Strasbourg, France
AD  - INSERM 1114, Department of Psychiatry and Addictology, University Hospital of Strasbourg, Strasbourg, France
AD  - Douglas Hospital Research Center, Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, QC, Canada
AD  - Institut des Neurosciences Cellulaires et Intégratives, CNRS UPR 3212, Strasbourg, France
AD  - INT-UMR7289, CNRS Aix-Marseille Université, Marseille, France
AB  - Substance use disorders (SUD) and behavioral addictions are devastating conditions that impose a severe burden on all societies, and represent difficult challenges for clinicians. Therefore, biomarkers are urgently needed to help predict vulnerability, clinical course, and response to treatment. Here, we elaborate on the potential for addiction biomarker discovery of the opioid system, particularly within the emerging framework aiming to probe opioid function in peripheral tissues. Mu, delta, and kappa opioid receptors all critically regulate neurobiological and behavioral processes that define addiction, and are also targeted by major pharmacotherapies used in the management of patients with SUD. We propose that opioid biomarkers may have the potential to improve and guide diagnosis and therapeutic decisions in the addiction field. © 2017 Elsevier Ltd
KW  - addiction
KW  - biomarker
KW  - brain imaging
KW  - epigenetic
KW  - genetic
KW  - opioid receptor
KW  - delta opiate receptor
KW  - kappa opiate receptor
KW  - mu opiate receptor
KW  - biological marker
KW  - opiate receptor
KW  - alcohol consumption
KW  - behavioral addiction
KW  - binge eating disorder
KW  - CpG island
KW  - decision making
KW  - DNA methylation
KW  - drug dependence
KW  - enzyme activation
KW  - epigenetics
KW  - exosome
KW  - feasibility study
KW  - functional magnetic resonance imaging
KW  - genome-wide association study
KW  - human
KW  - induced pluripotent stem cell
KW  - neonatal abstinence syndrome
KW  - nonhuman
KW  - pathophysiology
KW  - pharmacogenomics
KW  - positron emission tomography
KW  - protein binding
KW  - Review
KW  - signal transduction
KW  - single nucleotide polymorphism
KW  - skin biopsy
KW  - transcriptomics
KW  - addiction
KW  - drug dependence
KW  - metabolism
KW  - Behavior, Addictive
KW  - Biomarkers
KW  - Humans
KW  - Receptors, Opioid
KW  - Substance-Related Disorders
PB  - Elsevier Ltd
N1  - Cited By :6
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
N1  - CODEN: TMMRC
C2  - 29396147
LA  - English
N1  - Correspondence Address: Lutz, P.-E.; McGill Group for Suicide Studies, Douglas Hospital Research Center, Department of Psychiatry, Faculty of Medicine, McGill UniversityCanada; email: pierreeric.lutz@gmail.com
N1  - Chemicals/CAS: Biomarkers; Receptors, Opioid
N1  - Funding details: Fondation Pierre Deniker pour la Recherche et la Prévention en Santé Mentale
N1  - Funding details: American Foundation for Suicide Prevention
N1  - Funding details: Fondation Fyssen
N1  - Funding details: Canadian Institutes of Health Research
N1  - Funding details: Fondation pour la Recherche Médicale
N1  - Funding text 1: R.B. was supported by a 1-year scholarship from the Fondation FondaMental (France). P-E.L. was supported by scholarships from the Fondation Fyssen , the Fondation Bettencourt-Schueller , the Canadian Institutes of Health Research , the American Foundation of Suicide Prevention , the Fondation pour la Recherche Médicale , and the Fondation Deniker . The authors are grateful to Cecilia Paasche for critical reading of the manuscript. Behavioral addiction syndrome analogous to substance addiction, with a behavioral focus other than the use of a psychoactive substance. It corresponds to a reinforcement derived from the performance of a specific behavior, and notably includes gambling disorder (now in DSM-5), sexual addiction, compulsive buying, and eating disorders. Biased agonism phenomenon whereby G-protein-coupled receptors exist under various agonist-dependent conformations that form specific ternary complexes (agonist + receptor + effector), which in turn recruit specific downstream signaling. Binge-eating disorders characterized by frequent and recurrent binge-eating episodes, with associated negative psychological and social problems. Bioavailability in PET scan studies, refers to the amount of radiotracer that binds to its target receptor, reflecting the protein levels of the receptor, its occupancy by competing endogenous ligands, and the pharmacokinetics of the tracer. Biomarker a characteristic measured as an indicator of normal biological or pathogenic processes, or responses to an exposure or intervention. They are classically classified according to their clinical purpose (e.g., risk or diagnostic) and type of measurement (e.g., genetic or metabolic). CpG site a cytosine is followed by a guanine in the linear DNA sequence; corresponds to the most-frequent site where DNA methylation occurs in mammals. DNA methylation chemical modification of DNA corresponding to the addition of a methyl group to a cytosine (typically at CpG sites). It affects DNA activity notably by repressing the expression of nearby genes. Epigenetic chemical and physical processes that regulate the architecture and activity of the genome (with no change in the DNA sequence). These include DNA methylation, histone modifications, and modulation by noncoding RNAs (e.g., miRNAs). Extracellular vesicles cell-derived vesicles present in almost all eukaryotic fluids (including saliva, blood, and urine). They contain proteins, nucleic acids, or specialized lipids. They are increasingly recognized as a new dimension of intercellular crosstalk (with the ability to send directional instructions to specific recipient cells), and are currently intensively explored as potential biomarkers relevant to numerous neuropsychiatric phenotypes Functional magnetic resonance imaging (fMRI) methodology that measures brain activity by visualizing changes associated with blood flow. Gα one of the subunits of the membrane-associated heterotrimeric G proteins, which are typically activated by, and couple with, 7-transmembrane G-protein-coupled receptors to inhibit, for example, (Gα i ) or stimulate (Gα s ) adenylate cyclase. Genome-wide association studies (GWAS) observational studies of a genome-wide set of genetic variants in different individuals to determine their degree of association with a trait of interest. Induced pluripotent stem cells type of pluripotent stem cell that can be generated directly by reprogramming mature cells, and that can be converted to every other cell type in the body, including neurons. L-Dopa L-3,4-dihydroxyphenylalanine: precursor to dopamine, noradrenaline, and adrenaline neurotransmitters; mainly used as a treatment for Parkinson’s disease. Maintenance therapy opioid addiction treatment based on prescribing opiates to substitute for illicit opiates. Mesolimbic pathway dopaminergic neurons located in the mammalian midbrain ventral tegmental area; send axonal projections to forebrain structures, including the nucleus accumbens and prefrontal cortex; can predict and encode the salience of environmental stimuli and natural rewards, and is disrupted in addictive disorders. Monoaminergic systems networks of neurons that utilize monoamine neurotransmitters; involved in the regulation of numerous physiological functions. Neonatal abstinence syndrome (NAS) withdrawal syndrome of infants after birth caused by in utero exposure to licit or illicit drugs, especially opiates. Opiate exogenous alkaloid compound derived from opium, either natural or synthetic; typically binds to opioid receptors and hijacks endogenous opioid signaling. Opioid refers to three opioid receptors, mu, delta, and kappa, which are activated under physiological conditions by endogenous opioid peptides. Opioid genes eight human opioid genes have been identified based on DNA sequence similarity. The POMC, PENK, and PDYN genes encode three groups of opioid peptides: endorphins, enkephalins, and dynorphins, respectively, with preferential affinity for MOR, DOR, and KOR, respectively (encoded by the OPRM1, OPRD1, and OPRK1 genes, respectively). The PNOC and OPRL1 genes encode nociceptin and the opioid-related nociceptin receptor 1, which do not cross-react with other opioid peptides and receptors. Optogenetics biological technique that uses light to control cells in living tissue, typically neurons, that have been genetically modified to express light-sensitive ion channels. Pharmacogenomics study of the influence of interindividual genetic variation on responses to medications and/or drugs. Positron emission tomography (PET) fMRI technique used to observe brain functional and metabolic processes. Ribonucleoproteic complexes an association between RNA and a RNA-binding protein. Single nucleotide polymorphism (SNP) variation in a single nucleotide that occurs among individuals at a specific position in the DNA sequence.
N1  - References: Grant, B.F., Epidemiology of DSM-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions-III (2016) JAMA Psychiatry, 73, pp. 39-47; 
Yau, Y.H., Potenza, M.N., Gambling disorder and other behavioral addictions: recognition and treatment (2015) Harv. Rev. Psychiatry, 23, pp. 134-146; 
Ambermoon, P., Compulsive use of dopamine replacement therapy: a model for stimulant drug addiction? (2012) Addiction, 107, pp. 241-247; 
Davies, M.N., Functional annotation of the human brain methylome identifies tissue–specific epigenetic variation across brain and blood (2012) Genome Biol., 13, p. R43; 
Tylee, D.S., On the outside, looking in: a review and evaluation of the comparability of blood and brain “-omes” (2013) Am. J. Med. Genet. B Neuropsychiatr. Genet., 162B, pp. 595-603; 
Lohoff, F.W., Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder (2017) Mol. Psychiatry, , Published online August 29, 2017; 
Zappulli, V., Extracellular vesicles and intercellular communication within the nervous system (2016) J. Clin. Invest., 126, pp. 1198-1207; 
Shao, H., Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma (2015) Nat. Commun., 6; 
Fell, G.L., Skin beta-endorphin mediates addiction to UV light (2014) Cell, 157, pp. 1527-1534; 
Buhler, K.M., Common single nucleotide variants underlying drug addiction: more than a decade of research (2015) Addict. Biol., 20, pp. 845-871; 
Xuei, X., Association of the kappa-opioid system with alcohol dependence (2006) Mol. Psychiatry, 11, pp. 1016-1024; 
Agrawal, A., Meta-analyses of genome-wide association data hold new promise for addiction genetics (2016) J. Stud. Alcohol Drugs, 77, pp. 676-680; 
Ducci, F., Goldman, D., The genetic basis of addictive disorders (2012) Psychiatr. Clin. North Am., 35, pp. 495-519; 
Verhagen, M., A systematic review of the A118G (Asn40Asp) variant of OPRM1 in relation to smoking initiation, nicotine dependence and smoking cessation (2012) Pharmacogenomics, 13, pp. 917-933; 
Kong, X., Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies (2017) BMC Med. Genet., 18, p. 120; 
Libbrecht, M.W., Noble, W.S., Machine learning applications in genetics and genomics (2015) Nat. Rev. Genet., 16, pp. 321-332; 
Hancock, D.B., Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1 (2015) Biol. Psychiatry, 78, pp. 474-484; 
Zhang, D., Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population (2007) Biol. Psychiatry, 61, pp. 1244-1251; 
Dlugos, A.M., OPRM1 gene variants modulate amphetamine-induced euphoria in humans (2011) Genes Brain Behav., 10, pp. 199-209; 
Wachman, E.M., Association of OPRM1 and COMT single-nucleotide polymorphisms with hospital length of stay and treatment of neonatal abstinence syndrome (2013) J. Am. Med. Assoc., 309, pp. 1821-1827; 
Wachman, E.M., Variations in opioid receptor genes in neonatal abstinence syndrome (2015) Drug Alcohol Depend., 155, pp. 253-259; 
Smith, A.H., Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1 (2017) Mol. Psychiatry, 22, pp. 346-352; 
Garbutt, J.C., Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence (2014) Addiction, 109, pp. 1274-1284; 
Oslin, D.W., Naltrexone vs placebo for the treatment of alcohol dependence: a randomized clinical trial (2015) JAMA Psychiatry, 72, pp. 430-437; 
Bilbao, A., A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice (2015) Biol. Psychiatry, 77, pp. 850-858; 
Ramchandani, V.A., A genetic determinant of the striatal dopamine response to alcohol in men (2011) Mol. Psychiatry, 16, pp. 809-817; 
Bernardi, R.E., A gene-by-sex interaction for nicotine reward: evidence from humanized mice and epidemiology (2016) Transl. Psychiatry, 6; 
Zhang, Y., Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice (2014) Neuropsychopharmacology, 40, pp. 1091-1100; 
Henderson-Redmond, A.N., Morphine-induced antinociception and reward in “humanized” mice expressing the mu opioid receptor A118G polymorphism (2016) Brain Res. Bull., 123, pp. 5-12; 
Robinson, J.E., Receptor reserve moderates mesolimbic responses to opioids in a humanized mouse model of the OPRM1 A118G polymorphism (2015) Neuropsychopharmacology, 40, pp. 2614-2622; 
Mague, S.D., Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 10847-10852; 
Mague, S.D., Blendy, J.A., OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models (2010) Drug Alcohol Depend., 108, pp. 172-182; 
Berrettini, W., Complexities of the mu opioid receptor (2015) Biol. Psychiatry, 77, pp. 844-845; 
Pena, C.J., Epigenetic signaling in psychiatric disorders (2014) J. Mol. Biol., 16, pp. 281-295; 
Clark, S.L., Combined whole methylome and genomewide association study implicates CNTN4 in alcohol use (2015) Alcohol. Clin. Exp. Res., 39, pp. 1396-1405; 
Liu, C., A DNA methylation biomarker of alcohol consumption (2016) Mol. Psychiatry, , Published online November 15, 2016; 
Zhang, H., Array-based profiling of DNA methylation changes associated with alcohol dependence (2013) Alcohol. Clin. Exp. Res., 37, pp. E108-E1015; 
Marie-Claire, C., Variability of response to methadone: genome-wide DNA methylation analysis in two independent cohorts (2016) Epigenomics, 8, pp. 181-195; 
Feng, J., Role of Tet1 and 5-hydroxymethylcytosine in cocaine action (2015) Nat. Neurosci., 18, pp. 536-544; 
Vassoler, F.M., Epigenetic inheritance of a cocaine-resistance phenotype (2013) Nat. Neurosci., 16, pp. 42-47; 
Nielsen, D.A., Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts (2009) Neuropsychopharmacology, 34, pp. 867-873; 
Doehring, A., Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain (2013) Pain, 154, pp. 15-23; 
Ebrahimi, G., Elevated levels of DNA methylation at the OPRM1 promoter region in men with opioid use disorder (2017) Am. J. Drug Alcohol Abuse, , Published online January 25, 2017; 
Wachman, E.M., Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndrome (2014) J. Pediatr., 165, pp. 472-478; 
Nielsen, D.A., Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts (2010) Hum. Genet., 127, pp. 639-649; 
Dempster, E.L., Genome-wide methylomic analysis of monozygotic twins discordant for adolescent depression (2014) Biol. Psychiatry, 76, pp. 977-983; 
Castillo-Fernandez, J.E., Epigenetics of discordant monozygotic twins: implications for disease (2014) Genome Med., 6, p. 60; 
Oertel, B.G., Genetic-epigenetic interaction modulates mu-opioid receptor regulation (2012) Hum. Mol. Genet., 21, pp. 4751-4760; 
Lutz, P.E., Epigenetic regulation of the kappa opioid receptor by child abuse (2017) Biol. Psychiatry, , Published online July 27, 2017; 
Pietrzak, R.H., Association of in vivo kappa-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology (2014) JAMA Psychiatry, 71, pp. 1262-1270; 
Yuferov, V., Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs (2011) Pharmacogenet. Genomics, 21, pp. 185-196; 
Jenkinson, G., Potential energy landscapes identify the information-theoretic nature of the epigenome (2017) Nat. Genet., 49, pp. 719-729; 
Ziller, M.J., Coverage recommendations for methylation analysis by whole-genome bisulfite sequencing (2015) Nat. Methods, 12, pp. 230-232; 
Wahl, S., Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity (2017) Nature, 541, pp. 81-86; 
Liu, Y., Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse (2015) Sci. Rep., 5; 
He, Y., Regulation of opioid tolerance by let-7 family microRNA targeting the {micro} opioid receptor (2010) J. Neurosci., 30, pp. 10251-10258; 
Wei, L.N., Loh, H.H., Transcriptional and epigenetic regulation of opioid receptor genes: present and future (2011) Annu. Rev. Pharmacol. Toxicol., 51, pp. 75-97; 
Xu, J., Stabilization of morphine tolerance with long-term dosing: association with selective upregulation of mu-opioid receptor splice variant mRNAs (2015) Proc. Natl. Acad. Sci. U. S. A., 112, pp. 279-284; 
Xu, J., Alternatively spliced mu opioid receptor C termini impact the diverse actions of morphine (2017) J. Clin. Invest., 127, pp. 1561-1573; 
Darcq, E., RSK2 signaling in medial habenula contributes to acute morphine analgesia (2012) Neuropsychopharmacology, 37, pp. 1288-1296; 
Steiner, D., Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation (2005) Biochem. J., 386, pp. 341-348; 
Zachariou, V., Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies (2008) Biol. Psychiatry, 63, pp. 1013-1021; 
Jolas, T., Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an up-regulation of the cyclic AMP pathway (2000) Neuroscience, 95, pp. 433-443; 
Sillivan, S.E., ELK1 transcription factor linked to dysregulated striatal Mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers (2013) Biol. Psychiatry, 74, pp. 511-519; 
Toskulkao, T., Alteration of lymphocyte opioid receptors in methadone maintenance subjects (2010) Neurochem. Int., 56, pp. 285-290; 
Breen, M.S., Systematic review of blood transcriptome profiling in neuropsychiatric disorders: guidelines for biomarker discovery (2016) Hum. Psychopharmacol., 31, pp. 373-381; 
Li, M.D., Transcriptome profiling and pathway analysis of genes expressed differentially in participants with or without a positive response to topiramate treatment for methamphetamine addiction (2014) BMC Med. Genomics, 7, p. 65; 
Zubieta, J.K., Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving (1996) Nat. Med., 2, pp. 1225-1229; 
Ghitza, U.E., Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients (2010) Biol. Psychiatry, 68, pp. 697-703; 
Heinz, A., Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil (2005) Arch. Gen. Psychiatry, 62, pp. 57-64; 
Weerts, E.M., Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects (2011) Alcohol. Clin. Exp. Res., 35, pp. 2162-2173; 
Bencherif, B., Regional mu-opioid receptor binding in insular cortex is decreased in bulimia nervosa and correlates inversely with fasting behavior (2005) J. Nucl. Med., 46, pp. 1349-1351; 
Hermann, D., Low mu-opioid receptor status in alcohol dependence identified by combined positron emission tomography and post-mortem brain analysis (2017) Neuropsychopharmacology, 42, pp. 606-614; 
Greenwald, M.K., Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: implications for clinical use and policy (2014) Drug Alcohol Depend., 144, pp. 1-11; 
Scott, D.J., Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans (2007) Neuropsychopharmacology, 32, pp. 450-457; 
Lutz, P.E., Kieffer, B.L., The multiple facets of opioid receptor function: implications for addiction (2013) Curr. Opin. Neurobiol., 23, pp. 473-479; 
Ray, R., Association of OPRM1 A118G variant with the relative reinforcing value of nicotine (2006) Psychopharmacology (Berl), 188, pp. 355-363; 
Weerts, E.M., Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects (2008) Neuropsychopharmacology, 33, pp. 653-665; 
Mick, I., Blunted endogenous opioid release following an oral amphetamine challenge in pathological gamblers (2016) Neuropsychopharmacology, 41, pp. 1742-1750; 
Majuri, J., Dopamine and opioid neurotransmission in behavioral addictions: a comparative PET study in pathological gambling and binge eating (2017) Neuropsychopharmacology, 42, pp. 1169-1177; 
Richiardi, J., BRAIN NETWORKS. Correlated gene expression supports synchronous activity in brain networks (2015) Science, 348, pp. 1241-1244; 
Heitzeg, M.M., Neuroimaging risk markers for substance abuse: recent findings on inhibitory control and reward system functioning (2015) Curr. Addict. Rep., 2, pp. 91-103; 
orris, L.S., Naltrexone ameliorates functional network abnormalities in alcohol-dependent individuals (2017) Addict. Biol., , Published February 27, 2017; 
Mechling, A.E., Deletion of the mu opioid receptor gene in mice reshapes the reward-aversion connectome (2016) Proc. Natl. Acad. Sci. U. S. A., 113, pp. 11603-11608; 
Cosa, A., Multi-modal MRI classifiers identify excessive alcohol consumption and treatment effects in the brain (2017) Addict. Biol., 22, pp. 1459-1472; 
Verbelen, M., Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet? (2017) Pharmacogenomics J., 17, pp. 395-402; 
Marques, S., Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system (2016) Science, 352, pp. 1326-1329; 
Zeisel, A., Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq (2015) Science, 347, pp. 1138-1142; 
Mo, A., Epigenomic signatures of neuronal diversity in the mammalian brain (2015) Neuron, 86, pp. 1369-1384; 
Warner-Schmidt, J.L., Cholinergic interneurons in the nucleus accumbens regulate depression-like behavior (2012) Proc. Natl. Acad. Sci. U. S. A., 109, pp. 11360-11365; 
Schmidt, E.F., Identification of the cortical neurons that mediate antidepressant responses (2012) Cell, 149, pp. 1152-1163; 
Jalabert, M., Neuronal circuits underlying acute morphine action on dopamine neurons (2011) Proc. Natl. Acad. Sci. U. S. A., 108, pp. 16446-16450; 
Shippenberg, T.S., Herz, A., Differential effects of mu and kappa opioid systems on motivational processes (1986) NIDA Res. Monogr., 75, pp. 563-566; 
Lalanne, L., The kappa opioid receptor: from addiction to depression, and back (2014) Front. Psychiatry, 5, p. 170; 
Goeldner, C., Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine (2011) Biol. Psychiatry, 69, pp. 236-244; 
Lutz, P.E., Distinct mu, delta, and kappa opioid receptor mechanisms underlie low sociability and depressive-like behaviors during heroin abstinence (2014) Neuropsychopharmacology, 39, pp. 2694-2705; 
Charbogne, P., Mu opioid receptors in gamma-aminobutyric acidergic forebrain neurons moderate motivation for heroin and palatable food (2017) Biol. Psychiatry, 81, pp. 778-788; 
Corder, G., Constitutive mu-opioid receptor activity leads to long-term endogenous analgesia and dependence (2013) Science, 341, pp. 1394-1399; 
Al-Hasani, R., Bruchas, M.R., Molecular mechanisms of opioid receptor-dependent signaling and behavior (2011) Anesthesiology, 115, pp. 1363-1381; 
Irannejad, R., Functional selectivity of GPCR-directed drug action through location bias (2017) Nat. Chem. Biol., 13, pp. 799-806; 
Epstein, D.H., Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency (2009) Drug Alcohol Depend., 101, pp. 92-100; 
Aboujaoude, E., Salame, W.O., Naltrexone: a pan-addiction treatment? (2016) CNS Drugs, 30, pp. 719-733; 
Bravo, M.J., Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users (2010) Drug Alcohol Depend., 112, pp. 62-68; 
Manglik, A., Structure-based discovery of opioid analgesics with reduced side effects (2016) Nature, 537, pp. 185-190; 
Berger, A.C., Whistler, J.L., Morphine-induced mu opioid receptor trafficking enhances reward yet prevents compulsive drug use (2011) EMBO Mol. Med., 3, pp. 385-397; 
Schmid, C.L., Bias factor and therapeutic window correlate to predict safer opioid analgesics (2017) Cell, 171. , 1165–1175. e13; 
Bigliardi, P.L., Opioids and skin homeostasis, regeneration and ageing – what's the evidence? (2016) Exp. Dermatol., 25, pp. 586-591; 
Bodnar, R.J., Endogenous opiates and behavior: 2015 (2017) Peptides, 88, pp. 126-188; 
Di Meo, A., Liquid biopsy: a step forward towards precision medicine in urologic malignancies (2017) Mol. Cancer, 16, p. 80; 
Sheng, Y., Using iPSC-derived human DA neurons from opioid-dependent subjects to study dopamine dynamics (2016) Brain Behav., 6; 
Lieberman, R., Examining the effects of alcohol on GABAA receptor mRNA expression and function in neural cultures generated from control and alcohol dependent donor induced pluripotent stem cells (2017) Alcohol, 66, pp. 45-53; 
Ninkovic, J., Roy, S., Role of the mu-opioid receptor in opioid modulation of immune function (2013) Amino Acids, 45, pp. 9-24; 
Smith, A.K., DNA extracted from saliva for methylation studies of psychiatric traits: evidence tissue specificity and relatedness to brain (2015) Am. J. Med. Genet. B Neuropsychiatr. Genet., 168B, pp. 36-44; 
Chu Sin Chung, P., Kieffer, B.L., Delta opioid receptors in brain function and diseases (2013) Pharmacol. Ther., 140, pp. 112-120; 
Olmstead, M.C., Mu and delta opioid receptors oppositely regulate motor impulsivity in the signaled nose poke task (2009) PLoS One, 4; 
Lutz, P.E., Kieffer, B.L., Opioid receptors: distinct roles in mood disorders (2013) Trends Neurosci., 36, pp. 195-206; 
Edgar, R.D., BECon: a tool for interpreting DNA methylation findings from blood in the context of brain (2017) Transl. Psychiatry, 7
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85041091319&doi=10.1016%2fj.molmed.2017.12.004&partnerID=40&md5=5655a41e03efab3d880d4b3ab45325d9
ER  - 

TY  - SER
TI  - Computer-aided drug design approaches to study key therapeutic targets in alzheimer’s disease
T2  - Neuromethods
J2  - Neuromethods
VL  - 132
SP  - 61
EP  - 106
PY  - 2018
DO  - 10.1007/978-1-4939-7404-7_3
SN  - 08932336 (ISSN) 
AU  - Lemos, A.
AU  - Melo, R.
AU  - Moreira, I.S.
AU  - Cordeiro, M.N.D.S.
AD  - LAQV@REQUIMTE, Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, Rua do Campo Alegre s/n, Porto, 4169-007, Portugal
AD  - GIGA Cyclotron Research Centre In Vivo Imaging, University of Liège, Liège, 4000, Belgium
AD  - CNC – Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Rua Larga, Coimbra, 3004-517, Portugal
AD  - Center for Nuclear Sciences and Technologies, Instituto Superior Técnico, University of Lisbon, Estrada Nacional 10 (ao km 139,7), Bobadela LRS, 2695-066, Portugal
AD  - Bijvoet Center for Biomolecular Research, Faculty of Science - Chemistry, Utrecht University, 3584CH, Utrecht, Netherlands
AD  - (MNDSC) LAQV@REQUIMTE/Department of Chemistry and Biochemistry, University of Porto, Porto, 4169-007, Portugal
AD  - (ISM) CNC – Center for Neuroscience and Cell Biology, Faculty of Medicine, University of Coimbra, Rua Larga, Coimbra, 3004-517, Portugal
AB  - Alzheimer’s Disease (AD) is one of the most common and complex age-related neurodegenerative disorders in elderly people. Currently there is no cure for AD, and available therapeutic alternatives only improve both cognitive and behavioral functions. For that reason, the search for anti-AD therapeutic agents with neuroprotective properties is highly demanding. Several research studies have implicated the involvement of G-Protein-Coupled Receptors (GPCRs) in diverse neurotransmitter systems that are dysregulated in AD, mainly in modulation of amyloidogenic processing of Amyloid Precursor Protein (APP) and of microtubule-associated protein tau phosphorylation and in learning and memory activities in in vivo AD models subjected to numerous behavioral procedures. In this chapter, a special focus will be given to the structure- and ligand-based in silico approaches and their applicability on the development of small molecules that target various GPCRs potentially involved in AD such as 5-hydroxytryptamine receptors, adenosine receptors, adrenergic receptors, chemokine receptors, histamine receptors, metabotropic glutamate receptors, muscarinic acetylcholine receptors, and opioid receptors. © Springer Science+Business Media LLC 2018.
KW  - Alzheimer’s disease
KW  - Docking
KW  - Drug design
KW  - G-proteins
KW  - GPCRs
KW  - Pharmacophore
KW  - QSAR
KW  - 2 (1 methyl 2 isoindolinylmethyl) 2 imidazoline
KW  - 2 [2 [4 (2 methoxyphenyl) 1 piperazinyl]ethyl] 4,4 dimethyl 1,3(2h,4h) isoquinolinedione
KW  - 2 [[2 (2,6 dimethoxyphenoxy)ethyl]aminomethyl] 1,4 benzodioxan
KW  - 4 [2 [7 amino 2 (2 furyl) 1,2,4 triazolo[2,3 a][1,3,5]triazin 5 ylamino]ethyl]phenol
KW  - adenosine receptor
KW  - adrenergic receptor
KW  - amyloid precursor protein
KW  - chemokine receptor
KW  - chlorpromazine
KW  - clonidine
KW  - clozapine
KW  - dexmedetomidine
KW  - dopamine
KW  - epinephrine
KW  - G protein coupled receptor
KW  - histamine receptor
KW  - jp 1302
KW  - metabotropic receptor
KW  - muscarinic receptor
KW  - n [2 [[1 [4 (1,3 benzodioxol 5 yl) 4 hydroxycyclohexyl] 4 ethoxy 3 pyrrolidinyl]amino] 2 oxoethyl] 3 (trifluoromethyl)benzamide
KW  - n [4 [[[6,7 dihydro 2 (4 methylphenyl) 5h benzocyclohepten 8 yl]carbonyl]amino]benzyl] n,n dimethyl 2h tetrahydropyran 4 aminium chloride
KW  - nootropic agent
KW  - opc 2836
KW  - opiate receptor
KW  - quinazoline derivative
KW  - serotonin receptor
KW  - spiperone
KW  - spiroxatrine
KW  - tau protein
KW  - unclassified drug
KW  - unindexed drug
KW  - Alzheimer disease
KW  - drug design
KW  - drug structure
KW  - human
KW  - molecular docking
KW  - neuromodulation
KW  - neuroprotection
KW  - nonhuman
KW  - pharmacophore
KW  - priority journal
KW  - protein phosphorylation
PB  - Humana Press Inc.
N1  - Cited By :1
N1  - Export Date: 13 November 2019
M3  - Book Chapter
DB  - Scopus
LA  - English
N1  - Correspondence Address: Cordeiro, M.N.D.S.; (MNDSC) LAQV@REQUIMTE/Department of Chemistry and Biochemistry, University of PortoPortugal; email: ncordeir@fc.up.pt
N1  - Chemicals/CAS: 2 (1 methyl 2 isoindolinylmethyl) 2 imidazoline, 118343-19-4; 2 [2 [4 (2 methoxyphenyl) 1 piperazinyl]ethyl] 4,4 dimethyl 1,3(2h,4h) isoquinolinedione, 67339-62-2; 2 [[2 (2,6 dimethoxyphenoxy)ethyl]aminomethyl] 1,4 benzodioxan, 613-67-2; 4 [2 [7 amino 2 (2 furyl) 1,2,4 triazolo[2,3 a][1,3,5]triazin 5 ylamino]ethyl]phenol, 139180-30-6; chlorpromazine, 50-53-3, 69-09-0; clonidine, 4205-90-7, 4205-91-8, 57066-25-8; clozapine, 5786-21-0; dexmedetomidine, 113775-47-6; dopamine, 51-61-6, 62-31-7; epinephrine, 51-43-4, 55-31-2, 6912-68-1; n [2 [[1 [4 (1,3 benzodioxol 5 yl) 4 hydroxycyclohexyl] 4 ethoxy 3 pyrrolidinyl]amino] 2 oxoethyl] 3 (trifluoromethyl)benzamide, 709018-37-1; n [4 [[[6,7 dihydro 2 (4 methylphenyl) 5h benzocyclohepten 8 yl]carbonyl]amino]benzyl] n,n dimethyl 2h tetrahydropyran 4 aminium chloride, 229005-80-5; spiperone, 749-02-0; spiroxatrine, 1054-88-2
N1  - Tradenames: arc 239; brl 44408; incb 3344; jp 1302; opc 2836; tak 779; wb 4101; zm 241385
N1  - References: Bartus, R.T., On neurodegenerative diseases, models, and treatment strategies: Lessons learned and lessons forgotten a generation following the cholinergic hypothesis (2000) Exp Neurol, 163 (2), pp. 495-529; 
Craig, L.A., Hong, N.S., McDonald, R.J., Revisiting the cholinergic hypothesis in the development of Alzheimer’s disease (2011) Neurosci Biobehav Rev, 35 (6), pp. 1397-1409; 
Hardy, J., Selkoe, D.J., The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics (2002) Science, 297 (5580), pp. 353-356; 
Karran, E., Mercken, M., Strooper, B.D., The amyloid cascade hypothesis for Alzheimer’s disease: An appraisal for the development of therapeutics (2011) Nat Rev Drug Discov, 10 (9), pp. 698-712; 
Tolnay, M., Probst, A., Review: Tau protein pathology in Alzheimer’s disease and related disorders (1999) Neuropathol Appl Neurobiol, 25 (3), pp. 171-187; 
Maccioni, R.B., Farias, G., Morales, I., Navarrete, L., The revitalized tau hypothesis on Alzheimer’s disease (2010) Arch Med Res, 41 (3), pp. 226-231; 
Nitsch, R.M., Deng, M., Growdon, J.H., Wurtman, R.J., Serotonin 5-HT2A and 5-HT2C receptors stimulate amyloid precursor protein ectodomain secretion (1996) J Biol Chem, 271 (8), pp. 4188-4194; 
Price, D.L., Bonhaus, D.W., McFarland, K., Pimavanserin, a 5-HT2A receptor inverse agonist, reverses psychosis-like behaviors in a rodent model of Alzheimer’s disease (2012) Behav Pharmacol, 23 (4), pp. 426-433; 
Arjona, A.A., Pooler, A.M., Lee, R.K., Wurtman, R.J., Effect of a 5-HT2A serotonin agonist, dexnorfenfluramine, on amyloid precursor protein metabolism in guinea pigs (2002) Brain Res, 951 (1), pp. 135-140; 
Giannoni, P., Gaven, F., De Bundel, D., Baranger, K., Marchetti-Gauthier, E., Roman, F.S., Valjent, E., Rivera, S., Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5xFAD mouse model of Alzheimer’s disease (2013) Front Aging, 5, 96p. , eCollection 2013; 
Pimenova, A.A., Thathiah, A., De Strooper, B., Tesseur, I., Regulation of amyloid precursor protein processing by serotonin signaling (2014) Plos One, 9 (1), pp. e87014; 
Robert, S.J., Zugaza, J.L., Fischmeister, R., Gardier, A.M., Lezoualc’H, F., The human serotonin 5-HT4 receptor regulates secretion of non-amyloidogenic precursor protein (2001) J Biol Chem, 276 (48), pp. 44881-44888; 
Tesseur, I., Pimenova, A.A., Lo, A.C., Ciesielska, M., Lichtenthaler, S., De Maeyer, J.H., Schuurkes, J.A., De Strooper, B., Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice (2013) Neurobiol Aging, 34 (7), pp. 1779-1789; 
Benhamu´, B., Martín-Fontecha, M., Vázquezvilla, H., Pardo, L., Lo´pezrod-R´ıguez, M.L., Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer’s disease (2014) J Med Chem, 57 (17), pp. 7160-7181; 
Maher-Edwards, G., Zvartau-Hind, M., Hunter, A., Gold, M., Hopton, G., Jacobs, G., Davy, M., Williams, P., Double-blind, controlled phase II study of a 5-HT6 receptor antagonist, SB-742457 (2010) Curr Alzheimer Res, 7 (5), pp. 374-385. , Alzheimer’s disease; 
Rosse, G., Schaffhauser, H., 5-HT6 (2010) Curr Top Med Chem, 10 (2), pp. 207-221; 
Upton, N., Chuang, T.T., Hunter, A.J., Virley, D.J., 5-HT6 receptor antagonists as novel (2008) Neurotherapeutics, 5 (3), pp. 458-469; 
Arendash, G., Schleif, W., Rezai-Zadeh, K., Jackson, E., Zacharia, L., Cracchiolo, J., Shippy, D., Tan, J., Caffeine protects Alzheimer’s mice against cognitive impairment and reduces brain β-amyloid production (2006) Neuroscience, 142 (4), pp. 941-952; 
Giunta, S., Riolo, V., Castorina, A., Dual blockade of the A1 and A2A adenosine receptor prevents amyloid β toxicity in neuroblastoma cells exposed to aluminum chloride (2014) Int J Biochem Cell Biol, 54, pp. 122-136; 
Angulo, E., Casado´, V., Mallol, J., Canela, E.I., Viñals, F., Ferrer, I., Lluis, C., Franco, R., A1 adenosine receptors accumulate in neurodegenerative structures in Alzheimer’s disease and mediate both amyloid precursor protein processing and tau phosphorylation and translocation (2003) Brain Pathol, 13 (4), pp. 440-451; 
Canas, P.M., Porciúncula, L.O., Cunha, G.M., Silva, C.G., Machado, N.J., Oliveira, J.M., Oliveira, C.R., Cunha, R.A., Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by β-amyloid peptides via p38 mitogen-activated protein kinase pathway (2009) J Neurosci, 29 (47), pp. 14741-14751; 
Espinosa, J., Rocha, A., Nunes, F., Costa, M.S., Schein, V., Kazlauckas, V., Kalinine, E., Porciúncula, L.O., Caffeineconsumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia (2013) J Alzheimers Dis, 34 (2), pp. 509-518; 
Nagpure, B.V., Bian, J.S., Hydrogen sulfide inhibits A2A adenosine receptor agonist induced β-amyloid production in SH-SY5Y neuroblastoma cells via a cAMP dependent pathway (2014) Plos One, 9 (2), pp. e88508. , eCollection, 2014; 
Orr, A.G., Hsiao, E.C., Wang, M.M., Ho, K., Kim, D.H., Wang, X., Guo, W., Adame, A., Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory (2015) Nat Neurosci, 18 (3), pp. 423-434; 
Chen, Y., Peng, Y., Che, P., Gannon, M., Liu, Y., Li, L., Bu, G., Wang, Q., α (2014) Proc Natl Acad Sci U S A, 111 (48), pp. 17296-17301; 
Branca, C., Wisely, E.V., Hartman, L.K., Caccamo, A., Oddo, S., Administration of a selective β (2014) Neurobiol Aging, 35 (12), pp. 2726-2735; 
Ni, Y., Zhao, X., Bao, G., Zou, L., Teng, L., Wang, Z., Song, M., Pei, G., Activation of β2-adrenergic receptor stimulates γ-secretase activity and accelerates amyloidplaque formation (2006) Nat Med, 12 (12), pp. 1390-1396; 
Wisely, E.V., Xiang, Y.K., Oddo, S., Genetic suppression of β (2014) Hum Mol Genet, 23 (15), pp. 4024-4034; 
El Khoury, J., Toft, M., Hickman, S.E., Means, T.K., Terada, K., Geula, C., Luster, A.D., CCR2 deficiency impairs microglial accumulation and accelerates progression of Alzheimerlike disease (2007) Nat Med, 13 (4), pp. 432-438; 
Westin, K., Buchhave, P., Nielsen, H., Minthon, L., Janciauskiene, S., Hansson, O., CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer’s disease (2012) Plos One, 7 (1), pp. e30525; 
Bakshi, P., Margenthaler, E., Laporte, V., Crawford, F., Mullan, M., Novel role of CXCR2 in regulation of γ-secretase activity (2008) ACS Chem Biol, 3 (12), pp. 777-789; 
Bakshi, P., Jin, C., Broutin, P., Berhane, B., Reed, J., Mullan, M., Structural optimization of a CXCR2-directed antagonist that indirectly inhibits γ-secretase and reduces Aβ (2009) Bioorg Med Chem, 17 (23), pp. 8102-8112; 
Bakshi, P., Margenthaler, E., Reed, J., Crawford, F., Mullan, M., Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer’s disease (2011) Cytokine, 53 (2), pp. 163-169; 
Carroll, J.C., Iba, M., Bangasser, D.A., Valentino, R.J., James, M.J., Brunden, K.R., Lee, V., Trojanowski, J.Q., Chronic stress exacerbates tau pathology, neurodegeneration, and cognitiveperformance through a corticotropin-releasing factor receptordependent mechanism in a transgenic mouse modelof tauopathy (2011) J Neurosci, 31 (40), pp. 14436-14449; 
Justice, N.J., Huang, L., Tian, J.B., Cole, A., Pruski, M., Hunt, A.J., Flores, R., Zheng, H., Posttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropinreleasing factor neurons to exacerbate stress responses (2015) J Neurosci, 35 (6), pp. 2612-2623; 
Rissman, R.A., Staup, M.A., Lee, A.R., Justice, N.J., Rice, K.C., Vale, W., Sawchenko, P.E., Corticotropin-releasing factor receptordependent effects of repeated stress on tau phosphorylation, solubility, and aggregation (2012) Procnatl Acad Sci U S A, 109 (16), pp. 6277-6282; 
Scullion, G.A., Hewitt, K.N., Pardon, M.C., Corticotropin-releasing factor receptor 1 activation during exposure to novelty stress protectsagainst Alzheimer’s disease-like cognitive decline in AβPP/PS1 mice (2013) J Alzheimers Dis, 34 (3), pp. 781-793; 
Cai, Z., Ratka, A., Opioid system and Alzheimer’s disease (2012) Neuromolecular Med, 14 (2), pp. 91-111; 
Medhurst, A.D., Atkins, A.R., Beresford, I.J., Brackenborough, K., Briggs, M.A., Calver, A.R., Cilia, J., Wilson, D.M., GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer’s disease brain and improves cognitive performance in preclinical models (2007) J Pharm Exp Ther, 321 (3), pp. 1032-1045; 
Nathan, P.J., Boardley, R., Scott, N., Berges, A., Maruff, P., Sivananthan, T., Upton, N., Lai, R., The safety, tolerability, pharmacokinetics and cognitive effects of GSK239512, a selective histamine H3 receptor antagonist in patients with mild to moderate Alzheimer’s disease: A preliminary investigation (2013) Curr Alzheimer Res, 10 (3), pp. 240-251; 
Haig, G.M., Pritchett, Y., Meier, A., Othman, A.A., Hall, C., Gault, L.M., Lenz, R.A., A randomized study of H3 antagonist ABT-288 in mild-to-moderate Alzheimer’s dementia (2014) J Alzheimer Dis, 42 (3), pp. 959-971; 
Kim, S.H., Fraser, P.E., Westaway, D., Georgehyslop, P., Ehrlich, M.E., Gandy, S., Group II metabotropic glutamate receptor stimulation triggers production and release of Alzheimer’s amyloid β42 from isolated intact nerve terminals (2010) J Neurosci, 30 (11), pp. 3870-3875; 
Kirazov, L., Löffler, T., Schliebs, R., Bigl, V., Glutamate-stimulated secretion of amyloid precursor protein from cortical rat brain slices (1997) Neurochem Int, 30 (6), pp. 557-563; 
Lee, R., Wurtman, R.J., Cox, A.J., Nitsch, R.M., Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors (1995) Proc Natl Acad Sci U S A, 92 (17), pp. 8083-8087; 
Nitsch, R.M., Deng, A., Wurtman, R.J., Growdon, J.H., Metabotropic glutamate receptor subtype mGluR1α stimulates the secretion of the amyloid β-protein precursor ectodomain (1997) J Neurochem, 69 (2), pp. 704-712; 
Lee, H.G., Zhu, X., Casadesus, G., Pallàs, M., Camins, A., O’Neill, M.J., Nakanishi, S., Smith, M.A., The effect of mGluR2 (2009) Brain Res, pp. 244-250; 
Spinelli, S., Ballard, T., Gatti-McArthur, S., Richards, G.J., Kapps, M., Woltering, T., Wichmann, J., Pryce, C.R., Effects of the mGluR2/3 agonist LY354740 on computerized tasks of attention and working memory in marmoset monkeys (2005) Psychopharmacol, 179 (1), pp. 292-302; 
Um, J.W., Kaufman, A.C., Kostylev, M., Heiss, J.K., Stagi, M., Takahashi, H., Kerrisk, M.E., Strittmatter, S.M., Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer Aβ oligomer bound to cellular prion protein (2013) Neuron, 79 (5), pp. 887-902; 
Kumar, A., Dhull, D.K., Mishra, P.S., Therapeutic potential of mGluR5 targeting in Alzheimer’s disease (2015) Front Neurosci, 9, 215p; 
Caccamo, A., Oddo, S., Billings, L.M., Green, K.N., Martinez-Coria, H., Fisher, A., Laferla, F.M., M1 receptors play a central role in modulating AD-like pathology in transgenic mice (2006) Neuron, 49 (5), pp. 671-682; 
Davis, A.A., Fritz, J.J., Wess, J., Lah, J.J., Levey, A.I., Deletion of M1 muscarinic acetylcholine receptors increases amyloid pathology in vitro and in vivo (2010) J Neurosci, 30 (12), pp. 4190-4196; 
Jiang, S., Wang, Y., Ma, Q., Zhou, A., Zhang, X., Zhang, Y.W., M1 muscarinic acetylcholine receptor interacts with BACE1 and regulates its proteosomal degradation (2012) Neurosci Lett, 515 (2), pp. 125-130; 
Nitsch, R.M., Slack, B.E., Wurtman, R.J., Growdon, J.H., Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors (1992) Science, 258 (5080), pp. 304-307; 
Züchner, T., Perez-Polo, J.R., Schliebs, R., β-secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling (2004) J Neurosci Res, 77 (2), pp. 250-257; 
Packard, M.G., Regenold, W., Quirion, R., White, N.M., Post-training injection of the acetylcholine M2 receptor antagonist AF-DX 116 improves memory (1990) Brain Res, 524 (1), pp. 72-76; 
Han, Y., Moreira, I.S., Urizar, E., Weinstein, H., Javitch, J.A., Allosteric communication between protomers of dopamine class a GPCR dimers modulates activation (2009) Nat Chem Biol, 5 (9), pp. 688-695; 
Moreira, I.S., Structural features of the G-protein/GPCR interactions. Biochim Biophys Acta (2014) Gen Subj, 1840 (1), pp. 16-33; 
Schioth, H.B., Fredriksson, R., The GRAFS classification system of G-protein coupled receptors in comparative perspective (2005) Gen Comp Endocrinol, 142 (1-2), pp. 94-101; 
Ji, T.H., Grossmann, M., Ji, I., G proteincoupled receptors. I. Diversity of receptorligand interactions (1998) J Biol Chem, 273 (28), pp. 17299-17302; 
Rosenbaum, D.M., Rasmussen, S.G., Kobilka, B.K., The structure and function of G-protein-coupledreceptors (2009) Nature, 459 (7245), pp. 356-363; 
Lang, M., Beck-Sickinger, A.G., Structure-activity relationship studies: Methods and ligand design for G-protein coupled peptide receptors (2006) Curr Protein Pept Sci, 7 (4), pp. 335-353; 
Marinissen, M.J., Gutkind, J.S., G-protein-coupled receptors and signaling networks:Emerging paradigms (2001) Trends Pharmacol Sci, 22 (7), pp. 368-376; 
Birnbaumer, L., The discovery of signal transduction by G proteins. A personal account and an overview of the initial findings and contributions that led to our present understanding (2007) Biochim Biophys Acta Biomembr, 1768 (4), pp. 756-771; 
Kontoyianni, M., Liu, Z., Structurebased design in the GPCR target space (2012) Curr Med Chem, 19 (4), pp. 544-556; 
Shukla, A.K., Xiao, K., Lefkowitz, R.J., Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling (2011) Trends Biochem Sci, 36 (9), pp. 457-469; 
Lefkowitz, R.J., G protein-coupled receptors. III New roles for receptor kinases andβ-arrestins in receptor signaling and desensitization (1998) J Biol Chem, 273 (30), pp. 18677-18680; 
Wolfe, B.L., Trejo, J., Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis (2007) Traffic, 8 (5), pp. 462-470; 
Tsao, P., Von Zastrow, M., Downregulation of G protein-coupled receptors (2000) Curr Opin Neurobiol, 10 (3), pp. 365-369; 
Collins, S., Caron, M.G., Lefkowitz, R.J., Regulation of adrenergic receptor responsiveness through modulation of receptor gene expression (1991) Annu Rev Physiol, 53, pp. 497-508; 
De Vries, L., Zheng, B., Fischer, T., Elenko, E., Farquhar, M.G., The regulator of G protein signaling family (2000) Annu Rev Pharmacol Toxicol, 40, pp. 235-271; 
Ross, E.M., Wilkie, T.M., GTPaseactivating proteins for heterotrimeric G proteins: Regulators of G protein signaling (RGS) and RGS-like proteins (2000) Annu Rev Biochem, 69, pp. 795-827; 
Ghemtio, L., Zhang, Y., Xhaard, H., CoMFA/CoMSIA and pharmacophore modelling as a powerful tools for efficient virtual screening: Application to anti-leishmanial betulin derivatives (2012) Virtual Screening, pp. 55-82. , Taha MO, In Tech, Croatia; 
Yang, S.Y., Pharmacophore modeling and applications in drug discovery: Challenges and recent advances (2010) Drug Discov Today, 15 (1112), pp. 444-450; 
Ghosh, E., Kumari, P., Jaiman, D., Shukla, A.K., Methodological advances: The unsung heroes of the GPCR structural revolution (2015) Nat Rev Mol Cell Biol, 16 (2), pp. 69-81; 
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., Le Trong, I., Miyano, M., Crystal structure of rhodopsin: A G protein-coupled receptor (2000) Science, 289 (5480), pp. 739-745; 
Costanzi, S., Siegel, J., Tikhonova, I.G., Jacobson, K.A., Rhodopsin and the others: A historical perspective on structural studies of G protein-coupled receptors (2009) Curr Pharm Des, 15 (35), pp. 3994-4002; 
Patny, A., Desai, P.V., Avery, M.A., Homology modeling of G-protein-coupled receptors and implications in drug design (2006) Curr Med Chem, 13 (14), pp. 1667-1691; 
Cherezov, V., Rosenbaum, D.M., Hanson, M.A., Rasmussen, S.G., Thian, F.S., Kobilka, T.S., Choi, H.J., Stevens, R.C., High-resolution crystal structure of an engineered human β (2007) Science, 318 (5854), pp. 1258-1265; 
Rasmussen, S.G., Choi, H.J., Rosenbaum, D.M., Kobilka, T.S., Thian, F.S., Edwards, P.C., Burghammer, M., Kobilka, B.K., Crystal structure of the human β (2007) Nature, 450 (7168), pp. 383-387; 
Warne, T., Serrano-Vega, M.J., Baker, J.G., Moukhametzianov, R., Edwards, P.C., Henderson, R., Leslie, A.G., Schertler, G.F., Structure of a β (2008) Nature, 454 (7203), pp. 486-491; 
Christopoulos, A., Allosteric binding sites on cell-surface receptors: Novel targets for drug discovery (2002) Nat Rev Drug Discov, 1 (3), pp. 198-210; 
Conn, P.J., Christopoulos, A., Lindsley, C.W., Allosteric modulators of GPCRs: A novel approach for the treatment of CNS disorders (2009) Nat Rev Drug Discov, 8 (1), pp. 41-54; 
Chang, S.D., Bruchas, M.R., Functional selectivity at GPCRs: New opportunities in psychiatric drug discovery (2014) Neuropsychopharmacol, 39 (1), pp. 248-249; 
Schrage, R., Kostenis, E., Functional selectivity and dualsteric/bitopic GPCR targeting (2017) Curr Opin Pharmacol, 32, pp. 85-90; 
Vishnivetskiy, S.A., Gimenez, L.E., Francis, D.J., Hanson, S.M., Hubbeil, W.L., Klug, C.S., Gurevich, V.V., Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins (2011) J Biol Chem, 286 (27), pp. 24288-24299; 
Rasmussen, S.G., Devree, B.T., Zou, Y., Kruse, A.C., Chung, K.Y., Kobilka, T.S., Thian, F.S., Kobilka, B.K., Crystal structure of the β (2011) Nature, 477 (7366), pp. 549-555; 
Dror, R.O., Arlow, D.H., Maragakis, P., Mildorf, T.J., Pan, A.C., Xu, H., Borhani, D.W., Shaw, D.E., Activation mechanism of the β (2011) Proc Natl Acad Sci U S A, 108 (46), pp. 18684-18689; 
Kohlhoff, K.J., Shukla, D., Lawrenz, M., Bowman, G.R., Konerding, D.E., Belov, D., Altman, R.B., Pande, V.S., Cloud-based simulations on Google Exacycle reveal ligand modulation of GPCR activation pathways (2014) Nat Chem, 6 (1), pp. 15-21; 
Bruno, A., Costantino, G., Molecular dynamics simulations of G protein-coupled receptors (2012) Mol Inform, 31 (34), pp. 222-230; 
Cozzini, P., Kellogg, G.E., Spyrakis, F., Abraham, D.J., Costantino, G., Emerson, A., Fanelli, F., Sotriffer, C.A., Target flexibility: An emerging consideration in drug discovery and design (2008) J Med Chem, 51 (20), pp. 6237-6255; 
Feixas, F., Lindert, S., Sinko, W., McCammon, J.A., Exploring the role of receptor flexibility in structure-based drug discovery (2014) Biophys Chem, 186, pp. 31-45; 
Jo, S., Lim, J.B., Klauda, J.B., Im, W., CHARMM-GUI membrane builder for mixed bilayers and its application to yeast membranes (2009) Biophys J, 97 (1), pp. 50-58; 
Wu, E.L., Cheng, X., Jo, S., Rui, H., Song, K.C., Dávila-Contreras, E.M., Qi, Y., Im, W., CHARMM-GUI Membrane Builder toward realistic biological membrane simulations (2014) J Comput Chem, 35 (27), pp. 1997-2004; 
Ribeiro, J.V., Bernardi, R.C., Rudack, T., Stone, J.E., Phillips, J.C., Freddolino, P.L., Schulten, K., QwikMD integrative molecular dynamics toolkit for novices and experts (2016) Sci Rep, 6, p. 26536; 
Doerr, S., Harvey, M.J., Noe´, F., De Fabritiis, G., HTMD: High-throughput molecular dynamics for molecular discovery (2016) J Chem Theory Comput, 12 (4), pp. 1845-1852; 
Guo, W., Shi, L., Filizola, M., Weinstein, H., Javitch, J.A., Crosstalk in G proteincoupledreceptors: Changes at the transmembrane homodimer interface determine activation (2005) Proc Natl Acad Sci U S A, 102 (48), pp. 17495-17500; 
Kitchen, D.B., Decornez, H., Furr, J.R., Bajorath, J., Docking and scoring in virtual screening for drug discovery: Methods and applications (2004) Nat Rev Drug Discov, 3 (11), pp. 935-949; 
Morris, G.M., Huey, R., Olson, A.J., Using AutoDock for ligand-receptor docking (2008) Curr Protocbioinformatics, 24, pp. 1-8; 
Trott, O., Olson, A.J., AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading (2010) J Comput Chem, 31 (2), pp. 455-461; 
Wu, G., Robertson, D.H., Brooks, C.L., III, Vieth, M., Detailed analysis of grid-based moleculardocking: A case study of CDOCKER-A CHARMm-based MD dockingalgorithm (2003) J Comput Chem, 24 (13), pp. 1549-1562; 
Rarey, M., Kramer, B., Lengauer, T., Klebe, G., A fast flexible docking method using an incremental construction algorithm (1996) J Mol Biol, 261 (3), pp. 470-489; 
Verdonk, M.L., Cole, J.C., Hartshorn, M.J., Murray, C.W., Taylor, R.D., Improved proteinligand docking using GOLD (2003) Proteins, 52 (4), pp. 609-623; 
Repasky, M.P., Shelley, M., Friesner, R.A., Flexible ligand docking with GLIDE. (2007) Curr Protocbioinformatics, 18, pp. 1-8; 
Neves, M.A., Totrov, M., Abagyan, R., Docking and scoring with ICM: The benchmarking results and strategies for improvement (2012) J Comput Aided Mol Des, 26 (6), pp. 675-686; 
Marcou, G., Rognan, D., Optimizing fragment and scaffold docking by use of molecular interaction fingerprints (2007) J Chem Inf Model, 47 (1), pp. 195-207; 
Kalid, O., Toledo Warshaviak, D., Shechter, S., Sherman, W., Shacham, S., Consensus induced fit docking (CIFD): Methodology, validation, and application to the discovery of novel CRM1 inhibitors (2012) J Comput Aided Mol Des, 26 (11), pp. 1217-1228; 
Rao, S.N., Head, M.S., Kulkarni, A., Lalonde, J.M., Validation studies of the site-directed docking program LibDock (2007) J Chem Inf Model, 47 (6), pp. 2159-2171; 
Bai, Q., Shao, Y., Pan, D., Zhang, Y., Liu, H., Yao, X., Search for β (2014) Plos One, 9 (9), pp. e107837. , eCollection 2014; 
Korb, O., Stutzle, T., Exner, T.E., Empirical scoring functions for advanced proteinligand docking with PLANTS (2009) J Chem Inf Model, 49 (1), pp. 84-96; 
Gutiérrez-De-Terán, H., Centeno, N.B., Pastor, M., Sanz, F., Novel approaches for modeling of the A1 adenosine receptor and its agonist binding site (2004) Proteins: Struct Funct Bioinf, 54 (4), pp. 705-715; 
Kolb, P., Phan, K., Gao, Z.G., Marko, A.C., Sali, A., Jacobson, K.A., Limits of ligand selectivity from docking to models: In Silico screening for A1 adenosine receptor antagonists (2012) Plos One, 7 (11), pp. e49910; 
Ke, Y.R., Jin, H.W., Liu, Z.M., Zhang, L.R., Homology modeling and structure validation of the adenosine A1 receptor (2010) Acta Phys Chim Sin, 26 (10), pp. 2833-2839; 
Langmead, C.J., Rews, S.P., Congreve, M., Errey, J.C., Hurrell, E., Marshall, F.H., Mason, J.S., Weir, M., Identification of novel adenosine A2A receptor antagonists by virtual screening (2012) J Med Chem, 55 (5), pp. 1904-1909; 
Katritch, V., Jaakola, V.P., Lane, J., Lin, J., Ijzerman, A.P., Yeager, M., Kufareva, I., Abagyan, R., Structure-based discovery of novel chemotypes for adenosine A2A receptor antagonists (2010) J Med Chem, 53 (4), pp. 1799-1809; 
Ivanov, A.A., Barak, D., Jacobson, K.A., Evaluation of homology modeling of G-protein-coupled receptors in light of the A2A adenosine receptor crystallographic structure (2009) J Med Chem, 52 (10), pp. 3284-3292; 
Rodríguez, D., Gao, Z.G., Moss, S.M., Jacobson, K.A., Carlsson, J., Molecular docking screening using agonist-bound GPCR structures: Probing the A2A adenosine receptor (2015) J Chem Inf Model, 55 (3), pp. 550-563; 
Carlsson, J., Yoo, L., Gao, Z.G., Irwin, J.J., Shoichet, B.K., Jacobson, K.A., Structure-based discovery of A2A adenosine receptor ligands (2010) J Med Chem, 53 (9), pp. 3748-3755; 
Ostopovici-Halip, L., Curpăn, R., Mracec, M., Bologa, C.G., Structural determinants of the α (2011) J Mol Graph Model, 29 (8), pp. 1030-1038; 
Jayaraman, A., Jamil, K., Kakarala, K.K., Homology modelling and docking studies of humanα (2013) J Comput Sci Syst Biol, 6, pp. 136-149; 
Kooistra, A.J., Vischer, H.F., McNaught-Flores, D., Leurs, R., De Esch, I., De Graaf, C., Function-specific virtual screening for GPCR ligands using a combined scoring method (2016) Sci Rep, 6, pp. 28288; 
Kolb, P., Rosenbaum, D.M., Irwin, J.J., Fung, J.J., Kobilka, B.K., Shoichet, B.K., Structurebased discovery of β (2009) Proc Natl Acad Sci U S A, 106 (16), pp. 6843-6848; 
Kothandan, G., Gadhe, C.G., Cho, S.J., Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: A combined in silico study (2012) Plos One, 7 (3), pp. e32864; 
Singh, R., Sobhia, M.E., Structure prediction and molecular dynamics simulations of a G-protein coupled receptor: Human CCR2 receptor (2013) J Biomol Struct Dyn, 31 (7), pp. 694-715; 
Di Fabio, R., Arban, R., Bernasconi, G., Braggio, S., Blaney, F.E., Capelli, A.M., Castiglioni, E., St-Denis, Y., Dihydropyrrole [2,3-d]pyridine derivatives as novel corticotropin-releasing factor-1 antagonists: Mapping of the receptor binding pocket by in silico docking studies (2008) J Med Chem, 51 (22), pp. 7273-7286; 
Micovic, V., Ivanovic, M.D., Dosen-Micovic, L., Docking studies suggest ligandspecific δ-opioid receptor conformations (2009) J Mol Model, 15 (3), pp. 267-280; 
Bautista, D.L., Asher, W., Carpenter, L., Development of the humanμ-, κ-, and δ-opioid receptors and docking with morphine (2005) J Ky Acad Sci, 66 (2), pp. 107-117; 
Sirci, F., Istyastono, E.P., Vischer, H.F., Kooistra, A.J., Nijmeijer, S., Kuijer, M., Wijtmans, M., De Graaf, C., Virtual fragment screening: Discovery of histamine H3 receptor ligands using ligand-based and protein-based molecular fingerprints (2012) J Chem Inf Model, 52 (12), pp. 3308-3324; 
Schlegel, B., Laggner, C., Meier, R., Langer, T., Schnell, D., Seifert, R., Stark, H., Sippl, W., Generation of a homology model of the human histamine H3 receptor for ligand docking and pharmacophore-based screening (2007) J Comput Aided Mol Des, 21 (8), pp. 437-453; 
Levoin, N., Calmels, T., Poupardin-Olivier, O., Labeeuw, O., Danvy, D., Robert, P., Berrebibertrand, I., Capet, M., Refined docking as a valuable tool for lead optimization: Application to histamine H3 receptor antagonists (2008) Arch Pharm (Weinheim), 341 (10), pp. 610-623; 
Costantino, G., Pellicciari, R., Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists (1996) J Med Chem, 39 (20), pp. 3998-4006; 
Chin, S.P., Buckle, M.J., Chalmers, D.K., Yuriev, E., Doughty, S.W., Toward activated homology models of the human M1 muscarinic acetylcholine receptor (2014) J Mol Graph Model, 49, pp. 91-98; 
Swaminathan, M., Chee, C.F., Chin, S.P., Buckle, M.J., Rahman, N.A., Doughty, S.W., Chung, L.Y., Flavonoids with M1 muscarinic acetylcholine receptor binding activity (2014) Molecules, 19 (7), pp. 8933-8948; 
Kruse, A.C., Weiss, D.R., Rossi, M., Hu, J., Hu, K., Eitel, K., Gmeiner, P., Shoichet, B.K., Muscarinic receptors as model targets and antitargets for structurebased ligand discovery (2013) Mol Pharmacol, 84 (4), pp. 528-540; 
Gandhimathi, A., Sowdhamini, R., Molecularmodelling of human 5hydroxytryptamine receptor (5-HT2A) and virtual screening studies towards the identification of agonist and antagonist molecules (2016) J Biomol Struct Dyn, 34 (5), pp. 952-970; 
Kanagarajadurai, K., Malini, M., Bhattacharya, A., Panicker, M.M., Sowdhamini, R., Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding (2009) Mol Biosyst, 5 (12), pp. 1877-1888; 
Brea, J., Rodrigo, J., Carrieri, A., Sanz, F., Cadavid, M.I., Enguix, M.J., Villazón, M., Loza, M.I., New serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptor antagonists: Synthesis, pharmacology, 3DQSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones (2002) J Med Chem, 45 (1), pp. 54-71; 
Ahmed, A., Nagarajan, S., Doddareddy, M.R., Cho, Y.S., Pae, A.N., Binding mode prediction of 5-hydroxytryptamine 2C receptor ligands by homology modeling and molecular docking analysis (2011) Bull Kor Chem Soc, 32 (6), pp. 2008-2014; 
Perkins, R., Fang, H., Tong, W., Welsh, W.J., Quantitative structure-activity relationship methods: Perspectives on drug discovery and toxicology (2003) Environ Toxicol Chem, 22 (8), pp. 1666-1679; 
Dudek, A.Z., Arodz, T., Galvez, J., Computational methods in developing quantitativestructure-activity relationships (QSAR): A review (2006) Comb Chem High Throughput Screen, 9 (3), pp. 213-228; 
Roy, K., Kar, S., Das, R.N., Statistical (2015) A Primer on QSAR/QSPR Modeling, pp. 37-59. , SpringerBriefs in Molecular Science, Cham; 
Alexopoulos, E.C., Introduction to multivariate regression analysis (2010) Hippokratia, 14 (1), pp. 23-28; 
Abdi, H., Partial least square regression (PLS regression) (2003) Encyclopedia of Social Sciences Research Methods, pp. 792-795. , Lewis-Beck M et al, Sage, Thousand Oaks; 
Speck-Planche, A., Kleandrova, V.V., Luan, F., Cordeiro, M.N., Multi-target inhibitors for proteins associated with Alzheimer: In silico discovery using fragment-based descriptors (2013) Curr Alzheimer Res, 10 (2), pp. 117-124; 
Speck-Planche, A., Kleandrova, V.V., QSAR and molecular docking techniques for the discovery of potent monoamine oxidase B inhibitors: Computer-aided generation of new rasagiline bioisosteres (2012) Curr Top Med Chem, 12 (16), pp. 1734-1747; 
Chapelle, O., Vapnik, V., Bousquet, O., Mukherjee, S., Choosing multiple parameters for support vector machines (2002) Mach Learn, 46 (1), pp. 131-159; 
Cramer, R.D., Patterson, D.E., Bunce, J.D., Comparativemolecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins (1988) J am Chem Soc, 110 (18), pp. 5959-5967; 
Kubinyi, H., Comparative molecular field analysis (CoMFA) (2008) Handbook of Chemoinformatics: From Data to Knowledge, 4, pp. 1555-1574. , Gasteiger J (ed), Wiley-VCH Verlag GmbH, Weinheim; 
Klebe, G., Abraham, U., Mietzner, T., Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. (1994) J Med Chem, 37, pp. 4130-4146; 
Robinson, D.D., Winn, P.J., Lyne, P.D., Richards, W.G., Self-organizing molecular field analysis: A tool for structure-activity studies (1999) J Med Chem, 42 (4), pp. 573-583; 
Li, M., Du, L., Wu, B., Xia, L., Self-organizing molecular field analysis on α (2003) Bioorg Med Chem, 11 (18), pp. 3945-3951; 
Moda, T.L., Montanari, C.A., Ricopulo, A.D., Hologram QSAR model for the prediction of human oral bioavailability (2007) Bioorg Med Chem, 15, pp. 7738-7745; 
Doddareddy, M.R., Lee, Y.J., Cho, Y.S., Choi, K.I., Pan, K., Hologram quantitative structure activity relationship studies on 5HT6 antagonists (2004) Bioorg Med Chem, 12 (14), pp. 3815-3824; 
Palangsuntikul, R., Berner, H., Berger, M.L., Wolschann, P., Holographic quantitative structure-activity relationships of tryptamine derivatives at NMDA, 5HT1A and 5HT2A receptors (2013) Molecules, 18 (8), pp. 8799-8811; 
Muñoz-Gutiérrez, C., Caballero, J., Moralesbayuelo, A., HQSAR and molecular docking studies of furanyl derivatives as adenosine A2A receptor antagonists (2016) Med Chem Res, 25 (7), pp. 1316-1328; 
Doytchinova, I., CoMFA-based comparison of two models of binding site on adenosine A1 receptor (2001) J Comput Aided Mol Des, 15 (1), pp. 29-39; 
Lima, E., Teixeira-Salmela, L.F., Simoes, L., Guerra, A.C., Lemos, A., Assessment of the measurement properties of the post stroke motor function instruments available in Brazil: A systematic review (2016) Braz J Phys Ther, 20 (2), pp. 114-125; 
Pourbasheer, E., Shokouhi Tabar, S., Masand, V., Aalizadeh, R., Ganjali, M., 3D-QSAR and docking studies on adenosine A2A receptor antagonists by the CoMFA method (2015) SAR, 26 (6), pp. 461-477; 
Rieger, J.M., Brown, M.L., Sullivan, G.W., Linden, J., Macdonald, T.L., Design, synthesis, and evaluation of novel A2A adenosine receptor agonists (2001) J Med Chem, 44 (4), pp. 531-539; 
Baraldi, P.G., Borea, P.A., Bergonzoni, M., Cacciari, B., Ongini, E., Recanatini, M., Spalluto, G., Comparative molecular field analysis (CoMFA) of a series of selective adenosine receptor A2A antagonists. Drug (1999) Dev Res, 46 (2), pp. 126-133; 
Doytchinova, I., Valkova, I., Natcheva, R., CoMFA study on adenosine A2A receptor agonists (2001) Quant Struct-Act Relat, 20 (2), pp. 124-129; 
Vilar, S., Karpiak, J., Costanzi, S., Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the β (2010) J Comput Chem, 31 (4), pp. 707-720; 
Senthil Kumar, P., Bharatam, P.V., Comparative 3D QSAR study on β (2010) Med Chem Res, 19 (9), pp. 1121-1140; 
Jozwiak, K., Khalid, C., Tanga, M.J., Berzeteigurske, I., Jimenez, L., Kozocas, J.A., Woo, A., Wainer, I.W., Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the β (2007) J Med Chem, 50 (12), pp. 2903-2915; 
Jozwiak, K., Woo, A.Y., Tanga, M.J., Toll, L., Jimenez, L., Kozocas, J.A., Plazinska, A., Wainer, I.W., Comparative molecular field analysis of fenoterol derivatives: A platform towards highly selective and effective β (2010) Bioorg Med Chem, 18 (2), pp. 728-736; 
Plazinska, A., Pajak, K., Rutkowska, E., Jimenez, L., Kozocas, J., Koolpe, G., Tanga, M., Jozwiak, K., Comparative molecular field analysis of fenoterol derivatives interacting with an agonist-stabilized form of the β (2014) Bioorg Med Chem, 22 (1), pp. 234-246; 
Gunda, S.K., Anugolu, R.K., Tata, S.R., Mahmood, S., Structural investigations of CXCR2 receptor antagonists by CoMFA, CoMSIA and flexible docking studies (2012) Acta Pharma, 62 (3), pp. 287-304; 
Peng, Y., Keenan, S.M., Zhang, Q., Welsh, W.J., 3D-QSAR comparative molecular field (2005) J Mol Graph Model, 24 (1), pp. 25-33; 
Ghasemi, J.B., Tavakoli, H., Improvement of the prediction power of the CoMFA and CoMSIA models on histamine H3 antagonists by different variable selection methods (2012) Sci Pharm, 80 (3), pp. 547-566; 
Chen, H.F., Computational study of histamine H3-receptor antagonist with support vector machines and three dimension quantitative structure activity relationship methods (2008) Anal Chim Acta, 624 (2), pp. 203-209; 
Rivara, S., Mor, M., Bordi, F., Silva, C., Zuliani, V., Vacondio, F., Morini, G., Testa, B., Synthesis and threedimensional quantitative structure-activity relationship analysis of H3 receptor antagonists containing a neutral heterocyclic polar group (2003) Drug Des Discov, 18 (23), pp. 65-79; 
Sekhar, Y.N., Ravikumar, M., Nayana, M., Mallena, S.C., Kumar, M.K., 3D-QSAR studiesof (2008) Eur J Med Chem, 43 (5), pp. 1025-1034; 
Sekhar, Y.N., Nayana, M., Ravikumar, M., Mahmood, S., Comparative molecular field analysis of quinoline derivatives as selective and noncompetitive mGluR1 antagonists (2007) Chem Biol Drug Des, 70 (6), pp. 511-519; 
Tresadern, G., Cid, J.M., Trabanco, A.A., QSAR design of triazolopyridine mGlu2 receptor positive allosteric modulators (2014) J Mol Graph Model, 53, pp. 82-91; 
De Paulis, T., Hemstapat, K., Chen, Y., Zhang, Y., Saleh, S., Alagille, D., Baldwin, R.M., Conn, P.J., Substituent effects of N-(1,3-Diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes (2006) J Med Chem, 49 (11), pp. 3332-3344; 
Lowe, J., Ferrebee, A., Rodriguez, A.L., Conn, P.J., Meiler, J., 3D-QSAR CoMFA study of benzoxazepine derivatives as mGluR5 positive allosteric modulators. (2010) Bioorg Med Chem, 20 (19), pp. 5922-5924; 
Selvam, C., Thilagavathi, R., Narasimhan, B., Kumar, P., Jordan, B.C., Ranganna, K., Computer-aided design of negative allosteric modulators of metabotropic glutamate receptor 5 (MGluR5): Comparative molecular field analysis of aryl ether derivatives (2016) Bioorg Med Chem Lett, 26 (4), pp. 1140-1144; 
Zlotos, D.P., Buller, S., Stiefl, N., Baumann, K., Mohr, K., Probing the pharmacophore for allosteric ligands of muscarinic M2 receptors: SAR and QSAR studies in a series of bisquaternary salts of caracurine V and related ringsystems (2004) J Med Chem, 47 (14), pp. 3561-3571; 
Niu, Y.Y., Yang, L.M., Deng, K.M., Yao, J.H., Zhu, L., Chen, C.Y., Zhang, M., Chen, H.Z., Quantitative structure–selectivity relationship for M2 selectivity between M1 and M2 of piperidinyl piperidine derivatives as muscarinic antagonists (2007) Bioorg Med Chem Lett, 17 (8), pp. 2260-2266; 
Silva, M.E., Heim, R., Strasser, A., Elz, S., Dove, S., Theoretical studies on the interaction of partial agonists with the 5-HT2A receptor (2011) J Comput Aided Mol Des, 25 (1), pp. 51-66; 
Moeller, D., Salama, I., Kling, R.C., Hübner, H., Gmeiner, P., 1,4-Disubstituted aromatic piperazines with high 5-HT2A/D2 (2015) Bioorg Med Chem, 23 (18), pp. 6195-6209; 
Raviña, E., Negreira, J., Cid, J., Masaguer, C.F., Rosa, E., Rivas, M.E., Fontenla, J.A., Carrieri, A., Conformationally constrained butyrophenones with mixed dopaminergic (D2) and serotoninergic (5-HT2A, 5-HT2C) affinities: Synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzoand -thienocycloalkanones as putative atypical antipsychotics (1999) J Med Chem, 42 (15), pp. 2774-2797; 
Zhang, Z., An, L., Hu, W., Xiang, Y., 3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach. (2007) J Comput, 21 (4), pp. 145-153; 
Bromidge, S.M., Dabbs, S., Davies, D.T., Duckworth, D.M., Forbes, I.T., Ham, P., Jones, G.E., Wood, M.D., Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: Synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines (1998) J Med Chem, 41 (10), pp. 1598-1612; 
Lopez-Rodriguez, M.L., Murcia, M., Benhamú, B., Viso, A., Campillo, M., Pardo, L., 3DQSAR/CoMFA and recognition models of (2001) Bioorg Med Chem Lett, 11 (21), pp. 2807-2811; 
López-Rodríguez, M.L., Murcia, M., Benhamu´, B., Viso, A., Campillo, M., Pardo, L., Benzimidazole derivatives. 3. 3D-QSAR/CoMFA model and computational simulation for the recognition of 5-HT4 receptor antagonists (2002) J Med Chem, 45 (22), pp. 4806-4815; 
Iskander, M.N., Leung, L.M., Buley, T., Ayad, F., Di Iulio, J., Tan, Y.Y., Coupar, I.M., Optimization of a pharmacophore model for 5HT4 agonists using CoMFA and receptor based alignment (2006) Eur J Med Chem, 41 (1), pp. 16-26; 
Suzuki, T., Imanishi, N., Itahana, H., Watanuki, S., Miyata, K., Ohta, M., Nakahara, H., Mase, T., Novel 5-hydroxytryptamine 4 (5-HT4) receptor agonists. Synthesis and Gastroprokinetic activity of 4-amino-N (2(1-aminocycloalkan-1-yl)ethyl)-5-chloro 2 methoxybenzamides (1998) Chem Pharm Bull, 46 (7), pp. 1116-1124; 
Doddareddy, M.R., Cho, Y.S., Koh, H.Y., Pae, A.N., CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists (2004) Bioorg Med Chem, 12 (15), pp. 3977-3985; 
Guner, O.F., The impact of pharmacophore modeling in drug design (2005) Idrugs, 8 (7), pp. 567-572; 
Sun, H., Pharmacophore-based virtual screening (2008) Curr Med Chem, 15 (10), pp. 1018-1024; 
Dixon, S.L., Smondyrev, A.M., Knoll, E.H., Rao, S.N., Shaw, D.E., Friesner, R.A., PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results (2006) J Comput Aided Mol Des, 20 (1011), pp. 647-671; 
Golender, V., Vesterman, B., Eliyahu, O., Kardash, A., Kletzin, M., Shokhen, M., Vorpagel E (1994) Knowledge engineering approach to drug design and its implementation in the APEX-3D Expert System Prous Science, pp. 249-254. , Proceedings of the 10th European Symposium on StructureActivity Relationships, Barcelona; 
Harris, D.L., Loew, G., Development and assessment of a 3D pharmacophore for ligand recognition of BDZR/GABAA receptors initiating the anxiolytic response (2008) Bioorg Med Chem, 8 (11), pp. 2527-2538; 
Mills, J., De Esch, I., Perkins, T., Dean, P.M., SLATE: A method for the superposition of flexible ligands (2001) J Comput Aided Mol Des, 15 (1), pp. 81-96; 
Wolber, G., Langer, T., LigandScout: 3D pharmacophores derived from proteinbound ligands and their use as virtual screening filters (2005) J Chem Inf Model, 45 (1), pp. 160-169; 
Huang, P., Kim, S., Loew, G., Development of a common 3D pharmacophore for δ-opioid recognition from peptides and nonpeptides using a novel computer program (1997) J Comput Aided Mol Des, 11 (1), pp. 21-28; 
Clark, M., Cramer, R.D., Van Opdenbosch, N., Validation of the general purpose Tripos 5.2 force field (1989) J Comput Chem, 10 (8), pp. 982-1012; 
Patel, Y., Gillet, V.J., Bravi, G., Leach, A.R., A comparison of the pharmacophore identification programs: CATALYST, DISCO and GASP (2002) J Comput Aided Mol Des, 16 (89), pp. 653-681; 
Chen, I.J., Foloppe, N., Conformational sampling of druglike molecules with MOE and CATALYST: Implications for pharmacophore modeling and virtual screening (2008) J Chem Inf Model, 48 (9), pp. 1773-1791; 
Mustyala, K.K., Chitturi, A.R., Naikal James, P.S., Vuruputuri, U., Pharmacophore mapping and in silico screening to identify new potent leads for A2A adenosine receptor as antagonists (2012) J Recept Signal Transduct Res, 32 (2), pp. 102-113; 
Bacilieri, M., Ciancetta, A., Paoletta, S., Federico, S., Cosconati, S., Cacciari, B., Taliani, S., Moro, S., Revisiting a receptor-based pharmacophore hypothesis for human A2A adenosine receptor antagonists (2013) J Chem Inf Model, 53 (7), pp. 1620-1637; 
Wei, J., Wang, S., Gao, S., Dai, X., Gao, Q., 3D-Pharmacophore models for selective A2A and A2B adenosine receptor antagonists (2007) J Chem Inf Model, 47 (2), pp. 613-625; 
Khanfar, M.A., Al-Qtaishat, S., Habash, M., Taha, M.O., Discovery of potent adenosine A2A antagonists as potential anti-Parkinson disease agents. Non-linear QSAR analyses integrated with pharmacophore modeling (2016) Chem Biol Interact, 254, pp. 93-101; 
Balogh, B., Jójárt, B., Wágner, Z., Kovács, P., Máté, G., Gyires, K., Zádori, Z., Mátyus, P., 3D QSAR models for (2007) Neurochem Int, 51 (5), pp. 268-276; 
Kothandan, G., Gadhe, C.G., Madhavan, T., Cho, S.J., Binding site analysis of CCR2 through in silico methodologies: Docking, CoMFA, and CoMSIA (2011) Chem Biol Drug Des, 78 (1), pp. 161-174; 
Singh, R., Balupuri, A., Sobhia, M.E., Development of 3D-pharmacophore model followed by successive virtual screening, molecular docking and ADME studies for the design of potent CCR2 antagonists for inflammation-driven diseases (2013) Mol Simul, 39 (1), pp. 49-58; 
Ye, Y., Liao, Q., Wei, J., Gao, Q., 3D-QSAR (2010) Neurochem Int, 56 (5), pp. 107-117; 
Whitten, J.P., Xie, Y.F., Erickson, P.E., Webb, T.R., De Souza, E.B., Grigoriadis, D.E., McCarthy, J.R., Rapid microscale synthesis, a new method for lead optimization using robotics and solution phase chemistry: Application to thesynthesis and optimization of corticotropin-releasing factor 1 receptor antagonists (1996) J Med Chem, 39 (22), pp. 4354-4357; 
Kaur, P., Sharma, V., Kumar, V., Pharmacophore modelling and 3D-QSAR studies on (2012) Int J, 2012, pp. 452325; 
Bernard, D., Coop, A., Mackerell, A.D., 2D conformationally sampled pharmacophore: A ligand-based pharmacophore to differentiate δ opioid agonists from antagonists (2003) J am Chem Soc, 125 (10), pp. 3101-3107; 
Coop, A., Jacobson, A.E., The LMC δ opioid recognition pharmacophore: Comparison of SNC80 and oxymorphindole (1999) Bioorg Med Chem Lett, 9 (3), pp. 357-362; 
Bernard, D., Coop, A., Mackerell, A.D., Conformationally sampled pharmacophore for peptidic δ opioid ligands (2005) J Med Chem, 48 (24), pp. 7773-7780; 
Levoin, N., Labeeuw, O., Krief, S., Calmels, T., Poupardin-Olivier, O., Berrebi-Bertrand, I., Lecomte, J.M., Capet, M., Determination of the binding mode and interacting amino-acids for dibasic H3 receptor antagonists (2013) Bioorg Med Chem, 21 (15), pp. 4526-4529; 
De Esch, I., Mills, J., Perkins, T., Romeo, G., Hoffmann, M., Wieland, K., Leurs, R., Timmerman, H., Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE (2001) J Med Chem, 44 (11), pp. 1666-1674; 
Axe, F.U., Bembenek, S.D., Szalma, S., Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore (2006) J Mol Graph Model, 24 (6), pp. 456-464; 
Jullian, N., Brabet, I., Pin, J.P., Acher, F.C., Agonist selectivity of mGluR1 and mGluR2 metabotropic receptors: A different environment but similar recognition of an extended glutamate conformation (1999) J Med Chem, 42 (9), pp. 1546-1555; 
Filizola, M., Tasso, S.M., Loew, G.H., Villar, H.O., Global physicochemical properties as activity discriminants for the mGluR1 subtype of metabotropic glutamate receptors (2001) J Comput Chem, 22 (16), pp. 2018-2027; 
Zhang, M.Q., Zhang, X.L., Li, Y., Fan, W.J., Wang, Y.H., Hao, M., Zhang, S.W., Ai, C.Z., Investigation on quantitative structure activity relationships and pharmacophore modeling of a series of mGluR2 antagonists (2011) Int J Mol Sci, 12 (9), pp. 5999-6023; 
Lu, C., Jin, F., Li, C., Li, W., Liu, G., Tang, Y., Insights into binding modes of 5-HT2C receptor antagonists with ligand-based and receptor-based methods (2011) J Mol Model, 17 (10), pp. 2513-2523; 
Ahmed, A., Choo, H., Cho, Y.S., Park, W.K., Pae, A.N., Identification of novel serotonin 2C receptor ligands by sequential virtual screening (2009) Bioorg Med Chem, 17 (13), pp. 4559-4568; 
Iskander, M.N., Coupar, I.M., Winkler, D.A., Investigation of 5-HT4 agonist activities using molecular field analysis (1999) J Chem Soc Perkin Trans, 2 (2), pp. 153-158; 
Bureau, R., Daveu, C., Lemaˆıtre, S., Dauphin, F., Landelle, H., Lancelot, J.C., Rault, S., Moleculardesign based on 3Dpharmacophore. Application to 5-HT4 receptor (2002) J Chem Inf Comput Sci, 42 (4), pp. 962-967; 
López-Rodríguez, M.L., Benhamu´, B., De La Fuente, T., Sanz, A., Pardo, L., Campillo, M., A three-dimensional pharmacophore model for 5-hydroxytryptamine 6 (5-HT6) receptor antagonists (2005) J Med Chem, 48 (13), pp. 4216-4219; 
Kim, H.J., Doddareddy, M.R., Choo, H., Cho, Y.S., No, K.T., Park, W.K., Pae, A.N., New serotonin 5-HT6 ligands from common feature pharmacophore hypotheses (2008) J Chem Inf Model, 48 (1), pp. 197-206; 
Hayat, F., Cho, S., Rhim, H., Indu Viswanath, A.N., Pae, A.N., Lee, J.Y., Choo, D.J., Choo, H.Y., Design and synthesis of novel series of 5-HT6 receptor ligands having indole, a central aromatic core and 1-amino-4-methyl piperazine as a positive ionizable group (2013) Bioorg Med Chem, 21 (17), pp. 5573-5582
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85030698903&doi=10.1007%2f978-1-4939-7404-7_3&partnerID=40&md5=09ec339d6c4be990ef1056d9067a7c85
ER  - 

TY  - JOUR
TI  - Multi-modal MRI classifiers identify excessive alcohol consumption and treatment effects in the brain
T2  - Addiction Biology
J2  - Addict. Biol.
VL  - 22
IS  - 5
SP  - 1459
EP  - 1472
PY  - 2017
DO  - 10.1111/adb.12418
SN  - 13556215 (ISSN) 
AU  - Cosa, A.
AU  - Moreno, A.
AU  - Pacheco-Torres, J.
AU  - Ciccocioppo, R.
AU  - Hyytiä, P.
AU  - Sommer, W.H.
AU  - Moratal, D.
AU  - Canals, S.
AD  - Instituto de Neurociencias, Consejo Superior de Investigaciones Científicas and Universidad Miguel Hernández, Sant Joan d'Alacant, Spain
AD  - Center for Biomaterials and Tissue Engineering, Universitat Politècnica de València, Valencia, Spain
AD  - School of Pharmacy University of Camerino, Camerino, Italy
AD  - Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland
AD  - Department of Psychopharmacology, Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany
AD  - Central Institute of Mental Health, University of Heidelberg, Mannheim, Germany
AB  - Robust neuroimaging markers of neuropsychiatric disorders have proven difficult to obtain. In alcohol use disorders, profound brain structural deficits can be found in severe alcoholic patients, but the heterogeneity of unimodal MRI measurements has so far precluded the identification of selective biomarkers, especially for early diagnosis. In the present work we used a combination of multiple MRI modalities to provide comprehensive and insightful descriptions of brain tissue microstructure. We performed a longitudinal experiment using Marchigian–Sardinian (msP) rats, an established model of chronic excessive alcohol consumption, and acquired multi-modal images before and after 1 month of alcohol consumption (6.8 ± 1.4 g/kg/day, mean ± SD), as well as after 1 week of abstinence with or without concomitant treatment with the antirelapse opioid antagonist naltrexone (2.5 mg/kg/day). We found remarkable sensitivity and selectivity to accurately classify brains affected by alcohol even after the relative short exposure period. One month drinking was enough to imprint a highly specific signature of alcohol consumption. Brain alterations were regionally specific and affected both gray and white matter and persisted into the early abstinence state without any detectable recovery. Interestingly, naltrexone treatment during early abstinence resulted in subtle brain changes that could be distinguished from non-treated abstinent brains, suggesting the existence of an intermediate state associated with brain recovery from alcohol exposure induced by medication. The presented framework is a promising tool for the development of biomarkers for clinical diagnosis of alcohol use disorders, with capacity to further inform about its progression and response to treatment. © 2016 Society for the Study of Addiction
KW  - alcohol use disorders
KW  - classification algorithms
KW  - machine learning
KW  - multi-modal MRI
KW  - naltrexone
KW  - rat
KW  - biological marker
KW  - naltrexone
KW  - alcohol
KW  - central depressant agent
KW  - naltrexone
KW  - narcotic antagonist
KW  - alcohol abstinence
KW  - alcoholism
KW  - animal experiment
KW  - animal model
KW  - animal tissue
KW  - Article
KW  - brain tissue
KW  - classification
KW  - classifier
KW  - controlled study
KW  - disease course
KW  - exposure
KW  - gray matter
KW  - multimodal imaging
KW  - nonhuman
KW  - nuclear magnetic resonance imaging
KW  - nuclear magnetic resonance scanner
KW  - priority journal
KW  - rat
KW  - rat model
KW  - tissue structure
KW  - treatment response
KW  - white matter
KW  - alcoholism
KW  - animal
KW  - brain
KW  - diagnostic imaging
KW  - disease model
KW  - drinking behavior
KW  - drug effect
KW  - longitudinal study
KW  - nuclear magnetic resonance imaging
KW  - Alcohol Drinking
KW  - Alcoholism
KW  - Animals
KW  - Brain
KW  - Central Nervous System Depressants
KW  - Disease Models, Animal
KW  - Ethanol
KW  - Longitudinal Studies
KW  - Magnetic Resonance Imaging
KW  - Naltrexone
KW  - Narcotic Antagonists
KW  - Rats
PB  - Blackwell Publishing Ltd
N1  - Cited By :5
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: ADBIF
C2  - 27273582
LA  - English
N1  - Correspondence Address: Moratal, D.; Center for Biomaterials and Tissue Engineering, Universitat Politècnica de ValènciaSpain; email: dmoratal@eln.upv.es
N1  - Chemicals/CAS: naltrexone, 16590-41-3, 16676-29-2; alcohol, 64-17-5; Central Nervous System Depressants; Ethanol; Naltrexone; Narcotic Antagonists
N1  - Tradenames: BioSpect 70/30, Bruker, Germany
N1  - Manufacturers: Bruker, Germany
N1  - Funding details: Horizon 2020 Framework Programme, H2020, 668863-SyBil-AA
N1  - Funding details: University of Edinburgh
N1  - Funding details: PIM2010ERN-00679, BFU2015-64380-C2-1-R
N1  - Funding details: Ministerio de Economía y Competitividad
N1  - Funding details: Federación Española de Enfermedades Raras, FEDER, BFU2015-64380-C2-2-R, TEC2012-33778
N1  - Funding text 1: We are grateful to Bego?a Fern?ndez for her excellent technical assistance. Supported by grants from the Spanish MINECO to S.C. (BFU2015-64380-C2-1-R and PIM2010ERN-00679 as part of the Era-Net NEURON TRANSALC) and from the EU Horizon 2020 Program 668863-SyBil-AA grant, and to D.M. including FEDER funds under grant TEC2012-33778 and BFU2015-64380-C2-2-R. A.M. holds a studentship from the University of Edinburgh. The Instituto de Neurociencias is ?Centre of Excellence Severo Ochoa?.
N1  - References: Agosta, F., Ferraro, P.M., Canu, E., Copetti, M., Galantucci, S., Magnani, G., Marcone, A., Filippi, M., Differentiation between subtypes of primary progressive aphasia by using cortical thickness and diffusion-tensor MR imaging measures (2015) Radiology, 276, pp. 219-227; 
Akaike, H., A new look at the statistical model identification (1974) IEEE Trans Automat Contr, 19, pp. 716-723; 
Alexander, A.L., Lee, J.E., Lazar, M., Field, A.S., Diffusion tensor imaging of the brain (2007) Neurotherapeutics, 4, pp. 316-329; 
Ashburner, J., A fast diffeomorphic image registration algorithm (2007) Neuroimage, 38, pp. 95-113; 
Ashburner, J., Friston, K.J., Unified segmentation (2005) Neuroimage, 26, pp. 351-839; 
Bell-Temin, H., Zhang, P., Chaput, D., King, M.A., You, M., Liu, B., Stevens, S.M., Quantitative proteomic characterization of ethanol-responsive pathways in rat microglial cells (2013) J Proteome Res, 12, pp. 2067-2077; 
Biedermann, S., Fuss, J., Zheng, L., Sartorius, A., Falfan-Melgoza, C., Demirakca, T., Gass, P., Weber-Fahr, W., In vivo voxel based morphometry: detection of increased hippocampal volume and decreased glutamate levels in exercising mice (2012) Neuroimage, 61, pp. 1206-1212; 
Boretius, S., Escher, A., Dallenga, T., Wrzos, C., Tammer, R., Brück, W., Nessler, S., Stadelmann, C., Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI (2011) Neuroimage, 59, pp. 2678-2688; 
Breiman, L., Random forests (2001) Mach Learn, 45, pp. 5-32; 
Box, G.E.P., Cox, D.R., An analysis of transformations (1964) J Roy Stat Soc B, 26, pp. 211-252; 
Bühler, M., Mann, K., Alcohol and the human brain: a systematic review of different neuroimaging methods (2011) Alcohol Clin Exp Res, 35, pp. 1771-1793; 
Carnicella, S., Ron, D., Barak, S., Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse (2014) Alcohol, 48, pp. 243-252; 
Crabbe, J.C., Harris, R.A., Koob, G.F., Preclinical studies of alcohol binge drinking (2016) Ann N Y Acad Sci, 1216, pp. 24-40; 
Ciccocioppo, R., Economidou, D., Cippitelli, A., Cucculelli, M., Ubaldi, M., Soverchia, L., Lourdusamy, A., Massi, M., REVIEW: genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism (2006) Addict Biol, 11, pp. 339-355; 
Ciccocioppo, R., Economidou, D., Rimondini, R., Sommer, W., Massi, M., Heilig, M., Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system (2007) Biol Psychiatry, 61, pp. 4-12; 
Ciccocioppo, R., Geneticallyselected alcohol preferring rats to model human alcoholism (2013) Curr Top Behav Neurosci, 13, pp. 251-269; 
Chatzis, S., Varvarigou, T., Robust fuzzy clustering using mixtures of Student's-t distributions (2008) Pattern Recognit Lett, 29, pp. 1901-1905; 
Crews, F.T., Zou, J., Qin, L., Induction of innate immune genes in brain create the neurobiology of addiction (2011) Brain Behav Immun, 25, pp. S4-S12; 
Demirakca, T., Ende, G., Kämmerer, N., Welzel-Marquez, H., Hermann, D., Heinz, A., Mann, K., Effects of alcoholism and continued abstinence on brain volumes in both genders (2011) Alcohol Clin Exp Res, 35, pp. 1678-1685; 
Dempster, A.P., Laird, N.M., Rubin, D.B., Maximum likelihood from incomplete data via the EM algorithm (1977) J Roy Stat Soc B, 39, pp. 1-38; 
Dennis, C.V., Sheahan, P.J., Graeber, M.B., Sheedy, D.L., Kril, J.J., Sutherland, G.T., Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy (2014) Metab Brain Dis, 29, pp. 1027-1039; 
Dudek, M., Abo-Ramadan, U., Hermann, D., Brown, M., Canals, S., Sommer, W.H., Hyytia, P., Brain activation induced by voluntary alcohol and saccharin drinking in rats assessed with manganese-enhanced magnetic resonance imaging (2014) Addict Biol, 20, pp. 1012-1021; 
Dyrba, M., Grothe, M., Kirste, T., Teipel, S.J., Multimodal analysis of functional and structural disconnection in Alzheimer's disease using multiple kernel SVM (2015) Hum Brain Mapp, 36, pp. 2118-2131; 
Egli, M., Can experimental paradigms and animal models be used to discover clinically effective medications for alcoholism? (2005) Addict Biol, 10, pp. 309-319; 
El-Rafei, A., Engelhorn, T., Warntges, S., Dorfler, A., Hornegger, J., Michelson, G., Glaucoma classification based on visual pathway analysis using diffusion tensor imaging (2013) Magn Reson Imaging, 31, pp. 1081-1091; 
Farahat, A.K., Ghodsi, A., Kamel, M.S., An efficient greedy method for unsupervised feature selection (2007) Data Mining 2011 IEEE 11th International Conference on, pp. 161-170. , In, ICDM, IEEE; 
Fein, G., Landman, B., Tran, H., McGillivray, S., Finn, P., Barakos, J., Moon, K., Brain atrophy in long-term abstinent alcoholics who demonstrate impairment on a simulated gambling task (2006) Neuroimage, 32, pp. 1465-1471; 
Feis, D.L., Brodersen, K.H., von Cramon, D.Y., Luders, E., Tittgemeyer, M., Decoding gender dimorphism of the human brain using multimodal anatomical and diffusion MRI data (2013) Neuroimage, 70, pp. 250-257; 
Fischl, B., Salat, D.H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Dale, A.M., Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain (2002) Neuron, 33, pp. 341-355; 
Genuer, R., Poggi, J.M., Tuleau-Malot, C., Variable selection using random forests (2010) Pattern Recognition Lett, 31, pp. 2225-2236; 
Goubran, M., Bernhardt, B.C., Cantor-Rivera, D., Lau, J.C., Blinston, C., Hammond, R.R., de Ribaupierre, S., Khan, A.R., In vivo MRI signatures of hippocampal subfield pathology in intractable epilepsy (2016) Hum Brain Mapp, 37, pp. 1103-1119; 
Hanley, J.A., McNeil, B.J., The meaning and use of the area under a receiver operating characteristic (ROC) curve (1982) Radiology, 143, pp. 29-36; 
Harville, D.A., Maximum likelihood approaches to variance component estimation and to related problems (1977) J Am Stat Assoc, 72, pp. 320-338; 
He, J., Crews, F.T., Increased MCP-1 and microglia in various regions of the human alcoholic brain (2008) Exp Neurol, 210, pp. 349-358; 
Hermann, D., Weber-Fahr, W., Sartorius, A., Hoerst, M., Frischknecht, U., Tunc-Skarka, N., Perreau-Lenz, S., Sommer, W.H., Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats (2012) Biol Psychiatry, 71, pp. 1015-1021; 
Klöppel, S., Stonnington, C.M., Chu, C., Draganski, B., Scahill, R.I., Rohrer, J.D., Fox, N.C., Frackowiak, R.S.J., Automatic classification of MR scans in Alzheimer's disease (2008) Brain, 131, pp. 681-689; 
Kohavi, R., John, G.H., Wrappers for feature subset selection (1997) Relevance, 97, pp. 273-324; 
Kong, L.M., Zheng, W.B., Lian, G.P., Zhang, H.D., Acute effects of alcohol on the human brain: diffusion tensor imaging study (2012) Am J Neuroradiol, 33, pp. 928-934; 
Kril, J.J., Halliday, G.M., Svoboda, M.D., Cartwright, H., The cerebral cortex is damaged in chronic alcoholics (1997) Neuroscience, 79, pp. 983-998; 
Ling, J., Merideth, F., Caprihan, A., Pena, A., Teshiba, T., Mayer, A.R., Head injury or head motion? Assessment and quantification of motion artifacts in diffusion tensor imaging studies (2012) Hum Brain Mapp, 33, pp. 50-62; 
Lo, K., Brinkman, R.R., Gottardo, R., Automated gating of flow cytometry data via robust model-based clustering (2008) Cytometry A, 73, pp. 321-332; 
Lo, K., Hahne, F., Brinkman, R.R., Gottardo, R., flowClust: a Bioconductor package for automated gating of flow cytometry data (2009) BMC Bioinformatics, 10, p. 145; 
Magnin, B., Mesrob, L., Kinkingnéhun, S., Pélégrini-Issac, M., Colliot, O., Sarazin, M., Dubois, B., Benali, H., Support vector machine-based classification of Alzheimer's disease from whole-brain anatomical MRI (2009) Neuroradiology, 51, pp. 73-83; 
Makris, N., Oscar-Berman, M., Jaffin, S.K., Hodge, S.M., Kennedy, D.N., Caviness, V.S., Marinkovic, K., Harris, G.J., Decreased volume of the brain reward system in alcoholism (2008) Biol Psychiatry, 64, pp. 192-202; 
McClain, J.A., Morris, S.A., Deeny, M.A., Marshall, S.A., Hayes, D.M., Kiser, Z.M., Nixon, K., Adolescent binge alcohol exposure induces long-lasting partial activation of microglia (2011) Brain Behav Immun, 25, pp. S120-S128; 
McLaughlin, P.J., Immonen, J.A., Zagon, I.S., Topical naltrexone accelerates full-thickness wound closure in type 1 diabetic rats by stimulating angiogenesis (2013) Exp Biol Med (Maywood), 238, pp. 733-743; 
Meinhardt, M.W., Sommer, W.H., Postdependent state in rats as a model for medication development in alcoholism (2015) Addict Biol, 20, pp. 1-21; 
Moslehi, A., Nabavizadeh, F., Dehpour, A.R., Tavanga, S.M., Hassanzadeh, G., Zekri, A., Nahrevanian, H., Sohanaki, H., Naltrexone attenuates endoplasmic reticulum stress induced hepatic injury in mice (2014) Acta Physiol Hung, 101, pp. 341-352; 
Muller-Oehring, E.M., Jung, Y.C., Pfefferbaum, A., Sullivan, E.V., Schulte, T., The resting brain of alcoholics (2015) Cereb Cortex, 25, pp. 4155-4168; 
Mwangi, B., Tian, T.S., Soares, J.C., A review of feature reduction techniques in neuroimaging. - (2014) Neuroinformatics, 12, pp. 229-244; 
Nejad, A.B., Madsen, K.H., Ebdrup, B.H., Siebner, H.R., Rasmussen, H., Aggernaes, B., Glenthoj, B.Y., Baare, W.F., Neural markers of negative symptom outcomes in distributed working memory brain activity of antipsychotic-naive schizophrenia patients (2013) Int J Neuropsychopharmacol, 16, pp. 1195-1204; 
Nguyen, T.M., Wu, Q.M.J., Robust Student's-t mixture model with spatial constraints and its application in medical image segmentation (2012) IEEE Trans Med Imaging, 31, pp. 103-116; 
Orru, G., Pettersson-Yeo, W., Marquand, A.F., Sartori, G., Mechelli, A., Using Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: a critical review (2012) Neurosci Biobehav Rev, 36, pp. 1140-1152; 
Pettersson-Yeo, W., Benetti, S., Marquand, A.F., Joules, R., Catani, M., Williams, S.C., Allen, P., Mechelli, A., An empirical comparison of different approaches for combining multimodal neuroimaging data with support vector machine (2014) Front Neurosci, 8, p. 189; 
Pfefferbaum, A., Sullivan, E.V., Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism: evidence from diffusion tensor imaging (2005) Neuropsychopharmacology, 30, pp. 423-432; 
Qin, L., Crews, F.T., Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration (2012) J Neuroinflammation, 9, p. 130; 
Power, J.D., Barnes, K.A., Snyder, A.Z., Schlaggar, B.L., Petersen, S.E., Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion (2012) Neuroimage, 59, pp. 2142-2154; 
Qin, W., Zhang, M., Piao, Y., Guo, D., Zhu, Z., Tian, X., Li, K., Yu, C., Wallerian degeneration in central nervous system: dynamic associations between diffusion indices and their underlying pathology (2012) PLoS One, 7; 
Rando, K., Hong, K.I., Bhagwagar, Z., Li, C.S., Bergquist, K., Guarnaccia, J., Sinha, R., Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: a prospective study (2011) Am J Psychiatry, 168, pp. 183-192; 
Salvatore, C., Cerasa, A., Castiglioni, I., Gallivanone, F., Augimeri, A., Lopez, M., Arabia, G., Quattrone, A., Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy (2014) J Neurosci Methods, 222, pp. 230-237; 
Schwarz, G., Estimating the dimension of a model (1978) Ann Stat, 6, pp. 461-464; 
Sfikas, G., Nikou, C., Galatsanos, N., Edge preserving spatially varying mixtures for image segmentation (2008) Computer Vision and Pattern Recognition, 2008, pp. 1-7. , CVPR 2008, IEEE Conference; 
Smith, J.P., Bingaman, S.I., Ruggiero, F., Mauger, D.T., Mukherjee, A., McGovern, C.O., Zagon, I.S., Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial (2011) Dig Dis Sci, 56, pp. 2088-2097; 
Smyth, P., Model selection for probabilistic clustering using cross-validated likelihood (2000) Stat Comput, 10, pp. 63-72; 
Stopponi, S., de Guglielmo, G., Somaini, L., Cippitelli, A., Cannella, N., Kallupi, M., Ubaldi, M., Ciccocioppo, R., Activation of PPARgamma by pioglitazone potentiates the effects of naltrexone on alcohol drinking and relapse in msP rats (2013) Alcohol Clin Exp Res, 37, pp. 1351-1360; 
Teipel, S.J., Born, C., Ewers, M., Bokde, A.L.W., Reiser, M.F., Möller, H.J., Hampel, H., Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment (2007) Neuroimage, 38, pp. 13-24; 
Vapnik, V., (2000) The Nature of Statistical Learning Theory, , New York, Springer; 
Whiteford, H.A., Degenhardt, L., Rehm, J., Baxter, A.J., Ferrari, A.J., Erskine, H.E., Charlson, F.J., Vos, T., Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010 (2013) Lancet, 382, pp. 1575-1586; 
Wittchen, H.U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jonsson, B., Olesen, J., Steinhausen, H.C., The size and burden of mental disorders and other disorders of the brain in Europe 2010 (2011) Eur Neuropsychopharmacol, 21, pp. 655-679; 
Zahr, N.M., Kaufman, K.L., Harper, C.G., Clinical and pathological features of alcohol-related brain damage (2011) Nat Rev Neurol, 7, pp. 284-294
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84973867004&doi=10.1111%2fadb.12418&partnerID=40&md5=d3bf9a21dae56accca5bb1fef7dd1acc
ER  - 

TY  - JOUR
TI  - Granger causality reveals a dominant role of memory circuit in chronic opioid dependence
T2  - Addiction Biology
J2  - Addict. Biol.
VL  - 22
IS  - 4
SP  - 1068
EP  - 1080
PY  - 2017
DO  - 10.1111/adb.12390
SN  - 13556215 (ISSN) 
AU  - Zhang, Y.
AU  - Li, Q.
AU  - Wen, X.
AU  - Cai, W.
AU  - Li, G.
AU  - Tian, J.
AU  - Zhang, Y.E.
AU  - Liu, J.
AU  - Yuan, K.
AU  - Zhao, J.
AU  - Wang, W.
AU  - Zhou, Z.
AU  - Ding, M.
AU  - Gold, M.S.
AU  - Liu, Y.
AU  - Wang, G.-J.
AD  - School of Life Science and Technology, Xidian University, Xi'an, China
AD  - Department of Psychiatry & McKnight Brain Institute, University of Florida, Gainesville, FL, United States
AD  - Department of Radiology, Tangdu Hospital, Fourth Military Medical University, Xi'an, China
AD  - Department of Psychology, Renmin University of China, Beijing, China
AD  - Institute of Automation, Chinese Academy of Sciences, Beijing, China
AD  - Malcom Randall Veterans Affairs Medical Center, Gainesville, FL, United States
AD  - College of Mechanical and Electronic Engineering, Northwest A&F University, Yangling, China
AD  - J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL, United States
AD  - Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD, United States
AB  - Resting-state magnetic resonance imaging has uncovered abnormal functional connectivity in heroin-dependent individuals (HDIs). However, it remains unclear how brain regions implicated in addictions are related in baseline state without conditioned cues in heroin dependent individuals during opioid maintenance treatment (HDIs-OMT). Previous connectivity analysis assessed the strength of correlated activity between brain regions but lacked the ability to infer directional neural interactions. In the current study, we employed Granger causality analysis to investigate directional causal influences among the brain circuits in HDIs-OMT and non-opioid users. The results revealed a weaker effective connectivity between the caudate nucleus implicated in mediating the reward circuit and other brain regions and also a weaker connectivity between the anterior cingulate cortex and medial prefrontal cortex implicated in mediating inhibitory control. Conversely, HDIs-OMT exhibited stronger effective connectivity between the hippocampus and amygdala implicated in mediating learning-memory, and the anterior cingulate cortex involved in mediating inhibitory control while the putamen mediated learned habits, suggesting that the hippocampus and amygdala may propel the memory circuit to override the control circuit and drive the learned habit in HDIs-OMT. Alterations in learning-memory and inhibitory control may contribute jointly and form a basis for relapse risk even after a period of heroin abstinence. Sustained neural effect of opioid dependence on methadone maintenance including hyperactivation in the memory circuit and impairment in the control circuit support the role of the memory circuitry in relapse and may help redefine targets for treatment. © 2016 Society for the Study of Addiction
KW  - Granger causality
KW  - inhibitory control
KW  - learning-memory
KW  - opioid dependence
KW  - resting-state fMRI
KW  - diamorphine
KW  - opiate
KW  - adult
KW  - amygdala
KW  - anterior cingulate
KW  - Article
KW  - brain region
KW  - caudate nucleus
KW  - causality
KW  - clinical article
KW  - controlled study
KW  - drug withdrawal
KW  - heroin dependence
KW  - heroin dependent individual during opioid maintenance treatment
KW  - hippocampus
KW  - human
KW  - learning
KW  - maintenance therapy
KW  - male
KW  - medial prefrontal cortex
KW  - memory
KW  - methadone treatment
KW  - opiate addiction
KW  - priority journal
KW  - putamen
KW  - recurrence risk
KW  - brain
KW  - brain mapping
KW  - chemically induced
KW  - cingulate gyrus
KW  - complication
KW  - diagnostic imaging
KW  - drug effects
KW  - memory
KW  - memory disorder
KW  - middle aged
KW  - nuclear magnetic resonance imaging
KW  - opiate addiction
KW  - pathophysiology
KW  - physiology
KW  - prefrontal cortex
KW  - procedures
KW  - rest
KW  - Adult
KW  - Amygdala
KW  - Brain
KW  - Brain Mapping
KW  - Gyrus Cinguli
KW  - Hippocampus
KW  - Humans
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Memory
KW  - Memory Disorders
KW  - Middle Aged
KW  - Opioid-Related Disorders
KW  - Prefrontal Cortex
KW  - Putamen
KW  - Rest
PB  - Blackwell Publishing Ltd
N1  - Cited By :7
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: ADBIF
C2  - 26987308
LA  - English
N1  - Correspondence Address: Zhang, Y.; School of Life Science and Technology, Xidian UniversityChina; email: zhangyiuf@gmail.com
N1  - Chemicals/CAS: diamorphine, 1502-95-0, 561-27-3; opiate, 53663-61-9, 8002-76-4, 8008-60-4
N1  - Funding details: Natural Science Foundation of Shaanxi Provincial Department of Education, 2015JM3117
N1  - Funding details: 2011CB707700
N1  - Funding details: Renmin University of China, 15XNLQ05, 14XNLF11, 15XNQ037
N1  - Funding details: Fundamental Research Funds for the Central Universities
N1  - Funding details: National Natural Science Foundation of China, 61431013, 61131003, 81470816, 81571751, 81201081, 31400973, 81271549, 81571753
N1  - Funding details: CNLYB1216
N1  - Funding text 1: This work is supported by the National Natural Science Foundation of China under grant numbers 81271549, 81470816, 61431013, 61131003, 81201081, 31400973, 81571751 and 81571753; the Shaanxi Provincial Natural Science Foundation under grant no. 2015JM3117; the Project for the National Key Basic Research and Development Program (973) under grant no. 2011CB707700; the Fundamental Research Funds for the Central Universities; the Scientific Research Funds for Renmin University of China under grant nos. 14XNLF11, 15XNQ037 and 15XNLQ05; and the Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning under grant no. CNLYB1216.
N1  - References: Abler, B., Roebroeck, A., Goebel, R., Hose, A., Schonfeldt-Lecuona, C., Hole, G., Walter, H., Investigating directed influences between activated brain areas in a motor-response task using fMRI (2006) Magn Reson Imaging, 24, pp. 181-185; 
Adinoff, B., Devous, M.S., Best, S.M., George, M.S., Alexander, D., Payne, K., Limbic responsiveness to procaine in cocaine-addicted subjects (2001) Am J Psychiatry, 158, pp. 390-398; 
Aguirre, G.K., Zarahn, E., D'Esposito, M., The variability of human, BOLD hemodynamic responses (1998) Neuroimage, 8, pp. 360-369; 
Bechara, A., Van Der Linden, M., Decision-making and impulse control after frontal lobe injuries (2005) Curr Opin Neurol, 18, pp. 734-739; 
Beck, A., Schlagenhauf, F., Wustenberg, T., Hein, J., Kienast, T., Kahnt, T., Schmack, K., Heinz, A., Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics (2009) Biol Psychiatry, 66, pp. 734-742; 
Boileau, I., Assaad, J.M., Pihl, R.O., Benkelfat, C., Leyton, M., Diksic, M., Tremblay, R.E., Dagher, A., Alcohol promotes dopamine release in the human nucleus accumbens (2003) Synapse, 49, pp. 226-231; 
Bollimunta, A., Chen, Y., Schroeder, C.E., Ding, M., Neuronal mechanisms of cortical alpha oscillations in awake-behaving macaques (2008) J Neurosci, 28, pp. 9976-9988; 
Bollimunta, A., Mo, J., Schroeder, C.E., Ding, M., Neuronal mechanisms and attentional modulation of corticothalamic alpha oscillations (2011) J Neurosci, 31, pp. 4935-4943; 
Bossong, M.G., van Berckel, B.N., Boellaard, R., Zuurman, L., Schuit, R.C., Windhorst, A.D., van Gerven, J.M., Kahn, R.S., Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum (2009) Neuropsychopharmacology, 34, pp. 759-766; 
Bracken, B.K., Trksak, G.H., Penetar, D.M., Tartarini, W.L., Maywalt, M.A., Dorsey, C.M., Lukas, S.E., Response inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation (2012) Drug Alcohol Depend, 125, pp. 132-139; 
Breiter, H.C., Gollub, R.L., Weisskoff, R.M., Kennedy, D.N., Makris, N., Berke, J.D., Goodman, J.M., Riorden, J.P., Acute effects of cocaine on human brain activity and emotion (1997) Neuron, 19, pp. 591-611; 
Bressler, S.L., Tang, W., Sylvester, C.M., Shulman, G.L., Corbetta, M., Top-down control of human visual cortex by frontal and parietal cortex in anticipatory visual spatial attention (2008) J Neurosci, 28, pp. 10056-10061; 
Brody, A.L., Mandelkern, M.A., Olmstead, R.E., Allen-Martinez, Z., Scheibal, D., Abrams, A.L., Costello, M.R., Monterosso, J., Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette (2009) Neuropsychopharmacology, 34, pp. 282-289; 
Brovelli, A., Ding, M., Ledberg, A., Chen, Y., Nakamura, R., Bressler, S.L., Beta oscillations in a large-scale sensorimotor cortical network: directional influences revealed by Granger causality (2004) Proc Natl Acad Sci U S A, 101, pp. 9849-9854; 
Chen, Y., Bressler, S.L., Ding, M., Frequency decomposition of conditional Granger causality and application to multivariate neural field potential data (2006) J Neurosci Methods, 150, pp. 228-237; 
Chikazoe, J., Jimura, K., Asari, T., Yamashita, K., Morimoto, H., Hirose, S., Miyashita, Y., Konishi, S., Functional dissociation in right inferior frontal cortex during performance of go/no-go task (2009) Cereb Cortex, 19, pp. 146-152; 
Daglish, M.R., Weinstein, A., Malizia, A.L., Wilson, S., Melichar, J.K., Lingford-Hughes, A., Myles, J.S., Nutt, D.J., Functional connectivity analysis of the neural circuits of opiate craving: “more” rather than “different”? (2003) Neuroimage, 20, pp. 1964-1970; 
De Martino, F., Valente, G., Staeren, N., Ashburner, J., Goebel, R., Formisano, E., Combining multivariate voxel selection and support vector machines for mapping and classification of fMRI spatial patterns (2008) Neuroimage, 43, pp. 44-58; 
Ding, M., Chen, Y., Bressler, S., Granger causality basic theory and application to neuroscience (2006) Hand Book of Time Series Analysis, pp. 451-474. , In, Scheller B, Winterhalder M, Timmer J, eds., pp, Wiley-VCH Verlage, Berlin; 
Drevets, W.C., Gautier, C., Price, J.C., Kupfer, D.J., Kinahan, P.E., Grace, A.A., Price, J.L., Mathis, C.A., Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria (2001) Biol Psychiatry, 49, pp. 81-96; 
Dyer, K.R., White, J.M., Patterns of symptom complaints in methadone maintenance patients (1997) Addiction, 92, pp. 1445-1455; 
Everitt, B.J., Robbins, T.W., Neural systems of reinforcement for drug addiction: from actions to habits to compulsion (2005) Nat Neurosci, 8, pp. 1481-1489; 
Feltenstein, M.W., See, R.E., The neurocircuitry of addiction: an overview (2008) Br J Pharmacol, 154, pp. 261-274; 
Fu, L.P., Bi, G.H., Zou, Z.T., Wang, Y., Ye, E.M., Ma, L., Ming-Fan, Yang, Z., Impaired response inhibition function in abstinent heroin dependents: an fMRI study (2008) Neurosci Lett, 438, pp. 322-326; 
Garavan, H., Pankiewicz, J., Bloom, A., Cho, J.K., Sperry, L., Ross, T.J., Salmeron, B.J., Stein, E.A., Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli (2000) Am J Psychiatry, 157, pp. 1789-1798; 
Gavrilescu, M., Shaw, M.E., Stuart, G.W., Eckersley, P., Svalbe, I.D., Egan, G.F., Simulation of the effects of global normalization procedures in functional MRI (2002) Neuroimage, 17, pp. 532-542; 
Ge, T., Feng, J., Grabenhorst, F., Rolls, E.T., Componential Granger causality, and its application to identifying the source and mechanisms of the top-down biased activation that controls attention to affective vs sensory processing (2012) Neuroimage, 59, pp. 1846-1858; 
Goldstein, R.Z., Alia-Klein, N., Tomasi, D., Zhang, L., Cottone, L.A., Maloney, T., Telang, F., Ernst, T., Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? (2007) Am J Psychiatry, 164, pp. 43-51; 
Goldstein, R.Z., Volkow, N.D., Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex (2002) Am J Psychiatry, 159, pp. 1642-1652; 
Goldstein, R.Z., Volkow, N.D., Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications (2011) Nat Rev Neurosci, 12, pp. 652-669; 
Hamilton, J.P., Chen, G., Thomason, M.E., Schwartz, M.E., Gotlib, I.H., Investigating neural primacy in major depressive disorder: multivariate Granger causality analysis of resting-state fMRI time-series data (2011) Mol Psychiatry, 16, pp. 763-772; 
Haxby, J.V., Gobbini, M.I., Furey, M.L., Ishai, A., Schouten, J.L., Pietrini, P., Distributed and overlapping representations of faces and objects in ventral temporal cortex (2001) Science, 293, pp. 2425-2430; 
Jiang, G.H., Qiu, Y.W., Zhang, X.L., Han, L.J., Lv, X.F., Li, L.M., Lin, C.L., Tian, J.Z., Amplitude low-frequency oscillation abnormalities in the heroin users: a resting state fMRI study (2011) Neuroimage, 57, pp. 149-154; 
Jiao, Q., Lu, G., Zhang, Z., Zhong, Y., Wang, Z., Guo, Y., Li, K., Liu, Y., Granger causal influence predicts BOLD activity levels in the default mode network (2011) Hum Brain Mapp, 32, pp. 154-161; 
Junghofer, M., Schupp, H.T., Stark, R., Vaitl, D., Neuroimaging of emotion: empirical effects of proportional global signal scaling in fMRI data analysis (2005) Neuroimage, 25, pp. 520-526; 
Kalivas, P.W., Volkow, N.D., The neural basis of addiction: a pathology of motivation and choice (2005) Am J Psychiatry, 162, pp. 1403-1413; 
Kilts, C.D., Schweitzer, J.B., Quinn, C.K., Gross, R.E., Faber, T.L., Muhammad, F., Ely, T.D., Drexler, K.P., Neural activity related to drug craving in cocaine addiction (2001) Arch Gen Psychiatry, 58, pp. 334-341; 
Kreek, M.J., Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine (2000) Ann N Y Acad Sci, 909, pp. 186-216; 
Kriegeskorte, N., Goebel, R., Bandettini, P., Information-based functional brain mapping (2006) Proc Natl Acad Sci U S A, 103, pp. 3863-3868; 
Langleben, D.D., Ruparel, K., Elman, I., Busch-Winokur, S., Pratiwadi, R., Loughead, J., O'Brien, C.P., Childress, A.R., Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues (2008) Am J Psychiatry, 165, pp. 390-394; 
Lee, T.M., Zhou, W.H., Luo, X.J., Yuen, K.S., Ruan, X.Z., Weng, X.C., Neural activity associated with cognitive regulation in heroin users: a fMRI study (2005) Neurosci Lett, 382, pp. 211-216; 
Li, C.S., Sinha, R., Inhibitory control and emotional stress regulation: neuroimaging evidence for frontal-limbic dysfunction in psycho-stimulant addiction (2008) Neurosci Biobehav Rev, 32, pp. 581-597; 
Li, Q., Wang, Y., Zhang, Y., Li, W., Yang, W., Zhu, J., Wu, N., Qin, W., Craving correlates with mesolimbic responses to heroin-related cues in short-term abstinence from heroin: an event-related fMRI study (2012) Brain Res, 1469, pp. 63-72; 
Li, Q., Wang, Y., Zhang, Y., Li, W., Zhu, J., Zheng, Y., Chen, J., Liu, Y., Assessing cue-induced brain response as a function of abstinence duration in heroin-dependent individuals: an event-related fMRI study (2013) PLoS One, 8. , e62910031; 
Li, Q., Li, W., Wang, H., Wang, Y., Zhang, Y., Zhu, J., Zheng, Y., Liu, Y., Predicting subsequent relapse by drug-related cue-induced brain activation in heroin addiction: an event-related fMRI study (2015) Addict Biol, 20 (5), pp. 968-978; 
Liao, W., Mantini, D., Zhang, Z., Pan, Z., Ding, J., Gong, Q., Yang, Y., Chen, H., Evaluating the effective connectivity of resting state networks using conditional Granger causality (2010) Biol Cybern, 102, pp. 57-69; 
Liu, J., Liang, J., Qin, W., Tian, J., Yuan, K., Bai, L., Zhang, Y., Li, Q., Dysfunctional connectivity patterns in chronic heroin users: an fMRI study (2009) Neurosci Lett, 460, pp. 72-77; 
Liu, J., Qin, W., Yuan, K., Li, J., Wang, W., Li, Q., Wang, Y., Liu, Y., Interaction between dysfunctional connectivity at rest and heroin cues-induced brain responses in male abstinent heroin-dependent individuals (2011) PLoS One, 6; 
Lundqvist, T., Imaging cognitive deficits in drug abuse (2010) Curr Top Behav Neurosci, 3, pp. 247-275; 
Ma, N., Liu, Y., Li, N., Wang, C.X., Zhang, H., Jiang, X.F., Xu, H.S., Zhang, D.R., Addiction related alteration in resting-state brain connectivity (2010) Neuroimage, 49, pp. 738-744; 
Macey, P.M., Macey, K.E., Kumar, R., Harper, R.M., A method for removal of global effects from fMRI time series (2004) Neuroimage, 22, pp. 360-366; 
Martin-Soelch, C., Chevalley, A.F., Kunig, G., Missimer, J., Magyar, S., Mino, A., Schultz, W., Leenders, K.L., Changes in reward-induced brain activation in opiate addicts (2001) Eur J Neurosci, 14, pp. 1360-1368; 
Mechtcheriakov, S., Brenneis, C., Egger, K., Koppelstaetter, F., Schocke, M., Marksteiner, J., A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry (2007) J Neurol Neurosurg Psychiatry, 78, pp. 610-614; 
Moreno-Lopez, L., Stamatakis, E.A., Fernandez-Serrano, M.J., Gomez-Rio, M., Rodriguez-Fernandez, A., Perez-Garcia, M., Verdejo-Garcia, A., Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study (2012) PLoS One, 7; 
Norman, K.A., Polyn, S.M., Detre, G.J., Haxby, J.V., Beyond mind-reading: multi-voxel pattern analysis of fMRI data (2006) Trends Cogn Sci, 10, pp. 424-430; 
Peters, J., Bromberg, U., Schneider, S., Brassen, S., Menz, M., Banaschewski, T., Conrod, P.J., Garavan, H., Lower ventral striatal activation during reward anticipation in adolescent smokers (2011) Am J Psychiatry, 168, pp. 540-549; 
Qiu, Y.W., Han, L.J., Lv, X.F., Jiang, G.H., Tian, J.Z., Zhuo, F.Z., Su, H.H., Zhang, X.L., Regional homogeneity changes in heroin-dependent individuals: resting-state functional MR imaging study (2011) Radiology, 261, pp. 551-559; 
Roebroeck, A., Formisano, E., Goebel, R., Mapping directed influence over the brain using Granger causality and fMRI (2005) Neuroimage, 25, pp. 230-242; 
Rogers, B.P., Morgan, V.L., Newton, A.T., Gore, J.C., Assessing functional connectivity in the human brain by fMRI (2007) Magn Reson Imaging, 25, pp. 1347-1357; 
Rose, E.J., Ross, T.J., Salmeron, B.J., Lee, M., Shakleya, D.M., Huestis, M., Stein, E.A., Chronic exposure to nicotine is associated with reduced reward-related activity in the striatum but not the midbrain (2012) Biol Psychiatry, 71, pp. 206-213; 
Rubia, K., Smith, A.B., Brammer, M.J., Toone, B., Taylor, E., Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD (2005) Am J Psychiatry, 162, pp. 1067-1075; 
Rypma, B., Berger, J.S., Prabhakaran, V., Bly, B.M., Kimberg, D.Y., Biswal, B.B., D'Esposito, M., Neural correlates of cognitive efficiency (2006) Neuroimage, 33, pp. 969-979; 
Sridharan, D., Levitin, D.J., Chafe, C.H., Berger, J., Menon, V., Neural dynamics of event segmentation in music: converging evidence for dissociable ventral and dorsal networks (2007) Neuron, 55, pp. 521-532; 
Sridharan, D., Levitin, D.J., Menon, V., A critical role for the right fronto-insular cortex in switching between central-executive and default-mode networks (2008) Proc Natl Acad Sci U S A, 105, pp. 12569-12574; 
Tang, Y.L., Zhao, D., Zhao, C., Cubells, J.F., Opiate addiction in China: current situation and treatments (2006) Addiction, 101, pp. 657-665; 
Tapert, S.F., Schweinsburg, A.D., Drummond, S.P., Paulus, M.P., Brown, S.A., Yang, T.T., Frank, L.R., Functional MRI of inhibitory processing in abstinent adolescent marijuana users (2007) Psychopharmacology (Berl), 194, pp. 173-183; 
Vanderschuren, L.J., Everitt, B.J., Behavioral and neural mechanisms of compulsive drug seeking (2005) Eur J Pharmacol, 526, pp. 77-88; 
Volkow, N.D., Fowler, J.S., Addiction, a disease of compulsive and drive: involvement of the orbitofrontal cortex (2000) Cereb Cortex, 10, pp. 318-325; 
Volkow, N.D., Fowler, J.S., Wang, G.J., The addicted human brain: insights from imaging studies (2003) J Clin Invest, 111, pp. 1444-1451; 
Volkow, N.D., Fowler, J.S., Wolf, A.P., Hitzemann, R., Dewey, S., Bendriem, B., Alpert, R., Hoff, A., Changes in brain glucose metabolism in cocaine dependence and withdrawal (1991) Am J Psychiatry, 148, pp. 621-626; 
Volkow, N.D., Hitzemann, R., Wang, G.J., Fowler, J.S., Wolf, A.P., Dewey, S.L., Handlesman, L., Long-term frontal brain metabolic changes in cocaine abusers (1992) Synapse, 11, pp. 184-190; 
Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Gatley, S.J., Wong, C., Hitzemann, R., Pappas, N.R., Reinforcing effects of psychostimulants in humans are associated with increases in brain dopamine and occupancy of D(2) receptors (1999) J Pharmacol Exp Ther, 291, pp. 409-415; 
Volkow, N.D., Wang, G.J., Fowler, J.S., Tomasi, D., Telang, F., Addiction: beyond dopamine reward circuitry (2011) Proc Natl Acad Sci U S A, 108, pp. 15037-15042; 
Volkow, N.D., Wang, G.J., Telang, F., Fowler, J.S., Logan, J., Childress, A.R., Jayne, M., Wong, C., Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction (2006) J Neurosci, 26, pp. 6583-6588; 
Wang, G.J., Tomasi, D., Backus, W., Wang, R., Telang, F., Geliebter, A., Korner, J., Thanos, P.K., Gastric distention activates satiety circuitry in the human brain (2008) Neuroimage, 39, pp. 1824-1831; 
Wang, Y., Zhu, J., Li, Q., Li, W., Wu, N., Zheng, Y., Chang, H., Wang, W., Altered fronto-striatal and fronto-cerebellar circuits in heroin-dependent individuals: a resting-state FMRI study (2013) PLoS One, 8; 
Wen, X., Liu, Y., Yao, L., Ding, M., Top-down regulation of default mode activity in spatial visual attention (2013) J Neurosci, 33, pp. 6444-6453; 
Wen, X., Rangarajan, G., Ding, M., Is Granger causality a viable technique for analyzing fMRI data? (2013) PLoS One, 8; 
Wen, X., Yao, L., Liu, Y., Ding, M., Causal interactions in attention networks predict behavioral performance (2012) J Neurosci, 32, pp. 1284-1292; 
White, N.M., Addictive drugs as reinforcers: multiple partial actions on memory systems (1996) Addiction, 91, pp. 921-949. , discussion 951-65; 
Wrase, J., Schlagenhauf, F., Kienast, T., Wustenberg, T., Bermpohl, F., Kahnt, T., Beck, A., Knutson, B., Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics (2007) Neuroimage, 35, pp. 787-794; 
Xiao, Z., Lee, T., Zhang, J.X., Wu, Q., Wu, R., Weng, X., Hu, X., Thirsty heroin addicts show different fMRI activations when exposed to water-related and drug-related cues (2006) Drug Alcohol Depend, 83, pp. 157-162; 
Xie, C., Li, S.J., Shao, Y., Fu, L., Goveas, J., Ye, E., Li, W., Zhang, Z., Identification of hyperactive intrinsic amygdala network connectivity associated with impulsivity in abstinent heroin addicts (2011) Behav Brain Res, 216, pp. 639-646; 
Xue, Y., Luo, Y., Wu, P., Shi, H., Xue, L., Chen, C., Zhu, W., Shi, J., A memory retrieval-extinction procedure to prevent drug craving and relapse (2012) Science, 336, pp. 241-245; 
Yang, Z., Xie, J., Shao, Y.C., Xie, C.M., Fu, L.P., Li, D.J., Fan, M., Li, S.J., Dynamic neural responses to cue-reactivity paradigms in heroin-dependent users: an fMRI study (2009) Hum Brain Mapp, 30, pp. 766-775; 
Zang, Y.F., He, Y., Zhu, C.Z., Cao, Q.J., Sui, M.Q., Liang, M., Tian, L.X., Wang, Y.F., Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI (2007) Brain Dev, 29, pp. 83-91; 
Zarahn, E., Aguirre, G.K., D'Esposito, M., Empirical analyses of BOLD fMRI statistics. I. Spatially unsmoothed data collected under null-hypothesis conditions (1997) Neuroimage, 5, pp. 179-197; 
Zhang, Y., Tian, J., Yuan, K., Liu, P., Zhuo, L., Qin, W., Zhao, L., Klahr, N.J., Distinct resting-state brain activities in heroin-dependent individuals (2011) Brain Res, 1402, pp. 46-53; 
Zhang, Y., Wang, J., Zhang, G., Zhu, Q., Cai, W., Tian, J., Zhang, Y.E., Liu, Y., The neurobiological drive for overeating implicated in Prader–Willi syndrome (2015) Brain Res, 1620, pp. 72-80
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960984112&doi=10.1111%2fadb.12390&partnerID=40&md5=fdc021fbc18ab30acfa16a671fb3528e
ER  - 

TY  - JOUR
TI  - Exploring trends of nonmedical use of prescription drugs and polydrug abuse in the Twittersphere using unsupervised machine learning
T2  - Addictive Behaviors
J2  - Addict. Behav.
VL  - 65
SP  - 289
EP  - 295
PY  - 2017
DO  - 10.1016/j.addbeh.2016.08.019
SN  - 03064603 (ISSN) 
AU  - Kalyanam, J.
AU  - Katsuki, T.
AU  - R.G. Lanckriet, G.
AU  - Mackey, T.K.
AD  - Department of Electrical and Computer Engineering, University of California, San Diego, CA, United States
AD  - Kavli Institute for Brain and Mind, University of California, San Diego, CA, United States
AD  - Department of Anesthesiology, University of California, School of Medicine, San Diego, CA, United States
AD  - Division of Global Public Health, University of California, School of Medicine, Department of Medicine, San Diego, CA, United States
AD  - Global Health Policy Institute, San Diego, CA, United States
AB  - Introduction Nonmedical use of prescription medications/drugs (NMUPD) is a serious public health threat, particularly in relation to the prescription opioid analgesics abuse epidemic. While attention to this problem has been growing, there remains an urgent need to develop novel strategies in the field of “digital epidemiology” to better identify, analyze and understand trends in NMUPD behavior. Methods We conducted surveillance of the popular microblogging site Twitter by collecting 11 million tweets filtered for three commonly abused prescription opioid analgesic drugs Percocet® (acetaminophen/oxycodone), OxyContin® (oxycodone), and Oxycodone. Unsupervised machine learning was applied on the subset of tweets for each analgesic drug to discover underlying latent themes regarding risk behavior. A two-step process of obtaining themes, and filtering out unwanted tweets was carried out in three subsequent rounds of machine learning. Results Using this methodology, 2.3M tweets were identified that contained content relevant to analgesic NMUPD. The underlying themes were identified for each drug and the most representative tweets of each theme were annotated for NMUPD behavioral risk factors. The primary themes identified evidence high levels of social media discussion about polydrug abuse on Twitter. This included specific mention of various polydrug combinations including use of other classes of prescription drugs, and illicit drug abuse. Conclusions This study presents a methodology to filter Twitter content for NMUPD behavior, while also identifying underlying themes with minimal human intervention. Results from the study track accurately with the inclusion/exclusion criteria used to isolate NMUPD-related risk behaviors of interest and also provides insight on NMUPD behavior that has a high level of social media engagement. Results suggest that this could be a viable methodology for use in big data substance abuse surveillance, data collection, and analysis in comparison to other studies that rely upon content analysis and human coding schemes. © 2016 Elsevier Ltd
KW  - Digital surveillance
KW  - Nonmedical use of prescription drugs
KW  - Prescription opioid abuse
KW  - Social media
KW  - Substance abuse
KW  - Twitter
KW  - analgesic agent
KW  - benzodiazepine derivative
KW  - cannabis
KW  - diazepam
KW  - methylphenidate
KW  - oxycodone
KW  - oxycodone plus paracetamol
KW  - prednisone
KW  - prescription drug
KW  - Article
KW  - drug surveillance program
KW  - human
KW  - multiple drug abuse
KW  - prescription
KW  - risk factor
KW  - self report
KW  - social media
KW  - unsupervised machine learning
KW  - opiate addiction
KW  - prescription drug misuse
KW  - statistics and numerical data
KW  - unsupervised machine learning
KW  - Humans
KW  - Opioid-Related Disorders
KW  - Prescription Drug Misuse
KW  - Risk Factors
KW  - Social Media
KW  - Unsupervised Machine Learning
PB  - Elsevier Ltd
N1  - Cited By :20
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: ADBED
C2  - 27568339
LA  - English
N1  - Correspondence Address: Mackey, T.K.; Global Health Policy Institute, 6256 Greenwich Drive, Mail Code: 0172X, United States; email: tmackey@ucsd.edu
N1  - Chemicals/CAS: cannabis, 8001-45-4, 8063-14-7; diazepam, 439-14-5; methylphenidate, 113-45-1, 298-59-9; oxycodone, 124-90-3, 76-42-6; prednisone, 53-03-2
N1  - Tradenames: oxycontin; percocet
N1  - Funding details: National Science Foundation, CCF-0830535, IIS-1054960
N1  - Funding details: Alfred P. Sloan Foundation
N1  - Funding text 1: TM and TK received funding for the data collection phase of this project from the Alliance for Safe Online Pharmacies ( SA15-092 ) (ASOP), a 501(c)(4) social welfare organization engaged on the issue of illicit online pharmacies, for this research and greatly acknowledge this support. JK and GL acknowledge support from the National Science Foundation (grants CCF-0830535 and IIS-1054960 ). GL acknowledges support from the Alfred P. Sloan Foundation.
N1  - Funding text 2: TM is a non-compensated member of the ASOP academic advisory panel of ASOP and both TM and TK receiving funding for the data collection phase of this project from ASOP through a pilot research grant exploring prescription drug abuse risks online. Funder had no role or input in the study. There was no involvement of anyone other than the authors in the conception, design, collection, planning, conduct, analysis, interpretation, writing, and discussion to submit this work. Authors report no other financial relationships with any organizations that might have an interest in the submitted work.
N1  - References: Bishop, C., Pattern recognition and machine learning (2006), Springer (ISBN 978-0-387-31073-2); Blei, D.M., Ng, A.Y., Jordan, M.I., Latent dirichlet allocation (2003) The Journal of Machine Learning Research, 3, pp. 993-1022; 
Vital signs: Overdoses of prescription opioid pain relievers—United States, 1999–2008 (2011) MMWR. Morbidity and Mortality Weekly Report, 60 (43), pp. 1487-1492; 
Vital signs: Overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999–2010 (2013) MMWR. Morbidity and Mortality Weekly Report, 62 (26), pp. 537-542; 
Chen, L., Hossain, K.S., Butler, P., Ramakrishnan, N., Flu gone viral: Syndromic surveillance of flu on twitter using temporal topic models (2016) Data Mining and Knowledge Discovery, 30 (3), pp. 681-710; 
Fink, D.S., Hu, R., Cerdá, M., Keyes, K.M., Marshall, B.D.L., Galea, S., Martins, S.S., Patterns of major depression and nonmedical use of prescription opioids in the United States (2015) Drug and Alcohol Dependence, 153, pp. 258-264; 
Forman, R.F., Availability of opioids on the internet (2003) JAMA: The Journal of the American Medical Association, 290 (7), p. 889; 
Forman, R.F., Block, L.G., The marketing of opioid medications without prescription over the Internet (2006) Journal of Public Policy & Marketing, 25, pp. 133-146; 
Forman, R.F., Woody, G.E., McLellan, T., Lynch, K.G., The availability of web sites offering to sell opioid medications without prescriptions (2006) The American Journal of Psychiatry, 163 (7), pp. 1233-1238; 
Han, B., Compton, W.M., Jones, C.M., Cai, R., Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013 (2015) JAMA: The Journal of the American Medical Association, 314 (14), pp. 1468-1478; 
Hanson, C.L., Burton, S.H., Giraud-Carrier, C., West, J.H., Barnes, M.D., Hansen, B., Tweaking and tweeting: Exploring twitter for nonmedical use of a psychostimulant drug (Adderall) among college students (2013) Journal of Medical Internet Research, 15 (4). , e62; 
Hanson, C.L., Cannon, B., Burton, S., Giraud-Carrier, C., An exploration of social circles and prescription drug abuse through twitter (2013) Journal of Medical Internet Research, 15 (9). , e189; 
Harrison, L., Hughes, A., Introduction—the validity of self-reported drug use: Improving the accuracy of survey estimates (1997) NIDA Research Monograph, 167, pp. 1-16; 
Katsuki, T., Mackey, T.K., Cuomo, R., Establishing a link between prescription drug abuse and illicit online pharmacies: Analysis of twitter data (2015) Journal of Medical Internet Research, 17 (12). , e280; 
Kelly, B.C., Wells, B.E., Pawson, M., LeClair, A., Parsons, J.T., Combinations of prescription drug misuse and illicit drugs among young adults (2014) Addictive Behaviors, 39 (5), pp. 941-944; 
Longo, D.L., Compton, W.M., Jones, C.M., Baldwin, G.T., Relationship between nonmedical prescription-opioid use and heroin use (2016) New England Journal of Medicine, 374 (2), pp. 154-163; 
Mackesy-Amiti, M.E., Donenberg, G.R., Ouellet, L.J., Prescription opioid misuse and mental health among young injection drug users (2015) The American Journal of Drug and Alcohol Abuse, 41 (1), pp. 100-106; 
Mackey, T.K., Liang, B.A., Strathdee, S.A., Digital social media, youth, and nonmedical use of prescription drugs: The need for reform (2013) Journal of Medical Internet Research, 15 (7). , e143; 
McCabe, S.E., West, B.T., Teter, C.J., Boyd, C.J., Co-ingestion of prescription opioids and other drugs among high school seniors: Results from a national study (2012) Drug and Alcohol Dependence, 126 (1-2), pp. 65-70; 
McCabe, S.E., West, B.T., Boyd, C.J., Leftover prescription opioids and nonmedical use among high school seniors: A multi-cohort national study (2013) Journal of Adolescent Health, 52 (4), pp. 480-485; 
President Obama Is Taking More Steps to Address the Prescription Drug Abuse and Heroin Epidemic, President Obama is taking more steps to address the prescription drug abuse and heroin epidemic (2016), https://www.whitehouse.gov/blog/2016/03/29/president-obama-taking-more-action-address-prescription-drug-abuse-epidemic-0, Whitehouse Gov Retrieved May 31, 2016, from; Prier, K.W., Smith, M.S., Giraud-Carrier, C., Hanson, C.L., Identifying health related topics on twitter. An exploration of tobacco-related tweets as a test topic (2011) Lecture Notes in Computer Science, 6589, pp. 18-25; 
Raine, C., Webb, D.J., Maxwell, S.R.J., The availability of prescription-only analgesics purchased from the Internet in the UK (2009) British Journal of Clinical Pharmacology, 67 (2), pp. 250-254; 
Rudd, R.A., Aleshire, N., Zibbell, J.E., Gladden, R.M., Increases in drug and opioid overdose deaths—United States, 2000–2014 (2016) MMWR. Morbidity and Mortality Weekly Report, 64 (50-51), pp. 1378-1382; 
Salathé, M., Bengtsson, L., Bodnar, T.J., Brewer, D.D., Brownstein, J.S., Buckee, C., Digital epidemiology (2012) PLoS Computational Biology, 8 (7). , e1002616; 
Schepis, T.S., McCabe, S.E., Trends in older adult nonmedical prescription drug use prevalence: Results from the 2002–2003 and 2012–2013 national survey on drug use and health (2016) Addictive Behaviors, 60, pp. 219-222; 
Shutler, L., Nelson, L.S., Portelli, I., Blachford, C., Perrone, J., Drug use in the twittersphere: A qualitative contextual analysis of tweets about prescription drugs. PubMed–NCBI (2015) Journal of Addictive Diseases, 34 (4), pp. 303-310; 
Yan, X., Guo, J., Lan, Y., Cheng, X., A biterm topic model for short texts (2013) The 22nd international conference, pp. 1445-1456. , (New York, New York, USA: ACM)
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994091888&doi=10.1016%2fj.addbeh.2016.08.019&partnerID=40&md5=bcd92b1ce4c01288a63ca142f8ce0662
ER  - 

TY  - JOUR
TI  - Endogenous Opiates and Behavior: 2015
T2  - Peptides
J2  - Peptides
VL  - 88
SP  - 126
EP  - 188
PY  - 2017
DO  - 10.1016/j.peptides.2016.12.004
SN  - 01969781 (ISSN) 
AU  - Bodnar, R.J.
AD  - Department of Psychology and Neuropsychology Doctoral Sub-Program, Queens College, City University of New York, Flushing, NY  11367, United States
AB  - This paper is the thirty-eighth consecutive installment of the annual review of research concerning the endogenous opioid system. It summarizes papers published during 2015 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior, and the roles of these opioid peptides and receptors in pain and analgesia, stress and social status, tolerance and dependence, learning and memory, eating and drinking, drug abuse and alcohol, sexual activity and hormones, pregnancy, development and endocrinology, mental illness and mood, seizures and neurologic disorders, electrical-related activity and neurophysiology, general activity and locomotion, gastrointestinal, renal and hepatic functions, cardiovascular responses, respiration and thermoregulation, and immunological responses. © 2016 Elsevier Inc.
KW  - Beta-endorphin
KW  - Delta opioid receptor
KW  - Endomorphins
KW  - Enkephalins
KW  - Kappa opioid receptor
KW  - Morphine
KW  - Mu opioid receptor
KW  - Naloxone
KW  - Nociception
KW  - ORL-1 receptor
KW  - delta opiate receptor
KW  - delta opiate receptor agonist
KW  - endorphin
KW  - glucose
KW  - kappa opiate receptor
KW  - kappa opiate receptor agonist
KW  - morphine
KW  - mu opiate receptor
KW  - mu opiate receptor agonist
KW  - opiate
KW  - opiate peptide
KW  - opiate peptide
KW  - opiate receptor
KW  - age distribution
KW  - analgesia
KW  - aversion
KW  - blood pressure
KW  - breathing
KW  - cancer pain
KW  - chronic pain
KW  - development
KW  - drinking
KW  - drug discrimination
KW  - eating
KW  - emotion
KW  - endocrinology
KW  - genetic difference
KW  - genetic manipulation
KW  - heart protection
KW  - heart rate
KW  - human
KW  - hysterectomy
KW  - intestine function
KW  - ischemic preconditioning
KW  - kidney function
KW  - liver function
KW  - locomotion
KW  - memory
KW  - mental disease
KW  - meta analysis (topic)
KW  - mood
KW  - morphine addiction
KW  - morphine tolerance
KW  - neuroanatomy
KW  - neurochemistry
KW  - neurologic disease
KW  - neurophysiology
KW  - nonhuman
KW  - pancreas function
KW  - place preference
KW  - postoperative pain
KW  - pregnancy
KW  - priority journal
KW  - Review
KW  - reward
KW  - seizure
KW  - sex difference
KW  - sexual behavior
KW  - social status
KW  - spatial learning
KW  - stomach function
KW  - stress
KW  - thermoregulation
KW  - tooth pain
KW  - vomiting
KW  - animal
KW  - animal behavior
KW  - genetics
KW  - learning
KW  - metabolism
KW  - pain
KW  - physiology
KW  - Animals
KW  - Behavior, Animal
KW  - Eating
KW  - Humans
KW  - Learning
KW  - Memory
KW  - Nervous System Diseases
KW  - Opioid Peptides
KW  - Pain
KW  - Receptors, Opioid
KW  - Sexual Behavior
PB  - Elsevier Inc.
N1  - Cited By :31
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
N1  - CODEN: PPTDD
C2  - 28012859
LA  - English
N1  - Chemicals/CAS: endorphin, 60118-07-2; glucose, 50-99-7, 84778-64-3; morphine, 52-26-6, 57-27-2; opiate, 53663-61-9, 8002-76-4, 8008-60-4; Opioid Peptides; Receptors, Opioid
N1  - References: Abdallah, F.W., Morgan, P.J., McNaught, A., Escallon, J.M., Semple, J.L., Wu, W., Chan, V.W., Ultrasound- guided multilevel paravertebral blocks and total intravenous anesthesia improve the quality of recovery after ambulatory breast tumor resection (2014) Anesthesiology, 120, pp. 703-713; 
Abdelhalim, A.A., Al Harethy, S., Moustafa, M., Lornoxicam versus tramadol for post-operative pain relief in patients undergoing ENT procedures (2014) Saudi J. Anesth., 8, pp. 38-44; 
Abdul Jalil, R.M., Yahya, N., Sulaiman, O., Wan Mat, W.R., Teo, R., Izaham, A., Rahman, R.A., Comparing the effectiveness of ropivacaine 0.5% versus ropavacaine 0.2% for transabdominis plane block in providing postoperative analgesia after appendectomy (2014) Acta Anesthesiol. Taiwan, 52, pp. 49-53; 
Abed, A., Hajhashemi, V., Banafshe, H.R., Minaiyan, M., Mesdaghinia, A., Venlafaxine attenuates heat hyperalgesia independent of adenosine or opioid system in a rat model of peripheral neuropathy (2015) Iran. J. Pharm. Res., pp. 14843-14850; 
Abimussi, C.J., Menegheti, T.M., Wagatsuma, J.T., Floriano, B.P., Arruda, A.M., dos Santos, P.S., Oliva, V.N., Tumescent local anesthesia with ropivacaine in different concentrations in bitches undergoing mastectomy: plasma concentration and post-operative analgesia (2014) Vet. Anesth. Analg., 41, pp. 516-525; 
Abo-Einazar, S., Moasz, M., Ghoneim, H., Molokhia, T., El-Korany, W., Th17/Treg imbalance in opioids and cannabinoids addiction: relationship to NF-kB activation and CD4+ T cells (2014) Egypt. J. Immunol., 21, pp. 33-47; 
Abraham, S.M., Ghahramani, R., Heiranzadeh, N., Kermani-Alghoraishi, M., Ayatollahi, V., Pahiavanhosseni, H., Reduced morphine consumption and pain severity with transdermal fentanyl patches following total knee arthroplasty (2014) Knee Surg. Sports Traumatol. Athrosc., 22, pp. 1580-1584; 
Adamson, A.J., Sellman, J.D., Foulds, J.A., Frampton, C.M., Deering, D., Dunn, A., Berks, J., Cape, G., A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occuring alcohol dependence and major depression (2015) J. Clin. Psychopharmacol., 35, pp. 143-149; 
Addy, P.H., Garcia-Romeu, A., Metzger, M., Wade, J., The subjective experience of acute, experimentally-induced Salvia divinorum inebriation (2015) J. Psychopahrmacol., 29, pp. 426-435; 
Adriaens, A., Peremans, K., Waebers, T., Vandermeulen, E., Croubeis, S., Duchateau, L., Dobbeleir, A., Polis, J., The effect of morphine on regional cerebral blood flow measured by 99mTc-ECD SPECT in dogs (2014) PLoS One, 9, p. e109680; 
Afsharimani, B., Baran, J., Watanabe, S., Lindner, D., Cabot, P.J., Parat, M.O., Morphine and breast tumor metastasis: the role of matrix-degrading enzymes (2014) Clin. Exp. Metastasis, 31, pp. 149-158; 
Ahamad, K., Milloy, M.J., Nguyen, P., Uhlmann, S., Johnson, C., Korthuis, T.P., Kerr, T., Wood, E., Factors associated with willingness to take extended release naltrexone among injection drug users (2015) Addict. Sci. Clin. Pract., 10, p. 12; 
Ahmad, S., De Oliveira, G.S., Jr., Bialek, J.M., McCarthy, S.J., Thermal quantitative sensory testing to predict postoperative pain outcomes following gynecologic surgery (2014) Pain Med., 15, pp. 857-864; 
Ahmadi, K., Hashemian, A.M., Pishbin, E., Taherniya, A., Jafarpour, S., Rahimi-Movagher, V., The role of headache management in minor head injury before performing brain CT scan- can intravenous morphine sulfate predict intracranial injury (2014) Ulus Trauma Acil. Cerrahi. Derg., 20, pp. 432-436; 
Ahmadi, O., Isfahani, M.N., Feizi, A., Comparing low-dose intravenous ketamine-midazolam with intravenous morphine with respect to pain control in patients with closed limb fracture (2014) J. Res. Med. Sci., 19, pp. 502-508; 
Ahmadi, S., Karami, Z., Mohammadian, A., Khosrobakhsh, F., Rostamazadeh, J., Cholestasis induced antinocieption and decreased gene expression of MOR1 in rat brain (2015) Neuroscience, 284, pp. 78-88; 
Ahmedzai, S.H., Leppert, W., Janecki, M., Pakosz, A., Lomax, M., Duerr, H., Hopp, M., Long-term safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate-to severe chronic cancer pain (2015) Support Care Cancer, 23, pp. 823-830; 
Ahn, T., Fergani, C., Coolen, L.M., Padmanabhan, V., Lehman, M.N., Prenatal testosterone excess decreases neurokinin 3 receptor immunoreactivity within the arcuate nucleus KNDy cell population (2015) J. Neuroendocrinol., 27, pp. 100-110; 
Aira, Z., Barrenextea, T., Buesa, I., Azkue, J.J., Plasticity of alpha2-adrenergic spinal antinociception following nerve injury: selective, bidirectional interaction with the delta opioid receptor (2015) Brain Res., 1594, pp. 190-203; 
Ajimi, J., Yoshikawa, M., Takahashi, S., Miura, M., Tsukamoto, H., Kawaguchi, M., Kobayashi, H., Suzuki, T., Effect of three peptidase inhibitors on antinociceptive potential and toxicity with inracerebroventricular administration of dynorphin A(1–17) or (1–13) in the rat (2015) J. Anesth., 29, pp. 65-77; 
Akbari, M., Afshari, R., Sharif, M., Hashemy, S.I., Majdinia, S., Evaluation of the effect of diacetyl morphine on salivary function and their changes after methadone therapy (2014) J. Contemp. Dent. Pract., 15, pp. 730-734; 
Akgun, E., Javed, M.I., Lunzer, M.M., Powers, M.D., Sham, Y.Y., Watanabe, Y., Portoghese, P.S., Inhibition of inflammatory and neuropathic pain by targeting a mu-opioid receptor/chemokine receptor 5 heteromer (MOR-CCR5) (2015) J. Med. Chem., 58, pp. 8647-8657; 
Akhavanakban, G., Mohamadian, A., Entezariasi, M., Evaluation of the effects of adding ketamine to morphine in intravenous patient-controlled analgesia after orthopedic surgery (2014) Perspect. Clin. Res., 5, pp. 85-87; 
Akhondzade, R., Pipelzade, M.R., Gousheh, M.R., Sarrafan, N., Mahmoodi, K., Comparison of the analgesic effect of intra-articular and extra-articular injection of morphine and ketamine compound in arthrotomy lower limb surgery under spinal anesthesia (2014) Pak. J. Med. Sci., 30, pp. 942-945; 
Akshat, S., Ramachandran, R., Rewari, V., Chandralekha Tikha, A., Sinha, R., Morphine versus nalbuphine for open surgery: a randomized controlled double blinded trial (2014) Pain Res. Treat., 2014, p. 727952; 
Al Dabbagh, Z., Jansson, K.A., Stiller, C.O., Montgomery, S., Weiss, R.J., No signs of dose escalations of potent opioids prescribed after tibial shaft fractures: a study of Swedish National Registries (2014) BMC Anesthesiol., 14, p. 4; 
Al-Hasani, R., McCall, J.G., Shin, G., Gomez, A.M., Schmitz, G.P., Bernardi, J.M., Pyo, C.O., Bruchas, M.R., Distinct supopulations of nucleus accumbens dynorphin neurons drive aversion and reward (2015) Neuron, 87, pp. 1063-1077; 
Al-Zaben, K.R., Qudasait, I.Y., Abu-Halaweh, S.A., Zuabi, W.S., Al-Momani, H.M., Albsoul, N.M., Khatib, F.A., Comparison of ilioinginal/illohypogastric nerve blocks and intravenous morphine for control of post-orchidopexy pain in pediatric ambulatory surgery (2014) Middle East J. Anesthesiol., 22, pp. 393-398; 
Alebouyeh, M.R., Imani, F., Rahimzadeh, P., Entezary, S.R., Faiz, S.H., Soraya, P., Analgesic effect of adding lidocaine to morphine pumps after orthopedic surgery (2014) J. Res. Med. Sci., 19, pp. 122-127; 
Aletraris, L., Bond Edmond, M., Roman, P.M., Adoption of injectable naloxone in U.S. substance abuse disorder treatment programs (2015) J. Stud. Alcohol Drugs, 76, pp. 143-151; 
Alimian, M., Pournajafian, A., Kholdebarin, A., Ghodraty, M., Rokhabnak, F., Yardkhasti, P., Analgesic effect of paracetamol and morphine after elective laparotomy surgeries (2014) Anesth. Pain Med., 4, p. e12912; 
Alimohammadi, S., Zendehdel, M., Babapour, V., Modulation of opioid-induced feeding behavior by endogenous nitric oxide in neonatal layer-type chicks (2015) Vet. Res. Commun., 39, pp. 105-113; 
Alkan, M., Kaya, K., Postoperative analgesic effect of epidural neostigmine following cesarean section (2014) Hippokratia, 18, pp. 44-49; 
Allahverdiyev, O., Turkmen, A.Z., Nurten, A., Sehirli, I., Enginar, N., Spontaneous withdrawal in intermittent morphine administration in rats and mice: effect of clonidine coadministration and sex-related differences (2015) Turk. J. Med. Sci., 45, pp. 1380-1389; 
Allison, M.B., Patterson, C.M., Krashes, M.J., Lowell, B.B., Myers, M.G., Jr., Olson, D.P., TRAP-seq defines markers for novel populations of hypothalamic and brainstem LepRb neurons (2015) Mol. Metab., 4, pp. 299-309; 
Allouche, S., Le Marec, T., Coquerel, A., Noble, F., Marie, N., Striatal dopamine D1 and D2 receptors are differentially regulated following buprenorphine or methadone treatment (2015) Psychopharmacology (Berl)., 232, pp. 1527-1533; 
Almanza, A., Simon-Arceo, K., Coffeen, U., Fuentes-Garcia, R., Pellicer, F., Mercado, F., A D2-like receptor family agonist produces analgesia in mechanociception but not in thermonociception at the spinal cord level in rats (2015) Pharmacol. Biochem. Behav., 137, pp. 119-125; 
Almarakbi, W.A., Kaki, A.M., Addition of dexmedetomidine to bupivacaine in transversus abdominis plane block potentiates post-operative pain relief among abdominal hysterectomy patients: a prospective randomized controlled trial (2014) Saudi J. Anaesth., 8, pp. 161-166; 
Almatroudi, A., Husbands, S.M., Bailey, C.P., Bailey, S.J., Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice (2015) J. Psychopharmacol., 29, pp. 812-821; 
Almeida, M.B., Costa-Malaquias, A., Nascimento, J.L., Oliveira, K.R., Herculano, A.M., Crespo-Lopez, M.E., Therapeutic concentration of morphine reduces oxidative stress in glioma cell line (2014) Braz. J. Med. Biol. Res., 47, pp. 398-402; 
Altarifi, A.A., Rice, K.C., Negus, S.S., Effects of mu-opioid receptor agonists in assys of acute pain-stimulated and pain-depressed behavior in male rats: role of mu-agonist efficacy and noxious stimulus intensity (2015) J. Pharmacol. Exp. Ther., 352, pp. 208-217; 
Altarifi, A.A., Yuan, Y., Zhang, Y., Selley, D.E., Negus, S.S., Effects of the novel, selective and low-efficacy mu-opioid receptor ligand NAQ on intracranial self-stimulation in rats (2015) Psychopharmacology (Berl)., 232, pp. 815-824; 
Alvarez, P., Hernandez, A., Constandil, L., Infante, C., Pelissier, T., Stage-dependent C-reflex, pain-like behavior and opioid analgesia during the induction of chronic arthritis in rats (2014) Eur. J. Neurosci., 40, pp. 3264-3272; 
Amiani, A., McKee, G., Khamis, N., Raghukumar, G., Tsang, E., Buxton, J.A., Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada (2015) Harm. Reduct. J., 12, p. 54; 
Amini-Khoei, H., Rahimi-Balaei, M., Amiri, S., Haj-Mirzian, A., Hassanipour, M., Shirzadian, A., Gooshe, M., Dehpour, A.R., Morphine modulates the effects of histamine H1 and H3 receptors on seizure susceptibility in pentylenetetrazole-induced seizure model of mice (2015) Eur. J. Pharmacol., 769, pp. 43-47; 
Ammar, A.S., Mahmoud, K.M., Does the addition of magnesium to bupivacaine improve postoperative analgesia of ultrasound guided-thoracic paravertebral block in patients undergoing thoracic surgery (2014) J. Anesth., 28, pp. 55-63; 
Andersen, J.M., Haugen, K.S., Ripel, A., Morland, J., The interference of ethanol with heroin-stimulated psychomotor activation in mice is not related to changed brain concentrations of the active metabolites 6MAM or morphine (2014) Basic Clin. Pharmacol. Toxicol., 114, pp. 197-201; 
Anderson, E.M., Reeves, T., Kapermaros, K., Neubert, J.K., Caudle, R.M., Phosphorylation of the N-methyl-D-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal (2015) J. Pharmacol. Exp. Ther., 355, pp. 496-505; 
Andrade, C.A., De Oliveira, L.B., Andrade-Franze, G.M., De Luca, L.A., Jr., Colombari, D.S., Menani, J.V., GABAergic and opioid receptors mediate facilitation of NaCl intake induced by alpha2-adrenergic activation in the lateral parabrachial nucleus (2015) Behav. Brain Res., 278, pp. 535-541; 
Anghelescu, D.L., Goldberg, J.L., Faughnari, L.G., Wu, J., Mao, S., Furman, W.L., Santana, V.M., Navid, F., Comparisons of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma (2014) Pediatr. Blood Cancer, 8, p. 1002; 
Anselmi, L., Huynh, J., Duraffourd, C., Jaramillo, J., Vegezzi, G., Saccani, F., Boschetti, E., Sternini, C., Activation of mu opioid receptors modulates inflammation in acute experimental colitis (2015) Neurogastroenterol. Motil., 27, pp. 509-523; 
Antkowiak, B., Paluch, M., Ciechanowska, M., Nawrocka, M., Bankowski, K., Michalak, O., Kocik, J., Izdebski, J., Antinociceptive effect of D-Lys(2), Dab(4)N-(ureidoethyl)amide, a new cyclic 1–4 dermorphin/deltorphin analog (2014) Pharmacol. Rep., 66, pp. 600-605; 
Apergis-Schoute, J., Iordanidou, P., Faure, C., Jego, S., Schone, C., Aitta-Aho, T., Adamantidis, A., Burkadov, D., Optogenetic evidence for inhibitory signaling from orexin to MCH neurons via local microcircuits (2015) J. Neurosci., 35, pp. 5435-5441; 
Arabian, M., Aboutaleb, N., Soleimani, M., Mehrjerdi, F.Z., Ajami, M., Pazoki-Toroudi, H., Role of morphine preconditioning and nitric oxide following brain ischemia reperfusion injury in mice (2015) Iran. J. Basic Med. Sci., 18, pp. 14-21; 
Araldi, D., Ferrari, L.F., Levine, J.D., Repeated mu-opioid exposure induces a novel form of the hyperalgesic priming model for transition to chronic pain (2015) J. Neurosci., 35, pp. 12502-12517; 
Araujo, T.S., Costa, D.S., Sousa, N.A., Souza, L.K., de Araujo, S., Oliveira, A.P., Sousa, F.B., Medeiros, J.V., Antidiarrheal activity of cashew GUM, a complex heteropolysaccharide extreacted from exudate of Anacardium occidentale L in rodents (2015) J. Ethnopharmacol., 174, pp. 299-307; 
Arida, R.M., Gomes da Silva, S., de Almeida, A.A., Cavalheiro, E.A., Zavala-Tecupetia, C., Brand, S., Rocha, L., Differential effects of exercise on brain opioid receptor binding and activation in rats (2015) J. Neurochem., 132, pp. 206-217; 
Arout, C.A., Caldwell, M., Rossi, G., Kest, B., Spinal and supraspinal N-methyl-D-aspartate and melanocortin-1 receptors contribute to a qualitative sex difference in morphine-induced hyperalgesia (2015) Physiol. Behav., 147, pp. 364-372; 
Arttamamngkul, S., Birdsong, W., Williams, J.T., Does, P.K.C., activation increase the homologous desensitization of mu-opioid receptors (2015) Br. J. Pharmacol., 172, pp. 583-592; 
Asadikaram, G., Igder, S., Jamali, Z., Shahrokhi, N., Najafipour, H., Shokoohi, M., Jafarzadeh, A., Kazemi-Arababadi, M., Effects of different concentrations of opium on the secretion of interleukin-6, interferon-gamma and transforming growth factor beta cytokines from Jurkat cells (2015) Addict. Health, 7, pp. 47-53; 
Asche, C.V., Clay, E., Kharitonova, E., Zah, V., Ruby, J., Aballea, S., Budgetary impact of the utilization of buprenorphine/naloxone sublingual film and tablet for Medicaid in the United States (2015) J. Med. Econ., 18, pp. 600-611; 
Asth, L., Correia, L., Lobao-Soares, B., De Lima, T.C., Guerrini, R., Calo, G., Soares-Rachetti, V.P., Gavioli, E.C., Nociceptin/orphanin FQ induces imultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task (2015) Naunyn Schmiedeebergs Arch. Pharmacol., 388, pp. 33-41; 
Atluri, S., Sudarshan, G., Manchikanti, L., Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011 (2014) Pain Physician., 17, pp. E119-128; 
Attarian, S., Tran, L.C., Moore, A., Stanton, G., Meyer, E., Moore, R.P., The neurodevelopmental impact of neonatal morphine administration (2014) Brain Sci., 4, pp. 321-334; 
Aubin, H.J., Reimer, J., Nutt, D.J., Bladstrom, A., Torup, L., Francois, C., Chick, J., Clinical relevance of as-needed treatment with nalmefene in alcohol-dependent patients (2015) Eur. Addict. Res., 21, pp. 160-168; 
Auffret, Y., Gouillou, M., Jacob, G.R., Robin, M., Jenvrin, J., Soufflet, F., Alavi, Z., Does midazolam enhance pain control in prehospital management of traumatic severe pain (2014) Am. J. Emerg. Med., 32, pp. 655-659; 
Aujla, H., Nedjadrasul, D., Low-dose nociception/orphanin FQ reduces anxiety-like performance in alcohol-withdrawn, but not alcohol-naïve Wistar rats (2015) Neuropharmacology, 93, pp. 1-6; 
Avino, D., Zhang, W.H., De Ville, A., Johansson, A.B., Remifentanil versus morphine-midazolam premedication on the quality of endotracheal intubation in neonates: a noninferiority randomized trial (2014) J. Pediatr., 164, pp. 1032-1037; 
Ayling, O.G., Montbriand, J., Jiang, J., Ladak, S., Love, L., Eisenberg, N., Katz, J., Roche-Nagle, G., Continuous regional anesthesia provides effective pain management and reduces opioid requirement following major lower limb amputation (2014) Eur. J. Vasc. Endovasc. Surg., 48, pp. 559-564; 
Ayranci, G., Befort, K., Lalanne, L., Kieffer, B.L., Lutz, P.E., Dissociation of heroin-induced emotional dysfunction from psychomotor activation and physical dependence among inbred mouse strains (2015) Psychopharmacology (Berl)., 232, pp. 1957-1971; 
Azevedo Ade, O., Campos, J.J., de Souza, G.G., Veloso Cde, C., Duarte, I.D., Brega, F.C., Perez Ade, C., Antinociceptive and anti-inflammatory effects of myricetin 3-O-beta-galactoside isolated from Davilla elliptica: involvement of the nitrergic system (2015) J. Nat. Med., 69, pp. 487-493; 
Bach, P., Vollsta-Dt-Klein, S., Kirsch, M., Hoffmann, S., Jorde, A., Frank, J., Charlet, K., Kiefer, F., Increased mesolimbic cue-reactivity in carriers of the mu-opioid receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects (2015) Eur. Neuropsychopharmacol., 25, pp. 1128-1135; 
Bachhuber, M.A., McGinty, E.E., Kennedy-Hendricks, A., Niederdeppe, J., Barry, C.L., Messaging to increase public awareness for naloxone distribution policies in the United States: results from a randomized survey experiment (2015) PLoS One, 10, p. e0130050; 
Badzyriska, B., Lipkowski, A.W., Sadowski, J., An antihypertensive opioid: biphalin, a synthetic non-addictive enkephalin analog decreases blood pressure in spontaneously hypertensive rats (2015) Pharmacol. Rep., 68, pp. 51-55; 
Bagheri, S.M., Keyhani, L., Heydari, M., Dashti-R, M.H., Antinociceptive activity of Astragalus gummifer gum (gum tragacanth) through the noradrenergic system: a in vivo study in mice (2015) J. Ayurveda Integr. Med., 6, pp. 19-23; 
Bagley, S.M., Peterson, J., Cheng, D.M., Jose, C., Quinn, E., O'Connor, P.G., Walley, A.Y., Overdose education and naloxone rescue kits for family members of individuals who use opioids: characteristics, motivations and naloxone use (2015) Subst. Abuse, 36, pp. 149-154; 
Baharuddin, K.A., Rahman, N.H., Wahab, S.F., Halim, N.A., Ahmad, R., Intravenous parecoxib sodium as an analgesic alternative to morphine in acute trauma pain in the emergency department (2014) Int. J. Emerg. Med., 7, p. 2; 
Bai, L., Zhai, C., Han, K., Li, Z., Qian, J., Jing, Y., Zhang, W., Xu, J.T., Toll-like receptor 4-mediated nuclear factor-kappaB activation in spinal cord contributes to chronic morphine-induced analgesic tolerance and hyperalgesia in rats (2014) Neurosci. Bull., 30, pp. 936-948; 
Bai, X., Zhang, X., Li, Y., Lu, L., Li, B., He, X., Sex differences in peripheral mu-opioid receptor mediated analgesia in rat orofacial persistent pain model (2015) PLoS One, 10, p. e0122924; 
Bai, Y., Li, Y., Lv, Y., Liu, Z., Zheng, X., Complex motivated behaviors for natural rewards following a binge-like regimen of morphine administration: mixed phenotypes of anhedonia and craving after short-term withdrawal (2014) Front. Behav. Neurosci., 8, p. 23; 
Baik, S.W., Park, B.S., Kim, Y.H., Kim, Y.D., Kim, C.H., Yoon, J.Y., Yoon, J.U., Effects of remifentanil preconditioning on osteoblasts under hypoxia-reoxygenation condition (2015) Int. J. Med. Sci., 12, pp. 583-589; 
Baillie, L.D., Schmidhammer, H., Mulligan, S.J., Peripheral mu-opioid receptor mediated inhibition of calcium signaling and action potential-evoked calcium fluorescent transients in primary afferent CGRP nociceptive terminals (2015) Neuropharmacology, 93, pp. 267-273; 
Baiula, M., Monitoring opioid receptor dimerization in living cells by bioluminescence resonance energy transfer (BRET) (2015) Methods Mol. Biol., 1230, pp. 105-113; 
Bajic, D., Soiza-Reilly, M., Spalding, A.L., Berde, C.B., Commons, K.G., Endogenous cholinergic neurotransmission contributes to behavioral sensitization to morphine (2015) PLoS One, 10, p. e0117601; 
Balhara, Y.P., Ranjan, R., Dhawan, A., Yadav, D., Experiences from a community based substance use treatment centre in an urban resettlement colony in India (2014) J. Addict., 2014, p. 982028; 
Banafshe, H.R., Hajhashemi, V., Minaiyan, M., Mesdaghinia, A., Abed, A., Antinociceptive effects of maprotillane in a rat model of peripheral neuropathic pain: possible involvement of opioid system (2015) Iran. J. Basic Med. Sci., 18, pp. 752-757; 
Banerjee, J., Papu John, A.M., Schuller, H.M., Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides (2015) Int. J. Cancer, 137, pp. 2815-2824; 
Banerjee, P., The efficacy of multimodal high-volume wound infiltration in primary total knee replacement in facilitating post-operative pain relief and attainment of early rehabilitation milestones (2014) Eur. J. Orthop. Surg. Traumatol., 24, pp. 571-577; 
Banerjee, S., Ninkovic, J., Meng, J., Sharma, U., Ma, J., Charboneau, R., Roy, S., Morphine compromises bronchial epithelial TLR2?IL17R signaling crosstalk, necessary for lung IL17 homeostasis (2015) Sci. Rep., 5, p. 11384; 
Banghart, M.R., Neufeld, S.Q., Wong, N.C., Sabatini, B.L., Enkephalin disinhibits mu opioid receptor-rich striatal patches via delta opioid receptors (2015) Neuron, 88, pp. 1227-1239; 
Bao, Y., Gao, Y., Hou, W., Yang, L., Kong, X., Zheng, H., Li, C., Hua, B., Engagement of signaling pathways of protease-activated receptor 2 and mu-opioid receptor in bone cancer pain and morphine tolerance (2015) Int. J. Cancer, 137, pp. 1475-1483; 
Bao, Y.H., Zhou, O.H., Chen, R., Xu, H., Zeng, L.L., Zhang, X., Jiang, W., Du, D.P., Gabapentin enhances the morphine antinociceptive effect in neuropathic pain via the interleukin-10-heme oxygenase-1 signaling pathway in rats (2014) J. Mol. Neurosci., 54, pp. 137-146; 
Bao, Y.H., Zhou, O.H., Chen, R., Xu, H., Zeng, L., Zhang, X., Jiang, W., Du, D., Gabapentin attenuates morphine tolerance through interleukin-10 (2014) Neuroreport, 25, pp. 71-76; 
Barandiharan, G., Simpson, K.H., Dhandapani, K., Spinal cord stimulation for visceral pain −a novel approach (2014) Neuromodulation, 17, pp. 753-758; 
Barann, M., Stamer, U.M., Lyutenska, M., Stuber, F., Bonisch, H., Urban, B., Effects of opioids on human serotonin transporters (2015) Naunyn. Schmiedebergs Arch. Pharmacol., 388, pp. 43-49; 
Barbosa-Leiker, C., McPherson, S., Marney, M.R., Burns, G.L., Layton, M.E., Roll, J., Ling, W., Examining the factor structure of the clinical opiate withdrawal scale: a secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003 (2015) Drug Alcohol Depend., 152, pp. 218-223; 
Barocas, J.A., Baker, L., Hull, S.J., Stokes, S., Westergaard, R.P., High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants (2015) Drug Alcohol Depend., 154, pp. 283-288; 
Bartuzi, D., Kaczor, A.A., Matoshuk, D., Activation and allosteric modulation of human mu opioid receptor in molecular dynamics (2015) J. Chem. Inf. Model., 55, pp. 2421-2434; 
Bashandy, G.M., Elkholy, A.H., Reducing postoperative opioid consumption by adding an ultrasound-guided rectus sheath block to multimodal analgesia for abdominal cancer surgery with midline incision (2014) Anesth. Pain Med., 4, p. e18263; 
Bastami, S., Gupta, A., Zackrisson, A.L., Ahlner, J., Osman, A., Uppugunduri, S., Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption (2014) Basic Clin. Pharmacol. Toxicol., 115, pp. 423-431; 
Bastias-Candia, S., Di Benedetto, M., D'Addario, C., Candeletti, S., Romualdi, P., Combined exposure to agriculture pesicides, paraquat and maneb, induces alterations in the N/OFQ-NOPr and PDYN/KOPr systems in rats: relevance to sporadic Parkinon's disease (2015) Environ. Toxicol., 30, pp. 656-663; 
Bates, M.L., Emery, M.A., Wellman, P.J., Eitan, S., Social housing conditions influence morphine dependence and the extinction of morphine place preference in adolescent mice (2014) Drug Alcohol Depend., 142, pp. 283-289; 
Bauer, C.T., Banks, M.L., Blough, B.E., Negus, S.S., Role of 5HT-2C receptors in effects of monoamine releasers on intracranial self-stimulation in rats (2015) Psychopharmacology (Berl)., 232, pp. 3249-3258; 
Bawor, M., Dennis, B.B., Tan, C., Pare, G., Varenbut, M., Daiter, J., Plater, C., Samaan, Z., Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study (2015) Addict. Sci. Clin. Pract., 10, p. 19; 
Bazari, A.R., Zeleney, A., Fu, J.J., Yee, I., Kamarulzaman, A., Altice, F.L., High prevelance of non-fatal overdose among people who inject drugs in Malaysia: correlations of overdose and implications for overdose prevention from a cross-sectional study (2015) Int. J. Drug Policy, 26, pp. 675-681; 
Beaudoin, F.L., Lin, C., Guan, W., Merchant, R.C., Low-dose ketamine improves pain relief in patients receiving intravenous opioids for acute pain in the emergency department: results of a randomized, double-blind, clinical trial (2014) Acad. Emerg. Med., 21, pp. 1193-1202; 
Beaudry, H., Gendron, L., Moron, J.A., Implication of delta opioid receptor subtype 2, but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain (2015) Eur. J. Neurosci., 41, pp. 901-907; 
Beaudry, H., Mercier-Blais, A.A., Delaygue, C., Lavoie, C., Parent, J.L., Neugebauer, W., Gendron, L., Regulation of mu and delta opioid receptor functions: involvement of cyclin-dependent kinase 5 (2015) Br. J. Pharmacol., 172, pp. 2573-2587; 
Beck, T., Haasen, C., Verthein, U., Walcher, S., Schuler, C., Backmund, M., Ruckes, C., Reimer, J., Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone (2014) Addiction, 109, pp. 617-626; 
Becker, W.C., Ganoczy, D., Fiellin, D.A., Bohnert, A.S., Buprenorphine/naloxone dose and pain intensity among individuals initiating treatment for opioid use disorder (2015) J. Subxst. Abuse Treat., 48, pp. 128-131; 
Bedini, A., Bioluminescence resonance energy transfer (BRET) to detect the interactions between kappa opioid receptor and non visual arrestins (2015) Methods Mol. Biol., 1230, pp. 115-128; 
Behar, D., Santos, G.M., Wheeler, E., Rowe, C., Coffin, P.O., Brief overdose education is sufficient for naloxone distribution to opioid users (2015) Drug Alcohol Depend., 148, pp. 209-212; 
Beheshti, S., Hosseini, S.A., Noorbakhshnia, M., Eivani, M., Role of hippocampal CA1 area gap junction channels on morphine state-dependent learning (2014) Eur. J. Pharmacol., 745, pp. 196-200; 
Behrbalk, E., Halpern, P., Boszczyk, B.M., Parks, R.M., Chechik, O., Rosen, N., Shapira, A., Uri, O., Anxiolytic medication as an adjunct to morphine analgesia for acute low back pain management in the emergency department: a prospective randomized trial (2014) Spine (Phila PA 1976), 39, pp. 17-22; 
Bender, A.M., Griggs, N.W., Anand, J.P., Traynor, J.R., Jutkiewicz, E.M., Mosberg, H.I., Asymmetric synthesis and in vitro and in vivo activity of tetrahydroquinolines featuring a diverse set of polar substitutions at the 6 position as mixed-efficacy mu opioid receptor/delta opioid receptor ligands (2015) ACS Chem. Neurosci., 6, pp. 1428-1435; 
Benmansour, P., Husulak, M.L., Bracamonte, J.L., Beazley, S.G., Withnall, E., Duke-N.Ovakovski, T., Cardipulonary effects of an infusion of remifentanil or morphine in horses anesthetized with isoflurane and dexmedetomidine (2014) Vet. Anesth. Analg., 41, pp. 346-356; 
Berges, J., Kamar, A., de Oliveira, P., Pilme, J., Luppi, E., Houee-Levin, C., Toward an understanding of the oxidation process of methionine enkephalin: a combined electrochemistry, quantum chemistry and quantum chemical topology analysis (2015) J. Phys. Chem. B, 119, pp. 6885-6893; 
Bergmann, J., Szabanowski, T., Brauer, A., Crozier, T.A., Bauer, M., Hinz, J.M., Remifentanil added to sufentanil-sevoflurane anesthesia suppresses hemodynamic and metabolic stress responses to itetense surgical stimuli more effectively than high-dose sufentanil-sevoflurane alone (2015) BMC Anaesthesiol., 15, p. 3; 
Bernard, R., Salvi, N., Gall, O., Egan, M., Treluyer, J.M., Carli, P.A., Orliaguet, G.A., MORpH IT an observational study on morphine titration in the postanesthetic care unit of children (2014) Pediatr. Anaesth., 24, pp. 303-308; 
Betti, C., Starnowska, J., Mika, J., Dyniewicz, J., Frankiewicz, L., Novoa, A., Bochynska, M., Ballet, S., Dual alleviation of acute and neuropathic pain by fused opioid agonist-neurokinin 1 antagonist peptidomimetics (2015) ACS Med. Chem. Lett., 6, pp. 1209-11214; 
Bhalla, S., Pais, G., Tapia, M., Gulati, A., Endothelin, E.T.A., receptor antagonist reverses naloxone-precipitated opioid withdrawal in mice (2015) Can. J. Physiol. Pharmacol., 93, pp. 935-944; 
Bhatnagar, S., Devi, S., Vinod, N., Jain, P., Durgaprasad, G., Maroo, S.H., Patel, K.R., Safety and efficacy of oral transmucosal fentanyl citrate compared to morphine sulfate immediate release tablet in management of breakthrough cancer pain (2014) Indian J. Palliat. Care, 20, pp. 182-187; 
Biaesse, P., Goedecke, L., Bazelot, M., Capogna, M., Pape, H.C., Jungling, K., Mu-opioid receptor-mediated inhibition of intercalcated neurons and effect on synaptic transmission to the central amygdala (2015) J. Neurosci., 35, pp. 7317-7325; 
Bian, J.M., Wu, N., Su, R.B., Li, J., Phosphatidylethanolamine-binding protein is not involved in mu-opioid receptor-mediated regulation of extracellular signal-regulated kinase (2015) Mol. Med. Rep., 11, pp. 3368-3374; 
Biesiada, J., Chidambaran, V., Wagner, M., Zhang, X., Martin, L.J., Meller, J., Sadhasivam, S., Genetic risk signatures of opioid-induced respiratory depression following pediatric tonsillectomy (2014) Pharmacogenomics, 15, pp. 1749-1752; 
Bigliardi, P.L., Neumann, C., Teo, Y.L., Pant, A., Bigliardi-Qi, M., Activation of the delta-opioid receptor promotes cutaneous wound healing by affecting keratinocyte intercellular adhesion and migration (2015) Br. J. Pharmacol., 172, pp. 501-514; 
Bihel, F., Humbert, J.P., Schneider, S., Bertin, I., Wagner, P., Schmitt, M., Laboureyras, E., Bourguignon, J.J., Development of a peptidomimetic antagonist of neuropeptide FF receptors for the prevention of opioid-induced hyperalgesia (2015) ACS Chem. Neurosci., 6, pp. 438-445; 
Bilbao, A., Robinsion, J.E., Heilig, M., Malanga, C.J., Spanagel, R., Sommer, W.H., Thorsell, A., A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice (2015) Biol. Psychiatry, 77, pp. 850-858; 
Binswanger, I.A., Koester, S., Mueller, S.R., Gardner, E.M., Goddard, K., Glanz, J.M., Overdose education and naloxone for patients prescribed opioids in primary care: a qualitative study of primary care staff (2015) J. Gen. Intern. Med., 30, pp. 1837-1844; 
Biondi, D.M., Xiang, J., Etropolski, M., Moskovitz, B., Tolerability and efficacy of tapentadol extended release in elderly patients > 75 years of age with chronic osteoarthritis knee or low back pain (2015) J. Opioid Mange., 11, pp. 393-403; 
Bird, M.F., Vardanyan, R.B., Hruby, V.J., Calo, G., Guerrini, R., Salvadori, S., Trapella, C., Lambert, D.G., Development and characterization of novel fentanyl-delta opioid receptor antagonist based bivalent ligands (2015) Br. J. Anaesth., 114, pp. 546-556; 
Bird, S.M., Parmar, M.K., Strang, J., Take-home naloxone to prevent fatalities from opiate-overdose: protocol for Scotland's public health policy evaluation, and a new measure to assess impact (2015) Drugs (Abingdon Engl.), 22, pp. 56-76; 
Birkelund, T., Obad, D.S., Matejec, R., Betker, H.E., Ravn, H.B., Remote ischemic preconditioning does not increase circulating or effector concentrations of proopiomelanocortin derivatives (2015) Scand. Cardiovasc. J., 49, pp. 257-263; 
Birdsong, W.T., Arttamangkul, S., Bunzow, J.R., Williams, J.T., Agonist binding and desensitization of the mu-opioid receptor is modulated by phosphorylation of the C-terminal tail domain (2015) Mol. Pharmacol., 88, pp. 816-824; 
Bisaga, A., Sullivan, M.A., Glass, A., Mishlen, K., Pavlicova, M., Haney, M., Raby, W.N., Nunes, E.V., The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone (2015) Drug Alcohol Depend., 154, pp. 35-45; 
Bisignano, P., Burford, N.T., Shang, Y., Marlow, B., Livingston, K.E., Fenton, A.M., Rockwell, K., Filizola, M., Ligand-based discovery of a new scaffold for allosteric modulation of the mu-opioid receptor (2015) J. Chem. Int. Model., 55, pp. 1836-1843; 
Block, L., Lundborg, C., Biersing, J., Dahm, P., Hansson, E., Biber, B., Ultralow dose of naloxone as an adjuvant to intrathecal morphine infusion improves perceived quality of sleep but fails to alter persistent pain: a randomized, double-blind controlled study (2015) Clin. J. Pain, 31, pp. 968-975; 
Blum, K., Oscar-Berman, M., Jacobs, W., McLaughlin, T., Gold, M.S., Buprenorphine response as a function of neurogenic polymorphic antecedents: can dopamine genes affect clinical outcomes in reward deficiency syndrome (RDS)? (2014) J. Addict. Res., 5, p. 1000185; 
Bocsik, A., Danula, Z., Toth, G., Deli, M.A., Wollermann, M., Trnasfer of opiorphin through a blood-brain culture model (2015) Arch. Med. Res., 46, pp. 502-506; 
Bogdanova, N.G., Kolpakov, A.A., Sudakov, S.K., Effect of peptide agonists of peripheral opioid receptors on operant feeding behavior and food motivation in rats (2015) Bull. Exp. Biol. Med., 158, pp. 589-591; 
Bokoch, M.P., Behrends, J.M., Neice, A., Larson, M.D., Fentanyl, an agonist at the mu opioid receptor depressed pupillary unrest (2015) Auton. Neurosci., 189, pp. 68-74; 
Boland, J.W., Foulds, G.A., Ahmedzai, S.H., Pockley, A.G., A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function (2014) BMJ Support Palliat. Care, 4, pp. 357-367; 
Bomba, F.D., Wandji, B.A., Piegang, B.N., Awouafack, M.D., Sriram, D., Yogeeswari, P., Kamanyi, A., Nguelefack, T.B., Antinociceptive properties of the aqueous and methanol extracts of the stem bark of Petersianthus macrocarpus (P. Beauv.) Liben (Lecythidaceae) in mice (2015) J. Ethnopharmacol., 174, pp. 66-73; 
Bonnard, E., Poras, H., Nadal, X., Maldanado, R., Fournie-Zaluski, M.C., Roques, B.P., Long-lasting analgesic effects of N-protected aminophospinic dual ENKephalinase inhibitors (DENKIs) in peripherally controlled pain (2015) Pharmacol. Res. Perspect., 3, p. e00116; 
Borckardt, J.J., Reeves, S.T., Kotlowski, P., Abernathy, J.H., Feld, L.C., Dong, L., Frohman, H., George, M.S., Fast left prefrontal rTMS reduces post-gastric bypass surgery pain: findings from a large-scale, double-blind, sham-controlled clinical trial (2014) Brain Stimul., 7, pp. 42-48; 
Bordner, K., Deak, T., Endogenous opioids as substrates for ethanol intake in the neonatal rat: the impact of prenatal ethanol exposure on the opioid family in the early postnatal period (2015) Physiol. Behav., 148, pp. 100-110; 
Borgen, I.L., Boix, F., Nerem, E., Morland, J., Andersen, J.M., A monoclonal antibody specific for 6-monoacetylmorphine reduces acute heroin effects in mice (2014) J. Pharmacol. Exp. Ther., 349, pp. 568-576; 
Bot, A.G., Bekkars, S., Arnstein, P.M., Smith, R.M., Ring, D., Opioid use after fracture surgery correlates with pain intensity and satisfaction with pain relief (2014) Clin. Orthop. Relat. Res., 472, pp. 2541-2549; 
Boules, M., Shimizu, H., Zelisko, A., El-Hayek, K., Rizk, M.K., Kroh, M., Pre-operative opioid analgesia reduces clinical success of laparoscopic gastric electrical stimulation placement in patients with gastropareseis (2015) Surg. Endosc., 29, pp. 805-809; 
Bounes, V., Jouanjus, E., Roussin, A., Lapeyre-Mestre, M., Acute pain management for patients under opioid maintenance treatment: what physicians do in emergency departments (2014) Eur. J. Emerg. Med., 21, pp. 73-76; 
Bowman, B.R., Goodchild, A.K., GABA and enkephalin tonically alter sympathetic outflows in the rat spinal cord (2015) Auton. Neurosci., 193, pp. 84-91; 
Bowman, S.L., Soohoo, A.L., Shiwarski, D.J., Schulz, S., Pradhan, A.A., Puthenveedu, M.A., Cell-autonomous regulation of mu-opioid receptor recycling by substance P (2015) Cell Rep., 10, pp. 1925-1936; 
Braun, D.E., Gelbrich, T., Kahlenberg, V., Griesser, U.J., Insights into hydrate formation and stability of morphinanes from a combination of experimental and computational approaches (2014) Mol. Pharmacol., 11, pp. 3145-3163; 
Brederson, J.D., Honda, C.N., Primary afferent neurons express functional delta opioid receptors in inflamed skin (2015) Brain Res., 1614, pp. 105-111; 
Bress, A., Kittles, R., Wing, C., Hooker, S.E., Jr., King, A., Genetic ancestry as an effect modifier of naltrexone in smoking cessation among African-Americans: an analysis of a randomized controlled trial (2015) Pharmacogenet. Genom., 25, pp. 305-312; 
Brestoff, J.R., Kim, B.S., Saenz, S.A., Stine, R.R., Monticelli, L.A., Sonnenberg, G.F., Thome, J.J., Artis, D., Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity (2015) Nature, 519, pp. 242-246; 
Briand, L.A., Hilario, M., Dow, H.C., Brodkin, E.S., Blendy, J.A., Berton, O., Mouse model of OPRM1 (A118G) polymorphism increases sociability and dominance and confers resilience to social defeat (2015) J. Neurosci., 35, pp. 3582-3590; 
Brokjaer, A., Kreilgaard, M., Olesen, A.E., Simonsson, U.S., Christup, L.L., Dahan, A., Drewes, A.M., Population pharmacokinetics of morphine and morphine-6-glucuronide following rectal administration −a dose escalation study (2015) Eur. J. Pharm. Sci., 68, pp. 78-86; 
Brokjaer, A., Olesen, A.E., Christup, L.L., Dahan, A., Drewes, A.M., The effects of morphine and methylnaltrexone on gastrointestinal pain in healthy male participants (2015) Neurogastroenterol. Motil., 27, pp. 693-704; 
Brown, C.A., Matthews, J., Fairclough, M., McMahon, A., Barnett, E., Al-Kaysi, A., El-Deredy, W., Jones, A.K., Striatal opioid receptor availability is related to acute and chronic pain perception in arthritis: does opioid adaptation increase resilienece to chronic pain? (2015) Pain, 156, pp. 2267-2275. , (4.3); 
Brown, M.S., Hayes, M.J., Thornton, L.M., Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial (2015) J. Perinatol., 35, pp. 278-283; 
Browne, C.A., van Nest, D.S., Lucki, I., Antidepressant-like effects of buprenorphine in rats are strain-dependent (2015) Behav. Brain Res., 278, pp. 385-392; 
Bruehl, S., Burns, J.W., Passik, S.D., Gupta, R., Buvanendran, A., Chont, M., Schuster, E., France, C.R., The contribution of differential pain responsiveness to identification of opioid risk in chronic pain patients (2015) J. Pain, 16, pp. 666-675. , (4.3); 
Bruning, C.A., Gai, B.M., Soares, S.M., Martini, F., Nogueira, C.W., Serotonergic systems are implicated in antinociceptive effect of m-trifluoromethyl diphenyl diselenide in the mouse glutamate test (2014) Pharmacol. Biochem. Behav., 125, pp. 15-20; 
Bryczkowski, S.B., Lopreiato, M.C., Yonclas, P.P., Sacca, J.J., Mosenthal, A.C., Delirium prevention program in the surgical intensive care unit improved the outcomes of older adults (2014) J. Surg. Res., 190, pp. 280-288; 
Bu, H., Liu, X., Tian, X., Yang, H., Gao, F., Enhancement of morphine analgesia and prevention of morphine tolerance by downregulation of beta-arrestin 2 with antigene RNAs in mice (2015) Int. J. Neurosci., 125, pp. 56-65; 
Buda, J.J., Carroll, F.I., Kosten, T.R., Swearingen, D., Walters, R.B., A double-blind, placebo-controlled trial to evaluate the safety, tolerability and pharmacokinetics of single, escalating oral doses of JDTic (2015) Neuropsychopharmacology, 40, pp. 2059-2065; 
Bujalska-Zadrozny, M., Wolinska, R., Gasinska, E., Nagraba, L., Tapentadol and nitric oxide synthase systems (2015) Behav. Pharmacol., 26, pp. 282-288; 
Bull, J., Wellman, C.V., Israel, R.J., Barrett, A.C., Paterson, C., Forbes, W.P., Fixed-dose subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: results of a randomized, placebo-controlled study and open-label extension (2015) J. Palliat. Med., 18, pp. 593-600; 
Burford, N.T., Livingston, K.E., Canals, M., Ryan, M.R., Budenholzer, L.M., Han, Y., Shang, Y., Alt, A., Discovery, synthesis and molecular pharmacology of selective positive allosteric modulators of the delta-opioid receptor (2015) J. Med. Chem., 58, pp. 4220-4229; 
Burghardt, P.R., Rothberg, A.E., Dykhuis, K.E., Burant, C.F., Zubieta, J.K., Endogenous opioid mechanisms are implicated in obesity and weight loss in humans (2015) J. Clin. Endocrinol. Metab., 100, pp. 3193-3201; 
Bustamante, H.A., Rodriguez, A.R., Herzberg, D.E., Werner, M.P., Stress and pain response after oligofructose induced-lameness in dairy heifers (2015) J. Vet. Sci., 16, pp. 405-411; 
Butler, F.K., Kotwal, R.S., Buckenmaier, C.C., 3rd, Edgar, E.P., O'Connor, K.C., Montgomery, H.R., Shackelford, S.A., Bailey, J.A., A triple option analgesia plan for tactical combat casualty care: TCCC guidelines change 13-04 (2014) J. Spec. Oper. Med., 14, pp. 13-25; 
Butler, S.F., McNaughton, E.C., Black, R.A., Tapentadol abuse potential: a postmarketing evaluation using a sample of individuals evaluated for substance abuse treatment (2015) Pain Med., 16, pp. 119-130; 
Cachope, R., Pereda, A.E., Opioids potentiate electrical transmission at mixed synapses on the Mauthner cell (2015) J. Neurophysiol., 114, pp. 689-697; 
Cai, M., Su, Z., Zou, H., Zhang, Q., Shen, J., Zhang, L., Wang, T., Li, C., Association between the traditional Chinese medicine pathological factors of opioid addiction and DRD2/ANKK1 TaqlA polymorphisms (2015) BMC Complement. Altern. Med., 15, p. 209; 
Caldwell, A.S., Eid, S., Kay, C.R., Jimenez, M., McMahon, A.C., Desai, R., Allan, C.M., Walters, K.A., Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenizaation (2015) Endocrinology, 156, pp. 1441-1452; 
Calixto-Campos, C., Correa, M.P., Carcalho, T.T., Zarpelon, A.C., Hohmann, M.S., Rossaneis, A.C., Coelho-Silva, L., Verri, W.A., Jr., Quercitin reduces Ehrlich tumor-induced cancer pain in mice (2015) Anal. Cell Pathol. (Amst), 2015, p. 285708; 
Calle, G.A., Lopez, C.C., Sanchez, E., De Los Rios, J.F., Vasquez, E.M., Serna, E., Arango, A.M., Almanza, L.A., Transversus abdominis plane block after ambulatory total laparoscopic hysterectomy: randomized controlled tiral (2014) Acta Obstet. Gynecol. Scand., 93, pp. 345-350; 
Campa, V.A., Capilla, A., Varela, M.J., de la Rocha, A.M., Fernandez-Troyano, J.C., Barreiro, R.B., Lopez-Gimenez, J.F., Endocytosis as a biological response in receptor pharmacology: evaluation by fluorescence microscopy (2015) PLoS One, 10, p. e0122604; 
Camerani, S., Capuzzo, M., Ieffa, E., Pescolderung, M., Braccini, L., Volta, C.A., Total intravenous anesthesia with superficial cervical block or morphine transition in patients undergoing carotid endarectomy (2014) Minerva Anesthesiol., 80, pp. 676-684; 
Campos, J., Lobo, C., Queriroz, A.M., do Nascimento, E.M., Lima, C.B., Cardoso, G., Ballas, S.K., Treatment of the acute sickle cell vaso-occlusive crisis in the emergency department: a Brazilian method of switching from intravenous to oral morphine (2014) Eur. J. Haematol., 93, pp. 34-40; 
Cannella, M., Motolese, M., Bucci, D., Molinaro, G., Gradini, R., Bruno, V., Nicoletti, F., Battaglia, G., Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism (2015) Neuropharmacology, 95, pp. 50-58; 
Cao, L., Chang, Y., Lin, W., Zhou, J., Tan, H., Yuan, Y., Zeng, W., Long-term survival after resection of hepatocellular carcinoma: a potential risk associated with the choice of postoperative analgesia (2014) Anesth. Analg., 118, pp. 1309-1316; 
Cao, S., Chao, D., Zhou, H., Balboni, G., Xia, Y., A novel mechanism for cytoprotection against hypoxic injury: delta-opioid receptor-mediated increase in Nrf2 translocation (2015) Br. J. Pharmacol., 172, pp. 1869-1881; 
Cao, X., Wu, Z., Rou, K., Li, L., Lin, C., Wang, C., Luo, W., Li, J., Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study (2014) Drug Alcohol Depend., 145, pp. 87-93; 
Caprioli, G., Mammoli, V., Ricciutelli, M., Sagratini, G., Ubaldi, M., Domi, E., Mennuni, L., Del Bello, F., Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation (2015) Eur. J. Pharmacol., 769, pp. 219-224; 
Caputi, F.F., Carretta, D., Lattanzio, P., Palmisano, M., Candeletti, S., Romualdi, P., Proteasome subunit and opioid receptor gene expression down-regulation induced by paraquat and maneb in human neuroblastoma cells (2015) Environ. Toxicol. Pharmacol., 40, pp. 895-900; 
Cardoso, C.G., Marques, D.R., da Silva, T.H., de Mattos-Junior, E., Cardiorespiratory, sedative and antinociceptive effects of dexmedetomidine alone or in combination with methadone, morphine or tramadol in dogs (2014) Vet. Anaesth. Analg., 41, pp. 636-643; 
Carnlof, C., Insulander, P., Jensen-Urstad, M., An active supply of analgesics during pulmonary vein isolation reduces pain (2014) Scand. Cardiovasc. J., 48, pp. 35-40; 
Carregaro, A.P., Freitas, G.C., Lopes, C., Lukarsewski, R., Tamiozzo, F.S., Santos, R.R., Evaluation of analgesic and physiologic effects of epidural morphine at a thoracic or lumbar level in dogs undergoing thoracotomy (2014) Vet. Anesth. Analg., 41, pp. 205-211; 
Carrillo-Munguia, N., Gonzalez-Trujano, M.E., Huerta, M., Trujillo, X., Diaz-Reval, M.I., Tramadol and tramadol + caffeine synergism in the rat formalin test are mediated by central opioid and serotonergic mechanisms (2015) BioMed Res. Int., 2015, p. 686424; 
Carvalho, T.T., Borghi, S.M., Pinho-Ribeiro, F.A., Mizokami, S.S., Cunha, T.M., Ferreira, S.H., Cunha, F.Q., Verri, W.A., Jr., Granulocyte-colony stimulating factor (G-CSF)-induced mechanical hyperalgesia in mice: role for peripheral TNFalpha, IL-1beta and IL-10 (2015) Eur. J. Pharmacol., 749, pp. 62-72; 
Carvallo, L., Lopez, L., Che, F.Y., Lim, J., Eugenin, E.A., Williams, D.W., Nieves, E., Berman, J.W., Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes (2015) J. Immunol., 194, pp. 3246-3258; 
Castel, D., Willentz, E., Doron, O., Brenner, O., Meilin, S., Characterization of a porcine model of post-operative pain (2014) Eur. J. Pain, 18, pp. 496-505; 
Castren, S., Salonen, A.H., Alho, H., Lahti, T., Simojoki, K., Past-year gambling behavior among patients receiving opioid substitution treatment (2015) Subst. Abuse Treat. Prev. Policy, 10, p. 4; 
Cavalla, D., Chianelli, F., Korsak, A., Hosford, P.S., Gourine, A.V., Marina, N., Tianeptine prevents respiratory depression without affecting analgesic effect of opiates in conscious rats (2015) Eur. J. Pharmacol., 761, pp. 266-272; 
Cegielska-Perun, K., Tatarkiewicz, J., Siwek, A., Dybala, M., Bujalska-Zadrozny, M., Mechanisms of morphine-venlafaxine interactions in diabetic neuropathic pain model (2015) Pharmacol. Rep., 67, pp. 90-96; 
Cegielska-Perun, K., Bujalska-Zadrozny, M., Gasinska, E., Makulska-Nowak, H.E., Enhancement of antinociceptive effect of morphine by antidepressants in diabetic neuropathic pain (2014) Pharmacol. Rep., 66, pp. 228-234; 
Cengiz, P., Gokcinar, D., Karabeyoglu, I., Topcu, H., Cick, G.S., Gogus, N., Intraoperative low-dose ketamine infusion reduces acute postoperative pain following total knee replacement surgery: a prospective, randomized double-blind placebo-controlled trial (2014) J. Coll. Physicians Surg. Pak., 24, pp. 299-303; 
Cernea, M., Padmanabhan, V., Goodman, R.L., Coolen, L.M., Lehman, M.N., Prenatal testosterone treatment leads to changes in the morphology of KNDy neurons, their inputs, and projections to GnRH cells in female sheep (2015) Endocrinology, 156, pp. 3277-3291; 
Cetas, J.S., McFarlane, R., Kronfeld, K., Smitasin, P., Liu, J.J., Raskin, J.S., Brainstem opioidergic system is involved in early response to experimental SAH (2015) Transl. Stroke Res., 5, pp. 140-147; 
Chabot-Dore, A.J., Millecamps, M., Naso, L., Devost, D., Trieu, P., Pittonen, M., Diatchenko, L., Stone, L.S., Dual allosteric modulation of opioid antinociceptive potency by alpha2A-adrenoceptors (2015) Neuropharmacology, 99, pp. 285-300; 
Chajra, H., Amstutz, B., Schweikert, K., Auriol, D., Redziniak, G., Lefevre, F., Opioid receptor delta as a global modulator of skin differentiation and barrier function repair (2015) Int. J. Cosmet. Sci., 37, pp. 386-394; 
Chandon, M., Bonnet, A., Burg, Y., Barnichon, C., DesMesnards-Smaja, V., Sitbon, B., Foiret, C., Le Guen, M., Ultrasound-guided transversus abdominis plane block versus continuous wound infusion for post-cesarean analgesia: a randomized trial (2014) PLoS One, 8, p. e103971; 
Chang, C.H., Chao, P.C., Niu, H.S., Huang, G.C., Chen, L.C., Cheng, J.T., Canavanine activates imidazoline I-2 receptors to reduce hyperglycemia in type-1-like diabetic rats (2015) Chem. Biol. Interact., 240, pp. 304-308; 
Chang, Q., Hanania, T., Mash, D.C., Maillet, E.L., Noriborgaine reduces nicotine self-administration in rats (2015) J. Psychopharmacol., 29, pp. 704-711; 
Chang, S.D., Brieddy, L.E., Harvey, J.D., Lewin, A.H., Mascarella, S.W., Seltzman, H.H., Reddy, P.A., Carroll, F.I., Novel synthesis and pharmacological characterization of NOP receptor agonist 8-[\{1S,3aS)-2,3,3a, 4,5,6-hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one (Ro 64–6198) (2015) ACS Chem. Neurosci., 6, pp. 1956-1964; 
Chang, S.D., Mascarella, S.W., Spangler, S.M., Gurevich, V.V., Navarro, H.A., Carroll, F.I., Bruchas, M.R., Quantitative signaling and structure-activity analyses demonstrate functional selectivity at the nociception/orphanin FQ opioid receptor (2015) Mol. Pharmacol., 88, pp. 502-511; 
Chartoff, E.H., Ebner, S.R., Sparrow, A., Potter, D., Baker, P.M., Ragozzino, M.E., Roitman, M.F., Relative timing between kappa opioid receptor activation and cocaine determines the impact on reward and dopamine release (2015) Neuropsychopharmacology, 41, pp. 989-1002; 
Chau, N., Elliot, D.J., Lewis, B.C., Burns, K., Johnston, M.R., Mackenzie, P.I., Miners, J.O., Morphine gucoronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies (2014) J. Pharmacol. Exp. Ther., 349, pp. 126-137; 
Chauhan, E., Ball, A., Singh, N., Jaggi, A.S., Pharmacological investigations on cross adaptation in mice subjected to stress immobilization (2015) Life Sci., 127, pp. 98-105; 
Chavarria-Bolanos, D., Flores-Reyes, H., Lombana-Sanchez, N., Cerda-Cristerna, B., Pozos-Guillen, A., Sensory neuropeptides and endogenous opioids expression in human dental pulp with asymptotic inflammation: in vivo study (2015) Mediators Inflamm., 2015, p. 879126; 
Chaykovska, L., Blohme, L., Mayer, D., Gloekler, S., Rancic, Z., Schmidt, C.A., Tunesi, R., Bettex, D., Paraincisional subcutaneous infusion of ropivacaine after open abdominal vascular surgery shows significant advantages (2014) Ann. Vasc. Surg., 28, pp. 637-644; 
Chellappan, S., Ezhilarasu, P., Gnanadurai, A., George, R., Christopher, S., Can symptom relief be provided in the home to palliative care cancer patients by the primary caregivers? An Indian study (2014) Cancer Nurs., 37, pp. E40-47; 
Chen, C., Huang, P., Liu-Chen, L.Y., Identiication and verification of proteins interacting with the kappa opioid receptor (KOPR) (2015) Methods Mol. Biol., 1230, pp. 129-140; 
Chen, C., Lu, M., Pan, Q., Fichna, J., Zheng, L., Wang, K., Yu, Z., Kreis, M., Berberine improves intestinal motility and visceral pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symproms in an opioid-receptor dependent manner (2015) PLoS One, 10, p. e0145556; 
Chen, C., Upward, J., Arumugham, T., Stier, B., Davy, M., Gabapentin enacarbil and morphine administered in combination versus alone: a double-blind, randomized, pharmacokinetic and tolerability comparison (2015) Clin. Ther., 37, pp. 349-357; 
Chen, J., Zhang, R., Chen, X., Wang, C., Cai, X., Liu, H., Jiang, Y., Bai, B., Heterodimerization of human orexin receptor 1 and kappa opioid receptor promotes protein kinase A/cAMP-response element binding protein signaling via a GalphaS-mediated mechanism (2015) Cell. Signal., 27, pp. 1426-1438; 
Chen, L., Wang, K., Yang, T., Wang, W., Mei, X.P., Zhu, C., Wang, W., Li, Y.Q., Downregulation of spinal endomorphin-2 correlates with mechanical allodynia in a rat model of tibia cancer (2015) Neuroscience, 286, pp. 151-161; 
Chen, L.H., Hedegaard, H., Warner, M., Drug-poisoning deaths involving opioid analgesics: United States, 1999–2011 (2014) NCHS Data Brief, 166, pp. 1-8; 
Chen, M., Zhang, X., Xu, H., Ma, X., Jiang, W., Xu, T., Inhibitory effect of spinal mGlu(5) receptor antisense oligoneucleotide on the up-regulated expression of spinal G protein associated with chronic morphine treatment (2014) Eur. J. Pharmacol., 723, pp. 253-258; 
Chen, M.K., Chau, S.W., Shen, Y.C., Sun, Y.N., Tseng, K.Y., Long, C.Y., Feng, Y.T., Cheng, K.I., Dose-dependent attenuation of intravenous nalbuphine on epidural morphine-induced pruritis and analgesia after cesarean delivery (2014) Kaosiung J. Med. Sci., 30, pp. 248-253; 
Chen, Q., Li, P., Li, P., Xu, Y., Li, Y., Tang, B., Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen-activating protein kinase sinalling pathway (2015) Oncol. Rep., 33, pp. 840-848; 
Chen, T., Li, J., Feng, B., Hui, R., Dong, Y.L., Huo, F.Q., Zhang, T., Li, Y.Q., Mechanism underlying the analgesic effect exerted by endomorphin-1 in the rat ventrolateral periaqueductal gray (2015) Mol. Neurobiol., 53, pp. 2036-2053; 
Chen, Y.B., Huang, F.S., Fen, B., Yin, J.B., Wang, W., Li, Y.Q., Inhibitory effects of endomorphin-2 on excitatory synaptic transmission and the neuronal excitability of sacral parasympathetic preganglionic neurons in young rats (2015) Front. Cell. Neurosci., 9, p. 206; 
Chen, Z., Tang, Y., Tao, H., Li, C., Zhang, X., Liu, Y., Dynorphin activation of kappa opioid receptor reduces neuronal excitability in the paraventrciular nucleus of mouse thalamus (2015) Neuropharmacology, 97, pp. 259-269; 
Cheong, M.C., Artyukhin, A.B., You, Y.J., Avery, L., An opioid-like system regulating feeding behavior in C. elegans (2015) Elife, 4, p. 06683; 
Cheppudira, B.P., Garza, T.H., Petz, L.N., Clifford, J.L., Fowler, M., Anti-hyperalgesic effects of AG490, a Janus kinase inhibitor, in a rat model of inflammatory pain (2015) Biomed. Rep., 3, pp. 703-706; 
Cherng, C.H., Lee, K.C., Chien, C.C., Chou, K.Y., Cheng, Y.C., Hsin, S.T., Lee, S.O., Wong, C.S., Baicalin ameliorates neuropathic pain by suppressing HDAC1 expression in the spinal cord of spinal nerve ligation rats (2014) J. Formos. Med. Assoc., 113, pp. 513-520; 
Chernov, A.S., Serievich, L.A., Kamaukhova, N.A., Analysis of the effect of beta-endorphin-like peptide pentarphin on intracellular Ca(2+) concentration in early mouse embryos using fluorescent probes (2015) Bull. Exp. Biol. Med., 159, pp. 459-462; 
Cherprenet, A.L., Rambourdin-Perraud, M., Laforet, S., Faure, M., Guesmi, N., Baud, C., Rosset, E., Duale, C., Local anaesthetic infiltration at the end of carotid endarecomy improves post-operative analgesia (2015) Acta Anaesthesiol. Scand., 59, pp. 107-114; 
Cheung, C.W., Qiu, Q., Ying, A.C., Choi, S.W., Law, W.L., Irwin, M.G., The effects of intra-operative dexemedetomidine on postoperative pain, side-effects and recovery in colorectal surgery (2014) Anaethesia, 69, pp. 1214-1221; 
Chiang, J.K., Kao, Y.H., Prediction of patient survival by change in daily opioid dosage in advanced cancer patients: a prospective hospital-based epidemiologic study (2014) Jpn. J. Clin. Oncol., 44, pp. 1189-1197; 
Chiang, Y.C., Ye, L.C., Hsu, K.Y., Liao, C.W., Hung, T.W., Lo, W.J., Ho, I.K., Tao, P.L., Beneficial effects of co-treatment with dextromethorphan on prenatally methadone-exposed offspring (2015) J. Biomed. Sci., 22, p. 19; 
Chidambaran, V., Mavi, J., Esslinger, H., Pilipenko, V., Martin, L.J., Zhang, K., Sadhasivam, S., Association of OPRM1 A118G with risk of morphine-induced respiratory depression following spine fusion in adolescents (2015) Pharmacogenomics J., 15, pp. 255-262; 
Chiono, J., Raux, O., Bringuier, S., Sola, C., Bigorre, M., Capdevila, X., Dadure, C., Bilateral suprazygomatic maxillary nerve block for cleft palate repair in children: a prospective, randomized, double-blind study versus placebo (2014) Anesthesiology, 120, pp. 1362-1369; 
Chisholm, M.F., Bang, H., Maalouf, D.B., Marcello, D., Lotano, M.A., Marx, R.G., Liguori, G.A., YaDeau, J.T., Postoperative analgesia with saphenous block appears equivalent to femoral nerve block in ACL reconstruction (2014) HSS J., 10, pp. 245-251; 
Chizhmakov, I., Kulyk, V., Khasabova, I., Khasabov, S., Simone, D., Bakalkin, G., Gordienko, D., Krishtal, O., Molecular mechanism for opioid dichotomy: bidirectional effect of mu-opioid receptors on P2X(3) receptor currents in rat sensory neurons (2015) Purinergic Signal., 11, pp. 171-181; 
Choi, J.W., Kang, S.Y., Choi, J.G., Kang, D.W., Kim, S.J., Lee, S.D., Park, J.B., Kim, H.W., Analgesic effect of acupuncture on paclitaxel-induced neuropathic pain via spinal opioidergic and adrenergic mechanisms in mice (2015) Am. J. Chin. Med., 43, pp. 57-70; 
Choi, S., Rampersaud, Y.R., Chan, V.W., Persaud, O., Koshkin, A., Tumber, B., Brull, R., The addition of epidural local anaesthetic to systemic multimodal analgesia following lumbar spinal fusion: a randomized controlled tiral (2014) Can. J. Anaeth., 61, pp. 330-339; 
Cholanian, M., Krajewski-Hall, S.J., McMullen, N.T., Rance, N.E., Chronic oestradiol reduces the spine sdensity of KNDy (kisspeptin/neurokinin B/dynorphin) neurons in the arcuate nucleus of ovariectomized Tac2-enhanced green fluorescent protein transgenic mice (2015) J. Neuroendocrinol., 27, pp. 253-263; 
Chrastil, J., Sampson, C., Jones, K., Higgins, T.F., Evaluating the affect and reversibility of opioid-induced androgen deficiency in an orthopedic animal fracture model (2014) Clin. Orthop. Relat. Res., 472, pp. 1964-1971; 
Chu, L.F., Lin, J.C., Clemenson, A., Encisco, E., Sun, J., Hoang, D., Alva, H., Younger, J.W., Acute opioid withdrawal is associated with increased neural activity in reward-processing centers in healthy men: a functional magnetic resonance imaging study (2015) Drug Alcohol Depend., 153, pp. 314-322; 
Chu Sin Chung, P., Keyworth, H.L., Martin-Garcia, E., Charbogne, P., Darcq, E., Bailey, A., Filliol, D., Kieffer, B.L., A novel anxiogenic role for the delta opioid receptor expressed in GABAergic forebrain neurons (2015) Biol. Psychiatry, 77, pp. 404-415; 
Chuganji, S., Nakano, J., Sekino, Y., Hamaue, Y., Sakamoto, J., Okita, M., Hyperalgesia in an immobilized rat hindlimb: effect of treadmill exercise using non-immobilized limbs (2015) Neurosci. Lett., 584, pp. 66-70; 
Chung, F., Liao, P., Elsaid, H., Shapiro, C.M., Kang, W., Factors associated with postoperative exacerbation of sleep-disordered breathing (2014) Anesthesiology, 120, pp. 299-311; 
Chung, K.C., Barlev, A., Braun, A.H., Qian, Y., Zagari, M., Assessing analgesic use in patients with advanced cancer: development of a new scale −the Analgesic Quantification Algorithm (2014) Pain Med., 15, pp. 225-232; 
Chung, P.C., Boehrer, A., Stephan, A., Matifas, A., Scherrer, G., Darcq, E., Befort, K., Kieffer, B.L., Delta opioid receptors expressed in forebrain GABAergic nerurons are responsible for SNC80-induced seizures (2015) Behav. Brain Res., 278, pp. 429-434; 
Chung, Y.C., Tsou, M.Y., Chen, H.H., Lin, J.G., Yeh, M.L., Integrative acupoint stimulation to alleviate postoperative pain and morphine-related side effects: a sham-contolled study (2014) Int. J. Nurs. Stud., 51, pp. 370-378; 
Chung, Y.C., Chien, H.C., Chen, H.H., Yeh, M.L., Acupoint stimulation to improve analgesia quality for lumbar spine surgical patients (2014) Pain Manag. Nurs., 15, pp. 738-747; 
Cieslinska, A., Sienkiewicz-Szlapka, E., Kostyra, E., Fiedorowicz, E., Snarska, J., Wronski, K., Tenderenda, M., Malysiewicz, M., Mu-opioid receptor gene OPRM1 polymorphism in patients with breast cancer (2015) Tumour Biol., 36, pp. 4655-4660; 
Cieslinska, A., Sienkiewicz-Szlapka, E., Wasilewska, J., Fiedorowicz, E., Chwala, B., Moszynska-Dumara, M., Cieslinski, T., Kostyra, E., Influence of candidate polymorphisms on the dipeptidyl peptidase IV and mu-opioid receptor genes expression in aspect of the beta-casomorphin-7 functions in autism (2015) Peptides, 65, pp. 6-11; 
Ciftci Demirci, A., Gunes, H., Adaletti, H., Bulanik, E., Erdogan, A., Liver enzyme levels in adolescent patients treated with buprenorphine and additional psychotropic agents (2015) Am. J. Drug Alcohol Abuse, 41, pp. 107-113; 
Cillo, J.E., Jr., Dattilo, D.J., Pre-emptive analgesia with pregabalin and celecoxib decreases postsurgical pain following maxillomandibular advancement surgery: a randomized controlled clinical trial (2014) J. Oral Maxillofac. Surg., 72, pp. 1909-1914; 
Cioffi, U., Raveglia, F., Rizzi, A., Di Mauro, P., De Simone, M., Baisi, A., Paravertebral analgesia in video-assisted thoracic surgery: a new hybrid technique of catheter placement for continuous anaesthetic infusion (2015) Thorac. Cardiovasc. Surg., 63, pp. 533-534; 
Ciubotariu, D., Ghiciuc, C.M., Lupusoru, C.M., Lupusoru, C.E., Zinc involvement in opioid addiction and analgesia −should zinc supplementation be recommended for opioid-treated persons? (2015) Subst. Abuse Treat. Prev. Policy, 10, p. 29; 
Ciubotariu, D., Nechifor, M., Sertraline influence on morphine-induced conditioned place preference in rats (2014) Rev. Med. Chir. Soc. Med. Nat. Iasi, 118, pp. 712-716; 
Clarke, H.A., Katz, J., McCartney, C.J., Stratford, P., Kennedy, D., Page, M.G., Awad, I.T., Kay, J., Perioperative gabapentin reduces 24 h opioid consumption and improves in-hospital rehabilitation but not post-discharge outcomes after total knee arthroplasty with peripheral nerve block (2014) Br. J. Anaesth., 113, pp. 855-864; 
Cong, X., Compomanes, P., Kless, A., Schapitz, J., Wagener, M., Koch, T., Carloni, P., Structural determinants for the binding of morphinan agonists to the mu-opioid receptor (2015) PLoS One, 10, p. e0135998; 
Connor, M., Bagley, E.E., Chieng, B.C., Christie, M.J., Beta-arresin-2 knockout prevents development of cellular mu-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons (2015) Br. J. Pharmacol., 172, pp. 492-500; 
Convertino, M., Samoshkin, A., Viet, C.T., Gauthier, J., Li Fraine, S.P., Sharif-Naeini, R., Schmidt, B.L., Dokholyen, N.V., Differential regulation of 6- and 7-transmembrane helix variants of mu-opioid receptor in response to morphine stimulation (2015) PLoS One, 10, p. e0142826; 
Cook-Sather, S.D., Li, J., Goebel, T.K., Sussman, E.M., Rehman, M.A., Hakonarson, H., TAOK3, a novel genome-wide association study locus associated with morphine requirement and postoperative pain in a retrospective pediatric day surgery population (2014) Pain, 155, pp. 1773-1783; 
Cooke, A.E., Oldfield, S., Krasel, C., Mundell, S.J., Henderson, G., Kelly, E., Morphine-induced internalization of the L83I mutant of the rat mu-opioid receptor (2015) Br. J. Pharmacol., 172, pp. 593-605; 
Cooper, S.E., Wood, R.I., Androgens and opiates: testosterone interaction with morphine self-administration in male rats (2014) Neuroreport, 25, pp. 521-526; 
Cordes, M.A., Stevenson, S.A., Driessen, T.M., Eisinger, B.E., Riters, L.V., Sexually-motivated song is predicted by androgen- and opioid-related gene expression in the medial preoptic nucleus of male European starlings (Sturnus vulgaris) (2015) Behav. Brain Res., 278, pp. 12-20; 
Corrado, S., Battisti, U.M., Sorbi, C., Tait, A., Malfacini, D., Camarda, V., Calo, G., Brasili, L., Synthesis and structure-activity relationships of triazaspirodecanone derivatives as nociception/orphanin FQ receptor ligands (2015) Chem. Biol. Drug Des., 86, pp. 447-458; 
Corrigan, F., Wu, Y., Tuke, J., Coller, J.K., Rice, K.C., Diener, K.R., Hayball, J.D., Hutchinson, M.R., Alcohol-induced sedation and synergistic interactions between alcohol and morphine: a key mechanistic role for Toll-like receptors and MyD88-dependent signaling (2015) Brain Behav. Immun., 45, pp. 245-252; 
Coulthard, P., Patel, N., Bailey, E., Armstrong, D., Barriers to the use of morphine for the management of severe postoperative pain −a before and after study (2014) Int. J. Surg., 12, pp. 150-155; 
Cozzi, N.V., Daley, P.F., Receptor binding profiles and quantitative structure-affinity releationships of some 5-substituted-N,N-diallyltryptamines (2015) Bioorg. Med. Chem. Lett., 26, pp. 959-964; 
Crits-Christoph, P., Lundy, C., Stringer, M., Gallop, R., Gastfriend, D.R., Extended-release naltrexone for alcohol and opioid problems in Missouri parolees and probationers (2015) J. Subst. Abuse Treat., 56, pp. 54-60; 
Cruz, W.S., Pereira, L.A., Cezar, L.C., Camarini, R., Felicio, L.F., Bernardi, M.M., Teodorov, E., Role of steroid hormones and morphine treatment in the modulation of opioid receptor gene expression in brain structures in the female rat (2015) Springerplus, 4, p. 355; 
Cueva, J.P., Roche, C., Ostovar, M., Kumar, V., Clark, M.J., Hillhouse, T.M., Lewis, J.W., Husbands, S.M., C7beta-methyl analogues of the orvinols: the discovery of kappa opioid antagonists with nociception/orphanin FQ peptide (NOP) receptor partial agonism and low or even zero efficacy at mu-opioid receptors (2015) J. Med. Chem., 58, pp. 4242-4249; 
Currow, D.C., Quinn, S., Ekstrom, M., Kaasa, S., Johnson, M.J., Somogyi, A.A., Klepstad, P., Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors? (2015) BMJ Open, 5, p. e006818; 
D'Onofrio, G., O'Connor, P.G., Pantalon, M.V., Chawarski, M.C., Busch, S.H., Owens, P.H., Bernstein, S.L., Fiellin, D.A., Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial (2015) JAMA, 313, pp. 1636-1644; 
Dahlem, C.H., Horstman, M.J., Williams, B.C., Development and implementation of intranasal naloxone opioid overdose response priotocol at a homeless health clinic (2015) J. Am. Assoc. Nurse Pract., 28, pp. 11-18; 
Daitch, D., Daitch, J., Novinson, D., Frey, M., Mitnick, C., Pergolizzi, J., Jr., Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients (2014) Pain Med., 15, pp. 2087-2094; 
Dakwar, E., Kleber, H.D., Naltrexone-facilitated buprenorphine discontinuation: a feasibility trial (2015) J. Subst. Abuse Treat., 53, pp. 60-63; 
Daniulaityte, R., Carlson, R., Brigham, G., Cameron, D., Sheth, A., Sub is a weird drug: a web-based study of lay attitudes about use of buprenorphine to self-treat opioid withdrawal symptoms (2015) Am. J. Addict., 24, pp. 403-409; 
Darvas, M., Palmiter, R.D., Specific contributions of N-methyl-D-aspartate receptors in the dorsal stritum to cognitive flexibility (2015) Neuroscience, 284, pp. 934-942; 
Darwish, M., Bond, M., Tracewell, W., Robertson, P., Jr., Yang, R., Pharmacokinetics of hydrocodone extended-release tablets formulation with different levels of coating to achieve abuse deterrence compared with a hydrocodone immediate-release/acetaminophen tablet in healthy volunteers (2015) Clin. Drug Invest., 35, pp. 13-22; 
Darwish, M., Yang, R., Tracewell, W., Robertson, P., Jr., Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrte extended-release tablet formulated with achieve abuse deterrence technology in healthy naltrexone-blocked volunteers (2015) Clin. Ther., 37, pp. 390-401; 
David, H.N., Dhilly, M., Degoulet, M., Poisnel, G., Meckler, C., Vallee, N., Blatteau, J.E., Abraini, J.H., Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens (2015) Transl. Psychiatry, 5, p. e594; 
Davis, C.S., Carr, D., Legal changes to increase access to naloxone for opioid overdose reversal in the United States (2015) Drug Alcohol Depend., 157, pp. 112-120; 
Davis, C.S., Carr, D., Southwell, J.K., Beletsky, L., Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration (2015) Am. J. Public Health, 105, pp. 1530-1537; 
Davis, R.L., Das, S., Thomas Curtis, J., Stevens, C.W., The opioid antagonist, beta-funaltrexamine, inhibits NF-kappaB signaling and chemokine expression in human astrocytes and in mice (2015) Eur. J. Pharmacol., 762, pp. 193-201; 
Day, M.A., Rich, M.A., Thorn, B.E., Berbaum, M.L., Mangieri, E.A., A placebo-controlled trial of midazolam as an adjunct to morphine patient-controlled analgesia after spinal surgery (2014) J. Clin. Anesth., 26, pp. 300-308; 
de Graaf, J., van den Akker, E.L., van Lingen, R.A., Groot Jebbink, L.J., de Jong, F.H., Grunau, R.E., van Dijk, M., Tibboel, D., Five-year follow-up of effects of neonatal intensive care and morphine infusion during mechanical ventilation on diurnal cortisol rhythm (2014) J. Pediatr., 165, pp. 459-463; 
De Gregori, S., Minella, C.E., De Gregori, M., Tinelli, C., Ranzani, G.N., Govoni, S., Allegri, M., Regazzi, M., Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain (2014) Ther. Drug Monit., 36, pp. 335-344; 
De Guglielmo, G., Kallupi, M., Scuppa, G., Stopponi, S., Demopulos, G., Gaitanaris, G., Ciccocioppo, R., Analgesic tolerance to morphine is regulated by PPARgamma (2014) Br. J. Pharmacol., 171, pp. 5407-5416; 
De Gugliemo, G., Martin-Fardon, R., Tashima, K., Ciccocioppo, R., Weiss, F., MT-7716, a potent NOP receptor agonist, preferentially reduces ethanol seeking and reinforecement in post-dependent rats (2015) Addict. Biol., 20, pp. 643-651; 
De Guglielmo, G.K., Giordano, A., Senzacqua, M., Melis, M., De Luca, M.A., Li, H.W., Niswender, K., Ciccocioppo, R., PPARgamma activation attenuates opioid consumption and modulates mesolimbic dopamine transmission (2015) Neuropsychopharmacology, 40, pp. 927-937; 
De Lima, L., Pastrana, T., Radbruch, L., Wenk, R., Cross-sectional pilot study to monitor the availability, dispensed prices and affordability of opioids around the globe (2014) J. Pain Symptom Manage., 48, pp. 649-659; 
de Melo Leite, A.C., Teotonio, M.A., Girao, V.C., de Lima Pompeau, M.M., de Melo Nunes, R., Cunha, T.M., Pinto, A.C., Rocha, F.A., Meniscal transection rather than excision increases pain behavior and structural damage in experimental osteoarthritis in mice (2014) Osteoarthr. Cartil., 22, pp. 1878-1885; 
de Melo Nunes, R., Martins, M.R., da Silva Junior, F.S., de Melo Leite, A.C., Girao, V.C., de Queiroz Cunha, F., Marinho, A.L., Rocha, F.A., Strontium ranelate analgesia in arthritis models is associated to decreased cytokine release and opioid-dependent mechanisms (2015) Inflamm. Res., 64, pp. 781-787; 
de Oliveira, A.M., de Arraujo, A.F., Lyra lemonsa, R.P., Conserva, L.M., de Souza Ferro, J.N., Barreto, E., Antinociceptive and anti-inflammatory activity of the siaresinolic acid, a tripene isolated from the leaves of Sabicea grisea Cham. And Schitdl. Var. grisea (2015) J. Nat. Med., 69, pp. 232-240; 
De Oliveira, G.S., Jr., Castro-Alves, L.J., Nader, A., Kendall, M.C., McCarthy, R.J., Transversus abdomninis plane block to ameliorate postoperative pain outcomes after laparocopic surgey: a meta-analysis of randomized controlled trials (2014) Anesth. Analg., 118, pp. 454-463; 
De Oliveira, G.S., Jr., Duncan, K., Fitzgerald, P., Nader, A., Gould, R.W., McCarthy, R.J., Systemic lidocaine to improve quality of recovery after laparoscopic bariatric surgery: a randomized double-blinded placebo-controlled trial (2014) Obes. Surg., 24, pp. 212-218; 
De Oliveira, G.S., Jr., Castro-Alves, L.J., Nader, A., Kendall, M.C., Rahangdale, R., McCarthy, R.J., Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta-analysis of randomized controlled trials (2014) Pain Res. Treat., 2014, p. 179029; 
de Santana, M.F., Guimaraes, A.G., Chaves, D.O., Silva, J.C., Bonjardim, L.R., de Lucca Junior, W., Ferro, J.N., Quintans-Junior, L.J., The anti-hyperalgesic and anti-inflammatory profiles of p-cymene: evidence for involvement of opioid system and cytokines (2015) Pharm. Biol., 53, pp. 1583-1590; 
Declue, A.E., Yu, D.H., Prochnow, S., Axiak-Bechtel, S., Amorim, J., Tsuruta, K., Donaldson, R., Dodam, J., Effects of opioids on phagocytic function, oxidative burst capacity, cytokine production and apoptosis in canine leukocytes (2014) Vet. J., 200, pp. 270-275; 
Deekonda, S., Rankin, D., Davis, P., Lai, J., Kulkarni, V., Porreca, F., Hruby, V.J., Design, synthesis and biological evaluation of multifunctional ligands targeting opioid and bradykinin 2 receptors (2015) Bioorg. Med. Chem. Lett., 25, pp. 4148-4152; 
Deekonda, S., Wugalter, L., Kulkarni, V., Rankin, D., Largent-Milnes, T.M., Davis, P., Bassirirad, N.M., Hruby, V.J., Discovery of 5-substituted tetrahydronaphthalen-2yl—methyl with N-phenyl-N-(piperidin-4-yl)propionamide derivatives as potent opioid receptor ligands (2015) Bioorg. Med. Chem., 23, pp. 6185-6194; 
Deekonda, S., Wugalter, L., Rankin, D., Largent-Milnes, T.M., Davis, P., Wang, Y., Bassirirad, N.M., Hruby, V.J., Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anillidopiperidine derivatives (2015) Bioorg. Med. Chem. Lett., 25, pp. 4683-4688; 
Delfino, A.E., de la Fuente, N., Echevarria, G.C., Altermatt, F.R., Cortinez, L.I., Effect of acute arterial hypertension on morphine requirements and postsurgical pain (2015) J. Clin. Anesth., 27, pp. 226-232; 
Deng, X.D., Jiang, H., Ma, Y., Gao, Q., Zhang, B., Mu, B., Zhang, L.X., Liu, Y., Association between DRD2/ANKK1 TaqlA polymorphisms and common illicit drug dependence: evidence from a meta-analysis (2015) Hum. Immunol., 78, pp. 43-51; 
Deng, Y.K., Ding, J.F., Liu, J., Yang, Y.Y., Analgesic effects of melatonin on post-herpetic neuralgia (2015) Int. J. Clin. Exp. Med., 8, pp. 5004-5009; 
Denier, N., Schmidt, A., Gerber, H., Vogel, M., Huber, C.G., Lang, U.E., Riecher-Rossier, A., Borgwardt, S., Abnormal functional integration of thalamic low frequency oscillation in the BOLD signal after acute heroin treatment (2015) Hum. Brain Mapp., 36, pp. 5287-5300; 
Deuis, J.R., Whately, E., Brust, A., Inserra, M.C., Asvadi, N.H., Lewis, R.J., Alewood, P.F., Vetter, I., Activation of kappa opioid receptors in cutaneous nerve endings by conorphin-1, a novel subtype-selective conopeptide, does not mediate peripheral analgesia (2015) ACS Chem. Neurosci., 6, pp. 1751-1758; 
DeVido, J., Connery, H., Hill, K.P., Sleep-disordered breathing in patients with opioid use disorders in long-term maintenance on buprenorphine-naloxone: a case series (2015) J. Opioid Manag., 11, pp. 363-368; 
Dewinter, G., Van de Velde, M., Fieuws, S., D'Hoore, A., Rex, S., Transversus abdominus plane block versus perioperative intravenous lidocaine versus patient controlled intravenous morphine for postoperative pain control after laparoscopic colorectal surgery: study protocol for a prospective, randomized, double-blind controlled clinical trial (2014) Trials, 15, p. 476; 
Di Filippo, A., Magherini, M., Ruggiano, P., Ciardullo, A., Falsini, S., Postoperative analgesia in patients older than 75 years undergoing intervention for per-trochanteric hip fracture: a single centre retrospective cohort study (2015) Aging Clin. Exp. Res., 27, pp. 281-285; 
Di Matio, K.M., hen, C., Shi, L., Liu-Chen, L.Y., K303-6-5-8 in the mu opioid (MOR) receptor is important in conferring selectivity for covalent binding of beta-funaltrexamine (B-FNA) (2015) Eur. J. Pharmacol., 748, pp. 93-100; 
Di Matio, K.M., Ehlert, F.J., Liu-Chen, L.Y., Intrinsic relative activities of kappa opioid agonists in activating Galpha proteins and internalizing receptor: differences between human and mouse receptors (2015) Eur. J. Pharmacol., 761, pp. 235-244; 
Di Pede, A., Morini, F., Lombardi, M.H., Sgro, S., Laviani, R., Dotta, A., Picardo, S.G., Comparison of regional vs: systemic analgesia for post-thoracotomy care in infants (2014) Paediatr. Anaesth., 24, pp. 569-573; 
Diakomi, M., Papaioannou, M., Mela, A., Kouskouni, E., Makris, A., Preoperative fascia iliaca compartment block for positioning patients with hip fractures for central nervous blockade: a randomized tiral (2014) Reg. Anesth. Pain Med., 39, pp. 394-398; 
Diaz, D., Dambach, D., Siu, M., Hunt, K., Thomas, A., Lyssikatos, J., Liu, X., Ford, K., Mitigation of opioid off-target effects and identification of structural drivers of opioid receptor engagement for BACE-1 small molecule inhibitors (2015) Toxicol. Mech. Meth., 25, pp. 478-486; 
Digusto, M., Bhalla, T., Martin, D., Foerschler, D., Jones, M.J., Tobias, J.D., Patient-controlled analgesia in the pediatric population: morphine versus hydromorphone (2014) J. Pain Res., 7, pp. 471-475; 
Dilokthornsakul, P., Moore, G., Campbell, J.D., Lodge, R., Traugott, C., Zerzan, J., Allen, R., Page, R.L., 2nd, Risk factors of prescription opioid overdose among Colorado Medicaid beneficiaries (2015) J. Pain, 17, pp. 436-443; 
Ding, H., Hayashida, K., Suto, T., Sukhtankar, D.D., Kimura, M., Mendenhall, V., Ko, M.C., Supraspinal actions of nociception/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates (2015) Br. J. Pharmacol., 172, pp. 3302-3312; 
Ding, K., Jin, S., Niu, X., Wang, T., Zhao, X., Ren, H., Tong, Y., Li, Q., Morphine with adjuvant ketamine versus higher dose of morphine alone for acute pain: a meta-analysis (2014) Int. J. Clin. Exp. Med., 7, pp. 2504-2510; 
Djerada, Z., Fournet-Fayard, A., Gozalo, C., Lelarge, C., Lamiable, D., Millart, H., Malinovsky, J.M., Population pharmacokinetics on nefopam in elderly, with or without renal impairment, and its link to treatment response (2014) Br. J. Clin. Pharmacol., 77, pp. 1027-1038; 
Dodou, K., Armstrong, A., Kelly, I., Wilkenson, S., Carr, K., Shattock, P., Whiteley, P., Ex vivo studies for the transdermal delivery of low-dose naltrexone from a cream; detection of naltrexone and its active metabolite, 6beta-naltrexol, using a novel LC Q-ToF MS assay (2015) Pharm. Dev. Technol., 20, pp. 694-701; 
Dogra, S., Yadav, P.N., Biased agonism at kappa opioid receptors: implication in pain and mood disorders (2015) Eur. J. Pharmacol., 763, pp. 184-190; 
Dold, A.P., Murnaghan, L., Xing, J., Abdallah, F.W., Brull, R., Whelan, D.B., Preoperative femoral nerve block in hip arthroscopic surgery: a retrospective review of 108 consecutive cases (2014) Am. J. Sports Med., 42, pp. 144-149; 
Domb, B.G., Gupta, A., Hammarstedt, J.E., Stake, C.E., Sharp, K., Redmond, J.M., The effect of liposomal bupivacaine injection during total hip arthroplasty: a controlled cohort study (2014) BMC Musculoskelet Disord., 15, p. 310; 
Domino, E.F., Hirasawa-Fujita, M., Ni, L., Guthrie, S.K., Zubieta, J.K., Regional brain [(11)C]carfentanil binding following tobacco smoking (2015) Prog. Neuropsychopharmacol. Biol. Psychiatr., 59, pp. 100-104; 
Donahue, R.J., Landino, S.M., Golden, S.A., Carroll, F.J., Russo, S.J., Carlezon, W.A., Jr., Effects of acute and chronic social defeat stress are differentially mediated by the dynorphin/kappa opioid receptor system (2015) Behav. Pharmacol., 28, pp. 654-663; 
Donato, F., Pavin, N.F., Goes, A.T., Souza, L.C., Soares, L.C., Rodrigues, O.E., Jesse, C.R., Savegnago, L., Antinociceptive and anti-hyperalgesic effects of bis(4-methylbenzoyl) diselenide in mice: evidence for the mechanism of action (2016) Pharm. Biol. 2-015, 53, pp. 395-403; 
Donica, C.L., Cui, Y., Shi, S., Gutstein, H.B., Platelet-derived growth factor-beta antagonism restores morphine analgesic potency against neuropathic pain (2014) PLoS One, 9, p. e97105; 
Donnerer, J., Liebmann, I., pERJ1/2 immunofluorescence in rat dorsal horn and paraventricular nucleus neurons as a marker for sensitization and inhibition in the pain pathway (2015) Tissue Cell, 47, pp. 55-60; 
Dostbil, A., Celik, M., Alici, H.A., Erdem, A.F., Aksoy, M., Ahiskalioglu, A., Maternal and neonatal effects of adding morphine to low-dose bupivacaine for epidural labour analgesia (2014) Niger. J. Clin. Pract., 17, pp. 205-211; 
Dostbil, A., Gursac Celik, M., Aksoy, M., Ahiskalioglu, A., Celik, E.C., Alici, H.A., Ozbey, I., The effects of different doses of caudal morphine with levobupivacaine on postoperative vomiting and quality of analgesia after circumcision (2014) Anaesth. Intensive Care, 42, pp. 234-238; 
Doyle, G.A., Schwebel, C.L., Ruiz, S.E., Chou, A.D., Lai, A.T., Wang, M.J., Smith, G.G., Ferraro, T.N., Analysis of candidate genes for morphine preference quantitative trait locus Mop2 (2014) Neuroscience, 277, pp. 403-416; 
Due, M.R., Yang, X.F., Allette, Y.M., Randolph, A.L., Ripsch, M.S., Wilson, S.M., Dustrude, E.T., White, F.A., Carbamazepine potentiates the effectiveness of morphine in a rodent model of neuropathic pain (2014) PLoS One, 9, p. e107399; 
Dunn, K., DeFulio, A., Everly, J.J., Donlin, W.D., Aklin, W.M., Nuzzo, P.A., Leoutsakos, J.M., Silvarman, K., Employment-based reinforcement of adherence to oral naltrexone in unemployed injection drug users: 12-month outcomes (2015) Psychol. Addict. Behav., 29, pp. 270-276; 
Duthey, B., Scolten, W., Adequacy of opioid analgesic consumption at country, global and regional levels in 2010, its relationship with developmental level, and changes compared with 2006 (2014) J. Pain Symptom Manage., 47, pp. 283-297; 
Dutta, R., Roy, S., Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine streptococcus pneumoniae infection model (2015) J. Neuroinflamm., 12, p. 120; 
Dwyer, K., Walley, A.Y., Langlois, B.K., Mitchell, P.M., Nelson, K.P., Cromwell, J., Bernstein, E., Opioid education and nasal naloxone rescue kits in the emergency department (2015) West J. Emerg. Med., 16, pp. 381-384; 
Dzierienga, A.L., Clarke, J.D., Hargraves, T.L., Ainslie, G.R., Vanderah, T.W., Paine, M.F., Cherrington, N.J., Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis (2015) J. Pharmacol. Exp. Ther., 352, pp. 462-470; 
Eans, S.O., Ganno, M.L., Mizachi, E., Houghten, R.A., Dooley, C.T., McLaughlin, J.P., Netzi, A., Parallel synthesis of hexahydrodiimidazodiazepines heterocyclic peptidomimetics and their in vitro and in vivo activities at mu (MOR), delta (DOR) and kappa (KOR) opioid receptors (2015) J. Med. Chem., 58, pp. 4905-4917; 
Ebrahimi, L., Saboory, E., Roshan-Milani, S., Hashemi, P., Effect of prenatal forced swim stress and morphine co-administration on pentylentetrazol-induced epileptic behaviors in infant and prepubertal rats (2012) Dev. Psychobiol., 56, pp. 1179-11880; 
Ebrahimzadeh, M.H., Mousavi, S.K., Ashraf, H., Abubakri, R., Birjandinejad, A., Transdermal fentanyl patches versus patient-controlled intravenous morphine analgesia for postoperative pain management (2014) Iran. Red Crescent Med. J., 18, p. e11502; 
Eddib, A., Danakas, A., Hughes, S., Erk, M., Michalik, C., Narayanan, M.S., Krovi, V., Singhal, P., Inflouence of morbid obesity on surgical outcomes in robotic-assisted gynecologic surgery (2014) J. Gynecol. Surg., 30, pp. 81-88. , (4.6); 
Edlund, M.J., Austen, M.A., Sullivan, M.D., Martin, B.C., Williams, J.S., Fortney, J.C., Hudson, T.J., Patterns of opioid use for chronic noncancer pain in the Veterans Health Administration from 2009 to 2011 (2014) Pain, 155, pp. 2337-2343; 
Edwards, E.T., Edwards, E.S., Davis, E., Mulcare, M., Wiklund, M., Kelley, G., Comparative usability study of a novel auto-injector and an intranasal system of naloxone delivery (2015) Pain Ther., 4, pp. 89-105; 
Eftekhar-Vaghefi, S., Esmaeli-Mahani, S., Elyasi, L., Abbasnejad, M., Involvement of mu opioid receptor signaling in the protective effect of opioid against 6-hydroxydopamine-induced SH-SY5Y human neuroblastoma cells apoptosis (2015) Basic Clin. Neurosci., 6, pp. 171-178; 
Eghlidi, D.H., Urbanski, H.F., Effects of age and estradiol on gene expression in the rhesus macaque hypothalamus (2015) Neuroendocrinology, 101, pp. 236-245; 
Ehrich, E., Turncliff, R., Du, Y., Leigh-Pemberton, R., Fernandez, E., Jones, R., Fava, M., Evaluation of opioid modulation in major depressive disorder (2015) Neuropsychopharmacology, 40, pp. 1448-1455; 
Ehrich, J.M., Messinger, D.I., Knakel, C.R., Kuhar, J.R., Schattauer, S.S., Bruchas, M.R., Zweifel, L.S., Chavkin, C., Kappa-opioid receptor-induced aversion requires MAPK activation in VTA dopamine neurons (2015) J. Neurosci., 35, pp. 12917-12931; 
Eidi, A., Oryan, S., Zaringhalam, J., Rad, M., Antinociceptive and anti-inflammatory effects of the aerial parts of Artamisia dracunulus in mice (2015) Pharm. Biol., 54, pp. 549-554; 
Eizidi-Mood, N., Yaraghi, A., Sharifian, Z., Feizi, A., Hedaity, M., Sabzghabaee, A.M., Clinical presentation and outcome of therapy in a cohort of patients with methadone toxicity in Iran (2015) Mater. Sociomed., 27, pp. 276-279; 
Eken, C., Serinken, M., Elicabuk, H., Uyanik, E., Erdal, M., Intravenous paracetamol versus dexketoprofen versus morphine in acute mechanical back pain in the emergency department: a randomized double-blind controlled trial (2014) Emerg. Med. J., 31, pp. 177-181; 
Eldon, M.A., Kugler, A.R., Medve, R.A., Bui, K., Butler, K., Sostek, M., Safety, tolerability and pharmacokinetics of multiple ascending doses of naloxogel (2015) Clin. Pharmacol. Drug Dev., 4, pp. 442-448; 
Ekstrom, M.P., Bornefalk-Hermansson, A., Abernathy, A.P., Currow, D.C., Safety of benzodiazepines and opioids in very severe respiratory disease: national perspective study (2014) BMJ, 348, p. g445; 
El Shamaa, H.A., Ibrahim, M., A comparative study of the effect of caudal dexmedetomidine versus morphine added to bupivacaine in pediatric infra-umbilical surgery (2014) Saudi J. Anaesth., 8, pp. 155-160; 
El-Hage, N., Rodriguez, M., Podhaizer, E.M., Zou, S., Dever, S.M., Snider, S.E., Knapp, P.E., Hauser, K.F., Ibudilast (AV411) and its AV103 analog reduce HIV-1 replication and neuronal death induced by HIV-1 and morphine (2014) AIDS, 28, pp. 1409-1419; 
El-Hage, N., Rodriguez, M., Dever, S.M., Masvekar, R.R., Gerwitz, D.A., Shacka, J.J., HIV-1 and morphine regulation of autophagy in microglia: limited interactions in the context of HIV-1 infection and opioid abuse (2015) J. Virol., 89, pp. 1024-1035; 
Eldon, M.A., Kugler, A.R., Medve, R.A., Bui, K., Butler, K., Sostek, M., Safety, tolerability, pharmacokinetics and pharmacodynamics effects of naloxegol at peripheral and central nervous system receptors in healthy male subjects: a single ascending-dose study (2015) Clin. Pharmacol. Drug Dev., 4, pp. 434-441; 
Elhabazi, K., Ayachi, S., Ilien, B., Simonin, F., Assessment of morphine-induced hyperalgesia and analgesic tolerance in mice using thermal and mechanical nociceptive modalities (2014) J. Vis. Exp., 29, p. e51264; 
Elyasi, L., Eftekhar-Vaghefi, S.H., Esmaeli-Mahani, S., Morphine protects SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cell damage: involvement of anti-oxidant, calcium blocking and anti-apoptotic properties (2014) Rejuvenation Res., 17, pp. 255-263; 
Emery, M.A., Bates, M.L., Wellman, P.J., Eitan, S., Differential effects of oxycodone, hydrocodone and morphine on the responses of D2/D3 dopamine receptors (2015) Behav. Brain Res., 284, pp. 37-41; 
Engel, J.A., Nylander, I., Jerlhag, E., A ghrelin receptor (GHS-R1A) antagonist attenuates the rewarding properties of morphine and increases opioid peptide levels in reward areas in mice (2015) Eur. Neuropsychopharmacol., 25, pp. 2364-2371; 
Eppolito, A.K., Kodeih, H.R., Gerak, L.R., Using drug combinations to assess potential contributions of non-GABAA receptors in the discriminative stimulus effects of the neuroactive steroid pregnanolone in rats (2014) Physiol. Behav., 137, pp. 33-41; 
Erbs, E., Faget, L., Scherrer, G., Matifas, A., Filliol, D., Vonesch, J.L., Koch, M., Massotte, D., A mu-delta opioid receptor atlas reveals neuronal co-occurrence in subcortical networks (2015) Brain Struct. Funct., 220, pp. 677-702; 
Erfanparast, A., Tamaddonfard, E., Taati, M., Dabbaghi, M., Effects of crocin and safranal, saffron constituents, on the formalin-induced orofacial pain in rats (2015) Avicenna J. Phytomed., 5, pp. 392-402; 
Erfanparast, A., Tamaddonfard, E., Taati, M., Dabbaghi, M., Role of thalamic submedius nucleus histamine H1 and H2 and opioid receptors in modulation of formalin-induced orofacial pain in rats (2015) Naunyn Schmeidebergs Arch. Pharmacol., 388, pp. 1089-1096; 
Eriksson, O., Antoni, G., [11C]carfentanil binds preferentially to mu-opioid receptor subtype 1 compared to subtype 2 (2015) Mol. Imaging, 14, pp. 476-483; 
Ertas, I.E., Sehirali, S., Ozsezgin Ocek, S., Sanci, M., Arbak, G., Yildirim, Y., The effectiveness of subcutaneously implanted epidural ports for relief of severe pain in patients with advanced-stage gynecological cancer: a prospective study (2014) Agri, 26, pp. 8-14; 
Ertin, I.H., Gunduz, O., Ulugol, A., Contribution of nociception/orphanin FQ receptors to the anti-nociceptive and hypothermic effects of dipyrone (2015) Acta Neuropsychiatry, 27, pp. 48-52; 
Fabio, M.C., Macchione, A.F., Nizhnikov, M.E., Pautassi, R.M., Prenatal ethanol increases ethanol intake throughout adolescence, alters ethanol-mediated aversive learning, and affects mu, but not delta or kappa opioid receptor mRNA expression (2015) Eur. J. Neurosci., 41, pp. 1569-1579; 
Fadaei, A., Gorji, H.M., Hosseinei, S.M., Swimming reduces the severity of physical and psychological dependence and voluntary morphine consumption in morphine dependent rats (2015) Eur. J. Pharmacol., 747, pp. 88-95; 
Fahy, A.S., Jakub, J.W., Dy, B.M., Eldin, N.S., Harmsen, S., Sviggum, H., Boughey, J.C., Paravertebral blocks in patients undergoing mastectomy with or without immediate reconstruction provides improved pain control and decreased postoperative nausea and vomiting (2014) Ann. Surg. Oncol., 21, pp. 3284-3289; 
Falcon, E., Maier, K., Robinson, S.A., Hill-Smith, T.E., Lucki, I., Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice (2015) Psychpharmacology (Berl)., 232, pp. 907-915; 
Falk, S., Patel, R., Heegaard, A., Mercadante, S., Dickenson, A.H., Spinal neuronal correlates of tapentadol analgesia in cancer pain: a back-translational approach (2015) Eur. J. Pain, 19, pp. 152-158; 
Fan, H., Gong, N., Ma, A.N., Wu, X.Y., Wang, M.W., Wang, Y.X., The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating beta-endorphin release from spinal microglia (2015) Br. J. Pharmacol., 172, pp. 64-79; 
Fanelli, A., Ghisi, D., Pergolotti, B., Martinotti, M., Fanelli, G., Danelli, G., Pilot double-blinded study to assess efficacy and tolerability of morphine sulfate oral solution (Oramorph) given preoperatively as add-on therapy within a multimodal postoperative pain approach in patients undergoing laparoscopic cholecystectomy (2014) Minerva Anesthesiol., 80, pp. 66-75; 
Farag, E., Guirguis, M.N., Helou, M., Dalton, J.E., Ngo, F., Ghobrial, M., O'Hara, J., Goldfarb, D., Continuous transversus abdominis plane block catheter analgesia for postoperative pain control in renal transplant (2015) J. Anesth., 29, pp. 4-8; 
Farahmand, S., Shiralizadeh, S., Talebian, M.T., Bagheri-Hariri, S., Arbab, M., Basirghafouri, H., Saeedi, M., Mirzababai, H., Nebulized fentanyl vs intravenous morphine for ED patients with acute limb pain: a randomized clinical trial (2014) Am. J. Emerg. Med., 32, pp. 1011-1015; 
Fares, K.M., Mohamed, S.A., Abdel-Ghaffar, H.S., High dose intrathecal morphine for major abdominal cancer surgery: a prospective double-blind, dose-finding clinical study (2014) Pain Physcian, 17, pp. 255-264; 
Fares, K.M., Mohamed, S.A., Hamza, H.M., Sayed, D.M., Hetta, D.F., Effect of thoracic epidural analgesia on pro-inflammatory cytokines in patients subjected to protective lung ventilation during Ivor Lewis esophagectomy (2014) Pain Physician, 17, pp. 305-315; 
Faroudian, A., Sadeghi, M., Khoddami Vishteh, H.R., Moazen, B., Fekri, M., Rahimi Movaghar, A., Component analysis of Iranian crack: a newly abused narcotic substance in Iran (2014) Iran. J. Pharm. Res., 13, pp. 337-344; 
Farrag, M., Laufenberg, L.J., Steiner, J.L., Weller, G.E., Lang, C.H., Ruiz-Velasco, V., Modulation of voltage-gated Ca2+ channels by G protein-coupled receptors in celiac-mesenteric ganglion neurons of septic rats (2015) PLoS One, 10, p. e0125568; 
Farzi, A., Halica, J., Mayerhofer, R., Frolich, E.E., Tatzl, E., Holzer, P., Toll-like 4 receptor contributes to the inhibitory effect of morphine on colonic motility in vitro and in vivo (2015) Sci. Rep., 5, p. 9499; 
Fassini, A., Scopinho, A.A., Resstel, L.B., Correa, F.M., Kappa opioid receptors in infralimbic cortex modulate the cardiovascular responses to acute stress (2015) Exp. Physiol., 100, pp. 377-387; 
Fassoulaki, A., Chassiakos, D., Melemeni, A., Intermittent epidural vs continuous wound infusion of ropivacaine for acute and chronic pain control after hysterectomy or myomectomy: a randomized controlled trial (2014) Pain Med., 15, pp. 1603-1608; 
Fatahi, Z., Zeighamy Alamdary, S., Khodagholi, F., Shahmati, S.Z., Razavi, Y., Haghparast, A., Effect of physical stress on the alteration of mesolimbic system apoptotic factors in conditioned place preference paradigm (2014) Pharmacol. Biuochem. Behav., 124, pp. 231-237; 
Faul, M., Dailey, M.W., Sugerman, D.E., Sasser, S.M., Levy, B., Paulozzi, L.J., Disparity in naloxone administration by emergency medical providers and the burden of drug overdose in US rural communities (2015) Am. J. Public Health, 105, pp. e26-32; 
Fauno, P., Lund, B., Christiansen, S.E., Gjoderum, O., Lind, M., Analgesic effect of hamstring block after anterior cruciate ligament reconstruction compared with placebo: a prospective randomized trial (2015) Arthroscopy, 31, pp. 63-68; 
Fazio, E., Medica, P., Cravana, C., Ferizazzo, A., Release of beta-endorphin, adrenocrticotrophic hormone and cortisol in response to machine milking of dairy cows (2015) Vet. World, 8, pp. 284-289; 
Fechtner, L., El Ali, M., Sattar, A., Moore, M., Strohl, K.P., Fentanyl effects on breath generation in C57BL/6J and A/J mouse strains (2015) Respir. Physiol. Neurobiol., 215, pp. L20-29; 
Fejos, I., He, Y., Vogyi, G., Kazsocki, A., Sun, J., Chen, W., Sohajda, T., Beni, S., Tapentadol enantiomers: synthesis, physico-chemical characterization and cyclodextrin interactions (2014) J. Pharm. Biomed. Anal., 88, pp. 594-601; 
Fenalti, G., Zatsepin, N.A., Betti, C., Giguere, P., Han, G.W., Ishchenko, A., Liu, W., Conrad, C.E., Fromme R, fromme P, tounwe D, schiller PW, roth BL, ballet S, KatrichV, stevens RC, cherezov V. structural basis for bifunctional peptide recognition of human delta-opioid receptor (2015) Nat. Struct. Mol. Biol., 22, pp. 265-268; 
Fenten, M.G., Keilzer, B.A., Stienstra, R., No clinically relevant advantage of intrathecal morphine in total hip arthroplasty (2014) Acta Anaesthesiol. Belg., 65, pp. 161-166; 
Fenu, S., Espa, E., Cadoni, C., Di Chiara, G., Conditioned saccharin avoidance induced by infusion of amphetamine in the nucleus accumbens shell and morphine in the ventral tegmental area: behavioral and biochemical study (2014) Behav. Brain Res., 269, pp. 55-60; 
Fernando, A.B., Urcelay, G.P., Mar, A.C., Dickinson, A., Robbins, T.W., Safety signals as instrumental reinforcers during free-operant avoidance (2014) Learn. Mem., 21, pp. 488-497; 
Ferreira, M., Verloo, H., Mabire, C., Vieira, M.M., Marques-Vidal, P., Psychometric evaluation of the French version of the questionnaire attitudes towards morphine use; a cross-sectional study in Valais, Switzlerland (2014) BMC Nurs., 13, p. 1; 
Ferreira-Junior, J.C., Conserva, L.M., Lyra Lemos, R.P., de Omena-Neta, G.C., Cavalcante-Neto, A., Barreto, E., Isolation of a dihydronenzofuran lignin, icariside E4, with an antinociceptive effect from Tabebula roseo-alba (Ridley) Sandwith (Bignoniaceae) bark (2015) Arch. Pharm. Res., 38, pp. 950-956; 
Ferro, J.N., de Aquino, F.L., de Brito, R.G., dos Santos, P.L., Quintans Jde, S., de Souza, L.C., de Araujo, A.F., Barreto, E., Cyclo-Gly-Pro, a cyclic dipeptide, attenuates nociceptive behavior and inflammatory response in mice (2015) Clin. Exp. Pharmacol. Physiol., 42, pp. 1287-1295; 
Ferroni, M.C., Slater, R.C., Shen, B., Xiao, Z., Wang, J., Lee, A., Roppolo, J.R., Tai, C., Role of the brainstem in tibial inhibition of the micturition reflex in cats (2015) Am. J. Physiol. Renal Physiol., 309, pp. F242-F250; 
Fischer, A., Jonsson, M., Hjelmstrom, P., Pharmaceutical and pharmacokinetic characterization of a novel sublingual buprenorphine/naloxone tablet formulation in healthy volunteers (2015) Drug Dev. Ind. Pharm., 41, pp. 79-84; 
Fischer, B., Jones, W., Urbanoski, K., Skinner, R., Rehm, J., Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005–2011 (2014) Drug Alcohol Rev., 33, pp. 19-26; 
Fitting, S., Ngwainmbi, J., Kang, M., Khan, F.A., Stevens, D.L., Dewey, W.L., Knapp, P.E., Akbarali, H.I., Sensitization of enteric neurons to morphine by HIV-1 Tat protein (2015) Neurogastroenterol. Motil., 27, pp. 468-480; 
Flack, S.H., Martin, L.D., Walker, B.J., Bosenberg, A.T., Helmers, L.D., Goldin, A.B., Haberkern, C.M., Ultrasound-guided rectus sheath block or wound infiltration in children: a randomized blinded study of analgesia and bupivacaine absorption (2014) Paediatr. Anaesth., 24, pp. 968-973; 
Flax, S.M., Wakeford, A.G., Cheng, K., Rice, K.C., Riley, A.L., Effects of nor-binaltrophamine on delta9-tetrahyhdrocannibinol (TC)-induced taste avoidance in adolescent and adult Sprague-Dawley rats (2015) Psychopharmacology (Berl)., 232, pp. 3193-3201; 
Fleishman, R., Zhou, C., Gleason, C., Larison, C., Myaing, M.T., Mangione-Smith, R., Standardizing morphine use for ventilated preterm neonates with a nursing-driven comfort protocol (2015) J. Perinataol., 35, pp. 46-51; 
Flerlage, J.E., Baker, J.N., Methylnaltrexone for opioid-induced constipation in children and adolescents and young adults with progressive incurable cancer at the end of life (2015) J. Palliat. Med., 18, pp. 631-633; 
Florentino, I.F., Galdino, P.M., De Oliveira, L.P., Silva, D.P., Pazini, F., Vanderlinde, F.A., Liao, L.M., Costa, E.A., Involvement of the NO/cGMP/KATP pathway in the antinociceptive effect of the new pyrazole 5-(1-(3-fluorophenyl)-1H-pyrazol-4-yl)-2H-tetrazole (LQFM-021) (2015) Nitric Oxide, 47, pp. 17-24; 
Foinard, A., Decaudin, B., Barthelemy, C., Lebuffe, G., Debaene, B., Odou, P., Impact of infusion set characteristics on the accuracy of patient-controlled morphine administration: a controlled in vitro study (2014) Anaesthesia, 69, pp. 131-136; 
Forood, A., Malekpour-Afshar, R., Mahdavi, A., Serum level of plasminogen activator inhibitor type-1 in addicted patients with coronary artery disease (2014) Addict. Health, 6, pp. 119-126; 
Foulds, J.A., Ton, K., Kennedy, M.A., Adamson, S.J., Mulder, R.T., Sellman, J.D., OPRM1 genotype and naltrexone response in depressed alcohol-dependent patients (2015) Pharmacogenet. Genomics, 25, pp. 270-273; 
Fowler, M., Clifford, J.L., Garza, T.H., Slater, T.M., Arizpe, H.M., Novak, J., Petz, L.N., Loyd, D.R., A rat model of full thickness thermal injury characterized by thermal hyperalgesia, mechanical allodynia, pronociceptive peptide release and tramadol analgesia (2014) Burns, 40, pp. 759-771; 
Fraczak, O., Lasota, A., Kosson, P., Lesniak, A., Muchowska, A., Lipkowski, A.W., Olma, A., Biphalin analogues containing beta(3)-homo-amino acids at the 4,4′ positions: synthesis and opioid activity profiles (2015) Peptides, 66, pp. 13-18; 
Fraessdorf, J., Hollmann, M.W., Hanschmann, I., Heinen, A., Weber, N.C., Preckel, B., Huhn, R., Role of endogenous opioid system in ischemia-induced late preconditioning (2015) PLoS One, 10, p. e134283; 
Fraga, D., Zanoni, C.I., Zampronio, A.R., Parada, C.A., Rae, G.A., Souza, G.E., Endocannainoids, through opioids and prostaglandins, contribute to fever induced by key pyrogenic mediators (2015) Brain Behav. Immun., 51, pp. 204-211; 
Frances, F., Portoles, O., Castello, A., Costa, J.A., Verdu, F., Association between opioid receptor mu 1 (OPRM1) gene polymorphisms and tobacco and alcohol consumption in a Spanish population (2015) Bosn. J. Basic Med. Sci., 15, pp. 31-36; 
Frank, D., Mateu-Gelabert, P., Guarino, H., Bennett, A., Wendel, T., Jessell, L., Teper, A., High risk and little knowledge: overdose experiences and knowledge among young adult nonmedical prescription opioid users (2015) Int. J. Drug Policy, 26, pp. 84-91; 
Francois, C., Rahhali, N., Chalem, Y., Sorenson, P., Luquiens, A., Aubin, H.J., The effects of as-needed nalmefene on patient-reported outcomes and quality of life in relation to a reduction in alcohol consumption in alcohol-dependent patients (2015) PLoS One, 10, p. e0129289; 
Franklin, C., Fortepianai, L., Nguyen, T., Rangel, Y., Strong, R., Gottlieb, H.B., Renal responses produced by microinjection of the kappa opioid receptor agonist, U50-488H into sites within the rat lamina terminalis (2015) Pharmacol. Res. Perspect., 3, p. e00117; 
Frankowski, K.J., Slauson, S.R., Lovell, K.M., Phillips, A.M., Streicher, J.M., Zhou, L., Whipple, D.A., Aube, J., Potency enhancement of the kappa-opioid receptor antagonist probe ML 140 through sulfonamide constraint utilizing a tetrahydroisoquinoline motif (2015) Bioorg. Med. Chem., 23, pp. 3948-3956; 
Freet, C.S., Ballard, S.M., Alexander, D.N., Cox, T.A., Imperio, C.G., Anosike, N., Zarter, A.B., Grigson, P.S., Cocaine-induced suppression of saccharin intake and morphine modulation of Ca(2+) channel currents in sensory neurons of OPRM1 A118G mice (2015) Physiol. Behav., 139, pp. 216-223; 
Fulcher, P.H., Jr., Granase, M., Chun, Y., Welch, C.A., Seybold, D.J., Randall, G., De Poind, R.T., Intraoperative utilization of dexamethasone/bupivacaine/gentamicin solution in laparoscopic assisted vaginal hysterectomy and pain management (2014) WV Med. J., 110, pp. 10-15; 
Funada, M., Mori, T., Maeda, J., Tsuda, Y., Komiya, S., Shimizu, N., Kamei, J., Suzuki, T., Splenectomy modifies hyperactive states of the dopaminergic system induced by morphine in C57BL/6J-bg(J)/bg(J) (beige-J) mice (2014) Eur. J. Pharmacol., 742, pp. 89-93; 
Funes, F.J., Granados Mdel, M., Morgaz, J., Navarette, R., Fernandez-Sarmiento, A., Gomez-Nillamandos, R., Munoz, P., Dominguez, J.M., Anaesthetic and cardiorespiratory effects of a constant rate infusion of fentanyl in isoflurane-anesthetized sheep (2015) Vet. Anaesth. Analg., 42, pp. 157-164; 
Fuss, J., Steinie, J., Bindila, L., Auer, M.S., Kirchherr, H., Lutz, B., Gass, P., A runner's high depends on cannabinoid receptors in mice (2015) Proc. Natl. Acad. Sci. U. S. A., 112, pp. 13105-13108; 
Gagnon, B., Scott, S., Nadeau, L., Lawlor, P.G., Patterns of community-based opioid prescriptions in people dying of cancer (2015) J. Pain Symptom Manag., 49, pp. 36-44; 
Galeotti, N., Farzad, M., Bianchi, E., Ghelardini, C., PKC-mediated potentiation of morphine analgesia by St: john's Wort in rodents and humans (2014) J. Pharmacol. Sci., 124, pp. 409-417; 
Gamage, T.F., Ignatowska-Jankowska, B.M., Muldoon, P.P., Cravatt, B.F., Damaj, M.I., Lichtman, A.H., Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice (2015) Drug Alcohol Depend., 148, pp. 7-16; 
Gan, S.J., Wang, Y.H., Xu, Y.G., Guo, T., Wang, J., Song, Q., Xu, X.J., Liu, J.G., Discovery, stereospecific characterization and peripheral modification of 1-(pyrrolidin-1-ymethyl)-2-[(6[chloro-3-oxo-indan)-formyl]-1,2,3,4-tetrahydroisoquinolines as novel selective kappa opioid receptor agonists (2015) Org. Biomol. Chem., 13, pp. 5656-5673; 
Gao, J.L., Tu, S.A., Liu, J., Zhang, J.M., Huang, Y., Han, M., Liang, J.H., An-jun-ning, a traditional herbal formula, attenuates spontaneous withdrawal symptoms via modulation of the dopamine system in morphine-dependent rats (2014) BMC Complement Altern. Med., 14, p. 308; 
Gao, J.L., Xue, Q., Wang, S.W., Gao, L.F., Fang, Z., Fu, Y.C., Liu, Y., Fan, L., Association between cardiac changes and steress, and the effect of peroxisome proliferator-activated receptor-gamma on stress-induced mycocardial injury in mice (2015) J. Huazhong Univ. Sci. Technolog. Med. Sci., 35, pp. 26-34; 
Garbuz, O., Gulea, A., Dyniewicz, J., Jablocka, B., Lipkowski, A.W., The non-opioid receptor, antioxidant properties of morphine and the opioid peptide analog biphalin (2015) Peptides, 63, pp. 1-3; 
Garcia, M.M., Angelini, M.C., Thomas, T., Lenz, K., Jeffrey, P., Implementation of an opioid management initiative by a state Medicaid program (2014) J. Manag. Care Spec. Pharm., 20, pp. 447-454; 
Garcia, R., Zafra, M.A., Puerto, A., Rewarding effects of electrical stimulation of the insular cortex: decayed effectiveness after repeated tests and subsequent increase in vertical behavioral activity and conditioned place aversion after naloxone administration (2015) Neuroibiol. Learn. Mem., 118, pp. L64-L73; 
Garcia-Carmona, J.A., Baroja-Mazo, A., Milanes, M.V., Laorden, M.L., Sex differences between CRF1 receptor deficient mice following naloxone-precipitated morphine withdrawal in a conditioned place aversion paradigm: implication of HPA axis (2015) PLoS One, 10, p. e0121125; 
Garcia-Carmona, J.A., Martinez-Laorden, E., Milanes, M.N., Laorden, M.L., Sympathetic activity induced by naloxone-precipitated morphine withdrawal in genetically engineered mice lacking functional CRF1 receptor (2015) Toxicol. Appl. Pharmacol., 283, pp. 42-49; 
Garcia-Perez, D., Lopez-Bellido, R., Rodriguez, R.E., Laorden, M.L., Nunez, C., Milanes, M.V., Dysregulation of dopaminergic regulatory mechanisms in the mesolimbic pathway induced by morphine and morphine withdrawal (2015) Brain Struct. Funct., 220, pp. 1901-1919; 
Garcia-Perez, D., Luisa Laorden, M., Laorden, M.L., Nunez, C., Victoria Milanes, M., Glial activation and midkine and pleiotrophin transcription in the ventral tegmental area are modulated by morphine administration (2014) J. Neuroimmunol., 274, pp. 244-248; 
Garimella, T., Wang, R., Luo, W.L., Wastall, P., Kandoussi, H., DeMicco, M., Bruce, R.D., Bifano, M., Assessment of drug–drug interactions between daclatasvir and methadone or buprenorphine/naloxone (2015) Animicrob. Agents Chemother., 59, pp. 5503-5510; 
Garzon, J., Herrero-Labrador, R., Rodriguez-Munoz, M., Shah, R., Vicente-Sanchez, A., Wagner, C.R., Sanchez-Blazquez, P., HINT1 protein: a new therapeutic target to enhance opioid antinociception and bklock mechanical allodynia (2015) Neuropharmacology, 89, pp. 412-423; 
Gawel, K., Labuz, K., Jenda, M., Silberring, J., Kotlinska, J.H., Influence of cholinesterase inhibitors, donepezil and rivastigmine on the acquisition, expression and reinstatement of morphine-induced conditioned place preference in rats (2014) Behav. Brain Res., 268, pp. 169-176; 
Gaydos, S.J., Kelley, A.M., Grandizio, C.M., Athy, J.R., Walters, P.L., Comparison of the effects of ketamine and morphine on performance of representative military tasks (2015) J. Emerg. Med., 48, pp. 313-324; 
Gaztanaga, M., Aranda-Fernandez, P.E., Chotro, M.G., Prenatal exposure to vanilla or alcohol induces crawling after these odors in the neonate rat: the role of mu and kappa opioid receptor systems (2015) Physiol. Behav., 148, pp. 58-64; 
Ge, Z.H., Wang, Z.X., Yu, T.L., Yang, N., Sun, Y., Hao, C.L., Sun, L.X., Morphine improved the antitumor effects of MCF-7 cells in combination with 5-fluorouracil (2014) Biomed. Pharmacother., 68, pp. 299-305; 
Geffe, M., Opatz, T., Enantioselective synthesis of (−)-dihydrocodeine and formal synthesis of (−)-thebaine, (−)-codeine, and (−)-morphine from a deprotonated alpha-aminonitrile (2014) Org. Lett., 16, pp. 5282-5285; 
Gein, S.V., Baeva, T.A., Nebogatikov, V.O., Effects of beta-endorphin on functional activity of mouse spelnocytes under conditions of in vivo blockade of mu,delta-opioid receptors (2015) Bull. Exp. Biol. Med., 158, pp. 356-360; 
Gentzel, R.C., Toolan, D., Roberts, R., Koser, A.J., Kandebo, M., Hershey, J., Renger, J.J., Smith, S.M., The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents (2015) Neuropharmcology, 99, pp. 256-263; 
Geoffroy, H.A., Puig, S., Benturquia, N., Noble, F., Temporal regulation of peripheral BDNF levels during cocaine and morphine withdrawal: comparison with a natural reward (2014) Int. J. Neuropsychopharmacol., 18, p. 5; 
George, P., Ramasamy, P., Thurairajasingam, S., Shah, Z., Pateints that benefit from buprenorphine-naloxone on medically assisted treatment for opioid dependence in Malaysia (2015) Med. J. Malaysia, 70, pp. 251-255; 
George, R.B., McKeen, D.M., Andreou, P., Habib, A.S., A randomized placebo-controlled trial of two doses of pregabalin for postoperative analgesia in patients undergoing abdominal hysterectomy (2014) Can. J. Anaesth., 61, pp. 551-557; 
Georgiou, P., Zanos, P., Ehteramyan, M., Hourani, S., Kitchen, I., Maldonado, R., Bailey, A., Differential regulation of mGlu5R and MOPr by priming- and cue-induced reinstatement of cocaine-seeking behavior in mice (2015) Addict. Biol., 20, pp. 902-912; 
Gerhold, K.J., Drdla-Schutting, R., Honsek, S.D., Forsthuner, L., Sandkuhler, J., Pronociceptive and antinociceptive effects of buprenorphine in the spinal cord dorsal horn cover a dose range of four orders of magnitude (2015) J. Neurosci., 35, pp. 9580-9594. , (3.3); 
Geyer, M., Wellner, E., Jurva, U., Saloman, S., Armstrong, D., Tacke, R., Can silicon make an excellent drug even better? An in vitro and in vivo head-to-head comparison between loperamide and its silicon analog sila-loperamine (2015) ChemMedChem, 10, pp. 911-924; 
Ghafari, S., Golalipour, M.J., Prenatal morphine exposure reduces pyramidal neurons in CA1, CA2 and CA3 subfields of mice hippocampus (2014) Iran. J. Basic Med. Sci., 17, pp. 155-161; 
Ghasemi, F., Moradi, A., Izadparah, E., Moloudi, M.R., Hassanzadeh, K., Rahimmi, A., Hassanzadeh, K., Simvastatin prevents morphine antinociceptive tolerance and withdrawal symptoms in rats (2015) J. Formos. Med. Assoc., 114, pp. 399-406; 
Ghavimi, H., Azarfardian, A., Maleki-Dizaji, N., Hassanzadeh, K., Ghanbarzadeh, S., Charkhpour, M., Acute administration of piolitazone attenuates morphine withdrawal syndrome in rat: a novel role for pioglitazone (2015) Drug Res. (Stuttg), 65, pp. 113-118; 
Ghavimi, H., Charkhpour, M., Ghasemi, S., Mesgari, M., Hamishehkar, H., Hassanzadeh, K., Arami, S., Hassanzadeh, K., Piolitazone prevents morphine antinociceptive tolerance via ameliorating neuroinflammation in rat cerebral cortex (2015) Pharmacol. Rep., 67, pp. 78-84; 
Ghazvini, H., Rezayof, A., Ghasemzadeh, Z., Zarrindast, M.R., Mu-opioid and N-methyl-D-aspartate receptors in the amygdala contribute to minocycline-induced potentiation of morphine analgesia in rats (2015) Behav. Pharmacol., 26, pp. 383-392; 
Gholami, M., Saboory, E., Khalkhali, H.R., Chronic morphine and tramadol re-exposure induced an anti-anxiety effect in prepubertal rats exposed neonatally to the same drugs (2014) Clin. Exp. Pharmacol. Physiol., 41, pp. 838-843; 
Gholami, M., Saboory, E., Roshan-Milani, S., Proconvulsant effects of tramadol and morphine on pentylenetetrazol-induced seizures in adult rats using different routes of administration (2014) Epilepsy Behav., 36, pp. 90-96; 
Gibula-Bruzda, E., Marszalek-Grabska, M., Gawel, K., Witkowska, E., Izdebski, J., Kotlinska, J.H., The influence of the new enkephalin analog, cyclo[N(epsilon), N(beta)-carbonyl-D-Lys(2), Dap(5)] enkephalinamide (cUENK6) on reinstatement of ethanol-induced conditioned place preference in rats (2015) Physiol. Behav., 145, pp. 50-56; 
Gibula-Bruzda, E., Marszalek-Grabska, M., Witkowska, E., Izdebski, J., Kotlinska, J.H., Enkephalin analog, cyclo[N(epsilon), N(beta)-carbonyl-D-Lys(2), Dap(5)] enkephalinamide (cUENK6) inhibits the ethanol withdrawal-induced anxiety-like behavior in rats (2015) Alcohol, 49, pp. 229-236; 
Gim, H., Nam, J.H., Lee, S., Shim, J.H., Kim, H.J., Ha, K.T., Kim, B.J., Quercetin inhibits pacemaker potentials via nitric oxide/cGMP-dependent activation and TRPM7/ANO1 channels in cultured interstitial cells of Cajal from mouse small intestine (2015) Cell. Physiol. Biochem., 35, pp. 2422-2436; 
Giri, A.K., Apostol, C.R., Wang, Y., Forte, B.L., Largent-Milnes, T.M., Davis, P., Rankin, D., Hruby, V.J., Discovery of novel multifunctional ligands with mu/delta opioid agonist/neurokinin-1 (NK1) antagonist activities for the treatment of pain (2015) J. Med. Chem., 58, pp. 8573-8583; 
Gjeltema, J., Posner, L.P., Stoskopf, M., The use of injectale alphaxalone as a single agent and in combination with ketamikne, xylazine and morphine in the Chilean rose tarantula, Grammostola rosea (2014) J. Zoo Wildl. Med., 45, pp. 792-801; 
Gluck, L., Loktev, A., Mouledous, L., Mollereau, C., Law, P.Y., Schulz, S., Loss of morphine reward and dependence in mice lacking G protein-coupled receptor kinase 5 (2014) Biol. Psychiatry, 76, pp. 767-774; 
Godai, K., Hasegawa-Moriyama, M., Kurimoto, T., Saito, T., Yamada, T., Sato, T., Kojima, M., Kanmura, Y., Peripheral administration of morphine attenuates postincisional pain by regulating macrophage polarization through COX-2 dependent pathway (2014) Mol. Pain, 10, p. 36; 
Goldfeld, D.A., Murphy, R., Kim, B., Wang, L., Beuming, T., Abel, R., Friesner, R.A., Docking and the free energy perturbation studies of ligand binding in the kappa opioid receptor (2015) J. Phys. Chem. B, 119, pp. 824-835; 
Golster, M., Seven years of patient-controlled epidural analgesia in a Swedish hospital: a prospective survey (2014) Eur. J. Anaesthesiol., 31, pp. 589-596; 
Goncalves, L., Friend, L.V., Dickenson, A.H., The influence of mu-opioid and noradrenaline reuptake inhibition in the modulation of pain responsive neurons in the central amygdala by tapentadol in rats with neuropathy (2015) Eur. J. Pharmacol., 749, pp. 151-160; 
Gong, N., Li, X.Y., Xiao, Q., Wang, Y.X., Identification of a novel spinal dorsal horn astroglial D-amino acid oxidase-hydrogen peroxide pathway involved in morphine antinociceptive tolerance (2014) Anesthesiology, 120, pp. 962-975; 
Gonzalez, G., DiGirolamo, G., Romer-Gonzalez, M., Smelson, D., Ziedonis, D., Kolodziej, M., Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults (2015) Drug Alcohol Depend., 256, pp. 243-253; 
Gonzalez, W.G., Arango, A.S., Miksovska, J., Amphiphilic residues 29–44 of DREAM N-termini mediate calmodulain:DREAM complex formation (2015) Biochemical, 54, pp. 4391-4403; 
Gonzalez-Florez, A.I., Ahn, D.S., Gewinner, S., Schollkopf, W., von Holden, G., IR spectroscopy of proteonated leu-enkephalin and its 18-crown-6 complex embedded in helium droplets (2015) Phys. Chem. Chem. Phys., 17, pp. 21902-21911; 
Gooshe, M., Abdolghaffari, A.H., Aleyain, A.R., Chabouk, L., Tofigh, S., Hassanzadeh, G.R., Payandemehr, B., Dehpour, A.R., Hypoxia/ischemia a key player in early post stroke seizure: modulation by opiodergic and nitrergic systems (2015) Eur. J. Pharmacol., 746, pp. 6-13; 
Gottas, A., Boix, F., Oiestad, E.L., Vindenes, V., Morland, J., Role of 6-monoacetylmorphine in the acute release of striatal dopamine induced by intravenous heroin (2014) Int. J. Neuropsychopharmacol., 17, pp. 1357-1365; 
Gou, G., Leanez, S., Pol, O., The role of gaseous neurotransmitters in the antinociceptive effects of morphine during acute thermal pain (2014) Eur. J. Pharmacol., 737, pp. 41-46; 
Gozalo-Marcilla, M., Hopster, K., Gasthuys, F., Krajewski, A.E., Schwarz, A., Schauvliege, S., Minimum end-tidal sevoflurane concentration necessary to prevent movement during a constant rate infusion of morphine, or morphine plus dexmedetomidine in ponies (2014) Vet. Anaesth. Analg., 41, pp. 212-219; 
Grace, P.M., Ramos, K.M., Rodgers, K.M., Wang, X., Hutchinson, M.R., Lewis, M.T., Morgan, K.N., Watkins, L.R., Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological and behavior sequelae (2014) Neuroscience, 280, pp. 299-317; 
Grace, P.M., Shimizuu, K., Strand, K., Rice, K.C., Deng, G., Watkins, L.R., Herson, P.S., (+)-naltrexone is neuroprotective and promotes alternative activation after cardiac arrest/cardiopulmonary resuscitation (2015) Brain Behav. Immun., 48, pp. 115-122; 
Graham, R.F., Hughes, J., Johnson, A., Cuenca, P., Mosley, T., Intra-articular morphine versus lidocaine for acute knee pain (2014) J. Spec. Oper. Med., 14, pp. 74-79; 
Gramage, E., Vicente-Rodriguez, M., Herradon, G., Pleiotrophin modulates morphine withdrawal but has no effects on morphine-conditioned place preference (2015) Neurosci. Lett., 604, pp. 75-79; 
Grandi, D., Becchi, G., Guerrini, R., Calo, G., Morini, G., Nociceptin/orphanin FQ and stress regulate synaptophysin expression in the rat fundic and colonic mucosa (2015) Tissue Cell, 47, pp. 147-151; 
Granholm, L., Roman, E., Nylander, I., Single housing during early adolescence causes time-, area- and peptide-specific alterations of endogenous opioids of rat brain (2015) Br. J. Pharmacol., 172, pp. 606-614; 
Green, T.C., Dauria, E.F., Bratberg, J., Davis, C.S., Walley, A.Y., Orienting patients to greater opioid safety: models of community pharmacy-based naloxone (2015) Harm. Reduct. J., 12, p. 25; 
Groblewski, P.A., Zietz, C., Willuhn, I., Phillips, P.E., Chavkin, C., Repeated stress exposure causes strain-dependent shifts in the behavioral economics of cocaine in rats (2015) Addict. Biol., 20, pp. 297-301; 
Grodofsky, S.R., Sinha, A.C., The association of gender and body mass index with postoperative pain scores when undergoing ankle fracture surgery (2014) J. Anaesthesiol. Clin. Pharmacol., 30, pp. 248-252; 
Grosen, K., Drewes, A.M., Hojsgaard, A., Pfeiffer-Jensen, M., Hjortdal, V.E., Pilegaard, H.K., Perioperative gabapentin for the prevention of persistent pain after thoracotomy: a randomized controlled trial (2014) Eur. J. Cardiothorac. Surg., 46, pp. 76-85; 
Grosen, K., Vase, L., Pilegaard, H.K., Pfeiffer-Jensen, M., Drewes, A.M., Conditioned pain modulation and situational pain catastrophizing as preoperative predictors of pain following chest wall surgery: a prospective observational cohort study (2014) PLoS One, 9, p. e90185; 
Gregoire, S., Wattiez, A.S., Etienne, M., Marchand, F., Ardid, D., Monoarthritis-induced emotional and cognitive impairments in rats are sensitive to low systemic doses or intra-amygdala injections of morphine (2014) Eur. J. Pharmacol., 735, pp. 1-9; 
Grissom, N.M., Herdt, C.T., Desiltets, J., Lidsky-Everson, L., Reyes, T.M., Dissociable deficits of executive function caused by gestsational adversity are linked to specific transcriptional changes in the prefrontal cortex (2015) Neuropsychopharmacology, 40, pp. 1353-1363; 
Grosshans, M., Mutschler, J., Kiefer, F., Treatmant of cocaine craving with as-needed nalmefene, a partial kappa opioid receptor agonist: first clinical experience (2015) Int. Clin. Psychopharmacol., 30, pp. 237-238; 
Guerrini, E., Mallreddy, J.R., Toth, G., Schmidhammer, H., Spetea, M., Synthesis and pharmacological evaluzation of [(3)H]HS665, a novel highly selective radioligand for the kappa opioid receptor (2015) ACS Chem. Neurosci., 6, pp. 456-463; 
Guerrini, R., Marzola, E., Trapella, C., Pacifico, S., Cerlisi, M.C., Malfacini, D., Ferrari, F., Calo, G., Structure activity studies of nociception/orphanin FQ(1–13)-NH2 derivatives modified in position 5 (2015) Bioorg. Med. Chem., 23, pp. 1515-1520; 
Guilhan, C.C., Abdul Wahab, I.R., Boylan, F., Fernandes, P.D., Central antinociceptive and mechanism of action of Pereskia bleo Kunth leaves crude extract fraction, and isolated compounds (2015) Evid. Based Complement Alter. Med., p. 2015915927; 
Guillemyn, K., Kleczkowska, P., Lesniak, A., Dyniewicz, J., Van der Poorten, O., Van den Eynde, I., Keresztes, A., Ballet, S., Synthesis and biological evaluation of compact, confirmationally constrained bifunctional opioid agonist −neurokinin-1 antagonist peptidomimetics (2015) Eur. J. Med. Chem., 92, pp. 64-77; 
Guimaraes Alves, I.P., Montoro Nicacio, G., Diniz, M.S., Alves Rocha, T.L., Prada Kanashiro, G., Navarro Cassu, R., Analgesic comparison of systemic lidocaine, morphine or lidocaine plus morphine infusion in dogs undergoing fracture repair (2014) Acta Cir. Bras., 29, pp. 245-251; 
Guindon, J., Deng, L., Fan, B., Wager-Miller, J., Hohmann, A.G., Optimization of a cisplatin model of chemotherapy-induced peripheral neuropathy in mice: use of vitamin C and sodium bicarbonate pretreatments to reduce nephrotoxicity and improve animal health status (2014) Mol. Pain, 10, p. 56; 
Gulyam Kuruba, S.M., Mukhtar, K., Singh, S.K., A randomized controlled trial of ultrasound-guided transversus abdominis plane block for renal transplantation (2014) Anaesthesiology, 69, pp. 1222-1226; 
Gulyas, B., Sovago, J., Gomez-Mancilla, B., Jia, Z., Szigeti, C., Gulya, K., Schumacher, M., Halldin, C., Decrease of mGlu5 receptor density goes parallel with changes in enkephalin and substance P immunoreactivity in Huntington's disease: a preliminary investigation in the postmortem human brain (2015) Brain Struct. Funct., 220, pp. 3043-3051; 
Gunderson, E.W., Hjelmstrom, P., Sumner, M., Effects of a higher-bioavailability buporenorphine/naloxone sublingual tablet versus buprenorphine/naloxone film for the treatment of opioid dependence during induction and stabilization: a multicenter randomized tiral (2015) Clin. Ther., 37, pp. 2244-2255; 
Guo, M., Cao, D., Zhu, S., Fu, G., Wu, Q., Liang, J., Cao, M., Chronic exposure to morphine decreases the expression of EAAT3 via opioid receptors in hippocampal neurons (2015) Brain Res., 1628, pp. 40-49; 
Gupta, A., Fujita, W., Gomes, I., Bobeck, E., Devi, L.A., Endothelin-converting enzyme 2 differentially regulates opioid receptor activity (2015) Br. J. Pharmacol., 172, pp. 704-719; 
Gurbet, A., Bekar, A., Bilgin, H., Ozdemir, N., Kuytu, T., Preemptive wound infiltration in lumbar laminectomy for postoperative pain: comparison of bupivacaine and levobupivacaine (2014) Turk. Neurosurg., 24, pp. 48-53; 
Gurkan, Y., Tas, Z., Toker, K., Solak, M., Ultrasound guided bilateral cervical plexus block reduces postoperative opioid consumption following thyroid surgery (2015) J. Clin. Monit. Comput., 29, pp. 579-584. , (4.5); 
Gutierrez-Blanco, E., Victoria-Mora, J.M., Ibancovichi-Camarillo, J.A., Sauri-Arceo, C.H., Bolio-Gonzalez, M.E., Acevedo-Arcique, C.M., Marin-Cano, G., Steagall, P.V., Postoperative analgesic effects of either a constant rate infusion of fentanyl, lidocaine, ketamine, dexmedetomidine, or the combination lidocaine-ketamine-dexmedetomidine after ovariohysterectomy in dogs (2015) Vet. Anaesth. Analg., 42, pp. 309-318; 
Guzman, D.C., Garcia, E.H., Majia, G.B., Olguin, H.U., Gonzalez, J.A., Labra Ruiz, N.A., Effect of morphine and lacosamide on levels of dopamine and 5-HIAA in brain regions of rats with induced hypoglycemia (2014) Pak J. Biol. Sci., 17, pp. 292-296; 
Guzzo, L.S., Romero, T.R., Queiroz-Junior, C.M., Caliari, M.V., Azevedo, A.O., Perez, A.C., Duarte, I.D., Involvement of endogenous opioid system in the peripheral antinocieptive effect induced by the coffee specific diterpene kahweol (2015) Pharmacol. Rep., 67, pp. 1010-1015; 
Gwira Baumblatt, J.A., Wiedeman, C., Dunn, J.R., Schaffner, W., Paulozzi, L.J., Jones, T.F., High-risk use by patients prescribed opioids for pain and its role in overdose deaths (2014) JAMA Intern. Med., 174, pp. 796-801; 
Ha, J.Y., Lee, Y.C., Park, S.J., Jang, Y.H., Kim, J.H., Remifentanil postconditioning has cross talk with adenosine receptors in the ischemic-reperfused heart (2015) J. Surg. Res., 195, pp. 37-43; 
Habibi-Asi, B., Vaez, H., Najafi, M., Bidaghi, A., Ghanbarzadeh, S., Attenuation of morphine-induced dependence and tolerance by ceftriaxone and amitriptyline in mice (2014) Acta Anaesthesiol. Taiwan., 52, pp. 163-168; 
Haghparast, A., Fatahi, Z., Alamdary, S.Z., Reisi, Z., Khodagholi, F., Changes in the levels of p-ERK, p-CREB, and c-fos in rat mesocortical dopaminergic system after morphine-induced conditioned place preference: the role of acute and subchronic stress (2014) Cell Mol. Neurosci., 34, pp. 277-288; 
Hall Burton, D.M., Boretsky, K.R., A comparison of paravertebral nerve block catheters and thoracic epidural catheters for postoperative analgesia following the Nuss procedure for pectus excavatum repair (2014) Pediatr. Anaesth., 24, pp. 516-520; 
Hall, E.S., Wexelblatt, S.L., Crowley, M., Grow, J.L., Jasin, L.R., Klebanoff, M.A., McClead, R.E., Walsh, M.C., A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome (2014) Pediatrie, 134, pp. e527-534; 
Hamdani, M., Chassot, O., Fournier, R., Ultrasound-guided continuous interscalene block: the influence of local anaesthetic delivery method on postoperative analgesia after shoulder surgery: a randomized trial (2014) Reg. Anesth. Pain Med., 39, pp. 387-393; 
Hamed, A., Szyndler, J., Taracha, E., Turzyriska, D., Sobolewska, A., Lehner, M., KrascikP. Daszczuk, P., Kappa-opioid receptor as a key modulator in the regulation of appetitive 50-kHz ultrasonic vocalizations (2015) Psychopharmacology (Berl)., 232, pp. 1941-1955; 
Hamidi, G.A., Jafari-Sabet, M., Abed, A., Mesdaghinia, A., Mahlooji, M., Banafshe, H.R., Gabapentin enhances anti-nociceptive effects of morphine on heat, cold, and mechanical hyperalgesia in a rat model of neuropathic pain (2014) Iran. J. Basic Med. Sci., 17, pp. 753-759; 
Hammig, R., Kohler, W., Bonorden-Kleij, K., Weber, B., Lebentrau, K., Berthel, T., Babic-Hohnjec, L., Ruckes, C., Safety and tolerability of slow-release morphine versus methadone in the treatment of opioid dependence (2014) J. Subst. Abuse Treat., 47, pp. 275-281; 
Hamzeh-Gooshchi, N., Tamaddonfard, E., Farshid, A.A., Effects of microinjection of histamine into the anterior cingulate cortex on pain-related behaviors induced by formalin in rats (2015) Pharmacol. Rep., 67, pp. 593-599; 
Han, F.Y., Wise, B.D., Smith, M.T., Optimization and pharmacological characterization of a refined cisplatin-induced rat model of peripheral neuropathic pain (2014) Behav. Pharmacol., 25, pp. 732-740; 
Han, H., Kass, P.H., Wilsey, B.L., Li, C.S., Increasing trends in Schedule II opioid use and doctor shopping during 1999–2007 in California (2014) Pharmacoepidemiol. Drug Saf., 23, pp. 26-35; 
Han, Y., Jiang, C., Tang, J., Wang, C., Wu, P., Zhang, G., Liu, W., Song, X., Resveratrol reduces morphine tolerance by inhibiting microglial activation via AMPK signaling (2014) Eur. J. Pain, 18, pp. 1458-1470; 
Hanada, T., Kurihara, T., Tokudome, M., Tokimura, H., Arita, K., Miyata, A., Development and pharmacological verification of a new mouse model of central post-stroke pain (2014) Neurosci. Res., 78, pp. 72-80; 
Hancock, D.B., Levy, J.L., Gaddis, N.C., Glasheen, C., Saccone, N.L., Page, G.P., Hulse, G.K., Johnson, E.O., Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1 (2015) Biol. Psychiatry, 78, pp. 474-484; 
Haney, M., Ramesh, D., Glass, A., Pavlicova, M., Bedi, G., Cooper, Z.D., Naltrexone maintenance decreases cannabis self-administration and subjective effects in daily cannabis smokers (2015) Neuropsychopharmacology, 40, pp. 2489-2498; 
Hansen, T.M., Olesen, A.E., Simonsen, C.W., Drewes, A.M., Frokjaer, J.B., Cingulate metabolites during pain and morphine treatment as assessed by magnetic resonance spectroscopy (2014) J. Pain Res., 7, pp. 269-276; 
Hanson, N.A., Allen, C.J., Hostetter, L.S., Nagy, R., Derby, R.E., Slee, A.E., Arslan, A., Auyong, D.B., Continuous ultrasound-guided adductor canal block for total knee arthroplasty: a randomized, double-blind trial (2014) Anesth. Analg., 118, pp. 1370-1377; 
Harb, M.R., Almeida, O.F., Pavlovian conditioning and cross-sensitization studies raise challenges to the hypothesis that overeating is an addictive behavior (2014) Trends Psychiatry, 4, p. e387; 
Hargrove, V.M., Molina, D.K., Morphine concentrations in skeletal muscle (2014) Am. J. Forensic Med. Pathol., 35, pp. 73-75; 
Hargrove, V.M., Molina, D.K., Peripheral postmortem redistribution of morphine (2014) Am. J. Forensic Med. Pathol., 35, pp. 106-108; 
Harland, A.A., Yeomans, L., Griggs, N.W., Anand, J.P., Pogozhava, I.D., Jutkiewicz, E.M., Traynor, J.R., Mosberg, H.I., Further optimization and evaluation of bioavailable, mixed-efficacy mu-opioid receptor (MOR) agonists/delta-opioid receptor antagonists: balancing MOR and DOR affinities (2015) J. Med. Chem., 58, pp. 8952-8969; 
Harris, A.H., Bowe, T., Del Re, A.C., Finlay, A.K., Oliva, E., Myrick, H.L., Rubinsky, A.D., Extended release naltrexone for alcohol abuse disorders: quasi-experimental effects on mortality and subsequent detoxification (2015) Alcohol. Clin. Exp. Res., 39, pp. 79-83; 
Harte-Hargrove, L.C., Varga-Wesson, A., Duffy, A.M., Milner, T.A., Schrfman, H.E., Opioid receptor-dependent sex differences in synaptic plasticity in the hippocampal mossy fiber pathway of the adult rat (2015) J. Neurosci., 35, pp. 1723-1738; 
Harun, N., Hassan, Z., Navaratnam, V., Mansor, S.M., Shoaib, M., Discriminative stimulus properties of mitragynine (kratom) in rats (2015) Psychopharmacology (Berl)., 232, pp. 2227-2238; 
Harvey-Lewis, C., Brisebois, A.D., Franklin, K.B., Naloxone-precipitated withdrawal causes an increase in impulsivity in morphine-dependent rats (2015) Behav. Pharmacol., 26, pp. 326-329; 
Harvey-Lewis, C., Franklin, K.B., The effect of acute morphine on delay discounting in dependent and non-dependent rats (2015) Psychopharmacology (Berl)., 232, pp. 885-895; 
Harvey-Lewis, C., Perdrizet, J., Franklin, K.B., Delay discounting of oral morphine and sweetened juice rewards in dependent and non-dependent rats (2014) Psychopharmacology (Berl)., 231, pp. 2633-2645; 
Hasanein, P., Shakeri, S., Pregabalin role in inhibition of morphine analgesic tolerance and physical dependence in rats (2014) Eur. J. Pharmacol., 742, pp. 113-117; 
Hasanein, P., Teimuri Far, M., Emamjomeh, A., Salvia officinalis L. attenuates morphine analgesic tolerance and dependence in rats: possible analgesic and sedative mechanisms (2015) Am. J. Drug Alcohol Abuse, 41, pp. 405-413; 
Hashemi, S.J., Heydari, S.M., Hashemi, S.T., Paravertebral block using bupivacaine with/without fentanyl on postoperative pain after laparoscopic cholecystectomy: a double-blind, randomized controlled trial (2014) Adv. Biomed. Res., 3, p. 187; 
Hassanian-Moghaddam, H., Farnaghi, F., Rahimi, M., Tramadol overdose and apnea in hospitalized children: a review of 20 cases (2015) Res. Pharm. Sci., 10, pp. 544-552; 
Hassanpour-Ezatti, M., Comparison of acute effects of heroin and Kerack on sensory and motor activity of honey bees (Apis mellifera) (2015) Iran. J. Basic Med. Sci., 18, pp. 364-369; 
Hastie, B.A., Gilson, A.M., Maurer, M.A., Cleary, J.F., An examination of global and regional opioid consumption trends 1980–2011 (2014) J. Pain Palliat. Care Pharmacother., 28, pp. 259-275; 
Hayashi, T., Ikehata, S., Matsuzaki, H., Yasuda, K., Makihara, T., Futumura, A., Arakawa, Y., Yamadaa, S., Influence of serum albumin levels during opioid rotation from morphine or oxycodone to fentanyl for cancer pain (2014) Biol. Pharm. Bull., 37, pp. 1860-1865; 
Hayashi, Y., Koga, Y., Zhang, X., Peters, C., Yanagawa, Y., Wu, Z., Yokoyama, T., Nakanishi, H., Autophagy in superficial dorsal horn accelerates the cathepsin beta-dependent morphine antinociceptive tolerance (2014) Neuroscience, 275, pp. 384-394; 
Haydari, S., Miladi-Gonji, H., Mokhtari, A., Safari, M., Effects of voluntary exercise on anxiety-like behavior and voluntary morphine consumption in rats borne from morphine-dependent mothers during pregnancy (2014) Neurosci. Lett., 578, pp. 50-54; 
He, X., Ou, P., Wu, K., Huang, C., Wang, Y., Yu, Z., Guo, Q., Resveratrol attenuates morphine antinociceptive tolerance via SIRT1 regulation in the rat spinal cord (2014) Neurosci. Lett., 566, pp. 55-60; 
Heinrich, S., Janitz, K., Merkel, S., Klein, P., Schmidt, J., Short- and long-term effects of epidural analgesia on morbidity and mortality of esophageal cancer surgery (2015) Langenbecks Arch. Surg., 400, pp. 19-26; 
Helena, C.V., Toporikova, N., Kalil, B., Stathopoulos, A.M., Pogrebna, V.V., Carolino, R.O., Anselmo-Franci, J.A., Bertram, R., KNDy neurons modulate the magnitude of the steroid-induced leutinizing hotmone surges in ovariectomized rats (2015) Endocrinology, 156, pp. 4200-4213; 
Heller, E.A., Kaska, S., Fallon, B., Ferguson, D., Kennedy, P.J., Neve, R.L., Nestler, E.J., Mazei-Robison, M.S., Morphine and cocaine increase serum- and glucocorticoid-inducible kinase 1 activity in the ventral tegmental area (2015) J. Neurochem., 132, pp. 243-253; 
Henderson, Y.O., Victoria, N.C., Inoue, K., Murphy, A.Z., Parent, M.B., Early life inflammatory pain induces long-lasting deficits in hippocampal-dependent spatial memory in male and female rats (2015) Neurobiol. Learn Mem., 118, pp. 30-41; 
Heng, L.J., Huang, B., Guo, H., Ma, L.T., Yuan, W.X., Song, J., Wang, P., Gao, G.D., Blocking TRPV1 in nucleus accumbens inhibits persistent morphine conditioned place preference in rats (2014) PLoS One, 9, p. e104546; 
Henry, S.J., Wilsey, B.L., Melnikow, J., Iosif, A.M., Dose escalation during the first year of long-term opioid therapy for chronic pain (2015) Pain Med., 16, pp. 733-744; 
Heo, B.H., Pyeon, T.H., Lee, H.G., Kim, W.M., Choi, J.I., Yoon, M.H., Epidural infusion of morphine and levobupivacaine through a subcutaneous port for cancer pain management (2014) Korean J. Pain, 27, pp. 139-144; 
Hernandez, J., Prieto, I., Segarra, A.B., de Gasparo, M., Wangensteen, R., Villarejo, A.B., Benegas, I., Ramierez-Sanchez, M., Interaction of neuropeptidase activities in cortico-limbic regions after acute restraint stress (2015) Behav. Brain Res., 287, pp. 42-48; 
Hernandez-Leon, A., Fernandez-Guasti, A., Gonzalez-Trujano, M.E., Rutin antinociception involves opioidergic mechanism and descending modulation of ventrolateral periaqueductal gray (2015) Eur. J. Pain, 20, pp. 274-283; 
Herrero-Turrion, M.J., Rodriguez-Martin, I., Lopez-Bellido, R., Rodriguez, R.E., Whole-genome expression profile in zebrafish embryos after chronic exposure to morphine: identification of new genes associated with neural function and mu opioid receptor expression (2014) BMC Genomics, 15, p. 874; 
Herring, B.O., Ader, S., Maldanado, A., Hawkins, C., Kearson, M., Camejo, M., Impact of intravenous acetaminophen on reducing opioid use after hysterectomy (2014) Pharmacotherapy, 34, pp. 27S-33S; 
Herzig, S.J., Rothberg, M.B., Cheung, M., Ngo, L.H., Marcantonio, E.R., Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals (2014) J. Hosp. Med., 9, pp. 73-81; 
Hesselbarth, S., Hermanns, K., Oepen, P., Prolonged-release oxycodone/naloxone in opioid-naïve patients −subgroup analysis of a prospective observational study (2015) Expert Opin. Pharmacother., 16, pp. 357-464; 
Heusler, P., Tardif, S., Cussac, D., Agonist stimulation of human mu opioid receptors in a [(35)S]GTPgammaS incorporation assay: observation of bell-shaped concentration −response relationships under conditions of strong receptor G protein coupling (2015) J. Recept Signal Transduction, 36, pp. 158-166; 
Hipolito, L., Wilson-Poe, A., Campos-Jurado, Y., Zhong, E., Gonzalez-Romero, J., Virag, L., Whitington, R., Moron, J.A., Inflammatory pain promotes increased opioid self-administration: role of dysregulated ventral tegmental area mu opioid receptors (2015) J. Neurosci., 35, pp. 12217-12231; 
Hiranita, T., Kohut, S.J., Soto, P.L., Tanda, G., Kopatjtic, T.A., Katz, J.L., Preclinical efficacy of N-substituted benztropine analogues as antagonists of methamphetamine self-administration in rats (2014) J. Pharmacol. Exp. Ther., 348, pp. 174-191; 
Hirayama, S., Wada, N., Nemoto, T., Iwai, T., Fuji, H., Nagase, H., Synthesis and pharmacology of a novel kappa opioid receptor (KOR) agonist with a 1,3,5-trioxazatriquinane skeleton (2014) ACS Med. Chem. Lett., 5, pp. 868-872; 
Hirmanpour, A., Safavi, M., Honarmand, A., Hosseini, A.Z., Sepehrian, M., The comparative study of intravenous ondansetron and sub-hypnotic popofol dose in control and treatment of intrathecal sufentanil-induuced pruritus in elective cesarean surgery (2015) J. Res. Pharm. Pract., 4, pp. 57-63; 
Hironaka, K., Ozaki, N., Hattori, H., Nagamine, K., Nakashima, H., Ueda, M., Sugiura, Y., Involvement of glial activation in trigeminal ganglion in a rat model of lower gingival cancer pain (2014) Nagoya J. Med. Sci., 76, pp. 323-332; 
Hirsch, S., Dickenson, A., Corradini, L., Anesthesia influences neuronal activity and drug effectiveness in neuropathic rats (2014) Pain, 155, pp. 2583-2590; 
Hobl, E.L., Stimpfl, T., Ebner, J., Schoergenhofer, C., Derhaschnig, U., Sunder-Plassmann, R., Jilma-Stohlawtz, P., Jilma, B., Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial (2014) J. Am. Coll. Cardiol., 63, pp. 630-635; 
Hoffman, J.R., Ostfeld, I., Kaplan, Z., Zohar, J., Cohen, H., Exercise enhances the behavioral responses to acute stress in an animal model of PTSD (2015) Med. Sci. Sports Exerc., 47, pp. 2043-2052; 
Hollais, A.W., Patti, C.L., Zanin, K.A., Fukushiro, D.F., Berro, L.F., Carvalho, R.C., Kameda, S.R., Frussa-Filho, R., Effects of acute and long-term typical or atypical neuroleptics on morphine-induced behavioral effects in mice (2014) Clin. Exp. Pharmacol. Physiol., 41, pp. 255-263; 
Hollenbach, R., Sagar, D., Khan, Z.K., Callen, S., Yao, H., Shirazi, J., Buch, S., Jain, P., Effect of morphine and SIV on dendritic cell trafficking into the central nervous system of rhesus macaques (2014) J. Neurovirol., 20, pp. 175-183; 
Holtz, N.A., Radke, A.K., Zlebnik NE, Harris AC, Carroll ME. Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake (2015) Brain Res., 1602, pp. 119-126; 
Honsek, S.D., Seal, R.P., Sandkuhler, J., Presynaptic inhibition of optogentically identified VGluT3+ sensory fibres by opioids and baclofen (2015) Pain, 156, pp. 243-251; 
Hori-Hayashi, N., Sasagawa, T., Hashimoto, T., Kaneko, T., Takeuchi, K., Nishi, M., A newly identified mouse hypothalamic area having bidirectional neural connections with the lateral septum: the perifornical area of the anterior hypothalamus rich in chrondroitin sulfate proteoglycans (2015) Eur. J. Neurosci., 42, pp. 2322-2334; 
Hotta, H., Watanabe, N., Gentle mechanical skin stimulation inhibits micturition contractions via the spinal opioidergic system and by decreasing both ascending and descending transmissions of the micturition reflex in the spinal cord (2015) PLoS One, 10, p. e0135185; 
Hotujec, B.T., Spencer, R.J., Donnelly, M.J., Bruggink, S.M., Rose, S.L., Al-Niaimi, A., Chappell, R., Kushner, D.M., Transversus abdominis plane block in robotic gynecological oncology: a randomized placebo-controlled trial (2015) Gynecol. Oncol., 136, pp. 460-465; 
Hou, Y.Y., Cai, Y.Q., Pan, Z.Z., Persistent pain maintains morphine-seeking behavior after morphine withdrawal through reduced MeCP2 repression of GluA1 in rat central amygdala (2015) J. Neurosci., 35, pp. 3689-3700; 
Hough, L.B., Nalwalk, J.W., Yang, W., Ding, X., Neuronal cytochrome P450 activity and opioid analgesia: relevant sites and mechanisms (2015) Brain Res., 1616, pp. 10-18; 
Hsu, D.T., Sanford, B.J., Meyers, K.K., Love, T.M., Hazlett, K.E., Walker, S.J., Mickey, B.J., Zubieta, J.K., It still hurts: altered endogenous opioid activity in the brain during social rejection and acceptance in major depressive disorder (2015) Mol. Psychiatry, 20, pp. 193-200; 
Hu, M., Giulianotti, M.A., McLaughlin, J.P., Shao, J., Debevec, G., Maida, L.E., Geer, P., Yu, Y., Synthesis and biological evaluations of novel endomorphin analogues containing alpha-hydroxy-beta-phenylalanine (AHPBA) displaying mixed mu-delta opioid receptor agonist and delta opioid receptor antagonist activities (2015) Eur. J. Med. Chem., 92, pp. 270-281; 
Hu, X., Huang, F., Szymusiak, M., Liu, Y., Wang, Z.J., Curcumin attenuates opioid tolerance and dependence by inhibiting Ca2+/calmodulin-dependent protein kinase II alpha activity (2015) J. Pharmacol. Exp. Ther., 352, pp. 420-428; 
Huang, H.F., Chang, P.Y., Chen, Y.C., Tseng, K.Y., Hsu, H.T., Cheng, K.I., Lu, I.C., Single bolus parecoxib attenuates sore throat after laryngeal microsurgery: a randomized double-blind control study (2014) Kachsiung J. Med. Sci., 30, pp. 574-578; 
Huang, L., Tao, F., Wang, Z., Wan, H., Qu, P., Zheng, H., Combined neurolytic block of celiac and superior hypogastric plexuses for incapacitating upper abdominal cancer pain (2014) J. BUON, 19, pp. 826-830; 
Huang, W., Manglik, A., Venkatakrishnan, A.J., Laeremans, T., Feinberg, E.N., Sanborn, A.L., Kato, H.E., Kobilka, B.K., Structural insights into mu-opioid receptor activation (2015) Nature, 524, pp. 315-321; 
Huang, Z.X., Lu, Z.J., Ma, W.Q., Wu, F.X., Zhang, Y.Q., Yu, W.F., Zhao, Z.Q., Involvement of RVM-expressed P2 × 7 receptor in bone cancer pain: mechanism of descending facilitation (2014) Pain, 155, pp. 783-791; 
Hulin, M.W., Lawrence, M.N., Amato, R.J., Weed, P.F., Winsauer, P.J., Comparison of dehydroepiandrosterone (DHEA) and pregnanolone with existing pharmacotherapies for alcohol abuse on ethanol- and food-maintained responding in male rats (2015) Alcohol, 49, pp. 127-138; 
Hulskotte, E.G., Bruce, R.D., Feng, H.P., Webster, L.R., Xuan, F., Lin, W.H., O'Mara, E., Butterton, J.R., Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy (2015) Eu.r J. Clin. Pharmacol., 71, pp. 303-311; 
Hung, B.T., Traylor, K.S., Wong, C.Y., Revisiting morphine-augmented hepatobiliary imaging for diagnosing acute cholecystitis: the potential pitfall of high false positive rate (2014) Abdom. Imaging, 39, pp. 467-471; 
Hung, C.F., Li, H.J., Chang, H.H., Lee, G.A., Su, M.J., The differential effects of a selective kappa opioid receptor agonist, U50488H in guinea pig heart tissues (2015) BioMed Res. Int., 2015, p. 906039; 
Iamaroon, A., Tangwiwat, S., Sirivanasandha, B., Halilamien, P., Lertpenmetha, Y., Sirmaneewattana, S., Surachetpong, S., Puangchan, S., Femoral nerve block using 0.25% or 0.5% bupivacaine for analgesia after arthroscopic cruciate ligament reconstruction. J Med Assoc (2014) Thai, 97, pp. 717-723; 
Ibrahim, I.Y., Ibrahim, H.M., Aziz, N.M., Rahman, D.M., The protective role of the opioid antagonist LY255582 in the management of high fat diet-induced obesity in adult male albino rats (1549) Endocr. Regul., 20, pp. 198-205; 
Ickert, I., Herten, M., Vogl, M., Ziskoven, C., Zilkens, C., Krauspe, R., Kircher, J., Opioids as an alternative to amide-type local anaesthetics for intra-articular application (2015) Knee Surg. Sports Traumatol. Arthrosc., 23, pp. 2674-2681; 
Ide, S., Satoyoshi, H., Minami, M., Satoh, M., Amelioration of the reduced antinociceptive effect of morphine in the unpredictable chronic mild stress model by noradrenalin but not serotonin reuptake inhibitors (2015) Mol. Pain, 11, p. 47; 
Ikeda, H., Ardianto, C., Yonemochi, N., Yang, L., Ohashi, T., Ikegami, M., Nagase, H., Kamei, J., Inhibition of opioid systems in the hypothalamus as well as the mesolimbic area suppresses feeding behavior in mice (2015) Neuroscience, 311, pp. 9-21; 
Imanaka, K., Tominaga, Y., Etropolski, M., Ohashi, H., Hirose, K., Matsumura, T., Ready conversion of patients with well-controlled, moderate to severe chronic malignant tumor-related pain on other opioids to tapentadol extended release (2014) Clin. Drug Investig., 34, pp. 501-511; 
Imantalab, V., Mirmansouri, A., Sedighinejad, A., Naderi Nabi, B., Farzi, F., Atamanesh, H., Nassiri, N., Comparing the effects of morphine sulfate and diclofenac suppositories on postoperative pain in coronary artery bypass graft patients (2014) Anesth. Pain Med., 4, p. e19423; 
Imeh, A., Olaniyi, O., Simeon, O., Omotola, O., Dexamethasone versus a combination of dexamethasone and ondansetron as prophylactic antiemetic in patients receiving intrathecal morphine for cesarean section (2014) Afr. Health Sci., 14, pp. 453-459; 
Imeh-Nathaniel, A., Okon, M., Huber, R., Nathaniel, T.I., Exploratory behavior and withdrawal signs in crayfish: chronic central morphine injections and termination effects (2014) Behav. Brain Res., 264, pp. 181-187; 
Imenshahidi, M., Qaredashi, R., Hashemzaei, M., Hosseinzadeh, H., Inhbitory effect of Berberis vulgaris aqueous extract on acquisition and reinstatement effects of morphine in conditioned place preferences (CPP) in mice (2014) Jundishapur J. Nat. Pharm. Prod., 9, p. e16145; 
Imran-Khan, M., Shirzadian, A., Haj-Mirzajan, A., Mehr, S.E., Dehpour, A.R., Rahimi-Balaei, M., Amiri, S., Proconvulsant effect of post-weaning social isolation stress may be associated with dysregulation of opioid system in male mice (2015) Med. Hypotheses, 84, pp. 445-447; 
Inagaki, T.K., Irwin, M.R., Eisenberger, N.I., Blocking opioids attenuates physical warmth-induced feelings of social connection (2015) Emotion, 15, pp. 494-500; 
Inagi, T., Suzuki, M., Osumi, M., Bito, H., Remfentanil-based anesthesia increases the incidence of postoperative surgical site infection (2015) J. Hosp. Infect., 89, pp. 61-68; 
Ishikawa, G., Nagakura, Y., Taneshita, N., Shimizu, Y., Efficacy of drugs with different mechanisms of action in relieving spontaneous pain at rest and during movement in a rat model of osteoarthritis (2014) Eur. J. Pharmacol., 738, pp. 111-117; 
Ishola, I.O., Oreagba, I.A., Okeke Ogochukwu, N., Olayemi, S.O., Analgesic and anti-inflammatory actions of Alafia barteri: involvement of monoaminergic, nitrergic and opioidergic pathway (2015) Nig. Q. J. Hosp. Med., 25, pp. 118-123; 
Issa, M.A., Narang, S., Jamison, R.N., Michna, E., Edwards, R.R., Penetar, D.M., Wasan, A.D., The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain (2014) Clin. J. Pain, 30, pp. 472-478; 
Iyer, M.R., Rothman, R.B., Dersch, C.M., Jacobson, A.E., Rice, K.C., Probes for narcotic receptor mediated phenomnea 49 N-substituted rac-cis-4a-arylalkyl-1,2,3,4, 4a, 9a-hexahydrobenzofuo[2,3-c]pyridine-6-ois (2015) Eur. J. Med. Chem., 92, pp. 531-539; 
Jabalameli, M., Kalantari, F., Evaluation of the analgesic effect of subcutaneous methadone after cesarean section (2014) Adv. Biomed. Res., 3, p. 197; 
Jabbour, H.J., Naccache, N.M., Jawish, R.J., Zbou Zeid, H.A., Jabbour, K.B., Rabbaa-Khabbaz, L.G., Ghanem, I.B., Yazbeck, P.H., Ketamine and magnesium association reduces morphine consumption after scoliosis surgery: prospective randomized double-blind study (2014) Acta Anaesthesiol. Scand., 58, pp. 572-579; 
Jackson, K.J., Jackson, A., Carroll, F.I., Damaj, M.I., Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice (2015) Neuropharmacology, 97, pp. 270-274; 
Jacobs, P., Ang, A., Hillhouse, M.P., Saxon, A.J., Nielsen, S., Wakim, P.G., Mai, B.E., Blaine, J.D., Treatment outcome in opioid dependent patients with different buprenorphine/naloxone induction dosing patterns and trajectories (2015) Am. J. Addict., 24, pp. 667-675; 
Jagla, G., Mika, J., Makuch, W., Obara, I., Wordiczek, J., Przewocka, B., Analgesic effects of antidepressants alone and after their local co-administration with morphine in a rat model of neuropathic pain (2014) Pharmacol. Rep., 66, pp. 459-465; 
Jahangiri Fard, A., Babaee, T., Alavi, S.M., Nasiri, A.A., Ghoreishi, S.M., Noori, N.M., Mahjoubifard, M., Intravenous patient-controlled remifentanil versus paracetamol in post-operative pain management in patients undergoing coronary artery bypass graft surgery (2014) Anesth. Pain Med., 4, p. e19862; 
Jahanshahi, M., Shaabari, R., Nikmahzar, E.G., Babakordi, F., Female rat hippocampal cell density after conditioned place preference (2014) Folia Biol. (Praha), 60, pp. 47-51; 
Jamshidi, R.J., Jacobs, B.A., Sullivan, L.C., Chavera, T.A., Savior, R.M., Prisinzano, T.E., Clarke, W.P., Berg, K.A., Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons (2015) J. Pharmacol. Exp. Ther., 355, pp. 174-182; 
Javaheri, S., Harris, N., Howard, J., Chung, E., Adaptive servoventilation for treatment of opioid-associated central sleep apnea (2014) J. Clin. Sleep Med., 10, pp. 637-643; 
Jeanblanc, J., Balguerie, K., Courie, F., Legastelois, R., Jeanblanc, V., Naassila, M., Light alcohol intake during adolescence induces alcohol addicition in a neurodevelopmental model of schizophrenia (2015) Addict. Biol., 20, pp. 490-499; 
Jenda, M., Gawal, K., Marszalek, M., Komsta, L., Koblinska, J.H., AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice (2015) Prog. Neuropsychopharmacol. Biol. Psychiatry, 57, pp. 165-175; 
Jennings, C., Cassel, B., Fletcher, D., Wang, A., Archer, K.J., Skoro, N., Yanni, L., Del Fabbro, E., Response to pain management among patients with active cancer, no evidence of disease or chronic nonmalignant pain in an outpatient palliative care clinic (2014) J. Palliat. Med., 17, pp. 990-994; 
Ji, H., Wang, Y., Liu, G., Xu, X., Dai, D., Chen, Z., Zhou, D., Wang, Q., OPRK1 promoter hypermethylation increases the risk of Alzheimer's disease (2015) Neurosci. Lett., 606, pp. 24-29; 
Jia, Y., Gong, N., Li, T.F., Zhu, B., Wang, Y.X., Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/beta-endorphin pathway (2015) Pharmacol. Res., 102, pp. 276-285; 
Jian, M., Luo, Y.X., Xue, Y.X., Han, Y., Shi, H.S., Liu, J.F., Yan, W., Lu, L., elF2alpha dephosphorylation in basolateral amygdala mediates reconsolidation of drug memory (2014) J. Neurosci., 34, pp. 10010-10021; 
Jiang, C., Xu, L., Chen, L., Han, Y., Tang, J., Yang, Y., Zhang, G., Liu, W., Selective suppression of microglial activation by paeoniflorin attenuates morphine tolerance (2015) Eur. J. Pain, 19, pp. 908-919; 
Jiang, J.Y., Best, B.M., Morello, C.M., Atayee, R.S., Ma, J.D., Evaluation of concomitant methylphenidate and opioid use in patients with pain (2014) J. Anal. Toxicol., 38, pp. 421-426; 
Jiang, Y.L., He, X.F., Shen, Y.F., Yin, X.H., Du, J.Y., Liang, Y.I., Fang, J.Q., Analgesic roles of peripheral intrinsic met-enkephalin and dynorphin A in long-lasting inflammatory pain induced by complete Freund's adjuvant in rats (2015) Exp. Ther. Med., 9, pp. 2344-2348; 
Jiang, Z., Wu, S., Wu, X., Zhong, J., Lv, A., Jiao, J., Chen, Z., Blocking mammalian target of rapamycin alleviates bone cancer pain and morphine tolerance via mu-opioid receptor (2015) Int. J. Cancer, 138, pp. 2013-2020; 
Johnson, B., Richert, T., Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevelance estimates and risk factors (2015) Int. J. Drug Policy, 26, pp. 183-190; 
Johnson, J.L., Tolan, P.E., Johnson, M.E., Bobrovskaya, L., Williams, D.B., Johnson, K., Tuke, J., Hutchinson, M.R., Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation (2014) Transl. Psychiatry, 4, p. e482; 
Johnson, R.A., Lukens, J.M., Kole, J.W., Sisti, D.A., Views about responsibility for alcohol addiction and negative evaluations of naltrexone (2015) Subst. Abuse Treat. Prev. Policy, 10, p. 10; 
Johnston, C.E., Herschel, D.J., Lasek, A.W., Hammer, R.P., Jr., Nikulina, E.M., Knockdown of ventral tegmental area mu-opioid receptors in rats prevents effects of social defeat stress: implications for amphetamine cross-sensitization, social avoidance, weight regulation and expression of brain-derived neurotrophic factor (2015) Neuropharmacology, 89, pp. 325-334; 
Jones, C.M., Logan, J., Gladden, R.M., Bohm, M.K., (2002), Vital signs: demographic and substance use trends among heroin users −United States, –2013; Jones, J.D., Sullivan, M.A., Vosburg, S.K., Manubay, J.M., Mogali, S., Metz, V., Comer, S.D., Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users (2015) Addict. Biol., 20, pp. 784-798; 
Jonsson, S., Adermark, L., Ericson, M., Soderpalm, B., The involvement of accumbal glycine receptors in the dopamine-elevating effects of addictive drugs (2014) Neuropharmacology, 82, pp. 69-75; 
Joseph, D., Schobelock, M.J., Riesnberg, R.R., Vince, B.D., Webster, L.R., Adeniji, A., Elgadi, M., Huang, F., Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapy (2015) Antimicrob. Agents Chemother., 59, pp. 498-504; 
Joseph, T.T., Krishna, H.M., Kamath, S., Premedication with gabapentin, alprazolam or a placebo for abdominal hysterectomy: effects of preoperative anxiety, post-operative pain and morphine consumption (2014) Indian J. Anaesth., 58, pp. 693-699; 
Joshi, J.C., Ray, A., Gulati, K., Effects of morphine on stress induced anxiety in rats: role of nitric oxide and Hsp70 (2015) Physiol. Behav., 139, pp. 393-396; 
Joshi, A.A., Mrray, T.F., Aldrich, J.V., Structure-activity relationships of the peptide kappa opioid receptor antagonist zyklophin (2015) J. Med. Chem., 58, pp. 8783-8795; 
Joshi, J.C., Ray, A., Gulati, K., Differential modulatory effects of morphine on acute and chronic stress induced neurobehavioral and cellular markers in rats (2014) Eur. J. Pharmacol., 729, pp. 17-21; 
Jr, G.S., Fitzgerald, P., Ahmad, S., Kim, J., Rahangdale, R., McCarthy, R., Transversus abdominis plane infiltration for laparoscopic gastric banding: a pilot study (2014) World J. Gastroentest. Surg., 6, pp. 27-32; 
Ju, Y.Y., Long, J.D., Liu, Y., Liu, J.G., Formation of aversive memories associated with conditioned drug withdrawal requires BDNF expression in the amygdala in acute morphine-dependent rats (2015) Acta Pharmacol. Sin., 36, pp. 1437-1443; 
Juarez-Rojop, I.E., Morales-Hernandez, P.E., Tovilla-Zarate, C.A., Bermudez—Ocana, D.Y., Torres-Lopez, J.E., Bie-Castillo, J.L., Diaz-Zagoya, J.C., Granados-Soto, V., Celecoxib reduces hyperalgesia and tactile allodynia in diabetic rats (2015) Pharmacol. Rep., 67, pp. 545-552; 
Kamali-Sarvestani, F., Motiallah, T., Ghaffarinejad, F., The prevalence of musculoskeletal pain and forward head posture among heroin users during their withdrawal from methadone (2014) Addict. Health, 6, pp. 30-35; 
Kamalpour, M., Fereidoni, M., Moghimi, A., Effects of intrathecal carbenolxolone treatment on nociception and analgesia in the rat (2014) Balkan Med. J., 31, pp. 164-172; 
Kamboj, S.K., Conroy, L., Tookman, A., Carroll, E., Jones, L., Curran, H.V., Effects of immediate-release opioid on memory functioning: a randomized-controlled study in patients receiving sustained-release opioids (2014) Eur. J. Pain, 18, pp. 1376-1394; 
Kampe, S., Weinreich, G., Darr, C., Stamatis, G., Hachenberg, T., Controlled-release oxycodone as gold standard for postoperative pain therapy in patients undergoing video-assisted thoracic surgery or thoracoscopy: a retrospective evaluation of 788 cases (2015) Thorac. Cardiovasc. Surg., 63, pp. 510-513; 
Kanate, D., Folk, D., Cirone, S., Gordon, J., Kirlew, M., Veale, T., Bocking, N., Kelly, L., Community-wide measures of wellness in a remote First Nations community experiencing opioid dependence: evaluating outpatient buprenorphine/naloxone substitutuion therapy in the context of a First Nations healing program (2015) Can. Fam. Physician, 61, pp. 160-165; 
Kanbara, T., Nakamura, A., Shibasaki, M., Mori, T., Suzuki, T., Sakaguchi, G., Kanemasa, T., Morphine and oxycodone, but not fentanyl, exhibit antinociceptive effects mediated by G-protein inwardly rectifying potassium (GIRK) channels in an oxaliplatin-induced neuropathy rat model (2014) Neurosci. Lett., 580, pp. 119-124; 
Kanbara, T., Nakamura, A., Takasu, K., Ogawa, K., Shibasaki, M., Mori, T., Suzuki, T., Kanemasa, T., The contribution of Gi/o protein to opioid antinociception in an oxaliplatin-induced neuropathy rat model (2014) J. Pharmacol. Sci., 126, pp. 264-273; 
Kang-Park, M., Kieffer, B.L., Roberts, A.J., Siggins, G.R., Moore, S.D., Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala (2015) J. Pharmacol. Exp. Ther., 355, pp. 206-211; 
Kangas, B.D., Bergman, J., Operant nociception in nonhuman primates (2014) Pain, 155, pp. 1821-1828; 
Kantor, E., Montravers, P., Longrois, D., Guglielminotti, J., Pain assessment in the postanesthesia care unit using pupillometry: a cross-sectional study after standard anaesthetic care (2014) Eur. J. Anaesthesiol., 31, pp. 91-97; 
Kao, F.C., Su, S.H., Carlson, C.C., Liao, W., MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome (2015) Brain Struct. Funct., 220, pp. 419-434; 
Kao, J.H., Gao, M.J., Yang, P.P., Law, P.Y., Loh, H.H., Tao, P.L., Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant mu-opioid receptor gene in spinal cord (2015) Br. J. Pharmacol., 172, pp. 630-641; 
Karimi, S., Attarzadeh-Yazdi, G., Yazdi-Ravandi, S., Hesam, S., Azizi, P., Razavi, Y., Haghparast, A., Forced swim stress but not exogenous corticosterone could induce the reinstatement of extinguished morphine conditioned place preference in rats: involvement of glucocorticoid receptors in the basolateral amygdala (2014) Behav. Brain Res., 264, pp. 43-50; 
Karimi, S., Radahmadi, M., Fazilati, M., Azizi-Malekabadi, H., Alaei, H., Roles of the nucleus accumbens (shell) in the acquisition and expression of morphine-induced conditioned behavior in freely moving rats (2014) Int. J. Prev. Med., 5, pp. 262-268; 
Karllson, L., Gerdle, B., Ghafouri, B., Backryd, E., Olausson, P., Ghafouri, N., Larsson, B., Intramuscular pain modulatory substances before and after exercise in women with chronic neck pain (2015) Eur. J. Pain, 19, pp. 1075-1085; 
Karlsson, H.K., Tuominen, L., Tuulari, J.J., Hirvonen, J., Parkkola, R., Helin, S., Salminen, P., Nummenmaa, L., Obesity is associated with decreased mu-opioid but unaltered dopamine D2 receptor availability in the brain (2015) J. Neurosci., 35, pp. 3959-3965; 
Kasivisanathan, R., Abbassi-Ghadi, N., Prout, J., Clevenger, B., Fusai, G.K., Mallett, S.V., A prospective cohort study of intrathecal versus epidural analgesia for patients undergoing hepatic resection (2014) HPB (Oxford), 16, pp. 768-775; 
Katsidoni, V., Alexiou, P., Fotiadou, M., Pelecanou, M., Sagnou, M., Panagis, G., Curcumin, demetheoxycurcumin and bisdemethoxycurcumin differentially inhibit morphine's rewarding effect in rats (2014) Psychopaharmacology (Berl)., 231, pp. 4467-4478; 
Katsuyama, S., Otowa, A., Kamio, S., Sato, K., Yagi, T., Kishikawa, Y., Komatsu, T., Nakamura, H., Effect of plantar subcutaneous administration of bergamot essential oil and linalool on formalin-induced nociceptive behavior in mice (2015) Biomed. Res., 36, pp. 47-54; 
Kaufling, J., Aston-Jones, G., Persistent adaptations in afferents to ventral tegmental dopamine neurons after opiate withdrawal (2015) J. Neurosci., 35, pp. 10290-10303; 
Kawabe, T., Ueyama, T., Hano, T., Sapru, H.N., Cardiovascular responses to microinjection of endomorphin-2 into the nucleus of the solitary tract are attenuated in the spontaneously hypertensive rat (1537) Clin. Exp. Hypertens., 20, pp. 197-206; 
Kawano, T., Takahashi, T., Iwata, H., Morikawa, A., Imori, S., Waki, S., Tamura, T., Yokoyama, M., Effects of ketoprofen for prevention of postoperative cognitive dysfunction in aged rats (2014) J. Anesth., 28, pp. 932-936; 
Kaygisiz, B., Kilic, F.S., Senguleroglu, N., Baydemir, C., Erol, K., The antinociceptive effect and mechanisms of action of pregabalin in mice (2015) Pharmacol. Rep., 67, pp. 129-133; 
Kayser, V., Viguier, F., Melfort, M., Bourgoin, S., Hamon, M., Masson, J., Alrered nociception in mice with genetically induced hypoglutamatergic tone (2015) Neuroscience, 293, pp. 80-91; 
Kelly, E., Mundell, S.J., Sava, A., Roth, A.L., Felici, A., Maltby, K., Nathan, P.J., Henderson, G., The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviors (2015) Psychopharmacology (Berl)., 232, pp. 305-314; 
Kelly, J.S., Opsha, Y., Costello, J., Schiller, D., Hola, E.T., Opioid use in knee arthroplasty after receiving intravenous acetaminophen (2014) Pharmacotherapy, 34, pp. 22S-26S. , (4.5); 
Kelsey, J.E., Verhaak, A.M., Schierberi, K.C., The kappa opioid receptor antafonist, nor-binaltorphamine (nor-BNI) decreases morphine withdrawal and the consequent conditioned place preference (2015) Behav. Brain Res., 283, pp. 16-21; 
Khabbazi, S., Goumon, Y., Parat, M.Q., Morphine modulates interleukin-4- or breast cancer cell-induced pro-metastatic activation of macrophages (2015) Sci. Rep., 5, p. 11389; 
Khaleghzadeh-Ahangar, H., Haghparast, A., Intra-accumbal CB1 receptor blockade reduced extinction and reinstatement of morphine (2015) Physiol. Behav., 149, pp. 212-219; 
Khalilzadeh, E., Vafaei Saiah, G., Hasannejad, H., Ghaderi, A., Hamidian, G., Mahmoudi, R., Eshgi, D., Zangishah, M., Antinociceptive effects, acute toxicity and chemical composition of Vitex agnus-castus essential oil (2015) Avicenne J. Phytomed., 5, pp. 218-230; 
Khan, N., Woodruff, T.M., Smith, M.T., Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods (2014) Pharmacol. Biochem. Behav., 126, pp. 13-27; 
Khatun, A., Imam, M.Z., Rana, M.S., Antinociceptive effect of methanol extract of leaves of Persicaria hydropiper in mice (2015) BMC Complement. Altern. Med., 15, p. 63; 
Khelemsky, Y., Schauer, J., Loo, N., Effect of buprenorphine on total intravenous anaesthetic requirements during spine surgery (2015) Pain Physician, 18, pp. E261-E264; 
Khroyan, T.V., Wu, J., Polgar, W.E., Cami-Kobeci, G., Fotaki, N., Husbands, S.M., Toll, L., BU0873 a buprenorphine analog with partial agonist activity at mu-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice (2015) Br. J. Pharmacol., 172, pp. 668-680; 
Kim, Y.J., Byun, J.H., Choi, I.S., Effect of exercise on mu-opioid receptor expression in the rostral ventromedial medulla in neuropathic pain model (2015) Ann. Rehab. Med., 39, pp. 331-339; 
Kiraly, K., Caputi, F.F., Hanuska, A., Kato, E., Balogh, M., Koles, L., Palmisano, M., Al-Khrasani, M., A new potent analgesic agent with reduced liability to produce morphine tolerance (2015) Brain Res. Bull., 117, pp. 32-38; 
Kirchner, L., Graf-Rohrmeister, K., Klebermass-Schrehof, K., Weineger, M., Jagsch, R., Metz, V., Unger, A., Fischer, G., Neonatal abstinence syndrome in European and North American neonates: differences in clinical characteristics derived from a peospective randomized trial (2014) Klin. Padiatr., 226, pp. 274-280; 
Kirkpatrick, B.L., Bryant, C.D., Behavioral architecture of opioid reward and aversion in C57BL/6 substrains (2015) Front. Behav. Neurosci., 8, p. 450; 
Kitanaka, J., Kitanaka, N., Hall, F.S., Fujii, M., Goto, A., Kanda, Y., Koizumi, A., Takemura, M., Memory impairment and reduced exploratory behavior in mice after administration of systemic morphine (2016) J. Exp. Neurosci., 9, pp. 27-35; 
Kjeldsen, L.J., Birkholm, T., Fischer, H., Graabaek, T., Kibsdal, K.P., Ravn-Nielsen, L.V., Truelshoj, T.H., Characterization of drug-related problems identified by clinical pharmacy staff at Danish hospitals (2014) Int. J. Clin. Pharm., 36, pp. 734-741; 
Kleinjan, M., Engels, R.C., DiFranza, J.R., Parental smoke exposure and the development of nicotine craving in adolescent novice smokers: the roles of DRD2, DRD4 and OPRM1 genotypes (2015) BMC Pulm. Med., 15, p. 115; 
Kleinjan, M., Rozing, M., Engels, R.C., Verhagen, M., Co-development of early adolescent alcohol use and depressive feelings; the role of the mu-opioid receptor A118G polymorphism (2015) Dev. Psychopathol., 27, pp. 915-925; 
Knapman, A., Santiago, M., Connor, M., A6 V polymorphism of the human mu-opioid receptor decreases signaling of morphine and endogenous opioids in vitro (2015) Br. J. Pharmacol., 172, pp. 2258-2272; 
Knych, H.K., Steffey, E.P., MacKemie, D.S., Preliminary pharmacokinetics of morphine and its major maetabolites following intravenous administration of four doses to horses (2014) J. Vet. Pharmacol. Ther., 37, pp. 374-381; 
Kobayashi, T., Kiyokawa, Y., Takeuchi, Y., Mori, Y., Neural correlates underlying naloxone-induced amelioration of sexual behavior deterioration due to an alarm pheromone (2015) Front. Neurosci., 9, p. 52; 
Kobori, T., Fujiwara, S., Miyagi, K., Harada, S., Nakamoto, K., Nakagawa, T., Takahashi, H., Tokuyama, S., Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood-brain barrier (2014) Drug Metab. Pharmacokinet., 29, pp. 482-489. , (7.1); 
Koch, M., Varela, L., Kim, J.G., Kim, J.D., Hernandez-Nuno, F., Simonds, S.E., Castorena, C.M., Hypothalamic, P.O.M.C., neurons promote cannabinoid-induced feeding (2015) Nature, 519, pp. 45-50; 
Koh, R.B., Isaza, N., Xie, H., Cooke, K., Robertson, S.A., Effects of macropitant, acepromazine, and electroacupuncture on vomiting associated with administration of morphine in dogs (2014) J. Am. Vet. Med. Assoc., 244, pp. 820-829; 
Kolotkin, R.L., Chen, S., Klassen, P., Gilder, K., Greenway, F.L., Patient-reported quality of life in a randomized placebo trial of naltrexone/bupropion for obesity (2015) Clin. Obes., 5, pp. 237-244; 
Kong, Q., Song, D., Yu, L.C., Region-specific alterations in glutamate receptor 1 phosphorylation during context-induced drug seeking after withdrawal from morphine self-administration (2014) Neuroreport, 25, pp. 127-133; 
Konoura, K., Fujii, H., Imaide, S., Gouda, H., Hirayama, S., Hirono, S., Nagase, H., Transformation of naltrexone into mesembrane and investigation of the binding properties of its intermediate derivatives to opioid receptors (2015) Bioorg. Med. Chem., 23, pp. 439-448; 
Konstantatos, A.H., Kavnoudias, H., Stegeman, J.R., Boyd, D., Street, M., Bailey, M., Lyon, S.M., Thomson, K.R., A randomized, double-blind, placebo-controlled study of preemptive oral oxycodone with morphine patient-controlled anesthesia for postoperative pain management in patients undergoing uterine artery embolization for symptomatic uterine fibroids (2014) Cardiovasc. Intervent. Radiol., 37, pp. 1191-1197; 
Koo, J.W., Lobo, M.K., Chaudhury, D., Labonte, B., Friedman, A., Heller, E., Pena, C.J., Nestler, E.J., Loss of BDNF signaling in D1R-expressing neurons enhances morphine reward by reducing GABA inhibition (2014) Neuropsychopharmacology, 39, pp. 2646-2653; 
Korzeniewska-Eksterowicz, A., Przysio, L., Fendler, W., Stolarska, M., Mlynarski, W., Palliative sedation at home for terminally ill children with cancer (2014) J. Pain Sympt. Manag., 48, pp. 968-974; 
Kotrach, H.G., Bourbeau, J., Jensen, D., Does nebulized fentanyl relieve dyspnea during exercise in healthy man? (2015) J. Appl. Physiol. (1985), 118, pp. 1406-1414; 
Kotsovolis, G., Karakoulas, K., Grosomanidis, V., Tziris, N., Comparison between the combination of gabapentin, ketamine, lornoxicam and local ropivacaine and each of the three drugs alone for pain after laparoscopic cholecystectomy: a randomized trial (2015) Pain Pract., 15, pp. 355-363; 
Kozyrev, N., Coolen, L.M., Activation of mu or delta opioid receptors in the lumbosacral spinal cord is essential for ejaculatory reflexes in male rats (2015) PLoS One, 10, p. e0121130; 
Kraemer, W.J., Gordon, S.E., Fragala, M.S., Bush, J.A., Azivak, T.K., Flanagan, S.D., Hooper, D.R., Patton, J.F., The effects of exercise training programs on plasma concentrations of proenkephalin, Peptide F and catecholamines (2015) Peptides, 64, pp. 74-81; 
Kraft, T.T., Huang, D., Natanova, E., Lolier, M., Yakubov, Y., La Magna, S., Warshaw, D., Bodnar, R.J., Dopamine D1 and opioid receptor antagonist-induced reductions of fructose and saccharin intake in BALB/c and SWR inbred mice (2015) Pharmacol. Biochem. Behav., 131, pp. 13-18; 
Kraft, T.T., Yakubov, Y., Huang, D., Fitzgerald, G., Natanova, E., Sclafani, A., Bodnar, R.J., Dopamine D1 and opioid receptor antagonists differentially reduce the acquisition and expression of fructose-conditioned flavor preferences in BALB/c and SWR mice (2015) Physiol. Behav., 151, pp. 213-220; 
Kramer, P.R., Umorin, M., Bellinger, L.L., Attenuation of myogenic orofacial nociception and mechanical hypersensitivity by viral mediated enkephalin overproduction in male and female rats (2015) BMC Neurol., 15, p. 34; 
Kravets, J.L., Reyes, B.A., Unterwald, E.M., Van Bockstaele, E.J., Direct targeting of peptidergic amygdalar neurons by noradrenergic afferents linking stress-integrative circuitry (2015) Brain Struct. Funct., 220, pp. 541-558; 
Krekels, E.H., Tibboel, D., de Wildt, S.N., Ceelie, I., Dahan, A., van Dijk, M., Danhof, M., Knibbe, C.A., Evidence-based morphine dosing for postoperative neonates and infants (2014) Clin. Pharmacokinet., 53, pp. 553-563; 
Kren, N.P., Zagon, I.S., McLaughlin, P.J., Mutations in the opioid growth factor receptor in human cancers alter receptor function (2015) Int. J. Mol. Med., 36, pp. 289-293; 
Kren, N.P., Zagon, I.S., McLaughlin, P.J., Nuclear export of opioid growth factor receptor is CRM1 dependent (2015) Exp. Biol. Med. (Maywood), 241, pp. 273-281; 
Kress, H.G., Koch, E.D., Kosturski, H., Steup, A., Karcher, K., Lange, B., Dogan, C., Eerdekens, M., Tapentadol prolonged release for managing moderate to severe, chronic malignant tumor-related pain (2014) Pain Physician., 17, pp. 329-343; 
Kuhar, J.R., Bedini, A., Melief, E.J., Chiu, Y.C., Striegel, H.N., Chavkin, C., Mu opioid receptor activation activates c-Jun N-terminal kinase 2 by distinct arrestin-dependent and independent mechanisms (2015) Cell. Signal., 27, pp. 1799-1808; 
Kuki, F., Sugiyo, S., Niwa, H., Takemura, M., Inferior alveolar nerve transection enhanced formalin-induced nocifensive responses in the upper lip: systemic buprenorphine had more antinociceptive efficacy over morphine (2014) Pharmacology, 93, pp. 10-17; 
Kumar, A., Liu, N.J., Madia, P.A., Gintzler, A.R., Contribution of endogenous spinal endomorphin-2 to intrathecal opioid antinoception in rats is agonist dependent and sexually dimorphic (2015) J. Pain, 16, pp. 1200-1210; 
Kumar, A., Storman, E.M., Liu, N.J., Gintzler, A.R., Estrogens suppress spinal endomorphin-2 release in female rats in phase with the estrous cycle (2015) Neuroendocrinology, 102, pp. 33-43; 
Kumar, R., Reeta, K.H., Ray, S.B., Chronic spinal infusion of loperamide alleviates postsurgical pain in rats (2014) Indian J. Exp. Biol., 52, pp. 317-322; 
Kumarihamy, M., Leon, F., Pettaway, S., Wilson, L., Lambert, J.A., Wang, M., Hill, C., Muhammad, I., In vitro opioid receptor affinity and in vivo behavioral studies of Nelumbo nucifera flower (2015) J. Ethnopharmacol., 174, pp. 57-65; 
Kundra, S., Gupta, V., Bansal, H., Grewal, A., Katyai, S., Choudhary, A.K., Comparative study of epidural application of morphine versus gelfoam soaked in morphine for lumbar laminectomy (2014) J. Anaesthesiol. Clin. Pharmacol., 30, pp. 46-523; 
Kunopart, M., Chanthong, P., Thongpolswat, N., Intiyanaravut, T., Pethuahong, C., Effects of a single shot femoral nerve block combined with intrathecal morphine for postoperative analgesia: a randomized, controlled dose-ranging study after total knee arthroplasty (2014) J. Med. Assoc. Thai., 97, pp. 195-202; 
Kuo, A., Wyse, B.D., Meutermans, W., Smith, M.T., In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile (2015) Br. J. Pharmacol., 172, pp. 532-548; 
Kuo, M., Shamsian, A., Tzemis, D., Buxton, J.A., A drug use survey among clients of harm reduction sites across British Columbia, Canada, 2012 (2014) Harm. Reduct. J., 11, p. 13; 
Kurokawa, K., Mizuno, K., Ohkuma, S., Increase of type 2 ryanodine receptors in mouse nucleuas accumbens in the development and expression of morphine-induced place preference (2014) J. Pharmacol. Sci., 126, pp. 285-290; 
Kusumura, N., Nakajima, R., Koyama, Y., Miyata, Y., Saitoh, T., Yamamoto, N., Iwata, S., Nagase, H., Investigation of 7-benzylidenenaltrexone derivatives as a novel structural antitrichomonal lead compound (2015) Bioorg. Med. Chem. Lett., 25, pp. 4890-4892; 
Lalezari, J., Sullivan, J.D., Varunok, P., Galen, E., Kowdley, K.V., Rustgi, V., Aguilar, H., Cohen, D.E., Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine (2015) J. Hepatol., 63, pp. 364-369; 
Lalla, R.V., Choquette, L.E., Curley, K.F., Dowsett, R.J., Feinn, R.S., Hegde, U.P., Pilbeam, C.C., Peterson, D.E., Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer (2014) Oral Oncol., 50, pp. 1098-1103; 
Lam, J., Woodall, K.L., Solbeck, P., Ross, C.J., Carleton, B.C., Hayden, M.R., Koren, G., Madadi, P., Codeine-related deaths: the role of pharmacogenetics and drug interactions (2014) Forensic Sci. Int., 239, pp. 50-56; 
Langford, R., Brown, I., Vickery, J., Mitchell, K., Pritchard, C., Creanor, S., Study protocol for a sdouble blind, randomized, placebo-controlled trial of continuous subpectoral local anaesthetic infusion for pain and shoulder function following mastectomy: sub-pectoral local anaesthetic infusion following mastectomy (SUBLIME) (2014) BMJ Open, 4, p. e006318; 
Langlois, L., Meleine, M., Ouelaa, W., Caremel, R., Bridoux, V., Benard, M., Dechelotte, P., Gourcerol, G., Acute sacral nerve stimulation reduces visceral mechanosenstitivity in rat through spinal opioid pathway (2015) Neurogastroenterol. Motil., 27, pp. 816-823; 
Laoharatchatathanin, T., Terashima, R., Yonezawa, T., Kurusu, S., Kawamininami, M., Augmentation of mestatin/kisspeptin mRNA expression by the proestrous leutinizing hormone surge in granulosa cells of rats: implications for leutinization (2015) Biol. Reprod., 93, p. 15; 
Lapeyre-Mestre, M., Gony, M., Carvajal, A., Macias, D., Conforti, A., D'Incau, P., Heerdink, R., Bergman, M., A European community pharmacy-based survey to investigate patterns of prescription fraud through identification of falsified prescriptions (2014) Eur. Addict. Res., 20, pp. 174-182; 
Larance, B., Dietze, P., Ali, R., Lintzeris, N., White, N., Jenkinson, R., Degenhardt, L., The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: uptake and issues arising from changing buprenorphine formulations (2015) Drug Alcohol Rev., 34, pp. 603-610; 
Lardeux, S., Kim, J.J., Nicola, S.M., Intermittent-access binge consumption of sweet high-fat liquid does not require opioid or dopamine receptors in the nucleus accumbens (2015) Behav. Brain Res., 292, pp. 194-208; 
Laredo, S.A., Steinman, M.Q., Robles, C.F., Ferrer, E., Ragen, B.J., Trainor, B.C., Effects of defeat stress on behavioral flexibility in males and females: modulation by the mu-opioid receptor (2015) Eur. J. Neurosci., 41, pp. 434-441; 
Larson, D.W., Lovely, J.K., Cima, R.R., Dozois, E.J., Chua, H., Wolff, B.G., Pemberton, J.H., Huebner, M., Outcomes after implementation of a multimodal standard care pathway for laparoscopic colorectal surgery (2014) Br. J. Surg., 101, pp. 1023-1030; 
Lasheras, M.C., Laorden, M.L., Milanes, M.V., Nunez, C., Corticotropin-releasing factor 1 receptor mediates the activity of the reward system evoked by morphine-induced conditioned place preference (2015) Neuropharmcology, 95, pp. 168-180; 
Lasota, A., Fraczak, O., Lesniak, A., Muchowska, A., Lipkowski, A.W., Nowakowski, M., Ejchart, A., Olma, A., Analogues of deltorphin-1 containing confirmationally restricted amino acids in position 2: structure and opioid activity (2015) J. Pept. Sci., 21, pp. 120-125; 
Lasukova, T.V., Maslov, L.N., Gorbunov, A.S., Effects of mu opioid receptor agonist DAMGO on heart contractibility and necrotic injury to cardiomyocytes during ischemia and reperfusion of isolated rat heart (2015) Bull. Exp. Biol. Med., 159, pp. 722-725; 
Laukkanen, V., Karkkainen, O., Kautiainen, H., Tihonen, J., Storvik, M., Decreased [3H]naloxone binding in the dentate nucleus of Cloninger Type 1 anxiety-prone alcoholics: a post-mortum whole-hemisphere autoradiography study (2015) Alcohol. Clin. Exp. Res., 39, pp. 1352-1359; 
Launonen, E., Alho, H., Kotovirta, E., Wallace, I., Simojoki, K., Diversion of opioid maintenance treatment medications and predictors for diversion among Finnish maintenance treatment patients (2015) Int. J. Drug Policy, 26, pp. 875-882; 
Laurent, V., Wong, F.L., Balleine, B.W., Delta-opioid receptors in the accumbens shell mediate the influence of both excitatory and inhibitory predictions on choice (2015) Br. J. Pharmacol., 172, pp. 562-570; 
Lax, N.C., George, D.C., Ignatz, C., Kolber, B.J., The mGluR5 antagonist fenobam induces analgesic conditioned place preference in mice with spared nerve injury (2014) PLoS One, 9, p. e103524; 
Lazzari, M., Greco, M.T., Marcassa, C., Finocchi, S., Caldarulo, C., Corli, O., Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis (2015) Drug Des. Dvel. Ther., 9, pp. 5863-5872; 
Le, T., Xia, M., Jia, M., Sarkar, N., Chen, J., Li, H., Wynn, G.H., Choi, K.H., Association between initial morphine intake and body weight change, acoustic startle reflex and drug seeking in rats (2014) Psychopharmacology (Berl)., 231, pp. 4569-4577; 
Lebaron, V., Beck, S.L., Maurer, M., Black, F., Palat, G., An ethnographic study of barriers to cancer pain management and opioid availability in India (2014) Oncologist, 19, pp. 515-522; 
Le Guen, M., Liu, N., Tounou, F., Auge, M., Tull, O., Chazot, T., Dardelle, D., Fischler, M., Dexmedetomdine reduces propofol and remifemtanil requirements during bispectral index-guided closed-loop anesthesia: a double-blind, placebo-controlled trial (2014) Anesth. Analg., 118, pp. 946-955; 
Lee, B.H., Ku, J.Y., Zhao, R.J., Kim, H.Y., Yang, C.H., Gwak, Y.S., Chang, S.C., Lim, S.C., Acupuncture at HT7 suppresses morphine self-administration at high dose through GABA system (2014) Neurosci. Lett., 576, pp. 34-39; 
Lee, C.W., Muo, C.H., Liang, J.A., Sung, F.C., Kao, C.H., Yeh, J.J., Pulmonary embolism is associated with current morphine treatment in patients with deep vein thrombosis (2015) Clin. Respir. J., 9, pp. 233-237; 
Lee, C.W., Muo, C.H., Liang, J.A., Sung, F.C., Kao, C.H., Modest increase in risk of acute coronary syndrome associated with morphine use in cancer patients: a population-based nested case-control study (2014) Eur. J. Oncol. Nurs., 18, pp. 295-298; 
Lee, C.W., Muo, C.H., Liang, J.A., Sung, F.C., Kao, C.H., Subdural hemorrhage is associated with recent morphine treatment in patients with cancer: a retrospective population-based nested case-control study (2014) Brain Inj., 28, pp. 1353-1357; 
Lee, D., Armaghani, S., Archer, K.R., Bible, J., Shau, D., Kay, H., Zhang, C., Devin, C., Preoperative opioid use as a predictor of adverse postoperative self-reported outcomes in patients undergoing spine surgery (2014) J. Bone Joint Surg. Am., 96, p. e89; 
Lee, D.J., Gurkoff, G.G., Goodarzi, A., Muizelaar, J.P., Boggan, J.E., Shahlaie, K., Intracerebroventricular opiate infusion for refractory head and facial pain (2014) World J. Clin. Cases, 2, pp. 351-356; 
Lee, D.Y., Deng, G., Ma, Z., Xu, W., Yang, L., Liu, J., Dai, R., Liu-Chen, L.Y., Synthesis and biological evaluation of 2-alkyl-2-methoxymethyl-salvinorin ethers as selective kappa-opioid receptor agonists (2015) Bioorg. Med. Chem. Lett., 25, pp. 4689-4692; 
Lee, H., Ko, M.C., Distinct functions of opioid-related peptides and gastrin-releasing peptide in regulating itch and pain in the spinal cord of primates (2015) Sci. Rep., 5, p. 11676; 
Lee, I.S., Lee, B., Park, H.J., Olausson, H., Enck, P., Chae, Y., A new animal model of placebo analgesia: involvement of the dopaminergic system in reward learning (2015) Sci. Rep., 5, p. 17140; 
Lee, J.D., Friedmann, P.D., Boney, T.Y., Hoskinson, R.A., Jr., McDonald, R., Gordon, M., Fishman, M., O'Brien, C.P., Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectivenss trial (2015) Contemp. Clin. Trials, 41, pp. 110-117; 
Lee, J.H., Park, J.H., Kil, H.K., Choi, S.H., Noh, S.H., Koo, B.N., Efficacy of intrathecal morphine combined with intravenous analgesia versus thoracic epidural analgesia after gastrectomy (2015) Yonsei Med. J., 55, pp. 1106-1114; 
Lee, K.M., Chiu, K.B., Didier, P.J., Bker, K.C., Maclean, A.G., Naltrexone treatment reverses astrocyte atrophy and immune dysfunction in self-harming macaques (2015) Brain Behav. Immun., 50, pp. 288-297; 
Lee, K.W., Abrahamowicz, M., Leonard, G.T., Richer, L., Perron, M., Veillette, S., Reischl, E., Pausova, Z., Prenatal exposure to cigarette smoke interacts with OPRM1 to modulate dietary preference for fat (2015) J. Psychiatry Neurosci., 40, pp. 38-45; 
Lee, M.H., Chung, M.H., Han, C.S., Lee, J.H., Choi, Y.R., Choi, E.M., Lim, H.K., Cha, Y.D., Comparison of effects of intraoperative esmolol and ketamine infusion on acute postoperative pain after remifentanil-based anesthesia in patients undergoing laparoscopic cholecystectomy (2014) Korean J. Anesthesiol., 66, pp. 222-229; 
Lee, S.H., Kim, J.D., Park, S.A., Oh, C.S., Kim, S.H., Effects of mu-opioid receptor gene polymorphism on postoperative nausea and vomiting in patients undergoing general anesthesia with remifentanil: double binded randomized trial (2015) J. Korean Med. Sci., 30, pp. 651-657; 
Lee, Y.S., Hall, S.M., Ramos-Colon, C., Remesic, M., LeBaron, L., Nguyen, A., Rankin, D., Hruby, V.J., Modification of amphiphatic non-opioid dynorphin A analogues for rat brain bradykinin receptors (2015) Bioorg. Med. Chem. Lett., 25, pp. 30-33; 
Lee, Y.S., Hall, S.M., Ramos-Colon, C., Remesic, M., Rankin, D., Vanderah, T.W., Porreca, F., Hruby, V.J., Blockade of non-opioid excitatory effects of spinal dynorphin A at bradykinin receptors (2015) Receptors Clin. Investig., 2, p. 517. , (3.9); 
Lefever, M., Li, Y., Anglin, B., Muthu, D., Giuvelis, D., Lowery, J.J., Knapp, B.I., Polt, R., Structural requirements for CNS active opioid glycopeptides (2015) J. Med. Chem., 58, pp. 5728-5741; 
Leite-Morris, K.A., Kobrin, K.L., Guy, M.D., Young, A.J., Heinrichs, S.C., Kaplan, G.B., Extinction of opiate reward reduces dendritic arborization and c-Fos expression in the nucleus accumbens core (2014) Behav. Brain Res., 263, pp. 51-59; 
Lenton, S., Dietze, P., Olsen, A., Wiggins, N., McDonald, D., Fowlie, C., Working together: expanding the availability of naloxone for peer administration to prevent overdose deaths in the Australian capital territory and beyond (2015) Drug Alcohol Rev., 34, pp. 404-411; 
Leppert, W., Okulicz-Kozaryn, I., Kaminska, E., Szuic, M., Mikoajczak, P., Analgesic effects of morphine in combination with adjuvant drugs in rats (2014) Pharmacology, 94, pp. 207-213; 
Leslie, D.L., Milchak, W., Gastfriend, D.R., Herschman, P.L., Bixler, E.O., Velott, D.L., Meyer, R.E., Effects of injectable extended-release naltrexone (XR-NTX) for opioid dependence on residential rehabilitation outcomes and early follow-up (2015) Am. J. Addict., 24, pp. 265-270; 
Levitt, E.S., Abdala, A.P., Paton, J.F., Bissonnette, J.M., Williams, J.T., Mu opioid receptor activation hyperpolarizes respiratory-controlling Kolliker-Fuxe neurons and suppresses post-inspiratory drive (2015) J. Physiol., 593, pp. 4453-4469. , (18.1); 
Levy, A., Marshall, P., Zhou, Y., Kreek, M.J., Kent, K., Daniels, S., Shore, A., Fructose, L.F., glucose ratios −a study of sugar self-administration and associated neural and physiological responses in the rat (2015) Nutrients, 7, pp. 3869-3890; 
Li, C.Q., Luo, Y.W., Bi, F.F., Cui, T.T., Song, L., Cao, W.Y., Zjhang, J.Y., Dai, R.P., Development of anxiety-like behavior via hippocampal IGF-2 signaling in the offspring of parental morphine exposure: effect of enriched environment (2014) Neuropsychopharmacology, 39, pp. 2777-2787; 
Li, F., Cheng, K., Antoline, J.F., Iyer, M.R., Matyas, G.R., Torres, O.B., Jalan, R., Rice, K.C., Synthesis and immunological effects of heroin vaccines (2014) Org. Biomol. Chem., 12, pp. 7211-7232; 
Li, J.P., Zhang, T., Gao, C.J., Kou, Z.Z., Jao, X.W., Zhang, L.X., Wu, Z.Y., Li, Y.Q., Neurochemical features of endomorphin-2-containing neurons in the submucosal plexus of the rat colon (2015) World J. Gastroenterol., 21, pp. 9936-9944; 
Li, J.X., Thorn, D.A., Qiu, Y., Peng, B.W., Zhang, Y., Antihyperalgesic effects of imidazoline I(2) receptor ligands in rat models of inflammatory and neuropathic pain (2014) Br. J. Pharmacol., 171, pp. 1580-1590; 
Li, L., Cao, J., Zhang, S., Wang, C., Wang, J., Song, G., Wang, H., Zhang, L., NCAM signaling mediates the effects of GDNF on chronic morphine-induced neuroadaptations (2014) J. Mol. Neurosci., 53, pp. 580-589; 
Li, M.H., Suchland, K.L., Ingram, S.L., GABAergic transmission and enhanced modulation by opioids and endocannabinoids in adult rat rostroventromedial medulla (2015) J. Physiol., 593, pp. 217-230; 
Li, P., Tang, M., Li, H., Huang, X., Chen, L., Zhai, H., Effects of ginsenosides on opioid-induced hyperalgesia in mice (2014) Neuroreport, 25, pp. 749-752; 
Li, Q., Millar, R.P., Clarke, I.J., Smith, J.T., Evidence that neurokinin B controls basal for gonadotropin-releasing hormone secretion but is not critical for estrogen-positive feedback in sheep (2015) Neuroendocrinology, 101, pp. 161-174; 
Li, W., Li, Y., Zhu, S., Ji, Q., Shu, Y., Zhang, L., Liu, J., Rosuvastatin attenuated the existing morphine tolerance in rats with L5 spinal nerve transection through inhibiting activation of astrocytes and phosphorylation of ERK42/44 (2015) Neurosci. Lett., 584, pp. 314-319; 
Li, W., He, S., Zhou, Y., Li, Y., Hao, J., Zhou, X., Wang, F., Zheng, H., Neurod1 modulates opioid antinociceptive tolerance via two distinct mechanisms (2014) Biol. Psychiatry, 76, pp. 775-784; 
Li, X., Meng, Y., Plotnikoff, N.P., Youkilis, G., Griffin, N., Wang, E., Lu, C., Shan, F., Methionine enkephalin (Menk) inhibits tumor growth through regulating CD4 + FoxP3+ regulatory T cells (Tregs) in mice (2015) Cancer Biol. Ther., 16, pp. 450-459; 
Liang, N.C., Bello, N.T., Moran, T.H., Wheel running reduces high-fat intake, preference and mu-opioid agonist stimulated intake (2015) Behav. Brain Res., 284, pp. 1-10; 
Liang, Y., Turner, B.J., Assessing risk for drug overdose in a national cohort: role of both daily and total opioid dose (2015) J. Pain, 15, pp. 318-325; 
Liao, L., Long, H., Zhang, L., Chen, H., Zhou, Y., Ye, N., Lai, W., Evaluation of pain in rats through facial expression following experimental tooth movement (2014) Eur. J. Oral Sci., 122, pp. 121-124; 
Liaw, W.J., Tsao, C.M., Huang, G.S., Wu, C.C., Ho, S.T., Wang, J.J., Tao, Y.X., Shui, H.A., Phosphoproteomics and bioinformatics analyses of spinal cord proteins in rats with morphine tolerance (2014) PLoS One, 9, p. e83817; 
Lightfoot, M., Ng, C., Engelbretsen, S., Wallner, C., Huang, G., Li, R., Alsyouf, M., Baldwin, D.D., Analgesic use and complications following upper pole access for percutaneous nephrolthotomy (2014) J. Endourol., 28, pp. 909-914; 
Lim, G., Kim, H., McCabe, M.F., Chou, C.W., Wang, S., Chen, L.L., Morota, J.J., Mao, J., A leptin-mediated central mechanism in analgesia-enhanced opioid reward in rats (2014) J. Neurosci., 34, pp. 9779-9788; 
Lin, S.L., Chang, F.L., Ho, S.Y., Charoenkwan, P., Wang, K.W., Huang, H.L., Predicting neuroinflammation in morphine tolerance for tolerance therapy from immunostaining images of rat spinal cord (2015) PLoS One, 10, p. e0139806; 
Lindstrom, H.A., Clemency, B.M., Snyder, R., Consiglio, J.D., May, P.R., Moscati, R.M., Prehospital naloxone administration as a public health surveillance tool: a retrospective validation study (2015) Prehosp. Disaster Med., 30, pp. 385-389; 
Linnstaedt, S.D., Hu, J., Bortsov, A.V., Soward, A.C., Swor, R., Jones, J., Lee, D., McLean, S.A., Mu-opioid receptor gene A118G variants and persistent pain symptoms amog men and women experiencing motor vehicle collision (2015) J. Pain, 16, pp. 637-644; 
Little, J.W., Ford, A., Symons-Liguori, A.M., Chen, Z., Janes, K., Doyle, T., Xie, J., Salvemini, D., Endogenous adenosine A3 receptor activation selectively alleviates persistent pain states (2015) Brain, 138, pp. 28-35; 
Liu, C.Y., Lee, M.L., Yang, C.S., Chen, C.M., Min, M.Y., Yang, H.W., Morphological and physiological evidence of a synaptic connection between the lateral parabrachial nucleus and neurons in the A7 catecholamine cell group in rats (2015) J. Biomed. Sci., 22, p. 79; 
Liu, H., Chen, B., Zhang, Y., Qiu, Y., Xia, Y., Li, S., Yao, J., Protective effect of delta opioid agonist [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia reperfusion injury by regional perfusion into abdominal aorta in rabbits (2015) Neurosci. Lett., 584, pp. 1-6; 
Liu, H.J., Gao, X.Z., Liu, X.M., Xia, M., Li, W.Y., Jin, Y., Effect of intrathecal dexemedetomidine on spinal morphine analgesia in patients with refractory cancer pain (2014) J. Palliat. Med., 17, pp. 837-840; 
Liu, P., Wu, C., Song, W., Yu, L., Yang, X., Xiang, R., Wang, F., Yang, J., Uridine decreases morphine-induced behavioral sensitization by decreasing dorsal striatal dopamine release possibly via agonistic effects at GABAA receptors (2014) Eur. Neuropsychpharmaocol., 24, pp. 1557-1566; 
Liu, R., Cheng, J., Yang, J., Ding, X., Yang, S., Dong, F., Guo, N., Liu, S., GC–MS-based plasma metabolomics investigations of morphine dependent rats at different states of euphoria, tolerance and naloxone-precipitated withdrawal (2015) Metab. Brain Dis., 30, pp. 767-776; 
Liu, T., Li, J., Wang, X., Fan, F., Zhang, P., Tu, Y., Zhang, Y., The coexistence of VGluT2 and neurotensin or leu-enkephalin in the medullary dorsal horn: a confocal and electron microscopic immunohistochemical study in the rat (2015) Neurosci. Lett., 584, pp. 390-394; 
Liu, W., Xie, S., Yue, L., Woo, S.M., Liu, W., Miller, A.R., Zhang, J., Zhang, L., Investigation and analysis of oncologists’ knowledge of morphine usage in cancer pain treatment (2014) Oncol. Targets Ther., 7, pp. 729-737; 
Liu, X., Pan, Z., Su, D., Yang, Z., Zheng, B., Wang, X., Tian, J., Remifenatanil ameliorates liver ischemia-reperfusion injury through inhibition of interleukin-18 signaling (2015) Transplantation, 99, pp. 2109-2117; 
Liu, X., Zhao, L., Wang, Y., Mou, L., Yang, J., Zhang, Y., Wang, D., Wang, R., Design, synthesis and evaluation of new endomorphin analogues with enhanced central antinociception after peripheral administration (2015) Bioorg. Med. Chem. Lett., 25, pp. 5393-5397; 
Liu, X.S., Xu, G.H., Shen, Q.Y., Zhao, Q., Cheng, X.Q., Zhang, J., Gu, E.W., Dezocine prevents sufentanil-induced cough during general anesthesia induction: a randomized controlled trial (2015) Pharmacol. Rep., 67, pp. 52-55; 
Liu, X.Y., Wan, L., Huo, F.Q., Barry, D.M., Li, H., Zhao, Z.Q., Chen, Z.F., B-type natriuretic peptide is neither itch-specific nor functions upstream of the GRP/GRPR signaling pathway (2014) Mol. Pain, 10, p. 4; 
Liu, Y., Tang, J., Zhang, Y., Xun, X., Tang, D., Peng, D., Yi, J., Shi, X., Synthesis and analgesic effects of mu-TRTX-Hhn1b on models of inflammatory and neuropathic pain (2014) Toxins (Basel), 6, pp. 2363-2378; 
Liu, Z., Zhou, Z., Wang, L., Song, X., Chen, H., Wang, W., Liu, R., Song, L., The enkephalinergic nervous system and its immunomodulation on the developing immune system during the ontogenesis of oyster Crassotrea gigas (2015) Fish Shellfish Immunol., 45, pp. 250-259; 
Liu, Z., Zhou, Z., Wang, L., Jiang, S., Wang, W., Zhang, R., Song, L., The immunomodulation mediated by a delta-opioid receptor for [Met(5)]-enkephalin in oyster Crassotrea gigas (2015) Dev. Comp. Immunol., 49, pp. 217-224; 
Lloret-Linares, C., Hirt, D., Bardin, C., Bouillot, J.L., Oppert, J.M., Poitou, C., Chast, F., Decleves, X., Effect of a Roux-en-Y gastric bypass on pharmacokinetics of oral morphine using a population approach (2014) Clin. Pharmacokinet., 53, pp. 919-930; 
Llorian-Salvador, M., Pevida, M., Fernandez-Garcia, M.T., Lastra, A., Obaya, A., Cal, S., Hidalgo, A., Baamonde, A., Hypernociceptive responses following the intrathecal inoculation of RM1 prostate cancer cells in mice (2015) Prostate, 75, pp. 70-83; 
Lockie, S.H., Stefanidis, A., Tschop, M.H., Oldfield, B.J., Combination cannabinoid and opioid receptor antagonists improves metabolic outcomes in obese mice (2015) Mol. Cell. Endocrinol., 417, pp. 10-19; 
Logan, R.W., Wynne, O., Maglakelidze, G., Zhang, C., O'Connell, B., Boyadjieva, N.J., Sarkar, D.K., Beta-endorphin neuronal transplantation into the hypothalamus alters anxiety-like behaviors in prenatal alcohol-exposed rats and alcohol-non-preferring and alcohol-preferring rats (2015) Alcohol. Clin. Exp. Res., 39, pp. 146-157; 
Loh, R.M., Galvez, R., Kappa-opioid antagonism impairs forebrain-dependent associative learning: a trace eyeblink conditioning study (2015) Behav. Neurosci., 129, pp. 692-700; 
Lohman, R.J., Harrison, R.S., Ruiz-Gomez, G., Hoang, H.N., Shepherd, N.E., Chow, S., Hill, T.A., Fairlie, D.P., Helix-constrained nociceptin peptides are potent agonists and antagonists of ORL-1 sand nociception (2015) Vitam. Horm., 97, pp. 1-55; 
Loizzo, A., Spampinato, S.M., Fortuna, A., Vella, S., Fabi, F., Del Basso, P., Campana, G., Loizzo, S., Antisense versus proopiomelanocortin mRNA reduces vascular risk in a murine model of type-2 diabetes following stress exposure in early post-natal life (2015) Peptides, 64, pp. 34-39; 
Lobana, K., Middleton, N., Coddington, E., Suppression of sex behavior by kappa opiates and stress steroids occurs via independent neuroendocrine pathways (2015) Gen. Comp. Endocrinol., 210, pp. 81-86; 
Lord, B., Bendall, J., Reinten, T., The influence of paramedic and patient gender on the administration of analgesics in the out-of-hospital setting (2014) Prehosp. Emerg. Care, 18, pp. 195-200; 
Lorenzo, A.J., Lynch, J., El-Beheiry, H., Hayes, J., Ultrasound guided transversus abdominis plane vs: surgeon administered intraoperative regional field infiltration with bupivacaine for early postoperative pain control in children undergoing open pyeloplasty (2014) J. Urol., 192, pp. 207-213; 
Loriga, G., Lazzari, P., Manca, I., Ruiu, S., Falzoi, M., Murineddu, G., Bottazzi, M.E., Pinna, G.A., Novel diazabicycloalkane delta opioid agonists (2015) Bioorg. Med. Chem., 23, pp. 5527-5538; 
Lovallo, W.R., Enoch, M.A., Acheson, A., Cohoon, A.J., Sorocco, K.H., Hodgkinson, C.A., Vincent, A.S., Goldman, D., Cortisol stress response in men and women modulated differentially by the mu-opioid receptor gene polymorphism OPRM1 A118G (2015) Neuropsychopharmacol, 40, pp. 2546-2554; 
Lovell, K.M., Frankowski, K.J., Stahl, E.L., Saluson, S.R., Yoo, E., Prisinzano, T.E., Abe, J., Bohn, L.M., Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK1/2 phosphorylation while preserving G protein over beta-arrestin signaling bias (2015) ACS Chem. Neurosci., 6, pp. 1411-1419; 
Lowe, J.D., Bailey, C.P., Functional selectivity and time-dependence of mu-opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area (2015) Br. J. Pharmacol., 172, pp. 469-481; 
Lowe, J.D., Sanderson, H.S., Cooke, A.E., Ostovar, M., Tsisanva, E., Withey, S.L., Chavkin, C., Bailey, C.P., Role of G-protein coupled receptor kinases 2 and 3 in mu-opioid receptor desensitization and internalization (2015) Mol. Pharmacol., 88, pp. 347-356; 
Lu, C., Shi, L., Zhang, J., Kong, M., Liu, Y., Zhou, Y., Xu, L., Gu, X., Neuron-restrictive silencer factor in periaqueductal gray contributes to remifentanil-induced postoperative hyperalgesia via regression of the mu-opioid receptor (2015) J. Neurol. Sci., 352, pp. 48-52; 
Lu, Y., Hu, J., Zhang, Y., Dong, C.S., Wong, G.T., Remote intrathecal morphine preconditioning confers cardioprotection via spinal nitric oxide/cyclic guanosine monophosphate/protein kinase G pathway (2015) J. Surg. Res., 193, pp. 43-51; 
Lu, Z., Xu, J., Rossi, G.C., Majumdar, S., Pasternak, G.W., Pan, Y.X., Mediation of opioid analgesia by a truncated 6-transmembrane GPCR (2015) J. Clin. Invest., 125, pp. 2626-2630; 
Lucantonio, F., Kambhampati, S., Haney, R.Z., Atalayer, D., Rowland, N.E., Shaham, Y., Schoenbaum, G., Effects of prior cocaine versus morphine or heroin self-administration on extinction learning driven by overexpectation versus omission of reward (2015) Biol. Psychiatry, 77, pp. 912-920; 
Luiz, A.P., Schroeder, S.D., Rae, G.A., Calixto, J.B., Chichorro, J.G., Contribution and interaction of kinin receptors and dynorphin A in a model of trigeminal neuropathic pain in mice (2015) Neuroscience, 300, pp. 189-200; 
Lukosiene, L., Macas, A., Trepenaitis, D., Kalibatiene, L., Malcius, D., Barauskas, V., Single-shot intercostal block for pain management in pediatric patients undergoing the Nuss procedure: a double-blind, randomized, controlled study (2014) J. Pediatr. Surg., 49, pp. 1753-1757; 
Luong, S., Fu, S., Detection and identification of 2-nitro-morphine and 2-nitro-morphine-6-glucoronide in nitrite adulterated urine specimens containing morphine and its glucuronides (2014) Drug Test. Anal., 6, pp. 277-287; 
Lutz, P.E., Zhou, Y., Labbe, A., Mechawar, N., Turecki, G., Decreased expression of nociception/orphanin FQ in the doral anterior cingulate cortex of suicides (2015) Eur. Neuropsychopharmacol., 25, pp. 2008-2014; 
Ma, J., Yuan, X., Qu, H., Zhang, J., Wang, D., Sun, X., Zhang, Q., The role of reactive oxygen species in morphine addiction of SH-SY5Y cells (2015) Life Sci., 124, pp. 128-135; 
Ma, P., Liu, H., Huang, X., Chen, L., Zhai, H., Involvement of the insular nitric oxide signaling pathway in the expression of morphine-induced conditioned place preference in rat (2014) Neuroreport, 25, pp. 641-646; 
Ma, X., Xu, T., Xu, H., Jiang, W., Blockade and reversal of spinal morphine tolerance by P2 × 3 receptor antagonist (2015) Behav. Pharmacol., 26, pp. 260-267; 
Macey, T.A., Bobeck, E.N., Suchland, K.L., Morgan, M.M., Ingram, S.L., Change in the functional selectivity of morphine with the development of antinociceptive tolerance (2015) Br. J. Pharmacol., 172, pp. 549-561; 
Madeo, G., Schirinzi, T., Natoli, S., Pierantozzi, M., Stefani, A., Dauri, M., Pisani, A., Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain (2015) J. Neurol., 262, pp. 2164-2170; 
Mague, S.D., Port, R.G., McMullen, M.E., Garlson, G.C., Turner, J.R., Mouse model of OPRM1 (A118G) polymorphism has altered hippocampal function (2015) Neuropharmacology, 97, pp. 425-435; 
Maher, D.P., Wong, W., White, P.F., McKenna, R., Jr., Rosner, H., Shamloo, B., Louy, C., Zhang, V., Association of increased postoperative opioid administration with non-small-cell lung cancer recurrence: a retrospective analysis (2014) Br. J. Anaesth., 113, pp. i88-i94; 
Mahidol, C., Niyom, S., Thitiyanaporn, C., Suprasert, A., Thengcharisi, N., Effects of continuous intravenous infusion of morphine and morphine-tramadol on the minimum alveolar concentration of sevoflurane and electroencephalographic entropy indexes in dogs (2015) Vet. Anaeth. Analg., 42, pp. 182-186; 
Mahoori, A., Noroozinia, H., Hasani, E., Hosainzadeh, S., The effect of pre-operative administration of gabapentin on post-operative pain relief after herniorrhaphy (2014) Saudi J. Anaesth., 8, pp. 220-223; 
Maillet, E.L., Milon, N., Heighinian, M.D., Fishback, J., Schuer, S.C., Garamszegi, N., Mash, D.C., Noribogaine is a G-protein biased kappa-opioid receptor agonist (2015) Neuropharmcology, 99, pp. 675-688; 
Majidnejad, S., Esmailian, M., Emadi, M., Comparison of intravenous ketamine with morphine in pain relief of long bones fractures: a double blind randomized clinical trial (2014) Emerg. (Tehran), 2, pp. 77-80; 
Maki, A.E., Morris, K.A., Catherman, K., Chen, X., Hatcher, N.G., Gold, P.E., Sweedler, J.V., Fibrinogen alpha-chain-derived peptide is upregulated in hippocampus of rats exposed to acute morphine injection and spontaneous alternation testing (2014) Pharmacol. Res. Perspect., 2, p. e00037; 
Malfacini, D., Ambrosio, C., Gro, M.C., Sbraccia, M., Trapella, C., Guerrini, R., Bonora, M., Calo, G., Pharmacological profile of nociception/orphanin FQ receptors interacting with G-proteins and beta-arrestins 2 (2015) PLoS One, 10, p. e0132865; 
Malhotra, B.K., Matschke, L., Wang, Q., Bramson, C., Salageanu, J., Effects of ethanol on the pharmacokinetics of extended-release oxycodone with sequestered naltrexone (ALO-02) (2015) Clin. Drug Investig., 35, pp. 267-274; 
Malik, S., Saha, R., Seth, P., Involvement of extracellular signal-related kinase (ERK1/2)-p53-p21 axis in mediating neural stem/progenitor cell cycle arrest in co-morbid HIV-drug abuse exposure (2014) J. Neuroimmune Pharmacol., 9, pp. 340-353; 
Malin, D.H., Henceroth, M.M., Izygon, J.J., Nghiem, D.M., Moon, W.D., Anderson, A.P., Madison, C.A., Burstein, E.S., Reversal of morphine tolerance by a compound with NPFF receptor subtype-selective actions (2015) Neurosci. Lett., 584, pp. 141-145; 
Mandal, P., Jain, R., Jhanjee, S., Sreenivas, V., Psychological barriers to tobacco cessation in Indian buprenorphine-naloxone maintained patients: a pilot study (2015) Indian J. Psychol. Med., 37, pp. 299-304; 
Mansouri, M.T., Khodayar, M.J., Tabatabaee, A., Ghorbanzadeh, B., Naghizadeh, B., Modulation of morphine antinociceptive tolerance and physical dependence by co-administration of simvastatin (2015) Pharmacol. Biochem. Behav., 137, pp. 38-43; 
Manwell, L.A., Mallet, P.E., Comparative effects of pulmonary and parenteral delta9-tetrahydrocannibonol exposure on extinction of opiate-induced conditioned aversion in rats (2015) Psychopharmacology (Berl)., 232, pp. 1655-1665; 
Maqueda, A.E., Valle, M., Addy, P.H., Antonijoan, R.M., Puntes, M., Coimbra, J., Ballester, M.R., Riba, J., Salvanorin-A induces dissociative effects, blocking external sensory perception and modulating interoception and sense of body ownership in humans (2015) Int. J. Neuropsychopharmacol., 18, p. 18; 
Marashi, S.M., Sharifnia, H.R., Azimaraghi, O., Aghajani, Y., Barzin, G., Movafegh, A., Naloxone added to bupivacaine or bupivacaine-fentanyl prolonged motor and sensory block during supraclavicular brachial plexus blockade: a randomized clinical trial (2015) Acta Anaesthesiol. Scand., 59, pp. 921-927; 
Marcio, R.L., Monteiro, E.R., Moroz, L.R., Fantoni, D.T., Postoperative analgesic effect of epidural administration of neostigmine alone or in combination with morphine in dogs undergoing orthopedic surgery of the pelvic limbs (2014) Am. J. Vet. Res., 75, pp. 956-963; 
Marinho, E.A., Oliveira-Lima, A.J., Santos, R., Hollais, A.W., Baldaia, M.A., Wuo-Silva, R., Yokoyama, T.S., Frussa-Filho, R., Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice (2015) Prog. Neuropsychopharmacol. Biol. Psychiatry, 58, pp. 22-31; 
Marino, R., Struck, J., Hartmann, O., Maisel, A.S., Rehfeldt, M., Magrini, L., Melander, O., Di Somma, S., Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-Enk) for acute kidney injury in patients admitted with sepsis in the emergency department (2015) J. Nephrol., 28, pp. 717-724; 
Marrone, G.F., Majumdar, J., Pasternak, G.W., Radioligand binding assay for an exon-11 associated mu opioid receptor target (2015) Methods Mol. Biol., 1335, pp. 241-249; 
Marteau, D., McDonald, R., Patel, K., The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales (2015) BMJ Open, 5, p. e007629; 
Marti-Prats, L., Orrico, A., Polache, A., Granero, L., Dual motor responses elicited by ethanol in the posterior VTA: consequences of the blockade of mu-opioid receptors (2015) J. Psychopharmacol., 29, pp. 1029-1034; 
Martikainen, I.K., Neuchterlein, E.B., Pecina, M., Love, T.M., Cummiford, C.M., Green, C.R., Stohler, C.S., Zubieta, J.K., Chronic back pain is associated with alterations in dopamine neurotransmission in the ventral striatum (2015) J. Neurosci., 35, pp. 9957-9965; 
Martin, T.J., Sexton, T., Kim, S.A., Severino, A.L., Peters, C.M., Young, L.J., Childers, S.R., Regional differences in mu and kappa receptor G-protein activation in brain in male and female prairie voles (2015) Neuroscience, 311, pp. 422-429; 
Martin-Flores, M., Campoy, L., Kinsley, M.A., Mohammed, H.D., Gleed, R.D., Cheetham, J., Analgesic and gastrointestinal effects of epidural morphine in horses after laparoscopic cryptorchidectomy under general anesthesia (2014) Vet. Anesth. Analg., 41, pp. 430-437; 
Martinez, V., Cymerman, A., Ben Ammar, S., Fiaud, J.F., Rapon, C., Poindessous, F., Judet, T., Fletcher, D., The analgesic efficacy of combined pregabalin and ketamine for total hip arthroplasty: a randomized, double-blind, controlled study (2014) Anaesthsia, 69, pp. 46-52; 
Martinez-Laorden, E., Almela, P., Milanes, M.V., Laorden, M.L., Expression of heat shock protein 27 and troponin T and troponin I after naloxone-precipitated morphine withdrawal (2015) Eur. J. Pharmacol., 766, pp. 142-150; 
Martins, D.F., Emer, A.A., Batisti, A.P., Donatellio, N., Carlesso, N., Mazzardo-Martins, L., Venzke, D., dos Santos, A.R., Inhalation of Codrus atlantica essential oil alleviates pain behavior through activation of descending pain modulation pathways in a mouse model of postoperative pain (2015) J. Ethnopharmacol., 175, pp. 30-38; 
Martins, D.F., Brito, R.N., Stramosk, J., Batisti, A.P., Madeira, F., Turnes, B.L., Mazzardo-Martins, L., Piovezan, A.P., Peripheral neuobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain (2015) J. Neurosci. Res., 93, pp. 157-166; 
Mascarenhas, R., Pietrzak, M., Smith, R.M., Webb, A., Wang, D., Papp, A.C., Pinsonneault, J.K., Sadee, W., Allele-selective transcriptome recruitment to polysomes primed for translation: protein-coding and noncoding RNAs and RNA isoforms (2015) PLoS One, 10, p. e0136798; 
Maslov, L.N., Naryzhnaya, N.V., Prokudina, E.S., Kolar, F., Gorbunov, A.S., Zhang, Y., Wang, H., Lishmanov, Y.B., Preserved cardiac mitochondrial function and reduced ischemia/reperfusion injury afforded by chronic continuous hypoxia: role of opioid receptors (2015) Clin. Exp. Pharmacol. Physiol., 42, pp. 496-501; 
Mason, A.E., Laraia, B., Daubenmier, J., Hecht, F.M., Lustig, R.H., Puterman, E., Adler, N., Epel, E.S., Puttring the brakes on the drive to eat: pilot effects of naltrexone and reward-based eating on food cravings among obese women (2015) Eat. Behav., 19, pp. 53-56; 
Mason, A.E., Lustig, R.H., Brown, R.R., Acree, M., Bacchetti, P., Moran, P.J., Dallman, M., Epel, E.S., Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial (2015) Appetite, 91, pp. 311-320; 
Masoumi, K., Forouzan, A., Asgari Darian, A., Feli, M., Barzegari, H., Khavanin, A., Comparison of clinical efficacy of intravenous acetaminophen with intravenous morphine in acute renal colic: a randomized, double-blind, controlled trial (2014) Emerg. Med. Int., 2014, p. 571326; 
Matava, C.T., Crawford, M.W., Pehora, C., Naser, B., McDonnell, C., Early postoperative patient-controlled analgesia ratio predicts 24-h morphine consumption and pain in children undergoing scoliosis surgery (2014) J. Opioid Manag., 10, pp. 39-45; 
Matic, M., Norman, E., Rane, A., Beck, O., Andersson, M., Elens, L., Tibboel, D., van Schaik, R.H., Effect of UGT2B7-900G > A (-842G > A; rs7438135) on morphine glucuronidation in preterm newborns: results from a pilot cohort (2014) Pharmacogenomics, 15, pp. 1589-1597; 
Matsumoto, K., Umemoto, H., Mori, T., Akatsu, R., Saito, S., Tashima, K., Shibasaki, M., Horie, S., Differences in the morphine-induced inhibition of small and large intestinal transit: involvement of central and peripheral mu-opioid receptors in mice (2015) Eur. J. Pharmacol., 771, pp. 220-228; 
Matyas, G.R., Rice, K.C., Cheng, K., Li, F., Antoline, J.F., Iver, M.R., Jacobson, A.E., Alving, C.R., Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine and morphine (2014) Vaccine, 32, pp. 1473-1479; 
Maurer, U., Kager, C., Fellinger, C., Loader, D., Pollesbock, A., Spitzer, B., Jarisch, R., Risk of analphylaxis in opioid dependent persons: effects of heroin versus substitution substance (2014) Subst. Abuse Treat. Prev. Policy, 9, p. 12; 
Maximyuk, O., Khmyz, V., Lindskog, C.J., Vukojevic, J., Ivanova, T., Bazov, I., Hauser, K.F., Krishtal, O., Plasma membrane poration by opioid neuropeptides: a possible mechanism of pathological signal transduction (2015) Cell. Death. Dis., 6, p. e1683; 
Mayell, A., Srinivasan, J., Campbell, F., Peliowski, A., Analgesic effects of gabapentin after sciolosis surgery in children: a randomized controlled trial (2014) Paediatr. Anaesth., 24, pp. 1239-1244; 
Mazak, K., Hosztafi, S., Noszal, B., Species-spectific lipophilicity of morphine antagonists (2015) Eur. J. Pharm. Sci., 78, pp. 1-7; 
Mazer-Amirshahi, M., Mullins, P.M., Rasooly, I., van den Anker, J., Pines, J.M., Rising opioid prescribing in adult U: S. emergency department visits: 2001–2010 (2014) Acad. Emerg. Med., 21, pp. 236-243; 
Mazer-Amirshahi, M., Mullins, P.M., Rasooly, I., van den Anker, J., Pines, J.M., Trends in prescription opioid use in pediatric emergency department patients (2014) Pediatr. Emerg. Care, 30, pp. 230-235; 
Mazo, J., Roza, C., Zamanillo, D., Merios, M., Vela, J.M., Lopez-Garcia, J.A., Effects of centrally acting analgesics on spinal segmental reflexes and wind-up (2015) Eur. J. Pain, 19, pp. 1012-1020; 
McDermott, K.A., Griffin, M.L., Connery, H.S., Hilario, E.Y., Fiellin, D.A., Fitzmaurice, G.M., Weiss, R.D., Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population (2005) J. Clin. Psychiatry, 76, pp. 189-194; 
McIlwrath, S.L., Westlund, K.N., Pharmacological attenuation of chronic alcoholic pancreatitis induced hypersensitivity in rats (2015) World J. Gastroenterol., 21, pp. 836-853; 
McKeen, D.M., George, R.B., Boyd, J.C., Allen, V.M., Pink, A., Transversus abdominis plane block does not improve early or late pain after cesarean delivery: a randomized controlled trial (2014) Can. J. Anesth., 61, pp. 631-640. , (4.6); 
McLane, V.D., Cao, L., Willis, C.L., Morphine increases hippocampal viral load and suppresses frontal lobe CCL5 expression in the LP-BM5 AIDS model (2014) J. Neuroimmunol., 269, pp. 44-51; 
McLaughlin, P.J., McHugh, D.P., Magister, M.J., Zagon, I.S., Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis (2015) BMC Immunol., 16, p. 24; 
McLean, C.P., Su, Y.J., Foa, E.B., Mechanisms of symptom reduction in a combined treatment for comormorbid posttraumatic stress disorder and alcohol dependence (2015) J. Consult. Clin. Psychol., 83, pp. 655-661; 
McNabb, C.T., White, M.M., Harns, A.L., Fuchs, P.N., The elusive rat model of conditioned placebo analgesia (2014) Pain, 155, pp. 2022-2032; 
McPherson, S., Barbosa-Leiker, C., Mamey, M.R., McDonell, M., Enders, C.K., Roll, J., A ‘missing not at random’ (MNAR) and ‘missing at random’ growth model comparison with a naloxone-buprenorphine clinical trial (2015) Addiction, 110, pp. 510-518; 
M'Dahome, S., Bourgoin, S., Kayser, V., Barthelemy, S., Chevarin, C., Chali, F., Orsal, D., Hamon, M., Spinal cord transection-induced allodynia in rats- behavioral, psychopathological and pharmacological characterization (2014) PLoS One, 9, p. e102027; 
Medeiros, I.U., Ruzza, C., Asth, L., Guerrini, R., Romao, P.R., Gavioli, E.C., Calo, G., Blockade of nociception/orphanin FQ receptor signaling reverses LPS-induced depressive behavior in mice (2015) Peptides, 72, pp. 95-103; 
Medrano, M.C., Mendiguren, A., Pineda, J., Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated withdrawal and glutamate receptor desensitization in the rat locus coeruleus (2015) Psychopharmacology (Berl)., 232, pp. 2795-2809; 
Megat, S., Bohren, Y., Doridot, S., Gaveriaux-Ruff, C., Kieffer, B.L., Freund-Mercier, M.J., Yalcin, I., Barrot, M., Kappa-opioid receptors are not necessary for the antidepressant treatment of neuropathic pain (2015) Br. J. Pharmacol., 172, pp. 1034-1044; 
Meghani, S.H., Kang, Y., Chittams, J., McMenamin, E., Mao, J.J., Fudin, J., African Americans with cancer pain are more likely to receive an analgesic with toxic metabolite despite clinical risks: a mediation analysis study (2014) J. Clin. Oncol., 32, pp. 2773-2779; 
Mehr-un-Nisa Munawar, M.A., Lee, Y.S., Rankin, D., Munir, J., Lai, J., Khan, M.A., Hruby, V.J., Design, synthesis and biological evaluation of a series of bifunctional ligands of opioids/SSRIs (2015) Bioorg. Med. Chem., 23, pp. 1251-1259; 
Mehrzadi ShojaiiA. Pur, S.A., Motevalian, M., Anticonvulsant activity of hydroalcoholic extract of citrullus colocynthis fruit: involvement of benzodiazepine and opioid receptors (2015) J. Evid. Based Complementary Alt. Med., , (2156587215615455); 
Meijerink, H., Indrati, A.R., Soedarmo, S., Utami, F., de Jong, C.A., Alisjahbana, B., van Crevel, R., Ven den Ven, A.J., Heroin use in Indonesia is associated with higher expression of CCR5 on CD4+ cells and lower in-vivo production of CCR5 ligands (2015) AIDS, 29, pp. 385-388; 
Meinhardt, M.W., Sevin, D.C., Klee, M.L., Dieter, S., Sauer, U., Sommer, W.H., The neurometabolic blueprint of excessive alcohol drinking (2015) Neuropsychopharmacology, 40, pp. 1259-1268; 
Melander, O., Orho-Melander, M., Manier, J., Svensson, T., Almgren, P., Nilsson, P.M., Engstrom, G., Belting, M., Stable peptide of the endogenous opioid encephalin precursor and breast cancer risk (2015) J. Clin. Oncol., 33, pp. 2632-2638; 
Mendez, I.A., Ostlund, S.B., Maidment, N.T., Murphy, N.P., Involvement of endogenous enkephalins and beta-endorphin in feeding and diet-induced obesity (2015) Neuropsychopharmacology, 40, pp. 2103-2112; 
Mercadante, S., Vellucci, R., Cuomo, A., Adile, C., Cortegiani, A., Valle, A., Villari, P., Casuccio, A., Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain (2015) Support. Care Cancer, 23, pp. 1349-1354; 
Merkley, C.M., Coolen, L.M., Goodman, R.L., Lehman, M.N., Evidence for changes in the numbers of synaptic inputs onto KNDy and GnRH neurons during preovulatory LH surge in rats (2015) J. Neuroendocrinol., 27, pp. 624-635; 
Meshram, G.G., Kumar, A., Rizvi, W., Tripathi, C.D., Khan, R.A., Central analgesic activity of the aqueous and ethanolic extracts of the leaves of Albizia lebback: role of the GABAergic and serotonergic pathways (2015) Z Naturforsch C, 70, pp. 25-30; 
Metz, V.E., Comer, S.D., Wuerzl, J., Pribasnig, A., Fischer, G., Characteristics and quality of life of opioid-dependent pregnant women in Austria (2014) Arch. Womens Ment. Health, 17, pp. 529-539; 
Metzger, D.S., Donnell, D., Celentano, D.D., Jackson, J.B., Shao, Y., Aramrattana, A., Wei, L., Burns, D.N., Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058 (2015) J. Acquir. Immune Defic Synd., 68, pp. 554-561; 
Meyer, A.C., Miller, M.E., Sigmon, S.C., Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers (2015) Addict. Behav., 42, pp. 189-193; 
Mherekumombe, M.F., Collions, J.J., Patient-controlled analgesia for children at home (2015) J. Pain Sympt. Manag., 49, pp. 923-927; 
Michael, F.M., Mohapatra, A.N., Venkitasamy, L., Chandrasekar, K., Seldon, T., Venkatachalam, S., Contusive spinal cord injury up regulates mu-opioid receptor (mor) gene expression in the brain and down regulates its expression in the spinal cord: possible implications in spinal cord injury research (2015) Neurol. Res., 37, pp. 788-796; 
Micheli, L., Di Cesare Mannelli, L., Rizzi, A., Guerrini, R., Trapella, C., Calo, G., Ghelardini, C., Intrathecal administration of nociception/orphanin FQ receptor agonists in rats: a strategy to relieve chemotherapy-induced neuropathic hypersensitivity (2015) Eur. J. Pharmacol., 766, pp. 155-162; 
Micheli, L., Di Cesare Mannelli, L., Guerrini, R., Trapella, C., Zanardelli, M., Ciccocioppo, R., Rizzi, A., Calo, G., Acute and subchronic antinociceptive effects of nociception/orphanin FQ receptor agonists infused by intrathecal route in rats (2015) Eur. J. Pharmacol., 754, pp. 73-81; 
Miller, L.E., McGinnis, G.R., Peters, B.A., Ballmann, C.G., Nanayakkara, G., Amin, R., Quindry, J.C., Involvement of the delta-opioid receptor in exercise-induced cardioprotection (2015) Exp. Physiol., 100, pp. 410-421; 
Miller, R.L., Thompson, A.A., Trapella, C., Guerrini, R., Malfacini, D., Patel, N., Han, G.W., Stevens, R.C., The importance of ligand-receptor conformational pairs in stabilization: spotlight on the NOFQ G-protein-coupled receptors (2015) Structure, 23, pp. 2291-2299; 
Milne, B., Jhamandes, K., Sutak, M., Grenier, P., Cahill, C.M., Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the alpha2A-adrenoceptor selective antagonist BRL44408 (2014) Eur. J. Pharmacol., 743, pp. 89-97; 
Minami, K., Sudo, Y., Miyano, K., Murphy, R.S., Uezono, Y., Mu-opioid receptor activation by tramadol and O-desmethyltramadol (M1) (2015) J. Anesth., 29, pp. 475-479; 
Minett, M.S., Pereira, V., Sikandar, S., Matsuyama, A., Lolignier, S., Kanellopoulos, A.H., Mancini, F., Wood, J.N., Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7 (2015) Nat. Commun., 6, p. 8967; 
Miranda, J., Lamana, S.M., Dias, E.V., Athie, M., Parada, C.A., Tambeli, C.H., Effect of pain chronification and chronic pain on an endogenous pain modulation circuit in rats (2015) Neuroscience, 286, pp. 37-44; 
Mirza, N., Appleton, R., Burn, S., Carr, D., Crooks, D., du Plessis, D., Duncan, R., Pirmohamed, M., Identifying the biological pathways underlying human focal epilepsy: from complexity to coherence to centrality (2015) Hum. Mol. Genet., 24, pp. 4306-4316; 
Misailidis, G., Ragia, G., Ivanova, D.D., Tavridou, A., Manolopoulos, V.G., Gene-gene interaction of mu-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect (2015) Drug Met. Pers. Ther., 30, pp. 129-135; 
Mitchell, K., Lebovitz, E.E., Keller, J.M., Mannes, A.J., Nemenov, M.I., Iadarola, M.J., Nociception and inflammatory hyperalgesia in rodents using infrared laser stimulation agter Trpv1 gene knockout or resiniferatoxin lesion (2014) Pain, 155, pp. 733-745; 
Miura, T., Matsumoto, Y., Motonaga, S., Hasuo, H., Abe, K., Kinoshita, H., Dyspnea, relative youth and low daily doses of opioids predict increased opioid dosage in the last week of a terminal cancer patient's life (2014) Jpn. J. Clin. Oncol., 44, pp. 1082-1087; 
Miyano, K., Minami, K., Yokoyama, T., Ohbuchi, K., Yamaguchi, T., Murakami, S., Shiraishi, S., Uezono, Y., Tramadol and its metabolite m1 selectively suppress transient receptor potential Ankyrin 1 activity, but not transient receptor potential vanilloid 1 activity (2015) Anesth. Analg., 120, pp. 790-798; 
Miyazaki, M., Kawase, T., Nishimura, C., Kitamura, T., Iwanaga, K., Kakemi, M., Pharmacokinetics and toxicity of repeated oral etoposide is altered by morphine coadministration in rats (2015) Eur. J. Drug Metab. Pharmacokinet., 40, pp. 335-341; 
Miyazaki, T., Satou, S., Ohno, T., Yoshida, A., Nishimura, K., Topical morphine gel for pain management in head and neck cancer patients (2014) Auris Nasus Larynx, 41, pp. 496-498; 
Moaddab, M., Hyland, B.I., Brown, C.H., Oxytocin excites nucleus accumbens shell neuons in vivo (2015) Mol. Cell. Neurosci., 66, pp. 323-330; 
Moaddab, M., Hyland, B.I., Brown, C.H., Oxytocin enhances the expression of morphine-induced conditioned place preference in rats (2015) Psychoneuroendocrinology, 53, pp. 159-169; 
Moezi, L., Pirsalami, F., Inaloo, S., Constipation enhances the propensity to seizure in pentylenetetrazole-induced seizure models of mice (2015) Epilepsy Behav., 44, pp. 200-206; 
Moghtadaei, M., Farahini, H., Faiz, S.H., Mokarami, F., Safari, S., Pain management for total knee arthroplasty: single-injection femoral nerve block versus local infiltration analgesia (2014) Iran. Red Crescent Med. J., 16, p. e13247; 
Mohammad Ahmadi Soleimani, S., Azizi, H., Mirnajafi-Zadeh, J., Semnanian, S., Orexin type 1 receptor antagonism in rat locus coeruleus neurons prevents the analgesic effect of intra-LC met-enkephalin microinjection (2015) Pharmacol. Biochem. Behav., 136, pp. 102-106; 
Mokhtari-Zaer, A., Ghodrati-Jaldbakhan, S., Vafaei, A.A., Miladi-Gorji, H., Akhaven, M.M., Bandegi, A.R., Rashidy-Pour, A., Effects of voluntary and treadmill exercise on spontaneous withdrawal signs, cognitive deficits, and alterations in apoptosis-associated proteins in morphine-dependent rats (2014) Behav. Brain Res., 271, pp. 160-170; 
Molenweld, P., Bouzanne des Mazery, R., Sterk, G.K., Storcken, R.P., Autr, R., van Oss, B., ven der Haas, R.N., Soeberdt, M., Conformationally restricted kappa-opioid receptor agonists: synthesis and pharmacological evaluation of diastereoisomeric and enantiomeric decahydroquinolalines (2015) Bioorg. Med. Chem. Lett., 25, pp. 5326-5330; 
Molina-Martinez, L.M., Gonzalez-Espinosa, C., Cruz, S.L., Dissociation of immunosuppressive and nociceptive effects of fentanyl, but not morphine after repeated administration in mice: ferntanyl-induced sensitization to LPS (2014) Brain Behav. Immun., 42, pp. 60-64; 
Mollica, A., Costante, R., Novellino, E., Stefanucci, A., Pieretti, S., Zador, F., Samavati, R., Lewis, R.J., Design, synthesis and biological evaluation of two opioid agonist and Cav 2: 2 blocker multitarget ligands (2015) Chem. Biol. Drug Des., 86, pp. 156-162; 
Moniruzzaman, M., Fardous, A., Irin, S., Evaluation of the antinociceptive effect of ethanol extract of Hedyotis corymbosa Linn whole plant in mice (2015) J. Ethnopharmacol., 161, pp. 82-85; 
Moniruzzaman, M., Fardous, A., Wahid Bokul, F., Evaluation of the antinociceptive effect of ethanol extract of bark of Polyathia longfolia (2015) J. Ethnopharmacol., 172, pp. 364-367; 
Moniruzzaman, M., Khatun, A., Imam, M.Z., Evaluation of antinociceptive activity of ethanol extract of leaves of Adenathra pavonina (2015) Evid. Based Complement Med., 2015, p. 412497; 
Monteiro, E.R., Nunes-Junior, J.S., Bressan, T.F., Randomized clinical trial of the effects of a combination of acepromazine with morphine and midazolam on sedation, cardiovascular variables and the propofol dose requirements for induction of anesthesia in dogs (2014) Vet. J., 200, pp. 157-161; 
Morden, N.E., Munson, J.C., Colla, C.H., Skinner, J.S., Bynum, J.P., Zhou, W., Meara, E., Prescription opioid use among disabled Medicare beneficiaries: intensity, trends and regional variation (2014) Med. Care, 52, pp. 852-859; 
Moreira, H., Jr., Moreira, J.P., Isaac, R.R., Alves-Neto, O., Moreira, T.A., Vieira, T.H., Brasil, A.M., Morphine spinal block anesthesia in patients who undergo an open hemorrhoidectomy: a prospective analysis of pain control and postoperative complications (2014) Ann. Coloproctol., 30, pp. 135-140; 
Morgan, M.M., Reid, R.A., Saville, K.A., Functionally selective signaling for morphine and fentanyl antinociception and tolerance mediated by the rat periaqueductal gray (2014) PLoS One, 9, p. e114269; 
Mori, T., Itoh, T., Yoshizawa, K., Ise, Y., Mizuo, K., Saeki, T., Komiya, S., Suzuki, T., Involvement of mu- and delta-opioid receptor function in the rewarding effect of (+)-pentazocine (2015) Addict. Biol., 20, pp. 724-732; 
Mori, T., Ohya, J., Itoh, T., Shibasaki, M., Suzuki, T., Effects of (+)-pentazocine on the antinociceptive effects of (−)-pentazcine in mice (2015) Synapse, 69, pp. 166-171; 
Mori, T., Kanbara, T., Harumiya, M., Iwase, Y., Masumoto, A., Komiya, S., Nakamura, A., Suzuki, T., Establishment of opioid-induced rewarding effects under oxalipaltin- and paclitaxel-induced neuropathy in rats (2014) J. Pharmacol. Sci., 126, pp. 47-55; 
Mori, T., Rahmadi, M., Yoshizawa, K., Itoh, T., Shibasaki, M., Suzuki, T., Inhibitory effects of SA4503 on the rewarding effects of abused drugs (2014) Addict. Biol., 19, pp. 362-369; 
Morisot, N., Rouibi, K., Conrtarino, A., CRF2 receptor deficiency eliminates the long-lasting vulnerability of motivational states induced by opiate withdrawal (2015) Neuropsychopharmacology, 40, pp. 1990-2000; 
Morita, K., Shiraishi, S., Motoyama, N., Kitayama, T., Kanematsu, T., Uezono, Y., Dohi, T., Palliation of bone cancer pain by antagonists of platelet-activating factor receptors (2014) PLoS One, 9, p. e91746; 
Moriya, Y., Kasahara, Y., Hall, F.S., Sakakibara, Y., Uhl, G.R., Tomita, H., Sora, A., Sex diufferences in the effects of social deprivation on alcohol consumption in mu-opioid receptor knockout mice (2015) Psychopharmacology (Berl)., 232, pp. 1471-1482; 
Mota, A.S., de Lima, A.B., Albuquerque, T.L., Silveira, T.S., do Nascimento, J.L., da Silva, J.K., Ribeiro, A.F., Bastos, G.N., Antinociceptive activity and toxicity evaluation of the fatty oil from Plukenetia polyadenia Mull. Arg. (Euphorobiaceae) (2015) Molecules, 20, pp. 7925-7939; 
Motaghinejad, M., Bangash, M.Y., Hosseini, P., Karimian, M., Motaghinejad, O., Attenuation of morphine withdrawal syndrome by various dosages of curcumin in comparison with clonidine in mouse: possible mechanisms (2015) Iran. J. Med. Sci., 40, pp. 125-132; 
Motaghinejad, M., Ebrahimzadeh, A., Shabab, B., Preventive effect of central administration of venlafaxine on morphine physical dependence, nociception and blood cortisol level in rat (2014) Int. J. Prev. Med., 5, pp. 1422-1431; 
Motaghinejad, M., Karimian, M., Motaghinejad, O., Shabab, B., Asidighaleni, M., Fatima, S., The effect of various morphine weaning regimens on the sequelae of opioid tolerance involving physical dependency, anxiety and hippocampus cell neurodegeneration in rats (2015) Fundam. Clin. Pharmacol., 29, pp. 299-309; 
Motaghinejad, M., Karimian, M., Motaghinejad, O., Shabab, B., Yazdani, J., Fatima, S., Protective effects of various dosage of curcumin against morphine induced apoptosis and oxidative stress in rat isolated hippocampus (2015) Pharmacol. Rep., 67, pp. 230-235; 
Motaghinejad, M., Motaghinejad, O., Hosseini, P., Attenuation of morphine physical dependence and blood levels of cortisol by central and systemic administration of ramelteon in rat (2015) Iran. J. Med. Sci., 40, pp. 240-247. , (7.9); 
Mouledous, L., Froment, C., Burlet-Schlitz, O., Schulz, S., Mollereau, C., Phosphoproteomic analysis of the mouse brain mu-opioid (MOP) receptor (2015) FEBS Lett., 589, pp. 2401-2408; 
Mu, Y., Ren, Z., Jia, J., Gao, B., Zheng, L., Wang, G., Friedman, E., Zhen, X., Inhibition of phosphodiesterase 10A attenuates morphine-induced conditioned place preference (2014) Mol. Brain, 7, p. 70; 
Muhammad, N., Shrestha, R.L., Adhikari, A., Wadood, A., Khan, H., Khan, A.Z., Maione, F., De Feo, V., First evidence of the analgesic activity of govaniadine, an alkaloid isolated from Corydalis govaniana Wall (2015) Nat. Prod. Res., 29, pp. 430-437; 
Murray, R.C., Logan, M.C., Horner, K.A., Striatal patch compartment lesions reduce stereotypy following repeated cocaine administration (2015) Brain Res., 1618, pp. 286-298; 
Muscoli, C., Lauro, F., Dagostino, C., Ilari, S., Giancotti L.A.Gliozzi, M., Costa, N., Carresi, C., Mollace, V., Olea Europea-derived phenolic products attenuate antinociceptive morphine tolerance: and innovative strategic approach to treat cancer pain (2014) J. Biol. Reg. Homeostat. Agents, 28, pp. 105-116; 
Musazzi, U.M., Matera, C., Dallanoce, C., Vacondio, F., De Amici, M., Vistoli, G., Cilurzo, F., Minghetti, P., On the selection of an opioid for local skin analgesia: structure-skin permeability relationships (2015) Int. J. Pharm., 489, pp. 177-185; 
Naganawa, M., Zheng, M.Q., Henry, S., Nabuisi, N., Lin, S.F., Ropchan, J., Labaree, D., Huang, Y., Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the kappa opioid receptor (2015) J. Nucl. Med., 56, pp. 243-248; 
Nagi, K., Charfi, J., Pineyro, G., Kir3 channels undergo arrestin-dependent internalization following delta opioid receptor activation (2015) Cell. Mol. Life Sci., 72, pp. 3543-3557; 
Nair, P., Yamamoto, T., Cowell, S., Kulkarni, V., Moye, S., Navritilova, E., Davis, P., Hruby, V.J., Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities (2015) Bioorg. Med. Chem. Lett., 25, pp. 3716-3720; 
Najafi Anaraki, A., Mirzaei, K., The effect of gabapentin versus intrathecal fentanyl on postoperative pain and morphine consumption in cesarean delivery: a prospective, randomized, double-blind study (2014) Arch. Gynecol. Obstet., 290, pp. 47-52; 
Nakamoto, K., Aizawa, F., Nishinaka, T., Tokuyama, S., Regulation of prohormone convertase 2 protein expression via GPR40/FFA1 in the hypothalamus (2015) Eur. J. Pharmacol., 762, pp. 459-463; 
Nakamura, A., Fujita, M., Ono, H., Hongo, Y., Kanbara, T., Ogawa, K., Morioka, Y., Hasegawa, M., G-protein-gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but n ot morphine at supraspinal sites (2014) Br. J. Pharmacol., 171, pp. 253-284; 
Nakasone, T., Sato, T., Matsushima, Y., Inoue, T., Kamei, C., Characteristics of scratching behavior in ADJM mice (atopic dermatitis from Japanese mice) (2015) Immunopharmacol. Immunotoxicol., 37, pp. 202-206; 
Nalamachu, S.R., Pergolizzi, J., Taylor, R., Jr., Slatkin, N.E., Barrett, A.C., Yu, J., Bortey, E., Forbes, W.P., Efficacy and tolerability of subcutaneous methylnaltrexone in patients with advanced illness and opioid-induced constipation: a responder analysis with two randomized, placebo-controlled trials (2015) Pain Pract., 15, pp. 564-571; 
Naryzhnaya, N.Y., Maslov, L.N., Prokudina, E.S., Lishmanov, Y.B., Contribution of opioid receptors to the cytoprotective effect of adaptation to chroic hypoxia at anoxia/reoxygenation of isolated cardiomyocytes (2015) Bull. Exp. Biol. Med., 159, pp. 209-212; 
Nasirinezhad, F., Gajavelli, S., Priddy, B., Jergova, S., Zadina, J., Sagen, J., Viral vectors encoding endomorphins and serine histogranin attenuate neuropathic pain symptoms after spinal cord injury in rats (2015) Mol. Pain, 11, p. 2; 
Nasser, A., Ali, S., Wilsbech, S., Bjerrum, O.J., Moller, L.B., Intraplantar injection of tetrahydrobioferin induces nociception in mice (2015) Neurosci. Lett., 584, pp. 247-252; 
Nasser, A.F., Heidbreder, C., Liu, Y., Fudala, P.J., Pharmacokinetics of sublingual buprenorphine and naloxone in subjects with mild to severe hepatic impairment (Child-Pugh Classes A, B, and C) in hepatitis C virus-seropositive subjects, and in healthy volunteers (2015) Clin. Pharmacokinet., 54, pp. 837-849; 
Natalucci, G., Hagmann, C., Bernet, V., Bucher, H.U., Rousson, V., Latal, B., Impact of perinatal factors on continuous early monitoring of brain electrocortical activity in very preterm newborns by amplitude-integrated EEG (2014) Pediatr. Res., 75, pp. 774-780; 
Navarette-Calvo, R., Gomez-Villamandos, R.J., Morgaz, J., Manuel Dominguez, J., Fernandez-Sarmiento, A., Munoz-Rascon, P., Lopez Vllialba, I., Del Mar Granados, M., Cardiorespiratory, anaesthetic and recovery effects of morphine combined with medetomidine and alfaxalone in rabbits (2014) Vet. Rec., 174, p. 95; 
Navarro, M., Carvajal, F., Lerma-Cabrera, J.M., Cubero, P., Picker, M.J., Thiele, T.E., Evidence that melanocortin receptor agonist melanotan-II synergistically augments the ability of naltrexone to blunt binge-like ethanol intake in male C57BL/6J mice (2015) Alcohol. Clin. Exp. Res., 39, pp. 1425-1433; 
Navritilova, E., Xie, J.Y., Meske, D., Qu, C., Morimura, K., Okun, A., Arakawa, N., Porreca, F., Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain (2015) J. Neurosci., 35, pp. 7264-7271; 
Neale, J., Strang, J., Naloxone −does over-antagonism matter? Evidence of iatrogenic harm after emergency treatment of heroin/opioid overdose (2015) Addiction, 110, pp. 1644-1652; 
Neefjes, E.C., van der Vorst, M.J., Boddaert, M.S., Zuumond, W.W., van der Vliet, H.J., Beeker, A., van den Berg, H.P., Verhuel, H.M., Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone (2014) BMC Palliat Care, 13, p. 42; 
Negus, S.S., Neddenriep, B., Altarifi, A.A., Carroll, F.I., Leitl, M.D., Miller, L.L., Effects of ketoprofen, morphine and kappa opioids on pain-related depression of nesting in mice (2015) Pain, 156, pp. 1153-1160; 
Nemoto, T., Iihara, Y., Hirayama, S., Iwai, T., Higashi, E., Fujii, H., Nagase, H., Naltrindole derivatives with fluorinated ethyl substituents on the 17-nitrogen as delta opioid receptor inverse agonists (2015) Bioorg. Med. Chem. Lett., 25, pp. 2927-2930; 
Neto, J.O., Machado, M.D., de Alameida Correa, M., Scomparim, H.A., Posso, I.P., Ashwari, H.A., Methadone patient-controlled analgesia for postoperative pain: a randomized, controlled, double-blind study (2014) J. Anesth., 28, pp. 505-510; 
Neumann, C., Bigliardi-Qi, M., Widmann, C., Bigliardi, P.L., The delta-opioid receptor affects epidermal homeostasis via ERK-dependent inhibition of transcription factor POU2F3 (2015) J. Invest. Dermatol., 135, pp. 471-480; 
Neutel, C.I., Skurtveit, S., Berg, C., Sakshaug, S., Trends in prescription of strong opioids for 41–80 year old Norwegians, 2005–2010 (2014) Eur. J. Pain, 18, pp. 436-446; 
New, T., Venable, C., Fraser, L., Rosenberg, E., Schmidt, J., James-Henry, A., Osunkwo, J., Dampier, C., Management of refractory pain in hospitalized adolescents with sickle cell disease: changing from intravenous opioids to continuous infusion epidural analgesia (2014) J. Pediatr. Hematol. Oncol., 36, pp. e395-402; 
Newton-Brown, E., Fitzgerald, L., Mitra, B., Audit improves emergency department triage, assessment, multi-modal analgesia and nerve block use in the management of pain in older people with neck or femur fracture (2014) Aust. Emerg. Nurs. J., 17, pp. 176-183; 
Ng, C.M., Dombrowsky, E., Lin, H., Erlich, M.E., Moody, D.E., Barrett, J.S., Kraft, W.K., Population pharmacokinetic model of sublingual buprenorphine in neonatal abstinence syndrome (2015) Pharmacotherry, 35, pp. 670-680; 
Nie, T.W., Shukkoor, M.S., Nair, R.S., Amiruddin, F.K., Ramasamay, S., Involvement of opioidergic and serotonergic systems in the analgesic activity of Cissus quadrangularis L stem extract in mice (2015) J. Basic Clin. Physiol. Pharmacol., 26, pp. 35-41; 
Nielsen, S., Hillhouse, M., Mooney, L., Ang, A., Ling, W., Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination users (2015) J. Subst. Abuse Treat., 48, pp. 70-76; 
Nielsen, S., Lintzeris, N., Bruno, R., Campbell, G., Lerance, B., Hall, W., Hoban, B., Deenhardt, L., Benzodiazepine use among chronic pain patients prescribed opioids: associations with pain, physical and mental health, and health service utilization (2015) Pain Med., 16, pp. 356-366; 
Nieto, C.T., Gonzalez-Nunez, V., Rodriguez, R.E., Diez, D., Garrido, N.M., Design, synthesis, pharmacological evaluation and molecular dynamics of beta-amino acids morphan-derivatives as novel ligands for opioid receptors (2015) Eur. J. Med. Chem., 101, pp. 150-162; 
Nikaido, Y., Kurosawa, A., Saikawa, H., Kuroiwa, S., Suzuki, C., Kuwabara, N., Hoshino, H., Takeda, S., In vivo and in vitro evaluation of novel mu-opioid receptor agonist compounds (2015) Eur. J. Pharmacol., 767, pp. 193-200; 
Nishio, S., Fukunishi, S., Juichi, M., Sahoko, K., Fujihara, Y., Fukui, T., Yoshiva, S., Comparison of continuous femoral nerve block, caudal epidural block and intravenous patient-controlled analgesia after total hip arthroplasty: a prospective randomized study (2014) Orthop. Rev. (Pavia), 12, p. 5138; 
Nishizawa, D., Fukuda, K., Kasai, S., Hasegawa, J., Aoki, Y., Nishi, A., Saita, N., Ikeda, K., Genome-wide association study identifies a potent locus associated with human opioid sensitivity (2014) Mol. Psychiatry, 19, pp. 55-62; 
Nogueira Lde, M., da Silva, M.R., Dos Santos, S.M., de Albuquerque, J.F., Ferraz, I.C., de Albuquerque, T.T., Mota, C.R., Ximenes, R.M., Antinociceptive effect of the essential oil obtained from the leaves of Croton cordiifolius Baill. (Euphorbiaceae) in mice (2015) Evid. Based Complement Altert. Med., 2015, p. 620865; 
Northrup, T.F., Stotts, A.L., Green, C., Potter, J.S., Marino, E.N., Walker, R., Weiss, R.D., Trivedi, M., Opioid withdrawal, craving and use during and after outpatient buprenorphine stabilization and taper: a discrete survival and growth mixture model (2015) Addict. Behav., 41, pp. 20-28; 
Norwood, A.P., Al-Chaer, E.D., Fantegrossi, W.E., Predisposing effects of neonatal visceral pain on abuse-related effects of morphine in adult male Sprague-Dawley rats (2014) Psychopharmacology (Berl)., 231, pp. 4281-4289; 
Nosalova, G., Sivova, V., Ray, B., Franova, S., Ondrejka, I., Fleskova, D., Antitussive activity of Withania somnifera and opioid receptors (2015) Adv. Exp. Med. Biol., 838, pp. 19-25; 
Nosyk, B., Bray, J.W., Wittenberg, E., Aden, B., Eggman, A.A., Weiss, R.D., Potter, J., Schackman, B.R., Short-term health-related quality of life improvement during opioid agonist treatment (2015) Drug Alcohol Depend., 157, pp. 121-128; 
Nosyk, B., Fischer, B., Sun, H., Marsh, D.C., Kerr, T., Rehm, J.T., Anis, A.H., High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort study (2014) Am. J. Addict., 23, pp. 257-264; 
Nour, C., Ratsiu, J., Singh, N., Mason, L., Ray, A., Martin, M., Hassanian, M., Applegate, R.L., 2nd, Analgesic effectiveness of acaminophen for primary cleft palate repair in young children: a randomized placebo controlled trial (2014) Paediatr. Anaesth., 24, pp. 574-581; 
Nozu, T., Miyagashi, S., Nozu, R., Takakusaki, K., Okumura, T., Water avoidance stress induces visceral hyposensitivity through peripheral corticotropin releasing factor receptor type 2 and central dopamine D2 receptor in rats (2015) Neurogastroenterol. Motil., 28, pp. 522-531; 
Nummenmaa, L., Manninen, S., Tuominen, L., Hirvonen, J., Kalliokoski, K.K., Nuutila, P., Jaaskelainen, P., Sams, M., Adult attachment style is associated with cerebral mu-opioid receptor availability in humans (2015) Hum. Brain Mapp., 36, pp. 3621-3628; 
Nunes, B.C., Garcia, J.B., Sakata, R.K., Morphine as first medication for treatment of cancer pain (2014) Braz. J. Anesthesiol., 64, pp. 236-240; 
Nunes, E.V., Krupitsky, E., Ling, W., Zummo, J., Memisoglu, A., Silverman, B.L., Gastfriend, D.R., Treating opioid dependence with injectable extended-release naltrexone (XR-NTX): whio will respond (2015) J. Addict. Med., 9, pp. 238-243; 
Nuseir, K.Q., Alzoubi, K.H., Alabwaini, J., Khabour, O.F., Kassab, M.I., Sucrose-induced analgesia during early life modulates adulthood learning and memory formation (2015) Physiol. Behav., 145, pp. 84-90; 
Oakley, A.E., Steiner, R.A., Chavkin, C., Clifton, D.K., Ferrara, L.K., Reed, S.D., Kappa agonists as a novel therapy for menopausal hot flashes (2015) Menopause, 22, pp. 1328-1334; 
O'Connor, C., White, K.L., Doncescu, N., Didenko, T., Roth, B.L., Czaplicki, G., Stevens, R.C., Milon, A., NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor (2015) Proc. Natl. Acad. Sci. (U. S. A.), 112, pp. 11852-11857; 
Okude, J., Ueda, T., Kofuku, Y., Sato, M., N.Nobuyama, N., Kondo, K., Shiraishi, Y., Shimada, I., Identification of a conformational equilibrium that determines the efficacy and functional selectivity of the mu-opioid receptor (2015) Agnew. Chem. Int. Ed. Engl., 54, pp. 15771-15776; 
Okumura, T., Nozu, T., Kumei, S., Takakusaki, K., Miyagishi, S., Ohhira, M., Antinociceptive action against colonic distension by brain orexin in conscious rats (2015) Brain Res., 1598, pp. 12-17; 
Oladosu, F.A., Conrad, M.S., O'Buckley, S.C., Rashid, N.U., Slade, G.D., Nackley, A.G., Mu oipioid splice variant MOR-1K contributes to the development of opioid-induced hyperalgesia (2015) PLoS One, 10, p. e0135711; 
Olesen, A.E., Brock, C., Sverrisdottir, E., Larsen, I.M., Drewes, A.M., Sensitivity of quantitative sensory models to morphine analgesia in humans (2014) J. Pain Res., 7, pp. 717-726; 
Olesen, A.E., Sato, H., Nielsen, L.M., Staahl, C., Droney, J., Gretton, S., Branford, R., Ross, J., The genetic influences on oxycodone response characteristics in human experimental pain (2015) Fundam. Clin. Pharmacol., 29, pp. 417-425; 
Olischar, M., Palmer, G.M., Orsini, F., Davidson, A.J., Perkins, E.J., Lee, K.J., Everest, N.J., Hunt, R.W., The addition of tramadol to the standard of i.v. acetaminophen and morphine infusion for postoperative analgeasia in neonates offers no clinical benefit: a randomized placebo-controlled trial (2014) Paediatr. Anaesth., 24, pp. 1149-1157; 
Oliveira, A., Carvalho, F., Pinho, P.G., Remiao, F., Medeiros, R., Dinia-Oliveira, R.J., Quantification of morphine and its major metabolites M3G and M6G in antemortum and postmortem samples (2014) Biomed. Chromatogr., 28, pp. 1263-21270; 
Oliveira, A., Pinho, D., Albino-Teixeira, A., Medeiros, R., Dinia-Oliveira, R.J., Carvalho, F., Morphine glucoronidation increases its analgesic effect in guinea pigs (2014) Life Sci., 109, pp. 104-110; 
Omair, A., Mannioln, A.F., Holden, M., Fairbank, J., Lie, B.A., Hagg, O., Fitzell, P., Brox, J.I., Catechol-O-methyltransferase (COMT) gene polymorphisms are associated with baseline disability but not long-term treatment outcome in patients with chronic low back pain (2015) Eur. Spine J., 24, pp. 2425-2431; 
O'Malley, S.S., Corbin, W.R., Leeman, R.F., DeMartini, K.S., Fucito, L.M., Ikomi, J., Romano, D.M., Kranzler, H.R., Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized trial of efficacy and safety (2015) J. Clin. Psychiatry, 76, pp. e207-215; 
Ong, E.W., Xue, L., Olmstead, M.C., Cahill, C.M., Prolonged morphine treatment alters delta opioid receptor post-internalization trafficking (2015) Br. J. Pharmacol., 172, pp. 615-629; 
Ong, E.W., Cahill, C.M., Molecular perspectives for mu/delta opioid receptor heteromers as distinct, functional receptors (2014) Cells, 3, pp. 152-179; 
Oreskovic, Z., Bicanic, G., Hrabec, P., Tripkovic, B., Delimar, D., Treatment of postoperative pain after total hip arthroplasty: comparison between metamizol and paracetamol as adjunctives to opioid analgesics- prospective, double-blind, randomized study (2014) Arch. Orthop. Trauma Surg., 134, pp. 631-638; 
Oretti, R., A retrospective evaluation of inpatient transfer from high-dose methadone to buprenorphine substitution therapy (2015) J. Subst. Abuse Treat., 57, pp. 102-105; 
Ortega-Alvaro, A., Ternianov, A., Aracil-Fernandez, A., Navarrrete, F., Garcia-Gutierrez, M.S., Manzanares, J., Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol (2015) Addict. Biol., 20, pp. 43-55; 
Ortencio, K.P., Renzo, R., Sobrinho, B.A.A., Kobashigawa, K.K., Crivelaro, R.M., Silva, G.A., Aldrovani, M., Laus, J.L., Effects of morphine on the expression of cytokines and inflammatory mediators in a rabbit model of endotoxin-induced experimental uveitis (2015) Arg. Bras. Oftalmol., 78, pp. 371-375; 
Oslin, D.W., Leong, S.H., Lynch, K.G., Berrettini, W., O'Brien, C.P., Gordon, A.J., Rukstalis, M., Naltrexone versus placebo for the treatment of alcohol dependence: a randomized clinical trial (2015) JAMA Psychiatry, 72, pp. 730-737; 
Ozawa, A., Brunori, G., Marcatelli, D., Wu, J., Cipitelli, A., Zou, B., Xie, X.S., Toll, L., Knock-in mice with NOP-eGFP receptors identify receptor cellular and regional localization (2015) J. Neurosci., 35, pp. 11882-11893; 
Pablos, P., Mendiguren, A., Pineda, J., Contribution of nitric oxide-dependent guanylate cyclase and reactive oxygen species signaling pathwys to desensitization of mu-opioid receptors in the rat locus coeruleus (2015) Neuropharmacology, 99, pp. 422-431; 
Paech, M., Sng, B., Ng, L., Nathan, E., Sia, A., Carvalho, B., Methylnaltrexone to prevent morphine-induced pruritis after cesarean delivery: a multicenter, randomized clinical trial (2015) Br. J. Anaesth., 114, pp. 469-476; 
Pacesova, D., Volfova, B., Cervena, K., Hejnova, L., Novotny, J., Bendova, Z., Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3beta kinases and Per1 expression in the rat suprachiasmatic nucleus (2015) Br. J. Pharmacol., 172, pp. 3638-3649; 
Pahlevani, P., Fatahi, Z., Moradi, M., Haghparast, A., Morphine-induced conditioned place preference and the alterations of p-ERK, p-CREB and c-fos levels in hypothalamus and hippocampus: the effects of physical stress (2014) Cell Mol. Biol. (Noisy-le-grand), 60, pp. 48-55; 
Pal, R., Mendelson, J.E., Flower, K., Garrison, K., Yount, G., Coyle, J.R., Galloway, G.P., Impact of prospectively determined A118G polymorphism on treatment response to injectable naloxone among methamphetamine-dependent patients: an open-label pilot study (2015) J. Addict. Med., 9, pp. 130-135; 
Palus, K., Chrobok, L., Lewandowski, M.H., Orexins/hypocretins modulate the activity of NPY-positive and −negative neurons in the rat intergeniculate leaflet via OX1 and OX2 receptors (2015) Neuroscience, 300, pp. 370-380; 
Palus, K., Calka, J., The influence of prolonged acetylsalicylic acid supplementation-induced gastritis on the neurochemistry of the sympathetic neurons supplying prepyloric region of the porcine stomach (2015) PLoS One, 10, p. e143661; 
Papakonstantinou, M.P., Karoussiotis, C., Georgoussi, Z., RGS2 and RGS4 proteins: new modulators of the kappa-opioid receptor signaling (2015) Cell. Signal., 27, pp. 104-114; 
Papoiu, A.D., Kraft, R.A., Coghill, R.C., Yosipovitch, G., Butorphanol suppression of histamine itch is mediated by nucleus accumbens and septal nuclei: a pharmacological fMRI study (2015) J. Invest. Dermatol., 135, pp. 560-568; 
Pardey Bracho, G.F., Pereira de Souza Neto, E., Grousson, S., Mottolese, C., Dailler, F., Opioid consumption after levobupivacaine scalp nerve block for craniosynostosis surgery (2014) Acta Anaesthesiol. Taiwan, 52, pp. 64-69; 
Parikh, G.P., Veena, S.R., Vora, K., Parikh, B., Joshi, A., Comparison of epidural butorphanol versus epidural morphine in postoperative pain relief (2014) Middle East J. Anaesthesiol., 22, pp. 371-376; 
Park, J.S., Choi, G.S., Kwak, K.H., Jung, H., Jeon, Y., Park, S., Yeo, J., Effect of local wound infiltration and transversus abdominis plane block on morphine use after laparoscopic colectomy: a nonrandomized single-blind prospective study (2015) J. Surg. Res., 195, pp. 61-68; 
Park, P.E., Schlosberg, J.E., Vendruscolo, L.F., Schulteis, G., Edwards, S., Koob, G.F., Chronic CRF1 receptor blockade reduces heroin intake escalation and dependence-induced hyperalgesia (2015) Addict. Biol., 20, pp. 275-284; 
Parker, K.E., McCabe, M.P., Johns, H.W., Lund, D.K., Odu, F., Sharma, R., Thakkar, M.M., Will, M.J., Neural activation patterns underlying basolateral amygdala influence in intra-accumbens opioid-driven consummatory versus appetitive high-fat feeding behaviors in the rat (2015) Behav. Neurosci., 129, pp. 812-821; 
Parker, K.E., McCall, J.G., McGuirk, S.R., Trivedi, S., Miller, D.K., Will, M.J., Effects of co-administration of 2-arachidonylglyceerol (2-AG) and a selective mu-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat (2015) Brain Res., 1618, pp. 309-315; 
Parker, L.M., Kumar, N.N., Lonergan, T., McMullan, S., Goodchild, A.K., Distribution and neurochemical characterization of neurons in the rat ventrolateral medulla activated by glucoprivation (2015) Brain Struct. Funct., 220, pp. 117-134; 
Parkes, S.L., Bradfield, L.A., Baleine, B.W., Interaction of insular cortex and ventral striatum mediates the effect of incentive memory on choice between goal-directed actions (2015) J. Neurosci., 35. , 6484–6471; 
Parodi, G., Bellandi, B., Xanthopoulou, I., Capranzano, P., Capodanno, D., Valenti, R., Stavrou, K., Alexopoulos, D., Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (2014) Circ. Cardiovasc. Interv., 8, p. e001593; 
Partownavid, P., Sharma, S., Li, J., Umar, S., Rahman, S., Eghbali, M., Involvement of opioid receptors in the lipid rescue of bupivacaine-induced cardiotoxicity (2015) Anesth. Analg., 121, pp. 340-347; 
Passos, F.F., Lopes, E.M., de Araujo, J.M., de Sousa, D.P., Veras, L.M., Leite, J.R., Almeida, F.R., Involvement of cholinergic and opioid system in gamma-terpinene-mediated antinociception (2015) Evid. Based Complement Alt. Med., 2015, p. 829414; 
Patrick, S.W., Kaplan, H.C., Passarella, M., Davis, M.M., Lorch, S.A., Variation in treatment of neonatal abstinence syndrome in U S. children's hospitals, 2004–2011 (2014) J. Perinatol., 34, pp. 867-872; 
Paulozzi, L.J., Zhang, K., Jones, C.M., Mack, K.A., Risk of adverse health outcomes with increasing duration and regularity of opioid therapy (2014) J. Am. Board Fam. Med., 27, pp. 329-338; 
Paulsen, O., Klepstad, P., Rosland, J.H., Aass, N., Albert, E., Fayers, P., Kaasa, S., Efficacy of methylprednisolone on pain, fatigue and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial (2014) J. Clin. Oncol., 32, pp. 3221-3228; 
Pavan, C.G., Roncari, C.F., Barbosa, S.P., De Paula, P.M., Colombari, D.S., De Luca, L.A., Jr., Colombari, E., Mehani, J.V., Activation of mu opioid receptors in the LPBN facilitates sodium intake in rats (2015) Behav. Brain Res., 288, pp. 20-25; 
Payandemehr, P., Jalili, M., Mostafazadeh Davani, B., Dehpour, A.R., Sublingual buprenorphine for acute renal colic pain management: a double-blind, randomized controlled trial (2014) Int. J. Emerg. Med., 7, p. 1; 
Pazzola, M., Pira, E., Sedda, G., Vacca, G.M., Cocco, R., Sechi, S., Bonelli, P., Nicoolussi, P., Responses of hematological parameters, beta-endorphin, cortisol, reactive oxygen metabolites, and biological antioxidant potential in horses participating in a traditional tournament (2015) J. Anim. Sci., 93, pp. 1573-1580; 
Pecina, M., Bohnert, A.S., Sikora, M., Avery, E.T., Langenecker, S.A., Mickey, B.J., Zubieta, J.K., Association between placebo-activated neural systems and antidepressant responses: neurochemistry of placebo effects in major depression (2015) JAMA Psychiatry, 72, pp. 1087-1094; 
Pecina, M., Love, T., Stohler, C.S., Goldman, D., Zubieta, J.K., Effects of mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures (2015) Neuropsychopharmacology, 40, pp. 957-965; 
Peravali, R., Brock, R., Bright, E., Mills, P., Petty, D., Alberts, J., Enhancing the enhanced recovery program in colorectal surgery −use of extended-release epidural morphine (DepoDur) (2014) Ann. Coloproctol., 30, pp. 186-191; 
Peregud, D.I., Pancehnko, L.F., Gulyaeva, N.V., Elevation of BDNF exon 1-specific transcripts in the frontal cortex and midbrain of rat during spontaneous morphine withdrawal is accompanied by enhanced pCREB1 occupancy at the corresponding promoter (2015) Neurochem. Res., 40, pp. 130-138; 
Pereira, M.P., Donahue, R.R., Dahl, J.B., Werner, M., Taylor, B.K., Werner, M.U., Endogenous opioid-maked latent pain sensitization: studies from mouse to human (2015) PLoS One, p. 10e0134441; 
Perisamy, S., Poovathai, R., Pondiyadanar, S., Influences of gender on postoperative morphine consumption (2014) J. Clin. Diagn Res., 8, pp. GC04-GC07; 
Perlikowsla, R., Piekielna, J., Genilucci, L., De Marco, R., Cerlesi, M.C., Calo, G., Artali, R., Janecka, A., Syntheis of mixed MOR/KOR efficacy cyclic opioid peptide analogues with antinociceptive activity after systemic administration (2015) Eur. J. Med. Chem., 109, pp. 276-286; 
Pesactore, R., Marrone, G.F., Sedberry, S., Vinton, D., Finkelstein, N., Katlowitz, T.E., Pasternak, G.W., Majumdar, S., Synthesis and pharmacology of halogenated delta-opioid-selective [D-ala(2)]deltorphin II peptide analgogues (2015) ACS Chem. Neurosci., 6, pp. 305-310; 
Pestieau, S.R., Finkel, J.C., Junqueira, M.M., Cheng, Y., Lovejoy, J.F., Wang, J., Quezado, Z., Prolonged perioperative infusion of low-dose ketamine does not alter opioid use after pediatric sciolosis surgery (2014) Paediatr. Anaesth., 24, pp. 582-590; 
Pfeifer, P., Sariyar, M., Eggermann, T., Zerres, K., Vernalekaen, I., Tuscher, O., Fehr, C., Alcohol consumption in healthy OPRM1 G allele carriers and its association with impulsive behavior (2015) Alcohol., 50, pp. 379-384; 
Piekielna, J., Kluczyk, A., Gentilucci, L., Cerlesi, M.C., Calo, G., Tomboly, C., Lapinski, K., Janecka, A., Ring size in cyclcic endomorphin-2 analogues modulates receptor binding affinity and selectivity (2015) Org. Biomol. Chem., 13, pp. 6039-6046; 
Piekielna, J., Perlikowska, R., do-Rego, J.G., Cerlesi, M.C., Calo, G., Kluczyk, A., Lapinski, K., Janecka, A., Synthesis of mixed opioid affinity cyclcic endomorphin-2 analogues with fluorinated phenylalanines (2015) ACS Med. Chem. Lett., 6, pp. 579-583; 
Pierzchala-Koziec, K., Dziedzika-Wasylewska, M., Oeltgen, P., Zubel-Lojek, J., Latacz, A., Oclon, E., The effect of CRH and naltrexone on the mu, delta and kappa opioid receptor agonist binding in lamb hypothalamic-pituitary-adrenal axis (2015) Folia Biol. (Krakow), 63, pp. 187-193; 
Pinkston, J.W., Ginsberg, B.C., Lamb, R.J., Reinforcer magnitude and rate-dependency: evaluation of resistance-to-change mechanisms (2014) Behav. Pharmacol., 25, pp. 629-636; 
Piralshvilli, G., Otiashvili, D., Sikharulidze, Z., Kamkamidze, G., Poole, S., Woody, G.E., Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia (2015) J. Subst. Abuse Treat., 50, pp. 32-37; 
Pisanu, A., Lecca, D., Valentini, V., Bahi, A., Dreyer, J.L., Cacciapaglia, F., Scifo, A., Di Chiara, G., Impairment of acquisition of intravenous cocaine self-administration by RNA-interference of dopamine D1-receptors in the nucleus accumbens shell (2015) Neuropharmacology, 89, pp. 396-411; 
Pivec, R., Issa, K., Naziri, Q., Kapadia, B.H., Bonutti, P.M., Mont, M.A., Opioid use prior to total hip arthroplasty leads to worse clinical outcomes (2014) Int. Orthop., 38, pp. 1159-1165; 
Pluchino, N., Drakopoulos, P., Casarosa, E., Freschi, L., Petignat, P., Yaron, M., Genazzani, A.R., Effect of estetrol on beta-endorphin level in female rats (2015) Steroids, 95, pp. 104-110; 
Poblete, B., Konrad, C., Kothbauer, K.F., Intrathecal morphine analgesia after cervical and thoracic spinal cord tumor surgery (2014) J. Neurosurg. Spine, 21, pp. 899-904; 
Podolnikova, N.P., Brothwell, J.A., Ugarova, T.P., The opioid peptide dynorphin A induces leukocyte responses via integrin Mac-1 (alphaMbeta2, CD11b/CD18) (2015) Mol. Pain, 11, p. 53; 
Podvin, S., Bundey, R., Toneff, T., Ziegler, M., Hook, V., Profiles of secreted neuropeptides and catecholamines illustrate similarities and differences in response to stimulation by distinct secretalogues (2015) Mol. Cell. Neurosci., 68, pp. 177-185; 
Poelaert, J., Koopmans-Klein, G., Dioh, A., Louis, F., Gorissen, M., Loge, D., Van Op den Bosch, J., van Megen, Y.J., Treatment with prolonged-release oxycodone/naloxone improves pain relief and opioid-induced constipation compared with prolonged-release oxycodone in patients with chronic severe pain and laxative-refractory constipation (2015) Clin. Ther., 37, pp. 784-792; 
Poon, K., Alam, M., Karatayex, O., Barson, J.R., Leibowitz, S.F., Regulation of the orexigenic neuropeptide, enkephalin, by PPARdelta and fatty acids in neurons of the hypothalamus and forebrain (2015) J. Neurochem., 135, pp. 918-931; 
Poonai, N., Bhullar, G., Lin, K., Papini, A., Mainprize, D., Howard, J., Teefy, J., Ali, S., Oral administration of morphine versus ibuprofen to manage postfracture pain in children: a randomized trial (2014) CMAJ, 186, pp. 1358-1363; 
Popiolek-Barczak, K., Makuch, W., Rojewska, E., Pilat, D., Mika, J., Inhibition of intracellular signaling pathways NF-kappaB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia (2014) Pharmacol. Rep., 66, pp. 845-851; 
Poras, H., Bonnard, E., Fournie-Zaluski, M.C., Roques, B.P., Modulation of disulfide dual ENKephalinase inhibitors (DENKs) activity by a transient N-protection for pain alleviation by oral route (2015) Eur. J. Med. Chem., 102, pp. 58-67; 
Poretti, M.B., Rask-Andersen, M., Kumar, P., Rubiales de Barioglio, S., Fiol de Cuneo, M., Schioth, H.B., Carlini, V.P., Ghrelin effects expression of several genes associated with depression-like behavior (2015) Prog. Neuropsychopharmacol. Biol. Psychiatry, 56, pp. 227-234; 
Porto, G.P., Milanesi, L.H., Rubin, M.A., Mello, C.F., Effect of morphine on the persistence of long-term memory in rats (2015) Psychopharmacology (Berl)., 232, pp. 1747-1753; 
Posillico, C.K., Terasaki, L.S., Bilbo, S.D., Schwarz, J.M., Examination of sex and minocycline treatment on acute morphine-induced analgesia and inflammatory gene expression along the pain pathway in Sprague-Dawley rats (2015) Biol. Sex Fiffer, 6, p. 33; 
Potter, J.S., Dreifuss, J.A., Marino, E.N., Provost, S.E., Dodd, D.R., Rice, L.S., Fitzmaurice, G.M., Weiss, R.D., The multi-site prescription opioid addicition study: 18 month outcomes (2015) J. Subst. Abuse Treat., 48, pp. 62-69; 
Potts, L.F., Park, E.S., Woo, J.M., Dyaver Shetty, B.L., Singh, A., Braithwaite, S.P., Voronkov, M., Mouadian, M.M., Dual kappa-agonist/mu-antagonist opioid receptor modulation reduces levodopa-induced dsyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson's disease (2015) Ann. Neurol., 77, pp. 930-941; 
Prossin, A.R., Zalcman, S.S., Heitzeg, M.M., Koch, A.E., Campbell, P.L., Phan, K.L., Stohler, C.S., Zunieta, J.K., Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans (2015) Neuropsychopharmacology, 40, pp. 554-565; 
Provasi, D., Boz, M.B., Johnston, J.M., Filizaola, M., Preferred supramolecular organization and dimer interfaces of opioid receptors from simulated self-association (2015) PLoS Comput. Biol., 11, p. e1004148; 
Pu, H., Wang, X., Zhang, J., Ma, C., Su, Y., Li, X., Liu, X., Su, L., Cerebellar neuronal apoptosis in heroin-addicted rats and its moleculr mechanism (2015) Int. J. Clin. Exp. Pathol., 8, pp. 8260-8267; 
Pugsley, M.K., Saint, D.A., Hayes, E.S., Abraham, S., Walker, M.J., An examination of the cardiac actions of PD117,302, a kappa-opioid receptor agonist (2015) Eur. J. Pharmacol., 761, pp. 330-340; 
Qiao, Y., Han, K., Zhan, C.G., Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine (2014) Org. Biomol. Chem., 12, pp. 2214-2227; 
Qiu, S., Feng, Y., LeSage, G., Zhang, Y., Stuart, C., He, L., Li, Y., Yin, D., Chronic morphine-induced mRNA-124 promotes microglial immunosuppression by modulating P65 and TRAF6 (2015) J. Immunol., 194, pp. 1021-1030; 
Qu, C.L., Huo, F.Q., Huang, F.S., Tang, J.S., Activation of mu-opioid receptors in the ventrolateral orbital cortex inhibits the GABAergic miniature inhibitoty postsynaptic currents in rats (2015) Neurosci. Lett., 592, pp. 64-69; 
Radahmadi, M., Ramshini, E., Hosseini, N., Karimi, S., Alaei, H., Effect of electrical stimulation of nucleus accumbens with low, median and high current intensities on conditioned place preference induced by morphine in rats (2014) Adv. Biomed. Res., 3, p. 14; 
Rafiq, S., Steinbruchel, D.A., Wanscher, M.J., Andersen, L.W., Navne, A., Lilleoer, N.B., Olsen, P.S., Multimodal analgesia versus traditional opiate based analgesia after cardiac surgery, a randomized controlled trial (2014) J. Cardiothorac. Surg., 9, p. 52; 
Ragen, B.J., Freeman, S.M., Laredo, S.A., Mendoza, S.P., Bales, K.L., Mu and kappa opioid receptor distribution in the monogamous titi monkeys (Callicebus cupreus): implications for social behavior and endocrine functioning (2015) Neuroscience, 290, pp. 421-434; 
Ragen, B.J., Maninger, N., Mendoza, S.P., Bales, K.L., The effects of morphine, naloxone and kappa opioid manipulation on endocrine functioning and social behavior in monogamous titi monkeys (Callicebus cupreus) (2015) Neuroscience, 287, pp. 32-42; 
Ragsdale, L., Zhong, W., Morrison, W., Munson, D., Kang, T.I., Dai, D., Feudther, C., Pediatric exposure to opioid and sedation medications during terminal hospitalizations in the United States, 2007–2011 (2015) J. Pediatr., 166, pp. 587-593; 
Raiff, D., Vaughan, C., McGee, A., Impact of intraoperative acetaminophen administration on postoperative opioid consumption in patients undergoing hip or knee replacement (2014) Hosp. Pharm., 49, pp. 1022-1032; 
Raksakietisak, M., Chinachoti, T., Iamaroon, A., Thabpenthai, Y., Halilamien, P., Siriratwarangkul, S., Watanitanon, A., Oral rehydration with 10% carbohydrate drink for preventing postoperative nausea and vomiting (PONV) after low dose of spinal morphine (2014) J. Med. Assoc. Thai., 97, pp. 530-535; 
Raleigh, M.D., Pentel, P.R., LeSage, M.G., Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats (2014) PLoS One, 9, p. e115696; 
Ramirez, L., Cros, J., Marin, B., Boulogne, P., Bergeron, A., de Lafont, G.E., Renon-Carron, F., Beaulieu, P., Analgesic interaction between ondansetron and acetaminophen after tonsillectomy in children: a Paratron randomized controlled trial (2015) Eur. J. Pain, 19, pp. 661-668; 
Rando, J., Broering, D., Olson, J.E., Marco, C., Evans, S.B., Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths (2015) Am. J. Emerg. Med., 33, pp. ‘1201-1204; 
Rankovic, M., Lj Canon, F., Nahon, L., Giuliani, A., Milosavljevic, A.R., VUV action spectroscopy of protonated leucine-enkephalin peptide in the 6–14 eV range (2015) J. Chem. Phys., 143, p. 244311; 
Rasmussen, D.D., Kincaid, C.L., Froelich, J.C., Prazosin + naloxone decreases alcohol drinking moree effectively than does either drug alone in P rats with a protracted history of extensive voluntary alchol drinking, dependence and multiple withdrawals (2015) Alcohol. Clin. Exp. Res., 39, pp. 1832-1841; 
Rauck, R.L., Hale, M.E., Bass, A., Bramson, C., Pixton, G., Wilson, J.G., Setnik, B., Wolfram, G., A randomized double-blind, placebo-controlled efficacy and safety study of ALO-02 (extended-release oxycodone surrounding sequestered naltrexone) for moderate-to-severe chronic low back pain treatment (2015) Pain, l158, pp. 1660-1669; 
Ravn, P., Foster, D.J., Kreilgaard, M., Christrup, L., Werner, M.U., Secher, E.L., Skram, U., Upton, R., Pharmakokinetic-pharmacodynamic modeling of the analgesic and antihyperalgesic effects of morphine after intravenous infusion in human volunteers (2014) Basic Clin. Pharmacol. Toxicol., 115, pp. 257-267; 
Ray, B., O'Donnell, D., Kahre, K., Police officer attitudes towards intranasal naloxone training (2015) Drug Alcohol Depend., 146, pp. 107-110; 
Ray, L.A., Bujarski, S., Courtney, K.E., Moallem, N.R., Lunny, K., Roche, D., Leventhal, A.M., Miotto, K., The effects of naltrexone on subjective responses to methamphetamine in a clinical sample: a double-blind, placebo-controlled laboratory study (2015) Neuropsychopharmacology, 40, pp. 2347-2356; 
Ray, L.A., Courtney, K.E., Ghahremani, D.G., Miotto, K., Brody, A., London, E.D., Varenicline, naltrexone and their combination for heavy-drinking smokers: preliminary neuroimaging findings (2015) Am. J. Drug Alcohol Abuse, 41, pp. 35-44; 
Razavi, Y., Karimi, S., Bani-Ardalan, M., Haghparast, A., Chemical stimulation of the lateral hypothalamus potentiated the sensitization to morphine in rats: involvement of orexin-1 receptor in the ventral tegmental area (2014) EXCLI J., 13, pp. 1120-1130; 
Reddy, A., Yennurajalingam, S., Desai, H., Reddy, S., de la Cruz, M., Wu, J., Liu, D., Bruera, E., The opioid rotation ratio of hydrocodone to strong opioids in cancer patients (2014) Oncologist, 19, pp. 1186-1193; 
Reisi, Z., Bani-Ardalan, M., Zarepour, L., Haghparast, A., Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to aninociceptive effect of morphine (2014) Pharmacol. Biochem. Behav., 118, pp. 16-21; 
Remeniuk, B., Sukhtankar, D., Okun, A., Navratilova, E., Xie, J.Y., King, T., Porreca, F., Behavioral and neurochemical analysis of ongoing bone cancer pain in rats (2015) Pain, 156, pp. 1864-1873; 
Ren, B., Zhou, Z., Liu, Z., Li, B., Ou, J., Dai, Q., Con-T[M8Q] potently attenuates the expression and development of morphine tolerance in mice (2015) Neurosci. Lett., 597, pp. 38-42; 
Retson, T.A., Hoek, J.B., Sterling, R.C., van Bockstaele, E.J., Amygdalar neural plasticity and the interactions of alcohol, sex and stress (2015) Brain Struct. Funct., 220, pp. 3211-3232; 
Reyes, B.A., Zitnik, G., Foster, C., van Bockstaele, E.J., Valentino, R.J., Social stress engages neurochemically distinct afferents to the rat locus coeruleus depending on coping strategy (2015) eNeuro, 2. , (0042-015); 
Rezazadeh, H., Hosseini Kahnouei, M., Hassanshahi, G., Allahtavakoli, M., Shamsizadeh, A., Roohbaksh, A., Fatemi, I., Pourshanazari, A.A., Regulatory effect of chronic low-dose morphine on nitric oxide level along with baroreflex senisitivity in two-kidney one-clip hypertenive rats (2014) Iran. J. Kidney Dis., 8, pp. 194-200; 
Rezk, M., El-Shamy, E.S., Massod, A., Dawood, R., Habeeb, R., The safety and acceptability of intravenous fentanyl versus intramuscular pethidine for pain relief during labour (2015) Clin. Exp. Obstet. Gynecol., 42, pp. 781-784; 
Rialland, P., Otis, C., de Courval, M.L., Mulon, P.Y., Harvey, D., Bichot, S., Gauvin, D., Troncy, E., Assessing experimental visceral pain in dairy cattle: a pilot, prospective blinded randomized and controlled study focusing on spinal pain proteonomics (2014) J. Dairy Sci., 97, pp. 2118-2134; 
Richardson, K.J., Shelton, K.L., N-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gas (2015) J. Pharmacol. Exp. Ther., 352, pp. 156-165; 
Richert, T., Wasted, overdoses or beyond saving −to act or not to act? Heroin users’ views, assessments and responses to witnessed overdoses in Malmo, Sweden (2015) Int. J. Drug Policy, 26, pp. 92-99; 
Ricker, E.M., Pye, R.L., Barr, B.L., Wyatt, C.N., Selective mu and kappa opioid agonists inhibit voltage-gated Ca(2 + ) entry in isolated neonatal rat carotid body type 1 cells (2015) Adv. Exp. Med. Biol., 860, pp. 49-54; 
Riedel, R., Marrassini, C., Anesini, C., Gorzalczany, S., Anti-inflammatory and antinociceptive activity of Urea aurantiaca (2015) Phytother. Res., 29, pp. 59-66; 
Ries, R., Krupski, A., West, I.I., Maynard, C., Bumgardner, K., Donovan, D., Dunn, C., Roy-Byrne, P., Correlates of opioid use with self-reported drug use recruited from public safety-net primary care clinics (2015) J. Addict. Med., 9, pp. 417-426; 
Riley, J., Branford, R., Droney, J., Gretton, S., Sato, H., Kennett, A., Oyebode, C., Ross, J., Morphine or oxycodone for cancer-related pain: a randomized open-label controlled trial (2015) J. Pain Symptom Manage., 49, pp. 161-172; 
Ripley, T.L., Sanchez-Roige, S., Bullmore, E.T., Mugnaini, M., Maltby, K., Miller, S.R., Wille, D.R., Stephens, D.N., The novel mu-opioid antagonist, GSK1521498 reduces ethanol consumption in C57BL/6J mice (2015) Psychopharmacology (Berl)., 232, pp. 3431-3441; 
Ris, F., Findlay, J.M., Hompes, R., Rashid, A., Warwick, J., Cunningham, C., Jones, O., Lindsey, I., Addition of transversis palne block to patient controlled analgesia for laparoscopic high anterior resention improves analgesia, reduces opioid requirement and expedites recovery of bowel function (2014) Am. R. Coll. Surg. Eng., 96, pp. 579-585; 
Rizzi, A., Sukhtankar, D.D., Ding, H., Hayashida, K., Ruzza, C., Guerrini, R., Calo, G., Ko, M.C., Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys (2015) Br. J. Pharmacol., 172, pp. 3661-3670; 
Robinson, J.D., McDonald, P.H., The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism (2015) Cell. Signal., 27, pp. 1449-1456; 
Robinson, J.E., Vardy, E., DiBerto, J.F., Chefer, V.I., White, K.L., Fish, E.W., Chen, M., Malanga, C.J., Receptor reserve moderates mesolimbic responses to opioids in a humanized mouse model of the OPRM1 A118G polymorphism (2015) Neuropsychopharmacology, 40, pp. 2614-2622; 
Robinson, M.J., Burghardt, P.R., Patterson, C.M., Nobile, C.W., Akil, H., Watson, S.J., Berridge, K.C., Ferrario, C.R., Individual differences in cue-induced motivation and striatal systems in rats susceptible to diet-induced obesity (2015) Neuropsychopharmacology, 40, pp. 2113-2123; 
Roche, D.J., Bujarski, S., Hartwell, C., Green, R., Ray, L.A., Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers (2015) Pharmacol. Biochem. Behav., 134, pp. 92-98; 
Roche, D.J., King, A.C., Sex differences in acute hormonal and subjective response to naltrexone: the impact of menstrual cycle phase (2015) Psychoneuroendocrinology, 52, pp. 59-71; 
Roczniak, W., Babuska-Roczniak, M., Kwapulinski, J., Brodziak-Dopierala, B., Widuchowski, W., Cipora, E., Nowak, P., Oswiecimska, J.M., The effect of central noradrenergic system lesion on dopamine (DA) and serotonin (5-HT) synthesis rate following administration of 5-HT3 receptor ligands in chosen parts of the rat brain (2015) Pharmacol. Rep., 67, pp. 146-151; 
Roehl, B.C., Breese McCoy, S.J., Payton, M.E., Witter, L.C., Morphine after tubal ligation with bupivacaine: dosage versus body weight (2014) JSLS, 18. , e2014.00204; 
Roerecke, M., Sorensoen, P., Laramee, P., Rahhali, N., Rehm, J., Clinical relvance of nalmefene versus placebo in alcohol treatment: reduction in mortality risk (2015) J. Psychopharmacol., 29, pp. 1152-1158; 
Rogers, M.J., Xiao, Z., Shen, B., Wang, J., Schwen, Z., Roppolo, J.R., de Groat, W.C., Tai, C., Propranolol, but not naloxone, enhances spinal reflex bladder activity and reduces pudendal inhibition in cats (2015) Am. J. Physiol. Rgul. Integr. Comp. Physiol., 308, pp. R42-R49; 
Roncero, C., Dominguez- Hernandez, R., Diaz, T., Fernandez, J.M., Forcada, R., Martinez, J.M., Seijo, P., Oyaguez, I., Management of opioid-dependent patients: comparison of the cost associated with the use of buprenorphine/naloxone or methadone and their interactions with concomitant treatments for infections or psychiatric comorbidities (2015) Addicciones, 27, pp. 179-189; 
Roncon, C.M., Almada, R.C., Maraschin, J.C., Audi, E.A., Zangrossi, H., Jr., Graeff, F.G., Coimbra, N.C., Pharmacological evidence for the mediation of the panicolytic effect of fluoxetine by dorsal periaqueductal matter mu-opioid receptors (2015) Neuropharmacology, 99, pp. 620-626; 
Roohi, N., Sarihi, A., Shahidi, S., Zarei, M., Haghparast, A., Microinjection of the mGluR5 antagonist MTEP into the nucleus accumbens attenuates the acquisition but not expression of morphine-induced conditioned place preference in rats (2014) Pharmacol. Biochem. Behav., 126, pp. 109-115; 
Rosa, M., Caltabiano, G., Barreto-Valer, K., Gonzalez-Nunez, V., Gomez-Tamayo, J.C., Arda, A., Jimenez-Barbero, J., Valencia, G., Modulation of the interaction between a peptide ligand and a G protein coupled receptor by halogen atoms (2015) ACS Med. Chem. Lett., 6, pp. 872-876; 
Rose, A.R., Catcheside, P.G., McEvoy, R.D., Paul, D., Kapur, D., Peak, E., Vakulin, A., Antic, N.A., Sleep disordered breathing and chronic respiratory failure in patients with chronic pain on long term opioid therapy (2014) J. Clin. Sleep Med., 10, pp. 847-852; 
Rosenblatt, R.A., Andrilla, C.H., Catlin, M., Larson, E.H., Geographic and specialty distribution of US physicians trained to treat opioid use disorder (2015) Ann. Fam. Med., 13, pp. 23-26; 
Ross, T.M., Battista, K., Bignan, G.C., Brenneman, D.E., Connolly, P.J., Liu, J., Middleton, S.A., Vaidya, A.H., A selective small molecule NOP (ORL-1 receptor) partial agonist for the treatment of anxiety (2015) Bioorg. Med. Chem. Lett., 25, pp. 602-606; 
Rossaneis, A.C., Genaro, K., Dias, Q.M., Guethe, L.M., Fais, R.S., Del Bel, E.A., Prado, W.A., Descending mechanisms activated by the anterior pretectal nucleus inflate but do not maintain neuropathic pain in rats (2015) Eur. J. Pain, 19, pp. 1148-1157; 
Rossato, M.F., Oliveira, S.M., Trwevisan, G., Rotta, M., Machado, P., Martins, M.A., Ferreira, J., Structural improvement of compounds with analgesic activity: AC-MPF4, a compound with mixed anti-inflammatory and antinociceptive activity via opioid receptor (2015) Pharmacol. Biochem. Behav., 129, pp. 72-78; 
Roubalova, L., Vosahlikova, M., Brejchova, J., Sykora, J., Rudajev, V., Svoboda, P., High-efficacy, but low potency of delta-opioid receptor-G protein coupling in Brij-58-treated, low-density plasma membrane fragments (2015) PLoS One, 10, p. e0135664; 
Roughan, J.V., Coulter, C.A., Flecknell, P.A., Thomas, H.D., Sufka, K.J., The conditioned place preference test for assessing welfare consequences and potential refinements in a mouse bladder cancer model (2014) PLoS One, 9, p. e103362; 
Rowe, C., Santos, G.M., Vittinghoff, E., Wheeler, E., Davidson, P., Coffin, P.O., Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program (2015) Addiction, 110, pp. 1301-1310; 
Ruegseggar, G.N., Toedebusch, R.G., Will, M.J., Booth, F.W., Mu opioid receptor modulation in the nucleus accumbens lowers voluntary wheel running in rats bred for high running motivation (2015) Neuropharmacology, 97, pp. 171-181; 
Ruiu, S., Anzani, N., Orru, A., Floris, C., Caboni, P., Alcaro, S., Maccioni, E., Cottiglia, F., Methoxyflavones from Stachys glutinosa with binding affinity to opioid receptors: in silico, in vitro and in vivo studies (2015) J. Nat. Prod., 78, pp. 69-76; 
Ruiz-DeDiego, I., Mellstrom, B., Vallejo, M., Naranjo, J.R., Moratalia, R., Activation of DREAM (downstream regulatory element antagonistic modulator), a calcium-binding protein, reduces L-DOPA-induced dyskinesias in mice (2015) Biol. Psychiatry, 77, pp. 95-105; 
Ruiz-Pino, F., Garcia-Galiano, D., Manfredi-Lozano, M., Leon, S., Sanchez-Garrido, M.A., Roa, J., Pinilla, L., Tena-Sempere, M., Effects and interactions of tachykinins and dynorphin on FH and LH secretion in developing and adult rats (2015) Endocrinology, 156, pp. 576-588; 
Ruscitto, A., Smith, B.H., Guthrie, B., Changes in opioid and other analgesic use 1995–2010: repeated cross-sectional analysis of dispensed prescribing for a large geographical population in Scotland (2015) Eur. J. Pain, 19, pp. 59-66; 
Russ, J.B., Borromeo, M.D., Kollipara, R.K., Bommareddy, P.K., Johnson, J.E., Kalischmidt, J.A., Misexpression of ptf1a in cortical pyramidal cells in vivo promotes an inhibitory petptidergic identity (2015) J. Neurosci., 35, pp. 6028-6037; 
Rutgen, M., Seidel, E.M., Silani, G., Riecansky, I., Hummer, A., Windischberger, C., Petrovic, P., Lamm, C., Placebo analgesia and its opioid regulation suggest that empathy for pain is grounded in self pain (2015) Proc. Natl. Acad. Sci. (U. S. A.), 113, pp. E5638-5646; 
Sadegh, M., Fathollahi, Y., Repetitive systemic morphine alters activity-dependent plasticity of Schaffer-collateral-CA1 pyramidal cell synapses: involvement of adenosine A1 receptors and adenosine deaminase (2014) J. Neurosci. Res., 92, pp. 1395-1408; 
Sadegh, M., Tzschentke, T.M., Christie, M.J., Mu-opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons (2015) Br. J. Pharmacol., 172, pp. 460-468; 
Sadhasivam, S., Chidambaran, V., Olbrecht, V.A., Costandi, A., Clay, S., Prows, C.A., Zhang, X., Martin, L.J., Opioid-related adverse effects in children undergoing surgery: unequal burden on younger girls with higher doses of opioids (2015) Pain Med., 16, pp. 985-997; 
Sadhasivam, S., Chidambaran, V., Zhang, X., Meller, J., Esslinger, H., Zhang, K., Martin, L.J., McAuliffe, J., Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics (2015) Pharmacogenet. J., 15, pp. 119-126; 
Sadhasivam, S., Chidambaran, V., Olbrecht, V.A., Esslinger, H.R., Zhang, K., Zhang, X., Martin, L.J., Genetics of pain perception, COMT and postoperative pain management in children (2014) Pharmacogenomics, 15, pp. 277-284; 
Safrany-Fark, A., Petrovszki, Z., Kekesi, G., Keresztes, C., Benedek, G., Horvath, G., Telemetry monitoring for non-invasive assessment of changes in core temperature after spinal drug administration in freely moving rats (2015) J. Pharmacol. Toxicol. Methods, 72, pp. 19-25; 
Sahin, L., Korkmaz, H.F., Sahin, M., Atalan, G., Ultrasound-guided single-injection femoral nerve block provides effective analgesia after total knee arthroplasty up to 48 h (2014) Agriculutre, 26, pp. 113-118; 
Saidai, M., Beaudry, F., Liquid chromatography-electrospray linear ion trap mass spectroscopy analysis of targeted neuropeptides in Tac1(-/-) spinal cords reveals significant lower concentration of opioid peptides (2015) Neuropeptides, 52, pp. 79-87; 
Saigoh, K., Mitsui, J., Hirano, M., Shioyama, M., Samukawa, M., Ichikawa, Y., Goto, J., Kusunoki, S., The first Japanese familial case of spinocerebellar ataxia 23 with a novel mutation of the PDYN gene (2015) Parkinsonism Relat. Disord., 21, pp. 332-334; 
Sakamoto, K., Matsumura, S., Okafuji, Y., Eguchi, A., Lee, S., Adachi, S., Fujitani, M., Fushiki, T., Mechanisms involved in guiding the preference for fat emulsion differ depending on the concentration (2015) J. Nutr. Sci. Vitaminol. (Tokyo), 61, pp. 247-254; 
Sakamoto, K., Matsumura, S., Okafuji, Y., Eguchi, A., Yoneda, T., Mizushige, T., Tsuzuki, S., Fushiki, T., The opioid system contributes to the acquisition of reinforcement for dietary fat but is not required for its maintenance (2015) Physiol. Behav., 138, pp. 227-235; 
Sakamoto, K., Okahashi, T., Matsumura, S., Okafuji, Y., Adachi, S., Tsuzuki, S., Inoue, K., Fushiki, T., The opioid system majorly contributes to preference for fat emulsions but not sucrose solutions in mice (2015) Biosci. Biotechnol. Biochem., 79, pp. 658-663; 
Salaga, M., Polepally, P.R., Zielinska, M., Marynowski, M., Fabisak, A., Murawska, N., Sobczak, K., Salvanorin, A., analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice (2015) Br. J. Pharmacol., 172, pp. 4331-4341; 
Salat, K., Jakubowska, A., Cebranopadal, K.K., a first in-class analgesic agent with agonistic activity at nociception/orphanin FQ and opioid receptors (2015) Expert Opin. Investig. Drugs, 24, pp. 837-844; 
Salpeter, S.R., Buckley, J.S., Buckley, N.S., Bruera, E., The use of very-low-dose methadone and haloperidol for pain control in the hospital setting: a preliminary report (2015) J. Palliat. Med., 18, pp. 114-119; 
Samoshkin, A., Convertino, M., Viet, C.T., Wieskopf, J.S., Kambur, O., Marcovitz, J., Patel, P., Diatchenko, L., Structural and functional interactions between six-transmembrane mu-opioid receptors and beta-2-adrenoreceptors modulate opioid signaling (2015) Sci. Rep., 5, p. 18198; 
Sanders, M., Jones, S., Lowenstein, O., Jansen, J.P., Miles, H., Simpson, K., New formulation of sustained release naloxone can reverse opioid induced constipation without compromising the desired opioid effects (2015) Pain Med., 16, pp. 1540-1550; 
Santhappan, R., Crowder, A.T., Gouty, S., Cox, B.M., Cote, T.E., Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner (2015) J. Neurochem., 135, pp. 76-87; 
Sarnaghandian, S., Afshari, R., Farkhondeh, T., Effect of long-term treatment of morphine on enzymes, oxidative stress indices and antioxidant status in male rat liver (2014) Int. J. Clin. Exp. Med., 7, pp. 1449-1453; 
Samini Sede, S., Davari Tanha, P., Valadan, M., Modaressi, Z., Comparison between preoperative rectal diclofenac plus paracetamol and diclofenac alone for postoperative pain of hysterectomy (2014) J. Fam. Reprod. Health, 8, pp. 91-95; 
Samolsky Dekel, B.G., Tomasi, M., Vasarri, A., Gori, A., Adversi, M., Castagnoli, A., Di Nino, G., Melotti, R.M., Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate/severe cancer pain: a pilot assessment of the CoDem protocol (2014) J. Opioid Manag., 10, pp. 29-38; 
Sanchez-Covarrubias, L., Slosky, L.M., Thompson, B.J., Zhang, Y., Laracuente, M.L., DeMarco, K.M., Ronaldson, P.T., Davis, T.P., P-glycoprotein modulates morphine uptake into the CNS: a role for the non-steroidal anti-inflammatory drug diclofenac (2014) PLoS One, 9, p. e88516; 
Sanchez-Roige, S., Ripley, T.L., Stephens, D.N., Alleviating waiting impulsivity and perseverative responding by mu-opioid receptor antagonism in two inbred mouse strains (2015) Psychopharmacology (Berl)., 232, pp. 1483-1492; 
Sani, M.H., Taher, M., Susanti, D., Kek, T.L., Salleh, M.Z., Zakaria, Z.A., Mechanisms of alpha-manostin-induced antinociception in a rodent model (2015) Biol. Res. Nurs., 17, pp. 68-77; 
Sanna, M.D., Ghelardini, C., Galeotti, N., Activation of JNK pathway in spinal astrocytes contributes to acute ultra-low-dose morphine thermal hyperalgesia (2015) Pain, 156, pp. 1265-1275; 
Sanna, M.D., Mello, T., Ghelardini, C., Galeotti, N., Inhibition of spinal ERK 1–2/c-Jun signaling pathway counteracts the development of low doses morphine-induced hyperalgesia (2015) Eur. J. Pharmacol., 764, pp. 271-277; 
Santoso, J.T., Ulm, M.A., Jennings, P.W., Wan, J.Y., Multimodal pain control is associated with reduced hospital stay following open abdominal hysterectomy (2014) Eur. J. Obstet. Gynecol. Reprod. Biol., 183, pp. 48-51; 
Sarajarvi, T., Marttinen, M., Natunen, T., Kauppinen, T., Makinen, P., Helisalmi, S., Laitinen, M., Hiltunen, M., Genetic variation in delta-opioid receptor associates with increased beta- and gamma-secretase activity in the late stages of Alzheimer's disease (2015) J. Alzheimers Dis., 48, pp. 507-516; 
Saritas, T.B., Borazan, H., Okesli, S., Yel, M., Otelcioglu, S., Is intra-articular magnesium effective for postoperative analgesia in arthroscopic shoulder surgery (2015) Pain Res. Manag., 20, pp. 35-38; 
Sarkisyan, D., Hussain, M.Z., Watanabe, H., Kononecko, O., Bazov, I., Zhou, X., Yamskova, O., Bakalkin, G., Downregulation of the endogenous opioid peptides in the dorsal striatum of human alcoholics (2015) Front. Cell. Neurosci., 9, p. 187; 
Sasaki, K., Sumiyoshi, A., Nonaka, H., Kasahara, Y., Ikeda, K., Hall, F.S., Uhl, G.R., Sora, I., Specific regions display altered grey matter volume in mu-opioid receptor knockout mice: MRI voxel-based morphometry (2015) Br. J. Pharmacol., 172, pp. 654-667; 
Sasmail, P.K., Krishna, C.V., Adabala, S.S., Roshaiah, M., Rawoof, K.A., Thadi, E., Sukumar, K.P., Hogberg, T., Optimisation of in silico derived 2-aminobenzimidazole hits as unprecedented selective kappa opioid receptor agonists (2015) Bioorg. Med. Chem. Lett., 25, pp. 887-892; 
Sathitkammanee, T., Tribuddharat, S., Noiphitak, K., Threeapongpakdee, S., Pongjanyakul, S., Huntua, Y., Thananun, M., Transdermal fentanyl patch for postoperative analgesia in total knee arthroplasty: a randomized double-blind controlled trial (2014) J. Pain Res., 7, pp. 449-454; 
Sato, K., Adachi, T., Shirai, N., Naoi, N., Continuous versus single-injection sciatic nerve block added to continuous femoral nerve block for analgesia after total knee arthroplasty: a prospective, randomized, double-blind study (2014) Reg. Anesth. Pain Med., 39, pp. 225-229; 
Saurabh, S., Smith, J.K., Pedersen, M., Jose, P., Nau, P., Samuel, I., Scheduled intravenous acetaminophen reduces postoperative narcotic analgesic demand and requirement after laparoscopic Roux-en-Y gastric bypass (2015) Surg. Obes. Relat. Dis., 11, pp. 424-430; 
Savic, D., Knezevic, G., Matic, G., Damjanovic, S., Spiric, Z., Posttraumatic and depressive symptoms in beta-endorphin dynamics (2015) J. Affect. Disord., 181, pp. 61-66. , (12.2); 
Savilampi, J., Magnuson, A., Ahlstrand, R., Effects of remifentanil on esophageal motility: a double-blind, randomnized, cross-over study in healthy volunteers (2015) Acta Anaesthesiol. Scand., 59, pp. 1126-1136; 
Sayan-Ozacmak, H., Ozacmak, V.H., Turan, I., Barut, F., Hanci, V., Pretreatment with remifentanil protects against the reduced-intestinal contractility related to the ischemia and reperfusion injury in rat (2015) Braz. J. Anesthesiol., 65, pp. 483-490; 
Scardino, M., Grappiolo, G., Gurgone, A., Mazziotta, G., Astore, F., Ferrari, M., Single-shot epidural-spinal anesthesia followed by oral oxycodone/naloxone and ketoprofen combination in patients undergoing total hip replacement surgery: analgesic efficacy and tolerability (2015) Minerva Anestesiol., 81, pp. 19-27; 
Schank, J.R., Nelson, B.S., Damadzic, R., Tapocik, J.D., Yao, M., King, C.E., Rowe, K.E., Heilig, M., Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking (2015) Neuropharmacology, 99, pp. 106-114; 
Schembri, L.S., Stoddart, L.A., Briddon, S.J., Kellam, B., Canals, M., Graham, B., Scammells, P.J., Synthesis, biological evaluation and utility of fluorescent ligands targeting the mu-opioid receptor (2015) J. Med. Chem., 58, pp. 9754-9767; 
Schiene, K., Tzschentke, T.M., Schroder, W., Christopf, T., Mechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociception/orphanin FQ receptor and mu-opioid receptor agonism (2015) Eur. J. Pharmacol., 754, pp. 61-65; 
Schmitt, S., Colloc'h, N., Perno, C., Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist, JDTic: design, synthesis, pharmacology and molecular modeling studies (2015) Eur. J. Med. Chem., 90, pp. 742-750; 
Schroeder, J.A., Tolman, N.G., McKenna, F.F., Watkins, K.L., Passeri, S.M., Hsu, A.H., Shinn, B.R., Rawls, S.M., Clavulanic acid reduces rewarding, hyperthermic and locomotor-sensitizing effects of morphine in rats: a new indication for an old drug (2014) Drug Alcohol Depend., 142, pp. 41-45; 
Schuster, D.J., Metcalf, M.D., Kitto, K.F., Messing, R.D., Fairbanks, C.A., Wilcox, G.L., Ligand requirements for involvement of PKC-epsilon in synergistic analgesic interactions between spinal mu and delta opioid receptors (2015) Br. J. Pharmacol., 172, pp. 542-553; 
Schwartz, S., Etropolski, M.S., Shapiro, D.Y., Rauschkolb, C., Vinik, A.I., Lange, B., Cooper, K., Haeussler, J., A pooled analysis evaluating the efficacy and tolerability of tapentadol extended release for chronic, painful diabetic peripheral neuropathy (2015) Clin. Drug Investig., 35, pp. 95-108; 
Seddighi, R., Elliot, S.B., Whitlock, B.K., Egger, C.M., Doherty, T.J., Antinociceptive and selected physiological effects of morphine and xylazine on tiletamine-zolazepam anesthesia in llamas (2014) Vet. Anaesth. Analg., 41, pp. 365-371; 
Sedki, F., Eigenmann, K., Gelinas, J., Schouela, N., Courchesne, S., Shalev, U., A role for kappa-, but not mu-opioid, receptor activation in acute food-deprivation-induced reinstatement of heroin seeking in rats (2015) Addict. Biol., 20, pp. 423-432; 
Segal, D., Awad, N., Nasir, H., Mustafa, S., Lowenstein, L., Combined spinal and general anesthesia vs general anesthesia for robotic sacrocervicopexy: a randomized controlled trial (2014) Int. Urogynecol. J., 25, pp. 369-374; 
Seleman, M., Chapy, H., Cisternino, S., Courtin, C., Smirnova, M., Schlatter, J., Chiadmi, F., Marie-Claire, C., Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties (2014) Psychopharmacology (Berl)., 231, pp. 3139-3149; 
Selfridge, B.R., Wang, X., Zhang, Y., Yin, H., Grace, P.M., Watkins, L.R., Jacobson, A.E., Rice, K.C., Structure-activity relationships of (+)-naltrexone-inspired toll-like receptor 4 (TLR4) antagonists (2015) J. Med. Chem., 58, pp. 5038-5052; 
Selleck, R.A., Lake, C., Estrada, V., Riederer, J., Andrzewski, M., Sadeghian, K., Baldo, B.A., Endogenous opioid signaling in the medial prefrontal cortex is required for the expression of hunger-induced impulsive action (2015) Neuropsychopharmacology, 40, pp. 2464-2474; 
Sepehri, G., Parsania, S., Hajzadeh, M.A., Haghpanah, T., Sheibani, V., Divsalar, K., Shekarforoush, S., Afarinesh, M.R., The effects of co-administration of opium and morphine with nicotine during pregnancy on spatial learning and memory of adult male offspring rats (2014) Iran. J. Basic Med. Sci., 17, pp. 694-701; 
Serpa Neto, A., Simonis, F.D., Barbas, C.S., Biehl, M., Determann, R.M., Elmer, J., Friedman, G., Schultz, M.J., Association between tidal volume size, duration of ventilation and sedation needs in patients without acute respiratory distress syndrome: an individual patient data meta-analysis (2014) Intensive Care Med., 40, pp. 950-957; 
Sessler, N.E., Downing, J.M., Kale, H., Chilcoat, H.D., Baumgartner, T.F., Coplan, P.M., Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation (2014) Pharmacoepidemiol. Drug Saf., 23, pp. 1238-1248; 
Setnik, B., Bramson, C., Bass, A., Levy-Cooperman, N., Malhotra, B., Matschke, K., Sommerville, K.W., Geoffrey, P., Intranasal administration of crushed ALO-02 (extended-release oxycodone with sequestered naloxone): a randomized, controlled abuse-potential study in nondependent recreational opioid users (2015) J. Clin. Pharmacol., 55, pp. 1351-1361; 
Setnik, B., Sokolowska, M., Johnson, F., Oidenhof, J., Romach, M., Evaluation of the safety, pharmacodynamic and pharmacokinetic effects following oral coadministration of immediate-release morphine with ethanol in healthy male participants (2014) Hum. Psychopharmacol., 29, pp. 251-265; 
Shah, K.S., Taub, P., Patel, M., Rehfeldt, M., Struck, J., Clopton, P., Mehta, R.L., Maisel, A.S., Proenkephalin predicts acute kidney injury in cardiac surgery patients (2015) Clin. Nephrol., 83, pp. 29-35; 
Shah, S.M., Shah, S.M., Phytochemicals, antioxidant and antinociceptive and anti-inflammatory potential of the aqueous extract of Teucrium stocksianum bioss (2015) BMC Complement. Altern. Med., 15, p. 351; 
Shahraki, M.R., Mirshekari, H., Sabri, A., Aloe vera aqueous extract effect on morphine withdrawal syndrome in morphine-dependent female rats (2014) Int. J. High Risk Behav. Addict., 3, p. e11358; 
Shajib, M.S., Akter, S., Ahmed, T., Imam, M.Z., Antincocieptive and neuropharmacological activites of methanol extract of Phoenix sylvestris fruit pulp (2015) Front. Pharmacol., 6, p. 212; 
Shams Vahdati, S., Morteza Baghi, H.R., Ghobadi, J., Rajaei Ghafouri, R., Habiboliahi, P., Comparison of paracetamol (apotel) and morphine in reducing post pure head trauma headache (2014) Anesth. Pain Med., 4, p. e14903; 
Shang, Y., Guo, F., Li, J., Fan, R., Ma, X., Wang, Y., Feng, N., Pei, J., Activation of kappa-opioid receptor exerts the glucose-homeostatic effect in streptozotocin-induced diabetic mice (2015) J. Cell. Biochem., 116, pp. 252-259; 
Sharifipour, M., Izadpanah, E., Nikkhoo, B., Zare, S., Abdolmaleki, A., Hassanzadeh, K., Moradi, F., Hassanzadeh, K., A new pharmacological role for donepezil: attenuation of morphine-induced tolerance and apoptosis in rat central nervous system (2014) J. Biomed. Sci., 21, p. 6; 
Shen, F., Wang, N., Qi, C., Li, Y.J., Cui, C.L., The NO/sGC/PKG signaling pathway in the NAc shell is necessary for the acquisition of morphine-induced place preference (2014) Behav. Neurosci., 128, pp. 446-459; 
Shen, J.C., Sun, H.L., Zhang, M.Q., Liu, X.Y., Wang, Z., Yang, J.J., Flurbiprofen improves dysfunction of T-lymphocyte subsets and natural killer cells in cancer patients receiving post-operative morphine analgesia (2014) Int. J. Clin. Pharmacol. Ther., 52, pp. 669-675; 
Shen, Q., Qian, Y.Y., Xu, X.J., Li, W., Liu, J.G., Fu, W., Design, synthesis and biological evaluation of N-phenylalkyl-substituted tramadol derivatives as novel mu opioid receptor ligands (2015) Acta Pharmacol. Sin., 36, pp. 887-894; 
Shen, W., Shen, L., Chen, G., Wang, F., Li, C., Lin, F., Yang, X., Fu, S., Ovariectomy modulation of morphine analgesia of neuropathic pain is associated with the change of K(+)-Cl(−) cotransporter 2 protein level in spinal dorsal horn (2014) Int. J. Clin. Exp. Med., 7, pp. 3467-3472; 
Shimia, M., Parish, M., Abedini, N., The effect of intravenous paracetamol on postoperative pain after lumbar discectomy (2014) Asian Spine J., 8, pp. 400-404; 
Shimoyama, N., Gomyo, I., Teromoto, O., Kojima, K., Higuchi, H., Yukitoshi, N., Ohta, E., Shimoyama, M., Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain (2015) Jpn. J. Clin. Oncol., 45, pp. 189-196; 
Shin, S.H., Lee, H.S., Kim, Y.S., Choi, Y.J., Kim, S.H., Kwon, H.C., Oh, S.Y., Chung, J.S., Clinical usefulness of hydromorphone-OROS in improving sleep disturbances in Korean cancer patients: a multicenter, prospective open-label study (2014) Cancer Res. Treat., 46, pp. 331-338; 
Shinde, S., Gordon, P., Sharma, P., Gross, J., Davis, M.P., Use of non-opioid analgesics as adjuvants to opioid analgesia for cancer pain management in an inpatient palliative unit: does this improve pain control and reduce opioid requirements (2015) Support. Care Cancer, 23, pp. 695-703; 
Shinozaki, T., Yamada, T., Nonaka, T., Yamamoto, T., Acetaminophen and non-steroidal anti-inflammatory drugs interact with morphine and tramadol analgesia for the treatment of neuropathic pain in rats (2015) J. Anesth., 29, pp. 386-395; 
Shokravyain, M., Miladi-Gorji, H., Vaezi, G.H., Voluntary and forced exercise prevent the development of tolerance to analgesic effects of morphine in rats (2014) Iran. J. Basic Med. Sci., 17, pp. 271-277; 
Shram, M.J., Silverman, B., Ehrich, E., Sellers, E.M., Turncliff, R., Use of remifentanil in a novel clinical paradigm to characterize onset and duration of opioid blockade by samidorphan, a potent mu-receptor antagonist (2015) J. Clin. Psychopharmacol., 35, pp. 242-249; 
Shu, H., Wang, Z., Ye, F., Li, Q., Dou, Y., Lin, Y., Huang, W., Xiao, X., High-dose pentzocine antagonizes the antinociception induced by high-dose morphine (2015) Life Sci., 130, pp. 1-6; 
Sibaev, A., Fichna, J., Saur, D., Yeuce, B., Timmermans, J.P., Storr, M., Nocicpetin effect on intestinal motility depends on opioid-receptor like-1 receptors and nitric oxide synthase co-localization (2015) World J. Pharmacol. Ther., 6, pp. 73-83; 
Siciliano, C.A., Calipari, E.S., Cuzon Carlson, V.C., Helms, C.M., Lovinger, D.M., Grant, K.A., Jones, S.R., Voluntary ethanol intake predicts kappa-opioid receptor supersensitivity and regionally distinct dopaminergic adaptations in macaques (2015) J. Neurosci., 35, pp. 5959-5968; 
Siddigi, S., Verney, C., Dargan, P., Wood, D.M., Understanding the availability, prevwelance of use, desired effects,acute toxicity and dependence potential of the novel opioid MT-45 (2015) Clin. Toxicol. (Phila), 53, pp. 54-59; 
Silva, G.D., Lopes, P.S., Fonoff, E.T., Pagano, R.L., The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (2015) J. Neuroinflamm., 12, p. 10; 
Silva, J.C., Araujo Cde, S., de Lima-Saraiva, S.R., de Oliveira, R.G., Jr., Diniz, T.C., Wanderley, C.W., Palheta, R.C., Jr., Almeida, J.R., Antinociceptive and anti-inflammatory activities of the ethanollic extract of Annona vepretorum Mart. (Annonaceae) in rodents (2015) BMC Complement. Altern. Med., 15, p. 197; 
Silva, M.L., Ribeiro, A.P., Silva, G.A., Sanchez, I.X., Renzo, R., Uscategui, R., Lima, T.B., Laus, J.L., Expressions of matrix metalloproteinases-1 and −9 and opioid growth factor in rabbit cornea after lamellar keratectomy and treatment with 1% nalbuphine (2015) Arq. Bras. Oftalmol., 78, pp. 141-145; 
Simdes, R.R., Coelho, I.S., Jungueira, S.C., Maldaner, G., Morel, A.F., Venzke, D., Ruani, A.P., Santos, A.R., Pharmacological evidence favoring the traditional use of the root bark of Condalia buxifolia Reissek in the relief of pain and inflammation in mice (2015) J. Ethnopharmacol., 175, pp. 370-377; 
Simmonds, M.J., Finley, E.P., Vale, S., Pugh, M.J., Turner, B.J., A qualitative study of veterans on long-term opioid analgesics: barriers and facilitators to multimodality pain management (2015) Pain Med., 16, pp. 726-732; 
Simonson, B., Morani, A.S., Ewald, A.W., Walker, L., Kumar, N., Simpson, D., Miller, J.H., Kivell, B.M., Pharmacology and anti-addiction effects of the novel kappa-opioid receptor agonist, Mesyl Sal B, a potent and long-lasting analog of salvinorin A (2015) Br. J. Pharmacol., 172, pp. 515-531; 
Sinaei, M., Kargarfard, M., The evaluation of BMI and serum beta-endorphin levels: the study of acute exercise intervention (2015) J. Sports Med. Phys. Fitness, 55, pp. 488-494; 
Sindberg, G.M., Sharma, U., Banerjee, S., Anand, V., Dutta, R., Gu, C.J., Volsky, D.J., Roy, S., An infectious murine model for the studying the systemic effects of opioids on early HIV pathogenesis in the gut (2015) J. Neuroimmune Pharmacol., 10, pp. 74-87; 
Singh, P., Sharma, B., Gupta, S., Sharma, B.M., In vivo and in vitro attenuation of naloxone e-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP modulator (2015) Psychopharmacology (Berl)., 232, pp. 465-478; 
Sirohi, S., Walker, B.M., Maturational alterations in constitutive activity of medial prefrontal cortex kappa-opioid receptors in Wistar rats (2015) J. Neurochem., 135, pp. 659-665; 
Siuda, E.R., Copits, B.A., Schmidt, M.J., Baird, M.A., Al-Hasani, R., Planer, W.J., Funderburk, S.C., Bruchas, M.R., Spatiotemporal control of opioid signaling and behavior (2015) Neuron, 86, pp. 923-935; 
Sivikoz, N., Koltka, K., Guresti, E., Buget, M., Senturk, M., Ozvalcin, S., Perioperative dexketoprofen or lornoicam administration for pain management after major orthopedic surgery: a randomized, controlled study (2014) Agriculture, 26, pp. 23-28; 
Skobowiat, C., Siominski, A.T., UVB activates hypothalamic-pituitary-adrenal axis in C57BL/6 mice (2015) J. Invest. Dermatol., 135, pp. 1638-1648; 
Slezak, J.M., Ricaurte, G.A., Tallarida, R.J., Katz, J.L., Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats (2014) Psychopharmacology (Berl)., 231, pp. 191-198; 
Smeets, C.J., Jezierska, J., Watanabe, H., Duarri, A., Fokkens, M.R., Meijer, M., Zhou, Q., Verbeek, D.S., Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23 (2015) Brain, 138, pp. 2537-2552; 
Smith, C.J., Wilkins, K.B., Mogavero, J.N., Veenema, A.H., Social novelty investigation in the juvenile rat: modulation by the mu-opioid system (2015) J. Neuroendocrinol., 27, pp. 752-764; 
Smith, S.N., Paige, C., Velazquez, K.T., Smith, T.P., Faja, S.N., Wilson, S.P., Sweitzer, S.M., Injury-specific promoters enhance herpes simplex virus-mediated gene therapy for treating neuropathic pain in rodents (2015) J. Pain, 16, pp. 283-290; 
Somaini, M., Brambillasca, P., Ingelmo, P.M., Lovisari, F., Catenacci, S.S., Rossini, V., Bucciero, M., Diemunsch, P., Effects of peritoneal ropivacine nebulization for pain control after laparoscopic gynecologic surgery (2014) J. Minim. Invasive Gynecol., 21, pp. 863-869; 
Song, L., Wu, C., Zuo, Y., Melatonin prevents morphine-induced hyperalgesia and tolerance in rats: role of protein kinase C and N-methyl-D-aspartate receptors (2015) BMC Anesthesiol., 15, p. 12; 
Song, Y., Su, D., Lu, T., Mao, C., Ji, D., Liu, Y., Wei, B., Fan, R., Differential pharmacokinetics and the brain distribution of morphine and ephedrine constitutional isomers in rats after oral administration with Keke capsule using rapid-resolution LC–MS/MS (2014) J. Sep. Sci., 37, pp. 352-359; 
Song, Y.T., Liu, T.T., Feng, L., Zhang, T., Xiang, H.B., Melanocortin-4 receptor expression in the cuneiform nucleus is involved in modulation of opioidergic signaling (2015) J. Huazhong Univ. Sci. Technolog. Med. Sci., 35, pp. 662-665; 
Soto, M., Chaumontet, C., Even, P.C., Nadkarni, N., Piedcoq, J., Darcel, N., Tome, D., Fromentin, G., Intermittent access to liquid sucrose differentially modulates energy intake and related central pathways in control of high-fat fed mice (2015) Physiol. Behav., 140, pp. 44-53; 
Soto, N., Fauber, A.E., Ko, J.C., Moore, G.E., Lambrechts, N.E., Analgesic effect of intra-articularly administered morphine, dexmedetomidine, or a morphine-dexemedetomadine combination immediately following stifle joint surgery in dogs (2014) J. Am. Vet. Med. Assoc., 244, pp. 1291-1297; 
Soukup-Baljak, Y., Greer, A.M., Amiani, A., Sampson, O., Buxton, J.A., Drug quality assessment practices and communication of drug alerts among people who use drugs (2015) Int. J. Drug Policy, 26, pp. 1251-1257; 
Sounier, R., Mas, C., Steyaert, J., Laremans, T., Manglik, A., Huang, W., Kobilka, B.K., Ranier, S., Propogation of conformational changes during mu-opioid receptor activation (2015) Nature, 524, pp. 375-378; 
Sousa, A.M., Ashmawi, H.A., Local analgesic effect of tramadol is not mediated by opioid receptors in early postoperative pain in rats (2015) Braz. J. Anaesthesiol., 65, pp. 186-190; 
Spanos, E., Karlsson, L.O., Redfors, B., Shao, Y., Omerovic, E., Bobrova, I., Grip, L., Bergh, N., Cardioprotection of the enkephalin analog Eribis peptide 94 in a rat model of ischemia and reperfusion is highly dependent on dosing regimen and timing of administration (2015) Eur. J. Pharmacol., 747, pp. 1-6; 
Spring, K., Melroy, M.J., Whipple, O.C., Optimizing multimodal analgesia with intravenous acetaminophen and opioids in postoperative bariatric patients (2014) Pharmacotherapy, 34, pp. 14S-21S; 
Springer, S.A., Brown, S.E., Di Paola, A., Altice, F.L., Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system (2015) Drug Alcohol Depend., 157, pp. 158-166; 
Srivastava, V.K., Hiney, J.K., Stevener, K., Dees, W.L., Differential effects of alcohol on excitatory and inhibitory puberty-related peptides in ther basal hypothalamus of the female rat (2015) Alcohol. Clin. Exp. Res., 39, pp. 2386-2393; 
Stafford, A.M., Anderson, S.M., Shelton, K.L., Brunzell, D.H., Oral operant ethanol self-administration in the absence of explicit cues, food restriction, water restriction and ethanol fading in C57BL/6J mice (2015) Psychopharmacology (Berl)., 232, pp. 3783-3795; 
Statnick, M.A., Chen, Y., Ansonoff, M., Witkin, J.M., Rorick-Kehn, L., Suter, T.M., Song, M., Pintar, J.E., A novel nociceptin receptor antagonist LY2940094 inhibits excessive feeding behavior in rodents: a possible mechanism for the treatment of binge-erating disorder (2015) J. Pharmacol. Exp. Ther., 356, pp. 493-502; 
Stein, M.D., Herman, D.S., Moitra, E., Hecht, J., Lopez, R., Anderson, B.J., Brown, R.A., A preliminary randomized controlled trial of a distress tolerance treatment for opioid dependent persons initiating buprenorphine (2015) Drug Alcohol Depend., 147, pp. 243-250; 
Stevenson, G.W., Luginbuhl, A., Dunbar, C., LaVigne, J., Dutra, J., Atherton, P., Cone, K., Bilsky, E.J., The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference, but does maintain self-administration in rats, and induces in vitro markers of tolerance and dependence (2015) Pharmacol. Biochem. Behav., 132, pp. 49-55; 
Stolz, E.D., Muller, L.G., Antonio, C.B., da Costa, P.F., von Poser, G.L., Noel, F., Rates, S.M., Determination of pharmacological interactions of uligosin B, a natural phloroglucinol derivative with amitryptaline, clonidine and morphine by isobolographic analysis (2014) Phytomedicine, 21, pp. 1684-1688; 
Stoner, S.A., Arenella, P.B., Hendershot, C.S., Randomized controlled trial of a mobile phone intervention for improving adherence to naltrexone for alcohol use disorders (2015) PLoS One, 10, p. e0124613; 
Stoops, W.W., Pike, E., Hays, L.R., Glaser, P.E., Rush, C.R., Naltrexone and bupropion, alone or combined, do not alter the reinforcing effects of intranasal methamphetamine (2015) Pharmacol. Biochem. Behav., 129, pp. 45-50; 
Strickland, E.R., Woller, S.A., Hook, M.A., Grau, J.W., Miranda, R.C., The association between spinal cord trauma-sensitive miRNAs and pain sensitivity, and their regulation by morphine (2014) Neurochem. Int., 77, pp. 40-49; 
Strickland, J.C., Rush, C.R., Stoops, W.W., Mu opioid mediated discriminative-stimulus effects of tramadol: an individual subjects analysis (2015) J. Exp. Anal. Behav., 103, pp. 361-374; 
Stucke, A.G., Miller, J.R., Prkic, I., Zuperku, E.J., Hopp, F.A., Stuth, E.A., Opioid-induced respiratory depression is only partially mediated by the preBotzinger complex in young and adult rabbits in vivo (2015) Anesthesiology, 122, pp. 1288-1298; 
Suarez-Boomgaard, D., Gago, B., Valderrama-Carvajal, A., Roales-Bujan, R., Craenenbroeck, K.V., Duchou, J., Borroto-Escuela, D.O., Rivera, A., Dopamine D4 receptor counteracts morphine-induced changes in mu opioid receptor signaling in the striosomes of the rat caudate putamen (2014) Int. J. Mol. Sci., 15, pp. 1481-1498; 
Sucharski, F., Noga, M.J., Suder, P., Kotlinska, J., Silberring, J., Integrated workflow for quantitative phosphoproteomic analysis of the selected brain structures in the development of morphine dependence (2014) Pharmacol. Rep., 66, pp. 1003-1010; 
Sudakov, S.K., Nazarova, G.A., Alekseeva, E.V., Kolpakov, A.A., Peripheral administration of a mu-opioid receptor agonist DAMGO suppresses the anxiolytic and stimulatory effects of caffeine (2015) Bull. Exp. Biol. Med., 158, pp. 295-297; 
Sudo, R.T., Neto, M.L., Monteiro, C.E., Amaral, R.V., Resende, A.C., Souza, P.J., Zapata-Sudo, G., Moura, R.S., Antinociceptive effect of hydroalcoholic extract from Euterpe oleracea Mart: in a rodent model of acute and neuropathic pain (2015) BMC Complement. Altern. Med., 15, p. 208; 
Sullivan, J.G., Webster, L., Novel buccal film formulation of buprenorphine-naloxone for the maintenance treatment of opioid dependence: a 12-week conversion study (2015) Clin. Ther., 37, pp. 1064-1075; 
Sullivan, L.C., Berg, K.A., Clarke, W.P., Dual regulation of delta-opioid receptor function by arachidonic acid metabolites in rat peripheral sensory neurons (2015) J. Pharmacol. Exp. Ther., 353, pp. 44-51; 
Sullivan, M.A., Bisaga, A., Glass, A., Mishlen, K., Pavlicova, M., Carpenter, K.M., Mariani, J.J., Nunes, E.V., Opioid use and dropout in patients receiving oral naltrexone with or without single administration of injection naltrexone (2015) Drug Alcohol Depend., 147, pp. 122-129; 
Sun, G.C., Ho, W.Y., Chen, B.R., Cheng, P.W., Cheng, W.H., Hsu, M.C., Yeh, T.C., Tseng, C.J., GPCR dimerization in brainstem nuclei contributes to the development of hypertension (2015) Br. J. Pharmacol., 172, pp. 2507-2518; 
Sun, H.L., Dong, Y.C., Wang, C.Q., Qian, Y.N., Wang, Z.Y., Effects of postoperative analgesia with the combination of tramadol and lornoxicam on serum inflammatory cytokines in patients with gastric cancer (2014) Int. J. Clin. Pharmacol. Ther., 52, pp. 1023-1029; 
Sun, J.F., Wang, Y.H., Chai, J.R., Li, F.Y., Hang, A., Lu, G., Tao, Y.M., Wang, Y.J., Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with kappa agonist and mu agonist/antagonist activity (2014) Eur. J. Pharmacol., 740, pp. 455-463; 
Suzuki, M., Chiwaki, F., Sawada, Y., Ashikawa, M., Aoyagi, K., Fujita, T., Yanagihara, K., Sasaki, H., Peripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivo (2015) PLoS One, 10, p. e0123407; 
Szacon, E., Rzadkowska, M., Kaczor, A.A., Kedzierska, E., Mazur, A., Fidecka, S., Malosiuk, D., Synthesis, central nervous system activity and structure-activity relationships of N-substituted derivatives of 1-arylimidazolidyn-2-ylideneurea and products of their cyclization (2015) J. Enzyme Inhib. Med. Chem., 30, pp. 746-760; 
Szental, J.A., Webb, A., Weeraratne, C., Campbell, A., Sivakumar, H., Leong, S., Postoperative pain after laparoscopic cholecystectomy is not reduced by intraoperative analgesia guided by analgesia nociception index (ANI) monitoring: a randomized clinical trial (2015) Br. J. Anaesth., 114, pp. 640-645; 
Szklarczyk, K., Korostynski, M., Cieslak, P.E., Wawrzczak-Bargiela, A., Przewlocki, R., Opioid-dependent regulation of high and low fear responses in two inbred mouse strains (2015) Behav. Brain Res., 292, pp. 95-101; 
Szlavicz, E., Perera, P.S., Tomboly, C., Helyes, Z., Zador, F., Benyhe, S., Borsodi, A., Bojnik, E., Further haracterization of hemopressin peptide fragments in the opioid and cannabinoid systems (2015) Anesth. Analg., 121, pp. 1488-1494; 
Tacelosky, D.M., Alexander, D.N., Morse, M., Hajnal, A., Berg, A., Levenson, R., Grigson, P.S., Low expression of D2R and Wntless correlates with high motivation for heroin (2015) Behav. Neurosci., 129, pp. 744-755; 
Takita, K., Morimoto, Y., Nociceptin/orphanin FQ slows inspiratory rhythm via its direct effects on the pre-Botzinger complex (2015) Respir. Physiol. Neurobiol., 207, pp. 14-21; 
Tamaddonfard, E., Tamaddonfard, S., Pourbaba, S., Effects of intra-fourth ventricle injection of crocin on capsaicin-induced orofacial pain in rats (2015) Avicenna J. Phytomed., 5, pp. 450-457; 
Tan, J.W., Duan, T.T., Zhou, Q.X., Ding, Z.Y., Jing, L., Cao, J., Wang, L.P., Xu, L., Impaired contextual fear extinction and hippocampal synaptic plasticity in adult rats induced by prenatal morphine exposure (2015) Addict. Biol., 20, pp. 652-662; 
Tanabe, P., Martinovich, Z., Buckley, B., Schmelzer, A., Paice, J.A., Safety of an ED high-dose opioid protocol for sickle cell disease pain (2015) J. Emerg. Nurs., 41, pp. 227-235; 
Tang, S., Rashed, H., Nurulain, S.M., Emerald, B.S., Koturan, S., Tekes, K., Adeghate, E., Distribution of nociception in pancreatic islet cells of normal and diabetic rats (2015) Pancreas, 44, pp. 602-607; 
Tang, X., Chen, Y., Ran, H., Jiang, Y., He, B., Wang, B., Kong, S., Wang, H., Systemic morphine treatment derails normal uterine receptivity, leading to embryo implantation failure in mice (2015) Biol. Reprod., 92, p. 118; 
Tanno, T., Maguire, D.R., Henson, C., France, C.P., Effects of amphetamine and methylphenidate on delay discounting in rats: interactions with order of delay presentation (2014) Psychopharmacology (Berl)., 231, pp. 85-95; 
Tarakanov, A.O., Fuxe, K., The triplet puzzle theory indicates extensive formation of heteromers between opioid and chemokine receptor subtypes (2015) J. Neural Transm. (Vienna), 122, pp. 1509-1514; 
Tarawneh, A., Leon, F., Pettaway, S., Elokey, K.M., Klein, M.L., Lambert, J., Mansoor, A., Cutler, S.J., Flavinoids from perovskia atriplicifolia and their in vitro displacement of the respective radioligands for human opioid and cannabinoid receptors (2015) J. Nat. Prod., 78, pp. 1481-1485; 
Targownik, L.E., Nugent, Z., Singh, H., Bugden, S., Bernstein, C.N., The prevelance and predictors of opioid use in inflammatory bowel disease: a population-based analysis (2014) Am. J. Gastroenterol., 109, pp. 1613-1620; 
Taschler, U., Eichmann, T.O., Radner, F.P., Grabner, G.F., Wolinski, H., Storr, M., Lass, A., Zimmermann, R., Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic mu-opioid receptor sensitivity (2015) Br. J. Pharmacol., 172, pp. 4419-4429; 
Tauzin-Fin, P., Bernard, O., Sesay, M., Richebe, P., Quinart, A., Revel, P., Sztark, F., Benefits of intravenous lidocaine on post-operative pain and acute rehabilitation after laparoscopic nephrectomy (2014) J. Anaesthesiol. Clin. Pharmacol., 30, pp. 366-372; 
Taylor, A.M., Roberts, K.W., Pradhan, A.A., Abari, H.A., Walwyn, W., Lufty, K., Carroll, F.I., Evans, C.J., Anti-nociception mediated by a kappa receptor agonist is blocked by a delta receptor agonist (2015) Br. J. Pharmacol., 172, pp. 691-703; 
Tejeda, H.A., Hanks, A.N., Scott, L., Mejias-Aponte, C., Hughes, Z.A., O'Donnell, P., Prefrontal cortical kappa opioid receptors attenuate responses to amygdala inputs (2015) Neuropsychopharmacology, 40, pp. 2856-2864; 
Telegdy, G., Adamik, A., Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats (2015) Behav. Brain Res., 281, pp. 333-338; 
Terkawi, A.S., Durieux, M.E., Gottschalk, A., Brenin, D., Tiourinine, M., Effect of intravenous lidocaine on postoperative recovery of patients undergoing mastectomy: a double-blind, placebo-controlled randomized trial (2014) Reg. Anesth. Pain Med., 39, pp. 472-477; 
Thakur, D., Malde, A., Buprenorphine for postoperative analgesia: axillary brachial plexus block versus intramuscular administration in a placebo-controlled trial (2015) J. Anaesthesiol. Clin. Pharmacol., 31, pp. 360-364; 
Thanapal, M.R., Tata, M.D., Tan, A.J., Subramaniam, T., Tong, J.M., Palayan, K., Rampal, S., Gurunathan, R., Pre-emptive intraperitoneal local anesthesia: an effective method in immediate post-operative pain management and metabolic stress response in laparoscopic appendicectomy: a randomized, double-blinded, placebo-controlled study (2014) ANZ J. Surg., 84, pp. 47-51; 
Thielke, S.M., Turner, J.A., Shortreed, S.M., Saunders, K., Leresche, L., Campbell, C.I., Weisner, C.C., Korff, M.V., Do patient-perceived pros and cons of opioids predict sustained higher-dose use (2014) Clin. J. Pain, 30, pp. 93-101; 
Thomas, A.N., Taylor, R.J., An analysis of patient safety incidents associated with medications reported from critical care units in the North West of England between 2009 and 2012 (2014) Anaesthsia, 69, pp. 735-745; 
Thompson, G.L., Lane, J.R., Coudrat, T., Sexton, P.M., Christopoulos, A., Canals, M., Biased agonism of endogenous opioid peptides at the mu-opioid receptor (2015) Mol. Pharmacol., 88, pp. 335-346; 
Thongkhamcharoen, R., Phungrassami, T., Atthakul, N., Regulation of opioid drugs in Thai government hospitals: thailand national survey 2012 (2014) Indian J. Palliat Care, 20, pp. 6-11; 
Thorn, D.A., Siemian, J.N., Zhang, Y., Li, J.X., Anti-hyperalgesic effects of imidazoline I2 receptors in a rat model of inflammatory pain: interactions with oxycodone (2015) Psychopharmacology (Berl)., 232, pp. 3309-3316; 
Thronaes, M., Kaasa, S., Dale, O., A pilot study of nasal fentanyl for patient controlled treatment of cancer pain (2014) J. Opioid Manag., 10, pp. 21-28; 
Tian, H., Xu, Y., Liu, F., Wang, G., Hu, S., Effect of acute fentanyl treatment on synaptic plasticity in the hippocampal CA1 region in rats (2015) Front. Pharmacol., 6, p. 251; 
Tian, P., Shi, W., Liu, J., Wang, J., Ma, C., Qi, Q., Cong, B., Li, Y., Expression of the mu, kappa and delta-opioid receptors and tyrosine hydroxylase in MN9D cells (2015) Int J Clin Exp Pathol, 8, pp. 4863-4868; 
Tian, X.Z., Chen, Y., Bai, L., Luo, P., Du, X.J., Chen, Q., Tain, X.M., Effects and underlying mechanisms of human opiorphan on cardiovascular activity in anesthetized rats (2015) Eur. J. Pharmacol., 749, pp. 32-38; 
Tirgar, F., Rezayof, A., Zarrindast, M.R., Central amygdala nicotinic and 5-HT1A receptors mediate the reversal effect of nicotine ans MDMA on morphine-induced amnesia (2014) Neurosci, 277, pp. 392-402; 
Tomaszewski, D., Balkota, M., Truszczynski, A., Machowicz, A., Intrathecal morphine increases the incidence of urinary retention in orthopedic patients undergoing spinal anesthesia (2014) Anaesth. Intensive Ther., 46, pp. 29-33; 
Torkaman-Boutorabi, A., Hashemi-Hezaveh, S.M., Sheidodouat, H., Zarrindast, M.R., The possible role of medial prefrontal cortex beta-1-adrenoceptors in morphine-induced amnesia (2014) Pharmacology, 93, pp. 272-277; 
Torkzadeh-Mahani, S., Nasri, S., Esmaeli-Mahani, S., Ginger (zingiber officinale roscoe) prevents morphine-induced addictive behaviors in conditioned place preference test in rats (2014) Addict. Health, 6, pp. 65-72; 
Torres, L.M., Revnic, J., Knight, A.D., Perelman, M., Relationship between onset of pain relief and patient satisfaction with fentanyl pectin nasal spray for breakthrough pain in cancer (2014) J. Palliat. Med., 17, pp. 1150-1157; 
Torres, O.B., Jalah, R., Rice, K.C., Li, F., Antoline, J.F., Iver, M.R., Jacobson, A.E., Malvas, G.R., Characterization and optimization of heroin haptin-BSA conjugates: method development for the synthesis of reproducible hapten-based vaccines (2014) Anal. Bioanal. Chem., 406, pp. 5927-5937; 
Tran, K.P., Nguyen, Q., Truong, X.N., Le, V., Le, V.P., Mai, N., Husum, H., Losvik, O.K., A comparison of ketamine and morphine analgesia in prehospital trauma care: a cluster randomized clinical trial in rural Quang Tri province, Vietnam (2014) Prehosp. Emerg. Care, 18, pp. 257-264; 
Trenkwalder, C., Chaudhuri, K.R., Martinez-Martin, P., Rascol, O., Ehret, R., Valis, M., Satori, M., Hopp, M., Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson's disease (PANDA): a double-blind, randomized placebo-controlled tiral (2015) Lancet Neurosci., 14, pp. 1161-1170; 
Treskatsch, S., Klambeck, M., Mousa, S.A., Kopf, A., Schafer, M., Influence of high-dose intraoperative remifentanil with or without amantadine on postoperative pain intensity and morphine consumption in major abdominal surgery patients: a randomized trial (2014) Eur. J. Anaesthesiol., 31, pp. 41-49; 
Treskatsch, S., Shaqura, M., Dehe, L., Feldheiser, A., Roepke, T.K., Sahkibaei, M., Spies, C.D., Mousa, S.A., Upregulation of the kappa opioideric system in left ventricular rat myocardium in response to volume overload: adaptive changes of the cardia kappa opioid system in heart failure (2015) Pharmacol. Res., 102, pp. 33-41; 
Tsai, H.J., Huang, S.S., Tsou, M.T., Wang, H.T., Chiu, J.H., Role of opioid receptor signaling in reanov AVmote electrostimulation-induced protection against ischemia/reperfusion injury in rat hearts (2015) PLoS One, 10, p. e0138108; 
Tsai, H.J., Wang, S.C., Liu, S.W., Ho, I.K., Chang, Y.S., Tsai, Y.T., Lin, K.M., Liu, Y.L., Assessment of CYP450 genetic variability on methadone dose and tolerance (2014) Pharmacogenomics, 15, pp. 977-986; 
Tsai, R.Y., Cheng, Y.C., Wong, C.S., (+)-naloxone inhibits morphine-induced chemotaxis via prevention of heat shock protein 90 cleavage in microglia (2015) J. Formos. Med. Assoc., 114, pp. 446-455; 
Tsakova, A., Surcheva, S., Simeonova, K., Altankova, I., Marinova, T., Usunoff, A., Vlaskovska, M., Nitroxidergic modulation of behavioral, cardiovascular and immune responses, and brain NADpH diaphorase activity upon morphine tolerance-dependence in rats (2015) Biotechnol. Biotechnol. Equip., 29, pp. 92-100; 
Tsanova, A., Jordanova, A., Laichev, Z., Effects of leucine-enkephalin on surface characteristics and morphology of model membranes composed of raft-forming lipids (2015) J. Membr. Biol., 249, pp. 229-238; 
Tsibulnikov, S.Y., Maslov, L.N., Mukhomedzrylatov, A.V., Krylatov, A.V., Tsibulnikova, M.R., Lishmanov, Y.B., Prospects of using kappa-opioid receptor agonists U50488H and ICI199,441 for improving heart resistance to ischemia/reperfusion (2015) Bull. Exp. Biol. Med., 159, pp. 718-721; 
Tsiklauri, N.D., Nozadze, I.R., Nebieridze, M.I., Garisukaia, G.P., Abzianidze, E.B., Tsagareli, M.G., Antinociceptive tolerance to non-steroidal anti-inflammatory drugs microinjected into dorsal hippocampus is due to pharmacological tolerance (2015) Georgian Med. News, 239, pp. 108-112; 
Tsutaoka, B.T., Ho, R.Y., Fung, S.M., Kearney, T.E., Comparative toxicity of tapentadol and tramadol utilizing data reported in the National Poison data system (2015) Ann. Pharmacother., 49, pp. 1311-1316; 
Tu, S., Gao, J., Liu, J., Zhang, J., Huang, Y., Xu, S., Han, M., Liang, J., Effects of Jitai tablet, a traditional Chinese medicine, on spontaneous withdrawal symptos and modulation of dopaminergic functions in morphine-dependent rats (2015) Phytoter. Res., 29, pp. 687-694; 
Tung, K.H., Angus, J.A., Wright, C.E., Contrasting cardiovascular properties of the mu-opioid agonists morphine and methadone in the rat (2015) Eur. J. Pharmacol., 762, pp. 372-381; 
Tuominen, L., Tuulari, J., Karlsson, H., Hirvonen, J., Helin, S., Salminen, P., Parkkola, R., Nummenmaa, L., Aberrant mesolimbic dopamine-opiate interaction in obesity (2015) Neuroimage, 122, pp. 80-86; 
Turktan, M., Unlugenc, H., Gulec, E., Gezer, S., Isik, G., Coadministration of intravenous remifentanil and morphine for post-thoracotomy pain: comparison with intravenous morphine alone (2015) J. Cardiothorac. Vasc. Anesth., 29, pp. 133-138; 
Turncliff, R., DiPetrillo, L., Silverman, B., Ehrich, E., Single- and multiple-dose pharmacokinetics of samidorphan, a novel opioid antagonist in healthy volunteers (2015) Clin. Ther., 37, pp. 338-348; 
Turner, A.L., Stevenson, M.D., Cross, K.P., Impact of ultrasound-guided femoral nerve blocks in the pediatric emergency department (2014) Pediatr. Emerg. Care, 30, pp. 227-229; 
Turner, L., Kruszewski, S.P., Alexander, G.C., Trends in the use of buprenorphine by office-based physicians in the United States, 2003–2013 (2015) Am. J. Addict., 24, pp. 24-29; 
Tuzcu, K., Tuzcu, E.A., Karcioglu, M., Davarci, I., Coskun, M., Ilhan, O., Daglioglu, M.C., Turhanoglu, S., The effects of remifentanil and esmolol on increase in intraocular pressure due to laryngoscopy and tracheal intubation: a double-blind, randomized clinical tiral (2015) J. Glaucoma, 24, pp. 372-376; 
Twardowschy, A., Coimbra, N.C., Mu- and kappa-opioid receptor activation in the dorsal periaqueductal gray matter differentially modulates panic-like behaviors induced by electrical and chemical stimulation of the inferior colliculus (2015) Brain Res., 1597, pp. 168-179; 
Uchida, H., Matsushita, Y., Araki, K., Mukae, T., Ueda, H., Histone decarboxylase inhibitors relieve morphine resistance in neuropathic pain after peripheral nerve injury (2015) J. Pharmacol. Sci., 128, pp. 208-211; 
Ueberall, M.A., Mueller-Schwerfe, G.H., Development of opioid-induced constipation: post-hoc analysis of data from a 12-week prospective, open-label, blinded-endpoint streamlined study in low-back pain patients with prolonged-release WHO step III opioids (2015) J. Pain Res., 8, pp. 459-475; 
Ueberall, M.A., Mueller-Schwerfe, G.H., Safety and efficacy of oxycodone/naloxone vs oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations (2015) Curr. Med. Res. Opin., 31, pp. 1413-1429; 
Uesugi, K., Kitano, N., Kikuchi, T., Sekiguchi, M., Konno, S., Comparison of peripheral nerve block with periarticular injection analgesia after total knee arthroplasty: a randomized, controlled study (2014) Knee, 21, pp. 348-352; 
Ujcikova, H., Eckhardt, A., Kagan, D., Roubalova, L., Svoboda, P., Proteomic analysis of post-nuclear supernatant fraction and percoll-purified membranes prepared from brain cortex of rats exposed to increasing doses of morphine (2014) Proteome Sci., 12, p. 11; 
Urban-Kowalczyk, M., Pigonska, J., Smigelski, J., Pain perception in schizophrenia: influence of neuropeptides, cognitive disorders and negative symptoms (2015) Neuropsychiatry Dis. Treat., 11, pp. 2023-2031; 
Uskur, T., Barlas, M.A., Akkan, A.G., Shahzadi, A., Uzbay, T., Dexmedetomidine induces conditioned place preference in rats: involvement of opioid receptors (2015) Behav. Brain Res., 296, pp. 163-168; 
Vahabi, S., Nadri, S., Izadi, F., The effects of gabapentin on severity of post spinal anesthesia headache (2014) Pak J. Pharm Sci., 27, pp. 1203-1207; 
Vahidi, E., Shakoor, D., Aghaie Meybodi, M., Saeedi, M., Comparison of intravenous lidocaine versus morphine in alleviating pain in patients with critical limb ischemia (2015) Emerg. Med. J., 32, pp. 516-519; 
Valdes-Tovar, M., Escobar, C., Solis-Chagoyan, H., Asai, M., Benitez-King, G., Constant light suppresses production of met-enkephalin-containing peptides in cultured splenic macrophages and impairs primary immune response in rats (2015) Chronobiol. Int., 32, pp. 164-177; 
Valverde-Filho, J., da Cunha Neto, M.B., Fonoff, E.T., Meirelles Ede, S., Teixeira, M.J., Chronic spinal and oral morphine-induced neuroendocrine and metabolic changes in noncancer pain patients (2015) Pain Med., 16, pp. 715-725; 
van den Brink, W., Strang, J., Gual, A., Sorensen, P., Jensen, T.J., Mann, K., Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical program (2015) Expert Opin. Drug Saf., 14, pp. 495-504; 
van den Heuvel, J.K., Furman, K., Gumbs, M.C., Eggels, L., Opland, D.M., Land, B.B., Kolk, S.M., Neuropeptide, Y., activity in the nucleus accumbens modulates feeding behavior and neuronal activity (2015) Biol. Psychiatry, 77, pp. 633-641; 
Vander Wheele, C.M., Porter-Stransky, K.A., Mabrouk, O.S., Lovic, V., Singer, B.F., Kennedy, R.T., Aragona, B.J., Rapid dopamine transmission within the nucleus accumbens: dramatic difference between morphine and oxycodone delivery (2014) Eur. J. Neurosci., 40, pp. 3041-3054; 
Vanderlip, E.R., Sullivan, M.D., Edlund, M.J., Martin, B.C., Fortney, J., Austern, M., Williams, J.S., Hudson, T., National study of discontinuation of long-term opioid therapy among veterans (2014) Pain, 155, pp. 2673-2679; 
Vang, D., Paul, J.A., Nguyen, J., Tran, H., Vincent, L., Yasuda, D., Zaveri, N.T., Gupta, K., Small-molecule nociception receptor agonist ameliorates mast cell activation and pain in sickle mice (2015) Haematologia, 100, pp. 1517-1525; 
Van Hateren, K.J., Landman, G.W., Arnold, J.F., Joosten, H., Groenier, K.H., Navis, G.J., Sparwasser, A., Kleefstra, N., Serum proenkephalin A levels and mortality after long-term follow-up in patients with Type-2 diabetes mellitus (ZODIAC-32) (2015) PLoS One, 10, p. e133065; 
Van Waes, V., Ehrlich, S., Beverley, J.A., Steiner, H., Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT-1B receptor (2015) Neuropharmacology, 89, pp. 77-86; 
Varadi, A., Marrone, G.F., Eans, S.O., Ganno, M.L., Subrath, J.J., Le Rouzic, V., Hunkele, A., Majumdar, S., Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior (2015) ACS Chem. Neurosci., 6, pp. 1813-1824; 
Vardy, E., Sassano, M.F., Rennekamp, A.J., Kroeze, W.K., Mosier, P.D., Westkaemper, R.B., Stevens, C.W., Roth, B.L., Single amino acid variation underlies species-specific sensitivity to amphibian skin-derived opioid-like peptides (2015) Chem. Biol., 22, pp. 764-775; 
Vaseghi, G., Hajhashemi, V., Rabbani, M., The effect of nimodipine on memory loss following naloxone-induced morphine withdrawal in object recognition (2014) Res. Pharm. Sci., 9, pp. 445-451; 
Velazquez Rivera, I., Munoz Garrido, J.C., Garcia Velasco, P., Espana Ximenez de Enciso, I., Velazquez Clavarana, L., Efficacy of sublingual fentanyl vs: oral morphine for cancer-related breakthrough pain (2014) Adv. Ther., 31, pp. 107-117; 
Venkatasubramanian, R., Fukada, T., Niu, J., Mizuno, T., Chidambaran, V., Vinks, A.A., Sadhasivam, S., ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children (2014) Pharmacogenomics, 15, pp. 1297-1309; 
Verbeken, M., Wynendaele, E., Mauchauffee, E., Bracke, N., Stalmans, S., Bojnik, E., Benyhe, S., De Spiegeleer, B., Blood-brain transfer and antinociception of linear and cyclic N-methyl-guanidine and thiourea-enkephalins (2015) Peptides, 63, pp. 10-21; 
Verlaat, C.W., Heesen, G.P., Vet, N.J., de Hoog, M., van der Hoeven, J.G., Kox, M., Pickkers, P., Randomized controlled trial of daily interruption of sedatives in critically ill children (2014) Paediatr. Anaesth., 24, pp. 151-156; 
Verplaetse, T.L., Czachowski, C., Low-dose prazosin alone and its combination with propranolol or naltrexone: effects of ethanol and sucrose seeking and self-administration in the P rat (2015) Psychopharmacology (Berl)., 232, pp. 2647-2657; 
Verthein, U., Beck, T., Haasen, C., Reimer, J., Mental symptoms and drug use in maintenance treatment with slow-release oral morphine compared to methadone: results of a randomized crossover study (2015) Eur. Addict. Res., 21, pp. 97-104; 
Vicknasingam, B., Dazali, M.N., Singh, D., Schottenfeld, R.S., Chawarski, M.C., Buprenorphine/naloxone treatment practices in Malaysia: results from national surveys of physicians and patients (2015) Drug Alcohol Depend., 152, pp. 154-159; 
Victoria, N.C., Karom, M.C., Murphy, A.Z., Analgesia for early-life pain prevents deficits in adult anxiety and stress in rats (2015) Dev. Neurosci., 37, pp. 1-13; 
Vocci, F.J., Schwartz, R.P., Wilson, M.E., Gordon, M.S., Kinlock, T.W., Fitzgerald, T.T., O'Grady, K.E., Jaffe, J.H., Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners (2015) Drug Alcohol Depend., 156, pp. 133-138; 
Votinov, M., Pripfl, J., Windischberger, C., Moser, E., Sailer, U., Lamm, C., A functional polymorphism in the prodynorphin gene affects cognitive flexibility and brain activation during reversal learning (2015) Front. Behav. Neurosci., 9, p. 172; 
Vuckovic, S.M., Savic Vuckovic, K.R., Srebro, D.P., Medic, B.M., Stojanovic, R.M., Vucetic, C.S., Divac, N., Prostran, M.S., The antinociceptive efficacy of morphine-ketamine-magnesium combination is influenced by the order of medication administration (2015) Eur. Rev. Med. Pharmacol. Sci., 19, pp. 3286-3294; 
Wachman, E.M., Hayes, M.J., Sherva, R., Brown, M.S., Davis, J.M., Farrer, L.A., Nielsen, D.A., Variation in opioid receptor genes in neonatal abstinence syndrome (2015) Drug Alcohol Depend., 155, pp. 253-259; 
Wagner, K.D., Liu, L., Davidson, P.J., Cuevas-Mota, J., Armenta, R.F., Garfein, R.S., Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: identifying opportunities for intervention (2015) Drug Alcohol Depend., 153, pp. 215-220; 
Wahid, H.H., Dorian, C.L., Chin, P.Y., Hutchinson, M.R., Rice, K.C., Olson, D.M., Moldenhauer, L.M., Robertson, S.A., Toll-like receptor 4 is an essential upstream regulator of on-time parturition and perinatal viability in mice (2015) Endocrinology, 156, pp. 3828-3841; 
Wang, C., Li, Y., Wang, H., Xie, K., Shu, R., Zhang, L., Hu, N., Wang, G., Inhibition of DOR prevents remifentanil induced postoperative hyperalgesia through regulating the trafficking and function of spinal NMDA receptors in vivo and in vitro (2015) Brain Res. Bull., 110, pp. 30-39; 
Wang, C., Sun, D., Liu, C., Zhu, C., Jing, X., Chen, S., Liu, C., Lin, T., Mother root of Aconitum carmichaelii Debeaux exerts antinociceptive effect in complete Freund's adjuvant-induced mice: roles of dynorphin/kappa-opioid system and transient potential vanilloid type-1 ion channel (2015) J. Transl. Med., 13, p. 284; 
Wang, C.L., Qiu, T.T., Diao, Y.X., Zhang, Y., Gu, N., Novel endomorphin-1 analogues with C-terminal oligoarginine-conjugation display systemic antinociceptive activity with less gastrointestinal side effects (2015) Biochimie, 116, pp. 24-33; 
Wang, D., Li, J., Chen, P., Hong, Y., Upregulation of pronociceptive mediators and downregulation of opioid peptide by adrenomedullin following chronic exposure to morphine in rats (2014) Neuroscience, 280, pp. 31-39; 
Wang, H., Li, S., Kirouac, G.J., Effects of footshocks on anxiety-like behavior and mRNA levels of precursor peptides for corticotropin factor and opioids in the forebrain of the rat (2015) Neuropeptides, 54, pp. 1-7; 
Wang, J.Q., Qi, R.R., Zhou, W., Tang, Y.F., Pan, L.L., Cai, Y.L., Differential gene expression profile in the rat caudal vestibular nucleus is associated with individual differences in motion sickness susceptibility (2015) PLoS One, 10, p. e24203; 
Wang, K., Qu, X., Wang, Y., Shen, H., Liu, Q., Du, J., Effect of mu agonists on long-term survival and recurrence in nonsmall cell lung cancer patients (2015) Medicine (Balt), 94, p. e1333; 
Wang, K.H., Fiellin, D.A., Becker, W.C., Source of prescription drugs used nonmedically in rural and urban populations (2014) Am. J. Drug Alcohol Abuse, 40, pp. 292-303; 
Wang, K.P., Bai, Y., Wang, J., Zhang, J.Z., Morphine protects SH-SY5Y human neuroblastoma cells against Dickkopff-induced apoptosis (2015) Mol. Med. Rep., 11, pp. 1174-1180; 
Wang, L., Wei, X., Wang, X., Li, J., Li, H., Jia, W., Long-term effects of methadone maintenance treatment with different psychosocial intervention models (2014) PLoS One, 9, p. e87931; 
Wang, M.L., Yu, G., Yi, S.P., Zhang, F.Y., Wang, Z.T., Huang, B., Su, R.B., Gong, Z.H., Antinociceptive effects of incarvillateine, a monoterpene alkaloid from Incarvillea sinensuis, and possible role of the adenosine system (2015) Sci. Rep., 5, p. 16107; 
Wang, P.C., Ho, I.K., Lee, C.W., Buprenorphine-elicited alteration of adenylate cyclase activity in human embryonic kidney cells co-expressing kappa-, mu-opioid and nociception receptors (2015) J. Cell. Mol. Med., 19, pp. 2587-2596; 
Wang, P.K., Cao, J., Wang, H., Liang, L., Zhang, J., Lutz, B.M., Shieh, K.R., Tao, Y.X., Short-term sleep disturbance-induced stress does not affect basal pain perception, but does delay postsurgical pain recovery (2015) J. Pain, 16, pp. 1186-1199; 
Wang, W.S., Chen, Z.G., Liu, W.T., Chi, Z.Q., He, L., Liu, J.G., Dorsal hippocampal NMDA receptor blockade impairs extinction of naloxone-precipitated conditioned place aversion in acute morphine-treated rats by suppressing ERK and CREB phosphorylation in the basolateral amygdala (2015) Br. J. Pharmacol., 172, pp. 482-491; 
Wang, X., Qiao, Z.W., Zhou, Z.J., Zhuang, P.J., Zheng, S., Postoperative morphine concentration in infants with or without biliary atresia and its association with hepatic blood flow (2014) Anaesthsia, 69, pp. 583-590; 
Wang, Y., Ge, Y.H., Wang, Y.X., Liu, T., Law, P.Y., Loh, H.H., Chen, H.Z., Qiu, Y., Modulation of mTOR activity by mu-opioid receptor is dependent upon the association of receptor and FK506-binding protein 12 (2015) CNS Neurosci. Ther., 21, pp. 591-598; 
Wang, Y., Lai, J., Cui, H., Zhu, Y., Zhao, B., Wang, W., Wei, S., Inhibition of histone deacetylase in the basolateral amygdala facilitates morphine context-associated memory formation in rats (2015) J. Mol. Neurosci., 55, pp. 269-278; 
Wang, Y., Liu, X., Wang, D., Yang, J., Zhao, L., Yu, J., Wang, R., Endomorphin-1 analogues (MELs) penetrate the blood-brain barrier and exhibit good analgesic effects with minimal side effects (2015) Neuropharmacology, 97, pp. 312-321; 
Wang, Y., Long, H., Jian, F., Li, X., Yang, X., Zhao, Z., Lai, W., Nociceptin/orphanin FQ up-regulates P2 × 3 receptors in primary cultures of neonatal rat trigeminalganglion neurons (2015) Eur. J. Oral Sci., 123, pp. 409-415; 
Wang, Y., Wang, Y.X., Liu, T., Law, P.Y., Loh, H.H., Qiu, Y., Chen, H.Z., Mu-opioid receptor attenuates A-beta oligomer-induced neurotoxicity through mTOR signaling (2015) CNS Neurosci. Ther., 21, pp. 8-14; 
Wang, Z., Tang, B., Tang, F., Li, Y., Zhang, G., Zhong, L., Dong, C., He, S., Protection of rat intestinal epithelial cells from ischemia/reperfusion injury by (D-Ala2, D-Leu5)-enkephalin through inhibition of the MKK7-JNK signaling pathway (2015) Mol. Med. Rep., 12, pp. 4079-4088; 
Ward, V.D., McCrory, C.R., An assessment of intrathecal catheters in the perioperative period: an analysis of 84 cases (2014) Ir. J. Med. Sci., 183, pp. 293-296. , (4.5); 
Wardhan, R., Auroux, A.S., Ben-David, B., Chelly, J.E., Is L2 paravertebral block comparable to lumbar plexus block for postoperative analgesia after total hip arthroplasty (2014) Clin. Orthop. Relat. Res., 472, pp. 1475-1481; 
Watanabe, H., Fitting, S., Hussain, M.Z., Kononecko, O., Iatsyshyna, A., Yoshitake, T., Kehr, J., Bakalkin, G., Asymmetry of the endogenous opioid system in the human anterior cingulate: a putative molecular basis for lateralization of emotions and pain (2015) Cereb. Cortex, 25, pp. 97-108; 
Watanabe, N., Piche, M., Hotta, H., Types of skin afferent fibres and spinal opioid receptors that contribute to touch-induced inhibition of heart rate changes evoked by noxious cutaneous heat stimulation (2015) Mol. Pain, 11, p. 4; 
Webster, L., Chey, W.D., Tack, J., Lappalainen, J., Diva, U., Sostek, M., Randomised clinical trial: the long-term study and tolerability of naloxegol in patients with pain and opioid-induced constipation (2014) Aliment. Pharmacol. Ther., 40, pp. 771-779; 
Webster, L.R., Smith, M.D., Unal, C., Finn, A., Low-dose naloxone provides an abuse-deterrent effect to buprenorphine (2015) J. Pain Res., 8, pp. 791-798; 
Wei, J., Lei, G.H., Gao, S.G., Zeng, C., Qin, J.B., Kong, F.J., Yang, T.B., Single-dose intra-articular bupivacaine versus morphine after arthroscopic knee surgery: a meta-analysis of randomized-controlled studies (2014) Clin. J. Pain, 30, pp. 630-638; 
Wei, S., Li, X., Differential effects of propranolol on conditioned hyperactivity and locomotor sensitization induced by morphine in rats (2014) Sci. Rep., 4, p. 3786; 
Weingarten, T.N., Heraservich, V., McGlinch, M.C., Beatty, N.C., Christensen, E.D., Hannifan, S.K., Koenig, A.E., Sprung, J., Predictors of delayed postoperative respiratory depression assessed from naloxone administration (2015) Anesth. Analg., 121, pp. 422-429; 
Weiss, R.D., Potter, J.S., Griffin, M.L., Provost, S.E., Fitzmaurice, G.M., McDermott, K.A., Srisarajivakul, E.N., Carroll, K.M., Long-term outcomes from the national drug abuse treatment clinical trials netwotk prescription opioid addiction treatment study (2015) Drug Alcohol Depend., 150, pp. 112-119. , (10.2); 
Wen, D., Sun, D., Zang, G., Hao, L., Liu, X., Yu, F., Ma, C., Cong, B., Cholecystokinin octapeptide induces endogenous opioid-dependent anxiolytic effects in morphine-withdrawal rats (2014) Neuroscience, 277, pp. 14-25; 
West, N., Ansermino, J.M., Carr, R.R., Leung, K., Zhou, G., Lauder, G.R., A naloxone admixture to prevent opioid-induced pruritius in children: a randomized controlled trial (2015) Can. J. Anesth., 62, pp. 891-900; 
White, K.L., Robinson, J.E., Zhu, H., DiBerto, J.F., Polepally, P.R., Ziawiony, J.K., Nichols, D.E., The, G., protein-biased kappa-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo (2015) J. Pharmacol. Exp. Ther., 352, pp. 98-109; 
Whitehead, R.A., Schwarz, S.K., Asiri, Y.I., Fung, T., Puil, E., MacLeod, B.A., The efficacy and safety of the novel peripheral analgesic isovaline as adjuvant to proporfol for general anesthesia and conscious sedation: a proof-of-principle in mice (2015) Anesth. Analg., 121, pp. 1481-1487; 
Whitfield, T.W., Jr., Schlosburg, J.E., Wee, S., Gould, A., George, O., Grant, Y., Zamora-Martinez, E.R., Koob, G.F., Kappa opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake (2015) J. Neurosci., 35, pp. 4296-4305; 
Wibbenmeyer, L., Eid, A., Liao, J., Heard, J., Horsfield, A., Kral, L., Kealey, P., Rosenquist, R., Gabapentin is ineffective as an analgesic adjuvant in the immediate postburn period (2014) J. Burn Care Res., 35, pp. 136-142; 
Wel, E., Zitouni, E., Assez, N., Sebilleau, Q., Lys, S., Duval, A., Mauriaucourt, P., Hubert, H., Continuous infusion of ketamine for out-of-hospital orthopedic injuries secondary to trauma: a randomized controlled trial (2015) Prehosp. Emerg. Care, 19, pp. 10-16; 
Wiegand, S.L., Stringer, S.M., Stuebe, A.M., Jones, H., Seashore, C., Thorp, J., Buprenorphine and naloxone compared with methadone treatment in pregnancy (2015) Obstet. Gynecol., 125, pp. 363-368; 
Wieskopf, J.S., Pan, Y.X., Marcovitz, J., Tuttle, A.H., Majumdar, S., Pidakala, J., Pasternak, G.W., Mogil, J.S., Broad-spectrum analgesic efficacy of IBNtxA is mediated by exon 11-associated splice variants of the mu-opioid receptor gene (2014) Pain, 155, pp. 2063-2070; 
Wilartratsami, S., Sanansilp, V., Ariyawatkul, T., Chotigavanichaya, C., Pichaisak, W., Chotivichit, A., Luksanapruska, P., The effect of epidural low-dose morphine-soaked microfibrillar collagen sponge in postoperative pain control after laminectomy and instrumented fusion: a randomized double-blind placebo-controlled study (2014) J. Med. Assoc. Thai., 9, pp. S62-67; 
Wilson-Poe, A.R., Lau, B.K., Vaughan, C.W., Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission with the rat periaqueductal gray (2015) Br. J. Pharmacol., 172, pp. 681-690; 
Winter, R.J., Stoove, M., Degenhardt, L., Hellard, M.E., Spelman, T., Jenkinson, R., McCarthy, D.R., Kinner, S.A., Incidence and predictors of non-fatal drug overdose after release from prison among people who inject drugs in Queensland, Australia.Drug Alcohol (2015) Depend, 153, pp. 43-49; 
Woldu, S.L., Weinberg, A.C., Bergman, A., Shapiro, E.Y., Koerts, R., Motamedinia, P., Badani, K.K., Pain and analgesic use after robot-assisted radical prostatectomy (2014) J. Endourol., 28, pp. 544-548; 
Wolf, A., McKay, A., Spowart, C., Granville, H., Boland, A., Petrou, S., Sutherland, A., Gamble, C., Prospective multicenter randomized, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically-ill children: the SLEEPS (Safety prfiLe, Efficacy and Equivalence in Pediatric Intenstive care Sedation) study (2014) Health Technol. Assess., 18, pp. 1-212; 
Wolf, S., Grunewald, S., Sequence, structure and ligand binding evolution of rhodopsin-like G- protein-coupled receptors: a crystal structure-based phylogenetic analysis (2015) PLoS One, 10, p. e0123533; 
Woller, S.A., Malik, J.S., Aceves, M., Hook, M.A., Morphine self-administration following spinal cord injury (2014) J. Neurotrauma, 31, pp. 1570-1583; 
Wong, A., Macleod, D., Robinson, J., Koutsogiannis, Z., Graudins, A., Greene, S.L., Oxycodone/naloxone preparation can cause acute withdrawal symptoms when misused parentally or taken orally (2015) Clin. Toxicol. (Phila), 53, pp. 815-818; 
Woodcock, E.A., Ludahl, L.H., Burmeister, M., Greenwald, M.L., Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: a pilot study (2015) Am. J. Addict., 24, pp. 329-335; 
Worley, M.J., Heinzerling, K.G., Shoptaw, S.J., Ling, W., Pain volatility and prescription opioid addiction outcomes in patients with chronic pain (2015) Exp. Clin. Psychopharmacol., 23, pp. 428-435; 
Worley, M.J., Shoptaw, S.J., Bickel, W.K., Ling, W., Using behavioral economics to predict opioid use during prescription opioid dependence treatment (2015) Drug Alcohol Depend., 148, pp. 62-68; 
Worley, M.J., Witkiewicz, K., Brown, S.A., Kivlahan, D.R., Longabaugh, R., Social network moderators of naltrexone and behavioral treatment effects on heavy drinking in the COMBINE study (2015) Alcohol. Clin. Exp. Res., 39, pp. 93-100; 
Wu, J., Buggy, D., Fleischman, E., Parra-Sanchez, I., Treschan, T., Kurz, A., Mascha, E.J., Sessler, D.I., Thoracic paravertebral regional anesthesia improves analgesia after breast cancer surgery: a randomized controlled multicenter clinical trial (2015) Can. J. Anesth., 62, pp. 241-251; 
Wu, J., Li, P., Wu, X., Chen, W., Chronic intermittent hypoxia decreases pain sensitivity and increases the expression of HIF1alpha and opioid receptors in experimental rats (2015) Sleep Breath., 19, pp. 561-568; 
Wu, J., Liu, B., Tong, W., Zhang, A., Li, F., Lin, J., Wang, L.I., Opioid receptors and associated regulator of G protein signaling are involved in the cathartic colon of rats (2015) Exp. Ther. Med., 9, pp. 1229-1234; 
Wu, L., Dong, Y.P., Sun, L., Sun, L., Low concentration of dezocine in combination with morphine enhance the postoperative analgesia for thoracotomy (2015) J. Cardiothorac. Vasc. Anesth., 29, pp. 950-954; 
Wu, L., Huang, X., Sun, L., The efficacy of N-methyl-D-aspartate receptor antagonists on improving the postoperative pain intensity and satisfaction after remifentanil-based anesthesia in adults: a meta-analysis (2015) J. Clin. Anesth., 27, pp. 311-324; 
Wu, W., Li, H., Liu, Y., Huang, X., Chen, L., Zhai, H., Involvement of insular muscarinic cholinergic receptors in morphine-induced conditioned place preference in rats (2014) Psychopharmacology (Berl)., 231, pp. 4109-4118; 
Wu, X., Pang, G., Zhang, Y.M., Li, G., Xu, S., Dong, L., Stackman, R.W., Jr., Zhang, G., Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice (2015) Neurosci. Lett., 607, pp. 23-28; 
Wu, X.N., Zhang, T., Qian, N.S., Gup, X.D., Yang, H.J., Huang, K.B., Luo, G.Q., Pan, S.Y., Antinociceptive effects of endomorphin-2: suppression of substance P release in the inflammatory pain model rat (2015) Neuroschem. Int., 82, pp. 1-9; 
Wu, Y., Na, X., Zang, Y., Cui, Y., Xin, W., Pang, R., Zhou, L., Liu, X., Upregulation of tumor necrosis factor-alpha in nucleus accumbens attenuates morphine-induced rewarding in a neuropathic pain model (2014) Biochem. Biophys. Res. Commun., 449, pp. 502-507; 
Wu, Y., Li, Y., Yang, X., Sui, N., Differential effect of beta-adrenergic receptor antagonism in basolateral amygdala on reconsolidation of aversive and appetitive memories associated with morphine in rats (2014) Addict. Biol., 19, pp. 5-15; 
Wu, Z., Kong, M., Chern, J., Wang, J., Tan, J., Continuous epidural butorphanol decreases the incidence of intrathecal morphine-related pruritus after cesarean section: a randomized, double-blinded, placebo-controlled trail: epidural; butophanol decreases the incicdence of intrathcal morphine-related pruritus (2014) Cell Biochem. Biophys., 70, pp. 209-213; 
Xia, X., Persaud, S., Birnbaum, A., Exploratory study on association of single −nucloeotide polymorphisms with hydromorphone analgesia in ED (2015) Am. J. Emerg. Med., 33, pp. 444-447; 
Xiao, Y., Lei, J., Ye, G., Xu, H., You, H.J., Role of thalamic nuclei in the modulation of Fos expression within the cerebral cortex during hypertonic saline-induced muscle nociception (2015) Neuroscience, 304, pp. 36-46; 
Xiao, Y., Wu, L., Zhou, Q., Xiong, W., Duan, X., Huang, X., A randomized clinical trial of the effects of ultra-low-dose naloxone infusion on postoperative opioid requirements and recovery (2015) Acta Anaesthesiol. Scand., 59, pp. 1194-1203; 
Xiaoli, W., Lirong, W., Xueliang, W., Jinsong, L., Hengxin, L., Wei, J., Risk factors of hepatitis C virus infection in drug users form eleven methadone maintenance treatment clinics in Xi'an, China (2014) Hepat. Mon., 14, p. e19601; 
Xie, X., Lin, W., Xing, C., Yang, Y., Chi, Q., Zhang, H., Li, Y., Li, M., In vitro and in vivo evaluations of PLGA microspheres containing nalmefene (2015) PLoS One, 10, p. 0125953; 
Xu, C., Zhang, Y., Zheng, H., Loh, H.H., Law, P.Y., Morphine modulates mouse hippocampal progenitor cell lineages by upregulating miR-181a level (2014) Stem Cells, 32, pp. 2961-2972; 
Xu, G.H., Gao, M., Sheng, Q.Y., Liu, X.S., Gu, E.W., Opioid receptor A118G polymorphism does not affect the consumption of sufentanil and ropivacaine by patient-controlled epidural analgesia after cesarean section (2015) Ther. Drug Monit., 37, pp. 53-57; 
Xu, H., Xu, T., Ma, X.Q., Jiang, W., Chronic morphine treatment increased the expression of myeloid differentiation primary response protein 88 in rat spinal cord (2014) J. Integr. Neurosci., 13, pp. 607-615; 
Xu, J., Faskowitz, A.J., Rossi, G.C., Xu, M., Lu, Z., Pan, Y.X., Pasternak, G.W., Stabilization of morphine tolerance with long-term dosing: association with selective upregulation of mu-opioid receptor splice variant mRNAs (2015) Proc. Natl. Acad. Sci. (U. S. A.), 112, pp. 279-284; 
Xu, J., Lu, Z., Xu, M., Rossi, G.C., Kest, B., Waxman, A.R., Pasternak, G.W., Pan, Y.X., Differential expressions of the alternatively spliced variant mRNAs of the mu opioid receptor gene, OPRM1, in brain regions of four inbred mouse strains (2014) PLoS One, 9, p. e111267; 
Xu, J., Sun, J., Xue, Z., Li, X., An enriched environment reduces the stress level and locomotor activity induced by acute morphine treatment and by saline after chronic morphine treatment (2014) Neuroreport, 25, pp. 701-709; 
Xu, J., Zhao, Q., Wei, L., Yang, Y., Xu, R., Yu, N., Zhao, Y., Phytochemical composition and antinociceptive activity of Bauhinia glauca subsp. Hupehana in rats (2015) PLoS One, 10, p. e0117801; 
Xu, T., Zhong, W., Zhao, J., Ma, X., Zhao, D., Jiang, W., Zhang, X., Does modulation of spinal N-methyl-D-aspartate acid receptor by preactivation accelerate the development of morphine tolerance (2015) Med. Hypotheses, 84, pp. 91-93; 
Xu, Y.C., Li, R.P., Xue, F.S., Cui, X.L., Wang, S.Y., Liu, G.P., Yang, G.Z., Liao, X., Kappa-opioid receptors are involved in enhanced cardioprotection by combined fentanyl and limb remote ischemic postconditioning (2015) J. Anesth., 29, pp. 535-543; 
Xue, Y.X., Xue, L.F., Liu, J.F., He, J., Deng, J.H., Sun, S.C., Han, H.B., Lu, L., Depletion of perineuronal nets in the amygdala to enhance the erasure of drug memories (2014) J. Neurosci., 34, pp. 6647-6658; 
Yager, L.M., Pitchers, K.K., Flagel, S.B., Robinson, T.E., Individual variation in the motivational and neurobiological effects of an opioid cue (2015) Neuropsychopharmacology, 40, pp. 1269-1277; 
Yamamoto, R.T., Kanarek, R.B., Central and peripheral relationships between morphine and glucose on antinociception in rats (2014) Ann. Neurosci. Psychol., 1, pp. 1-6; 
Yamasaki, H., Funbai, Y., Funao, T., Mori, T., Nishikawa, K., Effects of tramadol on substantia gelatinosa neurons in the spinal cord: an in vivo patch-clamp analysis (2015) PLoS One, 10, p. e0125147; 
Yan, T., Rizak, J.D., Yang, S., Li, H., Huang, B., Ma, Y., Hu, X., Acute morphine treatments alleviate tremor in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys (2014) PLoS One, 9, p. e88404; 
Yang, H.C., Lin, C.W., Chen, C.W., Chen, J.J., Applying genome-wide gene-based expression quantitative trait locus mapping to study population ancestry and pharmacogenetics (2014) BMC Genomics, 15, p. 319; 
Yang, L., Islam, M.R., Karamyan, V.T., Abbruscato, T.J., In vitro and in vivo efficacy of a potent opioid receptor agonist, biphalin, compared to subtype-selective opioid receptor agonists for stroke treatment (2015) Brain Res., 1609, pp. 1-11; 
Yang, X., Liu, J., Liu, Z.J., Xia, Q.J., He, M., Liu, R., Liu, W., Wang, T.H., Reversal of bone cancer pain by HSV-1-mediated silencing of CNTF in an afferent area of the spinal cord associated with AKT-ERK signal inhibition (2014) Curr. Gene Ther., 14, pp. 377-388; 
Yao, P., Ding, Y.Y., Wang, Z.B., Ma, J.M., Hong, T., Pan, S.N., Effect of gene polymorphisms of COMT and OPRM1 on the preoperative pain sensitivity in patients with cancer (2015) Int. J. Clin. Exp. Med., 8, pp. 10036-10039; 
Yao, Y.S., Yao, R.Y., Zhuang, L.K., Qi, W.W., Lv, J., Zhou, F., Qiu, W.S., Yue, L., MOR1 expression in gastric cancer: a biomarker associated with poor outcome (2015) Clin. Transl. Sci., 8, pp. 137-142; 
Ye, J., Yang, Z., Li, C., Cai, M., Zhou, D., Zhang, Q., Wei, Y., Liu, Y., NF-kappaB signaling and vesicle transport are correlated with the reactivation of the memory trace of morphine dependence (2014) Diagn. Pathol., 9, p. 142; 
Yee, D.A., Hughes, M.M., Guo, A.Y., Barakat, N.H., Tse, S.A., Ma, J.D., Best, B.M., Atayee, R.S., Observation of improved adherence with frequent urine drug testing in patients with pain (2014) J. Opioid Manag., 10, pp. 111-118; 
Yeselyurt, O., Seyrek, M., Tasdemir, S., Kahraman, S., Deveci, M.S., Karakus, E., Halici, Z., Dogrul, A., The critical role of spinal 5-HT7 receptors in opioid and non-opioid type of stress-induced analgesia (2015) Eur. J. Pharmacol., 762, pp. 402-419; 
Yi, P.L., Lu, C.Y., Jou, S.B., Chang, F.C., Low-frequency electroacupuncture suppresses focal epilepsy and improves epilepsy-induced sleep disruptions (2015) J. Biomed. Sci., 22, p. 49; 
Yin, H., Cai, H.Z., Wang, S.K., Yang, L.G., Sun, G.J., Wheat peptides reduce oxidative stress and inhibit NO production through modulating mu-opioid receptor in a rat NSAID-induced stomach damage model (2015) Chin. J. Nat. Med., 13, pp. 22-29; 
Yong, Z., Yan, L., Gao, X., Gong, Z., Su, R., Effects of thienorphine on synaptic structure and synaptophysin expression in rat nucleus accumbens (2014) Neuroscience, 274, pp. 53-58; 
Yoon, H., Thakur, V., Isham, D., Fayad, M., Chattopadhyay, M., Moderate exercise training attenuates inflammatory mediators in DRG of type 1 diabetic rats (2015) Exp. Neurol., 267, pp. 107-114; 
Yoon, S.Y., Woo, J., Park, J.O., Choi, E.J., Shin, H.S., Roh, D.H., Kim, K.S., Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test (2015) Anesth. Analg., 120, pp. 671-677; 
Younge, N., Smith, P.B., Goldberg, R.N., Brandon, D.H., Simmons, C., Cotton, C.M., Bidegain, M., Impact of a palliative care program on end-of-life care in a neonatal intensive care unit (2015) J. Perinatol., 35, pp. 218-222; 
Yousefpour, M., Naderi, N., Mansouri, Z., Janahmadi, M., Alizadeh, A.M., Motamedi, F., The comparison of the effects of acute and repeated morphine administration on fast synaptic transmission in magnocellular neurons of supraoptic nucleus, plasma vasopressin levels and urine volume of male rats (2014) Iran. J. Pharm. Res., 13, pp. 975-985; 
Yousofizadeh, S., Tamaddonfard, E., Farshid, A.A., The role of nicotinic acetylcholine and opioid systems of the ventral orbital cortex in modulation of formalin-induced orofacial pain in rats (2015) Eur. J. Pharmacol., 758, pp. 147-152; 
Youssef, N., Orlov, D., Alie, T., Chong, M., Cheng, J., Thabane, L., Paul, J., What epidural opioid results in the best analgesia outcomes and fewest side effects after surgery?: a meta-analysis of randomized controlled trials (2014) Anesth. Analg., 119, pp. 965-977; 
Yousuf, A., Miess, E., Sianati, S., Du, Y.P., Schulz, S., Christie, M.J., Role of phosphorylation sites in desensitization of mu-opioid receptor (2015) Mol. Pharmacol., 88, pp. 825-835; 
Yu, G., Zhang, F.Q., Tang, S.E., Lai, M.J., Su, R.B., Gong, Z.H., Continuous infusion versus intermittent bolus dosing of morphine: a comparison of analgesia, tolerance and subsequent voluntary morphine intake (2014) J. Psychiatry Res., 59, pp. 161-166; 
Yu, Z.Q., Zhang, C.L., Xu, Y.J., Chang, M.J., Jin, J.J., Luo, L., Li, X.P., Liu, D., Chronopharmacology of analgesic effect and tolerance induced by six narcotic analgesics in mice (2015) Drug Res. (Stuttg), 65, pp. 141-146; 
Yuan, S., Palczewski, K., Peng, Q., Kolinski, M., Vogel, H., Filipek, S., The mechanism of ligand-induced activation of mu- and kappa-opioid receptors (2015) Agnew. Chem. Int. Ed. Engl., 54, pp. 7560-7563; 
Yuan, Y., Zaidi, S.A., Stevens, D.L., Scoggins, K.L., Mosier, P.D., Kellogg, G.E., Dewey, W.L., Zhang, Y., Design, syntheses, and pharmacological characterization of 17-cyclopropylmethyl-3, 14beta-dihydroxy-4, 5alpha-epoxy-6alpha-(isoquinoline-3(-carboxyamido)morphinan analogues as opioid receptor ligands (2015) Bioorg. Med. Chem., 23, pp. 1701-1715; 
Yun, J., Lee, Y., Yun, K., Oh, S., Bergenin decreases the morphine-induced physical dependence via antioxidative activity in mice (2015) Arch. Pharm. Res., 38, pp. 1248-1254; 
Yun, J., Jung, Y.S., A Scutellaria baicalensis radix water extract inhibits morphine-induced conditioned place preference (2014) Pharm. Biol., 52, pp. 1382-1387; 
Zaaijer, E.R., de Bruin, K., la Fleur, S.E., Goudriaan, A.E., van den Brink, W., Booji, J., Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter activity, food intake or body weight gain in rats (2015) J. Psychopharmacol., 29, pp. 344-348; 
Zaaijer, E.R., van Dijk, L., de Bruin, K., Goudriaan, A.E., Lammers, L.A., Koeter, M.W., van den Brink, W., Booji, J., Effect of extended-release naltrexone on striatal dopamine transporter, depression and anhedonia in heroin-dependent patients (2015) Psychopharmacology (Berl)., 232, pp. 2597-2607; 
Zacny, J.P., Wroblewski, K., Coalson, D.W., Methylnaltrexone: its pharmacological effects alone and effects on morphine in healthy volunteers (2015) Psychopharmacology (Berl)., 232, pp. 63-73; 
Zadina, J.E., Nunes, M.R., Morgenweck, J., Zhang, X., Hackler, L., Fasold, M.B., Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance and glial activation relative to morphine (2015) Neuropharmacology, 105, pp. 215-227; 
Zador, F., Lenart, N., Csibrany, B., Santha, M., Molnar, M., Tuka, B., Samavati, R., Paldy, E., Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner (2015) Neuropharmacology, 89, pp. 298-307; 
Zalewska-Kaszubska, J., Bajer, B., Gorska, D., Andrzejczak, D., Dyr, W., Bienkowski, P., Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol-preferring rats chronically treated with lamotrigine (2015) Physiol. Behav., 139, pp. 7-12; 
Zalon, M.L., Mild, moderate and severe pain in patients recovering from major abdominal surgery (2014) Pain Manag. Nurs., 15, pp. e1-12; 
Zamani, N., Hassanian-Moghaddam, H., Bayat, A.H., Haghparast, A., Shadnia, S., Rahimi, M., Hashemi Demaneh, B., Assar, N., Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine (2015) Toxicol. Lett., 232, pp. 590-594; 
Zan, G.Y., Wang, Q., Wang, Y.J., Liu, Y., Hang, A., Shu, X.H., Liu, J.G., Antagonism of kappa opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence (2015) Behav. Brain Res., 291, pp. 334-341; 
Zand, F., Amini, A., Asadi, S., Farbood, A., The effect of methylnaltrexone on the side effects of intrathecal morphine after orthopedic surgery under spinal anesthesia (2015) Pain Pract., 15, pp. 348-354; 
Zarepour, L., Fatahi, Z., Sarihi, A., Haghparast, A., Blockade of orexin-1 receptors in the ventral tegmental area could attenuate the lateral hypothalamic stimulation-induced potentiation of rewarding properties of morphine (2014) Neuropeptides, 48, pp. 179-185; 
Zaslansky, R., Ben-Nun, O., Ben-Shitrit, S., Ullmann, Y., Kopf, A., Stein, C., A randomized, controlled, clinical pilot study assessing the analgesic effect of morphine applied topically onto split-thickness skin wounds (2014) J. Pharm. Pharmacol., 66, pp. 1559-1566; 
Zaveri, N.T., Joumigan, V.B., Polgar, W.E., Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa and nocieptin opioid receptors (2015) ACS Chem. Neurosci., 6, pp. 646-657; 
Zeiler, G.E., Dzikiti, B.T., Fosgate, G.T., Stegmann, F.G., Venter, F.J., Rioja, E., Aaesthetic, analgesic and cardiorespiratory effects of intramuscular medetomidine-ketamine combination alone or with morphine or tramadol for orchidectomy in cats (2014) Vet. Anaesth. Analg., 41, pp. 411-420; 
Zeinivand, M., Shamsizadeh, A., Pourshanazari, A.A., Hassanshahi, G., Allatatvakoli, M., Morphine and nicotine addiction and withdrawal influence baroreflex sensitivity and blood pressure in two-kidney one clip hypertensive (2K1C) rats (2014) Bratisl. Lek. Listy, 115, pp. 743-748; 
Zeng, X., Lin, M.Y., Wang, D., Zhang, Y., Hong, Y., Involvement of adrenomedullin in spinal glial activation following chronic administration of morphine in rats (2014) Eur. J. Pain, 18, pp. 1323-1332; 
Zeraati, F., Araghchian, M., Farjoo, M.H., Ascorbic acid interaction with analgesic effect of morphine and tramadol in mice (2014) Anesth. Pain Med., 4, p. e19529; 
Zgierska, A., Wallace, M.L., Burzinski, C.A., Cox, J., Backonja, M., Pharmacological and toxicological profile of opioid-treated, chronic low back pain patients entering a mindfulness intervention randomized controlled trial (2014) J. Opioid Manag., 10, pp. 323-335; 
Zhang, C., Li, S.S., Zhao, N., Yu, C., Phosphorylation of the GluN1 subunit in dorsal horn neurons by remifentanil: a mechanism for opioid-induced hyperalgesia (2015) Genet. Mol. Res., 14, pp. 1846-1854; 
Zhang, C., Murugan, S., Boyadjieva, N., Jabbar, S., Shrivastava, P., Sarkar, D.K., Beta-endorphin cell therapy for cancer prevention (2015) Cancer Prev. Res. (Phila), 8, pp. 56-67; 
Zhang, H., Chen, L., Bu, H.Q., Yu, Q.J., Jiang, D.D., Pan, F.P., Wang, Y., Lin, S.Z., Effects of emodin on the demethylation of tumor-suppressor genes in pancreatic cancer PANC-1 cells (2015) Oncol. Rep., 33, pp. 3015-3023; 
Zhang, J., Muller, J.F., McDonald, A.J., Mu opioid receptor localization in the basolateral amygdala: an ultrastructural analysis (2015) Neuroscience, 303, pp. 352-363; 
Zhang, J.J., Han, J., Sui, N., Okadaic acid blocks the effects of 5-aza-2-deoxycytidine on consolidation, acquisition and retrieval of morphine-induced conditioned place preference in rats (2014) Neuropharmacology, 86, pp. 282-293; 
Zhang, L.S., Wang, J., Chen, J.C., Tao, Y.M., Wang, Y.H., Xu, X.J., Chen, J., Liu, J.G., Novel kappa-opioid receptor agonist MB-1C-OH produces potent analgesia with less depression and sedation (2015) Acta Pharmacol. Sin., 36, pp. 565-571; 
Zhang, M.M., Jiang, Y.S., Ly, H.C., Mu, H.B., Li, J., Shang, Z.W., Zhang, R.J., Pathway-based association analysis of two genome-wide screening data identified rheumatoid arthritis-related pathways (2014) Genes Immun., 15, pp. 487-494; 
Zhang, R.S., Xui, J., Jiang, J.H., Han, R.W., Chang, M., Peng, Y.L., Wang, Y., Wang, R., Endomorphin-1 attenuates Abeta42 induced impairment of novel object and object location recognition tasks in mice (2015) Brain Res., 1629, pp. 210-220; 
Zhang, W., Song, S., Liu, F., Liu, Y., Zhang, Y., Beta-casomorphin-7 prevents epithelial-mesenchymal transdifferentiation of NRK-52E cells at high glucose levels: involvement of AngII-TGF-beta1 pathway (2015) Peptides, 70, pp. 37-44; 
Zhang, W., Yang, H.L., Song, J.J., Chen, M., Dong, Y., Lai, B., Yu, Y.G., Zheng, P., DAMGO depresses inhibitory synaptic transmission via different downstream pathways of mu opioid receptors in ventral tegmental area and periaqueductal gray (2015) Neuroscience, 301, pp. 144-154; 
Zhang, W.Z., Yu, W.J., Zhao, X.L., He, B.X., Pharmacoeconomomics evaluation of morphine, MS contin and oxycodone in the treatment of cancer pain (2014) Asian Pac. J. Cancer Prev., 15, pp. 8797-8800; 
Zhang, X., van den Pol, A.N., Dopamine/tyrosine hydroxylase neurons of the hypothalamic arcuate nucleus release GABA, communicate with dopaminergic and other arcuate neurons and respond to dynorphin, met-enkephalin and oxytocin (2015) J. Neurosci., 35, pp. 14966-14982; 
Zhang, Y., Brownstein, A.J., Buonora, M., Nikura, K., Ho, A., Correa da Rosa, J., Kreek, M.J., Ott, J., Self-administration of oxycodone alters synaptic plasticity gene expression in the hippocampus differentially in male adolescent and adult mice (2015) Neuroscience, 285, pp. 34-46; 
Zhang, Y., Picetti, R., Butelman, E.R., Ho, A., Blendy, J.A., Kreek, M.J., Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice (2015) Neuropsychopharmacology, 40, pp. 1091-1100; 
Zhang, Y., Qu, H., Zhou, Y., Wang, Y., Zhang, D., Yang, X., Yang, C., Xu, M., The involvement of norepinephrine in pain modulation in the nucleus accumbens of morphine-dependent rats (2015) Neurosci. Lett., 585, pp. 6-11; 
Zhang, Y., Simpson-Durand, C.D., Standifer, K.M., Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder (2015) Br. J. Pharmacol., 172, pp. 571-582; 
Zhang, Y., Zhao, S., Rodriguez, E., Takatoh, J., Han, B.X., Zhou, X., Wang, F., Identifying local and descending nputs for primary sensory neurons (2015) J. Clin. Invest., 125, pp. 3782-3794; 
Zhang, Y.F., Xu, Q.X., Liao, L.D., Xu, X.E., Wu, J.Y., Shen, J.H., Li, E.M., Xu, L.Y., Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma (2015) Dis. Esophagus, 28, pp. 196-203; 
Zhang, Y.L., Ou, P., Lu, X.H., Chen, Y.P., Xu, J.M., Dai, R.P., Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical tiral (2014) PLoS One, 9, p. e91454; 
Zhang, Z., Slater, R.C., Ferroni, M.C., Kadow, B.T., Lyon, T.D., Shen, B., Xiao, Z., Tai, C., Role of mu, kappa and delta opioid receptors in tibial inhibition of bladder overactivity in cats (2015) J. Pharmacol. Exp. Ther., 355, pp. 228-234; 
Zhang, Z., Tao, W., Hou, Y.Y., Wang, W., Kenny, P.J., Pan, Z.Z., MeCP2 repression of g9a in regulation of pain and morphine reward (2014) J. Neurosci., 34, pp. 9076-9087; 
Zhao, C., Du, H., Xu, L., Wang, J., Tang, L., Cao, Y., Li, C., Gao, P., Metabolomic analysis revealed glycylglycine accumulation in astrocytes after methionine enkephalin administration exhibiting neuron protective effects (2015) J. Pharm. Biomed. Anal., 115, pp. 48-54; 
Zhao, M., Nakamura, S., Miyake, T., So, K., Shirakawa, H., Tokuyama, S., Narita, M., Kaneko, S., Pharmacological characterization of standard analgesics on oxliplatin-induced acute cold hypersensitivity in mice (2014) J. Pharmacol. Sci., 124, pp. 514-517; 
Zhao, X.H., Zhang, X.O., Zhu, G., Chen, L., Hu, W., Zhang, T., Dong, Y.L., Li, Y.Q., Different analgesic effects of intrathecal endomorphin-2 on thermal hyperalgesia and evoked inflammatory pain in ovariectomized rats (1518) Pain Physician., 20, pp. 195-205; 
Zheng, J., Li, H., Guo, R., Chen, R., Lin, S., Liu, M., You, C., Neuroprotection for nalmefene for postoperative patients with spontaneous intracerebral hemorrhage (2015) Int. J. Neurosci., 125, pp. 918-923; 
Zheng, Q., Liu, Z., Wei, C., Han, J., Liu, Y., Zhang, X., Ren, W., Activation of the D1 receptors inhibits the long-term potentiation in vivo by acute morphine administration through a D1-GluN2A interaction in the nucleus accumbens (2014) Neuroreport, 25, pp. 1191-1197; 
Zhong, T., Ojha, M., Bagher, S., Butler, K., Srinivas, C., McCluskey, S.A., Clarke, H., Hofer, S.O., Transversus abdominis plane block reduces morphine consumption in the early postoperative period following microsurgical abdominal tissue breast reconstruction: a doubleblind, placebo-controlled, randomized trial (2014) Plast. Reconstr. Surg., 134, pp. 870-878; 
Zhou, L., Stahl, E.L., Lovell, K.M., Frankowski, K.J., Prisinzano, T.E., Aube, J., Bohn, L.M., Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPgammaS binding for the evaluation of selective KOR ligands in an endogenous setting (2015) Neuropharmacology, 99, pp. 131-141; 
Zhou, M., Luo, P., Lu, Y., Li, C.J., Wang, D.S., Lu, Q., Xu, X.L., Guo, L.J., Imbalance of HCN1 and HCN2 expression in hippocampal CA1 area impairs spatial learning and memory in rats with chronic morphine exposure (2015) Prog. Neuropsychopharmacol. Biol. Psychiatry, 56, pp. 207-214; 
Zhou, P., Jiang, J., Dong, Z., Yan, H., You, Z., Su, R., Gong, Z., The proteins interacting with C-terminal of mu receptor are identified by bacterial two-hybrid system from brain cDNA library in morphine-dependent rats (2015) Life Sci., 143, pp. 156-167; 
Zhou, P., Li, T., Su, R., Gong, Z., Effects of thienophine on contraction of the guinea pig sphincter of Oddi, choledochus and gall bladder (2014) Eur. J. Pharmacol., 737, pp. 22-28; 
Zhou, X., Wang, D., Zhang, Y., Zhang, J., Xiang, D., Wang, H., Activation of kappa-opioid receptor by U50488H improves vascular dysfunction in streptozotocin-induced diabetic rats (2015) BMC Endor. Disord., 15, p. 7; 
Zhou, X.L., Yu, L.N., Wang, Y., Tang, L.H., Peng, Y.N., Cao, J.L., Yan, M., Increased methylation of the MOR gene proximal promoter in primary sensory neurons plays a crucial role in the decreased analgesic effect of opioids in neuropathic pain (2014) Mol. Pain, 10, p. 51; 
Zhou, Y., Kreek, M.J., Persistent increases in rat hypothalamic POMC gene expression following chronic withdrawal from chronic binge pattern escalating-dose, but not steady-dose, cocaine (2015) Neuroscience, 289, pp. 63-70; 
Zhu, Y., Wang, S., Wu, H., Wu, Y., Effect of perioperative parecoxib on postoperative pain and local inflammation factors PGE2 and IL-6 for total knee arthroplasty: a randomized, double-blinf, placebo-controlled study (2014) Eur. J. Orthop. Surg. Traumatol., 24, pp. 395-401; 
Zielinska, M., Ben Haddou, T., Cami-Kobeci, G., Salaga, M., Jarmuz, A., Padysz, M., Kordek, R., Fichna, J., Anti-inflammatory effect of dual nociception and opioid receptor agonist, BU08070, in experimental colitis in mice (2015) Eur. J. Pharmacol., 765, pp. 582-590
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85008384446&doi=10.1016%2fj.peptides.2016.12.004&partnerID=40&md5=b23fd3e498b313b6de4ac4aebf0fc7d2
ER  - 

TY  - JOUR
TI  - Pharmacoepigenetics of the role of DNA methylation in μ-opioid receptor expression in different human brain regions
T2  - Epigenomics
J2  - Epigenomics
VL  - 8
IS  - 12
SP  - 1583
EP  - 1599
PY  - 2016
DO  - 10.2217/epi-2016-0072
SN  - 17501911 (ISSN) 
AU  - Knothe, C.
AU  - Oertel, B.G.
AU  - Ultsch, A.
AU  - Kettner, M.
AU  - Schmidt, P.H.
AU  - Wunder, C.
AU  - Toennes, S.W.
AU  - Geisslinger, G.
AU  - Lötsch, J.
AD  - Institute of Clinical Pharmacology, Goethe - University, Theodor-Stern-Kai 7, Frankfurt am Main, 60590, Germany
AD  - Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Project Group Translational Medicine and Pharmacology TMP, Theodor-Stern-Kai 7, Frankfurt am Main, 60590, Germany
AD  - DataBionics Research Group, University of Marburg, Hans-Meerwein-Straße, Marburg, 35032, Germany
AD  - Institute of Legal Medicine, Saarland University, Building 80.2, Homburg, Saar, 66421, Germany
AD  - Institute of Legal Medicine, Goethe - University, Kennedyallee 104, Frankfurt am Main, 60596, Germany
AB  - Aim: Exposure to opioids has been associated with epigenetic effects. Studies in rodents suggested a role of varying degrees of DNA methylation in the differential regulation of μ-opioid receptor expression across the brain. Methods: In a translational investigation, using tissue acquired postmortem from 21 brain regions of former opiate addicts, representing a human cohort with chronic opioid exposure, μ-opioid receptor expression was analyzed at the level of DNA methylation, mRNA and protein. Results & conclusion: While high or low μ-opioid receptor expression significantly correlated with local OPRM1 mRNA levels, there was no corresponding association with OPRM1 methylation status. Additional experiments in human cell lines showed that changes in DNA methylation associated with changes in μ-opioid expression were an order of magnitude greater than differences in brain. Hence, different degrees of DNA methylation associated with chronic opioid exposure are unlikely to exert a major role in the region-specificity of μ-opioid receptor expression in the human brain. © 2016 Jorn Lotsch.
KW  - DNA methylation
KW  - human brain
KW  - OPRM1 methylation
KW  - μ-opioid receptor regulation
KW  - DNA
KW  - messenger RNA
KW  - mu opiate receptor
KW  - opiate
KW  - protein
KW  - messenger RNA
KW  - mu opiate receptor
KW  - narcotic analgesic agent
KW  - OPRM1 protein, human
KW  - adult
KW  - aged
KW  - anterior cingulate
KW  - Article
KW  - autopsy
KW  - basolateral amygdala
KW  - brain region
KW  - caudate nucleus
KW  - cerebellum
KW  - cerebellum vermis
KW  - cohort analysis
KW  - controlled study
KW  - DNA methylation
KW  - epigenetics
KW  - female
KW  - gene expression regulation
KW  - genetic association
KW  - genetic correlation
KW  - HEK293 cell line
KW  - hemisphere
KW  - hippocampus
KW  - human
KW  - human cell
KW  - human tissue
KW  - hypothalamus
KW  - insula
KW  - limit of quantitation
KW  - long term exposure
KW  - male
KW  - medulla oblongata
KW  - middle aged
KW  - neuroblastoma cell line
KW  - nucleus accumbens
KW  - occipital cortex
KW  - opiate addiction
KW  - orbital cortex
KW  - pharmacoepigenetics
KW  - pharmacogenetics
KW  - pontine nucleus
KW  - pontine tegmentum
KW  - prefrontal cortex
KW  - priority journal
KW  - putamen
KW  - spinal cord
KW  - thalamus
KW  - thalamus lateralis
KW  - thalamus medialis
KW  - very elderly
KW  - young adult
KW  - brain
KW  - drug dependence
KW  - drug effects
KW  - genetic epigenesis
KW  - genetics
KW  - metabolism
KW  - pain
KW  - tumor cell line
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Analgesics, Opioid
KW  - Brain
KW  - Cell Line, Tumor
KW  - DNA Methylation
KW  - Epigenesis, Genetic
KW  - Female
KW  - HEK293 Cells
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Pain
KW  - Receptors, Opioid, mu
KW  - RNA, Messenger
KW  - Substance-Related Disorders
KW  - Young Adult
PB  - Future Medicine Ltd.
N1  - Cited By :5
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C2  - 27685027
LA  - English
N1  - Correspondence Address: Lötsch, J.; Institute of Clinical Pharmacology, Goethe - University, Theodor-Stern-Kai 7, Germany; email: j.loetsch@em.uni-frankfurt.de
N1  - Chemicals/CAS: DNA, 9007-49-2; opiate, 53663-61-9, 8002-76-4, 8008-60-4; protein, 67254-75-5; Analgesics, Opioid; OPRM1 protein, human; Receptors, Opioid, mu; RNA, Messenger
N1  - References: Doehring, A., Oertel, B.G., Sittl, R., Lotsch, J., Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain (2013) Pain., 154 (1), pp. 15-23; 
Knothe, C., Doehring, A., Ultsch, A., Lotsch, J., Methadone induces hypermethylation of human DNA (2015) Epigenomics., 8 (2), pp. 167-179; 
Hwang, C.K., Song, K.Y., Kim, C.S., Epigenetic programming of mu opioid receptor gene in mouse brain is regulated by MeCP2 and Brg1 chromatin remodeling factor (2009) J. Cell. Mol. Med., 13 (9 B), pp. 3591-3615; 
Hwang, C.K., Song, K.Y., Kim, C.S., Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters (2007) Mol. Cell. Biol., 27 (13), pp. 4720-4736; 
Hwang, C.K., Kim, C.S., Kim, D.K., Law, P.Y., Wei, L.N., Loh, H.H., Up-regulation of the mu-opioid receptor gene is mediated through chromatin remodeling and transcriptional factors in differentiated neuronal cells (2010) Mol. Pharmacol., 78 (1), pp. 58-68; 
Lotsch, J., Schneider, G., Reker, D., Common nonepigenetic drugs as epigenetic modulators (2013) Trends Mol. Med., 19 (12), pp. 742-753; 
Stefanidou, M., Athanaselis, S., Spiliopoulou, C., Dona, A., Maravelias, C., Biomarkers of opiate use (2010) Int. J. Clin. Pract., 64 (12), pp. 1712-1718; 
Brodersen, K.H., Wiech, K., Lomakina, E.I., Decoding the perception of pain from fMRI using multivariate pattern analysis (2012) Neuroimage., 63 (3), pp. 1162-1170; 
Apkarian, A.V., Bushnell, M.C., Treede, R.D., Zubieta, J.K., Human brain mechanisms of pain perception and regulation in health and disease (2005) Eur J. Pain., 9 (4), pp. 463-484; 
Treede, R.D., Apkarian, A.V., Bromm, B., Greenspan, J.D., Lenz, F.A., Cortical representation of pain: Functional characterization of nociceptive areas near the lateral sulcus (2000) Pain., 87 (2), pp. 113-119; 
Ma, N., Liu, Y., Li, N., Addiction related alteration in restingstate brain connectivity (2010) Neuroimage., 49 (1), pp. 738-744; 
Miquel, M., Vazquez-Sanroman, D., Carbo-Gas, M., Have we been ignoring the elephant in the room Seven arguments for considering the cerebellum as part of addiction circuitry (2016) Neurosci. Biobehav. Rev., 60, pp. 1-11; 
Zubieta, J.K., Smith, Y.R., Bueller, J.A., Regional mu opioid receptor regulation of sensory and affective dimensions of pain (2001) Science., 293 (5528), pp. 311-315; 
Firestone, L.L., Gyulai, F., Mintun, M., Adler, L.J., Urso, K., Winter, P.M., Human brain activity response to fentanyl imaged by positron emission tomography (1996) Anesth. Analg., 82 (6), pp. 1247-1251; 
Schlaepfer, T.E., Strain, E.C., Greenberg, B.D., Site of opioid action in the human brain: Mu and kappa agonists' subjective and cerebral blood flow effects (1998) Am. J. Psychiatry., 155 (4), pp. 470-473; 
Jones, A.K., Qi, L.Y., Fujirawa, T., In vivo distribution of opioid receptors in man in relation to the cortical projections of the medial and lateral pain systems measured with positron emission tomography (1991) Neurosci. Lett., 126 (1), pp. 25-28; 
Frost, J.J., Wagner, H.N., Jr., Dannals, R.F., Imaging opiate receptors in the human brain by positron tomography (1985) J. Comput. Assist. Tomogr., 9, pp. 231-236; 
Oertel, B.G., Kettner, M., Scholich, K., A common human micro-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain (2009) J. Biol. Chem., 284 (10), pp. 6530-6535; 
Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal. Biochem., 72, pp. 248-254; 
Oertel, B.G., Doehring, A., Roskam, B., Genetic-epigenetic interaction modulates mu-opioid receptor regulation (2012) Hum. Mol. Genet., 21 (21), pp. 4751-4760; 
Di Francesco, A., Arosio, B., Falconi, A., Global changes in DNA methylation in Alzheimer's disease peripheral blood mononuclear cells (2015) Brain Behav. Immun., 45, pp. 139-144; 
Chorbov, V.M., Todorov, A.A., Lynskey, M.T., Cicero, T.J., Elevated levels of DNA methylation at the OPRM1 promoter in blood and sperm from male opioid addicts (2011) J. Opioid Manag., 7 (4), pp. 258-264; 
Nielsen, D.A., Yuferov, V., Hamon, S., Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts (2009) Neuropsychopharmacology., 34 (4), pp. 867-873; 
Bollati, V., Baccarelli, A., Hou, L., Changes in DNA methylation patterns in subjects exposed to low-dose benzene (2007) Cancer Res., 67 (3), pp. 876-880; 
Kile, M.L., Baccarelli, A., Tarantini, L., Hoffman, E., Wright, R.O., Christiani, D.C., Correlation of global and gene-specific DNA methylation in maternal-infant pairs (2010) PLoS ONE., 5 (10), p. e13730; 
Andria, M.L., Simon, E.J., Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation (1999) Brain Res. Mol. Brain Res., 70 (1), pp. 54-65; 
Murphy, K.P., (2012) Machine Learning: A Probabilistic Perspective, , The MIT Press, London, UK; 
Ultsch, A., Pareto density estimation: A density estimation for knowledge discovery (2003) Innovations in Classification, Data Science, and Information Systems-Proceedings 27th Annual Conference of the German Classification Society (GfKL), , Baier D, Werrnecke KD (Eds). Springer, Berlin, Germany; 
Lachin, J.M., McGee, P.L., Greenbaum, C.J., Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes (2011) PLoS ONE., 6 (11), p. e26471; 
Altman, N.S., An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression (1992) Am. Stat., 46 (3), pp. 175-185; 
Ultsch, A., Maps for visualization of high-dimensional data spaces (2003) Proceedings of the 4th Workshop on SelfOrganizing Maps (WSOM, pp. 225-230. , Information and Software Engineering Group, Kyushu, Japan; 
Ultsch, A., Sieman, H.P., Kohonen's self organizing feature maps for exploratory data analysis (1990) INNC'90, Int. Neural Network Conference, pp. 305-308. , Kluwer, Dordrecht, The Netherlands; 
Lotsch, J., Ultsch, A., Exploiting the structures of the U-matrix (2014) Advances in Intelligent Systems and Computing, pp. 248-257. , Villmann T, Schleif F-M, Kaden M, Lange M (Eds.) Springer, Heidelberg, Germany; 
Thrun, M.C., Lerch, F., Lotsch, J., Ultsch, A., Visualization and 3D printing of multivariate data of biomarkers (2016) Proceedings of International Conference in Central Europe on Computer Graphics, Visualization and Computer Vision. Computer Science Research Notes, , Plzen, Czech Republic; 
Software, , www.uni-marburg.de/fb12/datenbionik/software, Phillips Universitat Marburg; 
(2008) R: A Language and Environment for Statistical Computing, , https://cran.r-project.org, Vienna, Austria R Development Core Team; 
The Comprehensive R Archive Network, , http://CRAN.R-project.org/; 
Kruskal, W.H., Wallis, W.A., Use of ranks in one-criterion variance anaylsis (1952) J. Am. Stat. Assoc., 47 (260), pp. 583-621; 
Dunn, O.J., Multiple comparisons using rank sums (1964) Technometrics., 6 (3), pp. 241-252; 
The probable error of a mean (1908) Biometrika., 6 (1), pp. 1-25. , www.aliquote.org/cours/2012-biomed/biblio/ Student1908.pdf; 
Spearman, C., The proof and measurement of association between two things (1904) Am. J. Psychol., 15, pp. 72-101; 
Hochberg, Y., A sharper Bonferroni procedure for multiple tests of significance (1988) Biometrika., 75 (4), pp. 800-802; 
Ultsch, A., Weingart, M., Lotsch, J., 3-D printing as a tool for knowledge discovery in high dimensional data spaces (2015) Statistical Computing, pp. 12-13. , Furstberger A, Lausser L, Kraus JM, Schmid M, Kestler HA (Eds.) Universitat Ulm, Fakultat fur Ingenieurwissenschaften und Informatik, Schloss Reisensburg, Gunzburg; 
Borner, C., Martella, E., Hollt, V., Kraus, J., Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine (2012) Neuroimmunomodulation., 19 (3), pp. 180-186; 
Oertel, B.G., Kettner, M., Scholich, K., A common human mu-opioid receptor genetic variant diminishes the receptor signaling efficacy in brain regions processing the sensory information of pain (2009) J. Biol. Chem., 284 (10), pp. 6530-6535; 
Hameed, H., Hameed, M., Christo, P.J., The effect of morphine on glial cells as a potential therapeutic target for pharmacological development of analgesic drugs (2010) Curr. Pain Headache Rep., 14 (2), pp. 96-104; 
Ruzicka, B.B., Fox, C.A., Thompson, R.C., Meng, F., Watson, S.J., Akil, H., Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA (1995) Brain Res. Mol. Brain Res., 34 (2), pp. 209-220; 
Stiene-Martin, A., Zhou, R., Hauser, K.F., Regional, developmental, and cell cycle-dependent differences in , and , and -opioid receptor expression among cultured mouse astrocytes (1998) Glia., 22 (3), p. 249; 
Wen, L., Li, X., Yan, L., Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain (2014) Genome Biol., 15 (3), p. 1; 
Wei, L.N., Loh, H.H., Transcriptional and epigenetic regulation of opioid receptor genes: Present and future (2011) Annu. Rev. Pharmacol. Toxicol., 51, pp. 75-97; 
Borner, C., Hollt, V., Kraus, J., Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene (2002) Mol. Pharmacol., 61 (4), pp. 800-805; 
Kraus, J., Borner, C., Giannini, E., Hollt, V., The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene (2003) Mol. Pharmacol., 64 (4), pp. 876-884; 
Borner, C., Woltje, M., Hollt, V., Kraus, J., STAT6 transcription factor binding sites with mismatches within the canonical 5-TTCGAA-3 motif involved in regulation of deltaand mu-opioid receptors (2004) J. Neurochem., 91 (6), pp. 1493-1500; 
Borner, C., Hollt, V., Kraus, J., Cannabinoid receptor type 2 agonists induce transcription of the mu-opioid receptor gene in Jurkat T cells (2006) Mol. Phamracol., 69 (4), pp. 1486-1491; 
Ono, T., Kaneda, T., Muto, A., Yoshida, T., Positive transcriptional regulation of the human micro opioid receptor gene by poly(ADP-ribose) polymerase-1 and increase of its DNA binding affinity based on polymorphism of G-172-> T (2009) J. Biol. Chem., 284 (30), pp. 20175-20183; 
Andria, M.L., Simon, E.J., Identification of a neurorestrictive suppressor element (NRSE) in the human mu-opioid receptor gene (2001) Brain Res. Mol. Brain Res., 91 (1-2), pp. 73-80; 
Trivedi, M., Shah, J., Hodgson, N., Byun, H.M., Deth, R., Morphine induces redox-based changes in global DNA methylation and retrotransposon transcription by inhibition of excitatory amino acid transporter type 3-mediated cysteine uptake (2014) Mol. Pharmacol., 85 (5), pp. 747-757; 
Denk, F., McMahon, S.B., Chronic pain: Emerging evidence for the involvement of epigenetics (2012) Neuron., 73 (3), pp. 435-444
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85002874181&doi=10.2217%2fepi-2016-0072&partnerID=40&md5=45c780267966074266d0120a25b0a545
ER  - 

TY  - JOUR
TI  - A Spiking Neural Network Methodology and System for Learning and Comparative Analysis of EEG Data from Healthy Versus Addiction Treated Versus Addiction Not Treated Subjects
T2  - IEEE Transactions on Biomedical Engineering
J2  - IEEE Trans. Biomed. Eng.
VL  - 63
IS  - 9
SP  - 1830
EP  - 1841
PY  - 2016
DO  - 10.1109/TBME.2015.2503400
SN  - 00189294 (ISSN) 
AU  - Doborjeh, M.G.
AU  - Wang, G.Y.
AU  - Kasabov, N.K.
AU  - Kydd, R.
AU  - Russell, B.
AD  - Knowledge Engineering and Discovery Research Institute, Auckland University of Technology, Auckland, 1010, New Zealand
AD  - Faculty of Health and Environmental Science, Auckland University of Technology, New Zealand
AD  - Knowledge Engineering and Discovery Research Institute, Auckland University of Technology, New Zealand
AD  - Department of Psychological Medicine and Centre for Brain Research, University of Auckland, New Zealand
AD  - School of Pharmacy and Centre for Brain Research, University of Auckland, New Zealand
AB  - This paper introduces a method utilizing spiking neural networks (SNN) for learning, classification, and comparative analysis of brain data. As a case study, the method was applied to electroencephalography (EEG) data collected during a GO/NOGO cognitive task performed by untreated opiate addicts, those undergoing methadone maintenance treatment (MMT) for opiate dependence and a healthy control group. Methods: The method is based on an SNN architecture called NeuCube, trained on spatiotemporal EEG data. Objective: NeuCube was used to classify EEG data across subject groups and across GO versus NOGO trials, but also facilitated a deeper comparative analysis of the dynamic brain processes. Results: This analysis results in a better understanding of human brain functioning across subject groups when performing a cognitive task. In terms of the EEG data classification, a NeuCube model obtained better results (the maximum obtained accuracy: 90.91%) when compared with traditional statistical and artificial intelligence methods (the maximum obtained accuracy: 50.55%). Significance: more importantly, new information about the effects of MMT on cognitive brain functions is revealed through the analysis of the SNN model connectivity and its dynamics. Conclusion: This paper presented a new method for EEG data modeling and revealed new knowledge on brain functions associated with mental activity which is different from the brain activity observed in a resting state of the same subjects. © 1964-2012 IEEE.
KW  - EEG data
KW  - EEG data classification
KW  - Electroencephalography (EEG) comparative analysis
KW  - evolving spiking neural networks (eSNNs)
KW  - GO/NOGO tasks
KW  - methadone maintenance treatment (MMT)
KW  - NeuCube
KW  - opiate addicts
KW  - spatiotemporal brain data (STBD)
KW  - Artificial intelligence
KW  - Brain
KW  - Electroencephalography
KW  - Electrophysiology
KW  - Intelligent agents
KW  - Neural networks
KW  - Brain data
KW  - Comparative analysis
KW  - Eeg datum
KW  - Go/no-go tasks
KW  - Maintenance treatments
KW  - NeuCube
KW  - opiate addicts
KW  - Spiking neural networks
KW  - Classification (of information)
KW  - methadone
KW  - Article
KW  - artificial intelligence
KW  - artificial neural network
KW  - attention
KW  - brain function
KW  - case study
KW  - cognition
KW  - comparative study
KW  - controlled study
KW  - electroencephalography
KW  - executive function
KW  - human
KW  - learning
KW  - methadone treatment
KW  - opiate addiction
KW  - postsynaptic potential
KW  - spatiotemporal analysis
KW  - spiking neural network
KW  - visual memory
KW  - voluntary movement
KW  - adult
KW  - automated pattern recognition
KW  - brain
KW  - computer assisted diagnosis
KW  - drug effects
KW  - electroencephalography
KW  - female
KW  - machine learning
KW  - male
KW  - Opioid-Related Disorders
KW  - pathophysiology
KW  - procedures
KW  - randomized controlled trial
KW  - reproducibility
KW  - sensitivity and specificity
KW  - Adult
KW  - Brain
KW  - Cognition
KW  - Diagnosis, Computer-Assisted
KW  - Electroencephalography
KW  - Female
KW  - Humans
KW  - Machine Learning
KW  - Male
KW  - Methadone
KW  - Neural Networks (Computer)
KW  - Opioid-Related Disorders
KW  - Pattern Recognition, Automated
KW  - Reproducibility of Results
KW  - Sensitivity and Specificity
PB  - IEEE Computer Society
N1  - Cited By :22
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
C7  - 7336519
N1  - CODEN: IEBEA
C2  - 26625401
LA  - English
N1  - Correspondence Address: Doborjeh, M.G.; Knowledge Engineering and Discovery Research Institute, Auckland University of TechnologyNew Zealand; email: mgholami@aut.ac.nz
N1  - Chemicals/CAS: methadone, 1095-90-5, 125-56-4, 23142-53-2, 297-88-1, 76-99-3; Methadone
N1  - References: (2014) Electroencephalography of Surgery, 15. , http://www.surgeryencyclopedia.com/Ce-Fi/Electroencephalography.html, Sep; 
Gevins, A., Combined neuropsychological and neurophysiological assessment of drug effects on groups and individuals (2011) J. Psychopharmacol, 25 (8), pp. 1062-1075; 
Knyazev, G.G., Motivation, emotion, and their inhibitory control mirrored in brain oscillations (2007) Neurosci. Biobehav. Rev, 31 (3), pp. 377-395; 
Indiveri, G., Neuromorphic silicon neuron circuits (2011) Front. Neurosci, 5 (73), pp. 1-23; 
(2014) APT Advanced Processor Technologies Research Group, School Comput. Sci., Univ. Manchester, 10. , http://apt.cs.manchester.ac.uk/projects/SpiNNaker./, Oct [Online].Manchester, U.K. Available; 
Kasabov, N., NeuCube: A spiking neural network architecture for mapping, learning and understanding of spatio-Temporal brain data (2014) Neural Netw, 52, pp. 62-76; 
Gholami Doborjeh, M., Classification and segmentation of fMRI spatio-Temporal brain data with a NeuCube evolving spiking neural network model (2014) Proc IEEE Symp. Ser. Comput. Intell, pp. 73-80. , Orlando, FL, USA; 
Kasabov, N., Capecci, E., Spiking neural network methodology for modelling, classification and understanding of EEG spatio-Temporal data measuring cognitive processes (2015) Inf. Sci, 294, pp. 565-575; 
Benikos, N., Varying task difficulty in the Go/Nogo task: The effects of inhibitory control, arousal, and perceived effort on ERP components (2013) Int. J. Psychophysiol, 87 (3), pp. 262-272; 
Ahmadi, A., Influence of alcohol use on neural response to go/nogo task in college drinkers (2013) Neuropsychopharmacology, 38 (11), pp. 2197-2208; 
Maass, W., Real-Time computingwithout stable states: Anewframework for neural computation based on perturbations (2002) Neural Comput, 14 (11), pp. 2531-2560; 
Chan, V., AER EAR: A matched silicon cochlea pair with address event representation interface (2007) IEEE Trans. Circuits Syst, 54 (1), pp. 48-59. , Jan; 
Delbruck, T., (2007) JAER, , http://http://sourceforge.net; 
Lichtsteiner, P., A 128 128 120 dB 15 us latency asynchronous temporal contrast vision sensor (2008) IEEE J. Solid State Circuits, 43 (2), pp. 566-576. , Feb; 
Song, S., Competitive Hebbian learning through spike-Timingdependent synaptic plasticity (2000) Nature Neurosci, 3 (9), pp. 919-926; 
Dhoble, K., Online spatio-Temporal pattern recognition with evolving spiking neural networks utilising address event representation, rank order, and temporal spike learning (2012) Proc IEEE World Congr. Comput. Intell, pp. 1-7. , Brisbane, Qld., Australia; 
Verstraeten, D., An experimental unification of reservoir computing methods (2007) Neural Netw, 20 (3), pp. 391-403; 
Scott, N., NeuCube neuromorphic framework for spatio-Temporal brain data and its python implementation (2013) Neural Information Processing, pp. 78-84. , New York, NY, USA: Springer-Verlag; 
Kasabov, N., (2007) Evolving Connectionist Systems, , New York, NY, USA: Springer-Verlag; 
Wysoski, S.G., Evolving spiking neural networks for audiovisual information processing (2010) Neural Netw, 23 (7), pp. 819-835; 
Anderson, C.W., Multivariate autoregressive models for classification of spontaneous electroencephalographic signals during mental tasks (1998) IEEE Trans. Biomed. Eng, 45 (3), pp. 277-286. , Mar; 
Kasabov, N., Dynamic evolving spiking neural networks for on-line spatio-And spectro-Temporal pattern recognition (2013) Neural Netw, 41, pp. 188-201; 
Natschlager, T., Maass, W., Spiking neurons and the induction of finite state machines (2002) Theor. Comput. Sci, 287 (1), pp. 251-265; 
Tu, E., NeuCube(ST) for spatio-Temporal data predictive modelling with a case study on ecological data (2014) Proc. Int. Joint Conf. Neural Netw., Beijing, China, pp. 638-645; 
Kasabov, N., Spatio-Temporal data machines based on the Neu-Cube neuromorphic framework: Design methodology and selected applications (2015) Neural Netw; 
Koessler, L., Automated cortical projection of EEG sensors: Anatomical correlation via the international 10-10 system (2009) Neuroimage, 46 (1), pp. 64-72; 
Capecci, E., Analysis of connectivity in NeuCube spiking neural network models trained on EEG data for the understanding of functional changes in the brain:Acase study on opiate dependence treatment (2015) Neural Netw, 68, pp. 62-77; 
Marsch, L.A., The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A metaanalysis (1998) Addiction, 93 (4), pp. 515-532; 
Gibson, D.R., Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users (1999) AIDS, 13 (14), pp. 1807-1818; 
Ball, J.C., Reducing the risk of AIDS through methadone maintenance treatment (1988) J. Health Social Behavior, 29 (3), pp. 214-226; 
Wang, G.Y., Methadone maintenance treatment and cognitive function: Asystematic review (2013) CurrentDrug Abuse Rev, 6 (3), pp. 220-230; 
Wang, G.Y., Changes in restingEEGfollowing methadone treatment in opiate addicts (2015) Clin. Neurophysiol, 126 (5), pp. 943-950; 
Wang, G.Y., Quantitative EEG and low-resolution electromagnetic tomography (LORETA) imaging of patients undergoing methadone treatment for opiate addiction (2015) Clin. EEG Neurosci; 
Wang, G.Y., Auditory event-related potentials in methadone substituted opiate users (2015) J. Psychopharmacol, 29 (9), pp. 983-995; 
Kasabov, N., To spike or not to spike: A probabilistic spiking neuron model (2010) Neural Netw, 23 (1), pp. 16-19
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84984861175&doi=10.1109%2fTBME.2015.2503400&partnerID=40&md5=2f745432bb254b86a1c257199db43859
ER  - 

TY  - JOUR
TI  - Probabilistic reward- and punishment-based learning in opioid addiction: Experimental and computational data
T2  - Behavioural Brain Research
J2  - Behav. Brain Res.
VL  - 296
SP  - 240
EP  - 248
PY  - 2016
DO  - 10.1016/j.bbr.2015.09.018
SN  - 01664328 (ISSN) 
AU  - Myers, C.E.
AU  - Sheynin, J.
AU  - Balsdon, T.
AU  - Luzardo, A.
AU  - Beck, K.D.
AU  - Hogarth, L.
AU  - Haber, P.
AU  - Moustafa, A.A.
AD  - Department of Veterans Affairs, New Jersey Health Care System, East Orange, NJ, United States
AD  - Department of Pharmacology, Physiology and Neuroscience, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, United States
AD  - Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, United States
AD  - Department of Psychiatry, University of Michigan, Ann Arbor, MI, United States
AD  - School of Social Sciences and Psychology, University of Western Sydney, Sydney, NSW, Australia
AD  - School of Mathematics, Computing Sciences and Engineering at City University London, United Kingdom
AD  - School of Psychology, University of New South Wales, Sydney, NSW, Australia
AD  - School of Psychology, University of Exeter, Exeter, United Kingdom
AD  - Drug Health Services, Addiction Medicine, Central Clinical School, Royal Prince Alfred Hospital, The University of Sydney, Sydney, NSW, Australia
AD  - Marcs Institute for Brain and Behaviour, University of Western Sydney, Sydney, NSW, Australia
AB  - Addiction is the continuation of a habit in spite of negative consequences. A vast literature gives evidence that this poor decision-making behavior in individuals addicted to drugs also generalizes to laboratory decision making tasks, suggesting that the impairment in decision-making is not limited to decisions about taking drugs. In the current experiment, opioid-addicted individuals and matched controls with no history of illicit drug use were administered a probabilistic classification task that embeds both reward-based and punishment-based learning trials, and a computational model of decision making was applied to understand the mechanisms describing individuals' performance on the task. Although behavioral results showed that opioid-addicted individuals performed as well as controls on both reward- and punishment-based learning, the modeling results suggested subtle differences in how decisions were made between the two groups. Specifically, the opioid-addicted group showed decreased tendency to repeat prior responses, meaning that they were more likely to "chase reward" when expectancies were violated, whereas controls were more likely to stick with a previously-successful response rule, despite occasional expectancy violations. This tendency to chase short-term reward, potentially at the expense of developing rules that maximize reward over the long term, may be a contributing factor to opioid addiction. Further work is indicated to better understand whether this tendency arises as a result of brain changes in the wake of continued opioid use/abuse, or might be a pre-existing factor that may contribute to risk for addiction. © 2015 Elsevier B.V.
KW  - Addiction
KW  - Punishment learning
KW  - Reward learning
KW  - buprenorphine
KW  - diamorphine
KW  - methadone
KW  - actor critic model
KW  - adult
KW  - Article
KW  - behavior assessment
KW  - clinical article
KW  - computer model
KW  - controlled study
KW  - correlational study
KW  - decision making
KW  - drug dependence treatment
KW  - expectancy
KW  - female
KW  - habit
KW  - heroin dependence
KW  - human
KW  - learning
KW  - learning curve
KW  - male
KW  - middle aged
KW  - priority journal
KW  - punishment learning
KW  - reinforcement
KW  - reward learning
KW  - task performance
KW  - opiate addiction
KW  - pathophysiology
KW  - physiology
KW  - punishment
KW  - reward
KW  - Adult
KW  - Decision Making
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Opioid-Related Disorders
KW  - Probability Learning
KW  - Punishment
KW  - Reward
PB  - Elsevier B.V.
N1  - Cited By :17
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: BBRED
C2  - 26381438
LA  - English
N1  - Correspondence Address: Moustafa, A.A.Locked Bag 1797, Australia; email: a.moustafa@uws.edu.au
N1  - Chemicals/CAS: buprenorphine, 52485-79-7, 53152-21-9; diamorphine, 1502-95-0, 561-27-3; methadone, 1095-90-5, 125-56-4, 23142-53-2, 297-88-1, 76-99-3
N1  - Funding details: National Institutes of Health, NIH, R01AA018737
N1  - References: Baldacchino, A., Balfour, D.J., Passetti, F., Humphris, G., Matthews, K., Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis (2012) Neurosci. Biobehav. Rev., 36 (9), pp. 2056-2068; 
Barto, A.G., Sutton, R.S., Anderson, C.W., Neuronlike adaptive elements that can solve difficult learning control problems (1983) IEEE Trans. Syst. Man Cybern., SMC13 (5), pp. 834-846; 
Bauer, A.S., Timpe, J.C., Edmonds, E.C., Bechara, A., Tranel, D., Denburg, N.L., Myopia for the future or hypersensitivity to reward? Age-related changes in decision making on the Iowa Gambling Task (2013) Emotion, 13 (1), pp. 19-24; 
Bentzley, B.S., Barth, K.S., Back, S.E., Book, S.W., Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes (2015) J. Subst. Abuse Treat., 52, pp. 48-57; 
Bódi, N., Kéri, S., Nagy, H., Moustafa, A., Myers, C.E., Daw, N., Gluck, M.A., Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson's patients (2009) Brain, 132, pp. 2385-2395; 
Brooner, R.K., King, V.L., Kidorf, M., Schmidt, C.W., Bigelow, G.E., Psychiatric and substance use comorbidity among treatment-seeking opioid abusers (1997) Arch. Gen. Psychiatry, 54, pp. 71-80; 
Chase, H.W., Frank, M.J., Michael, A., Bullmore, E.T., Sahakian, B.J., Robbins, T.W., Approach and avoidance learning in patients with major depression and healthy controls: relation to anhedonia (2010) Psychol. Med., 40, pp. 433-440; 
Dayan, P., Balleine, B.W., Reward, motivation, and reinforcement learning (2002) Neuron, 36 (2), pp. 285-298; 
de Ruiter, M.B., Veltman, D.J., Goudriaan, A.E., Oosterlaan, J., Sjoerds, Z., van den Brink, W., Response perseveration and ventral prefrontal sensitivity to reward and punishment in male problem gamblers and smokers (2009) Neuropsychopharmacology, 34 (4), pp. 1027-1038; 
Dempster, A.P., Laird, N.M., Rubin, D.B., Maximum likelihood from incomplete data via the EM algorithm (1977) J. R. Stat. Soc.: Ser. B (Stat. Method.), 39, pp. 1-38; 
Fiorillo, C., Tobler, P., Schultz, W., Discrete coding of reward probability and uncertainty by dopamine neurons (2003) Science, 299, pp. 1898-1902; 
Frank, M.J., Moustafa, A.A., Haughey, H.M., Curran, T., Hutchison, K.E., Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning (2007) Proc. Natl. Acad. Sci. U. S. A., 104 (41), pp. 16311-16316; 
Frank, M.J., Seeberger, L., O'Reilly, R., By carrot or by stick: cognitive reinforcement learning in Parkinsonism (2004) Science, 306 (5703), pp. 1940-1943; 
Gold, J.M., Waltz, J.A., Matveeva, T.M., Kasanova, Z., Strauss, G.P., Herbener, E.S., Frank, M.J., Negative symptoms and the failure to represent the expected reward value of actions (2012) Arch. Gen. Psychiatry, 69 (2), pp. 129-138; 
Haber, S.N., Behrens, T.E., The neural network underlying incentive-based learning: implications for interpreting circuit disruptions in psychiatric disorders (2014) Neuron, 83, pp. 1019-1039; 
Herzallah, M.M., Moustafa, A.A., Natsheh, J.Y., Abdellatif, S.M., Taha, M.B., Tayem, Y.I., Gluck, M.A., Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants (2013) Front. Integr. Neurosci., 7; 
Hollerman, J., Schultz, W., Dopamine neurons report an error in the temporal prediction of reward during learning (1998) Nat. Neurosci., 1 (4), pp. 304-309; 
Huys, Q.J., Eshel, N., O'Nions, E., Sheridan, L., Dayan, P., Roiser, J.P., Bonsai trees in your head: how the Pavlovian system sculpts goal-directed choices by pruning decision trees (2012) PLoS Comput. Biol., 8, p. e1002410; 
Le Carret, N., Lafont, S., Mayo, W., Fabrigoule, C., The effect of education on cognitive performances and its implication for the constitution of the cognitive reserve (2003) Dev. Neuropsychol., 23, pp. 317-337; 
Lyvers, M., Yakimoff, M., Neuropsychological correlates of opioid dependence and withdrawal (2003) Addict. Behav., 28 (3), pp. 605-611; 
MacKay, D.J.C., (2003) Information Theory, Inference, and Learning Algorithms, , Cambridge University Press, Cambridge, UK; 
Mattfeld, A.T., Gluck, M.A., Stark, C.E.L., Functional specialization within the striatum along both the dorsal.ventral and anterior/posterior axes during associative learning via reward and punishment (2011) Learn. Mem., 18, pp. 703-711; 
Milby, J.B., Sims, M.K., Khuder, S., Schumacher, J.E., Huggins, N., McLellan, A.T., Haas, N., Psychiatric comorbidity: prevalence in methadone maintenance treatment (1996) Am. J. Drug Alcohol Abuse, 22, pp. 95-107; 
Moustafa, A.A., Gluck, M.A., Herzallah, M.M., Myers, C.E., The influence of trial order on learning from reward vs. punishment in a probabilistic categorization task: experimental and computational analysis (2015) Front. Behav. Neurosci., 9, p. 153; 
Myers, C.E., Moustafa, A.A., Sheynin, J., VanMeenen, K., Gilbertson, M.W., Orr, S.P., Servatius, R.J., Learning to obtain reward, but not avoid punishment, is affected by presence of PTSD symptoms in male veterans: empirical data and computational model (2013) PLoS One, 8 (8), p. e72508; 
Petry, N.M., Bickel, W.K., Arnett, M., Shortened time horizons and insensitivity to future consequences in heroin addicts (1998) Addiction, 93 (5), pp. 729-738; 
Piray, P., Zeighami, Y., Bahrami, F., Eissa, A.M., Hewedi, D.H., Moustafa, A.A., Impulse control disorders in Parkinson's disease are associated with dysfunction in stimulus valuation but not action valuation (2014) J. Neurosci., 34 (23), pp. 7814-7824; 
Prevost, C., McCabe, J.A., Jessup, R.K., Bossaerts, P., O'Doherty, J.P., Differential contributions of human amygdalar subregions in the computations underlying reward and avoidance learning (2011) Eur. J. Neurosci., 34, pp. 134-145; 
Rutledge, R.B., Lazzaro, S.C., Lau, B., Myers, C.E., Gluck, M.A., Glimcher, P.W., Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task (2009) J. Neurosci., 29, pp. 15104-15114; 
Schiltenwolf, M., Akbar, M., Hug, A., Pfüller, U., Gantz, S., Neubauer, E., Wang, H., Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids (2014) Pain Physician, 17 (1), pp. 9-20; 
Schultz, W., Predictive reward signal of dopamine neurons (1998) J. Neurophysiol., 80, pp. 1-27; 
Sheynin, J., Moustafa, A.A., Beck, K.D., Servatius, R.J., Casbolt, P., Haber, P., Myers, C.E., Exaggerated acquisition and resistance to extinction of avoidance behavior in heroin-dependent males (but not females) (2016) J. Clin. Psychiatry, , in press, to appear; 
Sheynin, J., Moustafa, A.A., Beck, K.D., Servatius, R.J., Myers, C.E., Testing the role of reward and punishment sensitivity in avoidance behavior: a computational modeling approach (2015) Behav. Brain Res., 283, pp. 121-138; 
Sheynin, J., Shikari, S., Gluck, M.A., Moustafa, A.A., Servatius, R.J., Myers, C.E., Enhanced avoidance learning in behaviorally-inhibited young men and women (2013) Stress, 16 (3), pp. 289-299; 
Simon, J.R., Howard, J.H., Howard, D.V., Adult age differences in learning from positive and negative probabilistic feedback (2010) Neuropsychology, 24 (4), pp. 534-541; 
Smyth, B.P., Barry, J., Keenan, E., Ducray, K., Lapse and relapse following inpatient treatment of opiate dependence (2010) Ir. Med. J., 103 (6), pp. 176-179; 
Somlai, Z., Moustafa, A.A., Keri, S., Myers, C.E., Gluck, M.A., General functioning predicts reward and punishment learning in schizophrenia (2011) Schizophr. Res., 127 (1-3), pp. 131-136; 
Spanagel, R., Herz, A., Shippenberg, T.S., Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway (1992) Proc. Natl. Acad. Sci. U. S. A., 89 (6), pp. 2046-2050; 
Strain, E.C., Assessment and treatment of comorbid psychiatric disorders in opioid dependent patients (2002) Clin. J. Pain, 18, pp. S14-S27; 
Sutton, R.S., Learning to predict by the methods of temporal differences (1988) Mach. Learn., 3, pp. 9-44; 
Sutton, R.S., Barto, A.G., (1998) Reinforcement Learning: An Introduction, , MIT Press, Cambridge, MA; 
van Ree, J.M., Gerrits, M.A., Vanderschuren, L.J., Opioids, reward and addiction: an encounter of biology, psychology, and medicine (1999) Pharmacol. Rev., 51 (2), pp. 341-396; 
Vassileva, J., Ahn, W.Y., Weber, K.M., Busemeyer, J.R., Stout, J.C., Gonzalez, R., Cohen, M.H., Computational modeling reveals distinct effects of HIV and history of drug use on decision-making processes in women (2013) PLoS One, 8 (8), p. e68962; 
Volkow, N.D., Fowler, J.S., Wang, J.J., Swanson, J.M., Dopamine in drug abuse and addiction: results from imaging studies and treatment implications (2004) Mol. Psychiatry, 9 (6), pp. 557-569; 
Watkins, C.J.C.H., Dayan, P., Q-learning (1992) Mach. Learn., 8, pp. 279-292; 
Whitton, A.E., Treadway, M.T., Pizzagalli, D.A., Reward processing dysfunction in major depression, bipolar disorder and schizophrenia (2015) Curr. Opin. Psychiatry, 28, pp. 7-12; 
Widrow, B., Gupta, N., Maitra, S., Punish/reward: learning with a critic in adaptive systems (1973) IEEE Transactions on Systems, Man and Cybernetics, SMC-3, 5, pp. 455-465; 
Woicik, P.A., Urban, C., Alia-Klein, N., Henry, A., Maloney, T., Telang, F., Goldstein, R.Z., A pattern of perseveration in cocaine addiction may reveal neurocognitive processes implicit in the Wisconsin Card Sorting Test (2011) Neuropsychologia, 49 (7), pp. 1660-1669; 
Liang, C.S., Ho, P.S., Yen, C.H., Kuo, S.C., Huang, C.C., Chen, C.Y., Huang, S.Y., (2014) Reduced striatal dopamine transporter density associated with working memory deficits in opioid-dependent male subjects: a SPECT study, , Addiction Biology, 2014, [epub ahead of print]; 
Vo, H.T., Schacht, R., Mintzer, M., Fishman, M., Working memory impairment in cannabis- and opioid-dependent adolescents (2014) Substance Abuse, 35 (4), pp. 387-390
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84945588633&doi=10.1016%2fj.bbr.2015.09.018&partnerID=40&md5=f483dc6e39c115444deb30f2b0f09c64
ER  - 

TY  - JOUR
TI  - Biomarkers to predict opioid analgesia, a most difficult conundrum: Commentary on a paper by Gram et al.
T2  - European Journal of Pain (United Kingdom)
J2  - Eur. J. Pain
VL  - 19
IS  - 10
SP  - 1387
EP  - 1388
PY  - 2015
DO  - 10.1002/ejp.776
SN  - 10903801 (ISSN) 
AU  - Plaghki, L.
AD  - Institute of Neuroscience (IoNS), Faculty of Medicine, Université Catholique de Louvain, Brussels, Belgium
KW  - biological marker
KW  - opiate
KW  - narcotic analgesic agent
KW  - analgesia
KW  - analgesic activity
KW  - cold pressor test
KW  - electroencephalogram
KW  - experimental pain
KW  - genetic variability
KW  - headache
KW  - human
KW  - musculoskeletal pain
KW  - neuroimaging
KW  - neuropathic pain
KW  - Note
KW  - postoperative pain
KW  - prediction
KW  - priority journal
KW  - support vector machine
KW  - analgesia
KW  - opiate addiction
KW  - Analgesia
KW  - Analgesics, Opioid
KW  - Biomarkers
KW  - Humans
KW  - Opioid-Related Disorders
PB  - Blackwell Publishing Ltd
N1  - Export Date: 13 November 2019
M3  - Note
DB  - Scopus
N1  - CODEN: EJPAF
C2  - 26447815
LA  - English
N1  - Correspondence Address: Plaghki, L.; Institute of Neuroscience (IoNS), Faculty of Medicine, Université Catholique de LouvainBelgium
N1  - Chemicals/CAS: opiate, 53663-61-9, 8002-76-4, 8008-60-4; Analgesics, Opioid; Biomarkers
N1  - References: Gram, M., Graversen, C., Olesen, A.E., Drewes, A.M., Machine learning on encephalographic activity may predict opioid analgesia (2015) Eur J Pain, 19, pp. 1552-1561; 
Grosen, K., Fischer, I.W., Olesen, A.E., Drewes, A.M., Can quantitative sensory testing predict responses to analgesic treatment? (2013) Eur J Pain, 17, pp. 1267-1280; 
Statnikov, A., Aliferis, C.F., Hardin P. D, G.I., (2011) A Gentle Introduction to Support Vector Machines in Biomedicine, Volume 1: Theory and Methods, , (Singapore: World Scientific Publishing Co. Pte. Ltd.)
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84943644999&doi=10.1002%2fejp.776&partnerID=40&md5=5f5e94bfbcd866bb7183813dd9cc63b4
ER  - 

TY  - SER
TI  - Pharmacologic treatments for esophageal disorders
T2  - Annals of the New York Academy of Sciences
J2  - Ann. New York Acad. Sci.
VL  - 1325
IS  - 1
SP  - 23
EP  - 39
PY  - 2014
DO  - 10.1111/nyas.12520
SN  - 00778923 (ISSN) 
AU  - Blackshaw, L.A.
AU  - Bordin, D.S.
AU  - Brock, C.
AU  - Brokjaer, A.
AU  - Drewes, A.M.
AU  - Farmer, A.D.
AU  - Krarup, A.L.
AU  - Lottrup, C.
AU  - Masharova, A.A.
AU  - Moawad, F.J.
AU  - Olesen, A.E.
AD  - Centre for Digestive Diseases, Blizard Institute of Cell and Molecular Science, Wingate Institute of Neurogastroenterology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
AD  - Central Research Institute of Gastroenterology, Moscow, Russian Federation
AD  - Department of Medical Gastroenterology, Aalborg University Hospital, Aalborg, Denmark
AD  - Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, United States
AB  - The following, from the 12th OESO World Conference: Cancers of the Esophagus, includes commentaries on the role for ketamine and other alternative treatments in esophageal disorders; the use of linaclotide in the treatment of esophageal pain; the alginate test as a diagnostic criterion in gastroesophageal reflux disease (GERD); the use of baclofen in treatment of GERD; the effects of opioids on the esophagus; the use of antagonists on the receptor level in GERD; the effect of local formulation of drugs on the esophageal mucosa; and the use of electroencephalographic fingerprints to predict the effect of pharmacological treatment. © 2014 New York Academy of Sciences.
KW  - Alginate test
KW  - Baclofen
KW  - EEG
KW  - Esophagus
KW  - Gastroesophageal reflux disease
KW  - Ketamine
KW  - Linaclotide
KW  - OESO
KW  - Opiods
KW  - Pharmacology
KW  - analgesic agent
KW  - antidepressant agent
KW  - baclofen
KW  - biological marker
KW  - budesonide
KW  - digestive tract agent
KW  - fluticasone
KW  - ketamine
KW  - linaclotide
KW  - opiate
KW  - purinergic P2X receptor agonist
KW  - vanilloid receptor 1 antagonist
KW  - baclofen
KW  - linaclotide
KW  - narcotic analgesic agent
KW  - peptide
KW  - purinergic receptor blocking agent
KW  - alginate test
KW  - analgesia
KW  - antinociception
KW  - Article
KW  - binding site
KW  - chewing gum
KW  - constipation
KW  - diagnostic procedure
KW  - drug absorption
KW  - drug delivery system
KW  - drug effect
KW  - drug formulation
KW  - electroencephalography
KW  - eosinophilic esophagitis
KW  - esophageal pH monitoring
KW  - esophagus cancer
KW  - esophagus disease
KW  - esophagus mucosa
KW  - esophagus pain
KW  - finger dermatoglyphics
KW  - gastroesophageal reflux
KW  - gastrointestinal motility
KW  - heartburn
KW  - human
KW  - in vitro study
KW  - in vivo study
KW  - intestinal secretion
KW  - lower esophagus sphincter pressure
KW  - lozenge
KW  - myenteric plexus
KW  - nonhuman
KW  - off label drug use
KW  - prescription
KW  - reflux esophagitis
KW  - sitting
KW  - supine position
KW  - treatment outcome
KW  - animal
KW  - drug effects
KW  - Esophageal Diseases
KW  - gastroesophageal reflux
KW  - intestine innervation
KW  - pain
KW  - pathology
KW  - Analgesics, Opioid
KW  - Animals
KW  - Baclofen
KW  - Enteric Nervous System
KW  - Esophageal Diseases
KW  - Gastroesophageal Reflux
KW  - Humans
KW  - Pain
KW  - Peptides
KW  - Purinergic Antagonists
KW  - Treatment Outcome
PB  - Blackwell Publishing Inc.
N1  - Cited By :3
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: ANYAA
C2  - 25266012
LA  - English
N1  - Chemicals/CAS: baclofen, 1134-47-0; budesonide, 51333-22-3, 51372-29-3; fluticasone, 90566-53-3; ketamine, 1867-66-9, 6740-88-1, 81771-21-3; linaclotide, 851199-59-2, 851199-60-5; opiate, 53663-61-9, 8002-76-4, 8008-60-4; Analgesics, Opioid; Baclofen; linaclotide; Peptides; Purinergic Antagonists
N1  - References: Park, S.W., Lee, H., Lee, H.J., Low-dose amitriptyline combined with proton pump inhibitor for functional chest pain (2013) World J. Gastroenterol., 19, pp. 4958-4965; 
Holloway, R.H., Systemic pharmacomodulation of transient lower esophageal sphincter relaxations (2001) Am. J. Med., 111, pp. 178S-185S; 
Bell, R.F., Ketamine for chronic non-cancer pain (2009) Pain, 141, pp. 210-214; 
Noppers, I., Niesters, M., Aarts, L., Ketamine for the treatment of chronic non-cancer pain (2010) Expert Opin. Pharmacother., 11, pp. 2417-2429; 
Bouwense, S.A.W., Buscher, H.C.J.L., van Goor, H., Wilder-Smith, O.H.G., S-Ketamine modulates hyperalgesia in patients with chronic pancreatitis pain (2011) Reg. Anesth. Pain Med., 36, pp. 303-307; 
Strigo, I.A., Duncan, G.H., Bushnell, C., The effects of racemic ketamine on painful stimulation of skin and viscera in human subjects (2005) Pain, 113, pp. 255-264; 
Willert, R.P., Woolf, C.J., Hobson, A.R., The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor (2004) Gastroenterol, 126, pp. 683-692; 
Rao, S.S., Mudipalli, R.S., Remes-Troche, J.M., Theophylline improves esophageal chest pain-a randomized, placebo-controlled study (2007) Am. J. Gastroenterol., 10, pp. 930-938; 
Field, M., Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine (1978) Proc. Nat. Acad. Sci. USA, 75, pp. 2800-2804; 
Roque, M.V., Camilleri, M., Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation (2011) Expert Rev. Gastroenterol. Hepatol., 5, pp. 301-310; 
Lembo, A.J., Two randomized trials of linaclotide for chronic constipation (2011) N. Engl. J. Med., 365, pp. 527-536; 
Chey, W.D., Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety (2012) Am. J. Gastroenterol., 107, pp. 1702-1712; 
Rao, S., A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation (2012) Am. J. Gastroenterol., 107, pp. 1714-1724. , quiz p 1725; 
Sager, G., Cyclic GMP transporters (2004) Neurochem. Int., 45, pp. 865-873; 
Silos-Santiago, I., Gastrointestinal pain: unraveling a novel endogenous pathway through uroguanylin/guanylate cyclase-C/cGMP activation (2013) Pain., 154, pp. 1820-1830; 
Castro, J., Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate (2013) Gastroenterology., 145, pp. e1-11; 
Debruyne, P.R., Bile acids induce ectopic expression of intestinal guanylyl cyclase C Through nuclear factor-kappaB and Cdx2 in human esophageal cells (2006) Gastroenterology, 130, pp. 1191-1206; 
Hak, N.G., Acid and bile reflux in erosive reflux disease, non-erosive reflux disease and Barrett's esophagus (2008) Hepato-gastroenterology, 55, pp. 442-447; 
Vakil, N., van Zanden, S.V., Kahrilas, P., The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus (2006) Am. J. Gastroenterol., 101, pp. 1900-1920; 
Gasiorowska, A., Fass, R., The proton pump inhibitor (PPI) test in GERD: does it still have a role (2008) J. Clin. Gastroenterol., 42 (8), pp. 867-874; 
Tytgat, G.N., McColl, K., Tack, J., New algorithm for the treatment of gastro-oesophageal reflux disease (2008) Aliment. Pharmacol. Ther., 27, pp. 249-256; 
Sifrim, D., Zebrib, F., Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors (2012) Gut, 61, pp. 1340-1354; 
Holloway, R.H., Hongo, M., Berger, K., McCallum, R.W., Gastric distention: a mechanism for post-prandial gastroesophageal reflux (1985) Gastroenterology, 89, pp. 779-784; 
Lee, K.J., Vos, R., Janssens, J., Tack, J., Differential effects of baclofen on lower esophageal sphincter pressure and proximal gastric motility in humans (2003) Aliment Pharmacol. Ther., 18, pp. 199-207; 
Ciccaglione, A.F., Marzio, L., Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastrooesophageal reflux disease (2003) Gut, 52, pp. 464-470; 
Cossentino, M.J., Mann, K., Armbruster, S.P., Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux-a randomised prospective study (2012) Aliment Pharmacol. Ther., 35, pp. 1035-1044; 
Orr, W.C., Goodrich, S., Wright, S., The effect of baclofen on nocturnal gastroesophageal reflux and measures of sleep quality: a randomized, cross-over trial (2012) Neurogastroenterol. Motil., 24, pp. 553-559; 
Koek, G.H., Sifrim, D., Lerut, T., Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors (2003) Gut, 52, pp. 1397-1402; 
Gerson, L.B., Huff, F.J., Hila, A., Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease (2010) Am. J. Gastroenterol., 105, pp. 1266-1275; 
Vakil, N.B., Huff, F.J., Bian, A., Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study (2011) Am. J. Gastroenterol., 106, pp. 1427-1438; 
Vakil, N.B., Huff, F.J., Cundy, K.C., Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease-insights into study design for transient lower sphincter relaxation inhibitors (2013) Aliment Pharmacol. Ther., 38, pp. 107-117; 
Brock, C., Olesen, S.S., Olesen, A.E., Opioid-induced bowel dysfunction: pathophysiology and management (2012) Drugs, 72 (14), pp. 1847-1865. , available from: PM:22950533; 
Sarna, S.K., Otterson, M.F., Small intestinal amyogenesia and dysmyogenesia induced by morphine and loperamide (1990) Am. J. Physiol., 258 (2), pp. G282-G289; 
Wood, J.D., Galligan, J.J., Function of opioids in the enteric nervous system (2004) Neurogastroenterol. Motil., 16 (Suppl 2), pp. 17-28; 
Kraichely, R.E., Arora, A.S., Murray, J.A., Opiate-induced oesophageal dysmotility (2010) Aliment Pharmacol. Ther., 31 (5), pp. 601-606; 
Storr, M., Geisler, F., Neuhuber, W.L., Endomorphin-1and-2, endogenous ligands for the mu-opioid receptor, inhibit striated and smooth muscle contraction in the rat oesophagus (2000) Neurogastroenterol. Motil., 12 (5), pp. 441-448; 
Dowlatshahi, K., Evander, A., Walther, B., Skinner, D.B., Influence of morphine on the distal oesophagus and the lower oesophageal sphincter-a manometric study (1985) Gut, 26 (8), pp. 802-806; 
Mittal, R.K., Frank, E.B., Lange, R.C., McCallum, R.W., Effects of morphine and naloxone on esophageal motility and gastric emptying in man (1986) Dig. Dis. Sci., 31 (9), pp. 936-942; 
Penagini, R., Picone, A., Bianchi, P.A., Effect of morphine and naloxone on motor response of the human esophagus to swallowing and distension (1996) Am. J. Physiol., 271 (4), pp. G675-G680; 
Thoren, T., Carlsson, E., Sandmark, S., Wattwil, M., Effects of thoracic epidural analgesia with morphine or bupivacaine on lower oesophageal motility-an experimental study in man (1988) Acta. Anaesthesiol. Scand., 32, pp. 391-394; 
Holzer, P., Taste receptors in the gastrointestinal tract. V. Acid sensing in the gastrointestinal tract (2007) Am. J. Physiol. Gastrointest. Liver Physiol., 292, pp. G699-G705; 
Holzer, P., Acid-sensitive ion channels in gastrointestinal function (2003) Curr. Opin. Pharmacol., 3, pp. 618-625; 
Guarino, M.P., Cheng, L., Ma, J., Increased TRPV1 gene expression in esophageal mucosa of patients with non-erosive and erosive reflux disease (2010) Neurogastroenterol. Motil., 22, pp. 746-751; 
Chizh, B.A., O'Donnell, M.B., Napolitano, A., The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans (2007) Pain, 132, pp. 132-141; 
Quiding, H., Jonzon, B., Svensson, O., TRPV1 antagonistic analgesic effect: a randomized study of AZD1386 in pain after third molar extraction (2013) Pain, 154, pp. 808-812; 
Gavva, N.R., Treanor, J.J., Garami, A., Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans (2008) Pain, 136, pp. 202-210; 
Krarup, A.L., Ny, L., Astrand, M., Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain (2011) Aliment Pharmacol. Ther., 33, pp. 1113-1122; 
Krarup, A.L., Ny, L., Gunnarsson, J., Randomized clinical trial: inhibition of the TRPV1 system in patients with nonerosive gastroesophageal reflux disease and a partial response to PPI treatment is not associated with analgesia to esophageal experimental pain (2013) Scand. J. Gastroenterol., 48, pp. 274-284; 
North, R.A., Jarvis, M.F., P2X receptors as drug targets (2013) Mol. Pharmacol., 83, pp. 759-769; 
Batchelor, H., Bioadhesive dosage forms for esophageal drug delivery (2005) Pharm. Res., 22, pp. 175-181; 
Gaucher, G., Satturwar, P., Jones, M.C., Polymeric micelles for oral drug delivery (2010) Eur. J. Pharm. Biopharm., 76, pp. 147-158; 
Tang, M., Dettmar, P., Batchelor, H., Bioadhesive oesophageal bandages: protection against acid and pepsin injury (2005) Int. J. Pharm., 292, pp. 169-177; 
Zur, E., Eosinophilic esophagitis: treatment with oral viscous budesonide (2012) Int. J. Pharm. Compd., 16, pp. 288-293; 
Dellon, E.S., Sheikh, A., Speck, O., Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis (2012) Gastroenterology, 143, pp. 321-324; 
Dellon, E.S., Gonsalves, N., Hirano, I., ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE) (2013) Am. J. Gastroenterol., 108, pp. 679-692; 
Prieto, R., Richter, J.E., Eosinophilic esophagitis in adults: an update on medical management (2013) Curr. Gastroenterol. Rep., 15, pp. 324013-03246; 
Lottrup, C., Krarup, A., Drewes, A., (2013), Esophageal acid clearance in Barrett's esophagus [abstract]. 12th OESO World Congress; Castell, D., What are the most recent data on alginates (1994) The Esophageal Mucosa. 300 Questions-300 Answers, , In . Giuli, R., G. Tytgat, T. DeMeester, Eds. Elsevier; 
Moawad, F.J., Veerappan, G.R., Dias, J.A., Randomized controlled trial comparing aerosolized swallowed fluticasone to esomeprazole for esophageal eosinophilia (2013) Am. J. Gastroenterol., 108, pp. 366-372; 
Cook, I.A., Leuchter, A.F., Morgan, M., Early changes in prefrontal activity characterize clinical responders to antidepressants (2002) Neuropsychopharmacology, 27, pp. 120-131; 
Bares, M., Brunovsky, M., Kopecek, M., Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study (2007) J. Psychiatr. Res., 41, pp. 319-325; 
Leuchter, A.F., Cook, I.A., Gilmer, W.S., Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder (2009) Psychiatry. Res., 169, pp. 132-138; 
Leuchter, A.F., Cook, I.A., Marangell, L.B., Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study (2009) Psychiatr. Res., 169, pp. 124-131; 
Ulrich, G., Haug, H.J., Stieglitz, R.D., Fahndrich, E., EEG characteristics of clinically defined on-drug-responders and non-responders-a comparison clomipramine vs. maprotiline (1988) Pharmacopsychiatry, 21, pp. 367-368; 
Iosifescu, D.V., Greenwald, S., Devlin, P., Frontal EEG predictors of treatment outcome in major depressive disorder (2009) Eur. Neuropsychopharmacol., 19, pp. 772-777; 
Knott, V., Mahoney, C., Kennedy, S., Evans, K., Pre-treatment EEG and it's relationship to depression severity and paroxetine treatment outcome (2000) Pharmacopsychiatry, 33, pp. 201-205; 
Bruder, G.E., Stewart, J.W., Tenke, C.E., Electroencephalographic and perceptual asymmetry differences between responders and nonresponders to an SSRI antidepressant (2001) Biol. Psychiatr., 49, pp. 416-425; 
Khodayari-Rostamabad, A., Reilly, J.P., Hasey, G.M., A machine learning approach using EEG data to predict response to SSRI treatment for major depressive disorder (2013) Clin. Neurophysiol., 124, pp. 1975-1985; 
Kumar, A.R., Katz, P.O., Functional esophageal disorders: a review of diagnosis and management (2013) Expert Rev. Gastroenterol. Hepatol., 7, pp. 453-461; 
Fass, R., Sifrim, D., Management of heartburn not responding to proton pump inhibitors (2009) Gut, 58, pp. 295-309; 
Eherer, A.J., Netolitzky, F., Högenauer, C., Positive effect of abdominal breathing exercise on gastroesophageal reflux disease: a randomized, controlled study (2012) Am. J. Gastroenterol., 107, pp. 372-378; 
Sifrim, D., Zebrib, F., Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors (2012) Gut, 61, pp. 1340-1354; 
Cannon, R.O., III, Quyyumi, A.A., Mincemoyer, R., Imipramine in patients with chest pain despite normal coronary angiograms (1994) N. Engl. J. Med., 330, pp. 1411-1417; 
Peghini, P.L., Katz, P.O., Castell, D.O., Imipramine decreases oesophageal pain perception in human male volunteers (1998) Gut, 42, pp. 807-813; 
Clouse, R.E., Lustman, P.J., Eckert, T.C., Low-dose trazadone for symptomatic patients with esophageal contraction abnormalities (1987) Gastroenterology, 92, pp. 1027-1036; 
Nguyen, T.M., Eslick, G.D., Systematic review: the treatment of noncardiac chest pain with antidepressants (2012) Aliment Pharmacol. Ther., 35, pp. 493-500; 
Lee, H., Kim, J.H., Min, B.H., Efficacy of venlafaxine for symptomatic relief in young adult patients with functional chest pain: a randomized, double-blinded, placebo-controlled, crossover trial (2010) Am. J. Gastroenterol., 105, pp. 1504-1512
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84926123232&doi=10.1111%2fnyas.12520&partnerID=40&md5=ceff13b80982163710b970f04c7af667
ER  - 

TY  - JOUR
TI  - Putative kappa opioid heteromers as targets for developing analgesics free of adverse effects
T2  - Journal of Medicinal Chemistry
J2  - J. Med. Chem.
VL  - 57
IS  - 15
SP  - 6383
EP  - 6392
PY  - 2014
DO  - 10.1021/jm500159d
SN  - 00222623 (ISSN) 
AU  - Le Naour, M.
AU  - Lunzer, M.M.
AU  - Powers, M.D.
AU  - Kalyuzhny, A.E.
AU  - Benneyworth, M.A.
AU  - Thomas, M.J.
AU  - Portoghese, P.S.
AD  - Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, WDH 8-114, 308 Harvard Street SE, Minneapolis, MN 55455, United States
AD  - Department of Neuroscience, University of Minnesota, Minneapolis, MN 55455, United States
AD  - NINDS Mouse Behavioral Phenotyping Core, University of Minnesota, Minneapolis, MN 55455, United States
AB  - It is now generally recognized that upon activation by an agonist, β-arrestin associates with G protein-coupled receptors and acts as a scaffold in creating a diverse signaling network that could lead to adverse effects. As an approach to reducing side effects associated with κ opioid agonists, a series of β-naltrexamides 3-10 was synthesized in an effort to selectively target putative κ opioid heteromers without recruiting β-arrestin upon activation. The most potent derivative 3 (INTA) strongly activated KOR-DOR and KOR-MOR heteromers in HEK293 cells. In vivo studies revealed 3 to produce potent antinociception, which, when taken together with antagonism data, was consistent with the activation of both heteromers. 3 was devoid of tolerance, dependence, and showed no aversive effect in the conditioned place preference assay. As immunofluorescence studies indicated no recruitment of β-arrestin2 to membranes in coexpressed KOR-DOR cells, this study suggests that targeting of specific putative heteromers has the potential to identify leads for analgesics devoid of adverse effects. © 2014 American Chemical Society.
KW  - analgesic agent
KW  - beta arrestin
KW  - beta arrestin 2
KW  - delta opiate receptor
KW  - inta
KW  - kappa opiate receptor
KW  - kappa opiate receptor agonist
KW  - morphine
KW  - naloxone
KW  - naltrexamine derivative
KW  - opiate agonist
KW  - salvinorin A
KW  - unclassified drug
KW  - 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-((2′-indolyl)acetamido)morphinan
KW  - analgesic agent
KW  - beta arrestin
KW  - calcium
KW  - delta opiate receptor
KW  - indole derivative
KW  - kappa opiate receptor
KW  - mu opiate receptor
KW  - naltrexone
KW  - retina S antigen
KW  - analgesia
KW  - animal experiment
KW  - antinociception
KW  - article
KW  - cell membrane
KW  - conditioned place preference test
KW  - controlled study
KW  - drug design
KW  - drug potency
KW  - drug selectivity
KW  - drug synthesis
KW  - drug targeting
KW  - HEK293 cell line
KW  - human
KW  - human cell
KW  - immunofluorescence
KW  - in vitro study
KW  - in vivo study
KW  - male
KW  - mouse
KW  - nonhuman
KW  - protein expression
KW  - agonists
KW  - analogs and derivatives
KW  - animal
KW  - avoidance behavior
KW  - chemistry
KW  - drug effects
KW  - drug tolerance
KW  - metabolism
KW  - protein multimerization
KW  - stereoisomerism
KW  - structure activity relation
KW  - Substance-Related Disorders
KW  - Analgesics
KW  - Animals
KW  - Arrestins
KW  - Avoidance Learning
KW  - Calcium
KW  - Drug Tolerance
KW  - HEK293 Cells
KW  - Humans
KW  - Indoles
KW  - Mice
KW  - Naltrexone
KW  - Protein Multimerization
KW  - Receptors, Opioid, delta
KW  - Receptors, Opioid, kappa
KW  - Receptors, Opioid, mu
KW  - Stereoisomerism
KW  - Structure-Activity Relationship
KW  - Substance-Related Disorders
PB  - American Chemical Society
N1  - Cited By :20
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: JMCMA
C2  - 24978316
LA  - English
N1  - Correspondence Address: Portoghese, P.S.; Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, WDH 8-114, 308 Harvard Street SE, Minneapolis, MN 55455, United States; email: porto001@umn.edu
N1  - Chemicals/CAS: morphine, 52-26-6, 57-27-2; naloxone, 357-08-4, 465-65-6; calcium, 7440-70-2, 14092-94-5; naltrexone, 16590-41-3, 16676-29-2; retina S antigen, 113315-03-0; 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-((2′-indolyl)acetamido)morphinan; Analgesics; Arrestins; beta-arrestin; Calcium; Indoles; Naltrexone; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu
N1  - Funding details: National Institutes of Health, NIH, DA030316
N1  - Funding details: National Institutes of Health, NIH, NS062158
N1  - References: Milligan, G., G protein-coupled receptor dimerization: Function and ligand pharmacology (2004) Mol. Pharmacol., 66, pp. 1-7; 
Rachid, A.J., O'Dowd, B.F., George, S.R., Diversity and complexity of signaling though peptidergic G protein-coupled receptors (2005) Endocrinology, 145, pp. 2645-2652; 
Hiller, C., Kuehhorn, J., Gmeiner, P., Class A G protein-coupled receptor (GPCR) dimers and bivalent ligands (2013) J. Med. Chem., 56 (17), pp. 6542-6559; 
Ferre, S., Baler, R., Bouvier, M., Caron, M.G., Devi, L.A., Durroux, T., Fuxe, K., Franco, R., Building a new conceptual framework for receptor heteromers (2009) Nature Chem. Biol., 5, pp. 131-134; 
Angers, S., Salahpour, A., Bouvier, M., Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function (2002) Annu. Rev. Pharmacol. Toxicol., 42, pp. 409-435; 
Gomes, I., Jordan, B.A., Gupta, A., Rios, C., Trapaidze, N., Devi, L.A., G protein-coupled receptor dimerization: Implications in modulating receptor function (2001) J. Mol. Med., 79, pp. 226-242; 
Jordan, B.A., Devi, L.A., G protein-coupled receptor heterodimerization modulates receptor function (1999) Nature, 399, pp. 697-700; 
Gomes, I., Jordan, B.A., Gupta, A., Trapaidze, N., Nagy, V., Devi, L.A., Heterodimerization of mu and delta opioid receptors: A role in opiate synergy (2000) J. Neurosci., 20 (22), pp. 110/1-RC110/5; 
Gomes, I., Gupta, A., Filipovska, J., Szeto, H.H., Pintar, J.E., Devi, L.A., A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia (2004) Proc. Natl. Acad. Sci. U. S. A., 101, pp. 5135-5139; 
Chakrabarti, S., Liu, N.-J., Gintzler, A.R., Formation of opioid receptor heterodimer is sex-dependent and mediates female-specific opioid analgesia (2010) Proc. Natl. Acad. Sci. U. S. A., 107 (46), pp. 20115-20119; 
Ong, E.W., Cahill, C.M., Molecular perspectives for mu/delta opioid receptor heteromers as distinct, functional receptors (2014) Cells, 3 (1), pp. 152-179; 
Constantino, C.M., Gomes, I., Stockton, S.D., Lim, M.P., Devi, L.A., Opioid receptor heteromers in analgesia (2012) Expert Rev. Mol. Med., 14, p. 9; 
George, S.R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., O'Dowd, B.F., Oligomerization of mu-and delta-opioid receptors. Generation of novel functional properties (2000) J. Biol. Chem., 275, pp. 26128-26135; 
George, S.R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., O'Dowd, B.F., Oligomerization of mu-and delta-opioid receptors. Generation of novel functional properties (2000) J. Biol. Chem., 275, pp. 26128-26135; 
Gomes, I., Filipovska, J., Jordan, B.A., Devi, L.A., Oligomerization of opioid receptors (2002) Methods, 27, pp. 358-365; 
Wang, D., Sun, X., Bohn, L.M., Sade, W., Opioid receptor homo-and heterodimerization in living cells by quantitative bioluminescence resonance energy transfer (2005) Mol. Pharmacol., 67, pp. 2173-2184; 
Khelashvili, G., Dorff, K., Shan, J., Camacho-Artacho, M., Skrabanek, L., Vroling, B., Bouvier, M., Filizola, M., GPCR-OKB: The G protein-coupled receptor oligomer knowledge base (2010) Bioinformatics, 26, pp. 1804-1805; 
Ritter, S.L., Hall, R.A., Fine-tuning of GPCR activity by receptor-interacting proteins (2009) Nature Rev. Mol. Cell Biol., 10, pp. 819-830; 
Hoffmann, C., Zürn, A., Bünemann, M., Lohse, M.J., Conformational changes in G protein-coupled receptors: The quest for functionally selective conformations is open (2008) Br. J. Pharmacol., 153, pp. 358-S366; 
Kenakin, T.P., Biased signalling and allosteric machines: New vistas and challenges for drug discovery (2012) Br. J. Pharmacol., 165, pp. 1659-1669; 
Kenakin, T., Christopoulos, A., Signalling bias in new drug discovery: Detection, quantification and therapeutic impact (2013) Nature Rev. Drug Discovery, 12 (3), pp. 205-216; 
Bohn, L.M., (2009) Functional Selectivity of G Protein-Coupled Receptor Ligands, pp. 71-85. , 1st ed. Neve, K. A. Humana Press Inc. Totowa, NJ; 
Reiter, E., Ahn, S., Shukla, A.K., Lefkowitz, R.J., Molecular mechanism of b-arrestin-biased agonism at seven-transmembrane receptors (2012) Annu. Rev. Pharmacol. Toxicol., 52, pp. 179-197; 
Pradahan, A.A., Smith, M.L., Kieffer, B.L., Evans, C.J., Ligand-directed signalling within the opioid receptor family (2012) Br. J. Pharmacol., 167, pp. 960-969; 
Rozenfeld, R., Devi, L.A., Exploring the role for heteromerization in GPCR signalling specificity (2011) Biochem. J., 433, pp. 11-18; 
Whalen, E.J., Rajagopal, S., Lefkowitz, R.J., Therapeutic potential of β-arrestin-and G protein-biased agonists (2011) Trends Mol. Med., 17, pp. 126-139; 
Yekkirala, A.S., Lunzer, M.M., McCurdy, C.R., Powers, M.D., Kalyuzhny, A.E., Roerig, S.C., Portoghese, P.S., N-Naphthoyl-beta-naltrexamine (NNTA), a highly selective and potent activator of μ/κ-opioid heteromers (2011) Proc. Natl. Acad. Sci. U. S. A., 108 (12), pp. 5098-5103; 
Waldhoer, M., Fong, J., Jones, R.M., Lunzer, M.M., Sharma, S.K., Kostenis, E., Portoghese, P.S., Whistler, J.L., A heterodimer-selective agonist shows in vivo relevance of G protein-coupled receptor dimers (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 9050-9055; 
Le Naour, M., Lunzer, M.M., Powers, M.D., Portoghese, P.S., Opioid activity of spinally selective analogues of N-naphthoyl-β- naltrexamine in HEK-293 cells and mice (2012) J. Med. Chem., 55 (2), pp. 670-677; 
D'Amour, F.E., Smith, D.L., A method for determining loss of pain sensation (1941) J. Pharmacol. Exp. Ther., 72, pp. 74-79; 
Dewey, W.L., Harris, L.S., Howes, J.F., Nuite, J.A., Effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests (1970) J. Pharmacol. Exp. Ther., 175, pp. 435-442; 
Harris, L.S., Pierson, A.K., Narcotic antagonists in the benzomorphan series (1964) J. Pharmacol. Exp. Ther., 143, pp. 141-148; 
Portoghese, P.S., Lipkowski, A.W., Takemori, A.E., Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists (1987) Life Sci., 40, pp. 1287-1292; 
Takemori, A.E., Ho, B.Y., Naeseth, J.S., Portoghese, P.S., Nor-Binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays (1988) J. Pharmacol. Exp. Ther., 246, pp. 255-258; 
Portoghese, P.S., Nagase, H., Maloneyhuss, K.E., Lin, C.E., Takemori, A.E., Role of spacer and address components in peptidomimetic delta opioid receptor antagonists related to naltrindole (1991) J. Med. Chem., 34, pp. 1715-1720; 
Ward, S.J., Portoghese, P.S., Takemori, A.E., Pharmacological profiles of beta-funaltrexamine (beta-FNA) and beta-chlornaltrexamine (beta-CNA) on the mouse vas deferens preparation (1982) Eur. J. Pharmacol., 80, pp. 377-384; 
Ward, S.J., Portoghese, P.S., Takemori, A.E., Pharmacological characterization in vivo of the novel opiate, beta-funaltrexamine (1982) J. Pharmacol. Exp. Ther., 220, pp. 494-498; 
Guo, X.-H., Fairbanks, C.A., Stone, L.S., Loh, H.H., DPDPE-UK14,304 synergy is retained in mu-opioid receptor knockout mice (2003) Pain, 104, pp. 209-217; 
Tang, Y., Yang, J., Lunzer, M.M., Powers, M.D., Portoghese, P.S., A κ opioid pharmacophore becomes a spinally selective κ-δ Agonist when modified with a basic extender arm (2011) ACS Med. Chem. Lett., 2 (1), pp. 7-10; 
Fairbanks, C.A., Kitto, K.F., Nguyen, H.O., Stone, L.S., Wilcox, G.L., Clonidine and dexmedetomidine produce antinociceptive synergy in mouse spinal cord (2009) Anesthesiology, 110 (3), pp. 638-647; 
Ayman, O.S., Sharif, E.-K., Sharif, S.I., The influence of various experimental conditions on the expression of naloxone-induced withdrawal symptoms in mice (2004) Gen. Pharm., 25 (7), pp. 1505-1510; 
Suzuki, T., Conditioned place preference in mice (1996) Methods Find. Exp. Clin. Pharmacol., 18, pp. 75-83; 
Wadenberg, M.L., A review of the properties of spiradoline: A potent and selective kappa-opioid receptor agonist (2003) CNS Drug Rev., 9, pp. 187-198; 
Funada, M., Suzuki, T., Narita, M., Misawa, M., Nagase, H., Blockage of morphine reward through the activation of κ-opioid receptors in mice (1993) Neuropharmacology, 32, pp. 1315-1323; 
Cunningham, C.L., Gremel, C.M., Groblewski, P.A., Drug-induced conditioned place preference and aversion in mice (2006) Nature Protoc., 1 (4), pp. 1662-1670; 
Shippenberg, T.S., Zapata, A., Chefer, V.I., Dynorphin and the pathophysiology of drug addiction (2007) Pharmacol. Ther., 116, pp. 306-32135; 
Bruchas, M.R., Land, B.B., Chavkin, C., The dynorphin/kappa-opioid receptor impacts the pathophysiology and behavior of substance use (2010) Brain Res., 16, pp. 44-55; 
Braida, D., Limonta, V., Capurro, V., Fadda, P., Rubino, T., Mascia, P., Zani, A., Sala, M., Involvement of kappa-opioid and endocannabinoid system on salvinorin A-induced reward (2008) Biol. Psychiatry, 63 (3), pp. 286-292; 
Carlezon Jr., W.A., Beguin, C., Dinieri, J.A., Baumann, M.H., Richards, M.R., Todtenkopf, M.S., Rothman, R.B., Cohen, B.M., Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats (2006) J. Pharmacol. Exp. Ther., 316 (1), pp. 440-447; 
Zhang, Y., Butelman, E.R., Schlussman, S.D., Ho, A., Kreek, M.J., Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: Agonist actions at kappa opioid receptors (2005) Psychopharmacology (Berlin), 179 (3), pp. 551-558; 
Yang, C.-H., Huang, W.-W., Chen, K.-H., Chen, Y.-S., Sheen-Chen, S.-M., Lin, C.-R., Antinociceptive potentiation and attenuation of tolerance by intrathecal β-arrestin2 small interfering RNA in rats (2011) Br. J. Anaesth., 107, pp. 774-781; 
Bohn, L.M., Lefkowitz, R.J., Gainetdinov, R.R., Peppel, K., Caron, M.G., Lin, F.T., Enhanced morphine analgesia in mice lacking beta-arrestin2 (1999) Science, 286, pp. 2495-2498; 
Bohn, L.M., Gainetdinov, R.R., Lin, F.T., Lefkowitz, R.J., Caron, M.G., Mu-opioid receptor desensitization by beta-arrestin2 determines morphine tolerance but not dependence (2000) Nature, 408, pp. 720-723; 
Bohn, L.M., Lefkowitz, R.J., Caron, M.G., Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin2 knock-out mice (2002) J. Neurosci., 22, pp. 10494-10500; 
Raehal, K.M., Walker, J.K., Bohn, L.M., Morphine side-effects in beta-arrestin2 knock-out mice (2005) J. Pharmacol. Exp. Ther., 314, pp. 1195-1201; 
Raehal, K.M., Bohn, L.M., The role of beta-arrestin 2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics (2011) Neuropharmacology, 60, pp. 58-65; 
Groer, C.E., Schmid, C.L., Jaeger, A.M., Bohn, L.M., Agonist-directed interactions with specific beta-arrestins determine mu-opioid receptor trafficking, ubiquitination, and dephosphorylation (2011) J. Biol. Chem., 286 (36), pp. 31731-31741; 
Hales, T.G., Arresting the development of morphine tolerance and dependence (2011) Br. J. Anaesth., 107 (5), pp. 653-655; 
Raehal, K.M., Schmid, C.L., Groer, C.E., Bohn, L.M., Functional selectivity at the μ-opioid receptor: Implications for understanding opioid analgesia and tolerance (2011) Pharmacol. Rev., 63 (4), pp. 1001-1019; 
Raehal, K.M., Bohn, L.M., The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics (2011) Neuropharmacology, 60 (1), pp. 58-65; 
Zuo, Z., The role of opioid receptor internalization and β-arrestins in the development of opioid tolerance (2005) Anesth. Analg., 101, pp. 728-734; 
Bruchas, M.R., Chavkin, C., Kinase cascades and ligand-directed signaling at the kappa opioid receptor (2010) Psychopharmacology (Berlin), 210 (2), pp. 137-147; 
Handa, B.K., Land, A.C., Lord, J.A., Morgan, B.A., Rance, M.J., Smith, C.F., Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors (1981) Eur. J. Pharmacol., 70, pp. 531-540; 
Mosberg, H.I., Hurst, R., Hruby, V.J., Gee, K., Yamamura, H.I., Galligan, J.J., Burks, T.F., Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors (1983) Proc. Natl. Acad. Sci. U. S. A., 80, pp. 5871-5874; 
Lahti, R.A., Mickelson, M.M., McCall, J.M., Von Voigtlander, P.F., 3H]U-69593 a highly selective ligand for the opioid kappa receptor (1985) Eur. J. Pharmacol., 109, pp. 281-284; 
Rives, M.-L., Rossillo, M., Liu-Chen, L.-Y., Javitch, J.A., 6′-Guanidinonaltrindole (6′-GNTI) is a G protein-coupled biased κ-opioid receptor agonist that inhibits arrestin recruitment (2012) J. Biol. Chem., 287 (32), pp. 27050-27054; 
Schmid, C.L., Streicher, J.M., Groer, C.E., Munro, T.A., Zhou, L., Bohn, L., Functional selectivity of 6′-guanidinonaltrindole (6′-GNTI) at κ-opioid receptors in striatal neurons (2013) J. Biol. Chem., 288 (31), pp. 22387-22398; 
Groer, C.E., Tidgewell, K., Moyer, R.A., Harding, W.W., Rothman, R.B., Prisinzano, T.E., Bohn, L.M., An opioid agonist that does not induce m-opioid receptor-arrestin interactions or receptor internalization (2007) Mol. Pharmacol., 71 (2), pp. 549-557; 
Dewire, S.M., Yamashita, D.S., Rominger, D.H., Liu, G., Cowan, C.L., Graczyk, T.M., Chen, X.T., Violin, J.D., A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine (2013) J. Pharmacol. Exp. Ther., 344 (3), pp. 708-717; 
Zhou, L., Lovell, K.M., Frankowski, K.J., Slauson, S.R., Phillips, A.M., Streicher, J.M., Stahl, E., Bohn, L.M., Development of functionally selective, small molecule agonists at kappa opioid receptors (2013) J. Biol. Chem., 288 (51), pp. 36703-36716; 
Abdel-Hamid, E.E., Sultana, M., Portoghese, P.S., Takemori, A.E., Selective blockage of delta opioid receptors prevents the development of morphine tolerance in mice (1991) J. Pharm. Exp. Ther., 258, pp. 299-303; 
Kest, B., Lee, C.E., McLenmore, G.L., Inturrisi, C.E., An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice (1996) Brain Res. Bull., 39, pp. 185-189; 
Zhu, Y., King, M.A., Schuller, A.G., Nitsche, J.F., Reidl, M., Elde, R.P., Unterwald, E., Pintar, J.E., Retention of supraspinal morphine-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice (1999) Neuron, 24, pp. 243-252; 
Daniels, D.J., Lenard, N.R., Etienne, C.L., Law, P.-Y., Roerig, S.C., Portoghese, P.S., Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series (2005) Proc. Natl. Acad. Sci. U. S. A., 102, pp. 19208-19213; 
Lenard, N.R., Daniels, D.J., Portoghese, P.S., Roerig, S.C., Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist (2007) Eur. J. Pharmacol., 566, pp. 75-82; 
Yekkirala, A.S., Kalyuzhny, A.E., Portoghese, P.S., Standard opioid agonists activate heteromeric opioid receptors: Evidence for morphine and [ d-Ala2,MePhe4Glyol5] enkkephalin as selective μ-δ Agonists (2010) ACS Chem. Neurosci., 1, pp. 146-154; 
Aceto, M.D., Harris, L.S., Negus, S.S., Banks, M.L., Hughes, L.D., Akgun E, E., Portoghese, P.S., MDAN-21: A bivalent opioid ligand containing mu-agonist and delta-antagonist pharmacophores and its effects in rhesus monkeys (2012) Int. J. Med. Chem., 30, pp. 4617-4624; 
Yekkirala, A.S., Banks, M.L., Lunzer, M.M., Negus, S.S., Rice, K.C., Portoghese, P.S., Clinically employed opioid analgesics produce antinociception via μ-δ Opioid receptor heteromers in rhesus monkeys (2012) ACS Chem. Neurosci., 3, pp. 720-727; 
Hasbi, A., Nguyen, T., Fan, T., Cheng, R., Rashid, A., Alijaniaram, M., Rasenick, M.M., George, S.R., Trafficking of preassembled opioid mu-delta heterooligomer-Gz signaling complexes to the plasma membrane: Coregulation by agonists (2007) Biochemistry, 46 (45), pp. 12997-13009; 
Akgun, E., Javed, M.I., Lunzer, M.M., Smeester, B.A., Beitz, A.J., Portoghese, P.S., Ligands that interact with putative MOR-mGluR5 heteromer produce potent antinociception in mice with inflammatory pain (2013) Proc. Nat. Acad. Sci. U. S. A., 110, pp. 11595-11599; 
Milan-Lobo, L., Whistler, J.L., Heteromerization of the μ-and δ-opioid receptors produces ligand-biased antagonism and alters μ-receptor trafficking (2011) J. Pharmacol. Exp. Ther., 337 (3), pp. 868-875; 
Rozenfeld, R., Devi, L.A., Receptor heterodimerization leads to a switch in signaling: β-arrestin2-mediated ERK activation by μ-δ Opioid receptor heterodimers (2007) FASEB J., 21, pp. 2455-2465; 
Gomes, I., Fujita, W., Gupta, A., Saldanha, A.S., Negri, A., Pinello, C.E., Roberts, E., Devi, L.A., Identification of a μ-δ Opioid receptor heteromer-biased agonist with antinociceptive activity (2013) Proc. Natl. Acad. Sci. U. S. A., 110 (29), pp. 12072-12077; 
Wade, P.R., Palmer, J.M., McKenney, S., Kenigs, V., Chevalier, K., Moore, B.A., Mabus, J.R., Hornby, P.J., Modulation of gastrointestinal function by MuDelta, a mixed μ opioid receptor agonist/μ opioid receptor antagonist (2012) Br. J. Pharmacol., 167 (5), pp. 1111-1125; 
Beslin, H.J., Diamond, C.J., Kavash, R.W., Cai, C., Dyatkin, A.B., Miskowski, T.A., Zhang, S.P., He, W., Identification of a dual δ or antagonist/μ or agonist as a potential therapeutic for diarrhea-predominant irritable bowel syndrome (IBS-d) (2012) Bioorg. Med. Chem. Lett., 22 (14), pp. 4869-4872; 
Milligan, G., A day in the life of a G protein-coupled receptor: The contribution to function of G protein-coupled receptor dimerization (2008) Br. J. Pharmacol., 153 (SUPPL. 1), pp. 216-229; 
Bulenger, S., Marullo, S., Bouvier, M., Emerging role of homo-and heterodimerization in G-protein-coupled receptor biosynthesis and maturation (2005) Trends Pharmacol. Sci., 26, pp. 131-137; 
Christopoulos, A., Kenakin, T., G protein-coupled receptor allosterism and complexing (2002) Pharmacol. Rev., 54 (2), pp. 323-374; 
Agnati, L.F., Guidolin, D., Albertin, G., Trivello, E., Ciruela, F., Genedani, S., Tarakanov, A., Fuxe, K., An integrated view on the role of receptor mosaics at perisynaptic level: Focus on adenosine A(2A), dopamine D(2), cannabinoid CB(1), and metabotropic glutamate mGlu(5) receptors (2010) J. Recept. Signal Transduction, 30 (5), pp. 355-369; 
Zhang, Y.Q., Limbird, L.E., Hetero-oligomers of alpha2A-adrenergic and mu-opioid receptors do not lead to transactivation of G proteins or altered endocytosis profiles (2004) Biochem. Soc. Trans., 32, pp. 856-860; 
Pfeiffer, M., Koch, T., Schroder, H., Laugsch, M., Hollt, V., Schulz, S., Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization (2002) J. Biol. Chem., 277, pp. 19762-19772; 
Jordan, B.A., Trapaidze, N., Gomes, I., Nivarthi, R., Devi, L.A., Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation (2001) Proc. Natl. Acad. Sci. U. S. A., 98, pp. 343-348; 
Javitch, J.A., The ants go marching two by two: Oligomeric structure of G-protein-coupled receptors (2004) Mol. Pharmacol., 66 (5), pp. 1077-1082; 
Prinster, S.C., Hague, C., Hall, R.A., Heterodimerization of G protein-coupled receptors: Specificity and functional significance (2005) Eur. J. Pharmacol., 57, pp. 289-298; 
Mackie, K., Cannabinoid receptor homo-and heterodimerization (2005) Life Sci., 77, pp. 1667-1673; 
Schroder, H., Wu, D.F., Seifert, A., Rankovic, M., Schulz, S., Hollt, V., Koch, T., Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the micro-opioid receptor (2009) Neuropharmacology, 56, pp. 768-778
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84906094177&doi=10.1021%2fjm500159d&partnerID=40&md5=034474970cac03a86d7cca26342137bb
ER  - 

TY  - JOUR
TI  - An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure
T2  - Neuropsychopharmacology
J2  - Neuropsychopharmacology
VL  - 39
IS  - 1
SP  - 88
EP  - 103
PY  - 2014
DO  - 10.1038/npp.2013.227
SN  - 0893133X (ISSN) 
AU  - Stockton, S.D.
AU  - Devi, L.A.
AD  - Department of Pharmacology and Systems Therapeutics and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
AB  - Morphine is a classic analgesic for the treatment of chronic pain. However, its repeated use is known to produce tolerance, physical dependence, and addiction; these properties limit its long-term therapeutic use and this has led to a quest for therapeutics without these unwanted side effects. Understanding the molecular changes in response to long-term use of morphine is likely to aid in the development of novel therapeutics for the treatment of pain. Studies examining the effects of chronic morphine administration have reported alterations in gene expression, synapse morphology, and synaptic transmission implying changes in synaptic protein profile. To fully understand the changes in protein profiles, proteomic techniques have been used. Studies using two-dimensional gel electrophoresis of various brain regions combined with mass spectrometry have found alterations in the levels of a number of proteins. However, neither the changes in brain regions relevant to morphine effects nor changes in the abundance of synaptic proteins have been clearly delineated. Recent studies employing subcellular fractionation to isolate the striatal synapse, combined with quantitative proteomics and graph theory-inspired network analyses, have begun to quantify morphine-regulated changes in synaptic proteins and facilitate the generation of networks that could serve as targets for the development of novel therapeutics for the treatment of chronic pain. Thus, an integrated quantitative proteomics and systems biology approach can be useful to identify novel targets for the treatment of pain and other disorders of the brain. © 2014 American College of Neuropsychopharmacology.
KW  - μ-opioid receptor
KW  - addiction
KW  - opiate
KW  - pain
KW  - proteomics
KW  - synaptic plasticity
KW  - brain protein
KW  - calcium ion
KW  - clonidine
KW  - cysteine string protein
KW  - heat shock protein
KW  - methadone
KW  - morphine
KW  - n methyl dextro aspartic acid receptor
KW  - neurexin
KW  - opiate receptor
KW  - potassium ion
KW  - synaptic protein
KW  - unclassified drug
KW  - morphine
KW  - narcotic analgesic agent
KW  - nerve protein
KW  - animal behavior
KW  - brain cortex
KW  - cell fractionation
KW  - corpus striatum
KW  - down regulation
KW  - electrospray mass spectrometry
KW  - endocytosis
KW  - forebrain
KW  - gene expression
KW  - high performance liquid chromatography
KW  - hippocampus
KW  - human
KW  - hyperpolarization
KW  - liquid chromatography
KW  - long term exposure
KW  - mass spectrometry
KW  - matrix assisted laser desorption ionization time of flight mass spectrometry
KW  - morphine addiction
KW  - nerve cell plasticity
KW  - neurotransmitter release
KW  - nonhuman
KW  - place preference
KW  - postsynaptic density
KW  - postsynaptic potential
KW  - priority journal
KW  - protein analysis
KW  - protein expression
KW  - protein protein interaction
KW  - proteomics
KW  - quantitative study
KW  - review
KW  - signal transduction
KW  - synapse
KW  - synaptic membrane
KW  - synaptic transmission
KW  - systematic review
KW  - systems biology
KW  - tandem mass spectrometry
KW  - two dimensional electrophoresis
KW  - two dimensional gel electrophoresis
KW  - upregulation
KW  - withdrawal syndrome
KW  - animal
KW  - biological model
KW  - brain
KW  - drug effects
KW  - metabolism
KW  - procedures
KW  - proteomics
KW  - synapse
KW  - systems biology
KW  - Analgesics, Opioid
KW  - Animals
KW  - Brain
KW  - Models, Neurological
KW  - Morphine
KW  - Nerve Tissue Proteins
KW  - Proteomics
KW  - Synapses
KW  - Systems Biology
N1  - Cited By :6
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
N1  - CODEN: NEROE
C2  - 24045585
LA  - English
N1  - Correspondence Address: Devi, L.A.; Department of Pharmacology and Systems Therapeutics and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States; email: lakshmi.devi@mssm.edu
N1  - Chemicals/CAS: calcium ion, 14127-61-8; clonidine, 4205-90-7, 4205-91-8, 57066-25-8; methadone, 1095-90-5, 125-56-4, 23142-53-2, 297-88-1, 76-99-3; morphine, 52-26-6, 57-27-2; potassium ion, 24203-36-9; Analgesics, Opioid; Morphine; Nerve Tissue Proteins
N1  - Funding details: National Institutes of Health, NIH, R37DA008863
N1  - References: Abul-Husn, N.S., Annangudi, S.P., Ma'ayan, A., Ramos-Ortolaza, D.L., Stockton Jr., S.D., Gomes, I., Chronic morphine alters the presynaptic protein profile: Identification of novel molecular targets using proteomics and network analysis (2011) PLoS One, 6, pp. e25535; 
Abul-Husn, N.S., Bushlin, I., Morón, J.A., Jenkins, S.L., Dolios, G., Wang, R., Systems approach to explore components and interactions in the presynapse (2009) Proteomics, 9, pp. 3303-3315; 
Abul-Husn, N.S., Devi, L.A., Neuroproteomics of the synapse and drug addiction (2006) J Pharmacol Exp Ther, 318, pp. 461-468; 
Abul-Husn, N.S., Sutak, M., Milne, B., Jhamandas, K., Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu-And deltaopioid receptor antagonists (2007) Br J Pharmacol, 151, pp. 877-887; 
Al-Hasani, R., Bruchas, M.R., Molecular mechanisms of opioid receptordependent signaling and behavior (2011) Anesthesiology, 115, pp. 1363-1381; 
Albert, R., Barabási, A.L., Statistical mechanics of complex networks (2002) Rev Mod Phys, 74, pp. 47-97; 
(2000) Diagnostic and Statistical Manual of Mental Disorders, , Association A.P. (4th edn, text revision; DSMIV-TR) Washington, D.C; 
Barabasi, A.L., Albert, R., Emergence of scaling in random networks (1999) Science, 286, pp. 509-512; 
Barabási, A.L., Oltvai, Z.N., Network biology: Understanding the cell's functional organization (2004) Nat Rev Genet, 5, pp. 101-113; 
Bayes, A., Grant, S.G., Neuroproteomics: Understanding the molecular organization and complexity of the brain (2009) Nat Rev Neurosci, 10, pp. 635-646; 
Berger, S.I., Posner, J.M., Ma'ayan, A., Genes2Networks: Connecting lists of gene symbols using mammalian protein interactions databases (2007) BMC Bioinformatics, 8, p. 372; 
Berland, D., Rodgers, P., Rational use of opioids for management of chronic nonterminal pain (2012) Am Fam Physician, 86, pp. 252-258; 
Brun, C., Herrmann, C., Guénoche, A., Clustering proteins from interaction networks for the prediction of cellular functions (2004) BMC Bioinformatics, 5, p. 95; 
Bu, Q., Yang, Y., Yan, G., Hu, Z., Hu, C., Duan, J., Proteomic analysis of the nucleus accumbens in rhesus monkeys of morphine dependence and withdrawal intervention (2012) J Proteomics, 75, pp. 1330-1342; 
Calignano, A., Moncada, S., Di Rosa, M., Endogenous nitric oxide modulates morphine-induced constipation (1991) Biochem Biophys Res Commun, 181, pp. 889-893; 
Carlin, R.K., Grab, D.J., Cohen, R.S., Siekevitz, P., Isolation and characterization of postsynaptic densities from various brain regions: Enrichment of different types of postsynaptic densities (1980) J Cell Biol, 86, pp. 831-845; 
Chao, J., Nestler, E.J., Molecular neurobiology of drug addiction (2004) Annu Rev Med, 55, pp. 113-132; 
Cheng, D., Hoogenraad, C.C., Rush, J., Ramm, E., Schlager, M.A., Duong, D.M., Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum (2006) Mol Cell Proteomics, 5, pp. 1158-1170; 
Cho, K.O., Hunt, C.A., Kennedy, M.B., The rat brain postsynaptic density fraction contains a homolog of the Drosophila disc-large tumor suppressor protein (1992) Neuron, 9, pp. 929-942; 
Cohen, R.S., Blomberg, F., Berzins, K., Siekevitz, P., The structure of postsynaptic densities isolated from dog cerebral cortex. I. Overall morphology and protein composition (1977) J Cell Biol, 74, pp. 181-203; 
Collins, M.O., Husi, H., Yu, L., Brandon, J.M., Anderson, C.N., Blackstock, W.P., Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome (2006) J Neurochem, 97, pp. 16-23; 
Cotman, C.W., Banker, G., Churchill, L., Taylor, D., Isolation of postsynaptic densities from rat brain (1974) J Cell Biol, 63, pp. 441-455; 
Dosemeci, A., Tao-Cheng, J.H., Vinade, L., Jaffe, H., Preparation of postsynaptic density fraction from hippocampal slices and proteomic analysis (2006) Biochem Biophys Res Commun, 339, pp. 687-694; 
Duman, R.S., Tallman, J.F., Nestler, E.J., Acute and chronic opiate-regulation of adenylate cyclase in brain: Specific effects in locus coeruleus (1988) J Pharmacol Exp Ther, 246, pp. 1033-1039; 
Faber, E.S., Sah, P., Opioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current (2004) J Neurosci, 24, pp. 3031-3039; 
Farrell, M., Opiate withdrawal (1994) Addiction, 89, pp. 1471-1475; 
Fernandez, E., Collins, M.O., Uren, R.T., Kopanitsa, M.V., Komiyama, N.H., Croning, M.D., Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins (2009) Mol Syst Biol, 5, p. 269; 
Fioravante, D., Liu, R.Y., Byrne, J.H., The ubiquitin-proteasome system is necessary for long-Term synaptic depression in Aplysia (2008) J Neurosci, 28, pp. 10245-10256; 
Granados-Soto, V., Kalcheva, I., Hua, X., Newton, A., Yaksh, T.L., Spinal PKC activity and expression: Role in tolerance produced by continuous spinal morphine infusion (2000) Pain, 85, pp. 395-404; 
Grant, S.G., Synapse signalling complexes and networks: Machines underlying cognition (2003) BioEssays, 25, pp. 1229-1235; 
Hajó S, F., An improved method for the preparation of synaptosomal fractions in high purity (1975) Brain Res, 93, pp. 485-489; 
Hartwell, L.H., Hopfield, J.J., Leibler, S., Murray, A.W., From molecular to modular cell biology (1999) Nature, 402, pp. C47-C52; 
Hegde, A.N., Goldberg, A.L., Schwartz, J.H., Regulatory subunits of cAMPdependent protein kinases are degraded after conjugation to ubiquitin: A molecular mechanism underlying long-Term synaptic plasticity (1993) Proc Natl Acad Sci USA, 90, pp. 7436-7440; 
Hsia, J.A., Moss, J., Hewlett, E.L., Vaughan, M., ADP-ribosylation of adenylate cyclase by pertussis toxin. Effects on inhibitory agonist binding (1984) J Biol Chem, 259, pp. 1086-1090; 
Husi, H., Ward, M.A., Choudhary, J.S., Blackstock, W.P., Grant, S.G., Proteomic analysis of NMDA receptor-Adhesion protein signaling complexes (2000) Nat Neurosci, 3, pp. 661-669; 
Jenkins, S.L., Ma'ayan, A., Systems pharmacology meets predictive, preventive, personalized and participatory medicine (2013) Pharmacogenomics, 14, pp. 119-122; 
Jeong, H., Tombor, B., Albert, R., Oltvai, Z.N., Barabási, A.L., The large-scale organization of metabolic networks (2000) Nature, 407, pp. 651-654; 
Jordan, B.A., Devi, L.A., G-protein-coupled receptor heterodimerization modulates receptor function (1999) Nature, 399, pp. 697-700; 
Jordan, B.A., Fernholz, B.D., Boussac, M., Xu, C., Grigorean, G., Ziff, E.B., Identification and verification of novel rodent postsynaptic density proteins (2004) Mol Cell Proteomics, 3, pp. 857-871; 
Kelly, P.T., McGuinness, T.L., Greengard, P., Evidence that the major postsynaptic density protein is a component of a Ca2/calmodulin-dependent protein kinase (1984) Proc Natl Acad Sci USA, 81, pp. 945-949; 
Kennedy, M.B., Bennett, M.K., Erondu, N.E., Biochemical and immunochemical evidence that the 'major postsynaptic density protein' is a subunit of a calmodulin-dependent protein kinase (1983) Proc Natl Acad Sci USA, 80, pp. 7357-7361; 
Kim, S.I., Voshol, H., Van Oostrum, J., Hastings, T.G., Cascio, M., Glucksman, M.J., Neuroproteomics: Expression profiling of the brain's proteomes in health and disease (2004) Neurochem Res, 29, pp. 1317-1331; 
Kim, S.Y., Chudapongse, N., Lee, S.M., Levin, M.C., Oh, J.T., Park, H.J., Proteomic analysis of phosphotyrosyl proteins in the rat brain: Effect of butorphanol dependence (2004) J Neurosci Res, 77, pp. 867-877; 
Kim, S.Y., Chudapongse, N., Lee, S.M., Levin, M.C., Oh, J.T., Park, H.J., Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains (2005) Brain Res Mol Brain Res, 133, pp. 58-70; 
Klemmer, P., Smit, A.B., Li, K.W., Proteomics analysis of immuno-precipitated synaptic protein complexes (2009) J Proteomics, 72, pp. 82-90; 
Law, P.Y., Wong, Y.H., Loh, H.H., Molecular mechanisms and regulation of opioid receptor signaling (2000) Annu Rev Pharmacol Toxicol, 40, pp. 389-430; 
Li, K.W., Hornshaw, M.P., Van Der Schors, R.C., Watson, R., Tate, S., Casetta, B., Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology (2004) J Biol Chem, 279, pp. 987-1002; 
Li, K.W., Jimenez, C.R., Van Der Schors, R.C., Hornshaw, M.P., Schoffelmeer, A.N., Smit, A.B., Intermittent administration of morphine alters protein expression in rat nucleus accumbens (2006) Proteomics, 6, pp. 2003-2008; 
Li, Q., Zhao, X., Zhong, L.J., Yang, H.Y., Wang, Q., Pu, X.P., Effects of chronic morphine treatment on protein expression in rat dorsal root ganglia (2009) Eur J Pharmacol, 612, pp. 21-28; 
Li, Y., Kolb, B., Robinson, T.E., The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen (2003) Neuropsychopharmacology, 28, pp. 1082-1085; 
Lin, X., Wang, Q., Cheng, Y., Ji, J., Yu, L.C., Changes of protein expression profiles in the amygdala during the process of morphine-induced conditioned place preference in rats (2011) Behav Brain Res, 221, pp. 197-206; 
Lovinger, D.M., Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum (2010) Neuropharmacology, 58, pp. 951-961; 
Lovinger, D.M., Partridge, J.G., Tang, K.C., Plastic control of striatal glutamatergic transmission by ensemble actions of several neurotransmitters and targets for drugs of abuse (2003) Ann NY Acad Sci, 1003, pp. 226-240; 
Ma'ayan, A., Jenkins, S.L., Neves, S., Hasseldine, A., Grace, E., Dubin-Thaler, B., Formation of regulatory patterns during signal propagation in a Mammalian cellular network (2005) Science, 309, pp. 1078-1083; 
Meyer, U., The history of antitussive and expectorants (2008) Pharm Unserer Zeit, 37, pp. 450-456; 
Milo, R., Shen-Orr, S., Itzkovitz, S., Kashtan, N., Chklovskii, D., Alon, U., Network motifs: Simple building blocks of complex networks (2002) Science, 298, pp. 824-827; 
Minneman, K.P., Iversen, I.L., Enkephalin and opiate narcotics increase cyclic GMP accumulation in slices of rat neostriatum (1976) Nature, 262, pp. 313-314; 
Moron, J.A., Abul-Husn, N.S., Rozenfeld, R., Dolios, G., Wang, R., Devi, L.A., Morphine administration alters the profile of hippocampal postsynaptic densityassociated proteins: A proteomics study focusing on endocytic proteins (2007) Mol Cell Proteomics, 6, pp. 29-42; 
Nestler, E.J., Under siege: The brain on opiates (1996) Neuron, 16, pp. 897-900; 
Nestler, E.J., Molecular basis of long-Term plasticity underlying addiction (2001) Nat Rev Neurosci, 2, pp. 119-128; 
Nestler, E.J., Historical review: Molecular and cellular mechanisms of opiate and cocaine addiction (2004) Trends Pharmacol Sci, 25, pp. 210-218; 
Okada, K., Kanaya, S., Asai, K., Accurate extraction of functional associations between proteins based on common interaction partners and common domains (2005) Bioinformatics, 21, pp. 2043-2048; 
Patel, V.J., Thalassinos, K., Slade, S.E., Connolly, J.B., Crombie, A., Murrell, J.C., A comparison of labeling and label-free mass spectrometry-based proteomics approaches (2009) J Proteome Res, 8, pp. 3752-3759; 
Peng, J., Kim, M.J., Cheng, D., Duong, D.M., Gygi, S.P., Sheng, M., Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry (2004) J Biol Chem, 279, pp. 21003-21011; 
Phillips, G.R., Huang, J.K., Wang, Y., Tanaka, H., Shapiro, L., Zhang, W., The presynaptic particle web: Ultrastructure, composition, dissolution and reconstitution (2001) Neuron, 32, pp. 63-77; 
Phillips, G.R., Florens, L., Tanaka, H., Khaing, Z.Z., Fidler, L., Yates III, J.R., Proteomic comparison of two fractions derived from the transsynaptic scaffold (2005) J Neurosci Res, 81, pp. 762-775; 
Pocklington, A.J., Cumiskey, M., Armstrong, J.D., Grant, S.G., The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour (2006) Mol Syst Biol, 2. , 2006.0023; 
Prokai, L., Zharikova, A.D., Stevens Jr., S.M., Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: A quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/ mass spectrometry (2005) J Mass Spectrom, 40, pp. 169-175; 
Ramos-Ortolaza, D.L., Bushlin, I., Abul-Husn, N., Annangudi, S.P., Sweedler, J., Devi, L.A., Quantitative neuroproteomics of the synapse (2010) Methods Mol Biol, 615, pp. 227-246; 
Robinson, T.E., Kolb, B., Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine (1997) J Neurosci, 17, pp. 8491-8497; 
Robinson, T.E., Kolb, B., Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine (1999) Eur J Neurosci, 11, pp. 1598-1604; 
Robinson, T.E., Kolb, B., Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats (1999) Synapse, 33, pp. 160-162; 
Robinson, T.E., Kolb, B., Structural plasticity associated with exposure to drugs of abuse (2004) Neuropharmacology, 47, pp. 33-46; 
Russo, S.J., Dietz, D.M., Dumitriu, D., Morrison, J.H., Malenka, R.C., Nestler, E.J., The addicted synapse: Mechanisms of synaptic and structural plasticity in nucleus accumbens (2010) Trends Neurosci, 33, pp. 267-276; 
Samanta, M.P., Liang, S., Predicting protein functions from redundancies in large-scale protein interaction networks (2003) Proc Natl Acad Sci USA, 100, pp. 12579-12583; 
Satoh, K., Takeuchi, M., Oda, Y., Deguchi-Tawarada, M., Sakamoto, Y., Matsubara, K., Identification of activity-regulated proteins in the postsynaptic density fraction (2002) Genes Cells, 7, pp. 187-197; 
Schrimpf, S.P., Meskenaite, V., Brunner, E., Rutishauser, D., Walther, P., Eng, J., Proteomic analysis of synaptosomes using isotope-coded affinity tags and mass spectrometry (2005) Proteomics, 5, pp. 2531-2541; 
Sharan, R., Ulitsky, I., Shamir, R., Network-based prediction of protein function (2007) Mol Sys Biol, 3, p. 88; 
Shui, H.A., Ho, S.T., Wang, J.J., Wu, C.C., Lin, C.H., Tao, Y.X., Proteomic analysis of spinal protein expression in rats exposed to repeated intrathecal morphine injection (2007) Proteomics, 7, pp. 796-803; 
Song, Z., Guo, Q., Zhang, J., Li, M., Liu, C., Zou, W., Proteomic analysis of PKCgamma-related proteins in the spinal cord of morphine-Tolerant rats (2012) PLoS One, 7, pp. e42068; 
Spirin, V., Mirny, L.A., Protein complexes and functional modules in molecular networks (2003) Proc Natl Acad Sci USA, 100, pp. 12123-12128; 
Stevens Jr., S.M., Zharikova, A.D., Prokai, L., Proteomic analysis of the synaptic plasma membrane fraction isolated from rat forebrain (2003) Brain Res Mol Brain Res, 117, pp. 116-128; 
Suder, P., Bodzon-Kulakowska, A., Mak, P., Bierczynska-Krzysik, A., Daszykowski, M., Walczak, B., The proteomic analysis of primary cortical astrocyte cell culture after morphine administration (2009) J Proteome Res, 8, pp. 4633-4640; 
Tan, R., Zou, D., Chang, Y., Proteomic analysis of morphine rabbit myocardium with matrix-Assisted laser desorption/ionization time-offlight mass spectrometry (2010) Zhong Nan Da Xue Xue Bao Yi Xue Ban, 35, pp. 607-611; 
Taussig, R., Iniguez-Lluhi, J.A., Gilman, A.G., Inhibition of adenylyl cyclase by Gi alpha (1993) Science, 261, pp. 218-221; 
Taylor, I.W., Wrana, J.L., Protein interaction networks in medicine and disease (2012) Proteomics, 12, pp. 1706-1716; 
Terwilliger, R.Z., Beitner-Johnson, D., Sevarino, K.A., Crain, S.M., Nestler, E.J., A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function (1991) Brain Res, 548, pp. 100-110; 
Wagner, A., Fell, D.A., The small world inside large metabolic networks (2001) Proc Biol Sci, 268, pp. 1803-1810; 
Walikonis, R.S., Jensen, O.N., Mann, M., Provance Jr., D.W., Mercer, J.A., Kennedy, M.B., Identification of proteins in the postsynaptic density fraction by mass spectrometry (2000) J Neurosci, 20, pp. 4069-4080; 
Wang, X.J., Yu, J., Wong, S.H., Cheng, A.S., Chan, F.K., Ng, S.S., A novel crosstalk between two major protein degradation systems: Regulational of proteasomal activity by autophagy (2013) Autophagy, 11. , (e-pub ahead of print; 
Watts, D.J., Strogatz, S.H., Collective dynamics of 'small-world' networks (1998) Nature, 393, pp. 440-442; 
Wei, Q.H., Wu, N., Bian, J.M., Chen, Y., Su, R.B., Li, J., Involvement of hippocampal phosphatidylethanolamine-binding protein in morphine dependence and withdrawal (2013) Addict Biol, 18, pp. 230-240; 
Wolters, D.A., Washburn, M.P., Yates III, J.R., An automated multidimensional protein identification technology for shotgun proteomics (2001) Anal Chem, 73, pp. 5683-5690; 
Wu, K., Carlin, R., Siekevitz, P., Binding of L-[3H]glutamate to fresh and frozen synaptic membrane and postsynaptic density fractions isolated from cerebral cortex and cerebellum of fresh or frozen canine brain (1986) J Neurochem, 46, pp. 831-841; 
Yang, L., Sun, Z.S., Zhu, Y.P., Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference (2007) J Proteome Res, 6, pp. 2239-2247; 
Yoshimura, Y., Yamauchi, T., Phosphorylation-dependent revesible association of Ca+2/calmodulin- dependent protein kinase II with the postsynaptic densities (1997) J Biol Chem, 272, pp. 26354-26359; 
Yoshimura, Y., Yamauchi, Y., Shinkawa, T., Taoka, M., Donai, H., Takahashi, N., Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-Tandem mass spectrometry (2004) J Neurochem, 88, pp. 759-768; 
Zeitz, K.P., Malmberg, A.B., Gilbert, H., Basbaum, A.I., Reduced development of tolerance to the analgesic effects of morphine and clonidine in PKC gamma mutant mice (2001) Pain, 94, pp. 245-253
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84890507787&doi=10.1038%2fnpp.2013.227&partnerID=40&md5=52c9795cf3a677c1c502e6aa7fc9bfc6
ER  - 

TY  - JOUR
TI  - The cerebellum and addiction: Insights gained from neuroimaging research
T2  - Addiction Biology
J2  - Addict. Biol.
VL  - 19
IS  - 3
SP  - 317
EP  - 331
PY  - 2014
DO  - 10.1111/adb.12101
SN  - 13556215 (ISSN) 
AU  - Moulton, E.A.
AU  - Elman, I.
AU  - Becerra, L.R.
AU  - Goldstein, R.Z.
AU  - Borsook, D.
AD  - Center for Pain and the Brain, Boston Children's Hospital, Massachusetts General Hospital, Boston, MA, United States
AD  - Providence Veterans Administration Medical Center, Providence, RI, United States
AD  - Department of Psychiatry, Cambridge Health Alliance, Harvard Medical School, Cambridge, MA, United States
AD  - Brookhaven National Laboratory, Upton, NY, United States
AB  - Although cerebellar alterations have been consistently noted in the addiction literature, the pathophysiology of this link remains unclear. The cerebellum is commonly classified as a motor structure, but human functional neuroimaging along with clinical observations in cerebellar stroke patients and anatomical tract tracing in non-human primates suggests its involvement in cognitive and affective processing. A comprehensive literature search on the role of the cerebellum in addiction was performed. This review article (1) considers the potential role of the cerebellum in addiction; (2) summarizes the cerebellar structural alterations linked to addiction; (3) presents the functional neuroimaging evidence linking the cerebellum with addiction; and (4) proposes a model for addiction that underscores the role of the cerebellum. The data implicate the cerebellum as an intermediary between motor and reward, motivation and cognitive control systems, as all are relevant etiologic factors in addiction. Furthermore, consideration of these findings could contribute to deeper and more sophisticated insights into normal reward and motivational function. The goal of this review is to spread awareness of cerebellar involvement in addictive processes, and to suggest a preliminary model for its potential role. © 2013 Society for the Study of Addiction.
KW  - Alcohol
KW  - cocaine
KW  - craving
KW  - marijuana
KW  - MRI
KW  - opioids
KW  - PET.
KW  - cannabis
KW  - methylphenidate
KW  - nicotine
KW  - addiction
KW  - alcoholism
KW  - article
KW  - brain size
KW  - cannabis addiction
KW  - cerebellum
KW  - cocaine dependence
KW  - diffusion tensor imaging
KW  - drug exposure
KW  - executive function
KW  - eye movement
KW  - fractional anisotropy
KW  - functional magnetic resonance imaging
KW  - functional neuroimaging
KW  - human
KW  - motivation
KW  - motor coordination
KW  - opiate addiction
KW  - positron emission tomography
KW  - priority journal
KW  - reward
KW  - tobacco dependence
KW  - voxel based morphometry
KW  - withdrawal syndrome
KW  - addiction
KW  - biological model
KW  - cerebellum
KW  - cerebellum disease
KW  - female
KW  - male
KW  - neuroimaging
KW  - nuclear magnetic resonance imaging
KW  - pathology
KW  - pathophysiology
KW  - procedures
KW  - Behavior, Addictive
KW  - Cerebellar Diseases
KW  - Cerebellum
KW  - Female
KW  - Humans
KW  - Magnetic Resonance Imaging
KW  - Male
KW  - Models, Biological
KW  - Neuroimaging
KW  - Positron-Emission Tomography
KW  - Substance-Related Disorders
PB  - Blackwell Publishing Ltd
N1  - Cited By :53
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: ADBIF
C2  - 24851284
LA  - English
N1  - Correspondence Address: Moulton, E.A.; P.A.I.N. Group, Boston Children's Hospital, 9 Hope Ave, Waltham, MA 02453, United States; email: eric.moulton@childrens.harvard.edu
N1  - Chemicals/CAS: cannabis, 8001-45-4, 8063-14-7; methylphenidate, 113-45-1, 298-59-9; nicotine, 54-11-5
N1  - Funding details: National Institute on Drug Abuse, NIDA, K01DA024289
N1  - Funding details: National Institute of Neurological Disorders and Stroke, NINDS, K24NS064050
N1  - Funding details: National Institute on Drug Abuse, NIDA, R01DA023579
N1  - Funding details: National Institute on Drug Abuse, NIDA, R21DA034954
N1  - References: Anderson, C.M., Maas, L.C., Frederick, B.D., Bendor, J.T., Spencer, T.J., Livni, E., Lukas, E.S., Kaufman, M.J., Cerebellar vermis involvement in cocaine-related behaviors (2006) Neuropsychopharmacology, 31, pp. 1318-1326; 
Ashton, J.C., Appleton, I., Darlington, C.L., Smith, P.F., Immunohistochemical localization of cannabinoid CB1 receptor in inhibitory interneurons in the cerebellum (2004) Cerebellum, 3, pp. 222-226; 
Barrós-Loscertales, A., Garavan, H., Bustamante, J.C., Ventura-Campos, N., Llopis, J.J., Belloch, V., Parcet, M.A., Avila, C., Reduced striatal volume in cocaine-dependent patients (2011) Neuroimage, 56, pp. 1021-1026; 
Bauer, D.J., Kerr, A.L., Swain, R.A., Cerebellar dentate nuclei lesions reduce motivation in appetitive operant conditioning and open field exploration (2011) Neurobiol Learn Mem, 95, pp. 166-175; 
Benegal, V., Antony, G., Venkatasubramanian, G., Jayakumar, P.N., Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence (2007) Addict Biol, 12, pp. 122-132; 
Berridge, K.C., Robinson, T.E., Parsing reward (2003) Trends Neurosci, 26, pp. 507-513; 
Block, R.I., O'Leary, D.S., Ehrhardt, J.C., Augustinack, J.C., Ghoneim, M.M., Arndt, S., Hall, J.A., Effects of frequent marijuana use on brain tissue volume and composition (2000) Neuroreport, 11, pp. 491-496; 
Block, R.I., O'Leary, D.S., Hichwa, R.D., Augustinack, J.C., Ponto, L.L., Ghoneim, M.M., Arndt, S., Andreasen, N.C., Cerebellar hypoactivity in frequent marijuana users (2000) Neuroreport, 11, pp. 749-753; 
Bonson, K.R., Grant, S.J., Contoreggi, C.S., Links, J.M., Metcalfe, J., Weyl, H.L., Kurian, V., London, E.D., Neural systems and cue-induced cocaine craving (2002) Neuropsychopharmacology, 26, pp. 376-386; 
Bora, E., Yücel, M., Fornito, A., Pantelis, C., Harrison, B.J., Cocchi, L., Pell, G., Lubman, D.I., White matter microstructure in opiate addiction (2012) Addict Biol, 17, pp. 141-148; 
Bostan, A.C., Strick, P.L., The cerebellum and basal ganglia are interconnected (2010) Neuropsychol Rev, 20, pp. 261-270; 
Brody, A.L., Mandelkern, M.A., Jarvik, M.E., Lee, G.S., Smith, E.C., Huang, J.C., Bota, R.G., London, E.D., Differences between smokers and nonsmokers in regional gray matter volumes and densities (2004) Biol Psychiatry, 55, pp. 77-84; 
Buckner, R.L., Krienen, F.M., Castellanos, A., Diaz, J.C., Yeo, B.T.T., The organization of the human cerebellum estimated by intrinsic functional connectivity (2011) J Neurophysiol, 106, pp. 2322-2345; 
Chanraud, S., Martelli, C., Delain, F., Kostogianni, N., Douaud, G., Aubin, H.-J., Reynaud, M., Martinot, J.-L., Brain morphometry and cognitive performance in detoxified alcohol-dependents with preserved psychosocial functioning (2007) Neuropsychopharmacology, 32, pp. 429-438; 
Chanraud, S., Pitel, A.-L., Rohlfing, T., Pfefferbaum, A., Sullivan, E.V., Dual tasking and working memory in alcoholism: Relation to frontocerebellar circuitry (2010) Neuropsychopharmacology, 35, pp. 1868-1878; 
Courchesne, E., Allen, G., Prediction and preparation, fundamental functions of the cerebellum (1997) Learn Mem, 4, pp. 1-35; 
Cousijn, J., Wiers, R.W., Ridderinkhof, K.R., Van Den Brink, W., Veltman, D.J., Goudriaan, A.E., Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls (2012) Neuroimage, 59, pp. 3845-3851; 
Craig, A.D., How do you feel-now? The anterior insula and human awareness (2009) Nat Rev Neurosci, 10, pp. 59-70; 
D'Angelo, E., Casali, S., Seeking a unified framework for cerebellar function and dysfunction: From circuit operations to cognition (2012) Front Neural Circuits, 6, p. 116; 
De Bellis, M.D., Narasimhan, A., Thatcher, D.L., Keshavan, M.S., Soloff, P., Clark, D.B., Prefrontal cortex, thalamus, and cerebellar volumes in adolescents and young adults with adolescent-onset alcohol use disorders and comorbid mental disorders (2005) Alcohol Clin Exp Res, 29, pp. 1590-1600; 
Diedrichsen, J., A spatially unbiased atlas template of the human cerebellum (2006) Neuroimage, 33, pp. 127-138; 
Diedrichsen, J., Balsters, J.H., Flavell, J., Cussans, E., Ramnani, N., A probabilistic MR atlas of the human cerebellum (2009) Neuroimage, 46, pp. 39-46; 
Diedrichsen, J., Maderwald, S., Küper, M., Thürling, M., Rabe, K., Gizewski, E.R., Ladd, M.E., Timmann, D., Imaging the deep cerebellar nuclei: A probabilistic atlas and normalization procedure (2011) Neuroimage, 54, pp. 1786-1794; 
Diedrichsen, J., Verstynen, T., Schlerf, J., Wiestler, T., Advances in functional imaging of the human cerebellum (2010) Curr Opin Neurol, 23, pp. 382-387; 
Domino, E.F., Minoshima, S., Guthrie, S., Ohl, L., Ni, L., Koeppe, R.A., Zubieta, J.K., Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers (2000) Synapse, 38, pp. 313-321; 
Doyon, J., Penhune, V., Ungerleider, L.G., Distinct contribution of the cortico-striatal and cortico-cerebellar systems to motor skill learning (2003) Neuropsychologia, 41, pp. 252-262; 
Ersche, K.D., Jones, P.S., Williams, G.B., Turton, A.J., Robbins, T.W., Bullmore, E.T., Abnormal brain structure implicated in stimulant drug addiction (2012) Science, 335, pp. 601-604; 
Ferrucci, M., Busceti, C.L., Falleni, A., Giorgi, F.S., Ruggieri, S., Fornai, F., Effects of methamphetamine on the cerebellar cortex: A preliminary study (2006) Ann N y Acad Sci, 1074, pp. 149-153; 
Gallinat, J., Meisenzahl, E., Jacobsen, L.K., Kalus, P., Bierbrauer, J., Kienast, T., Witthaus, H., Staedtgen, M., Smoking and structural brain deficits: A volumetric MR investigation (2006) Eur J Neurosci, 24, pp. 1744-1750; 
Gallucci, M., Amicarelli, I., Rossi, A., Stratta, P., Masciocchi, C., Zobel, B.B., Casacchia, M., Passariello, R., MR imaging of white matter lesions in uncomplicated chronic alcoholism (1989) J Comput Assist Tomogr, 13, pp. 395-398; 
Geller, T., Loftis, L., Brink, D.S., Cerebellar infarction in adolescent males associated with acute marijuana use (2004) Pediatrics, 113, pp. e365-e370; 
Goldstein, R.Z., Volkow, N.D., Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex (2002) Am J Psychiatry, 159, pp. 1642-1652; 
Goldstein, R.Z., Volkow, N.D., Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications (2011) Nat Rev Neurosci, 12, pp. 652-669; 
Grant, S., London, E.D., Newlin, D.B., Villemagne, V.L., Liu, X., Contoreggi, C., Phillips, R.L., Margolin, A., Activation of memory circuits during cue-elicited cocaine craving (1996) PNAS, 93, pp. 12040-12045; 
Habas, C., Kamdar, N., Nguyen, D., Prater, K., Beckmann, C.F., Menon, V., Greicius, M.D., Distinct cerebellar contributions to intrinsic connectivity networks (2009) J Neurosci, 29, pp. 8586-8594; 
Haubek, A., Lee, K., Computed tomography in alcoholic cerebellar atrophy (1979) Neuroradiology, 18, pp. 77-79; 
Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., De Costa, B.R., Rice, K.C., Cannabinoid receptor localization in brain (1990) PNAS, 87, pp. 1932-1936; 
Hill, S.Y., Wang, S., Carter, H., Tessner, K., Holmes, B., McDermott, M., Zezza, N., Stiffler, S., Cerebellum volume in high-risk offspring from multiplex alcohol dependence families: Association with allelic variation in GABRA2 and BDNF (2011) Psychiatry Res, 194, pp. 304-313; 
Hillbom, M., Muuronen, A., Holm, L., Hindmarsh, T., The clinical versus radiological diagnosis of alcoholic cerebellar degeneration (1986) J Neurol Sci, 73, pp. 45-53; 
Hyman, S.E., Malenka, R.C., Nestler, E.J., Neural mechanisms of addiction: The role of reward-related learning and memory (2006) Annu Rev Neurosci, 29, pp. 565-598; 
Ito, M., Cerebellar circuitry as a neuronal machine (2006) Prog Neurobiol, 78, pp. 272-303; 
Ivry, R., Cerebellar timing systems (1997) Int Rev Neurobiol, 41, pp. 555-573; 
Kelly, R.M., Strick, P.L., Cerebellar loops with motor cortex and prefrontal cortex of a nonhuman primate (2003) J Neurosci, 23, pp. 8432-8444; 
Kilts, C.D., Schweitzer, J.B., Quinn, C.K., Gross, R.E., Faber, T.L., Muhammad, F., Ely, T.D., Drexler, K.P., Neural activity related to drug craving in cocaine addiction (2001) Arch Gen Psychiatry, 58, pp. 334-341; 
Kohlmeyer, K., Stober, B., Jennen, C., Computed tomography in chronic alcoholism (1986) Acta Radiol Suppl, 369, pp. 393-395; 
Koob, G.F., Drug addiction: The yin and yang of hedonic homeostasis (1996) Neuron, 16, pp. 893-896; 
Krienen, F.M., Buckner, R.L., Segregated fronto-cerebellar circuits revealed by intrinsic functional connectivity (2009) Cereb Cortex, 19, pp. 2485-2497; 
Kühn, S., Romanowski, A., Schilling, C., Mobascher, A., Warbrick, T., Winterer, G., Gallinat, J., Brain grey matter deficits in smokers: Focus on the cerebellum (2012) Brain Struct Funct, 217, pp. 517-522; 
Lin, W.-C., Chou, K.-H., Chen, H.-L., Huang, C.-C., Lu, C.-H., Li, S.-H., Wang, Y.-L., Chen, C.-C., Structural deficits in the emotion circuit and cerebellum are associated with depression, anxiety and cognitive dysfunction in methadone maintenance patients: A voxel-based morphometric study (2012) Psychiatry Res, 201, pp. 89-97; 
Lou, M., Wang, E., Shen, Y., Wang, J., Cue-elicited craving in heroin addicts at different abstinent time: An fMRI pilot study (2012) Subst Use Misuse, 47, pp. 631-639; 
Manto, M., Toxic agents causing cerebellar ataxias (2012) Handb Clin Neurol, 103, pp. 201-213. , edited by P.J. Vinken and G.W. Bruyn; 
Martin, P.R., Singleton, C.K., Hiller-Sturmhöfel, S., The role of thiamine deficiency in alcoholic brain disease (2003) Alcohol Res Health, 27, pp. 134-142; 
Mathew, R.J., Wilson, W.H., Turkington, T.G., Coleman, R.E., Cerebellar activity and disturbed time sense after THC (1998) Brain Res, 797, pp. 183-189; 
Mathew, R.J., Wilson, W.H., Turkington, T.G., Hawk, T.C., Coleman, R.E., Degrado, T.R., Provenzale, J., Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography (2002) Psychiatry Res, 116, pp. 173-185; 
Matochik, J.A., Eldreth, D.A., Cadet, J.-L., Bolla, K.I., Altered brain tissue composition in heavy marijuana users (2005) Drug Alcohol Depend, 77, pp. 23-30; 
Mechtcheriakov, S., Brenneis, C., Egger, K., Koppelstaetter, F., Schocke, M., Marksteiner, J., A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry (2007) J Neurol Neurosurg Psychiatry, 78, pp. 610-614; 
Medina, K.L., Nagel, B.J., Tapert, S.F., Abnormal cerebellar morphometry in abstinent adolescent marijuana users (2010) Psychiatry Res, 182, pp. 152-159; 
Middleton, F.A., Strick, P.L., Anatomical evidence for cerebellar and basal ganglia involvement in higher cognitive function (1994) Science, 266, pp. 458-461; 
Middleton, F.A., Strick, P.L., Basal ganglia and cerebellar loops: Motor and cognitive circuits (2000) Brain Res Brain Res Rev, 31, pp. 236-250; 
Middleton, F.A., Strick, P.L., Cerebellar projections to the prefrontal cortex of the primate (2001) J Neurosci, 21, pp. 700-712; 
Miquel, M., Toledo, R., García, L.I., Coria-Avila, G.A., Manzo, J., Why should we keep the cerebellum in mind when thinking about addiction? (2009) Curr Drug Abuse Rev, 2, pp. 26-40; 
Moulton, E.A., Elman, I., Pendse, G., Schmahmann, J., Becerra, L., Borsook, D., Aversion-related circuitry in the cerebellum: Responses to noxious heat and unpleasant images (2011) J Neurosci, 31, pp. 3795-3804; 
Mouraux, A., Diukova, A., Lee, M.C., Wise, R.G., Iannetti, G.D., A multisensory investigation of the functional significance of the 'pain matrix' (2011) Neuroimage, 54, pp. 2237-2249; 
Mulholland, P.J., Susceptibility of the cerebellum to thiamine deficiency (2006) Cerebellum, 5, pp. 55-63; 
O'Reilly, J.X., Beckmann, C.F., Tomassini, V., Ramnani, N., Johansen-Berg, H., Distinct and overlapping functional zones in the cerebellum defined by resting state functional connectivity (2010) Cereb Cortex, 20, pp. 953-965; 
Phillips, S.C., Harper, C.G., Kril, J., A quantitative histological study of the cerebellar vermis in alcoholic patients (1987) Brain, 110 (PART 2), pp. 301-314; 
Ramnani, N., Frontal lobe and posterior parietal contributions to the cortico-cerebellar system (2012) Cerebellum, 11, pp. 366-383; 
Ramos, A., Quintana, F., Díez, C., Leno, C., Berciano, J., CT findings in spinocerebellar degeneration (1987) AJNR Am J Neuroradiol, 8, pp. 635-640; 
Risinger, R.C., Salmeron, B.J., Ross, T.J., Amen, S.L., Sanfilipo, M., Hoffmann, R.G., Bloom, A.S., Stein, E.A., Neural correlates of high and craving during cocaine self-administration using BOLD fMRI (2005) Neuroimage, 26, pp. 1097-1108; 
Sang, L., Qin, W., Liu, Y., Han, W., Zhang, Y., Jiang, T., Yu, C., Resting-state functional connectivity of the vermal and hemispheric subregions of the cerebellum with both the cerebral cortical networks and subcortical structures (2012) Neuroimage, 61, pp. 1213-1225; 
Schadrack, J., Willoch, F., Platzer, S., Bartenstein, P., Mahal, B., Dworzak, D., Wester, H.J., Tölle, T.R., Opioid receptors in the human cerebellum: Evidence from [11C]diprenorphine PET, mRNA expression and autoradiography (1999) Neuroreport, 10, pp. 619-624; 
Schmahmann, J.D., An emerging concept. The cerebellar contribution to higher function (1991) Arch Neurol, 48, pp. 1178-1187; 
Schmahmann, J.D., From movement to thought: Anatomic substrates of the cerebellar contribution to cognitive processing (1996) Hum Brain Mapp, 4, pp. 174-198; 
Schmahmann, J.D., Doyon, J., Toga, A.W., Petrides, M., Evans, A.C., (2000) MRI Atlas of the Human Cerebellum, p. 167. , p. San Diego, CA: Academic Press; 
Schmahmann, J.D., Disorders of the cerebellum: Ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome (2004) J Neuropsychiatry Clin Neurosci, 16, pp. 367-378; 
Schmahmann, J.D., Sherman, J.C., The cerebellar cognitive affective syndrome (1998) Brain, 121 (PART 4), pp. 561-579; 
Schneider, F., Habel, U., Wagner, M., Franke, P., Salloum, J.B., Shah, N.J., Toni, I., Zilles, K., Subcortical correlates of craving in recently abstinent alcoholic patients (2001) Am J Psychiatry, 158, pp. 1075-1083; 
Seidman, L.J., Biederman, J., Liang, L., Valera, E.M., Monuteaux, M.C., Brown, A., Kaiser, J., Makris, N., Gray matter alterations in adults with attention-deficit/hyperactivity disorder identified by voxel based morphometry (2011) Biol Psychiatry, 69, pp. 857-866; 
Sell, L.A., Morris, J.S., Bearn, J., Frackowiak, R.S.J., Friston, K.J., Dolan, R.J., Neural responses associated with cue evoked emotional states and heroin in opiate addicts (2000) Drug Alcohol Depend, 60, pp. 207-216; 
Shear, P.K., Sullivan, E.V., Lane, B., Pfefferbaum, A., Mammillary body and cerebellar shrinkage in chronic alcoholics with and without amnesia (1996) Alcohol Clin Exp Res, 20, pp. 1489-1495; 
Sim, M.E., Lyoo, I.K., Streeter, C.C., Covell, J., Sarid-Segal, O., Ciraulo, D.A., Kim, M.J., Renshaw, P.F., Cerebellar gray matter volume correlates with duration of cocaine use in cocaine-dependent subjects (2007) Neuropsychopharmacology, 32, pp. 2229-2237; 
Sneider, J.T., Pope Jr., H.G., Silveri, M.M., Simpson, N.S., Gruber, S.A., Yurgelun-Todd, D.A., Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers (2008) Eur Neuropsychopharmacol, 18, pp. 612-619; 
Solowij, N., Yücel, M., Respondek, C., Whittle, S., Lindsay, E., Pantelis, C., Lubman, D.I., Cerebellar white-matter changes in cannabis users with and without schizophrenia (2011) Psychol Med, 41, pp. 2349-2359; 
Sorensen, S.M., Johnson, S.W., Freedman, R., Persistent effects of amphetamine on cerebellar Purkinje neurons following chronic administration (1982) Brain Res, 247, pp. 365-371; 
Stoodley, C.J., The cerebellum and cognition: Evidence from functional imaging studies (2012) Cerebellum, 11, pp. 352-365; 
Stoodley, C.J., Schmahmann, J.D., Functional topography in the human cerebellum: A meta-analysis of neuroimaging studies (2009) Neuroimage, 44, pp. 489-501; 
Strick, P.L., Dum, R.P., Fiez, J.A., Cerebellum and nonmotor function (2009) Annu Rev Neurosci, 32, pp. 413-434; 
Sullivan, E.V., Deshmukh, A., Desmond, J.E., Mathalon, D.H., Rosenbloom, M.J., Lim, K.O., Pfefferbaum, A., Contribution of alcohol abuse to cerebellar volume deficits in men with schizophrenia (2000) Arch Gen Psychiatry, 57, pp. 894-902; 
Sullivan, E.V., Rohlfing, T., Pfefferbaum, A., Pontocerebellar volume deficits and ataxia in alcoholic men and women: No evidence for 'telescoping' (2010) Psychopharmacology (Berl), 208, pp. 279-290; 
Swain, R.A., Kerr, A.L., Thompson, R.F., The cerebellum: A neural system for the study of reinforcement learning (2011) Front Behav Neurosci, 5, p. 8; 
Tessner, K.D., Hill, S.Y., Neural circuitry associated with risk for alcohol use disorders (2010) Neuropsychol Rev, 20, pp. 1-20; 
Thoma, P., Bellebaum, C., Koch, B., Schwarz, M., Daum, I., The cerebellum is involved in reward-based reversal learning (2008) Cerebellum, 7, pp. 433-443; 
Tzilos, G.K., Cintron, C.B., Wood, J.B.R., Simpson, N.S., Young, A.D., Pope Jr., H.G., Yurgelun-Todd, D.A., Lack of hippocampal volume change in long-term heavy cannabis users (2005) Am J Addict, 14, pp. 64-72; 
Uǧurbil, K., Xu, J., Auerbach, E.J., Moeller, S., Vu, A.T., Duarte-Carvajalino, J.M., Lenglet, C., Yacoud, E., Pushing spatial and temporal resolution for functional and diffusion MRI in the Human Connectome Project (2013) Neuroimage, 80, pp. 80-104; 
Upadhyay, J., Maleki, N., Potter, J., Elman, I., Rudrauf, D., Knudsen, J., Wallin, D., Borsook, D., Alterations in brain structure and functional connectivity in prescription opioid-dependent patients (2010) Brain, 133 (PART 7), pp. 2098-2114; 
Volkow, N.D., Fowler, J.S., Wang, G.-J., The addicted human brain: Insights from imaging studies (2003) J Clin Invest, 111, pp. 1444-1451; 
Volkow, N.D., Gillespie, H., Mullani, N., Tancredi, L., Grant, C., Ivanovic, M., Hollister, L., Cerebellar metabolic activation by delta-9-tetrahydro-cannabinol in human brain: A study with positron emission tomography and 18F-2-fluoro-2- deoxyglucose (1991) Psychiatry Res, 40, pp. 69-78; 
Volkow, N.D., Gillespie, H., Mullani, N., Tancredi, L., Grant, C., Valentine, A., Hollister, L., Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication (1996) Psychiatry Res, 67, pp. 29-38; 
Volkow, N.D., Wang, G.J., Fowler, J.S., Hitzemann, R., Angrist, B., Gatley, S.J., Logan, J., Pappas, N., Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: Implications in addiction (1999) Am J Psychiatry, 156, pp. 19-26; 
Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Angrist, B., Hitzemann, R., Lieberman, J., Pappas, N., Effects of methylphenidate on regional brain glucose metabolism in humans: Relationship to dopamine D2 receptors (1997) Am J Psychiatry, 154, pp. 50-55; 
Volkow, N.D., Wang, G.-J., Fowler, J.S., Tomasi, D., Telang, F., Baler, R., Addiction: Decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit (2010) Bioessays, 32, pp. 748-755; 
Volkow, N.D., Wang, G.-J., Ma, Y., Fowler, J.S., Wong, C., Jayne, M., Telang, F., Swanson, J.M., Effects of expectation on the brain metabolic responses to methylphenidate and to its placebo in non-drug abusing subjects (2006) Neuroimage, 32, pp. 1782-1792; 
Volkow, N.D., Wang, G.-J., Ma, Y., Fowler, J.S., Zhu, W., Maynard, L., Telang, F., Swanson, J.M., Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers (2003) J Neurosci, 23, pp. 11461-11468; 
Walhovd, K.B., Moe, V., Slinning, K., Due-Tønnessen, P., Bjørnerud, A., Dale, A.M., Van Der Kouwe, A., Fischl, B., Volumetric cerebral characteristics of children exposed to opiates and other substances in utero (2007) Neuroimage, 36, pp. 1331-1344; 
Wang, G.J., Volkow, N.D., Fowler, J.S., Cervany, P., Hitzemann, R.J., Pappas, N.R., Wong, C.T., Felder, C., Regional brain metabolic activation during craving elicited by recall of previous drug experiences (1999) Life Sci, 64, pp. 775-784; 
Wilson, W., Mathew, R., Turkington, T., Hawk, T., Coleman, R.E., Provenzale, J., Brain morphological changes and early marijuana use: A magnetic resonance and positron emission tomography study (2000) J Addict Dis, 19, pp. 1-22; 
Yokota, O., Tsuchiya, K., Terada, S., Oshima, K., Ishizu, H., Matsushita, M., Kuroda, S., Akiyama, H., Frequency and clinicopathological characteristics of alcoholic cerebellar degeneration in Japan: A cross-sectional study of 1509 postmortems (2006) Acta Neuropathol (Berl), 112, pp. 43-51; 
Zarei, M., Mataix-Cols, D., Heyman, I., Hough, M., Doherty, J., Burge, L., Winmill, L., James, A., Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder (2011) Biol Psychiatry, 70, pp. 1083-1090; 
Zubieta, J.-K., Heitzeg, M.M., Xu, Y., Koeppe, R.A., Ni, L., Guthrie, S., Domino, E.F., Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence (2005) Am J Psychiatry, 162, pp. 567-577
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84899465796&doi=10.1111%2fadb.12101&partnerID=40&md5=3aa7b46eebf313a22949e504667b3e63
ER  - 

TY  - JOUR
TI  - Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels
T2  - Molecular Psychiatry
J2  - Mol. Psychiatry
VL  - 18
IS  - 11
SP  - 1205
EP  - 1210
PY  - 2013
DO  - 10.1038/mp.2012.140
SN  - 13594184 (ISSN) 
AU  - Jacobs, M.M.
AU  - Ökvist, A.
AU  - Horvath, M.
AU  - Keller, E.
AU  - Bannon, M.J.
AU  - Morgello, S.
AU  - Hurd, Y.L.
AD  - Departments of Psychiatry, Pharmacology and Systems Therapeutics and Neuroscience, Mount Sinai School of Medicine, One Gustave Levy Place-Box 1603, New York, NY 10029-6574, United States
AD  - Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
AD  - National Board of Forensic Medicine/Department of Forensic Medicine, Uppsala University, Uppsala, Sweden
AD  - Department of Forensic Medicine, Semmelweis University, Budapest, Hungary
AD  - Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI, United States
AD  - Department of Neurology, Mount Sinai School of Medicine, New York, NY, United States
AD  - Department of Neuroscience, Mount Sinai School of Medicine, New York, NY, United States
AB  - Opioid drugs are highly addictive and their abuse has a strong genetic load. Dopamine-glutamate interactions are hypothesized to be important for regulating neural systems central for addiction vulnerability. Balanced dopamine-glutamate interaction is mediated through several functional associations, including a physical link between discs, large homolog 4 (Drosophila) (DLG4, PSD-95) and dopamine receptor 1 (DRD1) within the postsynaptic density to regulate DRD1 trafficking. To address whether genetic associations with heroin abuse exist in relation to dopamine and glutamate and their potential interactions, we evaluated single-nucleotide polymorphisms of key genes within these systems in three populations of opiate abusers and controls, totaling 489 individuals from Europe and the United States. Despite significant differences in racial makeup of the separate samples, polymorphisms of DRD1 and DLG4 were found to be associated with opiate abuse. In addition, a strong gene-gene interaction between homer 1 homolog (Drosophila) (HOMER1) and DRD1 was predicted to occur in Caucasian subjects. This interaction was further analyzed by evaluating DRD1 genotype in relation to HOMER1b/c protein expression in postmortem tissue from a subset of Caucasian subjects. DRD1 rs265973 genotype correlated with HOMER1b/c levels in the striatum, but not cortex or amygdala; the correlation was inversed in opiate abusers as compared with controls. Cumulatively, these results support the hypothesis that there may be significant, genetically influenced interactions between glutamatergic and dopaminergic pathways in opiate abusers. © 2013 Macmillan Publishers Limited.
KW  - Addiction
KW  - Epistasis
KW  - Glutamate
KW  - Heroin
KW  - Plasticity
KW  - Postmortem
KW  - glutamic acid
KW  - messenger RNA
KW  - protein homer 1b
KW  - protein homer 1c
KW  - adult
KW  - African American
KW  - amygdaloid nucleus
KW  - article
KW  - brain cortex
KW  - Caucasian
KW  - controlled study
KW  - corpus striatum
KW  - DLG4 gene
KW  - down regulation
KW  - Drd1 gene
KW  - female
KW  - gene
KW  - gene expression
KW  - gene frequency
KW  - gene interaction
KW  - genetic association
KW  - genetic variability
KW  - genotype
KW  - heroin dependence
KW  - HOMER1 gene
KW  - human
KW  - major clinical study
KW  - male
KW  - opiate addiction
KW  - postsynaptic density
KW  - priority journal
KW  - protein expression
KW  - single nucleotide polymorphism
KW  - Adult
KW  - Amygdala
KW  - Carrier Proteins
KW  - Case-Control Studies
KW  - Cerebral Cortex
KW  - Corpus Striatum
KW  - Down-Regulation
KW  - Epistasis, Genetic
KW  - Female
KW  - Genetic Predisposition to Disease
KW  - Genetic Variation
KW  - Genotype
KW  - Humans
KW  - Intracellular Signaling Peptides and Proteins
KW  - Male
KW  - Membrane Proteins
KW  - Opioid-Related Disorders
KW  - Post-Synaptic Density
KW  - Receptors, Dopamine D1
N1  - Cited By :27
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: MOPSF
C2  - 23044706
LA  - English
N1  - Correspondence Address: Hurd, Y.L.; Departments of Psychiatry, Pharmacology and Systems Therapeutics and Neuroscience, Mount Sinai School of Medicine, One Gustave Levy Place-Box 1603, New York, NY 10029-6574, United States; email: Yasmin.Hurd@mssm.edu
N1  - Chemicals/CAS: glutamic acid, 11070-68-1, 138-15-8, 56-86-0, 6899-05-4
N1  - Funding details: CTSA, ETT/098/2009
N1  - Funding details: National Institute of Mental Health, R25MH080663, U01MH083501
N1  - Funding details: UL1RR029887
N1  - Funding details: National Institute on Drug Abuse, R01DA015446, T32DA007135, R01DA006470
N1  - Funding text 1: This work was funded by grants from the National Institute on Drug Abuse, T32DA007135 (MMJ), R01DA006470 (MJB) and R01DA015446 (YLH) and the National Institute of Mental Health, R25MH080663 (MMJ, SM) and U01MH083501 (SM), and the NIH UL1RR029887 (MSSM CTSA). EK was also supported by grant ETT/098/2009.
N1  - References: (2011) Results from the 2010 National Survey on Drug Use and Health: National Findings, , SAMHSA Office of Applied Studies, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658: Rockville MD; 
(2011) Substance Abuse and Mental Health Services Administration, , DAWN Drug Abuse Warning Network 2009 Area Profiles of Drug-Related Mortality; 
Warner-Smith, M., Darke, S., Day, C., Morbidity associated with non-fatal heroin overdose (2002) Addiction, 97, pp. 963-967; 
Uhl, G.R., Molecular genetic underpinnings of human substance abuse vulnerability: Likely contributions to understanding addiction as a mnemonic process (2004) Neuropharmacology, 47 (SUPPL1), pp. 140-147; 
Drakenberg, K., Nikoshkov, A., Horvath, M.C., Fagergren, P., Gharibyan, A., Saarelainen, K., Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers (2006) Proc Natl Acad Sci USA, 103, pp. 7883-7888; 
Nikoshkov, A., Drakenberg, K., Wang, X., Horvath, M.C., Keller, E., Hurd, Y.L., Opioid neuropeptide genotypes in relation to heroin abuse: Dopamine tone contributes to reversed mesolimbic proenkephalin expression (2008) Proc Natl Acad Sci USA, 105, pp. 786-791; 
Bart, G., Heilig, M., Laforge, K.S., Pollak, L., Leal, S.M., Ott, J., Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden (2004) Mol Psychiatry, 9, pp. 547-549; 
Zhang, H., Kranzler, H.R., Yang, B.Z., Luo, X., Gelernter, J., The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk (2008) Mol Psychiatry, 13, pp. 531-543; 
Kalivas, P.W., Volkow, N.D., The neural basis of addiction: A pathology of motivation and choice (2005) Am J Psychiatry, 162, pp. 1403-1413; 
Kennedy, M.B., Signal-processing machines at the postsynaptic density (2000) Science, 290, pp. 750-754; 
Kim, E., Sheng, M., PDZ domain proteins of synapses (2004) Nat Rev Neurosci, 5, pp. 771-781; 
Zhang, J., Vinuela, A., Neely, M.H., Hallett, P.J., Grant, S.G., Miller, G.M., Inhibition of the dopamine D1 receptor signaling by PSD-95 (2007) J Biol Chem, 282, pp. 15778-15789; 
Naisbitt, S., Kim, E., Tu, J.C., Xiao, B., Sala, C., Valtschanoff, J., Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin (1999) Neuron, 23, pp. 569-582; 
Thomas, U., Modulation of synaptic signalling complexes by Homer proteins (2002) J Neurochem, 81, pp. 407-413; 
Tu, J.C., Xiao, B., Naisbitt, S., Yuan, J.P., Petralia, R.S., Brakeman, P., Coupling of mGluR/ Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins (1999) Neuron, 23, pp. 583-592; 
Szumlinski, K.K., Ary, A.W., Lominac, K.D., Homers regulate drug-induced neuroplasticity: Implications for addiction (2008) Biochem Pharmacol, 75, pp. 112-133; 
Knackstedt, L.A., Moussawi, K., Lalumiere, R., Schwendt, M., Klugmann, M., Kalivas, P.W., Extinction training after cocaine self-Administration induces glutamatergic plasticity to inhibit cocaine seeking (2010) J Neurosci, 30, pp. 7984-7992; 
Yao, W.D., Gainetdinov, R.R., Arbuckle, M.I., Sotnikova, T.D., Cyr, M., Beaulieu, J.M., Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity (2004) Neuron, 41, pp. 625-638; 
Albertson, D.N., Schmidt, C.J., Kapatos, G., Bannon, M.J., Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse (2006) Neuropsychopharmacology, 31, pp. 2304-2312; 
Okvist, A., Fagergren, P., Whittard, J., Garcia-Osta, A., Drakenberg, K., Horvath, M.C., Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers (2011) Biol Psychiatry, 69, pp. 245-252; 
Michelhaugh, S.K., Lipovich, L., Blythe, J., Jia, H., Kapatos, G., Bannon, M.J., Mining Affymetrix microarray data for long non-coding RNAs: Altered expression in the nucleus accumbens of heroin abusers (2011) J Neurochem, 116, pp. 459-466; 
Morgello, S., Gelman, B.B., Kozlowski, P.B., Vinters, H.V., Masliah, E., Cornford, M., The national neuroaids tissue consortium: A new paradigm in brain banking with an emphasis on infectious disease (2001) Neuropathol Appl Neurobiol, 27, pp. 326-335; 
Batel, P., Houchi, H., Daoust, M., Ramoz, N., Naassila, M., Gorwood, P., A haplotype of the DRD1 gene is associated with alcohol dependence (2008) Alcohol Clin Exp Res, 32, pp. 567-572; 
Huang, W., Ma, J.Z., Payne, T.J., Beuten, J., Dupont, R.T., Li, M.D., Significant association of DRD1 with nicotine dependence (2008) Hum Genet, 123, pp. 133-140; 
Levran, O., Londono, D., O'Hara, K., Randesi, M., Rotrosen, J., Casadonte, P., Heroin addiction in African Americans: A hypothesis-driven association study (2009) Genes Brain Behav, 8, pp. 531-540; 
Le Foll, B., Gallo, A., Le Strat, Y., Lu, L., Gorwood, P., Genetics of dopamine receptors and drug addiction: A comprehensive review (2009) Behav Pharmacol, 20, pp. 1-17; 
Dahl, J.P., Kampman, K.M., Oslin, D.W., Weller, A.E., Lohoff, F.W., Ferraro, T.N., Association of a polymorphism in the Homer1 gene with cocaine dependence in an African American population (2005) Psychiatr Genet, 15, pp. 277-283; 
Preuss, U.W., Ridinger, M., Rujescu, D., Fehr, C., Koller, G., Wodarz, N., No association of alcohol dependence with HOMER 1 and 2 genetic variants (2010) Am J Med Genet B Neuropsychiatr Genet, 153 B, pp. 1102-1109; 
Wang, X., Dow-Edwards, D., Anderson, V., Minkoff, H., Hurd, Y.L., In utero marijuana exposure associated with abnormal amygdala dopamine D2 gene expression in the human fetus (2004) Biol Psychiatry, 56, pp. 909-915; 
Fagergren, P., Smith, H.R., Daunais, J.B., Nader, M.A., Porrino, L.J., Hurd, Y.L., Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine selfadministration (2003) Eur J Neurosci, 17, pp. 2212-2218; 
Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-Time quantitative PCR and the 2(-delta delta C(T)) method (2001) Methods, 25, pp. 402-408; 
Parent, A., Cote, P.Y., Lavoie, B., Chemical anatomy of primate basal ganglia (1995) Prog Neurobiol, 46, pp. 131-197; 
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., PLINK: A tool set for whole-genome association and population-based linkage analyses (2007) Am J Hum Genet, 81, pp. 559-575; 
Blum, K., Sheridan, P.J., Wood, R.C., Braverman, E.R., Chen, T.J., Cull, J.G., The D2 dopamine receptor gene as a determinant of reward deficiency syndrome (1996) J R Soc Med, 89, pp. 396-400; 
Comings, D.E., Blum, K., Reward deficiency syndrome: Genetic aspects of behavioral disorders (2000) Prog Brain Res, 126, pp. 325-341; 
Blum, K., Chen, A.L., Oscar-Berman, M., Chen, T.J., Lubar, J., White, N., Generational association studies of dopaminergic genes in reward deficiency syndrome (RDS) subjects: Selecting appropriate phenotypes for reward dependence behaviors (2011) Int J Environ Res Public Health, 8, pp. 4425-4459; 
Li, Y., Shao, C., Zhang, D., Zhao, M., Lin, L., Yan, P., The effect of dopamine D2, D5 receptor and transporter (SLC6A3) polymorphisms on the cue-elicited heroin craving in Chinese (2006) Am J Med Genet B Neuropsychiatr Genet, 141 B, pp. 269-273; 
Lawford, B.R., Young, R.M., Noble, E.P., Sargent, J., Rowell, J., Shadforth, S., The D (2) dopamine receptor A(1) allele and opioid dependence association with heroin use and response to methadone treatment (2000) Am J Med Genet, 96, pp. 592-598; 
Shahmoradgoli Najafabadi, M., Ohadi, M., Joghataie, M.T., Valaie, F., Riazalhosseini, Y., Mostafavi, H., Association between the DRD2 A1 allele and opium addiction in the Iranian population (2005) Am J Med Genet B Neuropsychiatr Genet, 134 B, pp. 39-41; 
Li, T., Xu, K., Deng, H., Cai, G., Liu, J., Liu, X., Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects (1997) Mol Psychiatry, 2, pp. 413-416; 
Szilagyi, A., Boor, K., Szekely, A., Gaszner, P., Kalasz, H., Sasvari-Szekely, M., Combined effect of promoter polymorphisms in the dopamine D4 receptor and the serotonin transporter genes in heroin dependence (2005) Neuropsychopharmacol Hung, 7, pp. 28-33; 
Shao, C., Li, Y., Jiang, K., Zhang, D., Xu, Y., Lin, L., Dopamine D4 receptor polymorphism modulates cue-elicited heroin craving in Chinese (2006) Psychopharmacology (Berl, 186, pp. 185-190; 
Lai, J.H., Zhu, Y.S., Huo, Z.H., Sun, R.F., Yu, B., Wang, Y.P., Association study of polymorphisms in the promoter region of DRD4 with schizophrenia, depression, and heroin addiction (2010) Brain Res, 1359, pp. 227-232; 
Kotler, M., Cohen, H., Kremer, I., Mel, H., Horowitz, R., Ohel, N., No association between the serotonin transporter promoter region (5-HTTLPR) and the dopamine D3 receptor (BalI D3DR) polymorphisms and heroin addiction (1999) Mol Psychiatry, 4, pp. 313-314; 
Li, T., Liu, X., Zhao, J., Hu, X., Ball, D.M., Loh El, W., Allelic association analysis of the dopamine D2 D3, 5-HT2A, and GABA(A)gamma2 receptors and serotonin transporter genes with heroin abuse in Chinese subjects (2002) Am J Med Genet, 114, pp. 329-335; 
Nicola, S.M., Surmeier, J., Malenka, R.C., Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens (2000) Annu Rev Neurosci, 23, pp. 185-215; 
Kalivas, P.W., Glutamate systems in cocaine addiction (2004) Curr Opin Pharmacol, 4, pp. 23-29; 
Hyman, S.E., Malenka, R.C., Nestler, E.J., Neural mechanisms of addiction: The role of reward-related learning and memory (2006) Annu Rev Neurosci, 29, pp. 565-598; 
Ghasemzadeh, M.B., Permenter, L.K., Lake, R., Worley, P.F., Kalivas, P.W., Homer1 proteins and AMPA receptors modulate cocaine-induced behavioural plasticity (2003) Eur J Neurosci, 18, pp. 1645-1651; 
Szumlinski, K.K., Dehoff, M.H., Kang, S.H., Frys, K.A., Lominac, K.D., Klugmann, M., Homer proteins regulate sensitivity to cocaine (2004) Neuron, 43, pp. 401-413
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84888302271&doi=10.1038%2fmp.2012.140&partnerID=40&md5=3f0e8504a668b217cea7fe550d7ba541
ER  - 

TY  - JOUR
TI  - Sleep disordered breathing in patients receiving therapy with buprenorphine/naloxone
T2  - European Respiratory Journal
J2  - Eur. Respir. J.
VL  - 42
IS  - 2
SP  - 394
EP  - 403
PY  - 2013
DO  - 10.1183/09031936.00120012
SN  - 09031936 (ISSN) 
AU  - Farney, R.J.
AU  - McDonald, A.M.
AU  - Boyle, K.M.
AU  - Snow, G.L.
AU  - Nuttall, R.T.
AU  - Coudreaut, M.F.
AU  - Wander, T.J.
AU  - Walker, J.M.
AD  - Intermountain Sleep Disorders Center, LDS Hospital, 325 8th Ave and C Street, Salt Lake City, UT 84143, United States
AD  - Statistical Data Center, LDS Hospital, Salt Lake City, UT, United States
AD  - Psychiatry Dept, LDS Hospital, Salt Lake City, UT, United States
AB  - Patients using chronic opioids are at risk for exceptionally complex and potentially lethal disorders of breathing during sleep, including central and obstructive apnoeas, hypopnoeas, ataxic breathing and nonapnoeic hypoxaemia. Buprenorphine, a partial m-opioid agonist with limited respiratory toxicity, is widely used for the treatment of opioid dependency and chronic nonmalignant pain. However, its potential for causing sleep disordered breathing has not been studied. 70 consecutive patients admitted for therapy with buprenorphine/ naloxone were routinely evaluated with sleep medicine consultation and attended polysomnography. The majority of patients were young (mean-SD age 31.8±12.3 years), nonobese (mean-SD body mass index 24.9±5.9 kgm-2) and female (60%). Based upon the apnoea/hypopnoea index (AHI), at least mild sleep disordered breathing (AHI o5 events?h-1) was present in 63% of the group. Moderate (AHI 15&lt;,30 eventsh-1) and severe (AHI o30 events?h-1) sleep apnoea was present in 16% and 17%, respectively. Hypoxaemia, defined as an arterial oxygen saturation measured by pulse oximetry, of ,90% for o10% of sleep time, was present in 27 (38.6%) patients. Despite the putative protective ceiling effect regarding ventilatory suppression observed during wakefulness, buprenorphine may induce significant alterations of breathing during sleep at routine therapeutic doses. Copyright © ERS 2013.
KW  - buprenorphine
KW  - buprenorphine plus naloxone
KW  - adult
KW  - aged
KW  - apnea hypopnea index
KW  - article
KW  - body mass
KW  - consultation
KW  - disease severity
KW  - female
KW  - hospital admission
KW  - human
KW  - major clinical study
KW  - male
KW  - opiate addiction
KW  - oxygen saturation
KW  - polysomnography
KW  - prevalence
KW  - priority journal
KW  - pulse oximetry
KW  - sleep disordered breathing
KW  - sleep medicine
KW  - sleep time
KW  - Adolescent
KW  - Adult
KW  - Buprenorphine
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Naloxone
KW  - Narcotic Antagonists
KW  - Opioid-Related Disorders
KW  - Polysomnography
KW  - Respiration
KW  - Sleep Apnea Syndromes
KW  - Young Adult
N1  - Cited By :31
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: ERJOE
C2  - 23100497
LA  - English
N1  - Correspondence Address: Farney, R.J.; Intermountain Sleep Disorders Center, LDS Hospital, 325 8th Ave and C Street, Salt Lake City, UT 84143, United States; email: rjfmd@msn.com
N1  - Chemicals/CAS: buprenorphine, 52485-79-7, 53152-21-9
N1  - Tradenames: suboxone; subutex
N1  - References: Farney, R.J., Walker, J.M., Cloward, T.V., Sleep-disordered breathing associated with long-term opioid therapy (2003) Chest, 123, pp. 632-639; 
Walker, J.M., Farney, R.J., Rhondeau, S.M., Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing (2007) J Clin Sleep Med, 3, pp. 455-461; 
Teichtahl, H., Prodomidis, A., Miller, B., Sleep-disordered breathing in stable methadone programme patients: A pilot study (2001) Addiction, 96, pp. 395-403; 
Webster, L.R., Choi, Y., Desai, H., Sleep-disordered breathing and chronic opioid therapy (2008) Pain Med, 9, pp. 425-432; 
Farney, R.J., Walker, J.M., Central sleep apnea due to drug or substance (2013) The Encyclopedia of Sleep., 3, pp. 253-264. , Kushida C, ed Waltham, MA, Academic Press; 
Increase in poisoning deaths caused by non-illicit drugs - Utah, 1991-2003 (2005) MMWR Morb Mortal Wkly Rep, 54, pp. 33-36. , Centers for Disease Control and Prevention (CDC); 
Vital signs: Overdoses of prescription opioid pain relievers - United States, 1999-2008 (2011) MMWR Morb Mortal Wkly Rep, 60, pp. 1487-1492. , Centers for Disease Control and Prevention (CDC); 
Chung, F., Yegneswaran, B., Liao, P., STOP questionnaire: A tool to screen patients for obstructive sleep apnea (2008) Anesthesiology, 108, pp. 812-821; 
Kuehn, B.M., Opioid prescriptions soar: Increase in legitimate use as well as abuse (2007) JAMA, 297, pp. 249-251; 
(2009) National Forensic Laboratory Information System (NFLIS). Special Report: Methadone and Buprenorphine, 2003-2008, , Office of Diversion Control Washington, US Drug Enforcement Administration; 
Walsh, S.L., Preston, K.L., Stitzer, M.L., Clinical pharmacology of buprenorphine: Ceiling effects at high doses (1994) Clin Pharmacol Ther, 55, pp. 569-580; 
Johnson, R.E., Fudala, P.J., Payne, R., Buprenorphine: Considerations for pain management (2005) J Pain Symptom Manage, 29, pp. 297-326; 
Kahan, M., Srivastava, A., Ordean, A., Buprenorphine: New treatment of opioid addiction in primary care (2011) Can Fam Physician, 57, pp. 281-289; 
Dahan, A., Yassen, A., Romberg, R., Buprenorphine induces ceiling in respiratory depression but not in analgesia (2006) Br J Anaesth, 96, pp. 627-632; 
Dahan, A., Yassen, A., Bijl, H., Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats (2005) Br J Anaesth, 94, pp. 825-834; 
Auriacombe, M., Franques, P., Tignol, J., Deaths attributable to methadone vs buprenorphine in France (2001) JAMA, 285, p. 45; 
Auriacombe, M., Fatséas, M., Dubernet, J., French field experience with buprenorphine (2004) Am J Addict, 13 (SUPPL. 1), pp. S17-S28; 
http://buprenorphine.samhsa.gov/fulllaw.html, Substance Abuse and Mental Health Services Administration. Buprenorphine Drug Addiction Treatment Act of 2000 Date last accessed June 9, 2013. Date last updated 2000; Ladi, L., Wang, J., Getsy, J., Sleep-disordered breathing with buprenorphine-naloxone use: A case report (2010) Chest, 138, pp. 700A; 
McNicholas, L., Clinical Guidelines for the use of Buprenorphine in the Treatment of Opioid Addiction (2004) A Treatment Improvement Protocol. TIP 40, , Rockville, US Department of Health and Human Services; 
Farney, R.J., Walker, J.M., Cloward, T.V., Polysomnography in hospitalized patients using a wireless wide area network (2006) J Clin Sleep Med, 2, pp. 28-34; 
Iber, C., Ancoli-Israel, S., Chesson, A., (2007) The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, , 1st Edn. Westchester, American Academy of Sleep Medicine; 
Farney, R.J., Walker, J.M., Boyle, K.M., Adaptive servoventilation (ASV) in patients with sleep disordered breathing associated with chronic opioid medications for non-malignant pain (2008) J Clin Sleep Med, 4, pp. 311-319; 
Breiman, L., Random forests (2001) Machine Learning, 45, pp. 5-32; 
Breiman, L., Manual on Setting Up Using and Understanding Random Forests V3.1., , http://oz.berkeley.edu/users/breiman/Using_random_forests_V31.pdf, Date last accessed: June 10, 2013; 
Liaw, A., Wiener, M., Classification and regression by random forest (2002) R News, 2, pp. 18-22; 
Conover, W.J., One-sample Kolmogorov test (1971) Practical Nonparametric Statistics, pp. 295-301. , 1st Edn. New York, John Wiley & Sons; 
Conover, W.J., Two-sample Smirnov test (1971) Practical Nonparametric Statistics, pp. 309-314. , 1st Edn. New York, John Wiley & Sons; 
Farney, R.J., Walker, B.S., Farney, R.M., The STOP-Bang equivalent model and prediction of severity of obstructive sleep apnea: Relation to polysomnographic measurements of the apnea/hypopnea index (2011) J Clin Sleep Med, 7, pp. 459-465; 
Hukins, C., Mallampati class is not useful in the clinical assessment of sleep clinic patients (2010) J Clin Sleep Med, 6, pp. 545-549; 
Bowman, A.W.A., (1997) Applied Smoothing Techniques for Data Analysis. The Kernel Approach with S-Plus Illustrations, , NewYork, Oxford University Press; 
Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: A practical and powerful approach to multiple testing (1995) J R Stat Soc Series B Stat Methodol, 57, pp. 289-300; 
Mégarbane, B., Hreiche, R., Pirnay, S., Does high-dose buprenorphine cause respiratory depression? Possible mechanisms and therapeutic consequences (2006) Toxicol Rev, 25, pp. 79-85; 
Labby, D., Koder, M., Amann, T., Opioids and chronic non-malignant pain: A clinician?s handbook (2003) Portland Care Oregon; 
Pattinson, K.T., Opioids and the control of respiration (2008) Br J Anaesth, 100, pp. 747-758; 
Pasternak, G.W., Incomplete cross tolerance and multiple m-opioid peptide receptors (2001) Trends Pharmacol Sci, 22, pp. 67-70; 
Xie, G.X., Palmer, P.P., RGS proteins: New players in the field of opioid signaling and tolerance mechanisms (2005) Anesth Analg, 100, pp. 1034-1042; 
Walsh, S.L., Eissenberg, T., The clinical pharmacology of buprenorphine: Extrapolating from the laboratory to the clinic (2003) Drug Alcohol Depend, 70 (SUPPL. 2), pp. S13-S27; 
Walsh, S.L., Preston, K.L., Bigelow, G.E., Acute administration of buprenorphine in humans: Partial agonist and blockade effects (1995) J Pharmacol Exp Ther, 274, pp. 361-372; 
Walsh, S.L., June, H.L., Schuh, K.J., Effects of buprenorphine and methadone in methadone-maintained subjects (1995) Psychopharmacology (Berl), 119, pp. 268-276; 
Kintz, P., Deaths involving buprenorphine: A compendium of French cases (2001) Forensic Sci Int, 121, pp. 65-69; 
Kintz, P., A new series of buprenorphine-related deaths (2002) Clin Biochem, 35, pp. 513-516; 
Boyd, J., Randell, T., Luurila, H., Serious overdoses involving buprenorphine in Helsinki (2003) Acta Anaesthesiol Scand, 47, pp. 1031-1033; 
Mogri, M., Desai, H., Webster, L., Hypoxemia in patients on chronic opiate therapy with and without sleep apnea (2009) Sleep Breath, 13, pp. 49-57; 
Javaheri, S., Malik, A., Smith, J., Adaptive pressure support servoventilation: A novel treatment for sleep apnea associated with use of opioids (2008) J Clin Sleep Med, 4, pp. 305-310
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84882726713&doi=10.1183%2f09031936.00120012&partnerID=40&md5=3de4178031ebafc8f3f86de8706328f8
ER  - 

TY  - CONF
TI  - A multi-objective program for quantitative subtyping of clinically relevant phenotypes
C3  - Proceedings - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012
J2  - Proc. - IEEE Int. Conf. Bioinformatics Biomed., BIBM
SP  - 256
EP  - 261
PY  - 2012
DO  - 10.1109/BIBM.2012.6392679
SN  - 9781467325585 (ISBN)
AU  - Sun, J.
AU  - Bi, J.
AU  - Kranzler, H.R.
AD  - Department of Computer Science and Engineering, University of Connecticut, Storrs, CT, United States
AD  - Treatment Research Center, University of Pennsylvania, Philadelphia, PA, United States
AB  - Identifying genetic variations that underlie human disease is very important to advance our understanding of the disease's pathophysiology and promote its personalized treatment. However, many disease phenotypes have complex clinical manifestations and a complicated etiology. Gene finding efforts for complex diseases have had limited success to date. Research results suggest that one way to enhance these efforts is to differentiate subtypes of a complex multifactorial disease phenotype. Existing subtyping methods rely on cluster analysis using only clinical features of a disorder without guidance from genetic data, resulting in subtypes for which genotype association may be limited. In this work, we seek to derive a novel computational method based on multi-objective programming that is capable of clinically categorizing a disease phenotype so as to discover genetically different subtypes. Our approach optimizes two objectives: (1) the cluster-derived subtypes should differ significantly on clinical features; (2) these subtypes can be well separated using candidate genes. This work has been motivated by clinical studies of opioid dependence, a serious, prevalent disorder that is heterogeneous phenotypically. Analyses on a sample of 1,470 European American subjects aggregated from multiple genetic studies of opioid dependence show that the proposed algorithm is superior to existing subtyping methods. © 2012 IEEE.
KW  - Cluster analysis
KW  - Gene finding
KW  - Multi-objective optimization
KW  - Opioid dependence
KW  - Subtyping
KW  - Candidate genes
KW  - Clinical features
KW  - Clinical manifestation
KW  - Clinical study
KW  - Complex disease
KW  - Gene finding
KW  - Genetic data
KW  - Genetic studies
KW  - Genetic variation
KW  - Human disease
KW  - Multi objective
KW  - Multi objective optimizations (MOO)
KW  - Multifactorial disease
KW  - Multiobjective programming
KW  - Opioid dependence
KW  - Pathophysiology
KW  - Research results
KW  - Subtypings
KW  - Cluster analysis
KW  - Genes
KW  - Genetic programming
KW  - Multiobjective optimization
KW  - Bioinformatics
T2  - 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM2012
Y2  - 4 October 2012 through 7 October 2012
CY  - Philadelphia, PA
N1  - Conference code: 95020
N1  - Cited By :2
N1  - Export Date: 13 November 2019
M3  - Conference Paper
DB  - Scopus
C7  - 6392679
LA  - English
N1  - Correspondence Address: Sun, J.; Department of Computer Science and Engineering, University of Connecticut, Storrs, CT, United States; email: javon@engr.uconn.edu
N1  - References: Sorlie, T., Introducing molecular subtyping of breast cancer into the clinic? (2009) Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 27 (8), p. 1153; 
Godfrey, A., Leonard, M., Donnelly, S., Conroy, M., Laighin, G.I., Meagher, D., Validating a new clinical subtyping scheme for delirium with electronic motion analysis (2010) Psychiatry Research, 178 (1), pp. 186-190; 
Glahn, D.C., Curran, J.E., Winkler, A.M., High dimensional endophenotype ranking in the search for major depression risk genes (2012) Biological Psychiatry, 71 (1), pp. 6-14; 
Kendler, K.S., Jacobson, K.C., Prescott, C.A., Neale, M.C., Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins (2003) Am J Psychiatry, 160 (4), pp. 687-695; 
(2000) Diagnostic and Statistical Manual of Mental Disorders DSMIV-TR, , 4th ed. Amer Psychiatric Pub; 
Gelernter, J., Panhuysen, C., Wilcox, M., Hesselbrock, V., Rounsaville, B., Poling, J., Weiss, R., Kranzler, H.R., Genomewide linkage scan for opioid dependence and related traits (2006) Am J Hum Genet, 78 (5), pp. 759-769; 
Chan, G., Gelernter, J., Oslin, D., Farrer, L., Kranzler, H.R., Empirically derived subtypes of opioid use and related behaviors (2011) Addiction, 106 (6), pp. 1146-1154; 
Sun, J., Bi, J., Chan, G., Oslin, D., Farrer, L., Gelernter, J., Kranzler, H., Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors (2012) Addictive Behaviors; 
Dunn, J.C., Well separated clusters and optimal fuzzypartitions (1974) Journal of Cybernetics, 4, pp. 95-104; 
Davies, D.L., Bouldin, D.W., A cluster separation measure (1979) IEEE Transactions on Pattern Analysis and Machine Intelligence, PAMI-1 (2), pp. 224-227. , Apr; 
Bi, J., Multi-objective programming in svms International Conference on Machine Learning, 2003, pp. 35-42; 
Luxburg, U., A tutorial on spectral clustering (2007) Statistics and Computing, 17, pp. 395-416. , December; 
Zhu, J., Rosset, S., Hastie, T., Tibshirani, R., 1-Norm support vector machines (2003) Neural Information Processing Systems, p. 16. , MIT Press; 
Ng, A.Y., Jordan, M.I., Weiss, Y., On spectral clustering: Analysis and an algorithm (2001) Advances in Neural Information Processing Systems, pp. 849-856. , MIT Press; 
Kirkpatrick, S., Gelatt, C.D., Vecchi, M.P., Optimization by simulated annealing (1983) Science, 220 (4598), pp. 671-680. , 13 May 4598, 1983; 
Ingber, L., Very fast simulated re-annealing (1989) Mathematical and Computer Modelling, 12 (8), pp. 967-973; 
Pierucci-Lagha, A., Gelernter, J., Chan, G., Arias, A., Cubells, J.F., Farrer, L., Kranzler, H.R., Reliability of dsm-iv diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (ssadda) (2007) Drug Alcohol Depend, 91 (1), pp. 85-90; 
Abdi, H., Valentin, D., Multiple correspondence analysis (2007) Encyclopedia of Measurement and Statistics, p. 7. , Salkind N., editor. vol. Thousand Oaks, CA: SAGE
A4  - IEEE; IEEE Computer Society; National Science Foundation (NSF); OmicSoft Corporation; IEEE Computer Society Technical Committee on Bioinformatics
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872503665&doi=10.1109%2fBIBM.2012.6392679&partnerID=40&md5=497f552159e3ab5a4fd3253bc20acb87
ER  - 

TY  - JOUR
TI  - Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors
T2  - Addictive Behaviors
J2  - Addict. Behav.
VL  - 37
IS  - 10
SP  - 1138
EP  - 1144
PY  - 2012
DO  - 10.1016/j.addbeh.2012.05.010
SN  - 03064603 (ISSN) 
AU  - Sun, J.
AU  - Bi, J.
AU  - Chan, G.
AU  - Oslin, D.
AU  - Farrer, L.
AU  - Gelernter, J.
AU  - Kranzler, H.R.
AD  - Department of Computer Science and Engineering, University of Connecticut, Storrs, CT, United States
AD  - Department of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, United States
AD  - Department of Psychiatry, University of Pennsylvania School of Medicine and the VISN 4 MIRECC, Philadelphia VAMC, Philadelphia, PA, United States
AD  - Departments of Medicine (Genetics Program), Neurology, Genetics and Genomics, Epidemiology, and Biostatistics, Boston University Schools of Medicine and Public Health, Boston, MA, United States
AD  - Departments of Psychiatry, Genetics, and Neurobiology, Yale University School of Medicine, New Haven, CT and VA CT Healthcare Center, West Haven, CT, United States
AB  - Although there is evidence that opioid dependence (OD) is heritable, efforts to identify genes contributing to risk for the disorder have been hampered by its complex etiology and variable clinical manifestations. Decomposition of a complex set of opioid users into homogeneous subgroups could enhance genetic analysis. We applied a series of data mining techniques, including multiple correspondence analysis, variable selection and cluster analysis, to 69 opioid-related measures from 5390 subjects aggregated from family-based and case-control genetic studies to identify homogeneous subtypes and estimate their heritability. Novel aspects of this work include our use of 1) heritability estimates of specific clinical features of OD to enhance the heritability of the subtypes and 2) a k-medoids clustering method in combination with hierarchical clustering to yield replicable clusters that are less sensitive to noise than previous methods. We identified five homogeneous groups, including two large groups comprised of 762 and 1353 heavy opioid users, with estimated heritability of 0.69 and 0.76, respectively. These methods represent a promising approach to the identification of highly heritable subtypes in complex, heterogeneous disorders. © 2012.
KW  - Heritability
KW  - Hierarchical clustering
KW  - K-medoids clustering
KW  - Opioid dependence
KW  - Phenotype
KW  - Subtypes
KW  - opiate
KW  - adult
KW  - article
KW  - clinical feature
KW  - cluster analysis
KW  - comorbidity
KW  - controlled study
KW  - data analysis
KW  - female
KW  - genetic analysis
KW  - heritability
KW  - human
KW  - major clinical study
KW  - male
KW  - opiate addiction
KW  - prevalence
KW  - procedures
KW  - substance abuse
KW  - Adult
KW  - Behavior, Addictive
KW  - Case-Control Studies
KW  - Data Mining
KW  - Female
KW  - Genetic Linkage
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Opioid-Related Disorders
KW  - Phenotype
N1  - Cited By :24
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: ADBED
C2  - 22694982
LA  - English
N1  - Correspondence Address: Kranzler, H.R.; Department of Psychiatry, University of Pennsylvania School of Medicine, Treatment Research Center, 3900 Chestnut St., Philadelphia, PA 19104, United States; email: kranzler_h@mail.trc.upenn.edu
N1  - Chemicals/CAS: opiate, 53663-61-9, 8002-76-4, 8008-60-4
N1  - Funding details: Novartis Pharmaceuticals Canada
N1  - Funding details: Eisai
N1  - Funding details: National Institutes of Health, DA22288, AA11330, GM08607, DA12690, DA005186, DA12849, DA15105, AA13736, AA03510
N1  - Funding text 1: Mr. Sun and Drs. Bi, Chan, Gelernter, and Oslin have no disclosures. Dr. Farrer received a research grant from Eisai Pharmaceuticals and consultant fees from Novartis Pharmaceuticals. Dr. Kranzler has been a paid consultant for Alkermes, Lilly, Lundbeck, Pfizer, and Roche. He also reports associations with Eli Lilly, Janssen, Schering Plough, Lundbeck, Alkermes, GlaxoSmithKline, Abbott, and Johnson & Johnson, as these companies provide support to the ACNP Alcohol Clinical Trials Initiative (ACTIVE) and he receives support from ACTIVE.
N1  - Funding text 2: This work was supported by NIH grants DA12849 , DA12690 , DA22288 , DA15105 , DA005186 , AA03510 , AA11330 , AA13736 , and GM08607 and the VA CT and Philadelphia VA Mental Illness Research, Education, and Clinical Centers (MIRECCs) . Appendix A
N1  - References: Abdi, H., Valentin, D., Multiple correspondence analysis (2007) Encyclopedia of measurement and statistics, pp. 651-657. , Sage, Thousand Oaks, N. Salkind (Ed.); 
Almasy, L., Blangero, J., Multipoint quantitative-trait linkage analysis in general pedigrees (1998) The American Journal of Human Genetics, 62, pp. 1198-1211; 
(1994) Diagnosis and statistical manual of mental disorders (fourth edition), , American Psychiatric Press, Inc, Washington DC, American Psychiatric Association; 
Anthony, J., Warner, L., Kessler, R., Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey (1994) Experimental and Clinical Psychopharmacology, 2 (3), pp. 244-268; 
Ball, S.A., Carroll, K.M., Babor, T.F., Rounsaville, B.J., Subtypes of cocaine abusers: Support for a type A-type B distinction (1995) Journal of Consulting and Clinical Psychology, 63 (1), pp. 115-124; 
Basu, D., Ball, S.A., Feinn, R., Gelernter, J., Kranzler, H.R., Typologies of drug dependence: Comparative validity of a multivariate and four univariate models (2004) Drug and Alcohol Dependence, 73 (3), pp. 289-300; 
Bell, A.E., Heritability in retrospect (1977) Journal of Heredity, 68 (5), pp. 297-300; 
Benzecri, J.P., (1992) Correspondence analysis handbook, , Marcel Dekker, New York; 
Calinski, T., Harabasz, J., A dendrite method for cluster analysis (1974) Communications in Statistics - Simulation and Computation, 3, pp. 1-27; 
Chan, G., Gelernter, J., Oslin, D., Farrer, L., Kranzler, H.R., Empirically derived subtypes of opioid use and related behaviors (2011) Addiction, 106 (6), pp. 1146-1154; 
Craig, R.J., Olson, R., MMPI subtypes for cocaine abusers (1992) The American Journal of Drug and Alcohol Abuse, 18 (2), pp. 197-205; 
Day, W.H., Edelsbrunner, H., Efficient algorithms for agglomerative hierarchical clustering methods (1984) Journal of Classification, 1, pp. 7-24; 
Dick, D.M., Agrawal, A., The genetics of alcohol and other drug dependence (2008) Alcohol Research & Health, 31 (2), pp. 111-118; 
Epstein, E.E., Labouvie, E., McCrady, B.S., Jensen, N.K., Hayaki, J., A multi-site study of alcohol subtypes: Classification and overlap of unidimensional and multi-dimensional typologies (2002) Addiction, 97 (8), pp. 1041-1053; 
Gelernter, J., Panhuysen, C., Weiss, R., Brady, K., Hesselbrock, V., Rounsaville, B., Genomewide linkage scan for cocaine dependence and related traits: Significant linkages for a cocaine-related trait and cocaine-induced paranoia (2005) American Journal of Medical Genetics, 136 B (1), pp. 45-52; 
Gelernter, J., Panhuysen, C., Wilcox, M., Hesselbrock, V., Rounsaville, B., Poling, J., Genomewide linkage scan for opioid dependence and related traits (2006) The American Journal of Human Genetics, 78 (5), pp. 759-769; 
Greenacre, M., Hastie, T., The geometric interpretation of correspondence analysis (1987) Journal of the American Statistical Association, 82, pp. 437-447; 
Guyon, I., Elisseeff, A., An introduction to variable and feature selection (2003) Journal of Machine Learning Research, 3, pp. 1157-1182; 
Hastie, T., Tibshirani, R., Friedman, J., (2001) The elements of statistical learning: Data mining, inference and prediction, , Springer, New York; 
Kaufman, L., Rousseeuw, P.J., (1990) Finding groups in data: An introduction to cluster analysis, , Wiley, New York; 
Kendler, K.S., Jacobson, K.C., Prescott, C.A., Neale, M.C., Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins (2003) The American Journal of Psychiatry, 160 (4), pp. 687-695; 
Kranzler, H.R., Wilcox, M., Weiss, R.D., Brady, K., Hesselbrock, V., Rounsaville, B., The validity of cocaine dependence subtypes (2008) Addictive Behaviors, 33 (1), pp. 41-53; 
LeRoux, B., Rouanet, H., (2009) Multiple correspondence analysis, , Sage, Los Angeles; 
Moss, H.B., Chen, C.M., Yi, H.Y., Subtypes of alcohol dependence in a nationally representative sample (2007) Drug and Alcohol Dependence, 91 (2-3), pp. 149-158; 
Milligan, G.W., Ultrametric hierarchical clustering algorithms (1979) Psychometrika, 44, pp. 343-346; 
Murtagh, F., Multiple correspondence analysis and related methods (2007) Psychometrika, 72, pp. 275-277; 
Pierucci-Lagha, A., Gelernter, J., Chan, G., Arias, A., Cubells, J.F., Farrer, L., Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA) (2007) Drug and Alcohol Dependence, 91 (1), pp. 85-90; 
Pierucci-Lagha, A., Gelernter, J., Feinn, R., Cubells, J.F., Pearson, D., Pollastri, A., Diagnostic reliability of the semi-structured assessment for drug dependence and alcoholism (SSADDA) (2005) Drug and Alcohol Dependence, 80 (3), pp. 303-312; 
Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L., Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study (1990) Journal of the American Medical Association, 264 (19), pp. 2511-2518; 
Sabb, F., Burggren, A., Higier, R., Fox, J., He, J., Parker, D., Challenges in phenotype definition in the whole-genome era: Multivariate models of memory and intelligence (2009) Neuroscience, 164 (1), pp. 88-107; 
(2008) SAS(r) 9.2 enhanced logging facilities, , SAS Institute Inc, Cary, NC, SAS Institute Inc; 
Saxon, A.J., Oreskovich, M.R., Brkanac, Z., Genetic determinants of addiction to opioids and cocaine (2005) Harvard Review of Psychiatry, 13 (4), pp. 218-232; 
Seber, G.A.F., (1984) Multivariate observations, , Wiley, New York; 
Results from the 2006 National Survey on Drug Use and Health: National findings (2007) Office of Applied Studies, NSDUH Series H-32, DHHS Publication No. SMA 07-4293) Rockville, , Substance Abuse and Mental Health Services Administration; 
Tan, P.-N., Steinbach, M., Kumar, V., (2006) Introduction to data mining, , Pearson Addison Wesley, Boston; 
Theodoridis, S., Koutroumbas, K., (1999) Pattern recognition, , Academic Press, San Diego; 
van der Laan, M., Pollard, K., Bryan, J., A new partitioning around medoids algorithm (2003) Journal of Statistical Computation and Simulation, 73 (8), pp. 575-584
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863220072&doi=10.1016%2fj.addbeh.2012.05.010&partnerID=40&md5=182549e9ef5e46d0849d978521de512b
ER  - 

TY  - JOUR
TI  - Prenatal morphine alters the synaptic complex of postsynaptic density 95 with N-methyl-d-aspartate receptor subunit in hippocampal CA1 subregion of rat offspring leading to long-term cognitive deficits
T2  - Neuroscience
J2  - Neuroscience
VL  - 158
IS  - 4
SP  - 1326
EP  - 1337
PY  - 2009
DO  - 10.1016/j.neuroscience.2008.11.007
SN  - 03064522 (ISSN) 
AU  - Lin, C.S.
AU  - Tao, P.L.
AU  - Jong, Y.J.
AU  - Chen, W.F.
AU  - Yang, C.H.
AU  - Huang, L.T.
AU  - Chao, C.F.
AU  - Yang, S.N.
AD  - Graduate Institute of Medical Sciences, National Defense Medical Center, Taiwan
AD  - Department of Emergency and Critical Care Medicine, Cheng Hsin Rehabilitation Medical Center, Taiwan
AD  - Department of Pharmacology, National Defense Medical Center, Taiwan
AD  - Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Taiwan
AD  - Graduate Institute of Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, No. 100, Tz-Yu 1st Road, Kaohsiung, 807, Taiwan
AD  - Department of Neurosurgery, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan
AD  - Department of Pediatrics, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan
AD  - Center of Excellence for Environmental Medicine, Kaohsiung Medical University, Taiwan
AB  - Infants who are passively exposed to morphine or heroin through their addicted mothers usually develop neurobiological changes. The postsynaptic density 95 (PSD-95) protein, a submembranous cytoskeletal specialization, is dynamically linked with N-methyl-d-aspartate receptors (NMDARs) to form a synaptic complex in postsynaptic neurons. This complex serves important neurobiological functions, including mammalian learning and memory. However, the effects of prenatal morphine exposure on this synaptic complex are not well understood. In this study, we determined whether prenatal morphine exposure altered the synaptic complex association between PSD-95 and three major NMDAR subunits (NR1, NR2A, and NR2B), at the mRNA and protein levels, within the hippocampal CA1 subregion (an important integration area for mammalian learning and memory) of rat offspring along with the performance of long-term cognitive functions. Sprague-Dawley rat offspring from morphine-addicted mothers were studied at a younger age (postnatal day 14; P14) and at an older age (P45). Subsequently, an eight-arm radial maze task was applied to analyze the working and cued reference memory in such offspring (P45). The real-time polymerase chain reaction results showed that prenatal morphine exposure caused significant decreases in mRNA levels of the PSD-95 and three NMDAR subunits (NR1, NR2A, and NR2B) in offspring (P14 and P45). Similarly, at the protein level, immunoblotting showed that decreased whole levels of PSD-95 and NMDAR subunits were seen in offspring subjected with prenatal morphine. Furthermore, the protein interaction of the synaptic complex between the PSD-95 and NMDAR subunit, as indicated by coimmunoprecipitation, was less in prenatal morphine samples than in vehicle controls (P14 and P45). The prenatal morphine group also showed poorer performance for an eight-arm radial maze task than the vehicle-control group. These results are particularly important for a better understanding of certain opioid-mediated neurobehavioral cognitive changes in offspring associated with altered protein interaction between PSD-95 and NMDAR subunits within the developing brain. © 2009 IBRO.
KW  - glutamate receptor
KW  - heroin
KW  - learning and memory
KW  - opiate addiction
KW  - synaptic plasticity
KW  - diamorphine
KW  - messenger RNA
KW  - morphine
KW  - n methyl dextro aspartic acid receptor 1
KW  - n methyl dextro aspartic acid receptor 2A
KW  - n methyl dextro aspartic acid receptor 2B
KW  - postsynaptic density protein 95
KW  - animal experiment
KW  - animal tissue
KW  - article
KW  - cognitive defect
KW  - controlled study
KW  - hippocampus
KW  - immunoblotting
KW  - immunoprecipitation
KW  - learning
KW  - maze test
KW  - memory
KW  - nerve cell plasticity
KW  - neurobiology
KW  - nonhuman
KW  - opiate addiction
KW  - prenatal drug exposure
KW  - priority journal
KW  - progeny
KW  - protein blood level
KW  - protein interaction
KW  - rat
KW  - real time polymerase chain reaction
KW  - reference memory
KW  - Sprague Dawley rat
KW  - synapse
KW  - Western blotting
KW  - working memory
KW  - Age Factors
KW  - Animals
KW  - Animals, Newborn
KW  - Body Weight
KW  - Cognition Disorders
KW  - Female
KW  - Gene Expression Regulation, Developmental
KW  - Hippocampus
KW  - Immunoprecipitation
KW  - Intracellular Signaling Peptides and Proteins
KW  - Male
KW  - Maze Learning
KW  - Membrane Proteins
KW  - Morphine
KW  - Pregnancy
KW  - Prenatal Exposure Delayed Effects
KW  - Protein Subunits
KW  - Rats
KW  - Rats, Sprague-Dawley
KW  - Receptors, N-Methyl-D-Aspartate
KW  - RNA, Messenger
N1  - Cited By :30
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: NRSCD
C2  - 19041927
LA  - English
N1  - Correspondence Address: Yang, S.N.; Department of Pediatrics, Kaohsiung Medical University Hospital, Kaohsiung Medical UniversityTaiwan; email: y520729@gmail.com
N1  - Chemicals/CAS: diamorphine, 1502-95-0, 561-27-3; morphine, 52-26-6, 57-27-2; Dlgh4 protein, rat; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Morphine, 57-27-2; Protein Subunits; RNA, Messenger; Receptors, N-Methyl-D-Aspartate
N1  - Funding details: National Science Council, NSC, NSC96-2320-B-182A-010-MY2
N1  - Funding details: Kaohsiung Medical University, KMU-97-EM3.2
N1  - Funding details: Yen Tjing Ling Industrial Research Institute, National Taiwan University, NHRI-EX97-9601NP
N1  - Funding text 1: This study was financially supported by National Health Research Institute, Taiwan (grant number: NHRI-EX97-9601NP), National Science Council, Taiwan (grant number: NSC96-2320-B-182A-010-MY2), Kaohsiung Medical University (grant number: KMU-97-EM3.2.b).
N1  - References: Bannerman, D.M., Niewoehner, B., Lyon, L., Romberg, C., Schmitt, W.B., Taylor, A., Sanderson, D.J., Rawlins, J.N.P., NMDA receptor subunit NR2A is required for rapidly acquired spatial working memory but not incremental spatial reference memory (2008) J Neurosci, 28, pp. 3623-3630; 
Bender, R.A., Luterborn, J.C., Gall, C.M., Cariage, W., Baram, T.Z., Enhanced phosphorylation in immature dentate gyrus cells precedes neurotrophin expression and indicates a specific role of CREB in granule cells differentiation (2001) Eur J Neurosci, 13, pp. 679-686; 
Bhargava, H.N., Reddy, P.L., Gudehithlu, K.P., Down-regulation of N-methyl-D-aspartate (NMDA) receptors of brain regions and spinal cord of rats treated chronically with morphine (1995) Gen Pharmacol, 26, pp. 131-136; 
Chen, W.F., Chang, H., Huang, L.T., Yang, C.H., Lai, M.C., Wan, T.H., Yang, S.N., Alterations in long-term seizure susceptibility and the complex of PSD-95 with NMDA receptor from animals previously exposed to perinatal hypoxia (2006) Epilepsia, 47, pp. 288-296; 
Chen, W.F., Chang, H., Wong, C.S., Huang, L.T., Yang, C.H., Yang, S.N., Impaired expression of postsynaptic density proteins in the hippocampal CA1 region of rats following perinatal hypoxia (2007) Exp Neurol, 204, pp. 400-410; 
Chiou, L.C., Yeh, G.C., Fan, S.H., How, C.H., Chuang, K.C., Tao, P.L., Prenatal morphine exposure decreases analgesia but not K+ channel activation (2003) Neuroreport, 14, pp. 239-242; 
Crino, P., Khodakhah, K., Becker, K., Ginsberg, S., Hemby, S., Eberwine, J., Presence and phosphorylation of transcription factors in developing dendrites (1998) Proc Natl Acad Sci U S A, 95, pp. 2313-2318; 
Deisseroth, K., Bito, H., Tsien, R.W., Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity (1996) Neuron, 16, pp. 89-101; 
Erreger, K., Dravid, S.M., Banke, T.G., Wyllie, D.J., Traynelis, S.F., Subunit-specific gating controls rat NR1/NR2A and NR1/NR2B NMDA channel kinetics and synaptic signaling profiles (2005) J Physiol, 563, pp. 345-358; 
Hardingham, G.E., Fukunaga, Y., Bading, H., Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways (2002) Nat Neurosci, 5, pp. 405-414; 
Herdegen, T., Zimmermann, M., Expression of c-Jun and Jun-D transcription factors represent specific changes in neuronal gene expression following axotomy (1994) Prog Brain Res, 103, pp. 153-171; 
Hol, T., Niesink, M., van Ree, J.M., Spruijt, B.M., Prenatal exposure to morphine affects juvenile play behavior and adult social behavior in rats (1996) Pharmacol Biochem Behav, 55, pp. 615-618; 
Hu, B.R., Park, M., Martone, M.E., Fischer, W.H., Ellisman, M.H., Zivin, J.A., Assembly of proteins to the postsynaptic density after transient cerebral ischemia (1998) J Neurosci, 18, pp. 625-633; 
Iida, N., Namikawa, K., Kiyama, H., Ueno, H., Nakamura, S., Hattori, S., Requirement of Ras for the activation of mitogen-activated protein kinase by calcium influx, cAMP, and neurotrophin in hippocampal neurons (2001) J Neurosci, 21, pp. 6459-6566; 
Impey, S., Obrietan, K., Wong, S.T., Poser, S., Yano, S., Wayman, G., Deloulme, J.C., Storm, D.R., Cross talk between ERK and PKA required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation (1998) Neuron, 21, pp. 869-883; 
Impey, S., Obrietan, K., Storm, D.R., Making new connections: role of ERK/MAP kinase signalling in neuronal plasticity (1999) Neuron, 23, pp. 11-14; 
Kelley, A.E., Memory and addiction: shared neural circuitry and molecular mechanisms (2004) Neuron, 44, pp. 161-179; 
Kennedy, M.B., Signal-processing machines at the postsynaptic density (2000) Science, 290, pp. 750-754; 
Kim, M.J., Dunah, A.W., Wang, Y.T., Sheng, M., Differential roles of NR2A- and NR2B-containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking (2005) Neuron, 40, pp. 745-760; 
Kirby, M.L., DeRossett, S.E., Holtzman, S.G., Enhanced analgesic response to morphine in adult rats exposed to morphine prenatally (1982) Pharmacol Biochem Behav, 17, pp. 1161-1164; 
Kirson, E.D., Schirra, C., Konnerth, A., Yaari, Y., Early postnatal switch in magnesium sensitivity of NMDA receptors in rat CA1 pyramidal cells (1999) J Physiol (Lond), 52, pp. 99-111; 
Kohr, G., NMDA receptor function: subunit composition versus spatial distribution (2006) Cell Tissue Res, 326, pp. 439-446; 
Kornau, H.C., Schenker, L.T., Kennedy, M.B., Seeburg, P.H., Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95 (1995) Science, 269, pp. 1737-1740; 
Krapivinsky, G., Krapivinsky, L., Manasian, Y., Ivanov, A., Tyzio, R., Pellegrino, C., Ben-Ari, Y., Medina, I., The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1 (2003) Neuron, 40, pp. 775-784; 
Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Mishina, M., Molecular diversity of the NMDA receptors (1992) Nature, 358, pp. 36-41; 
Lau, L.F., Huganir, R., Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits (1995) J Biol Chem, 270, pp. 20036-20041; 
Le Greves, P., Huang, W., Zhou, Q., Thornwall, M., Nyberg, F., Acute effects of morphine on the expression of mRNAs for NMDA receptor subunits in the rat hippocampus, hypothalamus and spinal cord (1998) Eur J Pharmacol, 341, pp. 161-164; 
Li, S., Tian, X., Hartley, D.M., Feig, L.A., Distinct roles for Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression (2006) J Neurosci, 26, pp. 1721-1729; 
Mao, J., NMDA and opioid receptor: their interactions in antinociception, tolerance and neuroplasticity (1999) Brain Res Rev, 30, pp. 289-304; 
Martone, M.E., Jones, Y.Z., Young, S.J., Ellisman, M.H., Zivin, J.A., Hu, B.R., Modification of postsynaptic densities after transient cerebral ischemia: a quantitative and three-dimensional ultrastructural study (1999) J Neurosci, 19, pp. 1988-1997; 
Migaud, M., Charlesworth, R., Dempster, M., Webster, L.C., Watabe, A.M., Makhinson, M., He, Y., Grant, S.G., Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein (1998) Nature, 396, pp. 433-439; 
Mizuno, M., Yamada, K., Olariu, A., Nawa, H., Nabeshima, T., Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats (2000) J Neurosci, 20, pp. 7116-7121; 
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Seeburg, P.H., Heteromeric NMDA receptors: molecular and functional distinction of subtypes (1992) Science, 256, pp. 1217-1221; 
Monyer, H., Burnashev, N., Laurie, D.J., Sakmann, B., Seeburg, P.H., Developmental and regional expression in the rat brain and functional properties of four NMDA receptors (1994) Neuron, 12, pp. 529-540; 
Mori, H., Mishina, M., Structure and function of the NMDA receptor channel (1995) Neuropharmacology, 34, pp. 1219-1237; 
Moriyoshi, K., Masayuki, M., Takahiro, I., Ryuichi, S., Mizuno, N., Nakanishi, S., Molecular cloning and characterization of the rat NMDA receptor (1991) Nature, 354, pp. 31-37; 
Morris, R.G., Anderson, E., Lynch, G.S., Baudry, M., Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist AP5 (1986) Nature, 319, pp. 774-776; 
Morris, R.G., Garrud, P., Rawlings, J.N., O'Keefe, J., Place navigation impaired in rats with hippocampal lesions (1982) Nature, 297, pp. 681-683; 
Niesink, R.J., van Buren-van Duinkerken, L., van Ree, J.M., Social behavior of juvenile rats after in utero exposure to morphine: dose-time-effect relationship (1999) Neuropharmacology, 38, pp. 1207-1223; 
Niesink, R.J., Vanderschuren, L.J., van Ree, J.M., Social play in juvenile rats after in utero exposure to morphine (1996) Neurotoxicology, 17, pp. 905-912; 
Niethammer, M., Kim, E., Sheng, M., Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases (1996) J Neurosci, 16, pp. 2157-2163; 
O'Callaghan, J.P., Holtzman, S.G., Prenatal administration of morphine to the rat: tolerance to the analgesic effect of morphine in the offspring (1976) J Pharmacol Exp Ther, 197, pp. 533-544; 
Oler, J.A., Markus, E.J., Age-related deficits on the radial maze and in fear conditioning: hippocampal processing and consolidation (1998) Hippocampus, 8, pp. 402-415; 
Olton, D.S., Samuelson, R.J., Remembrances of places passed: spatial memory in rats (1976) J Exp Psychol, 2, pp. 97-116; 
Petralia, R.S., Sans, N., Wang, Y.X., Wenthold, R.J., Ontogeny of postsynaptic density proteins at glutamatergic synapses (2005) Mol Cell Neurosci, 29, pp. 436-452; 
Pirnik, Z., Schwendt, M., Jezova, D., Single dose of morphine influences plasma corticosterone and gene expression of main NMDA receptor subunit in the adrenal gland but not in the hippocampus (2001) Endocr Regul, 35, pp. 187-193; 
Roberson, E.D., English, J.D., Adams, J.P., Selcher, J.C., Kondratic, K.C., Sweatt, J.D., The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus (1999) J Neurosci, 19, pp. 4337-4346; 
Robinson, T.E., Berridge, K.C., Addiction (2003) Annu Rev Psychol, 54, pp. 25-53; 
Robinson, T.E., Kolb, B., Structural plasticity associated with exposure to drugs of abuse (2004) Neuropharmacology, 47, pp. 33-46; 
Sattler, R., Xiong, Z., Lu, W.Y., Hafner, M., MacDonald, J.F., Tymianski, M., Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein (1999) Science, 284, pp. 1845-1848; 
Sheng, M., Cummings, J., Roldan, L.A., Jan, Y.N., Jan, L.Y., Changing subunit composition of heteromeric NMDA receptors during development of rat cortex (1994) Nature, 368, pp. 144-147; 
Silva, A.J., Kogan, J.H., Frankland, P.W., Kida, S., CREB and memory (1998) Annu Rev Neurosci, 21, pp. 127-148; 
Sprengel, R., Suchanek, B., Amico, C., Brusa, R., Burnashev, N., Rozov, A., Hvalby, O., Seeburg, P.H., Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo (1998) Cell, 92, pp. 279-289; 
Stocca, G., Vicini, S., Increased contribution of NR2A subunit to synaptic NMDA receptors in developing rat cortical neurons (1998) J Physiol, 507 (PART 1), pp. 13-24; 
Sutherland, R.J., Whishaw, I.Q., Kolb, B., A behavioral analysis of spatial localization following electrolytic, kinate-, or colchicine-induced damage to the hippocampal formation in the rat (1983) Behav Brain Res, 7, pp. 133-153; 
Takagi, N., Logan, R., Teves, L., Altered interaction between PSD-95 and the NMDA receptor following transient global ischemia (2000) J Neurochem, 74, pp. 169-178; 
Tao, P.L., Yeh, G.C., Su, C.H., Wu, Y.H., Co-administration of dextromethorphan during pregnancy and throughout lactation significantly decreases the adverse effects associated with chronic morphine administration in rat offspring (2001) Life Sci, 69, pp. 2439-2450; 
Tezuka, T., Umemori, H., Akiyama, T., Nakanishi, S., Yamamoto, T., PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A (1999) Proc Natl Acad Sci U S A, 96, pp. 435-440; 
Thomas, C.G., Miller, A.J., Westbrook, G.L., Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons (2006) J Neurophysiol, 95, pp. 1727-1734; 
Tovar, K.R., Westbrook, G.L., The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro (1999) J Neurosci, 19, pp. 4180-4188; 
Tsien, J.Z., Huerta, P.T., Tonegawa, S., The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory (1996) Cell, 87, pp. 1327-1338; 
Tso, P.H., Wong, Y.H., Molecular basis of opioid dependence: role of signal regulation by G-proteins (2003) Clin Exp Pharmacol Physiol, 30, pp. 307-316; 
Turchan, J., Maj, M., Przewlocka, B., The effect of drugs of abuse on NMDAR1 receptor expression in the rat limbic system (2003) Drug Alcohol Depend, 72, pp. 193-196; 
Van Baar, A.L., Soepatmi, S., Gunning, W.B., Akkerhuis, G.W., Development after prenatal exposure to cocaine, heroin and methadone (1994) Acta Paediatr Suppl, 404, pp. 40-46; 
Vathy, I., Prenatal opiate exposure: long CNS consequences in the stress system of offspring (2002) Psychoneuroendocrinology, 27, pp. 273-283; 
Veliskova, J., Moshe, S.L., Vathy, I., Prenatal morphine exposure differentially alters seizure susceptibility in developing female rats (1999) Dev Brain Res, 116, pp. 119-121; 
Vo, N., Goodman, H., CREB-binding protein and p300 in transcriptional regulation (2001) J Biol Chem, 276, pp. 13505-13508; 
Wyneken, U., Smalla, K.H., Marengo, J.J., Soto, D., Cerda, A., Kainate-induced seizures alter protein composition and N-methyl-D-aspartate receptor function of rat forebrain postsynaptic densities (2001) Neuroscience, 102, pp. 65-74; 
Wyneken, U., Marengo, J.J., Villanueva, S., Soto, D., Sandoval, R., Gundelfinger, E.D., Orrego, F., Epilepsy-induced changes in signaling systems of human and rat postsynaptic densities (2003) Epilepsia, 44, pp. 243-246; 
Xing, G.G., Wang, R., Yang, B., Zhang, D., Postnatal switching of NMDA receptor subunits from NR2B to NR2A in rat facial motor neurons (2006) Eur J Neurosci, 24, pp. 2987-2992; 
Yamada, Y., Chochi, Y., Takamiya, K., Sobue, K., Inui, M., Modulation of the channel activity of the ε2/ζ1-subtype N-methyl-D-aspartate receptor by PSD-95 (1999) J Biol Chem, 274, pp. 6647-6652; 
Yang, S.N., Huang, L.T., Wang, C.L., Chen, W.F., Yang, C.H., Lin, S.Z., Lai, M.C., Tao, P.L., Prenatal administration of morphine decreases CREBSerine-133 phosphorylation and synaptic plasticity range-mediated by glutamatergic transmission in the hippocampal CA1 area of cognitive deficient rat offspring (2003) Hippocampus, 13, pp. 915-921; 
Yang, S.N., Liu, C.A., Chung, M.Y., Huang, H.C., Yeh, G.C., Wong, C.S., Lin, W.W., Tao, P.L., Alterations of postsynaptic density proteins in the hippocampus of cognitive deficient rat offspring from the morphine-addicted mother: beneficial effect of dextromethorphan (2006) Hippocampus, 16, pp. 521-530; 
Yang, S.N., Yang, J.M., Wu, J.N., Kao, Y.S., Hsieh, W.Y., Chao, C.C., Tao, P.L., Prenatal exposure to morphine alters kinetic properties of NMDA receptor-mediated synaptic currents in the hippocampus of rat offspring (2000) Hippocampus, 10, pp. 654-662; 
Yao, W.D., Gainetdinov, R.R., Arbuckle, M.I., Sotnikova, T.D., Cyr, M., Beaulieu, J.M., Torres, G.E., Cardn, M.G., Identification of PSD-95 as regulator of dopamine-mediated synaptic and behavioral plasticity (2004) Neuron, 41, pp. 625-638; 
Zhou, M., Baudry, M., Development changes in NMDA neurotoxicity reflect development changes in subunit composition of NMDA receptors (2006) J Neurosci, 26, pp. 2956-2963; 
Zhu, H., Jang, C.G., Ma, T., Oh, S., Rockhold, R.W., Ho, I.K., Region specific expression of NMDA receptor NR1 subunit mRNA in hypothalamus and pons following chronic morphine treatment (1999) Eur J Pharmacol, 365, pp. 47-54; 
Zola-Morgan, S., Squire, L.R., Neuroanatomy of memory (1993) Annu Rev Neurosci, 16, pp. 547-563; 
Zuckerman, B., Bresnahan, K., Developmental and behavioral consequences of prenatal drug and alcohol exposure (1991) Pediatr Clin North Am, 38, pp. 1387-1406
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-60149112575&doi=10.1016%2fj.neuroscience.2008.11.007&partnerID=40&md5=ff724cebf6ae92bfbf346eb89971b040
ER  - 

TY  - JOUR
TI  - The systems view in addiction research
T2  - Addiction Biology
J2  - Addict. Biol.
VL  - 13
IS  - 3-4
SP  - 449
EP  - 454
PY  - 2008
DO  - 10.1111/j.1369-1600.2008.00137.x
SN  - 13556215 (ISSN) 
AU  - Gebicke-Haerter, P.J.
AU  - Tretter, F.
AD  - Department of Psychopharmacology, Central Institute of Mental Health, University of Heidelberg, Germany
AD  - Department of Addictions, Isar Amper Clinics, Germany
AD  - Department of Psychopharmacology, Central Institute of Mental Health, University of Heidelberg, J5, 68159 Mannheim, Germany
AB  - The wealth of information accessible on the molecular level after completion of sequencing of the human and other genomes and in conjunction with new high-throughput technologies like microarrays has paved the way for research on whole systems rather than on single components. Here we describe exemplarily the construction of a rather complex molecular network involved in alcohol addiction by using information from DNA-microarray studies in alcohol-dependent animals. In this network, haemoglobin downregulation in different parts of the brain reward system plays a central role in affecting synaptic plasticity, circadian rhythmicity and opioid receptors. Furthermore, we discuss the dynamic aspect of biological systems with respect to repeated and intermittent drug intake. This aspect can best be captured by the allostatic model on the molecular level. Using a molecular oscillator model where levels of oscillations are changed by repetitive drug administration, changes in set point adjustment are described that underlay allostatic shifts in drug reinforcement processes. © 2008 The Authors.
KW  - Alcoholism
KW  - Chaos theory
KW  - Haemoglobin
KW  - Microarrays
KW  - Molecular networks
KW  - Systems biology
KW  - hemoglobin
KW  - opiate receptor
KW  - alcoholism
KW  - article
KW  - circadian rhythm
KW  - DNA microarray
KW  - down regulation
KW  - drug use
KW  - medical research
KW  - molecular mechanics
KW  - molecular model
KW  - nerve cell plasticity
KW  - nonhuman
KW  - oscillation
KW  - priority journal
KW  - reinforcement
KW  - reward
KW  - Behavior, Addictive
KW  - Hemoglobins
KW  - Humans
KW  - Neuronal Plasticity
KW  - Nonlinear Dynamics
KW  - Oligonucleotide Array Sequence Analysis
KW  - Substance-Related Disorders
KW  - Synapses
N1  - Cited By :5
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: ADBIF
C2  - 18782387
LA  - English
N1  - Correspondence Address: Gebicke-Haerter, P. J.; Department of Psychopharmacology, Central Institute of Mental Health, University of Heidelberg, J5, 68159 Mannheim, Germany; email: peter.gebicke@zi-mannheim.de
N1  - Chemicals/CAS: hemoglobin, 9008-02-0; Hemoglobins
N1  - References: Ahn, A.C., Tewari, M., Poon, C.S., Phillips, R.S., The limits of reductionism in medicine: Could systems biology offer an alternative? (2006) PLoS Med, 3, pp. e208; 
Al-Shahrour, F., Minguez, P., Tárraga, J., Medina, I., Alloza, E., Montaner, D., Dopazo, J., FatiGO +: A functional profiling tool for genomic data. Integration of functional annotation, regulatory motifs and interaction data with microarray experiments (2007) Nucleic Acids Res, 35, pp. W91-W96. , Epub 2007 May 3; 
Albiston, A.L., Mustafa, T., McDowall, S.G., Mendelsohn, F.A., Lee, J., Chai, S.Y., AT4 receptor is insulin-regulated membrane aminopeptidase: Potential mechanisms of memory enhancement (2003) Trends Endocrinol Metab, 14, pp. 72-77; 
Albiston, A.L., Pederson, E.S., Burns, P., Purcell, B., Wright, J.W., Harding, J.W., Mendelsohn, F.A., Chai, S.Y., Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms (2004) Behav Brain Res, 154, pp. 239-243; 
Alon, U., Systems biology-design principles of biological circuits (2007) New York, , Chapman & Hall; 
Antle, M.C., Foley, D.K., Foley, N.C., Silver, R., Gates and oscillators: A network model of the brain clock (2003) J Biol Rhythms, 18, pp. 339-350; 
Assmus, H.E., Herwig, R., Cho, K.H., Wolkenhauer, O., Dynamics of biological systems: Role of systems biology in medical research (2006) Expert Rev Mol Diagn, 6, pp. 891-902; 
Bassett, D.S., Meyer-Lindenberg, A., Achard, S., Duke, T., Bullmore, E., Adaptive reconfiguration of fractal small-world human brain functional networks (2006) Proc Natl Acad Sci USA, 103, pp. 19518-19523; 
Bell, R.L., Rodd, Z.A., Lumeng, L., Murphy, J.M., McBride, W.J., The alcohol-preferring P rat and animal models of excessive alcohol drinking (2006) Addict Biol, 11, pp. 270-288; 
Bertalanffy, L., (1940) Vom Molekül Zur Organismenwelt., , Potsdam: Akademische Verlagsgesellschaft Athenaion; 
Bertalanffy, L., (1968) General System Theory: Foundations, Development, Applications., , New York: George Braziller, revised edition 1976; 
Bieberich, E., Recurrent fractal neural networks: A strategy for the exchange of local and global information processing in the brain (2002) Biosystems, 66, pp. 145-164; 
Brower, K.J., Insomnia, alcoholism and relapse (2003) Sleep Med Rev, 7, pp. 523-539; 
Chai, S.Y., Fernando, R., Peck, G., Ye, S.Y., Mendelsohn, F.A., Jenkins, T.A., Albiston, A.L., The angiotensin IV/AT4 receptor (2004) Cell Mol Life Sci, 61, pp. 2728-2737; 
Crabbe, J.C., Phillips, T.J., Harris, R.A., Arends, M.A., Koob, G.F., Alcohol-related genes: Contributions from studies with genetically engineered mice (2006) Addict Biol, 11, pp. 195-269; 
Derisi, J.L., Iyer, V.R., Brown, P.O., Exploring the metabolic and genetic control of gene expression on a genomic scale (1997) Science, 278, pp. 680-686; 
Edenberg, H.J., Strother, W.N., McClintick, J.N., Tian, H., Stephens, M., Jerome, R.E., Lumeng, L., McBride, W.J., Gene expression in the hippocampus of inbred alcohol-preferring and -nonpreferring rats (2005) Genes Brain Behav, 4, pp. 20-30; 
Gebicke-Haerter, P., Expression profiling methods used in drug abuse research (2005) Addict Biol, 10, pp. 37-46; 
Gilles-Gonzalez, M.A., Gonzalez, G., Signal transduction by heme-containing PAS-domain proteins (2004) J Appl Physiol, 96, pp. 774-783; 
Huang, S., Wikswo, J., Dimensions of systems biology (2006) Rev Physiol Biochem Pharmacol, 157, pp. 81-104; 
Hyman, S.E., Can neuroscience be integrated into the DSM-V? (2007) Nat Rev Neurosci, 8, pp. 725-732; 
Kanamaru, T., Chaotic pattern transitions in pulse neural networks (2007) Neural Netw, 20, pp. 781-790; 
Kerns, R.T., Ravindranathan, A., Hassan, S., Cage, M.P., York, T., Sikela, J.M., Williams, R.W., Miles, M.F., Ethanol-responsive brain region expression networks: Implications for behavioral responses to acute ethanol in DBA/2J versus C57BL/6J mice (2005) J Neurosci, 25, pp. 2255-2266; 
King, C.C., Fractal and chaotic dynamics in nervous systems (1991) Pro Neurobiol, 36, pp. 279-308; 
Koob, G.F., Alcoholism: Allostasis and beyond (2003) Alcohol Clin Exp Res, 27, pp. 232-243; 
Koob, G.F., Le Moal, M., Drug addiction, dysregulation of reward, and allostasis (2001) Neuropsychopharmacology, 24, pp. 97-129; 
Koob, G.F., Le Moal, M., Addiction and the brain antireward system (2008) Annu Rev Psychol, 59, pp. 29-53; 
Lew, R.A., Mustafa, T., Ye, S., McDowall, S.G., Chai, S.Y., Albiston, A.L., Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP) (2003) J Neurochem, 86, pp. 344-350; 
Li, C.Y., Mao, X., Wei, L., Genes and (common) pathways underlying drug addiction (2008) PLoS Comput Biol, 4, pp. e2; 
McKinley, M.J., Albiston, A.L., Allen, A.M., Mathai, M.L., May, C.N., McAllen, R.M., Oldfield, B.J., Chai, S.Y., The brain renin-angiotensin system: Location and physiological roles (2003) Int J Biochem Cell Biol, 35 (6), pp. 901-6918; 
Nyberg, F., Sanderson, K., Glämsta, E.L., The hemorphins: A new class of opioid peptides derived from the blood protein hemoglobin (1997) Biopolymers, 43, pp. 147-156; 
Perreau-Lenz, S., Spanagel, R., The effects of drugs of abuse on clock genes (2008) Drug News Perspect, 21, pp. 211-217; 
Rapaport, F., Zinovyev, A., Dutreix, M., Barillot, E., Vert, J.-P., Classification of microarray data using gene networks (2007) BMC Bioinformatics, 8, p. 35; 
Reijenga, K.A., Westerhoff, H.V., Kholodenko, B.N., Snoep, J.L., Control analysis for autonomously oscillating biochemical networks (2002) Biophys J, 82 (11), pp. 99-108; 
Sanchis-Segura, C., Spanagel, R., Behavioural assessment of drug reinforcement and addictive features in rodents: An overview (2006) Addict Biol, 11, pp. 2-38; 
Sel'Kov, E.E., Self-oscillations in glycolysis (1968) Eur J. Biochem, 4, p. 79; 
Skarda, C.A., Freeman, W.J., How brains make chaos in order to make sense of the world (1987) Behav Brain Sci, 10, pp. 161-195; 
Solomon, R.L., Corbit, J.D., An opponent-process theory of motivation. I. Temporal dynamics of affect (1974) Psychol Rev, 81, pp. 119-145; 
Sommer, W., Arlinde, C., Heilig, M., The search for candidate genes of alcoholism: Evidence from expression profiling studies (2005) Addict Biol, 10, pp. 71-79; 
Sommer, W., Hyytiä, P., Kiianmaa, K., The alcohol-preferring AA and alcohol-avoiding ANA rats: Neurobiology of the regulation of alcohol drinking (2006) Addict Biol, 11, pp. 289-309; 
Spanagel, R., Heilig, M., Addiction and its brain science (2005) Addiction, 100, pp. 1813-1822; 
Spanagel, R., Pendyala, G., Abarca, C., Zghoul, T., Sanchis-Segura, C., Magnone, M.C., Lascorz, J., Albrecht, U., The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption (2005) Nat Med, 11, pp. 35-42; 
Thelen, E., Smith, L., (1994) A Dynamic Systems Approach to the Development of Cognition and Action., p. 376. , Cambridge, MA: MIT Press. p; 
Vengeliene, V., Leonardi-Essmann, F., Perreau-Lenz, S., Gebicke-Haerter, P., Drescher, K., Gross, G., Spanagel, R., The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse (2006) FASEB J, 20, pp. 2223-2233; 
Vengeliene, V., Siegmund, S., Singer, M.V., Sinclair, J.D., Li, T.K., Spanagel, R., A comparative study on alcohol-preferring rat lines: Effects of deprivation and stress phases on voluntary alcohol intake (2003) Alcohol Clin Exp Res, 27, pp. 1048-1054; 
Werner, T., Regulatory networks: Linking microarray data to systems biology (2007) Mech Ageing Dev, 128, pp. 168-172. , Epub 2006 Nov 20; 
Wiener, N., (1948) Cybernetics: Or the Control and Communication in the Animal and the Machine., , Cambridge, MA: MIT Press; 
Zhao, Q., Piot, J.M., Investigation of inhibition angiotensin-converting enzyme (ACE) activity and opioid activity of two hemorphins, LVV-hemorphin-5 and VV-hemorphin-5, isolated from a defined peptic hydrolysate of bovine hemoglobin (1997) Neuropeptides, 31, pp. 147-153; 
Zhu, H., Wu, Y., Huang, S., Sun, Y., Dhar, P., Cellular automata with object-oriented features for parallel molecular network modelling (2005) IEEE Trans Nanobioscience, 4, pp. 141-148
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-49349116344&doi=10.1111%2fj.1369-1600.2008.00137.x&partnerID=40&md5=24172496e26fee872f6ede22c8917376
ER  - 

TY  - JOUR
TI  - Pathological gambling: An update on neuropathophysiology and pharmacotherapy
T2  - CNS Drugs
J2  - CNS Drugs
VL  - 22
IS  - 2
SP  - 123
EP  - 138
PY  - 2008
DO  - 10.2165/00023210-200822020-00004
SN  - 11727047 (ISSN) 
AU  - Iancu, I.
AU  - Lowengrub, K.
AU  - Dembinsky, Y.
AU  - Kotler, M.
AU  - Dannon, P.N.
AD  - Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
AD  - Psychiatry B. Department, Beer Yaakov Mental Health Center, Tel Aviv University, Tel Aviv, Israel
AD  - Rehovot Community Mental Health and Rehabilitation Clinic, Rehovot, Israel
AD  - Rehovot Com-munity Mental Health and Rehabilitation Clinic, Remez Str. 80, Rehovot 76449, Israel
AB  - Neurobiological research has shown the potential involvement of serotonergic, dopaminergic and opioid dysfunction in the pathophysiology of pathological gambling. In this review, we present current theories of the neuropathology of pathological gambling, paying particular attention to the role of the neural circuitry underlying motivation, reward, decision-making and impulsivity. This review also presents a literature review of current pharmacological treatment strategies for pathological gambling, such as selective serotonin reuptake inhibitors (SSRIs), opioid receptor antagonists, anti-addiction drugs and mood stabilizers, and also discusses the role of nonpharmacological interventions. A hypothetical model of the clinical subtypes of pathological gambling is presented, e.g. the impulsive subtype, the obsessive-compulsive subtype and the addictive subtype. This model attempts to integrate current knowledge in the field of pathological gambling regarding neuropathology, psychiatric co-morbidity, family history, genetics, course of illness, gender and response to pharmacological treatment. Finally, it is proposed that the existence of possible clinical subtypes of pathological gambling may provide a potential framework for matching the various subtypes with specific pharmacotherapies. © 2008 Adis Data Information BV. All rights reserved.
KW  - Bupropion, therapeutic use
KW  - Gambling
KW  - Impulse control disorders
KW  - Mood stabilisers, therapeutic use
KW  - Opioid receptor antagonists, therapeutic use
KW  - Psychotherapy
KW  - Serotonin reuptake inhibitors, therapeutic use
KW  - amfebutamone
KW  - aminotransferase
KW  - citalopram
KW  - dopamine
KW  - fluvoxamine
KW  - lamotrigine
KW  - lithium
KW  - mood stabilizer
KW  - nalmefene
KW  - naltrexone
KW  - nefazodone
KW  - nonsteroid antiinflammatory agent
KW  - opiate
KW  - opiate antagonist
KW  - paroxetine
KW  - serotonin
KW  - serotonin noradrenalin reuptake inhibitor
KW  - serotonin uptake inhibitor
KW  - sertraline
KW  - topiramate
KW  - trazodone
KW  - valproic acid
KW  - aminotransferase blood level
KW  - clinical trial
KW  - cognitive therapy
KW  - comorbidity
KW  - decision making
KW  - disease course
KW  - dizziness
KW  - dopaminergic system
KW  - drug dose increase
KW  - drug substitution
KW  - drug withdrawal
KW  - family history
KW  - gender
KW  - human
KW  - impulsiveness
KW  - insomnia
KW  - liver function test
KW  - liver toxicity
KW  - monotherapy
KW  - motivation
KW  - nausea
KW  - neuropathology
KW  - obsessive compulsive disorder
KW  - pathological gambling
KW  - pathophysiology
KW  - priority journal
KW  - review
KW  - reward
KW  - serotoninergic system
KW  - side effect
KW  - treatment outcome
KW  - treatment response
KW  - Behavior, Addictive
KW  - Gambling
KW  - Humans
KW  - Impulsive Behavior
KW  - Serotonin Uptake Inhibitors
N1  - Cited By :44
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
N1  - CODEN: CNDRE
C2  - 18193924
LA  - English
N1  - Correspondence Address: Dannon, P.N.; Rehovot Com-munity Mental Health and Rehabilitation Clinic, Remez Str. 80, Rehovot 76449, Israel; email: pinhasd@post.tau.ac.il
N1  - Chemicals/CAS: amfebutamone, 31677-93-7, 34911-55-2; aminotransferase, 9031-66-7; citalopram, 59729-33-8; dopamine, 51-61-6, 62-31-7; fluvoxamine, 54739-18-3; lamotrigine, 84057-84-1; lithium, 7439-93-2; nalmefene, 55096-26-9; naltrexone, 16590-41-3, 16676-29-2; nefazodone, 82752-99-6, 83366-66-9; opiate, 53663-61-9, 8002-76-4, 8008-60-4; paroxetine, 61869-08-7; serotonin, 50-67-9; sertraline, 79617-96-2; topiramate, 97240-79-4; trazodone, 19794-93-5, 25332-39-2; valproic acid, 1069-66-5, 99-66-1; Serotonin Uptake Inhibitors
N1  - References: Petry, N.M., Armentano, C., Prevalence, assessment, and treatment of pathological gambling: A review (1999) Psychiatr Serv, 50 (8), pp. 1021-1027; 
Shaffer, H.J., Hall, M.N., Van der Bilt, J., Estimating the prevalence of disorder gambling behavior in the United States and Canada: A research synthesis (1999) Am J Public Health, 89, pp. 1369-1376; 
Hollander, E., Buchalter, A.J., DeCaria, C.M., Pathological gambling (2000) Psychiatr Clin North Am, 23 (3), pp. 629-642; 
Dell'Osso, B., Allen, A., Hollander, E., Comorbidity issues in the pharmacological treatment of pathological gambling: A critical review (2005) Clin Pract Epidemol Ment Health, 1, p. 21; 
Dell'Osso, B., Hollander, E., The impact of comorbidity on the management of pathological gambling (2005) CNS Spectr, 10 (8), pp. 619-621; 
Ibanez, A., Blanco, C., Donahue, E., Psychiatric comorbidity in pathological gamblers seeking treatment (2001) Am J Psychiatry, 158 (10), pp. 1733-1735; 
(1994) Diagnostic and statistical manual of mental disorders, , American Psychiatric Association, 4th ed. Washington, DC: American Psychiatric Association Inc; 
The ICD-10 classification of mental and behavioral disorders. Geneva: World Health Organization, 1992; Shah, K.R., Eisen, S.A., Xian, H., Genetic studies of pathological gambling: A review of methodology and analyses of data from the Vietnam era twin registry (2005) J Gambl Stud, 21 (2), pp. 179-203; 
Black, D.W., Monahan, P.O., Temkit, M., A family study of pathological gambling (2006) Psychiatry Res, 141 (3), pp. 295-303; 
Steel, Z., Blaszczynski, A., Impulsivity, personality disorders and pathological gambling severity (1998) Addiction, 93 (6), pp. 895-905; 
Scherrer, J.F., Xian, H., Shah, K.R., Effect of genes, environment, and lifetime co-occurring disorders on health-related quality of life in problem and pathological gamblers (2005) Arch Gen Psychiatry, 62 (6), pp. 677-683; 
Hollander, E., Treatment of obsessive-compulsive spectrum disorders with SSRIs (1998) Br J Psychiatry Suppl, 35, pp. 7-12; 
Blaszczynski, A., Pathological gambling and obsessive-compulsive spectrum disorders (1999) Psychol Rep, 84, pp. 107-113; 
Frost, R.O., Meagher, B.M., Riskind, J.H., Obsessive-compulsive features in pathological lottery and scratch-ticket gamblers (2001) J Gambl Stud, 17 (1), pp. 5-19; 
Tamminga, C.A., Nestler, E.J., Pathological gambling: Focusing on the addiction, not the activity (2006) Am J Psychiatry, 163 (2), pp. 180-181; 
Petry, N.M., Should the scope of addictive behaviors be broadened to include pathological gambling? (2006) Addiction, 101 (SUPPL. 1), pp. 152-160; 
Nutt, D.J., Addiction: Brain mechanisms and their treatment implications (1996) Lancet, 347 (8993), pp. 31-36; 
Spinella, M., Evolutionary mismatch, neural reward circuits, and pathological gambling (2003) Int J Neurosci, 113 (4), pp. 503-512; 
Volkow, N.D., Fowler, J.S., Wang, G.J., Role of dopamine in drug reinforcement and addiction in humans: Results from imaging studies (2002) Behav Pharmacol, 13 (5-6), pp. 355-366; 
Reuter, J., Raedler, T., Rose, M., Pathological gambling is linked to reduced activation of the mesolimbic reward system (2005) Nat Neurosci, 8 (2), pp. 147-148; 
Kalivas, P.W., Volkow, N.D., The neural basis of addiction: A pathology of motivation and choice (2005) Am J Psychiatry, 162 (8), pp. 1403-1413; 
Chambers, R.A., Potenza, M.N., Neurodevelopment, impulsivity, and adolescent gambling (2003) J Gambl Stud, 19 (1), pp. 53-84; 
Berridge, K.C., The debate over dopamine's role in reward: The case for incentive salience (2007) Psychopharmacology (Berl), 191 (3), pp. 391-431; 
Goldstein, R.Z., Volkow, N.D., Drug addiction and its underlying neurological basis: Neuroimaging evidence for the involvement of the frontal cortex (2002) Am J Psychiatry, 159 (10), pp. 1642-1652; 
Jentsch, J.D., Taylor, J.R., Impulsivity resulting from frontostriatal dysfunction in drug abuse: Implications for the control of behavior by reward-related stimuli (1999) Psychopharmacology (Berl), 146 (4), pp. 373-390; 
Potenza, M.N., Steinberg, M.A., Skudlarski, P., Gambling urges in pathological gambling: A functional magnetic resonance imaging study (2003) Arch Gen Psychiatry, 60 (8), pp. 818-836; 
Bechara, A., Neurobiology of decision-making: Risk and reward (2001) Semin Clin Neuropsychiatry, 6 (3), pp. 205-216; 
Brand, M., Kalbe, E., Labudda, K., Decision-making impairments in patients with pathological gambling (2005) Psychiatry Res, 133, pp. 91-99; 
Kertzman, S., Lowengrub, K., Aizer, A., Stroop performance in pathological gamblers (2006) Psychiatry Res, 142 (1), pp. 1-10; 
Potenza, M.N., Leung, H.C., Blumberg, H.P., An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers (2003) Am J Psychiatry, 160 (11), pp. 1990-1994; 
Cavedini, P., Riboldi, G., Keller, R., Frontal lobe dysfunction in pathological gambling patients (2002) Biol Psychiatry, 51 (4), pp. 334-341; 
Soubrie, P., Serotonergic neurons and behaviour (1986) J Pharmacol, 17 (2), pp. 107-112. , in French; 
Zald, D.H., Boileau, I., El-Dearedy, W., Dopamine transmission in the human striatum during monetary reward tasks (2004) J Neurosci, 24 (17), pp. 4105-4112; 
Nordin, C., Eklundh, T., Altered CSF 5-HIAA disposition in pathological male gamblers (1999) CNS Spectr, 4, pp. 25-33; 
Carrasco, J.L., Saiz-Ruiz, J., Hollander, E., Low platelet monoamine oxidase activity in pathological gambling (1994) Acta Psychiatr Scand, 90 (6), pp. 427-431; 
Moreno, I., Saiz-Ruiz, J., Lopez-Ibor, J.J., Serotonin and gambling behavior (1991) Hum Psychopharmacol, 6, pp. S9-12; 
DeCaria, C.M., Begaz, T., Holander, E., Serotonergic and noradrenergic function in pathological gambling (1998) CNS Spectr, 3, pp. 38-47; 
Roy, A., DeJong, J., Ferraro, T., CSF GABA and neuropeptides in pathological gamblers and normal controls (1989) Psychiatry Res, 30 (2), pp. 137-144; 
Grant, J.E., Kim, S.W., Potenza, M.N., Advances in the pharmacological treatment of pathological gambling (2003) J Gambl Stud, 19 (1), pp. 85-109; 
Di Chiara, G., Drug addiction as dopamine-dependent associative learning disorder (1999) Eur J Pharmacol, 375 (1-3), pp. 13-30; 
Black, K.J., Friedman, J.H., Repetitive and impulsive behaviors in treated Parkinson disease (2006) Neurology, 67 (7), pp. 1118-1119; 
Grant, J.E., Williams, K.A., Kim, S.W., Update on pathological gambling (2006) Curr Psychiatry Rep, 8 (1), pp. 53-58; 
Koran, L.M., Bullock, K.D., Hartston, H.J., Citalopram treatment of compulsive shopping: An open-label study (2002) J Clin Psychiatry, 63 (8), pp. 704-708; 
Hollander, E., DeCaria, C.M., Finkell, J.N., A randomized double-blind fluvoxamine/placebo crossover trial in pathologic gambling (2000) Biol Psychiatry, 47 (9), pp. 813-817; 
Blanco, C., Petkova, E., Ibanez, A., A pilot placebo-controlled study of fluvoxamine for pathological gambling (2002) Ann Clin Psychiatry, 14 (1), pp. 9-15; 
Kim, S.W., Grant, J.E., Adson, D.E., A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling (2002) J Clin Psychiatry, 63 (6), pp. 501-507; 
Grant, J.E., Kim, S.W., Potenza, M.N., Paroxetine treatment of pathological gambling: A multi-centre randomized controlled trial (2003) Int Clin Psychopharmacol, 18 (4), pp. 243-249; 
Saiz-Ruiz, J., Blanco, C., Ibanez, A., Sertraline treatment of pathological gambling: A pilot study (2005) J Clin Psychiatry, 66 (1), pp. 28-33; 
Grant, J.E., Potenza, M.N., Escitalopram treatment of pathological gambling with co-occurring anxiety: An open-label pilot study with double-blind discontinuation (2006) Int Clin Psychopharmacol, 21 (4), pp. 203-209; 
Zimmerman, M., Breen, R.B., Posternak, M.A., An open-label study of citalopram in the treatment of pathological gambling (2002) J Clin Psychiatry, 63 (1), pp. 44-48; 
Pallanti, S., Baldini Rossi, N., Sood, E., Nefazodone treatment of pathological gambling: A prospective open-label controlled trial (2002) J Clin Psychiatry, 63 (11), pp. 1034-1039; 
Coccaro, E.F., Kavoussi, R.J., Sheline, Y.I., Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet (1996) Arch Gen Psychiatry, 53 (6), pp. 531-536; 
Hollister, L.E., Schwin, R.L., Kasper, P., Naltrexone treatment of opiate-dependent persons (1977) Drug Alcohol Depend, 2 (3), pp. 203-209; 
Anton, R.F., Pharmacologic approaches to the management of alcoholism (2001) J Clin Psychiatry, 62 (SUPPL. 20), pp. 11-17; 
Kim, S.W., Grant, J.E., An open naltrexone treatment study in pathological gambling disorder (2001) Int Clin Psychopharmacol, 16 (5), pp. 285-289; 
Kim, S.W., Grant, J.E., Adson, D.E., Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling (2001) Biol Psychiatry, 49 (11), pp. 914-921; 
Grant, J.E., Potenza, M.N., Hollander, E., Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling (2006) Am J Psychiatry, 163 (2), pp. 303-312; 
Zwar, N., Richmond, R., Bupropion sustained release: A therapeutic review of Zyban (2002) Aus Fam Physician, 31, pp. 443-447; 
(1997) The practitioner's guide to psychoactive drugs, , Gelenberg AJ, Bassuk EL, editors, 4th ed. New York: Plenum; 
Bechara, A., Risky business: Emotion, decision-making, and addiction (2003) J Gambl Stud, 19 (1), pp. 23-51; 
Tardieu, S., Poirier, Y., Micallef, J., Amphetamine-like stimulant cessation in an abusing patient treated with bupropion (2004) Acta Psychiatr Scand, 109 (1), pp. 75-77. , discussion 77-8; 
Black, D., An open-label trial of bupropion in the treatment of pathological gambling (2004) J Clin Psychopharmacology, 24 (1), pp. 108-109; 
Dannon, P.N., Lowengrub, K., Musin, E., Sustained-release bupropion versus naltrexone in the treatment of pathological gambling: A preliminary blind-rater study (2005) J Clin Psychopharmacol, 25 (6), pp. 593-596; 
Dannon, P.N., Lowengrub, K., Musin, E., Sustained release bupropion in the treatment of SSRI nonresponder pathological gamblers: Pilot study and review of the literature (2005) Therapy, 2 (5), pp. 753-759; 
Pallanti, S., Quercioli, L., Sood, E., Lithium and valproate treatment of pathological gambling: A randomized single-blind study (2002) J Clin Psychiatry, 63 (7), pp. 559-565; 
Hollander, E., Pallanti, S., Allen, A., Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? (2005) Am J Psychiatry, 162 (1), pp. 137-145; 
Lyseng-Williamson, K.A., Yang, L.P., Topiramate: A review of its use in the treatment of epilepsy (2007) Drugs, 67 (15), pp. 2231-2256; 
McElroy, S.L., Arnold, L.M., Shapira, N.A., Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial (2003) Am J Psychiatry, 160 (2), pp. 255-261; 
Dannon, P.N., Topiramate for the treatment of kleptomania: A case series and review of the literature (2003) Clin Neuropharmacol, 26 (1), pp. 1-4; 
Dannon, P.N., Lowengrub, K., Gonopolski, Y., Topiramate versus fluvoxamine in the treatment of pathological gambling: A randomized, blind-rater comparison study (2005) Clin Neuropharmacol, 28 (1), pp. 6-10; 
Sylvain, C., Ladoucuer, R., Boisvert, J.M., Cognitive and behavioral treatment of pathological gambling: A controlled study (1997) J Consult Clin Psychol, 65 (5), pp. 727-732; 
Echeburua, E., Baez, C., Fernandez-Montalvo, J., Comparative effectiveness of three therapeutic modalities in the psychological treatment of pathological gambling (1996) Behav Cogn Psychother, 24, pp. 51-72; 
Echeburua, E., Fernandez-Montalvo, J., Baez, C., Prevention in the treatment of slot-machine pathological gambling: Long-term outcome (2000) Behavior Therapy, 31, pp. 351-364; 
Petry, N.M., Ammerman, Y., Bohl, J., Cognitive-behavioral therapy for pathological gamblers (2006) J Consult Clin Psychol, 74 (3), pp. 555-567; 
McCusker, C.G., Cognitive biases and addiction: An evolution in theory and method (2001) Addiction, 96 (1), pp. 47-56; 
Toneatto, T., Cognitive psychopathology of problem gambling (1999) Subst Use Misuse, 34 (11), pp. 1593-1604; 
Ladouceur, R., Sylvain, C., Boutin, C., Group therapy for pathological gamblers: A cognitive approach (2003) Behav Res Ther, 41 (5), pp. 587-596; 
Toneatto, T., Ladoceur, R., Treatment of pathological gambling: A critical review of the literature (2003) Psychol Addict Behav, 17 (4), pp. 284-292; 
Kausch, O., Rugle, L., Rowland, D.Y., Lifetime histories of trauma among pathological gamblers (2006) Am J Addict, 15 (1), pp. 35-43; 
Waska, R., Addictions and the quest to control the object (2006) Am J Psychoanal, 66 (1), pp. 43-62; 
Goudriaan, A.E., Oosterlaan, J., de Beurs, E., Neurocognitive functions in pathological gambling: A comparison with alcohol dependence, Tourette syndrome and normal controls (2006) Addiction, 101 (4), pp. 534-547; 
Ravindran, A.V., Telner, J., Bhatla, R., Pathological gambling: Treatment correlates (2006) Eur Neuropsychopharmacol, 16 (SUPPL. 4), p. 20; 
Dannon, P.N., Lowengrub, K., Sasson, M., Comorbid psychiatric diagnoses in kleptomania and pathological gambling: A preliminary comparison study (2004) Eur Psychiatry, 19 (5), pp. 299-302; 
Dannon, P.N., Lowengrub, K., Mester, R., Pathological gambling: Comorbid psychiatric diagnoses in patients and their families (2006) Israeli J Psychiatry, 43 (2), pp. 88-92; 
Dannon, P.N., Lowengrub, K., Shagi, B., Dual psychiatric diagnoses and substance abuse in pathological gamblers: A preliminary gender comparison study (2006) J Addict Disord, 25 (3), pp. 49-54; 
Grant, J.E., Kim, S.W., Comorbidity of impulse control disorders in pathological gamblers (2003) Acta Psychiatr Scand, 108 (3), pp. 203-207; 
Lynch, W.J., Maciejewski, P.K., Potenza, M.N., Psychiatric correlates of gambling in adolescents and young adults grouped by age at gambling onset (2004) Arch Gen Psychiatry, 61 (11), pp. 1116-1122; 
Vachon, J., Vitaro, F., Wanner, B., Adolescent gambling: Relationships with parent gambling and parenting practices (2004) Psychol Addict Behav, 18 (4), pp. 398-401; 
Kvale, G., Holsten, F., Outcome of pharmacological treatments of pathological gambling meta-analysis (2007) J Clin Psychopharmacol, 27 (4), pp. 357-364; 
Pettinati, H.M., The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes (2001) J Clin Psychiatry, 62 (SUPPL. 20), pp. 26-31; 
Blanco, C., Hasin, D.S., Petry, N., Sex differences in subclinical and DSM-IV pathological gambling: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (2006) Psychol Med, 36 (7), pp. 943-953; 
Desai, R.A., Maciejewski, P.K., Pantalon, M.V., Gender differences in adolescent gambling (2005) Ann Clin Psychiatry, 17 (4), pp. 249-258; 
Hollander, E., Wong, C.M., Obsessive-compulsive spectrum disorders (1995) J Clin Psychiatry, 56 (SUPPL. 4), pp. 3-6. , discussion 53-5; 
Thase ME. Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence. CNS Spectr 2004; 9 (11): 808-16, 818-21; Potenza, M.N., Fiellin, D.A., Heninger, G.R., Gambling: An addictive behavior with health and primary care implications (2002) J Gen Intern Med, 17 (9), pp. 721-732; 
Petry, N.M., How treatments for pathological gambling can be informed by treatments for substance use disorders (2002) Exp Clin Psychopharmacol, 10 (3), pp. 184-192; 
Kim, S.W., Grant, J.E., Yoon, G., Safety of high-dose naltrex-one treatment: Hepatic transaminase profiles among outpatients (2006) Clin Neuropharmacol, 29 (2), pp. 77-79; 
Slutske, W.S., Natural recovery and treatment-seeking in pathological gambling: Results of two US national surveys (2006) Am J Psychiatry, 163 (2), pp. 297-302; 
Welte, J.W., Wieczorek, W.F., Barnes, G.M., The relationship of ecological and geographic factors to gambling behavior and pathology (2004) J Gambl Stud, 20 (4), pp. 405-410
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-38149091011&doi=10.2165%2f00023210-200822020-00004&partnerID=40&md5=969df3d2048e0e472e78229584fc2a17
ER  - 

TY  - JOUR
TI  - Endogenous opiates and behavior: 2003
T2  - Peptides
J2  - Peptides
VL  - 25
IS  - 12
SP  - 2205
EP  - 2256
PY  - 2004
DO  - 10.1016/j.peptides.2004.09.005
SN  - 01969781 (ISSN) 
AU  - Bodnar, R.J.
AU  - Klein, G.E.
AD  - Dept. of Psychol. and Neuropsychol., Doctoral Sub-Program, Queens Coll., City Univ. New Y., United States
AB  - This paper is the 26th consecutive installment of the annual review of research concerning the endogenous opioid system, now spanning over a quarter-century of research. It summarizes papers published during 2003 that studied the behavioral effects of molecular, pharmacological and genetic manipulation of opioid peptides, opioid receptors, opioid agonists and opioid antagonists. The particular topics that continue to be covered include the molecular-biochemical effects and neurochemical localization studies of endogenous opioids and their receptors related to behavior (Section 2), and the roles of these opioid peptides and receptors in pain and analgesia (Section 3); stress and social status (Section 4); tolerance and dependence (Section 5); learning and memory (Section 6); eating and drinking (Section 7); alcohol and drugs of abuse (Section 8); sexual activity and hormones, pregnancy, development and endocrinology (Section 9); mental illness and mood (Section 10); seizures and neurologic disorders (Section 11); electrical-related activity and neurophysiology (Section 12); general activity and locomotion (Section 13); gastrointestinal, renal and hepatic functions (Section 14); cardiovascular responses (Section 15); respiration and thermoregulation (Section 16); and immunological responses (Section 17). © 2004 Elsevier Inc. All rights reserved.
KW  - Endogenous opiates
KW  - Opioid agon
KW  - Opioid receptors
KW  - 1 (1 cyclooctylmethyl 3 hydroxymethyl 4 piperidyl) 3 ethyl 1,3 dihydro 2h benzimidazol 2 one
KW  - 1 (2,3 dihydro 1 methyl 2 oxo 5 phenyl 1h 1,4 benzodiazepin 3 yl) 3 (3 methylphenyl)urea
KW  - 1 (2,4 dichlorophenyl) 5 (4 iodophenyl) 4 methyl n (1 piperidyl) 1h pyrazole 3 carboxamide
KW  - 1 (4 aminophenyl) 3,4 dihydro 4 methyl 3 methylcarbamoyl 7,8 methylenedioxy 5h 2,3 benzodiazepine
KW  - 1,4 diamino 1,4 bis(2 aminophenylthio) 2,3 dicyanobutadiene
KW  - 2 [1 (3 dimethylaminopropyl) 3 indolyl] 3 (3 indolyl)maleimide
KW  - 2 morpholino 8 phenylchromone
KW  - 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine
KW  - 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine
KW  - 3 (difluoromethyl) 1 (4 methoxyphenyl) 5 [4 (methylsulfinyl)phenyl]pyrazole
KW  - 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide
KW  - 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide methanesulfonate
KW  - 4 (1,1 dimethylheptyl) 1',2',3',4',5',6' hexahydro 2,3' dihydroxy 6' (3 hydroxypropyl)biphenyl
KW  - 4 [alpha (4 allyl 2,5 dimethyl 1 piperazinyl) 3 methoxybenzyl] n,n diethylbenzamide
KW  - 5 amino 2 (2 furyl) 7 (2 phenylethyl)pyrazolo[4,3 e][1,2,4]triazolo[1,5 c]pyrimidine
KW  - 5 dimethylamino n (3,4 dimethyl 5 isoxazolyl) 1 naphthalenesulfonamide
KW  - 6 chloro 2,3,4,5 tetrahydro 3 methyl 1h 3 benzazepine
KW  - 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate
KW  - bemesetron
KW  - bp 897
KW  - brefeldin A
KW  - brimonidine
KW  - bupivacaine
KW  - buprenorphine
KW  - butorphanol
KW  - calphostin C
KW  - cgrp8 37
KW  - cgs 10764b
KW  - chf 3381
KW  - codeine
KW  - cyclazocine
KW  - cyclo(dextro tryptophyl dextro aspartylprolyl dextro valylleucyl)
KW  - decahydro 6 phosphonomethyl 3 isoquinolinecarboxylic acid
KW  - dezocine
KW  - dihydrocodeine
KW  - dizocilpine
KW  - docebenone
KW  - dpi 3290
KW  - endorphin
KW  - enzyme inhibitor
KW  - etorphine
KW  - f 13640
KW  - fentanyl
KW  - go 7874
KW  - hydromorphone
KW  - jct 801
KW  - kt 5720
KW  - lofentanil
KW  - ly 306740
KW  - metazocine
KW  - mifepristone
KW  - morphine
KW  - n [2 [4 (2 methoxyphenyl) 1 piperazinyl]ethyl] n (2 pyridyl)cyclohexanecarboxamide
KW  - n [2 [[n [3 (4 chlorophenyl) 2 propenyl] n methylamino]methyl]phenyl] n (2 hydroxyethyl) 4 methoxybenzenesulfonamide
KW  - n acetyl alpha intermedin[4-10]cyclo[4 norleucine 5 aspartic acid 7 [3 (2 naphthyl)alanine] 10 lysinamide]
KW  - n methyl n [7 (1 pyrrolidinyl) 1 oxaspiro[4.5]dec 8 yl]benzeneacetamide
KW  - nalbuphine
KW  - nalfurafine
KW  - nalorphine
KW  - naloxone
KW  - naltrexone
KW  - opiate agonist
KW  - opiate antagonist
KW  - opiate peptide
KW  - opiate receptor
KW  - oxycodone
KW  - pethidine
KW  - piritramide
KW  - r 004333
KW  - r 820
KW  - rb 3007
KW  - rimonabant
KW  - ro 646198
KW  - saredutant
KW  - tacrolimus
KW  - trk 20
KW  - u 69563
KW  - unclassified drug
KW  - unindexed drug
KW  - allodynia
KW  - analgesia
KW  - behavioral science
KW  - biochemistry
KW  - breathing
KW  - cancer pain
KW  - cardiovascular response
KW  - chronic pain
KW  - dizziness
KW  - drinking
KW  - drug abuse
KW  - eating
KW  - electric activity
KW  - endocrinology
KW  - gastrointestinal tract function
KW  - genetic manipulation
KW  - human
KW  - immune response
KW  - kidney function
KW  - learning
KW  - locomotion
KW  - memory
KW  - mental disease
KW  - molecular biology
KW  - mood
KW  - nausea
KW  - neurochemistry
KW  - neurologic disease
KW  - neurophysiology
KW  - nonhuman
KW  - pain
KW  - pregnancy
KW  - priority journal
KW  - protein function
KW  - protein localization
KW  - review
KW  - scratching
KW  - seizure
KW  - sexual behavior
KW  - side effect
KW  - social status
KW  - somnolence
KW  - stress
KW  - thermoregulation
KW  - vomiting
KW  - Analgesia
KW  - Animals
KW  - Behavior
KW  - Behavior, Animal
KW  - Cardiovascular Physiology
KW  - Electrophysiology
KW  - Feeding Behavior
KW  - Gastrointestinal Tract
KW  - Humans
KW  - Learning
KW  - Mental Disorders
KW  - Nervous System Diseases
KW  - Opioid Peptides
KW  - Receptors, Opioid
KW  - Respiration
KW  - Sexual Behavior
KW  - Stress
KW  - Substance-Related Disorders
N1  - Cited By :41
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
N1  - CODEN: PEPTD
C2  - 15572211
LA  - English
N1  - Correspondence Address: Dept. of Psychol. and Neuropsychol., Doctoral Sub-Program, Queens Coll., City Univ. New Y.United States; email: richard_bodnar@qc.edu
N1  - Chemicals/CAS: 1 (1 cyclooctylmethyl 3 hydroxymethyl 4 piperidyl) 3 ethyl 1,3 dihydro 2h benzimidazol 2 one, 256640-45-6; 1 (2,3 dihydro 1 methyl 2 oxo 5 phenyl 1h 1,4 benzodiazepin 3 yl) 3 (3 methylphenyl)urea, 118101-09-0; 1 (2,4 dichlorophenyl) 5 (4 iodophenyl) 4 methyl n (1 piperidyl) 1h pyrazole 3 carboxamide, 183232-66-8; 1 (4 aminophenyl) 3,4 dihydro 4 methyl 3 methylcarbamoyl 7,8 methylenedioxy 5h 2,3 benzodiazepine, 143692-48-2; 1,4 diamino 1,4 bis(2 aminophenylthio) 2,3 dicyanobutadiene, 109511-58-2; 2 [1 (3 dimethylaminopropyl) 3 indolyl] 3 (3 indolyl)maleimide, 133052-90-1; 2 morpholino 8 phenylchromone, 154447-36-6; 2,3 dihydro 5 methyl 3 (morpholinomethyl) 6 (1 naphthoyl)pyrrolo[1,2,3 de][1,4]benzoxazine, 134959-51-6; 2,3,4,5 tetrahydro 7,8 dihydroxy 1 phenyl 1h 3 benzazepine, 67287-49-4; 3 (difluoromethyl) 1 (4 methoxyphenyl) 5 [4 (methylsulfinyl)phenyl]pyrazole, 151506-44-4; 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide, 67198-13-4; 3,4 dichloro n methyl n [2 (1 pyrrolidinyl)cyclohexyl]benzeneacetamide methanesulfonate, 83913-06-8; 4 (1,1 dimethylheptyl) 1',2',3',4',5',6' hexahydro 2,3' dihydroxy 6' (3 hydroxypropyl)biphenyl, 83003-12-7; 4 [alpha (4 allyl 2,5 dimethyl 1 piperazinyl) 3 methoxybenzyl] n,n diethylbenzamide, 156727-74-1; 5 amino 2 (2 furyl) 7 (2 phenylethyl)pyrazolo[4,3 e][1,2,4]triazolo[1,5 c]pyrimidine, 160098-96-4; 5 dimethylamino n (3,4 dimethyl 5 isoxazolyl) 1 naphthalenesulfonamide, 153042-42-3; 6 chloro 2,3,4,5 tetrahydro 3 methyl 1h 3 benzazepine, 73943-10-9; 8 chloro 2,3,4,5 tetrahydro 3 methyl 5 phenyl 1h 3 benzazepin 7 ol hydrogen maleate, 87134-87-0; bemesetron, 40796-97-2; brefeldin A, 20350-15-6; brimonidine, 59803-98-4; bupivacaine, 18010-40-7, 2180-92-9, 55750-21-5; buprenorphine, 52485-79-7, 53152-21-9; butorphanol, 42408-82-2; calphostin C, 121263-19-2; codeine, 76-57-3; cyclazocine, 3572-80-3; cyclo(dextro tryptophyl dextro aspartylprolyl dextro valylleucyl), 136553-81-6; decahydro 6 phosphonomethyl 3 isoquinolinecarboxylic acid, 136109-04-1, 137433-06-8; dezocine, 53648-55-8; dihydrocodeine, 125-28-0, 24204-13-5, 5965-13-9; dizocilpine, 77086-21-6; docebenone, 80809-81-0; endorphin, 60118-07-2; etorphine, 13764-49-3, 14521-96-1; fentanyl, 437-38-7; hydromorphone, 466-99-9, 71-68-1; kt 5720, 108068-98-0; lofentanil, 61380-40-3; metazocine, 3734-52-9; mifepristone, 84371-65-3; morphine, 52-26-6, 57-27-2; n [2 [4 (2 methoxyphenyl) 1 piperazinyl]ethyl] n (2 pyridyl)cyclohexanecarboxamide, 146714-97-8; n [2 [[n [3 (4 chlorophenyl) 2 propenyl] n methylamino]methyl]phenyl] n (2 hydroxyethyl) 4 methoxybenzenesulfonamide, 139298-40-1; n acetyl alpha intermedin[4-10]cyclo[4 norleucine 5 aspartic acid 7 [3 (2 naphthyl)alanine] 10 lysinamide], 168482-23-3; n methyl n [7 (1 pyrrolidinyl) 1 oxaspiro[4.5]dec 8 yl]benzeneacetamide, 96744-75-1; nalbuphine, 20594-83-6, 23277-43-2; nalfurafine, 152657-84-6, 152658-17-8; nalorphine, 1041-90-3, 57-29-4, 62-67-9; naloxone, 357-08-4, 465-65-6; naltrexone, 16590-41-3, 16676-29-2; oxycodone, 124-90-3, 76-42-6; pethidine, 28097-96-3, 50-13-5, 57-42-1; piritramide, 302-41-0; rimonabant, 158681-13-1, 168273-06-1; saredutant, 142001-63-6; tacrolimus, 104987-11-3; Opioid Peptides; Receptors, Opioid
N1  - Tradenames: aa 861; am 251; bms 182874; bp 897; bq 123; cgrp8 37; cgs 10764b; chf 3381; cp 55940; dpi 3290; f 13640; fk 506; fr 140423; gf 109203x; go 7874; j 113397; jct 801; kn 93; kt 5720; l 365260; ly 235959; ly 274614; ly 294002; ly 300168; ly 306740; mdl 72222; mk 801; r 004333; r 820; rb 3007; ro 646198; ru 486; sch 23390; sch 58261; shu 9119; skf 38393; skf 86466; snc 80; sr 141716a; sr 48968; trk 20; trk 820; u 0126; u 50488; u 50488h; u 69563; u 69593; uk 14304; way 100635; win 55212 2
N1  - References: Abe, K., Taguchi, K., Kato, M., Utsunomiya, I., Chikuma, T., Hojyo, H., Characterization of muscarinic receptor subtypes in the rostral ventrolateral medulla and effects on morphine-induced antinociception in rats (2003) Eur J Pharmacol, 465 (3), pp. 237-249; 
Ackerman, L.L., Follett, K.A., Rosenquist, R.W., Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations (2003) J Pain Symptom Manage, 26 (1), pp. 668-677; 
Ackerman, S.J., Mordin, M., Reblando, J., Xu, X., Schein, J., Vallow, S., Patient-reported utilization patterns of fentanyl transdermal system and oxycodone hydrochloride controlled-release among patients with chronic nonmalignant pain (2003) J Manag Care Pharm, 9 (3), pp. 223-231; 
Ackerman, T.F., Lamonte, N., Bodnar, R.J., Lack of intersite GABA receptor subtype antagonist effects upon mu opioid receptor agonist-induced feeding elicited from either the ventral tegmental area or nucleus accumbens shell in rats (2003) Physiol Behav, 79 (2), pp. 191-198; 
Adams, D.H., Hanson, G.R., Keefe, K.A., Distinct effects of methamphetamine and cocaine on preprodynorphin messenger RNA in rat striatal patch and matrix (2003) J Neurochem, 84 (1), pp. 87-93; 
Agmo, A., Lack of opioid or dopaminergic effects on unconditioned sexual incentive motivation in male rats (2003) Behav Neurosci, 117 (1), pp. 55-68; 
Ahmadi, J., Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients (2003) J Subst Abuse Treat, 24 (3), pp. 217-220; 
Ali, R., Thomas, P., White, J., McGregor, C., Danz, C., Gowing, L., Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: Determinants of withdrawal severity (2003) Drug Alcohol Rev, 22 (4), pp. 425-431; 
Allen, G.J., Hartl, T.L., Duffany, S., Smith, S.F., VanHeest, J.L., Anderson, J.M., Cognitive and motor function after administration of hydrocodone bitartrate plus ibuprofen, ibuprofen alone, or placebo in healthy subjects with exercise-induced muscle damage: A randomized, repeated-dose, placebo-controlled study (2003) Psychopharmacology (Berl), 166 (3), pp. 228-233; 
Allen, R.M., Granger, A.L., Dykstra, L.A., The competitive N-methyl-d-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235,959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor (2003) J Pharmacol Exp Ther, 307 (2), pp. 785-792; 
Almeida, R.A., Lauretti, G.R., Mattos, A.L., Antinociceptive effect of low-dose intrathecal neostigmine combined with intrathecal morphine following gynecologic surgery (2003) Anesthesiology, 98 (2), pp. 495-498; 
Alonzo, N.C., Bayer, B.M., Antagonism of N-methyl-d-aspartate receptors reduces the vulnerability of the immune system to stress after chronic morphine (2003) J Pharmacol Exp Ther, 307 (2), pp. 793-800; 
Alvarez, P., Saavedra, G., Hernandez, A., Paeile, C., Pelissier, T., Synergistic antinociceptive effects of ketamine and morphine in the orofacial capsaicin test in the rat (2003) Anesthesiology, 99 (4), pp. 969-975; 
Ammon, S., Mayer, P., Riechert, U., Tischmeyer, H., Hollt, V., Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal (2003) Brain Res Mol Brain Res, 112 (1-2), pp. 113-125; 
Andersen, G., Christrup, L., Sjogren, P., Relationships among morphine metabolism, pain and side effects during long-term treatment: An update (2003) J Pain Symptom Manage, 25 (1), pp. 74-91; 
Andreassen, O.A., Waage, J., Finsen, B., Jorgensen, H.A., Memantine attenuates the increase in striatal preproenkephalin mRNA expression and development of haloperidol-induced persistent oral dyskinesias in rats (2003) Brain Res, 994 (2), pp. 188-192; 
Antonilli, L., Suriano, C., Paolone, G., Badiani, A., Nencini, P., Repeated exposures to heroin and/or cadmium alter the rate of formation of morphine glucuronides in the rat (2003) J Pharmacol Exp Ther, 307 (2), pp. 651-660; 
Antonilli, L., Semeraro, F., Suriano, C., Signore, L., Nencini, P., High levels of morphine-6-glucuronide in street heroin addicts (2003) Psychopharmacology (Berl), 170 (2), pp. 200-204; 
Aoki, T., Narita, M., Ohnishi, O., Mizuo, K., Narita, M., Yajima, Y., Disruption of the type 1 inositol 1,4,5-trisphosphate receptor gene suppresses the morphine-induced antinociception in the mouse (2003) Neurosci Lett, 350 (2), pp. 69-72; 
Appleyard, S.M., Hayward, M., Young, J.I., Butler, A.A., Cone, R.D., Rubinstein, M., A role for the endogenous opioid beta-endorphin in energy homeostasis (2003) Endocrinology, 144 (5), pp. 1753-1760; 
Aricioglu, F., Utkan, T., Inhibitory effect of harmane on morphine-dependent Guinea pig ileum (2003) Ann NY Acad Sci, 1009, pp. 185-189; 
Aricioglu, F., Ercil, E., Dulger, G., Agmatine inhibits naloxone-induced contractions in morphine-dependent Guinea pig ileum (2003) Ann NY Acad Sci, 1009, pp. 147-151; 
Armstrong, S.C., Cozza, K.L., Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: Theory and clinical reality (part II) (2003) Psychosomatics, 44 (6), pp. 515-520; 
Aubrun, F., Kalfon, F., Mottet, P., Bellanger, A., Langeron, O., Coriat, P., Adjunctive analgesia with intravenous propacetamol does not reduce morphine-related adverse effects (2003) Br J Anaesth, 90 (3), pp. 314-319; 
Aubrun, F., Bunge, D., Langeron, O., Saillant, G., Coriat, P., Riou, B., Postoperative morphine consumption in the elderly patient (2003) Anesthesiology, 99 (1), pp. 160-165; 
Aubrun, F., Langeron, O., Quesnel, C., Coriat, P., Riou, B., Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration (2003) Anesthesiology, 98 (6), pp. 1415-1421; 
Azar, M.R., Jones, B.C., Schulteis, G., Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal (2003) Psychopharmacology (Berl), 170 (1), pp. 42-50; 
Backmund, M., Schutz, C.G., Meyer, K., Eichenlaub, D., Soyka, M., Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients - Frequency and correlates of use (2003) Eur Addict Res, 9 (1), pp. 45-50; 
Bailey, A., Hawkins, R.M., Hourani, S.M., Kitchen, I., Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated mice (2003) Br J Pharmacol, 139 (6), pp. 1187-1195; 
Bailey, C.P., Couch, D., Johnson, E., Griffiths, K., Kelly, E., Henderson, G., Mu-opioid receptor desensitization in mature rat neurons: Lack of interaction between DAMGO and morphine (2003) J Neurosci, 23 (33), pp. 10515-10520; 
Bain, J.N., Prendergast, M.A., Terry Jr., A.V., Arneric, S.P., Smith, M.A., Buccafusco, J.J., Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential (2003) Psychopharmacology (Berl), 169 (2), pp. 150-160; 
Baker, A., Meert, T., Morphine and d-amphetamine nullify each others' hypothermic effects in mice (2003) Pharmacol Toxicol, 92 (2), pp. 64-70; 
Ballet, S., Conrath, M., Fischer, J., Kaneko, T., Hamon, M., Cesselin, F., Expression and G-protein coupling of mu-opioid receptors in the spinal cord and dorsal root ganglia of polyarthritic rats (2003) Neuropeptides, 37 (4), pp. 211-219; 
Bar-Oz, B., Bulkowstein, M., Benyamini, L., Greenberg, R., Soriano, I., Zimmerman, D., Use of antibiotic and analgesic drugs during lactation (2003) Drug Saf, 26 (13), pp. 925-935; 
Bardin, L., Tarayre, J.P., Malfetes, N., Koek, W., Colpaert, F.C., Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F13,640 in the formalin model of tonic nociceptive pain (2003) Pharmacology, 67 (4), pp. 182-194; 
Bardo, M.T., Gehrke, B.J., Shortridge, B.E., Rauhut, A.S., Effects of beta-funaltrexamine and naloxonazine on single-trial morphine-conditioned place preference and locomotor activity (2003) Pharmacol Biochem Behav, 74 (3), pp. 617-622; 
Barnes, M.J., Lapanowski, K., Conley, A., Rafols, J.A., Jen, K.L., Dunbar, J.C., High fat feeding is associated with increased blood pressure, sympathetic nerve activity and hypothalamic mu opioid receptors (2003) Brain Res Bull, 61 (5), pp. 511-519; 
Barr, G.A., Limon, E., Luthmann, R.A., Barr, G.A., Cheng, J., Wang, S., Analgesia induced by local plantar injections of opiates in the formalin test in infant rats (2003) Dev Psychobiol, 42 (2), pp. 111-122; 
Barr, M.C., Huitron-Resendiz, S., Sanchez-Alavez, M., Henriksen, S.J., Phillips, T.R., Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: A model for HIV infection in chronic opiate abusers (2003) Drug Alcohol Depend, 72 (2), pp. 141-149; 
Barrett, A.C., Smith, E.S., Picker, M.J., Capsaicin-induced hyperalgesia and mu-opioid-induced antihyperalgesia in male and female Fischer 344 rats (2003) J Pharmacol Exp Ther, 307 (1), pp. 237-245; 
Bart, G., Borg, L., Schluger, J.H., Green, M., Ho, A., Kreek, M.J., Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects (2003) J Pharmacol Exp Ther, 306 (2), pp. 581-587; 
Bartus, R.T., Emerich, D.F., Hotz, J., Blaustein, M., Dean, R.L., Perdomo, B., Vivitrex, an injectable, extended-release formulation of naltrexone, provides pharmacokinetic and pharmacodynamic evidence of efficacy for 1 month in rats (2003) Neuropsychopharmacology, 28 (11), pp. 1973-1982; 
Belda, M., Covenas, R., Narvaez, J.A., Aguirre, J.A., Tramu, G., An immunocytochemical mapping of methionine-enkephalin-Arg6-Gly7-Leu8 in the cat brainstem (2003) Anat Embryol (Berl), 206 (5), pp. 399-408; 
Benamar, K., Yondorf, M.Z., Kon, D., Geller, E.B., Adler, M.W., Role of the nitric-oxide synthase isoforms during morphine-induced hyperthermia in rats (2003) J Pharmacol Exp Ther, 307 (1), pp. 219-222; 
Benavides, M., Laorden, M.L., Garcia-Borron, J.C., Milanes, M.V., Regulation of tyrosine hydroxylase levels and activity and Fos expression during opioid withdrawal in the hypothalamic PVN and medulla oblongata catecholaminergic cell groups innervating the PVN (2003) Eur J Neurosci, 17 (1), pp. 103-112; 
Bennett, L., Ratka, A., Delta opioid receptors are involved in morphine-induced inhibition of luteinizing hormone releasing hormone in SK-N-SH cells (2003) Neuropeptides, 37 (5), pp. 264-270; 
Berchenko, O.G., Vorob'eva, T.M., Geiko, V.V., Morphine and its potentiated form: Effects on pain sensitivity in rats (2003) Bull Exp Biol Med, 135 (SUPPL.), pp. 1105-1106; 
Beregovoi, N.A., Sorokina, N.S., Starostina, M.V., Shtark, M.B., Epstein, O.I., Effect of antibodies to morphine in ultralow doses on induction of long-term potentiation in hippocampal slices from rats with chronic morphine dependence (2003) Bull Exp Biol Med, 135 (SUPPL.), pp. 126-128; 
Beregovoi, N.A., Pankova, T.M., Sorokina, N.S., Starostina, M.V., Effect of antibodies to morphine on synaptic plasticity of the hippocampus (2003) Bull Exp Biol Med, 135 (2), pp. 114-116; 
Berrendero, F., Castane, A., Ledent, C., Parmentier, M., Maldonado, R., Valverde, O., Increase of morphine withdrawal in mice lacking A2a receptors and no changes in CB1/A2a double knockout mice (2003) Eur J Neurosci, 17 (2), pp. 315-324; 
Bhalla, S., Matwyshyn, G., Gulati, A., Endothelin receptor antagonists restore morphine analgesia in morphine tolerant rats (2003) Peptides, 24 (4), pp. 553-561; 
Bie, B., Fields, H.L., Williams, J.T., Pan, Z.Z., Roles of alpha1- and alpha2-adrenoceptors in the nucleus raphe magnus in opioid analgesia and opioid abstinence-induced hyperalgesia (2003) J Neurosci, 23 (21), pp. 7950-7957; 
Bie, B., Pan, Z.Z., Presynaptic mechanism for anti-analgesic and anti-hyperalgesic actions of kappa-opioid receptors (2003) J Neurosci, 23 (19), pp. 7262-7268; 
Bigliardi, P.L., Sumanovski, L.T., Buchner, S., Rufli, T., Bigliardi-Qi, M., Different expression of mu-opiate receptor in chronic and acute wounds and the effect of beta-endorphin on transforming growth factor beta type II receptor and cytokeratin 16 expression (2003) J Invest Dermatol, 120 (1), pp. 145-152; 
Bland, S.T., Hargrave, D., Pepin, J.L., Amat, J., Watkins, L.R., Maier, S.F., Stressor controllability modulates stress-induced dopamine and serotonin efflux and morphine-induced serotonin efflux in the medial prefrontal cortex (2003) Neuropsychopharmacology, 28 (9), pp. 1589-1596; 
Blogowska, A., Rzepka-Gorska, I., Krzyzanowska-Swiniarska, B., Zoltowski, S., Kosmowska, B., Leptin, neuropeptide Y, beta-endorphin, gonadotropin, and estradiol levels in girls before menarche (2003) Gynecol Endocrinol, 17 (1), pp. 7-12; 
Bocheva, A., Lazarova, M., Involvement of nitric oxide in the nociception of kyotorphin, TYR-CAV and MIF-s analogues in the rat spinal cord (2003) Methods Find Exp Clin Pharmacol, 25 (2), pp. 91-95; 
Bodnar, R.J., Hadjimarkou, M.M., Krzanowska, E.K., Silva, R.M., Stein, J.A., Differential dose-dependent effects of central morphine treatment upon food intake in male and female rats receiving neonatal hormone manipulations (2003) Nutr Neurosci, 6 (1), pp. 53-57; 
Bohn, L.M., Gainetdinov, R.R., Sotnikova, T.D., Medvedev, I.O., Lefkowitz, R.J., Dykstra, L.A., Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice (2003) J Neurosci, 23 (32), pp. 10265-10273; 
Bolanos, C.A., Perrotti, L.I., Edwards, S., Eisch, A.J., Barrot, M., Olson, V.G., Phospholipase Cgamma in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors (2003) J Neurosci, 23 (20), pp. 7569-7576; 
Bonci, A., Bernardi, G., Grillner, P., Mercuri, N.B., The dopamine-containing neuron: Maestro or simple musician in the orchestra of addiction? (2003) Trends Pharmacol Sci, 24 (4), pp. 172-177; 
Bouwmeester, N.J., Hop, W.C., Van Dijk, M., Anand, K.J., Van Den Anker, J.N., Tibboel, D., Postoperative pain in the neonate: Age-related differences in morphine requirements and metabolism (2003) Intensive Care Med, 29 (11), pp. 2009-2015; 
Breitfeld, C., Peters, J., Vockel, T., Lorenz, C., Eikermann, M., Emetic effects of morphine and piritramide (2003) Br J Anaesth, 91 (2), pp. 218-223; 
Brewer, K.L., McMillan, D., Nolan, T., Shum, K., Cortical changes in cholecystokinin mRNA are related to spontaneous pain behaviors following excitotoxic spinal cord injury in the rat (2003) Brain Res Mol Brain Res, 118 (1-2), pp. 171-174; 
Bridge, K.E., Wainwright, A., Reilly, K., Oliver, K.R., Autoradiographic localization of (125)i[Tyr(14)] nociceptin/orphanin FQ binding sites in macaque primate CNS (2003) Neuroscience, 118 (2), pp. 513-523; 
Bruehl, S., Chung, O.Y., Burns, J.W., Biridepalli, S., The association between anger expression and chronic pain intensity: Evidence for partial mediation by endogenous opioid dysfunction (2003) Pain, 106 (3), pp. 317-324; 
Bruins Slot, L.A., Colpaert, F.C., A persistent opioid-addiction state of memory (2003) Behav Pharmacol, 14 (2), pp. 167-171; 
Budai, M., Szabo, Z., Szogyi, M., Grof, P., Molecular interactions between DPPC and morphine derivatives: A DSC and EPR study (2003) Int J Pharm, 250 (1), pp. 239-250; 
Bujdoso, E., Jaszberenyi, M., Farkas, J., Toth, G., Wollemann, M., Telegdy, G., Behavioral and neuroendocrine actions of the Met-enkephalin-related peptide MERF (2003) Horm Behav, 43 (2), pp. 302-311; 
Bull, P.M., Ludwig, M., Blackburn-Munro, G.J., Gado-Cohen, H., Brown, C.H., Russell, J.A., The role of nitric oxide in morphine dependence and withdrawal excitation of rat oxytocin neurons (2003) Eur J Neurosci, 18 (9), pp. 2545-2551; 
Butelman, E.R., Ball, J.W., Harris, T.J., Kreek, M.J., Topical capsaicin-induced allodynia in unanesthetized primates: Pharmacological modulation (2003) J Pharmacol Exp Ther, 306 (3), pp. 1106-1114; 
Byrnes, E.M., Rigero, B.A., Bridges, R.S., Induction of maternal behavior in adult female rats following chronic morphine exposure during puberty (2003) Dev Psychobiol, 43 (4), pp. 367-372; 
Cadet, P., Mantione, K.J., Stefano, G.B., Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene (2003) J Immunol, 170 (10), pp. 5118-5123; 
Cadet, P., Zhu, W., Mantione, K., Rymer, M., Dardik, I., Reisman, S., Cyclic exercise induces anti-inflammatory signal molecule increases in the plasma of Parkinson's patients (2003) Int J Mol Med, 1-2 (4), pp. 485-492; 
Cadoni, C., Solinas, M., Valentini, V., Di Chiara, G., Selective psychostimulant sensitization by food restriction: Differential changes in accumbens shell and core dopamine (2003) Eur J Neurosci, 18 (8), pp. 2326-2334; 
Cahill, C.M., Dray, A., Coderre, T.J., Enhanced thermal antinociceptive potency and anti-allodynic effects of morphine following spinal administration of endotoxin (2003) Brain Res, 960 (1-2), pp. 209-218; 
Cahill, C.M., Dray, A., Coderre, T.J., Intrathecal nerve growth factor restores opioid effectiveness in an animal model of neuropathic pain (2003) Neuropharmacology, 45 (4), pp. 543-552; 
Caille, S., Rodriguez-Arias, M., Minarro, J., Espejo, E.F., Cador, M., Stinus, L., Changes in dopaminergic neurotransmission do not alter somatic or motivational opiate withdrawal-induced symptoms in rats (2003) Behav Neurosci, 117 (5), pp. 995-1005; 
Caille, S., Stinus, L., Espejo, E.F., De Deurwaerdere, P., Spampinato, U., Koob, G.F., Inhibition of 5-HT neurotransmission increases clonidine protective effects on naloxone-induced conditioned place aversion in morphine-dependent rats (2003) Neuropsychopharmacology, 28 (2), pp. 276-283; 
Caille, S., Parsons, L.H., SR141,716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats (2003) Eur J Neurosci, 18 (11), pp. 3145-3149; 
Cao, Z., Liu, L., Van Winkle, D.M., Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels (2003) Am J Physiol Heart Circ Physiol, 285 (3), pp. H1032-H1039; 
Capasso, A., Casapullo, A., Randazzo, A., Gomez-Paloma, L., Petrosaspongiolide M reduces morphine withdrawal in vitro (2003) Life Sci, 73 (5), pp. 611-616; 
Capasso, A., De Feo, V., Alkaloids from Brugmansia arborea (L.) Lagerhein reduce morphine withdrawal in vitro (2003) Phytother Res, 17 (7), pp. 826-829; 
Capasso, A., Loizzo, A., The effect of papaverine on acute opiate withdrawal in guinea pig ileum (2003) Phytother Res, 17 (7), pp. 774-777; 
Castro, C., Tharmaratnam, U., Brockhurst, N., Tureanu, L., Tam, K., Windrim, R., Patient-controlled analgesia with fentanyl provides effective analgesia for second trimester labour: A randomized controlled study (2003) Can J Anaesth, 50 (10), pp. 1039-1046; 
Celerier, E., Yazdi, M.T., Castane, A., Ghozland, S., Nyberg, F., Maldonado, R., Effects of nandrolone on acute morphine responses, tolerance and dependence in mice (2003) Eur J Pharmacol, 465 (1-2), pp. 69-81; 
Cepeda, M.S., Carr, D.B., Women experience more pain and require more morphine than men to achieve a similar degree of analgesia (2003) Anesth Analg, 97 (5), pp. 1464-1468; 
Cepeda, M.S., Farrar, J.T., Baumgarten, M., Boston, R., Carr, D.B., Strom, B.L., Side effects of opioids during short-term administration: Effect of age, gender, and race (2003) Clin Pharmacol Ther, 74 (2), pp. 102-112; 
Cha, E.Y., Mouledous, L., Harris, J.R., Weech, M.A., Gutstein, H.B., Nitroglycerin inhibits the development of morphine tolerance and dependence in rats (2003) Pharmacol Biochem Behav, 74 (3), pp. 551-557; 
Chadzinska, M., Scislowska-Czarnecka, A., Pierzchala-Koziec, K., Plytycz, B., Inflammation-induced alternations in local and central Met-enkephalin in mice (2003) Pol J Pharmacol, 55 (3), pp. 467-470; 
Chakrabarti, S., Liu, N.J., Gintzler, A.R., Reciprocal modulation of phospholipase Cbeta isoforms: Adaptation to chronic morphine (2003) Proc Natl Acad Sci USA, 100 (23), pp. 13686-13691; 
Chakrabarti, S., Gintzler, A.R., Phosphorylation of Gbeta is augmented by chronic morphine and enhances Gbetagamma stimulation of adenylyl cyclase activity (2003) Brain Res Mol Brain Res, 119 (2), pp. 144-151; 
Chandran, P., Sluka, K.A., Development of opioid tolerance with repeated transcutaneous electrical nerve stimulation administration (2003) Pain, 102 (1-2), pp. 195-201; 
Chartoff, E.H., Papadopoulou, M., Konradi, C., Carlezon Jr., W.A., Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum (2003) J Neurochem, 87 (1), pp. 107-118; 
Chefer, V.I., Kieffer, B.L., Shippenberg, T.S., Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice (2003) Eur J Neurosci, 18 (7), pp. 1915-1922; 
Chen, F., Rezvani, A.H., Lawrence, A.J., Autoradiographic quantification of neurochemical markers of serotonin, dopamine and opioid systems in rat brain mesolimbic regions following chronic St. John's wort treatment (2003) Naunyn Schmiedebergs Arch Pharmacol, 367 (2), pp. 126-133; 
Chen, J.C., Tao, P.L., Li, J.Y., Wong, C.H., Huang, E.Y., Endomorphin-1 and -2 induce naloxone-precipitated withdrawal syndromes in rats (2003) Peptides, 24 (3), pp. 477-481; 
Chen, S.R., Pan, H.L., Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats (2003) Anesthesiology, 98 (1), pp. 217-222; 
Chen, S.R., Pan, H.L., Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats (2003) Anesthesiology, 99 (6), pp. 1409-1414; 
Cheng, J.T., Liu, I.M., Tzeng, T.F., Chen, W.C., Hayakawa, S., Yamamoto, T., Release of beta-endorphin by caffeic acid to lower plasma glucose in streptozotocin-induced diabetic rats (2003) Horm Metab Res, 35 (4), pp. 251-258; 
Cheng, S.B., Kuchiiwa, S., Kawachi, A., Gao, H.Z., Gohshi, A., Kozako, T., Up-regulation of methionine-enkephalin-like immunoreactivity by 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment in the forebrain of the Long-Evans rat (2003) J Chem Neuroanat, 25 (2), pp. 73-82; 
Cherry, D.A., Gourlay, G.K., Eldredge, K.A., Management of chronic intractable angina - Spinal opioids offer an alternative therapy (2003) Pain, 102 (1-2), pp. 163-166; 
Chesler, E.J., Ritchie, J., Kokayeff, A., Lariviere, W.R., Wilson, S.G., Mogil, J.S., Genotype-dependence of gabapentin and pregabalin sensitivity: The pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited (2003) Pain, 106 (3), pp. 325-335; 
Chew, S.T., Ip-Yam, P.C., Kong, C.F., Recovery following tonsillectomy a comparison between tramadol and morphine for analgesia (2003) Singapore Med J, 44 (6), pp. 296-298; 
Chiou, L.C., Yeh, G.C., Fan, S.H., How, C.H., Chuang, K.C., Tao, P.L., Prenatal morphine exposure decreases analgesia but not K + channel activation (2003) NeuroReport, 14 (2), pp. 239-242; 
Cho, C.H., Wu, K.K., Wu, S., Wong, T.M., So, W.H., Liu, E.S., Morphine as a drug for stress ulcer prevention and healing in the stomach (2003) Eur J Pharmacol, 460 (23), pp. 177-182; 
Ciccocioppo, R., Fedeli, A., Economidou, D., Policani, F., Weiss, F., Massi, M., The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ (2003) J Neurosci, 23 (28), pp. 9445-9451; 
Ciccocioppo, R., Economidou, D., Fedeli, A., Massi, M., The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: A review of recent work in alcohol-preferring rats (2003) Physiol Behav, 79 (1), pp. 121-128; 
Cicero, T.J., Aylward, S.C., Meyer, E.R., Gender differences in the intravenous self-administration of mu opiate agonists (2003) Pharmacol Biochem Behav, 74 (3), pp. 541-549; 
Cichewicz, D.L., McCarthy, E.A., Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration (2003) J Pharmacol Exp Ther, 304 (3), pp. 1010-1015; 
Ciga-Campos, M., Lopez, U.G., Reval, M.I., Lopez-Munoz, F.J., Enhancement of antinociception by co-administration of an opioid drug (morphine) and a preferential cyclooxygenase-2 inhibitor (rofecoxib) in rats (2003) Eur J Pharmacol, 460 (2-3), pp. 99-107; 
Clarke, S., Zimmer, A., Zimmer, A.M., Hill, R.G., Kitchen, I., Region selective up-regulation of micro-, delta- and kappa-opioid receptors but not opioid receptor-like 1 receptors in the brains of enkephalin and dynorphin knockout mice (2003) Neuroscience, 122 (2), pp. 479-489; 
Clarke, S., Chen, Z., Hsu, M.S., Hill, R.G., Pintar, J.E., Kitchen, I., Nociceptin/orphanin FQ knockout mice display up-regulation of the opioid receptor-like 1 receptor and alterations in opioid receptor expression in the brain (2003) Neuroscience, 117 (1), pp. 157-168; 
Coda, B.A., Rudy, A.C., Archer, S.M., Wermeling, D.P., Pharmacokinetics and bioavailability of single-dose intranasal hydromorphone hydrochloride in healthy volunteers (2003) Anesth Analg, 97 (1), pp. 117-123; 
Coffman, B.L., Kearney, W.R., Goldsmith, S., Knosp, B.M., Tephly, T.R., Opioids bind to the amino acids 84 to 118 of UDP-glucuronosyltransferase UGT2B7 (2003) Mol Pharmacol, 63 (2), pp. 283-288; 
Cole, J.C., Sumnall, H.R., O'Shea, E., Marsden, C.A., Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse (2003) Psychopharmacology (Berl), 166 (4), pp. 383-390; 
Coles Jr., J.A., Sigg, D.C., Iaizzo, P.A., Role of kappa-opioid receptor activation in pharmacological preconditioning of swine (2003) Am J Physiol Heart Circ Physiol, 284 (6), pp. H2091-H2099; 
Compan, V., Scearce-Levie, K., Crosson, C., Daszuta, A., Hen, R., Enkephalin contributes to the locomotor stimulating effects of 3,4-methylenedioxy-N-methylamphetamine (2003) Eur J Neurosci, 18 (2), pp. 383-390; 
Compton, P., Athanasos, P., Elashoff, D., Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: A preliminary study (2003) J Pain, 4 (9), pp. 511-519; 
Cook, C.D., Beardsley, P.M., The modulatory actions of dopamine D2/3 agonists and antagonists on the locomotor-activating effects of morphine and caffeine in mice (2003) Pharmacol Biochem Behav, 75 (2), pp. 363-371; 
Cowan, A., Buprenorphine: New pharmacological aspects (2003) Int J Clin Pract Suppl, (133), pp. 3-8; 
Csaba, G., Kovacs, P., Pallinger, E., Effect of a single neonatal endorphin treatment on the hormone content of adult rat white blood cells and mast cells (2003) Cell Biol Int, 27 (5), pp. 423-427; 
Csaba, G., Knippel, B., Karabelyos, C., Inczefi-Gonda, A., Hantos, M., Tothfalusi, L., Effect of neonatal beta-endorphin imprinting on sexual behavior and brain serotonin level in adult rats (2003) Life Sci, 73 (1), pp. 103-114; 
Da, S.T., Cucco, S.N., Bassani, M., Duarte, M.S., Silveira, P.P., Vasconcellos, A.P., Long-lasting delayed hyperalgesia after chronic restraint stress in rats-effect of morphine administration (2003) Neurosci Res, 45 (3), pp. 277-283; 
Davies, M.F., Haimor, F., Lighthall, G., Clark, J.D., Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration (2003) Anesth Analg, 96 (1), pp. 195-200; 
De Castro, S., Sabate, E., Adherence to heroin dependence therapies and human immunodeficiency virus/acquired immunodeficiency syndrome infection rates among drug abusers (2003) Clin Infect Dis, 37 (5 SUPPL.), pp. S464-S467; 
De Los Santos-Arteaga, Sierra-Dominguez, S.A., Fontanella, G.H., Gado-Garcia, J.M., Carrion, A.M., Analgesia induced by dietary restriction is mediated by the kappa-opioid system (2003) J Neurosci, 23 (35), pp. 11120-11126; 
Depner, U.B., Reinscheid, R.K., Takeshima, H., Brune, K., Zeilhofer, H.U., Normal sensitivity to acute pain, but increased inflammatory hyperalgesia in mice lacking the nociceptin precursor polypeptide or the nociceptin receptor (2003) Eur J Neurosci, 17 (11), pp. 2381-2387; 
Dernedde, M., Stadler, M., Bardiau, F., Boogaerts, J.G., Continuous epidural infusion of large concentration/small volume versus small concentration/large volume of levobupivacaine for postoperative analgesia (2003) Anesth Analg, 96 (3), pp. 796-801; 
Devine, D.P., Hoversten, M.T., Ueda, Y., Akil, H., Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress (2003) J Neuroendocrinol, 15 (1), pp. 69-74; 
Devoino, L., Cheido, M., Alperina, E., Idova, G., Evidence for a role of dopaminergic mechanisms in the immunostimulating effect of mu-opioid receptor agonist DAGO (2003) Int J Neurosci, 113 (10), pp. 1381-1394; 
Devys, J.M., Mora, A., Plaud, B., Jayr, C., Laplanche, A., Raynard, B., Intrathecal + PCA morphine improves analgesia during the first 24 h after major abdominal surgery compared to PCA alone (2003) Can J Anaesth, 50 (4), pp. 355-361; 
Di Ciano, P., Everitt, B.J., Differential control over drug-seeking behavior by drug-associated conditioned reinforcers and discriminative stimuli predictive of drug availability (2003) Behav Neurosci, 117 (5), pp. 952-960; 
Di Ciano, P., Everitt, B.J., The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats (2003) Neuropsychopharmacology, 28 (3), pp. 510-518; 
Diaz, S.L., Kemmling, A.K., Balerio, G.N., Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal (2003) Neurochem Int, 42 (4), pp. 293-298; 
Dougherty, M., DeBaun, M.R., Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain (2003) J Pediatr, 142 (4), pp. 373-376; 
Douglas, A.J., Brunton, P.J., Bosch, O.J., Russell, J.A., Neumann, I.D., Neuroendocrine responses to stress in mice: Hyporesponsiveness in pregnancy and parturition (2003) Endocrinology, 144 (12), pp. 5268-5276; 
Duarte, C., Lefebvre, C., Chaperon, F., Hamon, M., Thiebot, M.H., Effects of a dopamine D3 receptor ligand, BP 897, on acquisition and expression of food-, morphine-, and cocaine-induced conditioned place preference, and food-seeking behavior in rats (2003) Neuropsychopharmacology, 28 (11), pp. 1903-1915; 
Dudas, B., Merchenthaler, I., Topography and associations of leu-enkephalin and luteinizing hormone-releasing hormone neuronal systems in the human diencephalon (2003) J Clin Endocrinol Metab, 88 (4), pp. 1842-1848; 
Dujourdy, L., Barbati, G., Taroni, F., Gueniat, O., Esseiva, P., Anglada, F., Evaluation of links in heroin seizures (2003) Forensic Sci Int, 131 (2-3), pp. 171-183; 
Dunbar, S.A., Karamian, I.G., Periodic abstinence enhances nociception without significantly altering the antinociceptive efficacy of spinal morphine in the rat (2003) Neurosci Lett, 344 (3), pp. 145-148; 
Dunbar, S.A., Karamian, I.G., Cross-tolerance between spinal neostigmine and morphine in the rat (2003) Br J Anaesth, 91 (3), pp. 427-429; 
Eckert III, W.A., McNaughton, K.K., Light, A.R., Morphology axonal arborization of rat spinal inner lamina II neurons hyperpolarized by mu-opioid-selective agonists (2003) J Comp Neurol, 458 (3), pp. 240-256; 
Eidi, M., Oryan, S., Eidi, A., Sepehrara, L., Effect of morphine, naloxone and histamine system on water intake in adult male rats (2003) Eur J Pharmacol, 478 (2-3), pp. 105-110; 
Eisenach, J.C., Hood, D.D., Curry, R., Shafer, S.L., Cephalad movement of morphine and fentanyl in humans after intrathecal injection (2003) Anesthesiology, 99 (1), pp. 166-173; 
Eitan, S., Bryant, C.D., Saliminejad, N., Yang, Y.C., Vojdani, E., Keith Jr., D., Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization (2003) J Neurosci, 23 (23), pp. 8360-8369; 
Elliott, J.C., Picker, M.J., Nelson, C.J., Carrigan, K.A., Lysle, D.T., Sex differences in opioid-induced enhancement of contact hypersensitivity (2003) J Invest Dermatol, 121 (5), pp. 1053-1059; 
Epstein, O.I., Shtark, M.B., Zapara, T.A., Simonova, O.G., Ratushnyak, A.S., Reaction of neurons to alkaloid agonists of opioid receptors during modulation of phosphodiesterases (2003) Bull Exp Biol Med, 1 (SUPPL.), pp. 17-19; 
Epstein, O.I., Vorob'eva, T.M., Geiko, V.V., Pan, I.R., Berchenko, O.G., Neurotropic compounds and their antibodies: Effect on the brain system of positive emotional reinforcement (2003) Bull Exp Biol Med, 135 (SUPPL.), pp. 1130-1131; 
Epstein, O.I., Vorob'eva, T.M., Geiko, V.V., Berchenko, O.G., Psychoactive compounds and their antibodies: Effect on self-stimulation of the lateral hypothalamus in morphinized rats (2003) Bull Exp Biol Med, 135 (SUPPL.), pp. 1132-1133; 
Evans, S.M., Nasser, J., Comer, S.D., Foltin, R.W., Smoked heroin in rhesus monkeys: Effects of heroin extinction and fluid availability on measures of heroin seeking (2003) Pharmacol Biochem Behav, 74 (3), pp. 723-737; 
Fabian, G., Tombor, B., Nemeth, I., Kicsi, E.G., Szikszay, M., Horvath, G., Upregulation of mu opioid receptors by voluntary morphine administration in drinking water (2003) Acta Biol Hung, 54 (2), pp. 157-166; 
Fadda, P., Scherma, M., Fresu, A., Collu, M., Fratta, W., Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat (2003) Synapse, 50 (1), pp. 1-6; 
Fagergren, P., Smith, H.R., Daunais, J.B., Nader, M.A., Porrino, L.J., Hurd, Y.L., Temporal upregulation of prodynorphin mRNA in the primate striatum after cocaine self-administration (2003) Eur J Neurosci, 17 (10), pp. 2212-2218; 
Faletti, A.G., Mohn, C., Farina, M., Lomniczi, A., Rettori, V., Interaction among beta-endorphin, nitric oxide and prostaglandins during ovulation in rats (2003) Reproduction, 125 (4), pp. 469-477; 
Fan, L.W., Tien, L.T., Tanaka, S., Ma, T., Chudapongse, N., Sinchaisuk, S., Changes in the brain kappa-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol (2003) Neuroscience, 121 (4), pp. 1063-1074; 
Fan, X.L., Zhang, J.S., Zhang, X.Q., Yue, W., Ma, L., Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine (2003) Neuroscience, 117 (2), pp. 383-389; 
Fan, X.L., Zhang, J.S., Zhang, X.Q., Ma, L., Chronic morphine treatment and withdrawal induce up-regulation of c-Jun N-terminal kinase 3 gene expression in rat brain (2003) Neuroscience, 122 (4), pp. 997-1002; 
Fanciulli, G., Dettori, A., Fenude, E., Demontis, M.P., Alberico, E., Delitala, G., Intravenous administration of the food-derived opioid peptide gluten exorphin B5 stimulates prolactin secretion in rats (2003) Pharmacol Res, 47 (1), pp. 53-58; 
Farias III, M., Jackson, K.E., Yoshishige, D., Caffrey, J.L., Cardiac enkephalins interrupt vagal bradycardia via delta 2-opioid receptors in sinoatrial node (2003) Am J Physiol Heart Circ Physiol, 284 (5), pp. H1693-H1701; 
Farias III, M., Jackson, K., Johnson, M., Caffrey, J.L., Cardiac enkephalins attenuate vagal bradycardia: Interactions with NOS-1-cGMP systems in canine sinoatrial node (2003) Am J Physiol Heart Circ Physiol, 285 (5), pp. H2001-H2012; 
Fattore, L., Spano, M.S., Cossu, G., Deiana, S., Fratta, W., Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats (2003) Eur J Neurosci, 17 (8), pp. 1723-1726; 
Feld, J.M., Laurito, C.E., Beckerman, M., Vincent, J., Hoffman, W.E., Non-opioid analgesia improves pain relief and decreases sedation after gastric bypass surgery (2003) Can J Anaesth, 50 (4), pp. 336-341; 
Fitzgibbon, D., Morgan, D., Dockter, D., Barry, C., Kharasch, E.D., Initial pharmacokinetic, safety and efficacy evaluation of nasal morphine gluconate for breakthrough pain in cancer patients (2003) Pain, 106 (3), pp. 309-315; 
Fleron, M.H., Weiskopf, R.B., Bertrand, M., Mouren, S., Eyraud, D., Godet, G., A comparison of intrathecal opioid and intravenous analgesia for the incidence of cardiovascular, respiratory, and renal complications after abdominal aortic surgery (2003) Anesth Analg, 97 (1), pp. 2-12; 
Flogegard, H., Ljungman, G., Characteristics and adequacy of intravenous morphine infusions in children in a paediatric oncology setting (2003) Med Pediatr Oncol, 40 (4), pp. 233-238; 
Flores, C.A., Shughrue, P., Petersen, S.L., Mokha, S.S., Sex-related differences in the distribution of opioid receptor-like 1 receptor mRNA and colocalization with estrogen receptor mRNA in neurons of the spinal trigeminal nucleus caudalis in the rat (2003) Neuroscience, 118 (3), pp. 769-778; 
Foster, J., Brewer, C., Steele, T., Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: A pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels (2003) Addict Biol, 8 (2), pp. 211-217; 
Franchini, L.F., Rubinstein, M., Vivas, L., Reduced sodium appetite and increased oxytocin gene expression in mutant mice lacking beta-endorphin (2003) Neuroscience, 121 (4), pp. 875-881; 
Frei, A., Andersen, S., Hole, P., Jensen, N.H., A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain (2003) J Pain Palliat Care Pharmacother, 17 (2), pp. 5-26; 
Friedrich, A.E., Gebhart, G.F., Modulation of visceral hyperalgesia by morphine and cholecystokinin from the rat rostroventral medial medulla (2003) Pain, 104 (12), pp. 93-101; 
Fruiter-Arnaudin, I.I., Cohen, M.M., Nervi, S.S., Bordenave, S.S., Sannier, F.F., Piot, J.M., Reduced level of opioid peptides, hemorphin-7 peptides, in serum of diabetic patients (2003) Diabetes Care, 26 (8), p. 2480; 
Fuentes, V.O., Alvarez, J.J., Hernandez, A., Fuentes, P.I., Sanchez, R., The effect of small doses of naloxone on the initiation and duration of the first estrus after weaning in sows (2003) Anim Reprod Sci, 79 (1-2), pp. 121-125; 
Fukuizumi, T., Ohkubo, T., Kitamura, K., Spinally delivered N-, P/Q- and L-type Ca 2+-channel blockers potentiate morphine analgesia in mice (2003) Life Sci, 73 (22), pp. 2873-2881; 
Fukunaga, A.F., Alexander, G.E., Stark, C.W., Characterization of the analgesic actions of adenosine: Comparison of adenosine and remifentanil infusions in patients undergoing major surgical procedures (2003) Pain, 101 (1-2), pp. 129-138; 
Gabis, L., Shklar, B., Geva, D., Immediate influence of transcranial electrostimulation on pain and beta-endorphin blood levels: An active placebo-controlled study (2003) Am J Phys Med Rehabil, 82 (2), pp. 81-85; 
Gadd, C.A., Murtra, P., De Felipe, C., Hunt, S.P., Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse (2003) J Neurosci, 23 (23), pp. 8271-8280; 
Gagliese, L., Katz, J., Age differences in postoperative pain are scale dependent: A comparison of measures of pain intensity and quality in younger and older surgical patients (2003) Pain, 103 (1-2), pp. 11-20; 
Galizio, M., Keith, J.R., Mansfield, W.J., Pitts, R.C., Repeated spatial acquisition: Effects of NMDA antagonists and morphine (2003) Exp Clin Psychopharmacol, 11 (1), pp. 79-90; 
Gammaitoni, A.R., Galer, B.S., Lacouture, P., Domingos, J., Schlagheck, T., Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain (2003) Pain Med, 4 (1), pp. 21-30; 
Garcia-Fuster, M.J., Ferrer-Alcon, M., Miralles, A., Garcia-Sevilla, J.A., Modulation of Fas receptor proteins and dynamin during opiate addiction and induction of opiate withdrawal in rat brain (2003) Naunyn Schmiedebergs Arch Pharmacol, 368 (5), pp. 421-431; 
Garcia, M.M., Anderson, A.T., Edwards, R., Harlan, R.E., Morphine induction of c-fos expression in the rat forebrain through glutamatergic mechanisms: Role of non-N-methyl-d-aspartate receptors (2003) Neuroscience, 119 (3), pp. 787-794; 
Garnier, M., Zaratin, P.F., Ficalora, G., Valente, M., Fontanella, L., Rhee, M.H., Up-regulation of regulator of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine (2003) J Pharmacol Exp Ther, 304 (3), pp. 1299-1306; 
Gaudette, K.E., Weaver, S.J., Intraspinal use of morphine (2003) Ann Pharmacother, 37 (7-8), pp. 1132-1135; 
Gengo, P.J., Pettit, H.O., O'Neill, S.J., Wei, K., McNutt, R., Bishop, M.J., DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1- piperazinyl)-3-hyd roxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]: I. A mixed opioid agonist with potent antinociceptive activity (2003) J Pharmacol Exp Ther, 307 (3), pp. 1221-1226; 
Gengo, P.J., Pettit, H.O., O'Neill, S.J., Su, Y.F., McNutt, R., Chang, K.J., DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1- piperazinyl)-3-hyd roxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]: II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function (2003) J Pharmacol Exp Ther, 307 (3), pp. 1227-1233; 
Georgescu, D., Zachariou, V., Barrot, M., Mieda, M., Willie, J.T., Eisch, A.J., Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal (2003) J Neurosci, 23 (8), pp. 3106-3111; 
Gerak, L.R., Gauthier, C.R., France, C.R., Discriminative stimulus and antinociceptive effects of dihydroetorphine in rhesus monkeys (2003) Psychopharmacology (Berl), 166 (4), pp. 351-359; 
Gerrits, M.A., Lesscher, H.B., Van Ree, J.M., Drug dependence and the endogenous opioid system (2003) Eur Neuropsychopharmacol, 13 (6), pp. 424-434; 
Gharagozlou, P., Demirci, H., David, C.J., Lameh, J., Activity of opioid ligands in cells expressing cloned mu opioid receptors (2003) BMC Pharmacol, 3 (1), p. 1; 
Gholami, A., Zarrindast, M.R., Sahraei, H., Haerri-Rohani, A., Nitric oxide within the ventral tegmental area is involved in mediating morphine reward (2003) Eur J Pharmacol, 458 (1-2), pp. 119-128; 
Gianoulakis, C., Dai, X., Brown, T., Effect of chronic alcohol consumption on the activity of the hypothalamic-pituitary-adrenal axis and pituitary beta-endorphin as a function of alcohol intake, age, and gender (2003) Alcohol Clin Exp Res, 27 (3), pp. 410-423; 
Gill, A.C., Oei, J., Lewis, N.L., Younan, N., Kennedy, I., Lui, K., Strabismus in infants of opiate-dependent mothers (2003) Acta Paediatr, 92 (3), pp. 379-385; 
Gilron, I., Biederman, J., Jhamandas, K., Hong, M., Gabapentin blocks and reverses antinociceptive morphine tolerance in the rat paw-pressure and tail-flick tests (2003) Anesthesiology, 98 (5), pp. 1288-1292; 
Gimbel, J.S., Richards, P., Portenoy, R.K., Controlled-release oxycodone for pain in diabetic neuropathy: A randomized controlled trial (2003) Neurology, 60 (6), pp. 927-934; 
Ginsberg, B., Sinatra, R.S., Adler, L.J., Crews, J.C., Hord, A.H., Laurito, C.E., Conversion to oral controlled-release oxycodone from intravenous opioid analgesic in the postoperative setting (2003) Pain Med, 4 (1), pp. 31-38; 
Girardin, F., Rentsch, K.M., Schwab, M.A., Maggiorini, M., Pauli-Magnus, C., Kullak-Ublick, G.A., Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts (2003) Clin Pharmacol Ther, 74 (4), pp. 341-352; 
Gironi, M., Furlan, R., Rovaris, M., Comi, G., Filippi, M., Panerai, A.E., Beta endorphin concentrations in PBMC of patients with different clinical phenotypes of multiple sclerosis (2003) J Neurol Neurosurg Psychiatry, 74 (4), pp. 495-497; 
Gold, S.J., Han, M.H., Herman, A.E., Ni, Y.G., Pudiak, C.M., Aghajanian, G.K., Regulation of RGS proteins by chronic morphine in rat locus coeruleus (2003) Eur J Neurosci, 17 (5), pp. 971-980; 
Gomaa, A., Hashem, T., Mohamed, M., Ashry, E., Matricaria chamomilla extract inhibits both development of morphine dependence and expression of abstinence syndrome in rats (2003) J Pharmacol Sci, 92 (1), pp. 50-55; 
Gonzalez-Cuello, A., Milanes, M.V., Castells, M.T., Laorden, M.L., Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal (2003) Br J Pharmacol, 138 (4), pp. 626-633; 
Gonzalez, B., De Miguel, R., Martin, S., Perez-Rosado, A., Romero, J., Garcia-Lecumberri, C., Effects of perinatal exposure to delta 9-tetrahydrocannabinol on operant morphine-reinforced behavior (2003) Pharmacol Biochem Behav, 75 (3), pp. 577-584; 
Gonzalez, N.V., Gonzalez, S.R., Rodriguez, R.E., Characterization of zebrafish proenkephalin reveals novel opioid sequences (2003) Brain Res Mol Brain Res, 114 (1), pp. 31-39; 
Gonzalez, S., Schmid, P.C., Fernandez-Ruiz, J., Krebsbach, R., Schmid, H.H., Ramos, J.A., Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats (2003) Addict Biol, 8 (2), pp. 159-166; 
Gradert, T.L., Baze, W.B., Satterfield, W.C., Hildebrand, K.R., Johansen, M.J., Hassenbusch, S.J., Safety of chronic intrathecal morphine infusion in a sheep model (2003) Anesthesiology, 99 (1), pp. 188-198; 
Grasing, K., Li, N., He, S., Parrish, C., Delich, J., Glowa, J., A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats (2003) Psychopharmacology (Berl), 168 (4), pp. 387-396; 
Grossman, H.C., Hadjimarkou, M.M., Silva, R.M., Giraudo, S.Q., Bodnar, R.J., Interrelationships between mu opioid and melanocortin receptors in mediating food intake in rats (2003) Brain Res, 991 (1-2), pp. 240-244; 
Guarna, M., Bartolini, A., Ghelardini, C., Galeotti, N., Bracci, L., Stefano, G.B., Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist (2003) Brain Res Mol Brain Res, 119 (1), pp. 100-110; 
Guo, X.H., Fairbanks, C.A., Stone, L.S., Loh, H.H., DPDPE-UK14,304 synergy is retained in mu opioid receptor knockout mice (2003) Pain, 104 (12), pp. 209-217; 
Gupta, D.S., Gintzler, A.R., Influence of ovarian sex steroids on spinal methionine-enkephalin release: Comparison with dynorphin reveals asymmetrical regulation (2003) J Pharmacol Exp Ther, 304 (2), pp. 738-744; 
Gutierrez, M., Ortega-Alvaro, A., Gibert-Rahola, J., Mico, J.A., Interactions of acute morphine with chronic imipramine and fluvoxamine treatment on the antinociceptive effect in arthritic rats (2003) Neurosci Lett, 352 (1), pp. 37-40; 
Guttinger, F., Gschwend, P., Schulte, B., Rehm, J., Uchtenhagen, A., Evaluating long-term effects of heroin-assisted treatment: The results of a 6-year follow-up (2003) Eur Addict Res, 9 (2), pp. 73-79; 
Gwak, H.S., Cho, Y.M., Chun, I.K., Analgesic effects of intra-nasal enkephalins (2003) J Pharm Pharmacol, 55 (9), pp. 1207-1212; 
Haberstock-Debic, H., Wein, M., Barrot, M., Colago, E.E., Rahman, Z., Neve, R.L., Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons (2003) J Neurosci, 23 (10), pp. 4324-4332; 
Hack, S.P., Vaughan, C.W., Christie, M.J., Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro (2003) Neuropharmacology, 45 (5), pp. 575-584; 
Hadjimarkou, M.M., Khaimova, E., Pan, Y-X., Rossi, G.C., Pasternak, G.W., Bodnar, R.J., Feeding induced by food deprivation is differentially reduced by opioid receptor antisense oligodeoxynucleotide probes in rats (2003) Brain Res, 987, pp. 223-232; 
Haji, A., Yamazaki, H., Ohi, Y., Takeda, R., Distribution of mu receptors in the ventral respiratory group neurons; immunohistochemical and pharmacological studies in decerebrate cats (2003) Neurosci Lett, 351 (1), pp. 37-40; 
Haji, A., Okazaki, M., Ohi, Y., Yamazaki, H., Takeda, R., Biphasic effects of morphine on bulbar respiratory neuronal activities in decerebrate cats (2003) Neuropharmacology, 45 (3), pp. 368-379; 
Halford, S., Simpson, H., Towards evidence based emergency medicine: Best BETs from the Manchester Royal Infirmary: Diamorphine or morphine for ischaemic cardiac chest pain (2003) Emerg Med J, 20 (3), pp. 263-264; 
Hall, F.S., Li, X.F., Goeb, M., Roff, S., Hoggatt, H., Sora, I., Congenic C57BL/6 mu opiate receptor (MOR) knockout mice: Baseline and opiate effects (2003) Genes Brain Behav, 2 (2), pp. 114-121; 
Hanna, M.H., Elliott, K.M., Stuart-Taylor, M.E., Roberts, D.R., Buggy, D., Arthurs, G.J., Comparative study of analgesic efficacy and morphine-sparing effect of intramuscular dexketoprofen trometamol with ketoprofen or placebo after major orthopaedic surgery (2003) Br J Clin Pharmacol, 55 (2), pp. 126-133; 
Hao, S., Mata, M., Goins, W., Glorioso, J.C., Fink, D.J., Transgene-mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain (2003) Pain, 102 (1-2), pp. 135-142; 
Hao, Y.S., Li, P.F., Zhang, F.X., Huang, D.A., Liu, X.H., Li, G., Morphine alleviates early stages of apoptosis in cultured CEM x174 cells infected with simian immunodeficiency virus (2003) Cell Biol Int, 27 (9), pp. 719-725; 
Hargrave, B.Y., Tiangco, D.A., Lattanzio, F.A., Beebe, S.J., Cocaine, not morphine, causes the generation of reactive oxygen species and activation of NF-kappaB in transiently cotransfected heart cells (2003) Cardiovasc Toxicol, 3 (2), pp. 141-151; 
Harris, G.C., Aston-Jones, G., Enhanced morphine preference following prolonged abstinence: Association with increased Fos expression in the extended amygdala (2003) Neuropsychopharmacology, 28 (2), pp. 292-299; 
Harris, G.C., Aston-Jones, G., Altered motivation and learning following opiate withdrawal: Evidence for prolonged dysregulation of reward processing (2003) Neuropsychopharmacology, 28 (5), pp. 865-871; 
Harris, J.T., Suresh Kumar, K., Rajagopal, M.R., Intravenous morphine for rapid control of severe cancer pain (2003) Palliat Med, 17 (3), pp. 248-256; 
Hartwig, A.C., Mathias, S.I., Law, A.S., Gebhart, G.F., Characterization and opioid modulation of inflammatory temporomandibular joint pain in the rat (2003) J Oral Maxillofac Surg, 61 (11), pp. 1302-1309; 
Hasan, S.S., Khan, F.H., Ahmed, M., Comparison of ketorolac with morphine for intra-operative analgesia in patients undergoing total abdominal hysterectomy (2003) J Pak Med Assoc, 53 (10), pp. 467-471; 
Hashiba, E., Hirota, K., Kudo, T., Calo, G., Guerrini, R., Matsuki, A., Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs (2003) Naunyn Schmiedebergs Arch Pharmacol, 367 (4), pp. 342-347; 
Hayashi, T., Su, T.P., Chronic [d-Ala2, d-Leu5]enkephalin treatment increases the nerve growth factor in adult mouse brain (2003) Eur J Pharmacol, 464 (23), pp. 237-239; 
Hayashida, K., Takeuchi, T., Shimizu, H., Ando, K., Harada, E., Lactoferrin enhances opioid-mediated analgesia via nitric oxide in the rat spinal cord (2003) Am J Physiol Regul Integr Comp Physiol, 285 (2), pp. R306-R312; 
Hayes, C.S., Mulkmus, S.A., Cizkova, D., Yaksh, T.L., Hua, X.Y., A double-lumen intrathecal catheter for studies of modulation of spinal opiate tolerance (2003) J Neurosci Methods, 126 (2), pp. 165-173; 
Hebb, A.L., Zacharko, R.M., Central d-Ala2-Met5-enkephalinamide mu/delta-opioid receptor activation blocks behavioral sensitization to cholecystokinin in CD-1 mice (2003) Brain Res, 970 (1-2), pp. 20-34; 
Hebb, A.L., Zacharko, R.M., Central d-Ala2-Met5-enkephalinamide mu/delta-opioid receptor activation reverses the anxiogenic-like properties of cholecystokinin on locomotor and rearing activity in CD-1 mice (2003) Brain Res, 970 (1-2), pp. 9-19; 
Hebb, A.L., Zacharko, R.M., Central d-Ala2-Met5-enkephalinamide mu/delta-opioid receptor activation reverses the anxiogenic-like properties of cholecystokinin on locomotor and rearing activity in CD-1 mice (2003) Brain Res, 970 (12), pp. 9-19; 
Heinricher, M.M., Orphanin FQ/nociceptin: From neural circuitry to behavior (2003) Life Sci, 73 (6), pp. 813-822; 
Henry, B., Duty, S., Fox, S.H., Crossman, A.R., Brotchie, J.M., Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease (2003) Exp Neurol, 183 (2), pp. 458-468; 
Hernandez-Avila, C.A., Wand, G., Luo, X., Gelernter, J., Kranzler, H.R., Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1) (2003) Am J Med Genet, 118 B (1), pp. 60-65; 
Hernandez-Delgadillo, G.P., Lopez-Munoz, F.J., Salazar, L.A., Cruz, S.L., Morphine and dipyrone co-administration delays tolerance development and potentiates antinociception (2003) Eur J Pharmacol, 469 (1-3), pp. 71-79; 
Hernandez-Palazon, J., Tortosa, J.A., Nuno De, lR.V., Gimenez-Viudes, J., Ramirez, G., Robles, R., Intraperitoneal application of bupivacaine plus morphine for pain relief after laparoscopic cholecystectomy (2003) Eur J Anaesthesiol, 20 (11), pp. 891-896; 
Herradon, G., Morales, L., Alguacil, L.F., Differences of mu-opioid receptors between Lewis and F344 rats (2003) Life Sci, 73 (12), pp. 1537-1542; 
Hess, P.E., Vasudevan, A., Snowman, C., Pratt, S.D., Small dose bupivacaine-fentanyl spinal analgesia combined with morphine for labor (2003) Anesth Analg, 97 (1), pp. 247-252; 
Hickman, M., Madden, P., Henry, J., Baker, A., Wallace, C., Wakefield, J., Trends in drug overdose deaths in England and Wales 1993-1998: Methadone does not kill more people than heroin (2003) Addiction, 98 (4), pp. 419-425; 
Hikida, T., Kitabatake, Y., Pastan, I., Nakanishi, S., Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine (2003) Proc Natl Acad Sci USA, 100 (10), pp. 6169-6173; 
Hirota, K., Kushikata, T., Kudo, M., Ohkawa, H., Kudo, T., Lambert, D.G., Lack of an interaction between orexinergic and opioid/nociceptinergic systems in rat cerebrocortical slices (2003) Neurosci Lett, 340 (3), pp. 173-176; 
Hitosugi, N., Hatsukari, I., Ohno, R., Hashimoto, K., Mihara, S., Mizukami, S., Comparative analysis of apoptosis-inducing activity of codeine and codeinone (2003) Anesthesiology, 98 (3), pp. 643-650; 
Hoffmann, V.L., Baker, A.K., Vercauteren, M.P., Adriaensen, H.F., Meert, T.F., Epidural ketamine potentiates epidural morphine but not fentanyl in acute nociception in rats (2003) Eur J Pain, 7 (2), pp. 121-130; 
Hoffmann, V.L., Vermeyen, K.M., Adriaensen, H.F., Meert, T.F., Effects of NMDA receptor antagonists on opioid-induced respiratory depression and acute antinociception in rats (2003) Pharmacol Biochem Behav, 74 (4), pp. 933-941; 
Holan, V., Zajicova, A., Krulova, M., Blahoutova, V., Wilczek, H., Augmented production of proinflammatory cytokines and accelerated allotransplantation reactions in heroin-treated mice (2003) Clin Exp Immunol, 132 (1), pp. 40-45; 
Holtman Jr., J.R., Jing, X., Sloan, J.W., Wala, E.P., The effects of flumazenil on the antinociceptive actions of morphine in rats (2003) Receptors Channels, 9 (5), pp. 325-328; 
Holtman Jr., J.R., Jing, X., Wala, E.P., Sex-related differences in the enhancement of morphine antinociception by NMDA receptor antagonists in rats (2003) Pharmacol Biochem Behav, 76 (2), pp. 285-293; 
Holtman Jr., J.R., Sloan, J.W., Jing, X., Wala, E.P., Modification of morphine analgesia and tolerance by flumazenil in male and female rats (2003) Eur J Pharmacol, 470 (3), pp. 149-156; 
Holtzman, S.G., Discrimination of a single dose of morphine followed by naltrexone: Substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence (2003) J Pharmacol Exp Ther, 304 (3), pp. 1033-1041; 
Homayoun, H., Khavandgar, S., Mehr, S.E., Namiranian, K., Dehpour, A.R., The effects of FK506 on the development and expression of morphine tolerance and dependence in mice (2003) Behav Pharmacol, 14 (2), pp. 121-127; 
Homayoun, H., Khavandgar, S., Zarrindast, M.R., Morphine state-dependent learning: Interactions with alpha2-adrenoceptors and acute stress (2003) Behav Pharmacol, 14 (1), pp. 41-48; 
Homayoun, H., Khavandgar, S., Dehpour, A.R., The selective role of nitric oxide in opioid-mediated footshock stress antinociception in mice (2003) Physiol Behav, 79 (45), pp. 567-573; 
Horta, M.L., Vianna, P.T., Effect of intravenous alizapride on spinal morphine-induced pruritus (2003) Br J Anaesth, 91 (2), pp. 287-289; 
Horvath, G., Agil, A., Joo, G., Dobos, I., Benedek, G., Baeyens, J.M., Evaluation of endomorphin-1 on the activity of Na(+),K(+)-ATPase using in vitro and in vivo studies (2003) Eur J Pharmacol, 458 (3), pp. 291-297; 
Hou, M., Uddman, R., Tajti, J., Edvinsson, L., Nociceptin immunoreactivity and receptor mRNA in the human trigeminal ganglion (2003) Brain Res, 964 (2), pp. 179-186; 
Houshyar, H., Gomez, F., Manalo, S., Bhargava, A., Dallman, M.F., Intermittent morphine administration induces dependence and is a chronic stressor in rats (2003) Neuropsychopharmacology, 28 (11), pp. 1960-1972; 
Hsueh, C.M., Kuo, J.S., Chen, S.F., Ischemia/reperfusion-induced changes of hypothalamic-pituitary-adrenal (HPA) activity is opioid related in Sprague-Dawley rat (2003) Neurosci Lett, 349 (3), pp. 155-158; 
Hu, J.H., Yang, N., Ma, Y.H., Zhou, X.G., Zhang, X.Y., Jiang, J., Decrease of morphine-induced reward effects and withdrawal symptoms in mice overexpressing gamma-aminobutyric acid transporter I (2003) J Neurosci Res, 74 (4), pp. 614-621; 
Huang, C., Long, H., Shi, Y.S., Han, J.S., Wan, Y., Nocistatin potentiates electroacupuncture antinociceptive effects and reverses chronic tolerance to electroacupuncture in mice (2003) Neurosci Lett, 350 (2), pp. 93-96; 
Huang, E.Y., Liu, T.C., Tao, P.L., Co-administration of dextromethorphan with morphine attenuates morphine rewarding effect and related dopamine releases at the nucleus accumbens (2003) Naunyn Schmiedebergs Arch Pharmacol, 368 (5), pp. 386-392; 
Huang, Y.S., Jiang, J.W., Cao, X.D., Wu, G.C., Melatonin enhances lymphocyte proliferation and decreases the release of pituitary pro-opiomelanocortin-derived peptides in surgically traumatized rats (2003) Neurosci Lett, 343 (2), pp. 109-112; 
Husbands, S.M., Lewis, J.W., Opioid ligands having delayed long-term antagonist activity: Potential pharmacotherapies for opioid abuse (2003) Mini Rev Med Chem, 3 (2), pp. 137-144; 
Ibuki, T., Marsala, M., Masuyama, T., Yaksh, T.L., Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats (2003) Br J Pharmacol, 138 (4), pp. 689-697; 
Iglesias, M., Segura, M.F., Comella, J.X., Olmos, G., Mu-opioid receptor activation prevents apoptosis following serum withdrawal in differentiated SH-SY5Y cells and cortical neurons via phosphatidylinositol 3-kinase (2003) Neuropharmacology, 44 (4), pp. 482-492; 
Ingman, K., Salvadori, S., Lazarus, L., Korpi, E.R., Honkanen, A., Selective delta-opioid receptor antagonist N,N(CH 3) 2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats (2003) Addict Biol, 8 (2), pp. 173-179; 
Inoue, M., Kawashima, T., Takeshima, H., Calo, G., Inoue, A., Nakata, Y., In vivo pain-inhibitory role of nociceptin/orphanin FQ in spinal cord (2003) J Pharmacol Exp Ther, 305 (2), pp. 495-501; 
Inoue, M., Kawashima, T., Allen, R.G., Ueda, H., Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of G i/o in capsaicin-sensitive and of G s in capsaicin-insensitive nociceptors, respectively (2003) J Pharmacol Exp Ther, 306 (1), pp. 141-146; 
Inoue, M., Mishina, M., Ueda, H., Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence (2003) J Neurosci, 23 (16), pp. 6529-6536; 
Iqbal, J., Henry, B.A., Pompolo, S., Rao, A., Clarke, I.J., Long-term alteration in bodyweight and food restriction does not affect the gene expression of either preproorexin or prodynorphin in the sheep (2003) Neuroscience, 118 (1), pp. 217-226; 
Irazusta, J., Larrinaga, G., Agirregoitia, N., Varona, A., Casis, L., Effects of morphine administration and its withdrawal on rat brain aminopeptidase activities (2003) Regul Pept, 110 (3), pp. 225-230; 
Isgor, C., Shieh, K.R., Akil, H., Watson, S.J., Colocalization of estrogen beta-receptor messenger RNA with orphanin FQ, vasopressin and oxytocin in the rat hypothalamic paraventricular and supraoptic nuclei (2003) Anat Embryol (Berl), 206 (6), pp. 461-469; 
Jagolino, A.L., Armstead, W.M., PTK, MAPK, and NOC/oFQ impair hypercapnic cerebrovasodilation after hypoxia/ischemia (2003) Am J Physiol Heart Circ Physiol, 284 (1), pp. H101-H107; 
Jain, N.K., Patil, C.S., Singh, A., Kulkarni, S.K., Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine (2003) Pharmacology, 67 (3), pp. 150-156; 
Janik, J., Krupica, T., Dengler, L., Murphree, E., Callahan, P., Acetyl-RYYRIK-NH2, a purported orphanin FQ antagonist, does not block the orphanin FQ-induced prolactin secretory response in female rats (2003) Neurosci Lett, 345 (3), pp. 149-152; 
Jansen, H.T., Cutter, C., Hardy, S., Lehman, M.N., Goodman, R.L., Seasonal plasticity within the gonadotropin-releasing hormone (GnRH) system of the ewe: Changes in identified GnRH inputs and glial association (2003) Endocrinology, 144 (8), pp. 3663-3676; 
Jenab, S., Festa, E.D., Russo, S.J., Wu, H.B., Inturrisi, C.E., Quinones-Jenab, V., MK-801 attenuates cocaine induction of c-fos and preprodynorphin mRNA levels in Fischer rats (2003) Brain Res Mol Brain Res, 117 (2), pp. 237-239; 
Jiang, Y., Yang, W., Zhou, Y., Ma, L., Up-regulation of murine double minute clone 2 (MDM2) gene expression in rat brain after morphine, heroin, and cocaine administrations (2003) Neurosci Lett, 352 (3), pp. 216-220; 
Johnston, I.N., Westbrook, R.F., Acute and conditioned sickness reduces morphine analgesia (2003) Behav Brain Res, 142 (1-2), pp. 89-97; 
Jones, T.L., Sweitzer, S.M., Wilson, S.P., Yeomans, D.C., Afferent fiber-selective shift in opiate potency following targeted opioid receptor knockdown (2003) Pain, 106 (3), pp. 365-371; 
Jordan, B.A., Gomes, I., Rios, C., Filipovska, J., Devi, L.A., Functional interactions between mu opioid and alpha 2A-adrenergic receptors (2003) Mol Pharmacol, 64 (6), pp. 1317-1324; 
Joshi, W., Connelly, N.R., Reuben, S.S., Wolckenhaar, M., Thakkar, N., An evaluation of the safety and efficacy of administering rofecoxib for postoperative pain management (2003) Anesth Analg, 97 (1), pp. 35-38; 
Judd, A.K., Kaushanskaya, A., Tuttle, D.J., Sanchez, A., Khroyan, T., Polgar, W., N-terminal modifications leading to peptide ORL1 partial agonists and antagonists (2003) J Pept Res, 62 (5), pp. 191-198; 
Kakinohana, M., Marsala, M., Carter, C., Davison, J.K., Yaksh, T.L., Neuraxial morphine may trigger transient motor dysfunction after a noninjurious interval of spinal cord ischemia: A clinical and experimental study (2003) Anesthesiology, 98 (4), pp. 862-870; 
Kakinohana, M., Fuchigami, T., Nakamura, S., Sasara, T., Kawabata, T., Sugahara, K., Intrathecal administration of morphine, but not small dose, induced spastic paraparesis after a noninjurious interval of aortic occlusion in rats (2003) Anesth Analg, 96 (3), pp. 769-775; 
Kalinichev, M., Holtzman, S.G., Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: Similarities and differences between acute and chronic dependence (2003) J Pharmacol Exp Ther, 304 (2), pp. 603-609; 
Kalinichev, M., Easterling, K.W., Holtzman, S.G., Long-lasting changes in morphine-induced locomotor sensitization and tolerance in Long-Evans mother rats as a result of periodic postpartum separation from the litter: A novel model of increased vulnerability to drug abuse? (2003) Neuropsychopharmacology, 28 (2), pp. 317-328; 
Kamei, J., Morita, K., Miyata, S., Onodera, K., Effects of second generation of histamine H1 antagonists, cetirizine and ebastine, on the antitussive and rewarding effects of dihydrocodeine in mice (2003) Psychopharmacology (Berl), 166 (2), pp. 176-180; 
Kamp, E.H., Jones III, R.C., Tillman, S.R., Gebhart, G.F., Quantitative assessment and characterization of visceral nociception and hyperalgesia in mice (2003) Am J Physiol Gastrointest Liver Physiol, 284 (3), pp. G434-G444; 
Kaplan, G.B., Leite-Morris, K.A., Joshi, M., Shoeb, M.H., Carey, R.J., Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions (2003) Brain Res, 987 (1), pp. 122-125; 
Karami, M., Zarrindast, M.R., Sepehri, H., Sahraei, H., Sulpiride injections into the medial septum reverse the influence of intra-medial septum injection of l-arginine on expression of place conditioning-induced by morphine in rats (2003) Brain Res, 976 (1), pp. 30-40; 
Kararmaz, A., Kaya, S., Karaman, H., Turhanoglu, S., Ozyilmaz, M.A., Intraoperative intravenous ketamine in combination with epidural analgesia: Postoperative analgesia after renal surgery (2003) Anesth Analg, 97 (4), pp. 1092-1096; 
Kashyap, L., Pawar, D.K., Kaul, H.L., Mohan, V.K., Dwivedi, S.N., Effect of epidural morphine on minimum alveolar concentration of isoflurane in humans (2003) J Postgrad Med, 49 (3), pp. 211-213; 
Katz, J., Cohen, L., Schmid, R., Chan, V.W., Wowk, A., Postoperative morphine use and hyperalgesia are reduced by preoperative but not intraoperative epidural analgesia: Implications for preemptive analgesia and the prevention of central sensitization (2003) Anesthesiology, 98 (6), pp. 1449-1460; 
Kauser, S., Schallreuter, K.U., Thody, A.J., Gummer, C., Tobin, D.J., Regulation of human epidermal melanocyte biology by beta-endorphin (2003) J Invest Dermatol, 120 (6), pp. 1073-1080; 
Kayemba-Kay's, S., Laclyde, J.P., Buprenorphine withdrawal syndrome in newborns: A report of 13 cases (2003) Addiction, 98 (11), pp. 1599-1604; 
Keita, H., Benifla, J.L., Le, B., Porcher, R., Wachowska, B., Bedairia, K., Prophylactic ip injection of bupivacaine and/or morphine does not improve postoperative analgesia after laparoscopic gynecologic surgery (2003) Can J Anaesth, 50 (4), pp. 362-367; 
Keita, H., Geachan, N., Dahmani, S., Couderc, E., Armand, C., Quazza, M., Comparison between patient-controlled analgesia and subcutaneous morphine in elderly patients after total hip replacement (2003) Br J Anaesth, 90 (1), pp. 53-57; 
Kelley, A.E., Will, M.J., Steininger, T.L., Zhang, M., Haber, S.N., Restricted daily consumption of a highly palatable food (chocolate Ensure(R)) alters striatal enkephalin gene expression (2003) Eur J Neurosci, 18 (9), pp. 2592-2598; 
Kharasch, E.D., Hoffer, C., Whittington, D., Sheffels, P., Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine (2003) Clin Pharmacol Ther, 74 (6), pp. 543-554; 
Khavandgar, S., Homayoun, H., Dehpour, A.R., Mediation of nitric oxide in inhibitory effect of morphine against electroshock-induced convulsions in mice (2003) Pharmacol Biochem Behav, 74 (4), pp. 795-801; 
Khodorova, A., Navarro, B., Jouaville, L.S., Murphy, J.E., Rice, F.L., Mazurkiewicz, J.E., Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury (2003) Nat Med, 9 (8), pp. 1055-1061; 
Kim, J., Jung, J.I., Na, H.S., Hong, S.K., Yoon, Y.W., Effects of morphine on mechanical allodynia in a rat model of central neuropathic pain (2003) NeuroReport, 14 (7), pp. 1017-1020; 
Kim, K.W., Choi, S.S., Woo, R.S., Suh, H.W., Development of antinociceptive tolerance and changes of opioid receptor ligand binding in central nervous system of the mouse forced to single and repeated swimming in the cold water (2003) Brain Res Bull, 61 (1), pp. 93-97; 
King, M.A., Su, W., Nielan, C.L., Chang, A.H., Schutz, J., Schmidhammer, H., 14-Methoxymetopon, a very potent mu-opioid receptor-selective analgesic with an unusual pharmacological profile (2003) Eur J Pharmacol, 459 (2-3), pp. 203-209; 
Klepstad, P., Kaasa, S., Jystad, A., Hval, B., Borchgrevink, P.C., Immediate- or sustained-release morphine for dose finding during start of morphine to cancer patients: A randomized, double-blind trial (2003) Pain, 101 (1-2), pp. 193-198; 
Klepstad, P., Borchgrevink, P.C., Dale, O., Zahlsen, K., Aamo, T., Fayers, P., Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients (2003) Palliat Med, 17 (8), pp. 679-687; 
Klepstad, P., Dale, O., Kaasa, S., Zahlsen, K., Aamo, T., Fayers, P., Influences on serum concentrations of morphine, M6G and M3G during routine clinical drug monitoring: A prospective survey in 300 adult cancer patients (2003) Acta Anaesthesiol Scand, 47 (6), pp. 725-731; 
Ko, M.C., Lee, H., Harrison, C., Clark, M.J., Song, H.F., Naughton, N.N., Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys (2003) J Pharmacol Exp Ther, 306 (1), pp. 179-186; 
Ko, M.C., Lee, H., Song, M.S., Sobczyk-Kojiro, K., Mosberg, H.I., Kishioka, S., Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys (2003) J Pharmacol Exp Ther, 305 (1), pp. 173-179; 
Ko, S., Goldstein, D.H., VanDenKerkhof, E.G., Definitions of "respiratory depression" with intrathecal morphine postoperative analgesia: A review of the literature (2003) Can J Anaesth, 50 (7), pp. 679-688; 
Koch, T., Brandenburg, L.O., Schulz, S., Liang, Y., Klein, J., Hollt, V., ADP-ribosylation factor-dependent phospholipase D2 activation is required (2003) J Biol Chem, 278 (11), pp. 9979-9985; 
Kolesnikov, Y.A., Wilson, R.S., Pasternak, G.W., The synergistic analgesic interactions between hydrocodone and ibuprofen (2003) Anesth Analg, 97 (6), pp. 1721-1723; 
Kolesnikov, Y.A., Cristea, M., Pasternak, G.W., Analgesic synergy between topical morphine and butamben in mice (2003) Anesth Analg, 97 (4), pp. 1103-1107; 
Koppert, W., Angst, M., Alsheimer, M., Sittl, R., Albrecht, S., Schuttler, J., Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans (2003) Pain, 106 (12), pp. 91-99; 
Kotlinska, J., Wichmann, J., Rafalski, P., Talarek, S., Dylag, T., Silberring, J., Non-peptidergic OP4 receptor agonist inhibits morphine antinociception but does not influence morphine dependence (2003) NeuroReport, 14 (4), pp. 601-604; 
Kozela, E., Pilc, A., Popik, P., Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-d-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice (2003) Psychopharmacology (Berl), 165 (3), pp. 245-251; 
Krantz, A.J., Hershow, R.C., Prachand, N., Hayden, D.M., Franklin, C., Hryhorczuk, D.O., Heroin insufflation as a trigger for patients with life-threatening asthma (2003) Chest, 123 (2), pp. 510-517; 
Kratzer, U., Schmidt, W.J., Caroverine inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats (2003) Neurosci Lett, 349 (2), pp. 91-94; 
Kratzer, U., Spanagel, R., Schmidt, W.J., The effect of acamprosate on the development of morphine-induced behavioral sensitization in rats (2003) Behav Pharmacol, 14 (4), pp. 351-356; 
Kroin, J.S., Buvanendran, A., Nagalla, S.K., Tuman, K.J., Postoperative pain and analgesic responses are similar in male and female Sprague-Dawley rats (2003) Can J Anaesth, 50 (9), pp. 904-908; 
Kruzich, P.J., Chen, A.C., Unterwald, E.M., Kreek, M.J., Subject-regulated dosing alters morphine self-administration behavior and morphine-stimulated [ 35S]GTPgammaS binding (2003) Synapse, 47 (4), pp. 243-249; 
Kung, J.C., Su, N.M., Fan, R.J., Chai, S.C., Shyu, B.C., Contribution of the anterior cingulate cortex to laser-pain conditioning in rats (2003) Brain Res, 970 (1-2), pp. 58-72; 
Kushida, K., Ishida, K., Kikuta, J., Kato, M., Uchiyama, T., Taguchi, K., Alpha 2-adrenoceptor modulates the release of acetylcholine from the rostral ventrolateral medulla in response to morphine (2003) Biol Pharm Bull, 26 (11), pp. 1548-1551; 
Kuzmin, A., Sandin, J., Terenius, L., Ogren, S.O., Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: Effects of opioid receptor-like 1 receptor agonists and naloxone (2003) J Pharmacol Exp Ther, 304 (1), pp. 310-318; 
Kuzume, K., Wolff, R.A., Amakawa, K., Kuzume, K., Van Winkle DM (2003) Am J Physiol Heart Circ Physiol, 285 (6), pp. H2463-H2470; 
Labuz, D., Chocyk, A., Wedzony, K., Toth, G., Przewlocka, B., Endomorphin-2, deltorphin II and their analogs suppress formalin-induced nociception and c-Fos expression in the rat spinal cord (2003) Life Sci, 73 (4), pp. 403-412; 
LaForge, K.S., Yuferov, V., Zhou, Y., Ho, A., Nyberg, F., Jeanne, K.M., "Binge" cocaine differentially alters preproenkephalin mRNA levels in guinea pig brain (2003) Brain Res Bull, 59 (5), pp. 353-357; 
Lahdesmaki, J., Scheinin, M., Pertovaara, A., Mansikka, H., The alpha2A-adrenoceptor subtype is not involved in inflammatory hyperalgesia or morphine-induced antinociception (2003) Eur J Pharmacol, 468 (3), pp. 183-189; 
Lalley, P.M., Mu-opioid receptor agonist effects on medullary respiratory neurons in the cat: Evidence for involvement in certain types of ventilatory disturbances (2003) Am J Physiol Regul Integr Comp Physiol, 285 (6), pp. R1287-R1304; 
Lan, C.Y., Tan, P.H., Cheng, J.T., Lu, H.F., Lin, M.W., Hsiao, P.N., Immunoneutralization of c-Fos using intrathecal antibody electroporation attenuates chronic constrictive injury-induced hyperalgesia and regulates preprodynorphin expression in rats (2003) Anesthesiology, 99 (4), pp. 938-946; 
Laorden, M.L., Castells, M.T., Milanes, M.V., Effects of U-50,488H and U-50,488H withdrawal on c-fos expression in the rat paraventricular nucleus: Correlation with c-fos in brainstem catecholaminergic neurons (2003) Br J Pharmacol, 138 (8), pp. 1544-1552; 
Laorden, M.L., Milanes, M.V., Angel, E., Tankosic, P., Burlet, A., Quantitative analysis of corticotropin-releasing factor and arginine vasopressin mRNA in the hypothalamus during chronic morphine treatment in rats: An in situ hybridization study (2003) J Neuroendocrinol, 15 (6), pp. 586-591; 
Lauretti, G.R., Oliveira, G.M., Pereira, N.L., Comparison of sustained-release morphine with sustained-release oxycodone in advanced cancer patients (2003) Br J Cancer, 89 (11), pp. 2027-2030; 
Le Guen, S., Catheline, G., Fournie-Zaluski, M.C., Roques, B.P., Besson, J.M., Buritova, J., Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S): A spinal c-Fos protein study in the rat under carrageenin inflammation (2003) Brain Res, 967 (1-2), pp. 106-112; 
Le Guen, S., Mas, N.M., Canestrelli, C., Chen, H., Fournie-Zaluski, M.C., Cupo, A., Pain management by a new series of dual inhibitors of enkephalin degrading enzymes: Long lasting antinociceptive properties and potentiation by CCK2 antagonist or methadone (2003) Pain, 104 (1-22), pp. 139-148; 
Le Guen, S., Gestreau, C., Besson, J.M., Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: A c-Fos protein study in the rat central nervous system (2003) Eur J Neurosci, 17 (11), pp. 2425-2437; 
Leal, M.B., Michelin, K., Souza, D.O., Elisabetsky, E., Ibogaine attenuation of morphine withdrawal in mice: Role of glutamate N-methyl-d-aspartate receptors (2003) Prog Neuropsychopharmacol Biol Psychiatry, 27 (5), pp. 781-785; 
Lee, H., Naughton, N.N., Woods, J.H., Ko, M.C., Characterization of scratching responses in rats following centrally administered morphine or bombesin (2003) Behav Pharmacol, 14 (7), pp. 501-508; 
Lee, J.J., Hahm, E.T., Min, B.I., Han, S.H., Cho, J.J., Cho, Y.W., Roles of protein kinase A and C in the opioid potentiation of the GABAA response in rat periaqueductal gray neuron (2003) Neuropharmacology, 44 (5), pp. 573-583; 
Lee, M.C., Smith, F.L., Stevens, D.L., Welch, S.P., The role of several kinases in mice tolerant to delta 9-tetrahydrocannabinol (2003) J Pharmacol Exp Ther, 305 (2), pp. 593-599; 
Lee, M.H., Kim, H., Lim, B.V., Chang, H.K., Lee, T.H., Jang, M.H., Naloxone potentiates treadmill running-induced increase in c-Fos expression in rat hippocampus (2003) Life Sci, 73 (2-4), pp. 3139-3147; 
Lee, P.W., Lee, Y.M., Transcriptional regulation of mu opioid receptor gene by cAMP pathway (2003) Mol Pharmacol, 64 (6), pp. 1410-1418; 
Lee, T.H., Yang, L.C., Chou, A.K., Wu, P.C., Lin, C.R., Wang, C.H., In vivo electroporation of proopiomelanocortin induces analgesia in a formalin-injection pain model in rats (2003) Pain, 104 (12), pp. 159-167; 
Leri, F., Flores, J., Rajabi, H., Stewart, J., Effects of cocaine in rats exposed to heroin (2003) Neuropsychopharmacology, 28 (12), pp. 2102-2116; 
Lerman, J., Nolan, J., Eyres, R., Schily, M., Stoddart, P., Bolton, C.M., Efficacy, safety, and pharmacokinetics of levobupivacaine with and without fentanyl after continuous epidural infusion in children: A multicenter trial (2003) Anesthesiology, 99 (5), pp. 1166-1174; 
Lessov, C.N., Phillips, T.J., Cross-sensitization between the locomotor stimulant effects of ethanol and those of morphine and cocaine in mice (2003) Alcohol Clin Exp Res, 27 (4), pp. 616-627; 
Lewanowitsch, T., Irvine, R.J., Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates (2003) Brain Res, 964 (2), pp. 302-305; 
Lewkowski, M.D., Ditto, B., Roussos, M., Young, S.N., Sweet taste and blood pressure-related analgesia (2003) Pain, 106 (1-2), pp. 181-186; 
Li, C.S., Davis, B.J., Smith, D.V., Opioid modulation of taste responses in the nucleus of the solitary tract (2003) Brain Res, 965 (1-2), pp. 21-34; 
Li, H., Wu, L., Li, Y.Q., Opioid peptides modulate the response of neurons of the superficial laminae of the rat spinal dorsal horn to GABA (2003) Biochem Biophys Res Commun, 307 (3), pp. 730-736; 
Li, J.G., Zhang, F., Jin, X.L., Liu-Chen, L.Y., Differential regulation of the human kappa opioid receptor by agonists: Etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation (2003) J Pharmacol Exp Ther, 305 (2), pp. 531-540; 
Li, M., McMillan, D.E., Retention of sequential drug discriminations under fixed-interval schedules for long time periods without training (2003) Eur J Pharmacol, 476 (1-2), pp. 79-85; 
Li, N., He, S., Parrish, C., Delich, J., Grasing, K., Differences in morphine and cocaine reinforcement under fixed and progressive ratio schedules; effects of extinction, reacquisition and schedule design (2003) Behav Pharmacol, 14 (8), pp. 619-630; 
Li, Q., Goodchild, A.K., Pilowsky, P.M., Effect of haemorrhage on the expression of neurotransmitter-related genes in rat ventrolateral medulla: A quantitative real-time RT-PCR study (2003) Brain Res Mol Brain Res, 114 (1), pp. 46-54; 
Li, S., Zhao, Z.Q., Morphine-induced decrease in mechanical allodynia is mediated by central, but not peripheral, opioid receptors in rats with inflammation (2003) Eur J Pharmacol, 481 (2-3), pp. 203-206; 
Li, Y., Eitan, S., Wu, J., Evans, C.J., Kieffer, B., Sun, X., Morphine induces desensitization of insulin receptor signaling (2003) Mol Cell Biol, 23 (17), pp. 6255-6266; 
Li, Y., Merrill, J.D., Mooney, K., Song, L., Wang, X., Guo, C.J., Morphine enhances HIV infection of neonatal macrophages (2003) Pediatr Res, 54 (2), pp. 282-288; 
Liang, D., Li, X., Lighthall, G., Clark, J.D., Heme oxygenase type 2 modulates behavioral and molecular changes during chronic exposure to morphine (2003) Neuroscience, 121 (4), pp. 999-1005; 
Lin, C.R., Yang, L.C., You, H.L., Lee, C.T., Tai, M.H., Tan, P.H., Antinociceptive potentiation and attenuation of tolerance by intrathecal electric stimulation in rats (2003) Anesth Analg, 96 (6), pp. 1711-1716; 
Lin, H.C., Neevel, C., Chen, P.S., Suh, G., Chen, J.H., Slowing of intestinal transit by fat or peptide YY depends on beta-adrenergic pathway (2003) Am J Physiol Gastrointest Liver Physiol, 285 (6), pp. G1310-G1316; 
Lindner, M.D., Frydel, B.R., Francis, J.M., Cain, C.K., Analgesic effects of adrenal chromaffin allografts: Contingent on special procedures or due to experimenter bias? (2003) J Pain, 4 (2), pp. 64-73; 
Littleton, J., Zieglgansberger, W., Pharmacological mechanisms of naltrexone and acamprosate in the prevention of relapse in alcohol dependence (2003) Am J Addict, 12 (1 SUPPL.), pp. S3-S11; 
Litvinova, S.V., Kostanyan, I.A., Aristova, V.V., Kalyuzhnyi, A.L., Shul'govskii, V.V., Terebilina, N.N., Use of HLDF-6 peptide for correction of disturbances in the endogenous opioid system in offspring of morphine-tolerant animals (2003) Bull Exp Biol Med, 135 (2), pp. 133-135; 
Liu, I.M., Chen, W.C., Cheng, J.T., Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats (2003) J Pharmacol Exp Ther, 307 (3), pp. 1196-1204; 
Liu, L.L., Gropper, M.A., Postoperative analgesia and sedation in the adult intensive care unit: A guide to drug selection (2003) Drugs, 63 (8), pp. 755-767; 
Liu, Z.H., Jin, W.Q., Dai, Q.Y., Chen, X.J., Zhang, H.P., Chi, Z.Q., Opioid activity of C8813, a novel and potent opioid analgesic (2003) Life Sci, 73 (2), pp. 233-241; 
Liu, Z.H., Jin, W.Q., Zhang, H.P., Chen, X.J., Jin, G.Z., Suppression of morphine-induced conditioned place preference by l-12-chloroscoulerine, a novel dopamine receptor ligand (2003) Pharmacol Biochem Behav, 75 (2), pp. 289-294; 
Lo, W.C., Harris, J., Clarke, R.W., Endogenous opioids support the spinal inhibitory action of an alpha 2-adrenoceptor agonist in the decerebrated, spinalised rabbit (2003) Neurosci Lett, 340 (2), pp. 95-98; 
Loizzo, A., Capasso, A., Galietta, G., Severini, C., Campana, G., Spampinato, S., Vas deferens response to selective opioid receptor agonists in adult mice is impaired following postnatal repeated mild stress (2003) Eur J Pharmacol, 458 (1-2), pp. 201-205; 
Lonergan, T., Goodchild, A.K., Christie, M.J., Pilowsky, P.M., Presynaptic delta opioid receptors differentially modulate rhythm and pattern generation in the ventral respiratory group of the rat (2003) Neuroscience, 121 (4), pp. 959-973; 
Low, M.J., Hayward, M.D., Appleyard, S.M., Rubinstein, M., State-dependent modulation of feeding behavior by proopiomelanocortin- derived beta-endorphin (2003) Ann NY Acad Sci, 99 (4), pp. 192-201; 
Lu, G., Su, R.B., Li, J., Qin, B.Y., Modulation by alpha-difluoromethyl-ornithine and aminoguanidine of pain threshold, morphine analgesia and tolerance (2003) Eur J Pharmacol, 478 (2-3), pp. 139-144; 
Lu, Y., Vera-Portocarrero, L.P., Westlund, K.N., Intrathecal coadministration of D-APV and morphine is maximally effective in a rat experimental pancreatitis model (2003) Anesthesiology, 98 (3), pp. 734-740; 
Lucas, L.R., Grillo, C.A., McEwen, B.S., Involvement of mesolimbic structures in short-term sodium depletion: In situ hybridization and ligand-binding analyses (2003) Neuroendocrinology, 77 (6), pp. 406-415; 
Ludwig, L.M., Patel, H.H., Gross, G.J., Kersten, J.R., Pagel, P.S., Warltier, D.C., Morphine enhances pharmacological preconditioning by isoflurane: Role of mitochondrial K(ATP) channels and opioid receptors (2003) Anesthesiology, 98 (3), pp. 705-711; 
Luginbuhl, M., Gerber, A., Schnider, T.W., Petersen-Felix, S., Rendt-Nielsen, L., Curatolo, M., Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans (2003) Anesth Analg, 96 (3), pp. 726-732; 
Lutfy, K., Eitan, S., Bryant, C.D., Yang, Y.C., Saliminejad, N., Walwyn, W., Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors (2003) J Neurosci, 23 (32), pp. 10331-10337; 
Ma, F., Xie, H., Dong, Z.Q., Wang, Y.Q., Wu, G.C., Effect of intrathecal nocistatin on nociceptin/orphanin FQ analgesia in chronic constriction injury rat (2003) Brain Res, 988 (1-2), pp. 189-192; 
Ma, J., Ye, N., Lange, N., Cohen, B.M., Dynorphinergic GABA neurons are a target of both typical and atypical antipsychotic drugs in the nucleus accumbens shell, central amygdaloid nucleus and thalamic central medial nucleus (2003) Neuroscience, 121 (4), pp. 991-998; 
MacDonald, A.F., Billington, C.J., Levine, A.S., Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat (2003) Am J Physiol Regul Integr Comp Physiol, 285 (5), pp. R999-R1004; 
Maile, R., Walker, R.J., Sharma, R.P., Bagust, J., Effects of nociceptin and analogues of nociceptin upon spontaneous dorsal root activity recorded from an in vitro preparation of rat spinal cord (2003) Neurosci Lett, 350 (3), pp. 190-192; 
Maj, M., Turchan, J., Smialowska, M., Przewlocka, B., Morphine and cocaine influence on CRF biosynthesis in the rat central nucleus of amygdala (2003) Neuropeptides, 37 (2), pp. 105-110; 
Malan Jr., T.P., Marsh, G., Hakki, S.I., Grossman, E., Traylor, L., Hubbard, R.C., Parecoxib sodium, a parenteral cyclooxygenase 2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty (2003) Anesthesiology, 98 (4), pp. 950-956; 
Maldonado, C., Rodriiuez-Arias, M., Aguilar, M.A., Minarro, J., GHB differentially affects morphine actions on motor activity and social behaviours in male mice (2003) Pharmacol Biochem Behav, 76 (2), pp. 259-265; 
Maldonado, C., Cauli, O., Rodriguez-Arias, M., Aguilar, M.A., Minarro, J., Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal (2003) Behav Brain Res, 144 (12), pp. 25-35; 
Mandyam, C.D., Thakker, D.R., Standifer, K.M., Micro-opioid-induced desensitization of opioid receptor-like 1 and micro-opioid receptors: Differential intracellular signaling determines receptor sensitivity (2003) J Pharmacol Exp Ther, 306 (3), pp. 965-972; 
Mann, C., Pouzeratte, Y., Eledjam, J.J., Postoperative patient-controlled analgesia in the elderly: Risks and benefits of epidural versus intravenous administration (2003) Drugs Aging, 20 (5), pp. 337-345; 
Mantione, K., Hong, R., Im, R., Nam, J.H., Simon, M., Cadet, P., Effects of cold stress on morphine-induced nitric oxide production and mu-opiate receptor gene expression in Mytilus edulis pedal ganglia (2003) Neuroendocrinol Lett, 24 (12), pp. 68-72; 
Marek, G.J., Behavioral evidence for mu-opioid and 5-HT2A receptor interactions (2003) Eur J Pharmacol, 474 (1), pp. 77-83; 
Margolis, E.B., Hjelmstad, G.O., Bonci, A., Fields, H.L., Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons (2003) J Neurosci, 23 (31), pp. 9981-9986; 
Marinelli, P.W., Quirion, R., Gianoulakis, C., A microdialysis profile of beta-endorphin and catecholamines in the rat nucleus accumbens following alcohol administration (2003) Psychopharmacology (Berl), 169 (1), pp. 60-67; 
Marti, M., Stocchi, S., Paganini, F., Mela, F., De Risi, C., Calo, G., Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex (2003) Br J Pharmacol, 138 (1), pp. 91-98; 
Martin, M., Otto, C., Santamarta, M.T., Torrecilla, M., Pineda, J., Schutz, G., Morphine withdrawal is modified in pituitary adenylate cyclase-activating polypeptide type I-receptor-deficient mice (2003) Brain Res Mol Brain Res, 110 (1), pp. 109-118; 
Martin, S., Lyupina, Y., Crespo, J.A., Gonzalez, B., Garcia-Lecumberri, C., Ambrosio, E., Genetic differences in NMDA and D1 receptor levels, and operant responding for food and morphine in Lewis and Fischer 344 rats (2003) Brain Res, 973 (2), pp. 205-213; 
Martinez, M.D., Milanes, M.V., Laorden, M.L., Implication of the signal transduction pathways in the enhancement of noradrenaline turnover induced by morphine withdrawal in the heart (2003) Eur J Pharmacol, 471 (2), pp. 113-119; 
Martorana, A., Fusco, F.R., D'Angelo, V., Sancesario, G., Bernardi, G., Enkephalin, neurotensin, and substance P immunoreactivite neurones of the rat GP following 6-hydroxydopamine lesion of the substantia nigra (2003) Exp Neurol, 183 (2), pp. 311-319; 
Masocha, W., Horvath, G., Agil, A., Ocana, M., Del, P.E., Szikszay, M., Role of Na(+), K(+)-ATPase in morphine-induced antinociception (2003) J Pharmacol Exp Ther, 306 (3), pp. 1122-1128; 
Massi, P., Vaccani, A., Rubino, T., Parolaro, D., Cannabinoids and opioids share cAMP pathway in rat splenocytes (2003) J Neuroimmunol, 145 (1-2), pp. 46-54; 
Matejec, R., Ruwoldt, R., Bodeker, R.H., Hempelmann, G., Teschemacher, H., Release of beta-endorphin immunoreactive material under perioperative conditions into blood or cerebrospinal fluid: Significance for postoperative pain? (2003) Anesth Analg, 96 (2), pp. 481-486; 
Mattick, R.P., Ali, R., White, J.M., O'Brien, S., Wolk, S., Danz, C., Buprenorphine versus methadone maintenance therapy: A randomized double-blind trial with 405 opioid-dependent patients (2003) Addiction, 98 (4), pp. 441-452; 
McCleane, G.J., A randomised, double blind, placebo controlled crossover study of the cholecystokinin 2 antagonist L-365,260 as an adjunct to strong opioids in chronic human neuropathic pain (2003) Neurosci Lett, 338 (2), pp. 151-154; 
McCleane, G.J., The cholecystokinin antagonist proglumide enhances the analgesic effect of dihydrocodeine (2003) Clin J Pain, 19 (3), pp. 200-201; 
McDougall, J.J., Involvement of sympathetic efferents but not capsaicin-sensitive afferents in nociceptin-mediated dual control of rat synovial blood flow (2003) Am J Physiol Regul Integr Comp Physiol, 284 (6), pp. R1477-R1485; 
McGeehan, A.J., Olive, M.F., The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine (2003) Br J Pharmacol, 138 (1), pp. 9-12; 
McGeehan, A.J., Olive, M.F., The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse (2003) Synapse, 47 (3), pp. 240-242; 
McLaughlin, J.P., Marton-Popovici, M., Chavkin, C., Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses (2003) J Neurosci, 23 (13), pp. 5674-5683; 
McNally, G.P., Akil, H., Selective down-regulation of hippocampal glucocorticoid receptors during opiate withdrawal (2003) Brain Res Mol Brain Res, 118 (1-2), pp. 152-155; 
McNally, G.P., Westbrook, R.F., Temporally graded, context-specific retrograde amnesia and its alleviation by context preexposure: Effects of postconditioning exposures to morphine in the rat (2003) J Exp Psychol Anim Behav Process, 29 (2), pp. 130-142; 
McNicol, E., Horowicz-Mehler, N., Fisk, R.A., Bennett, K., Gialeli-Goudas, M., Chew, P.W., Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review (2003) J Pain, 4 (5), pp. 231-256; 
Mehr, S.E., Samini, M., Namiranian, K., Homayoun, H., Gaskari, S.A., Dehpour, A.R., Inhibition by immunophilin ligands of morphine-induced tolerance and dependence in guinea pig ileum (2003) Eur J Pharmacol, 467 (1-3), pp. 205-210; 
Meis, S., Nociceptin/orphanin FQ: Actions within the brain (2003) Neuroscientist, 9 (2), pp. 158-168; 
Melichar, J.K., Myles, J.S., Eap, C.B., Nutt, D.J., Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test (2003) Addict Biol, 8 (1), pp. 59-66; 
Mellen, N.M., Janczewski, W.A., Bocchiaro, C.M., Feldman, J.L., Opioid-induced quantal slowing reveals dual networks for respiratory rhythm generation (2003) Neuron, 37 (5), pp. 821-826; 
Mendez, M., Leriche, M., Carlos, C.J., Acute ethanol administration transiently decreases [ 3H]-DAMGO binding to mu opioid receptors in the rat substantia nigra pars reticulata but not in the caudate-putamen (2003) Neurosci Res, 47 (2), pp. 153-160; 
Menendez, L., Lastra, A., Villanueva, N., Hidalgo, A., Baamonde, A., Spinal nociceptin inhibits AMPA-induced nociceptive behavior and Fos expression in rat spinal cord (2003) Pharmacol Biochem Behav, 74 (3), pp. 657-661; 
Menendez, L., Lastra, A., Fresno, M.F., Llames, S., Meana, A., Hidalgo, A., Initial thermal heat hypoalgesia and delayed hyperalgesia in a murine model of bone cancer pain (2003) Brain Res, 969 (1-2), pp. 102-109; 
Menendez, L., Lastra, A., Hidalgo, A., Baamonde, A., Nociceptive reaction and thermal hyperalgesia induced by local ET-1 in mice: A behavioral and Fos study (2003) Naunyn Schmiedebergs Arch Pharmacol, 367 (1), pp. 28-34; 
Menendez, L., Lastra, A., Hidalgo, A., Meana, A., Garcia, E., Baamonde, A., Peripheral opioids act as analgesics in bone cancer pain in mice (2003) NeuroReport, 14 (6), pp. 867-869; 
Mercadante, S., Villari, P., Ferrera, P., Arcuri, E., Local anesthetic switching for intrathecal tachyphylaxis in cancer patients with pain (2003) Anesth Analg, 97 (1), pp. 187-189; 
Meunier, J.C., Utilizing functional genomics to identify new pain treatments: The example of nociceptin (2003) Am J Pharmacogenom, 3 (2), pp. 117-130; 
Meuser, T., Giesecke, T., Gabriel, A., Horsch, M., Sabatowski, R., Hescheler, J., Mu-opioid receptor mRNA regulation during morphine tolerance in the rat peripheral nervous system (2003) Anesth Analg, 97 (5), pp. 1458-1463; 
Micevych, P.E., Rissman, E.F., Gustafsson, J.A., Sinchak, K., Estrogen receptor-alpha is required for estrogen-induced mu-opioid receptor internalization (2003) J Neurosci Res, 71 (6), pp. 802-810; 
Michaud, N., Couture, R., Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: Characterization with tachykinin antagonists (2003) Neuropeptides, 37 (6), pp. 345-354; 
Mierzejewski, P., Koros, E., Goldberg, S.R., Kostowski, W., Stefanski, R., Intravenous self-administration of morphine and cocaine: A comparative study (2003) Pol J Pharmacol, 55 (5), pp. 713-726; 
Miller, R., Aaron, W., Toneff, T., Vishnuvardhan, D., Beinfeld, M.C., Hook, V.Y., Obliteration of alpha-melanocyte-stimulating hormone derived from POMC in pituitary and brains of PC2-deficient mice (2003) J Neurochem, 86 (3), pp. 556-563; 
Minnis, J.G., Patierno, S., Kohlmeier, S.E., Brecha, N.C., Tonini, M., Sternini, C., Ligand-induced mu opioid receptor endocytosis and recycling in enteric neurons (2003) Neuroscience, 119 (1), pp. 33-42; 
Minowa, S., Ishihara, S., Tsuchiya, S., Horie, S., Watanabe, K., Murayama, T., Involvement of glutamate and gamma-amino-butyric acid receptor systems on gastric acid secretion induced by activation of kappa-opioid receptors in the central nervous system in rats (2003) Br J Pharmacol, 138 (6), pp. 1049-1058; 
Miranda-Paiva, C.M., Ribeiro-Barbosa, E.R., Canteras, N.S., Felicio, L.F., A role for the periaqueductal grey in opioidergic inhibition of maternal behaviour (2003) Eur J Neurosci, 18 (3), pp. 667-674; 
Mitchell, T.B., White, J.M., Somogyi, A.A., Bochner, F., Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence (2003) Drug Alcohol Depend, 72 (1), pp. 85-94; 
Mitrovic, I., Margeta-Mitrovic, M., Bader, S., Stoffel, M., Jan, L.Y., Basbaum, A.I., Contribution of GIRK2-mediated post-synaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences (2003) Proc Natl Acad Sci USA, 100 (1), pp. 271-276; 
Mizoguchi, H., Spaulding, A., Leitermann, R., Wu, H.E., Nagase, H., Tseng, L.F., Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse (2003) J Pharmacol Exp Ther, 306 (1), pp. 394-400; 
Mizoguchi, H., Hung, K.C., Leitermann, R., Narita, M., Nagase, H., Suzuki, T., Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice (2003) Eur J Pharmacol, 461 (1), pp. 35-39; 
Mizoguchi, H., Wu, H.E., Narita, M., Sora, I., Hall, S.F., Uhl, G.R., Lack of mu-opioid receptor-mediated G-protein activation in the spinal cord of mice lacking Exon 1 or Exons 2 and 3 of the MOR-1 gene (2003) J Pharmacol Sci, 93 (4), pp. 423-429; 
Molina, P.E., Endogenous opioid analgesia in hemorrhagic shock (2003) J Trauma, 54 (5 SUPPL.), pp. S126-S132; 
Moncada, A., Cendan, C.M., Baeyens, J.M., Del, P.E., Effects of serine/threonine protein phosphatase inhibitors on morphine-induced antinociception in the tail flick test in mice (2003) Eur J Pharmacol, 465 (1-2), pp. 53-60; 
Morgan, M.M., Clayton, C.C., Lane, D.A., Behavioral evidence linking opioid-sensitive GABAergic neurons in the ventrolateral periaqueductal gray to morphine tolerance (2003) Neuroscience, 118 (1), pp. 227-232; 
Morinville, A., Cahill, C.M., Esdaile, M.J., Aibak, H., Collier, B., Kieffer, B.L., Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: Evidence from mu-opioid receptor knock-out mice (2003) J Neurosci, 23 (12), pp. 4888-4898; 
Morley-Forster, P.K., Clark, A.J., Speechley, M., Moulin, D.E., Attitudes toward opioid use for chronic pain: A Canadian physician survey (2003) Pain Res Manag, 8 (4), pp. 189-194; 
Mousa, S.A., Bopaiah, C.P., Stein, C., Schafer, M., Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain (2003) Pain, 106 (3), pp. 297-307; 
Muir III, W.W., Wiese, A.J., March, P.A., Effects of morphine, lidocaine, ketamine, and morphine-lidocaine-ketamine drug combination on minimum alveolar concentration in dogs anesthetized with isoflurane (2003) Am J Vet Res, 64 (9), pp. 1155-1160; 
Mura, P., Kintz, P., Ludes, B., Gaulier, J.M., Marquet, P., Martin-Dupont, S., Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: Results of a French collaborative study (2003) Forensic Sci Int, 133 (1-2), pp. 79-85; 
Murphy, P.M., Stack, D., Kinirons, B., Laffey, J.G., Optimizing the dose of intrathecal morphine in older patients undergoing hip arthroplasty (2003) Anesth Analg, 97 (6), pp. 1709-1715; 
Mystakidou, K., Tsilika, E., Parpa, E., Kouloulias, V., Kouvaris, I., Georgaki, S., Long-term cancer pain management in morphine pre-treated and opioid naive patients with transdermal fentanyl (2003) Int J Cancer, 107 (3), pp. 486-492; 
Naef, M., Curatolo, M., Petersen-Felix, S., Rendt-Nielsen, L., Zbinden, A., Brenneisen, R., The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions (2003) Pain, 105 (12), pp. 79-88; 
Nagakura, Y., Okada, M., Kohara, A., Kiso, T., Toya, T., Iwai, A., Allodynia and hyperalgesia in adjuvant-induced arthritic rats: Time course of progression and efficacy of analgesics (2003) J Pharmacol Exp Ther, 306 (2), pp. 490-497; 
Nagata, T., Suzuki, H., Zhang, R., Ozaki, M., Kawakami, Y., Mechanical stimulation activates small fiber mediated nociceptive responses in the nucleus gigantocellularis (2003) Exp Brain Res, 149 (4), pp. 505-511; 
Nahi, F., Arbogast, L.A., Prolactin modulates hypothalamic preproenkephalin, but not proopiomelanocortin, gene expression during lactation (2003) Endocrine, 20 (1-2), pp. 115-122; 
Naidu, P.S., Singh, A., Joshi, D., Kulkarni, S.K., Possible mechanisms of action in quercetin reversal of morphine tolerance and dependence (2003) Addict Biol, 8 (3), pp. 327-336; 
Nakama-Kitamura, M., Doe, N., The influence of contextual cue on antinociceptive tolerance and facilitation of memory with morphine (2003) J Pharmacol Sci, 92 (3), pp. 237-244; 
Nandigama, P., Borszcz, G.S., Affective analgesia following the administration of morphine into the amygdala of rats (2003) Brain Res, 959 (2), pp. 343-354; 
Narita, M., Khotib, J., Mizoguchi, H., Suzuki, M., Ozaki, S., Yajima, Y., Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse (2003) Eur J Neurosci, 18 (9), pp. 2498-2504; 
Narita, M., Suzuki, M., Mizoguchi, H., Narita, M., Yajima, Y., Sakurada, S., Up-regulation of mu-opioid receptor-mediated G-protein activation in protein kinase Cgamma knockout mice following repeated naloxone treatment (2003) Neurosci Lett, 338 (2), pp. 103-106; 
Narita, M., Mizuo, K., Mizoguchi, H., Sakata, M., Narita, M., Tseng, L.F., Molecular evidence for the functional role of dopamine D3 receptor in the morphine-induced rewarding effect and hyperlocomotion (2003) J Neurosci, 23 (3), pp. 1006-1012; 
Narita, M., Ohnishi, O., Narita, M., Aoki, T., Suzuki, M., Yajima, Y., Direct evidence for the activation of phospholipase C gamma 1 by in vivo treatment with morphine in the mouse periaqueductal gray matter (2003) Brain Res, 970 (1-2), pp. 140-148; 
Narita, M., Shibasaki, M., Mizuo, K., Suzuki, T., Changes in G-protein activity mediated through the stimulation of dopamine and GABA(B) receptors in the mesolimbic dopaminergic system of morphine-sensitized mice (2003) Addict Biol, 8 (3), pp. 319-325; 
Natalini, C.C., Robinson, E.P., Effects of epidural opioid analgesics on heart rate, arterial blood pressure, respiratory rate, body temperature, and behavior in horses (2003) Vet Ther, 4 (4), pp. 364-375; 
Navolotskaya, E.V., Zargarova, T.A., Malkova, N.V., Zharmukhamedova, T.Y., Kolobov, A.A., Kampe-Nemm, E.A., Macrophage-stimulating peptides VKGFY and cyclo(VKGFY) act through nonopioid beta-endorphin receptors (2003) Biochem Biophys Res Commun, 303 (4), pp. 1065-1072; 
Neilan, C.L., Janvey, A.J., Bolan, E., Berezowska, I., Nguyen, T.M., Schiller, P.W., Characterization of the binding of [ 3H][Dmt1]H-Dmt-d-Arg-Phe- Lys-NH2, a highly potent opioid peptide (2003) J Pharmacol Exp Ther, 306 (2), pp. 430-436; 
Neilan, C.L., King, M.A., Rossi, G., Ansonoff, M., Pintar, J.E., Schiller, P.W., Differential sensitivities of mouse strains to morphine and [Dmt1]DALDA analgesia (2003) Brain Res, 974 (1-2), pp. 254-257; 
Nemmani, K.V., Mogil, J.S., Serotonin-GABA interactions in the modulation of mu- and kappa-opioid analgesia (2003) Neuropharmacology, 44 (3), pp. 304-310; 
Nicklous, D.M., Simansky, K.J., Neuropeptide FF exerts pro- and anti-opioid actions in the parabrachial nucleus to modulate food intake (2003) Am J Physiol Regul Integr Comp Physiol, 285 (5), pp. R1046-R1054; 
Niederberger, E., Schmidtko, A., Rothstein, J.D., Geisslinger, G., Tegeder, I., Modulation of spinal nociceptive processing through the glutamate transporter GLT-1 (2003) Neuroscience, 116 (1), pp. 81-87; 
Noble, F., Roques, B.P., The role of CCK2 receptors in the homeostasis of the opioid system (2003) Drugs Today (Barc), 39 (11), pp. 897-908; 
Nojima, H., Simons, C.T., Cuellar, J.M., Carstens, M.I., Moore, J.A., Carstens, E., Opioid modulation of scratching and spinal c-fos expression evoked by intradermal serotonin (2003) J Neurosci, 23 (34), pp. 10784-10790; 
Nong, Y., Sorenson, E.M., Chiappinelli, V.A., Opioid receptor activation attenuates nicotinic enhancement of spontaneous GABA release in lateral spiriform nucleus of the chick (2003) Brain Res, 961 (1), pp. 45-52; 
Norwood, C.S., Cornish, J.L., Mallet, P.E., McGregor, I.S., Pre-exposure to the cannabinoid receptor agonist CP55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats (2003) Eur J Pharmacol, 465 (1-2), pp. 105-114; 
Nyland, S.B., Cao, C., Bai, Y., Loughran, T.P., Ugen, K.E., Modulation of infection and type 1 cytokine expression parameters by morphine during in vitro coinfection with human T-cell leukemia virus type I and HIV-1 (2003) J Acquir Immune Defic Syndr, 32 (4), pp. 406-416; 
Ochi, T., Ohkubo, Y., Mutoh, S., Effect of systemic FR140423, a new analgesic compound, in a rat model of postoperative pain: Contribution of delta-opioid receptors (2003) Neurosci Lett, 350 (1), pp. 29-32; 
Ohmori, Y., Suzuki, M., Fukuta, K., Anatomical relationship between enkephalin-containing neurones and caecum-projecting neurones in the chicken intestinal nerve (2003) Anat Histol Embryol, 32 (3), pp. 179-182; 
Ojanen, S., Koistinen, M., Backstrom, P., Kankaanpaa, A., Tuomainen, P., Hyytia, P., Differential behavioural sensitization to intermittent morphine treatment in alcohol-preferring AA and alcohol-avoiding ANA rats: Role of mesolimbic dopamine (2003) Eur J Neurosci, 17 (8), pp. 1655-1663; 
Okada, Y., Tsuda, Y., Fujita, Y., Yokoi, T., Sasaki, Y., Ambo, A., Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia (2003) J Med Chem, 46 (15), pp. 3201-3209; 
Okrasa, S., Skowronski, M.T., Staszkiewicz, J., Kotwica, G., Lakomy, M., Ziecik, A.J., The effects of estradiol on beta-endorphin, GnRH and galanin content in the oviduct and the uterus of ovariectomized gilts (2003) Reprod Biol, 3 (1), pp. 63-80; 
Okura, T., Saito, M., Nakanishi, M., Komiyama, N., Fujii, A., Yamada, S., Different distribution of morphine and morphine-6 beta-glucuronide after intracerebroventricular injection in rats (2003) Br J Pharmacol, 140 (1), pp. 211-217; 
Oliva, J.M., Ortiz, S., Palomo, T., Manzanares, J., Behavioural and gene transcription alterations induced by spontaneous cannabinoid withdrawal in mice (2003) J Neurochem, 85 (1), pp. 94-104; 
Osaki, M.Y., Castellan-Baldan, L., Calvo, F., Carvalho, A.D., Felippotti, T.T., De, O.R., Neuroanatomical and neuropharmacological study of opioid pathways in the mesencephalic tectum: Effect of mu(1)- and kappa-opioid receptor blockade on escape behavior induced by electrical stimulation of the inferior colliculus (2003) Brain Res, 992 (2), pp. 179-192; 
Ossowska, K., Wardas, J., Pietraszek, M., Konieczny, J., Wolfarth, S., The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats (2003) Neurosci Lett, 342 (1-2), pp. 21-24; 
Ouagazzal, A.M., Moreau, J.L., Pauly-Evers, M., Jenck, F., Impact of environmental housing conditions on the emotional responses of mice deficient for nociceptin/orphanin FQ peptide precursor gene (2003) Behav Brain Res, 144 (1-2), pp. 111-117; 
Ozaki, M., Masuda, Y., Kishioka, S., Yamamoto, H., Actions of domperidone on the opioid system in isolated guinea-pig ileum: Differences between dopamine antagonists on opioid system (2003) Auton Autacoid Pharmacol, 23 (1), pp. 57-62; 
Ozaki, S., Narita, M., Narita, M., Iino, M., Miyoshi, K., Suzuki, T., Suppression of the morphine-induced rewarding effect and G-protein activation in the lower midbrain following nerve injury in the mouse: Involvement of G-protein-coupled receptor kinase 2 (2003) Neuroscience, 116 (1), pp. 89-97; 
Ozdogan, U.K., Lahdesmaki, J., Scheinin, M., Influence of prazosin and clonidine on morphine analgesia, tolerance and withdrawal in mice (2003) Eur J Pharmacol, 460 (2-3), pp. 127-134; 
Ozek, M., Uresin, Y., Gungor, M., Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice (2003) Life Sci, 72 (17), pp. 1943-1951; 
Pakulska, W., Wejman, I., Czarnecka, E., Influence of felbamate on the antinociceptive action of morphine, metamizol and indomethacin in mice (2003) Acta Pol Pharm, 60 (3), pp. 201-206; 
Pandita, R.K., Pehrson, R., Christoph, T., Friderichs, E., Andersson, K.E., Actions of tramadol on micturition in awake, freely moving rats (2003) Br J Pharmacol, 139 (4), pp. 741-748; 
Panksepp, J., Neuroscience, Feeling the pain of social loss (2003) Science, 302 (5643), pp. 237-239; 
Paolone, G., Burdino, R., Badiani, A., Dissociation in the modulatory effects of environmental novelty on the locomotor, analgesic, and eating response to acute and repeated morphine in the rat (2003) Psychopharmacology (Berl), 166 (2), pp. 146-155; 
Papageorgiou, C., Rabavilas, A., Liappas, I., Stefanis, C., Do obsessive-compulsive patients and abstinent heroin addicts share a common psychophysiological mechanism? (2003) Neuropsychobiology, 47 (1), pp. 1-11; 
Parada, C.A., Vivancos, G.G., Tambeli, C.H., De Queiroz, C.F., Ferreira, S.H., Activation of presynaptic NMDA receptors coupled to NaV1.8-resistant sodium channel C-fibers causes retrograde mechanical nociceptor sensitization (2003) Proc Natl Acad Sci USA, 100 (5), pp. 2923-2928; 
Parisod, E., Siddall, P.J., Viney, M., McClelland, J.M., Cousins, M.J., Allodynia after acute intrathecal morphine administration in a patient with neuropathic pain after spinal cord injury (2003) Anesth Analg, 97 (1), pp. 183-186; 
Park, Y., Jang, C.G., Yang, K.H., Loh, H.H., Ma, T., Ho, I.K., Regional specific increases of [ 3H]AMPA binding and mRNA expression of AMPA receptors in the brain of mu-opioid receptor knockout mice (2003) Brain Res Mol Brain Res, 113 (1-2), pp. 116-123; 
Patel, K., Bhaskaran, M., Dani, D., Reddy, K., Singhal, P.C., Role of heme oxygenase-1 in morphine-modulated apoptosis and migration of macrophages (2003) J Infect Dis, 187 (1), pp. 47-54; 
Pavlov, I.F., Epstein, O.I., Morphine and antibodies to mu-opiate receptors in ultralow doses: Effect on oxygen consumption (2003) Bull Exp Biol Med, 1 (SUPPL.), pp. 137-139; 
Pelissier, T., Laurido, C., Kramer, V., Hernandez, A., Paeile, C., Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats (2003) Eur J Pharmacol, 477 (1), pp. 23-28; 
Perier, C., Marin, C., Jimenez, A., Bonastre, M., Tolosa, E., Hirsch, E.C., Effect of subthalamic nucleus or entopeduncular nucleus lesion on levodopa-induced neurochemical changes within the basal ganglia and on levodopa-induced motor alterations in 6-hydroxydopamine-lesioned rats (2003) J Neurochem, 86 (6), pp. 1328-1337; 
Persson, A.I., Thorlin, T., Bull, C., Zarnegar, P., Ekman, R., Terenius, L., Mu- and delta-opioid receptor antagonists decrease proliferation and increase neurogenesis in cultures of rat adult hippocampal progenitors (2003) Eur J Neurosci, 17 (6), pp. 1159-1172; 
Pertovaara, A., Wei, H., A dissociative change in the efficacy of supraspinal versus spinal morphine in the neuropathic rat (2003) Pain, 101 (3), pp. 237-250; 
Philip, S., Armstead, W.M., Newborn pig nociceptin/orphanin FQ activates protein tyrosine kinase and mitogen activated protein kinase to impair NMDA cerebrovasodilation after ischemia (2003) NeuroReport, 14 (2), pp. 201-203; 
Philippe, D., Dubuquoy, L., Groux, H., Brun, V., Chuoi-Mariot, M.T., Gaveriaux-Ruff, C., Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation (2003) J Clin Invest, 111 (9), pp. 1329-1338; 
Pil, J., Tytgat, J., Serine 329 of the mu-opioid receptor interacts differently with agonists (2003) J Pharmacol Exp Ther, 304 (3), pp. 924-930; 
Pillai Riddell, R.R., Craig, K.D., Time-contingent schedules for postoperative analgesia: A review of the literature (2003) J Pain, 4 (4), pp. 169-175; 
Pinardi, G., Sierralta, F., Miranda, H.F., Atropine reverses the antinociception of nonsteroidal anti-inflammatory drugs in the tail-flick test of mice (2003) Pharmacol Biochem Behav, 74 (3), pp. 603-608; 
Piras, G., Lecca, D., Corda, M.G., Giorgi, O., Repeated morphine injections induce behavioural sensitization in Roman high- but not in Roman low-avoidance rats (2003) NeuroReport, 14 (18), pp. 2433-2438; 
Planas, E., Poveda, R., Sanchez, S., Romero, A., Puig, M.M., Non-steroidal anti-inflammatory drugs antagonise the constipating effects of tramadol (2003) Eur J Pharmacol, 482 (1-3), pp. 223-226; 
Pleym, H., Spigset, O., Kharasch, E.D., Dale, O., Gender differences in drug effects: Implications for anesthesiologists (2003) Acta Anaesthesiol Scand, 47 (3), pp. 241-259; 
Ploj, K., Nylander, I., Long-term effects on brain opioid and opioid receptor like-1 receptors after short periods of maternal separation in rats (2003) Neurosci Lett, 345 (3), pp. 195-197; 
Ploj, K., Roman, E., Nylander, I., Long-term effects of short and long periods of maternal separation on brain opioid peptide levels in male Wistar rats (2003) Neuropeptides, 37 (3), pp. 149-156; 
Pollo, A., Vighetti, S., Rainero, I., Benedetti, F., Placebo analgesia and the heart (2003) Pain, 102 (1-2), pp. 125-133; 
Popik, P., Kozela, E., Wrobel, M., Wozniak, K.M., Slusher, B.S., Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA (2003) Neuropsychopharmacology, 28 (3), pp. 457-467; 
Popik, P., Wrobel, M., Rygula, R., Bisaga, A., Bespalov, A.Y., Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice (2003) Behav Pharmacol, 14 (3), pp. 237-244; 
Popova, I.Y., Vinogradova, O.S., Kokoz, Y.M., Ziganshin, R.K., Ivanov, V.T., Neuropeptide modulation of evoked responses of neurons in the medial septal region of hibernating ground squirrels in conditions of chronic isolation of the medial septal region from preoptic-hypothalamic structures (2003) Neurosci Behav Physiol, 33 (5), pp. 521-528; 
Porras, G., De Deurwaerdere, P., Moison, D., Spampinato, U., Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum (2003) Eur J Neurosci, 17 (4), pp. 771-781; 
Porro, C.A., Functional imaging and pain: Behavior, perception, and modulation (2003) Neuroscientist, 9 (5), pp. 354-369; 
Portoghese, P.S., Law, P.Y., Loh, H.H., Effect of opioid receptor ligands on the mu-S196A knock-in and mu knockout mouse vas deferens (2003) Eur J Pharmacol, 478 (2-3), pp. 207-210; 
Prado, W.A., Antinociceptive potency of intrathecal morphine in the rat tail flick test: A comparative study using acute lumbar catheter in rats with or without a chronic atlanto-occipital catheter (2003) J Neurosci Methods, 129 (1), pp. 33-39; 
Quigley, C., Joel, S., Patel, N., Baksh, A., Slevin, M., Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain (2003) Palliat Med, 17 (2), pp. 185-190; 
Quinn, J.G., O'Hare, E., Levine, A.S., Kim, E.M., Evidence for a mu-opioid-opioid connection between the paraventricular nucleus and ventral tegmental area in the rat (2003) Brain Res, 991 (1-2), pp. 206-211; 
Radhakrishnan, R., Sluka, K.A., Spinal muscarinic receptors are activated during low or high frequency TENS-induced antihyperalgesia in rats (2003) Neuropharmacology, 45 (8), pp. 1111-1119; 
Rahim, R.T., Meissler, J.J., Zhang, L., Adler, M.W., Rogers, T.J., Eisenstein, T.K., Withdrawal from morphine in mice suppresses splenic macrophage function, cytokine production, and costimulatory molecules (2003) J Neuroimmunol, 144 (1-2), pp. 16-27; 
Rajagopal, A., Vassilopoulou-Sellin, R., Palmer, J.L., Kaur, G., Bruera, E., Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy (2003) J Pain Symptom Manage, 26 (5), pp. 1055-1061; 
Rajashekara, V., Patel, C.N., Patel, K., Purohit, V., Yoburn, B.C., Chronic opioid antagonist treatment dose-dependently regulates mu-opioid receptors and trafficking proteins in vivo (2003) Pharmacol Biochem Behav, 75 (4), pp. 909-913; 
Ramos, S.P., Revisiting Anna O.: A case of chemical dependence (2003) Hist Psychol, 6 (3), pp. 239-250; 
Randall-Thompson, J.F., Riley, A.L., Morphine-induced conditioned taste aversions: Assessment of sexual dimorphism (2003) Pharmacol Biochem Behav, 76 (2), pp. 373-381; 
Rasmussen, K., Vandergriff, J., The selective iGluR1-4 (AMPA) antagonist LY300,168 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioural signs of morphine withdrawal (2003) Neuropharmacology, 44 (1), pp. 88-92; 
Rasmussen, N.A., Farr, L.A., Effects of morphine and time of day on pain and beta-endorphin (2003) Biol Res Nurs, 5 (2), pp. 105-116; 
Rauck, R.L., Cherry, D., Boyer, M.F., Kosek, P., Dunn, J., Alo, K., Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain (2003) J Pain, 4 (8), pp. 441-447; 
Rawls, S.M., Adler, M.W., Gaughan, J.P., Baron, A., Geller, E.B., Cowan, A., NMDA receptors modulate morphine-induced hyperthermia (2003) Brain Res, 984 (1-2), pp. 76-83; 
Redell, J.B., Moore, A.N., Dash, P.K., Expression of the prodynorphin gene after experimental brain injury and its role in behavioral dysfunction (2003) Exp Biol Med (Maywood), 228 (3), pp. 261-269; 
Redwine, K.E., Trujillo, K.A., Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat (2003) Pharmacol Biochem Behav, 76 (2), pp. 361-372; 
Reis, G.M., Doretto, M.C., Duarte, I.D., Tatsuo, M.A., Do endogenous opioids and nitric oxide participate in the anticonvulsant action of dipyrone? (2003) Braz J Med Biol Res, 36 (9), pp. 1263-1268; 
Reti, I.M., Baraban, J.M., Opiate withdrawal induces Narp in the extended amygdala (2003) Neuropsychopharmacology, 28 (9), pp. 1606-1613; 
Reynolds, L.W., Hoo, R.K., Brill, R.J., North, J., Recker, D.P., Verburg, K.M., The COX-2 specific inhibitor, valdecoxib, is an effective, opioid-sparing analgesic in patients undergoing total knee arthroplasty (2003) J Pain Symptom Manage, 25 (2), pp. 133-141; 
Rezayof, A., Zarrindast, M.R., Sahraei, H., Haeri-Rohani, A., Involvement of dopamine receptors of the dorsal hippocampus on the acquisition and expression of morphine-induced place preference in rats (2003) J Psychopharmacol, 17 (4), pp. 415-423; 
Reznikov, A.G., Nosenko, N.D., Tarasenko, L.V., Participation of endogenous opioids in pathogenesis of early neuroendocrine manifestations of prenatal stress syndrome (2003) Bull Exp Biol Med, 135 (5), pp. 421-423; 
Ribeiro Do, C.B., Aguilar, M.A., Manzanedo, C., Rodriguez-Arias, M., Minarro, J., Reinstatement of morphine-induced conditioned place preference in mice by priming injections (2003) Neural Plast, 10 (4), pp. 279-290; 
Rimanoczy, A., Slamberova, R., Riley, M.A., Vathy, I., Adrenocorticotropin stress response but not glucocorticoid-negative feedback is altered by prenatal morphine exposure in adult male rats (2003) Neuroendocrinology, 78 (6), pp. 312-320; 
Roberts, R.C., Lapidus, B., Ultrastructural correlates of haloperidol-induced oral dyskinesias in rats: A study of unlabeled and enkephalin-labeled striatal terminals (2003) J Neural Transm, 110 (9), pp. 961-975; 
Robertson, S.A., Taylor, P.M., Lascelles, B.D., Dixon, M.J., Changes in thermal threshold response in eight cats after administration of buprenorphine, butorphanol and morphine (2003) Vet Rec, 153 (15), pp. 462-465; 
Rocha, L., Maidment, N.T., Opioid peptide release in the rat hippocampus after kainic acid-induced status epilepticus (2003) Hippocampus, 13 (4), pp. 472-480; 
Rodriguez-Arias, M., Aguilar, M.A., Minarro, J., The dopamine release inhibitor CGS10,746B blocks conditioned physical signs of morphine withdrawal (2003) Addict Biol, 8 (2), pp. 167-172; 
Roerig, S.C., Spinal supraspinal agmatine activate different receptors to enhance spinal morphine antinociception (2003) Ann NY Acad Sci, 1009, pp. 116-126; 
Romberg, R., Olofsen, E., Sarton, E., Teppema, L., Dahan, A., Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers (2003) Anesthesiology, 99 (4), pp. 788-798; 
Romberg, R., Sarton, E., Teppema, L., Matthes, H.W., Kieffer, B.L., Dahan, A., Comparison of morphine-6-glucuronide and morphine on respiratory depressant and antinociceptive responses in wild type and mu-opioid receptor deficient mice (2003) Br J Anaesth, 91 (6), pp. 862-870; 
Ropper, A.H., Blair, R., Symmetric deep cerebellar lesions after smoking heroin (2003) Arch Neurol, 60 (11), pp. 1605-1606; 
Rosin, A., Kitchen, I., Georgieva, J., Effects of single and dual administration of cocaine and ethanol on opioid and ORL1 receptor expression in rat CNS: An autoradiographic study (2003) Brain Res, 978 (1-2), pp. 1-13; 
Roth-Deri, I., Zangen, A., Aleli, M., Goelman, R.G., Pelled, G., Nakash, R., Effect of experimenter-delivered and self-administered cocaine on extracellular beta-endorphin levels in the nucleus accumbens (2003) J Neurochem, 84 (5), pp. 930-938; 
Roumy, M., Garnier, M., Zajac, J.M., Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones (2003) Neurosci Lett, 348 (3), pp. 159-162; 
Roy, S., Balasubramanian, S., Wang, J., Chandrashekhar, Y., Charboneau, R., Barke, R., Morphine inhibits VEGF expression in myocardial ischemia (2003) Surgery, 134 (2), pp. 336-344; 
Ruiz-Durantez, E., Torrecilla, M., Pineda, J., Ugedo, L., Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neurons (2003) Br J Pharmacol, 138 (3), pp. 494-500; 
Ruiz-Durantez, E., Llorente, J., Ulibarri, I., Pineda, J., Ugedo, L., Agmatine-morphine interaction on nociception in mice (2003) Ann NY Acad Sci, 1009, pp. 133-136; 
Runkorg, K., Veraksits, A., Kurrikoff, K., Luuk, H., Raud, S., Abramov, U., Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice (2003) Behav Brain Res, 144 (1-2), pp. 125-135; 
Russell, A., Watson, C.P., Clark, A.J., Arkinstall, W., Moulin, D., Hays, H., Evaluation of dosing guidelines for use of controlled-release codeine in chronic noncancer pain (2003) Pain Res Manage, 8 (3), pp. 143-148; 
Russell, J.A., Leng, G., Douglas, A.J., The magnocellular oxytocin system, the fount of maternity: Adaptations in pregnancy (2003) Front Neuroendocrinol, 24 (1), pp. 27-61; 
Sacerdote, P., Effects of in vitro and in vivo opioids on the production of IL-12 and IL-10 by murine macrophages (2003) Ann NY Acad Sci, 992, pp. 129-140; 
Saitoh, Y., Kato, A., Ninomiya, H., Baba, T., Shibata, M., Mashimo, T., Primary motor cortex stimulation within the central sulcus for treating deafferentation pain (2003) Acta Neurochir Suppl, 87, pp. 149-152; 
Sakai, T., Use, T., Shimamoto, H., Fukano, T., Sumikawa, K., Mini-dose (0.05 mg) intrathecal morphine provides effective analgesia after transurethral resection of the prostate (2003) Can J Anaesth, 50 (10), pp. 1027-1030; 
Salmanzadeh, F., Fathollahi, Y., Semnanian, S., Shafizadeh, M., Long-term potentiation as an electrophysiological assay for morphine dependence and withdrawal in rats: An in vitro study (2003) J Neurosci Methods, 124 (2), pp. 189-196; 
Salmanzadeh, F., Fathollahi, Y., Semnanian, S., Shafizadeh, M., Dependence on morphine impairs the induction of long-term potentiation in the CA1 region of rat hippocampal slices (2003) Brain Res, 965 (1-2), pp. 108-113; 
Salmanzadeh, F., Fathollahi, Y., Semnanian, S., Shafizadeh, M., Kazemnejad, A., Dependence on morphine leads to a prominent sharing among the different mechanisms of long-term potentiation in the CA1 region of rat hippocampus (2003) Brain Res, 963 (1-2), pp. 93-100; 
Samadi, P., Gregoire, L., Bedard, P.J., Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: Interaction between dopamine and opioid systems (2003) Neuropharmacology, 45 (7), pp. 954-963; 
Sandor, P., Reivich, M., Komjati, K., Significance of endogenous opioids in the maintenance of cerebral and spinal vascular CO 2-sensitivity in deep hemorrhagic hypotension (2003) Brain Res Bull, 59 (6), pp. 433-438; 
Sartain, J.B., Barry, J.J., Richardson, C.A., Branagan, H.C., Effect of combining naloxone and morphine for intravenous patient-controlled analgesia (2003) Anesthesiology, 99 (1), pp. 148-151; 
Sayyid, S.S., Jabbour, D.G., Baraka, A.S., Hypothermia and excessive sweating following intrathecal morphine in a parturient undergoing cesarean delivery (2003) Reg Anesth Pain Med, 28 (2), pp. 140-143; 
Scallet, A.C., Wofford, M., Meredith, J.C., Allaben, W.T., Ferguson, S.A., Dietary exposure to genistein increases vasopressin but does not alter beta-endorphin in the rat hypothalamus (2003) Toxicol Sci, 72 (2), pp. 296-300; 
Schiller, P.W., Weltrowska, G., Nguyen, T.M., Lemieux, C., Chung, N.N., Lu, Y., Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists (2003) Life Sci, 73 (6), pp. 691-698; 
Schindler, C.J., Slamberova, R., Vathy, I., Bicuculline seizure susceptibility and nigral GABAA alpha1 receptor mRNA is altered in adult prenatally morphine-exposed females (2003) Psychoneuroendocrinology, 28 (3), pp. 348-363; 
Schlussman, S.D., Zhang, Y., Yuferov, V., LaForge, K.S., Ho, A., Kreek, M.J., Acute 'binge' cocaine administration elevates dynorphin mRNA in the caudate putamen of C57BL/6J but not 129/J mice (2003) Brain Res, 974 (1-2), pp. 249-253; 
Schmidt, B.L., Tambeli, C.H., Levine, J.D., Gear, R.W., Adaptations in nucleus accumbens circuitry during opioid withdrawal associated with persistence of noxious stimulus-induced antinociception in the rat (2003) J Pain, 4 (3), pp. 141-147; 
Schmidt, P., Schmolke, C., Musshoff, F., Menzen, M., Prohaska, C., Madea, B., Area-specific increased density of mu-opioid receptor immunoreactive neurons in the cerebral cortex of drug-related fatalities (2003) Forensic Sci Int, 133 (3), pp. 204-211; 
Schmitt, T.K., Mousa, S.A., Brack, A., Schmidt, D.K., Rittner, H.L., Welte, M., Modulation of peripheral endogenous opioid analgesia by central afferent blockade (2003) Anesthesiology, 98 (1), pp. 195-202; 
Schreiber, S., Backler, M.M., Herman, I., Shamir, D., Rigai, T., Bar-Hamburger, R., Mianserin and trazodone significantly attenuate the intensity of opioid withdrawal symptoms in mice (2003) Addict Biol, 8 (1), pp. 107-114; 
Schroeder, B.E., Schiltz, C.A., Kelley, A.E., Neural activation profile elicited by cues associated with the anxiogenic drug yohimbine differs from that observed for reward-paired cues (2003) Neuropsychopharmacology, 28 (1), pp. 14-21; 
Schulte, H., Graven-Nielsen, T., Sollevi, A., Jansson, Y., Rendt-Nielsen, L., Segerdahl, M., Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers (2003) Acta Anaesthesiol Scand, 47 (8), pp. 1020-1030; 
Schulteis, G., Morse, A.C., Liu, J., Repeated experience with naloxone facilitates acute morphine withdrawal: Potential role for conditioning processes in acute opioid dependence (2003) Pharmacol Biochem Behav, 76 (3-4), pp. 493-503; 
Sell, S.L., McMahon, L.R., France, C.P., Relative efficacy of buprenorphine, nalbuphine and morphine in opioid-treated rhesus monkeys discriminating naltrexone (2003) J Pharmacol Exp Ther, 306 (3), pp. 1167-1173; 
Selley, D.E., Herbert, J.T., Morgan, D., Cook, C.D., Picker, M.J., Sim-Selley, L.J., Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain (2003) Brain Res Bull, 60 (3), pp. 201-208; 
Sellings, L.H., Clarke, P.B., Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core (2003) J Neurosci, 23 (15), pp. 6295-6303; 
Senagore, A.J., Delaney, C.P., Mekhail, N., Dugan, A., Fazio, V.W., Randomized clinical trial comparing epidural anaesthesia and patient-controlled analgesia after laparoscopic segmental colectomy (2003) Br J Surg, 90 (10), pp. 1195-1199; 
Sevostianova, N., Zvartau, E., Bespalov, A., Danysz, W., Effects of morphine on formalin-induced nociception in rats (2003) Eur J Pharmacol, 462 (1-3), pp. 109-113; 
Shah, N., Chitravanshi, V.C., Sapru, H.N., Cardiovascular responses to microinjections of nociceptin into a midline area in the commissural subnucleus of the nucleus tractus solitarius of the rat (2003) Brain Res, 984 (1-2), pp. 93-103; 
Shahabi, N.A., McAllen, K., Sharp, B.M., Phosphorylation of activating transcription factor in murine splenocytes through delta opioid receptors (2003) Cell Immunol, 221 (2), pp. 122-127; 
Shahak, H., Slotkin, T.A., Yanai, J., Alterations in PKCgamma in the mouse hippocampus after prenatal exposure to heroin: A link from cell signaling to behavioral outcome (2003) Brain Res Dev Brain Res, 140 (1), pp. 117-125; 
Shalev, U., Robarts, P., Shaham, Y., Morales, M., Selective induction of c-Fos immunoreactivity in the prelimbic cortex during reinstatement of heroin seeking induced by acute food deprivation in rats (2003) Behav Brain Res, 145 (1-2), pp. 79-88; 
Shane, R., Acosta, J., Rossi, G.C., Bodnar, R.J., Reciprocal interactions between the amygdala and ventrolateral periaqueductal gray in mediating of Q/N(1-17)-induced analgesia in the rat (2003) Brain Res, 980 (1), pp. 57-70; 
Sharp, B.M., Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity (2003) Adv Exp Med Biol, 521, pp. 98-105; 
Shi, E., Jiang, X., Bai, H., Gu, T., Chang, Y., Wang, J., Cardioprotective effects of morphine on rat heart suffering from ischemia and reperfusion (2003) Chin Med J (Engl), 116 (7), pp. 1059-1062; 
Shi, X.D., Ren, W., Wang, G.B., Luo, F., Han, J.S., Cui, C.L., Brain opioid-receptors are involved in mediating peripheral electric stimulation-induced inhibition of morphine conditioned place preference in rats (2003) Brain Res, 981 (1-2), pp. 23-29; 
Shin, I.C., Kim, H.C., Swanson, J., Hong, J.T., Oh, K.W., Anxiolytic effects of acute morphine can be modulated by nitric oxide systems (2003) Pharmacology, 68 (4), pp. 183-189; 
Shin, K.W., Hong, J.T., Yoo, H.S., Song, S., Oh, K.W., Inhibitory effects of glycine on morphine-induced hyperactivity, reverse tolerance and post-synaptic dopamine receptor supersensitivity in mice (2003) Arch Pharm Res, 26 (12), pp. 1074-1078; 
Shin, S.W., Sandner-Kiesling, A., Eisenach, J.C., Systemic, but not intrathecal ketorolac is antinociceptive to uterine cervical distension in rats (2003) Pain, 105 (1-2), pp. 109-114; 
Shin, S.W., Eisenach, J.C., Intrathecal morphine reduces the visceromotor response to acute uterine cervical distension in an estrogen-independent manner (2003) Anesthesiology, 98 (6), pp. 1467-1471; 
Shyu, B.C., Chai, S.C., Kung, J.C., Fan, R.J., A quantitative method for assessing of the affective component of the pain: Conditioned response associated with CO2 laser-induced nocifensive reaction (2003) Brain Res Brain Res Protoc, 12 (1), pp. 1-9; 
Siggins, G.R., Martin, G., Roberto, M., Nie, Z., Madamba, S., De, L.L., Glutamatergic transmission in opiate and alcohol dependence (2003) Ann NY Acad Sci, 1003, pp. 196-211; 
Silbert, S.C., Beacham, D.W., McCleskey, E.W., Quantitative single-cell differences in mu-opioid receptor mRNA distinguish myelinated and unmyelinated nociceptors (2003) J Neurosci, 23 (1), pp. 34-42; 
Simons, S.H., Van, D.M., Van Lingen, R.A., Roofthooft, D., Duivenvoorden, H.J., Jongeneel, N., Routine morphine infusion in preterm newborns who received ventilatory support: A randomized controlled trial (2003) JAMA, 290 (18), pp. 2419-2427; 
Sinchak, K., Micevych, P., Visualizing activation of opioid circuits by internalization of G protein-coupled receptors (2003) Mol Neurobiol, 27 (2), pp. 197-222; 
Singal, P., Kinhikar, A.G., Singh, S., Singh, P.P., Neuroimmunomodulatory: Effects of morphine in Leishmania donovani-infected hamsters (2003) Neuroimmunomodulation, 10 (5), pp. 261-269; 
Singh, K.P., Sanyal, A.K., Effect of undernutrition on morphine analgesia, haloperidol catalepsy and pentobarbitone sodium hypnosis in developing new born rats (2003) Indian J Med Sci, 57 (4), pp. 164-170; 
Skarke, C., Darimont, J., Schmidt, H., Geisslinger, G., Lotsch, J., Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers (2003) Clin Pharmacol Ther, 73 (1), pp. 107-121; 
Skarke, C., Jarrar, M., Erb, K., Schmidt, H., Geisslinger, G., Lotsch, J., Respiratory and miotic effects of morphine in healthy volunteers when P-glycoprotein is blocked by quinidine (2003) Clin Pharmacol Ther, 74 (4), pp. 303-311; 
Skarke, C., Schmidt, H., Geisslinger, G., Darimont, J., Lotsch, J., Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndrome (2003) Br J Clin Pharmacol, 56 (2), pp. 228-231; 
Slamberova, R., Rimanoczy, A., Bar, N., Schindler, C.J., Vathy, I., Density of mu-opioid receptors in the hippocampus of adult male and female rats is altered by prenatal morphine exposure and gonadal hormone treatment (2003) Hippocampus, 13 (4), pp. 461-471; 
Slamberova, R., Bar, N., Vathy, I., Long-term effects of prenatal morphine exposure on maternal behaviors differ from the effects of direct chronic morphine treatment (2003) Dev Psychobiol, 43 (4), pp. 281-289; 
Slamberova, R., Rimanoczy, A., Schindler, C.J., Vathy, I., Cortical and striatal mu-opioid receptors are altered by gonadal hormone treatment but not by prenatal morphine exposure in adult male and female rats (2003) Brain Res Bull, 62 (1), pp. 47-53; 
Smith, D.J., Leil, T.A., Liu, X., Neurotrophin-4 is required for tolerance to morphine in the mouse (2003) Neurosci Lett, 340 (2), pp. 103-106; 
Smith, F.L., Javed, R.R., Elzey, M.J., Dewey, W.L., The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA (2003) Brain Res, 985 (1), pp. 78-88; 
Smith, L.J., Krugner-Higby, L., Clark, M., Wendland, A., Heath, T.D., A single dose of liposome-encapsulated oxymorphone or morphine provides long-term analgesia in an animal model of neuropathic pain (2003) Comp Med, 53 (3), pp. 280-287; 
Smith, M.A., Yancey, D.L., Sensitivity to the effects of opioids in rats with free access to exercise wheels: Mu-opioid tolerance and physical dependence (2003) Psychopharmacology (Berl), 168 (4), pp. 426-434; 
Sneddon, L.U., Braithwaite, V.A., Gentle, M.J., Novel object test: Examining nociception and fear in the rainbow trout (2003) J Pain, 4 (8), pp. 431-440; 
Soares, L.G., Martins, M., Uchoa, R., Intravenous fentanyl for cancer pain: A "fast titration" protocol for the emergency room (2003) J Pain Symptom Manage, 26 (3), pp. 876-881; 
Somogyvari-Vigh, A., Kastin, A.J., Liao, J., Zadina, J.E., Pan, W., Endomorphins exit the brain by a saturable efflux system at the basolateral surface of cerebral endothelial cells (2003) Exp Brain Res, 156 (2), pp. 224-230; 
Song, B., Marvizon, J.C., Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids (2003) J Neurosci, 23 (5), pp. 1847-1858; 
Song, B., Marvizon, J.C., Dorsal horn neurons firing at high frequency, but not primary afferents, release opioid peptides that produce micro-opioid receptor internalization in the rat spinal cord (2003) J Neurosci, 23 (27), pp. 9171-9184; 
Souron, V., Delaunay, L., Schifrine, P., Intrathecal morphine provides better postoperative analgesia than psoas compartment block after primary hip arthroplasty (2003) Can J Anaesth, 50 (6), pp. 574-579; 
Spangler, R., Goddard, N.L., Avena, N.M., Hoebel, B.G., Leibowitz, S.F., Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine (2003) Brain Res Mol Brain Res, 111 (1-2), pp. 74-83; 
Spiga, S., Serra, G.P., Puddu, M.C., Foddai, M., Diana, M., Morphine withdrawal-induced abnormalities in the VTA: Confocal laser scanning microscopy (2003) Eur J Neurosci, 17 (3), pp. 605-612; 
Spivak, C.E., Beglan, C.L., Zollner, C., Surratt, C.K., Beta-Funaltrexamine, a gauge for the recognition site of wildtype and mutant H297Q mu-opioid receptors (2003) Synapse, 49 (1), pp. 55-60; 
St-Hilaire, M., Landry, E., Levesque, D., Rouillard, C., Denervation and repeated L-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats (2003) Neurobiol Dis, 14 (1), pp. 98-109; 
Starowicz, K., Sieja, A., Bilecki, W., Obara, I., Przewlocka, B., The effect of morphine on MC4 and CRF receptor mRNAs in the rat amygdala and attenuation of tolerance after their blockade (2003) Brain Res, 990 (1-2), pp. 113-119; 
Steele, A.D., Henderson, E.E., Rogers, T.J., Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication (2003) Virology, 309 (1), pp. 99-107; 
Stein, C., Schafer, M., Machelska, H., Attacking pain at its source: New perspectives on opioids (2003) Nat Med, 9 (8), pp. 1003-1008; 
Steinhoff, M., Neisius, U., Ikoma, A., Fartasch, M., Heyer, G., Skov, P.S., Proteinase-activated receptor-2 mediates itch: A novel pathway for pruritus in human skin (2003) J Neurosci, 23 (15), pp. 6176-6180; 
Steinmiller, C.L., Maisonneuve, I.M., Glick, S.D., Effects of dextromethorphan on dopamine release in the nucleus accumbens: Interactions with morphine (2003) Pharmacol Biochem Behav, 74 (4), pp. 803-810; 
Stella, L., De Novellis, V., Vitelli, M.R., Capuano, A., Mazzeo, F., Berrino, L., Interactive role of adenosine and dopamine in the opiate withdrawal syndrome (2003) Naunyn Schmiedebergs Arch Pharmacol, 368 (2), pp. 113-118; 
Sterious, S.N., Walker, E.A., Potency differences for d-Phe-Cys-Tyr-d-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay (2003) J Pharmacol Exp Ther, 304 (1), pp. 301-309; 
Sternberg, W.F., Ridgway, C.G., Effects of gestational stress and neonatal handling on pain, analgesia, and stress behavior of adult mice (2003) Physiol Behav, 78 (3), pp. 375-383; 
Stevens, B., McGrath, P., Gibbins, S., Beyene, J., Breau, L., Camfield, C., Procedural pain in newborns at risk for neurologic impairment (2003) Pain, 105 (1-2), pp. 27-35; 
Stevenson, G.W., Folk, J.E., Linsenmayer, D.C., Rice, K.C., Negus, S.S., Opioid interactions in rhesus monkeys: Effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception (2003) J Pharmacol Exp Ther, 307 (3), pp. 1054-1064; 
Stewart, J., Stress and relapse to drug seeking: Studies in laboratory animals shed light on mechanisms and sources of long-term vulnerability (2003) Am J Addict, 12 (1), pp. 1-17; 
Stoffel, E.C., Ulibarri, C.M., Craft, R.M., Gonadal steroid hormone modulation of nociception, morphine antinociception and reproductive indices in male and female rats (2003) Pain, 103 (3), pp. 285-302; 
Stornetta, R.L., Sevigny, C.P., Guyenet, P.G., Inspiratory augmenting bulbospinal neurons express both glutamatergic and enkephalinergic phenotypes (2003) J Comp Neurol, 455 (1), pp. 113-124; 
Su, R.B., Li, J., Qin, B.Y., A biphasic opioid function modulator: Agmatine (2003) Acta Pharmacol Sin, 24 (7), pp. 631-636; 
Suchitra, A.D., Dkhar, S.A., Shewade, D.G., Shashindran, C.H., Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice (2003) World J Gastroenterol, 9 (4), pp. 779-783; 
Sudakov, S.K., Medvedeva, O.F., Rusakova, I.V., Figurina, I.B., Effect of social isolation on behavioral parameters and sensitivity of rats to morphine and caffeine (2003) Bull Exp Biol Med, 135 (1), pp. 6-8; 
Suder, P., Bogusiewicz, A., Rolka, K., Laidler, P., Kotlinska, J., Silberring, J., Rat neuronal cells in primary culture as a model for nociceptin/orphanin FQ metabolism (2003) Neurosci Lett, 348 (3), pp. 167-170; 
Summers, R.L., Li, Z., Hildebrandt, D., Effect of a delta receptor agonist on duration of survival during hemorrhagic shock (2003) Acad Emerg Med, 10 (6), pp. 587-593; 
Sun, H.L., Zheng, J.W., Wang, K., Liu, R.K., Liang, J.H., Tramadol reduces the 5-HTP-induced head-twitch response in mice via the activation of mu and kappa opioid receptors (2003) Life Sci, 72 (11), pp. 1221-1230; 
Sun, Y.G., Gu, X.L., Lundeberg, T., Yu, L.C., An antinociceptive role of galanin in the arcuate nucleus of hypothalamus in intact rats and rats with inflammation (2003) Pain, 106 (1-2), pp. 143-150; 
Suyama, H., Kawamoto, M., Gaus, S., Yuge, O., Effect of JTC-801 (nociceptin antagonist) on neuropathic pain in a rat model (2003) Neurosci Lett, 351 (3), pp. 133-136; 
Svensson, C.I., Rew, Y., Malkmus, S., Schiller, P.W., Taulane, J.P., Goodman, M., Spinal analgesic activity of a delta-opioid-selective lanthionine enkephalin analog (2003) J Pharmacol Exp Ther, 304 (2), pp. 827-832; 
Sveticic, G., Gentilini, A., Eichenberger, U., Luginbuhl, M., Curatolo, M., Combinations of morphine with ketamine for patient-controlled analgesia: A new optimization method (2003) Anesthesiology, 98 (5), pp. 1195-1205; 
Szarvas, S., Chellapuri, R.S., Harmon, D.C., Owens, J., Murphy, D., Shorten, G.D., A comparison of dexamethasone, ondansetron, and dexamethasone plus ondansetron as prophylactic antiemetic and antipruritic therapy in patients receiving intrathecal morphine for major orthopedic surgery (2003) Anesth Analg, 97 (1), pp. 259-263; 
Szeto, H.H., Dynorphin and the hypothalamo-pituitary-adrenal axis during fetal development (2003) Life Sci, 73 (6), pp. 749-758; 
Szeto, H.H., Soong, Y., Wu, D., Qian, X., Zhao, G.M., Endogenous opioid peptides contribute to antinociceptive potency of intrathecal [Dmt1]DALDA (2003) J Pharmacol Exp Ther, 305 (2), pp. 696-702; 
Taddio, A., Shah, V., Shah, P., Katz, J., Beta-endorphin concentration after administration of sucrose in preterm infants (2003) Arch Pediatr Adolesc Med, 157 (11), pp. 1071-1074; 
Takahashi, M., Ohara, T., Yamanaka, H., Shimada, A., Nakaho, T., Makoto, Y., The oral-to-intravenous equianalgesic ratio of morphine based on plasma concentrations of morphine and metabolites in advanced cancer patients receiving chronic morphine treatment (2003) Palliat Med, 17 (8), pp. 673-678; 
Takenaka, Y., Nakamura, F., Usui, H., Lipkowski, A.W., Toth, G., Yoshikawa, M., Anti-analgesic activity of enterostatin (VPDPR) is mediated by corticosterone (2003) Peptides, 24 (5), pp. 735-739; 
Takita, K., Morimoto, Y., Kemmotsu, O., Roles of nociceptin/orphanin FQ and nociceptin/orphanin FQ peptide receptor in respiratory rhythm generation in the medulla oblongata: An in vitro study (2003) Br J Anaesth, 91 (3), pp. 385-389; 
Tambeli, C.H., Quang, P., Levine, J.D., Gear, R.W., Contribution of spinal inhibitory receptors in heterosegmental antinociception induced by noxious stimulation (2003) Eur J Neurosci, 18 (11), pp. 2999-3006; 
Tan-No, K., Niijima, F., Nakagawasai, O., Sato, T., Satoh, S., Tadano, T., Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice (2003) Eur J Pharm Sci, 20 (3), pp. 357-363; 
Tan, M., Groszer, M., Tan, A.M., Pandya, A., Liu, X., Xie, C.W., Phosphoinositide 3-kinase cascade facilitates mu-opioid desensitization in sensory neurons by altering G-protein-effector interactions (2003) J Neurosci, 23 (32), pp. 10292-10301; 
Tancin, V., Schams, D., Kraetzl, W.D., The effect of morphine and naloxone on the release of prolactin during machine milking in dairy cows (2003) J Dairy Res, 70 (3), pp. 277-282; 
Tassain, V., Attal, N., Fletcher, D., Brasseur, L., Degieux, P., Chauvin, M., Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain (2003) Pain, 104 (1), pp. 389-400; 
Tateishi, M., Ohashi, K., Kobayashi, K., Hashimoto, T., Yamaguchi, J., Fujioka, H., Interindividual variation in the ratio between plasma morphine and its metabolites in cancer patients (2003) Int J Clin Pharmacol Res, 23 (2-3), pp. 75-82; 
Taylor, B.K., Basbaum, A.I., Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray (2003) J Neurochem, 86 (5), pp. 1129-1141; 
Tegeder, I., Grosch, S., Schmidtko, A., Haussler, A., Schmidt, H., Niederberger, E., G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: Involvement of p53 phosphorylation (2003) Cancer Res, 63 (8), pp. 1846-1852; 
Teng, Y.D., Bingaman, M., Taveira-DaSilva, A.M., Pace, P.P., Gillis, R.A., Wrathall, J.R., Serotonin 1A receptor agonists reverse respiratory abnormalities in spinal cord-injured rats (2003) J Neurosci, 23 (10), pp. 4182-4189; 
Terner, J.M., Barrett, A.C., Cook, C.D., Picker, M.J., Sex differences in (-)-pentazocine antinociception: Comparison to morphine and spiradoline in four rat strains using a thermal nociceptive assay (2003) Behav Pharmacol, 14 (1), pp. 77-85; 
Terner, J.M., Lomas, L.M., Smith, E.S., Barrett, A.C., Picker, M.J., Pharmacogenetic analysis of sex differences in opioid antinociception in rats (2003) Pain, 106 (3), pp. 381-391; 
Thomas, S.H., Silen, W., Cheema, F., Reisner, A., Aman, S., Goldstein, J.N., Effects of morphine analgesia on diagnostic accuracy in Emergency Department patients with abdominal pain: A prospective, randomized trial (2003) J Am Coll Surg, 196 (1), pp. 18-31; 
Tjoumakaris, S.I., Rudoy, C., Peoples, J., Valentino, R.J., Van Bockstaele, E.J., Cellular interactions between axon terminals containing endogenous opioid peptides or corticotropin-releasing factor in the rat locus coeruleus and surrounding dorsal pontine tegmentum (2003) J Comp Neurol, 466 (4), pp. 445-456; 
Todd, B.J., Ladyman, S.R., Grattan, D.R., Suppression of pulsatile luteinizing hormone secretion but not luteinizing hormone surge in leptin resistant obese Zucker rats (2003) J Neuroendocrinol, 15 (1), pp. 61-68; 
Tomassini, N., Renaud, F.L., Roy, S., Loh, H.H., Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages (2003) J Neuroimmunol, 136 (1-2), pp. 9-16; 
Tordjman, S., Carlier, M., Cohen, D., Cesselin, F., Bourgoin, S., Colas-Linhart, N., Aggression and the three opioid families (endorphins, enkephalins, and dynorphins) in mice (2003) Behav Genet, 33 (5), pp. 529-536; 
Tortorici, V., Nogueira, L., Salas, R., Vanegas, H., Involvement of local cholecystokinin in the tolerance induced by morphine microinjections into the periaqueductal gray of rats (2003) Pain, 102 (1-2), pp. 9-16; 
Trang, T., Sutak, M., Quirion, R., Jhamandas, K., Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal (2003) Br J Pharmacol, 140 (2), pp. 295-304; 
Truong, W., Cheng, C., Xu, Q.G., Li, X.Q., Zochodne, D.W., Mu opioid receptors and analgesia at the site of a peripheral nerve injury (2003) Ann Neurol, 53 (3), pp. 366-375; 
Tse, D.M., Sham, M.M., Ng, D.K., Ma, H.M., An ad libitum schedule for conversion of morphine to methadone in advanced cancer patients: An open uncontrolled prospective study in a Chinese population (2003) Palliat Med, 17 (2), pp. 206-211; 
Tso, P.H., Wong, Y.H., Molecular basis of opioid dependence: Role of signal regulation by G-proteins (2003) Clin Exp Pharmacol Physiol, 30 (5-6), pp. 307-316; 
Tzeng, J.I., Chu, K.S., Ho, S.T., Cheng, K.I., Liu, K.S., Wang, J.J., Prophylactic iv ondansetron reduces nausea, vomiting and pruritus following epidural morphine for postoperative pain control (2003) Can J Anaesth, 50 (10), pp. 1023-1026; 
Ueda, H., Inoue, M., Mizuno, K., New approaches to study the development of morphine tolerance and dependence (2003) Life Sci, 74 (2-3), pp. 313-320; 
Ulucan, C., Schnell, C., Messlinger, K., Ellrich, J., Effects of acetylsalicylic acid and morphine on neurons of the rostral ventromedial medulla in rat (2003) Neurosci Res, 47 (4), pp. 391-397; 
Umbricht, A., Hoover, D.R., Tucker, M.J., Leslie, J.M., Chaisson, R.E., Preston, K.L., Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection (2003) Drug Alcohol Depend, 69 (3), pp. 263-272; 
Umeuchi, H., Togashi, Y., Honda, T., Nakao, K., Okano, K., Tanaka, T., Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system (2003) Eur J Pharmacol, 477 (1), pp. 29-35; 
Unlugenc, H., Ozalevli, M., Gunes, Y., Guler, T., Isik, G., Pre-emptive analgesic efficacy of tramadol compared with morphine after major abdominal surgery (2003) Br J Anaesth, 91 (2), pp. 209-213; 
Unlugenc, H., Ozalevli, M., Guler, T., Isik, G., Postoperative pain management with intravenous patient-controlled morphine: Comparison of the effect of adding magnesium or ketamine (2003) Eur J Anaesthesiol, 20 (5), pp. 416-421; 
Upton, R.N., Ludbrook, G.L., Martinez, A.M., Grant, C., Milne, R.W., Cerebral and lung kinetics of morphine in conscious sheep after short intravenous infusions (2003) Br J Anaesth, 90 (6), pp. 750-758; 
Vaanholt, L.M., Turek, F.W., Meerlo, P., Beta-endorphin modulates the acute response to a social conflict in male mice but does not play a role in stress-induced changes in sleep (2003) Brain Res, 978 (1-2), pp. 169-176; 
Vallerand, A.H., The use of long-acting opioids in chronic pain management (2003) Nurs Clin North Am, 38 (3), pp. 435-445; 
Valles, R., Cardon, A.L., Heard, H.M., Bratton, G.R., Nation, J.R., Morphine conditioned place preference is attenuated by perinatal lead exposure (2003) Pharmacol Biochem Behav, 75 (2), pp. 295-300; 
Valtchanova-Matchouganska, A., Ojewole, J.A., Mechanisms of opioid delta (delta) and kappa (kappa) receptors' cardioprotection in ischaemic preconditioning in a rat model of myocardial infarction (2003) Cardiovasc J S Afr, 14 (2), pp. 73-80; 
Van Seventer, R., Smit, J.M., Schipper, R.M., Wicks, M.A., Zuurmond, W.W., Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain (2003) Curr Med Res Opin, 19 (6), pp. 457-469; 
Varona, A., Gil, J., Saracibar, G., Maza, J.L., Echevarria, E., Irazusta, J., Effects of imipramine treatment on delta-opioid receptors of the rat brain cortex and striatum (2003) Arzneimittelforschung, 53 (1), pp. 21-25; 
Vaughan, C.W., Bagley, E.E., Drew, G.M., Schuller, A., Pintar, J.E., Hack, S.P., Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1 (2003) Br J Pharmacol, 139 (2), pp. 362-367; 
Veinante, P., Stoeckel, M.E., Lasbennes, F., Freund-Mercier, M.J., c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal (2003) Eur J Neurosci, 18 (5), pp. 1295-1305; 
Velisek, L., Slamberova, R., Vathy, I., Prenatal morphine exposure suppresses mineralocorticoid receptor-dependent basal synaptic transmission and synaptic plasticity in the lateral perforant path in adult male rats (2003) Brain Res Bull, 61 (6), pp. 571-576; 
Venkatesan, P., Baxi, S., Evans, C., Neff, R., Wang, X., Mendelowitz, D., Glycinergic inputs to cardiac vagal neurons in the nucleus ambiguus are inhibited by nociceptin and mu-selective opioids (2003) J Neurophysiol, 90 (3), pp. 1581-1588; 
Ventura, C., Zinellu, E., Maninchedda, E., Maioli, M., Dynorphin, B is an agonist of nuclear opioid receptors coupling nuclear protein kinase C activation to the transcription of cardiogenic genes in GTR1 embryonic stem cells (2003) Circ Res, 92 (6), pp. 623-629; 
Vera-Portocarrero, L.P., Lu, Y., Westlund, K.N., Nociception in persistent pancreatitis in rats: Effects of morphine and neuropeptide alterations (2003) Anesthesiology, 98 (2), pp. 474-484; 
Veraksits, A., Runkorg, K., Kurrikoff, K., Raud, S., Abramov, U., Matsui, T., Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors (2003) Psychopharmacology (Berl), 166 (2), pp. 168-175; 
Vetulani, J., Pavone, F., Przewlocka, B., Borghi, V., Nalepa, I., The interaction of tetrahydroisoquinoline derivatives with antinociceptive action of morphine and oxotremorine in mice (2003) J Neural Transm, 110 (11), pp. 1205-1213; 
Vierck Jr., C.J., Kline, R.H., Wiey, R.G., Intrathecal substance p-saporin attenuates operant escape from nociceptive thermal stimuli (2003) Neuroscience, 119 (1), pp. 223-232; 
Vigano, D., Rubino, T., Di, C.G., Ascari, I., Massi, P., Parolaro, D., Mu opioid receptor signaling in morphine sensitization (2003) Neuroscience, 117 (4), pp. 921-929; 
Villetti, G., Bergamaschi, M., Bassani, F., Bolzoni, P.T., Maiorino, M., Pietra, C., Antinociceptive activity of the N-methyl-d-aspartate receptor antagonist N-(2-Indanyl)-glycinamide hydrochloride (CHF3381) in experimental models of inflammatory and neuropathic pain (2003) J Pharmacol Exp Ther, 306 (2), pp. 804-814; 
Vinner, E., Vignau, J., Thibault, D., Codaccioni, X., Brassart, C., Humbert, L., Hair analysis of opiates in mothers and newborns for evaluating opiate exposure during pregnancy (2003) Forensic Sci Int, 133 (1-2), pp. 57-62; 
Vonhof, S., Gudka, B.D., Siren, A.L., Tolerance and dependence following chronic intracerebroventricular infusions of Tyr-d-Arg2-Phe-Sar4 (TAPS) (2003) Eur J Pharmacol, 459 (1), pp. 41-48; 
Vorob'eva, T.M., Berchenko, O.G., Geiko, V.V., Kolyadko, S.P., Bevzyuk, D.A., Pan, I.R., Effect of potentiated antibodies to morphine on behavioral reactions in rats with morphine dependence (2003) Bull Exp Biol Med, 135 (SUPPL.), pp. 134-135; 
Vrinten, D.H., Gispen, W.H., Kalkman, C.J., Adan, R.A., Interaction between the spinal melanocortin and opioid systems in a rat model of neuropathic pain (2003) Anesthesiology, 99 (2), pp. 449-454; 
Wacnik, P.W., Kehl, L.J., Trempe, T.M., Ramnaraine, M.L., Beitz, A.J., Wilcox, G.L., Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan (2003) Pain, 101 (1-2), pp. 175-186; 
Wakonigg, G., Sturm, K., Saria, A., Zernig, G., Opioids, cocaine, and food change runtime distribution in a rat runway procedure (2003) Psychopharmacology (Berl), 169 (1), pp. 52-59; 
Walker, B.M., Ettenberg, A., The effects of alprazolam on conditioned place preferences produced by intravenous heroin (2003) Pharmacol Biochem Behav, 75 (1), pp. 75-80; 
Walker, J.R., Chen, S.A., Moffitt, H., Inturrisi, C.E., Koob, G.F., Chronic opioid exposure produces increased heroin self-administration in rats (2003) Pharmacol Biochem Behav, 75 (2), pp. 349-354; 
Walker, J.S., Anti-inflammatory effects of opioids (2003) Adv Exp Med Biol, 521, pp. 148-160; 
Walsh, T.D., Rivera, N.I., Kaiko, R., Oral morphine and respiratory function amongst hospice inpatients with advanced cancer (2003) Support Care Cancer, 11 (12), pp. 780-784; 
Walters, C.L., Kuo, Y.C., Blendy, J.A., Differential distribution of CREB in the mesolimbic dopamine reward pathway (2003) J Neurochem, 87 (5), pp. 1237-1244; 
Wan, X., Huang, M., He, Y., Li, W., You, Z., Lu, C., Involvement of dynorphin A in the inhibition of morphine physical dependence by N-nitro-l-arginine in rats (2003) Chin Med J (Engl), 116 (7), pp. 1055-1058; 
Wang, B., Luo, F., Ge, X., Fu, A., Han, J., Effect of 6-OHDA lesions of the dopaminergic mesolimbic system on drug priming induced reinstatement of extinguished morphine CPP in rats (2003) Beijing Da Xue Xue Bao, 35 (5), pp. 449-452; 
Wang, B., Zhang, B., Ge, X., Luo, F., Han, J., Inhibition by peripheral electric stimulation of the reinstatement of morphine-induced place preference in rats and drug-craving in heroin addicts (2003) Beijing Da Xue Xue Bao, 35 (3), pp. 241-247; 
Wang, H., Cuzon, V.C., Pickel, V.M., Postnatal development of mu-opioid receptors in the rat caudate-putamen nucleus parallels asymmetric synapse formation (2003) Neuroscience, 118 (3), pp. 695-708; 
Wang, H., Cuzon, V.C., Pickel, V.M., Ultrastructural localization of delta-opioid receptors in the rat caudate-putamen nucleus during postnatal development: Relation to synaptogenesis (2003) J Comp Neurol, 467 (3), pp. 343-353; 
Wang, Y., Li, J.G., Huang, P., Xu, W., Liu-Chen, L.Y., Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: Adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation (2003) J Pharmacol Exp Ther, 307 (3), pp. 1127-1134; 
Wang, Y.Y., Wu, S.X., Liu, X.Y., Wang, W., Li, Y.Q., Effects of c-fos antisense oligodeoxynucleotide on 5-HT-induced upregulation of preprodynorphin, preproenkephalin, and glutamic acid decarboxylase mRNA expression in cultured rat spinal dorsal horn neurons (2003) Biochem Biophys Res Commun, 309 (3), pp. 631-636; 
Wang, Z.J., Tang, L., Xin, L., Reversal of morphine antinociceptive tolerance by acute spinal inhibition of Ca(2+)/calmodulin-dependent protein kinase II (2003) Eur J Pharmacol, 465 (1-2), pp. 199-200; 
Wardas, J., Pietraszek, M., Dziedzicka-Wasylewska, M., SCH58,261, a selective adenosine A2A receptor antagonist, decreases the haloperidol-enhanced proenkephalin mRNA expression in the rat striatum (2003) Brain Res, 977 (2), pp. 270-277; 
Wardas, J., Pietraszek, M., Wolfarth, S., Ossowska, K., The role of metabotropic glutamate receptors in regulation of striatal proenkephalin expression: Implications for the therapy of Parkinson's disease (2003) Neuroscience, 122 (3), pp. 747-756; 
Watanabe, C., Sakurada, T., Okuda, K., Sakurada, C., Ando, R., Sakurada, S., The role of spinal nitric oxide and glutamate in nociceptive behaviour evoked by high-dose intrathecal morphine in rats (2003) Pain, 106 (3), pp. 269-283; 
Watanabe, C., Okuda, K., Sakurada, C., Ando, R., Sakurada, T., Sakurada, S., Evidence that nitric oxide-glutamate cascade modulates spinal antinociceptive effect of morphine: A behavioural and microdialysis study in rats (2003) Brain Res, 990 (1-2), pp. 77-86; 
Watanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M., Satoh, M., Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats (2003) Psychopharmacology (Berl), 170 (1), pp. 80-88; 
Watanobe, H., Schioth, H.B., Izumi, J., Pivotal roles of alpha-melanocyte-stimulating hormone and the melanocortin 4 receptor in leptin stimulation of prolactin secretion in rats (2003) J Neurochem, 85 (2), pp. 338-347; 
Watson, C.P., Moulin, D., Watt-Watson, J., Gordon, A., Eisenhoffer, J., Controlled-release oxycodone relieves neuropathic pain: A randomized controlled trial in painful diabetic neuropathy (2003) Pain, 105 (1-2), pp. 71-78; 
Weinbroum, A.A., A single small dose of postoperative ketamine provides rapid and sustained improvement in morphine analgesia in the presence of morphine-resistant pain (2003) Anesth Analg, 96 (3), pp. 789-795; 
Weisse, C.S., Sorum, P.C., Dominguez, R.E., The influence of gender and race on physicians' pain management decisions (2003) J Pain, 4 (9), pp. 505-510; 
Wenk, H.N., Nannenga, M.N., Honda, C.N., Effect of morphine sulphate eye drops on hyperalgesia in the rat cornea (2003) Pain, 105 (3), pp. 455-465; 
Wiley, J.L., Martin, B.R., Cannabinoid pharmacological properties common to other centrally acting drugs (2003) Eur J Pharmacol, 471 (3), pp. 185-193; 
Will, M.J., Franzblau, E.B., Kelley, A.E., Nucleus accumbens mu-opioids regulate intake of a high-fat diet via activation of a distributed brain network (2003) J Neurosci, 23 (7), pp. 2882-2888; 
Williams, K.L., Ko, M.C., Rice, K.C., Woods, J.H., Effect of opioid receptor antagonists on hypothalamic-pituitary-adrenal activity in rhesus monkeys (2003) Psychoneuroendocrinology, 28 (4), pp. 513-528; 
Willuhn, I., Sun, W., Steiner, H., Topography of cocaine-induced gene regulation in the rat striatum: Relationship to cortical inputs and role of behavioural context (2003) Eur J Neurosci, 17 (5), pp. 1053-1066; 
Wilson, B.C., Ingram, C.D., Convergent effects of oxytocin and a delta-opioid agonist in the bed nuclei of the stria terminalis of the peripartum rat (2003) Brain Res, 991 (1-2), pp. 267-270; 
Wilson, G.R., Reisfield, G.M., Morphine hyperalgesia: A case report (2003) Am J Hosp Palliat Care, 20 (6), pp. 459-461; 
Wilson, J.D., Nicklous, D.M., Aloyo, V.J., Simansky, K.J., An orexigenic role for mu-opioid receptors in the lateral parabrachial nucleus (2003) Am J Physiol Regul Integr Comp Physiol, 285 (5), pp. R1055-R1065; 
Wilson, M.A., Burghardt, P.R., Lugo Jr., J.N., Primeaux, S.D., Wilson, S.P., Effect of amygdalar opioids on the anxiolytic properties of ethanol (2003) Ann NY Acad Sci, 985, pp. 472-475; 
Wilson, S.G., Smith, S.B., Chesler, E.J., Melton, K.A., Haas, J.J., Mitton, B., The heritability of antinociception: Common pharmacogenetic mediation of five neurochemically distinct analgesics (2003) J Pharmacol Exp Ther, 304 (2), pp. 547-559; 
Winkler, C., Bentlage, C., Cenci, M.A., Nikkhah, G., Bjorklund, A., Regulation of neuropeptide mRNA expression in the basal ganglia by intrastriatal and intranigral transplants in the rat Parkinson model (2003) Neuroscience, 118 (4), pp. 1063-1077; 
Winter, L., Nadeson, R., Tucker, A.P., Goodchild, C.S., Antinociceptive properties of neurosteroids: A comparison of alphadolone and alphaxalone in potentiation of opioid antinociception (2003) Anesth Analg, 97 (3), pp. 798-805; 
Winzer-Serhan, U.H., Chen, Y., Leslie, F.M., Expression of opioid peptides and receptors in striatum and substantia nigra during rat brain development (2003) J Chem Neuroanat, 26 (1), pp. 17-36; 
Wu, A., Drummond, G.B., Sleep arousal after lower abdominal surgery and relation to recovery from respiratory obstruction (2003) Anesthesiology, 99 (6), pp. 1295-1302; 
Wu, H.E., Sun, H.S., Darpolar, M., Leitermann, R.J., Kampine, J.P., Tseng, L.F., Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord (2003) J Pharmacol Exp Ther, 307 (3), pp. 1135-1141; 
Wu, S.D., Kong, J., Wang, W., Zhang, Q., Jin, J.Z., Effect of morphine and M-cholinoceptor blocking drugs on human sphincter of Oddi during choledochofiberscopy manometry (2003) Hepatobiliary Pancreat Dis Int, 2 (1), pp. 121-125; 
Wunsch, M.J., Stanard, V., Schnoll, S.H., Treatment of pain in pregnancy (2003) Clin J Pain, 19 (3), pp. 148-155; 
Xu, H., Lu, Y.F., Rothman, R.B., Opioid peptide receptor studies: 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor (2003) Synapse, 47 (1), pp. 1-9; 
Xu, N.J., Bao, L., Fan, H.P., Bao, G.B., Pu, L., Lu, Y.J., Morphine withdrawal increases glutamate uptake and surface expression of glutamate transporter GLT1 at hippocampal synapses (2003) J Neurosci, 23 (11), pp. 4775-4784; 
Xu, W., Lundeberg, T., Wang, Y.T., Li, Y., Yu, L.C., Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: Activating opioid receptors through amygdala-periaqueductal gray pathway (2003) Neuroscience, 118 (4), pp. 1015-1022; 
Xu, Y., Gu, Y., Xu, G.Y., Wu, P., Li, G.W., Huang, L.Y., Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: A strategy to increase opioid antinociception (2003) Proc Natl Acad Sci USA, 100 (10), pp. 6204-6209; 
YaDeau, J.T., Morelli, C.M., Billingsley, J.K., Ketamine stimulates secretion of beta-endorphin from a mouse pituitary cell line (2003) Reg Anesth Pain Med, 28 (1), pp. 12-16; 
Yaksh, T.L., Horais, K.A., Tozier, N.A., Allen, J.W., Rathbun, M., Rossi, S.S., Chronically infused intrathecal morphine in dogs (2003) Anesthesiology, 99 (1), pp. 174-187; 
Yamada, H., Ishii, K., Ishii, Y., Ieiri, I., Nishio, S., Morioka, T., Formation of highly analgesic morphine-6-glucuronide following physiologic concentration of morphine in human brain (2003) J Toxicol Sci, 28 (5), pp. 395-401; 
Yamamoto, S., Nakanishi, O., Matsui, T., Shinohara, N., Kinoshita, H., Lambert, C., Intrathecal adenosine A1 receptor agonist attenuates hyperalgesia without inhibiting spinal glutamate release in the rat (2003) Cell Mol Neurobiol, 23 (2), pp. 175-185; 
Yamamoto, S., Yamaguchi, H., Sakaguchi, M., Yamashita, S., Satsumae, T., Preoperative droperidol improved postoperative pain relief in patients undergoing rotator-cuff repair during general anesthesia using intravenous morphine (2003) J Clin Anesth, 15 (7), pp. 525-529; 
Yamamoto, T., Brain mechanisms of sweetness and palatability of sugars (2003) Nutr Rev, 61 (5 PART 2), pp. S5-S9; 
Yamanouchi, K., Yanaga, K., Okudaira, S., Eguchi, S., Furui, J., Kanematsu, T., [d-Ala2, d-Leu5] enkephalin (DADLE) protects liver against ischemia-reperfusion injury in the rat (2003) J Surg Res, 114 (1), pp. 72-77; 
Yang, H.Y., Iadarola, M.J., Activation of spinal neuropeptide FF and the neuropeptide FF receptor 2 during inflammatory hyperalgesia in rats (2003) Neuroscience, 118 (1), pp. 179-187; 
Yang, S.N., Huang, L.T., Wang, C.L., Chen, W.F., Yang, C.H., Lin, S.Z., Prenatal administration of morphine decreases CREBSerine-133 phosphorylation and synaptic plasticity range mediated by glutamatergic transmission in the hippocampal CA1 area of cognitive-deficient rat offspring (2003) Hippocampus, 13 (8), pp. 915-921; 
Yang, W., Law, P.Y., Guo, X., Loh, H.H., In vivo activation of a mutant mu-opioid receptor by antagonist: Future direction for opiate pain treatment paradigm that lacks undesirable side effects (2003) Proc Natl Acad Sci USA, 100 (4), pp. 2117-2121; 
Yang, Z.L., Gao, Y.J., Wu, G.C., Zhang, Y.Q., The rostral ventromedial medulla mediates the facilitatory effect of microinjected orphanin FQ in the periaqueductal gray on spinal nociceptive transmission in rats (2003) Neuropharmacology, 45 (5), pp. 612-622; 
Yeomans, M.R., Caton, S., Hetherington, M.M., Alcohol and food intake (2003) Curr Opin Clin Nutr Metab Care, 6 (6), pp. 639-644; 
Yesilyurt, O., Dogrul, A., Gul, H., Seyrek, M., Kusmez, O., Ozkan, Y., Topical cannabinoid enhances topical morphine antinociception (2003) Pain, 105 (1-2), pp. 303-308; 
Yoburn, B.C., Gomes, B.A., Rajashekara, V., Patel, C., Patel, M., Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo (2003) Synapse, 47 (2), pp. 109-116; 
Yoo, J.H., Yang, E.M., Lee, S.Y., Loh, H.H., Ho, I.K., Jang, C.G., Differential effects of morphine and cocaine on locomotor activity and sensitization in mu-opioid receptor knockout mice (2003) Neurosci Lett, 344 (1), pp. 37-40; 
Zachariou, V., Brunzell, D.H., Hawes, J., Stedman, D.R., Bartfai, T., Steiner, R.A., The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal (2003) Proc Natl Acad Sci USA, 100 (15), pp. 9028-9033; 
Zacny, J.P., Gutierrez, S., Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers (2003) Psychopharmacology (Berl), 170 (3), pp. 242-254; 
Zagon, I.S., Essis Jr., F.M., Verderame, M.F., Healy, D.A., Atnip, R.G., McLaughlin, P.J., Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery (2003) J Vasc Surg, 37 (3), pp. 636-643; 
Zagon, I.S., McLaughlin, P.J., Opioids the apoptotic pathway in human cancer cells (2003) Neuropeptides, 37 (2), pp. 79-88; 
Zahn, P.K., Lansmann, T., Berger, E., Speckmann, E.J., Musshoff, U., Gene expression and functional characterization of melatonin receptors in the spinal cord of the rat: Implications for pain modulation (2003) J Pineal Res, 35 (1), pp. 24-31; 
Zangen, A., Shalev, U., Nucleus accumbens beta-endorphin levels are not elevated by brain stimulation reward but do increase with extinction (2003) Eur J Neurosci, 17 (5), pp. 1067-1072; 
Zarrindast, M.R., Rezayof, A., Sahraei, H., Haeri-Rohani, A., Rassouli, Y., Involvement of dopamine D1 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat (2003) Brain Res, 965 (1-2), pp. 212-221; 
Zarrindast, M.R., Faraji, N., Rostami, P., Sahraei, H., Ghoshouni, H., Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice (2003) Pharmacol Biochem Behav, 74 (2), pp. 363-369; 
Zarrindast, M.R., Gholami, A., Sahraei, H., Haeri-Rohani, A., Role of nitric oxide in the acquisition and expression of apomorphine- or morphine-induced locomotor sensitization (2003) Eur J Pharmacol, 482 (1-3), pp. 205-213; 
Zarrindast, M.R., Torkaman-Boutorabi, A., Effects of imipramine on the expression and development of morphine dependence in mice (2003) Eur J Pharmacol, 473 (1), pp. 19-25; 
Zarrindast, M.R., Assadi, E., Oryan, S., Torkaman-Boutorabi, A., Sahebgharani, M., Influence of histamine, cimetidine and pyrilamine on naloxone-induced jumping in morphine-dependent mice (2003) Eur J Pharmacol, 471 (2), pp. 105-112; 
Zawertailo, L.A., Busto, U.E., Kaplan, H.L., Greenblatt, D.J., Sellers, E.M., Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital (2003) J Clin Psychopharmacol, 23 (3), pp. 269-280; 
Zeilhofer, H.U., Calo, G., Nociceptin/orphanin FQ and its receptor - Potential targets for pain therapy? (2003) J Pharmacol Exp Ther, 306 (2), pp. 423-429; 
Zeng, Z., McDonald, T.P., Wang, R., Liu, Q., Austin, C.P., Neuropeptide FF receptor 2 (NPFF2) is localized to pain-processing regions in the primate spinal cord and the lower level of the medulla oblongata (2003) J Chem Neuroanat, 25 (4), pp. 269-278; 
Zhang, M., Balmadrid, C., Kelley, A.E., Nucleus accumbens opioid, GABaergic, and dopaminergic modulation of palatable food motivation: Contrasting effects revealed by a progressive ratio study in the rat (2003) Behav Neurosci, 117 (2), pp. 202-211; 
Zhang, Q., Li, J.X., Zheng, J.W., Liu, R.K., Liang, J.H., L-type Ca(2+) channel blockers inhibit the development but not the expression of sensitization to morphine in mice (2003) Eur J Pharmacol, 467 (1-3), pp. 145-150; 
Zhang, R.X., Lao, L., Qiao, J.T., Ruda, M.A., Strain differences in pain sensitivity and expression of preprodynorphin mRNA in rats following peripheral inflammation (2003) Neurosci Lett, 353 (3), pp. 213-216; 
Zheng, X., Ke, X., Tan, B., Luo, X., Xu, W., Yang, X., Susceptibility to morphine place conditioning: Relationship with stress-induced locomotion and novelty-seeking behavior in juvenile and adult rats (2003) Pharmacol Biochem Behav, 75 (4), pp. 929-935; 
Zhou, Q., Frandberg, P.A., Kindlundh, A.M., Le, G.P., Nyberg, F., Substance P(1-7) affects the expression of dopamine D2 receptor mRNA in male rat brain during morphine withdrawal (2003) Peptides, 24 (1), pp. 147-153; 
Zhou, X., Li, J.J., Yu, L.C., Plastic changes of calcitonin gene-related peptide in morphine tolerance: Behavioral and immunohistochemical study in rats (2003) J Neurosci Res, 74 (4), pp. 622-629; 
Zhou, Y., Spangler, R., Schlussman, S.D., Ho, A., Kreek, M.J., Alterations in hypothalamic-pituitary-adrenal axis activity and in levels of proopiomelanocortin and corticotropin-releasing hormone-receptor 1 mRNAs in the pituitary and hypothalamus of the rat during chronic 'binge' cocaine and withdrawal (2003) Brain Res, 964 (2), pp. 187-199; 
Zhu, H., Zhou, W., Morphine-induced potentiation in the dentate gyrus of the hippocampus involves norepinephrine (2003) Eur J Pharmacol, 467 (1-3), pp. 141-144; 
Zhu, H., Barr, G.A., Ontogeny of NMDA receptor-mediated morphine tolerance in the postnatal rat (2003) Pain, 104 (3), pp. 437-447; 
Zhu, H., Brodsky, M., Gorman, A.L., Inturrisi, C.E., Region-specific changes in NMDA receptor mRNA induced by chronic morphine treatment are prevented by the co-administration of the competitive NMDA receptor antagonist LY274,614 (2003) Brain Res Mol Brain Res, 114 (2), pp. 154-162; 
Zhu, H., Jenab, S., Jones, K.L., Inturrisi, C.E., The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the neonatal rat (2003) Brain Res Dev Brain Res, 142 (2), pp. 209-213; 
Zocchi, A., Girlanda, E., Varnier, G., Sartori, I., Zanetti, L., Wildish, G.A., Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse (2003) Synapse, 50 (4), pp. 293-302; 
Zollner, C., Shaqura, M.A., Bopaiah, C.P., Mousa, S., Stein, C., Schafer, M., Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons (2003) Mol Pharmacol, 64 (2), pp. 202-210
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-9744223599&doi=10.1016%2fj.peptides.2004.09.005&partnerID=40&md5=68605252060885bb36c7dafae4b7fa17
ER  - 

TY  - JOUR
TI  - Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons
T2  - Pharmacological Reviews
J2  - Pharmacol. Rev.
VL  - 55
IS  - 3
SP  - 509
EP  - 550
PY  - 2003
DO  - 10.1124/pr.55.3.2
SN  - 00316997 (ISSN) 
AU  - Agnati, L.F.
AU  - Ferré, S.
AU  - Lluis, C.
AU  - Franco, R.
AU  - Fuxe, K.
AD  - Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden
AB  - The molecular basis for the known intramembrane receptor/receptor interactions among G protein-coupled receptors was postulated to be heteromerization based on receptor subtype-specific interactions between different types of receptor homomers. The discovery of GABAB heterodimers started this field rapidly followed by the discovery of heteromerization among isoreceptors of several G protein-coupled receptors such as δ/κ opioid receptors. Heteromerization was also discovered among distinct types of G protein-coupled receptors with the initial demonstration of somatostatin SSTR5/dopamine D2 and adenosine A 1/dopamine D1 heteromeric receptor complexes. The functional meaning of these heteromeric complexes is to achieve direct or indirect (via adapter proteins) intramembrane receptor/receptor interactions in the complex. G protein-coupled receptors also form heteromeric complexes involving direct interactions with ion channel receptors, the best example being the GABAA/dopamine D5 receptor heteromerization, as well as with receptor tyrosine kinases and with receptor activity modulating proteins. As an example, adenosine, dopamine, and glutamate metabotropic receptor/receptor interactions in the striatopallidal GABA neurons are discussed as well as their relevance for Parkinson's disease, schizophrenia, and drug dependence. The heterodimer is only one type of heteromeric complex, and the evidence is equally compatible with the existence of higher order heteromeric complexes, where also adapter proteins such as homer proteins and scaffolding proteins can exist. These complexes may assist in the process of linking G protein-coupled receptors and ion channel receptors together in a receptor mosaic that may have special integrative value and may constitute the molecular basis for some forms of learning and memory.
KW  - 4 aminobutyric acid
KW  - 4 aminobutyric acid A receptor
KW  - 4 aminobutyric acid B receptor
KW  - 4 aminobutyric acid receptor
KW  - adenosine A1 receptor
KW  - adenosine A2a receptor
KW  - angiotensin receptor
KW  - bradykinin B2 receptor
KW  - calcitonin receptor
KW  - delta opiate receptor
KW  - dopamine 2 receptor
KW  - dopamine 3 receptor
KW  - dopamine 5 receptor
KW  - G protein coupled receptor
KW  - heptahelical receptor
KW  - ion channel
KW  - kappa opiate receptor
KW  - membrane protein
KW  - membrane receptor
KW  - metabotropic receptor
KW  - mu opiate receptor
KW  - oligomer
KW  - protein tyrosine kinase
KW  - receptor activity modifying protein
KW  - serotonin 1B receptor
KW  - serotonin 1D receptor
KW  - somatostatin 1 receptor
KW  - somatostatin receptor
KW  - unclassified drug
KW  - unindexed drug
KW  - cell communication
KW  - central nervous system
KW  - corpus striatum
KW  - drug dependence
KW  - globus pallidus
KW  - learning
KW  - memory
KW  - molecular mechanics
KW  - nigroneostriatal system
KW  - oligomerization
KW  - Parkinson disease
KW  - priority journal
KW  - protein conformation
KW  - protein interaction
KW  - protein protein interaction
KW  - protein structure
KW  - review
KW  - schizophrenia
KW  - striatopallidal neuron
KW  - Animals
KW  - Brain
KW  - Cell Membrane
KW  - Dimerization
KW  - Drug Design
KW  - Heterotrimeric GTP-Binding Proteins
KW  - Humans
KW  - Neurons
KW  - Neurotransmitter Agents
KW  - Parkinson Disease
KW  - Receptor Protein-Tyrosine Kinases
KW  - Receptors, G-Protein-Coupled
KW  - Receptors, GABA
KW  - Schizophrenia
KW  - Signal Transduction
KW  - Substance-Related Disorders
N1  - Cited By :283
N1  - Export Date: 13 November 2019
M3  - Review
DB  - Scopus
N1  - CODEN: PAREA
C2  - 12869660
LA  - English
N1  - Correspondence Address: Fuxe, K.; Department of Neuroscience, Karolinska Institutet, 171 77 Stockholm, Sweden; email: Kjell.Fuxe@neuro.ki.se
N1  - Chemicals/CAS: 4 aminobutyric acid, 28805-76-7, 56-12-2; protein tyrosine kinase, 80449-02-1; Heterotrimeric GTP-Binding Proteins, EC 3.6.1.46; Neurotransmitter Agents; Receptor Protein-Tyrosine Kinases, EC 2.7.1.112; Receptors, G-Protein-Coupled; Receptors, GABA
N1  - References: AbdAlla, S., Lother, H., El Massiery, A., Quitterer, U., Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness (2001) Nat Med, 7, pp. 1003-1009; 
AbdAlla, S., Lother, H., Quietterer, U., AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration (2000) Nature (Lond), 407, pp. 94-98; 
Abel, T., Kandel, E., Positive and negative regulatory mechanims that mediate long-term memory storage (1998) Brain Res Rev, 26, pp. 360-378; 
Adams, M.R., Brandon, E.P., Chartoff, E.H., Idzerda, R.L., Dorsa, D.M., McKnight, G.S., Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice (1997) Proc Natl Acad Sci USA, 94, pp. 12157-12161; 
Agnati, L., Fuxe, K., Benfenati, F., Mutt, V., Hökfelt, T., Differential modulation by CCK-8 and CCK-4 of [3H]spiperone binding sites linked to dopamine and 5-HT receptors in the brain of the rat (1983) Neurosci Lett, 35, pp. 179-183; 
Agnati, L.F., Benfenati, F., Ferri, M., Morpurgo, A., Apolloni, B., Fuxe, K., Molecular basis of learning and memory: Modeling based on receptor mosaics (2002) From Synapses to Rules: Discovering Symbolic Rules From Neural Processed Data, pp. 165-195. , (Apolloni B and Kurfess F eds), Kluwer Academic/Plenum Press Publisher, New York; 
Agnati, L.F., Benfenati, F., Solfrini, V., Biagini, G., Fuxe, K., Guidolin, D., Carani, C., Zini, I., Intramembrane receptor/receptor interactions: Integration of signal transduction pathways in the nervous system (1993) Neurochem Int, 22, pp. 213-222; 
Agnati, L.F., Celani, M.F., Fuxe, K., Cholecystokinin peptides in vitro modulate the characteristics of striatal [3H] N-propylnorapomorphine binding sites (1983) Acta Physiol Scand, 118, pp. 79-81; 
Agnati, L.F., Franzén, O., Ferré, S., Franco, R., Fuxe, K., Possible role of intramembrane receptor/receptor interactions in memor and learning via formation of long-lived heteromeric complexes: Focus on motor learning in basal ganglia (2003) J Neural Transm, 65, pp. 195-222; 
Agnati, L.F., Fuxe, K., Volume transmission as a key feature of information handling in the central nervous system. Possible new interpretative value of the Turing's B-type machine (2000) Prog Brain Res, 125, pp. 3-19; 
Agnati, L.F., Fuxe, K., Benfenati, F., Battistini, N., Neurotensin in vitro markedly reduces the affinity in subcortical limbic [3H] N-propylnorapomorphine binding sites (1983) Acta Physiol Scand, 119, pp. 459-461; 
Agnati, L.F., Fuxe, K., Benfenati, F., Battistini, N., Härfstrand, A., Tatemoto, K., Hökfelt, T., Mutt, V., Neuropeptide Y in vitro selectively increases the number of a 2-adrenergic binding sites in membranes of the medulla obolngata of the rat (1983) Acta Physiol Scand, 118, pp. 293-295; 
Agnati, L.F., Fuxe, K., Benfenati, F., Battistini, N., Zini, I., Camurri, M., Hökfelt, T., Postsynaptic effects of neuropeptide comodulators at central monoamine synapses (1984) Neurology and Neurobiology, pp. 191-198. , (Usdin E, Carlsson A, Dahlström A, and Engel J eds), Alan R. Liss, New York; 
Agnati, L.F., Fuxe, K., Benfenati, F., Zini, I., Hökfelt, T., On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of [3H] 5-HT binding sites (1983) Acta Physiol Scand, 117, pp. 299-301; 
Agnati, L.F., Fuxe, K., Giardiano, L., Calza, L., Zoli, M., Battistini, N., Benfenati, F., Ruggeri, M., Evidence for cholecystokinin-dopamine receptor interactions in the central nervous system of the adult and old rat (1985) Ann NY Acad Sci, 448, pp. 315-333; 
Agnati, L.F., Fuxe, K., Merlo-Pich, E., Zoli, M., Zini, I., Benfenati, F., Härfstrand, A., Goldstein, M., Aspects on the integrative capabilities of the central nervous system: Evidence for "volume transmission" and its possible relevance for receptor/receptor interactions (1987) Receptor/Receptor Interactions, pp. 236-249. , (Fuxe, K and Agnati LF eds), Macmillan, London; 
Agnati, L.F., Fuxe, K., Zini, I., Lenzi, P., Hökfelt, T., Aspects on receptor regulation and isoreceptor identification (1980) Med Biol (Helsinki), 58, pp. 182-187; 
Agnati, L.F., Fuxe, K., Zoli, M., Merlo Pich, E., Benfenati, F., Zini, I., Goldstein, M., Aspects on the information handling by the central nervous system: Focus on cotransmission in the aged rat brain (1986) Prog Brain Res, 68, pp. 291-301; 
Agnati, L.F., Fuxe, K., Zoli, M., Rondanini, C., Ogren, S.O., New vistas on synaptic pasticity: Mosaic hypothesis on the engram (1982) Med Biol, 60, pp. 183-190; 
Agnati, L.F., Zoli, M., Merlo Pich, E., Benfenati, F., Fuxe, K., Aspects of neural plasticity in the central nervous system. VII. Theoretical aspects of brain communication and computation (1990) Neurochem Int, 16, pp. 479-500; 
Agnati, L.F., Zoli, M., Merlo-Pich, E., Ruggeri, M., Fuxe, K., The emerging complexity of the brain. Limits of brain-computr analogy (1988) Traffic Engineering for ISDN Design and Planning, pp. 209-230. , (Bonatti M and Decina M eds), Elsevier Science B.V., Amsterdam; 
Aguirre, J.A., Fuxe, K., Hedlund, P., Narváez, J.A., Cintra, A., Rosén, L., Agnati, L.F., Neuropeptide Y/angiotensin II interactions in central cardiovascular regulation of the rat (1991) Brain Res, 566, pp. 61-69; 
Alexander, G.E., Crutcher, M.D., Functional architecture of basal ganglia circuits: Neural substrates of parallel processing (1990) Trends Neurosci, 13, pp. 266-327; 
Alger, B.E., Nicoll, R.A., GABA mediated biphasic inhibitory responses in hippocampus (1979) Nature (Lond), 281, pp. 315-317; 
Angers, S., Salahpour, A., Joly, E., Hilaret, S., Chelsky, D., Dennis, M., Bouvier, M., Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET) (2000) Proc Natl Acad Sci USA, 97, pp. 3684-3689; 
Aoyama, S., Kase, H., Borrelli, E., Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist (2000) J Neurosci, 20, pp. 5848-5852; 
Avissar, S., Amitai, G., Sokolovsky, M., Oligomeric structure of muscarinic receptors is shown by photoaffinity labeling: Subunit assembly may explain high- and low-affinity agonist states (1983) Proc Natl Acad Sci USA, 80, pp. 156-159; 
Banks, R.E., Dunn, M.J., Hochstrasser, D.F., Sanchez, J.C., Blackstock, W., Pappin, D.J., Selby, P.J., Proteomics: New perspectives, new biomedical opportunities (2000) Lancet, 356, pp. 1749-1756; 
Barraco, R.A., Martens, K.A., Parizon, M., Normile, H.J., Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression (1993) Brain Res Bull, 31, pp. 397-404; 
Bergson, C., Mazljak, L., Sniley, J.F., Pappy, M., Levenson, R., Goldman-Rakic, P.S., Regional cellular and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain (1995) J Neurosci, 15, pp. 7821-7836; 
Berke, J.D., Hyman, S.E., Addiction, dopamine and the molecular mechanisms of memory (2000) Neuron, 25, pp. 515-532; 
Bettler, B., Kaupmann, K., Bowery, N.G., GABAB receptors: Drugs meet clones (1998) Curr Opin Neurobiol, 8, pp. 345-350; 
Bockaert, J., Pin, J.P., Molecular tinkering of G protein-coupled receptors: An evolutionary success (1999) EMBO (Eur Mol Biol Organ) J, 18, pp. 1723-1729; 
Boegman, R.J., Vincent, S.R., 5 Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol (1996) Synapse, 22, pp. 70-77; 
Bohen, S.P., Kralli, A., Yamamoto, K.R., Hold'em and fold'em: Chaperones and signal transduction (1995) Science (Wash DC), 268, pp. 1303-1304; 
Bond, R.A., Bouvier, M., (1998) Receptor-Based Drug Design, pp. 363-377. , (Leff P ed), Marcel Dekker, Inc., New York; 
Borsook, D., Hyman, S.E., Proenkephalin gene regulation in the neuroendocrine hypothalamus: A model of gene regulation in the CNS (1995) Am J Physiol, 269, pp. E393-E408; 
Bouvier, M., Oligomerization of G-protein-coupled transmitter receptors (2001) Nat Neurosci, 2, pp. 274-286; 
Breysse, N., Baunez, C., Spooren, W., Gasparini, F., Amalric, M., Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits n a rat model of Parkinsonism (2002) J Neurosci, 22, pp. 5669-5678; 
Caplan, A.J., Langley, E., Wilson, E.M., Vidal, J., Hormone-dependent trans-activation by the human androgen receptor is regulated by a dnaJ protein (1995) J Biol Chem, 270, pp. 5251-5257; 
Carlezon W.A., Jr., Wise, R.A., Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex (1996) J Neurosci, 16, pp. 3112-3122; 
Carlsson, M., Carlsson, A., Interactions between glutamatergic and monoaminergic systems within the basal ganglia. Implications for schizophrenia and Parkinson's disease (1990) Trends Neurosci, 13, pp. 272-276; 
Cartmell, J., Goepfert, F., Knoflach, F., Pink, J.R., Bleuel, Z., Richards, J.G., Schaffhauser, H., Mutel, V., Effect of metabotropic glutamate receptor activation on receptor-mediated cyclic AMP responses in primary cultures of rat striatal neurones (1998) Brain Res, 791, pp. 191-199; 
Casadó, V., Cantí, C., Mallol, J., Canela, E.I., Lluis, C., Franco, R., Solubilization of A1 adenosine receptor from pig brain. Characterization and evidence of the role of the cell membrane on the coexistence of the high and low-affinity states (1990) J Neurosci Res, 26, pp. 461-473; 
Casadó, V., Mallol, J., Lluís, C., Franco, R., Canela, E.I., Adenosine receptors in myelin fractions and subfractions: The effect of the agonist (R)-phenylisopropyladenosine on myelin membrane microviscosity (1991) J Neurochem, 57, pp. 1623-1629; 
Casas, M., Ferre, S., Guix, T., Jane, F., Theophylline reverses haloperidol-induced catalepsy in the rat. Possible relevance to the pharmacological treatment of psychosis (1988) Biol Psychiatry, 24, pp. 642-648; 
Changeux, J., Edelstein, S.J., Allosteric mechanisms in normal and pathological nicotinic acetylcholine receptors (2001) Curr Opin Neurobiol, 11, pp. 369-377; 
Changeux, J.-P., Thiéry, J.-P., Tung, T., Kittel, C., On the cooperativity of biological membranes (1967) PNAS, 57, pp. 335-341; 
Chase, T.N., Oh, J.D., Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism (2000) Trends Neurosci, 23, pp. S86-S91; 
Chen, J.F., Beilstein, M., Xu, Y.H., Turner, T.J., Moratalla, R., Standaert, D.G., Aloyo, V.J., Schwarzschild, M.A., Selective attenuation of psychostimulant-induced behavioral responses in mice lacking A(2A) adenosine receptors (2000) Neuroscience, 97, pp. 195-204; 
Chen, J.F., Moratalla, R., Impagnatiello, F., Grandy, D.K., Cuellar, B., Rubinstein, M., Beilstein, M.A., Low, M.J., The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice (2001) Proc Natl Acad Sci USA, 98, pp. 1970-1975; 
Chen, W.J., Armour, S., Way, J., Chen, G., Watson, C., Irveng, P., Cobb, J., Rimele, T., Expression cloning and receptor pharmacology of human calcitonin receptors from MCF-7 cells and their relationship to amylin receptors (1997) Mol Pharmacol, 52, pp. 1164-1175; 
Chiacchio, S., Scarselli, M., Armogida, M., Maggio, R., Pharmacological evidence of muscarinic receptor heterodimerization (2000) Pharm Acta Helv, 74, pp. 315-326; 
Chneiweiss, J., Glowinski, J., Premont, J., Modulation by monoamines of somatostatin-sensitive adenylate cyclase on neuronal and glial cells from the mouse brain in primary cultures (1985) Neurochemistry, 44, p. 1825; 
Cho, K., Bashir, Z., Cooperation between mglu receptors: A depressing mechanism? (2002) Trends Neurosci, 25, pp. 405-411; 
Choe, E.S., Wang, J.Q., Group I metabotropic glutamate receptors control phosphorylation of CREB, Elk-1 and ERK via a CaMKII-dependent pathway in rat striatum (2001) Neurosci Lett, 313, pp. 129-132; 
Christopoulos, G., Perry, K.J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N.J., Main, M.J., Sexton, P.M., Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product (1999) Mol Pharmacol, 56, pp. 235-242; 
Ciruela, F., Casadó, V., Mallol, J., Canela, E.I., Lluis, C., Franco, R., Immunological identification of A1 adenosine receptors in brain cortex (1995) J Neurosci Res, 42, pp. 818-828; 
Ciruela, F., Escriche, M., Burgueno, J., Angulo, E., Casado, V., Soloviev, M.M., Canela, E.I., Lluis, C., Metabotropic glutamate 1alpha and adenosine A1 receptors assemble into functionally interacting complexes (2001) J Biol Chem, 276, pp. 18345-18351; 
Ciruela, F., Escriche, M., Soloviev, M.M., Canela, E.I., Burgeño, J., Mallol, J., Chan, W.Y., Franco, R., Adenosine-glutamate receptor/receptor interactions in the central nervous system (2001) Drug Dev Res, 52, pp. 316-322; 
Ciruela, F., Saura, C., Canela, El., Mallol, J., Lluis, C., Franco, R., Adenosine deaminase affects ligand-induced signalling by interacting with cell surface adenosine receptors (1996) FEBS Lett, 380, pp. 219-223; 
Ciruela, F., Soloviev, M.M., Chan, W.Y., McChinney, R.A., Homer-1c/Ves1-1L modulates the cell surface targeting of metabotropic glutamate receptor type 1α: Evidence for an anchoring function (2000) Mol Cell Neurosci, 15, pp. 36-50; 
Cochran, A., Antagonists of protein-protein interactions (2000) Chem Biol, 7, pp. R85-R94; 
Cochran, A., Protein-protein interfaces: Mimics and inhibitors (2001) Curr Opin Chem Biol, 5, pp. 654-659; 
Cohn, M.L., Cohn, M., "Barrel rotation" induced by somatostatin in the nonlesioned rat (1975) Brain Res, 96, p. 138; 
Conn, P.M., Rogers, D.C., Stewart, J.M., Niedel, J., Sheffield, T., Conversion of a gonadotrohin-releasing hormone antagonist to an agonist (1982) Nature (Lond), 296, pp. 653-655; 
Cordeaux, Y., Briddon, S.J., Megson, A.E., McDonnell, J., Dickenson, J.M., Hill, S.J., Influence of receptor number on functional responses elicited by agonists acting at the human adenosine A1 receptor: Evidence for signaling pathway-dependent changes in agonist potency and relative intrinsic activity (2000) Mol Pharmacol, 58, pp. 1057-1084; 
D'Alcantara, P., Ledent, C., Swillens, S., Schiffmann, S.N., Inactivation of adenosine A(2A) receptor impairs long term potentiation in the accumbens nucleus without altering basal (2001) Neuroscience, 107, pp. 455-464; 
Dale, L.B., Babwah, A.V., Ferguson, S.S.G., Mechanisms of metabotropic glutamate receptor desensitization: Role in the patterning of effector enzyme activation (2002) Neurochem Int, 41, pp. 319-326; 
Dasgupta, S., Ferré, S., Kull, B., Hedlund, P.B., Finnman, U.-B., Ahlberg, S., Arenas, E., Fuxe, K., Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells (1996) Eur J Pharmacol, 316, pp. 325-331; 
Dasgupta, S., Li, X.-M., Jansson, A., Finnman, U.-B., Matsui, T., Rinken, A., Arenas, E., Fuxe, K., Regulation of dopamine D2 receptor affinity by cholecystokinin octapeptide in fibroblast cells cotransfected with human CCKB and D2L receptor cDNAs (1996) Mol Brain Res, 36, pp. 292-299; 
Dassesse, D., Massie, A., Ferrari, R., Ledent, C., Parmentier, M., Arckens, L., Zoli, M., Schiffmann, S.N., Functional striatal hypodopaminergic activity in mice lacking adenosine A(2A) receptors (2001) J Neurochem, 78, pp. 183-198; 
Delle Donne, K.T., Sesack, S.R., Pickel, V.M., Ultrastructural immunocyto-chemical localization of the dopamine D2 receptor within GABAergic neurons of the rat striatum (1997) Brain Res, 746, pp. 239-255; 
Deutch, A.Y., Lee, M.C., Iadarola, M.J., Regional specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action (1992) Mol Cell Neurosci, 3, pp. 322-341; 
Diaz-Cabiale, Z., Fuxe, K., Narváez, J.A., Finetti, S., Antonelli, T., Tanganelli, S., Ferraro, L., Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum. Counteraction by a NTR1-like receptor antagonist (2002) Neuroreport, 13, pp. 763-766; 
Díaz-Cabiale, Z., Hurd, Y., Guidolin, D., Finnman, U.B., Zoli, M., Agnati, L.F., Vanderhaeghen, J.J., Ferré, S., Adenosine A2A agonist CGS 21680 decreases the affinity of dopamine D2 receptors for dopamine in human striatum (2001) Neuroreport, 12, pp. 1831-1834; 
Diaz-Cabiale, Z., Narváez, J.A., Finnman, U.-B., Bellido, I., Ogren, S.O., Fuxe, K., Galanin(1-16) modulates 5-HT1A receptors in the ventral limbic cortex of the rat (2000) Neuroreport, 11, pp. 515-519; 
Diaz-Cabiale, Z., Narváez, J.A., Garrido, R., Petersson, M., Uvnäs-Moberg, K., Fuxe, K., Antagonistic ocytocin/a2-adrenoreceptor interactions in the nucleus tractus solitarii: Relevance for central cardiovascular contol (2000) J Neuroendocrinol, 12, pp. 1167-1173; 
Diaz-Cabiale, Z., Narváez, J.A., Petersson, M., Uvnäs-Moberg, K., Fuxe, K., Oxytocin/alpha2-adrenoceptor interactions in feeding responses (2000) Neuroendocrinology, 71, pp. 209-218; 
Diaz-Cabiale, Z., Narváez, J.A., Yanaihara, N., González-Barón, S., Fuxe, K., Galanin/alpha2-receptor interactions in central cardiovascular control (2000) Neuropharmacology, 39, pp. 1377-1385; 
Diaz-Cabiale, Z., Petersson, M., Narváez, J.A., Uvnäs-Moberg, K., Fuxe, K., Systemic oxytocin treatment modulates a2-adrenoreceptors in telencephalic and diencephalic regions of the rat (2000) Brain Res, 887, pp. 421-425; 
Díaz-Cabiale, Z., Vivo, M., Del Arco, A., O'Connor, W.T., Harte, M.K., Müller, C.E., Martínez, E., Ferré, S., Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway. Interactions with adenosine A2A and dopamine D2 receptors (2002) Neurosci Lett, 324, pp. 154-158; 
Dixon, A.K., Widdowson, L., Richardson, P.J., Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum (1997) J Neurochem, 69, pp. 315-321; 
Domingues, H., Cregut, D., Sebald, W., Oschkiat, H., Serrano, L., Rational design of a GCN4-derived mimetic of interleukin-4 (1999) Nat Struct Biol, 6, pp. 652-656; 
Duke, T.A., Bray, D., Heightened sensitivity of a lattice of membrane receptors (1999) Proc Natl Acad Sci USA, 96, pp. 10104-10108; 
Edwards, A.S., Scott, J.D., A-kinase anchoring proteins: Protein kinase A and beyond (2000) Curr Opin Cell Biol, 12, pp. 217-221; 
Egan, S.E., Weinberg, R.A., The pathway to signal achievement (1993) Nature (Lond), 365, pp. 781-783; 
Evers, B.M., Wang, X., Zhou, Z., Townsend C.M., Jr., McNeil, G.P., Dobner, P.R., Characterization of promoter elements required for cell-specific expression of the neurotensin/neuromedin N gene in a human endocrine cell line (1995) Mol Cell Biol, 15, pp. 3870-3881; 
Fenu, S., Cauli, O., Morelli, M., Cross-sensitization between the motor activating effects of bromocriptine and caffeine: Role of adenosine A2A receptors (2000) Behav Brain Res, 114, pp. 97-105; 
Fenu, S., Morelli, M., Motor stimulant effects of caffeine in 6-hydroxydopamine-lesioned rats are dependent on previous stimulation of dopamine receptors: A different role of D1 and D2 receptors (1998) Eur J Neurosci, 10, pp. 1878-1884; 
Fenu, S., Pinna, A., Ongini, E., Morelli, M., Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats (1997) Eur J Pharmacol, 321, pp. 143-147; 
Ferraguti, F., Baldani-Guerra, B., Corsi, M., Nakanishi, S., Corti, C., Activation of the extracellular signal-regulated kinase 2 by metabotropic glutamate receptors (1999) Eur J Neurosci, 11, pp. 2073-2082; 
Ferraro, L., O'Connor, W.T., Antonelli, T., Fuxe, K., Tanganelli, S., Differential effects of intrastriatal neurotensin(1-13) and neurotensin(8-13) on striatal dopamine and pallidal GABA release. A dual-probe microdialysis study in the awake rat (1997) Eur J Neurosci, 9, pp. 1838-1846; 
Ferré, S., Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia (1997) Psychopharmacology, 133, pp. 107-120; 
Ferré, S., Fredholm, B.B., Morelli, M., Popoli, P., Fuxe, K., Adenosine-dopamine receptor/receptor interactions as an integrative mechanism in the basal ganglia (1997) Trends Neurosci, 20, pp. 482-487; 
Ferré, S., Fuxe, K., Dopamine denervation leads to an increase in the membrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum (1992) Brain Res, 594, pp. 124-130; 
Ferré, S., Fuxe, K., Adenosine as a volume transmission signal. A feedback detector of neuronal activation (2000) Progress in Brain Research, 125, pp. 353-361. , (Agnati LF, Fuxe K, Nicholson C, and Syková E eds), Elsevier Science B.V., Amsterdam; 
Ferré, S., Fuxe, K., Von Euler, G., Johansson, B., Fredholm, B.B., Adenosine-dopamine interactions in the brain (1992) Neuroscience, 51, pp. 501-512; 
Ferré, S., Herrera-Marschitz, M., Grabowska-Andén, M., Ungerstedt, U., Casas, M., Andén, N.-E., Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit a D-2 mediated behaviour in short-term reserpinized mice (1991) Eur J Pharmacol, 192, pp. 25-30; 
Ferré, S., Herrera-Marschitz, M., Grabowska-Andén, M., Ungerstedt, U., Casas, M., Andén, N.-E., Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice (1991) Eur J Pharmacol, 192, pp. 31-37; 
Ferré, S., Karcz-Kubícha, M., Hope, B.T., Popoli, P., Burgueno, J., Gutierrez, M.A., Casado, V., Lluis, C., Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: Implications for striatal neuronal function (2002) Proc Natl Acad Sci USA, 99, pp. 11940-11945; 
Ferré, S., O'Connor, W.T., Fuxe, K., Ungerstedt, U., The striopallidal neuron: A main locus for adenosine-dopamine interactions in the brain (1993) J Neurosci, 13, pp. 5402-5406; 
Ferré, S., O'Connor, W.T., Snaprud, P., Ungerstedt, U., Fuxe, K., Antagonistic interaction between adenosine A2A and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia (1994) Neuroscience, 63, pp. 765-773; 
Ferré, S., O'Connor, W.T., Svennungsson, P., Björklund, L., Lindberg, J., Tinner, B., Strömberg, I., Ungerstedt, U., Dopamine D1 receptor-mediated facilitation of GABAergic neurotransmission in the rat strioentopeduncular pathway and its modulation by adenosine A1 receptor-mediated mechanisms (1996) Eur J Neurosci, 8, pp. 1545-1553; 
Ferré, S., Popoli, P., Giménez-Llort, L., Finnman, U.-B., Martinez, E., Scotti de Carolis, A., Fuxe, K., Postsynaptic antagonistic interaction between adenosine A1 and dopamine D1 receptors (1994) Neuroreport, 6, pp. 73-76; 
Ferré, S., Popoli, P., Giménez-Llort, L., Rimondini, R., Müller, C.E., Strömberg, I., Ögren, S.O., Fuxe, K., Adenosine/dopamine interaction: Implications for the treatment of Parkinson's disease (2001) Parkinsonism Relat Disord, 7, pp. 235-241; 
Ferré, S., Popoli, P., Rimondini, R., Reggio, R., Kehr, J., Fuxe, K., Adenosine A2A and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum (1999) Neuropharmacology, 39, pp. 129-140; 
Ferré, S., Popoli, P., Tinner-Staines, B., Fuxe, K., Adenosine A1 receptor-dopamine D1 receptor interaction in the rat limbic system: Modulation of dopamine D1 receptor antagonist binding sites (1996) Neurosci Lett, 208, pp. 109-112; 
Ferré, S., Rimondini, R., Popoli, P., Reggio, R., Pezzola, A., Hansson, A.C., Andersson, A., Fuxe, K., Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviour (1999) Eur J Neurosci, 11, pp. 3884-3892; 
Ferré, S., Rubio, A., Fuxe, K., Stimulation of adenosine A2 receptors induces catalepsy (1991) Neurosci Lett, 130, pp. 162-164; 
Ferré, S., Snaprud, P., Fuxe, K., Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal memmbranes (1993) Eur J Pharmacol Mol Pharmacol Sec, 244, pp. 311-315; 
Ferré, S., Torvinen, M., Antoniou, K., Irenius, E., Civelli, O., Arenas, E., Fredholm, B.B., Fuxe, K., Adenosine A1 receptor-mediated modulation of dopamine D1 receptors in stably cotransfected fibroblast cells (1998) J Biol Chem, 273, pp. 4718-4724; 
Ferré, S., Von Euler, G., Johansson, B., Fredholm, B.B., Fuxe, K., Stimulation of high-affinity adenosine A-2 receptors decreases the affinity of dopamine D-2 receptors in rat striatal membranes (1991) Proc Natl Acad Sci USA, 88, pp. 7238-7241; 
Fink, J.S., Weaver, D.R., Rivkees, S.A., Peterfreund, R.A., Pollack, A., Adler, E.M., Reppert, S.M., Molecular cloning of the rat A2 adenosine receptor: Selective coexpression with D2 dopamine receptors in rat striatum (1992) Brain Res Mol Brain Res, 14, pp. 186-195; 
Fior, D., Fuxe, K., Bradykinin modulation of α2-adrenoceptors in the nucleus tractus solitarius of the rat. An in vitro autoradiographical study (1995) Neuropharmacology, 34, pp. 81-88; 
Fior, D., Yang, S.-N., Hedlund, P., Narvaez, J.A., Agnati, L.F., Fuxe, K., α2-adrenoreceptor/angiotensin II receptor interactions in the nucleus tractus solitarius lead to an enhancement of angiotensin II receptor transduction (1994) Pharm Pharmacol Lett, 3, pp. 237-240; 
Fior, D.R., Hedlund, P.B., Fuxe, K., Autoradiographic evidence for a bradykinin/angiotensin II receptor/receptor interaction in the rat brain (1993) Neurosci Lett, 163, pp. 58-62; 
Franco, R., Casadó, V., Ciruela, F., Mallo, J., Lluís, C., Canela, E.I., The cluster-arranged cooperative model: A model that accounts for the kinetics of binding to A1 adenosine receptors (1996) Biochemistry, 35, pp. 3007-3015; 
Franco, R., Casadó, V., Ciruela, F., Saura, C., Mallol, J., Canela, E.I., Lluis, C., Cell surface adenosine deaminase: Much more than an ectoenzyme (1997) Prog Neurobiol (Oxf), 52, pp. 283-294; 
Franco, R., Ferré, S., Agnati, L., Torvinen, M., Gines, S., Hillion, J., Casado, V., Lluis, C., Evidence for adenosine/dopamine receptor interactions: Indications for heteromerization (2000) Neuropsychopharmacology, 25, pp. S50-S59; 
Franco, R., Ferré, S., Torvinen, M., Ginés, S., Hillion, J., Ciruela, F., Canela, E.I., Lluís, C., Adenosine/dopamine receptor/receptor interactions in the central nervous system (2001) Drug Dev Res, 52, pp. 296-302; 
Franco, R., Mallol, J., Casadó, V., Lluí, C., Canela, E.I., Saura, C., Blanco, J., Ciruela, F., Ecto-adenosine deaminase: An ectoenzyme and a costimulatory protein acting on a variety of cell surface receptors (1999) Drug Dev Res, 45, pp. 261-268; 
Franco, R., Valenzuela, A., Lluís, C., Blanco, R., Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes (1998) Immunol Rev, 161, pp. 27-42; 
Fraser, C.M., Venter, J.C., The size of the mammalian lung β2-adrenergic receptor as determined by target size analysis and immunoaffinity chromatography (1982) Biochem Biophys Res Commun, 109, pp. 21-29; 
Fraser, I.D., Cong, M., Kim, J., Rollins, E.N., Daaka, Y., Lefkowitz, R.J., Scott, J.D., Assembly of an A kinase-anchoring protein-β2-adrenergic receptor complex facilitates receptor phosphorylation and signaling (2000) Curr Biol, 10, pp. 409-412; 
Frauenfelder, H., Slígar, S.G., Wolynes, P.G., The energy landscapes and motions of proteins (1991) Science (Wash DC), 254, pp. 1598-1603; 
Fredholm, B.B., Purinoceptors in the nervous system (1995) Pharmacol Toxicol, 76, pp. 228-239; 
Fredholm, B.B., Astra Award Lecture. Adenosine, adenosine receptors and the actions of caffeine (1995) Pharmacol Toxicol, 76, pp. 93-101; 
Fredholm, B.B., Abbracchio, M.P., Burnstock, G., Daly, J.W., Harden, T.K., Jacobson, K.A., Leff, P., Williams, M., Nomenclature and classification of purinoceptors (1994) Pharmacol Rev, 46, pp. 143-156; 
Fredholm, B.B., Herrera-Marschitz, M., Jonzon, B., Lindström, K., Ungerstedt, U., On the mechanism by which methylxanthines enhance apomorphine induced rotation behaviour in the rat (1983) Pharmacol Biochem Behav, 19, pp. 535-541; 
Fredholm, B.B., Uzerman, A.P., Jacobson, K.A., Klotz, K.N., Linden, J., International union of pharmacology. XXV. Nomenclature and classification of adenosine receptor (2001) Pharmacol Rev, 53, pp. 527-552; 
Freedman, J.E., Weight, F.F., Single K+ channels activated by D2 dopamine receptors in acutely dissociated neurons from rat corpus striatum (1988) Proc Natl Acad Sci USA, 85, pp. 3618-3622; 
Fuxe, K., Agnati, L.F., Receptor/receptor interactions in the central nervous system. A new integrative mechanism in synapses (1985) Med Res Rev, 5, pp. 441-482; 
Fuxe, K., Agnati, L., (1987) Receptor/Receptor Interactions. A New Intramembrane Integrative Mechanism, , Macmillan, London; 
Fuxe, K., Agnati, L., Härfstrand, A., Zoli, M., Von Euler, G., Grimaldi, R., Merlo Pich, E., Benfenati, F., On the role of neuropeptide Y in information handling in the central nervous system in normal and physiopathological states (1990) Ann NY Acad Sci, 579, pp. 28-67; 
Fuxe, K., Agnati, L., Ogren, S., Andersson, K., Benfenati, F., Neurobiology of central monoamine neurotransmission: Functional neuroanatomy and noradrenaline and 5-hydroxytryptamine involvement in learning and memory (1983) Neural Transmission, Learning and Memory, pp. 237-255. , (Caputto R and Marsan C eds), Raven Press Ltd., New York; 
Fuxe, K., Agnati, L.F., Benfenati, F., Celani, M.F., Zini, I., Zoli, M., Mutt, V., Evidence for the existence of receptor/receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides (1983) J Neural Transm, 18, pp. 165-179; 
Fuxe, K., Agnati, L.F., Benfenati, F., Cimmino, M., Algeri, S., Hökfelt, T., Modulation by cholecystokinins of [3H]spiroperidol binding in rat striatum: Evidence for increased affinity and reduction in the number of binding sites (1981) Acta Physiol Scand, 113, pp. 567-569; 
Fuxe, K., Agnati, L.F., Celani, M.F., Evidence for interactions between 3H-glutamate and 3H-kainic acid binding sites in rat striatal membranes. Possible relevance for kainic acid neurotoxicity (1983) Neurosci Lett, 35, pp. 233-238; 
Fuxe, K., Agnati, L.F., Von Euler, G., Benfenati, F., Tanganelli, S., Modulation of dopamine D1 and D2 transmission lines in the central nervous system (1990) Current Aspects of the Neurosciences, pp. 203-243. , (Osborne NN ed), MacMillan, London; 
Fuxe, K., Agnati, L.F., Von Euler, G., Benfenati, F., Zoli, M., Härfstrand, A., Fredholm, B., Receptor/receptor interactions and development of psychoactive drugs (1989) Neurochemical Pharmacology, pp. 211-227. , (Costa E ed), Raven Press Ltd., New York; 
Fuxe, K., Agnati, L.F., Von Euler, G., Tanganelli, S., O'Connor, W.T., Ferré, S., Hedlund, P., Zoli, M., Neuropeptide, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor/receptor interactions. Relevance for Parkinson's disease and schizophrenia (1992) Neurochem Int, 20 (SUPPL.), pp. 215S-224S; 
Fuxe, K., Aguirre, J.A., Agnati, L.F., Von Euler, G., Hedlund, P., Covenas, R., Zoli, M., Eneroth, P., Neuropeptide Y and central cardiovascular regulation. Focus on its role as a cotransmitter in cardiovascular adrenergic neurons (1990) Ann NY Acad Sci, 611, pp. 111-132; 
Fuxe, K., Celani, M.F., Martire, M., Zini, I., Zoli, M., Agnati, L.F., l-glutamate reduces the affinity of 3H-N-propylnorapomorphine binding sites in striatal membranes (1984) Eur J Pharmacol, 100, pp. 127-130; 
Fuxe, K., Ferré, S., Snaprud, P., Von Euler, G., Johansson, B., Fredholm, B., Antagonistic A2a/D2 receptor interactions in the striatum as a basis for adenosine/dopamine interactions in the central nervous system (1993) Drug Dev Res, 28, pp. 374-380; 
Fuxe, K., Ferré, S., Torvinen, M., Hillion, J., Strömberg, I., Franzén, O., Ibáñez, C., Agnati, L.F., Heteromerization of adenosine and dopamine receptor subtypes. Relevance for neuronal integration in normal and pathological states (2001) Catecholamine Research: From Molecular Insights to Clinical Medicine, 9th Int Catecholamine Symposium, Kyoto, Japan, , in press; Kluwer Academic/Plenum Publishers, New York; 
Fuxe, K., Ferré, S., Zoli, M., Agnati, L.F., Integrated events in central dopamine transmission as analyzed at multiple levels. Evidence for intramembrane adenosine A2A/dopamine D2 and adenosine A1/dopamine D1 receptor interactions in the basal ganglia (1998) Brain Res Rev, 26, pp. 258-273; 
Fuxe, K., Hedlund, P., Von Euler, G., Lundgren, K., Martire, M., Ögren, S., Eneroth, P., Agnati, L., Galanin/5-HT interactions in the rat central nervous system. Relevance for depression (1991) Galanin: A New Multifunctional Peptide in the Neuro-Endocrine System. Wenner-Gren Center International Symposium Series, 58, pp. 221-235. , (Hökfelt T, Bartfai T, Jacobowitz D, and Ottoson D eds), MacMillan, London; 
Fuxe, K., Li, X.-M., Hedlund, P., Benfenati, F., Agnati, L., Ferré, S., Integrative aspects of brain function: Receptor/receptor interactions in dopamine transmission of the basal ganglia (1996) CNS Neurotransmitters and Neuromodulators. Dopamine, pp. 89-106. , (Stones TW ed), CRC Press LLC, Boca Raton, Florida; 
Fuxe, K., Li, X.-M., Tanganelli, S., Hedlund, P., O'Connor, W., Ferraro, L., Ungerstedt, U., Agnati, L., Receptor/receptor interactions and their relevance for receptor diversity (1995) Diversity of Interacting Receptors, pp. 365-376. , (Abood L and Lajtha A eds), New York Academy of Sciences, New York; 
Fuxe, K., O'Connor, W.T., Antonelli, T., Osborne, P.G., Tanganelli, S., Agnati, L.F., Ungerstedt, U., Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum (1992) Proc Natl Acad Sci USA, 89, pp. 5591-5595; 
Fuxe, K., Strömberg, I., Popoli, P., Rimondini-Giorgini, R., Torvinen, M., Ogren, S.O., Franco, R., Ferré, S., Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatum (2001) Adv Neurol, 86, pp. 345-353; 
Fuxe, K., Ungerstedt, U., Action of caffeine and theophyllamine on supersensitive dopamine receptors: Considerable enhancement of receptor response to treatment with dopa and dopamine receptor agonists (1974) Med Biol (Helsinki), 52, pp. 48-54; 
Fuxe, K., Von Euler, G., Agnati, L., Angiotensin II reduces the affinity of 3H-paraaminoclonidine binding sites in membrane preparations from the rat dorsomedial medulla oblongata (1988) Acta Physiol Scand, 134, pp. 317-318; 
Fuxe, K., Von Euler, G., Agnati, L.F., Reduction of [3H]nicotine binding by clonidine in membrane preparations of the rat cerebral cortex (1988) Acta Physiol Scand, 132, pp. 265-266; 
Fuxe, K., Von Euler, G., Agnati, L.F., Ögren, S.O., Galanin selectively modulates 5-hydroxytryptamine 1A receptors in the rat ventral limbic cortex (1988) Neurosci Lett, 85, pp. 163-167; 
Fuxe, K., Von Euler, G., Agnati, L.F., Pich, E.M., O'Connor, W.T., Tanganelli, S., Li, X.M., Carani, C., Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin (1992) Ann NY Acad Sci, 668, pp. 186-204; 
Fuxe, K., Von Euler, G., Finnman, U.-B., Agnati, L., Reduction of 3H-nicotine binding in hypothalamic and cortical membranes by dopamine D1 receptors (1989) Acta Physiol Scand, 136, pp. 295-296; 
Garrett, B.E., Holtzman, S.G., Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction (1994) Eur J Pharmacol, 262, pp. 65-75; 
George, S.R., Fan, T., Xie, Z., Tse, R., Tam, V., Varghese, G., O'Dowd, B.F., Oligomerization of μ- and δ-opioid receptors (2000) J Biol Chem, 275, pp. 26128-26135; 
George, S.R., Lee, S.P., Varghese, G., Zeman, P.R., Seeman, P., Ng, G.Y., O'Dowd, B.F., A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization (1998) J Biol Chem, 273, pp. 30244-30248; 
Gerfen, C.R., Wilson, C.J., The basal ganglia (1996) Handbook of Chem Neuroanatomy, 12 (PART III), pp. 371-468. , (Swanson LW, Björklund A, and Hökfelt T eds), Elsevier Science B.V., Amsterdam; 
Gether, U., Uncovering molecular mechanisms involved in activation of G protein-coupled receptors (2000) Endocr Rev, 21, pp. 90-113; 
Giménez-Llort, L., Martinez, E., Ferré, S., Dopamine-independent and adenosine-dependent mechanisms involved in the effects of N-methyl-D-aspartate on motor activity in mice (1995) Eur J Pharmacol, 275, pp. 171-177; 
Ginés, S., Ciruela, F., Burgueño, J., Casadó, V., Canela, E.I., Mallol, J., Lluís, C., Franco, R., Involvement of caveolin in ligand-induced recruitment and internalization of A1 adenosine receptors and adenosine deaminase in an epithelial cell line (2001) Mol Pharmacol, 59, pp. 1314-1323; 
Ginés, S., Hillion, J., Torvinen, M., LeCrom, S., Casado, V., Canela, E., Rondin, S., Zoli, M., Dopamine D1 and adenosine A1 receptors assemble into functionally interacting heteromeric complexes (2000) Proc Natl Acad Sci USA, 97, pp. 8606-8611; 
Goldman-Rakic, P.S., Selemon, L.D., Functional and anatomical aspects of prefrontal pathology in schizophrenia (1997) Schizophr Bull, 23, pp. 437-458; 
Gordon, Y.K., Clark, J., Coulombe, N., Ethier, N., Herbert, T.E., Sullivan, R., Kargman, S., McDonald, T., Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity (1999) J Biol Chem, 274, pp. 7607-7610; 
Gouldson, P.R., Higgs, C., Smith, R.E., Dean, M.K., Gkoutos, G.V., Reynolds, C.A., Dimerization and domain swapping in G-protein-coupled receptors: A computational study (2000) Neuropsychopharmacology, 23, pp. 60-77; 
Gouldson, P.R., Snell, C.R., Bywater, R.P., Higgs, C., Reynolds, C.A., Domain swapping in G-protein coupled receptor dimers (1998) Protein Eng, 11, pp. 1181-1193; 
Grant, S., Blackstock, W., Proteomics in neuroscience: From protein to network (2001) J Neurosci, 21, pp. 8315-8318; 
Grant, S.G.N., Husi, H., Proteomics of multiprotein complexes: Answering fundamental questions in neuroscience (2001) Trends Biotechnol, 19, pp. 49-54; 
Greengard, P., Allen, P.B., Nairn, A.C., Beyond the dopamine receptor: The DARPP-32/protein pnosphatase-1 cascade (1999) Neuron, 23, pp. 435-447; 
Greengard, P., Nairn, A., Girault, J.A., Ouimet, C.C., Snyder, G.L., Fisone, G., Allen, P.B., Nishi, A., The DARPP-32/protein phosphate-1 cascade: A model for signal integration (1998) Brain Res Rev, 26, pp. 274-284; 
Grondin, R., Bedard, P.J., Hadj Tahar, A., Gregoire, L., Mori, A., Kase, H., Antiparkinsonian effect of a new selective adenosine A2A receptor antagonist in MPTP-treated monkeys (1999) Neurology, 52, pp. 1673-1677; 
Gurevich, E.V., Joyce, J.N., Distribution of dopamine D3 receptor expressing neurons in the human forebrain: Comparison with D2 receptor expressing neurons (1999) Neuropsychopharmacology, 20, pp. 60-80; 
Gutkind, J.S., Coso, O.A., Xu, N., Gα12 and Gα13-subunits of heterotrimeric G proteins: A novel family of oncogenes (1998) G Proteins, Receptors and Disease, pp. 101-117. , (Spiegel AM ed) Humana Press, Inc., New Jersey; 
Härfstrand, A., Fuxe, K., Cintra, A., Agnati, L., Aspects on neuropeptide Y/epinephrine cotransmission in central cardiovascular regulation (1988) Progress in Catecholamine Research. Part B: Central Aspects, pp. 225-232. , (Ed.) Alan R. Liss, New York; 
Hauber, W., Munkle, M., Motor depressant effects mediated by dopamine D2 and adenosine A2A receptors in the nucleus accumbens and the caudate-putamen (1997) Eur J Pharmacol, 323, pp. 127-131; 
Hauber, W., Neuscheler, P., Nagel, J., Muller, C.E., Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats (2001) Eur J Neurosci, 14, pp. 1287-1293; 
Havlicek, V., Rezek, M., Friesen, H., Somatostatin and thyrotropin releasing hormone: Central effect on sleep and motor system (1976) Pharmacol Biochem Behav, 4, pp. 455-459; 
Hebb, D.O., (1949) The Organization of Behavior; A Neuropsychological Theory, , John Wiley & Sons, New York; 
Hebert, T.E., Moffett, S., Morello, J.P., Loisel, T.P., Bichet, D.G., Barret, C., Bouvier, M., A peptide derived from a β2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation (1996) J Biol Chem, 271, pp. 16384-16392; 
Hedlund, P., Finnman, U.-B., Yanaihara, N., Fuxe, K., Galanin-(1-15), but not galanin-(1-29), modulates 5-HT1A receptors in the dorsal hippocampus of the rat brain: Possible existence of galanin receptor subtypes (1994) Brain Res, 634, pp. 163-167; 
Hedlund, P., Fuxe, K., Galanin and 5-HT1A receptor interactions as an integrative mechanism in 5-HT neurotransmission in the brain (1996) Neuropeptides: Basic and Clinical Advances, pp. 193-212. , (Crawley J and McLean S eds), New York Academy of Sciences, New York; 
Hedlund, P., Von Euler, G., Fuxe, K., Activation of 5-hydroxytryptamine1A receptors increases the affinity of galanin receptors in di- and telencephalic areas of the rat (1991) Brain Res, 560, pp. 251-259; 
Heffner, T.G., Wiley, J.N., Williams, A.E., Bruns, R.E., Coughenour, L.L., Downs, D.A., Comparison of the behavioural effects of adenosine agonists and dopamine antagonists in mice (1989) Psychopharmacology, 98, pp. 31-37; 
Heimer, L., Zahm, D.S., Alheid, G.F., Basal ganglia (1995) The Rat Nervous System, pp. 579-628. , (Paxinos G ed), Academic Press, Inc., San Diego, CA; 
Helldin, C.H., Dimerization of cell surface receptors in signal transduction (1995) Cell, 80, pp. 213-223; 
Herberg, J.T., Codina, J., Rich, K.A., Rojas, F.J., Lyengar, R., The hepatic glucagon receptor. Solubilization, characterization and development of an affinity adsorption assay for the soluble receptor (1984) J Biol Chem, 259, pp. 9285-9294; 
Herdegen, T., Leah, J.D., Inducible and constitutive transcription factors in the mammalian nervous system: Control of gene expression by Jun, Fos and Krox and CREB/ATF proteins (1998) Brain Res Rev, 28, pp. 370-490; 
Hermans, E., Challiss, R.A., Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: Prototypic family C G-protein-coupled receptors (2001) Biochem J, 359, pp. 465-484; 
Herrera, C., Casadó, V., Ciruela, F., Schofield, P., Mallol, J., Llufs, C., Franco, R., Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells (2001) Mol Pharmacol, 59, pp. 127-134; 
Herrera-Marschitz, M., Casas, M., Ungerstedt, U., Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: Comparisons with apomorphine-induced responses (1988) Psychopharmacology, 94, pp. 38-45; 
Hettinger, B.D., Lee, A., Linden, J., Rosin, D.L., Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum (2001) J Comp Neurol, 431, pp. 331-346; 
Heuss, C., Gerber, U., G-protein-independent signaling by G-protein-coupled receptors (2000) Trends Neurosci, 23, pp. 469-475; 
Hillefors, M., Hedlund, P.B., Von Euler, G., Effects of adenosine A(2A) receptor stimulation in vivo on dopamine D3 receptor agonist binding in the rat brain (1999) Biochem Pharmacol, 58, pp. 1961-1964; 
Hillion, J., Canals, M., Torvinen, M., Casado, V., Scott, R., Terasmaa, A., Hansson, A., Mallol, J., Coaggregation, cointernalization and codesensitization of adenosine A2A receptors and dopamine D2 receptors (2002) J Biol Chem, 277, pp. 18091-18097; 
Hollenberg, M.D., Structure-activity relationship for transmembrane signalling: The receptor's turn (1991) FASEB J, 5, pp. 178-186; 
Huganir, R.L., Greengard, P., Regulation of receptor function by protein phosphorylation (1987) Trends Pharmacol Sci, 8, pp. 472-477; 
Hughes, P., Dragunow, M., Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system (1995) Pharmacol Rev, 47, pp. 133-178; 
Hukovic, N., Panetta, R., Kumar, U., Rocheville, M., Patel, Y.C., The cytoplasmic tail of the human somatostatin receptor type 5 is crucial for interaction with adenylate cyclase and in mediating desensitization and internalization (1998) J Biol Chem, 273, pp. 21410-21422; 
Hunter, T., Signalling 2000 and beyond (2000) Cell, 100, pp. 113-127; 
Huntsman, M.M., Tran, B.V., Potkin, S.G., Bunney W.R., Jr., Jones, E.G., Altered ratios of alternatively spliced long and short γ2 subunit mRNAs of the GABAA receptor in prefrontal cortex of schizophrenia (1998) Proc Natl Acad Sci USA, 95, pp. 15066-15071; 
Husi, H., Grant, S.G., Proteomics of the nervous system (2001) Trends Neurosci, 24, pp. 259-266; 
Impey, S., Obrietan, K., Storm, D.R., Making new connections: Role of ERK/ MAP kinase signaling in neuronal plasticity (1999) Neuron, 23, pp. 11-14; 
Izquierdo-Claros, R.M., Boyano-Adanez, M.C., Larsson, C., Gustavsson, L., Arilla, E., Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum (1997) Brain Res Mol Brain Res, 47, pp. 99-107; 
Jentsch, J.D., Roth, R.H., The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia (1999) Neuropsychopharmacology, 20, pp. 201-225; 
Jiang, H., Jackson-Lewis, V., Muthane, U., Dollison, A., Ferreira, M., Espinosa, A., Parsons, B., Przedborski, S., Adenosine receptor antagonists potentiate dopamine receptor agonist-induced rotational behavior in 6-hydroxydopamine-lesioned rats (1993) Brain Res, 613, pp. 347-351; 
Johansson, B., Halldner, L., Dunwiddie, T.V., Masino, S.A., Poelchen, W., Gimenez-Llort, L., Escoribuela, R.M., Xu, X.J., Hyperalgesia, anxiety and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor (2001) Proc Natl Acad Sci USA, 98, pp. 9407-9412; 
Jones, K.A., Borowsky, B., Tamm, J.A., Craig, D.A., Durkin, M.M., Dai, M., Yao, W.J., Huang, L.Y., GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2 (1998) Nature (Lond), 396, pp. 674-682; 
Jordan, B.A., Cvejic, S., Devi, L.A., Opioids and their complicated receptor complexes (2000) Neuropsychopharmacology, 23, pp. S5-S18; 
Jordan, B.A., Devi, L.A., G-protein-coupled receptor heterodimerization modulates receptor function (1999) Nature (Lond), 399, pp. 697-700; 
Jordan, B.A., Trapaidze, N., Gomes, I., Nivarthi, R., Devi, L.A., Oligomerization of opioid receptors with β2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation (2001) Proc Natl Acad Sci USA, 98, pp. 343-348; 
Kafka, S.H., Corbett, R., Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia (1996) Eur J Pharmacol, 295, pp. 147-154; 
Kammerer, R.A., Frank, S., Schulthess, T., Landwehr, R., Lustig, A., Engel, J., Heteromerization of a functional GABAB receptor is mediated by parallel coiled-coil α helices (1999) Biochemistry, 38, pp. 13263-13269; 
Kanda, T., Jackson, M.J., Smith, L.A., Pearce, R.K., Nakamura, J., Kase, H., Kuwana, Y., Jenner, P., Adenosine A2A antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys (1998) Ann Neurol, 43, pp. 507-513; 
Kanda, T., Jackson, M.J., Smith, L.A., Pearce, R.K., Nakamura, J., Kase, H., Kuwana, Y., Jenner, P., Combined use of the adenosine A(2A) antagonist KW-6002 with L-DOPA or with selective D1 or D2 dopamine agonists increases antiparkinsonian activity but not dyskinesia in MPTP-treated monkeys (2000) Exp Neurol, 162, pp. 321-327; 
Kanda, T., Shiozaki, S., Shimada, J., Suzuki, F., Nakamura, J., KF17837: A novel selective adenosine A2A receptor antagonist with anticataleptic activity (1994) Eur J Pharmacol, 256, pp. 263-268; 
Kanda, T., Tashiro, T., Kuwana, Y., Jenner, P., Adenosine A2A receptors modify motor function in MPTP-treated common marmosets (1998) Neuroreport, 9, pp. 2857-2860; 
Kastin, A.J., Coy, D.H., Jacquet, Y., Schally, A.V., Plotnikoff, N.P., CNS effects of somatostatin (1978) Metabolism, 27, pp. 1247-1252; 
Kaupmann, K., Malitschek, B., Schuler, V., Heid, J., Froesti, W., Beck, P., Mosbacher, J., Shigemoto, R., GABAB-receptor subtypes assemble into functional heteromeric complexes (1998) Nature (Lond), 396, pp. 683-687; 
Kenakin, T., Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity (1995) Trends Pharmacol Sci, 16, pp. 188-192; 
Kenakin, T., Agonist-specific receptor conformations (1997) TIPS, 18, pp. 416-417; 
Keverne, E.B., GABA-ergic neurons and the neurobiology of schizophrenia and other psychosis (1999) Brain Res Bull, 48, pp. 467-473; 
Khakh, B.S., Zhou, X., Sydes, J., Galligan, J.J., Lester, H.A., State-dependent cross-inhibition between transmitter-gated cation channels (2000) Nature (Lond), 406, pp. 405-410; 
Kieffer, B.L., Opioids: First lessons from knockout mice (1999) TIPS, 20, pp. 19-26; 
Koga, K., Kurokawa, M., Ochi, M., Nakamura, J., Kuwana, Y., Adenosine A(2A) receptor antagonists KF17837 and KW-6002 potentiate rotation induced by dopaminergic drugs in hemi-Parkinsonian rats (2000) Eur J Pharmacol, 408, pp. 249-255; 
Kohout, T.A., Lin, F.T., Perry, S.J., Conner, D.A., Lefkowitz, R.J., β-arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking (2001) Proc Natl Acad Sci USA, 98, pp. 1601-1606; 
Koob, G.F., The role of the striatopallidal and extended amygdala systems in drug addiction (1999) Ann NY Acad Sci, 877, pp. 445-460; 
Kozell, L.B., Machida, C.A., Neve, R.L., Neve, K.A., Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency and signal transduction (1994) J Biol Chem, 269, pp. 30299-30306; 
Kozell, L.B., Neve, K.A., Constitutive activity of a chimeric D1/D2 dopamine receptor (1997) Mol Pharmacol, 52, pp. 1137-1149; 
Kroeger, K.M., Hanyaloglu, A.C., Seeber, R.M., Miles, L.E.C., Eidne, K.A., Constitutive and agonist-dependent homo-oligomerization of the thyrotropin-releasing hormone receptor; detection in living cells using bioluminescence resonance energy transfer (2001) J Biol Chem, 276, pp. 12736-12743; 
Kull, B., Ferre, S., Arslan, G., Svenningsson, P., Fuxe, K., Owman, C., Fredholm, B.B., Reciprocal interactions between adenosine A2A and dopamine D2 receptors in Chinese hamster ovary cells co-transfected with the two receptors (1999) Biochem Pharmacol, 58, pp. 1035-1045; 
Kull, B., Svenningsson, P., Fredholm, B.B., Adenosine A(2A) receptors are colocalized with and activate G(olf) in rat striatum (2000) Mol Pharmacol, 58, pp. 771-777; 
Kuner, R., Köhr, G., Grünewald, S., Eisenhardt, G., Bach, A., Kornau, H.C., Role of heteromer formation in GABAB receptor function (1999) Science (Wash DC), 283, pp. 74-77; 
Kunishima, N., Shimada, Y., Tsuji, Y., Sato, T., Yamamoto, M., Kumasaka, T., Nakanishi, S., Morikawa, K., Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor (2000) Nature (Lond), 407, pp. 971-977; 
Kurokawa, M., Kirk, I.P., Kirkpatrick, K.A., Kase, H., Richardson, P.J., Inhibition by KF17837 of adenosine A2a receptor-mediated modulation of striatal GABA and Ach release (1994) Br J Pharmacol, 113, pp. 43-48; 
Latini, S., Pedata, F., Adenosine in the central nervous system: Release mechanisms and extracellular concentrations (2001) J Neurochem, 79, pp. 463-484; 
Le, F., Groshan, K., Zeng, X.P., Richelson, E., Characterization of the genomic structure, promoter region and a tetranucleotide repeat polymorphism of the human neurotensin receptor gene (1997) J Biol Chem, 272, pp. 1315-1322; 
Leblanc, R., Gauthier, S., Gauvin, M., Quirion, R., Palmour, R., Masson, H., Neurobehavioral effects of intrathecal somatostatinergic treatment in subhuman primates (1988) Neurology, 38, pp. 1887-1890; 
Lee, S.P., Xie, Z., Varghese, G., Nguyen, T., O'Dowd, B.F., George, S.R., Oligomerization of dopamine and serotonin receptors (2000) Neuropsychopharmacology, 23, pp. S32-S40; 
Lefkowitz, R.J., The superfamily ofheptahelical receptors (2000) Nat Cell Biol, 2, pp. E133-E136; 
Lemmon, M.A., Engelman, D.M., Specificity and promiscuity in membrane helix interactions (1994) FEBS Lett, 346, pp. 17-20; 
Lemmon, M.A., Flanagan, J.M., Hunt, J.F., Adair, B.D., Bormann, B.J., Dempsey, C.E., Engelman, D.M., Glycophorin A dimerization is driven by specific interactions between transmembrane alpha-helices (1992) J Biol Chem, 267, pp. 7683-7689; 
Le Moine, C., Bloch, B., D1 and D2 dopamine receptor gene expression in rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum (1995) J Comp Neurol, 355, pp. 418-426; 
Le Moine, C., Bloch, B., Expression of the D3 dopamine receptor in peptideric neurons of the nucleus accumbens: Comparison with the D1 and D2 dopamine receptors (1996) Neuroscience, 73, pp. 131-143; 
Lepiku, M., Rinken, A., Jarv, J., Fuxe, K., Modulation of [3H]quinpirole binding to dopaminergic receptors by adenosine A2A receptors (1997) Neurosci Lett, 239, pp. 61-64; 
Levac, B.A., O'Dowd, B.F., George, S.R., Oligomerization of opioid receptors: Generation of novel signaling units (2002) Curr Opin Pharmacol, 2, pp. 76-81; 
Lezcano, N., Mrzljak, L., Eubanks, S., Levenson, R., Goldman-Rakic, P., Bergson, C., Dual signaling regulated by Calcyon, a D1 dopamine receptor interacting protein (2000) Science (Wash DC), 287, pp. 1660-1664; 
Li, X.M., Ferraro, L., Tanganelli, S., O'Connor, W., Hasselrot, U., Ungerstedt, U., Fuxe, K., Neurotensin peptides antagonistically regulate postsynaptic dopamine D2 receptors in rat nucleus accumbens: A receptor binding and microdialysis study (1995) J Neural Transm, 102, pp. 125-137; 
Li, X.M., Finnman, U.B., Von Euler, G., Hedlund, P.B., Fuxe, K., Neuromedin N is more potent than neurotensin in modulating DA D 2 receptor agonist binding in the rat neostriatum (1993) Neurosci Lett, 155, pp. 121-124; 
Li, X.M., Hedlund, P., Agnati, L.F., Fuxe, K., Dopamine D1 receptors are involved in the modulation of D2 receptors induced by cholecystokinin receptor subtypes in rat neostriatal membranes (1994) Brain Res, 650, pp. 289-298; 
Li, X.-M., Hedlund, P., Fuxe, K., Strong effects of NT/NN peptides on DA D2 receptors in rat neostriatal sections (1994) Neuroreport, 5, pp. 1621-1624; 
Li, X.M., Hedlund, P.B., Fuxe, K., Cholecystokinin octapeptide in vitro and ex vivo strongly modulares striatal dopamine D2 receptors in rat forebrain sections (1995) Eur J Neurosci, 7, pp. 962-971; 
Li, X.M., Von Euler, G., Hedlund, P.B., Finnman, U.B., Fuxe, K., The C-terminal neurotensin-(8-13) fragment potently modulates rat neostriatal dopamine D2 receptors (1993) Eur J Pharmacol, 234, pp. 125-128; 
Lillrank, S.M., Lipska, B.K., Weinberger, D.R., Fredholm, B.B., Fuxe, K., Ferré, S., Adenosine and dopamine receptor antagonist binding in the rat ventral and dorsal striatum: Lack of changes after a neonatal bilateral lesion of the ventral hippocampus (1999) Neurochem Int, 34, pp. 235-244; 
Limbird, L.E., Lefkowitz, R.J., Negative cooperativity among β-adrenergic receptors in frog erythrocyte membranes (1976) J Biol Chem, 251, pp. 5007-5014; 
Limbird, L.E., Mayts, P.D., Lefkowitz, R.J., Beta-adrenergic receptors: Evidence for negative cooperativity (1975) Biochem Biophys Res Commun, 64, pp. 1160-1168; 
Lindskog, M., Svenningsson, P., Fredholm, B.B., Greengard, P., Fisone, G., Activation of dopamine D2 receptors decreases DARPP-32 phosphorylation in striatonigral and striatopallidal projection neurons via different mechanisms (1999) Neuroscience, 88, pp. 1005-1008; 
Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y., Fienberg, A.A., Bibb, J.A., Fredholm, B.B., Fisone, G., Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine (2002) Nature (Lond), 418, pp. 774-778; 
Liu, F., Wan, Q., Pristupa, Z.B., Yu, X.M., Wang, Y.T., Niznik, H.B., Direct protein-protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors (2000) Nature (Lond), 403, pp. 274-280; 
Lluis, C., Cordero, O., Franco, R., Ecto-adenosine deaminase may play a relevant role in the development of the immune syste (1998) Immunol Today, 19, pp. 533-534; 
Lundberg, J.M., Hedlund, B., Bartfai, T., Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland (1982) Nature (Lond), 295, pp. 147-149; 
Luttrell, L.M., Ferguson, S.S., Daaka, Y., Miller, W.E., Maudsley, S., Della Rocca, G.J., Lin, F., Luttrell, D.K., β-arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes (1999) Science (Wash DC), 283, pp. 655-661; 
Luttrell, L.M., Roudabush, F.L., Choy, E.W., Miller, W.E., Field, M.E., Pierce, K.L., Lefkowitz, R.J., Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds (2001) Proc Natl Acad Sci USA, 98, pp. 2449-2454; 
Maggi, A., U'Prichard, D.C., Enna, S.J., Beta-adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system (1980) Science (Wash DC), 207, pp. 645-647; 
Maggio, R., Vogel, Z., Wess, J., Coexpression studies with mutant muscarinic/ adrenergic receptors provide evidence for intermolecular 'cross-talk' between G-protein-linked receptors (1993) Proc Natl Acad Sci USA, 90, pp. 3103-3107; 
Malec, D., Haloperidol-induced catalepsy is infiuenced by adenosine receptor antagonists (1997) Pol J Pharmacol Pharm, 49, pp. 323-327; 
Manzoni, O., Pujalte, D., Williams, J., Bockaert, J., Decreased presynaptic sensitivity to adenosine after cocaine withdrawal (1998) J Neurosci, 18, pp. 7996-8002; 
Margeta-Mitrovic, M., Jan, Y.N., Jan, L.Y., A trafficking checkpoint controls GABAB receptor heterodimerization (2000) Neuron, 27, pp. 97-106; 
Marinissen, M.J., Gurkind, J.S., G-protein-coupled receptors and signaling networks: Emerging paradigms (2001) Trends Pharmacol Sci, 22, pp. 368-376; 
Marshall, F.H., Heterodimerization of G protein coupled receptors in the CNS (2001) Curr Opin Pharmacol, 1, pp. 40-44; 
Marshall, F.H., Jones, K.A., Kaupmann, K., Bettler, B., GABAA receptors -the first 7TM heterodimers (1999) Trends Pharmacol Sci, 10, pp. 369-399; 
Martin-Iverson, M.T., Radke, J.M., Vincent, S.R., The effects of cysteamine on dopamine-mediated behaviors: Evidence for dopamine-somatostatin interactions in the striatum (1986) Pharmacol Biochem Behav, 24, pp. 1707-1714; 
Maudsley, S., Pierce, K.L., Zamah, M., Miller, W.E., Ahn, S., Daaka, Y., Lefkowitz, R.J., Luttrell, L.M., The β2-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor (2000) J Biol Chem, 275, pp. 9572-9580; 
Mayfield, R., Larson, G., Orona, R.A., Zahniser, N.R., Opposing actions of adenosine A2a and dopamine D2 receptor activation on GABA release in the basal ganglia: Evidence for an A 2a/D2 receptor interaction in globus pallidus (1996) Synapse, 22, pp. 132-138; 
Mayfield, R.D., Jones, B.A., Miller, H.A., Simosky, J.K., Larson, G.A., Zahniser, N.R., Modulation of endogenous GABA release by an antagonistic adenosine A1/dopamineD1 receptor interaction in rat brain limbic regions but not basal ganglia (1999) Synapse, 33, pp. 274-281; 
Mayr, B., Montminy, M., Transcriptional regulation by the phosphorylation-dependent factor CREB (2001) Nat Rev, 2, pp. 599-609; 
McDonald, P.H., Lefkowitz, R.J., βarrestins: New roles in regulating hepta-helical receptors' functions (2001) Cell Signal, 13, pp. 683-689; 
McLatchie, L.M., Fraser, N.J., Main, M.J., Wise, A., Brown, J., Thompson, N., Solari, R., Foord, S.M., Ramps regulate the transport and ligand specificity of the calcitonin-receptor-like receptor (1998) Nature (Lond), 393, pp. 333-339; 
McVey, M., Ramsay, D., Kellett, E., Rees, S., Wilson, S., Pope, A.J., Milligan, G., Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer (2001) J Biol Chem, 276, pp. 14092-14099; 
Mendoza-Fernandez, V., Andrew, R.D., Barajas-López, C., ATP inhibits glutamate synaptic release by acting at P2Y receptors in pyramidal neurons of hippocampus slices (2000) J Pharmacol Exp Ther, 293, pp. 172-179; 
Merchant, K.M., Dorsa, D.M., Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics (1993) Proc Natl Acad Sci USA, 90, pp. 3447-3451; 
Migaud, M., Charlesworth, P., Dempster, M., Webster, L.C., Watabe, A.M., Makhinson, M., He, Y., Morrison, J.H., Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein (1998) Nature (Lond), 396, pp. 433-439; 
Miller, W.E., Lefkowitz, R.J., Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking (2001) Curr Opin Cell Biol, 13, pp. 139-145; 
Milligan, G., White, J.H., Protein-protein interactions at G-protein-coupled receptors (2001) Trends Pharmacol Sci, 22, pp. 513-518; 
Mirabet, M., Herrera, C., Cordero, O.J., Mallol, J., Lluis, C., Franco, R., Expression of A2B adenosine receptors in human lymphocytes: Their role in T cell activation (1999) J Cell Sci, 112, pp. 491-502; 
Missale, C., Nash, S.R., Robinson, S.W., Jaber, M., Caron, M.G., Dopamine receptors: From structure to function (1998) Physiol Rev, 78, pp. 189-225; 
Mitrovic, M.M., Nung Jan, Y., Yeh Jan, L., A trafficking checkpoint controls GABAB receptor heterodimerization (2000) Neuron, 27, pp. 97-106; 
Monnot, C., Bihroreau, C., Conchou, S., Curnow, K.M., Corvol, P., Clauser, E., Polar residues in the transmembrane domain of the type I angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by coexpression of two deficient mutants (1996) J Biol Chem, 271, pp. 1507-1513; 
Morelli, M., Pinna, A., Wardas, J., Di Chiara, G., Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats (1995) Neuroscience, 67, pp. 49-55; 
Morelli, M., Wardas, J., Adenosine A2A receptor antagonists: Potential therapeutic and neuroprotective effects in Parkinson's disease (2001) Neurotox Res, 3, pp. 545-556; 
Mori, A., Shindou, T., Ichimura, M., Nonaka, H., Kase, H., The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons (1996) J Neurosci, 15, pp. 605-611; 
Mrzljak, L., Levey, A.I., Goldman-Rakic, P.S., Association of m1 and m2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: Morphological evidence for cholinergic modulation of excitatory neurotransmission (1993) Proc Natl Acad Sci USA, 90, pp. 5194-5198; 
Naisbitt, S., Kim, E., Tu, J., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R., Sheng, M., Shank, a novel family of postsynaptic density proteins that binds to the NMDA receptor/PSD-95/GKAP complex and cortactin (1999) Neuron, 23, pp. 569-582; 
Nakanishi-Matsui, M., Zheng, Y.W., Sulciner, D.J., Weiss, E.J., Ludeman, M.J., Coughlin, S.R., PAR3 is a cofactor for PAR4 activation by thrombin (2000) Nature (Lond), 404, pp. 609-613; 
Nemeroff, C.B., The interactions of neurotensin with dopaminergic pathways in the central nervous system: Basic neurobiology and implications for the pathogenesis and treatment of schizophrenia (1986) Psychoneuroendocrinology, 11, pp. 15-37; 
Ng, G.Y., Bertrand, S., Sullivan, R., Ethier, N., Wang, J., Yergey, J., Belley, M., Alder, L., Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action (2001) Mol Pharmacol, 59, pp. 144-152; 
Ng, G.Y., Clark, J., Coulombe, N., Ethier, N., Hebert, T.E., Sullivan, R., Kargman, S., McDonald, T., Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity (1999) J Biol Chem, 274, pp. 7607-7610; 
Ng, G.Y., George, S.R., Zastawny, R.L., Caron, M., Bouvier, M., Dennis, M., O'Dowd, B.F., Human serotonin1B receptor expression in Sf9 cells: Phospholylation, palmitoylation and adenylyl cyclase inhibition (1993) Biochemistry, 32, pp. 11727-11733; 
Ng, G.Y., Mouillac, B., George, S.R., Caron, M., Dennis, M., Bouvier, M., O'Dowd, B.F., Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor (1994) Eur J Pharmacol, 267, pp. 7-19; 
Ng, G.Y., O'Dowd, B.F., Caron, M., Dennis, M., Brann, M.R., George, S.R., Phosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cells (1994) J Neurochem, 63, pp. 1589-1595; 
Ng, G.Y., O'Dowd, B.F., Lee, S.P., Chung, H.T., Brann, M.R., Seeman, P., George, S.R., Dopamine D2 receptor dimers and receptor-blocking peptides (1996) Biochem Biophys Res Commun, 227, pp. 200-204; 
Nguyen, J.T., Turck, C.W., Cohen, F.E., Zuckermann, R.N., Lim, W.A., Exploiting the basis of proline recognition by SH3 and WW domains: Design of N-substituted inhibitors (1998) Science (Wash DC), 282, pp. 2088-2092; 
Nimchinsky, E.A., Hof, P.R., Janssen, W.G., Morrison, J.H., Schmauss, C., Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells (1997) J Biol Chem, 272, pp. 29229-29237; 
Nishi, A., Bibb, J.A., Snyder, G.L., Higashi, H., Nairn, A.C., Greengard, P., Amplification of dopaminergic signaling by a positive feedback loop (2002) Proc Natl Acad Sci USA, 97, pp. 12840-12845; 
Nusser, Z., Roberts, J.D., Baude, A., Richards, J.G., Somogyi, P., Immunocytochemical localization of α 1 and β2/3 subunits of the GABAA receptor in relation to specific GABAergic synapses in the dentate gyrus (1995) Eur J Neurosci, 7, pp. 630-636; 
Obeso, J.A., Rodriguez-Oroz, C., Rodriguez, M., Macias, R., Alvarez, L., Guridi, J., Vitek, J., DeLong, M.R., Pathophysiologic basis of surgery for Parkinson's disease (2000) Neurology, 55, pp. S7-S12; 
Ochi, M., Koga, K., Kurokawa, M., Kase, H., Nakamura, J., Kuwana, Y., Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: A microdialysis study (2000) Neuroscience, 100, pp. 53-62; 
Ogren, S.O., The behavioural pharmacology of typical and atypical antipsychotic drugs (1996) Handbook of Experimental Pharmacology, 120, pp. 225-265. , (Csernansky JG ed), Springer-Verlag, Berlin, Germany; 
Ogren, S.O., Goldstein, M., Phencyclidine- and dizocilpine-induced hyperlocomotion are (1994) Neuropsychopharmacology, 11, pp. 167-177; 
Okubo, Y., Suhara, T., Suzuki, K., Kobayashi, K., Inoue, O., Terasaki, O., Someya, Y., Matsushima, E., Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET (1997) Nature (Lond), 385, pp. 634-636; 
Ossowska, K., Konieczny, J., Wolfarth, S., Wieronska, J., Pilc, A., Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats (2001) Neuropharmacology, 41, pp. 413-420; 
Ostrom, R.S., Steven, R.P., Insel, P.A., Stoichiometry and compartmentation in G protein coupled receptor signaling: Implcations for therapeutic interventions involving Ga (2000) J Pharmacol Exp Ther, 294, pp. 407-412; 
Overton, M.C., Blumer, K.J., G protein coupled receptors function as oligomers in vivo (2000) Curr Biol, 10, pp. 341-344; 
Paolillo, M., Montecucco, A., Zanassi, P., Schinelli, S., Potentiation of dopamine-induced cAMP formation by group I metabotropic glutamate receptors via protein kinase C in cultured striatal neurons (1998) Eur J Neurosci, 10, pp. 1937-1945; 
Pawson, T., Protein modules and signalling networks (1995) Nature (Lond), 373, pp. 573-580; 
Pawson, T., Gish, G., Nash, P., SH2 domains, interaction modules and cellular wiring (2001) Trends Cell Biol, 11, pp. 504-511; 
Pawson, T., Scott, J.D., Signaling through scaffold, anchoring and adaptor proteins (1997) Science (Wash DC), 278, pp. 2075-2080; 
Pérez de la Mora, M., Ferré, S., Faxe, K., GABA-dopamine receptor/receptor interactions in neostriatal membranes of the rat (1997) Neurochem Res, 22, pp. 1051-1054; 
Perry, K.J., Quiza, M., Myers, D.E., Morfis, M., Christopoulos, G., Sexton, P.M., Characterization of amylin and calcitonin receptor binding in the mouse alpha-thyroid-stimulating hormone thyrotroph cell line (1997) Endocrinology, 138, pp. 3486-3496; 
Peterson, G.L., Rosenbaum, L.C., Brederick, D.J., Schimerlick, M.I., Physical properties of the purified cardiac muscarinic acetylcholine receptor (1986) Biochemistry, 25, pp. 3189-3202; 
Pierce, K.L., Lefkowitz, R.J., Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors (2001) Neuroscience, 2, pp. 727-733; 
Pin, J.P., Duvoisin, R., The metabotropic glutamate receptors: Structure and functions (1995) Neuropharmacology, 34, pp. 1-26; 
Pinna, A., Fenu, S., Morelli, M., Motor stimulant effects of the adenosine A(2A) receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats (2001) Synapse, 39, pp. 233-238; 
Pinna, A., Wardas, J., Cozzolino, A., Morelli, M., Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol (1999) Neuropsychopharmacology, 20, pp. 44-51; 
Pinna, A., Wardas, J., Cristalli, G., Morelli, M., Adenosine A2A receptor agonists increase Fos-like immunoreactivity in mesolimbic areas (1997) Brain Res, 759, pp. 41-49; 
Phonphok, Y., Rosenthal, K.S., Stabilization of clathrin vesicles by amantadine, tromantadine and other hydrophobic amines (1991) FEBS Lett, 281, pp. 188-190; 
Poleszak, E., Malec, D., Influence of adenosine receptor agonists and antagonists on amphetamine-induced stereotypy in rats (2000) Pol J Pharmacol Pharm, 52, pp. 423-429; 
Pollack, A.E., Fink, J.S., Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway (1995) Neuroscience, 68, pp. 721-728; 
Popoli, P., Caporali, M.G., Scotti de Carolis, A., Akinesia due to catecholamine depletion in mice is prevented by caffeine. Further evidence for an involvement of adenosinergic system in the control of motility (1991) J Pharm Pharmacol, 43, pp. 280-281; 
Popoli, P., Pezzola, A., Scotti de Carolis, A.S., Modulation of striatal adenosine A1 and A2 receptors induces rotational behaviour in response to dopaminergic stimulation in intact rats (1994) Eur J Pharmacol, 257, pp. 21-25; 
Popoli, P., Pezzola, A., Torvinen, M., Reggio, R., Pintor, A., Scarchilli, L., Fuxe, K., Ferré, S., The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: Interactions with adenosine A(2a) receptors (2001) Neuropsychopharmacology, 25, pp. 505-513; 
Popoli, P., Reggio, R., Pezzola, A., Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake (2000) Neuropsychopharmacology, 22, pp. 522-529; 
Quijano V.J., Jr., Sheffield, L.G., Prolactin decreases epidermal growth factor receptor kinase activity via a phosphorylation-dependent mechanism (1998) J Biol Chem, 273, pp. 1200-1207; 
Richardson, P.J., Kase, H., Jenner, Adenosine A2A receptor antagonists as new agents for the treatment of Parkinson's disease (1997) Trends Pharmacol Sci, 18, pp. 338-344; 
Rimondini, R., Ferre, S., Ogren, S.O., Fuxe, K., Adenosine A2A agonists: A potential new type of atypical antipsychotic (1997) Neuropsychopharmacology, 17, pp. 82-91; 
Rimondini, R., Ferre, S., Gimenez-Llort, L., Ogren, S.O., Fuxe, K., Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats (1998) Eur J Pharmacol, 347, pp. 153-158; 
Rimondini, R., Fuxe, K., Ferré, S., Multiple intramembrane receptor/receptor interactions in the regulation of striatal dopamine D2 receptors (1999) Neuroreport, 10, pp. 2051-2054; 
Robertson, G.S., Fibiger, H.C., Neuroleptics increase c-fos expression in the forebrain: Contrasting effects of haloperidol and clozapine (1992) Neuroscience, 46, pp. 315-328; 
Robertson, G.S., Jian, M., D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain (1995) Neuroscience, 64, pp. 1019-1034; 
Robinsson, S.W., Caron, M.G., Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor (1997) Mol PharmacoI, 52, pp. 508-514; 
Rocheville, M., Lange, D.C., Kumar, U., Patel, S.C., Patel, R.C., Patel, Y.C., Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity (2000) Science (Wash DC), 288, pp. 154-157; 
Rocheville, M., Lange, D.C., Kumar, U., Sasi, R., Patel, R.C., Patel, Y.C., Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers (2000) J Biol Chem, 275, pp. 7862-7869; 
Rodriguez-Sanchez, M.N., Puebla, L., Lopez-Samudo, S., Rodriguez-Martin, E., Marti-Espinosa, A., Rodriguez-Pena, M.S., Juarranz, M.G., Arilla, E., Dopamine enhances somatostatin receptor-mediated inhibition of adenylate cyclase in rat striatum and hippocampus (1997) J Neurosci Res, 47, pp. 238-248; 
Romano, C., Yang, W.L., O'Malley, K.L., Metabotropic glutamate receptor 5 is a disulfide-linked dimer (1996) J Biol Chem, 271, pp. 28612-28616; 
Rosin, D.L., Robeva, A., Woodard, R.L., Guyenet, P.G., Linden, J., Immunohistochemical localization of adenosine A2A receptors in the rat central nervous system (1998) J Comp Neurol, 401, pp. 163-186; 
Rostene, W.H., Fischette, C.T., McEwen, B.S., Modulation by VIP of serotonin receptors in membranes from rat hippocampus (1983) J Neurosci, 3, pp. 2414-2419; 
Rostene, W.H., Fischette, C.T., Rainbow, T.C., McEwen, B.S., Modulation by VIP of serotonin receptors in the dorsal hippocampus of the rat brain: An autoradiographic study (1983) Neurosci Lett, 37, pp. 143-148; 
Rothmann, R.B., Long, J.B., Bykov, V., Jacobson, A.E., Rice, K.C., Holaday, J.W., Beta-FNA binds irreversibly to the opiate receptor complex: In vivo and in vitro evidence (1988) J Pharmacol Exp Ther, 247, pp. 405-416; 
Ruiz, M.A., Escriche, M., Lluis, C., Franco, R., Martin, M., Andres, A., Ros, M., Adenosine A1 receptor in cultured neurons from reat cerebral cortex: Colocalization with adenosine, deaminase (2000) J Neurochem, 75, pp. 656-664; 
Salim, H., Ferré, S., Dalal, A., Peterfreund, R.A., Fuxe, K., Vincent, J.D., Lledo, P.M., Activation of adenosine A1 and A2A receptors modulates dopamine D2 receptor-induced responses in stably transfected human neuroblastoma cells (2000) J Neurochem, 74, pp. 432-439; 
Sarrió, S., Casadó, V., Escriche, M., Ciruela, F., Mallol, J., Canela, E.I., Lluís, C., Franco, R., The heat shock cognate protein hsc73 assembles with A1 adenosine receptors to form functional modules in the cell membrane (2000) Mol Cell Biol, 20, pp. 5164-5174; 
Saura, C., Ciruela, F., Casadó, V., Canela, E.I., Mallol, J., Lluís, C., Franco, R., Adenosine deaminase interacts with A1 adenosine receptors in pig brain cortical membranes (1996) J Neurochem, 66, pp. 1675-1682; 
Saura, C., Mallol, J., Canela, E.I., Lluis, C., Franco, R., Adenosine deaminase and A1 adenosine receptors internalize together following agonist-induced receptor desensitization (1998) J Biol Chem, 27, pp. 17610-17617; 
Scarselli, M., Novi, F., Schallmach, E., Lin, R., Baragli, A., Colzi, A., Griffon, N., Levenson, R., D2/D3 dopamine receptor heterodimers exhibit unique functional properties (2001) J Biol Chem, 276, pp. 30308-30314; 
Schiffmann, S.N., Jacobs, O., Vanderhaeghen, J.-J., Striatal restricted adenosine A2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: An in situ hybridization histochemistry study (1991) J Neurochem, 57, pp. 1062-1067; 
Schiffmann, S.N., Vanderhaeghen, J.J., Adenosine A2 receptors regulate the gene expression of striatopallidal and striatonigral neurons (1993) J Neurosci, 13, pp. 1080-1087; 
Schlessinger, J., Signal transduction by allosteric receptor oligomerization (1988) Trends Biochem Sci, 13, pp. 443-447; 
Schlessinger, J., Cell signaling by receptor tyrosine kinases (2000) Cell, 103, pp. 211-225; 
Schoffelmeer, A.N., Yao, Y.H., Gioannini, T.L., Hiller, J.M., Ofri, D., Roques, B.P., Simon, E.J., Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membrane: Biochemical evidence for the existence of a mu/delta opioid receptor complex (1990) J Pharmacol Exp Ther, 253, pp. 419-426; 
Schulte, G., Fredholm, B.B., Human adenosine A(1), A(2A), A(2B) and A(3) receptors expressed in Chinese hamster ovary cells mediate the phosphorylation of extracellular-regulated kinase (2000) Mol Pharmacol, 58, pp. 477-482; 
Schulz, A., Grosse, R., Schultz, G., Gudermann, T., Schoneberg, T., Structural implications for receptor oligomerization from functional reconstitution studies of mutant V2 vasopressin receptors (2000) J Biol Chem, 275, pp. 2381-2389; 
Seeman, P., Niznik, H.B., Guan, H.C., Booth, G., Ulpian, C., Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain (1989) Proc Natl Acad Sci USA, 86, pp. 10156-10160; 
Sheng, M., Kim, E., The Shank family of scaffold proteins (2000) J Cell Sci, 113, pp. 1851-1856; 
Shigemoto, R., Nomura, S., Ohishi, H., Sugihara, H., Nakanishi, S., Mizuno, N., Immunohistochemical localization ofa metabotropic glutamate receptor, mGluR5, in the rat brain (1993) Neurosci Lett, 163, pp. 53-57; 
Shiozaki, S., Ichikawa, S., Nakamura, J., Kitamura, S., Yamada, K., Kuwana, Y., Actions of adenosine A2A receptor antagonist KW-6002 on drug-induced catalepsy and hypokinesia caused by reserpine or MPTP (1999) Psychopharmacology, 147, pp. 90-95; 
Sills, T.L., Azampanah, A., Fletcher, P.J., The adenosine A2A agonist CGS 21680 reverses the reduction in prepulse inhibition of the acoustic startle response induced by phencyclidine, but not by apomorphine and amphetamine (2001) Psychopharmacology, 156, pp. 187-193; 
Smith, Y., Charara, A., Hanson, J.E., Paquet, M., Levey, A.I., GABA(B) and group I metabotropic glutamate receptors in the striatopallidal complex in primates (2000) J Anat, 196, pp. 555-576; 
Snaprud, P., Gerwins, P., Caron, M.G., Libert, F., Persson, H., Fredholm, B.B., Fuxe, K., A2A/D2 receptor interactions are not observed in COS-7 cells transiently transfected with dopamine and adenosine A2A receptor cDNA (1994) Biochem Pharmacol, 48, pp. 2043-2047; 
Snyder, S.H., Adenosine as a neuromodulator (1985) Ann Rev Neurosci, 8, pp. 103-124; 
Strömberg, I., Popoli, P., Muller, C.E., Ferré, S., Fuxe, K., Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum (2000) Eur J Neurosci, 12, pp. 4033-4037; 
Sung, K.W., Choi, S., Lovinger, D.M., Activation ofgroup I mGluRs is necessary for induction of long-term depression at striatal synapses (2001) J Neurophysiol, 86, pp. 2405-2412; 
Svenningsson, P., Fourreau, L., Bloch, B., Fredholm, B.B., Gonon, F., Le Moine, C., Opposite tonic modulation of dopamine and adenosine on c-fos gene expression in striatopallidal neurons (1999) Neuroscience, 89, pp. 827-837; 
Svenningsson, P., Le Moine, C., Fisone, G., Fredholm, B.B., Distribution, biochemistry and function of striatal adenosine A2A receptors (1999) Prog Neurobiol (Oxford), 59, pp. 355-396; 
Svenningsson, P., Le Moine, C., Kull, B., Sunahara, R., Bloch, B., Fredholm, B.B., Cellular expression of adenosine A2A receptor messenger RNA in the rat central nervous system with special reference to dopamine innervated areas (1997) Neuroscience, 80, pp. 1171-1185; 
Svenningsson, P., Lindskog, M., Ledent, C., Parmentier, M., Greengard, P., Fredholm, B.B., Fisone, G., Regulation of the phosphorylation of the dopamine- and cAMP-regulated phosphoprotein of 32 kDa in vivo by dopamine D1 dopamine D2, and adenosine A2A receptors (2000) Proc Natl Acad Sci USA, 97, pp. 1856-1860; 
Svenningsson, P., Lindskog, M., Rognoni, F., Fredholm, B.B., Greengard, P., Fisone, G., Activation of adenosine A2A and dopamine D1 receptors stimulates cyclic AMP-dependent phosphorylation of DARPP-32 in distinct populations of striatal projection neurons (1998) Neuroscience, 84, pp. 223-228; 
Sweatt, J.D., The neuronal MAP kinase cascade: A biochemical signal integration system subserving synaptic plasticity and memory (2001) J Neurochem, 76, pp. 1-10; 
Tallaksen-Greene, S.J., Kaatz, K.W., Romano, C., Albin, R.L., Localization of mGluR1α-like immunoreactiv¡ty and mGlur5-like immunoreactivity in identified populations of striatal neurons (1998) Brain Res, 780, pp. 210-217; 
Tallman, J., Dimerization of G-protein-coupled receptors: Implications for drug design and signaling (2000) Neuropsychopharmacology, 23, pp. S1-S2; 
Tanganelli, S., Fuxe, K., Antonelli, T., O'Connor, W.T., Ferraro, L., Cholecystokinin/dopamine/GABA interactions in the nucleus accumbens: Biochemical and functional correlates (2001) Peptides, 22, pp. 1229-1234; 
Tanganelli, S., Fuxe, K., Von Euler, G., Agnati, L.F., Ferraro, L., Ungerstedt, U., Involvement of cholecystokinin in the control of striatal dopamine autoreceptors (1990) Naunyn-Schmiedeberg's Arch Pharmacol, 342, pp. 300-304; 
Tanganelli, S., Li, X.-M., Ferraro, L., Von Euler, G., O'Connor, W.T., Bianchi, C., Beani, L., Fuxe, K., Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum (1993) Eur J Pharmacol, 230, pp. 159-166; 
Tanganelli, S., Von Euler, G., Fuxe, K., Agnati, L.F., Ungerstedt, U., Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum (1989) Brain Res, 502, pp. 319-324; 
Testa, C.M., Standaert, D.G., Landwehrmeyer, G.B., Penney, J.B., Young, A.B., Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons (1995) J Comp Neurol, 354, pp. 241-252; 
Testa, C.M., Standaert, D.G., Young, A.B., Penney, J.B., Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat (1994) J Neurosci, 14, pp. 3005-3018; 
Torvinen, M., Ginés, S., Hillion, J., Latini, S., Canals, M., Ciruela, F., Bordoni, F., Agnati, L.F., Interactions among adenosine deaminase, adenosine A1 receptors and dopamine D1 receptors in stably cotransfected fibroblast cells and neurons (2002) Neuroscience, 113, pp. 709-719; 
Torvinen, M., Liu, Y., Kozell, L.B., Neve, K.A., Ferré, S., Ibañez, C., Fuxe, K., Dopamine D2 receptor domains involved in the intramembrane interaction between adenosine A2A and dopamine D2 receptors (2001) Soc Neurosci Abstr, 27, p. 3793; 
Tu, J.C., Xiao, B., Naisbitt, S., Yuan, J.P., Petralia, R.S., Brakeman, P., Doan, A., Sheng, M., Coupling of mGluR/Homer and PSD-95 complexes by the shank family of postsynaptic density proteins (1999) Neuron, 23, pp. 583-592; 
Tu, J.C., Xiao, B., Yuan, J.P., Lanahan, A.A., Leoffert, K., Li, M., Linden, D.J., Worley, P.F., Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors (1998) Neuron, 21, pp. 717-726; 
Ungerstedt, U., Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system (1971) Acta Physiol Scand Suppl, 367, pp. 69-93; 
Uslaner, J., Badiani, A., Norton, C.S., Day, H.E., Watson, S.J., Akil, H., Robinson, T.E., Amphetamine and cocaine induce different patterns of c-fos mRNA expression in the striatum and subthalamic nucleus depending on environmental context (2001) Eur J Neurosci, 13, pp. 1977-1983; 
Vanhoutte, P., Barnier, J.V., Guibert, B., Pages, C., Besson, M.J., Hipskind, R.A., Caboche, J., Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices (1999) Mol Cell Biol, 19, pp. 136-146; 
Venter, J.C., Fraser, C.M., Beta-adrenergic receptor isolation and characterization with immobilized drugs and monoclonal antibodies (1983) Fed Proc, 42, pp. 273-278; 
Von Euler, G., Biochemical characterization of the intramembrane interaction between neurotensin and dopamine D2 receptors in the rat brain (1991) Brain Res, 561, pp. 93-99; 
Von Euler, G., Fuxe, K., Neurotensin reduces the affinity of D2 dopamine receptors in rat striatal membranes (1987) Acta Physiol Scand, 131, pp. 525-526; 
Von Euler, G., Fuxe, K., Ploeg van der, I., Fredholm, B., Agnati, L., Pertussis toxin treatment counteracts intramembrane interactions between neuropeptide Y receptors and α2-adrenoceptors (1989) Eur J Pharmacol, 172, pp. 435-441; 
Von Euler, G., Van der Ploeg, I., Fredholm, B.B., Fuxe, K., Neurotensin decreases the affinity of dopamine D2 agonist binding by a G protein-independent mechanism (1991) J Neurochem, 56, pp. 178-183; 
Wang, J.Q., McGinty, J.F., The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: Regulation of D1/D2 interactions by muscarinic receptors (1997) J Pharmacol Exp Ther, 281, pp. 972-982; 
Wang, Y.T., (2002) Dopamine D5/GABA-A Heteromerization - A Mechanism to Regulate Synaptic Weight, , Collegium Internationale Neuro-Psychopharmacologicum 2002, June 23-27; Abstract, ref nr: 901, Animula Publishing House, Budapest, Hungary; 
Ward, R.P., Dorsa, D.M., Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration (1999) Neuroscience, 89, pp. 927-938; 
Wardas, J., Konieczny, J., Lorenc-Koci, E., SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats (2001) Synapse, 41, pp. 160-171; 
Weng, G., Bhalla, U.S., Iyengar, R., Complexity in biological signalling systems (1999) Science (Wash DC), 284, pp. 92-96; 
White, J.H., Wise, A., Main, M.J., Green, A., Fraser, N.J., Disney, G.H., Barnes, A.A., Marshall, F.H., Heterodimerization is required for the formation of a functional GABA(B) receptor (1998) Nature (Lond), 396, pp. 679-682; 
Williams, G.V., Goldman-Rakic, P.S., Modulation of memory fields by dopamine D1 receptors in prefrontal cortex (1995) Nature (Lond), 376, pp. 572-575; 
Wirkner, K., Assmann, H., Koles, L., Gerevich, Z., Franke, H., Norenberg, W., Boehm, R., Illes, P., Inhibition by adenosine A(2A) receptors of NMDA but not AMPA currents in rat neostriatal neurons (2000) Br J Pharmacol, 130, pp. 259-269; 
Wrighton, N.C., Farrell, F.X., Chang, R., Kashvap, A.K., Barbone, F.P., Mulcahy, L.S., Johnson, D.L., Dower, W.J., Small peptides as potent mimetics of the protein hormone erythropoietin (1996) Science (Wash DC), 273, pp. 458-463; 
Wu, G.Y., Deisseroth, K., Tsien, R.W., Activity-dependent CREB phosphorylation: Convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway (2001) Proc Natl Acad Sci USA, 98, pp. 2808-2813; 
Xiao, B., Tu, J.C., Worley, P.F., Homer: A link between neural activity and glutamate receptor function (2000) Curr Opin Neurobiol, 10, pp. 370-374; 
Xie, Z., Lee, S.P., O'Dowd, B.F., George, S.R., Serotonin 5-HT1B and 5-HT1D receptors from homodimers when expressed alone and heterodimers when coexpressed (1999) FEBS Lett, 456, pp. 63-67; 
Yamauchi, T., Ueki, K., Tobe, K., Tamemoto, H., Sekine, N., Wada, M., Honjo, M., Hirai, T., Tyrosine phosphorylation of the EGF receptor by the kinase Jak2 is induced by growth hormone (1997) Nature (Lond), 390, pp. 91-96; 
Yan, Z., Feng, J., Fienberg, A.A., Greengard, P., D2 dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons (1999) Proc Natl Acad Sci USA, 96, pp. 11607-11612; 
Yang, S.-N., Dasgupta, S., Lledo, P.-M., Vincent, J.-D., Fuxe, K., Reduction of dopamine D2 receptor transduction by activation of adenosine A2a receptors in stably A2a/D2 (long-form) receptor co-transfected mouse fibroblast cell lines: Studies on intracellular calcium levels (1995) Neuroscience, 68, pp. 729-736; 
Yang, S.-N., Finnman, U.-B., Fuxe, K., The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31,Pro34]neuropeptide Y-induced modulation of a2-adrenoceptors in the nucleus tractus solitarii of the rat (1996) Neuroreport, 7, pp. 2701-2705; 
Yang, S.-N., Fior, D., Hedlund, P., Agnati, L.F., Fuxe, K., Selective modulation of the NPY receptors of the Y2 subtype by a2 receptors in the nucleus tractus solitarii of the rat. A cardiovascular and quantitative receptor autoradiographical analysis (1994) Brain Res, 654, pp. 137-144; 
Yang, S.-N., Fior, D., Hedlund, P.B., Agnati, L.F., Fuxe, K., Antagonistic egulation of α2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus, solitarii (1994) Eur J Pharmacol, 271, pp. 201-212; 
Yoshioka, K., Saitoh, O., Nakata, H., Heteromeric association creates a P2Y-like adenosine receptor (2001) Proc Natl Acad Sci USA, 98, pp. 7617-7622; 
Yung, K.K., Bolam, J.P., Smith, A.D., Hersch, S.M., Ciliax, B.J., Levey, A.I., Immunocytochemical localization of D1 and D2 dopamine receptors in the basal ganglia of the rat: Light and electron microscopy (1995) Neuroscience, 65, pp. 709-730; 
Zahniser, N.R., Simosky, J.K., Mayfield, R.D., Negri, C.A., Hanania, T., Larson, G.A., Kelly, M.A., Low, M.J., Functional uncoupling of adenosine A(2A) receptors and reduced response to caffeine in mice lacking dopamine D2 receptors (2000) J Neurosci, 20, pp. 5949-5957; 
Zarbin, M.A., Wamsley, J.K., Kuhar, M.J., Axonal tansport of muscarinic cholinergic receptors in rat vagus nerve: High and low affinity agonist receptors move in opposite directions and differ in nucleotide sensitivity (1982) J Neurosci, 2, pp. 934-941; 
Zawarynski, P., Tallerico, T., Seeman, P., Lee, S.P., O'Dowd, B.F., George, S.R., Dopamine D2 receptor dimers in human and rat brain (1998) FEBS Lett, 441, pp. 383-386; 
Zeng, E.Y., Pearce, R.K., MacKenzie, G.M., Jenner, P., Alterations in preproenkephalin and adenosine-2a receptor mRNA, but not preprotachykinin mRNA correlate with occurence of dyskinesia in normal monkeys chronically treated with L-DOPA (2000) Eur J Neurosci, 12, pp. 1096-1104; 
Zoli, M., Agnati, L.F., Hedlund, P.B., Li, X.M., Ferré, S., Fuxe, K., Receptor/receptor interactions as an integrative mechanism in nerve cells (1993) Mol Neurobiol, 7, pp. 293-334; 
Zoli, M., Guidolin, D., Fuxe, K., Agnati, L., The receptor mosaic hypothesis of the engram: Possible relevance of Boolean network modeling (1996) Int J Neural Syst, 7, pp. 363-368
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0042467972&doi=10.1124%2fpr.55.3.2&partnerID=40&md5=99a6606a33d810869efc18e463a2716b
ER  - 

TY  - JOUR
TI  - Self-report vs. laboratory measures of aggression as predictors of substance abuse
T2  - Drug and Alcohol Dependence
J2  - Drug Alcohol Depend.
VL  - 25
IS  - 1
SP  - 1
EP  - 11
PY  - 1990
DO  - 10.1016/0376-8716(90)90133-Y
SN  - 03768716 (ISSN) 
AU  - Muntaner, C.
AU  - Walter, D.
AU  - Nagoshi, C.
AU  - Fishbein, D.
AU  - Haertzen, C.A.
AU  - Jaffe, J.H.
AD  - National Institute on Drug Abuse Addiction Research, Center, P.O. Box 5180, Baltimore, MD 21224, United States
AB  - Measures of aggressive behavior, antisocial personality, criminality, and impulsivity were obtained on a sample of 85 drug abusing volunteers for studies at the Addiction Research Center in Baltimore. Measures included the Buss-Durkee Hostility Inventory, Diagnostic Interview Schedule Antisocial Personality Disorder diagnosis, Elliott-Huizinga Lifetime Events Scale, Eysenck's Impulsiveness-Venturesomeness-Empathy scales, and a laboratory measure of aggression patterned after the Buss 'aggression machine'. All of the self-report measures of aggression and antisocial personality were moderately correlated with each other, but did not correlate with the laboratory aggression measure. This laboratory measure, nevertheless, made a significant contribution to the prediction of certain substance abuse diagnoses over and above the contributions of the other measures. © 1990.
KW  - cocaine
KW  - laboratory agression
KW  - marijuana
KW  - opioids
KW  - personality
KW  - substance abuse
KW  - adult
KW  - aggression
KW  - antisocial behavior
KW  - article
KW  - criminal behavior
KW  - drug abuse
KW  - human
KW  - impulsiveness
KW  - major clinical study
KW  - personality
KW  - priority journal
KW  - psychological aspect
KW  - Adult
KW  - Aggression
KW  - Antisocial Personality Disorder
KW  - Female
KW  - Hostility
KW  - Human
KW  - Impulsive Behavior
KW  - Male
KW  - Personality Tests
KW  - Psychometrics
KW  - Substance-Related Disorders
KW  - Cannabis sativa
N1  - Cited By :17
N1  - Export Date: 13 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: DADED
C2  - 2323302
LA  - English
N1  - Correspondence Address: Muntaner, C.; National Institute on Drug Abuse Addiction Research, Center, P.O. Box 5180, Baltimore, MD 21224, United States
N1  - References: Allen, Frances, Varieties of psychopathology found in patients with addictive disorders: a review (1986) Psychopathology and Addictive Disorders, , R.E. Meyer, Guilford; 
Rounsaville, Kleber, Psychiatric disorders in opiate addicts: preliminary findings on the course and interaction with program type (1986) Psychopathology and Addictive Disorders, , R.E. Meyer; 
Nurco, (1985) J. Nerv. Ment. Dis., 173, p. 94; 
Alterman, Tarter, (1981) J. Nerv. Ment. Dis., 171, p. 147; 
Block, Block, Keyes, (1988) Child Dev., 59, p. 336; 
Kellam, Brown, Fleming, (1982) NIDA Res. Monograph, 41, p. 21; 
Labouvie, McGee, (1986) J. Consult. Clin. Psychol., 54, p. 289; 
Cherek, (1981) Psychopharmacology, 75, p. 339; 
Cherek, Steinberg, Brauchi, (1983) Psychiatr. Res., 8, p. 137; 
Cherek, (1986) Psychopharmacology, 88, p. 381; 
Pihl, Zacchia, (1986) Aggress. Behav., 12, p. 367; 
Taylor, Leonard, Alcohol and physical aggression (1983) Aggression: Theoretical and Empirical Reviews, 2. , third edition, R.G. Geen, E.I. Donnerstein, Academic Press; 
Peele, (1987) J. Stud. Alcohol, 48, p. 61; 
APA, (1980) Diagnostic and Statistical Manual of Mental Disorders, , third edition, American Psychiatric Association; 
Buss, (1961) The Psychology of Aggression, , Wiley; 
Baron, (1977) Human Aggression, , Plenum; 
Berkowitz, Cochran, Embree, (1981) J. Pers. Soc. Psychol., 40, p. 687; 
Zillmann, (1979) Hostility and Aggression, , Erlbaum; 
Buss, Durkee, (1957) J. Consult. Psychol., 21, p. 343; 
Taylor, (1967) J. Pers., 35, p. 297; 
Cleckley, (1976) The Mask of Sanity, , Mosby; 
Hare, Twenty years of experience with the Cleckley psychopath (1986) Unmasking the Psychopath: Antisocial Personality and Related Syndromes, , W.H. Reid et al., W.W. Norton; 
Hare, (1985) J. Consult. Clin. Psychol., 53, p. 7; 
Hare, (1983) Am. J. Psychiatry, 140, p. 877; 
Millon, (1981) Disorders of Personality: DSM-III, Axis II, , Wiley; 
Berkowitz, The experience of anger as a parallel process in the display of impulsive, “angry” aggression (1983) Aggression: Theoretical and Empirical Review, , R.G. Geen, E. Donnerstein, Academic; 
Wilson, Herrnstein, Crime and Human Nature (1985) Touchstone; 
Ellis, (1987) Pers. Indiv. Diff., 8, p. 905; 
Elliott, Huizinga, The relationship between delinquent behavior and ADM problem behaviors (1984) Paper prepared for the ADAMHA/OJJDP State of the Art Research Conference on Juvenile Offenders with Serious Drug/Alcohol and Mental Health Problems, , April 17–18, Bethesda, Maryland; 
Eysenck, Levels of personality (1985) Personality and Individual Differences, 5, p. 613; 
Wright, Mischel, (1987) J. Pers. Soc. Psychol., 53, p. 1159; 
Shipley, (1940) Shipley-Hartford Retreat Scale: Manual, , Neuropsychiatric Institute, Hartford Retreat; 
Derogatis, Lipman, Covi, (1973) Psychopharmacol. Bull., 9, p. 13; 
Robins, NIMH Diagnostic Interview Schedule: Version III (1981) Public Health Service (HHS) M-T-42-3:5, 81; 
Hollingshead, Redlich, (1958) Social Class and Mental Illness: A Community Study, , John Wiley; 
Sutker, Allain, (1988) J. Consult. Clin. Psychol., 56, p. 172; 
Eysenck, Learning, memory, and personality (1981) A Model for Personality, , H.J. Eysenck, Springer-Verlag; 
Kaplan, The measurement of human aggression (1984) Aggression in Children and Youth, , R.M. Kaplan, V.J. Konecni, R.W. Novaco, Martinus Nijhoff; 
Edmunds, Kendrick, (1980) The Measurement of Human Aggression, , Ellis Horwood; 
Buss, Craik, (1983) Psychol. Rev., 90, p. 105; 
Gottheil, (1983) Alcohol, Drug Abuse and Aggression, , Charles C. Thomas
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-0025265093&doi=10.1016%2f0376-8716%2890%2990133-Y&partnerID=40&md5=6a329744c0c0a840e401e554e4c0f874
ER  - 

